PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Denyer, S; Bhimani, AD; Papastefan, S; Kheirkhah, P; Aguilar, T; Zakrzewski, J; Rosinski, CL; Patel, AS; Patel, S; Zakrzewski, V; Seksenyan, A; Prins, GS; Mehta, AI				Denyer, Steven; Bhimani, Abhiraj D.; Papastefan, Steven; Kheirkhah, Pouyan; Aguilar, Tania; Zakrzewski, Jack; Rosinski, Clayton L.; Patel, Akash S.; Patel, Saavan; Zakrzewski, Victoria; Seksenyan, Akop; Prins, Gail S.; Mehta, Ankit I.			Magnetic kyphoplasty: A novel drug delivery system for the spinal column	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; NANOPARTICLES; POLYMERS; THERAPY; DESIGN	Vertebral compression fractures (VCFs) caused by metastatic malignancies or osteoporosis are devastating injuries with debilitating outcomes for patients. Minimally invasive kyphoplasty is a common procedure used for symptomatic amelioration. However, it fails in treating the underlying etiologies of VCFs. Use of systemic therapy is limited due to low perfusion to the spinal column and systemic toxicity. Localized delivery of drugs to the vertebral column can provide a promising alternative approach. A porcine kyphoplasty model was developed to study the magnetically guided drug delivery of systemically injected magnetic nanoparticles (MNPs). Jamshidi cannulated pedicle needles were placed into the thoracic vertebra and, following inflatable bone tamp expansion, magnetic bone cement was injected to the vertebral body. Histological analysis was performed after intravenous injection of MNPs. Qualitative analysis of harvested tissues revealed successful placement of magnetic cement into the vertebral body. Further quantitative analysis of histological sections of several vertebral bodies demonstrated enhanced accumulation of MNPs to regions that had magnetic cement injected during kyphoplasty compared to those that did not. By modifying the kyphoplasty bone cement to include magnets, thereby providing a guidance stimulus and a localizer, we were successfully able to guide intravenously injected magnetic nanoparticles to the thoracic vertebra. These results demonstrate an in-vivo proof of concept of a novel drug delivery strategy that has the potential to treat the underlying causes of VCFs, in addition to providing symptomatic support.	[Denyer, Steven; Bhimani, Abhiraj D.; Papastefan, Steven; Kheirkhah, Pouyan; Aguilar, Tania; Zakrzewski, Jack; Rosinski, Clayton L.; Patel, Akash S.; Patel, Saavan; Zakrzewski, Victoria; Seksenyan, Akop; Mehta, Ankit I.] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA; [Seksenyan, Akop] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA; [Prins, Gail S.] Univ Illinois, Dept Urol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rosalind Franklin University Medical & Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, AI (corresponding author), Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.	ankitm@uic.edu	Mehta, Ankit/AAL-3851-2020	Papastefan, Steven/0000-0002-6576-1631; Zakrzewski, Jack/0000-0002-9824-8148; Denyer, Steven/0000-0001-5631-8788	University of Illinois at Chicago Department of Neurosurgery; NATIONAL CANCER INSTITUTE [R01CA172220] Funding Source: NIH RePORTER	University of Illinois at Chicago Department of Neurosurgery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by University of Illinois at Chicago Department of Neurosurgery.	Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110904; Dayyani N, 2015, EUR J MED CHEM, V98, P190, DOI 10.1016/j.ejmech.2015.05.028; Gholibegloo E, 2018, J PHOTOCH PHOTOBIO B, V181, P14, DOI 10.1016/j.jphotobiol.2018.02.004; Huang YP, 2017, MAT SCI ENG C-MATER, V70, P763, DOI 10.1016/j.msec.2016.09.052; Katonis P, 2013, CLIN MED INSIGHTS-ON, V7, P199, DOI 10.4137/CMO.S10099; Kudr J, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7090243; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; Lueshen E, 2014, NANOMEDICINE-UK, V9, P1155, DOI [10.2217/NNM.13.69, 10.2217/nnm.13.69]; Malekzadeh AM, 2017, J COLLOID INTERF SCI, V490, P64, DOI 10.1016/j.jcis.2016.11.014; Mathis JM, 2001, AM J NEURORADIOL, V22, P373; Mir M, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2249-8; Prasad Mandava, 2016, J Clin Exp Dent, V8, pe164, DOI 10.4317/jced.52352; Rezaei SJT, 2018, APPL ORGANOMET CHEM, V32, DOI 10.1002/aoc.4303; Sadr SH, 2018, J DRUG DELIV SCI TEC, V45, P240, DOI 10.1016/j.jddst.2018.03.019; Sadr SH, 2018, J BIOMAT SCI-POLYM E, V29, P277, DOI 10.1080/09205063.2017.1414482; Stadelmann VA, 2008, EUR CELLS MATER, V16, P10, DOI 10.22203/eCM.v016a02; Tarasi R, 2016, J MAGN MAGN MATER, V417, P451, DOI 10.1016/j.jmmm.2016.05.080; Venugopal I, 2017, NANOMEDICINE-UK, V12, P865, DOI 10.2217/nnm-2016-0418; Watts N B, 2001, Neurosurg Focus, V10, pE12; Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031; Yamashita S, 2018, BIOMATERIALS, V154, P74, DOI 10.1016/j.biomaterials.2017.10.053	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201402	10.1371/journal.pone.0201402	http://dx.doi.org/10.1371/journal.pone.0201402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052650	Green Published, Green Submitted, gold			2022-12-26	WOS:000440006600041
J	Eavarone, DA; Al-Alem, L; Lugovskoy, A; Prendergast, JM; Nazer, RI; Stein, JN; Dransfield, DT; Behrens, J; Rueda, BR				Eavarone, David A.; Al-Alem, Linah; Lugovskoy, Alexey; Prendergast, Jillian M.; Nazer, Rawan I.; Stein, Jenna N.; Dransfield, Daniel T.; Behrens, Jeff; Rueda, Bo R.			Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma	PLOS ONE			English	Article							POTENT ANTITUMOR-ACTIVITY; METASTATIC BREAST-CANCER; DRUG CONJUGATE; PRECLINICAL DEVELOPMENT; KLH VACCINE; GLYCOSYLATION; PHARMACOKINETICS; SPECIFICITY; EXPRESSION; PREVENTION	The expression of Sialyl-Tn (STn) in tumors is associated with metastatic disease, poor prognosis, and reduced overall survival. STn is expressed on ovarian cancer biomarkers including CA-125 (MUC16) and MUC1, and elevated serum levels of STn in ovarian cancer patients correlate with lower five-year survival rates. In the current study, we humanized novel anti-STn antibodies and demonstrated the retention of nanomolar (nM) target affinity while maintaining STn antigen selectivity. STn antibodies conjugated to Monomethyl Auristatin E (MMAE-ADCs) demonstrated in vitro cytotoxicity specific to STn-expressing ovarian cancer cell lines and tumor growth inhibition in vivo with both ovarian cancer cell line- and patient-derived xenograft models. We further validated the clinical potential of these STn-ADCs through tissue cross-reactivity and cynomolgus monkey toxicity studies. No membrane staining for STn was present in any organs of human or cynomolgus monkey origin, and the toxicity profile was favorable and only revealed MMAE-class associated events with none being attributed to the targeting of STn. The up-regulation of STn in ovarian carcinoma in combination with high affinity and STn-specific selectivity of the mAbs presented herein warrant further investigation for anti-STn antibody-drug conjugates in the clinical setting.	[Eavarone, David A.; Prendergast, Jillian M.; Nazer, Rawan I.; Stein, Jenna N.; Dransfield, Daniel T.; Behrens, Jeff] Siamab Therapeut Inc, Newton, MA 02458 USA; [Al-Alem, Linah; Rueda, Bo R.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Al-Alem, Linah; Rueda, Bo R.] Harvard Med Sch, Boston, MA USA; [Lugovskoy, Alexey] Morph Therapeut, Waltham, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Eavarone, DA (corresponding author), Siamab Therapeut Inc, Newton, MA 02458 USA.	david@siamab.com		Prendergast, Jillian/0000-0001-7965-4143	SBIR [HHSN261201600042C]; Advanced Medical Research Foundation; Siamab Therapeutics, Inc.	SBIR; Advanced Medical Research Foundation; Siamab Therapeutics, Inc.	This work was supported by SBIR Contract #HHSN261201600042C: DAE, JMP, RIN, DTD; Advanced Medical Research Foundation: BRR, LA. Siamab Therapeutics, Inc. provided support in the form of salaries or compensation for authors [DAE, AL, JMP, RIN, JNS, DTD, JB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akita K, 2012, INT J GYNECOL CANCER, V22, P531, DOI 10.1097/IGC.0b013e3182473292; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Challita-Eid PM, 2016, CANCER RES, V76, P3003, DOI 10.1158/0008-5472.CAN-15-1313; Chen KW, 2013, J PROTEOME RES, V12, P1408, DOI 10.1021/pr3010474; Christon M.A., 2013, P 15 INT TOP M NUCL, P1, DOI [10.1002/pmic.201300387.This, DOI 10.1002/PMIC.201300387.THIS]; CO MS, 1991, NATURE, V351, P501, DOI 10.1038/351501a0; Cont NT, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.584; Cotton S, 2017, MOL ONCOL, V11, P895, DOI 10.1002/1878-0261.12035; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Fang LY, 2006, J MED CHEM, V49, P6290, DOI 10.1021/jm060647f; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Groeneweg JW, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0095-1; Hauselmann I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00028; Hege KM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0222-9; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Holmberg LA, 2001, EXPERT OPIN BIOL TH, V1, P881, DOI 10.1517/14712598.1.5.881; Ibrahim NK, 2013, J CANCER, V4, P577, DOI 10.7150/jca.7028; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Julien S, 2012, BIOMOLECULES, V2, P435, DOI 10.3390/biom2040435; Kailemia MJ, 2016, ANAL BIOANAL CHEM AN, DOI [10.1007/s00216-016-9880, DOI 10.1007/S00216-016-9880-]; KASHMIRI SVS, 1995, HYBRIDOMA, V14, P461, DOI 10.1089/hyb.1995.14.461; KOBAYASHI H, 1991, J CLIN ONCOL, V9, P983, DOI 10.1200/JCO.1991.9.6.983; KOBAYASHI H, 1992, J CLIN ONCOL, V10, P95, DOI 10.1200/JCO.1992.10.1.95; Kolbl AC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00219; Lambert JM, 2017, ADV THER, V34, P1015, DOI 10.1007/s12325-017-0519-6; Leal M, 2015, BIOCONJUGATE CHEM, V26, P2223, DOI 10.1021/acs.bioconjchem.5b00205; Lin KD, 2015, CLIN CANCER RES, V21, P5139, DOI 10.1158/1078-0432.CCR-14-3383; Liu JF, 2016, ANN ONCOL, V27, P2124, DOI 10.1093/annonc/mdw401; Ma DS, 2006, CLIN CANCER RES, V12, P2591, DOI 10.1158/1078-0432.CCR-05-2107; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Miles David, 2003, Clin Breast Cancer, V3 Suppl 4, pS134, DOI 10.3816/CBC.2003.s.002; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; MILES DW, 1994, BRIT J CANCER, V70, P1272, DOI 10.1038/bjc.1994.486; Moore KN, 2018, FUTURE ONCOL, V14, P1669, DOI 10.2217/fon-2017-0646; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Nezhat FR, 2015, AM J OBSTET GYNECOL, V213, P262, DOI 10.1016/j.ajog.2015.03.044; Ohyama C, 2008, INT J CLIN ONCOL, V13, P308, DOI 10.1007/s10147-008-0809-8; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Prendergast JM, 2017, MABS-AUSTIN, V9, P615, DOI 10.1080/19420862.2017.1290752; Qi RG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02390-7; Scales SJ, 2014, MOL CANCER THER, V13, P2630, DOI 10.1158/1535-7163.MCT-14-0487-T; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Yu X, 2016, TUMOR BIOL, V37, P12213, DOI 10.1007/s13277-016-5086-y; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048	52	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201314	10.1371/journal.pone.0201314	http://dx.doi.org/10.1371/journal.pone.0201314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052649	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600038
J	Kodidela, S; Ranjit, S; Sinha, N; McArthur, C; Kumar, A; Kumar, S				Kodidela, Sunitha; Ranjit, Sabina; Sinha, Namita; McArthur, Carole; Kumar, Anil; Kumar, Santosh			Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; VIRUS TYPE-1 REPLICATION; ANTIRETROVIRAL THERAPY; OXIDATIVE STRESS; EXTRACELLULAR VESICLES; INFLAMMATORY CYTOKINES; ETHANOL-CONSUMPTION; IMMUNE ACTIVATION; LIVER-DISEASE; MURINE AIDS	Cytokines and chemokines circulate in plasma and may be transferred to distant sites, via exosomes. HIV infection is associated with dysregulation of cytokines and chemokines, which subsequently contribute to the pathogenesis of HIV. Alcohol and tobacco exposure, which are prevalent in HIV-infected individuals, may induce changes in the expression of cytokines and chemokines. Therefore, our aim in this study was to quantify plasma exosomal cytokines and chemokines that we expect to exacerbate toxicity or disease progression in HIV-positive drug abusers. We measured the levels of cytokines and chemokines in the plasma and plasma exosomes of 39 patients comprising six groups: HIV-negative and HIV-positive non drug abusers, HIV-negative and HIV-positive alcohol users, and HIV-negative and HIV positive tobacco smokers. We measured six cytokines (TNF-alpha, IL-1 beta, IL-8, IL-6, IL1-ra, IL-10) and two chemokines (MCP-1 and RANTES). All were present in exosomes of healthy subjects, but their levels varied between different study groups. HIV-positive alcohol drinkers had higher levels of plasma IL-8 compared to those of HIV-positive non-drinkers. The IL-1ra level was significantly higher in exosomes of non-HIV-infected alcohol drinkers compared to those of HIV-positive alcohol drinkers. Interestingly, the IL-10 level was higher in exosomes compared with their respective plasma levels in all study groups except HIVpositive non-alcohol drinkers. IL-10 was completely packaged in exosomes of HIV-positive smokers. HIV-positive smokers had significantly higher levels of plasma IL-8 compared with HIV-positive non-smokers and significantly higher exosomal IL-6 levels compared with HIV-negative subjects. HIV-positive smokers had significantly increased plasma levels of IL-1ra compared to HIV-positive non-smokers. The MCP-1 levels in the plasma of HIV-positive smokers was significantly higher than in either HIV-positive non-drug abusers or HIV-negative smokers. Overall, the findings suggest that plasma cytokines and chemokines are packaged in exosomes at varying degrees in different study groups. Exosomal cytokines and chemokines are likely to have a significant biological role at distant sites including cells in the brain.	[Kodidela, Sunitha; Ranjit, Sabina; Sinha, Namita; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN 38163 USA; [McArthur, Carole] Univ Missouri Kansas City, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO USA; [Kumar, Anil] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO USA	University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN 38163 USA.	ksantosh@uthsc.edu	, sunitha/J-4231-2019; ranjit, sabina/ABE-5008-2021; Boothapati, Anil Kumar/HHS-1813-2022; Kodidela, Sunitha/AAB-2816-2019; KUMAR, ANIL/ACD-8340-2022	Kumar, Santosh/0000-0001-7846-5674	National Institute on Alcohol Abuse and Alcoholism [AA022063]; National Institute on Drug Abuse [DA042374]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Alcohol Abuse and Alcoholism, AA022063, Dr. Santosh Kumar; National Institute on Drug Abuse, DA042374, Dr. Santosh Kumar.	Ande A, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0071-x; Ande A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122402; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Arimilli S, 2017, INFLAMMATION, V40, P1622, DOI 10.1007/s10753-017-0602-9; Bagasra O, 1996, J INFECT DIS, V173, P550, DOI 10.1093/infdis/173.3.550; BAGASRA O, 1989, ALCOHOL CLIN EXP RES, V13, P636, DOI 10.1111/j.1530-0277.1989.tb00396.x; BAGASRA O, 1993, J INFECT DIS, V167, P789, DOI 10.1093/infdis/167.4.789; Bagby GJ, 2003, ALCOHOL CLIN EXP RES, V27, P495, DOI 10.1097/01.ALC.0000057947.57330.BE; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; BREEN EC, 1990, J IMMUNOL, V144, P480; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Chander G, 2008, HIV MED, V9, P196, DOI 10.1111/j.1468-1293.2008.00545.x; Chen CC, 2016, CELL MOL BIOENG, V9, P509, DOI 10.1007/s12195-016-0458-3; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen JI, 2011, J DIGEST DIS, V12, P3, DOI 10.1111/j.1751-2980.2010.00468.x; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; CSCHB, 2017, ALC DRUG US HIV RISK; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Dong R, 2016, INT J CHRONIC OBSTR, V11, P31, DOI 10.2147/COPD.S96412; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; EMILIE D, 1994, INT J IMMUNOPHARMACO, V16, P391, DOI 10.1016/0192-0561(94)90026-4; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fuster D, 2014, AIDS, V28, P1059, DOI 10.1097/QAD.0000000000000184; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Haque S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16301-9; Hodge-Bell KC, 2007, INHAL TOXICOL, V19, P361, DOI 10.1080/08958370601144076; Iho S, 2003, J LEUKOCYTE BIOL, V74, P942, DOI 10.1189/jlb.1202626; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Johnson K, 2013, J IMMUNOL, V190; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kawaratani H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/495156; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kekwaletswe CT, 2014, AIDS CARE, V26, pS78, DOI 10.1080/09540121.2014.906558; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Konadu KA, 2015, J INFECT DIS, V211, P1712, DOI 10.1093/infdis/jiu676; Kumar S, 2015, J DRUG METAB TOXICOL, P1, DOI [10.4172/2157-7609.1000e124, DOI 10.4172/2157-7609.1000E124]; Kumar S, 2017, BIOCHEM BIOPH RES CO, V491, P675, DOI 10.1016/j.bbrc.2017.07.145; Kumar S, 2015, EXPERT OPIN DRUG MET, V11, P343, DOI 10.1517/17425255.2015.996546; Kumar S, 2012, EXPERT OPIN DRUG MET, V8, P1363, DOI 10.1517/17425255.2012.714366; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Li JJ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-017-1038-8; Lin Jin, 2015, ScientificWorldJournal, V2015, P657086, DOI 10.1155/2015/657086; Louis H, 2003, ACTA GASTRO-ENT BELG, V66, P7; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810; Marshall MM, 2009, AIDS EDUC PREV, V21, P28, DOI 10.1521/aeap.2009.21.3_supp.28; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; McMaster SK, 2008, BRIT J PHARMACOL, V153, P536, DOI 10.1038/sj.bjp.0707595; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; Momen-Heravi F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0623-9; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Morojele NK, 2014, AIDS BEHAV, V18, P519, DOI 10.1007/s10461-013-0583-0; Nakamura M, 2014, BIOMARKERS, V19, P368, DOI 10.3109/1354750X.2014.915342; Parsons JT, 2008, HEALTH PSYCHOL, V27, P628, DOI 10.1037/a0012664; Persidsky Y, 2011, BRAIN BEHAV IMMUN, V25, pS61, DOI 10.1016/j.bbi.2011.03.001; Potula R, 2006, AM J PATHOL, V168, P1335, DOI 10.2353/ajpath.2006.051181; Promadej-Lanier N, 2010, JAIDS-J ACQ IMM DEF, V53, P574, DOI 10.1097/QAI.0b013e3181d3521f; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Saha B, 2016, J BIOL CHEM, V291, P149, DOI 10.1074/jbc.M115.694133; Samanta S, 2018, ACTA PHARMACOL SIN, V39, P501, DOI 10.1038/aps.2017.162; Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Sarko DK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00082; Sereti I, 2016, CURR OPIN HIV AIDS, V11, P129, DOI 10.1097/COH.0000000000000244; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Silverstein PS, 2014, CURR HIV RES, V12, P282, DOI 10.2174/1570162X12666140721122956; Singh SP, 2000, TOXICOL APPL PHARM, V164, P65, DOI 10.1006/taap.2000.8897; Teow SY, 2016, ADV VIROL, V2016, DOI 10.1155/2016/9852494; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wang JY, 1997, ALCOHOL, V14, P155, DOI 10.1016/S0741-8329(97)83138-2; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; WANG YJ, 1994, ALCOHOL CLIN EXP RES, V18, P976, DOI 10.1111/j.1530-0277.1994.tb00069.x; Wood MJA, 2011, THER DELIV, V2, P1095, DOI 10.4155/TDE.11.83; Wu KR, 2017, BBA-REV CANCER, V1868, P538, DOI 10.1016/j.bbcan.2017.10.001	78	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201144	10.1371/journal.pone.0201144	http://dx.doi.org/10.1371/journal.pone.0201144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052665	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600025
J	Menon, PS; Said, FA; Mei, GS; Berhanuddin, DD; Umar, AA; Shaari, S; Majlis, BY				Menon, P. Susthitha; Said, Fairus Atida; Mei, Gan Siew; Berhanuddin, Dilla Duryha; Umar, Akrajas Ali; Shaari, Sahbudin; Majlis, Burhanuddin Yeop			Urea and creatinine detection on nano-laminated gold thin film using Kretschmann-based surface plasmon resonance biosensor	PLOS ONE			English	Article							ENHANCED RAMAN-SCATTERING; SPR-BASED SENSOR; FABRICATION; AMMONIA	This work investigates the surface plasmon resonance (SPR) response of 50-nm thick nano-laminated gold film using Kretschmann-based biosensing for detection of urea and creatinine in solution of various concentrations (non-enzymatic samples). Comparison was made with the presence of urease and creatininase enzymes in the urea and creatinine solutions (enzymatic samples), respectively. Angular interrogation technique was applied using optical wavelengths of 670 nm and 785 nm. The biosensor detects the presence of urea and creatinine at concentrations ranging from 50-800 mM for urea samples and 10-200 mM for creatinine samples. The purpose of studying the enzymatic sample was mainly to enhance the sensitivity of the sensor towards urea and creatinine in the samples. Upon exposure to 670 nm optical wavelength, the sensitivity of 1.4 degrees/M was detected in non-enzymatic urea samples and 4 degrees/M in non-enzymatic creatinine samples. On the other hand, sensor sensitivity as high as 16.2 degrees/M in urea-urease samples and 10 degrees/M in creatinine-creatininase samples was detected. The enhanced sensitivity possibly attributed to the increase in refractive index of analyte sensing layer due to urea-urease and creatinine-creatininase coupling activity. This work has successfully proved the design and demonstrated a proof-of-concept experiment using a low-cost and easy fabrication of Kretschmann based nano-laminated gold film SPR biosensor for detection of urea and creatinine using urease and creatininase enzymes.	[Menon, P. Susthitha; Said, Fairus Atida; Mei, Gan Siew; Berhanuddin, Dilla Duryha; Umar, Akrajas Ali; Shaari, Sahbudin; Majlis, Burhanuddin Yeop] Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Ukm Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Menon, PS (corresponding author), Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Ukm Bangi, Selangor, Malaysia.	susi@ukm.edu.my	Umar, Akrajas Ali/B-4780-2010; Umar, Akrajas Ali/K-3921-2016; bin Ahmad, Ibrahim/AAL-9554-2021; Menon, P Susthitha/H-6080-2011; Menon, P Susthitha/AAK-5229-2020	Umar, Akrajas Ali/0000-0001-8299-4827; Umar, Akrajas Ali/0000-0001-8299-4827; Menon, P Susthitha/0000-0003-4693-7934; Menon, P Susthitha/0000-0003-4693-7934	UNIVERSITI KEBANGSAAN MALAYSIA [DIP-2016-022, GUP-2016-062]; Higher Institution Centre of Excellence (HiCOE) grant from Malaysian Ministry of Higher Education [AKU-95]; Malaysian Ministry of Higher Education (KPT); Universiti Kebangsaan Malaysia (UKM) [DIP-2016-022, GUP-2016-062, AKU-95]; Institute of Microengineering and Nanoelectronics (IMEN); National University of Malaysia (UKM); KPT; Public Services Department (JPA) Malaysia	UNIVERSITI KEBANGSAAN MALAYSIA; Higher Institution Centre of Excellence (HiCOE) grant from Malaysian Ministry of Higher Education; Malaysian Ministry of Higher Education (KPT); Universiti Kebangsaan Malaysia (UKM); Institute of Microengineering and Nanoelectronics (IMEN); National University of Malaysia (UKM); KPT; Public Services Department (JPA) Malaysia	This work was supported by Grants DIP-2016-022 (Dana Impak Perdana, National Impact Grant), GUP-2016-062 (Grant Universiti Penyelidikan, Research University Grant) provided by UNIVERSITI KEBANGSAAN MALAYSIA (http://research.ukm.my/muat-turun/) AND Higher Institution Centre of Excellence (HiCOE) AKU-95 grant from Malaysian Ministry of Higher Education (https://www.mohe.gov.my/en/download/awam/borang-1/hicoe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Malaysian Ministry of Higher Education (KPT) and Universiti Kebangsaan Malaysia (UKM) using the Higher Institution Centre of Excellence (HiCOE) Grant of AKU-95, National Impact Grant DIP-2016-022 and Research University Grant GUP-2016-062. The authors would like to thank the Institute of Microengineering and Nanoelectronics (IMEN), National University of Malaysia (UKM), KPT and Public Services Department (JPA) Malaysia for the support.	Abdullah NA, 2017, ADV NAT SCI-NANOSCI, V8, P4; Ashley J, 2017, BIOSENS BIOELECTRON, V88, P109, DOI 10.1016/j.bios.2016.07.101; Bakar NA, 2017, INT J BIOMEDICAL NAN, V3, P335; Bhardwaj SK, 2018, THIN SOLID FILMS, V645, P10, DOI 10.1016/j.tsf.2017.10.021; Bhatia P, 2012, SENSOR ACTUAT B-CHEM, V161, P434, DOI 10.1016/j.snb.2011.10.056; Gomez-Grana S, 2015, CHEM MATER, V27, P8310, DOI 10.1021/acs.chemmater.5b03620; Jamil NA, 2017, PROCEEDINGS OF THE 2017 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM), P112, DOI 10.1109/RSM.2017.8069122; Karim MN, 2018, BIOSENS BIOELECTRON, V110, P8, DOI 10.1016/j.bios.2018.03.025; Kumar G, 2006, J PHYS D APPL PHYS, V39, P4436, DOI 10.1088/0022-3727/39/20/021; Lee C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11644; Leordean C, 2012, SPECTROSC LETT, V45, P550, DOI 10.1080/00387010.2011.649439; Liu CS, 2006, J APPL PHYS, V100, DOI 10.1063/1.2213151; Mahadeva SK, 2013, IEEE SENS J, V13, P2223, DOI 10.1109/JSEN.2013.2250497; Meyer SA, 2012, J PHYS CHEM A, V116, P1000, DOI 10.1021/jp2107507; Mishra SK, 2014, SENSOR ACTUAT B-CHEM, V199, P190, DOI 10.1016/j.snb.2014.03.109; Mishra YK, 2013, PLASMONICS, V8, P811, DOI 10.1007/s11468-013-9477-2; Moon J, 2005, KEY ENG MATER, V277-279, P383, DOI 10.4028/www.scientific.net/KEM.277-279.383; Nooke A, 2010, SENSOR ACTUAT B-CHEM, V149, P194, DOI 10.1016/j.snb.2010.05.061; Pernites R, 2011, BIOSENS BIOELECTRON, V26, P2766, DOI 10.1016/j.bios.2010.10.027; Polavarapu L, 2016, J AM CHEM SOC, V138, P11453, DOI 10.1021/jacs.6b06706; Polinder-Bos HA, 2017, KIDNEY INT REP, V2, P676, DOI 10.1016/j.ekir.2017.02.021; Prabhash PG, 2017, SENSOR ACTUAT B-CHEM, V240, P580, DOI 10.1016/j.snb.2016.08.159; Premanode B, 2007, SENSOR ACTUAT B-CHEM, V120, P732, DOI 10.1016/j.snb.2006.03.051; Raveendran J, 2017, SENSOR ACTUAT B-CHEM, V243, P589, DOI 10.1016/j.snb.2016.11.158; Reddy KK, 2013, SENSOR ACTUAT B-CHEM, V183, P356, DOI 10.1016/j.snb.2013.04.015; Rodal-Cedeira S, 2016, CHEM MATER, V28, P9169, DOI 10.1021/acs.chemmater.6b04941; Said FA, 2017, IET NANOBIOTECHNOL, V11, P981, DOI 10.1049/iet-nbt.2017.0051; Saini A, 2015, PLASMONICS, V10, P617, DOI 10.1007/s11468-014-9847-4; Tran TQN, 2017, SENSOR ACTUAT B-CHEM, V243, P78, DOI 10.1016/j.snb.2016.11.126; Vala M, 2010, SENSOR ACTUAT B-CHEM, V148, P544, DOI 10.1016/j.snb.2010.05.067; Verma R, 2014, ANALYST, V139, P1449, DOI 10.1039/c3an01983g; Wu CM, 2005, SENSOR ACTUAT B-CHEM, V110, P231, DOI 10.1016/j.snb.2005.01.047; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001	33	33	34	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201228	10.1371/journal.pone.0201228	http://dx.doi.org/10.1371/journal.pone.0201228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052647	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600030
J	Messchaert, M; Dona, M; Broekman, S; Peters, TA; Corral-Serrano, JC; Slijkerman, RWN; van Wijk, E; Collin, RWJ				Messchaert, Muriel; Dona, Margo; Broekman, Sanne; Peters, Theo A.; Corral-Serrano, Julio C.; Slijkerman, Ralph W. N.; van Wijk, Erwin; Collin, Rob W. J.			Eyes shut homolog is important for the maintenance of photoreceptor morphology and visual function in zebrafish	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; MULLER CELLS; EYS; ORTHOLOG; DAMAGE	Mutations in eyes shut homolog (EYS), a gene predominantly expressed in the photoreceptor cells of the retina, are among the most frequent causes of autosomal recessive (ar) retinitis pigmentosa (RP), a progressive retinal disorder. Due to the absence of EYS in several rodent species and its retina-specific expression, still little is known about the exact function of EYS and the pathogenic mechanism underlying EYS-associated RP. We characterized eys in zebrafish, by RT-PCR analysis on zebrafish eye-derived RNA, which led to the identification of a 8,715 nucleotide coding sequence that is divided over 46 exons. The transcript is predicted to encode a 2,905-aa protein that contains 39 EGF-like domains and five laminin A G-like domains, which overall shows 33% identity with human EYS. To study the function of EYS, we generated a stable eys(rmc101/rmc101) mutant zebrafish model using CRISPR/Cas9 technology. The introduced lesion is predicted to result in premature termination of protein synthesis and lead to loss of Eys function. Immunohistochemistry on retinal sections revealed that Eys localizes at the region of the connecting cilium and that both rhodopsin and cone transducin are mislocalized in the absence of Eys. Electroretinogram recordings showed diminished b-wave amplitudes in eys(rmc101/rmc101) zebrafish (5 dpf) compared to age- and strain-matched wild-type larvae. In addition, decreased locomotor activity in response to light stimuli was observed in eys mutant larvae. Altogether, our study shows that absence of Eys leads to a disorganized retinal architecture and causes visual dysfunction in zebrafish.	[Messchaert, Muriel; Corral-Serrano, Julio C.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Messchaert, Muriel; Peters, Theo A.; van Wijk, Erwin; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Dona, Margo; Broekman, Sanne; Peters, Theo A.; Slijkerman, Ralph W. N.; van Wijk, Erwin] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Nijmegen, Netherlands; [Dona, Margo; Corral-Serrano, Julio C.; Slijkerman, Ralph W. N.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.; Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	rob.collin@radboudumc.nl	Dona, Margo/B-3167-2016; van Wijk, Erwin/J-8913-2014; Peters, T.A./L-4571-2015	van Wijk, Erwin/0000-0002-5702-3460; Peters, T.A./0000-0001-8443-5500; Corral Serrano, Julio Cesar/0000-0002-4277-4931	Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Oogfonds Nederland; Stichting Macula Degeneratie Fonds; Stichting Retina Nederland Fonds [UitZicht 2015-31]; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Stichting voor Ooglijders; Stichting Dowilvo; Foundation Fighting Blindness USA [PPA-0517-0717-RAD]	Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Oogfonds Nederland; Stichting Macula Degeneratie Fonds; Stichting Retina Nederland Fonds; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Stichting voor Ooglijders; Stichting Dowilvo; Foundation Fighting Blindness USA	This work was supported by the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Stichting Blinden-Penning, Landelijke Stichting voor Blinden en Slechtzienden, Stichting Oogfonds Nederland, Stichting Macula Degeneratie Fonds and Stichting Retina Nederland Fonds that contributed through UitZicht 2015-31, together with the Rotterdamse Stichting Blindenbelangen, Stichting Blindenhulp, Stichting tot Verbetering van het Lot der Blinden, Stichting voor Ooglijders and Stichting Dowilvo (to RWJC), and by the Foundation Fighting Blindness USA (PPA-0517-0717-RAD) to EvW and RWJC.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chen A, 2002, GLIA, V38, P115, DOI 10.1002/glia.10061; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Easter SS, 1996, DEV BIOL, V180, P646; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fleisch Valerie C, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4973; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Ganzen L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061185; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hosono K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031036; Huber-Reggi Sabina P, 2013, Methods Mol Biol, V935, P139, DOI 10.1007/978-1-62703-080-9_10; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Lu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46098; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morris AC, 2005, PHYSIOL BEHAV, V86, P306, DOI 10.1016/j.physbeh.2005.08.020; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; Sifuentes CJ, 2016, INVEST OPHTH VIS SCI, V57, P5148, DOI 10.1167/iovs.16-19973; Sirisi S, 2014, HUM MOL GENET, V23, P5069, DOI 10.1093/hmg/ddu231; Slijkerman RWN, 2015, PROG RETIN EYE RES, V48, P137, DOI 10.1016/j.preteyeres.2015.04.004; Tucker BA, 2013, ELIFE, V2, DOI 10.7554/eLife.00824; Wan J, 2016, CURR OPIN GENET DEV, V40, P41, DOI 10.1016/j.gde.2016.05.009; Yu M, 2016, BIOL OPEN, V5, P1662, DOI 10.1242/bio.021584; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047	29	26	28	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200789	10.1371/journal.pone.0200789	http://dx.doi.org/10.1371/journal.pone.0200789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052645	gold, Green Published, Green Submitted			2022-12-26	WOS:000440006600015
J	Chen, HH; Chao, WC; Liao, TL; Lin, CH; Chen, DY				Chen, Hsin-Hua; Chao, Wen-Cheng; Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Der-Yuan			Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; SYSTEMIC INFLAMMATION; CYTOKINE PRODUCTION; JAPANESE PATIENTS; ARTHRITIS; ASSOCIATION; HLA; PROGRESSION; KOREANS; CELLS	Objective To estimate the relative risk of autoimmune rheumatic diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogrens syndrome (SS), dermatomyositis (DM) and polymyositis (PM), among patients with palindromic rheumatism (PR) compared with non-PR individuals. Methods The study utilized 2003-2013 claims data from the Taiwanese National Health Insurance Research Database. We identified 4,421 cases of PR from 2007 to 2012 and randomly chose 44,210 non-PR individuals who matched (1:10) for age, sex and the year of index date without prior history of RA, SLE, SSc, SS, DM, or PM. After adjusting for age, sex, and the Charlson comorbidity index, we calculated the hazard ratios (HRs) with 95% confidence intervals (CIs) using the Cox proportional hazard model to quantify the risk of RA, SLE, SS, DM and PM in PR patients compared with that in matched non-PR individuals. Results Among the 4,421 patients with PR, 569 (12.87%) developed RA, 269 (6.08%) developed SS, 113 (2.56%) developed SLE, 5 (0.11%) developed SSc, 8 (0.18%) developed PM, and 1 (0.02%) developed DM. After adjusting for potential confounders, the patients with PR had an increased risk of RA (HR, 118.76; 95% CI, 89.81-157.04), SS (HR, 59.57; 95% CI, 43.87-80.88), SLE (HR, 51.56; 95% CI, 32.96-80.66) PM (HR, 57.38; 95% CI, 6.90-476.83), and SSc (HR, 13.42; 95% CI, 3.79-47.55) but not of DM (HR, 3.44; 95% CI, 0.34-34.59). Conclusion Patients with PR had an increased risk of developing RA, SS, SLE, PM, and SSc.	[Chen, Hsin-Hua; Chao, Wen-Cheng; Liao, Tsai-Ling; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Hsin-Hua; Liao, Tsai-Ling; Chen, Der-Yuan] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua; Liao, Tsai-Ling; Chen, Der-Yuan] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital	Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, DY (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, DY (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, DY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan.	epid@vghtc.gov.tw; dychen@vghtc.gov.tw						Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Ceelen JJM, 2014, CURR OPIN SUPPORT PA, V8, P339, DOI 10.1097/SPC.0000000000000088; Chen HH, 2010, J MED ULTRASOUND, V18, P17; Chen HH, 2009, J ULTRAS MED, V28, P1193, DOI 10.7863/jum.2009.28.9.1193; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Duncan BB, 2006, DIABETES TECHNOL THE, V8, P7, DOI 10.1089/dia.2006.8.7; Emad Y, 2014, CLIN RHEUMATOL, V33, P791, DOI 10.1007/s10067-014-2569-3; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Furuya T, 1998, J RHEUMATOL, V25, P1109; Furuya T, 2004, J RHEUMATOL, V31, P1768; Gardner AW, 2014, ANGIOLOGY, V65, P683, DOI 10.1177/0003319713501376; Gonzalez-Lopez L, 1999, J RHEUMATOL, V26, P540; Grabulosa CC, 2018, EXP CELL RES, V365, P157, DOI 10.1016/j.yexcr.2018.02.022; GUERNE PA, 1992, AM J MED, V93, P451, DOI 10.1016/0002-9343(92)90177-D; HANNONEN P, 1987, SCAND J RHEUMATOL, V16, P413, DOI 10.3109/03009748709165412; Haydari Aghigh, 2017, Acta Med Iran, V55, P597; Hench PR, 1944, ARCH INTERN MED, V73, P28; Huang RL, 2015, J AUTOIMMUN, V57, P53, DOI 10.1016/j.jaut.2014.11.006; Kang SH, 2001, J RHEUMATOL, V28, P1577; Kim SK, 2006, ANN RHEUM DIS, V65, P1539, DOI 10.1136/ard.2006.052928; Koskinen E, 2009, J RHEUMATOL, V36, P1873, DOI 10.3899/jrheum.090025; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Maksymowych WP, 2002, J RHEUMATOL, V29, P2319; MATTINGLY S, 1966, ANN RHEUM DIS, V25, P307, DOI 10.1136/ard.25.4.307; McColl BW, 2007, BIOCHEM SOC T, V35, P1163, DOI 10.1042/BST0351163; Morimoto S, 2000, Mod Rheumatol, V10, P235, DOI 10.3109/s101650070009; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Peila R, 2006, ACTA NEUROL SCAND, V114, P102, DOI 10.1111/j.1600-0404.2006.00693.x; Pitsavos Christos, 2007, Rev Diabet Stud, V4, P98, DOI 10.1900/RDS.2007.4.98; Powell A, 2008, J RHEUMATOL, V35, P992; Azambuja MIR, 2010, LANCET INFECT DIS, V10, P142, DOI 10.1016/S1473-3099(10)70029-3; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008; ROWLEY MJ, 1968, LANCET, V2, P24; Russell AS, 2006, J RHEUMATOL, V33, P1240; Sanmarti R, 2004, BEST PRACT RES CL RH, V18, P647, DOI 10.1016/j.berh.2004.05.005; SKAER TL, 1992, CLIN THER, V14, P496; WAJED MA, 1977, ANN RHEUM DIS, V36, P56, DOI 10.1136/ard.36.1.56; WILLIAMS MH, 1971, ANN RHEUM DIS, V30, P375, DOI 10.1136/ard.30.4.375; YOUSSEF W, 1991, J RHEUMATOL, V18, P35	43	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201340	10.1371/journal.pone.0201340	http://dx.doi.org/10.1371/journal.pone.0201340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048527	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400079
J	Tian, XM; Wang, ZY; Zhang, Q; Ci, HC; Wang, PS; Yu, L; Jia, GX				Tian, Xiaoming; Wang, Zhenyu; Zhang, Qing; Ci, Huacong; Wang, Pengshan; Yu, Lu; Jia, Guixia			Genome-wide transcriptome analysis of the salt stress tolerance mechanism in Rosa chinensis	PLOS ONE			English	Article							PROLINE ACCUMULATION; GENE-EXPRESSION; COLD STRESS; SALINITY; ANNOTATION; RESPONSES; DROUGHT; WATER; PHOTOSYNTHESIS; BIOSYNTHESIS	Plants regulate responses to salt stress using biological pathways, such as signal perception and transduction, photosynthesis, and energy metabolism. Little is known about the genetics of salt tolerance in Rosa chinensis. Tineke and Hiogi are salt-tolerant and salt-sensitive varieties of R. chinensis, respectively, and are good choices for studying salt-tolerance genes. We studied leaf and root tissues from 1-year-old Hiogi and Tineke plants simultaneously grown under the same conditions. A 0.4%-mmol/L salt ion mixture was added to the basic growth medium. Illumina sequencing was used to identify differentially expressed transcripts. GO and KEGG pathway enrichment analyses were performed to identify differentially expressed genes. We identified many differentially expressed genes associated with salt tolerance. The abscisic acid-dependent signaling pathway was the main pathway that mediated the salt stress response in R. chinensis. Two pathways ( plant hormone signal transduction and glutathione metabolism) were also active in salt stress responses in R. chinensis. The difference in salt tolerance in the cultivars was due to different gene sensitivity to salt in these two pathways. Roots also play a role in salt stress response. The effects of salt stress in the roots are eventually manifested in the leaves, causing changes in processes such as photosynthesis, which eventually result in leaf wilting. In Tineke, Snrk2, ABF, HSP, GSTs, and GSH1 showed high activity during salt stress, indicating that these genes are markers of salt tolerance.	[Tian, Xiaoming; Jia, Guixia] Beijing Forestry Univ, Beijing, Peoples R China; [Wang, Zhenyu; Zhang, Qing; Ci, Huacong; Wang, Pengshan; Yu, Lu] Tianjin TEDA Salina Ecolandscape Res Ctr, Tianjin, Peoples R China	Beijing Forestry University	Jia, GX (corresponding author), Beijing Forestry Univ, Beijing, Peoples R China.	1270050018@qq.com			industrial platform construction of coastal saline ecological afforestation in Beijing-Tianjin-Hebei region [15YDLJSF00050]	industrial platform construction of coastal saline ecological afforestation in Beijing-Tianjin-Hebei region	This work was supported by industrial platform construction of coastal saline ecological afforestation in Beijing-Tianjin-Hebei region, 15YDLJSF00050 (http://www.tstc.gov.cn/zhengwugongkai/ztzl/kjgzhy/2016/dxfy/kjtd/201602/t20160205_87310.html) to XT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harrasi I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191492; Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Bittsanszky A, STRESS CAPACITY ZN P; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chutipaijit S, 2010, PHILIPP AGRIC SCI, V93, P165; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Ding W., 2016, P 11 INT C ECOLOGICA, P1; Ergun E, 2004, ANAL BIOANAL CHEM, V379, P803, DOI 10.1007/s00216-004-2637-7; Fu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39865; Fu JJ, 2016, J PHOTOCH PHOTOBIO B, V163, P30, DOI 10.1016/j.jphotobiol.2016.08.008; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hatano-Iwasaki A, 2012, PLANT CELL PHYSIOL, V53, P1195, DOI 10.1093/pcp/pcs075; Hoque MA, 2007, J PLANT PHYSIOL, V164, P1457, DOI 10.1016/j.jplph.2006.10.004; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Josine TL, 2012, BREEDING EXPRESSION; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WJ, 2017, INT J AGRIC BIOL, V19, P1201, DOI [10.17957/IJAB/15.0422, 10.17957/ijab/15.0422]; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Mattison CP, 2017, J AGR FOOD CHEM; Nianiou-Obeidat I, 2017, PLANT CELL REP, V36, P791, DOI 10.1007/s00299-017-2139-7; Pan Xiaodong, 2002, PRODUCTION TECHNOLOG; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Parida A, 2010, GLUTATHIONE S TRANSF; Santos CV, 2004, SCI HORTIC-AMSTERDAM, V103, P93, DOI 10.1016/j.scienta.2004.04.009; Schellingen K, 2015, ENVIRON EXP BOT, V117, P1, DOI 10.1016/j.envexpbot.2015.04.005; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Skaggs TH, 2006, AGR WATER MANAGE, V86, P140, DOI 10.1016/j.agwat.2006.06.005; Teh CY, 2015, PLANT GROWTH REGUL, V75, P771, DOI 10.1007/s10725-014-9980-2; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Wachter A, 2005, PLANT J, V41, P15, DOI 10.1111/j.1365-313X.2004.02269.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XS, 2009, AGR SCI CHINA, V8, P431, DOI 10.1016/S1671-2927(08)60229-1; Wu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171451; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiuzhen Zh, 2006, ROSA CHINENSIS; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4484-5; Yaish MW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3633-6; Yang GY, 2016, PLANT CELL REP, V35, P681, DOI 10.1007/s00299-015-1912-8; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang ZH, 2012, AFRICAN J AGR RES, V7; Zhang Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01231; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	50	19	24	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200938	10.1371/journal.pone.0200938	http://dx.doi.org/10.1371/journal.pone.0200938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048505	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400034
J	Walder, A; Muller, M; Dahdal, S; Sidler, D; Devetzis, V; Leichtle, AB; Fiedler, MG; Popp, AW; Lippuner, K; Vogt, B; Uehlinger, D; Huynh-Do, U; Arampatzis, S				Walder, Anna; Muller, Martin; Dahdal, Suzan; Sidler, Daniel; Devetzis, Vasilios; Leichtle, Alexander B.; Fiedler, Martin G.; Popp, Albrecht W.; Lippuner, Kurt; Vogt, Bruno; Uehlinger, Dominik; Huynh-Do, Uyen; Arampatzis, Spyridon			The effect of a previous created distal arteriovenous-fistula on radial bone DXA measurements in prevalent renal transplant recipients	PLOS ONE			English	Article							POSITION DEVELOPMENT CONFERENCE; ABDOMINAL AORTIC-ANEURYSM; CHRONIC KIDNEY-DISEASE; MINERAL DENSITY; FRACTURE RISK; HEMODIALYSIS-PATIENTS; CKD; CALCANEUS; TURNOVER; PLAYERS	Background Accelerated bone loss occurs rapidly following renal transplantation due to intensive immunosuppression and persistent hyperparathyroidism. In renal transplant recipients (RTRs) due to the hyperparathyroidism the non-dominant forearm is often utilized as a peripheral measurement site for dual-energy x-ray absorptiometry (DXA) measurements. The forearm is also the site of previous created distal arteriovenous fistulas (AVF). Although AVF remain patent long after successful transplantation, there are no data available concerning their impact on radial bone DXA measurements. Methods In this cross-sectional study we performed DXA in 40 RTRs with preexisting distal AVF (RTRs-AVF) to assess areal bone mineral density (aBMD) differences between both forearms (three areas) and compared our findings to patients with chronic kidney disease (CKD, n = 40), pre-emptive RTRs (RTRs-pre, n = 15) and healthy volunteers (n = 20). In addition, we assessed relevant demographic, biochemical and clinical aspects. Results We found a marked radial asymmetry between the forearms in RTRs with preexisting AVF. The radial aBMD at the distal AVF forearm was lower compared to the contralateral forearm, resulting in significant differences for all three areas analyzed: the Rad-1/3: median (interquartile range) in g/cm(2), Rad-1/3: 0.760 (0.641 +/- 0.804) vs. 0.742 (0.642, 0.794), p = 0.016; ultradistal radius, Rad-UD: 0.433 (0.392 +/- 0.507) vs. 0.420 (0.356, 0.475), p = 0.004; and total radius, Rad-total: 0.603 (0.518, 0.655) vs. 0.599 (0.504, 0.642), p = 0.001). No such asymmetries were observed in any other groups. Lower aBMD in AVF forearm subregions resulted in misclassification of osteoporosis. Conclusions In renal transplant recipients, a previously created distal fistula may exert a negative impact on the radial bone leading to significant site-to-site aBMD differences, which can result in diagnostic misclassifications.	[Walder, Anna; Dahdal, Suzan; Sidler, Daniel; Devetzis, Vasilios; Vogt, Bruno; Uehlinger, Dominik; Huynh-Do, Uyen; Arampatzis, Spyridon] Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland; [Walder, Anna; Muller, Martin; Dahdal, Suzan; Sidler, Daniel; Devetzis, Vasilios; Leichtle, Alexander B.; Fiedler, Martin G.; Popp, Albrecht W.; Lippuner, Kurt; Vogt, Bruno; Uehlinger, Dominik; Huynh-Do, Uyen; Arampatzis, Spyridon] Univ Bern, Bern, Switzerland; [Muller, Martin] Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland; [Leichtle, Alexander B.; Fiedler, Martin G.] Bern Univ Hosp, Inselspital, Ctr Lab Med, Bern, Switzerland; [Popp, Albrecht W.; Lippuner, Kurt] Bern Univ Hosp, Inselspital, Dept Osteoporosis, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Arampatzis, S (corresponding author), Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland.; Arampatzis, S (corresponding author), Univ Bern, Bern, Switzerland.	Spiros.arampatzis@insel.ch	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Vogt, Bruno/AAS-2876-2020; Sidler, Daniel/G-2447-2019	Fiedler, Georg Martin/0000-0001-5689-4574; Vogt, Bruno/0000-0002-1548-6387; Arampatzis, Spyridon/0000-0002-6959-0411; Popp, Albrecht/0000-0002-5954-7495	AMGEN	AMGEN(Amgen)	This PIs of this Study (SA, UH) received an independent medical education grant by AMGEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaberi S, 2008, AM J TRANSPLANT, V8, P2647, DOI 10.1111/j.1600-6143.2008.02423.x; [Anonymous], CLIN J AM SOC NEPHRO, V4, P1494, DOI [10.2215/CJN.01470209, DOI 10.2215/CJN.01470209]; [Anonymous], SEMINARS NEPHROLOGY, V33, P191, DOI [10.1016/j.semnephrol.2012.12.019, DOI 10.1016/J.SEMNEPHROL.2012.12.019]; Aydogan M, 2008, SPINE J, V8, P394, DOI 10.1016/j.spinee.2006.12.001; Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014; Barbour KE, 2010, J BONE MINER RES, V25, P1017, DOI 10.1002/jbmr.6; Cruz DN, 2001, TRANSPLANTATION, V72, P83, DOI 10.1097/00007890-200107150-00017; Diekerhof CH, 2002, SPINE, V27, P382; Ducher G, 2011, J BONE MINER RES, V26, P1321, DOI 10.1002/jbmr.323; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Iyer SP, 2014, J AM SOC NEPHROL, V25, P1331, DOI 10.1681/ASN.2013080851; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P1191, DOI 10.1007/s00198-011-1781-0; Jamal SA, 2006, J BONE MINER RES, V21, P543, DOI 10.1359/JBMR.060105; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; Karacan I, 2004, J BONE MINER METAB, V22, P44, DOI 10.1007/s00774-003-0447-1; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Mancini F, 2014, J ORTHOP TRAUMATOL, V15, P291, DOI 10.1007/s10195-014-0308-9; Mikuls TR, 2003, TRANSPLANTATION, V75, P49, DOI 10.1097/00007890-200301150-00009; Min JY, 2007, J CLIN DENSITOM, V10, P184, DOI 10.1016/j.jocd.2006.12.004; Muxi A, 2009, CLIN J AM SOC NEPHRO, V4, P1494, DOI 10.2215/CJN.01470209; Muyshondt I, 2003, NEPHROL DIAL TRANSPL, V18, P2185, DOI 10.1093/ndt/gfg331; Naylor KL, 2013, TRANSPLANTATION, V95, P1461, DOI 10.1097/TP.0b013e31828eead8; Nikkel LE, 2009, TRANSPLANTATION, V87, P1846, DOI 10.1097/TP.0b013e3181a6bbda; Nishiyama KK, 2015, J BONE MINER RES, V30, P456, DOI 10.1002/jbmr.2358; Rajapakse CS, 2012, RADIOLOGY, V262, P912, DOI 10.1148/radiol.11111044; Schousboe JT, 2013, J CLIN DENSITOM, V16, P455, DOI 10.1016/j.jocd.2013.08.004; Sergi G, 2009, J ENDOCRINOL INVEST, V32, P298, DOI 10.1007/BF03345715; Shen JI, 2012, AM J KIDNEY DIS, V60, P473, DOI 10.1053/j.ajkd.2012.03.017; Shepherd JA, 2015, J CLIN DENSITOM, V18, P274, DOI 10.1016/j.jocd.2015.06.013; Shin A, 2004, OSTEOPOROSIS INT, V15, P639, DOI 10.1007/s00198-004-1587-4; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Tasbas BA, 2003, J RECONSTR MICROSURG, V19, P395; Uhlig K, 2010, AM J KIDNEY DIS, V55, P773, DOI 10.1053/j.ajkd.2010.02.340; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200708	10.1371/journal.pone.0200708	http://dx.doi.org/10.1371/journal.pone.0200708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048464	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400013
J	Wehrens, EJ; Wong, KA; Gupta, A; Khan, A; Benedict, CA; Zuniga, EI				Wehrens, Ellen J.; Wong, Kurt A.; Gupta, Ankan; Khan, Ayesha; Benedict, Chris A.; Zuniga, Elina I.			IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPLETION; IMMUNE-RESPONSES; CUTTING EDGE; INFECTION; RECEPTOR; WSX-1; EXPRESSION; IL-10; INTERLEUKIN-27	The role of IL-27 in antiviral immunity is still incompletely understood, especially in the context of chronic viruses that induce a unique environment in their infected host. Cytomegalovirus (CMV) establishes a persistent, tissue localized infection followed by lifelong latency. CMV infects the majority of people and although asymptomatic in healthy individuals, can cause serious disease or death in those with naive or compromised immune systems. Therefore, there is an urgent need to develop a protective CMV vaccine for people at-risk and identifying key regulators of the protective immune response towards CMV will be crucial. Here we studied mouse CMV (MCMV) in IL-27 receptor deficient animals (IL27ra(-/-)) to assess the role of IL-27 in regulating CMV immunity. We found that IL-27 enhanced the number of antiviral CD4 T cells upon infection. However, in contrast to a well-established role for CD4 T cells in controlling persistent replication and a positive effect of IL-27 on their numbers, IL-27 promoted MCMV persistence in the salivary gland. This coincided with IL-27 mediated induction of IL-10 production in CD4 T cells. Moreover, IL-27 reduced expression of the transcription factor T-bet and restricted a cytotoxic phenotype in antiviral CD4 T cells. This is a highly intriguing result given the profound cytotoxic phenotype of CMV-specific CD4 T cells seen in humans and we established that dendritic cell derived IL-27 was responsible for this effect. Together, these data show that IL-27 regulates the number and effector functions of MCMV-specific CD4 T cells and could be targeted to enhance control of persistent/latent infection.	[Wehrens, Ellen J.; Wong, Kurt A.; Khan, Ayesha; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gupta, Ankan; Benedict, Chris A.] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA	University of California System; University of California San Diego; La Jolla Institute for Immunology	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eizuniga@ucsd.edu			National Institutes of Health (NIH) [AI113923, AI081923, AI101423]; Dutch Society for Scientific Research (NWO); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113923, R01AI081923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Society for Scientific Research (NWO); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institutes of Health (NIH) (https://www.nih.gov/) grant AI113923 and AI081923 (to E.I.Z.), and AI101423 (to C.B.). E.J.W. was supported by a Dutch Society for Scientific Research (NWO) (https://www.nwo.nl/en) Rubicon postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chemin K, 2018, EUR J IMMUNOL, V48, P655, DOI 10.1002/eji.201747296; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Cheroutre H, 2013, SEMIN IMMUNOL, V25, P273, DOI 10.1016/j.smim.2013.10.022; Clement M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006050; Crompton L, 2008, BLOOD, V111, P2053, DOI 10.1182/blood-2007-04-079863; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; de Aquino MTP, 2014, J IMMUNOL, V193, P285, DOI 10.4049/jimmunol.1400058; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gamadia LE, 2004, HUM IMMUNOL, V65, P486, DOI 10.1016/j.humimm.2004.02.020; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Harker JA, 2018, J VIROL, V92, DOI 10.1128/JVI.02196-17; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; JONJIC S, 1990, J VIROL, V64, P5457; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Juno JA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00019; Kim G, 2013, J IMMUNOL, V190, P1510, DOI 10.4049/jimmunol.1201017; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee HM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004635; Lewis GM, 2016, J CLIN INVEST, V126, P3799, DOI 10.1172/JCI87041; Liu FDM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004110; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; LUCIN P, 1992, J VIROL, V66, P1977, DOI 10.1128/JVI.66.4.1977-1984.1992; Mandaric S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002846; Marshall NB, 2017, J IMMUNOL, V198, P1142, DOI 10.4049/jimmunol.1601297; Muallem G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006173; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muraro E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00197; Pachnio A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005832; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pyle CJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006640; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takeda A, 2005, INT IMMUNOL, V17, P889, DOI 10.1093/intimm/dxh268; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Verma S, 2016, J VIROL, V90, P650, DOI 10.1128/JVI.02123-15; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Zhang S, 2013, HEPATOLOGY, V57, P1620, DOI 10.1002/hep.26166; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	73	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201249	10.1371/journal.pone.0201249	http://dx.doi.org/10.1371/journal.pone.0201249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044874	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500095
J	Richins, RD; Rodriguez-Uribe, L; Lowe, K; Ferral, R; O'Connell, MA				Richins, Richard D.; Rodriguez-Uribe, Laura; Lowe, Kiah; Ferral, Rebekah; O'Connell, Mary A.			Accumulation of bioactive metabolites in cultivated medical Cannabis	PLOS ONE			English	Article							ACID-SYNTHASE; SATIVA L.; CHEMOTAXONOMIC ANALYSIS; CHEMICAL PHENOTYPE; GENES; PLANT; IDENTIFICATION; TRICHOMES; CYCLASE; FRUIT	There has been an increased use of medical Cannabis in the United States of America as more states legalize its use. Complete chemical analyses of this material can vary considerably between producers and is often not fully provided to consumers. As phytochemists in a state with legal medical Cannabis we sought to characterize the accumulation of phytochemicals in material grown by licensed commercial producers. We report the development of a simple extraction and analysis method, amenable to use by commercial laboratories for the detection and quantification of both cannabinoids and terpenoids. Through analysis of developing flowers on plants, we can identify sources of variability of floral metabolites due to flower maturity and position on the plant. The terpenoid composition varied by accession and was used to cluster cannabis strains into specific types. Inclusion of terpenoids with cannabinoids in the analysis of medical cannabis should be encouraged, as both of these classes of compounds could play a role in the beneficial medical effects of different cannabis strains.	[Richins, Richard D.; Rodriguez-Uribe, Laura; Lowe, Kiah; Ferral, Rebekah; O'Connell, Mary A.] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Richins, Richard D.] Rio Grande Analyt, Las Cruces, NM USA	New Mexico State University	O'Connell, MA (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	moconnel@nmsu.edu		O'Connell, Mary/0000-0003-4430-6733	Agricultural Experiment Station at New Mexico State University	Agricultural Experiment Station at New Mexico State University	MOC, LRU, and RDR received support from the Agricultural Experiment Station at New Mexico State University. This funder provided support in the form of salaries for authors MOC, LRU, KL, RF, RDR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Rio Grande Analytics, a commercial licensed medical marijuana testing laboratory provided access to research space licensed for analysis of the plant material in this report. All material costs and salaries of staff working on this project were paid through the Agricultural Experiment Station at New Mexico State University. RDR is an owner of Rio Grande Analytics, in addition to his full-time position at NMSU, however, Rio Grande Analytics did not provide salary support or have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Carvalho A, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox037; Chandra S, 2010, PLANTA MED, V76, P743, DOI 10.1055/s-0029-1240628; Curry J, 1999, PLANT SCI, V148, P47, DOI 10.1016/S0168-9452(99)00118-1; de Meijer EPM, 2003, GENETICS, V163, P335; Fischedick JT, 2017, CANNABIS CANNABINOID, V2, P34, DOI 10.1089/can.2016.0040; Fischedick JT, 2010, PHYTOCHEMISTRY, V71, P2058, DOI 10.1016/j.phytochem.2010.10.001; Friedman D, 2015, NEW ENGL J MED, V373, P1048, DOI 10.1056/NEJMra1407304; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Happyana N, 2016, PLANTA MED, V82, P1217, DOI 10.1055/s-0042-108058; Happyana N, 2013, PHYTOCHEMISTRY, V87, P51, DOI 10.1016/j.phytochem.2012.11.001; Hillig KW, 2004, BIOCHEM SYST ECOL, V32, P875, DOI 10.1016/j.bse.2004.04.004; Hillig KW, 2004, AM J BOT, V91, P966, DOI 10.3732/ajb.91.6.966; Ibrahim EA, 2018, PLANTA MED, V84, P250, DOI 10.1055/s-0043-124088; Jin D, 2017, J ANAL BIOANALYTICAL, V08; Keyhaninejad N, 2014, PLANT SCI, V215, P59, DOI 10.1016/j.plantsci.2013.10.013; Marks MD, 2009, J EXP BOT, V60, P3715, DOI 10.1093/jxb/erp210; Martin C, 2012, LAVENDER CULTIVAR TR; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Medina-Holguin AL, 2008, PHYTOCHEMISTRY, V69, P919, DOI 10.1016/j.phytochem.2007.11.006; Mudge EM, 2017, ANAL BIOANAL CHEM, V409, P3153, DOI 10.1007/s00216-017-0256-3; National Academies of Sciences. Engineering and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice, 2017, HLTH EFF CANN CANN C; Onofri C, 2015, PHYTOCHEMISTRY, V116, P57, DOI 10.1016/j.phytochem.2015.03.006; Pacifico D, 2008, EUPHYTICA, V160, P231, DOI 10.1007/s10681-007-9543-y; Page J.E., 2015, Patent No. [2015/196275 A1, 2015196275]; Page J.E., 2012, US patent, Patent No. [US20120144523A1, 20120144523]; Potter DJ, 2014, DRUG TEST ANAL, V6, P31, DOI 10.1002/dta.1531; Rodriguez-Uribe L, 2014, HORTSCIENCE, V49, P1370, DOI 10.21273/HORTSCI.49.11.1370; Rodriguez-Uribe L, 2012, J EXP BOT, V63, P517, DOI 10.1093/jxb/err302; Russo E., 2007, CHEM BIODIVER; Russo E., 2011, BRIT J PHARM, V163; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; SMALL E, 1973, LLOYDIA, V36, P144; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; Thomas B, 2016, ANAL CHEM CANNABIS, P1; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Weiblen GD, 2015, NEW PHYTOL, V208, P1241, DOI 10.1111/nph.13562; Welling MT, 2016, EUPHYTICA, V208, P463, DOI 10.1007/s10681-015-1585-y; Yang XM, 2016, FEBS J, V283, P1088, DOI 10.1111/febs.13654	43	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201119	10.1371/journal.pone.0201119	http://dx.doi.org/10.1371/journal.pone.0201119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036388	Green Submitted, Green Published, gold			2022-12-26	WOS:000439429200029
J	Tangsuwansri, C; Saeliw, T; Thongkorn, S; Chonchaiya, W; Suphapeetiporn, K; Mutirangura, A; Tencomnao, T; Hu, VW; Sarachana, T				Tangsuwansri, Chayanin; Saeliw, Thanit; Thongkorn, Surangrat; Chonchaiya, Weerasak; Suphapeetiporn, Kanya; Mutirangura, Apiwat; Tencomnao, Tewin; Hu, Valerie Wailin; Sarachana, Tewarit			Investigation of epigenetic regulatory networks associated with autism spectrum disorder (ASD) by integrated global LINE-1 methylation and gene expression profiling analyses	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; DNA METHYLATION; L1 RETROTRANSPOSITION; ALU METHYLATION; ELEMENTS; CHILDREN; PATTERNS; REVEAL; TRANSCRIPTOME; DISRUPTION	Background The exact cause and mechanisms underlying the pathobiology of autism spectrum disorder (ASD) remain unclear. Dysregulation of long interspersed element-1 (LINE-1) has been reported in the brains of ASD-like mutant mice and ASD brain tissues. However, the role and methylation of LINE-1 in individuals with ASD remain unclear. In this study, we aimed to investigate whether LINE-1 insertion is associated with differentially expressed genes (DEGs) and to assess LINE-1 methylation in ASD. Methods To identify DEGs associated with LINE-1 in ASD, we reanalyzed previously published transcriptome profiles and overlapped them with the list of LINE-1-containing genes from the TranspoGene database. An Ingenuity Pathway Analysis (IPA) of DEGs associated with LINE-1 insertion was conducted. DNA methylation of LINE-1 was assessed via combined bisulfite restriction analysis (COBRA) of lymphoblastoid cell lines from ASD individuals and unaffected individuals, and the methylation levels were correlated with the expression levels of LINE-1 and two LINE-1-inserted DEGs, Clorf27 and ARMC8. Results We found that LINE-1 insertion was significantly associated with DEGs in ASD. The IPA showed that LINE-1-inserted DEGs were associated with ASD-related mechanisms, including sex hormone receptor signaling and axon guidance signaling. Moreover, we observed that the LINE-1 methylation level was significantly reduced in lymphoblastoid cell lines from ASD individuals with severe language impairment and was inversely correlated with the transcript level. The methylation level of LINE-1 was also correlated with the expression of the LINE-1-inserted DEG Clorf27but not ARMC8. Conclusions In ASD individuals with severe language impairment, LINE-1 methylation was reduced and correlated with the expression levels of LINE-1 and the LINE-1-inserted DEG Clorf27. Our findings highlight the association of LINE-1 with DEGs in ASD blood samples and warrant further investigation. The molecular mechanisms of LINE-1 and the effects of its methylation in ASD pathobiology deserve further study.	[Tangsuwansri, Chayanin; Saeliw, Thanit; Thongkorn, Surangrat] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, MSc Program Clin Biochem & Mol Med, Bangkok, Thailand; [Chonchaiya, Weerasak] Chulalongkorn Univ, Fac Med, Div Growth & Dev, Dept Pediat, Bangkok, Thailand; [Chonchaiya, Weerasak] Chulalongkorn Univ, Fac Med, Dept Pediat, Maximizing Thai Childrens Dev Potential Res Unit, Bangkok, Thailand; [Chonchaiya, Weerasak] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Suphapeetiporn, Kanya] Chulalongkorn Univ, Fac Med, Ctr Excellence Med Genet, Dept Pediat, Bangkok, Thailand; [Suphapeetiporn, Kanya] Thai Red Cross Soc, Excellence Ctr Med Genet, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Dept Anat, Bangkok, Thailand; [Tencomnao, Tewin; Sarachana, Tewarit] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand; [Hu, Valerie Wailin] George Washington Univ, Dept Biochem & Mol Med, Sch Med & Hlth Sci, Washington, DC 20037 USA	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; George Washington University	Sarachana, T (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand.	tewarit.sa@chula.ac.th	Chonchaiya, Weerasak/AAJ-8062-2020	Chonchaiya, Weerasak/0000-0002-0223-9969; Tencomnao, Tewin/0000-0003-4177-2165	Office of the Higher Education Commission [MRG6080118]; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project" [RGN_2557_007_01_37]; Faculty of Allied Health Sciences Research Fund [AHS-CU 58003]; 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125601058M 53-4, GCUGR1125601055M 53-1, GCUGR1125601056M 53-2]; Research Assistant Scholarship, Chulalongkorn University; Graduate School, Chulalongkorn University; NIEHS [R21 ES023061]; Thailand Research Fund [MRG6080118, DPG5980005, BRG5980001]; National Institute of Mental Health [1U24MH081810]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	Office of the Higher Education Commission; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project"; Faculty of Allied Health Sciences Research Fund; 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Research Assistant Scholarship, Chulalongkorn University; Graduate School, Chulalongkorn University(Chulalongkorn University); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Thailand Research Fund(Thailand Research Fund (TRF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CT, TSae, and ST are graduate students in the M.Sc. Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University. This work is part of CT's thesis research to be presented in partial fulfillment of the requirements for the M.Sc. degree. This research is supported by the Research Grant for New Scholar by The Thailand Research Fund and Office of the Higher Education Commission (MRG6080118), the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project" (RGN_2557_007_01_37), and the Faculty of Allied Health Sciences Research Fund (AHS-CU 58003) to TS. CT, TSae, and ST were financially supported by The 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CT-GCUGR1125601058M 53-4; TSae-GCUGR1125601055M 53-1; ST-GCUGR1125601056M 53-2). CT received the Research Assistant Scholarship, Chulalongkorn University, while TSae and ST received additional financial support from "The Scholarship from the Graduate School, Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". VWH is supported by NIEHS grant R21 ES023061. AM is supported by the Thailand Research Fund (DPG5980005). KS is supported by the Thailand Research Fund (BRG5980001).; CT, TSae, and ST are graduate students in the M.Sc. Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University. This work is part of CT's thesis research to be presented in partial fulfillment of the requirements for the M.Sc. degree. This research is supported by the Research Grant for New Scholar by The Thailand Research Fund and Office of the Higher Education Commission (MRG6080118), the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project" (RGN_2557_007_01_37), and the Faculty of Allied Health Sciences Research Fund (AHS-CU 58003) to TS. CT, TSae, and ST were financially supported by The 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CT-GCUGR1125601058M 53-4; TSae-GCUGR1125601055M 53-1; ST-GCUGR11256 01056M 53-2). CT received the Research Assistant Scholarship, Chulalongkorn University, while TSae and ST received additional financial support from "The Scholarship from the Graduate School, Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". VWH is supported by NIEHS grant R21 ES023061. AM is supported by the Thailand Research Fund (DPG5980005). KS is supported by the Thailand Research Fund (BRG5980001). We wish to thank Dr. Charoenchai Puttipanyalears for teaching CT and TSae to conduct the COBRA and also thank Ms.Kannika Saina, Ms.Nungruthai Suntronwong, Mr.Perawatt Akaraamornthum, and Ms.Surangkhanan Khamthong for their assistance in LCL culture and RNA isolation. We also gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). The AGRE Consortium: Dan Geschwind, M.D., Ph.D., UCLA, Los Angeles, CA; Maja Bucan, Ph.D., University of Pennsylvania, Philadelphia, PA; W.Ted Brown, M.D., Ph.D., F.A.C.M.G., N.Y.S. Institute for Basic Research in Developmental Disabilities, Long Island, NY; Rita M. Cantor, Ph.D., UCLA School of Medicine, Los Angeles, CA; John N. Constantino, M.D., Washington University School of Medicine, St. Louis, MO; T. Conrad Gilliam, Ph.D., University of Chicago, Chicago, IL; Martha Herbert, M.D., Ph.D., Harvard Medical School, Boston, MA; Clara Lajonchere, Ph.D, Cure Autism Now, Los Angeles, CA; David H. Ledbetter, Ph.D., Emory University, Atlanta, GA; Christa Lese-Martin, Ph.D., Emory University, Atlanta, GA; Janet Miller, J.D., Ph.D., Cure Autism Now, Los Angeles, CA; Stanley F. Nelson, M.D., UCLA School of Medicine, Los Angeles, CA; Gerard D. Schellenberg, Ph.D., University of Washington, Seattle, WA; Carol A. Samango-Sprouse, Ed.D., George Washington University, Washington, D.C.; Sarah Spence, M.D., Ph.D., UCLA, Los Angeles, CA; Matthew State, M.D., Ph.D., Yale University, New Haven, CT. Rudolph E. Tanzi, Ph.D., Massachusetts General Hospital, Boston, MA.	Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Altun H, 2017, PSYCHIAT RES, V257, P67, DOI 10.1016/j.psychres.2017.06.008; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Bodo C, 2006, FRONT NEUROENDOCRIN, V27, P217, DOI 10.1016/j.yfrne.2006.02.004; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bruchhage Muriel M K, 2018, Handb Clin Neurol, V155, P61, DOI 10.1016/B978-0-444-64189-2.00004-4; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Christensen DL, 2016, J DEV BEHAV PEDIATR, V37, P1, DOI 10.1097/DBP.0000000000000235; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crider A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-46; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Ansary A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-265; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Fadini CC, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00347, 10.3389/fnhum.2015.00347]; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hu V. W., 2013, N AM J MED SCI BOSTO, V6; Hu VW, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-7; Hu VW, 2012, DIS MARKERS, V33, P277, DOI [10.1155/2012/835728, 10.3233/DMA-2012-0916]; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kanherkar RR, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00049; Kitkumthorn N, 2012, ASIAN PAC J CANCER P, V13, P4469, DOI 10.7314/APJCP.2012.13.9.4469; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Kwan V, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9176-3; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehman CW, 2005, GENOMICS, V85, P386, DOI 10.1016/j.ygeno.2004.11.009; Lertkhachonsuk R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421747; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Macia A, 2017, GENOME RES, V27, P335, DOI 10.1101/gr.206805.116; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; Mueller Stefan O., 2001, Current Opinion in Pharmacology, V1, P613, DOI 10.1016/S1471-4892(01)00105-9; Mukaetova-Ladinska EB, 2004, NEUROPATH APPL NEURO, V30, P615, DOI 10.1111/j.1365-2990.2004.00574.x; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nardone S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.70; Newkirk SJ, 2017, P NATL ACAD SCI USA, V114, pE5635, DOI 10.1073/pnas.1701069114; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pramparo T, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156108; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saeliw T, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0213-9; Sarachana T., 2013, MOL AUTISM, V4; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Schaefer GB, 2008, GENET MED, V10, P4, DOI 10.1097/GIM.0b013e31815efdd7; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Senthong A, 2014, INT J GYNECOL CANCER, V24, P36, DOI 10.1097/IGC.0000000000000021; Shpyleva S., 2017, MOL NEUROBIOL; Sirivanichsuntorn P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-10; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Suda S, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-14; Sukapan P, 2014, J HUM GENET, V59, P178, DOI 10.1038/jhg.2013.140; Talebizadeh Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067569; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Tonacci A, 2017, CHILD NEUROPSYCHOL, V23, P1, DOI 10.1080/09297049.2015.1081678; Tordjman S, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00001; Tremblay A, 2000, MOL CELL BIOL, V20, P54, DOI 10.1128/MCB.20.1.54-60.2000; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Wangsri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045292; Wanichnopparat W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-205; Wong CCY, 2014, MOL PSYCHIATR, V19, P495, DOI 10.1038/mp.2013.41; Xie CY, 2014, TUMOR BIOL, V35, P8903, DOI 10.1007/s13277-014-2162-z; Yeung KS, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0182-4	90	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201071	10.1371/journal.pone.0201071	http://dx.doi.org/10.1371/journal.pone.0201071			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036398	gold, Green Published, Green Submitted			2022-12-26	WOS:000439429200026
J	Abron, JD; Singh, NP; Price, RL; Nagarkatti, M; Nagarkatti, PS; Singh, UP				Abron, Jessicca D.; Singh, Narendra P.; Price, Robert L.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.; Singh, Udai P.			Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; IMMUNE-RESPONSES; IL-10(-/-) MICE; T-CELLS; ACTIVATION; SOY; INTERLEUKIN-1; PATHOGENESIS; INHIBITION	Mucosal changes in Crohn's disease (CD) and ulcerative colitis (UC), two major forms of inflammatory bowel disease (IBD), are characterized by a prominent infiltration of inflammatory cells including lymphocytes, macrophages, T cells and neutrophils. The precise etiology of IBD is unknown but it involves a complex interplay of factors associated with the immune system, environment, host genotype and enteric commensal bacteria. As there is no known safe cure for IBD, natural alternative therapeutic options without side effects are urgently needed. To this end, Soy-based foods, which have been eaten for centuries in Asian countries, have potential benefits, including lowering the incidence of coronary heart disease, atherosclerosis, type-2 diabetes, allergic response, and autoimmune diseases. This study describes the effect of Soy isoflavons 4', 5, 7 Trihydroxyisoflavone (genistein) on dextran sodium sulphate (DSS) induced experimental colitis. The extent and severity of disease was analyzed through body weight, histopathological analysis, cellular immune response, systemic cytokine levels, and inflammation score using a disease activity index. Genistein treatment significantly attenuated DSS-induced colitis severity and resulted in increase in body weight, colon length and reduction in inflammation score. Genistein also skews M1 macrophages towards the M2 phenotype. Further, gen also reduced the systemic cytokine levels as compared to vehicle control. This serves as the first detailed study towards natural soya based product that shows the polarization of Ml towards M2 macrophages, and reduction of systemic cytokine in part to attenuate the colitis symptoms. Thus, our work demonstrates that genistein, a soya compound, may be useful for the treatment of IBD.	[Abron, Jessicca D.; Singh, Narendra P.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.; Singh, Udai P.] Univ South Carolina, Sch Med, Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Price, Robert L.] Univ South Carolina, Sch Med, Cell Biol & Anat, Columbia, SC USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Singh, UP (corresponding author), Univ South Carolina, Sch Med, Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Udai.singh@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	NIH [R56 DK087836, P01AT003961, P20 GM 0103641, R01 AI123947, R01 AI129788]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants R56 DK087836, P01AT003961, P20 GM 0103641, R01 AI123947 and R01 AI129788.; This work was supported, in part by NIH grants R56 DK087836, P01AT003961, P20 GM 0103641, R01 AI123947 and R01 AI129788.	Anthony MS, 2000, J NUTR, V130, p662S, DOI 10.1093/jn/130.3.662S; Anthony MS, 1998, AM J CLIN NUTR, V68, p1390S, DOI 10.1093/ajcn/68.6.1390S; Arai Y, 1998, CYTOKINE, V10, P890, DOI 10.1006/cyto.1998.0355; Autenrieth IB, 1997, GUT, V41, P793, DOI 10.1136/gut.41.6.793; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Cosin-Roger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078128; Cui SN, 2014, INT IMMUNOPHARMACOL, V18, P142, DOI 10.1016/j.intimp.2013.11.016; Dia VP, 2008, J AGR FOOD CHEM, V56, P11707, DOI 10.1021/jf802475z; Elson CO, 1996, J IMMUNOL, V157, P2174; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gaetke LM, 2002, J NUTR, V132, P893, DOI 10.1093/jn/132.5.893; Hristodorov D, 2012, TOXINS, V4, P676, DOI 10.3390/toxins4090676; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Kogiso M, 2006, NUTRITION, V22, P802, DOI 10.1016/j.nut.2006.04.003; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mukund V, 2017, CRIT REV ONCOL HEMAT, V119, P13, DOI 10.1016/j.critrevonc.2017.09.004; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Reimund JM, 1996, GUT, V39, P684, DOI 10.1136/gut.39.5.684; Sakai T, 2006, J NUTR SCI VITAMINOL, V52, P293, DOI 10.3177/jnsv.52.293; Sakai T, 2011, BIOSCI BIOTECH BIOCH, V75, P593, DOI 10.1271/bbb.100710; Seibel J, 2009, EUR J NUTR, V48, P213, DOI 10.1007/s00394-009-0004-3; Singh UP, 2012, TOXICOL APPL PHARM, V258, P256, DOI 10.1016/j.taap.2011.11.005; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Singh UP, 2003, J IMMUNOL, V171, P1401, DOI 10.4049/jimmunol.171.3.1401; Singh UP, 2003, J INTERFERON CYTOKIN, V23, P2000; STROBER W, 1986, J CLIN IMMUNOL, V6, P415, DOI 10.1007/BF00915248; Sureda A, 2017, CHEM-BIOL INTERACT, V268, P37, DOI 10.1016/j.cbi.2017.02.012; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Verdrengh M, 2003, INFLAMM RES, V52, P341, DOI 10.1007/s00011-003-1182-8; Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574; Weisser SB, 2011, J LEUKOCYTE BIOL, V90, P483, DOI 10.1189/jlb.0311124	40	42	43	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199631	10.1371/journal.pone.0199631	http://dx.doi.org/10.1371/journal.pone.0199631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024891	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000008
J	Zeitelhofer, M; Li, H; Adzemovic, MZ; Nilsson, I; Muhl, L; Scott, AM; Eriksson, U				Zeitelhofer, Manuel; Li, Hong; Adzemovic, Milena Z.; Nilsson, Ingrid; Muhl, Lars; Scott, Andrew M.; Eriksson, Ulf			Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; TRANSGENIC MICE; FIBROSIS; IMATINIB; CELL; IDENTIFICATION; FIBROBLASTS; CARCINOMA	Platelet-derived growth factor CC (PDGF-CC) is important during foetal development but also in pathogenesis of neurologic diseases, cancer and fibrosis. We have previously demonstrated that blocking the PDGF-CC/PDGF receptor alpha (PDGFRa) axis resulted in reduction of stroke volume and cerebrovascular permeability after experimentally induced stroke. Recently, we could translate these findings into the clinic showing that imatinib, a small tyrosine kinase inhibitor targeting PDGF receptors, can significantly improve neurological outcome after ischemic stroke in human. Herein we report preclinical toxicological analyses of our newly generated monoclonal anti-human PDGF-CC antibody 6B3 (mAb 6B3) in PDGF-CC humanized mice. Beside histological organ assessment, we also analysed serum, urine, haematological parameters and the general health status of the treated mice. We could not find any indications that mAb 6B3 is toxic or has other significant side effects neither in short, nor in long treatment regimens. Our results indicate that mAb 6B3 can be further developed for clinical use. This opens up the possibility to assess the therapeutic potential of blocking PDGF-CC in diverse pathological conditions such as neurologic diseases, cancer and fibrosis.	[Zeitelhofer, Manuel; Li, Hong; Adzemovic, Milena Z.; Nilsson, Ingrid; Muhl, Lars; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Scott, Andrew M.] La Trobe Univ, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia; [Scott, Andrew M.] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia	Karolinska Institutet; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University	Zeitelhofer, M; Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	manuel.zeitelhofer@ki.se; ulf.pe.eriksson@ki.se		Eriksson, Ulf/0000-0002-4439-3980; Zeitelhofer, Manuel/0000-0002-4324-2355; Scott, Andrew/0000-0002-6656-295X	Swedish Heart and Lung Foundation [20110451, 20120077]; Swedish Research Council [2011-03861, 2016-02593, 2017-00691]; Cancerfonden [CAN 2016/633, CAN 2014/630]; Karolinska Institutet; Australian National Health and Medical Research Council (NHMRC) [1038334, 1075898]; Practitioner Fellowship; Victorian Government, Australia	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government, Australia	This study was supported by the Swedish Heart and Lung Foundation (20110451 and 20120077, U.E.), the Swedish Research Council (2011-03861, 2016-02593, 2017-00691, U.E.), Cancerfonden (CAN 2016/633, CAN 2014/630, U.E.), Karolinska Institutet, the Australian National Health and Medical Research Council (NHMRC) Development Grants (1038334 and 1075898, A.M.S.), the Practitioner Fellowship (A.M.S.) and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders provided support in the form of salaries for authors [HL, MZ, IN, LM, AMS and UE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2002, MECH DEVELOP, V110, P187, DOI 10.1016/S0925-4773(01)00560-3; Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Adzemovic MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056586; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Andrae J, 2016, BIOL OPEN, V5, P461, DOI 10.1242/bio.017368; [Anonymous], 2015, ASS HLTH STAT SMALL; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; de la Ossa NP, 2008, NEUROLOGY, V70, P1238, DOI 10.1212/01.wnl.0000291008.63002.a5; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fredriksson L, 2015, ANN CLIN TRANSL NEUR, V2, P722, DOI 10.1002/acn3.209; Fredriksson L, 2012, AM J PATHOL, V180, P1136, DOI 10.1016/j.ajpath.2011.12.006; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Kulkens Sonja, 2007, Expert Rev Neurother, V7, P783, DOI 10.1586/14737175.7.7.783; Lewandowski SA, 2016, ACTA NEUROPATHOL, V131, P453, DOI 10.1007/s00401-015-1520-2; Li H, 2018, PLOS ONE; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lynch CM, 2009, MABS-AUSTIN, V1, P2, DOI 10.4161/mabs.1.1.7377; Mughal TI, 2010, BIOL-TARGETS THER, V4, P315, DOI 10.2147/BTT.S5775; Podolin PL, 2000, IMMUNOLOGY, V99, P287, DOI 10.1046/j.1365-2567.2000.00946.x; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; Presta LG, 2006, ADV DRUG DELIVER REV, V58, P640, DOI 10.1016/j.addr.2006.01.026; Pye SM, 2008, BLOOD, V111, P5505, DOI 10.1182/blood-2007-10-114900; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Sharma A, 2000, J PHARMACOL EXP THER, V293, P33; Stefanitsch C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00456; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Wahlgren N, 2017, J INTERN MED, V281, P273, DOI 10.1111/joim.12576; Whiteley WN, 2016, LANCET NEUROL, V15, P925, DOI [10.1016/s1474-4422(16)30076-X, 10.1016/S1474-4422(16)30076-X]; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	36	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200649	10.1371/journal.pone.0200649	http://dx.doi.org/10.1371/journal.pone.0200649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021009	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400064
J	Fonte, C; Kaminski, S; Vanet, A; Lanfumey, L; Cohen-Salmon, C; Ghislin, S; Frippiat, JP				Fonte, Coralie; Kaminski, Sandra; Vanet, Anne; Lanfumey, Laurence; Cohen-Salmon, Charles; Ghislin, Stephanie; Frippiat, Jean-Pol			Socioenvironmental stressors encountered during spaceflight partially affect the murine TCR- repertoire and increase its self-reactivity	FASEB JOURNAL			English	Article						lymphopoiesis; immunity; T cell; lymphocytes; antigen receptor	CHRONIC ULTRAMILD STRESS; BONE-MARROW; LYMPHOID ORGANS; CELL; RECEPTOR; EXPOSURE; TRANSCRIPTION; RECOMBINASE; MODEL; USAGE	Spaceflights are known to affect the immune system. In a previous study, we demonstrated that hypergravity exposure during murine development modified 85% of the T-cell receptor (TCR)- repertoire. In this study, we investigated whether socioenvironmental stressors encountered during space missions affect T lymphopoiesis and the TCR- repertoire. To address this question, pregnant mice were subjected throughout gestation to chronic unpredictable mild stressors (CUMS), a model used to mimic socioenvironmental stresses encountered during space missions. Then, newborn T lymphopoiesis and the TCR- repertoire were studied by flow cytometry and high-throughput sequencing, respectively. No change in thymocyte maturation or TCR expression were noted. TCR- repertoire analysis revealed that 75% of neonate TCR- sequences resulted from the expression of 3 variable (V) segments and that this core repertoire was not affected by CUMS. However, the minor repertoire, representing 25% of the global repertoire, was sensitive to CUMS exposure. We also showed that the variable (diversity) joining [V(D)J] recombination process was unlikely to be affected. Finally, we noted that the CUMS neonatal minor repertoire was more self-reactive than the one of control pups. These findings show that socioenvironmental stressors such as those encountered during space missions affect a fraction (25%) of the TCR- repertoire and that these stressors could increase self-reactivity.Fonte, C., Kaminski, S., Vanet, A., Lanfumey, L., Cohen-Salmon, C., Ghislin, S., Frippiat, J.-P. Socioenvironmental stressors encountered during spaceflight partially affect the murine TCR- repertoire and increase its self-reactivity.	[Fonte, Coralie; Kaminski, Sandra; Ghislin, Stephanie; Frippiat, Jean-Pol] Univ Lorraine, EA7300, Fac Med, Stress Immun Pathogens Lab, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France; [Vanet, Anne] Univ Sorbonne Paris Cite, Paris Diderot Univ, Inst Jacques Monod, CNRS,Unite Mixte Rech 7592,Epole Genoinformat, Paris, France; [Lanfumey, Laurence] INSERM, Unit Mixte Rech 894, Ctr Psychiat & Neurosci, Paris, France; [Cohen-Salmon, Charles] Univ Paris Diderot, Sorbonne Paris Cite, Hop Robert Debre, INSERM,Unite 1141, Paris, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Frippiat, JP (corresponding author), Univ Lorraine, EA7300, Fac Med, Stress Immun Pathogens Lab, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@univ-lorraine.fr	Lanfumey, Laurence/P-3037-2017; Kaminski, Sandra/AAM-6134-2021	Vanet, Anne/0000-0002-6018-3158	French Space Agency [DAR 4800000894, 4800000950]; French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine; INSERM; Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir) [ANR 15-004]; ImagoSeine Core Facility of the Institut Jacques Monod; France BioImaging [ANR-10.INBS-04]; La Ligue Contre le Cancer [R03/75-79]	French Space Agency(Centre National D'etudes Spatiales); French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir)(French National Research Agency (ANR)); ImagoSeine Core Facility of the Institut Jacques Monod; France BioImaging(French National Research Agency (ANR)); La Ligue Contre le Cancer(Ligue nationale contre le cancer)	The authors thank T. Marday, N. Boggetto, and G. Wentzinger for efficient technical support and assistance. This work was supported by the French Space Agency (Grants DAR 4800000894 and 4800000950), the French Ministry of Higher Education and Research, the Universite de Lorraine, the Region Lorraine, and INSERM; the Stress Immunity Pathogens Laboratory received support from the Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir; ANR 15-004). The study was supported by the ImagoSeine Core Facility of the Institut Jacques Monod, a member of France BioImaging (ANR-10.INBS-04), and La Ligue Contre le Cancer (R03/75-79). The authors declare no conflicts of interest.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818; Bevington S, 2013, EMBO J, V32, P1381, DOI 10.1038/emboj.2013.42; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; Dong MQ, 2017, J IMMUNOL, V199, P965, DOI 10.4049/jimmunol.1602137; Fonte C, 2015, DEV COMP IMMUNOL, V53, P371, DOI 10.1016/j.dci.2015.08.006; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Gaignier F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00514; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Hunter MC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00613; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Madi A, 2017, ELIFE, V6, DOI 10.7554/eLife.22057; Madi A, 2014, GENOME RES, V24, P1603, DOI 10.1101/gr.170753.113; Massart R, 2016, DEV PSYCHOPATHOL, V28, P1259, DOI 10.1017/S0954579416000833; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Misdrahi D, 2005, PSYCHIAT RES, V137, P123, DOI 10.1016/j.psychres.2005.07.020; MORAHAN G, 1987, EMBO J, V6, P3679, DOI 10.1002/j.1460-2075.1987.tb02701.x; Murray JM, 2012, J IMMUNOL, V189, P2356, DOI 10.4049/jimmunol.1200382; Ndifon W, 2012, P NATL ACAD SCI USA, V109, P15865, DOI 10.1073/pnas.1203916109; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pardon MC, 2000, BIOL PSYCHIAT, V47, P858, DOI 10.1016/S0006-3223(99)00253-X; Rangon CM, 2007, J NEUROSCI, V27, P7532, DOI 10.1523/JNEUROSCI.5330-06.2007; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Sethna Z, 2017, P NATL ACAD SCI USA, V114, P2253, DOI 10.1073/pnas.1700241114; Subrahmanyam R, 2012, NAT IMMUNOL, V13, P1205, DOI 10.1038/ni.2447; Taves MD, 2017, HORM BEHAV, V88, P4, DOI 10.1016/j.yhbeh.2016.10.022; VACEK A, 1991, FOLIA BIOL-PRAGUE, V37, P35; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; Woods CC, 2003, FASEB J, V17, P1526, DOI 10.1096/fj.02-0749fje; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488	39	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					896	908		10.1096/fj.201800969R	http://dx.doi.org/10.1096/fj.201800969R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052484	Green Submitted			2022-12-26	WOS:000457401500070
J	Xu, ZY; Wang, YL; Xiao, ZG; Zou, C; Zhang, X; Wang, Z; Wu, DL; Yu, S; Chan, FL				Xu, Zhenyu; Wang, Yuliang; Xiao, Zhan Gang; Zou, Chang; Zhang, Xian; Wang, Zhu; Wu, Dinglan; Yu, Shan; Chan, Franky Leung			Nuclear receptor ERRa and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; MOLECULAR CHARACTERIZATION; INCREASED EXPRESSION; PSA RECURRENCE; CELL-LINE; ALPHA; REARRANGEMENT; ASSOCIATION; HIF-1-ALPHA	The TMPRSS2:ERG (T:E) fusion gene is generally believed to be mainly regulated by the activated androgen receptor (AR) signaling in androgen-dependent prostate cancer. However, its persistent expression in castration-resistant and neuroendocrine prostate cancers implies that other transcription factors might also regulate its expression. Here, we showed that up-regulation of nuclear receptor estrogen-related receptor alpha (ERR alpha) was closely associated with the oncogenic transcription factor ERG expression in prostate cancer, and their increased coexpression patterns were closely associated with high Gleason scores and metastasis in patients. Both ERRa and ERG exhibited a positive expression correlation in a castration-resistant prostate cancer (CRPC) xenograft model VCaP-CRPC. We showed that ERR alpha could directly transactivate T:E fusion gene in both AR-positive and -negative prostate cancer cells via both ERR-binding element- and AR-binding element-dependent manners. Ectopic T:E expression under ERRa regulation could promote both in vitro invasion and in vivo metastasis capacities of AR-negative prostatic cells. Intriguingly, ERG expressed by the T:E fusion could also transactivate the ERR alpha (ESRRA) gene. Hereby, ERR alpha and ERG can synergistically regulate each other and form a reciprocal regulatory loop to promote the advanced growth of prostate cancer. Inhibition of ERR alpha activity by ERR alpha inverse agonist could suppress T:E expression in prostate cancer cells, implicating that targeting ERR alpha could be a potential therapeutic strategy for treating the aggressive T:E-positive prostate cancer.	[Xu, Zhenyu; Zhang, Xian] Wannan Med Coll, Yijishan Affiliated Hosp, Dept Pharm, Wuhu, Anhui, Peoples R China; [Xu, Zhenyu; Wang, Yuliang; Xiao, Zhan Gang; Zou, Chang; Wang, Zhu; Wu, Dinglan; Yu, Shan; Chan, Franky Leung] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Xiao, Zhan Gang] Southwest Med Univ, Dept Pharmacol, Luzhou, Peoples R China; [Zou, Chang] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Clin Med Res Ctr, Shenzhen, Peoples R China	Wannan Medical College; Chinese University of Hong Kong; Southwest Medical University; Jinan University	Yu, S; Chan, FL (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	yushan771@hotmail.com; franky-chan@cuhk.edu.hk	Zou, Chang/AAS-3356-2021; Chan, Franky L./M-1043-2018	Zou, Chang/0000-0002-2003-7834; Chan, Franky L./0000-0003-0567-2052; Wu, Dinglan/0000-0002-5057-9626; Wang, Zhu/0000-0002-5457-3731	General Research Funds [14100914, 14107116]; Research Grants Council of Hong Kong; University Natural Science Research Project of Anhui Province [KJ2016A732]; National Natural Science Foundation of China [81602240, 81402370]	General Research Funds; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Natural Science Research Project of Anhui Province(Natural Science Foundation of Anhui Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the General Research Funds (Project numbers 14100914 and 14107116), Research Grants Council of Hong Kong (to F.L.C.), University Natural Science Research Project of Anhui Province (KJ2016A732) (to Z.X.) and National Natural Science Foundation of China (81602240 to Z.X.; 81402370 to C.Z.).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Adamo P, 2016, ONCOGENE, V35, P403, DOI 10.1038/onc.2015.109; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Bismar TA, 2012, EUR J CANCER, V48, P538, DOI 10.1016/j.ejca.2012.01.001; Bonaccorsi L, 2009, J ENDOCRINOL INVEST, V32, P590, DOI 10.1007/BF03346514; Boormans JL, 2010, EUR UROL, V57, P830, DOI 10.1016/j.eururo.2009.08.013; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Cai G, 2017, ONCOGENE, V36, P546, DOI 10.1038/onc.2016.227; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Danila DC, 2011, EUR UROL, V60, P897, DOI 10.1016/j.eururo.2011.07.011; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Esgueva R, 2010, MODERN PATHOL, V23, P539, DOI 10.1038/modpathol.2009.193; Falzarano SM, 2010, MODERN PATHOL, V23, P1499, DOI 10.1038/modpathol.2010.150; Feng FY, 2014, CLIN CANCER RES, V20, P4442, DOI 10.1158/1078-0432.CCR-13-0275; Font-Tello A, 2015, PROSTATE, V75, P1216, DOI 10.1002/pros.23004; Fradet A, 2016, ONCOTARGET, V7, P77071, DOI 10.18632/oncotarget.12787; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Hagglof C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086824; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Hoogland AM, 2012, MODERN PATHOL, V25, P471, DOI 10.1038/modpathol.2011.176; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Polson ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2627; Rubin MA, 2012, ASIAN J ANDROL, V14, P393, DOI 10.1038/aja.2011.145; Scheble VJ, 2012, VIRCHOWS ARCH, V461, P157, DOI 10.1007/s00428-012-1270-7; Schelling LA, 2013, HUM PATHOL, V44, P2227, DOI 10.1016/j.humpath.2013.05.005; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Spencer ES, 2013, PROSTATE, V73, P905, DOI 10.1002/pros.22636; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toubaji A, 2011, MODERN PATHOL, V24, P1511, DOI 10.1038/modpathol.2011.111; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Z, 2018, ENDOCR-RELAT CANCER, V25, P35, DOI 10.1530/ERC-17-0280; Washington MN, 2010, ENDOCRINOLOGY, V151, P1409, DOI 10.1210/en.2009-0991; Wu DL, 2016, BBA-REV CANCER, V1866, P23, DOI 10.1016/j.bbcan.2016.06.001; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu S, 2014, J PATHOL, V234, P514, DOI 10.1002/path.4413; Yu S, 2013, CANCER LETT, V328, P83, DOI 10.1016/j.canlet.2012.09.006; Yu S, 2009, BIOCHEM BIOPH RES CO, V382, P756, DOI 10.1016/j.bbrc.2009.03.110; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	58	33	34	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 29	2018	37	48					6259	6274		10.1038/s41388-018-0409-7	http://dx.doi.org/10.1038/s41388-018-0409-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HC2HE	30042415	Green Published, hybrid			2022-12-26	WOS:000451622100005
J	Poppe, J; Reichelt, J; Blankenfeldt, W				Poppe, Juliane; Reichelt, Joachim; Blankenfeldt, Wulf			Pseudomonas aeruginosa pyoverdine maturation enzyme PvdP has a noncanonical domain architecture and affords insight into a new subclass of tyrosinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; Pseudomonas aeruginosa (P-aeruginosa); infectious disease; copper; protein structure; tyrosinase; biosynthesis; enzyme; streptavidin	CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; IDENTIFICATION; SIDEROPHORE; MECHANISM; CRYSTALLOGRAPHY; BIOSYNTHESIS; CHROMOPHORE; VALIDATION; SECRETION	Pyoverdines (PVDs) are important chromophore-containing siderophores of fluorescent pseudomonad bacteria such as the opportunistic human pathogen Pseudomonas aeruginosa in which they play an essential role in host infection. PVD biosynthesis encompasses a complex pathway comprising cytosolic nonribosomal peptide synthetases that produce a polypeptide precursor that periplasmic enzymes convert to the final product. The structures of most enzymes involved in PVD chromophore maturation have been elucidated, but the structure of the essential tyrosinase PvdP, a monooxygenase required for the penultimate step in PVD biosynthesis, is not known. Here, we closed this gap by determining the crystal structure of PvdP in an apo and tyrosine-complexed state at 2.1 and 2.7 , respectively. These structures revealed that PvdP is a homodimer, with each chain consisting of a C-terminal tyrosinase domain and an N-terminal eight-stranded beta-barrel reminiscent of streptavidin that appears to have a structural role only. We observed that ligand binding leads to the displacement of a "placeholder" tyrosine that blocks the active site in the apo structure. This exposes a large, deep binding site that seems suitable for accommodating ferribactin, a substrate of PvdP in PVD biosynthesis. The binding site consists almost exclusively of residues from the tyrosinase domain. Of note, we also found that this domain is more closely related to tyrosinases from arthropods rather than to tyrosinases from other bacteria. In conclusion, our work unravels the structural basis of PvdP's activity in PVD biosynthesis, observations that may inform structure-guided development of PvdP-specific inhibitors to manage P. aeruginosa infections.	[Poppe, Juliane; Reichelt, Joachim; Blankenfeldt, Wulf] Helmholtz Ctr Infect Res, Dept Struct & Funct Proteins, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Blankenfeldt, Wulf] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Spielmannstr 7, D-38106 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Blankenfeldt, W (corresponding author), Helmholtz Ctr Infect Res, Dept Struct & Funct Proteins, Inhoffenstr 7, D-38124 Braunschweig, Germany.	wulf.blankenfeldt@helmholtz-hzi.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguilera F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-96; ALBRECHTGARY AM, 1994, INORG CHEM, V33, P6391, DOI 10.1021/ic00104a059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; Burkhardt A, 2016, EUR PHYS J PLUS, V131, P1, DOI 10.1140/epjp/i2016-16056-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dorrestein PC, 2003, ORG LETT, V5, P2215, DOI 10.1021/ol034531e; Drake EJ, 2016, ACTA CRYSTALLOGR F, V72, P403, DOI 10.1107/S2053230X16006257; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldfeder M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5505; Han HY, 2007, BBA-PROTEINS PROTEOM, V1774, P822, DOI 10.1016/j.bbapap.2007.04.011; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanteev M, 2015, PROTEIN SCI, V24, P1360, DOI 10.1002/pro.2734; Kanteev M, 2013, J BIOL INORG CHEM, V18, P895, DOI 10.1007/s00775-013-1034-0; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Le Trong I, 2011, ACTA CRYSTALLOGR D, V67, P813, DOI 10.1107/S0907444911027806; Lee SY, 2016, J ENZYM INHIB MED CH, V31, P1, DOI 10.3109/14756366.2015.1004058; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McMorran BJ, 2001, MICROBIOL-SGM, V147, P1517, DOI 10.1099/00221287-147-6-1517; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Meyer JM, 2008, BIOMETALS, V21, P259, DOI 10.1007/s10534-007-9115-6; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ringel MT, 2018, J BIOL CHEM, V293, P2330, DOI 10.1074/jbc.RA117.000121; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Royer WE, 2006, STRUCTURE, V14, P1167, DOI 10.1016/j.str.2006.05.011; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Vandenende CS, 2004, J BACTERIOL, V186, P5596, DOI 10.1128/JB.186.17.5596-5602.2004; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0; Yuan ZL, 2017, BIOCHEM BIOPH RES CO, V484, P195, DOI 10.1016/j.bbrc.2016.12.181	57	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14926	14936		10.1074/jbc.RA118.002560	http://dx.doi.org/10.1074/jbc.RA118.002560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30030378	Green Published, hybrid			2022-12-26	WOS:000446155000028
J	Da Pozzo, E; Giacomelli, C; Cavallini, C; Martini, C				Da Pozzo, Eleonora; Giacomelli, Chiara; Cavallini, Chiara; Martini, Claudia			Cytokine secretion responsiveness of lymphomonocytes following cortisol cell exposure: Sex differences	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; TNF-ALPHA; ANTIINFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; DOSAGE COMPENSATION; GENDER-DIFFERENCE; GENE-EXPRESSION; IMMUNE-SYSTEM; STRESS; AGE	The stress hormone cortisol has been recognized as a coordinator of immune response. However, its different ability to modulate the release of inflammatory mediators in males and females has not been clarified yet. Indeed, the dissection of cortisol specific actions may be difficult due to the complex hormonal and physio-pathological individual status. Herein, the release of inflammatory mediators following increasing cortisol concentrations was investigated in an in vitro model of primary human male and female lymphomonocytes. The use of a defined cellular model to assess sex differences in inflammatory cytokine secretion could be useful to exclude the effects of divergent and fluctuating sex hormone levels occurring in vivo. Herein, the cells were challenged with cortisol concentrations resembling the plasma levels achieving in physiological and stressful conditions. The production of cytokines and other molecules involved in inflammatory process was determined. In basal conditions, male cells presented higher levels of some pro-inflammatory molecules (NF-kB and IDO-1 mRNAs, IL-6 and kynurenine) than female cells. Following cortisol exposure, the levels of the pro-inflammatory cytokines, IL-6 and IL-8, were increased in male cells. Conversely, in female cells IL-6 release was unchanged and IL-8 levels were decreased. Anti-inflammatory cytokines, IL-4 and IL-10, did not change in male cells and increased in female cells. Interestingly, kynurenine levels were higher in female cells than in male cells following cortisol stimulus. These results highlighted that cortisol differently affects male and female lymphomonocytes, shifting the cytokine release in favour of a pro-inflammatory pattern in male cells and an anti-inflammatory secretion profile in female cells, opening the way to study the influences of other stressful factors involved in the neurohumoral changes occurring in the response to stress conditions.	[Da Pozzo, Eleonora; Giacomelli, Chiara; Cavallini, Chiara; Martini, Claudia] Univ Pisa, Dept Pharm, Pisa, Italy	University of Pisa	Da Pozzo, E; Martini, C (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	eleonora.dapozzo@unipi.it; claudia.martini@unipi.it	Giacomelli, Chiara/K-4954-2016; Da Pozzo, Eleonora/AAW-8186-2020; Martini, Claudia/AAC-4089-2019; Cavallini, Chiara/ABC-9438-2020	Giacomelli, Chiara/0000-0002-6244-602X; Da Pozzo, Eleonora/0000-0003-4762-8949; Martini, Claudia/0000-0001-9379-3027; Cavallini, Chiara/0000-0002-3456-5152	Seventh FRAMEWORK PROGRAMME, 'Science in Society', Project title: Transforming Institutions by gendering contents and gaining equality in research (TRIGGER), GA [611034]	Seventh FRAMEWORK PROGRAMME, 'Science in Society', Project title: Transforming Institutions by gendering contents and gaining equality in research (TRIGGER), GA	Funding for this study was provided by the Seventh FRAMEWORK PROGRAMME, 'Science in Society', Project title: Transforming Institutions by gendering contents and gaining equality in research (TRIGGER), GA. No 611034. The FP7 EU commission had no role in the design of the study and collection, analysis, or interpretation of data, nor in writing the manuscript.	Agarwal SK, 1998, J INTERF CYTOK RES, V18, P1059, DOI 10.1089/jir.1998.18.1059; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Andersen MH, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv154; Aoyama M, 2009, SHOCK, V32, P401, DOI 10.1097/SHK.0b013e31819c358a; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; ARNOLD R, 1995, IMMUNOLOGY, V85, P364; Balestri F, 2013, J ENVIRON MANAGE, V117, P76, DOI 10.1016/j.jenvman.2012.12.030; Bauer I, 2006, ANAESTHESIST, V55, P515, DOI 10.1007/s00101-006-0983-x; Beck KD, 2003, INTEGR PHYS BEH SCI, V38, P179, DOI 10.1007/BF02688852; Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Casimir GJA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-28; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Choi Joungbum, 2014, Immune Netw, V14, P289, DOI 10.4110/in.2014.14.6.289; Daniele S, 2015, CELL SIGNAL, V27, P1609, DOI 10.1016/j.cellsig.2015.04.006; DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V; Dementyeva EV, 2009, BIOESSAYS, V31, P21, DOI 10.1002/bies.080149; Elsenmenger SJ, 2004, CELL IMMUNOL, V230, P17, DOI 10.1016/j.cellimm.2004.08.002; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; Feuerecker M, 2013, CLIN EXP IMMUNOL, V172, P290, DOI 10.1111/cei.12049; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Guilbault C, 2002, IMMUNOLOGY, V107, P297, DOI 10.1046/j.1365-2567.2002.01508.x; Hermes GL, 2006, AM J PHYSIOL-REG I, V290, pR273, DOI 10.1152/ajpregu.00368.2005; Hol JW, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0102-2; Holden C, 2005, SCIENCE, V308, P1574, DOI 10.1126/science.308.5728.1574; Howard RR, 1996, CYTOMETRY, V26, P231, DOI 10.1002/(SICI)1097-0320(19960915)26:3<231::AID-CYTO9>3.3.CO;2-3; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Jankord R, 2007, ENDOCRINOLOGY, V148, P3758, DOI 10.1210/en.2006-1650; Jansky L, 2003, PHYSIOL RES, V52, P593; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Katial RK, 1998, CLIN DIAGN LAB IMMUN, V5, P78, DOI 10.1128/CDLI.5.1.78-81.1998; Kinser PA, 2014, BRAIN BEHAV, V4, P665, DOI 10.1002/brb3.249; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lestage J, 2002, BRAIN BEHAV IMMUN, V16, P596, DOI 10.1016/S0889-1591(02)00014-4; Lovallo WR, 2015, NEUROPSYCHOPHARMACOL, V40, P2546, DOI 10.1038/npp.2015.101; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundberg U, 2005, PSYCHONEUROENDOCRINO, V30, P1017, DOI 10.1016/j.psyneuen.2005.03.014; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Moxley G, 2004, J RHEUMATOL, V31, P686; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Pallotta MT, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00497; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Porreca E, 1999, ATHEROSCLEROSIS, V146, P345, DOI 10.1016/S0021-9150(99)00160-4; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P622, DOI 10.1016/j.bbi.2008.11.004; Prothero KE, 2009, CHROMOSOME RES, V17, P637, DOI 10.1007/s10577-009-9063-9; Queen AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152289; READE MC, 2009, CRIT CARE MED, V37, P1809, DOI DOI 10.1097/CCM.0B013E3181A1A12B; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Spolarics Z, 2007, SHOCK, V27, P597, DOI 10.1097/SHK.0b013e31802e40bd; TOLLERUD DJ, 1989, J CLIN IMMUNOL, V9, P214, DOI 10.1007/BF00916817; Turck J, 2005, MED MICROBIOL IMMUN, V194, P47, DOI 10.1007/s00430-003-0210-1; Tyagi P, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-23; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; WILDER RL, 1995, ANNU REV IMMUNOL, V13, P307; Wolf JM, 2009, BRAIN BEHAV IMMUN, V23, P742, DOI 10.1016/j.bbi.2008.09.009; Xiang LB, 2013, INT IMMUNOPHARMACOL, V17, P556, DOI 10.1016/j.intimp.2013.07.019	72	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200924	10.1371/journal.pone.0200924	http://dx.doi.org/10.1371/journal.pone.0200924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048487	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400031
J	Holmes, G; Zhang, LN; Rivera, J; Murphy, R; Assouline, C; Sullivan, L; Oppeneer, T; Jabs, EW				Holmes, Greg; Zhang, Lening; Rivera, Joshua; Murphy, Ryan; Assouline, Claudia; Sullivan, Lorraine; Oppeneer, Todd; Jabs, Ethylin Wang			C-type natriuretic peptide analog treatment of craniosynostosis in a Crouzon syndrome mouse model	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SKELETAL DYSPLASIAS; FACTOR RECEPTOR-2; ACHONDROPLASIA; MUTATIONS; EXPRESSION; GENE; CNP; ORGANOGENESIS; OSSIFICATION	Activating mutations of fibroblast growth factor receptors (FGFRs) are a major cause of skeletal dysplasias, and thus they are potential targets for pharmaceutical intervention. BMN 111, a C-type natriuretic peptide analog, inhibits FGFR signaling at the level of the RAF1 kinase through natriuretic peptide receptor 2 (NPR2) and has been shown to lengthen the long bones and improve skull morphology in the Fgfr3(Y367C/+) thanatophoric dysplasia mouse model. Here we report the effects of BMN 111 in treating craniosynostosis and aberrant skull morphology in the Fgfr2c(C342Y/+) Crouzon syndrome mouse model. We first demonstrated that NPR2 is expressed in the murine coronal suture and spheno-occipital synchondrosis in the newborn period. We then gave Fgfr2c(C342Y/+) and Fgfr2c(+/+) (WT) mice once-daily injections of either vehicle or reported therapeutic levels of BMN 111 between post-natal days 3 and 31. Changes in skeletal morphology, including suture patency, skull dimensions, and long bone length, were assessed by micro-computed tomography. Although BMN 111 treatment significantly increased long bone growth in both WT and mutant mice, skull dimensions and suture patency generally were not significantly affected. A small but significant increase in the relative length of the anterior cranial base was observed. Our results indicate that the differential effects of BMN 111 in treating various skeletal dysplasias may depend on the process of bone formation targeted (endochondral or intramembranous), the specific FGFR mutated, and/or the specific signaling pathway changes due to a given mutation.	[Holmes, Greg; Rivera, Joshua; Assouline, Claudia; Jabs, Ethylin Wang] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhang, Lening; Murphy, Ryan; Sullivan, Lorraine; Oppeneer, Todd] BioMarin Pharmaceut, Novato, CA USA	Icahn School of Medicine at Mount Sinai; BioMarin Pharmaceutical Inc.	Holmes, G (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	gregory.holmes@mssm.edu		Holmes, Greg/0000-0003-0717-6722	BioMarin Pharmaceutical, Inc.; National Institute of Health (NIH) National Institute of Dental and Craniofacial Research [R01 DE022988]; NIH National Institute of Child Health and Human Development [P01 HD078233]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022988] Funding Source: NIH RePORTER	BioMarin Pharmaceutical, Inc.; National Institute of Health (NIH) National Institute of Dental and Craniofacial Research; NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc., provided support in the form of partial salaries (GH, EWJ), reagents, equipment, and facilities, and had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of the authors employed by BioMarin Pharmaceutical included imaging methodology, data curation, visualization, and analysis, which were performed by LZ and RM, who along with LS and TO reviewed and edited the manuscript. Their specific roles are articulated in the Author Contributions section. Additional funding was supplied by National Institute of Health (NIH) National Institute of Dental and Craniofacial Research (https://www.nidcr.nih.gov/) R01 DE022988 (to EWJ) and NIH National Institute of Child Health and Human Development (https://www.nichd.nih.gov/) P01 HD078233 (to EWJ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Di Rocco F, 2014, HUM MOL GENET, V23, P2914, DOI 10.1093/hmg/ddu004; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Goodrich JT, 2005, CHILD NERV SYST, V21, P871, DOI 10.1007/s00381-004-1113-1; Helman SN, 2014, ORAL MAXILLOFAC SURG, V18, P373, DOI 10.1007/s10006-014-0467-0; Heuze Yann, 2014, Curr Genet Med Rep, V2, P135; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Legeai-Mallet L, 2016, ENDOCR DEV, V30, P98, DOI 10.1159/000439334; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Martinez-Abadias N, 2013, DEV DYNAM, V242, P80, DOI 10.1002/dvdy.23903; Nakao K, 2013, J DENT RES, V92, P58, DOI 10.1177/0022034512466413; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Pannier S, 2009, BBA-MOL BASIS DIS, V1792, P140, DOI 10.1016/j.bbadis.2008.11.010; Perlyn CA, 2006, NEUROSURGERY, V59, P210, DOI 10.1227/01.NEU.0000224323.53866.1E; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; PETERS KG, 1992, DEVELOPMENT, V114, P233; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; Rijken BFM, 2013, PLAST RECONSTR SURG, V132, p993E, DOI 10.1097/PRS.0b013e3182a8077e; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Vora SR, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00417; Wang SR, 2015, HUM MUTAT, V36, P474, DOI 10.1002/humu.22773; Wendt DJ, 2015, J PHARMACOL EXP THER, V353, P132, DOI 10.1124/jpet.114.218560; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 2010, ENDOCR J, V57, P659, DOI 10.1507/endocrj.K10E-164; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201492	10.1371/journal.pone.0201492	http://dx.doi.org/10.1371/journal.pone.0201492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048539	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400095
J	Link, KG; Stobb, MT; Di Paola, J; Neeves, KB; Fogelson, AL; Sindi, SS; Leiderman, K				Link, Kathryn G.; Stobb, Michael T.; Di Paola, Jorge; Neeves, Keith B.; Fogelson, Aaron L.; Sindi, Suzanne S.; Leiderman, Karin			A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow	PLOS ONE			English	Article							SURFACE-MEDIATED CONTROL; FACTOR PATHWAY INHIBITOR; BLOOD-COAGULATION; THROMBIN GENERATION; ANTITHROMBIN-III; ACTIVATED PLATELETS; BINDING-SITE; FACTOR-IXA; FACTOR-XI; UNCERTAINTY	The hemostatic response involves blood coagulation and platelet aggregation to stop blood loss from an injured blood vessel. The complexity of these processes make it difficult to intuit the overall hemostatic response without quantitative methods. Mathematical models aim to address this challenge but are often accompanied by numerous parameters choices and thus need to be analyzed for sensitivity to such choices. Here we use local and global sensitivity analyses to study a model of coagulation and platelet deposition under flow. To relate with clinical assays, we measured the sensitivity of three specific thrombin metrics: lag time, maximum relative rate of generation, and final concentration after 20 minutes. In addition, we varied parameters of three different classes: plasma protein levels, kinetic rate constants, and platelet characteristics. In terms of an overall ranking of the model's sensitivities, we found that the local and global methods provided similar information. Our local analysis, in agreement with previous findings, shows that varying parameters within 50-150% of baseline values, in a one-at-a-time (OAT) fashion, always leads to significant thrombin generation in 20 minutes. Our global analysis gave a different and novel result highlighting groups of parameters, still varying within the normal 50-150%, that produced little or no thrombin in 20 minutes. Variations in either plasma levels or platelet characteristics, using either OAT or simultaneous variations, always led to strong thrombin production and overall, relatively low output variance. Simultaneous variation in kinetics rate constants or in a subset of all three parameter classes led to the highest overall output variance, incorporating instances with little to no thrombin production. The global analysis revealed multiple parameter interactions in the lag time and final concentration leading to relatively high variance; high variance was also observed in the thrombin generation rate, but parameters attributed to that variance acted independently and additively.	[Fogelson, Aaron L.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Link, Kathryn G.; Fogelson, Aaron L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Stobb, Michael T.; Sindi, Suzanne S.] Univ Calif Merced, Dept Appl Math, Merced, CA USA; [Leiderman, Karin] Colorado Sch Mines, Dept Appl Math & Stat, Golden, CO 80401 USA; [Di Paola, Jorge; Neeves, Keith B.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Neeves, Keith B.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Merced; Colorado School of Mines; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Mines	Leiderman, K (corresponding author), Colorado Sch Mines, Dept Appl Math & Stat, Golden, CO 80401 USA.	kleiderman@mines.edu	Neeves, Keith/J-9494-2019	Neeves, Keith/0000-0001-7546-4588; Sindi, Suzanne/0000-0003-2742-4332; Di Paola, Jorge/0000-0002-1461-2871; Link, Kathryn/0000-0002-2148-9883	National Institutes of Health [R01 HL120728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120728, R01HL126864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (www.nih.gov) grant R01 HL120728 to JDP, KBN, ALF, and K. Leiderman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AHMAD SS, 1989, J BIOL CHEM, V264, P3244; Anand M, 2008, J THEOR BIOL, V253, P725, DOI 10.1016/j.jtbi.2008.04.015; Anand M., 2003, J THEOR MED, V5, P183, DOI [10.1080/10273660412331317415, DOI 10.1080/10273660412331317415]; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Archer GEB, 1997, J STAT COMPUT SIM, V58, P99, DOI 10.1080/00949659708811825; Ataullakhanov FI, 2002, INT J BIFURCAT CHAOS, V12, P1969, DOI 10.1142/S0218127402005637; BAGLIA FA, 1995, J BIOL CHEM, V270, P6734, DOI 10.1074/jbc.270.12.6734; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bungay SD, 2003, MATH MED BIOL, V20, P105, DOI 10.1093/imammb20.1.105; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Edgington E., 2007, STAT SERIES TXB MONO, VFourth; Elizondo P, 2016, BIOPHYS J, V111, P2722, DOI 10.1016/j.bpj.2016.10.030; Flamm MH, 2012, BLOOD, V120, P190, DOI 10.1182/blood-2011-10-388140; Fogelson AL, 2012, BIOPHYS J, V102, P10, DOI 10.1016/j.bpj.2011.10.048; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; Govindarajan V, 2018, BIOPHYS J, V114, P978, DOI 10.1016/j.bpj.2017.12.034; Govindarajan V, 2016, BIOPHYS J, V110, P1869, DOI 10.1016/j.bpj.2016.03.010; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Iooss B, UNCERTAINTY MANAGEME, P101, DOI [10.1007/978-1-4899-7547-8, DOI 10.1007/978-1-4899-7547-8]; JANSEN MJW, 1994, PREDICTABILITY AND NONLINEAR MODELLING IN NATURAL SCIENCES AND ECONOMICS, P334; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Leiderman K, 2016, ARTERIOSCL THROM VAS, V36, P2334, DOI 10.1161/ATVBAHA.116.308186; Leiderman K, 2013, B MATH BIOL, V75, P1255, DOI 10.1007/s11538-012-9784-3; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; London FS, 2004, J BIOL CHEM, V279, P19854, DOI 10.1074/jbc.M310624200; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; MANN KG, 1992, SEMIN HEMATOL, V29, P213; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Miller TN, 2007, BIOCHEMISTRY-US, V46, P14450, DOI 10.1021/bi701310x; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Naidu PP, 2014, MATH MODEL NAT PHENO, V9, P17, DOI 10.1051/mmnp/20149603; NESHEIM ME, 1988, J BIOL CHEM, V263, P16467; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Susree M, 2017, SADHANA-ACAD P ENG S, V42, P291, DOI 10.1007/s12046-017-0602-3; Susree M, 2018, ACTA BIOTHEOR, P1; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; WALSH PN, 1994, HEMOSTASIS THROMBOSI, P629; Wilkinson FH, 2001, J BIOL CHEM; Xu ZL, 2010, BIOPHYS J, V98, P1723, DOI 10.1016/j.bpj.2009.12.4331; Zarnitsina VI, 2001, CHAOS, V11, P57, DOI 10.1063/1.1345728	56	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200917	10.1371/journal.pone.0200917	http://dx.doi.org/10.1371/journal.pone.0200917			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048479	Green Submitted, gold, Green Published			2022-12-26	WOS:000439952400030
J	Soutome, S; Hayashida, S; Funahara, M; Sakamoto, Y; Kojima, Y; Yanamoto, S; Umeda, M				Soutome, Sakiko; Hayashida, Saki; Funahara, Madoka; Sakamoto, Yuki; Kojima, Yuka; Yanamoto, Souichi; Umeda, Masahiro			Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?	PLOS ONE			English	Article							TREATMENT OUTCOMES; ZOLEDRONIC ACID; SINGLE-CENTER; MANAGEMENT; PREVENTION; DIAGNOSIS; TRIALS; COHORT; BRONJ	Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who have received high-dose bisphosphonate (BP) or denosumab (Dmab) have not yet been established. Tooth extraction after starting medication has been believed to be a major risk factor for MRONJ, and therefore this procedure tends to be avoided. This study investigated the risk factors for MRONJ, with a special reference to the correlation between tooth extraction and development of MRONJ. One hundred and thirty-five cancer patients who were administrated high-dose BP or Dmab were enrolled in the study. Demographic factors, general condition, treatment factors, and dental findings were examined retrospectively using medical records and panoramic X-ray findings. The cumulative occurrence rate of MRONJ was calculated using the Kaplan-Meier method, and the correlation between these variables and development of MRONJ was analyzed by univariate and multivariate Cox regression analysis. MRONJ developed in 18 of 135 patients. The 1-, 2-, and 3-year cumulative occurrence rates were 8.6%, 21.5%, and 29.2%, respectively. The duration of medication before first visit to the dental unit and the presence of a tooth with clinical symptoms were significantly correlated with the development of MRONJ. The rate of MRONJ occurrence in patients who had teeth with clinical symptoms, but who did not undergo tooth extraction, became higher 2 years later than that in patients who underwent extraction of teeth with symptoms, although not significant. Early dental examination and effective preventative care to avoid infection/inflammation are important for preventing MRONJ.	[Soutome, Sakiko] Nagasaki Univ Hosp, Perioperat Oral Management Ctr, Nagasaki, Japan; [Hayashida, Saki; Funahara, Madoka; Sakamoto, Yuki; Yanamoto, Souichi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan; [Kojima, Yuka] Kansai Med Univ, Dept Dent & Oral Surg, Osaka, Japan	Nagasaki University; Nagasaki University; Kansai Medical University	Hayashida, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan.	sakihaya@nagasaki-u.ac.jp	Yanamoto, Souichi/X-2576-2019	Yanamoto, Souichi/0000-0003-2372-8347				Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Fedele S, 2010, AM J MED, V123, P1060, DOI 10.1016/j.amjmed.2010.04.033; Fliefel R, 2015, INT J ORAL MAX SURG, V44, P568, DOI 10.1016/j.ijom.2015.01.026; Graziani F, 2012, J ORAL MAXIL SURG, V70, P2501, DOI 10.1016/j.joms.2012.05.019; Hayashida S, 2017, J BONE MINER RES, V32, P2022, DOI 10.1002/jbmr.3191; Jacobsen C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13605; Kajizono M, 2015, BIOL PHARM BULL, V38, P1850, DOI 10.1248/bpb.b15-00385; Khan A, 2016, OSTEOPOROSIS INT, V27, P853, DOI 10.1007/s00198-015-3335-3; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kim HY, 2017, J ORAL MAXIL SURG, V75, P1404, DOI 10.1016/j.joms.2016.12.014; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Lazarovici TS, 2009, J ORAL MAXIL SURG, V67, P850, DOI 10.1016/j.joms.2008.11.015; Lerman MA, 2013, ORAL ONCOL, V49, P977, DOI 10.1016/j.oraloncology.2013.05.012; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Mozzati M, 2012, ORAL ONCOL, V48, P817, DOI 10.1016/j.oraloncology.2012.03.009; Mucke T, 2011, J CANCER RES CLIN, V137, P907, DOI 10.1007/s00432-010-0953-1; Nisi M, 2016, BRIT J ORAL MAX SURG, V54, P930, DOI 10.1016/j.bjoms.2016.06.015; Otto S, 2015, J CRANIO MAXILL SURG, V43, P847, DOI 10.1016/j.jcms.2015.03.039; Ruggiero SL, 2015, J ORAL MAXIL SURG, V73, pS94, DOI 10.1016/j.joms.2015.09.024; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Rupel K, 2014, ORAL ONCOL, V50, P1049, DOI 10.1016/j.oraloncology.2014.08.016; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Schubert M, 2012, ORAL ONCOL, V48, P349, DOI 10.1016/j.oraloncology.2011.11.004; Scoletta M, 2013, J ORAL MAXIL SURG, V71, P994, DOI 10.1016/j.joms.2013.01.006; Vahtsevanos K, 2009, J CLIN ONCOL, V27, P5356, DOI 10.1200/JCO.2009.21.9584; Vescovi P, 2012, J ORAL PATHOL MED, V41, P214, DOI 10.1111/j.1600-0714.2011.01091.x; Yamazaki T, 2012, INT J ORAL MAX SURG, V41, P1397, DOI 10.1016/j.ijom.2012.06.020; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7	30	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201343	10.1371/journal.pone.0201343	http://dx.doi.org/10.1371/journal.pone.0201343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048523	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400081
J	Tivane, A; Daniels, R; Nguenha, N; Machalele, L; Nacoto, A; Pale, M; Mateonane, E; Mavale, S; Chilundo, J; Muteto, D; Salencia, J; Albati, F; Gudo, E; Mussa, T; McCauley, J				Tivane, Almiro; Daniels, Rodney; Nguenha, Neuza; Machalele, Loira; Nacoto, Afonso; Pale, Mirela; Mateonane, Edirsse; Mavale, Sandra; Chilundo, Josina; Muteto, Delcio; Salencia, Judite; Albati, Felix; Gudo, Eduardo; Mussa, Tufaria; McCauley, John			Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season	PLOS ONE			English	Article							HEMAGGLUTININ; NEURAMINIDASE; ADAPTATION; H1N1	Background Due to the high rate of antigenic variation of influenza virus, seasonal characterization of the virus is crucial to assess and monitor the emergence of new pathogenic variants and hence formulate effective control measures. However, no study has yet been conducted in Mozambique to assess genetic, antigenic and antiviral susceptibility profile of influenza virus. Methods A subset of samples (n = 20) from influenza positive children detected in two hospitals in Maputo city during 2015 season as part of the implementation of influenza surveillance system, were selected. The following assays were performed on these samples: antigenic characterization by hemagglutination inhibition assay, genetic characterization by Sanger sequencing of hemagglutinin (HA) and neuraminidase (NA) and susceptibility to oseltamivir and zanamivir (NA inhibitors) by enzymatic assay. Results The A(H1N1) pdm09 subtype viruses remained closely related antigenically and genetically to the 2016 vaccine virus A/California/7/2009 and other widely distributed viruses belonging to genetic group 6B. The majority of influenza A(H3N2) viruses studied were antigenically similar to the 2016-2017 vaccine virus, A/Hong Kong/4801/2014, and their HA and NA gene sequences fell into genetic subclade 3C.2a being closely related to viruses circulating in southern Africa. The influenza B viruses were antigenically similar to the 2016 season vaccine virus and HA sequences of all three fell into the B/Yamagata-lineage, clade 3, but contained NA genes of the B/Victoria-lineage. All tested viruses were sensitive to oseltamivir and zanamivir. Conclusion Overall, all Mozambican influenza A and B viruses were most closely related to Southern African viruses and all were sensitive to oseltamivir and zanamivir. These findings suggest the existence of an ecological niche of influenza viruses within the region and hence highlighting the need for joint epidemiologic and virologic surveillance to monitor the evolution of influenza viruses.	[Tivane, Almiro; Nguenha, Neuza; Machalele, Loira; Nacoto, Afonso; Pale, Mirela; Mateonane, Edirsse; Muteto, Delcio; Salencia, Judite; Albati, Felix; Gudo, Eduardo; Mussa, Tufaria] Minist Hlth, Inst Nacl Saude, Dept Technol Platforms, Maputo, Mozambique; [Daniels, Rodney; McCauley, John] Worldwide Influenza Ctr, Francis Crick Inst, London, England; [Mavale, Sandra; Chilundo, Josina] Maputo Cent Hosp, Dept Pediat, Maputo, Mozambique; [Mussa, Tufaria] Eduardo Mondlane Univ, Fac Med, Dept Microbiol, Maputo, Mozambique	Francis Crick Institute; Eduardo Mondlane University	Tivane, A (corresponding author), Minist Hlth, Inst Nacl Saude, Dept Technol Platforms, Maputo, Mozambique.	artivane@gmail.com		Tivane, Almiro/0000-0002-8308-4136; Mussa, Tufaria/0000-0002-9635-3585	Francis Crick Institute - Cancer Research UK [FC001030]; Francis Crick Institute - Medical Research Council [FC001030]; Francis Crick Institute - Wellcome Trust [FC001030]; Centre for Disease Control and Prevention [U51IP000825]; World Health Organization (WHO)	Francis Crick Institute - Cancer Research UK; Francis Crick Institute - Medical Research Council; Francis Crick Institute - Wellcome Trust; Centre for Disease Control and Prevention; World Health Organization (WHO)(World Health Organization)	The work done at the Crick Worldwide Influenza Centre, a WHO Collaborating Centre for Reference and Research on Influenza, was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001030), the Medical Research Council (FC001030) and the Wellcome Trust (FC001030). The influenza surveillance in Mozambique is supported by the Centre for Disease Control and Prevention (Grant # U51IP000825) and by the World Health Organization (WHO). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P545; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P121; [Anonymous], 2017, WEEKLY EPIDEMIOLOGIC, V92, P117; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Christman MC, 2011, INFECT GENET EVOL, V11, P803, DOI 10.1016/j.meegid.2011.02.021; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Fazekas de St Groth, 1969, Bull World Health Organ, V41, P651; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Lin YP, 2017, INFLUENZA OTHER RESP, V11, P263, DOI 10.1111/irv.12447; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McCauley J, 2016, REPORT PREPARED WHO; McCauley JW, 2015, REPOR PREPARED WHO A; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P197, DOI 10.1016/B978-0-12-803109-4.00023-4; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1985, VIROLOGY, V143, P166, DOI 10.1016/0042-6822(85)90105-9; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Seleka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177655; Shaw ML, 2013, FIELDS VIROLOGY, P1151; Skowronski DM, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.3.30112; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Stohr Klaus, 2012, Methods Mol Biol, V865, P147, DOI 10.1007/978-1-61779-621-0_9; Tivane A, 2014, INT J INFECT DIS, V21, P275, DOI 10.1016/j.ijid.2014.03.991; Tivane AR, 2014, INFLUENZA SURVEILLAN, P2579; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WHO, 2015, INFL TRANSM ZON; WHO, 2017, GLOB INFL SURV RESP; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2014, INF PREV CONTR EP PA	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201248	10.1371/journal.pone.0201248	http://dx.doi.org/10.1371/journal.pone.0201248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048502	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400065
J	Xiong, QF; Xiong, T; Huang, P; Zhong, YD; Wang, HL; Yang, YF				Xiong, Qing-Fang; Xiong, Tian; Huang, Ping; Zhong, Yan-Dan; Wang, Hua-Li; Yang, Yong-Feng			Early predictors of acute hepatitis B progression to liver failure	PLOS ONE			English	Article							FULMINANT-HEPATITIS; VIRUS; DISEASE; HEPATOCYTES; INFECTION; ETIOLOGY	Background and aims 1 similar to 4% of acute hepatitis B (AHB) cases in adults progresses to acute liver failure (ALF).The predictors of ALF and prognosis for patients with ALF are not clear. This study investigated some of predictive and prognostic factors for AHB progression to ALF. Methods A retrospective analysis was used to assess the clinical and laboratory features of 293 patients diagnosed with AHB; the patients were divided into the following two groups: ALF (n = 13) and non-ALF (n = 280). Results In total,13 of the 293 (4.43%) patients developed ALF (10 recovered?3 died). The variables of age, anti-HBc IgM titers >= 10 S/CO, HBeAg negativity, and total bilirubin (TB) at admission were significantly higher in ALF patients than in non-ALF patients. Compared to non-ALF patients, ALF patients had significantly lower values for prothrombin time activity (PTA), serum albumin, and HBV DNA. At discharge, ALF patients had lower TB normalization rates and much faster clearance of HBsAg, HBeAg and HBVDNA than non-ALF patients. In multivariate analysis, TB >= 5xupper limit of normal (ULN) and HBeAg negative status were independent predictors for ALF development at admission, with 84.6% sensitivity, 85.7% specificity, a likelihood ratio of 5.91 and an area under the receiver operating characteristics curve (AUROC) of 0.850.Those who died had lower levels of peak PTA (<20%) and higher levels of peak hepatic encephalopathy (HE) grade (III-IV) than those who recovered. Conclusions Of the patients with ALF, 23.1% died. TB >= 5xULN and HBeAg negative status were the most effective and practicable factors distinguishing ALF from AHB at admission before the onset of encephalopathy. Peak PTA<20% and/or HE grade III-IV were independent predictors of a high probability of death or a need for transplantation.	[Xiong, Qing-Fang; Huang, Ping; Zhong, Yan-Dan; Wang, Hua-Li; Yang, Yong-Feng] South East Univ, Hosp Nanjing 2, Sch Med, Liver Dis Dept, Nanjing, Jiangsu, Peoples R China; [Xiong, Tian] Beijing Aerosp Gen Hosp, Dept Anesthesiol, Beijing 100076, Peoples R China	Southeast University - China	Xiong, QF; Yang, YF (corresponding author), South East Univ, Hosp Nanjing 2, Sch Med, Liver Dis Dept, Nanjing, Jiangsu, Peoples R China.	qfx12345@126.com; tongxqf@163.com		xiong, fang/0000-0003-2743-555X				Agrawal S, 2016, POSTGRAD MED J, V92, P223, DOI 10.1136/postgradmedj-2015-133715; Bianco E, 2003, DIGEST LIVER DIS, V35, P404, DOI 10.1016/S1590-8658(03)00157-9; Canbay A, 2011, DTSCH ARZTEBL INT, V108, P714, DOI 10.3238/arztebl.2011.0714; Dao DY, 2012, HEPATOLOGY, V55, P676, DOI 10.1002/hep.24732; Dhiman RK, 1998, DIGEST DIS SCI, V43, P1311, DOI 10.1023/A:1018876328561; European Assoc Study Liver, 2017, J HEPATOL, V66, P1047, DOI 10.1016/j.jhep.2016.12.003; FEUTREN G, 1984, J IMMUNOL METHODS, V75, P85, DOI 10.1016/0022-1759(84)90227-8; Fink K, 2007, J IMMUNOL, V179, P5877, DOI 10.4049/jimmunol.179.9.5877; Garfein RS, 2004, HEPATOLOGY, V40, P865, DOI 10.1002/hep.20383; Hadem J, 2008, CLIN GASTROENTEROL H, V6, P339, DOI 10.1016/j.cgh.2007.12.039; Han YN, 2008, J GASTROEN HEPATOL, V23, P1728, DOI 10.1111/j.1440-1746.2008.05600.x; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Ichai P, 2008, LIVER TRANSPLANT, V14, pS67, DOI 10.1002/lt.21612; Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271; Kanada A, 2007, INTERVIROLOGY, V50, P394, DOI 10.1159/000110651; Kantola T, 2011, SCAND J SURG, V100, P8, DOI 10.1177/145749691110000103; Kew MC, 2000, LANCET, V355, P591, DOI 10.1016/S0140-6736(99)00219-6; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lisotti Andrea, 2008, Int J Med Sci, V5, P309; MONDELLI M, 1982, J IMMUNOL, V129, P2773; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Rantala Merja, 2008, Euro Surveill, V13; Shiffman Mitchell L, 2010, Clin Liver Dis, V14, P75, DOI 10.1016/j.cld.2009.11.013; Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x; Tillmann HL, 2014, INTERVIROLOGY, V57, P181, DOI 10.1159/000360939; Tseng TC, 2017, J INFECT DIS, V216, pS765, DOI 10.1093/infdis/jix356; Wai CT, 2005, J VIRAL HEPATITIS, V12, P192, DOI 10.1111/j.1365-2893.2005.00581.x; Wang CY, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-23; Wang DW, 2013, WORLD J GASTROENTERO, V19, P7069, DOI 10.3748/wjg.v19.i41.7069; Wei G, 2007, J INTERN MED, V262, P393, DOI 10.1111/j.1365-2796.2007.01818.x; Zhao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080991	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201049	10.1371/journal.pone.0201049	http://dx.doi.org/10.1371/journal.pone.0201049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048531	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400043
J	Zamora-Martinez, FJ; Espana-Boquera, S; Castro-Bleda, MJ; Palacios-Corella, A				Zamora-Martinez, Francisco J.; Espana-Boquera, Salvador; Castro-Bleda, Maria Jose; Palacios-Corella, Adrian			Fallback Variable History NNLMs: Efficient NNLMs by precomputation and stochastic training	PLOS ONE			English	Article							LANGUAGE MODEL	This paper presents a new method to reduce the computational cost when using Neural Networks as Language Models, during recognition, in some particular scenarios. It is based on a Neural Network that considers input contexts of different length in order to ease the use of a fallback mechanism together with the precomputation of softmax normalization constants for these inputs. The proposed approach is empirically validated, showing their capability to emulate lower order N-grams with a single Neural Network. A machine translation task shows that the proposed model constitutes a good solution to the normalization cost of the output softmax layer of Neural Networks, for some practical cases, without a significant impact in performance while improving the system speed.	[Zamora-Martinez, Francisco J.] Veridas SL, R&D Dept, Pol Ind Talluntxe 2, Tajonar 31192, Spain; [Espana-Boquera, Salvador; Castro-Bleda, Maria Jose; Palacios-Corella, Adrian] Univ Politecn Valencia, Valencia, Spain	Universitat Politecnica de Valencia	Castro-Bleda, MJ (corresponding author), Univ Politecn Valencia, Valencia, Spain.	mcastro@dsic.upv.es	Castro-Bleda, M. J./H-2372-2011	Castro-Bleda, MariaJose/0000-0003-1001-8258	Spanish MINECO; FEDER [TIN2017-85854-C4-2-R]	Spanish MINECO(Spanish Government); FEDER(European Commission)	This work was partially supported by the Spanish MINECO and FEDER founds under project TIN2017-85854-C4-2-R (to MJCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisoy E.S., 2012, NAACL HLT 2012 WORKS, P20; Arisoy E, 2013, INT CONF ACOUST SPEE, P8242, DOI 10.1109/ICASSP.2013.6639272; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bengio Y, 2008, IEEE T NEURAL NETWOR, V19, P713, DOI 10.1109/TNN.2007.912312; Callison-Burch Chris, 2008, P 3 WORKSH STAT MACH; Callison-Burch Chris, 2010, P JOINT 5 WORKSH STA, P17; Chen W, 2015, STRATEGIES TRAINING; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Devlin J, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1370; Goodman JT, 2001, MSRTR200172; Graves A., 2006, P 23 INT C MACH LEAR; Graves A, 2014, PR MACH LEARN RES, V32, P1764; Hinton G., 2015, DISTILLING KNOWLEDGE; Jozefowicz Rafal, 2016, EXPLORING LIMITS LAN; KATZ SM, 1987, IEEE T ACOUST SPEECH, V35, P400, DOI 10.1109/TASSP.1987.1165125; Koehn P., 2007, P 45 ANN M ACL INT P, P177, DOI DOI 10.3115/1557769.1557821; Koehn P, 2003, P 2003 C N AM CHAPT, V1, P48, DOI DOI 10.3115/1073445.1073462; Le HS, 2011, INT CONF ACOUST SPEE, P5524; Martin S, 1999, P 6 EUR C SPEECH COM, V5, P1939; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov T., 2013, ARXIV 160705368, P746, DOI DOI 10.3109/10826089109058901; Mnih A., 2012, FAST SIMPLE ALGORITH; NEY H, 1994, COMPUT SPEECH LANG, V8, P1, DOI 10.1006/csla.1994.1001; Och F. J., 2003, Computational Linguistics, V29, P19, DOI 10.1162/089120103321337421; Och FJ, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P160; Palacios-Corella A., 2015, THESIS; Paul Baltescu, 2014, Prague Bulletin of Mathematical Linguistics, P81, DOI 10.2478/pralin-2014-0016; Rastogi P, 2015, SUBLINEAR PARTITION; Rosenfeld R, 1996, COMPUT SPEECH LANG, V10, P187, DOI 10.1006/csla.1996.0011; Schwenk H, 2007, COMPUT SPEECH LANG, V21, P492, DOI 10.1016/j.csl.2006.09.003; Schwenk Holger, 2008, P INT JOINT C NAT LA, P661; Schwenk Holger, 2006, P COLINGACL 2006 MAI, P723; Shi YZ, 2014, IEEE SIGNAL PROC LET, V21, P377, DOI 10.1109/LSP.2014.2303136; Shrivastava Anshumali, 2014, NEURIPS; Siu MH, 2000, IEEE T SPEECH AUDI P, V8, P63, DOI 10.1109/89.817454; Stolcke A., 2002, P INT C SPOK LANG PR, V2, P901; Vijayanarasimhan S, 2014, DEEP NETWORKS LARGE; Wang R., 2013, P 2013 C EMP METH NA, P845; Xuedong Huang, 1993, Computer Speech and Language, V7, P137, DOI 10.1006/csla.1993.1007; Zamora-Martinez F, 2014, PATTERN RECOGN, V47, P1642, DOI 10.1016/j.patcog.2013.10.020; Zamora-Martinez F, 2009, LECT NOTES COMPUT SC, V5517, P33, DOI 10.1007/978-3-642-02478-8_5; Zamora-Martinez FJ, 2012, THESIS; Zamora-Martinez F, 2018, INT J NEURAL SYST, V28, DOI 10.1142/S0129065718500077	45	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200884	10.1371/journal.pone.0200884	http://dx.doi.org/10.1371/journal.pone.0200884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048480	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400027
J	Byrou, S; Makrigiorgos, GM; Christofides, A; Kallikas, I; Papasavva, T; Kleanthous, M				Byrou, Stefania; Makrigiorgos, G. Mike; Christofides, Agathoklis; Kallikas, Ioannis; Papasavva, Thessalia; Kleanthous, Marina			Fast Temperature-Gradient COLD PCR for the enrichment of the paternally inherited SNPs in cell free fetal DNA; an application to non-invasive prenatal diagnosis of beta-thalassaemia	PLOS ONE			English	Article							MATERNAL PLASMA; CLINICAL-APPLICATION; MONOGENIC DISEASES; RHD STATUS; MUTATIONS; AMNIOCENTESIS; SENSITIVITY; CANCER	Objective To develop a sensitive, specific, simple, cost-effective and reproducible platform for the non-invasive prenatal detection of paternally inherited alleles for beta-thalassaemia. The development of such an assay is of major significance in order to replace currently-applied invasive methods containing inherent fetal loss risks. Methods We present a fast Temperature-Gradient Co-amplification at Lower Denaturation Temperature Polymerase Chain Reaction (fast TG COLD PCR) methodology for the detection of the paternally-inherited fetal alleles in maternal plasma. Two single-nucleotide polymorphisms (SNPs), rs7480526 (G/T) and rs968857 (G/A) that are located on the beta-globin gene cluster and exhibit a high degree of heterozygosity in the Cypriot population were selected for evaluation. Seventeen maternal plasma samples from pregnancies at risk for beta-thalassemia were analysed for the selected SNPs using the novel fast TG COLD PCR assay. Results Using fast TG COLD PCR, the paternally inherited allele in cell free fetal DNA was correctly determined for all the 17 maternal plasma samples tested, showing full agreement with the Chorionic Villus Sampling (CVS) analysis. Conclusions Our findings are encouraging and demonstrate the efficiency and sensitivity of fast TG COLD PCR in detecting the minor paternally-inherited fetal alleles in maternal plasma for the development of a NIPD assay for beta-thalassaemia.	[Byrou, Stefania; Papasavva, Thessalia; Kleanthous, Marina] Cyprus Inst Neurol & Genet, Mol Genet Thalassaemia Dept, Nicosia, Cyprus; [Byrou, Stefania; Papasavva, Thessalia; Kleanthous, Marina] Cyprus Sch Mol Med, Nicosia, Cyprus; [Makrigiorgos, G. Mike] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Med Phys & Biophys, Boston, MA USA; [Christofides, Agathoklis] Archbishop Makarios III Hosp, Med Ctr, Fetal Med Dept, Nicosia, Cyprus; [Kallikas, Ioannis] Ultrasound & Fetal Med Ctr, Nicosia, Cyprus	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Papasavva, T (corresponding author), Cyprus Inst Neurol & Genet, Mol Genet Thalassaemia Dept, Nicosia, Cyprus.; Papasavva, T (corresponding author), Cyprus Sch Mol Med, Nicosia, Cyprus.	thesalia@cing.ac.cy	Makrigiorgos, Mike/AFC-4575-2022	Papasavva, Thessalia/0000-0001-9279-4810	TELETHON GRANT [2015/4]; Molecular Genetics Thalassaemia Department of the Cyprus Institute of Neurology and Genetics; NATIONAL CANCER INSTITUTE [R33CA217652] Funding Source: NIH RePORTER	TELETHON GRANT(Fondazione Telethon); Molecular Genetics Thalassaemia Department of the Cyprus Institute of Neurology and Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by TELETHON GRANT with grant number 2015/4 to TP and by the Molecular Genetics Thalassaemia Department of the Cyprus Institute of Neurology and Genetics. There was no additional external funding received	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bombard AT, 2011, PRENATAL DIAG, V31, P802, DOI 10.1002/pd.2770; Carotenuto P, 2012, INT J ONCOL, V40, P378, DOI 10.3892/ijo.2011.1221; Castellanos-Rizaldos E, 2012, CLIN CHEM, V58, P1130, DOI 10.1373/clinchem.2012.183095; Castellanos-Rizaldos E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051362; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Galbiati S, 2016, J MED GENET, V53, P481, DOI 10.1136/jmedgenet-2015-103229; Galbiati S, 2012, EXPERT OPIN BIOL TH, V12, pS181, DOI 10.1517/14712598.2012.677428; Galbiati S, 2011, CLIN CHEM, V57, P136, DOI 10.1373/clinchem.2010.155671; Fernandez-Martinez FJ, 2012, GENET MED, V14, P101, DOI 10.1038/gim.2011.8; Jenkins LA, 2018, PRENATAL DIAG, V38, P44, DOI 10.1002/pd.5197; Kountouris P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26371; Kyrri AR, 2013, HEMOGLOBIN, V37, P435, DOI 10.3109/03630269.2013.801851; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Li J, 2009, HUM MUTAT, V30, P1583, DOI 10.1002/humu.21112; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; LO YMD, 1989, LANCET, V2, P1363; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Milbury CA, 2012, CLIN CHEM, V58, P580, DOI 10.1373/clinchem.2011.176198; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; New MI, 2014, J CLIN ENDOCR METAB, V99, pE1022, DOI 10.1210/jc.2014-1118; Orhant L, 2016, PRENATAL DIAG, V36, P397, DOI 10.1002/pd.4790; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Papasavva Thessalia, 2016, BMC Res Notes, V9, P198, DOI 10.1186/s13104-016-2002-x; Papasavva T, 2013, EUR J HUM GENET, V21, P1403, DOI 10.1038/ejhg.2013.47; Papasavva TE, 2013, ANN HUM GENET, V77, P115, DOI 10.1111/ahg.12004; Parks M, 2017, EUR J HUM GENET, V25, P416, DOI 10.1038/ejhg.2016.195; Parks M, 2016, PRENATAL DIAG, V36, P312, DOI 10.1002/pd.4781; Qi GJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005126; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Song C, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw650; Song C, 2011, DIAGN MOL PATHOL, V20, P81, DOI 10.1097/PDM.0b013e3181fde92f; Vermeulen C, 2017, AM J HUM GENET, V101, P326, DOI 10.1016/j.ajhg.2017.07.012; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; Xiong L, 2015, PRENATAL DIAG, V35, P258, DOI 10.1002/pd.4536; Zhou QY, 2014, PRENATAL DIAG, V34, P1061, DOI 10.1002/pd.4428	43	6	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200348	10.1371/journal.pone.0200348	http://dx.doi.org/10.1371/journal.pone.0200348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044883	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500046
J	Keeley, BW; Keeley, ATH; Houlahan, P				Keeley, Brian W.; Keeley, Annika T. H.; Houlahan, Padraig			Ridge number in bat ears is related to both guild membership and ear length	PLOS ONE			English	Article							ECHOLOCATION CALLS; SPECIALIZATIONS; SENSITIVITY; CHIROPTERA; MORPHOLOGY; PENGUINS; SOUNDS; NARROW; SONAR; PREY	The ears of many mammals have a set of uniformly spaced horizontal ridges that form groove arrays. Contact of coherent waves (e.g. acoustic waves) with a series of slits or grooves causes diffraction, which produces constructive and destructive interference patterns. Increases in signal strength will occur but will depend on the frequencies involved, the groove number and their separations. Diffraction effects can happen for a wide range of frequencies and wavelengths, but no array can diffract wavelengths greater than twice the groove separation, and it is for those wavelengths comparable in size with the groove separation that the effects are greatest. For example, when ridges in bat ears are 1 mm apart, the strongest influence will occur for a 1 mm wavelength which corresponds to a frequency of 343 kHz. If bats could use these wavelengths, it would help them to resolve objects or surface textures of about 0.5 mm. Given how critical acoustics are for bat function, we asked whether bats may be taking advantage of diffraction effects generated by the grooves. We hypothesize that groove number varies with bat foraging strategy. Examining 120 species, we found that groove number is related to both guild and ear length. Bats in guilds that glean prey items from foliage or ground have on average more grooves than bats in other guilds. Harmonics generated by echolocation calls are the most likely source for the wavelengths that would correspond to the groove separations. We apply the physical principles of wave reflection, diffraction, and superposition to support the hypothesis that acoustic responses generated from grooves may be useful to bats. We offer an explanation why some bat species do not have grooves. We also discuss the presence of groove arrays in non-echolocating Chiropterans, and five additional mammalian orders.	[Keeley, Brian W.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Keeley, Annika T. H.] Univ Calif Berkeley, Dept Environm Sci Policy & Planning, Berkeley, CA 94720 USA; [Houlahan, Padraig] Embry Riddle Aeronaut Univ, Dept Phys, Prescott, AZ USA; [Houlahan, Padraig] Coconino Community Coll, Flagstaff, AZ USA	Northern Arizona University; University of California System; University of California Berkeley; Embry-Riddle Aeronautical University	Keeley, BW (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	bkeeley62@yahoo.com						Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Bohn KM, 2004, J COMP PHYSIOL A, V190, P185, DOI 10.1007/s00359-003-0485-0; BRUNS V, 1989, J MORPHOL, V199, P103, DOI 10.1002/jmor.1051990109; Burnham KP, 2002, MODEL SELECTION MULT, P66; DALLAND JI, 1965, J AUD RES, V5, P95; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Falcao F, 2015, BIOACOUSTICS, V24, P175, DOI 10.1080/09524622.2015.1017840; Falk JJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0520; FAURE PA, 1993, J EXP BIOL, V178, P173; FAURE PA, 1992, ANIM BEHAV, V44, P31, DOI 10.1016/S0003-3472(05)80751-1; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2013, ANIM BEHAV, V85, P869, DOI 10.1016/j.anbehav.2013.02.024; Firbas W, 1972, MONATSSCHR OHR LARYN, V106, P156; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goerlitz HR, 2008, J EXP BIOL, V211, P2799, DOI 10.1242/jeb.019596; Griffin D.R., 1958, LISTENING DARK ACOUS; Hallam J, 2004, P 8 INT C SIM AD BEH; Halliday D., 2013, FUNDAMENTALS PHYS; Hickey M. B. C., 2000, Mammalian Species, P1; Hill J., 1984, BATS NATURAL HIST; Ho YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062938; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; Jennings NV, 2004, ACTA CHIROPTEROL, V6, P75, DOI 10.3161/001.006.0106; Jones G, 2003, J EXP BIOL, V206, P4209, DOI 10.1242/jeb.00678; Kingston T, 1999, J ZOOL, V249, P359, DOI 10.1017/S0952836999009917; Konstantinov A, 1971, ZH VYSSHEI NERVNOI D; Kuc R, 2009, J ACOUST SOC AM, V125, P3454, DOI 10.1121/1.3097500; LONG GR, 1975, J COMP PHYSIOL, V100, P211, DOI 10.1007/BF00614531; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Muller R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108701; OBRIST MK, 1993, J EXP BIOL, V180, P119; Parsons S, 2000, J EXP BIOL, V203, P2641; R Core Team, R PROJECT STAT COMPU; ROBISSON P, 1992, AUK, V109, P654; Schmieder DA, 2010, BIOL LETTERS, V6, P604, DOI 10.1098/rsbl.2010.0114; Schneider H., 1961, Zoologische Jahrbuecher (Anatomie), V79, P93; Schoner MG, 2015, CURR BIOL, V25, P1911, DOI 10.1016/j.cub.2015.05.054; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Simon R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00064; Sowell WA, 1983, AFITGEPPH83D13; Wang XB, 2009, J ACOUST SOC AM, V126, P3311, DOI 10.1121/1.3257210	41	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200255	10.1371/journal.pone.0200255	http://dx.doi.org/10.1371/journal.pone.0200255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044815	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500035
J	D'Amario, B; Ziveri, P; Grelaud, M; Oviedo, A				D'Amario, Barbara; Ziveri, Patrizia; Grelaud, Michael; Oviedo, Angela			Emiliania huxleyi coccolith calcite mass modulation by morphological changes and ecology in the Mediterranean Sea	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CARBONATE CHEMISTRY; SOUTHERN-OCEAN; ENVIRONMENTAL CONTROLS; EXPORT PRODUCTION; CALCIFICATION; MORPHOTYPES; PRYMNESIOPHYCEAE; GULF; RECOGNITION	To understand the response of marine calcifying organisms under high CO2 scenarios, it is critical to study their calcification patterns in the natural environment. This paper focuses on a major calcifying phytoplankton group, the coccolithophores, through the analysis of water samples collected along a W-E Mediterranean transect during two research cruises, in April 2011 (Meteor cruise M84/3) and May 2013 (MedSeA cruise 2013). The Mediterranean Sea is a marginal sea characterized by large biogeochemical gradients. Currently, it is undergoing both warming and ocean acidification, processes which are rapidly modifying species distribution and calcification. The species Emiliania huxleyi largely dominates the total coccolithophore production in present day oceans and marine basins, including the Mediterranean Sea. A series of morphometric measurements were performed on the coccoliths of this species to estimate their mass, length and calculate a calcification index (proxy for the size-normalized calcification degree). The most abundant morphotype of E. huxleyi in the Mediterranean Sea is Type A. Coccoliths of this morphotype were additionally analyzed based on scanning electron microscopy images: four calcification varieties were quantified, according to the relationship between slit length-tube width, and the state of the central area (open or closed). The average E. huxleyi coccolith mass along the Mediterranean oceanographic transect depended strongly on both the average coccolith length and calcification index. The variability in average coccolith length and calcification index across samples reflected oscillations in the relative abundance of the calcification varieties. We also demonstrated that the distribution of the calcification varieties followed the main environmental gradients (carbonate chemistry, salinity, temperature, nutrient concentrations). Hence, shifts in the distribution of the calcification varieties and of the average E. huxleyi coccolith mass are to be expected in the Mediterranean Sea under climate change. These physiological and ecological responses will modulate the net coccolithophore calcification and, ultimately, the regional carbonate export to the seafloor.	[D'Amario, Barbara; Ziveri, Patrizia; Grelaud, Michael; Oviedo, Angela] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra, Spain; [Ziveri, Patrizia] ICREA, Barcelona, Spain	Autonomous University of Barcelona; ICREA	D'Amario, B; Ziveri, P (corresponding author), Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra, Spain.; Ziveri, P (corresponding author), ICREA, Barcelona, Spain.	3damario@gmail.com; Patrizia.Ziveri@uab.cat	Ziveri, Patrizia/I-3856-2015	Ziveri, Patrizia/0000-0002-5576-0301; Oviedo Sabogal, Angela/0000-0003-1945-8882; Grelaud, Michael/0000-0001-8649-9743; D'Amario, Barbara/0000-0001-5608-5283	EU [265103]; CALMED project [CTM2016-79547-R]; Generalitat de Catalunya [MERS] [2014 SGR- 1356]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [FI-DGR scholarship]; MinECo [MDM2015-0552]	EU(European Commission); CALMED project; Generalitat de Catalunya [MERS]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [FI-DGR scholarship]; MinECo(Spanish Government)	This work was supported by the EU-FP7 "Mediterranean Sea Acidification in a changing climate" project (MedSeA) [grant number 265103], the CALMED project [CTM2016-79547-R], the Generalitat de Catalunya [MERS, 2014 SGR- 1356] and the Agencia de Gestio d'Ajuts Universitaris i de Recerca [FI-DGR scholarship to B.D.]. This work is contributing to the ICTA "Unit of Excellence" [MinECo, MDM2015-0552]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober J, 1994, STUD BOT, V13, P61; [Anonymous], 2013, CLIMATE CHANGE 2013; Beaufort L, 2008, BIOGEOSCIENCES, V5, P1101, DOI 10.5194/bg-5-1101-2008; Beaufort L, 2004, MAR MICROPALEONTOL, V51, P57, DOI 10.1016/j.marmicro.2003.09.003; Beaufort L, 2005, MICROPALEONTOLOGY, V51, P289, DOI 10.2113/gsmicropal.51.4.289; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaufort L, 2001, MAR MICROPALEONTOL, V43, P27, DOI 10.1016/S0377-8398(01)00020-2; Bendif E, 2014, J PHYCOL, V50, P140, DOI 10.1111/jpy.12147; Berger C, 2014, BIOGEOSCIENCES, V11, P929, DOI 10.5194/bg-11-929-2014; Blanco-Ameijeiras S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157697; Bonomo S, 2016, PALAEOGEOGR PALAEOCL, V459, P15, DOI 10.1016/j.palaeo.2016.06.037; Broecker W, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001731; Cook SS, 2011, J PHYCOL, V47, P615, DOI 10.1111/j.1529-8817.2011.00992.x; Cros L, 2002, SCI MAR, V66, P5; Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; D'Amario B, 2017, J PLANKTON RES, V39, P781, DOI 10.1093/plankt/fbx044; Dimiza MD, 2008, MICROPALEONTOLOGY, V54, P159; Dimiza MD, 2008, HELL J GEOSCI, V45, P55; Dollfus D, 1999, NEURAL NETWORKS, V12, P553, DOI 10.1016/S0893-6080(99)00011-8; Fielding SR, 2009, LIMNOL OCEANOGR, V54, P1475, DOI 10.4319/lo.2009.54.5.1475; Flores JA, 1997, MAR MICROPALEONTOL, V29, P351, DOI 10.1016/S0377-8398(96)00029-1; Green JC, 1998, PHYCOLOGIA, V37, P121, DOI 10.2216/i0031-8884-37-2-121.1; Hagino K, 2005, MAR MICROPALEONTOL, V55, P19, DOI 10.1016/j.marmicro.2005.02.002; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; Hainbucher D., 2013, OCEAN SCI DISCUSS, V10, P2399, DOI [10.5194/osd-10-2399-2013, DOI 10.5194/0SD-10-2399-2013]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henderiks J, 2012, MAR ECOL PROG SER, V448, P51, DOI 10.3354/meps09535; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Horigome MT, 2014, BIOGEOSCIENCES, V11, P2295, DOI 10.5194/bg-11-2295-2014; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Incarbona A, 2010, CLIM PAST, V6, P795, DOI 10.5194/cp-6-795-2010; Incarbona A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001581; Jin P, 2016, MAR POLLUT BULL, V103, P101, DOI 10.1016/j.marpolbul.2015.12.039; Karatsolis BT, 2017, CONT SHELF RES, V149, P138, DOI 10.1016/j.csr.2016.12.005; Kershaw S, 2013, OCEANOGRAPHY EARTH S; KNAPPERTSBUSCH M, 1993, MAR MICROPALEONTOL, V21, P219, DOI 10.1016/0377-8398(93)90016-Q; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; MCINTYRE A, 1967, DEEP-SEA RES, V14, P561, DOI 10.1016/0011-7471(67)90065-4; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; Meier KJS, 2014, BIOGEOSCIENCES, V11, P2857, DOI 10.5194/bg-11-2857-2014; Meyer J, 2015, BIOGEOSCIENCES, V12, P1671, DOI 10.5194/bg-12-1671-2015; Milner S, 2016, LIMNOL OCEANOGR, V61, P1322, DOI 10.1002/lno.10292; Muller MN, 2017, ISME J, V11, P1777, DOI 10.1038/ismej.2017.53; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oviedo A, 2015, OCEAN SCI, V11, P13, DOI 10.5194/os-11-13-2015; Oviedo AM, 2014, J EXP MAR BIOL ECOL, V459, P105, DOI 10.1016/j.jembe.2014.04.021; Paasche E, 1996, PHYCOLOGIA, V35, P394, DOI 10.2216/i0031-8884-35-5-394.1; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Poulton AJ, 2011, MAR ECOL PROG SER, V443, P1, DOI 10.3354/meps09445; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; RIAUXGOBIN C, 1995, MAR GEOL, V123, P239, DOI 10.1016/0025-3227(94)00126-6; Rickaby REM, 2016, DEEP-SEA RES PT II, V127, P28, DOI 10.1016/j.dsr2.2016.02.010; Rosas-Navarro A, 2016, BIOGEOSCIENCES, V13, P2913, DOI 10.5194/bg-13-2913-2016; Saruwatari K, 2016, BIOGEOSCIENCES, V13, P2743, DOI 10.5194/bg-13-2743-2016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder DC, 2005, J PHYCOL, V41, P874, DOI 10.1111/j.1529-8817.2005.04188.x; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Tanhua T, 2013, EARTH SYST SCI DATA, V5, P289, DOI 10.5194/essd-5-289-2013; Triantaphyllou M, 2010, GEOBIOS-LYON, V43, P99, DOI 10.1016/j.geobios.2009.09.002; VANBLEIJSWIJK J, 1991, J PHYCOL, V27, P566; von Dassow P, 2015, ISME J, V9, P1365, DOI 10.1038/ismej.2014.221; Winter A., 1994, COCCOLITHOPHORES; Young JR, 2014, BIOGEOSCIENCES, V11, P4771, DOI 10.5194/bg-11-4771-2014; Young J.R., 2003, J NANNOPLANKT RES, V125; Young Jeremy R., 2002, Journal of Nannoplankton Research, V24, P27; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Zhang Y, 2018, BIOGEOSCIENCES DISCU, DOI [10.5194/bg-2018-47, DOI 10.5194/BG-2018-47]; ZIVERI P, 1995, MAR MICROPALEONTOL, V24, P335, DOI 10.1016/0377-8398(94)00017-H; Ziveri P, 2000, DEEP-SEA RES PT II, V47, P2073, DOI 10.1016/S0967-0645(00)00017-5; Ziveri P, 2000, DEEP-SEA RES PT II, V47, P1853, DOI 10.1016/S0967-0645(00)00009-6	77	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201161	10.1371/journal.pone.0201161	http://dx.doi.org/10.1371/journal.pone.0201161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040853	Green Submitted, gold, Green Published			2022-12-26	WOS:000439749200029
J	Ferdosi, S; Ho, TH; Castle, EP; Stanton, ML; Borges, CR				Ferdosi, Shadi; Ho, Thai H.; Castle, Erik P.; Stanton, Melissa L.; Borges, Chad R.			Behavior of blood plasma glycan features in bladder cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; O-GLYCANS; PANCREATIC-CANCER; N-GLYCOSYLATION; SERUM; BIOMARKERS; GLYCOME; MICROVESICLES; CARCINOMA; DIAGNOSIS	Despite systemic therapy and cystectomy, bladder cancer is characterized by a high recurrence rate. Serum glycomics represents a promising source of prognostic markers for monitoring patients. Our approach, which we refer to as "glycan node analysis", constitutes the first example of molecularly "bottom-up" glycomics. It is based on a global glycan methylation analysis procedure that is applied to whole blood plasma/serum. The approach detects and quantifies partially methylated alditol acetates arising from unique glycan features such as alpha 2-6 sialylation, beta 1-4 branching, and core fucosylation that have been pooled together from across all intact glycans within a sample into a single GC-MS chromatographic peak. We applied this method to 122 plasma samples from former and current bladder cancer patients (n = 72 former cancer patients with currently no evidence of disease (NED); n = 38 non-muscle invasive bladder cancer (NMIBC) patients; and n = 12 muscle invasive bladder cancer (MIBC) patients) along with plasma from 30 certifiably healthy living kidney donors. Markers for alpha 2-6 sialylation, beta 1-4 branching, beta 1-6 branching, and outer-arm fucosylation were able to separate current and former (NED) cases from certifiably healthy controls (ROC curve c-statistics similar to 0.80); but NED, NMIBC, and MIBC were not distinguished from one another. Based on the unexpectedly high levels of these glycan nodes in the NED patients, we hypothesized that recurrence of this disease could be predicted by some of the elevated glycan features. Indeed, alpha 2-6 sialylation and beta 1-6 branching were able to predict recurrence from the NED state using a Cox proportional hazards regression model adjusted for age, gender, and time from cancer. The levels of these two glycan features were correlated to C-reactive protein concentration, an inflammation marker and known prognostic indicator for bladder cancer, further strengthening the link between inflammation and abnormal plasma protein glycosylation.	[Ferdosi, Shadi; Borges, Chad R.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Ferdosi, Shadi; Borges, Chad R.] Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA; [Ho, Thai H.] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA; [Castle, Erik P.] Mayo Clin, Dept Urol, Phoenix, AZ USA; [Stanton, Melissa L.] Mayo Clin, Dept Lab Med & Pathol, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Borges, CR (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Borges, CR (corresponding author), Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA.	chad.borges@asu.edu		Ho, Thai/0000-0003-0023-2939; Borges, Chad/0000-0002-8122-3438	Flinn Foundation [1977]; National Cancer Institute of the National Institutes of Health [R33 CA191110]; NATIONAL CANCER INSTITUTE [R33CA191110] Funding Source: NIH RePORTER	Flinn Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Flinn Foundation (https://www.flinn.org) (Grant No. 1977 to CB) and the National Cancer Institute of the National Institutes of Health (https://www.cancer.gov) under Award Number R33 CA191110 (to CB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Flinn Foundation or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ansar W, 2013, IMMUNOL RES, V56, P131, DOI 10.1007/s12026-013-8384-0; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Azevedo R, 2017, ONCOTARGET, V8, P91734, DOI 10.18632/oncotarget.19433; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Baker ES, 2012, GENOME MED, V4, DOI 10.1186/gm364; Borges CR, 2013, ANAL CHEM, V85, P2927, DOI 10.1021/ac3035579; Cagnoni AJ, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00109; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Eggers H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0705-6; Ferdosi S, 2018, J PROTEOME RES, V17, P543, DOI 10.1021/acs.jproteome.7b00672; Fontana S, 2013, PROTEOMICS, V13, P1581, DOI 10.1002/pmic.201200398; Goodison S, 2013, MOL DIAGN THER, V17, P71, DOI 10.1007/s40291-013-0023-x; GRYSKA K, 1995, ADV EXP MED BIOL, V376, P239; Hafeez S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-104; Hamfjord J, 2015, J PROTEOME RES, V14, P5144, DOI 10.1021/acs.jproteome.5b00395; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hegele A, 2010, ANTICANCER RES, V30, P5195; Ho TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132831; Hu YM, 2017, ANALYST, V142, P2748, DOI 10.1039/c7an00396j; Hulsmeier AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33927; Jansen BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23296; Kehinde EO, 2011, SCAND J UROL NEPHROL, V45, P113, DOI 10.3109/00365599.2010.533694; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; Mbeutcha A, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.05.013; Mendez-Huergo SP, 2017, CURR OPIN IMMUNOL, V45, P8, DOI 10.1016/j.coi.2016.12.003; Mitra AP, 2012, SEMIN ONCOL, V39, P524, DOI 10.1053/j.seminoncol.2012.08.008; Miyahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074861; Nagata M, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/8205836; Narisada M, 2008, BIOCHEM BIOPH RES CO, V377, P792, DOI 10.1016/j.bbrc.2008.10.061; Oikawa M, 2018, EUR UROL FOCUS, V4, P405, DOI 10.1016/j.euf.2016.11.004; Okamoto T, 2013, MOL MED REP, V7, P359, DOI 10.3892/mmr.2012.1189; Rabinovich GA, 2016, J MOL BIOL, V428, P3266, DOI 10.1016/j.jmb.2016.03.021; Ries LAG, 2007, NATL CANC I, V07-6215, P7; Roberts AA, 2003, MODERN PATHOL, V16, P543, DOI 10.1097/01.MP.0000071840.84469.06; Roy S, 2013, INT BRAZ J UROL, V39, P631, DOI 10.1590/S1677-5538.IBJU.2013.05.04; Saldova R, 2008, DIS MARKERS, V25, P219, DOI 10.1155/2008/601583; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; Scheffer AR, 2014, WORLD J UROL, V32, P353, DOI 10.1007/s00345-012-1010-2; Sethi MK, 2016, ACCOUNTS CHEM RES, V49, P2099, DOI 10.1021/acs.accounts.6b00193; Shrotriya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143080; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Suzuki Y, 2012, INT J ONCOL, V40, P1831, DOI 10.3892/ijo.2012.1411; Tanaka T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122632; Tsuboi S, 2015, SUGAR CHAINS DECODIN, P177; Tsuboi S, 2013, TRENDS GLYCOSCI GLYC, V25, P117, DOI 10.4052/tigg.25.117; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; Vasseur JA, 2012, GLYCOBIOLOGY, V22, P1684, DOI 10.1093/glycob/cws108; Wang DZ, 2015, CARCINOGENESIS, V36, P1085, DOI 10.1093/carcin/bgv123; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Yun SJ, 2012, INT J ONCOL, V41, P1871, DOI 10.3892/ijo.2012.1622; Zaare S, 2016, JOVE-J VIS EXP, DOI 10.3791/53961; Zhou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12733	58	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201208	10.1371/journal.pone.0201208	http://dx.doi.org/10.1371/journal.pone.0201208			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040854	gold, Green Submitted, Green Published			2022-12-26	WOS:000439749200031
J	Heidarian, R; Fotouhifar, KB; Debets, AJM; Aanen, DK				Heidarian, Reza; Fotouhifar, Khalil-Berdi; Debets, Alfons J. M.; Aanen, Duur K.			Phylogeny of Paecilomyces, the causal agent of pistachio and some other trees dieback disease in Iran	PLOS ONE			English	Article							POLYPHASIC TAXONOMY; PCR; IDENTIFICATION; BYSSOCHLAMYS; DNA	One of the most important fungal agents of pistachio dieback disease belongs to the ascomycete genus Paecilomyces that has been identified as P. variotii. In 2012-2014, 700 plant samples from pistachio trees and 27 other plant species with dieback symptoms were collected from 10 provinces of Iran. Of the 567 pistachio samples, 277 Paecilomyces strains were obtained and from the 133 samples of other plants (except pistachio and including Pistacia mutica, Punica granatum, Prunus amygdalus, Caesalpinia gilliesii, Nerium oleander, Tamarix aphylla, Tamarix hispida and Haloxylon sp.), 23 fungal isolates were recovered and five isolates were obtained from the air of infected pistachio orchards. Based on morphology, all 305 isolates were identified as P. variotii. Physiological studies revealed that 299 isolates belong to P. formosus. Three isolates were assigned to P. variotii, while three isolates could not be assigned to any of the known species. Of the 305 isolates, 62 were selected for phylogenetic analysis based on DNA variation (ITS, beta-tubulin and calmodulin). This analysis showed that all of our isolates form a clade with P. formosus. P. formosus consists of the three former species P. formosa, P. lecythidis and P. maximus. This study shows that our isolates form a strongly supported clade with strains of P. lecythidis. So, the causal agent of dieback disease of pistachio and other examined trees is P. formosus which is closely related to the former species P. lecythidis and has some differences with the former species P. formosa and P. maximus. Based on phylogenetic studies P. formosus thus seems to be a species complex that could be divided into three separate species.	[Heidarian, Reza; Fotouhifar, Khalil-Berdi] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Plant Protect, Karaj, Iran; [Debets, Alfons J. M.; Aanen, Duur K.] Wageningen Univ, Hlth Food & Living Environm Fac, Plant Sci Dept, Lab Genet, Wageningen, Netherlands; [Heidarian, Reza] Agr Jahad Rafsanjan, Rafsanjan, Iran	University of Tehran; Wageningen University & Research	Fotouhifar, KB (corresponding author), Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Plant Protect, Karaj, Iran.	fotowhi@ut.ac.ir	Fotouhifar, Khalil-Berdi/ABH-1857-2021	Fotouhifar, Khalil-Berdi/0000-0002-4790-6171				Alizadeh A., 2000, J AGR SCI TECH-IRAN, V1, P53; AMINAEI M.M, 1989, P 9 IR PLANT PROT C, P82; [Anonymous], EVOLUTION; Bainer G, 1907, B SOC MYCOL FR, V23, P26; BROWN AGNES H. S., 1957, TRANS BRIT MYCOL SOC, V40, P17; Ershad D., 2009, FUNGI IRAN; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frisvad JC, 2004, STUD MYCOL, P1; Ghelichi M., 2012, International Journal of Nuts and Related Sciences (IJNRS), V3, P23; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Heidarian A, 1998, P 13 IR PLANT PROT C, P220; Heidarian R, 2012, ACTA HORTIC, V963, P101; Heidarian R, 2015, P 2 IR MYC C KAR, P206; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2006, ADV EXP MED BIOL, V571, P211, DOI 10.1007/0-387-28391-9_14; Houbraken J, 2010, J CLIN MICROBIOL, V48, P2754, DOI 10.1128/JCM.00764-10; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Luangsa-Ard JJ, 2004, MYCOLOGIA, V96, P773, DOI 10.2307/3762111; Mohammadi A, 2006, DIS DRIED FRUIT TREE; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson R., 1974, STUDIES MYCOLOGY CBS, V6, DOI DOI 10.1016/S0007-1536(75)80098-2; Samson RA, 2009, PERSOONIA, V22, P14, DOI 10.3767/003158509X418925; Tazick Z, 2012, P 20 IR PLANT PROT C, P417; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	25	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200794	10.1371/journal.pone.0200794	http://dx.doi.org/10.1371/journal.pone.0200794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040828	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200010
J	Yang, YM; Lee, JJ; Jeong, E; Kim, SY; Han, MA; Choi, EJ				Yang, Young-Mo; Lee, Jae-Joon; Jeong, Eun; Kim, Sun Young; Han, Mi Ah; Choi, Eun Joo			A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea	PLOS ONE			English	Article							HEALTH-CARE; PHARMACISTS; INFORMATION; KNOWLEDGE; BEHAVIOR; TRENDS; MEDIA; DTCA	Direct-to-consumer advertising (DTCA) of prescription drugs can be both beneficial and harmful to healthcare consumers. Therefore, DTCA for prescription drugs is a topic that should be considered crucially, at this point, when the interests of patients as well as pharmaceutical companies in DTCA of prescription drugs are growing in South Korea. The goals of this study were to investigate Korean college students' perceptions and attitudes about DTCA of prescription drugs through a survey as well as to analyze data according to their college majors in order to identify differences in their perceptions and attitudes about prescription drug DTCAs as future health care professionals and consumers, respectively. A descriptive, cross-sectional survey was conducted between September and November 2015. Participants were recruited from Chosun University in Gwangju, South Korea. Ethical approval for this study was obtained from the Chosun University Institutional Review Board. Of 1,040 questionnaires initially distributed, 774 were collected, and 742 were included in the analysis. The results of this study indicated that most students who had participated in the survey did not have sufficient knowledge of DTCA for prescription drugs. Approximately, 17% reported being cognizant of DTCA for prescription drugs. More healthcare students (24.6%) knew this term than non-healthcare students did (6.3%). In this study, most of the students were likely to feel that healthcare professionals (e.g., doctors and pharmacists) had the responsibility of delivering information about prescription drugs to patients, and that all prescription drugs DTCA, if it were permitted, had to be pre-approved by the Korean government. The results of this study indicated that DTCA for prescription drugs had to be permitted under the condition of pre-approval of the DTCA contents by the Korean government, and prescription drugs should not be advertised through the Internet. It is recommended that the Korean government cautiously examine whether DTCA of prescription drugs should be permitted, after considering the current marketing strategies of pharmaceutical companies on the Internet and the effects of online electronic-DTCA on Korean consumers.	[Yang, Young-Mo; Choi, Eun Joo] Chosun Univ, Coll Pharm, Dept Pharm, Gwangju, South Korea; [Lee, Jae-Joon; Jeong, Eun] Chosun Univ, Dept Food & Nutr, Gwangju, South Korea; [Kim, Sun Young] Chosun Univ, Dept Biol Educ, Gwangju, South Korea; [Han, Mi Ah] Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea	Chosun University; Chosun University; Chosun University; Chosun University	Choi, EJ (corresponding author), Chosun Univ, Coll Pharm, Dept Pharm, Gwangju, South Korea.	ejchoi@chosun.ac.kr	Kim, Sun/GSN-4867-2022		National Research Foundation of Korea (NRF) - Korea government [2016R1C1B1015938]; National Research Foundation of Korea (NRF) - Korean government [2016R1C1B1015938]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2016R1C1B1015938). -Grant recipient: EJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (2016R1C1B1015938).	Abel GA, 2009, J CLIN ONCOL, V27, P4182, DOI 10.1200/JCO.2008.20.6599; Alperstein Neil M, 2014, Health Mark Q, V31, P231, DOI 10.1080/07359683.2014.936291; Chaar Betty, 2010, Int J Pharm Pract, V18, P43; Dens N, 2008, HEALTH COMMUN, V23, P45, DOI 10.1080/10410230701805190; Deshpande A, 2004, J HEALTH COMMUN, V9, P499, DOI 10.1080/10810730490523197; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Gibson S, 2014, LAWS, V3, P410, DOI [10.3390/laws3030410], DOI 10.3390/LAWS3030410]; Gilbody S, 2005, QUAL SAF HEALTH CARE, V14, P246, DOI 10.1136/qshc.2004.012781; Harrington AR, 2013, RES SOC ADMIN PHARM, V9, P458, DOI 10.1016/j.sapharm.2012.07.005; Herzenstein M, 2005, MARKET LETT, V15, P201, DOI 10.1007/s11002-005-0458-x; Humphreys G, 2009, B WORLD HEALTH ORGAN, V87, P576, DOI 10.2471/BLT.09.040809; Kannan S, 2015, Int J Risk Saf Med, V27, P77, DOI 10.3233/JRS-150644; Kim BK, 2005, DIRECT TO CONSUMER P, P20; Kim HJ, 2008, HEALTH AFFAIR, V27, pW260, DOI 10.1377/hlthaff.27.4.w260; 오지운, 2015, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V25, P42; Liang BA, 2011, JAMA-J AM MED ASSOC, V305, P824, DOI 10.1001/jama.2011.203; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Mackey TK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0885-1; Main K.J., 2004, INT J ADVERT, V23, P119, DOI [10.1080/02650487.2004.11072875, DOI 10.1080/02650487.2004.11072875], DOI 10.1080/02650487.2004.11072875]; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Murray E, 2004, J AM BOARD FAM PRACT, V17, P6, DOI 10.3122/jabfm.17.1.6; Naik RK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710586; Peyrot M, 1998, MARK HEALTH SERV, V18, P26; Singh T, 2005, J CONSUM MARK, V22, P369, DOI 10.1108/07363760510631101; Spake Deborah F, 2014, Health Mark Q, V31, P31, DOI 10.1080/07359683.2013.847344; Suh HS, 2011, HEALTH POLICY, V101, P260, DOI 10.1016/j.healthpol.2011.05.005; Tyrawski J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4357; Viale PH, 2004, ONCOL NURS FORUM, V31, P777, DOI 10.1188/04.ONF.777-783; Williams PA, 2016, PATIENT EDUC COUNS, V99, P583, DOI 10.1016/j.pec.2015.10.019; Wu MH, 2016, CONTRACEPTION, V93, P398, DOI 10.1016/j.contraception.2016.01.010	31	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201108	10.1371/journal.pone.0201108	http://dx.doi.org/10.1371/journal.pone.0201108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040833	Green Submitted, Green Published, gold			2022-12-26	WOS:000439749200026
J	Vangoitsenhoven, R; van der Ende, M; Corbeels, K; Cunha, JPMCM; Lannoo, M; Bedossa, P; van der Merwe, S; Mertens, A; Gesquiere, I; Meulemans, A; Matthys, C; Mathieu, C; Overbergh, L; Van der Schueren, B				Vangoitsenhoven, Roman; van der Ende, Miranda; Corbeels, Katrien; Cunha, Joao Paulo Monteiro Carvalho Mori; Lannoo, Matthias; Bedossa, Pierre; van der Merwe, Schalk; Mertens, Ann; Gesquiere, Ina; Meulemans, Ann; Matthys, Christophe; Mathieu, Chantal; Overbergh, Lut; Van der Schueren, Bart			At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice	PLOS ONE			English	Article							FAT	Background Achieving weight loss is the cornerstone of the treatment of the metabolic consequences of obesity, in particular of glucose intolerance. Objective To determine whether improvement in glucose control depends on dietary macronutrient composition of the diet at identical weight loss. Materials and methods Twenty-two weeks old diet-induced obese C57BU6 mice lost weight through caloric restriction on normal chow (R-NC) or high fat diet (R-HF). Control mice were fed normal chow (LEAN) or high fat diet (OBESE) ad libitum. Body weight and composition were assessed after 8 weeks of dietary intervention. Glucose homeostasis was evaluated by intraperitoneal glucose tolerance tests (IPGTT). Epididymal white adipose (eWAT) and hepatic tissues were analyzed by immunohistochemistry and RT-qPCR. Results By 30 weeks of age, the body weight of the mice on R-NC (31.6 +/- 1.7g, mean +/- SEM) and RHF (32.3 +/- 0.9g) was similar to LEAN mice (31.9 +/- 1.4g), while OBESE mice weighed 51.7 +/- 2.4g. Glucose tolerance in R-NC was better than in LEAN mice (69% AUC IPGTT, P 0.0168) whereas R-HF mice remained significantly less glucose tolerant (125% AUC IPGTT, P 0.0279 vs LEAN), despite identical weight loss. The eWAT pads and adipocyte size were similar in LEAN and R-NC mice, while the eWAT pad size of R-HF was 180% of R-NC (P < 0.0001) and the average adipocyte size of R-HF mice was 134% of R-NC fed mice (P 0.0285). No LEAN or R-NC mice had hepatic steatosis, in contrast to 28.6% of R-HF mice. Compared to OBESE mice, inflammatory markers were lower in eWAT and liver tissue of R-NC, but not in R-HF mice. Measures of visceral adiposity correlated well with glucose tolerance parameters. Conclusions In mice, caloric restriction on a normal chow diet improved glucose tolerance significantly more when identical weight loss was achieved on a high fat diet.	[Vangoitsenhoven, Roman; van der Ende, Miranda; Corbeels, Katrien; Cunha, Joao Paulo Monteiro Carvalho Mori; Mertens, Ann; Gesquiere, Ina; Meulemans, Ann; Matthys, Christophe; Mathieu, Chantal; Overbergh, Lut; Van der Schueren, Bart] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [Vangoitsenhoven, Roman; Mertens, Ann; Meulemans, Ann; Matthys, Christophe; Mathieu, Chantal; Van der Schueren, Bart] Univ Hosp Leuven, Dept Endocrinol, Leuven, Belgium; [Lannoo, Matthias] Univ Hosp Leuven, Dept Abdominal Surg, Leuven, Belgium; [Bedossa, Pierre] Univ Paris Diderot, Dept Anat Pathol, INSERM U773, Paris, France; [van der Merwe, Schalk] Katholieke Univ Leuven, Lab Hepatol, Leuven, Belgium; [van der Merwe, Schalk] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; KU Leuven; KU Leuven; University Hospital Leuven	Vangoitsenhoven, R (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium.; Vangoitsenhoven, R (corresponding author), Univ Hosp Leuven, Dept Endocrinol, Leuven, Belgium.	Roman.vangoitsenhoven@kuleuven.be	da Cunha, João Paulo Monteiro Carvalho Mori/M-3310-2017; Matthys, Christophe/I-4203-2016; lannoo, matthias/AAB-1706-2020; Overbergh, Lut/AAC-3515-2020; Corbeels, Katrien/AAH-1232-2020; mathieu, chantal/ABD-5505-2021; Vangoitsenhoven, Roman/B-3196-2018	da Cunha, João Paulo Monteiro Carvalho Mori/0000-0002-0749-6534; Matthys, Christophe/0000-0003-1770-6862; Corbeels, Katrien/0000-0001-9494-1650; mathieu, chantal/0000-0002-4055-5233; Vangoitsenhoven, Roman/0000-0003-3523-669X; Van der Merwe, Schalk/0000-0002-9891-2686; van der Ende, Miranda/0000-0001-9864-0505; Mertens, Ann/0000-0002-1649-4311; Van der Schueren, Bart/0000-0003-4754-784X; Meulemans, Ann/0000-0003-3938-2408; Lannoo, matthias/0000-0001-7815-1157	Flemish Research Foundation [G.0857.13]; clinical fellowship	Flemish Research Foundation(FWO); clinical fellowship	This work was supported by the Flemish Research Foundation (www.fwo.be): G.0857.13 and clinical fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Bray GA, 2012, INT J OBESITY, V36, P448, DOI 10.1038/ijo.2011.173; Brehm BJ, 2008, NAT CLIN PRACT ENDOC, V4, P140, DOI 10.1038/ncpendmet0730; Daniel S, 2013, CURR OPIN ENDOCRINOL, V20, P377, DOI 10.1097/01.med.0000433067.01671.f5; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044; Dubois V, 2016, ENDOCRINOLOGY, V157, P648, DOI 10.1210/en.2015-1713; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Goss AM, 2013, OBESITY, V21, P1133, DOI 10.1002/oby.20191; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hall KD, 2015, CELL METAB, V22, P427, DOI 10.1016/j.cmet.2015.07.021; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kosinski C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050517; Matsui Y, 2010, BIOL PHARM BULL, V33, P963, DOI 10.1248/bpb.33.963; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schwingshackl L, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0455-1; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Wei P, 2004, DIABETOLOGIA, V47, P1541, DOI 10.1007/s00125-004-1489-1; Williamson DA, 2010, J BEHAV MED, V33, P305, DOI 10.1007/s10865-010-9253-0	28	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200779	10.1371/journal.pone.0200779	http://dx.doi.org/10.1371/journal.pone.0200779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036374	Green Published, Green Submitted, gold			2022-12-26	WOS:000439429200016
J	Corder, KM; Cortes, MA; Bartley, AF; Lear, SA; Lubin, FD; Dobrunz, LE				Corder, Katelynn M.; Cortes, Mariana A.; Bartley, Aundrea F.; Lear, Samantha A.; Lubin, Farah D.; Dobrunz, Lynn E.			Prefrontal cortex-dependent innate behaviors are altered by selective knockdown of Gad1 in neuropeptide Y interneurons	PLOS ONE			English	Article							SPECIES-TYPICAL BEHAVIORS; ANXIETY-LIKE BEHAVIOR; ELEVATED PLUS-MAZE; GABA NEUROTRANSMISSION; MAJOR DEPRESSION; MATERNAL-CARE; ANIMAL-MODELS; MOUSE MODEL; DISORDERS; INHIBITION	GABAergic dysfunction has been implicated in a variety of neurological and psychiatric disorders, including anxiety disorders. Anxiety disorders are the most common type of psychiatric disorder during adolescence. There is a deficiency of GABAergic transmission in anxiety, and enhancement of GABA transmission through pharmacological means reduces anxiety behaviors. GAD67-the enzyme responsible for GABA production-has been linked to anxiety disorders. One class of GABAergic interneurons, Neuropeptide Y (NPY) expressing cells, is abundantly found in brain regions associated with anxiety and fear learning, including prefrontal cortex, hippocampus and amygdala. Additionally, NPY itself has been shown to have anxiolytic effects, and loss of NPY+ interneurons enhances anxiety behaviors. A previous study showed that knockdown of Gad1 from NPY+ cells led to reduced anxiety behaviors in adult mice. However, the role of GABA release from NPY+ interneurons in adolescent anxiety is unclear. Here we used a transgenic mouse that reduces GAD67 in NPY+ cells (NPYGAD1-TG) through Gad1 knockdown and tested for effects on behavior in adolescent mice. Adolescent NPYGAD1-TG mice showed enhanced anxiety-like behavior and sex-dependent changes in locomotor activity. We also found enhancement in two other innate behavioral tasks, nesting construction and social dominance. In contrast, fear learning was unchanged. Because we saw changes in behavioral tasks dependent upon prefrontal cortex and hippocampus, we investigated the extent of GAD67 knockdown in these regions. Immunohistochemistry revealed a 40% decrease in GAD67 in NPY+ cells in prefrontal cortex, indicating a significant but incomplete knockdown of GAD67. In contrast, there was no decrease in GAD67 in NPY+ cells in hippocampus. Consistent with this, there was no change in inhibitory synaptic transmission in hippocampus. Our results show the behavioral impact of cell-specific interneuron dysfunction and suggest that GABA release by NPY+ cells is important for regulating innate prefrontal cortex-dependent behavior in adolescents.	[Corder, Katelynn M.; Cortes, Mariana A.; Bartley, Aundrea F.; Lubin, Farah D.; Dobrunz, Lynn E.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Lear, Samantha A.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dobrunz, LE (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dobrunz@uab.edu		Dobrunz, Lynn E./0000-0002-3317-554X; Corder, Katelynn/0000-0001-8086-5925	National Institutes of Health [1R01MH108342]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant 1R01MH108342 to L.E.D. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Arrant AE, 2016, GENES BRAIN BEHAV, V15, P588, DOI 10.1111/gbb.12300; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Bartley AF, 2015, J NEUROSCI, V35, P15276, DOI 10.1523/JNEUROSCI.1834-15.2015; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Behlke LM, 2016, NEUROPSYCHOPHARMACOL, V41, P2492, DOI 10.1038/npp.2016.49; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; BLANCHARD RJ, 1990, NEUROSCI BIOBEHAV R, V14, P463, DOI 10.1016/S0149-7634(05)80069-7; Blue ME, 1999, EXP NEUROL, V156, P345, DOI 10.1006/exnr.1999.7030; Botta P, 2015, NAT NEUROSCI, V18, P1493, DOI 10.1038/nn.4102; Britton JC, 2013, AM J PSYCHIAT, V170, P1195, DOI 10.1176/appi.ajp.2013.12050651; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Chan T, 2011, J NEUROSCI, V31, P4991, DOI 10.1523/JNEUROSCI.5216-10.2011; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Cipriani A, 2016, LANCET, V388, P881, DOI 10.1016/S0140-6736(16)30385-3; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Corvino V, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00433, 10.3389/fncel.2015.00433]; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; DAWSON GR, 1995, PSYCHOPHARMACOLOGY, V118, P316, DOI 10.1007/BF02245961; Deacon RMJ, 2003, BEHAV BRAIN RES, V139, P139, DOI 10.1016/S0166-4328(02)00225-5; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Demuyser T, 2016, PHYSIOL BEHAV, V156, P199, DOI 10.1016/j.physbeh.2015.12.018; Doremus-Fitzwater TL, 2009, PHYSIOL BEHAV, V97, P484, DOI 10.1016/j.physbeh.2009.03.025; Eaton K, 2007, CURR TOP MED CHEM, V7, P1645, DOI 10.2174/156802607782341037; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fatemi SH, 2013, TRANSL PSYCHIAT, V3, DOI [10.1038/tp.2013.64, 10.1038/tp.2013.46]; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Fatemi SH, 2011, ANAT REC, V294, P1635, DOI 10.1002/ar.21299; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; Garbett KA, 2010, MOL PSYCHIATR, V15, P987, DOI 10.1038/mp.2010.1; Garnefski N, 2002, J ADOLESCENCE, V25, P603, DOI 10.1006/jado.2002.0507; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112; Isokawa M, 2005, J PHYSIOL-LONDON, V567, P1001, DOI 10.1113/jphysiol.2005.094219; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kalkman HO, 2003, J NEURAL TRANSM, V110, P803, DOI 10.1007/s00702-003-0826-8; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Karl T, 2008, EUR J NEUROSCI, V28, P173, DOI 10.1111/j.1460-9568.2008.06306.x; Kavushansky Alexandra, 2009, Stress, V12, P412, DOI 10.1080/10253890802556081; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kilb W, 2012, NEUROSCIENTIST, V18, P613, DOI 10.1177/1073858411422114; Kim SS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-6; KOLB B, 1985, BEHAV NEUROSCI, V99, P691, DOI 10.1037/0735-7044.99.4.691; Landgraf R, 1999, J NEUROENDOCRINOL, V11, P405; Li Q, 2017, J NEUROSCI, V37, P23, DOI 10.1523/JNEUROSCI.2599-16.2016; Li X, 2015, NEUROPHARMACOLOGY, V97, P357, DOI 10.1016/j.neuropharm.2015.05.001; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Mason GF, 2001, BRAIN RES, V914, P81, DOI 10.1016/S0006-8993(01)02778-0; MCCARTHY MM, 1995, J COMP NEUROL, V360, P685, DOI 10.1002/cne.903600412; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; MILNER TA, 1992, HIPPOCAMPUS, V2, P107, DOI 10.1002/hipo.450020204; Mitra S, 2017, PHYSIOL BEHAV, V168, P103, DOI 10.1016/j.physbeh.2016.11.002; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Murphy DD, 1998, J NEUROSCI, V18, P2550; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Reichmann F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28182; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Reis FMCV, 2014, PSYCHONEUROENDOCRINO, V49, P130, DOI 10.1016/j.psyneuen.2014.06.019; Rock ML, 2014, J AM ASSOC LAB ANIM, V53, P24; Schmidt MJ, 2014, MOL PSYCHIATR, V19, P580, DOI 10.1038/mp.2013.167; Schmidt MJ, 2015, NEUROPSYCHOPHARMACOL, V40, P190, DOI 10.1038/npp.2014.95; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Serova LI, 2013, NEUROSCIENCE, V236, P298, DOI 10.1016/j.neuroscience.2013.01.040; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Shoji H, 2014, JOVE-J VIS EXP, DOI 10.3791/50871; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smialowska M, 2007, NEUROPSYCHOPHARMACOL, V32, P1242, DOI 10.1038/sj.npp.1301258; Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Velosa JF, 2000, CHILD ADOL PSYCH CL, V9, P119; Vlainic J, 2009, NEUROPHARMACOLOGY, V56, P1124, DOI 10.1016/j.neuropharm.2009.03.010; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weiss SM, 1998, NEUROSCI BIOBEHAV R, V23, P265, DOI 10.1016/S0149-7634(98)00027-X; Wu HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180638; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726	95	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200809	10.1371/journal.pone.0200809	http://dx.doi.org/10.1371/journal.pone.0200809			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024942	Green Submitted, gold, Green Published			2022-12-26	WOS:000439120000055
J	Wu, YW; Ke, YZ; Wen, J; Guo, PC; Ran, F; Wang, MM; Liu, MM; Li, PF; Li, JN; Du, H				Wu, Yunwen; Ke, Yunzhuo; Wen, Jing; Guo, Pengcheng; Ran, Feng; Wang, Mangmang; Liu, Mingming; Li, Pengfeng; Li, Jiana; Du, Hai			Evolution and expression analyses of the MADS-box gene family in Brassica napus	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; PHYSCOMITRELLA-PATENS; TRANSCRIPTION FACTORS; HOMEOTIC GENES; DOMAIN PROTEIN; SEED PLANTS; ARABIDOPSIS; DNA; ANGIOSPERMS; HOMOLOGS	MADS-box transcription factors are important for plant growth and development, and hundreds of MADS-box genes have been functionally characterized in plants. However, less is known about the functions of these genes in the economically important allopolyploid oil crop, Brassica napus. We identified 307 potential MADS-box genes (BnMADSs) in the B. napus genome and categorized them into type I (M-alpha, M-beta, and M-gamma) and type II (MADS DNA-binding domain, intervening domain, keratin-like domain, and C-terminal domain [MIKC](c) and MIKC*) based on phylogeny, protein motif structure, and exon-intron organization. We identified one conserved intron pattern in the MADS-box domain and seven conserved intron patterns in the K-box domain of the MIKCc genes that were previously ignored and may be associated with function. Chromosome distribution and synteny analysis revealed that hybridization between Brassica rapa and Brassica oleracea, segmental duplication, and homologous exchange (HE) in B. napus were the main BnMADSs expansion mechanisms. Promoter cis-element analyses indicated that BnMADSs may respond to various stressors (drought, heat, hormones) and light. Expression analyses showed that homologous genes in a given subfamily or sister pair are highly conserved, indicating widespread functional conservation and redundancy. Analyses of BnMADSs provide a basis for understanding their functional roles in plant development.	[Wu, Yunwen; Ke, Yunzhuo; Wen, Jing; Guo, Pengcheng; Ran, Feng; Wang, Mangmang; Liu, Mingming; Li, Pengfeng; Li, Jiana; Du, Hai] Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China; [Wu, Yunwen; Ke, Yunzhuo; Wen, Jing; Guo, Pengcheng; Ran, Feng; Wang, Mangmang; Liu, Mingming; Li, Pengfeng; Li, Jiana; Du, Hai] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China	Li, JN; Du, H (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China.; Li, JN; Du, H (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.	ljn1950@swu.edu.cn; haidu81@aliyun.com	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Du, Hai/AHD-1445-2022	Du, Hai/0000-0003-4274-5724	"111" Project of China [B12006]; National Natural Science Foundation of China [31671727, 31471528]; National Basic Research Program of China (973 Program) [2015CB150201]	"111" Project of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the "111" Project of China (B12006), National Natural Science Foundation of China (31671727 and 31471528), the National Basic Research Program of China (973 Program; 2015CB150201).	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Angenent GC, 1996, TRENDS PLANT SCI, V1, P228; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11037; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Fernandez DE, 2014, PLANT PHYSIOL, V165, P1591, DOI 10.1104/pp.114.242990; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Gramzow L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00214; Gu Q, 1998, DEVELOPMENT, V125, P1509; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; HAYES TE, 1988, GENE DEV, V2, P1713, DOI 10.1101/gad.2.12b.1713; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; Jaradat Masrur R, 2014, GM Crops Food, V5, P302, DOI 10.4161/21645698.2014.947827; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Khan MR, 2013, MOL BIOTECHNOL, V54, P25, DOI 10.1007/s12033-012-9540-9; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Krogan NT, 2000, NEW PHYTOL, V147, P505, DOI 10.1046/j.1469-8137.2000.00728.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Munster T, 1997, P NATL ACAD SCI USA, V94, P2415, DOI 10.1073/pnas.94.6.2415; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nilsson L, 2007, PLANTA, V225, P589, DOI 10.1007/s00425-006-0374-1; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Rani V, 2007, J BIOSCIENCES, V32, P1325, DOI 10.1007/s12038-007-0142-9; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; TANDRE K, 1995, PLANT MOL BIOL, V27, P69, DOI 10.1007/BF00019179; Thangavel G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00510; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, NATURE, V404, P711, DOI 10.1038/35008171; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Wei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084781; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; Yan J, 2014, MOL GENET GENOMICS, V289, P25, DOI 10.1007/s00438-013-0786-0; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yu LH, 2017, MOL PLANT, V10, P834, DOI 10.1016/j.molp.2017.04.004; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang ZB, 2012, J PLANT PHYSIOL, V169, P797, DOI 10.1016/j.jplph.2011.12.020	64	14	18	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200762	10.1371/journal.pone.0200762	http://dx.doi.org/10.1371/journal.pone.0200762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024950	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000047
J	Jiao, J; Huang, WL; Bai, ZQ; Liu, F; Ma, CD; Liang, ZS				Jiao, Jie; Huang, Wenli; Bai, Zhenqing; Liu, Feng; Ma, Cunde; Liang, Zongsuo			DNA barcoding for the efficient and accurate identification of medicinal polygonati rhizoma in China	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MOLECULAR AUTHENTICATION; CROCUS-SATIVUS; TOTAL SAPONINS; ADULTERANTS; PLANTS; CHLOROPLAST; ODORATUM; CONSTITUENTS; PHARMACOPEIA	Polygonati rhizoma (PR), a traditional medicinal and edible product with various bioactive components (Polygonatum polysaccharides, saponins, phenols, and flavonoids), is widely consumed in China. However, other species with morphological characteristics similar to those of the actual components are being used to replace or adulterate PR, causing issues with quality control and product safety. The morphological similarity of PR and its substitutes makes classic morphological identification challenging. To address this issue, DNA barcoding-based identification using ITS2 and psbA-trnH sequences was applied in this study to evaluate the efficiency and accuracy of this approach in identifying PR samples collected from 39 different regions in China. The identification of PR by this method was confirmed by other methods (phylogeny-based and character-based methods), and all the samples were clearly and accurately distinguished. This study highlights the efficient and accurate nature of DNA barcoding in PR identification. Applying this technique will provide a means to differentiate PR from other altered formulations, thus improving product quality and safety for consumers of PR and its products.	[Jiao, Jie; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Huang, Wenli] Shaanxi Univ Chinese Med, Coll Pharm, Xianyang, Shaanxi, Peoples R China; [Bai, Zhenqing] Yanan Univ, Coll Life Sci, Yanan, Shaanxi, Peoples R China; [Liu, Feng; Ma, Cunde] Buchang Pharma, Res Dept, Xian, Shaanxi, Peoples R China; [Liang, Zongsuo] Zhejiang SCI TECH Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Shaanxi University of Chinese Medicine; Yanan University; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Liang, ZS (corresponding author), Zhejiang SCI TECH Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	liangzs@ms.iswc.ac.cn	huang, wen/GXW-0661-2022		Huimin Plan of Ministry of Science and Technology [2012GS610102]; Support Plan Project of the state Ministry of Science Technology [2015BAC01B03]	Huimin Plan of Ministry of Science and Technology; Support Plan Project of the state Ministry of Science Technology	This work was supported by the Huimin Plan of Ministry of Science and Technology [grant numbers 2012GS610102] and the Support Plan Project of the state Ministry of Science & Technology [grant number 2015BAC01B03]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2015, MOL ECOL RESOUR, V15, P337, DOI 10.1111/1755-0998.12319; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen XC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42325; Chinese PC, 2015, PHARM CHIN; Dev SA, 2014, ANN FOREST SCI, V71, P517, DOI 10.1007/s13595-013-0354-0; Du L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32261; Enan MR, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038470; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gao T, 2009, PLANTA MED, V75, P417; Gao ZT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05892-y; Guo HY, 2010, SCI CHINA LIFE SCI, V53, P992, DOI 10.1007/s11427-010-4044-y; Guo SY, 2016, INT J SYST EVOL MICR, V66, P1488, DOI 10.1099/ijsem.0.000906; Gvazava LN, 2011, CHEM NAT COMPD+, V47, P818, DOI 10.1007/s10600-011-0072-5; Han YW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01707; He Li-hong, 2006, Wei Sheng Wu Xue Bao, V46, P162; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hirsch AM, 2014, ABSTR PAP AM CHEM S, V248; Huang W, 2014, PLANTA MED, V80, P846; Huang WJ, 2015, IRAN J BIOTECHNOL, V13, P36, DOI 10.15171/ijb.1034; Jiang QG, 2013, INT J BIOL MACROMOL, V54, P131, DOI 10.1016/j.ijbiomac.2012.12.010; Jin JN, 2006, NATL BOT BBS ASIA PA, P323; Khan H, 2016, TOXICOL IND HEALTH, V32, P841, DOI 10.1177/0748233713512362; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kim WJ, 2016, GENET MOL RES, V15; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kvist S, 2016, MITOCHONDRIAL DNA A, V27, P2241, DOI 10.3109/19401736.2014.984166; Lan GS, 2012, FOOD RES INT, V49, P406, DOI 10.1016/j.foodres.2012.07.047; Li S., 1993, COMPENDIUM MAT MED; Li YH, 2010, J MED PLANTS RES, V4, P2706; Liu Y, 2018, FOOD CHEM, V242, P62, DOI 10.1016/j.foodchem.2017.09.040; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Lu JM, 2016, J ETHNOPHARMACOL, V179, P291, DOI 10.1016/j.jep.2015.12.057; Luo K, 2009, PLANTA MED, V75, P416; Lv TW, 2015, PLANTA, V242, P1167, DOI 10.1007/s00425-015-2353-x; Ma K, 2013, CHEM NAT COMPD+, V49, P888, DOI 10.1007/s10600-013-0770-2; Mahadani P, 2013, PHARMACOGN MAG, V9, P255, DOI 10.4103/0973-1296.113284; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Moon BC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017064; Nithaniyal S, 2017, GENOME, V60, P139, DOI 10.1139/gen-2015-0225; Nithaniyal S, 2016, BIOCHEM SYST ECOL, V68, P223, DOI 10.1016/j.bse.2016.08.001; Oberlies N, 2017, TOXICOL LETT, V280, pS39, DOI 10.1016/j.toxlet.2017.07.100; Pang XH, 2009, PLANTA MED, V75, P417; Parvathy VA, 2015, PHARM BIOL, V53, P1774, DOI 10.3109/13880209.2015.1005756; Peng MJ, 2016, J LIQ CHROMATOGR R T, V39, P171, DOI 10.1080/10826076.2016.1141298; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raja HA, 2017, FOOD CHEM, V214, P383, DOI 10.1016/j.foodchem.2016.07.052; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Rhie YH, 2014, KOREAN J HORTIC SCI, V32, P296, DOI 10.7235/hort.2014.13146; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sgamma T, 2017, PLANTA MED, V83, P1117, DOI 10.1055/s-0043-113448; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Song M, 2017, CHIN J NAT MEDICINES, V15, P481, DOI 10.1016/S1875-5364(17)30073-0; Song XN, 2017, MITOCHONDRIAL DNA A, V28, P355, DOI 10.3109/19401736.2015.1122777; Sui XY, 2011, PLANTA MED, V77, P492, DOI 10.1055/s-0030-1250468; Swetha VP, 2014, FOOD BIOTECHNOL, V28, P183, DOI 10.1080/08905436.2014.931239; Tai Y, 2016, EXP THER MED, V12, P2681, DOI 10.3892/etm.2016.3630; Takagi H, 2001, J JPN SOC HORTIC SCI, V70, P424, DOI 10.2503/jjshs.70.424; Tang YL, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-015-0072-7; Umdale SD, 2017, PHARMACOGN MAG, V13, pS224, DOI 10.4103/pm.pm_499_16; Wang J, 2016, J ASIAN NAT PROD RES, V18, P697, DOI 10.1080/10286020.2015.1135905; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wujisguleng WJGL, 2012, ACTA SOC BOT POL, V81, P239, DOI 10.5586/asbp.2012.045; Xu MNA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178012; Yan HL, 2017, PHYTOMEDICINE, V26, P45, DOI 10.1016/j.phymed.2017.01.007; Yang P., 2015, WORLD CHINESE MED, V10, P1173; Yang Y, 2011, PLANTA MED, V77, P87, DOI 10.1055/s-0030-1250072; Yang ZH, 2017, MOL ECOL, V26, P3028, DOI 10.1111/mec.14093; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yu M, 2016, HOLZFORSCHUNG, V70, P127, DOI 10.1515/hf-2014-0234; Zhang DQ, 2016, AFR J TRADIT COMPLEM, V13, P74, DOI 10.21010/ajtcam.v13i6.12; Zhao XY, 2015, NAT PROD COMMUN, V10, P683; Zheng SH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/843923; Zhou J, 2014, PHARMACOGN MAG, V10, P385, DOI 10.4103/0973-1296.141754; Zou SM, 2016, MAR BIOTECHNOL, V18, P327, DOI 10.1007/s10126-016-9692-x	76	14	14	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0201015	10.1371/journal.pone.0201015	http://dx.doi.org/10.1371/journal.pone.0201015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021015	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400090
J	Palko, E; Poliska, S; Sziklai, I; Penyige, A				Palko, Eniko; Poliska, Szilard; Sziklai, Istvan; Penyige, Andras			Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma	PLOS ONE			English	Article							ACQUIRED CHOLESTEATOMA; BONE DESTRUCTION; IN-SITU; C-MYC; PROLIFERATION; MIGRATION; INCREASES; PATTERNS	Cholesteatoma is an epidermal cyst with still unknown pathomechanism. The aim of the current study was to investigate molecular differences in the background of the hyperproliferative property and aggressive behavior typical of the cholesteatoma epithelium. The expression of three cytokeratin genes (KRT1, KRT10 and KRT19), the matrix metalloproteinase 9 gene (MMP9) and the tumor suppressor TP53 gene was measured by qRT-PCR in surgical samples of pediatric and adult cholesteatoma cases and their expression level was compared to that of normal skin samples from the retroauricular region of control individuals. Cholesteatoma samples were stratified according to the age of onset and recurrence for more detailed analysis. Our results showed identical expression pattern for KRT1 and KRT10, their expression was higher in pediatric cases than in adults, especially in pediatric recurrent samples. The expression level of KRT19 was inversely proportional to that of KRT1/KRT10, it was lower in the more invasive recurrent cases both in our pediatric and adult groups. As it was expected from the bone destructive behavior of cholesteatoma, a significantly elevated expression of MMP9 was measured in cholesteatoma samples, the highest level was found in adult recurrent cases. Low expression levels characterize the TP53 gene without significant differences in our samples. These findings demonstrate that cytokeratin expression distinguishes between pediatric/adult, nonrecurrent/recurrent cases, suggesting that distinct differentiation state and cell division potential characterize these cholesteatoma cases. KRT19 with a tumor suppressor potential might restrict the recurrence of cholesteatoma. The differences observed in gene expression profiles between cholesteatoma and control samples support the notion that cholesteatoma is a cystic lesion with tumor-like behavior because it is characterized by invasive, destructive growth and high tendency for recurrence.	[Palko, Eniko; Penyige, Andras] Univ Debrecen, Fac Med, Dept Human Genet, Debrecen, Hungary; [Poliska, Szilard] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Debrecen, Hungary; [Sziklai, Istvan] Univ Debrecen, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Debrecen, Hungary; [Penyige, Andras] Univ Debrecen, Fac Pharm, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Palko, E (corresponding author), Univ Debrecen, Fac Med, Dept Human Genet, Debrecen, Hungary.	enikopalko@freemail.hu		Poliska, Szilard/0000-0002-9722-251X	Hungarian National Research Foundation [OTKA K81480]; Department of Human Genetics, University of Debrecen, Faculty of General Medicine	Hungarian National Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Department of Human Genetics, University of Debrecen, Faculty of General Medicine	This work was supported by the Hungarian National Research Foundation under Grant no. OTKA K81480; https://www.otka.hu. The authors received specific funding for this work from the Department of Human Genetics, University of Debrecen, Faculty of General Medicine.	Abbas O, 2011, MODERN PATHOL, V24, P90, DOI 10.1038/modpathol.2010.180; Ars BMPJ, 1999, PATHOGENESIS CHOLEST, P1; Britze A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104103; Cohen M, 2008, REPRODUCTION, V10, P2273, DOI [10.1093/humrep/den264, DOI 10.1093/HUMREP/DEN264]; Crowel DL, 1999, J DENT RES, V78, P1256, DOI 10.1177/00220345990780061001; Dornelles Cristina, 2006, Braz J Otorhinolaryngol, V72, P641; Ecsedi S, 2008, OTOLARYNG HEAD NECK, V139, P635, DOI 10.1016/j.otohns.2008.07.019; Ferekidis E, 2006, INT MED SCI MONIT, V12, P368; Frohwitter G, 2016, ONCOL LETT, V12, P107, DOI 10.3892/ol.2016.4588; Haake AR, 1997, EXP CELL RES, V231, P83, DOI 10.1006/excr.1996.3441; Jackler RK, 2015, LARYNGOSCOPE, V125, pS1, DOI 10.1002/lary.25261; Jeong JH, 2006, LARYNGOSCOPE, V116, P1180, DOI 10.1097/01.mlg.0000224345.59291.da; Ju JH, 2013, CLIN CANCER RES, V19, P4335, DOI 10.1158/1078-0432.CCR-12-3295; Juhasz A, 2009, OTOL NEUROTOL, V30, P559, DOI 10.1097/MAO.0b013e31819fe6ed; Jung P., 2007, THESIS, P28; Kim HJ, 2002, J KOREAN MED SCI, V17, P381, DOI 10.3346/jkms.2002.17.3.381; Klenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052718; Koc A, 2015, ACU SAGLIK BIL DERG, V1, P1; Kuo CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854024; Kuo CL, 2015, LARYNGOSCOPE, V125, P234, DOI 10.1002/lary.24890; Kuo KCL, 2016, RECENT ADV OTOLARYNG, P167; Kwon KH, 2006, ACTA OTO-LARYNGOL, V126, P691, DOI 10.1080/00016480500475633; Min Hyun Jung, 2012, Korean J Audiol, V16, P124, DOI 10.7874/kja.2012.16.3.124; Mohammadizadeh Fereshteh, 2009, Indian J Med Sci, V63, P152; Olszewska E, 2007, HISTOL HISTOPATHOL, V22, P37, DOI 10.14670/HH-22.37; Olszewska E, 2005, EUR ARCH OTO-RHINO-L, V262, P731, DOI 10.1007/s00405-004-0875-0; Ozturk K, 2006, OTOL NEUROTOL, V27, P588, DOI 10.1097/01.mao.0000226290.04048.d9; Palko E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639896; Papakosta V, 2006, ANTICANCER RES, V26, P2957; Rothschild S, 2009, AM J OTOLARYNG, V30, P256, DOI 10.1016/j.amjoto.2008.06.011; Saha SK, 2017, ONCOGENE, V36, P332, DOI 10.1038/onc.2016.221; Sawair F, 2016, Asian Pac J Cancer Prev, V17, P1243; Tokuriki M, 2003, LARYNGOSCOPE, V113, P808, DOI 10.1097/00005537-200305000-00008; Yildirim MS, 2003, ACTA OTO-LARYNGOL, V123, P372, DOI 10.1080/00016480310001286	34	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200840	10.1371/journal.pone.0200840	http://dx.doi.org/10.1371/journal.pone.0200840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021014	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400082
J	Gu, YT; Cai, RP; Zhang, C; Xue, YX; Pan, YL; Wang, JH; Zhang, Z				Gu, Yanting; Cai, Ruiping; Zhang, Cai; Xue, Yixue; Pan, Yali; Wang, Jiahong; Zhang, Zhou			miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway	FASEB JOURNAL			English	Article						BTB; caveolin-1; permeability; miRNA	BARRIER PERMEABILITY; CEREBRAL-ISCHEMIA; UP-REGULATION; BRAIN; MICRORNA-132; PHOSPHORYLATION; EXPRESSION; SRC; PROLIFERATION; POLARIZATION	Blood-brain tumor barrier (BTB) impedes the transportation of antitumor therapeutic drugs into brain tumors. Its mechanism is still unknown, but learning how to improve the BTB permeability is critical for drug intervention. Recently, microRNAs (miRNAs) have appeared as regulation factors of numerous biologic processes and therapeutic targets of diverse diseases. In this study, we have identified that miR-132-3p is an essential miRNA by increasing the transcellular transport through the BTB. We found that miR-132-3p expression was significantly up-regulated in glioma endothelial cells (GECs). Furthermore we showed that miR132-3p(+) greatly induced the endocytosis of cholera toxin subunit B and FITC-bovine serum albumin and up-regulated the expression of p-PKB, p-Src and Tyr14 phosphorylation of caveolin-1 (p-Cav-1), while phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression was markedly down-regulated in GECs. Our results identify PTEN as a direct and functional downstream target of miR-132-3p, which is involved in the regulation of p-PKB, p-Src, and p-Cav-1. The inhibitors for PI3K and Src significantly reversed the increase of p-Cav-1 induced by miR-132-3p. Moreover, overexpression of PTEN greatly reduced the endocytosis of cholera toxin subunit B and the up-regulation of p-Cav-1 induced by agomiR132-3p, suggesting that miR132-3p(+) increases the endothelial permeability by inhibition of PTEN expression. In addition, miR132-3p(+) significantly increased the delivery of doxorubicin across the BTB in vitro and contributed to the accumulation of doxorubicin within the brain tumor tissue. Our results show that miR-132-3p contributes to the increased permeability of BTB by targeting PTEN/PI3K/PKB/Src/Cav-1, thereby revealing a novel drug target for the treatment of brain gliomas.Gu, Y., Cai, R., Zhang, C., Xue, Y., Pan, Y., Wang, J., Zhang, Z. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.	[Gu, Yanting; Cai, Ruiping; Zhang, Cai; Pan, Yali; Wang, Jiahong; Zhang, Zhou] Shenyang Pharmaceut Univ, Life Sci & Biopharmaceut Inst, Dept Physiol, Shenyang 110016, Liaoning, Peoples R China; [Xue, Yixue] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning, Peoples R China	Shenyang Pharmaceutical University; China Medical University	Zhang, Z (corresponding author), Shenyang Pharmaceut Univ, Life Sci & Biopharmaceut Inst, Dept Physiol, Shenyang 110016, Liaoning, Peoples R China.	zzhouzhang@163.com			National Science Foundation for China [81201989, 81773289]; Special and Scientific Research Foundation of Shenyang Pharmaceutical University for Middle and Young Teachers' Career Development [ZCJJ2014407]; National Science Foundation for Liaoning Province [2015020564]; Innovative Entrepreneurship Training Plan of Shenyang Pharmaceutical University	National Science Foundation for China; Special and Scientific Research Foundation of Shenyang Pharmaceutical University for Middle and Young Teachers' Career Development; National Science Foundation for Liaoning Province; Innovative Entrepreneurship Training Plan of Shenyang Pharmaceutical University	The authors thank Dr. P.-O. Couraud (Institute Cochin, Paris, France) for providing the hCMECs. This work was supported by National Science Foundation for China (Grants 81201989 and 81773289), Special and Scientific Research Foundation of Shenyang Pharmaceutical University for Middle and Young Teachers' Career Development (Grant ZCJJ2014407), National Science Foundation for Liaoning Province (Grant 2015020564), and the Innovative Entrepreneurship Training Plan of Shenyang Pharmaceutical University. The authors declare no conflicts of interest.	Akers JC, 2017, ONCOTARGET, V8, P68769, DOI 10.18632/oncotarget.18332; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Belhadj Z, 2017, ONCOTARGET, V8, P66889, DOI 10.18632/oncotarget.17976; Biemans EALM, 2017, J NEUROSCI RES, V95, P1513, DOI 10.1002/jnr.23964; Chen S, 2016, BIOMED PHARMACOTHER, V83, P898, DOI 10.1016/j.biopha.2016.08.004; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Devalliere J, 2014, FASEB J, V28, P908, DOI 10.1096/fj.13-238527; Gao FY, 2015, MOL MED REP, V12, P7005, DOI 10.3892/mmr.2015.4253; Geng F, 2016, J NEURO-ONCOL, V129, P211, DOI 10.1007/s11060-016-2173-2; Gross S, 2017, J CEREBR BLOOD F MET, V37, P2471, DOI 10.1177/0271678X16669365; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; HE J, 2017, BIOMED RES INT, V2017, DOI DOI 10.1155/2017/3681707; Kilic U, 2017, REDOX BIOL, V12, P657, DOI 10.1016/j.redox.2017.04.006; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20486; Li JY, 2017, ACTA PHARMACOL SIN, V38, P182, DOI 10.1038/aps.2016.109; Li YJ, 2016, BIOMED PHARMACOTHER, V78, P177, DOI 10.1016/j.biopha.2016.01.022; Liao YW, 2017, J CELL BIOCHEM, V118, P1889, DOI 10.1002/jcb.25910; Liu F, 2015, EXP LUNG RES, V41, P261, DOI 10.3109/01902148.2015.1004206; Liu Q, 2014, TUMOR BIOL, V35, P12299, DOI 10.1007/s13277-014-2541-5; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Ma J, 2014, J CEREBR BLOOD F MET, V34, P1826, DOI 10.1038/jcbfm.2014.152; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Pan LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099526; Poirier C, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0856-5; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rathor N, 2014, AM J PHYSIOL-GASTR L, V306, pG650, DOI 10.1152/ajpgi.00003.2014; Shang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32180; Shao Y, 2016, ONCOTARGET, V7, P34011, DOI [10.18632/oncotarget.8514, 10.18632/oncotarget.12708]; Srinivasan VM, 2017, NEUROTHERAPEUTICS, V14, P345, DOI 10.1007/s13311-017-0522-2; Wang HZ, 2015, ONCOTARGETS THER, V8, P3211, DOI 10.2147/OTT.S79282; Wang Y, 2018, FASEB J, V32, P935, DOI 10.1096/fj.201700139RRR; Watson LJ, 2016, CELL SIGNAL, V28, P1580, DOI 10.1016/j.cellsig.2016.05.006; Wu F, 2017, ONCOTARGET, V8, P53110, DOI 10.18632/oncotarget.18162; Wu H, 2015, NEUROBIOL AGING, V36, P1439, DOI 10.1016/j.neurobiolaging.2014.12.029; Yang F, 2016, MED SCI MONITOR, V22, P3562, DOI 10.12659/MSM.897773; Zhang LW, 2014, CARDIOVASC DRUG THER, V28, P303, DOI 10.1007/s10557-014-6533-x; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhao Y, 2018, BIOFACTORS, V44, P609, DOI 10.1002/biof.1411; Zhou YF, 2018, FASEB J, V32, P2181, DOI 10.1096/fj.201700786RR	41	26	28	4	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					441	454		10.1096/fj.201800095RR	http://dx.doi.org/10.1096/fj.201800095RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024792	Bronze			2022-12-26	WOS:000457401500035
J	Dhabal, S; Das, P; Biswas, P; Kumari, P; Yakubenko, VP; Kundu, S; Cathcart, MK; Kundu, M; Biswas, K; Bhattacharjee, A				Dhabal, Sukhamoy; Das, Pradip; Biswas, Pritam; Kumari, Priyanka; Yakubenko, Valentin P.; Kundu, Suman; Cathcart, Martha K.; Kundu, Manjari; Biswas, Kaushik; Bhattacharjee, Ashish			Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						monoamine oxidase A; monocyte; cytokine; inflammation; cell migration; gene expression; 15-lipoxygenase; A549 lung cancer cells; alternative activation; gene regulation; human monocyte; signal transducer and activator of transcription; peroxisome proliferator-activated receptor	15-LIPOXYGENASE GENE-EXPRESSION; CENTRIFUGAL ELUTRIATION CCE; PERIPHERAL-BLOOD MONOCYTES; BRONCHIAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; ALTERNATIVE ACTIVATION; MACROPHAGE ACTIVATION; ENRICHED FRACTIONS; CANCER METASTASIS	Monoamine oxidase A (MAO-A) is a mitochondrial flavoenzyme implicated in the pathogenesis of atherosclerosis and inflammation and also in many neurological disorders. MAO-A also has been reported as a potential therapeutic target in prostate cancer. However, the regulatory mechanisms controlling cytokine-induced MAO-A expression in immune or cancer cells remain to be identified. Here, we show that MAO-A expression is co-induced with 15-lipoxygenase (15-LO) in interleukin 13 (IL-13)-activated primary human monocytes and A549 non-small cell lung carcinoma cells. We present evidence that MAO-A gene expression and activity are regulated by signal transducer and activator of transcription 1, 3, and 6 (STAT1, STAT3, and STAT6), early growth response 1 (EGR1), and cAMP-responsive element-binding protein (CREB), the same transcription factors that control IL-13-dependent 15-LO expression. We further established that in both primary monocytes and in A549 cells, IL-13-stimulated MAO-A expression, activity, and function are directly governed by 15-LO. In contrast, IL-13-driven expression and activity of MAO-A was 15-LO-independent in U937 promonocytic cells. Furthermore, we demonstrate that the 15-LO-dependent transcriptional regulation of MAO-A in response to IL-13 stimulation in monocytes and in A549 cells is mediated by peroxisome proliferator-activated receptor (PPAR) and that signal transducer and activator of transcription 6 (STAT6) plays a crucial role in facilitating the transcriptional activity of PPAR. We further report that the IL-13-STAT6-15-LO-PPAR axis is critical for MAO-A expression, activity, and function, including migration and reactive oxygen species generation. Altogether, these results have major implications for the resolution of inflammation and indicate that MAO-A may promote metastatic potential in lung cancer cells.	[Dhabal, Sukhamoy; Das, Pradip; Biswas, Pritam; Kumari, Priyanka; Bhattacharjee, Ashish] Natl Inst Technol Durgapur, Dept Biotechnol, Mahatma Gandhi Ave, Burdwan 713209, W Bengal, India; [Yakubenko, Valentin P.; Kundu, Suman; Cathcart, Martha K.] Case Western Reserve Univ, Dept Cell Biol, Lerner Res Inst, Cleveland Clin, Cleveland, OH 44195 USA; [Yakubenko, Valentin P.; Kundu, Suman; Cathcart, Martha K.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Kundu, Manjari; Biswas, Kaushik] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Yakubenko, Valentin P.] East Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, Johnson City, TN 37614 USA	National Institute of Technology (NIT System); National Institute of Technology Durgapur; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Department of Science & Technology (India); Bose Institute; East Tennessee State University	Bhattacharjee, A (corresponding author), Natl Inst Technol, Dept Biotechnol, Durgapur 713209, W Bengal, India.	ashish15lo@yahoo.com	Biswas, Kaushik/AAR-1446-2020	Biswas, Kaushik/0000-0003-2502-9515	Department of Biotechnology, Government of India; SERB, Government of India [SERB/SR/SO/HS-093/2013]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); SERB, Government of India	This work was supported by Ramalingaswami Fellowship (to A. B.) by the Department of Biotechnology, Government of India, and by Research Grant SERB/SR/SO/HS-093/2013 from SERB, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Adeghate E, 2004, NEUROTOXICOLOGY, V25, P167, DOI 10.1016/S0161-813X(03)00091-3; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Bhattacharjee A, 2010, J IMMUNOL, V185, P5211, DOI 10.4049/jimmunol.1000514; Bianchi P, 2005, CIRCULATION, V112, P3297, DOI 10.1161/CIRCULATIONAHA.104.528133; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brown CD, 2001, INFLAMM RES, V50, P321, DOI 10.1007/PL00000251; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Cao H, 2016, ONCOTARGET, V7, P61183, DOI 10.18632/oncotarget.11282; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cathcart M.K., 2014, INFLAMM CELL SIGNAL, V1, DOI [10.14800/ics.161, DOI 10.14800/ICS.161]; Cathcart MK, 2000, FREE RADICAL BIO MED, V28, P1726, DOI 10.1016/S0891-5849(00)00230-6; Chaitidis P, 2005, MED SCI MONITOR, V11, pBR259; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Coatrieux C, 2007, FREE RADICAL BIO MED, V43, P80, DOI 10.1016/j.freeradbiomed.2007.03.036; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Czimmerer Z, 2012, IMMUNOBIOLOGY, V217, P1301, DOI 10.1016/j.imbio.2012.08.270; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kaludercic N, 2011, BBA-MOL CELL RES, V1813, P1323, DOI 10.1016/j.bbamcr.2010.09.010; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kundu S, 2013, J LIPID RES, V54, P436, DOI 10.1194/jlr.M031914; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lin YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46338; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Moskvitina T A, 2001, Med Sci Monit, V7, P17; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Naoi M, 2006, J NEURAL TRANSM-SUPP, P67; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; PANAGIOTIDIS G, 1993, METABOLISM, V42, P1398, DOI 10.1016/0026-0495(93)90189-U; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Robbesyn F, 2003, FASEB J, V17, P743, DOI 10.1096/fj.02-0240fje; Rosen RL, 1996, BLOOD, V88, P1206, DOI 10.1182/blood.V88.4.1206.bloodjournal8841206; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Schwartz TL, 2013, CNS SPECTRUMS, V18, P22, DOI 10.1017/S1092852913000734; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shih JC, 1999, POL J PHARMACOL, V51, P25; SINGER TP, 1995, FASEB J, V9, P605, DOI 10.1096/fasebj.9.8.7768351; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Valley MP, 2006, ANAL BIOCHEM, V359, P238, DOI 10.1016/j.ab.2006.09.035; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Wang CC, 2011, J BIOL CHEM, V286, P28322, DOI 10.1074/jbc.M111.241422; Wang LH, 2000, BLOOD, V95, P1249, DOI 10.1182/blood.V95.4.1249.004k39_1249_1257; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Wouters J, 1998, CURR MED CHEM, V5, P137; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu JB, 2014, J CLIN INVEST, V124, P2891, DOI 10.1172/JCI70982; Wu Ning, 2010, J Thorac Dis, V2, P76; Xu B, 2004, J BIOL CHEM, V279, P15954, DOI 10.1074/jbc.M400413200; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yakubenko VP, 2013, J BIOL CHEM, V288, P2778, DOI 10.1074/jbc.M112.381343; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Zhao JM, 2009, AM J RESP CRIT CARE, V179, P782, DOI 10.1164/rccm.200811-1744OC	71	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14040	14064		10.1074/jbc.RA118.002321	http://dx.doi.org/10.1074/jbc.RA118.002321			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30021838	hybrid, Green Published			2022-12-26	WOS:000444070700027
J	Gupta, S; Kelow, S; Wang, L; Andrake, MD; Dunbrack, RL; Kruger, WD				Gupta, Sapna; Kelow, Simon; Wang, Liqun; Andrake, Mark D.; Dunbrack, Roland L., Jr.; Kruger, Warren D.			Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine -synthase (CBS) reveal effects on CBS activity but not stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inborn error of metabolism; mouse genetics; structural model; methionine; pyridoxal phosphate; missense mutation; bortezomib; pyridoxine; cystathionine -synthase; transsulfuration pathway; sulfur metabolism; p; G307S; homocystinuria	BETA-SYNTHASE; GENE-EXPRESSION; MOLECULAR-BASIS; DEFICIENCY; HEME; HOMOCYSTINURIA; PROTEIN; ACTIVATION; RESCUE; CHARMM	Mutations in the cystathionine -synthase (CBS) gene are the cause of classical homocystinuria, the most common inborn error in sulfur metabolism. The p.G307S mutation is the most frequent cause of CBS deficiency in Ireland, which has the highest prevalence of CBS deficiency in Europe. Individuals homozygous for this mutation tend to be severely affected and are pyridoxine nonresponsive, but the molecular basis for the strong effects of this mutation is unclear. Here, we characterized a transgenic mouse model lacking endogenous Cbs and expressing human p.G307S CBS protein from a zinc-inducible metallothionein promoter (Tg-G307S Cbs(-/-)). Unlike mice expressing other mutant CBS alleles, the Tg-G307S transgene could not efficiently rescue neonatal lethality of Cbs(-/-) in a C57BL/6J background. In a C3H/HeJ background, zinc-induced Tg-G307S Cbs(-/-) mice expressed high levels of p.G307S CBS in the liver, and this protein variant forms multimers, similarly to mice expressing WT human CBS. However, the p.G307S enzyme had no detectable residual activity. Moreover, treating mice with proteasome inhibitors failed to significantly increase CBS-specific activity. These findings indicated that the G307S substitution likely affects catalytic function as opposed to causing a folding defect. Using molecular dynamics simulation techniques, we found that the G307S substitution likely impairs catalytic function by limiting the ability of the tyrosine at position 308 to assume the proper conformational state(s) required for the formation of the pyridoxal-cystathionine intermediate. These results indicate that the p.G307S CBS is stable but enzymatically inert and therefore unlikely to respond to chaperone-based therapy.	[Gupta, Sapna; Wang, Liqun; Andrake, Mark D.; Dunbrack, Roland L., Jr.; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Kelow, Simon] Univ Penn, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; University of Pennsylvania	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018; Dunbrack, Roland/ABG-7141-2020	kruger, warren/0000-0002-4990-3695; Andrake, Mark/0000-0003-2957-4350	National Institutes of Health [R01 DK101404, GM 098772, R35 GM122517]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098772, R35GM122517, R01GM111819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 DK101404 (to W. D. K.), GM 098772 (to W. D. K.), and R35 GM122517 (to R. L. D.) and an appropriation from the Commonwealth of Pennsylvania. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Ereno-Orbea J, 2014, P NATL ACAD SCI USA, V111, pE3845, DOI 10.1073/pnas.1414545111; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Gaustadnes M, 2002, HUM MUTAT, V20, P117, DOI 10.1002/humu.10104; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Gupta S, 2017, HUM MUTAT, V38, P863, DOI 10.1002/humu.23240; Gupta S, 2013, HUM MUTAT, V34, P1085, DOI 10.1002/humu.22335; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Kopecka J, 2011, J INHERIT METAB DIS, V34, P39, DOI 10.1007/s10545-010-9087-5; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kruger WD, 2003, HUM MUTAT, V22, P434, DOI 10.1002/humu.10290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodha PH, 2009, BIOCHEM CELL BIOL, V87, P531, DOI [10.1139/O09-003, 10.1139/o09-003]; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; McCorvie TJ, 2014, J BIOL CHEM, V289, P36018, DOI 10.1074/jbc.M114.610782; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Melenovska P, 2015, J INHERIT METAB DIS, V38, P287, DOI 10.1007/s10545-014-9781-9; Moat Stuart J, 2004, Hum Mutat, V23, P206, DOI 10.1002/humu.9214; Moorthie S, 2014, J INHERIT METAB DIS, V37, P889, DOI 10.1007/s10545-014-9729-0; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pey AL, 2016, FEBS LETT, V590, P4461, DOI 10.1002/1873-3468.12488; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Singh LR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000807; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vicente JB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8940321; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Yap S, 1998, J INHERIT METAB DIS, V21, P738, DOI 10.1023/A:1005445132327	53	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13921	13931		10.1074/jbc.RA118.002164	http://dx.doi.org/10.1074/jbc.RA118.002164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030379	hybrid, Green Published			2022-12-26	WOS:000444070700018
J	Sohn, JH; Lee, YK; Han, JS; Jeon, YG; Kim, JI; Choe, SS; Kim, SJ; Yoo, HJ; Kim, JB				Sohn, Jee Hyung; Lee, Yun Kyung; Han, Ji Seul; Jeon, Yong Geun; Kim, Jong In; Choe, Sung Sik; Kim, Su Jung; Yoo, Hyun Ju; Kim, Jae Bum			Perilipin 1 (Plin1) deficiency promotes inflammatory responses in lean adipose tissue through lipid dysregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; lipolysis; prostaglandin; insulin resistance; lipid metabolism; adipose tissue inflammation; adipose tissue macrophage; Plin1	DIET-INDUCED OBESITY; MEDIATED ADIPOCYTE LIPOLYSIS; ACTIVATED PROTEIN-KINASE; HORMONE-SENSITIVE LIPASE; INSULIN-RESISTANCE; NORMAL-WEIGHT; METABOLICALLY HEALTHY; HEPATIC STEATOSIS; STORAGE DROPLETS; SKELETAL-MUSCLE	Lipid droplets are specialized cellular organelles that contain neutral lipid metabolites and play dynamic roles in energy homeostasis. Perilipin 1 (Plin1), one of the major lipid droplet-binding proteins, is highly expressed in adipocytes. In mice, Plin1 deficiency impairs peripheral insulin sensitivity, accompanied with reduced fat mass. However, the mechanisms underlying insulin resistance in lean Plin1 knockout (Plin1(-/-)) mice are largely unknown. The current study demonstrates that Plin1 deficiency promotes inflammatory responses and lipolysis in adipose tissue, resulting in insulin resistance. M1-type adipose tissue macrophages (ATMs) were higher in Plin1(-/-) than in Plin1(+/+) mice on normal chow diet. Moreover, using lipidomics analysis, we discovered that Plin1(-/-) adipocytes promoted secretion of pro-inflammatory lipid metabolites such as prostaglandins, which potentiated monocyte migration. In lean Plin1(-/-) mice, insulin resistance was relieved by macrophage depletion with clodronate, implying that elevated pro-inflammatory ATMs might be attributable for insulin resistance under Plin1 deficiency. Together, these data suggest that Plin1 is required to restrain fat loss and pro-inflammatory responses in adipose tissue by reducing futile lipolysis to maintain metabolic homeostasis.	[Sohn, Jee Hyung; Lee, Yun Kyung; Han, Ji Seul; Jeon, Yong Geun; Kim, Jong In; Choe, Sung Sik; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, Natl Creat Res Initiat Ctr Adipose Tissue Remodel, KS-013 Seoul, South Korea; [Kim, Su Jung; Yoo, Hyun Ju] Univ Ulsan, Coll Med, Dept Convergence Med, Asan Inst Life Sci,Asan Med Ctr, KS-013 Seoul, South Korea	Seoul National University (SNU); University of Ulsan	Kim, JB (corresponding author), Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Initiat Ctr Adipose Tissue Remodel, Inst Mol Biol & Genet, San 56-1, Seoul 151742, South Korea.	jaebkim@snu.ac.kr	JEON, YONGGEUN/ABE-4093-2021; Lee, Yun Kyung/AAK-1675-2021; Lee, Yun Kyung/AFE-1810-2022; Lee, Yun Kyung/AAE-9520-2022	Lee, Yun Kyung/0000-0002-6476-0135; Jeon, Yong Geun/0000-0002-1422-9151; KIM, Jae Bum/0000-0003-2337-6935; Sohn, Jee Hyung/0000-0003-2739-134X	National Research Foundation of Korea (NRF) - South Korea government, Ministry of Science, ICT, and Future Planning [2011-0018312]; Brain Korea 21 program	National Research Foundation of Korea (NRF) - South Korea government, Ministry of Science, ICT, and Future Planning; Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the South Korea government, Ministry of Science, ICT, and Future Planning number 2011-0018312. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Brain Korea 21 program.	Ayache S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-40; Batista ML, 2012, CYTOKINE, V57, P9, DOI 10.1016/j.cyto.2011.10.008; Batista ML, 2016, J CACHEXIA SARCOPENI, V7, P37, DOI 10.1002/jcsm.12037; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carman GM, 2012, J BIOL CHEM, V287, P2272, DOI 10.1074/jbc.R111.323931; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; Choe SS, 2014, DIABETES, V63, P3359, DOI 10.2337/db13-1965; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; De Lorenzo A, 2007, AM J CLIN NUTR, V85, P40, DOI 10.1093/ajcn/85.1.40; de Matos-Neto EM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00629; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Gartung A, 2016, J BIOL CHEM, V291, P16001, DOI 10.1074/jbc.M116.725937; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; Ham M, 2016, DIABETES, V65, P2624, DOI 10.2337/db16-0060; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hoo RLC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40657; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu XQ, 2016, J LIPID RES, V57, P663, DOI 10.1194/jlr.M066530; Huh JY, 2017, DIABETES, V66, P835, DOI 10.2337/db16-1122; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Indulekha K, 2015, DIABETES TECHNOL THE, V17, P134, DOI 10.1089/dia.2014.0202; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim M, 2013, METABOLISM, V62, P554, DOI 10.1016/j.metabol.2012.10.006; Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Langlois D, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-169; Lee JH, 2016, J BIOL CHEM, V291, P20315, DOI 10.1074/jbc.M116.740464; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Montgomery MK, 2018, DIABETES, V67, P594, DOI 10.2337/db17-0923; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto K, 2018, ATHEROSCLEROSIS, V269, P192, DOI 10.1016/j.atherosclerosis.2018.01.019; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; ZHANG S.-Q., 2018, NATURE COMMUNICATION, V9, P1, DOI DOI 10.3389/fimmu.2018.00467; Zhou P. L., 2017, J CELL BIOCHEM, DOI [10.1002/jbc.26493, DOI 10.1002/JBC.26493]; Zou LQ, 2016, BBA-MOL BASIS DIS, V1862, P182, DOI 10.1016/j.bbadis.2015.10.024	67	44	49	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13974	13988		10.1074/jbc.RA118.003541	http://dx.doi.org/10.1074/jbc.RA118.003541			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30042231	hybrid, Green Published			2022-12-26	WOS:000444070700022
J	Terada, M; Suzuki, G; Nonaka, T; Kametani, F; Tamaoka, A; Hasegawa, M				Terada, Makoto; Suzuki, Genjiro; Nonaka, Takashi; Kametani, Fuyuki; Tamaoka, Akira; Hasegawa, Masato			The effect of truncation on prion-like properties of -synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; alpha-synuclein (a-synuclein); amyloid; electron microscopy (EM); fibril; immunohistochemistry; neurodegenerative disease; Parkinson's disease; Western blot; neurodegeneration; polymorphs; prion-like; truncation; protein truncation; protein structure; prion; neurodegeneration	HUMAN ALPHA-SYNUCLEIN; C-TERMINAL REGION; PARKINSONS-DISEASE; IN-VITRO; FIBRIL FORMATION; NEURODEGENERATIVE-DISEASES; INTRACELLULAR INCLUSIONS; STRUCTURAL-PROPERTIES; PROTEOLYTIC CLEAVAGE; MEMBRANE-BINDING	Increasing evidence suggests that -synuclein (S) aggregates in brains of individuals with Parkinson's disease and dementia with Lewy bodies can spread in a prion-like manner. Although the initial S nuclei are pivotal in determining S fibril polymorphs and resulting phenotypes, it is not clear how the initial fibril seeds are generated. Previous studies have shown that S truncation might have an important role in S aggregation. However, little is known about how this truncation influences S's propagation properties. In the present study, we generated S fibrils from a series of truncated human S constructs, characterized their structures and conformational stabilities, and investigated their ability to convert the conformation of full-length S in vitro, in cultured cells, and in WT mice. We show that both C- and N-terminal truncations of human S induce fibril polymorphs and exhibit different cross-seeding activities. N-terminally 10- or 30-residue-truncated human S fibrils induced more abundant S pathologies than WT fibrils in mice, whereas other truncated fibrils induced less abundant pathologies. Biochemical analyses of these truncated fibrils revealed that N-terminal 10- or 30-residue truncations of human S change the fibril conformation in a manner that increases their structural compatibility with WT mouse S fibrils and reduces their stability. C-terminally 20-residue-truncated fibrils displayed enhanced seeding activity in vitro. Our findings imply that truncation of S can influence its prion-like pathogenicity, resulting in phenotypic diversity of -synucleinopathies.	[Terada, Makoto; Suzuki, Genjiro; Nonaka, Takashi; Kametani, Fuyuki; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Terada, Makoto; Tamaoka, Akira] Univ Tsukuba, Fac Med, Dept Neurol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba	Terada, M; Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.; Terada, M (corresponding author), Univ Tsukuba, Fac Med, Dept Neurol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mterada-tuk@umin.ac.jp; hasegawa-ms@igakuken.or.jp	Kametani, Fuyuki/G-4752-2011	Kametani, Fuyuki/0000-0001-9125-7001	Ministry of Education, Culture, Sports, Science, and Technology [JP26117005]; Japan Society for the Promotion of Science [JP23228004]; Japan Agency for Medical Research and Development (AMED) [JP14533254]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (KAKENHI) Grant JP26117005 (to M. H.), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) Grant JP23228004 (to M. H.), and Japan Agency for Medical Research and Development (AMED) Grant-in-Aid for research on Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) Grant JP14533254 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.84; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kellie JF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05797; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Kim KS, 2012, J BIOL CHEM, V287, P24862, DOI 10.1074/jbc.M112.348128; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee SJ, 2015, NATURE, V522, P296, DOI 10.1038/nature14526; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lin S, 2016, P NATL ACAD SCI USA, V113, P2023, DOI 10.1073/pnas.1518442113; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Oikawa T, 2016, J BIOL CHEM, V291, P15046, DOI 10.1074/jbc.M116.736355; Oueslati Abid, 2014, Exp Neurobiol, V23, P324, DOI 10.5607/en.2014.23.4.324; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Porcari R, 2015, J BIOL CHEM, V290, P2395, DOI 10.1074/jbc.M114.610527; Prasad K, 2012, BRAIN PATHOL, V22, P811, DOI 10.1111/j.1750-3639.2012.00597.x; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Ulrih NP, 2008, BBA-MOL BASIS DIS, V1782, P581, DOI 10.1016/j.bbadis.2008.07.004; Uversky Vladimir N, 2017, F1000Res, V6, P525, DOI 10.12688/f1000research.10536.1; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Xu L, 2017, ACS CHEM NEUROSCI, V8, P837, DOI 10.1021/acschemneuro.6b00406; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zhang ZT, 2017, NAT STRUCT MOL BIOL, V24, P632, DOI 10.1038/nsmb.3433; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	73	47	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13910	13920		10.1074/jbc.RA118.001862	http://dx.doi.org/10.1074/jbc.RA118.001862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030380	hybrid, Green Published			2022-12-26	WOS:000444070700017
J	DuBois, C; Odame, HH; Haley, DB; Merkies, K				DuBois, Cordelie; Odame, Helen Hambly; Haley, Derek B.; Merkies, Katrina			An exploration of industry expert perception of Canadian equine welfare using a modified Delphi technique	PLOS ONE			English	Article							IRELAND	The diversity of sectors that comprise the equine industry makes reaching a consensus regarding welfare issues a challenge. To allow for productive discussion, equine professionals (n = 34) chosen to represent the diverse specializations from across Canada were surveyed using the Delphi technique D a survey technique employing multiple, iterative "rounds" to consolidate viewpoints D to gather and consolidate information regarding areas of welfare concern in the Canadian equine industry. Only participants who completed the prior round could participate in subsequent rounds. In the first round, respondents were asked to identify examples of welfare issues. Qualitative analysis was used to sort and group answers based on their similarities. Participants identified 12 welfare issues best addressed at the individual horse level, and an additional 12 welfare issues best addressed at the industry level. In the second (n = 24) and third (n = 14) rounds, welfare issues, solutions, and potential motives were consolidated based on order ranking. Themes of "ignorance" and "lack of knowledge" identified throughout all three rounds were cited as both potential risks to welfare as well as motives leading to poor welfare situations. Responses in this study suggest that in order to improve the welfare of equids in the Canadian industry, equine professionals propose that a greater effort is required to help educate industry members and stakeholders such that, through daily routine care and management, higher standards of welfare can be attained.	[DuBois, Cordelie; Merkies, Katrina] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [DuBois, Cordelie; Haley, Derek B.; Merkies, Katrina] Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON, Canada; [Odame, Helen Hambly] Univ Guelph, Sch Environm Design & Rural Dev, Guelph, ON, Canada; [Haley, Derek B.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph; University of Guelph	Merkies, K (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada.; Merkies, K (corresponding author), Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON, Canada.	kmerkies@uoguelph.ca	merkies, katrina/AAC-8577-2020	merkies, katrina/0000-0002-9462-4150; Haley, Derek/0000-0003-3502-120X				Aven T, 2010, RELIAB ENG SYST SAFE, V95, P1117, DOI 10.1016/j.ress.2010.05.006; Collins J, 2008, IRISH VET J, V61, P746, DOI 10.1186/2046-0481-61-11-746; Collins JA, 2012, VET REC, V170, P442, DOI 10.1136/vr.100281; Collins JA, 2010, EQUINE VET J, V42, P105, DOI 10.2746/042516409X471458; Collins J, 2009, VET J, V181, P63, DOI 10.1016/j.tvjl.2009.03.012; Derisoud E, 2016, J VET BEHAV, V15, DOI [10.1016/j.jveb.2016.08.066, DOI 10.1016/J.JVEB.2016.08.066]; Evans V., 2010, CANADIAN HORSE IND P; Faber M., 1992, ENVIRON VALUE, V1, P217, DOI DOI 10.3197/096327192776680089; Faucitano L, 2017, WOODHEAD PUBL FOOD S, P537, DOI 10.1016/B978-0-08-100593-4.00021-7; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hemsworth LM, 2015, APPL ANIM BEHAV SCI, V165, P1, DOI 10.1016/j.applanim.2014.11.019; Horseman SV, 2017, J APPL ANIM WELF SCI, V20, P9, DOI 10.1080/10888705.2016.1197776; Horseman SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160269; Lagerkvist CJ, 2011, EUR REV AGRIC ECON, V38, P55, DOI 10.1093/erae/jbq043; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; McNeill LR, 2018, J APPL ANIM WELF SCI, V21, P40, DOI 10.1080/10888705.2017.1372199; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; National Farm Animal Care Council, 2013, COD PRACT CAR HANDL; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Schemann K, 2012, PREV VET MED, V106, P97, DOI 10.1016/j.prevetmed.2012.01.013; Sumsion T., 1998, BRIT J OCCUP THER, V61, P153, DOI [10.1177/030802269806100403, DOI 10.1177/030802269806100403]; van der Kolk JH, 2014, EQUINE SPORTS MED SU, P769; Waller CC, 2017, DRUG TEST ANAL, V9, P1304, DOI 10.1002/dta.2112; Whay HR, 2003, ANIM WELFARE, V12, P205	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0201363	10.1371/journal.pone.0201363	http://dx.doi.org/10.1371/journal.pone.0201363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO7MT	30059509	Green Published, gold, Green Submitted			2022-12-26	WOS:000440251600034
J	Krammer, EM; Bouckaert, JMJ				Krammer, Eva-Maria; Bouckaert, Julie Maria Jozefa			Norovirus devours human milk oligosaccharides rich in alpha-fucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BLOOD GROUP ANTIGENS	Human norovirus binding to histo-blood group antigens (HBGAs) is thought to direct their entry into host cells. However, the glycan epitopes characteristic of HBGAs are also present on oligosaccharides abundant in human milk. In this issue of JBC, Hanisch et al. compared norovirus binding to human gastric mucins and human milk oligosaccharides, finding those bound most avidly are rich in alpha-fucose. Mimicry of these epitopes with alpha-fucose multivalently displayed on other carbohydrate scaffolds successfully scavenged this prevalent virus, providing new insights into norovirus biology and clues for future therapeutic development.	[Bouckaert, Julie Maria Jozefa] CNRS, UMR8576, UGSF, 50 Ave Halley, F-59658 Villeneuve Dascq, France; UdeLille, 50 Ave Halley, F-59658 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Bouckaert, JMJ (corresponding author), CNRS, UMR8576, UGSF, 50 Ave Halley, F-59658 Villeneuve Dascq, France.	julie.bouckaert@univ-lille.fr	; Krammer, Eva-Maria/H-2543-2013	Bouckaert, Julie/0000-0001-8112-1442; Krammer, Eva-Maria/0000-0002-4821-2550	H2020-MSC [750280]; CNRS, HiCare Grant from Agence Nationale de la Recherche (ANR) [ANR-17-CE07-0028-03]; ITN GlycoVax Grant from H2020-MSC [675671]	H2020-MSC; CNRS, HiCare Grant from Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ITN GlycoVax Grant from H2020-MSC	Recipient of H2020-MSC funding under Grant 750280.; Recipient of funding from CNRS, HiCare Grant ANR-17-CE07-0028-03 from Agence Nationale de la Recherche (ANR), and ITN GlycoVax Grant 675671 from H2020-MSC.	Bode L, 2015, EARLY HUM DEV, V91, P619, DOI 10.1016/j.earlhumdev.2015.09.001; Hanisch FG, 2018, J BIOL CHEM, V293, P11955, DOI 10.1074/jbc.RA117.001369; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Liu YH, 1998, J HISTOCHEM CYTOCHEM, V46, P69, DOI 10.1177/002215549804600109; Lonardi Emanuela, 2013, Biology (Basel), V2, P894, DOI 10.3390/biology2030894; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rademacher C, 2011, CHEM-EUR J, V17, P7442, DOI 10.1002/chem.201003432; Schroten H, 2016, J VIROL, V90, P5855, DOI 10.1128/JVI.00317-16	8	3	3	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11966	11967		10.1074/jbc.H118.004336	http://dx.doi.org/10.1074/jbc.H118.004336			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	30054292	Green Published, hybrid			2022-12-26	WOS:000440134500027
J	Amparo, ACB; Jayme, SI; Roces, MCR; Quizon, MCL; Mercado, MLL; Dela Cruz, MPZ; Licuan, DA; Villalon, EES; Baquilod, MS; Hernandez, LM; Taylor, LH; Nel, LH				Amparo, Anna Charinna B.; Jayme, Sarah I.; Roces, Maria Concepcion R.; Quizon, Maria Consorcia L.; Mercado, Maria Luisa L.; Dela Cruz, Maria Pinky Z.; Licuan, Dianne A.; Villalon, Ernesto E. S., III; Baquilod, Mario S.; Hernandez, Leda M.; Taylor, Louise H.; Nel, Louis H.			The evaluation of Animal Bite Treatment Centers in the Philippines from a patient perspective	PLOS ONE			English	Article							RABIES; ATTITUDES; KNOWLEDGE	Background The Philippines has built an extensive decentralised network of Animal Bite Treatment Centers (ABTCs) to help bite victims receive timely rabies post-exposure prophylaxis (PEP) at little cost. This study surveyed patients in the community and at ABTCs of three provinces to assess animal bite/scratch incidence, health-seeking behaviour and PEP-related out-of pocket expenses (OOPE). Methodology and principal findings During community surveys in 90 barangays (neighbourhoods), 53% of households reported at least one animal bite/scratch injury over the past 3 years, similar across urban and rural barangays. Overall bite/scratch incidences in 2016 +/- 17 were 67.3, 41.9 and 48.8 per 1,000 population per year for Nueva Vizcaya, Palawan and Tarlac respectively. Incidences were around 50% higher amongst those under 15 years of age, compared to-those older than 15. Household awareness of the nearest ABTCs was generally over 80%, but only 44.9% sought proper medical treatment and traditional remedies were still frequently used. The proportion of patients seeking PEP was not related to the distance or travel time to the nearest ABTC. For those that did not seek medical treatment, most cited a lack of awareness or insufficient funds and almost a third visited a traditional healer. No deaths from bite/scratch injuries were reported. A cohort of 1,105 patients were interviewed at six ABTCs in early 2017. OOPE varied across the ABTCs, from 5.53 USD to 37.83 USD per patient, primarily dependent on the need to pay for immunization if government supplies had run out. Overall, 78% of patients completed the recommended course, and the main reason for non-completion was a lack of time, followed by insufficient funds. Dog observation data revealed that 85% of patients were not truly exposed to rabies, and education in bite prevention might reduce provoked bites and demand for PEP. An accompanying paper details the ABTC network from the health provider's perspective.	[Amparo, Anna Charinna B.; Jayme, Sarah I.; Mercado, Maria Luisa L.; Dela Cruz, Maria Pinky Z.; Licuan, Dianne A.] Global Alliance Rabies Control, Sta Rosa City, Philippines; [Roces, Maria Concepcion R.; Quizon, Maria Consorcia L.] South Asia Field Epidemiol & Technol Network SAFE, Quezon City, Philippines; [Villalon, Ernesto E. S., III; Baquilod, Mario S.; Hernandez, Leda M.] Dis Prevent & Control Bur, Dept Hlth, Manila, Philippines; [Taylor, Louise H.; Nel, Louis H.] Global Alliance Rabies Control, Manhattan, KS USA; [Nel, Louis H.] Univ Pretoria, Pretoria, South Africa	Philippine Department Health; University of Pretoria	Amparo, ACB (corresponding author), Global Alliance Rabies Control, Sta Rosa City, Philippines.	chari.amparo@rabiesalliance.org	Nel, Louis H/F-1001-2012	Nel, Louis H/0000-0001-8963-0153; Amparo, Anna Charinna/0000-0002-9358-3983; Roces, Maria Concepcion/0000-0003-3047-9529	GlaxoSmithKline Biologicals SA (Belgium)	GlaxoSmithKline Biologicals SA (Belgium)(GlaxoSmithKline)	The Global Alliance for Rabies Control received funds from GlaxoSmithKline Biologicals SA (Belgium) to undertake the study. ACBA, SIJ, MLLM, MPZDC, DAL were funded by the study, while MCR, MCLQ, and LHT received partial funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparo AC, EVALUATION OPERATING; Deray R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189596; Dimaano EM, 2011, INT J INFECT DIS, V15, pE495, DOI 10.1016/j.ijid.2011.03.023; Elio-Villa LP, EPIDEMIOLOGICAL STUD; Fenelon N, 2017, EPIDEMIOL INFECT, V145, P1624, DOI 10.1017/S0950268816003125; Frey J, 2013, TROP MED INT HEALTH, V18, P1555, DOI 10.1111/tmi.12202; GAVI, 2013, RAB VACC INV STRAT B; Hampson K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000982; Moran David, 2015, BMC Res Notes, V8, P955, DOI 10.1186/s13104-014-0955-1; Mucheru GM, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.255.4745; OIE, 2016, GLOB STRAT FRAM EL D; Philippine Statistics Authority, 2017, PHIL STAND GEOGR COD; Philippines Department of Health Philippines Department of Agriculture, 2011, ADM ORD DOH 2011 200; Sharma S, 2016, ANN MED HEALTH SCI R, V6, P115, DOI 10.4103/2141-9248.181836; Shi JF, 2010, VACCINE, V28, P2573, DOI [10.1016/j.vaccine.2010.01.051, 10.1016/j.vaccine.2010.08.082]; Valenzuela LM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00054	16	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200873	10.1371/journal.pone.0200873	http://dx.doi.org/10.1371/journal.pone.0200873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048466	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400024
J	Hu, YX; Schafer, G; Duplay, J; Kuhn, NJ				Hu, Yaxian; Schafer, Gerhard; Duplay, Joelle; Kuhn, Nikolaus J.			Bioenergy crop induced changes in soil properties: A case study on Miscanthus fields in the Upper Rhine Region	PLOS ONE			English	Article							LAND-USE CHANGE; X GIGANTEUS; CARBON SEQUESTRATION; ENVIRONMENTAL IMPACTS; C-13 ABUNDANCE; ORGANIC-MATTER; CLIMATE-CHANGE; LOESS PLATEAU; BIOMASS; MITIGATION	Biomass as a renewable energy source has become increasingly prevalent in Europe to comply with greenhouse gas emission targets. As one of the most efficient perennial bioenergy crops, there is great potential in the Upper Rhine Region to explore biomass utilization of Miscanthus to confront climate change and land use demand in the future. Yet, the impacts of Miscanthus cultivation on soil quality have not been adequately explored. This study investigated the soil profiles of five-and 20-year-old Miscanthus fields (1 m depth) as well as grassland for reference in eastern France and Switzerland. The soil organic carbon (SOC) concentrations and delta(13) C compositions of four soil layers (0-10 cm, 10-40 cm, 40-70 cm and 70-100 cm) were determined. The CO2 emission rates of the topsoil were monitored for 42 days. Our results showed that Miscanthus, in general, could increase the SOC stocks compared to grassland, but the benefits of SOC sequestration were constrained to the surface soil. Isotopically, the Miscanthus-derived SOC ranged from 69% in the top 10 cm of soil down to only 7% in the 70 cm to 100 cm layer. This result raises the risk of overestimating the total net benefits of Miscanthus cultivation, when simply using the greater SOC stocks near the surface soil to represent the SOC-depleted deep soil layers. The Miscanthus fields had greater CO2 emissions, implying that the Miscanthus fields generated greater ecosystem respiration, rather than larger net ecosystem exchanges. Compared to the grassland soils, the surface soils of the Miscanthus fields tended to have a risk of acidification while having higher concentrations of phosphorus and potassium, calling for the inclusion of soil characteristics and SOC stability when evaluating the impacts of long-term Miscanthus cultivation on both current and future land use changes.	[Hu, Yaxian] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Hu, Yaxian; Kuhn, Nikolaus J.] Univ Basel, Dept Environm Sci, Phys Geog & Environm Change, Basel, Switzerland; [Schafer, Gerhard; Duplay, Joelle] Univ Strasbourg, CNRS, UMR 7517, Lab Hydrol & Geochim Strasbourg, Strasbourg, France	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hu, YX (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.; Hu, YX (corresponding author), Univ Basel, Dept Environm Sci, Phys Geog & Environm Change, Basel, Switzerland.	huyaxian@nwafu.edu.cn	Schäfer, Gerhard/GWV-4806-2022		Innovations for Sustainable Biomass Utilization in the Upper Rhine Region; Special Funds for Young Scientists with Oversea Doctoral Diploma from Department of Human Resources and Social Security of Shaanxi Province, China [2017036]; Fundamental Research Funds for the Central Universities [2452017191]	Innovations for Sustainable Biomass Utilization in the Upper Rhine Region; Special Funds for Young Scientists with Oversea Doctoral Diploma from Department of Human Resources and Social Security of Shaanxi Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Innovations for Sustainable Biomass Utilization in the Upper Rhine Region, and the Special Funds for Young Scientists with Oversea Doctoral Diploma from Department of Human Resources and Social Security of Shaanxi Province, China (2017036), and Fundamental Research Funds for the Central Universities (2452017191). The funders had no role in study de-sign, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2009, SOIL SCI, V174, P113, DOI 10.1097/SS.0b013e3181981ddc; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; Cattaneo F, 2014, BIOL FERT SOILS, V50, P1121, DOI 10.1007/s00374-014-0931-x; Christian DG, 1997, BIOMASS BIOENERG, V12, P21, DOI 10.1016/S0961-9534(96)00060-8; Cosentino SL, 2007, IND CROP PROD, V25, P75, DOI 10.1016/j.indcrop.2006.07.006; Danalatos NG, 2007, BIOMASS BIOENERG, V31, P145, DOI 10.1016/j.biombioe.2006.07.004; Dawson TE, 2001, CURR PLANT SCI BIOT, V40, P1; de Vries SC, 2014, EUR J AGRON, V52, P166, DOI 10.1016/j.eja.2013.09.012; Dufosse K, 2014, BIOMASS BIOENERG, V69, P198, DOI 10.1016/j.biombioe.2014.07.003; Farrelly DJ, 2013, RENEW SUST ENERG REV, V21, P712, DOI 10.1016/j.rser.2012.12.038; Foereid B, 2004, SOIL BIOL BIOCHEM, V36, P1075, DOI 10.1016/j.soilbio.2004.03.002; Hansen EM, 2004, BIOMASS BIOENERG, V26, P97, DOI 10.1016/S0961-9534(03)00102-8; Howlett DS, 2013, CATENA, V104, P127, DOI 10.1016/j.catena.2012.11.002; Kahle P, 2001, EUR J AGRON, V15, P171, DOI 10.1016/S1161-0301(01)00102-2; Kuhn NJ, 2016, AGR ECOSYST ENVIRON, V216, P155, DOI 10.1016/j.agee.2015.10.001; Kuhn NJ, 2010, NATURE GEOSCIENCE, V3, P1; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Murphy F, 2013, RENEW SUST ENERG REV, V23, P412, DOI 10.1016/j.rser.2013.01.058; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Poeplau C, 2014, GCB BIOENERGY, V6, P327, DOI 10.1111/gcbb.12043; Richter GM, 2015, AGR ECOSYST ENVIRON, V200, P169, DOI 10.1016/j.agee.2014.11.011; Robertson G., 1999, SOIL CARBON NITROGEN; Roth B, 2013, LAND-BASEL, V2, P437, DOI 10.3390/land2030437; Rowe RL, 2009, RENEW SUST ENERG REV, V13, P271, DOI 10.1016/j.rser.2007.07.008; Scordia D, 2013, BIOMASS BIOENERG, V59, P540, DOI 10.1016/j.biombioe.2013.09.011; Smeets EMW, 2009, RENEW SUST ENERG REV, V13, P1230, DOI 10.1016/j.rser.2008.09.006; Smith P, 2000, GLOB CHANGE BIOL, V6, P525, DOI 10.1046/j.1365-2486.2000.00331.x; van der Hilst F, 2012, RENEW SUST ENERG REV, V16, P2053, DOI 10.1016/j.rser.2012.01.027; Wang SF, 2014, GCB BIOENERGY, V6, P136, DOI 10.1111/gcbb.12123; Wang XY, 2008, AUST J SOIL RES, V46, P667, DOI 10.1071/SR08063; Yang J, 2011, RENEW SUST ENERG REV, V15, P2684, DOI 10.1016/j.rser.2011.02.028; Zatta A, 2014, GCB BIOENERGY, V6, P360, DOI 10.1111/gcbb.12054; Zibilske LM., 1994, METHODS SOIL ANAL 2, P835; Zimmermann J, 2013, EUR J SOIL SCI, V64, P747, DOI 10.1111/ejss.12087; Zimmermann J., 2013, SOIL CARBON SEQUESTR	38	9	9	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200901	10.1371/journal.pone.0200901	http://dx.doi.org/10.1371/journal.pone.0200901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048482	Green Published, gold			2022-12-26	WOS:000439952400028
J	Yang, X; Yu, XZ; Wei, YZ				Yang, Xi; Yu, Xianzhong; Wei, Yanzhang			Lentiviral delivery of novel fusion protein IL12/FasTI for cancer immune/gene therapy	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATORY ELEMENT; EXPRESSION; APOPTOSIS; VECTORS; CELLS; GENE	Many of the cytokine-based cancer immunotherapies are hindered by the devastating side effects of systemic delivery of the cytokines. To address this problem, we previously described a novel approach to locally achieve high doses of interleukin-12 (IL-12) in tumors and demonstrated that bi-functional fusion protein mIL-12/FasTI expressed by stable clones of TC-1 cells efficiently suppressed tumor proliferation by activating natural killer (NK) cells and other cytolytic killer cells and sending apoptotic signals into tumor cells. In the present study, we employed a lentiviral vector-based gene delivery system to deliver this fusion construct directly into tumor cells. We show that lentiviral vector efficiently delivers the fusion constructs into Hela cells in vitro as assayed by RT-PCR and immunohistochemistry (IHC). We also confirm that fusion protein mIL-12/FasTI delivered by the viral vector significantly enhanced killer cell activation, increased caspase-3 activity and decreased tumor growth in vitro. This study offers a further step for fusion protein cancer therapy for cancer patients.	[Yang, Xi; Yu, Xianzhong; Wei, Yanzhang] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	Wei, YZ (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ywei@clemson.edu		Yang, Xi/0000-0002-0908-8884				Dias S, 1998, INT J CANCER, V78, P361, DOI 10.1002/(SICI)1097-0215(19981029)78:3<361::AID-IJC17>3.0.CO;2-9; Lamboley C, 2002, J HEPATOL, V36, P385, DOI 10.1016/S0168-8278(01)00284-7; Lavrik IN, CELL DEATH DIFFER; Ngai SC, 2012, GENE, V498, P231, DOI 10.1016/j.gene.2012.01.071; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rubin B, 2008, CANC IMMUN, V8; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sotiriadou NN, 2005, CELL IMMUNOL, V234, P67, DOI 10.1016/j.cellimm.2005.05.002; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Yang X, 2016, INT J ONCOL, V48, P2381, DOI 10.3892/ijo.2016.3475; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	14	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201100	10.1371/journal.pone.0201100	http://dx.doi.org/10.1371/journal.pone.0201100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044833	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500080
J	Armstrong, E; Iriarte, A; Nicolini, P; De Los Santos, J; Ithurralde, J; Bielli, A; Bianchi, G; Penagaricano, F				Armstrong, Eileen; Iriarte, Andres; Nicolini, Paula; De Los Santos, Jorge; Ithurralde, Javier; Bielli, Alejandro; Bianchi, Gianni; Penagaricano, Francisco			Comparison of transcriptomic landscapes of different lamb muscles using RNA-Seq	PLOS ONE			English	Article							EXPRESSION ANALYSIS; SKELETAL-MUSCLE; PROTEIN; QUALITY; CELLS; IDENTIFICATION; ISOFORM; KINASE; FAMILY; GENES	Transcriptome deep sequencing is a powerful tool for exploring the genetic architecture of complex traits. Gene expression patterns may explain a high degree of the observed phenotypic differences in histochemical and metabolic parameters related to meat quality among different muscles. In this study, we sequenced by RNA-Seq the whole transcriptome of nine lamb muscles: Semimembranosus (SM), Semitendinosus (ST), Cranial gluteobiceps, Gluteus medius (GM), Rectus femoris, Supraspinatus (SS), Longissimus lumborum (LL), Adductor and Psoas major. Significant gene expression differences were detected between almost all pairwise comparisons, being more pronounced between SS and ST, SM and LL, and ST and GM. These differences can be explained in terms of ATPase and glycolytic activities, muscle fiber typing and oxidative score, clustering muscles as fast glycolytic, intermediate or slow oxidative. ST showed up-regulation of gene pathways related to carbohydrate metabolism, energy generation and protein turnover as expected from a fast white muscle. SS showed myosin isoforms typical of slow muscles and high expression of genes related to calcium homeostasis and vascularization. SM, LL and GM showed in general intermediate gene expression patterns. Several novel transcripts were detected, mostly related to muscle contraction and structure, oxidative metabolism, lipid metabolism and protein phosphorylation. Expression profiles were consistent with previous histochemical and metabolic characterization of these muscles. Up-regulation of ion transport genes may account for significant differences in water holding capacity. High expression of genes related to cell adhesion, cytoskeleton organization, extracellular matrix components and protein phosphorylation may be related to meat yellowness and lower tenderness scores. Differential expression of genes related to glycolytic activity and lactic acid generation among fast, intermediate and slow muscles may explain the detected final meat pH differences. These results reveal new candidate genes associated with lamb meat quality, and give a deeper insight into the genetic architecture of these complex traits.	[Armstrong, Eileen] Univ Republica, Fac Vet, Dept Genet & Mejora Anim, Montevideo, Uruguay; [Iriarte, Andres] Univ Republica, Fac Med, Inst Higiene, Dept Desarrollo Biotecnol, Montevideo, Uruguay; [Nicolini, Paula] Univ Republ, Ctr Univ Tacuarembo, Polo Desarrollo Univ Inst Super Carne, Tacuarembo, Uruguay; [De Los Santos, Jorge] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Ithurralde, Javier; Bielli, Alejandro] Univ Republica, Fac Vet, Dept Morfol & Desarrollo, Montevideo, Uruguay; [Penagaricano, Francisco] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Penagaricano, Francisco] Univ Florida, Genet Inst, Gainesville, FL USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Wisconsin System; University of Wisconsin Madison; Universidad de la Republica, Uruguay; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Armstrong, E (corresponding author), Univ Republica, Fac Vet, Dept Genet & Mejora Anim, Montevideo, Uruguay.	eileen.armstrong@gmail.com	Peñagaricano, Francisco/C-8083-2015	Peñagaricano, Francisco/0000-0001-6661-3991; Iriarte, Andres/0000-0002-5862-0152; Armstrong, Eileen/0000-0002-1769-1368	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay) [I+D 679]	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay)	Funding source: Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay). ID of the project: I+D 679 (year 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; BRIAND M, 1981, EUR J APPL PHYSIOL, V46, P347, DOI 10.1007/BF00422122; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen CC, 2011, CLIN IMMUNOL, V140, P268, DOI 10.1016/j.clim.2011.04.007; Chen LJ, 2016, J SCI FOOD AGR, V96, P1474, DOI 10.1002/jsfa.7244; CORNFORTH DP, 1980, MEAT SCI, V4, P103, DOI 10.1016/0309-1740(80)90036-4; Coumailleau P, 2009, INT J DEV BIOL, V53, P149, DOI 10.1387/ijdb.082659pc; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Damon M, 2013, MEAT SCI, V95, P744, DOI 10.1016/j.meatsci.2013.01.016; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Hnia K, 2015, CELL TISSUE RES, V360, P591, DOI 10.1007/s00441-014-2016-4; Hocquette JF, 2012, MEAT SCI, V92, P197, DOI 10.1016/j.meatsci.2012.04.007; Hsieh CM, 1996, J BIOL CHEM, V271, P17354, DOI 10.1074/jbc.271.29.17354; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huff-Lonergan E, 2005, MEAT SCI, V71, P194, DOI 10.1016/j.meatsci.2005.04.022; Ithurralde J, 2018, ANIM PROD SCI, V58, P1358, DOI 10.1071/AN16013; Ithurralde J, 2015, SMALL RUMINANT RES, V125, P88, DOI 10.1016/j.smallrumres.2015.02.006; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knight MI, 2014, MEAT SCI, V96, P1025, DOI 10.1016/j.meatsci.2013.07.008; Kotaka M, 2000, J CELL BIOCHEM, V78, P558, DOI 10.1002/1097-4644(20000915)78:4<558::AID-JCB5>3.0.CO;2-I; Krick S, 2001, AM J PHYSIOL-CELL PH, V280, pC970, DOI 10.1152/ajpcell.2001.280.4.C970; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Lei R, 2015, GENE, V557, P82, DOI 10.1016/j.gene.2014.12.013; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Penagaricano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072302; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Raz V, 2018, FASEB J, V32, P1579, DOI 10.1096/fj.201700861R; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez EJ, 2011, MOL CELL BIOCHEM, V353, P195, DOI 10.1007/s11010-011-0787-4; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sevane N, 2014, MOL BIOL REP, V41, P4721, DOI 10.1007/s11033-014-3343-y; Sun LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33586; Tao YX, 2003, J NEUROSCI, V23, P6703; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troxler H, 1999, ANAL BIOCHEM, V268, P64, DOI 10.1006/abio.1998.3015; Tschirhart-Hoelscher TE, 2006, MEAT SCI, V73, P48, DOI 10.1016/j.meatsci.2005.10.015; Vorachek WR, 2013, INT J MOL SCI, V14, P11484, DOI 10.3390/ijms140611484; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117327	65	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200732	10.1371/journal.pone.0200732	http://dx.doi.org/10.1371/journal.pone.0200732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040835	Green Published, Green Submitted, gold			2022-12-26	WOS:000439749200009
J	Lu, W; Gu, JY; Zhang, YY; Gong, DJ; Zhu, YM; Sun, Y				Lu, Wei; Gu, Jian-yu; Zhang, Yao-yao; Gong, Dan-jun; Zhu, Yi-ming; Sun, Ying			Tolerance induced by Porphyromonas gingivalis may occur independently of TLR2 and TLR4	PLOS ONE			English	Article							ENDOTOXIN TOLERANCE; PERIODONTAL HEALTH; SIGNALING PATHWAY; CELLS; LIPOPOLYSACCHARIDE; MACROPHAGES; INDUCTION; ASSOCIATION; EXPRESSION; COMPONENTS	Objective Periodontitis is a microbe-induced chronic inflammatory disease. Previous exposure of the host to bacteria or their virulence factors leads to refractory responses to further stimuli, which is called tolerance. Porphyromonas gingivalis (P. gingivalis) is one of the most important pathogenic microorganisms associated with periodontitis, and is a potent inducer of pro-and anti-inflammatory cytokines. The aim of this study was to explore the roles and possible mechanisms of tolerance induced by P. gingivalis. Methods THP-1-derived macrophages were pretreated with 1x10(8) colony-forming units/ml P. gingivalis ATCC 33277 or 21 clinical isolates from moderate to severe chronic periodontitis patients (24 h), washed (2 h) and treated with P. gingivalis ATCC 33277 or the same clinical isolates again (24 h). Levels of pro-inflammatory cytokines TNF-alpha and IL-1 beta and anti-inflammatory cytokine IL-10 in supernatants were detected by ELISA. Moreover, to identify the possible mechanisms for the changes in cytokine secretion, Toll-like receptor 2 (TLR2) and TLR4 protein expressions were explored in these cells by flow cytometry. Results After repeated challenge with P. gingivalis ATCC 33277 or clinical isolates, production of TNF-a and IL-1 beta in macrophages was decreased significantly compared with that following a single stimulation (p<0.05), while only comparable levels of IL-10 were detected in P. gingivalis ATCC 33277 or clinical isolate-tolerized cells (p>0.05). In addition, there was interstrain variability in the ability to induce IL-1 beta and IL-10 production after repeated P. gingivalis stimulation. However, no significant changes in TLR2 or TLR4 were detected in macrophages that were repeatedly treated with P. gingivalis ATCC 33277 or clinical isolates compared with those stimulated with P. gingivalis only once (p>0.05). Conclusions Repeated P. gingivalis stimulation triggered tolerance, which might contribute to limiting periodontal inflammation. However, tolerance induced by P. gingivalis might develop independently of TLR2 and TLR4 and be related to molecules in signaling pathways downstream of TLR2 and TLR4.	[Lu, Wei; Gu, Jian-yu; Zhang, Yao-yao; Gong, Dan-jun; Zhu, Yi-ming; Sun, Ying] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Lu, Wei; Gu, Jian-yu; Zhang, Yao-yao; Gong, Dan-jun; Zhu, Yi-ming; Sun, Ying] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China; [Gong, Dan-jun] Suzhou Hosp, Dept Stomatol, Suzhou, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, Y (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Sun, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China.	ebolasun@njmu.edu.cn	Zhang, Yaoyao/GWD-0693-2022	Sun, Ying/0000-0003-3996-9946	National Natural Science Foundation of China [81771075]; Natural Science Foundation of Jiangsu Province [BK20161565]; Science and Technology Development Fund of Nanjing Medical University [2016NJMU052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science and Technology Development Fund of Nanjing Medical University	Grant 81771075 (http://www.nsfc.gov.cn/) from National Natural Science Foundation of China and Grant BK20161565 (http://kxjst.jiangsu.gov.cn/) from Natural Science Foundation of Jiangsu Province were received by YS. Grant 2016NJMU052 (http://www.njmu.edu.cn/) from Science and Technology Development Fund of Nanjing Medical University was received by WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhogail S, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2677-x; Baek KJ, 2015, VIRULENCE, V6, P274, DOI 10.1080/21505594.2014.1000764; Cecil JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151967; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Eick S, 2006, ORAL MICROBIOL IMMUN, V21, P231, DOI 10.1111/j.1399-302X.2006.00282.x; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Fontaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100909; Gamboa Fredy, 2014, Acta odontol. latinoam., V27, P137, DOI 10.1590/S1852-48342014000300007; Goncalves PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085066; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Gunther J, 2017, INNATE IMMUN-LONDON, V23, P155, DOI 10.1177/1753425916681076; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Herrmann JM, 2015, PERIODONTOL 2000, V69, P111, DOI 10.1111/prd.12088; Holcombe SJ, 2016, VET IMMUNOL IMMUNOP, V173, P10, DOI 10.1016/j.vetimm.2016.03.016; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; How KY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00053; Ji S, 2015, J PERIODONTAL RES, V50, P570, DOI 10.1111/jre.12248; Kim HJ, 2018, J PERIODONTAL IMPLAN, V48, P60, DOI 10.5051/jpis.2018.48.1.60; Kristoffersen AK, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.29124; [李云鹏 Li Yunpeng], 2012, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V32, P64; Madianos PN, 1997, J PERIODONTAL RES, V32, P120; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Moreno S, 2015, COLOMB MEDICA, V46, P122; Murphy MB, 2015, J LEUKOCYTE BIOL, V98, P963, DOI 10.1189/jlb.2VMA0515-229RR; Palaska I, 2016, J BIOL REG HOMEOS AG, V30, P655; Rafiei Mohammad, 2017, Med J Islam Repub Iran, V31, P62, DOI 10.18869/mjiri.31.62; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Savidge TC, 2006, PEDIATR RES, V59, P89, DOI 10.1203/01.pdr.0000195101.74184.e3; Siqueira JF, 2004, J ENDODONT, V30, P638, DOI 10.1097/01.DON.0000125875.88377.85; Stobernack T, 2016, J PROTEOME RES, V15, P4532, DOI 10.1021/acs.jproteome.6b00634; Su H, 2015, EUR REV MED PHARMACO, V19, P2482; Sun Y, 2014, INFLAMMATION, V37, P268, DOI 10.1007/s10753-013-9737-5; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039224; VANWINKELHOFF AJ, 1993, ORAL MICROBIOL IMMUN, V8, P259; Wu X, 2015, ARCH ORAL BIOL, V60, P463, DOI 10.1016/j.archoralbio.2014.10.005; Xiong YB, 2013, J LEUKOCYTE BIOL, V94, P291, DOI 10.1189/jlb.0812401; Yasaki-Inagaki Y, 2006, FEMS IMMUNOL MED MIC, V47, P287, DOI 10.1111/j.1574-695X.2006.00091.x; Zaric SS, 2011, J BIOL CHEM, V286, P29492, DOI 10.1074/jbc.M111.252791; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2006, INFECT IMMUN, V74, P1204, DOI 10.1128/IAI.74.2.1204-1214.2006; Zhu MF, 2010, INFLAMM RES, V59, P855, DOI 10.1007/s00011-010-0197-1	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200946	10.1371/journal.pone.0200946	http://dx.doi.org/10.1371/journal.pone.0200946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040860	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200019
J	Saevarsson, E; Svansdottir, E; Arngrimsson, S; Sveinsson, T; Johannsson, E				Saevarsson, Elvar; Svansdottir, Erla; Arngrimsson, Sigurbjorn; Sveinsson, Thorarinn; Johannsson, Erlingur			Different cardiorespiratory fitness expressions based on the maximal cycle ergometer test show no effect on the relation of cardiorespiratory fitness to the academic achievement of nine-year-olds	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AEROBIC FITNESS; SOCIOECONOMIC-STATUS; BODY-COMPOSITION; PERFORMANCE; CHILDREN; HEALTH; EXERCISE; MOTOR; ASSOCIATIONS	The relationship between cardiorespiratory fitness and academic achievement has been inconclusive. The results may depend on how cardiorespiratory fitness is expressed. The aim of this study is to explore the impact of different cardiorespiratory fitness expression methods, measured by the maximal cycle ergometer test, on the relationship between cardiorespiratory fitness and academic achievement. A cross-sectional study consisting of 303 Icelandic 4th grade students (163 girls) was conducted. Cardiorespiratory fitness was assessed using a graded maximal cycle ergometer test and scores of standardized tests in Icelandic and math obtained from the Icelandic National Examination Institute. Cardiorespiratory fitness was measured as absolute power output in watts in a maximal progressive cycle ergometer test. To adjust for different body sizes, the power output was scaled to body weight, body height, body surface area, and allometrically expressed body weight. In addition, linear regression scaling was also used to adjust for different body sizes. No significant relationship was found between any of the cardiorespiratory fitness expressions and academic achievement, using both univariate and multivariate linear regression analyses. The use of different methods to express cardiorespiratory fitness does not significantly affect the association with the academic achievement of fourth grade students.	[Saevarsson, Elvar; Svansdottir, Erla; Arngrimsson, Sigurbjorn; Johannsson, Erlingur] Univ Iceland, Sch Educ, Reykjavik, Iceland; [Sveinsson, Thorarinn] Univ Iceland, Res Ctr Movements Sci, Reykjavik, Iceland; [Johannsson, Erlingur] Western Norway Univ Appl Sci, Dept Sport & Phys Act, Bergen, Norway	University of Iceland; University of Iceland; Western Norway University of Applied Sciences	Johannsson, E (corresponding author), Univ Iceland, Sch Educ, Reykjavik, Iceland.; Johannsson, E (corresponding author), Western Norway Univ Appl Sci, Dept Sport & Phys Act, Bergen, Norway.	erljo@hi.is	Sveinsson, Thorarinn/F-7554-2010	Sveinsson, Thorarinn/0000-0001-8989-5514; Svansdottir, Erla/0000-0001-6783-3195	Icelandic Centre for Research (RANNIS)	Icelandic Centre for Research (RANNIS)	The Icelandic Centre for Research (RANNIS) funded this study, along with the Ministry of Education, Science and Culture, and The Icelandic Primary Health Care Research Fund. The authors have no conflicts of interest.	ARMSTRONG N, 1995, ANN HUM BIOL, V22, P427, DOI 10.1080/03014469500004102; Armstrong N, 2011, BRIT J SPORT MED, V45, P849, DOI 10.1136/bjsports-2011-090200; Armstrong N, 2011, MED SPORT SCI, V56, P59, DOI 10.1159/000320633; Bass RW, 2013, ACTA PAEDIATR, V102, P832, DOI 10.1111/apa.12278; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Coe DP, 2013, J SCHOOL HEALTH, V83, P500, DOI 10.1111/josh.12058; Dencker M, 2012, J SCI MED SPORT, V15, pS161; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Dwyer T, 2001, PEDIATR EXERC SCI, V13, P225, DOI 10.1123/pes.13.3.225; Haapala EA, 2014, MED SCI SPORT EXER, V46, P1016, DOI 10.1249/MSS.0000000000000186; Haapala EA, 2013, J HUM KINET, V36, P55, DOI 10.2478/hukin-2013-0006; HANSEN HS, 1989, EUR J APPL PHYSIOL, V58, P618, DOI 10.1007/BF00418508; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P361, DOI 10.5717/jenb.2014.18.4.361; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; Kantomaaa MT, 2013, P NATL ACAD SCI USA, V110, P1917, DOI 10.1073/pnas.1214574110; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; KRAMER RA, 1995, AM J PUBLIC HEALTH, V85, P312, DOI 10.2105/AJPH.85.3.312; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Magnusson KT, 2012, HEALTH EDUC RES, V27, P484, DOI 10.1093/her/cys049; McMurray RG, 2011, ANN HUM BIOL, V38, P647, DOI 10.3109/03014460.2011.598561; Moore SA, 2015, MED SCI SPORT EXER, V47, P1755, DOI 10.1249/MSS.0000000000000588; Rauner RR, 2013, J PEDIATR-US, V163, P344, DOI 10.1016/j.jpeds.2013.01.006; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Rowland TW, 2005, CHILDRENSS EXERCISE; Saevarsson ES, 2016, ANN HUM BIOL, V43, P229, DOI 10.3109/03014460.2015.1042522; Sardinha LB, 2016, MED SCI SPORT EXER, V48, P839, DOI 10.1249/MSS.0000000000000830; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Skulason S, 2008, SKYRSLA SAMRAEMD PRO; Skulason S, 2004, SKYRSLA SAMRAEMD PRO; Sveinsson T, 2009, EUR J SPORT SCI, V9, P141, DOI 10.1080/17461390802638149; Tomkinson G.R., 2008, PAEDIAT EXERCISE SCI, P109, DOI [10.1093/med/9780199232482.003.0009, DOI 10.1093/MED/9780199232482.003.0009]; TOTH MJ, 1993, J APPL PHYSIOL, V75, P2288, DOI 10.1152/jappl.1993.75.5.2288; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Welk GJ, 2010, RES Q EXERCISE SPORT, V81, pS6, DOI 10.1080/02701367.2010.10599689; Welsman JR, 2000, PEDIATR EXERC SCI, V12, P112, DOI 10.1123/pes.12.2.112	38	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200643	10.1371/journal.pone.0200643	http://dx.doi.org/10.1371/journal.pone.0200643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036375	gold, Green Published, Green Submitted			2022-12-26	WOS:000439429200013
J	Paolini, KE; Strickland, BK; Tegt, JL; VerCauteren, KC; Street, GM				Paolini, Kelsey E.; Strickland, Bronson K.; Tegt, Jessica L.; VerCauteren, Kurt C.; Street, Garrett M.			Seasonal variation in preference dictates space use in an invasive generalist	PLOS ONE			English	Article							BOAR SUS-SCROFA; WILD BOAR; FUNCTIONAL-RESPONSES; RESOURCE SELECTION; HABITAT SELECTION; PLANT PHENOLOGY; HOME-RANGE; REGRESSION; DIET; MISSISSIPPI	Background The spatiotemporal distribution of resources is a critical component of realized animal distributions. In agricultural landscapes, space use by generalist consumers is influenced by ephemeral resource availability that may produce behavioral differences across agricultural seasons, resulting in economic and production consequences and increased human-wildlife conflict. Our objective was to assess changes in habitat selection across seasons in an invasive generalist omnivore (feral pigs, Sus scrofa). Hypothesizing that pig space use is primarily driven by forage availability, we predicted strong selection for the most nutritionally beneficial crops and resource types as agricultural seasons progressed. We deployed GPS collars on 13 adult feral pigs in the Mississippi Alluvial Valley to study resource selection in a fragmented agricultural landscape. We estimated resource selection using mixed-effect logistic regression to assess variation in selection across planting, growing, harvest, and fallow seasons. Results We found that feral pigs varied resource selection across seasons, particularly for corn (Zea mais). We also detected seasonal dependencies in proportional coverage on the net probability of selection of a land unit (e.g., selection was generally strongest for locations composed of both agricultural and natural habitat), resulting in marked variation in predicted space use among agricultural seasons. Conclusions These findings indicate behavioral changes in selection across agricultural seasons are driven by complex interactions between the availabilities of temporally dynamic resources and temporally static natural cover. Temporal variations in resource selection trends indicate seasonal responses to crop phenology which suggests a season-specific habitat functional response.	[Paolini, Kelsey E.; Strickland, Bronson K.; Tegt, Jessica L.; Street, Garrett M.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Starkville, MS 39759 USA; [VerCauteren, Kurt C.] USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA	Mississippi State University; United States Department of Agriculture (USDA)	Paolini, KE (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Starkville, MS 39759 USA.	kpaolini619@yahoo.com		Paolini, Kelsey/0000-0002-4947-2020	Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service National Wildlife Research Center [14-7428-1089CA]; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service/Wildlife Services	Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service National Wildlife Research Center; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service/Wildlife Services	This work was supported by Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services, and the National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service National Wildlife Research Center 14-7428-1089CA. Funding was received by GMS, BKS, JLT, and KCV.r We thank C.D. Gibson and D.H. Foster for their capturing and collaring efforts in the field. We also thank those who reviewed on earlier drafts. This work was supported by Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services, and the National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service/Wildlife Services.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; [Anonymous], 2016, USDA NATL AGR STAT S; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1076, DOI 10.2307/3802560; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Doorenbos J, 1979, IRRIG AGR DEV; Dupke C, 2017, ECOGRAPHY, V40, P1014, DOI 10.1111/ecog.02152; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; EASTLAND WG, 1989, J MAMMAL, V70, P824, DOI 10.2307/1381720; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A, 2007, DATA ANALYSIS USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Hanway J, 1966, SPECIAL REPORT, V38; Herrero J, 2006, EUR J WILDLIFE RES, V52, P245, DOI 10.1007/s10344-006-0045-3; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Keiter DA, 2016, WILDLIFE SOC B, V40, P384, DOI 10.1002/wsb.649; Keuling O, 2009, MAMM BIOL, V74, P145, DOI 10.1016/j.mambio.2008.05.007; Keuling O, 2008, EUR J WILDLIFE RES, V54, P403, DOI 10.1007/s10344-007-0157-4; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Manley SW, 2005, WILDLIFE SOC B, V33, P981, DOI 10.2193/0091-7648(2005)33[981:AIOWMI]2.0.CO;2; Manly B., 2002, RESOURCE SELECTION A, DOI [10.2307/5247, DOI 10.2307/5247]; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; Maul JD, 2000, AGR ECOSYST ENVIRON, V81, P171, DOI 10.1016/S0167-8809(00)00157-2; Mayer JJ, 2009, WILD PIGS BIOL DAMAG, DOI [10.1016/B978-0-08-024821-9.50009-3, DOI 10.1016/B978-0-08-024821-9.50009]; McClure ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133771; MEENTS JK, 1983, ECOLOGY, V64, P1022, DOI 10.2307/1937809; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mississippi Department of Wildlife Fisheries and Parks, 2017, WILD HOG REG MISS; Monteith KL, 2015, OECOLOGIA, V178, P1137, DOI 10.1007/s00442-015-3296-4; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Mungall EC, 2001, ECOLOGY MANAGEMENT L, p736 ; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Plard F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001828; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; R Core Team, 2021, R LANGUAGE ENV STAT; Reinecke K.J., 1989, P203; RICE SM, 1993, J WILDLIFE MANAGE, V57, P92, DOI 10.2307/3809005; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Seward N. W., 2004, Sheep & Goat Research Journal, V19, P34; SINGER FJ, 1981, J WILDLIFE MANAGE, V45, P343, DOI 10.2307/3807917; Snow NP, 2017, J APPL ECOL, V54, P2022, DOI 10.1111/1365-2664.12866; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stanturf JA, 2001, RESTOR ECOL, V9, P189, DOI 10.1046/j.1526-100x.2001.009002189.x; Street GM, 2016, LANDSCAPE ECOL, V31, P1939, DOI 10.1007/s10980-016-0372-z; Tanger SM, 2015, J NATL ASS CTY AGR A, V8, P357; Tobajas J, 2016, EUR J WILDLIFE RES, V62, P85, DOI 10.1007/s10344-015-0976-7; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; U. S. Geological Survey, 2016, NAT HYDR DAT NHD; van Beest FM, 2010, J ANIM ECOL, V79, P910, DOI 10.1111/j.1365-2656.2010.01701.x; Xu JG, 2010, J AGR FOOD CHEM, V58, P5751, DOI 10.1021/jf100364k; Zuur Alain F., 2009, P1	67	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0199078	10.1371/journal.pone.0199078	http://dx.doi.org/10.1371/journal.pone.0199078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028855	gold, Green Published, Green Submitted			2022-12-26	WOS:000439396900002
J	Cui, K; Wang, B; Zhang, NF; Tu, Y; Ma, T; Diao, QY				Cui, Kai; Wang, Bo; Zhang, Naifeng; Tu, Yan; Ma, Tao; Diao, Qiyu			iTRAQ-based quantitative proteomic analysis of alterations in the intestine of Hu sheep under weaning stress	PLOS ONE			English	Article							EARLY-WEANED PIGLETS; BARRIER FUNCTION; IMMUNE-SYSTEM; FEED-INTAKE; PERFORMANCE; EXPRESSION; SEPARATION; WELFARE	When Lambs are weaned off ewe's milk, metabolic, structural, and functional changes often occur in the small intestine. Because information on the effects of weaning stress on the proteome of the intestine is limited, an animal model was established with eight pairs of twin lambs divided into artificially reared and ewe-reared groups, which was followed by proteome analysis using iTRAQ technology. Changes occurred in the morphology of the intestine and 5,338 proteins in three biological replicates with less than a 1.2% false discovery rate were identified and quantified. Among them, a subset of 389 proteins were screened as significantly up- (143) and down-regulated (246) in artificially reared compared with ewe-reared. According to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, the differentially expressed proteins that were strongly downregulated were enriched in immune system processes, biological adhesion, and metabolic processes. The up-regulated proteins were enriched in gene expression, cellular biosynthetic processes, ribosome and RNA binding in response to weaning stress. A series of proteins associated with intestine morphology and immune function were identified, and levels of the mRNAs encoding these proteins were analyzed by real-time quantitative reverse transcription PCR. The results of this study increased our understanding of the response of lambs weaned off ewe's milk and helped to determine the mechanisms underlying weaning stress.	[Cui, Kai; Wang, Bo; Zhang, Naifeng; Tu, Yan; Ma, Tao; Diao, Qiyu] Chinese Acad Agr Sci, Feed Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS	Diao, QY (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Beijing, Peoples R China.	diaoqiyu@caas.cn	Ma, Tao/AAD-5514-2020; zhang, naifeng/P-8386-2014	Ma, Tao/0000-0003-4821-836X; zhang, naifeng/0000-0001-6272-7553	National Technology Program for the Meat Sheep Industry of China; Fundamental Research Funds for Central Non-profit Scientific Institution [1610382016012]	National Technology Program for the Meat Sheep Industry of China; Fundamental Research Funds for Central Non-profit Scientific Institution	The National Technology Program for the Meat Sheep Industry of China and Fundamental Research Funds for Central Non-profit Scientific Institution (1610382016012) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, P NATI ACAD SCI US, V101, P12781, DOI [10.1073/pnas.0404890101, DOI 10.1073/PNAS.0404890101]; Aw TY, 2005, TOXICOL APPL PHARM, V204, P320, DOI 10.1016/j.taap.2004.11.016; Awad WA, 2013, RES VET SCI, V95, P249, DOI 10.1016/j.rvsc.2013.02.009; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bomba L, 2014, FUNCT INTEGR GENOMIC, V14, P657, DOI 10.1007/s10142-014-0396-x; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Carroll MC, 2008, VACCINE, V26, pI28, DOI 10.1016/j.vaccine.2008.11.022; Eckersall PD, 2012, J PROTEOMICS, V75, P4187, DOI 10.1016/j.jprot.2012.05.014; Flower FC, 2001, APPL ANIM BEHAV SCI, V70, P275, DOI 10.1016/S0168-1591(00)00164-7; Gu XH, 2002, ARCH ANIM NUTR, V56, P275, DOI 10.1080/00039420214345; Hu PF, 2014, GENET MOL RES, V13, P9019, DOI 10.4238/2014.October.31.16; Johnsen JF, 2015, J DAIRY SCI, V98, P4800, DOI 10.3168/jds.2014-9128; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Meier R, 2003, CURR OPIN CLIN NUTR, V6, P563, DOI 10.1097/00075197-200309000-00010; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Napolitano F, 2008, APPL ANIM BEHAV SCI, V110, P58, DOI 10.1016/j.applanim.2007.03.020; Orgeur P, 1999, REPROD NUTR DEV, V39, P231, DOI 10.1051/rnd:19990208; Pascual-Alonso M, 2015, J APPL ANIM WELF SCI, V18, P42, DOI 10.1080/10888705.2014.941107; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; Ricklin Oikonomopoulou Katerina, 2011, INTERACTIONS COAGU L, P151, DOI [10.1007/s00281-011-0280-x, DOI 10.1007/S00281-011-0280-X]; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Spreeuwenberg MAM, 2001, J NUTR, V131, P1520, DOI 10.1093/jn/131.5.1520; Stokes CR, 2004, ANIM RES, V53, P325, DOI 10.1051/animres:2004020; Tao X, 2015, ARCH ANIM NUTR, V69, P201, DOI 10.1080/1745039X.2015.1034828; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Vente-Spreeuwenberg MAM, 2004, LIVEST PROD SCI, V86, P169, DOI 10.1016/S0301-6226(03)00166-0; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Yue GH, 1996, ANIM REPROD SCI, V44, P223, DOI 10.1016/0378-4320(96)01562-X	32	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200680	10.1371/journal.pone.0200680	http://dx.doi.org/10.1371/journal.pone.0200680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024939	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000041
J	Dobson, KL; Smith, ZH; Bellamy, TC				Dobson, Katharine L.; Smith, Zoe H.; Bellamy, Tomas C.			Distribution of vesicle pools in cerebellar parallel fibre terminals after depression of ectopic transmission	PLOS ONE			English	Article							BERGMANN GLIAL-CELLS; LONG-TERM DEPRESSION; CURRENTS; RELEASE; STIMULATION; GLUTAMATE; NEURON	At parallel fibre terminals in the cerebellar cortex, glutamate released outside of the active zone can activate AMPA receptors on juxtaposed Bergmann glial cell processes. This process is termed "ectopic" release, and allows for directed transmission to astroglial cells that is functionally independent of synaptic transmission to postsynaptic Purkinje neurons. The location of ectopic sites in presynaptic terminals is uncertain. Functional evidence suggests that stimulation of parallel fibres at 1 Hz exhausts ectopic transmission due to a failure to rapidly recycle vesicles to the ectopic pool, and so would predict a loss of vesicles in the near vicinity of extrasynaptic glial processes. In this study we used this stimulation protocol to investigate whether the distribution of vesicles within the presynaptic terminal is altered after suppression of ectopic release. Stimulation at 1 Hz had only a minor impact on the distribution of vesicles in presynaptic terminals when analysed with electron microscopy. Vesicle number and terminal size were unaffected by 1 Hz stimulation, but the relative abundance of vesicles in close proximity to the active zone was marginally reduced. In contrast, the fraction of vesicles facing glial membranes was unchanged after suppression of ectopic transmission. 1 Hz stimulation also resulted in a small but statistically-significant increase in the distance between glial membrane and presynaptic terminal, suggesting withdrawal of glial membranes from synapses is detectable in ultrastructural anatomy within minutes. These results raise doubts about the location of ectopic release sites, but indicate that neuron-glial association varies on a dynamic time scale.	[Dobson, Katharine L.; Smith, Zoe H.; Bellamy, Tomas C.] Univ Nottingham, Sch Life Sci, Med Sch, Nottingham, England; [Dobson, Katharine L.] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Midlothian, Scotland	University of Nottingham; University of Edinburgh	Dobson, KL (corresponding author), Univ Nottingham, Sch Life Sci, Med Sch, Nottingham, England.; Dobson, KL (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Midlothian, Scotland.	katharine.dobson@ed.ac.uk	Dobson, Katharine/AAG-8618-2020	Dobson, Katharine/0000-0003-4117-8684	Biotechnology and Biological Sciences Research Council [BB/J015660/1]; National Centre for the Replacement Refinement & Reduction of Animals in Research [NC/N003071/1]; BBSRC [BB/J015660/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement Refinement & Reduction of Animals in Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council, grant number BB/J015660/1 (http://www.bbsrc.ac.uk/), and by the National Centre for the Replacement Refinement & Reduction of Animals in Research, grant number NC/N003071/1 (https://www.nc3rs.org.uk/), both to TCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan S, 2011, GLIA, V59, P82, DOI 10.1002/glia.21078; Balakrishnan S, 2009, GLIA, V57, P393, DOI 10.1002/glia.20768; Bell JJL, 2010, NEURON GLIA BIOL, V6, P193, DOI 10.1017/S1740925X10000165; Bellamy TC, 2006, EUR J NEUROSCI, V23, P581, DOI 10.1111/j.1460-9568.2005.04588.x; Bellamy TC, 2005, GLIA, V52, P325, DOI 10.1002/glia.20248; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Dobson KL, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/602356; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Jung JH, 2016, P NATL ACAD SCI USA, V113, pE1098, DOI 10.1073/pnas.1523054113; Leenders AGM, 2002, NEUROSCIENCE, V109, P195, DOI 10.1016/S0306-4522(01)00450-X; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Marra V, 2014, NAT PROTOC, V9, P1337, DOI 10.1038/nprot.2014.088; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matsui K, 2006, CURR OPIN NEUROBIOL, V16, P305, DOI 10.1016/j.conb.2006.04.001; Nowak LG, 1996, J NEUROSCI METH, V67, P237, DOI 10.1016/0165-0270(96)00065-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; SMITH JE, 1980, J EXP BIOL, V89, P19	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200937	10.1371/journal.pone.0200937	http://dx.doi.org/10.1371/journal.pone.0200937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024947	gold, Green Submitted, Green Published			2022-12-26	WOS:000439120000070
J	Pitts, T; Poliacek, I; Rose, MJ; Reed, MD; Condrey, JA; Tsai, HW; Zhou, GN; Davenport, PW; Bolser, DC				Pitts, Teresa; Poliacek, Ivan; Rose, Melanie J.; Reed, Mitchell D.; Condrey, Jillian A.; Tsai, Hsiu-Wen; Zhou, Guannan; Davenport, Paul W.; Bolser, Donald C.			Neurons in the dorsomedial medulla contribute to swallow pattern generation: Evidence of inspiratory activity during swallow	PLOS ONE			English	Article							LOWER BRAIN-STEM; SUPERIOR LARYNGEAL NERVE; REFLEX PHARYNGEAL SWALLOW; NON-RESPIRATORY NEURONS; RHYTHMIC ORAL ACTIVITY; RETICULAR-FORMATION; SOMATOMOTOR FUNCTIONS; NEIGHBORING NEURONS; DISCHARGE PATTERNS; COMMON SYSTEM	Active contraction of the diaphragm and other inspiratory pump muscles during swallow create a negative thoracic pressure to improve the movement of the bolus (food/liquid) into the esophagus. We tested the hypothesis that dorsomedial medullary inspiratory neurons, including the nucleus tractus solitarius (NTS, pre-motor to the phrenic) would be active during swallow induced by oral water infusion. We recorded neurons in the NTS and medial reticular formation in anesthetized spontaneously breathing cats, and induced swallow by injection of water into the oropharynx. Our results indicate that: 1) a majority of inspiratory cells in the dorsomedial medulla are active during swallow, 2) expiratory neurons are present in the medial reticular formation (deeper to the NTS) in unparalyzed cats and a majority of these cells decreased firing frequency during swallow. Our findings suggest that the dorsomedial medulla is a source of inspiratory motor drive during swallow and that a novel population of breathing-modulated neurons that also are modulated during swallowing exist in the medial reticular formation in unparalyzed animals.	[Pitts, Teresa; Reed, Mitchell D.] Univ Louisville, Coll Med, Dept Neurol Surg, Louisville, KY 40292 USA; [Pitts, Teresa; Reed, Mitchell D.] Univ Louisville, Coll Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Poliacek, Ivan; Rose, Melanie J.; Condrey, Jillian A.; Tsai, Hsiu-Wen; Zhou, Guannan; Davenport, Paul W.; Bolser, Donald C.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Poliacek, Ivan] Comenius Univ, Jessenius Fac Med Martin, Inst Med Biophys, Martin, Slovakia	University of Louisville; University of Louisville; State University System of Florida; University of Florida; Comenius University Bratislava	Pitts, T (corresponding author), Univ Louisville, Coll Med, Dept Neurol Surg, Louisville, KY 40292 USA.; Pitts, T (corresponding author), Univ Louisville, Coll Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	t.pitts@louisville.edu	Bolser, Donald/CAI-2644-2022	Pitts, Teresa/0000-0001-9448-2175; Rose, Melanie/0000-0003-0021-3498	Kentucky Spinal Cord and Head Injury Trust; Commonwealth of Kentucky Challenge for Excellence; National Institute of Heart Lung and Blood of the National Institutes of Health [R00HL111215, R01HL103415, R01HL109025, R01HL131716]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131716, R00HL111215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [OT2OD023854] Funding Source: NIH RePORTER	Kentucky Spinal Cord and Head Injury Trust; Commonwealth of Kentucky Challenge for Excellence; National Institute of Heart Lung and Blood of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the Kentucky Spinal Cord and Head Injury Trust, The Commonwealth of Kentucky Challenge for Excellence, and the National Institute of Heart Lung and Blood of the National Institutes of Health under award R00HL111215; R01HL103415, R01HL109025, and R01HL131716. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arloing S., 1874, APPL METHODE GRAPHIQ; AVERILL DB, 1985, BRAIN RES, V346, P378, DOI 10.1016/0006-8993(85)90874-1; BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; BELLINGHAM MC, 1989, BRAIN RES, V486, P391, DOI 10.1016/0006-8993(89)90530-1; BERGER AJ, 1977, BRAIN RES, V135, P231, DOI 10.1016/0006-8993(77)91028-9; Berman A.L., 1968, BRAIN STEM CAT CYTOA; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; BOSMA JF, 1957, PHYSIOL REV, V37, P275, DOI 10.1152/physrev.1957.37.3.275; Cedborg AIH, 2009, EXP PHYSIOL, V94, P459, DOI 10.1113/expphysiol.2008.045724; CERENKO D, 1989, OTOLARYNG HEAD NECK, V100, P57, DOI 10.1177/019459988910000109; Chen ZX, 2003, AM J PHYSIOL-REG I, V285, pR68, DOI 10.1152/ajpregu.00054.2003; FEDORKO L, 1983, NEUROSCI LETT, V43, P285, DOI 10.1016/0304-3940(83)90202-1; Feroah TR, 2002, J APPL PHYSIOL, V92, P1923, DOI 10.1152/japplphysiol.01079.2000; Feroah TR, 2002, J APPL PHYSIOL, V93, P581, DOI 10.1152/japplphysiol.01268.2001; FIELDS HL, 1977, BRAIN RES, V120, P49, DOI 10.1016/0006-8993(77)90497-8; German RZ, 2009, J NEUROPHYSIOL, V102, P1017, DOI 10.1152/jn.00100.2009; Gestreau C, 1996, EXP BRAIN RES, V108, P247; HABER LH, 1982, J COMP NEUROL, V207, P75, DOI 10.1002/cne.902070107; JORDAN WP, 1982, J COMP PHYSIOL PSYCH, V96, P170, DOI 10.1037/h0077880; Langhorst P, 1996, J AUTONOM NERV SYST, V57, P149, DOI 10.1016/0165-1838(95)00132-8; LANGHORST P, 1983, J AUTONOM NERV SYST, V9, P411, DOI 10.1016/0165-1838(83)90005-X; Marckwald M., MOVEMENTS RESPIRATIO; McConnel F M, 1988, Dysphagia, V2, P187, DOI 10.1007/BF02414425; MCCONNEL FMS, 1988, OTOLARYNG CLIN N AM, V21, P625; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; MCCONNEL FMS, 1994, LARYNGOSCOPE, V104, P571, DOI 10.1002/lary.5541040512; MCCONNEL FMS, 1988, ARCH OTOLARYNGOL, V114, P1413; MCCONNEL FMS, 1992, OTOLARYNG HEAD NECK, V106, P169, DOI 10.1177/019459989210600219; MCCONNEL FMS, 1987, HEAD NECK-J SCI SPEC, V9, P142, DOI 10.1002/hed.2890090303; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P705; MCCONNEL FMS, 1991, LARYNGOSCOPE, V101, P510; MENDELSOHN MS, 1987, LARYNGOSCOPE, V97, P483; Nasse JS, 2014, J NEUROSCI METH, V237, P41, DOI 10.1016/j.jneumeth.2014.08.023; PETERSON BW, 1979, ANNU REV PHYSIOL, V41, P127, DOI 10.1146/annurev.ph.41.030179.001015; Pitts T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128245; Pitts T, 2015, LUNG, V193, P129, DOI 10.1007/s00408-014-9662-x; Pitts T, 2013, RESP PHYSIOL NEUROBI, V189, P543, DOI 10.1016/j.resp.2013.08.009; Pitts T, 2012, EXP PHYSIOL, V97, P469, DOI 10.1113/expphysiol.2011.063362; Rosenthal J, 1861, COMPTES RENDUS, V52, P764; Saito Y, 2002, J PHYSIOL-LONDON, V540, P1047, DOI 10.1113/jphysiol.2001.014985; SCHULZ B, 1983, J AUTONOM NERV SYST, V9, P433, DOI 10.1016/0165-1838(83)90006-1; SCHULZ G, 1985, J AUTONOM NERV SYST, V12, P35, DOI 10.1016/0165-1838(85)90039-6; Sherrington C.S., 1915, EXP PHYSIOL, V9, P147, DOI [10.1113/expphysiol.1915.sp000201, DOI 10.1113/EXPPHYSIOL.1915.SP000201]; Spearman DG, 2014, VARIABILITY PHARYNGE, DOI [10.1371/journal.pone.0106121, DOI 10.1371/JOURNAL.PONE.0106121]; Sun QJ, 2011, J PHYSIOL-LONDON, V589, P1819, DOI 10.1113/jphysiol.2010.203794; Thexton AJ, 2007, J APPL PHYSIOL, V102, P587, DOI 10.1152/japplphysiol.00456.2006; Thexton AJ, 2009, J NEUROPHYSIOL, V101, P1386, DOI 10.1152/jn.90847.2008; VANTRAPPEN G, 1967, AM J DIG DIS, V12, P255, DOI 10.1007/BF02233643; Venugopal S., 2008, ROLE OF INHIBITION A; Wallois F, 1997, BRAIN RES, V768, P71, DOI 10.1016/S0006-8993(97)00602-1; WILSON SL, 1981, J APPL PHYSIOL, V50, P851, DOI 10.1152/jappl.1981.50.4.851	51	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199903	10.1371/journal.pone.0199903	http://dx.doi.org/10.1371/journal.pone.0199903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024913	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000012
J	Ebel, C; BenFeki, A; Hanin, M; Solano, R; Chini, A				Ebel, Chantal; BenFeki, Asma; Hanin, Moez; Solano, Roberto; Chini, Andrea			Characterization of wheat (Triticum aestivum) TIFY family and role of Triticum Durum TdTIFY11 a in salt stress tolerance	PLOS ONE			English	Article							TIFY FAMILY GENES; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; JAZ REPRESSORS; JASMONIC ACID; EXPRESSION; COMPLEX; PROTEIN; IDENTIFICATION; MOTIF	The TIFY proteins constitute a plant-specific super-family and they are involved in regulating many plant processes, such as development, defences and stress responses. The Jasmonate-ZIM-Domain (JAZ) proteins, the best-characterized sub-group of the TIFY family are key regulator of the jasmonic acid (JA) signalling pathway. Jasmonates regulate several aspects of plant development, and play a primary role in defence mechanisms as well as in plant responses to abiotic stresses. The TIFY family is well studied in dicots but poorly investigated in monocots. The present study reports an extensive genomic identification of TIFY proteins from Triticum aestivum. We identified 49 TIFYgenes, which were annotated according to three sub-genomes (AABBDD) of T. aestivum. Following their clustering with Oryza sativa and Brachypodium distachyon, the 49 genes were grouped in 18 different TIFY homeologous subsets. Expression analyses of 6 representative TIFY genes on Tunisian durum wheat seedlings revealed their differential regulation by various stress treatment, including JA, ABA and salt stress. TIFY11a was specifically induced after salt treatment. Transgenic lines over-expressing TdITIFY11a showed higher germination and growth rates under high salinity conditions, compared to wild type plants. In summary, our results outline a relevant role of wheat TIFY proteins in promoting germination under salt stress.	[Ebel, Chantal; BenFeki, Asma; Hanin, Moez] Univ Sfax, Inst Biotechnol, Plant Physiol & Funct Genom Res Unit, Bp Sfax, Tunisia; [Solano, Roberto; Chini, Andrea] CSIC, CNB, Plant Mol Genet Dept, Madrid, Spain	Centre de Biotechnologie de Borj Cedria; Universite de Sfax; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Chini, A (corresponding author), CSIC, CNB, Plant Mol Genet Dept, Madrid, Spain.	achini@cnb.csic.es	Chini, Andrea/D-1336-2009	Chini, Andrea/0000-0001-5841-0254	Spanish Ministry for Science and Innovation (MINECO-AEI/FEDER) [BIO2016-77216-R]; Consejo Superior de Investigaciones Cientificas [iCOOP+2013/COOPB20060]; AECID [AP/040886/11]; "Mujeres por Africa" Foundation; Tunisian Higher Ministry of Education	Spanish Ministry for Science and Innovation (MINECO-AEI/FEDER)(Ministry of Science and Innovation, Spain (MICINN)); Consejo Superior de Investigaciones Cientificas; AECID; "Mujeres por Africa" Foundation; Tunisian Higher Ministry of Education	This work was supported by: 1) grant BIO2016-77216-R of the Spanish Ministry for Science and Innovation (MINECO-AEI/FEDER) to RS and AC (http://www.idi.mineco.gob.es/portal/site/MICINN?lang_choosen=en); 2) grant iCOOP+2013/COOPB20060 of the Consejo Superior de Investigaciones Cientificas to AC and CE (http://www.csic.es/i-coop); 3) grant AP/040886/11 from the (AECID) to AC (http://www.aecid.es/EN/aecid); 4) Science by Woman grant from "Mujeres por Africa" Foundation to CE (https://www.mujeresporafrica.es/en/content/science-women); 5) grant from the Tunisian Higher Ministry of Education to CE and MH (http://www.fundit.fr/en/institutions/ministry-higher-education-and-scientific-research-tunisia-mesrs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2018, NAT CHEM BIOL, V14, P171, DOI [10.1038/NCHEMBIO.2540, 10.1038/nchembio.2540]; Chini A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177381; Chini A, 2016, CURR OPIN PLANT BIOL, V33, P147, DOI 10.1016/j.pbi.2016.07.005; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Ge LF, 2016, P NATL ACAD SCI USA, V113, P12414, DOI 10.1073/pnas.1611763113; Gimenez-Ibanez S, 2017, NEW PHYTOL, V213, P1378, DOI 10.1111/nph.14354; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Goossens J, 2016, PLANT MOL BIOL, V91, P673, DOI 10.1007/s11103-016-0480-9; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lv Y, 2017, PLANT PHYSIOL, V173, P1475, DOI 10.1104/pp.16.01725; Moons A, 1997, PLANT CELL, V9, P2243, DOI 10.1105/tpc.9.12.2243; Pauwels L, 2015, PLANT PHYSIOL, V169, P1405, DOI 10.1104/pp.15.00479; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda Y, 2013, PLANT CELL, V25, P1709, DOI 10.1105/tpc.113.112052; Valenzuela CE, 2016, J EXP BOT, V67, P4209, DOI 10.1093/jxb/erw202; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545; Wang YK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3582-0; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Wu H, 2015, PLANT SCI, V232, P1, DOI 10.1016/j.plantsci.2014.12.010; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Zhang F, 2017, P NATL ACAD SCI USA, V114, P1720, DOI 10.1073/pnas.1616938114; Zhang LH, 2015, J PLANT RES, V128, P995, DOI 10.1007/s10265-015-0755-2; Zhang ZB, 2015, MOL GENET GENOMICS, V290, P1849, DOI 10.1007/s00438-015-1042-6; Zhao G, 2016, MOL GENET GENOMICS, V291, P2173, DOI 10.1007/s00438-016-1248-2; Zhou XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121824; Zhu D, 2013, PLANT CELL REP, V32, P263, DOI 10.1007/s00299-012-1360-7	49	39	47	11	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200566	10.1371/journal.pone.0200566	http://dx.doi.org/10.1371/journal.pone.0200566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021005	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400055
J	Evans, J; Infusini, G; McGovern, J; Cuttle, L; Webb, A; Nebl, T; Milla, L; Kimble, R; Kempf, M; Andrews, CJ; Leavesley, D; Salamonsen, LA				Evans, Jemma; Infusini, Giuseppe; McGovern, Jacqui; Cuttle, Leila; Webb, Andrew; Nebl, Thomas; Milla, Liz; Kimble, Roy; Kempf, Margit; Andrews, Christine J.; Leavesley, David; Salamonsen, Lois A.			Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair	FASEB JOURNAL			English	Article						migration; menstruation; proteomics	GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; PROTEOMIC ANALYSIS; CELL-ADHESION; LACTOFERRIN; MIGRATION; CYTOKINE; VEGF; VITRONECTIN; EXPRESSION	Repair after damage is essential for tissue homeostasis. Postmenstrual endometrial repair is a cyclical manifestation of rapid, scar-free, tissue repair taking approximate to 3-5 d. Skin repair after wounding is slower (approximate to 2 wk). In the case of chronic wounds, it takes months to years to restore integrity. Herein, the unique rapid-repair endometrial environment is translated to the slower repair skin environment. Menstrual fluid (MF), the milieu of postmenstrual endometrial repair, facilitates healing of endometrial and keratinocyte wounds in vitro, promoting cellular adhesion and migration, stimulates keratinocyte migration in an ex vivo human skin reconstruct model, and promotes re-epithelialization in an in vivo porcine wound model. Proteomic analysis of MF identified a large number of proteins: migration inhibitory factor, neutrophil gelatinase-associated lipocalin, follistatin like-1, chemokine ligand-20, and secretory leukocyte protease inhibitor were selected for further investigation. Functionally, they promote repair of endometrial and keratinocyte wounds by promoting migration. Translation of these and other MF factors into a migration-inducing treatment paradigm could provide novel treatments for tissue repair.Evans, J., Infusini, G., McGovern, J., Cuttle, L., Webb, A., Nebl, T., Milla, L., Kimble, R., Kempf, M., Andrews, C. J., Leavesley, D., Salamonsen, L. A. Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair.	[Evans, Jemma; Salamonsen, Lois A.] Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia; [Evans, Jemma; Salamonsen, Lois A.] Monash Univ, Dept Mol & Translat Med, Clayton, Vic, Australia; [Infusini, Giuseppe; Webb, Andrew; Nebl, Thomas; Milla, Liz] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [McGovern, Jacqui; Leavesley, David] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Cuttle, Leila] Queensland Univ Technol, Ctr Childrens Burns & Trauma Res, Inst Hlth & Biomed Innovat, Ctr Childrens Hlth Res,Sch Biomed Sci, Brisbane, Qld, Australia; [Kimble, Roy; Kempf, Margit; Andrews, Christine J.] Univ Queensland, Ctr Childrens Hlth Res, Ctr Childrens Burns & Trauma Res, South Brisbane, Qld, Australia; [Leavesley, David] Skin Res Inst Singapore, Singapore, Singapore	Hudson Institute of Medical Research; Monash University; Walter & Eliza Hall Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS)	Evans, J (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	jemma.evans@hudson.org.au	Leavesley, David/C-9532-2009; Andrews, Christine/J-4891-2015; Cuttle, Leila/U-9376-2017; Nebl, Thomas/N-1620-2017	Leavesley, David/0000-0002-1033-5459; Andrews, Christine/0000-0003-4513-1349; Cuttle, Leila/0000-0002-2282-4815; Nebl, Thomas/0000-0003-4003-9340; Milla, Liz/0000-0002-6139-4336; evans, jemma/0000-0002-3300-8127; Salamonsen, Lois/0000-0003-0558-7325	National Health Medical Research Council of Australia (NHHRC) [1047756]; Contributing to Australian Scholarship and Science (CASS) grant; Tissue Repair and Regeneration Program; Faculty of Health at Queensland University of Technology; National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship [1002028]; Victorian Government Infrastructure Support Program of the Hudson Institute from the Operational Infrastructure Research Support (OIRS) fund	National Health Medical Research Council of Australia (NHHRC)(National Health and Medical Research Council (NHMRC) of Australia); Contributing to Australian Scholarship and Science (CASS) grant; Tissue Repair and Regeneration Program; Faculty of Health at Queensland University of Technology; National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Infrastructure Support Program of the Hudson Institute from the Operational Infrastructure Research Support (OIRS) fund	The authors thank the women who volunteered for this study, and the patients who donated tissues; Rebecca D'Sylva, Patrick Martin, Samuel Hawthorn, and Laura Knott (all from Hudson Institute of Medical Research) for technical assistance; and Dr. Eugene Kapp (Walter and Eliza Hall Institute) for providing the Ludwig NR protein database. This study was funded by National Health Medical Research Council of Australia (NHHRC; Project Grant 1047756), a Contributing to Australian Scholarship and Science (CASS) grant, and the Tissue Repair and Regeneration Program and the Faculty of Health at Queensland University of Technology (to J.M.); National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship 1002028 (to L.A.S.); and the Victorian Government Infrastructure Support Program of the Hudson Institute, received from the Operational Infrastructure Research Support (OIRS) fund. The authors declare no conflicts of interest.	Allan GJ, 2008, J ENDOCRINOL, V199, P155, DOI 10.1677/JOE-08-0269; Bartelmez GW, 1933, CONTRIB EMBRYOL, V24, P143; Boomsma CM, 2009, REPROD BIOMED ONLINE, V18, P85, DOI 10.1016/S1472-6483(10)60429-4; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Boomsma CM, 2010, FERTIL STERIL, V94, P1764, DOI 10.1016/j.fertnstert.2009.10.044; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Cheong Y, 2013, FERTIL STERIL, V99, P1093, DOI 10.1016/j.fertnstert.2013.01.144; Chevronnay HPG, 2009, ENDOCRINOLOGY, V150, P5094, DOI 10.1210/en.2009-0750; Choi JS, 2013, TISSUE ENG PT A, V19, P329, DOI [10.1089/ten.tea.2011.0738, 10.1089/ten.TEA.2011.0738]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dawson RA, 2006, TRANSPLANTATION, V81, P1668, DOI 10.1097/01.tp.0000226060.51572.89; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Evans J, 2016, NAT REV ENDOCRINOL, V12, P654, DOI 10.1038/nrendo.2016.116; Evans J, 2014, MOL HUM REPROD, V20, P787, DOI 10.1093/molehr/gau032; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; Evans J, 2011, BIOL REPROD, V85, P511, DOI 10.1095/biolreprod.111.090993; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Kimber I, 2002, BIOCHEM CELL BIOL, V80, P103, DOI 10.1139/o01-227; Kwon CH, 2013, MOL CELLS, V35, P226, DOI 10.1007/s10059-013-2269-x; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Lu RQ, 2012, BIOCHEM BIOPH RES CO, V419, P274, DOI 10.1016/j.bbrc.2012.02.008; LUDWIG H, 1991, ANN NY ACAD SCI, V622, P28, DOI 10.1111/j.1749-6632.1991.tb37848.x; Lyons TE, 2007, AM J SURG, V193, P49, DOI 10.1016/j.amjsurg.2006.07.010; Malik S, 2006, HUM REPROD, V21, P2158, DOI 10.1093/humrep/del089; MCLENNAN CE, 1965, OBSTET GYNECOL, V26, P605; Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; NOYES RW, 1953, FERTIL STERIL, V4, P504; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shivhare SB, 2015, J REPROD IMMUNOL, V112, P88, DOI 10.1016/j.jri.2015.09.001; Smith and Nephew, REGR BEC GEL; Sugino T, 2007, J PATHOL, V212, P152, DOI 10.1002/path.2156; Sundaram GM, 2013, NATURE, V495, P103, DOI 10.1038/nature11890; Sureshbabu A, 2009, BIOCHEM SOC T, V37, P882, DOI 10.1042/BST0370882; Takayama Y, 2002, BIOCHEM BIOPH RES CO, V299, P813, DOI 10.1016/S0006-291X(02)02748-1; Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148; Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x; Veraldi Kristen L, 2012, Open Rheumatol J, V6, P140, DOI 10.2174/1874312901206010140; Vijayan A, 2013, INT J BIOCHEM CELL B, V45, P2774, DOI 10.1016/j.biocel.2013.10.001; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Xie Y, 2010, TISSUE ENG PART C-ME, V16, P1111, DOI [10.1089/ten.tec.2009.0725, 10.1089/ten.TEC.2009.0725]; Yang HY, 2012, MOL CELL PROTEOMICS, V11, P1024, DOI 10.1074/mcp.M112.018390; Zang T, 2016, J PROTEOMICS, V146, P122, DOI 10.1016/j.jprot.2016.06.026	57	16	16	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					584	605		10.1096/fj.201800086R	http://dx.doi.org/10.1096/fj.201800086R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30036086	Green Submitted			2022-12-26	WOS:000457401500046
J	Silverstein, N; Sliman, A; Stockner, T; Kanner, BI				Silverstein, Nechama; Sliman, Alaa; Stockner, Thomas; Kanner, Baruch I.			Both reentrant loops of the sodium-coupled glutamate transporters contain molecular determinants of cation selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurotransmitter transport; glutamate; site-directed mutagenesis; membrane transporter reconstitution; computational biology; amino acid transport; electrogenic process; ion selectivity; molecular dynamics simulations; reentry	AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; SUBSTRATE INTERACTIONS; ASPARTATE TRANSPORTER; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; BINDING; ION; EXPRESSION; MUTATION	In the brain, glutamate transporters terminate excitatory neurotransmission by removing this neurotransmitter from the synapse via cotransport with three sodium ions into the surrounding cells. Structural studies have identified the binding sites of the three sodium ions in glutamate transporters. The residue side-chains directly interact with the sodium ions at the Na1 and Na3 sites and are fully conserved from archaeal to eukaryotic glutamate transporters. The Na2 site is formed by three main-chain oxygens on the extracellular reentrant hairpin loop HP2 and one on transmembrane helix 7. A glycine residue on HP2 is located closely to the three main-chain oxygens in all glutamate transporters, except for the astroglial transporter GLT-1, which has a serine residue at that position. Unlike for WT GLT-1, substitution of the serine residue to glycine enables sustained glutamate transport also when sodium is replaced by lithium. Here, using functional and simulation studies, we studied the role of this serine/glycine switch on cation selectivity of substrate transport. Our results indicate that the side-chain oxygen of the serine residues can form a hydrogen bond with a main-chain oxygen on transmembrane helix 7. This leads to an expansion of the Na2 site such that water can participate in sodium coordination at Na2. Furthermore, we found other molecular determinants of cation selectivity on the nearby HP1 loop. We conclude that subtle changes in the composition of the two reentrant hairpin loops determine the cation specificity of acidic amino acid transport by glutamate transporters.	[Stockner, Thomas] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria; [Silverstein, Nechama; Sliman, Alaa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Fac Med, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel	Medical University of Vienna; Hebrew University of Jerusalem	Stockner, T (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.; Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Fac Med, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.	thomas.stockner@meduniwien.ac.at; baruch.kanner@mail.huji.ac.il	Stockner, Thomas/A-9509-2014	Stockner, Thomas/0000-0002-7071-8283	National Institutes of Health Grant from the NINDS [NS 16708]; United States-Israel Binational Science Foundation [2011268]; Austrian Science Fund (FWF) [F3524]; European Union [CM1306]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NINDS; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 16708 from the NINDS, United States-Israel Binational Science Foundation Grant 2011268 (to B. I. K.), Austrian Science Fund (FWF) for project F3524, and the European Union-sponsored COST Action CM1306 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Canul-Tec JC, 2017, NATURE, V544, P446, DOI 10.1038/nature22064; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Guskov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13420; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Silverstein N, 2015, J BIOL CHEM, V290, P28988, DOI 10.1074/jbc.M115.682666; Silverstein N, 2013, J BIOL CHEM, V288, P964, DOI 10.1074/jbc.M112.403576; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Venkatesan S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004551; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	54	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14200	14209		10.1074/jbc.RA118.003261	http://dx.doi.org/10.1074/jbc.RA118.003261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30026234	Green Published, hybrid			2022-12-26	WOS:000444671500002
J	Canalis, E; Yu, J; Schilling, L; Yee, SP; Zanotti, S				Canalis, Ernesto; Yu, Jungeun; Schilling, Lauren; Yee, Siu-Pok; Zanotti, Stefano			The lateral meningocele syndrome mutation causes marked osteopenia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch receptor; bone; osteoblast; osteoclast; osteocyte; bone loss; lateral meningocele syndrome; Lehman syndrome; osteopenia; skeletal abnormalities	HAJDU-CHENEY-SYNDROME; NOTCH SIGNALING PATHWAY; ZINC-FINGER TARGETER; BONE LOSS; OSTEOBLAST DIFFERENTIATION; LYMPHOBLASTIC-LEUKEMIA; TRUNCATING MUTATIONS; OSTEOCYTE APOPTOSIS; HUMAN-CELLS; LAST EXON	Lateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAGTAATGA) and verified this mutation (Notch3(tm1.1Ecan)) by DNA sequencing of F1 mice. One-month-old male and female heterozygous Notch3(tm1.1Ecan) mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3(tm1.1Ecan) calvarial osteoblasts had increased proliferation and increased bone -carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3(tm1.1Ecan) mice. Cultures of bone marrow-derived macrophages from Notch3(tm1.1Ecan) mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3(tm1.1Ecan) mice. In conclusion, the Notch3(tm1.1Ecan) mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes.	[Canalis, Ernesto; Yu, Jungeun; Schilling, Lauren; Zanotti, Stefano] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto; Zanotti, Stefano] UConn Hlth, Dept Med, Farmington, CT 06030 USA; [Yee, Siu-Pok] UConn Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Canalis, Ernesto; Yu, Jungeun; Schilling, Lauren; Zanotti, Stefano] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Yee, Siu-Pok] UConn Hlth, Ctr Mouse Genome Modificat, Farmington, CT 06030 USA; [Zanotti, Stefano] Sanofi, Rare Dis, Framingham, MA 01701 USA	Sanofi-Aventis	Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA.	canalis@uchc.edu			NIAMS from the National Institutes of Health [AR063049, AR072987]; NIDDK from the National Institutes of Health [DK045227]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063049, R01AR072987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	NIAMS from the National Institutes of Health; NIDDK from the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIAMS Grants AR063049 and AR072987 and NIDDK Grant DK045227 from the National Institutes of Health (all to E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Avela K, 2011, AM J MED GENET A, V155A, P595, DOI 10.1002/ajmg.a.33510; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bellavia D, 2008, ONCOGENE, V27, P5092, DOI 10.1038/onc.2008.230; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Breit S, 2006, BLOOD, V108, P1151, DOI 10.1182/blood-2005-12-4956; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2014, BONE, V64, P273, DOI 10.1016/j.bone.2014.04.028; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Delgado-Calle J, 2016, CANCER RES, V76, P1089, DOI 10.1158/0008-5472.CAN-15-1703; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dou XW, 2017, J DENT RES, V96, P347, DOI 10.1177/0022034516680349; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gripp KW, 2015, AM J MED GENET A, V167, P271, DOI 10.1002/ajmg.a.36863; Gripp KW, 2011, AM J MED GENET A, V155A, P1773, DOI 10.1002/ajmg.a.34075; Gripp KW, 1997, AM J MED GENET, V70, P229; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Joutel A, 2011, BIOESSAYS, V33, P73, DOI 10.1002/bies.201000093; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LEHMAN RAW, 1977, J PEDIATR-US, V90, P49, DOI 10.1016/S0022-3476(77)80763-4; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; McCright B, 2001, DEVELOPMENT, V128, P491; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Novack DV, 2007, CELL METAB, V6, P254, DOI 10.1016/j.cmet.2007.09.007; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Plotkin LI, 2015, J BIOL CHEM, V290, P18934, DOI 10.1074/jbc.M115.642090; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Williams Adam, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top087536; Wu J, 2007, TRENDS BIOCHEM SCI, V32, P477, DOI 10.1016/j.tibs.2007.09.002; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2017, J BIOL CHEM, V292, P12232, DOI 10.1074/jbc.M117.786129; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476	81	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14165	14177		10.1074/jbc.RA118.004242	http://dx.doi.org/10.1074/jbc.RA118.004242			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30042232	hybrid, Green Published			2022-12-26	WOS:000444070700037
J	Zhu, QW; Chang, A; Xu, A; Luo, KX				Zhu, Qingwei; Chang, Amanda; Xu, Albert; Luo, Kunxin			The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						activin; SMAD transcription factor; transforming growth factor (TGF-); obesity; adipocyte; differentiation; adipose tissue; SKI like proto-oncogene; SKIL; Smad2; SnoN; adipose tissue	GROWTH-FACTOR-BETA; HUMAN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; TGF-BETA; INSULIN-RESISTANCE; TUMOR-SUPPRESSOR; STEM-CELL; TRANSCRIPTIONAL CONTROL; MAMMALIAN DEVELOPMENT; ENERGY-EXPENDITURE	Ski-related oncogene SnoN (SnoN or SKIL) regulates multiple signaling pathways in a tissue- and developmental stage-dependent manner and has broad functions in embryonic angiogenesis, mammary gland alveologenesis, cancer, and aging. Here, we report that SnoN also plays a critical role in white adipose tissue (WAT) development by regulating mesenchymal stem cell (MSC) self-renewal and differentiation. We found that SnoN promotes MSC differentiation in the adipocyte lineage by antagonizing activin A/Smad2, but not TGF/Smad3 signaling. Mice lacking SnoN or expressing a mutant SnoN defective in binding to the Smads were protected from high-fat diet-induced obesity and insulin resistance, and MSCs lacking a functional SnoN exhibited defective differentiation. We further demonstrated that activin, via Smad2, appears to be the major regulator of WAT development in vivo. We also noted that activin A is abundantly expressed in WAT and adipocytes through an autocrine mechanism and promotes MSC self-renewal and inhibits adipogenic differentiation by inducing expression of the gene encoding the homeobox transcription factor Nanog. Of note, SnoN repressed activin/Smad2 signaling and activin A expression, enabling expression of adipocyte-specific transcription factors and promoting adipogenic differentiation. In conclusion, our study has revealed that SnoN plays an important in vivo role in adipocyte differentiation and WAT development in vivo by decreasing activity in the activin/Smad2 signaling pathway.	[Zhu, Qingwei; Chang, Amanda; Luo, Kunxin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Luo, Kunxin] Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Xu, Albert] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Luo, KX (corresponding author), Univ Calif Berkeley, Dept Mol Cell Biol, 382 Li Ka Shing Ctr 3370, Berkeley, CA 94720 USA.	kluo@berkeley.edu		Xu, Albert/0000-0001-5938-561X	Department of Defense CDMRP BCRP [W81XWH-15-1-0051]	Department of Defense CDMRP BCRP(United States Department of Defense)	This work was supported by Department of Defense CDMRP BCRP Grant W81XWH-15-1-0051 (to K. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Fain JN, 2005, METABOLISM, V54, P1546, DOI 10.1016/j.metabol.2005.05.024; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Grafe I, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022202; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Hirai S, 2005, MOL CELL ENDOCRINOL, V232, P21, DOI 10.1016/j.mce.2005.01.001; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Jahchan NS, 2012, DEVELOPMENT, V139, P3147, DOI 10.1242/dev.079616; Jahchan NS, 2010, CURR OPIN PHARMACOL, V10, P670, DOI 10.1016/j.coph.2010.08.006; JEOUNG DI, 1995, BIOCHEM BIOPH RES CO, V216, P964, DOI 10.1006/bbrc.1995.2714; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Lin YS, 2009, DIS MARKERS, V27, P23, DOI [10.1155/2009/529253, 10.3233/DMA-2009-0643]; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pan D, 2012, AGING CELL, V11, P902, DOI 10.1111/j.1474-9726.2012.00857.x; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Stewart WC, 2011, OBESITY, V19, P1731, DOI 10.1038/oby.2011.66; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; TORTI FM, 1989, J CELL BIOL, V108, P1105, DOI 10.1083/jcb.108.3.1105; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yusuf B, 2013, DEV GROWTH DIFFER, V55, P330, DOI 10.1111/dgd.12043; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06; Zhu QW, 2016, DEV CELL, V37, P399, DOI 10.1016/j.devcel.2016.05.002; Zhu QW, 2013, J CELL BIOL, V202, P937, DOI 10.1083/jcb.201208113; Zhu QW, 2012, FEBS LETT, V586, P1971, DOI 10.1016/j.febslet.2012.03.005	64	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14100	14111		10.1074/jbc.RA118.003678	http://dx.doi.org/10.1074/jbc.RA118.003678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030373	hybrid, Green Published			2022-12-26	WOS:000444070700031
J	Borkenhagen, LK; Mallinson, KA; Tsao, RW; Ha, SJ; Lim, WH; Toh, TH; Anderson, BD; Fieldhouse, JK; Philo, SE; Chong, KS; Lindsley, WG; Ramirez, A; Lowe, JF; Coleman, KK; Gray, GC				Borkenhagen, Laura K.; Mallinson, Kerry A.; Tsao, Rick W.; Ha, Siaw-Jing; Lim, Wei-Honn; Toh, Teck-Hock; Anderson, Benjamin D.; Fieldhouse, Jane K.; Philo, Sarah E.; Chong, Kuek-Sen; Lindsley, William G.; Ramirez, Alejandro; Lowe, James F.; Coleman, Kristen K.; Gray, Gregory C.			Surveillance for respiratory and diarrheal pathogens at the human-pig interface in Sarawak, Malaysia	PLOS ONE			English	Article							PORCINE CIRCOVIRUS TYPE-2; NUCLEIC-ACID AMPLIFICATION; ORAL FLUID SAMPLES; TIME PCR ASSAY; INFLUENZA-VIRUS; MODERN AGRICULTURE; UNITED-STATES; SWINE FARMS; INFECTION; QUANTIFICATION	Background The large livestock operations and dense human population of Southeast Asia are considered a hot-spot for emerging viruses. Objectives To determine if the pathogens adenovirus (ADV), coronavirus (CoV), encephalomyocarditis virus (EMCV), enterovirus (EV), influenza A-D (IAV, IBV, ICV, and IDV), porcine circovirus 2 (PCV2), and porcine rotaviruses A and C (RVA and RVC), are aerosolized at the animalinterface, and if humans working in these environments are carrying these viruses in their nasal airways. Study This cross-sectional study took place in Sarawak, Malaysia among 11 pig farms, 2 abattoirs, and 3 animal markets in June and July of 2017. Pig feces, pig oral secretions, bioaerosols, and worker nasal wash samples were collected and analyzed via rPCR and rRT-PCR for respiratory and diarrheal viruses. Results In all, 55 pig fecal, 49 pig oral or water, 45 bioaerosol, and 78 worker nasal wash samples were collected across 16 sites. PCV2 was detected in 21 pig fecal, 43 pig oral or water, 3 bioaerosol, and 4 worker nasal wash samples. In addition, one or more bioaerosol or pig samples were positive for EV, IAV, and RVC, and one or more worker samples were positive for ADV, CoV, IBV, and IDV. Conclusions This study demonstrates that nucleic acids from a number of targeted viruses were present in pig oral secretions and pig fecal samples, and that several viruses were detected in bioaerosol samples or in the nasal passages of humans with occupational exposure to pigs. These results demonstrate the need for future research in strengthening viral surveillance at the human-animal interface, specifically through expanded bioaerosol sampling efforts and a seroepidemiological study of individuals with exposure to pigs in this region for PCV2 infection.	[Borkenhagen, Laura K.; Mallinson, Kerry A.; Tsao, Rick W.; Fieldhouse, Jane K.; Philo, Sarah E.; Gray, Gregory C.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Borkenhagen, Laura K.; Anderson, Benjamin D.; Fieldhouse, Jane K.; Philo, Sarah E.; Gray, Gregory C.] Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA; [Ha, Siaw-Jing; Toh, Teck-Hock; Chong, Kuek-Sen] SEGi Univ, Sibu Clin Campus, Sibu, Sarawak, Malaysia; [Ha, Siaw-Jing; Toh, Teck-Hock] Sibu Hosp, Dept Paediat, Sibu, Sarawak, Malaysia; [Lim, Wei-Honn; Toh, Teck-Hock] Sibu Hosp, Clin Res Ctr, Sibu, Sarawak, Malaysia; [Chong, Kuek-Sen] Div Hlth Off, Sibu, Sarawak, Malaysia; [Lindsley, William G.] NIOSH, Morgantown, WV USA; [Ramirez, Alejandro] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Lowe, James F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Integrated Food Anim Management Syst, Champaign, IL USA; [Coleman, Kristen K.; Gray, Gregory C.] Duke NUS Med Sch, Singapore, Singapore	Duke University; Duke University; SEGi University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore	Borkenhagen, LK (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Borkenhagen, LK (corresponding author), Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA.	laura.borkenhagen@duke.edu	Toh, Teck-Hock/AAW-7715-2021; Coleman, Kristen/R-9172-2019; Philo, Sarah E./AGE-3506-2022; Gray, Gregory C./ABF-1298-2020; Lim, Wei Honn/N-4108-2017	Toh, Teck-Hock/0000-0001-5909-4855; Coleman, Kristen/0000-0003-0024-3400; Philo, Sarah E./0000-0002-9894-0425; Lim, Wei Honn/0000-0002-6408-4747; Fieldhouse, Jane/0000-0002-5450-0970; Lindsley, William/0000-0003-0720-5829	Duke Global Health Institute discretionary funding; Duke Global Health Institute graduate program; Duke's Bass Connections program	Duke Global Health Institute discretionary funding; Duke Global Health Institute graduate program; Duke's Bass Connections program	This study was supported by Professor Gray's Duke Global Health Institute discretionary funding, as well as funding from the Duke Global Health Institute graduate program and Duke's Bass Connections program.; We thank the Director General of Health, Malaysia for his permission to publish this paper. This study was supported by Professor Gray's Duke Global Health Institute discretionary funding, as well as funding from the Duke Global Health Institute graduate program and Duke's Bass Connections program. We thank all of the staff at the Clinical Research Center at Sibu Hospital, especially Kamilah Binti Dahian and Jimi Bin Jipri, and the Duke One Health team who supported this research. We thank Dr. Kiong-Kheng Wong, Head of Divisional Veterinary Office in Sibu and Kapit, for providing technical advice in the design of this study. A special thanks is due to SEGi University in Sibu, Sarawak, Malaysia for providing a lab space for this study. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.	Ahuja V., 2013, ASIAN LIVESTOCK CHAL; Allan GM, 2000, ARCH VIROL, V145, P853, DOI 10.1007/s007050050678; Anderson BD, 2016, J INFECT DIS, V214, P537, DOI 10.1093/infdis/jiw180; Bil-Lula I, 2012, MED SCI MONITOR, V18, pBR221, DOI 10.12659/MSM.882898; Bird BH, 2017, ANN REV ANIMAL BIOSC, V16; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Burbelo PD, 2013, BIOLOGICALS, V41, P430, DOI 10.1016/j.biologicals.2013.09.005; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; CDC, GUID CLIN US RT PCR; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Ellis JA, 2000, J AM VET MED ASSOC, V217, P1645, DOI 10.2460/javma.2000.217.1645; Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/ World Bank, 2010, 169 FAO; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Lindsley WG, 2017, NIOSH MANUAL ANAL ME, pBA1; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Lorincz M, 2010, ACTA VET HUNG, V58, P265, DOI 10.1556/AVet.58.2010.2.12; Marthaler D, 2014, J VIROL METHODS, V209, P30, DOI 10.1016/j.jviromet.2014.08.018; Neira V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146616; O'Brien KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149083; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Pabbaraju K, 2013, INFLUENZA OTHER RESP, V7, P954, DOI 10.1111/irv.12099; Pal N, 2008, J VIROL METHODS, V149, P217, DOI 10.1016/j.jviromet.2008.02.002; Patterson AR, 2011, VET MICROBIOL, V149, P225, DOI 10.1016/j.vetmic.2010.10.021; Patterson AR, 2011, VET MICROBIOL, V149, P91, DOI 10.1016/j.vetmic.2010.10.020; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Ronald B., 2011, BIOSECURITY PIG FARM; Rose N, 2012, VIRUS RES, V164, P78, DOI 10.1016/j.virusres.2011.12.002; Sarkar A, 2012, ENVIRON RES, V115, P37, DOI 10.1016/j.envres.2012.03.005; Takemae N, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0844-z; TISCHER I, 1995, ARCH VIROL, V140, P1427, DOI 10.1007/BF01322669; Torremorell M, 2016, AVIAN DIS, V60, P637, DOI 10.1637/11395-021816-Reg.1; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yuan WZ, 2014, J VIROL METHODS, V207, P60, DOI 10.1016/j.jviromet.2014.06.004; Zhai SL, 2016, ARCH VIROL, V161, P3237, DOI 10.1007/s00705-016-3004-7	40	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201295	10.1371/journal.pone.0201295	http://dx.doi.org/10.1371/journal.pone.0201295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052648	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600036
J	Gutierrez, JP; Garcia-Saiso, S; Aracena, BM				Gutierrez, Juan Pablo; Garcia-Saiso, Sebastian; Aracena, Belkis M.			Mexico's household health expenditure on diabetes and hypertension: What is the additional financial burden?	PLOS ONE			English	Article							GLOBAL BURDEN; CARE; TRENDS; IMPACT	Objective This study aimed to estimate the magnitude of the association between overall household health expenditures & the presence of members with a chronic disease in the household. Research design & methods This was a cross-sectional analysis of a probabilistic household survey, which gathered data on previously diagnosed type 2 diabetes mellitus and hypertension as well as health expenditure in Mexico. From an analytic sample of 44,000 households, we identified those having at least one member with diabetes or hypertension and determined their health expenditure. Using matching procedures, we compared these data with those of households lacking such individuals. Results We found that 24% of the households had at least one member who had been diagnosed with diabetes, hypertension, or both. Households with such members reported health expenditures that were 25%-34% (P <0.01) higher than households without such individuals. Such differences were more pronounced among households at lower socioeconomic levels and among those with no or limited health insurance. Conclusions In addition to their impact on individual health, chronic ailments exert financial pressure on households. The additional health-care expenditure for households owing to such diseases leaves them financially exposed-especially households with lower income levels.	[Gutierrez, Juan Pablo; Aracena, Belkis M.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Garcia-Saiso, Sebastian] Directorate Qual & Hlth Educ, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Garcia-Saiso, S (corresponding author), Directorate Qual & Hlth Educ, Mexico City, DF, Mexico.	sebastian.garcia@salud.gob.mx	Gutierrez, Juan Pablo/A-4253-2010	Gutierrez, Juan Pablo/0000-0002-0557-5562; Aracena-Genao, Belkis/0000-0001-5454-9531; Garcia-Saiso, Sebastian/0000-0003-4455-3080				Arredondo A, 2007, DIABETOLOGIA, V50, P2408, DOI 10.1007/s00125-007-0828-4; Arredondo A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0136-z; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Avila-Burgos L, 2013, SALUD PUBLICA MEXICO, V55, pS91; Bautista-Arredondo S, 2014, SALUD PUBLICA MEXICO, V56, P18; Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295; Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110; Cordova Villalobos J A, 2008, SALUD PUBLICA MEXICO, V50, P419; FID, 2012, ATL DIAB FED INT DIA; Figueroa-Lara A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145177; Garcia-Saiso S, 2015, BIBLIOTECA MEXICANA; Goryakin Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0107-1; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Heckman J, 1998, ECONOMETRICA, V66, P1017, DOI 10.2307/2999630; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lozano R., 2014, CARGA ENFERMEDAD MEX; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; OECD, 2016, OECD REV HLTH SYST M, DOI [10.1787/9789264230491-en, DOI 10.1787/9789264230491-EN]; Gutierrez JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-186; Gutierrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS341, DOI 10.21149/spm.v55s2.5133; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Ravallion M, 2001, WORLD BANK ECON REV, V15, P115, DOI 10.1093/wber/15.1.115; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Saito E, 2014, B WORLD HEALTH ORGAN, V92, P760, DOI 10.2471/BLT.13.126615; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wirtz VJ, 2012, VALUE HEALTH, V15, P593, DOI 10.1016/j.jval.2012.01.006	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201333	10.1371/journal.pone.0201333	http://dx.doi.org/10.1371/journal.pone.0201333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052668	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600039
J	Yang, L; Kong, XY; Yang, SL; Dong, XX; Yang, JF; Gou, X; Zhang, H				Yang, Lin; Kong, Xiaoyan; Yang, Shuli; Dong, Xinxing; Yang, Jianfa; Gou, Xiao; Zhang, Hao			Haplotype diversity in mitochondrial DNA reveals the multiple origins of Tibetan horse	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ANCIENT DNA; DOMESTICATION; EXPANSION; SEQUENCES; SPREAD	The Tibetan horse is a species endemic to the Tibetan plateau, with considerable economic value in the region. However, we currently have little genetic evidence to verify whether the breed originated in Tibet or if it entered the area via an ancient migratory route. In the present study, we analyzed the hypervariable segment I sequences of mitochondrial DNA (mtDNA) in 2,050 horses, including 290 individuals from five Tibetan populations and 1,760 from other areas across Asia. Network analysis revealed multiple maternal lineages in the Tibetan horse. Component analysis of sub-lineage F3 indicated that it decreased in frequency from east to west, a trend reflected both southward and northward from Inner Mongolia. Analysis of population genetics showed that the Deqen horse of eastern Tibet was more closely related to the Ningqiang horse of northern China than to other Tibetan horses or the Yunnan horse. These results indicated that the Tibetan horse migrated first from Central Asia to Mongolia, moved south to eastern Tibet (near Deqen), then finally westward to other regions of Tibet. We also identified a novel lineage K that mainly comprises Tibetan and Yunnan horses, suggesting autochthonous domesticated origin for some Tibetan horse breeds from local wild horses. In conclusion, our study demonstrated that modern Tibetan horse breeds originated from the introgression of local wild horses with exotic domesticated populations outside China.	[Yang, Lin; Zhang, Hao] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China; [Kong, Xiaoyan; Yang, Shuli; Dong, Xinxing; Yang, Jianfa; Gou, Xiao] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University	Zhang, H (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China.; Gou, X (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China.	gouxiaosa@163.com; zhanghao827@163.com			National Natural Science Foundation of China [31560617]; Yunnan Applied Basic Projects [2014FD020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Applied Basic Projects	This work was supported by the National Natural Science Foundation of China [31560617] and Yunnan Applied Basic Projects [2014FD020].	Cai DW, 2009, J ARCHAEOL SCI, V36, P835, DOI 10.1016/j.jas.2008.11.006; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Du D, 2011, ASIAN J ANIM VET ADV, V6, P564, DOI 10.3923/ajava.2011.564.571; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Guangxin E, 2017, MITOCHONDRIAL DNA A, V28, P579, DOI 10.3109/24701394.2016.1143469; Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-73; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Lei CZ, 2009, ANIM GENET, V40, P933, DOI 10.1111/j.1365-2052.2009.01950.x; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Ren ZJ, 2017, J GENET, V96, P119, DOI 10.1007/s12041-017-0753-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wang T, 2012, 50 YEARS HORSE STUDI; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215; Yang YZ, 2017, ANIM SCI J, V88, P19, DOI 10.1111/asj.12583; Zhang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172945; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; Zhao YX, 2017, MOL BIOL EVOL, V34, P2380, DOI 10.1093/molbev/msx181	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201564	10.1371/journal.pone.0201564	http://dx.doi.org/10.1371/journal.pone.0201564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052677	gold, Green Published, Green Submitted			2022-12-26	WOS:000440006600049
J	Deschodt-Arsac, V; Lalanne, R; Spiluttini, B; Bertin, C; Arsac, LM				Deschodt-Arsac, Veronique; Lalanne, Romain; Spiluttini, Beatrice; Bertin, Claire; Arsac, Laurent M.			Effects of heart rate variability biofeedback training in athletes exposed to stress of university examinations	PLOS ONE			English	Article							NEUROVISCERAL INTEGRATION; CONNECTIVITY; RESONANCE; DYNAMICS; ANXIETY; MODEL	Introduction Heart rate variability biofeedback (HRV-BFB) training, a method whereby one controls an unusually low breathing rate to reach cardiac coherence, has been shown to reduce anxiety and improve cardiac autonomic markers in diseased people, but much less is known about HRV-BFB benefits in healthy people. Here we investigated potential benefits in young competitors experiencing stress during university examinations as well as persistence of benefits after HRV-BFB training cessation. Methods A group of sports students (n = 12) practiced 5-min HRV-BFB training twice a day for 5-weeks using URGOfeel (R) (URGOTECH) and was compared to a control group (n = 6). University examinations occurred immediately after HRV-BFB training (Exam1), then 12-weeks later (Exam2). Anxiety markers and cardiac autonomic markers were assessed at baseline, Exam1 and Exam2. Principal Component Analyses (PCA) that combined all these markers were computed at Exam1 and Exam2 to emphasize covariations. Results At Exam 1, immediately after HRV-BFB training cessation, the experimental group demonstrated greater autonomic markers but similar states of anxiety when compared to the Control group. Twelve weeks later at Exam2, autonomic markers were greater and anxiety scores were lesser among the experimental group. PCA highlighted covariations only within cardiac autonomic markers at Exam1. Rather, variations in cardiac markers were associated with anxiety markers at Exam2. Conclusion Short sessions of HRV-BFB training for a brief period of 5 weeks bring substantial benefits to autonomic markers and anxiety levels in young competitors. Here beneficial effects persisted for 12 weeks. Dissociated profiles of anxiety and cardiac autonomic adaptations shed new light on the role of the amygdala in heart-brain interactions after cardiac coherence training.	[Deschodt-Arsac, Veronique; Lalanne, Romain; Arsac, Laurent M.] Univ Bordeaux, CNRS, Lab IMS, UMR 5218, Talence, France; [Deschodt-Arsac, Veronique; Lalanne, Romain; Arsac, Laurent M.] Univ Bordeaux, Fac STAPS, Pessac, France; [Spiluttini, Beatrice; Bertin, Claire] URGOTECH, 15 Ave Iena, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Deschodt-Arsac, V (corresponding author), Univ Bordeaux, CNRS, Lab IMS, UMR 5218, Talence, France.; Deschodt-Arsac, V (corresponding author), Univ Bordeaux, Fac STAPS, Pessac, France.	veronique.arsac@u-bordeaux.fr		Deschodt-Arsac, Veronique/0000-0002-9244-9862				Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Camm AJ, 1996, EUR HEART J, V17, P354; Chen S, 2016, J HUM HYPERTENS, V30, P105, DOI 10.1038/jhh.2015.27; Del Pozo JM, 2004, AM HEART J, V147, pG1, DOI 10.1016/j.ahj.2003.08.013; Dimitriev DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146131; Francis DP, 2002, J PHYSIOL-LONDON, V542, P619, DOI 10.1113/jphysiol.2001.013389; Gevirtz R., 2013, BIOFEEDBACK, V41, P110, DOI [10.5298/1081-5937-41.3.01, DOI 10.5298/1081-5937-41.3.01]; Gianaros PJ, 2015, CURR DIR PSYCHOL SCI, V24, P313, DOI 10.1177/0963721415581476; Gross MJ, 2016, APPL PSYCHOPHYS BIOF, V41, P263, DOI 10.1007/s10484-015-9330-9; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kim DK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00414; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lehrer PM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00756; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; McCraty Rollin, 2014, Front Psychol, V5, P1090, DOI 10.3389/fpsyg.2014.01090; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Paul Maman, 2012, Asian J Sports Med, V3, P29; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Pyne JM, 2016, BIOL PSYCHOL, V121, P91, DOI 10.1016/j.biopsycho.2016.10.008; Sakaki M, 2016, NEUROIMAGE, V139, P44, DOI 10.1016/j.neuroimage.2016.05.076; Schmidt F, 1998, VALIDITY UTILITY SEL, V24, P262; Shaw L., 2011, DISS ABSTR INT B, P4496; Skinner N, 2002, J PERS SOC PSYCHOL, V83, P678, DOI 10.1037//0022-3514.83.3.678; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Strack B. W., 2003, DISS ABSTR INT B, V64, P1540; Tada Y, 2017, J NUTR SCI VITAMINOL, V63, P249, DOI 10.3177/jnsv.63.249; Thayer JF, 2002, IEEE ENG MED BIOL, V21, P24, DOI 10.1109/MEMB.2002.1032635; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thome J, 2017, HUM BRAIN MAPP, V38, P27, DOI 10.1002/hbm.23340; Tomasino D., 2006, STRESS HLTH DIS, P342, DOI 10.1002/; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Yazar S, 2016, MED PRIN PRACT, V25, P374, DOI 10.1159/000444322; Young H, 2015, SCI REP-UK, V5, DOI 10.1038/srep16619	38	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201388	10.1371/journal.pone.0201388	http://dx.doi.org/10.1371/journal.pone.0201388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048519	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400084
J	Souza, TKF; Nucci, MP; Mamani, JB; da Silva, HR; Fantacini, DMC; de Souza, LEB; Picanco-Castro, V; Covas, DT; Vidoto, EL; Tannus, A; Gamarra, LF				Felix Souza, Taylla Klei; Nucci, Mariana Penteado; Mamani, Javier Bustamante; da Silva, Helio Rodrigues; Carvalho Fantacini, Daianne Maciely; Botelho de Souza, Lucas Eduardo; Picanco-Castro, Virginia; Covas, Dimas Tadeu; Vidoto, Edson Luis; Tannus, Alberto; Gamarra, Lionel Fernel			Image and motor behavior for monitoring tumor growth in C6 glioma model	PLOS ONE			English	Article							NEUROLOGICAL DEFICITS; PROGRESSION; DYSFUNCTION	The primary objective of this study is to monitor tumor growth by using image techniques and behavioral testing through general and specific motor activities (spontaneous movements and gait). Our sample includes male Wistar rats, 2 months old and weighing 250-300 g, that is categorized into three groups: control, sham, and experimental. The experimental group was anesthetized; the C6 cells with luciferase expression that were suspended in a culture medium were implanted into the right frontoparietal cortex of the rats. The sham group received implant only with culture medium without cells. Images and behavioral tests were evaluated at base time and at 7, 14, 21, and 28 days after induced tumor growth analysis. The tumor volume measured by magnetic resonance imaging (MRI) and quantitative bioluminescence imaging (BLI) signal showed a correlation coefficient of r = 0.96. The MRI showed that the mean tumor volume increased by approximately 10, 26, and 49 times according to a comparison of tumor volume on the seventh day with 14, 21, and 28 days, respectively. The quantification of the BLI signal was (4.12 +/- 2.01) x 10(8), (8.33 +/- 3.12) x 10(8), (28.43 +/- 6.32) x 10(8), and (63.02 +/- 10.53) x 10(8) photons/s at the seventh, fourteenth, twenty-first, and twenty-eighth day, respectively. After 14 days of tumor induction, both behavioral tests showed significant differences between tumor and sham or control groups. Our study showed a high correlation between MRI and BLI for tumor growth monitoring with complement aspects analysis in tumor volume. In addition, functional behavioral analysis displayed sensitivity to monitor tumor growth, as well as to detect early significant changes between groups, primarily in the tumor group. The results of gait analysis were more sensitive than general motor analysis.	[Felix Souza, Taylla Klei; Mamani, Javier Bustamante; da Silva, Helio Rodrigues; Gamarra, Lionel Fernel] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil; [Nucci, Mariana Penteado] Univ Sao Paulo, Fac Med, LIM44, Sao Paulo, SP, Brazil; [Carvalho Fantacini, Daianne Maciely; Botelho de Souza, Lucas Eduardo; Picanco-Castro, Virginia; Covas, Dimas Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Vidoto, Edson Luis; Tannus, Alberto] Univ Sao Paulo, Inst Fis Sao Carlos, CIERMag, Sao Paulo, Brazil; [Gamarra, Lionel Fernel] Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Gamarra, LF (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.; Gamarra, LF (corresponding author), Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil.	lgamarra@einstein.br	GAMARRA, LIONEL/AAF-7201-2020; Fantacini, Daianne Maciely C/N-9703-2018; Castro, Virginia P/H-2904-2015; Nucci, Mariana/AAC-4990-2020; Gamarra, Lionel fernel/AAA-9638-2020; Mamani, Javier B/D-3924-2013; Picanco-Castro, Virginia/AAC-7242-2019; Covas, Dimas T/C-5431-2013; Nucci, Mariana/AAM-6841-2021; Covas, Dimas/AAL-8499-2021	Fantacini, Daianne Maciely C/0000-0003-2694-0132; Castro, Virginia P/0000-0001-8474-4610; Gamarra, Lionel fernel/0000-0002-3910-0047; Picanco-Castro, Virginia/0000-0001-8474-4610; Covas, Dimas T/0000-0002-7364-2595; Nucci, Mariana/0000-0002-1502-9215; BUSTAMANTE MAMANI, JAVIER/0000-0001-5038-0070	National Council for Scientific and Technological Development [CNPq-400856/2016-6, CNPq-465259/2014-6]; Sao Paulo State Research Support Foundation [FAPESP:2016/21470-3, FAPESP: 2014/50983-3]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Support Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the National Council for Scientific and Technological Development (CNPq-400856/2016-6 to LFG and CNPq-465259/2014-6), Sao Paulo State Research Support Foundation (FAPESP:2016/21470-3 to LFG and FAPESP: 2014/50983-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Brain Tumor Association, 2017, BRAIN TUM STAT; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chien YC, 2014, ONCOL REP, V32, P691, DOI 10.3892/or.2014.3256; da Silva AC, 2012, EINSTEIN-SAO PAULO, V10, P11, DOI 10.1590/S1679-45082012000100004; De Oliveira PA, 2017, BRAIN RES, V1663, P78, DOI 10.1016/j.brainres.2017.03.002; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Fantacini DMC, 1674, RECOMBINANT GLYCOPRO, P63, DOI [10.1007/978-1-4939-7312-5, DOI 10.1007/978-1-4939-7312-5]; Gao SX, 2016, J CRANIOFAC SURG, V27, pE623, DOI 10.1097/SCS.0000000000002957; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hua Y, 2005, ACTA NEUROCHIR SUPPL, V95, P403; Huhndorf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168174; IBM Corp, 2015, REL 2015 IBM SPSS ST; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Jallo GI, 2006, CHILD NERV SYST, V22, P1519, DOI 10.1007/s00381-006-0174-8; Jost SC, 2009, MOL IMAGING, V8, P245, DOI 10.2310/7290.2009.00023; Karthigeyan M, 2017, WORLD NEUROSURG, V100, DOI 10.1016/j.wneu.2017.01.043; Kauppinen RA, 2011, CANCER BIOL THER, V12, P665, DOI 10.4161/cbt.12.8.18137; King GD, 2008, MOL THER, V16, P682, DOI 10.1038/mt.2008.18; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Kushner DS, 2015, NEURO-ONCOL PRACT, V2, P185, DOI 10.1093/nop/npv019; Liu Q, 2008, J NEUROSURG, V109, P849, DOI 10.3171/JNS/2008/109/11/0849; MOKRY J, 1995, PHYSIOL RES, V44, P143; Mollard S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36173; Noell S, 2015, CLIN NEUROL NEUROSUR, V136, P41, DOI 10.1016/j.clineuro.2015.05.021; Ostrom QT, 2013, NEOUROONCOLOGY, V12, P28, DOI DOI 10.1093/NEUONC/NOT151; Papoti D, 2010, CONCEPT MAGN RESON B, V37B, P193, DOI 10.1002/cmr.b.20168; Rasband WS, 2012, ASCL; Roth J, 2008, ACTA NEUROCHIR, V150, P41, DOI 10.1007/s00701-007-1454-0; Samano AK, 2010, TRANSGENIC RES, V19, P829, DOI 10.1007/s11248-010-9361-1; Sciacero Piera, 2014, Tumori, V100, pe74, DOI 10.1700/1578.17236; Silvani A, 2011, NEUROL SCI, V32, pS207, DOI 10.1007/s10072-011-0788-9; Skeie BS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/139674; Stojkovic S, 2016, MOLECULES, V21, DOI 10.3390/molecules21070843; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Swartz AM, 2014, IMMUNOTHERAPY-UK, V6, P679, DOI [10.2217/IMT.14.21, 10.2217/imt.14.21]; Vannini E, 2017, ONCOTARGET, V8, P23539, DOI 10.18632/oncotarget.15328; Yang HY, 2007, BEHAV BRAIN RES, V182, P42, DOI 10.1016/j.bbr.2007.05.013; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhou HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006087	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201453	10.1371/journal.pone.0201453	http://dx.doi.org/10.1371/journal.pone.0201453			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048545	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400090
J	Shoji, M; Minato, H; Ogaki, S; Seki, M; Suzuki, Y; Kume, S; Kuzuhara, T				Shoji, Masaki; Minato, Hiroki; Ogaki, Soichiro; Seki, Masahide; Suzuki, Yutaka; Kume, Shoen; Kuzuhara, Takashi			Different murine-derived feeder cells alter the definitive endoderm differentiation of human induced pluripotent stem cells	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; SELF-RENEWAL; HUMAN ESCS; HUMAN FIBROBLASTS; NANOG EXPRESSION; GROWTH-FACTOR; MOUSE; GENE; KLF4; GENERATION	The crosstalk between cells is important for differentiation of cells. Murine-derived feeder cells, SNL76/7 feeder cells (SNLs) or mouse primary embryonic fibroblast feeder cells (MEFs) are widely used for culturing undifferentiated human induced pluripotent stem cells (hiPSCs). It is still unclear whether different culture conditions affect the induction efficiency of definitive endoderm (DE) differentiation from hiPSCs. Here we show that the efficiency of DE differentiation from hiPSCs cultured on MEFs was higher than that of hiPSCs cultured on SNLs. The qPCR, immunofluorescent and flow cytometry analyses revealed that the expression levels of mRNA and/or proteins of the DE marker genes, SOX17, FOXA2 and CXCR4, in DE cells differentiated from hiPSCs cultured on MEFs were significantly higher than those cultured on SNLs. Comprehensive RNA sequencing and molecular network analyses showed the alteration of the gene expression and the signal transduction of hiPSCs cultured on SNLs and MEFs. Interestingly, the expression of non-coding hXIST exon 4 was up-regulated in hiPSCs cultured on MEFs, in comparison to that in hiPSCs cultured on SNLs. By qPCR analysis, the mRNA expression of undifferentiated stem cell markers KLF4, KLF5, OCT3/4, SOX2, NANOG, UTF1, and GRB7 were lower, while that of hXIST exon 4, LEFTY1, and LEFTY2 was higher in hiPSCs cultured on MEFs than in those cultured on SNLs. Taken together, our finding indicated that differences in murine-feeder cells used for maintenance of the undifferentiated state alter the expression of pluripotency-related genes in hiPSCs by the signaling pathways and affect DE differentiation from hiPSCs, suggesting that the feeder cells can potentiate hiPSCs for DE differentiation.	[Shoji, Masaki; Minato, Hiroki; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima, Japan; [Ogaki, Soichiro; Kume, Shoen] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan; [Seki, Masahide; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan	Tokushima Bunri University; Tokyo Institute of Technology; University of Tokyo	Shoji, M; Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima, Japan.	masaki-shoji@ph.bunri-u.ac.jp; kuzuhara@ph.bunri-u.ac.jp		Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [25460574, 26860083]; Tokushima Bunri University Grant for Educational Reform, and Collaborative Research Grants [TBU2013-2-1, TBU2015-2-2, TBU2016-2-3]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University Grant for Educational Reform, and Collaborative Research Grants	This work was supported by Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research (C) 25460574 (to TK), Grants-in-Aid for Young Scientists (B) 26860083 (to MS), the Tokushima Bunri University Grant for Educational Reform, and Collaborative Research Grants TBU2013-2-1, TBU2015-2-2, and TBU2016-2-3 (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Aksoy I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4719; Bergstrom R, 2011, METHODS MOL BIOL, V767, P125, DOI 10.1007/978-1-61779-201-4_9; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Caparros ML, 2002, CYTOGENET GENOME RES, V99, P99, DOI 10.1159/000071580; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Ghaedi Mahboobe, 2015, Curr Transplant Rep, V2, P81; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanawa M, 2017, STEM CELL REV REP, V13, P542, DOI 10.1007/s12015-016-9709-x; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Kim DK, 2014, STEM CELLS DEV, V23, P457, DOI 10.1089/scd.2013.0220; Kime C, 2016, P NATL ACAD SCI USA, V113, P12478, DOI 10.1073/pnas.1608564113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyazaki T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41165; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Ogaki S, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0120-2; Ogaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17297; Ojala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048659; Onishi K, 2015, DEVELOPMENT, V142, P2230, DOI 10.1242/dev.117598; Oulad-Abdelghani M, 1998, INT J DEV BIOL, V42, P23; Ozawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16479; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Shoji M, 2016, BIOCHEM BIOPH RES CO, V470, P798, DOI 10.1016/j.bbrc.2016.01.092; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama K, 2014, P NATL ACAD SCI USA, V111, P16772, DOI 10.1073/pnas.1413481111; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Toyoda T, 2015, STEM CELL RES, V14, P185, DOI 10.1016/j.scr.2015.01.007; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wade SL, 2015, STEM CELLS, V33, P2925, DOI 10.1002/stem.2084; Wang JL, 2016, P NATL ACAD SCI USA, V113, pE2029, DOI 10.1073/pnas.1520113113; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wills AE, 2015, DEV CELL, V32, P345, DOI 10.1016/j.devcel.2014.11.034; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	61	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201239	10.1371/journal.pone.0201239	http://dx.doi.org/10.1371/journal.pone.0201239			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048506	Green Submitted, gold, Green Published			2022-12-26	WOS:000439952400064
J	Al, WA; Jung, HY; Yun, ID; Jang, Y; Park, HB; Chang, HJ				Al, Walid Abdullah; Jung, Ho Yub; Yun, Il Dong; Jang, Yeonggul; Park, Hyung-Bok; Chang, Hyuk-Jae			Automatic aortic valve landmark localization in coronary CT angiography using colonial walk	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CARDIAC CT; ARM CT; TRANSCATHETER; IMPLANTATION; SEGMENTATION; STENOSIS; REPLACEMENT; FORESTS	The minimally invasive transcatheter aortic valve implantation (TAVI) is the most prevalent method to treat aortic valve stenosis. For pre-operative surgical planning, contrast-enhanced coronary CT angiography (CCTA) is used as the imaging technique to acquire 3D measurements of the valve. Accurate localization of the eight aortic valve landmarks in CT images plays a vital role in the TAVI workflow because a small error risks blocking the coronary circulation. In order to examine the valve and mark the landmarks, physicians prefer a view parallel to the hinge plane, instead of using the conventional axial, coronal or sagittal view. However, customizing the view is a difficult and time-consuming task because of unclear aorta pose and different artifacts of CCTA. Therefore, automatic localization of landmarks can serve as a useful guide to the physicians customizing the viewpoint. In this paper, we present an automatic method to localize the aortic valve landmarks using colonial walk, a regression tree-based machine-learning algorithm. For efficient learning from the training set, we propose a two-phase optimized search space learning model in which a representative point inside the valvular area is first learned from the whole CT volume. All eight landmarks are then learned from a smaller area around that point. Experiment with preprocedural CCTA images of TAVI undergoing patients showed that our method is robust under high stenotic variation and notably efficient, as it requires only 12 milliseconds to localize all eight landmarks, as tested on a 3.60 GHz single-core CPU.	[Al, Walid Abdullah; Yun, Il Dong] Hankuk Univ Foreign Studies, Div Comp & Elect Syst Engn, Yongin, South Korea; [Jung, Ho Yub] Chosun Univ, Dept Comp Engn, Gwangju, South Korea; [Jang, Yeonggul] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul, South Korea; [Park, Hyung-Bok] Yonsei Univ Hlth Syst, Yonsei Cedars Sinai Integrat Cardiovasc Imaging R, Seoul, South Korea; [Park, Hyung-Bok] Seonam Univ, Myongji Hosp, Div Cardiol, Cardiovasc Ctr,Coll Med, Goyang, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea	Hankuk University Foreign Studies; Chosun University; Yonsei University; Yonsei University; Yonsei University Health System; Myongji Hospital; Seonam University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, HY (corresponding author), Chosun Univ, Dept Comp Engn, Gwangju, South Korea.	hoyub@chosun.ac.kr		Chang, Hyuk-Jae/0000-0002-6139-7545; Jung, Ho Yub/0000-0002-2906-9170	Institute for Information and communications Technology Promotion(IITP) - Korea government(MSIP) [R0101-15-0171]; MIST (Ministry of Science & ICT), Korea, under the National Program for Excellence in SW [2017-0-00137]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, Technology, Hankuk University of fForeign Studies Research Fund of 2018 [2017R1A2B4004503, 2014M3C7A1046050]	Institute for Information and communications Technology Promotion(IITP) - Korea government(MSIP); MIST (Ministry of Science & ICT), Korea, under the National Program for Excellence in SW; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, Technology, Hankuk University of fForeign Studies Research Fund of 2018	The data collection, study design, analysis, and decision publish are supported by Institute for Information and communications Technology Promotion(IITP) grant funded by the Korea government(MSIP) (No.R0101-15-0171, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Following grants supported in preparation of the manuscript. This research was supported by MIST (Ministry of Science & ICT), Korea, under the National Program for Excellence in SW supervised by the IITP (Institute for Information & Communications Technology Promotion) (2017-0-00137). Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, Technology (No. 2017R1A2B4004503 and 2014M3C7A1046050), Hankuk University of Foreign Studies Research Fund of 2018.	Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Billings FT, 2009, ANESTH ANALG, V108, P1453, DOI 10.1213/ane.0b013e31819b07ce; Coeytaux RR, 2010, ANN INTERN MED, V153, P314, DOI 10.7326/0003-4819-153-5-201009070-00267; Collobert R, 2001, J MACH LEARN RES, V1, P143, DOI 10.1162/15324430152733142; Criminisi A, 2013, MED IMAGE ANAL, V17, P1293, DOI 10.1016/j.media.2013.01.001; Davidson I, 2006, LECT NOTES ARTIF INT, V4213, P478; Elattar M, 2015, INT J CARDIOVAS IMAG, P1; Gao YZ, 2014, LECT NOTES COMPUT SC, V8679, P165, DOI 10.1007/978-3-319-10581-9_21; Gessat M, SPIE MED IMAGING; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; GRUEN AW, 2003, GEN PROCRUSTES ANAL; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hennemuth A, 2005, INT CONGR SER, V1281, P317, DOI 10.1016/j.ics.2005.03.318; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Ionasec RI, 2010, IEEE T MED IMAGING, V29, P1636, DOI 10.1109/TMI.2010.2048756; Ionasec RI, 2008, LECT NOTES COMPUT SC, V5241, P686, DOI 10.1007/978-3-540-85988-8_82; Jung HY, 2015, PROC CVPR IEEE, P2467, DOI 10.1109/CVPR.2015.7298861; Jung HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138328; Karar ME, 2009, IEEE ENG MED BIO, P3645, DOI 10.1109/IEMBS.2009.5332516; Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lepetit V, IEEE COMP SOC C COMP, V2; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Mack MJ, 2010, TEX HEART I J, V37, P658; Nguyen MH, 2009, IEEE I CONF COMP VIS, P1925, DOI 10.1109/ICCV.2009.5459426; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Okuyama K, 2013, CATHETER CARDIO INTE, V82, pE754, DOI 10.1002/ccd.25059; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Raykar VC, 2007, SCALABLE MACH LEARNI; Ross A., 2004, PROCRUSTES ANAL; Russakovsky O, 2012, LECT NOTES COMPUT SC, V7573, P1, DOI 10.1007/978-3-642-33709-3_1; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Schoenhagen P, 2011, CARDIOVASC DIAGN THE, V1, P44, DOI 10.3978/j.issn.2223-3652.2011.08.01; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Steinberg D, 2009, CH CRC DATA MIN KNOW, P179, DOI 10.1201/9781420089653.ch10; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Syed N.A., 1999, P 5 ACM SIGKDD INT C, P317, DOI [10.1145/312129.312267, DOI 10.1145/312129.312267]; Tek H, 2008, INSIGHT J; Vahanian A, 2008, EUR J CARDIO-THORAC, V34, P1, DOI 10.1016/j.ejcts.2008.04.039; Wachter I., 2010, MED IMAGE COMPUT COM, P526, DOI DOI 10.1007/978-3-642-15705-9_; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zheng YF, 2012, IEEE T MED IMAGING, V31, P2307, DOI 10.1109/TMI.2012.2216541; Zheng YF, 2010, LECT NOTES COMPUT SC, V6361, P476	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200317	10.1371/journal.pone.0200317	http://dx.doi.org/10.1371/journal.pone.0200317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044802	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500041
J	Lee, CY; Chen, HC; Lin, HW; Huang, JY; Lin, TL; Yang, CH; Yeh, CB; Lin, HY; Yang, SF				Lee, Chia-Yi; Chen, Hung-Chi; Lin, Hui-Wen; Huang, Jing-Yang; Lin, Teng-Li; Yang, Chia-Hsuan; Yeh, Chao-Bin; Lin, Hung-Yu; Yang, Shun-Fa			Increased risk of keratopathy after psoriasis: A nationwide population-based study	PLOS ONE			English	Article							DRY EYE; DISEASES; CORNEA	Background To evaluate whether the presence of psoriasis increases the risk of keratopathy incidence by using Taiwan's National Health Insurance Research Database (NHIRD). Methodology/Principal findings This retrospective cohort study used data from the NHIRD for the 2009 to 2012 period. A total of 3,648 patients diagnosed with psoriasis were enrolled in the study group while another 14,592 individuals were selected as the control group. The study group was propensity score-matched with a group of controls who had not received a diagnosis of psoriasis. Multivariate Cox regression analysis was performed to estimate the adjusted hazard ratio (aHR) of keratopathy. For the events of keratopathy, 71 patients in the study group and 208 patients in the control group developed keratopathy with a attributable risk of 23.43 per 100,000 person-months (incidence rate ratio = 1.40; P = 0.01) which correlated to the elevated cumulative probability (P = 0.03). The multivariate analysis revealed that the risk of keratopathy was higher in patients who had psoriasis (aHR = 1.31, P = 0.04). In addition, age older than 60 years (aHR = 2.10, P<0.01) and dry eye disease (aHR = 2.79, P<0.01) would also increase the risk of developing keratopathy. Conclusions Psoriasis was associated with an increased risk of keratopathy in patients without preexisting prominent corneal disease. Moreover, the risk of incident keratopathy increases with exposure to psoriasis.	[Lee, Chia-Yi; Lin, Hung-Yu] Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chen, Hung-Chi] Chang Gung Univ, Dept Med, Coll Med, Taoyuan, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan; [Lin, Hui-Wen] Asia Univ, Dept Optometry, Taichung, Taiwan; [Lin, Hui-Wen; Yang, Shun-Fa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Jing-Yang] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Teng-Li] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Yang, Chia-Hsuan] Taipei Med Univ Hosp, Dept Med, Taipei, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Lin, Hung-Yu; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Hung-Yu] Chung Shan Med Univ, Dept Optometry, Taichung, Taiwan; [Lin, Hung-Yu] Yuanpei Univ Med Technol, Dept Optometry, Hsinchu, Taiwan; [Lin, Hung-Yu] Chung Chou Univ Sci & Technol, Coll Hlth, Changhua, Taiwan	Show Chwan Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Lin, HY (corresponding author), Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan.; Yang, SF (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, HY; Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lin, HY (corresponding author), Chung Shan Med Univ, Dept Optometry, Taichung, Taiwan.; Lin, HY (corresponding author), Yuanpei Univ Med Technol, Dept Optometry, Hsinchu, Taiwan.; Lin, HY (corresponding author), Chung Chou Univ Sci & Technol, Coll Hlth, Changhua, Taiwan.	anthonyhungyulin@hotmail.com; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Chen, Hung-Chi/0000-0002-1117-7878	Chung Shan Medical University Hospital [CSH-2018-E-001-Y2]	Chung Shan Medical University Hospital	This study was supported by a grant (CSH-2018-E-001-Y2 to Dr. Shun-Fa Yang) from Chung Shan Medical University Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Celik U, 2015, EYE CONTACT LENS, V41, P127, DOI 10.1097/ICL.0000000000000086; Chen JJ, 2014, J AM ACAD DERMATOL, V70, P569, DOI 10.1016/j.jaad.2013.10.036; Chi CC, 2017, JAMA OPHTHALMOL, V135, P415, DOI 10.1001/jamaophthalmol.2017.0569; Cohen EJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P979; Cosens W B, 1936, Br J Ophthalmol, V20, P315, DOI 10.1136/bjo.20.5.315; Gipson IK, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12840; Gonzalez-Andrades M, 2017, EYE CONTACT LENS, V43, pE1, DOI 10.1097/ICL.0000000000000178; Guidera AC, 2001, OPHTHALMOLOGY, V108, P936, DOI 10.1016/S0161-6420(00)00538-8; Guttman-Yassky E, 2018, EXP DERMATOL, V27, P409, DOI 10.1111/exd.13336; Henrich CF, 2014, CORNEA, V33, P819, DOI 10.1097/ICO.0000000000000173; Her Y, 2013, JPN J OPHTHALMOL, V57, P341, DOI 10.1007/s10384-012-0226-4; Itani S, 2016, INT J DERMATOL, V55, P390, DOI 10.1111/ijd.12811; Kilic B, 2013, INT J DERMATOL, V52, P554, DOI 10.1111/j.1365-4632.2011.05424.x; Kim WB, 2017, CAN FAM PHYSICIAN, V63, P278; Ljubimov AV, 2017, VISION RES, V139, P138, DOI 10.1016/j.visres.2017.03.002; Papadavid E, 2017, SLEEP BREATH, V21, P949, DOI 10.1007/s11325-017-1507-4; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Reddy VS, 2015, EYE, V29, P1585, DOI 10.1038/eye.2015.177; Rehal B, 2011, J AM ACAD DERMATOL, V65, P1202, DOI 10.1016/j.jaad.2010.10.032; Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557; Sadrai Z, 2012, INVEST OPHTH VIS SCI, V53, P3584, DOI 10.1167/iovs.11-9110; Sarac G, 2016, NORTH CLIN ISTANB, V3, P79, DOI 10.14744/nci.2016.16023; Takeshita J, 2017, J AM ACAD DERMATOL, V76, P377, DOI 10.1016/j.jaad.2016.07.064; Valim V, 2015, CLIN REV ALLERG IMMU, V49, P288, DOI 10.1007/s12016-014-8438-7; Villani E, 2007, INVEST OPHTH VIS SCI, V48, P2017, DOI 10.1167/iovs.06-1129	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201285	10.1371/journal.pone.0201285	http://dx.doi.org/10.1371/journal.pone.0201285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044880	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500100
J	Poulsen, JY; Miller, MJ; Sado, T; Hanel, R; Tsukamoto, K; Miya, M				Poulsen, Jan Y.; Miller, Michael J.; Sado, Tetsuya; Hanel, Reinhold; Tsukamoto, Katsumi; Miya, Masaki			Resolving deep-sea pelagic saccopharyngiform eel mysteries: Identification of Neocyema and Monognathidae leptocephali and establishment of a new fish family "Neocyematidae" based on larvae, adults and mitogenomic gene orders	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; NORTH PACIFIC; OCEAN PISCES; GULPER EEL; TELEOSTEI; SEQUENCE; ORIGIN; REARRANGEMENTS; BIODIVERSITY; ORGANIZATION	Deep-sea midwater "saccopharyngiform" eels of the families Cyematidae, Monognathidae, Eurypharyngidae and Saccopharyngidae (order Anguilliformes) are extraordinary fishes having major skeletal reductions and modifications compared to the general anguilliform body structure. Little is known about most aspects of the systematics, phylogeny, and ecology of these families, and few of the approximately 30 species described from adult specimens have been matched with their leptotocephalus larvae. Based on mitogenomic sequence data from rare new specimens, we show that the long-speculated-about larval form referred to as "Leptocephalus holt'', which was thought to possibly be the larva of the rare orange-colored eels of Neocyema (5 known specimens; speculated to belong to the Cyematidae) are actually the larvae of the one-jaw eels of the family Monognathidae. One of the 5 types of L. holti larvae that were collected in the Pacific is genetically matched with Monognathus jesperseni, but multiple species exist based on larval sequence data and the morphology of adult specimens. A rare leptocephalus from the Sargasso Sea, with unique morphological characteristics including many small orange spots on the gut, was found to be the larva of Neocyema, which is presently only known from the Atlantic Ocean. We demonstrate that Neocyema constitutes a separate family being most closely related to Eury-pharyngidae and Saccopharyngidae based on mitogenomic DNA sequences and unique mitochondrial gene orders.	[Poulsen, Jan Y.] Greenland Inst Nat Resources, Dept Fish & Shellfish, Kivioq, Nuuk, Greenland; [Poulsen, Jan Y.] Australian Museum, Fish Sect, Sydney, NSW, Australia; [Miller, Michael J.; Tsukamoto, Katsumi] Nihon Univ, Dept Marine Sci & Resources, Fujisawa, Kanagawa, Japan; [Sado, Tetsuya] Nat Hist Museum & Inst, Chuo Ku, Aoba Cho, Chiba, Japan; [Hanel, Reinhold; Miya, Masaki] Thunen Inst Fisheries Ecol, Hamburg, Germany	Greenland Institute of Natural Resources; Australian Museum; Nihon University; Johann Heinrich von Thunen Institute	Poulsen, JY (corresponding author), Greenland Inst Nat Resources, Dept Fish & Shellfish, Kivioq, Nuuk, Greenland.; Poulsen, JY (corresponding author), Australian Museum, Fish Sect, Sydney, NSW, Australia.	JaPo@natur.gl	Miya, Masaki/O-2664-2019; Hanel, Reinhold/AAO-4887-2021	Miya, Masaki/0000-0002-9791-9886; Poulsen, Jan Yde/0000-0003-2137-0759	JST CREST Grant, Japan [JPMJCR13A2]; Canon Foundation; JSPS KAKENHI Grant [JP 26291083]	JST CREST Grant, Japan; Canon Foundation(Canon Foundation); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST CREST Grant Number JPMJCR13A2, Japan, Canon Foundation and JSPS KAKENHI Grant Number JP 26291083. All awarded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anibaldi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166137; [Anonymous], 1989, FISHES W N ATLANTIC; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BERTELSEN E, 1987, Steenstrupia, V13, P141; Bertelsen E, 1989, FISHES W N ATLANTIC, V1, P636; Bertin L, 1936, CR HEBD ACAD SCI, V203, P1540; Bertin L., 1938, DANA REPORT, V15, P1; Bohlke E. B., 1989, FISHES W N ATLANTI 9, V1, P1; Bohlke EB, 1989, SEARS FDN MARINE RES, V9, P657; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Bu┬hlke, 1989, FISHES W N ATLANTIC, V1, P9; Castle P.H.J., 1975, Dana Reports, VNo. 85, P1; Castle P.H.J., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P62; CASTLE PHJ, 1977, ARCH FISCHEREIWISS, V28, P69; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; de Vera Alejandro, 2014, Vieraea, V42, P179; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DeVaney SC, 2016, INTEGR COMP BIOL, V56, P524, DOI 10.1093/icb/icw032; DeVaney SC, 2009, NORTHEAST NAT, V16, P409, DOI 10.1656/045.016.n308; Drazen JC, 2017, ANNU REV MAR SCI, V9, P337, DOI 10.1146/annurev-marine-010816-060543; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FORTUNO J M, 1986, Miscellania Zoologica (Barcelona), V10, P223; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hanel R, 2014, NATURWISSENSCHAFTEN, V101, P1041, DOI 10.1007/s00114-014-1243-6; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2003, MOL BIOL EVOL, V20, P1917, DOI 10.1093/molbev/msg206; Inoue Jun G., 2001, Japanese Journal of Ichthyology, V48, P75; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; Johnson GD, 2012, P R SOC B, V279, DOI [10.1098/rspb.2011, DOI 10.1098/RSPB.2011]; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kuck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036593; Kumazawa Y, 1998, GENETICS, V150, P313; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Ma T, 2007, FISHERIES SCI, V73, P989, DOI 10.1111/j.1444-2906.2007.01427.x; Miller MJ, 2015, PROG OCEANOGR, V137, P84, DOI 10.1016/j.pocean.2015.05.026; Miller MJ, 2013, MAR BIODIVERS, V43, P493, DOI 10.1007/s12526-013-0170-7; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Miller MJ, 2006, DEEP-SEA RES PT I, V53, P776, DOI 10.1016/j.dsr.2006.01.008; MILLER MJ, 1994, J MAR RES, V52, P743, DOI 10.1357/0022240943076948; Miller MJ, 2004, INTRO LEPTOCEPHALI B, P1; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Mochioka N., 2014, ATLAS EARLY STAGE FI, Vsecond, P2; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NIELSEN J G, 1985, Steenstrupia, V11, P157; NIELSEN JG, 1989, ACTA ZOOL-STOCKHOLM, V70, P187, DOI 10.1111/j.1463-6395.1989.tb01069.x; Nielsen JG, 1996, ICHTHYOL RES, V43, P113, DOI 10.1007/BF02348233; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Orton G. L., 1963, Copeia, V1963, P6, DOI 10.2307/1441268; Poulsen JY, 2018, MAR BIODIVERS, V48, P1009, DOI 10.1007/s12526-017-0762-8; Poulsen JY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-111; Poulsen JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159762; Poulsen Jan Yde, 2015, Marine Biodiversity Records, V8, pe53, DOI 10.1017/S175526721500024X; RAJU SN, 1974, FISH B-NOAA, V72, P547; Rambaut A., 2014, TRACER V1 6; Randall DJ., 1997, DEEP SEA FISHES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santini F, 2013, MOL PHYLOGENET EVOL, V69, P884, DOI 10.1016/j.ympev.2013.06.016; Satoh TP, 2006, MOL PHYLOGENET EVOL, V40, P129, DOI 10.1016/j.ympev.2006.02.014; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmidt, 1909, MEDDELELSER KOMMISSI, V3, P1; Smith David G., 1996, Breviora, V503, P1; Smith David G., 1989, P973; Smith DG, 1989, MEMOIR SEARS FDN MAR, V1, P630; Smith DG, 1989, FISHES W N ATLANTIC, V9, P948; SMITH DG, 1989, FISHES W N ATLANIC, V9, P1; Smith DG, 424 NOAA TECH NMFS, P1; Smith KF, 2002, GLOBAL ECOL BIOGEOGR, V11, P313, DOI 10.1046/j.1466-822X.2002.00286.x; SMITH KL, 1992, DEEP-SEA RES, V39, P659, DOI 10.1016/0198-0149(92)90094-A; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Tawa A, 2013, B MAR SCI, V89, P461, DOI 10.5343/bms.2012.1010; TCHERNAVIN V. V., 1947, JOUR LINNEAN SOC [LONDON] ZOOL, V41, P287; Tighe KA, 2000, ICHTHYOL RES, V47, P39, DOI 10.1007/BF02674311; VANUTRECHT WL, 1987, COPEIA, P517, DOI 10.2307/1445799; Wang CH, 2003, ZOOL SCR, V32, P231, DOI 10.1046/j.1463-6409.2003.00114.x; Wouthuyzen S, 2005, B MAR SCI, V77, P209	84	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199982	10.1371/journal.pone.0199982	http://dx.doi.org/10.1371/journal.pone.0199982			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044814	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500026
J	Fleps, I; Vuille, M; Melnyk, A; Ferguson, SJ; Guy, P; Helgason, B; Cripton, PA				Fleps, Ingmar; Vuille, Muriel; Melnyk, Angela; Ferguson, Stephen J.; Guy, Pierre; Helgason, Benedikt; Cripton, Peter A.			A novel sideways fall simulator to study hip fractures ex vivo	PLOS ONE			English	Article							QUALITY-OF-LIFE; PROXIMAL FEMORAL STRENGTH; TROCHANTERIC SOFT-TISSUES; FINITE-ELEMENT-ANALYSIS; BONE-MINERAL DENSITY; FEMUR STRENGTH; ELDERLY-MEN; PREDICTION; WOMEN; RISK	Falls to the side are the leading cause of hip fractures in the elderly. The load that a person experiences during a fall cannot be measured with volunteers for ethical reasons. To evaluate injurious loads, while considering relevant energy input and body posture for a sideways fall, a subject-specific cadaveric impact experiment was developed. Full cadaveric femurpelvis constructs (N = 2) were embedded in surrogate soft tissue material and attached to metallic surrogate lower limbs. The specimens were then subjected to an inverted pendulum motion, simulating a fall to the side with an impact to the greater trochanter. The load at the ground and the deformation of the pelvis were evaluated using a 6-axis force transducer and two high-speed cameras. Post-test, a trauma surgeon (PG) evaluated specimen injuries. Peak ground contact forces were 7132 N and 5641 N for the fractured and non-fractured specimen, respectively. We observed a cervical fracture of the femur in one specimen and no injuries in a second specimen, showing that the developed protocol can be used to differentiate between specimens at high and low fracture risk.	[Fleps, Ingmar; Vuille, Muriel; Ferguson, Stephen J.; Helgason, Benedikt] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Melnyk, Angela; Cripton, Peter A.] Univ British Columbia, Dept Mech Engn & Orthopaed, Orthopaed & Injury Biomech Grp, Vancouver, BC, Canada; [Melnyk, Angela; Cripton, Peter A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada; [Guy, Pierre] Univ British Columbia, Dept Orthopaed, Div Orthopaed Trauma, Vancouver, BC, Canada; [Helgason, Benedikt] Reykjav Univ, Sch Sci & Engn, Reykjavik, Iceland	ETH Zurich; University of British Columbia; University of British Columbia; University of British Columbia; Reykjavik University	Fleps, I (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	Ingmar.fleps@hest.ethz.ch	Fleps, Ingmar/GRK-5653-2022; Cripton, Peter Alec/AAC-8268-2020; Ferguson, Stephen J./A-4118-2012; Helgason, Benedikt/A-4386-2012	Fleps, Ingmar/0000-0002-6254-8878; Cripton, Peter Alec/0000-0002-5067-0833; Ferguson, Stephen J./0000-0003-0650-5889; Helgason, Benedikt/0000-0001-8324-2651	ETH-Foundation [ETH1514-1]; internal funds at the University of British Columbia; ANSYS, Inc.; BETA CAE Systems International AG	ETH-Foundation; internal funds at the University of British Columbia; ANSYS, Inc.(Ansys, Inc.); BETA CAE Systems International AG	This research was supported by the ETH-Foundation grant nr. ETH1514-1 (BH) and internal funds at the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gavin Vale and Xiaoheng Zhang for their help with manufacturing parts for the experimental setup, Jonah Killam for his help with the ballistic gel characterisation, Enrique Oliveira Chami for his help with specimen dissections and mould prototype manufacturing, and Canada Diagnostics, Vancouver for their help with CT scanning specimens. We also acknowledge the support of ANSYS, Inc. and BETA CAE Systems International AG who provided software on a university research license.	Abdel-Aziz YI, 2015, PHOTOGRAMM ENG REM S, V81, P103, DOI 10.14358/PERS.81.2.103; Amin S, 2011, J BONE MINER RES, V26, P1593, DOI 10.1002/jbmr.347; [Anonymous], 2014, INT BIOMECH; Ariza O, 2015, J BIOMECH, V48, P224, DOI 10.1016/j.jbiomech.2014.11.042; Beason DP, 2003, J BIOMECH, V36, P219, DOI 10.1016/S0021-9290(02)00330-5; Bessho M, 2009, BONE, V45, P226, DOI 10.1016/j.bone.2009.04.241; Black DM, 2008, J BONE MINER RES, V23, P1326, DOI 10.1359/JBMR.080316; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Cesari D, 1982, SAE TECHNICAL PAPER; Cody DD, 1999, J BIOMECH, V32, P1013, DOI 10.1016/S0021-9290(99)00099-8; Comley K, 2009, IUTAM BOOKSER, V12, P27, DOI 10.1007/978-1-4020-9404-0_4; Cooper C, 1997, AM J MED, V103, pS12, DOI [10.1016/S0002-9343(97)90022-X, DOI 10.1016/S0002-9343(97)90022-X]; COURTNEY AC, 1994, CALCIFIED TISSUE INT, V55, P53, DOI 10.1007/BF00310169; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Derler S, 2005, MED ENG PHYS, V27, P475, DOI 10.1016/j.medengphy.2005.02.001; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Eckstein F, 2004, J BONE MINER RES, V19, P379, DOI 10.1359/JBMR.0301247; Ekstrom W, 2009, J ORTHOP TRAUMA, V23, P39, DOI 10.1097/BOT.0b013e318191f5e4; Etheridge BS, 2005, ANN BIOMED ENG, V33, P248, DOI 10.1007/s10439-005-8984-5; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; Gilchrist S, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025390; Grassi LVSRMJJIH, 2017, BIOMECHANICS MODELIN; Guillemot H, 1998, P 16 INT TECHN C ENH; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Hayes WC, 1995, T ASME J BIOMECHANIC, V117; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Keyak JH, 2013, BONE, V57, P18, DOI 10.1016/j.bone.2013.07.028; Keyak JH, 2011, BONE, V48, P1239, DOI 10.1016/j.bone.2011.03.682; Keyak JH, 1998, J BIOMECH, V31, P125, DOI 10.1016/S0021-9290(97)00123-1; Kopperdahl DL, 2014, J BONE MINER RES, V29, P570, DOI 10.1002/jbmr.2069; Lafleur B., 2016, FACTORS INFLUENCING; Laing AC, 2010, J BIOMECH, V43, P1898, DOI 10.1016/j.jbiomech.2010.03.025; Lang TF, 2012, BONE, V50, P743, DOI 10.1016/j.bone.2011.12.001; Luo Y, 2016, OSTEOPOROSIS INT, V27, P423, DOI 10.1007/s00198-015-3316-6; Luo Y., 2014, J BIOMEDICAL SCI ENG, V07, P405, DOI DOI 10.4236/jbise.2014.77043; Magaziner J, 2003, AM J EPIDEMIOL, V157, P1023, DOI 10.1093/aje/kwg081; Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; Nachreiner NM, 2007, J WOMENS HEALTH, V16, P1437, DOI 10.1089/jwh.2006.0245; Nasiri M, 2016, BONE, V90, P90, DOI 10.1016/j.bone.2016.06.006; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Payne T, 2014, PROCEDIA ENGINEER, V72, P533, DOI 10.1016/j.proeng.2014.06.092; Qasim M, 2016, OSTEOPOROSIS INT, V27, P2815, DOI 10.1007/s00198-016-3597-4; REIKERAS O, 1983, ACTA ORTHOP SCAND, V54, P18, DOI 10.3109/17453678308992864; Robinovitch SN, 2009, OSTEOPOROSIS INT, V20, P1977, DOI 10.1007/s00198-009-1045-4; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Robinovitch SN, 1995, J ORTHOPAED RES, V13, P956, DOI 10.1002/jor.1100130621; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Sarvi MN, 2015, CLIN BIOMECH, V30, P881, DOI 10.1016/j.clinbiomech.2015.05.013; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; Van Ee CA, 2000, J BIOMECH ENG-T ASME, V122, P9, DOI 10.1115/1.429621; vandenKroonenberg AJ, 1996, J BIOMECH, V29, P807, DOI 10.1016/0021-9290(95)00134-4; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568	60	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201096	10.1371/journal.pone.0201096	http://dx.doi.org/10.1371/journal.pone.0201096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040858	Green Published, gold			2022-12-26	WOS:000439749200025
J	Guo, ZY; Zhou, D; Liu, PY; He, ZY; Lv, C				Guo, Ziyue; Zhou, Dong; Liu, Pengyan; He, Zhiyi; Lv, Chuan			A quantitative assessment method for the space design of products based on ergonomics and virtual simulation	PLOS ONE			English	Article							SWEPT VOLUMES; MUSCULOSKELETAL SYMPTOMS; GEOMETRIC REPRESENTATION; ENVIRONMENT; OBJECTS	Work spaces for assembly or maintenance operations are considered in the design stage of products. Maintenance space is a key factor in determining how well a product can be maintained. If the work space is sufficiently considered in the design stage, it will benefit both the user and the maintainer. From a maintenance perspective, this paper proposes a quantitative method to evaluate the maintenance space by virtual simulation and consideration of ergonomics. In this method, maintenance operations are concisely classified into three types. Based on the virtual simulation of the maintenance process and maintainer data, the swept volume of a hand is built using envelope theory. The operation range of the maintainer is derived by establishing a mathematical model for the upper limb. Combining the swept volume and operation range, the maintenance space can be quantitatively evaluated. A concise validation demonstrates that the proposed method is effective for evaluating the maintenance space to improve the space design. The proposed method could be applied to the space design of a complex product.	[Guo, Ziyue; Zhou, Dong; Liu, Pengyan; Lv, Chuan] State Key Lab Virtual Real Technol & Syst, Beijing, Peoples R China; [Guo, Ziyue; Zhou, Dong; Liu, Pengyan; He, Zhiyi; Lv, Chuan] Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China; [Zhou, Dong; He, Zhiyi; Lv, Chuan] State Key Def Sci & Technol Lab Reliabil & Enviro, Beijing, Peoples R China	Beihang University	Guo, ZY (corresponding author), State Key Lab Virtual Real Technol & Syst, Beijing, Peoples R China.; Guo, ZY (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China.	samsamsoo@163.com	Lv, Chuan/AAI-7076-2020					Abate AF, 2009, J VISUAL LANG COMPUT, V20, P318, DOI 10.1016/j.jvlc.2009.07.003; Abshire KJ, 1998, REL MAIN S 1998 P AN; [Anonymous], 2011, THESIS; [Anonymous], 2003, TOOL PROD, V69, P20; [Anonymous], 2001, MECH ENG, V123, P76; Baoxiang R, 2016, ERGONOMICS IND DESIG; Birolini A., 2017, RELIABILITY ENG THEO, V8; Blackmore D, 1999, COMPUT AIDED DESIGN, V31, P215, DOI 10.1016/S0010-4485(99)00017-2; BLACKMORE D, 1994, COMPUT AIDED DESIGN, V26, P315, DOI 10.1016/0010-4485(94)90077-9; BLACKMORE D, 1992, INT J ROBOT RES, V11, P516, DOI 10.1177/027836499201100602; Corvaglia D, 2004, P 1 INT WORKSH WEB3D; Cruz-Neira C., 1993, P 20 ANN C COMP GRAP; Cutler LD, 1997, P 1957 S INT 3D GRAP; Ganter M, 1993, ALGEBRAIC METHODS IM; Glor PJ, 1993, REL MAIN S 1993 P AN; Jayaram S, 1999, IEEE COMPUT GRAPH, V19, P44, DOI 10.1109/38.799739; Kilroy N, 2000, BRIT J BIOMED SCI, V57, P199; Lane K, 1998, DTIC DOCUMENT; Lanzerotti M. Y., 2016, PRODUCTION PLANNING, P1; LEU MC, 1986, J ENG IND-T ASME, V108, P113, DOI 10.1115/1.3187045; Li JR, 2003, COMPUT IND, V52, P109, DOI 10.1016/S0166-3615(03)00103-9; Lv C, 2012, DESIGN ANAL VERIFICA, P300; Macchiarella MD, 2004, DIGITAL AVIONICS SYS; MARTIN RR, 1990, COMPUT AIDED DESIGN, V22, P223, DOI 10.1016/0010-4485(90)90051-D; Massaccesi M, 2003, APPL ERGON, V34, P303, DOI 10.1016/S0003-6870(03)00052-8; Peng GL, 2010, ASSEMBLY AUTOM, V30, P333, DOI 10.1108/01445151011075799; Pourmahabadian M., 2006, Pakistan Journal of Medical Sciences, V22, P379; Saraviapinilla MH, 2015, APPL ERGONOMICS; Sebok A., 2006, Transactions of the American Nuclear Society, V94, P16; Shuval K, 2005, INT J IND ERGONOM, V35, P569, DOI 10.1016/j.ergon.2005.01.004; von Dziegielewski A, 2015, IEEE T AUTOM SCI ENG, V12, P183, DOI 10.1109/TASE.2013.2290193; Vora J, 2002, APPL ERGON, V33, P559, DOI 10.1016/S0003-6870(02)00039-X; Wang W, 2010, COMP SUPP COOP WORK; Wang W. P., 1986, IEEE Computer Graphics and Applications, V6, P8, DOI 10.1109/MCG.1986.276586; WELD JD, 1990, INT J ROBOT RES, V9, P105, DOI 10.1177/027836499000900507; Yu HQ, 2011, ASSEMBLY AUTOM, V31, P53, DOI 10.1108/01445151111104173; Zhou D, 2014, ASSEMBLY AUTOM, V34, P192, DOI 10.1108/AA-04-2013-044	37	4	4	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200880	10.1371/journal.pone.0200880	http://dx.doi.org/10.1371/journal.pone.0200880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036397	gold, Green Published, Green Submitted			2022-12-26	WOS:000439429200020
J	Hillebrand, AC; Pizzolato, LS; Neto, BS; Branchini, G; Brum, IS				Hillebrand, Ana Caroline; Pizzolato, Lolita Schneider; Neto, Brasil Silva; Branchini, Gisele; Brum, Ilma Simoni			Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer	PLOS ONE			English	Article							SPLICE VARIANT; FULL-LENGTH; PROGRESSION; GROWTH; DEGRADATION; RESISTANCE; AR-V7	The role of molecular changes in the androgen receptor (AR) as AR variants (AR-Vs) is not clear in the pathophysiology of benign prostatic hyperplasia (BPH) and hormone-naive PCa. The aim of the current work was to identify the presence of AR isoforms in benign tissue and primary PCa, and to evaluate the possible association with tumor aggressiveness and biochemical recurrence in primary PCa. The mRNA levels of full length AR (AR-FL) and AR-Vs (AR-V1, AR-V4 and AR-V7) were measured using RT-qPCR. The protein expression of AR-FL (AR-CTD and AR-NTD) and AR-V7 were evaluated by the H-Score in immunohistochemistry (IHC). All investigated mRNA targets were expressed both in BPH and PCa. AR-FL mRNA levels were similar in both groups. AR-V4 mRNA expression showed higher levels in BPH, and AR-V1 and AR-V7 mRNA expression were higher in PCa. The AR-V7 protein showed a similar H-Score in both groups, while AR-CTD and AR-NTD were higher in nuclei of epithelial cells from BPH. These results support the assumption that these constitutively active isoforms of AR are involved in the pathophysiology of primary PCa and BPH. The role of AR-Vs and their possible modulation by steroid tissue levels in distinct types of prostate tumors needs to be elucidated to help guide the best clinical management of these diseases.	[Hillebrand, Ana Caroline; Pizzolato, Lolita Schneider; Branchini, Gisele; Brum, Ilma Simoni] Univ Fed Rio Grande do Sul, Dept Physiol, Lab Endocrine & Mol Biol, Porto Alegre, RS, Brazil; [Neto, Brasil Silva] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Urol, Porto Alegre, RS, Brazil; [Branchini, Gisele] Univ Fed Ciencias Saude Porto Alegre, Dept Basic Sci Hlth, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Brum, IS (corresponding author), Univ Fed Rio Grande do Sul, Dept Physiol, Lab Endocrine & Mol Biol, Porto Alegre, RS, Brazil.	ilma@ufrgs.br	Branchini, Gisele/N-1930-2017; Hillebrand, Ana Caroline/J-7050-2014	Branchini, Gisele/0000-0003-2524-8603; Schneider Pizzolato, Lolita/0000-0002-7546-5131; Hillebrand, Ana Caroline/0000-0003-0496-4424	Brazilian Funding Agency FIPE - HCPA [14-0397]; Brazilian Funding Agency CNPq [477148/2013-1]; Brazilian Funding Agency CAPES; Brazilian Funding Agency FAPERGS	Brazilian Funding Agency FIPE - HCPA; Brazilian Funding Agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Funding Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Funding Agency FAPERGS(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Brazilian Funding Agencies FIPE - HCPA (Grant number 14-0397); CNPq (Grant number 477148/2013-1); CAPES; and FAPERGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Amirghofran Z, 2004, PATHOL ONCOL RES, V10, P37, DOI 10.1007/BF02893407; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; INCA, 2017, ESTIMATE 2018 CANCER; Krajewska M, 1996, AM J PATHOL, V148, P1567; Kruslin B, 2015, BOSNIAN J BASIC MED, V15, P1, DOI 10.17305/bjbms.2015.449; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; MIYAMOTO KK, 1993, J UROLOGY, V149, P1015, DOI 10.1016/S0022-5347(17)36284-5; Nacusi Lucas P, 2009, Expert Rev Endocrinol Metab, V4, P417, DOI 10.1586/eem.09.34; Qu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07654; Scher HI, 2017, EUR UROL, V71, P874, DOI 10.1016/j.eururo.2016.11.024; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Welti J, 2016, EUR UROL, V70, P599, DOI 10.1016/j.eururo.2016.03.049; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhan Y, 2017, MOL CANCER RES, V15, P59, DOI 10.1158/1541-7786.MCR-16-0236; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970; Zhao HJ, 2012, J UROLOGY, V188, P2158, DOI 10.1016/j.juro.2012.08.014	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200613	10.1371/journal.pone.0200613	http://dx.doi.org/10.1371/journal.pone.0200613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028845	Green Published, Green Submitted, gold			2022-12-26	WOS:000439396900009
J	Kanazawa, I; Sugimoto, T				Kanazawa, Ippei; Sugimoto, Toshitsugu			Prehypertension increases the risk of atherosclerosis in drug-naive Japanese patients with type 2 diabetes mellitus	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MULTIFACTORIAL INTERVENTION; ARTERIAL STIFFNESS; MEDIA THICKNESS; BLOOD-PRESSURE; GLUCOSE; STROKE; POPULATION; MORTALITY; OUTCOMES	Purpose Hypertension is a risk factor of atherosclerotic diseases. However, the importance of prehypertension in Japanese patients with type 2 diabetes mellitus (T2DM) is controversial. The aim of this study was to examine association between prehypertension, hypertension and atherosclerosis in T2DM. Methods We recruited 179 Japanese patients with T2DM, who never took any medication for diabetes, hypertension, dyslipidemia, or atherosclerosis. Intima-media thickness (IMT) of common carotid artery was evaluated by high-resolution B-mode ultrasonography. Results Multiple regression analysis adjusted for age, duration of diabetes, body mass index, HbA1c, fasting C-peptide, triglyceride, HDL-cholesterol, LDL-cholesterol, and estimated glomerular filtration rate showed that systolic blood pressure (SBP), but not diastolic BP, was significantly and positively associated with maximum IMT (IMT-max), mean IMT, and plaque score (beta = 0.28, p<0.001; beta = 0.26, p = 0.047; and beta = 0.25, p = 0.006, respectively). ROC analysis showed that the cut-off value of SBP to detect atherosclerosis (IMT-max 1.8mm, the mean of IMT-max of this subjects) was 133.5 (p = 0.008), while DBP was not useful to detect it (p = 0.433). Then, participants were categorized as normotension (SBP <119 mmHg), prehypertension (SBP 120-139 mmHg), and hypertension (>140 mmHg). Multiple logistic regression analysis adjusted for the variables described above plus gender and smoking showed that prehypertension and hypertension were significantly associated with the increased risk of atherosclerosis [prehypertension; odds ratio (OR) 3.45, 95% confidence interval (CI) 1.11-10.76, p = 0.033, and hypertension; OR 7.29, 95%CI 1.99-26.78, p = 0.003]. Conclusion These findings suggest that prehypertension categorized by SBP is an important risk factor of atherosclerosis independently of conventional risk factors in patients with T2DM.	[Kanazawa, Ippei; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Shimane, Japan	Shimane University	Kanazawa, I (corresponding author), Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Shimane, Japan.	ippei.k@med.shimane-u.ac.jp	Kanazawa, Ippei/F-8609-2010					Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Eastwood SV, 2015, HYPERTENSION, V66, P481, DOI 10.1161/HYPERTENSIONAHA.115.05672; Fujishima M, 1979, DIABETES S3, V45, pS14; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gde P, 2016, DIABETOLOGIA, V59, P2298, DOI 10.1007/s00125-016-4065-6; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; IMAI E, 2008, NIPPON NAIKA GAKKAI, V97, P921, DOI DOI 10.2169/NAIKA.97.921; Kanazawa I, 2011, CLIN ENDOCRINOL, V74, P467, DOI 10.1111/j.1365-2265.2010.03946.x; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Li J, 2016, J DIABETES, V8, P824, DOI 10.1111/1753-0407.12361; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Onat A, 2008, AM J HYPERTENS, V21, P890, DOI 10.1038/ajh.2008.212; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ravikumar R, 2002, AM J CARDIOL, V90, P702, DOI 10.1016/S0002-9149(02)02593-6; Roddgers A, 1996, BMJ-BRIT MED J, V313, P147; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; Tan JR, 2010, J DIABETES, V2, P56, DOI 10.1111/j.1753-0407.2009.00062.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ueki K, 2017, LANCET DIABETES ENDO, V5, P951, DOI 10.1016/S2213-8587(17)30327-3; UK Prospective Diabetes Study Group, 1999, BMJ-BRIT MED J, V317, P703; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201055	10.1371/journal.pone.0201055	http://dx.doi.org/10.1371/journal.pone.0201055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028862	Green Published, gold, Green Submitted			2022-12-26	WOS:000439396900037
J	Lacey, RE; McMunn, A; Webb, E				Lacey, Rebecca E.; McMunn, Anne; Webb, Elizabeth			Informal caregiving and markers of adiposity in the UK Household Longitudinal Study	PLOS ONE			English	Article							GENDER-DIFFERENCES; PHYSICAL HEALTH; METAANALYSIS; CARE; STRESS; CONSEQUENCES; MORTALITY; SPOUSES; SUPPORT; BURDEN	Objectives The aim was to investigate associations between caregiving and adiposity using a representative UK longitudinal study. We also investigated whether associations differed by age, gender and caregiving characteristics. Methods Data on 9,421 participants aged 16+ from three waves (2009-2012) of the UK Household Longitudinal Study were used. Body mass index, waist circumference and percentage body fat were assessed. Caregiving and caregiving characteristics (hours per week, number of people cared for, co-resident caregiving and combining working and caregiving) was available from the prior wave. Gender-stratified associations between caregiving/caregiving characteristics with adiposity were tested. Covariates included caregiver's health, socioeconomic position, parenthood and partnerships. Results Caregiving was associated with higher adiposity for women but not men. Younger women caregivers had particularly higher levels of adiposity. Men combining part-time paid work with caregiving had higher levels of adiposity than men working full-time and not caregiving. Women aged 16-44 or 65+ had particularly high levels of adiposity when combining full-time work and caregiving, compared to full-time work alone. Conclusion The health of caregivers should be a public health priority, particularly for younger women and those combining paid work with caregiving responsibilities.	[Lacey, Rebecca E.; McMunn, Anne; Webb, Elizabeth] UCL, Res Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Lacey, RE (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	rebecca.lacey@ucl.ac.uk		Lacey, Rebecca/0000-0002-3510-0795; McMunn, Anne/0000-0003-3237-9345	UK's Economic and Social Research Council [ES/N012054/1]; Economic and Social Research Council; ESRC [ES/N012054/1, ES/R008930/1, ES/N012054/2] Funding Source: UKRI	UK's Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the UK's Economic and Social Research Council (grant number: ES/N012054/1, PI: Elizabeth Webb). The Economic and Social Research Council funded the UK Household Longitudinal Study. The funders had no role in the study design of this specific study, analysis, decision to publish, or preparation of the manuscript.	ALLEN SM, 1994, J GERONTOL, V49, pS187, DOI 10.1093/geronj/49.4.S187; Arber S., 2007, HEALTH SOC CARE COMM, V3, P19, DOI DOI 10.1111/j.1365-2524.1995.tb00003.x; Bauer JM, 2015, J POPUL AGEING, V8, P113, DOI 10.1007/s12062-015-9116-0; CarersTrust, 2017, KEY FACTS CAR PEOPL; Carr E, 2018, J GERONTOL B-PSYCHOL, V73, P1253, DOI 10.1093/geronb/gbw156; Davis JMD, 2001, PSYCHOL MED, V31, P1475, DOI 10.1017/S003329170105398z; Feinberg L., 2012, FACT SHEET 271; Glaser K, 2005, HEALTH SOC CARE COMM, V13, P470, DOI 10.1111/j.1365-2524.2005.00574.x; Hajek A, 2017, PUBLIC HEALTH, V151, P81, DOI 10.1016/j.puhe.2017.06.022; Hajek A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4786-6; Hassink WHJ, 2011, SOC SCI MED, V73, P1508, DOI 10.1016/j.socscimed.2011.08.027; Hounsell C, 2015, CARE GIVING US AARP; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kim Y, 2005, PSYCHOSOMATICS, V46, P123, DOI 10.1176/appi.psy.46.2.123; KRAMER BJ, 1995, GERONTOLOGIST, V35, P340, DOI 10.1093/geront/35.3.340; Lacey RE, 2017, INT J OBESITY, V41, P332, DOI 10.1038/ijo.2016.197; Legg L, 2013, J EPIDEMIOL COMMUN H, V67, P95, DOI 10.1136/jech-2012-201652; LGA, 2016, AD SOC CAR FUND STAT; Lynn P., 2009, SAMPLE DESIGN UNDERS; McFall S, 2014, GUIDE NURSE HLTH ASS; O'Reilly D, 2008, SOC SCI MED, V67, P1282, DOI 10.1016/j.socscimed.2008.06.025; ONS, 2016, MORT 2014 BAS NAT PO; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Raschick M, 2004, FAM RELAT, V53, P317, DOI 10.1111/j.0022-2445.2004.0008.x; Roepke SK, 2009, INT J GERIATR PSYCH, V24, P1453, DOI 10.1002/gps.2286; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Vitaliano PP, 1996, PSYCHOL AGING, V11, P155, DOI 10.1037/0882-7974.11.1.155; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Vlachantoni A, 2016, SSM-POPUL HLTH, V2, P495, DOI 10.1016/j.ssmph.2016.05.009; Vlachantoni A, 2013, MATURITAS, V74, P114, DOI 10.1016/j.maturitas.2012.10.013; Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241; World Health Organization (WHO), 2017, BOD MASS IND BMI; Yee JL, 2000, GERONTOLOGIST, V40, P147, DOI 10.1093/geront/40.2.147	36	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200777	10.1371/journal.pone.0200777	http://dx.doi.org/10.1371/journal.pone.0200777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024946	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000052
J	Sharif, R; Fowler, B; Karamichos, D				Sharif, Rabab; Fowler, Ben; Karamichos, Dimitrios			Collagen cross-linking impact on keratoconus extracellular matrix	PLOS ONE			English	Article							ULTRAVIOLET-A; EXPRESSION; RIBOFLAVIN; PROTEOGLYCANS; SULFATE; RIBOFLAVIN/ULTRAVIOLET; ARCHITECTURE; DEGRADATION; KERATITIS; ENZYMES	Background Keratoconus (KC) is a common multifactorial ectatic corneal disease with unknown onset. KC most commonly appears in adolescence and affects approximately 1:400 people worldwide. Treatment options, for advanced KC cases, are collagen cross-linking (CXL) and corneal transplants. CXL is a new KC treatment that helps arrest the disease. Unfortunately, only a fraction of KC patients will qualify for CXL treatment. Our goal, in this study, was to begin to understand how CXL affects the corneal microenvironment and pave the way towards a more patient-driven CXL treatment. Methods Primary human corneal fibroblasts from healthy and KC donors were plated on transwell polycarbonate membranes and stimulated by a stable vitamin C. At 4 weeks, riboflavin was added followed by UVA irradiation. Transmission Electron Microscopy (TEM) and western blots were used to assess the effect of CXL on the extracellular matrix (ECM) and the resident cells, pre- and post CXL. Results Data shows CXL improved lamellar organization showing more organized collagen fibrils decorated with proteoglycans (PGs). The distribution of the collagen fibrils and interfibrillar spacing was also visibly improved, post-CXL. Lumican, mimecan, and decorin were the dominant PGs and were significantly upregulated in post-CXL cultures. ECM degradation proteins, matrix metalloproteinases (MMPs), MMP-1, -3, and -9, but not MMP-2, were significantly downregulated post-CXL. TIMP-1 and -2 were not modulated by CXL. Conclusion The unknown effects of CXL on the human corneal microenvironment have hampered our ability to make CXL available to all KC patients. Our current study provides a deeper understanding on CXL activity, using our unique 3D in vitro model.	[Sharif, Rabab; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73019 USA; [Fowler, Ben] OMRF, Imaging Core Facil, Oklahoma City, OK USA; [Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73019 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73019 USA.; Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73019 USA.	Dimitrios-Karamichos@ouhsc.edu		karamichos, dimitrios/0000-0002-8761-3824	National Disease Research Interchange (NDRI); National Institutes Health [U42OD11158]; National Institute of Health/National Eye Institute [EY028888]; Research to Prevent Blindness (RPB)	National Disease Research Interchange (NDRI); National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	This work was supported by National Disease Research Interchange (NDRI) with support from National Institutes Health, Grant number: U42OD11158; Dimitrios Karamichos funding from National Institute of Health/National Eye Institute, Grant number EY028888; and Unrestricted grant to Dean McGee Eye Institute (DMEI) from Research to Prevent Blindness (RPB), there is no grant number for the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, MOL VIS, V19, P1526; Al-Qarni A, 2015, MIDDLE EAST AFR J OP, V22, P389, DOI 10.4103/0974-9233.159777; Arnalich-Montiel F, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0033-y; Balasubramanian SA, 2013, CLIN EXP OPTOM, V96, P214, DOI 10.1111/cxo.12038; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Cheung IMY, 2013, CLIN EXP OPTOM, V96, P188, DOI 10.1111/cxo.12025; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; De Bernardo Maddalena, 2015, J Optom, V8, P180, DOI 10.1016/j.optom.2014.05.006; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Galvis V, 2015, EYE, V29, P843, DOI 10.1038/eye.2015.63; Galvis V, 2017, CLIN OPHTHALMOL, V11, P657, DOI 10.2147/OPTH.S101386; Garcia B, 2016, INVEST OPHTH VIS SCI, V57, P2618, DOI 10.1167/iovs.15-16692; Gkika Maria, 2011, International Ophthalmology, V31, P309, DOI 10.1007/s10792-011-9460-x; Godefrooij DA, 2017, AM J OPHTHALMOL, V175, P169, DOI 10.1016/j.ajo.2016.12.015; Gomes JAP, 2015, CORNEA, V34, P359, DOI 10.1097/ICO.0000000000000408; Gordon-Shaag A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795738; Hashemi H, 2013, OPHTHALMOLOGY, V120, P1515, DOI 10.1016/j.ophtha.2013.01.012; Ho LTY, 2014, MATRIX BIOL, V38, P59, DOI 10.1016/j.matbio.2014.06.004; Hollhumer R, 2017, CORNEA, V36, P382, DOI 10.1097/ICO.0000000000001134; Holopainen JM, 2011, AM J OPHTHALMOL, V152, P533, DOI 10.1016/j.ajo.2011.03.023; Hovakimyan M, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/406850; Ionescu C, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/1243819; Jablonska-Trypuc A, 2016, J ENZYM INHIB MED CH, V31, P177, DOI 10.3109/14756366.2016.1161620; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; Kanellopoulos AJ, 2012, CLIN OPHTHALMOL, V6, P97, DOI 10.2147/OPTH.S27170; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Khairy HA, 2014, CLIN OPHTHALMOL, V8, P819, DOI 10.2147/OPTH.S60453; Khaled ML, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7803029; Massoudi D, 2016, CELL TISSUE RES, V363, P337, DOI 10.1007/s00441-015-2233-5; Mastropasqua L, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0030-6; Matthews FJ, 2007, EXP EYE RES, V84, P1125, DOI 10.1016/j.exer.2007.02.013; Mckay TB, 2017, SCI REP-UK, V7, DOI 10.1038/srep42896; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Nishtala K, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0051-9; Pasztor D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153186; Perez-Santonja JJ, 2009, J CATARACT REFR SURG, V35, P1138, DOI 10.1016/j.jcrs.2009.01.036; Priyadarsini S, 2015, MOL VIS, V21, P577; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Rathi VM, 2013, INDIAN J OPHTHALMOL, V61, P410, DOI 10.4103/0301-4738.116066; Saravani R, 2017, JPN J OPHTHALMOL, V61, P218, DOI 10.1007/s10384-017-0503-3; SAWAGUCHI S, 1991, INVEST OPHTH VIS SCI, V32, P1846; Schuerch K, 2016, ACTA OPHTHALMOL, V94, pE592, DOI 10.1111/aos.13060; Sharif R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12598-8; Sherwin T, 2004, CLIN EXP OPHTHALMOL, V32, P211, DOI 10.1111/j.1442-9071.2004.00805.x; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Smith VA, 2006, BBA-MOL BASIS DIS, V1762, P431, DOI 10.1016/j.bbadis.2006.01.010; Sporl E, 1997, OPHTHALMOLOGE, V94, P902, DOI 10.1007/s003470050219; Wentz-Hunter K, 2001, MOL MED, V7, P470, DOI 10.1007/BF03401852; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117; Zotta PG, 2017, J AAPOS, V21, P397, DOI 10.1016/j.jaapos.2017.07.205	54	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200704	10.1371/journal.pone.0200704	http://dx.doi.org/10.1371/journal.pone.0200704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020979	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400066
J	Mittal, C; Culbertson, SJ; Shogren-Knaak, MA				Mittal, Chitvan; Culbertson, Sannie J.; Shogren-Knaak, Michael A.			Distinct requirements of linker DNA and transcriptional activators in promoting SAGA-mediated nucleosome acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; acetylation; histone modification; transcription factor; gene regulation; enzyme; epigenetics; SAGA family; Spt-Ada-Gcn5 acetyltransferase	TATA-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; IN-VIVO; CONFORMATIONAL FLEXIBILITY; RECOMBINANT HISTONES; H2B DEUBIQUITINATION; COACTIVATOR COMPLEX; YEAST	The Spt-Ada-Gcn5 acetyltransferase (SAGA) family of transcriptional coactivators are prototypical nucleosome acetyltransferase complexes that regulate multiple steps in gene transcription. The size and complexity of both the SAGA enzyme and the chromatin substrate provide numerous opportunities for regulating the acetylation process. To better probe this regulation, here we developed a bead-based nucleosome acetylation assay to characterize the binding interactions and kinetics of acetylation with different nucleosomal substrates and the full SAGA complex purified from budding yeast (Saccharomyces cerevisiae). We found that SAGA-mediated nucleosome acetylation is stimulated up to 9-fold by DNA flanking the nucleosome, both by facilitating the binding of SAGA and by accelerating acetylation turnover. This stimulation required that flanking DNA is present on both sides of the nucleosome and that one side is >15 bp long. The Gal4-VP16 transcriptional activator fusion protein could also augment nucleosome acetylation up to 5-fold. However, contrary to our expectations, this stimulation did not appear to occur by stabilizing the binding of SAGA toward nucleosomes containing an activator-binding site. Instead, increased acetylation turnover by SAGA stimulated nucleosome acetylation. These results suggest that the Gal4-VP16 transcriptional activator directly stimulates acetylation via a dual interaction with both flanking DNA and SAGA. Altogether, these findings uncover several critical mechanisms of SAGA regulation by chromatin substrates.	[Mittal, Chitvan; Culbertson, Sannie J.; Shogren-Knaak, Michael A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Mittal, Chitvan] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Culbertson, Sannie J.] Harvard Med Sch, Div Genet, Boston, MA 02115 USA	Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School	Shogren-Knaak, MA (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	knaak@iastate.edu	Mittal, Chitvan/GSN-2531-2022		American Cancer Society Research Scholar Grant [1206501]; Gary Roewe Research Award	American Cancer Society Research Scholar Grant(American Cancer Society); Gary Roewe Research Award	This work was supported in part by American Cancer Society Research Scholar Grant 1206501 (to M.A.S.-K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a Gary Roewe Research Award.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; Sanz AB, 2016, NUCLEIC ACIDS RES, V44, P7159, DOI 10.1093/nar/gkw324; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durand A, 2014, STRUCTURE, V22, P1553, DOI 10.1016/j.str.2014.07.017; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; FASSLER JS, 1988, GENETICS, V118, P203; Fersht A., 1999, STRUCTURE MECH PROTE, P139; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Ghosh S, 2011, MOL CELL BIOL, V31, P190, DOI 10.1128/MCB.00317-10; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Koehler C, 2014, J BIOL CHEM, V289, P8989, DOI 10.1074/jbc.M113.500868; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Laprade L, 2007, GENETICS, V177, P2007, DOI 10.1534/genetics.107.081976; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Mittal C, 2014, ANAL BIOCHEM, V457, P51, DOI 10.1016/j.ab.2014.04.024; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nedialkov YA, 2004, ARCH BIOCHEM BIOPHYS, V425, P77, DOI 10.1016/j.abb.2004.03.002; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Nguyen-Huynh NT, 2015, PROTEIN SCI, V24, P1232, DOI 10.1002/pro.2676; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; PARTHUN MR, 1990, J BIOL CHEM, V265, P209; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Ranjan A, 2013, CELL, V154, P1232, DOI 10.1016/j.cell.2013.08.005; Ringel AE, 2015, P NATL ACAD SCI USA, V112, pE5461, DOI 10.1073/pnas.1508449112; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; SILVERMAN N, 1994, P NATL ACAD SCI USA, V91, P11665, DOI 10.1073/pnas.91.24.11665; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170	81	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13736	13749		10.1074/jbc.RA118.004487	http://dx.doi.org/10.1074/jbc.RA118.004487			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30054274	Green Published, hybrid			2022-12-26	WOS:000443375500032
J	Yang, WK; Hsu, AD; Kang, CK; Lai, IP; Liao, PS; Lee, TH				Yang, Wen-Kai; Hsu, An-Di; Kang, Chao-Kai; Lai, Ivan Pochou; Liao, Pei-Shao; Lee, Tsung-Han			Intestinal FXYD12 and sodium-potassium ATPase: A comparative study on two euryhaline medakas in response to salinity changes	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; NA+/K+-ATPASE; ORYZIAS-LATIPES; FRESH-WATER; K+-ATPASE; OSMOREGULATORY ACCLIMATION; BRACKISH-WATER; ION REGULATION; GILL; SEAWATER	FXYD proteins are the regulators of sodium-potassium ATPase (Na+/K+-ATPase, NKA). In teleosts, NKA is a primary driving force for the operation of many ion transport systems in the osmoregulatory organs (e.g. intestines). Hence, the purpose of this study was to determine the expression of FXYD proteins and NKA alpha-subunit in the intestines of two closely related medakas (Oryzias dancena and O. latipes), which came from different salinity habitats and have diverse osmoregulatory capabilities, to illustrate the association between NKA and FXYD proteins of two medaka species in response to salinity changes. The results showed that the fxyd12 mRNA was the most predominant in the intestines of both medakas. The association of FXYD12 and NKA in the intestines of the two medaka species was demonstrated via double immunofluorescent staining and co-immunoprecipitation. Upon salinity challenge, the localization of FXYD12 and NKA was similar in the intestines of the two medaka species. However, the expression profiles of intestinal FXYD12 and NKA (mRNA and protein levels), as well as NKA activity differed between the medakas. These results showed that FXYD12 may play a role in modulating NKA activity in the intestines of the two medakas following salinity changes in the maintenance of internal homeostasis. These findings contributed to knowledge of the expression and potential role of vertebrate FXYD12, the regulators of NKA, upon salinity challenge.	[Yang, Wen-Kai; Hsu, An-Di; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Yang, Wen-Kai; Lee, Tsung-Han] Natl Chung Hsing Univ, iEGG, Taichung, Taiwan; [Yang, Wen-Kai; Lee, Tsung-Han] Natl Chung Hsing Univ, Anim Biotechnol Ctr, Taichung, Taiwan; [Yang, Wen-Kai] Hungkuang Univ, Bachelor Degree Program Anim Healthcare, Taichung, Taiwan; [Kang, Chao-Kai] Natl Cheng Kung Univ, Tainan Hydraul Lab, Tainan, Taiwan; [Lai, Ivan Pochou; Liao, Pei-Shao] Natl Taichung First Senior High Sch, Taichung, Taiwan; [Lai, Ivan Pochou; Liao, Pei-Shao] Natl Taiwan Univ, Coll Med, Sch Med, Taipei, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Hungkuang University; National Cheng Kung University; National Taiwan University	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.; Lee, TH (corresponding author), Natl Chung Hsing Univ, iEGG, Taichung, Taiwan.; Lee, TH (corresponding author), Natl Chung Hsing Univ, Anim Biotechnol Ctr, Taichung, Taiwan.	thlee@email.nchu.edu.tw		Lee, Tsung-Han/0000-0002-3542-4335; Yang, Wen-Kai/0000-0001-8095-2420; Liao, Pei-Shao/0000-0002-7182-6913; Lai, Ivan/0000-0001-8349-7056	Animal Biotechnology Center from The Feature Area Research Center Program by the Ministry of Education (MOE) in Taiwan [107S0023F]; iEGG; Ministry of Science and Technology, Taiwan [MOST 106-2313-B-005-038-MY3, MOST 105-2811-B-005-006]	Animal Biotechnology Center from The Feature Area Research Center Program by the Ministry of Education (MOE) in Taiwan; iEGG; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was in part financially supported by the iEGG and Animal Biotechnology Center from The Feature Area Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (107S0023F). This study was also in part financially supported by a grant to THL from the Ministry of Science and Technology, Taiwan (MOST 106-2313-B-005-038-MY3). WKY was supported by a postdoctoral fellowship of Ministry of Science and Technology, Taiwan (MOST 105-2811-B-005-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2011, J COMP PHYSIOL B, V181, P1045, DOI 10.1007/s00360-011-0592-0; Bagherie-Lachidan M, 2008, AM J PHYSIOL-REG I, V294, pR1638, DOI 10.1152/ajpregu.00039.2008; Bollinger RJ, 2016, J COMP PHYSIOL B, V186, P485, DOI 10.1007/s00360-016-0972-6; Chang CH, 2016, COMP BIOCHEM PHYS A, V194, P19, DOI 10.1016/j.cbpa.2016.01.013; Chew SF, 2010, J COMP PHYSIOL B, V180, P511, DOI 10.1007/s00360-009-0436-3; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; Hiroi J, 2012, RESP PHYSIOL NEUROBI, V184, P257, DOI 10.1016/j.resp.2012.07.019; Hu P, 2014, COMP BIOCHEM PHYS B, V174, P15, DOI 10.1016/j.cbpb.2014.05.002; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Juo JJ, 2016, ZOOL SCI, V33, P414, DOI 10.2108/zs150157; Kang CK, 2008, COMP BIOCHEM PHYS A, V151, P566, DOI 10.1016/j.cbpa.2008.07.020; Li ZQ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00066; Liang FF, 2017, J COMP PHYSIOL B, V187, P973, DOI 10.1007/s00360-017-1059-8; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Madsen SS, 2015, BIOL BULL-US, V229, P70, DOI 10.1086/BBLv229n1p70; Madsen SS, 2014, J EXP BIOL, V217, P3108, DOI 10.1242/jeb.105098; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Oguz AR, 2015, MAR FRESHW BEHAV PHY, V48, P135, DOI 10.1080/10236244.2015.1004838; Peh WYX, 2009, MAR BIOL, V156, P1751, DOI 10.1007/s00227-009-1210-5; Roberts TR, 1998, ICHTHYOL RES, V45, P213, DOI 10.1007/BF02673919; Saito K, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00129; Sardella BA, 2008, COMP BIOCHEM PHYS C, V148, P430, DOI 10.1016/j.cbpc.2008.05.006; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Sundell KS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1311; Sundell KS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00388; Sundh H, 2014, J FISH BIOL, V85, P1227, DOI 10.1111/jfb.12531; Takei Y, 2014, AM J PHYSIOL-REG I, V307, pR778, DOI 10.1152/ajpregu.00104.2014; Tang CH, 2012, COMP BIOCHEM PHYS A, V163, P302, DOI 10.1016/j.cbpa.2012.07.017; Teranishi K, 2010, J HISTOCHEM CYTOCHEM, V58, P707, DOI 10.1369/jhc.2010.955492; Tipsmark CK, 2010, AM J PHYSIOL-REG I, V299, pR1212, DOI 10.1152/ajpregu.00015.2010; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1367, DOI 10.1152/ajpregu.00454.2007; Tomy S, 2009, GEN COMP ENDOCR, V161, P123, DOI 10.1016/j.ygcen.2008.12.003; Wang PJ, 2008, J EXP BIOL, V211, P3750, DOI 10.1242/jeb.018440; Wang PJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00576; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wong MKS, 2016, ZOOL LETT, V2, DOI 10.1186/s40851-016-0050-7; Yang WK, 2016, COMP BIOCHEM PHYS B, V202, P23, DOI 10.1016/j.cbpb.2016.07.008; Yang Wen-Kai, 2016, Int J Biol Sci, V12, P730, DOI 10.7150/ijbs.15066; Yang WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055470, 10.1371/journal.pone.0076447]; Yang WK, 2011, J COMP PHYSIOL B, V181, P953, DOI 10.1007/s00360-011-0568-0; Yang WK, 2009, J EXP MAR BIOL ECOL, V375, P41, DOI 10.1016/j.jembe.2009.05.004	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201252	10.1371/journal.pone.0201252	http://dx.doi.org/10.1371/journal.pone.0201252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052675	Green Published, Green Submitted, gold			2022-12-26	WOS:000440006600033
J	Gibson, AD; Mazeri, S; Lohr, F; Mayer, D; Bailey, JLB; Wallace, RM; Handel, IG; Shervell, K; Bronsvoort, BMD; Mellanby, RJ; Gamble, L				Gibson, Andrew D.; Mazeri, Stella; Lohr, Frederic; Mayer, Dagmar; Bailey, Jordana L. Burdon; Wallace, Ryan M.; Handel, Ian G.; Shervell, Kate; Bronsvoort, Barend M. deC.; Mellanby, Richard J.; Gamble, Luke			One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns	PLOS ONE			English	Article							RURAL AFRICA; ELIMINATION; HEALTH; IMPACT	Background Canine transmitted rabies kills an estimated 59,000 people annually, despite proven methods for elimination through mass dog vaccination. Challenges in directing and monitoring numerous remote vaccination teams across large geographic areas remain a significant barrier to the up-scaling of focal vaccination programmes to sub-national and national level. Smartphone technology (mHealth) is increasingly being used to enhance the coordination and efficiency of public health initiatives in developing countries, however examples of successful scaling beyond pilot implementation are rare. This study describes a smartphone app and website platform, "Mission Rabies App", used to co-ordinate rabies control activities at project sites in four continents to vaccinate over one million dogs. Methods Mission Rabies App made it possible to not only gather relevant campaign data from the field, but also to direct vaccination teams systematically in near real-time. The display of user-allocated boundaries on Google maps within data collection forms enabled a project manager to define each team's region of work, assess their output and assign subsequent areas to progressively vaccinate across a geographic area. This ability to monitor work and react to a rapidly changing situation has the potential to improve efficiency and coverage achieved, compared to regular project management structures, as well as enhancing capacity for data review and analysis from remote areas. The ability to plot the location of every vaccine administered facilitated engagement with stakeholders through transparent reporting, and has the potential to motivate politicians to support such activities. Results Since the system launched in September 2014, over 1.5 million data entries have been made to record dog vaccinations, rabies education classes and field surveys in 16 countries. Use of the system has increased year-on-year with adoption for mass dog vaccination campaigns at the India state level in Goa and national level in Haiti. Conclusions Innovative approaches to rapidly scale mass dog vaccination programmes in a sustained and systematic fashion are urgently needed to achieve the WHO, OIE and FAO goal to eliminate canine-transmitted human deaths by 2030. The Mission Rabies App is an mHealth innovation which greatly reduces the logistical and managerial barriers to implementing large scale rabies control activities. Free access to the platform aims to support pilot campaigns to better structure and report on proof-of-concept initiatives, clearly presenting outcomes and opportunities for expansion. The functionalities of the Mission Rabies App may also be beneficial to other infectious disease interventions.	[Gibson, Andrew D.; Mazeri, Stella; Lohr, Frederic; Bailey, Jordana L. Burdon; Shervell, Kate; Gamble, Luke] Mission Rabies, Cranborne, Dorset, England; [Gibson, Andrew D.; Mazeri, Stella; Handel, Ian G.; Bronsvoort, Barend M. deC.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Roslin Inst, Roslin, Midlothian, Scotland; [Gibson, Andrew D.; Mazeri, Stella; Handel, Ian G.; Bronsvoort, Barend M. deC.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies,Div Genet & Genom, Roslin, Midlothian, Scotland; [Mayer, Dagmar; Gamble, Luke] Worldwide Vet Serv, Cranborne, Dorset, England; [Wallace, Ryan M.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA; [Mellanby, Richard J.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies,Div Vet Clin Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Centers for Disease Control & Prevention - USA; University of Edinburgh	Gamble, L (corresponding author), Mission Rabies, Cranborne, Dorset, England.; Gamble, L (corresponding author), Worldwide Vet Serv, Cranborne, Dorset, England.; Mellanby, RJ (corresponding author), Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies,Div Vet Clin Studies, Roslin, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk; Luke@missionrabies.com	Mazeri, Stella/AAH-7611-2020; Gamble, Luke/F-2746-2018	Mazeri, Stella/0000-0002-4591-8267; Mellanby, Richard John/0000-0002-3467-7007; Lohr, Frederic/0000-0002-7158-3122; Gamble, Luke/0000-0003-3095-5935; Gibson, Andrew/0000-0002-4641-2583	Dogs Trust; Wellcome Trust Intermediate Clinical Fellowship; BBSRC through the Institute Strategic Programme funding [BB/J004235/1, BB/P013740/1]	Dogs Trust; Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); BBSRC through the Institute Strategic Programme funding(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Mission Rabies vaccination and education campaign were funded by a grant from Dogs Trust. MSD Animal Health donated all Nobivac Rabies vaccine used in the campaigns. RJM was supported by a Wellcome Trust Intermediate Clinical Fellowship. BB and RM were supported by BBSRC through the Institute Strategic Programme funding (BB/J004235/1 and BB/P013740/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Ali M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-86; Aviles W, 2008, AM J TROP MED HYG, V78, P311, DOI 10.4269/ajtmh.2008.78.311; Bailey JLB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006293; Bernabe-Ortiz A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-11; Bourhy H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000839; Chigona, 2018, INT J PRIV HEAL INF, V6, P49, DOI [10.4018/IJPHIM.2018010104, DOI 10.4018/IJPHIM.2018010104]; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Cleaveland S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1880; Cleaveland S, 2014, VET REC, V175, P188, DOI 10.1136/vr.g4996; Ferguson EA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18232; Gibson AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004824; Gibson AD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1320-2; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; International Telecommunication Union (ITU), 2017, ITC FACTS 2017 FIG; Jibat T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003447; Kaare M, 2009, VACCINE, V27, P152, DOI 10.1016/j.vaccine.2008.09.054; Kim SS, 2017, VACCINE, V35, P1373, DOI 10.1016/j.vaccine.2017.01.058; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Mazeri S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006159; Mtema Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002002; Mwabukusi M, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.737; Schneider MC, 2007, CAD SAUDE PUBLICA, V23, P2049, DOI 10.1590/S0102-311X2007000900013; Stanton Michelle, 2016, JMIR Public Health Surveill, V2, pe2, DOI 10.2196/publichealth.5064; Susan Paul N.S., 2018, INT J COMMUNITY MED, V5, P81, DOI [10.18203/2394-6040.ijcmph20175514, DOI 10.18203/2394-6040.IJCMPH20175514]; Teng JE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003050; Thriemer Kamala, 2012, BMC Res Notes, V5, P113, DOI 10.1186/1756-0500-5-113; Tohma K, 2016, INFECT GENET EVOL, V38, P22, DOI 10.1016/j.meegid.2015.12.001; Wallace RM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00009; Welburn SC, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00032; Welburn SC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005000; Widyastuti MDW, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0061-1	35	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200942	10.1371/journal.pone.0200942	http://dx.doi.org/10.1371/journal.pone.0200942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048469	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400035
J	Petersen, MT; da Silveira, ID; Tatila-Ferreira, A; David, MR; Chouin-Carneiro, T; Van den Wouwer, L; Maes, L; Maciel-De-Freitas, R				Petersen, Martha Thieme; da Silveira, Isabella Dias; Tatila-Ferreira, Aline; David, Mariana Rocha; Chouin-Carneiro, Thais; Van den Wouwer, Liesbeth; Maes, Louis; Maciel-de-Freitas, Rafael			The impact of the age of first blood meal and Zika virus infection on Aedes aegypti egg production and longevity	PLOS ONE			English	Article							RIO-DE-JANEIRO; DAILY SURVIVAL RATES; CONTAINER PRODUCTIVITY; BODY-SIZE; DIPTERA; DISPERSAL; FECUNDITY; TRANSMISSION; MOSQUITOS; PARASITE	The impact of senescence and pathogen infection on Aedes aegypti life-history traits remains poorly understood. This laboratory study focused on the impact of Zika virus (ZIKV) infection and the age of first blood intake on blood meal and clutch sizes, and more importantly on the egg production ratio per mu L of blood. Three groups of ZIKV-infected and uninfected Ae. aegypti females that received their first blood meal at 7 (young feeders), 14 (mature feeders) and 21 days old (old feeders) were monitored daily for survival and received a blood meal free of ZIKV once a week. The number of eggs laid per female were registered 3-4 days after blood feeding. Infection by ZIKV and age of feeding produced a strong negative impact on survival and oviposition success (e.g. likelihood of laying at least one egg per gonotrophic cycle). Interestingly, clutch size presented a dramatic reduction on uninfected mosquitoes, but raised from 36.5 in clutch1 to 55.1 eggs in clutch 3. Blood meal size remained stable in uninfected females, while a slight increase was observed for the infected counterparts. In uninfected Ae. aegypti, egg production was strongly affected by the age of feeding with younger females laying three times more eggs than when older. On the other hand, ZIKV-infected mosquitoes had a constant but low egg production. Overall, mosquito senescence and ZIKV infection had an impact on mosquito egg production by causing a sharp decrease in the number of eggs along the clutches for uninfected mosquitoes and a slight increase for infected mosquitoes. Despite some study limitations, our results contribute to a better understanding of the effects of mosquito aging and pathogen infection on the vectorial capacity of Ae. aegypti.	[Petersen, Martha Thieme; da Silveira, Isabella Dias; Tatila-Ferreira, Aline; David, Mariana Rocha; Chouin-Carneiro, Thais; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoa, Rio De Janeiro, RJ, Brazil; [Chouin-Carneiro, Thais] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, RJ, Brazil; [Van den Wouwer, Liesbeth; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Maciel-De-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoa, Rio De Janeiro, RJ, Brazil.	freitas@ioc.fiocruz.br	Maciel-de-Freitas, Rafael/J-1997-2012; Maes, Louis JRM/A-2384-2017	Maes, Louis JRM/0000-0002-2324-9509; Maciel-de-Freitas, Rafael/0000-0002-2198-6492; Rocha David, Mariana/0000-0003-1241-3585	MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit [E14/2016 (440929/2016-4)]; Faperj [Faperj]	MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit; Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Brazilian Research Councils MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit E14/2016 (440929/2016-4) and Faperj E18/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; BRIEGEL H, 1980, EXPERIENTIA, V36, P1428, DOI 10.1007/BF01960142; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Chahad-Ehlers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052559; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; DYE C, 1986, Parasitology Today, V2, P203; Edman John D., 1992, Journal of Medical Entomology, V29, P1035, DOI 10.1093/jmedent/29.6.1035; Faria NR, 2016, PLOS CURR, V8; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320; Harbach R.E., 1980, TAXONOMISTS GLOSSARY, P1; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610; Lucio PS, 2013, J VECTOR ECOL, V38, P20, DOI 10.1111/j.1948-7134.2013.12005.x; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252; McCann S, 2009, J VECTOR ECOL, V34, P174, DOI [10.1111/j.1948-7134.2009.00024.x, 10.3376/038.034.0202]; Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933; Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200766	10.1371/journal.pone.0200766	http://dx.doi.org/10.1371/journal.pone.0200766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048481	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400018
J	Spillane, NT; Zamudio, S; Alvarez-Perez, J; Andrews, T; Nyirenda, T; Alvarez, M; Al-Khan, A				Spillane, Nicole T.; Zamudio, Stacy; Alvarez-Perez, Jesus; Andrews, Tracy; Nyirenda, Themba; Alvarez, Manuel; Al-Khan, Abdulla			Increased incidence of respiratory distress syndrome in neonates of mothers with abnormally invasive placentation	PLOS ONE			English	Article							PRETERM INFANTS; OUTCOMES; MORBIDITY; ACCRETA; RISK; PREVIA; BIRTH; WOMEN; BORN	Background The incidence of abnormally invasive placentation (AIP) is increasing. Most of these pregnancies are delivered preterm. We sought to characterize neonatal outcomes in AIP pregnancies. Methods In this retrospective case-control study (2006-2015), AIP neonates (n = 108) were matched to two controls each for gestational age, antenatal glucocorticoid exposure, sex, plurity, and delivery mode. Medical records were reviewed for neonatal and maternal characteristics/outcomes. Univariate and multivariate Poisson regressions were performed to determine relative risk ratios (RR). Results There were no mortalities. All neonatal outcomes were similar except for respiratory distress syndrome (RDS), which affected 37% of AIP neonates (versus 21% of controls). AIP neonates required respiratory support (64.8% vs. 51.9%) and continuous positive airway pressure (53.7% vs. 42.1%) for a longer duration. Univariate regression yielded elevated RRs for RDS for AIP (RR 1.78, 95% CI 1.24-2.54), placenta previa (RR = 1.94, 95% CI 1.36-2.76), and placenta previa with bleeding (RR 2.29, 95% CI 1.36-3.86). One episode of bleeding had a RR of 2.43 (95% CI 1.57-3.76), 2 or more episodes had a RR of 2.95 (95% CI 1.96-4.44), and bleeding/abruption as the delivery indication had a RR of 2.57 (95% CI 1.82-3.64). A multivariate regression stratifying for AIP and evaluating the combined and individual associations of AIP, bleeding, placenta previa, and GA, resulted in elevated RRs for placenta previa alone (RR 2.16, 95% CI 1.15-4.06) and placenta previa and bleeding (RR 1.69, 95% CI 1.001-2.85). Conclusions The increased incidence of RDS at later gestational ages in AIP is driven by placenta previa. AIP neonates required respiratory support for a longer duration than age-matched controls. Providers should be prepared to counsel expectant parents and care for affected neonates.	[Spillane, Nicole T.] Hackensack Univ, Med Ctr, Dept Pediat, Div Neonatol, Hackensack, NJ 07601 USA; [Spillane, Nicole T.; Alvarez-Perez, Jesus; Alvarez, Manuel; Al-Khan, Abdulla] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA; [Zamudio, Stacy; Alvarez-Perez, Jesus; Alvarez, Manuel; Al-Khan, Abdulla] Hackensack Univ, Med Ctr, Ctr Abnormal Placentat, Dept Obstet & Gynecol,Div Maternal Fetal Med & Su, Hackensack, NJ USA; [Andrews, Tracy; Nyirenda, Themba] Hackensack Univ, Med Ctr, Dept Res, Off Res Adm, Hackensack, NJ USA	Hackensack University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center	Spillane, NT (corresponding author), Hackensack Univ, Med Ctr, Dept Pediat, Div Neonatol, Hackensack, NJ 07601 USA.; Spillane, NT (corresponding author), Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA.	Nicole.Spillane@HackensackMeridian.org		Spillane, Nicole/0000-0002-9689-0743	National Institute of Health [U01 HD 087209]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Health, U01 HD 087209. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khan A, 2014, REPROD SCI, V21, P761, DOI 10.1177/1933719113512528; Alkozei A, 2014, J MATERN-FETAL NEO M, V27, P1738, DOI 10.3109/14767058.2014.942626; Altman M, 2013, PAEDIATR PERINAT EP, V27, P172, DOI 10.1111/ppe.12035; American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2016, Obstet Gynecol, V128, pe187, DOI 10.1097/AOG.0000000000001715; [Anonymous], 2017, Obstet Gynecol, V130, P493, DOI 10.1097/AOG.0000000000002231; [Anonymous], 2013, Obstet Gynecol, V121, P908, DOI 10.1097/01.AOG.0000428648.75548.00; [Anonymous], 2014, MAN OP 2, P1; Balayla J, 2013, J PERINAT MED, V41, P141, DOI 10.1515/jpm-2012-0219; Bekku S, 2000, J Matern Fetal Med, V9, P110; Belfort MA, 2011, SEMIN PERINATOL, V35, P252, DOI 10.1053/j.semperi.2011.05.002; Collins SL, 2015, OBSTET GYNECOL, V126, P645, DOI 10.1097/AOG.0000000000000962; Crane JMG, 1999, OBSTET GYNECOL, V93, P541, DOI 10.1016/S0029-7844(98)00480-3; Downes KL, 2017, AM J EPIDEMIOL, V186, P1319, DOI 10.1093/aje/kwx202; Eshkoli T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.037; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Gielchinsky Y, 2004, OBSTET GYNECOL, V104, P527, DOI 10.1097/01.AOG.0000136084.92846.95; Gouyon JB, 2008, PAEDIATR PERINAT EP, V22, P22, DOI 10.1111/j.1365-3016.2007.00875.x; Gregoire MC, 1998, PEDIATRICS, V101, P856, DOI 10.1542/peds.101.5.856; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hnat MD, 2005, AM J OBSTET GYNECOL, V193, P164, DOI 10.1016/j.ajog.2004.10.625; Holditch-Davis D, 2015, INFANT BEHAV DEV, V41, P154, DOI 10.1016/j.infbeh.2015.10.004; Hsu Y, 1998, CLIN NEONATOLOGY, V5, P1; Kassem GA, 2013, INT J WOMENS HEALTH, V5, P803, DOI 10.2147/IJWH.S53865; Koivisto M, 2005, J PEDIATR-US, V147, P486, DOI 10.1016/j.jpeds.2005.04.036; Lin CH, 2001, EARLY HUM DEV, V60, P215, DOI 10.1016/S0378-3782(00)00121-3; Martin R.J, 2020, FANAROFF MARTINS NEO, P1218; MCSHANE PM, 1985, OBSTET GYNECOL, V65, P176; Mehrabadi A, 2015, OBSTET GYNECOL, V125, P814, DOI 10.1097/AOG.0000000000000722; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Robinson BK, 2010, OBSTET GYNECOL, V116, P835, DOI 10.1097/AOG.0b013e3181f3588d; Schneiderman M, 2013, J MATERN-FETAL NEO M, V26, P1121, DOI 10.3109/14767058.2013.770465; SECKL JR, 2004, EUR J ENDOCRINOL S3, V151; SPINILLO A, 1994, AM J PERINAT, V11, P85, DOI 10.1055/s-2007-994562; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stroustrup A, 2012, J PEDIATR-US, V160, P38, DOI 10.1016/j.jpeds.2011.06.027; Stutchfield PR, 2016, NEW ENGL J MED, V375, P485, DOI 10.1056/NEJMc1605902; Warshak CR, 2010, OBSTET GYNECOL, V115, P65, DOI 10.1097/AOG.0b013e3181c4f12a; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074	38	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201266	10.1371/journal.pone.0201266	http://dx.doi.org/10.1371/journal.pone.0201266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048504	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400068
J	Shell-Duncan, B; Moreau, A; Wander, K; Smith, S				Shell-Duncan, Bettina; Moreau, Amadou; Wander, Katherine; Smith, Sarah			The role of older women in contesting norms associated with female genital mutilation/cutting in Senegambia: A factorial focus group analysis	PLOS ONE			English	Article							ATTITUDES; DYNAMICS	Social norms theory has become prominent framework for understanding the perpetuation of female genital mutilation/cutting (FGM/C), and has influenced the design of interventions aimed at stopping the practice. Theoretical advances draw attention to the fact that FGM/C is often upheld by multiple interconnected norms that may vary and shift over time, offering a potential resource for social transformation. Analyzing focus group data from Senegambian women, the questions we explore are: What are the constellation of norms associated with FGM/C? When are existing practices and norms being contested, and how does this reflect prevailing structures of power and authority? Our research identifies four overarching themes: 1) pressure to conform with FGM/C arising from sanctions such as ostracization, and moral norms linked to the embodiment of virtue; 2) upholding tradition as a means of venerating ancestors; 3) upholding social hierarchy by displaying respect for elders; and 4) shifting beliefs about the healthful vs. harmful nature of FGM/C. While strong value is placed on upholding tradition, there is also an appreciation that elements of tradition must be revised to meet fluctuating realities, including the novel threat of HIV infection. Moreover, older women are uniquely positioned to realize the dual goal of honoring tradition while negotiating change. Rather than resisting change, we find that some older women express an openness to reassessing norms and practices as they seek solutions to maintaining the physical well-being, moral integrity and cultural identity of girls in their families. Moreover, given the authority of older women over younger women, they also have power to negotiate change. By recognizing older women as potential change leaders, and drawing on variability and fluidity in social norms, it may be increasingly possible to design interventions that will shape possibilities for action and accelerate abandonment of FGM/C without undermining the cultural value of tradition.	[Shell-Duncan, Bettina] Univ Washington, Seattle, WA 98195 USA; [Moreau, Amadou; Smith, Sarah] Global Res & Advocacy Grp, Dakar, Senegal; [Wander, Katherine] SUNY Binghamton, Binghamton, NY USA	University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Shell-Duncan, B (corresponding author), Univ Washington, Seattle, WA 98195 USA.	bsd@uw.edu	Wander, Katherine/AAL-1551-2020	Wander, Katherine/0000-0002-4913-5075	Department for International Development project, "Evidence to End FGM/C: Research to Help Girls and Women Thrive"; National Science Foundation: Directorate for Social, Behavioral and Economic Sciences [0313503]; UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development, and Research Training in Human Reproduction; Eunice Kennedy Shriver National Institute of Health and Human Development award [5R24HD042828]	Department for International Development project, "Evidence to End FGM/C: Research to Help Girls and Women Thrive"; National Science Foundation: Directorate for Social, Behavioral and Economic Sciences; UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development, and Research Training in Human Reproduction; Eunice Kennedy Shriver National Institute of Health and Human Development award	This research was funded by Department for International Development project, "Evidence to End FGM/C: Research to Help Girls and Women Thrive," coordinated by Population Council; National Science Foundation: Directorate for Social, Behavioral and Economic Sciences (grant number 0313503); and UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development, and Research Training in Human Reproduction. Computing support and grant administration through the Center for the Study of Demography and Ecology was supported by the Eunice Kennedy Shriver National Institute of Health and Human Development award number 5R24HD042828.	Abdelshahid A, 2015, J COMMUNITY APPL SOC, V25, P49, DOI 10.1002/casp.2195; AHMADU Fuambai, 2005, THESIS; An-Na'im Abdullah A., 2002, CULTURAL TRANSFORMAT, P13; [Anonymous], 2011, RES METHODS ANTHR; Aubel J, 2004, SOC SCI MED, V59, P945, DOI 10.1016/j.socscimed.2003.11.044; Aubel J, 2012, MATERN CHILD NUTR, V8, P19, DOI 10.1111/j.1740-8709.2011.00333.x; Burke NJ, 2009, HEALTH EDUC BEHAV, V36, p55S, DOI 10.1177/1090198109335338; Campo S, 2004, COMMUN MONOGR, V71, P448, DOI 10.1080/0363452042000307498; Cowan J.K., 2001, CULTURE RIGHTS ANTHR, P1; Creswell J. W., 2007, QUALITATIVE INQUIRY; Daffeh J, 1999, LISTENING VOICE PEOP; Diop N., 2006, ENQUETE DEMOGRAPHIQU; Gruenbaum E, 2005, CULT HEALTH SEX, V7, P429, DOI 10.1080/13691050500262953; Hernlund Y., 2000, FEMALE CIRCUMCISION, P235; Hernlund Ylva, 2003, THESIS U WASHINGTON; Knodel J, 1993, SUCCESSFUL FOCUS GRO, P35, DOI DOI 10.4135/9781483349008; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Mackie G., 2000, FEMALE CIRCUMCISION, P253; Mackie G., 2015, WHAT ARE SOCIAL NORM; Mackie G., 2009, SPECIAL SERIES SOCIA; Merry Sally Engle, 2001, CULTURE RIGHTS ANTHR, P31, DOI DOI 10.1017/CBO9780511804687; Merry SallyEngle., 2009, HUMAN RIGHTS GENDER; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Nyamu-Musembi C, 2002, CULTURAL TRANSFORMAT, P126; O'Neill S., 2013, THESIS; Rah JH, 2004, J NUTR EDUC BEHAV, V36, P238, DOI 10.1016/S1499-4046(06)60386-2; Richards L., 2007, README 1 USERS GUIDE; Scholly K, 2005, J AM COLL HEALTH, V53, P159, DOI 10.3200/JACH.53.4.159-166; Shell-Duncan B., 2007, AFR TODAY, V53, P42, DOI [10.2979/AFT.2007.53.4.42, DOI 10.2979/AFT.2007.53.4.42]; Shell-Duncan B., 2016, STATE OF THE ART SYN; Shell-Duncan B, 2010, CONTINGENCY CHANGE P; Shell-Duncan B, 2011, SOC SCI MED, V73, P1275, DOI 10.1016/j.socscimed.2011.07.022; Skramstad H., 1990, FLUID MEANINGS FEMAL; Sylla MHS, 1990, EXCISION AU SENEGAL; UNAIDS, 2008, UNAIDS0825EJC151OE; UNICEF, 2013, FEM GEN MUT CUTT STA; Vogt S, 2016, NATURE, V538, P506, DOI 10.1038/nature20100	37	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199217	10.1371/journal.pone.0199217	http://dx.doi.org/10.1371/journal.pone.0199217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044770	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500010
J	Mortazavi, F; Nadian-Ghomsheh, A				Mortazavi, Fatemeh; Nadian-Ghomsheh, Ali			Stability of Kinect for range of motion analysis in static stretching exercises	PLOS ONE			English	Article							REHABILITATION; RELIABILITY; VALIDITY; TIME	Physical rehabilitation aims people with physical impairments to enhance and restore their functional ability. The Microsoft Kinect v1 and v2 technologies apply depth information and machine vision techniques to generate 3D coordinates of a set of anatomical landmarks on the human body regarded as Kinect joints. Trigonometry relationship between Kinect joints can be used to extract body Range of Motion ( ROM). The purpose of this study was to evaluate stability of Kinect for ROM measurement during static stretching exercises. According to the literature, the stability of Kinect in static exercises has been reported to a limited extent. 13 healthy men participated in this study and performed 5 exercises in 2 different distances from the cameras. Exercises were recorded by Kinect v1 and Kinect v2, concurrently. The stability of Kinect was also evaluated for 5 ROMs including: elbow flexion, shoulder abduction, wrist pronation, wrist flexion, and wrist ulnar deviation. Maximum and average joint displacement errors were used for stability analysis. Results showed that Kinect v2 is more stable compared to Kinect v1. Kinect v2 joints showed displacement error of more than 15 mm for wrist. For the other joints, Kinect showed an average displacement error of less than 10 mm.	[Mortazavi, Fatemeh; Nadian-Ghomsheh, Ali] Shahid Beheshti Univ, Cyber Space Res Inst, GC, Tehran, Iran	Shahid Beheshti University	Nadian-Ghomsheh, A (corresponding author), Shahid Beheshti Univ, Cyber Space Res Inst, GC, Tehran, Iran.	a_nadian@sbu.ac.ir		Nadian-Ghomsheh, Ali/0000-0002-2215-409X				BANDY WD, 1994, PHYS THER, V74, P845, DOI 10.1093/ptj/74.9.845; Bonnechere B, 2014, GAIT POSTURE, V39, P593, DOI 10.1016/j.gaitpost.2013.09.018; Chang YJ, 2013, RES DEV DISABIL, V34, P3654, DOI 10.1016/j.ridd.2013.08.021; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Fern'ndez-Baena, 2012, 4 INT C INT NETW COL, DOI 10.1109/iNCoS.2012.66; GAJDOSIK RL, 1987, PHYS THER, V67, P1867, DOI 10.1093/ptj/67.12.1867; Huang QX, 2016, ISIJ INT, V56, P288, DOI 10.2355/isijinternational.ISIJINT-2015-324; Kitsunezaki N, 2013, MED MEAS APPL P MEME; Kolar P, 2014, CLIN REHABILITATION; Lange B, 2011, ENG MED BIOL SOC EMB; Lee SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129398; Mousavi Hondori Hossein, 2014, J Med Eng, V2014, P846514, DOI 10.1155/2014/846514; Otte K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166532; Page P, 2012, INT J SPORTS PHYS TH, V7, P109; Pastor I, 2012, ENG MED BIOL SOC EMB; Reither LR, 2018, DISABIL REHABIL-ASSI, V13, P54, DOI 10.1080/17483107.2016.1278473; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Suma E. A, FLEXIBLE ACTION ARTI; Wade E, 2011, TOP STROKE REHABIL, V18, P685, DOI 10.1310/tsr1806-685; Wang Q, 2015, INT C HEALTHC INF IC; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Zulkarnain RF, 2017, J SHOULDER ELB SURG, V26, P895, DOI 10.1016/j.jse.2016.10.026	24	12	12	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200992	10.1371/journal.pone.0200992	http://dx.doi.org/10.1371/journal.pone.0200992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040848	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200021
J	Fang, H; Cui, YB; Wang, Z; Wang, S				Fang, Hao; Cui, Yibin; Wang, Zhuang; Wang, Se			Toxicological assessment of multi-walled carbon nanotubes combined with nonylphenol in male mice	PLOS ONE			English	Article							OXIDATIVE STRESS; SINGLE-WALL; BISPHENOL-A; DNA-DAMAGE; PULMONARY TOXICITY; GRAPHITIC CARBON; MEAT FLAVOR; CELL-CYCLE; IN-VITRO; KAPPA-B	Carbon nanotubes have attracted increasing attention attributable to their widespread application. To evaluate the joint toxicity of multi-walled carbon nanotubes (MWCNTs) and nonylphenol (NP), we investigated the toxicological effects of NP, pristine MWCNTs, and MWCNTs combined with NP in male mice. After exposing male mice by gavage for 5 days, intracellular superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activity, as well as malondialdehyde (MDA) and glutathione (GSH) levels in tissues were determined to evaluate in vivo oxidative stress. In addition, genotoxicity was assessed by examining DNA damage in mouse liver and sperm via the comet assay, and transmission electron microscopy (TEM) was used for direct visual observations of mitochondrial damage in the liver. Results from the oxidative damage and DNA damage experiments indicate that after adsorbing NP, MWCNTs at a high dose induce oxidative lesions in the liver and cause DNA damage in mouse sperm; these data offer new insights regarding the toxicological assessment of MWCNTs.	[Fang, Hao; Wang, Zhuang; Wang, Se] Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Atmospher Environm & Equip, Sch Environm Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Cui, Yibin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University of Information Science & Technology	Cui, YB (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	cyb@nies.org	Wang, Zhuang/M-1964-2016	Wang, Zhuang/0000-0001-7032-4500	Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology [2014r020]; Natural Science Foundation of Jiangsu Province [BK20170948]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [17KJB610007]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015C222]; National Natural Science Foundation of China, China [31572623]	Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC))	This project was supported by Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology (2014r020 to HF), The Natural Science Foundation of Jiangsu Province (BK20170948 to HF), The Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJB610007 to HF), Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015C222 to HF) and National Natural Science Foundation of China (31572623 to YC), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by Startup Foundation for Introducing Talent (2014r020) of Nanjing University of Information Science and Technology, The Natural Science Foundation of Jiangsu Province (BK20170948), The Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJB610007), Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015C222) and National Natural Science Foundation of China (31572623), China.	Aly HAA, 2012, TOXICOL APPL PHARM, V261, P134, DOI 10.1016/j.taap.2012.02.015; Aydogan M, 2008, TOXICOLOGY, V249, P35, DOI 10.1016/j.tox.2008.04.002; Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]; Brown DM, 2007, CARBON, V45, P1743, DOI 10.1016/j.carbon.2007.05.011; Chitra KC, 2002, ARCH TOXICOL, V76, P545, DOI 10.1007/s00204-002-0372-4; Clark KA, 2012, J TOXICOL ENV HEAL A, V75, P25, DOI 10.1080/15287394.2011.589105; Colerangle JB, 1996, ENDOCRINE, V4, P115, DOI 10.1007/BF02782756; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; DAVID NA, 1972, ANNU REV PHARMACOLOG, V12, P353, DOI 10.1146/annurev.pa.12.040172.002033; Deng X, 2007, CARBON, V45, P1419, DOI 10.1016/j.carbon.2007.03.035; El-Dakdoky MH, 2007, B ENVIRON CONTAM TOX, V79, P188, DOI 10.1007/s00128-007-9158-y; Ghosh M, 2011, J HAZARD MATER, V197, P327, DOI 10.1016/j.jhazmat.2011.09.090; Gong Y, 2006, REPROD TOXICOL, V22, P623, DOI 10.1016/j.reprotox.2006.04.019; Gundersen JL, 2001, J CHROMATOGR A, V914, P161, DOI 10.1016/S0021-9673(00)01235-8; Horiuchi K, 2005, ARCH HISTOL CYTOL, V68, P51, DOI 10.1679/aohc.68.51; Hu CW, 2013, ENVIRON SCI-PROC IMP, V15, P2125, DOI 10.1039/c3em00376k; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kisin ER, 2007, J TOXICOL ENV HEAL A, V70, P2071, DOI 10.1080/15287390701601251; Kudo C, 2004, J NEUROCHEM, V88, P1416, DOI 10.1046/j.1471-4159.2003.02270.x; Kyselova Vendula, 2003, Reprod Biol Endocrinol, V1, P30, DOI 10.1186/1477-7827-1-30; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Lee PC, 1998, ENDOCRINE, V9, P105, DOI 10.1385/ENDO:9:1:105; Lee S, 2009, ENVIRON TOXICOL PHAR, V27, P90, DOI 10.1016/j.etap.2008.08.009; Li XN, 2014, J COLLOID INTERF SCI, V415, P159, DOI 10.1016/j.jcis.2013.10.021; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Li ZY, 2013, ENVIRON MONIT ASSESS, V185, P5221, DOI 10.1007/s10661-012-2938-9; Liang GY, 2010, J TOXICOL ENV HEAL A, V73, P463, DOI 10.1080/15287390903523378; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Matsumoto M, 2012, J TOXICOL SCI, V37, P463; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Negishi T, 2004, ENVIRON HEALTH PERSP, V112, P1159, DOI 10.1289/ehp.6961; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P5480, DOI 10.1021/es8001184; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; RAMARATHNAM N, 1993, J AGR FOOD CHEM, V41, P939, DOI 10.1021/jf00030a020; RAMARATHNAM N, 1993, J AGR FOOD CHEM, V41, P933, DOI 10.1021/jf00030a019; Reddy ARN, 2011, REGUL TOXICOL PHARM, V59, P251, DOI 10.1016/j.yrtph.2010.10.007; Roy D, 1998, FRONT BIOSCI-LANDMRK, V3, P913; Sanchis J, 2016, ENVIRON SCI TECHNOL, V50, P961, DOI 10.1021/acs.est.5b03966; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/713853956; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; SUN Y, 1988, CLIN CHEM, V34, P497; Vazquez-Duhalt R., 2005, APPL ECOL ENV RES, V4, P1; Wang JX, 2006, BIOCHEM PHARMACOL, V71, P872, DOI 10.1016/j.bcp.2005.12.001; Wang WW, 2014, INT J MOL SCI, V15, P15981, DOI 10.3390/ijms150915981; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Watanabe H, 2004, J MOL ENDOCRINOL, V33, P243, DOI 10.1677/jme.0.0330243; Xu C, 2016, ONCOTARGET, V7, P39270, DOI 10.18632/oncotarget.9689; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Yang K, 2009, ENVIRON POLLUT, V157, P1095, DOI 10.1016/j.envpol.2008.11.007; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137	61	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200238	10.1371/journal.pone.0200238	http://dx.doi.org/10.1371/journal.pone.0200238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028835	Green Submitted, gold, Green Published			2022-12-26	WOS:000439396900005
J	Mastrangelo, T; Kovaleski, A; Botteon, V; Scopel, W; Costa, MDZ				Mastrangelo, Thiago; Kovaleski, Adalecio; Botteon, Victor; Scopel, Wanessa; Zamboni Costa, Maria de Lourdes			Optimization of the sterilizing doses and overflooding ratios for the South American fruit fly	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; INSECT TECHNIQUE; TEPHRITIDAE; POPULATIONS; FEMALES; COMPLEX; INDUCTION; MALES; FLIES	The Sterile Insect Technique (SIT) is an autocidal control method that relies on inundative releases of sterilized mass-reared insects. This technology has been used in several area-wide programmes for the suppression/eradication of fruit fly populations. Choosing the optimum sterilizing dose and the sterile release density is an essential step of the SIT. Considering unsolved issues related to the application of this technique against Anastrepha fraterculus (Wiedemann), this study aimed to define accurately the central target dose for both sexes of this species and to verify the induction of sterility in fertile flies at different sterile:fertile ratios. The results from the regression analyses proved that the sterilization process for the A. fraterculus Brazilian-1 morphotype (the most common in southern Brazil and Argentina) could consist of irradiating pupae 72 h before adult emergence at 40 Gy, with no detrimental effects to standard quality control parameters. The ovarian development in irradiated females was characterized, demonstrating that doses equal to or higher than 25 Gy cause complete and irreversible ovarian atrophy. The laboratory and field cage tests showed that the sterility induction increased with the proportion of sterile flies, and a sterile:fertile ratio of 50:1 should be appropriate in SIT field trials. The sterile females apparently did not distract the sterile males, despite of the slightly higher reductions in pupal yield for all ratios in their absence. The data generated in this study have a great practical value and will help decision-makers in planning field trials to evaluate the efficacy of the SIT against A. fraterculus populations.	[Mastrangelo, Thiago; Botteon, Victor; Zamboni Costa, Maria de Lourdes] Univ Sao Paulo, CENA, Sao Paulo, Brazil; [Kovaleski, Adalecio] Empresa Brasileira Pesquisa Agr EMBRAPA, Estacao Expt Fruticultura Clima Temperado, Vacaria, RS, Brazil; [Scopel, Wanessa] Univ Sao Paulo, ESALQ, Sao Paulo, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Mastrangelo, T (corresponding author), Univ Sao Paulo, CENA, Sao Paulo, Brazil.	piaui@cena.usp.br	Mastrangelo, Thiago/N-3569-2019	Mastrangelo, Thiago/0000-0003-1882-9565; Botteon, Victor Wilson/0000-0002-2660-3796	FAPESP [2016/24510-6]; CNPq [401369/2016-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The experiments of this study were supported by FAPESP (grant number 2016/24510-6) and CNPq (grant number 401369/2016-1) for Prof. Thiago Mastrangelo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abraham S, 2013, B ENTOMOL RES, V103, P310, DOI 10.1017/S0007485312000727; Abraham S, 2011, ENTOMOL EXP APPL, V141, P15, DOI 10.1111/j.1570-7458.2011.01160.x; Alba MG, 2016, 9 M TEPHR WORK W HEM; Allinghi A, 2007, FLA ENTOMOL, V90, P27, DOI 10.1653/0015-4040(2007)90[27:CACOAL]2.0.CO;2; Allinghi A, 2007, FLA ENTOMOL, V90, P96, DOI 10.1653/0015-4040(2007)90[96:IOSIAF]2.0.CO;2; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bartolucci AF, 2006, P 7 INT S FRUIT FLIE; Bron Ilana U., 2006, Braz. J. Plant Physiol., V18, P389, DOI 10.1590/S1677-04202006000300005; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; Cendra PG, 2007, FLA ENTOMOL, V90, P147, DOI 10.1653/0015-4040(2007)90[147:COLBAL]2.0.CO;2; Costa MLZ, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew071; Devescovi F, 2014, ENTOMOL EXP APPL, V152, P238, DOI 10.1111/eea.12219; Dias VS, 2016, BIOL J LINN SOC, V117, P725, DOI 10.1111/bij.12712; Dyck V.A., 2006, STERILE INSECT TECHN; Flores S, 2017, ENTOMOL EXP APPL, V164, P284, DOI 10.1111/eea.12580; Flores S, 2014, J ECON ENTOMOL, V107, P1502, DOI 10.1603/EC13398; Cendra PG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.17501; Gonzalez J, 1971, REV PERUANA ENTOMOLO, V14, P77; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hernandez-Ortiz V, 2015, ZOOKEYS, P95, DOI 10.3897/zookeys.540.6027; [IAEA USDA FAO], 2014, PROD QUAL CONTR STER; *IAEA, 2004, DOS SYST SIT STAND O; Knipling E.F., 1979, USDA SEA AGR HDB, V512, P659; Kovaleski A., 2007, P581, DOI 10.1007/978-1-4020-6059-5_54; Liendo MC, 2013, B ENTOMOL RES, V103, P1, DOI 10.1017/S0007485312000442; Machota JR, 2010, TECNICA CRIACAO ANAS; Mastrangelo T, 2010, J ECON ENTOMOL, V103, P85, DOI 10.1603/EC09139; Mehta K, 2011, RADIAT PHYS CHEM, V80, P107, DOI 10.1016/j.radphyschem.2010.08.011; Walder JMM, 2014, SCI AGR, V71, P281, DOI 10.1590/0103-9016-2013-233; Meza JS, 2016, 9 M TEPHR WORK W HEM; Orozco D, 2013, J APPL ENTOMOL, V137, P321, DOI 10.1111/j.1439-0418.2012.01748.x; Orozco-Davila D, 2017, ENTOMOL EXP APPL, V164, P176, DOI 10.1111/eea.12581; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; RHODE RH, 1971, J ECON ENTOMOL, V64, P708, DOI 10.1093/jee/64.3.708; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Rull J, 2013, ENTOMOL EXP APPL, V148, P213, DOI 10.1111/eea.12094; SAS Institute Inc, 2013, SAS SOFTW VERS 9 4; Segura DF, 2013, J APPL ENTOMOL, V137, P19, DOI 10.1111/j.1439-0418.2010.01534.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shelly T, 2016, ANN ENTOMOL SOC AM, V109, P1, DOI 10.1093/aesa/sav101; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; STEINER LF, 1969, J ECON ENTOMOL, V62, P4, DOI 10.1093/jee/62.1.4; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; Vera MT, 2002, FLA ENTOMOL, V85, P156, DOI 10.1653/0015-4040(2002)085[0156:FAFRFI]2.0.CO;2; Villasenor A., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P361	48	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201026	10.1371/journal.pone.0201026	http://dx.doi.org/10.1371/journal.pone.0201026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028883	Green Published, Green Submitted, gold			2022-12-26	WOS:000439396900032
J	Ibuki, A; Minematsu, T; Yoshida, M; Lizaka, S; Matsumoto, M; Sugama, J; Sanada, H				Ibuki, Ai; Minematsu, Takeo; Yoshida, Mikako; Lizaka, Shinji; Matsumoto, Masaru; Sugama, Junko; Sanada, Hiromi			Microsatellite polymorphism in the Heme oxygenase-1 gene promoter is associated with dermal collagen density in Japanese obese male subjects	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; HEME OXYGENASE-1; OXIDATIVE STRESS; ADIPOSE-TISSUE; HUMAN SKIN; SUSCEPTIBILITY; RISK; MICE; OUTCOMES	We previously reported elevated oxidative stress-related mechanical vulnerabilities of the skin as sparse distributions of hyperechoic areas. Although this helped establish a personalized skin care system to prevent skin disorders related to mechanical stress, obesity-related skin vulnerability involves individual differences. Here, we hypothesized that individual differences are caused by polymorphisms of GT repetitive sequences in the heme oxygenase1 (HMOX1) promoter region, which encodes an antioxidant enzyme. This cross-sectional study enrolled healthy male volunteers in a walking classroom aimed at weight control. Subjects with a body mass index <25 kg/m(2) were classified as non-obese and those with body mass index >= 25 kg/m(2) were classified as obese. Subject skin was categorized into sparse dermis or normal groups according to the distribution of hyperechoic areas by high-resolution skin ultrasonography (20 MHz). Genomic DNA and mRNA extracted from three body hairs with attached follicle cells were used to analyze GT repetitive sequences of the HMOX1 promoter, HMOX1 mRNA expression levels, and oxidative stress levels (8-hydroxy-2'-deoxyguanosine). Classifications of GT repetitive sequence of HMOX1 promoter were Short (<27 times) and Long (>= 27 times). Higher numbers of subjects with sparse dermis were in the obese group compared with the non-obese group. In obese subjects, the number of subjects that had the Long allele of the HMOX1 promoter with sparse dermis was significantly higher compared with the normal group, whereas no association was observed between the polymorphism and ultrasonographic features in non-obese subjects. Thus, HMOX1 polymorphisms detected a risk of low collagen density in Japanese obese male subjects.	[Ibuki, Ai] Yokohama City Univ, Sch Med, Dept Biol Sci & Nursing, Yokohama, Kanagawa, Japan; [Ibuki, Ai; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Minematsu, Takeo] Univ Tokyo, Grad Sch Med, Dept Skincare Sci, Tokyo, Japan; [Yoshida, Mikako; Matsumoto, Masaru] Univ Tokyo, Grad Sch Med, Dept Imaging Nursing Sci, Tokyo, Japan; [Lizaka, Shinji] Shukutoku Univ, Coll Nursing & Nutr, Sch Nutr, Chiba, Japan; [Sugama, Junko] Kanazawa Univ, Innovat Integrated Biores Core Inst Frontier Sci, Adv Hlth Care Sci Res Unit, Kanazawa, Ishikawa, Japan	Yokohama City University; University of Tokyo; University of Tokyo; University of Tokyo; Kanazawa University	Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Yoshida, Mikako/Y-6567-2018; Minematsu, Takeo/AAH-7406-2020; Matsumoto, Masaru/C-3221-2015	Minematsu, Takeo/0000-0001-5859-7290; Matsumoto, Masaru/0000-0003-0246-395X; Yoshida, Mikako/0000-0003-3495-6206; Sanada, Hiromi/0000-0003-1912-1251				Akase T, 2012, BIOL RES NURS, V14, P180, DOI 10.1177/1099800411401013; Amri R, 2014, AM J SURG, V207, P17, DOI 10.1016/j.amjsurg.2013.05.016; Angoa-Perez M, 2006, NEUROREPORT, V17, P629, DOI 10.1097/00001756-200604240-00014; CASTELOBRANCO C, 1994, MATURITAS, V18, P199, DOI 10.1016/0378-5122(94)90126-0; Chang YC, 2012, ARCH DERMATOL RES, V304, P739, DOI 10.1007/s00403-012-1289-2; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Courtney AE, 2007, AM J TRANSPLANT, V7, P908, DOI 10.1111/j.1600-6143.2006.01726.x; Division of Health Promotion and Nutrition Ministry of Health, 2018, ANN REP NAT NUTR SUR, V2, P20; Division of Health Promotion and Nutrition Ministry of Health Labour and Welfare, 2013, ANN REP NAT NUTR SUR; Eiberger W, 2008, DNA REPAIR, V7, P912, DOI 10.1016/j.dnarep.2008.03.002; ENSER M, 1984, DIABETOLOGIA, V27, P44; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Horii M., 2012, J JPN SOC WOUND OSTO, V17, P23; Ibuki A, 2012, EXP DERMATOL, V21, P178, DOI 10.1111/j.1600-0625.2011.01409.x; Kaneda H, 2002, ARTERIOSCL THROM VAS, V22, P1680, DOI 10.1161/01.ATV.0000033515.96747.6F; Kikuchi A, 2005, HUM GENET, V116, P354, DOI 10.1007/s00439-004-1162-2; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lakshmanan AP, 2011, FREE RADICAL RES, V45, P788, DOI 10.3109/10715762.2011.579121; LeBlanc K, 2013, ADV SKIN WOUND CARE, V26, P459, DOI 10.1097/01.ASW.0000434056.04071.68; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Matsumoto M, 2014, INT J COSMETIC SCI, V36, P477, DOI 10.1111/ics.12145; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MORAN CM, 1995, ULTRASOUND MED BIOL, V21, P1177, DOI 10.1016/0301-5629(95)00049-6; Murakami A, 2012, LUNG, V190, P333, DOI 10.1007/s00408-012-9371-2; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Okinaga S, 1996, BLOOD, V87, P5074, DOI 10.1182/blood.V87.12.5074.bloodjournal87125074; OLERUD JE, 1987, J INVEST DERMATOL, V88, P615, DOI 10.1111/1523-1747.ep12470221; Song FF, 2009, AM J EPIDEMIOL, V170, P747, DOI 10.1093/aje/kwp196; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; VanGilder C, 2009, J NURS CARE QUAL, V24, P127, DOI 10.1097/01.NCQ.0000347449.83052.1a; Wojtysiak D, 2013, FOLIA BIOL-KRAKOW, V61, P221, DOI 10.3409/fb61_3-4.221; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yamane T, 2010, MOL NUTR FOOD RES, V54, pS53, DOI 10.1002/mnfr.201000022; Yu H, 2013, MOL BIOL REP, V40, P5307, DOI 10.1007/s11033-013-2631-2	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199994	10.1371/journal.pone.0199994	http://dx.doi.org/10.1371/journal.pone.0199994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024897	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000014
J	Quah, SW; Majid, HA; Al-Sadat, N; Yahya, A; Sue, TT; Jalaludin, MY				Quah, Shiao Wei; Majid, Hazreen Abdul; Al-Sadat, Nabilla; Yahya, Abqariyah; Sue, Tin Tin; Jalaludin, Muhammad Yazid			Risk factors of vitamin D deficiency among 15-year-old adolescents participating in the Malaysian Health and Adolescents Longitudinal Research Team Study (MyHeARTs)	PLOS ONE			English	Article							25-HYDROXYVITAMIN D-3; SUN PROTECTION; CHILDREN; SCHOOLCHILDREN; EPIDEMIOLOGY; DETERMINANTS; CHILDHOOD; NUTRITION; ETHNICITY; ADULTHOOD	Background This study is to determine the prevalence and risk factors of vitamin D deficiency (vitamin D <= 50 nmol/L) among 15-year-old Malaysian adolescents. By identifying potential risk factors, prevention strategies and interventions can be carried out to improve the vitamin D status in adolescents. Methods and findings Stratified random sampling design was used to select adolescents from 15 urban and rural secondary schools in Selangor, Perak and Kuala Lumpur, Malaysia. Data collection was carried out from 1st April 2014 to 30th June 2014. Information regarding socio-demographic characteristics, sun exposure and sun protective behaviours, clinical data and environmental factors were collected. Blood for total vitamin D was sampled. Descriptive and multivariate logistic regressions were performed. Total 1061 participants were analyzed (62% were female; mean age 15.1 +/- 0.4 years). The prevalence of vitamin D deficiency was 33%. Mean vitamin D was lower in female (53 +/- 15 nmol), obese (body fat percentage (>= 25%(m); >33.8%(f)) (56 +/- 16 nmol/L), Malays (58 +/- 18 nmol/L) and Indians (58 +/- 15 nmol/L). In multivariate analysis, female (OR = 5.5; 95% CI: 3.4-7.5), Malay (OR = 3.2; 95% CI: 1.3-8.0), Indian (OR = 4.3; 95% CI: 1.6-12.0) and those always wearing long sleeve (OR = 2.4; 95% CI: 1.1-5.4) were more likely to have vitamin D deficiency. For female participants, ethnicity {Malays (OR = 6.7; 95% CI: 2.0-18.5), Indian (OR = 4.5; 95% CI: 1.8-19.3)} was an important risk factors. Cloud cover, school residence, skin pigmentation, sun-exposure and sun-protective behaviours were not significant risk factors. The limitation of this study was recall bias as it relied on self-reported on the sun exposure and protective behaviours. The diet factors were not included in this analysis. Conclusions The prevalence of Vitamin D deficiency among Malaysian adolescents was considerable. Gender, ethnicity and clothing style were important risk factors.	[Quah, Shiao Wei; Jalaludin, Muhammad Yazid] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Majid, Hazreen Abdul; Al-Sadat, Nabilla; Sue, Tin Tin] Univ Malaya, Fac Med, Ctr Populat Hlth CePH, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Yahya, Abqariyah] Univ Malaya, Fac Med, Dept Social & Prevent Med, JCUM, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Jalaludin, MY (corresponding author), Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia.	yazidj@ummc.edu.my	Yahya, Abqariyah/B-5638-2017; Jalaludin, Muhammad Yazid/B-9172-2010; Abdul Majid, Hazreen/B-8619-2010	Yahya, Abqariyah/0000-0001-9158-415X; Jalaludin, Muhammad Yazid/0000-0003-4513-8444; Su, Tin Tin/0000-0003-0387-6406; Abdul Majid, Hazreen/0000-0002-2718-8424	University of Malaya [RP022-14HTM]	University of Malaya(Universiti Malaya)	The study was funded by the grant from University of Malaya Research Program: RP022-14HTM to HAM. The funders had no role in study design, collection, analysis and interpretation of data, writing of the manuscript, or decision to submit for publication.	Abdullah NF, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090551; Al-Sadat N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010689; Alshahrani FM, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23351; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; [Anonymous], UV RES GUID SUNSCR; Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cashman KD, 2007, POSTGRAD MED J, V83, P230, DOI 10.1136/pgmj.2006.052787; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Chew A, 2013, NUTR REV, V71, P189, DOI 10.1111/nure.12015; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Foo LH, 2009, OSTEOPOROSIS INT, V20, P417, DOI 10.1007/s00198-008-0667-2; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Grober U, 2014, DERMATOENDOCRINOL, V4, P158; Harinarayan CV, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23873; Hazreen MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S6; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Holick MF, 2012, J PARENTERAL ENTERAL, V36; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Huh SY, 2008, REV ENDOCR METAB DIS, V9, P161, DOI 10.1007/s11154-007-9072-y; Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x; Jayaratne N, 2012, PREV MED, V55, P146, DOI 10.1016/j.ypmed.2012.05.011; Juonala M, 2015, J CLIN ENDOCR METAB, V100, P1469, DOI 10.1210/jc.2014-3944; Karaguzel G, 2014, J PEDIATR GASTR NUTR, V58, P654, DOI 10.1097/MPG.0000000000000274; KHOR GL, 2011, BMC PUBLIC HEALTH, V11, DOI DOI 10.1186/1471-2458-11-1; Kouda K, 2013, NUTRITION, V29, P1204, DOI 10.1016/j.nut.2013.03.010; Linos E, 2012, CANCER CAUSE CONTROL, V23, P133, DOI 10.1007/s10552-011-9862-0; Majid HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30544; Majid HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155447; MARTINEAU AR, 2017, BMJ OPEN, V356, DOI DOI 10.1136/BMJ.I6583; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McDonnell SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180483; McKenzie RL, 2009, PHOTOCHEM PHOTOBIOL, V85, P88, DOI 10.1111/j.1751-1097.2008.00400.x; Moy FM, 2011, J PHOTOCH PHOTOBIO B, V104, P444, DOI 10.1016/j.jphotobiol.2011.05.002; Narchi H, 2015, PAEDIATR INT CHILD H, V35, P36, DOI 10.1179/2046905514Y.0000000144; Nessvi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1173, DOI 10.1111/j.1751-1097.2011.00956.x; O'Neill V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067663; Parisi AV, 2007, ENV HLTH, V7, P1; Pike JW, 2016, VITAM HORM, V100, P44, DOI [10.1016/bs.vh.2015, DOI 10.1016/BS.VH.2015]; Pludowski P, 2017, J STEROID BIOCHEM, P125, DOI [10.1016/j.asbmb.2017.01.021, DOI 10.1016/J.ASBMB.2017.01.021]; Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092; Poomthavorn P, 2012, INT J OBESITY, V36, P491, DOI 10.1038/ijo.2011.260; Puri S, 2008, BRIT J NUTR, V99, P876, DOI 10.1017/S0007114507831758; Rahmadhani R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178695; Rajakumar K, 2008, OBESITY, V16, P90, DOI 10.1038/oby.2007.23; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Sim PY, 2014, BIOMED RES INT, V4, P1; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski AT, 2015, SCI REPORT; Soesanti F., 2013, INT J PEDIAT ENDO S1, V2013, pP167, 1687, DOI [10.1186/1687-9856-2013-S1-P167, DOI 10.1186/1687-9856-2013-S1-P167]; Sullivan SS, 2003, NUTR RES, V23, P631, DOI 10.1016/S0271-5317(03)00018-6; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; Villamor E, 2011, AM J CLIN NUTR, V94, P1020, DOI 10.3945/ajcn.111.018168; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wu FT, 2018, ANN MED, V50, P74, DOI 10.1080/07853890.2017.1399446; Zmuda JM, 2000, EPIDEMIOL REV, V22, P203, DOI 10.1093/oxfordjournals.epirev.a018033	63	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200736	10.1371/journal.pone.0200736	http://dx.doi.org/10.1371/journal.pone.0200736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024934	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000046
J	Roth, N; Rust, NC				Roth, Noam; Rust, Nicole C.			Inferotemporal cortex multiplexes behaviorally-relevant target match signals and visual representations in a manner that minimizes their interference	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; MACAQUE AREA V4; DECISION-MAKING; OBJECT RECOGNITION; MIXED SELECTIVITY; PERIRHINAL CORTEX; PARIETAL CORTEX; TRADE-OFF; MEMORY; NEURONS	Finding a sought visual target object requires combining visual information about a scene with a remembered representation of the target to create a "target match" signal that indicates when a target is in view. Target match signals have been reported to exist within high-level visual brain areas including inferotemporal cortex (IT), where they are mixed with representations of image and object identity. However, these signals are not well understood, particularly in the context of the real-world challenge that the objects we search for typically appear at different positions, sizes, and within different background contexts. To investigate these signals, we recorded neural responses in IT as two rhesus monkeys performed a delayed-match-to-sample object search task in which target objects could appear at a variety of identity-preserving transformations. Consistent with the existence of behaviorally-relevant target match signals in IT, we found that IT contained a linearly separable target match representation that reflected behavioral confusions on trials in which the monkeys made errors. Additionally, target match signals were highly distributed across the IT population, and while a small fraction of units reflected target match signals as target match suppression, most units reflected target match signals as target match enhancement. Finally, we found that the potentially detrimental impact of target match signals on visual representations was mitigated by target match modulation that was approximately (albeit imperfectly) multiplicative. Together, these results support the existence of a robust, behaviorally-relevant target match representation in IT that is configured to minimally interfere with IT visual representations.	[Roth, Noam; Rust, Nicole C.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	University of Pennsylvania	Rust, NC (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	nrust@psych.upenn.edu			National Eye Institute of the National Institutes of Health [R01EY020851]; Simons Foundation; McKnight Endowment for Neuroscience; NATIONAL EYE INSTITUTE [R01EY020851, P30EY001583] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Simons Foundation; McKnight Endowment for Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute of the National Institutes of Health (award R01EY020851), the Simons Foundation (through an award from the Simons Collaboration on the Global Brain), and the McKnight Endowment for Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak O, 2013, J NEUROSCI, V33, P3844, DOI 10.1523/JNEUROSCI.2753-12.2013; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Engel TA, 2011, J NEUROSCI, V31, P6982, DOI 10.1523/JNEUROSCI.6150-10.2011; ESKANDAR EN, 1992, J NEUROPHYSIOL, V68, P1277, DOI 10.1152/jn.1992.68.4.1277; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Kobak D, 2016, ELIFE, V5, DOI 10.7554/eLife.10989; Kosai Y, 2014, J NEUROSCI, V34, P8570, DOI 10.1523/JNEUROSCI.1375-14.2014; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Mruczek REB, 2007, J NEUROSCI, V27, P2825, DOI 10.1523/JNEUROSCI.4102-06.2007; Pagan M, 2016, NEURAL COMPUT, V28, P2291, DOI 10.1162/NECO_a_00890; Pagan M, 2014, J NEUROPHYSIOL, V112, P1584, DOI 10.1152/jn.00260.2014; Pagan M, 2014, J NEUROSCI, V34, P11067, DOI 10.1523/JNEUROSCI.4040-13.2014; Pagan M, 2013, NAT NEUROSCI, V16, P1132, DOI 10.1038/nn.3433; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rishel CA, 2013, NEURON, V77, P969, DOI 10.1016/j.neuron.2013.01.007; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Woloszyn L, 2009, J NEUROSCI, V29, P5494, DOI 10.1523/JNEUROSCI.5785-08.2009; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200528	10.1371/journal.pone.0200528	http://dx.doi.org/10.1371/journal.pone.0200528			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024905	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000027
J	van Andel, S; Cole, MH; Pepping, GJ				van Andel, Steven; Cole, Michael H.; Pepping, Gert-Jan			Regulation of locomotor pointing across the lifespan: Investigating age-related influences on perceptual-motor coupling	PLOS ONE			English	Article							MUSCLE STRENGTH; OLDER-ADULTS; GAIT; MOVEMENT; WALKING; SPEED	Introduction The regulation of one's step length by placing one's foot at a specific position within gait, otherwise known as locomotor pointing', is well understood in walking and running gait. The current study was the first to broaden this understanding to a larger cohort and to describe the influence of age on the regulation of locomotor pointing when walking up to and stepping onto a curb-like platform. Methods Younger (n = 17, mean age: 25.35 years, range: 19-33) and older adults (n = 105, mean age: 71.49 years, range: 61-86) participated in a walking experiment, requiring them to approach and step onto a curb-like platform. Linear mixed effects modeling was used to study the main outcome variables: onset of regulation, the regulation strategy and the strength of perceptual-motor coupling. Results Results showed that with older age, participants showed less variability in foot placement during their approach and seemed to prefer to shorten their steps. Furthermore, the strength of the perceptual-motor relationship was found to be related to age; regulation of step length of both younger and older participants was based on a participant's current foot position. The strength of this relationship increased as participants got closer to the curb and was stronger with increasing age. Furthermore, younger adults on average lengthened their steps as they got closer to the curb, whereas older adults showed significantly less lengthening compared to their younger counterparts. No age-related differences were found in terms of onset of regulation. Discussion The results suggest that the strength of the perceptual-motor relationship in gait is related to age. It is argued that this age-related increase in the strength of perceptual-motor coupling is required to cope with increasing demands linked to the age-related declines of action capabilities. The implications of the findings are discussed in the context of increased falls risks and deficits in perceptual-motor functioning.	[van Andel, Steven; Cole, Michael H.; Pepping, Gert-Jan] Australian Catholic Univ, Sch Exercise Sci, Banyo, Qld, Australia	Australian Catholic University	van Andel, S (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Banyo, Qld, Australia.	Steven.vanAndel@acu.edu.au	Cole, Michael H/O-6816-2018; van Andel, Steven/V-6956-2019; Pepping, Gert-Jan/Y-8545-2019; Pepping, Gert-Jan/B-2197-2010	van Andel, Steven/0000-0002-5374-8077; Pepping, Gert-Jan/0000-0002-5926-2000; Pepping, Gert-Jan/0000-0002-5926-2000; Cole, Michael/0000-0003-1817-7528	Australian Government	Australian Government(Australian GovernmentCGIAR)	Steven van Andel is supported by an Australian Government Research Training Program Scholarship.	Arnold P, 2014, EXP GERONTOL, V58, P58, DOI 10.1016/j.exger.2014.07.012; Barton SL, 2017, J EXP PSYCHOL HUMAN, V43, P1773, DOI 10.1037/xhp0000435; Bherer L., 2013, J AGING RES, V2013, DOI [10.1155/2013/657508., 10.1155/2013/657508]; Buekers M, 1999, NEUROSCI LETT, V275, P171, DOI 10.1016/S0304-3940(99)00750-8; Caetano MJD, 2016, GAIT POSTURE, V46, P35, DOI 10.1016/j.gaitpost.2016.02.003; Comalli D, 2013, EXP BRAIN RES, V228, P183, DOI 10.1007/s00221-013-3550-0; Cordovil R, 2015, NEW IDEAS PSYCHOL, V36, P50, DOI 10.1016/j.newideapsych.2014.10.007; Cornus S, 2009, ECOL PSYCHOL, V21, P334, DOI 10.1080/10407410903320991; Croft JL, 2018, J EXP CHILD PSYCHOL, V166, P134, DOI 10.1016/j.jecp.2017.07.012; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; de Rugy A, 2000, NEUROSCI LETT, V281, P87, DOI 10.1016/S0304-3940(00)00827-2; de Rugy A, 2002, BIOL CYBERN, V87, P141, DOI 10.1007/s00422-002-0325-2; de Rugy A, 2002, EXP BRAIN RES, V146, P129, DOI 10.1007/s00221-002-1155-0; de Rugy A, 2001, BEHAV BRAIN RES, V123, P11, DOI 10.1016/S0166-4328(01)00185-1; de Rugy A, 2000, BEHAV RES METH INS C, V32, P515, DOI 10.3758/BF03200823; HAY JG, 1988, INT J SPORT BIOMECH, V4, P114, DOI 10.1123/ijsb.4.2.114; Holland GJ, 2002, J AGING PHYS ACTIV, V10, P169, DOI 10.1123/japa.10.2.169; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Laessoe U, 2013, AGING CLIN EXP RES, V25, P299, DOI 10.1007/s40520-013-0038-5; Lafargue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051218; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; Liberman K, 2017, CURR OPIN CLIN NUTR, V20, P30, DOI 10.1097/MCO.0000000000000335; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; Luyat M, 2008, PSYCHOL NEUROPSYCHIA, V6, P287, DOI 10.1684/pnv.2008.0149; Montagne G, 2000, J MOTOR BEHAV, V32, P37, DOI 10.1080/00222890009601358; Montagne G, 2002, EXP BRAIN RES, V143, P133, DOI 10.1007/s00221-001-0990-8; OBERG T, 1993, J REHABIL RES DEV, V30, P210; Patla AE, 1999, EXP BRAIN RES, V128, P441, DOI 10.1007/s002210050867; PLUMERT JM, 1995, DEV PSYCHOL, V31, P866, DOI 10.1037/0012-1649.31.5.866; Sakurai R, 2013, BMC GERIATR, V13, P1, DOI [10.1186/1471-2318-13-1, DOI 10.1186/1471-2318-13-1]; van Andel S, 2018, GAIT POSTURE, V60, P164, DOI 10.1016/j.gaitpost.2017.12.006; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004; Vaz DV, 2017, HUM MOVEMENT SCI, V52, P117, DOI 10.1016/j.humov.2017.01.010; Zivotofsky AZ, 2012, HUM FACTORS, V54, P600, DOI 10.1177/0018720812447945	35	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200244	10.1371/journal.pone.0200244	http://dx.doi.org/10.1371/journal.pone.0200244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024895	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000017
J	Kovacs, L; Kezer, FL; Ruff, F; Jurkovich, V; Szenci, O				Kovacs, Levente; Kezer, Fruzsina Luca; Ruff, Ferenc; Jurkovich, Viktor; Szenci, Otto			Assessment of heat stress in 7-week old dairy calves with non-invasive physiological parameters in different thermal environments	PLOS ONE			English	Article							SUPPLEMENTAL SHADE; COWS; RESPONSES; LOSSES	We estimated thermal stress in 7-week old Holstein bull calves during a warm episode in summer to study acute physiological responses of calves to heat stress. Data were collected over a 5-day period: day 1 (control), day 2 (heat stress), and a 3-day post-stress period in shaded (n = 8) and unshaded (n = 8) thermal environments. On the control day, both groups were shaded. Thermal environment was characterized by relative humidity, ambient temperature, and the temperature-humidity index (THI). Physiological variables included respiratory rate, rectal temperature, ear skin temperature and heart rate. Correlations between animal-based and meteorological indices were calculated, and ambient temperature correlated slightly better with physiological measures than THI. Rectal temperature was the only animal-based parameter that showed stronger correlations with the thermal indices when calculated for the shaded than for the unshaded environment [r = 0.42 vs. r = 0.47, P= 0.032 (ambient temperature), r = -0.39 vs. r = -0.45, P = 0.012 P = 0.015 (relative humidity), r = 0.41 vs. r = 0.46, P= 0.022 (THI)]. No differences were found between groups during the control day for any of the physiological parameters. During days 2 and 3, average and maximal values of respiratory and heart rates were higher in unshaded calves than in shaded ones. Maximal respiratory rates were in average by 25.9, 17.8 and 10.1 breaths/min lower in shaded calves than in unshaded calves for days 2, 3 and 4, respectively (P < 0.001, P < 0.001 and P= 0.024). Maximal heart rate was 127.4 +/- 8.5 vs. 99.2 +/- 6.3 beats/min on the heat stress day (P < 0.001), and 121.0 +/- 6.9 vs. 103.4 +/- 7.7 beats/min on day 3 (P = 0.006) in unshaded and shaded calves, respectively. Maximal body temperatures were higher measured either in the rectum or on the ear skin in unshaded calves than in shaded ones (with 0.5 and 1.6 degrees C, P= 0.040 and P= 0.018, respectively), but only on the heat stress day. Based on our results, shading of young calves may be adequate for alleviating acute heat stress in continental regions. Ambient temperature is appropriate to estimate acute heat stress in dairy calves.	[Kovacs, Levente; Kezer, Fruzsina Luca; Szenci, Otto] MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary; [Kovacs, Levente; Kezer, Fruzsina Luca] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Anim Husb, Godollo, Hungary; [Ruff, Ferenc] Hungarian Cent Stat Off, Dept Methodol, Budapest, Hungary; [Jurkovich, Viktor] Univ Vet Med, Dept Anim Hyg Herd Hlth & Vet Ethol, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; University of Veterinary Medicine Budapest	Kovacs, L (corresponding author), MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary.; Kovacs, L (corresponding author), Szent Istvan Univ, Fac Agr & Environm Sci, Inst Anim Husb, Godollo, Hungary.	Kovacs.Levente@mkk.szie.hu	Jurkovich, Viktor/AAJ-2114-2020	Jurkovich, Viktor/0000-0002-6019-3508; Szenci, Otto/0000-0002-3248-173X	Hungarian Academy of Sciences, Hungary [BO/00040/16/4]; OTKA Postdoctoral Scholarship of the National Research, Development and Innovation Office, Hungary [NKFIH-6493-1/2016]; Research Center of Excellence project of the National Research, Development and Innovation Office, Hungary [1476-4/2016/FEKUT]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4-I/SZIE-7]; Hungarian Ministry of Human Resources [11475-4/2016/FEKUT]; Hungarian Academy of Sciences, Hungary	Hungarian Academy of Sciences, Hungary(Hungarian Academy of Sciences); OTKA Postdoctoral Scholarship of the National Research, Development and Innovation Office, Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Research Center of Excellence project of the National Research, Development and Innovation Office, Hungary; New National Excellence Program of the Ministry of Human Capacities; Hungarian Ministry of Human Resources; Hungarian Academy of Sciences, Hungary(Hungarian Academy of Sciences)	Levente Kovacs was supported by the following grants: 1) Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, Hungary [BO/00040/16/4], 2) OTKA Postdoctoral Scholarship of the National Research, Development and Innovation Office, Hungary [NKFIH-6493-1/2016], 3) Research Center of Excellence project of the National Research, Development and Innovation Office, Hungary [1476-4/2016/FEKUT], 4) New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4-I/SZIE-7]. Viktor Jurkovich was supported by the grant of the Hungarian Ministry of Human Resources [11475-4/2016/FEKUT] and by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, Hungary.; Levente Kovacs was supported by the following grants: 1) Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, Hungary [BO/00040/16/4], 2) OTKA Postdoctoral Scholarship of the National Research, Development and Innovation Office, Hungary [NKFIH-6493-1/2016], 3) Research Center of Excellence project of the National Research, Development and Innovation Office, Hungary [1476-4/2016/FEKUT], 4) New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4-I/SZIE-7].; Viktor Jurkovich was supported by the grant of the Hungarian Ministry of Human Resources [11475-4/2016/FEKUT] and by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, Hungary.	ARMSTRONG DV, 1994, J DAIRY SCI, V77, P2044, DOI 10.3168/jds.S0022-0302(94)77149-6; BIANCA W, 1962, NATURE, V195, P251, DOI 10.1038/195251a0; Bohmanova J, 2007, J DAIRY SCI, V90, P1947, DOI 10.3168/jds.2006-513; Bonk S, 2013, J DAIRY SCI, V96, P3265, DOI 10.3168/jds.2012-6003; Coleman DA, 1996, J DAIRY SCI, V79, P2038, DOI 10.3168/jds.S0022-0302(96)76577-3; Dikmen S, 2009, J DAIRY SCI, V92, P109, DOI 10.3168/jds.2008-1370; Edenhofer O, 2014, CLIMATE CHANGE 2014, P1086; Lammers B. P., 1996, Applied Engineering in Agriculture, V12, P741; Lima PDO, 2013, J ANIM BEHAV BIOMETE, V1, P7, DOI 10.14269/2318-1265.v01n01a02; Mader TL, 2006, J ANIM SCI, V84, P712, DOI 10.2527/2006.843712x; Maltz E, 1996, J DAIRY SCI, V79, P1621, DOI 10.3168/jds.S0022-0302(96)76525-6; MALTZ E, 1994, J DAIRY SCI, V77, P2630, DOI 10.3168/jds.S0022-0302(94)77204-0; MARTIN SW, 1975, CAN J COMP MED, V39, P377; NEUWIRTH JG, 1979, INT J BIOMETEOROL, V23, P243, DOI 10.1007/BF01553775; NRC, 2001, NUTR REQ DAIR CATTL, V7th; Pena G, 2016, J DAIRY SCI, V99, P1655, DOI 10.3168/jds.2015-10164; R Core Team, 2021, R LANGUAGE ENV STAT; Reiczigel J, 2009, MAGY ALLATORVOSOK, V131, P137; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; Spain JN, 1996, J DAIRY SCI, V79, P639, DOI 10.3168/jds.S0022-0302(96)76409-3; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Theurer ME, 2014, AM J VET RES, V75, P296, DOI 10.2460/ajvr.75.3.296	22	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200622	10.1371/journal.pone.0200622	http://dx.doi.org/10.1371/journal.pone.0200622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020993	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000439022400060
J	Li, M; Zhang, SQ; Zhao, W; Hou, CC; Ma, XL; Li, XK; Huang, BR; Chen, H; Chen, D				Li, Meng; Zhang, Shiqiang; Zhao, Wen; Hou, Congcong; Ma, Xiaoli; Li, Xuekun; Huang, Bingren; Chen, Hong; Chen, Deng			RYBP modulates stability and function of Ring1B through targeting UBE3A	FASEB JOURNAL			English	Article						polycomb-repressive complex 1; protein interaction; ubiquitination; proteasome	POLYCOMB PROTEIN RING1B; HISTONE H2A; UBIQUITIN LIGASE; SELF-UBIQUITINATION; LUNG-CANCER; EXPRESSION; RNF2; PROMOTES; COMPLEXES; INTERACTS	Ring1 and yin yang 1-binding protein (RYBP) are central components of noncanonical polycomb-repressive complex 1 (nc-PRC1), which represses target gene expression and is required for normal organismal development. However, the molecular function of RYBP in this complex is obscure. In this study, we showed that RYBP inhibits the polyubiquitination-mediated proteasomal degradation of Ring1B independently of its ubiquitin (Ub)-protein isopeptide ligase (E3) ligase activity, leading to its stabilization and increased catalytic activity toward monoubiquitination of histone H2A at lysine 119. Mechanistic dissection further disclosed that RYBP directly binds to ubiquitin protein ligase E3A (UBE3A) to promote its ubiquitination and proteasomal degradation in an autoubiquitination-independent manner. The resultant reduction of UBE3A protein level alleviates its effect on ubiquitination-mediated degradation of Ring1B, therefore resulting in increased stability and enhanced transcriptional repressor activity on its target genes. Thus, our current findings lay a foundation for understanding how RYBP functions in nc-PRC1 complexes, which is involved in development, stem cell maintenance, and carcinogenesis.Li, M., Zhang, S., Zhao, W., Hou, C., Ma, X., Li, X., Huang, B., Chen, H., Chen, D. RYBP modulates stability and function of Ring1B through targeting UBE3A.	[Li, Meng; Zhang, Shiqiang; Zhao, Wen; Hou, Congcong; Ma, Xiaoli; Huang, Bingren; Chen, Hong; Chen, Deng] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Biochem & Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Li, Meng; Zhang, Shiqiang; Zhao, Wen; Hou, Congcong; Ma, Xiaoli; Huang, Bingren; Chen, Hong; Chen, Deng] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Li, Xuekun] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang University	Chen, D (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Biochem & Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Chen, D (corresponding author), Peking Union Med Coll, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	chendeng2001@hotmail.com			National Natural Science Foundation of China [81272229]; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2017-I2M-3-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine	This project was supported by the National Natural Science Foundation of China (81272229) and the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2017-I2M-3-004). The authors declare no conflicts of interest.	Almeida M, 2017, SCIENCE, V356, P1081, DOI 10.1126/science.aal2512; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Bosch A, 2014, ONCOTARGET, V5, P2065, DOI 10.18632/oncotarget.1779; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dinglin XX, 2017, TRANSL ONCOL, V10, P280, DOI 10.1016/j.tranon.2017.01.004; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Koike H, 2014, HEPATOLOGY, V60, P323, DOI 10.1002/hep.27046; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; LaSalle JM, 2015, EPIGENOMICS-UK, V7, P1213, DOI 10.2217/epi.15.70; Li HH, 2017, CELL STEM CELL, V20, P462, DOI 10.1016/j.stem.2016.12.002; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu S, 2018, NAT IMMUNOL, V19, P41, DOI 10.1038/s41590-017-0003-0; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Ma W, 2016, CELL SIGNAL, V28, P779, DOI 10.1016/j.cellsig.2016.03.012; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Neira JL, 2009, BIOCHEMISTRY-US, V48, P1348, DOI 10.1021/bi801933c; Novak RL, 2008, CANCER GENE THER, V15, P713, DOI 10.1038/cgt.2008.25; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Rose NR, 2016, ELIFE, V5, DOI [10.7554/elife.18591, 10.7554/eLife.18591]; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Su WJ, 2013, P NATL ACAD SCI USA, V110, P1720, DOI 10.1073/pnas.1211604110; Tan K, 2017, CELL SIGNAL, V29, P127, DOI 10.1016/j.cellsig.2016.10.011; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Voruganti S, 2015, CANCER LETT, V369, P386, DOI 10.1016/j.canlet.2015.09.003; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang W, 2014, ONCOTARGET, V5, P11604, DOI 10.18632/oncotarget.2598; Wen W, 2014, ONCOGENE, V33, P421, DOI 10.1038/onc.2012.605; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zhang JF, 2017, ONCOL LETT, V13, P3817, DOI 10.3892/ol.2017.5868	52	2	2	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					683	695		10.1096/fj.201800397R	http://dx.doi.org/10.1096/fj.201800397R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30040487				2022-12-26	WOS:000457401500053
J	Lamriben, L; Oster, ME; Tamura, T; Tian, WH; Yang, Z; Clausen, H; Hebert, DN				Lamriben, Lydia; Oster, Michela E.; Tamura, Taku; Tian, Weihua; Yang, Zhang; Clausen, Henrik; Hebert, Daniel N.			EDEM1's mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic reticulum-associated protein degradation (ERAD); protein folding; oxidation-reduction (redox); protein degradation; intrinsically disordered protein; 1 antitrypsin (A1AT); ER degradation-enhancing mannosidase-like 1 protein (EDEM1); ERdj5	RETICULUM-ASSOCIATED DEGRADATION; INTRINSICALLY DISORDERED REGIONS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED PROTEINS; MAMMALIAN GLYCOPROTEINS; Z VARIANT; RECOGNITION; CALNEXIN; PATHWAY	Endoplasmic reticulum (ER) degradation-enhancing -mannosidase-like 1 protein (EDEM1) is a protein quality control factor that was initially proposed to recognize N-linked glycans on misfolded proteins through its mannosidase-like domain (MLD). However, recent studies have demonstrated that EDEM1 binds to some misfolded proteins in a glycan-independent manner, suggesting a more complex binding landscape for EDEM1. In this study, we have identified a thiol-dependent substrate interaction between EDEM1 and the (1)-antitrypsin ER-associated protein degradation (ERAD) clients Z and NHK, specifically through the single Cys residue on Z/NHK (Cys(256)), required for binding under stringent detergent conditions. In addition to the thiol-dependent interaction, the presence of weaker protein-protein interactions was confirmed, suggestive of bipartite client-binding properties. About four reactive thiols on EDEM1 were identified and were not directly responsible for the observed redox-sensitive binding by EDEM1. Moreover, a protein construct comprising the EDEM1 MLD had thiol-dependent binding properties along with its active glycan-trimming activities. Lastly, we identified an additional intrinsically disordered region (IDR) located at the C terminus of EDEM1 in addition to its previously identified N-terminal IDR. We also determined that both IDRs are required for binding to the ERAD component ERdj5 as an interaction with ERdj5 was not observed with the MLD alone. Together, our findings indicate that EDEM1 employs different binding modalities to interact with ERAD clients and ER quality control (ERQC) machinery partners and that some of these properties are shared with its homologues EDEM2 and EDEM3.	[Lamriben, Lydia; Oster, Michela E.; Tamura, Taku; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, 240 Thatcher Rd, Amherst, MA 01003 USA; [Lamriben, Lydia; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Tian, Weihua; Yang, Zhang; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Tamura, Taku] Akita Univ, Fac Engn Sci, Dept Life Sci, 1-1 Tegata Gakuenmachi, Akita 0108502, Japan	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Copenhagen; Akita University	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 240 Thatcher Rd, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu	Tian, Weihua/AAC-8919-2022; clausen, henrik/AAD-8016-2021; Yang, Zhang/I-8934-2016	Oster, Michela Elisabetta del Re/0000-0001-9556-018X; Tian, Weihua/0000-0003-2357-3947; Tamura, Taku/0000-0001-6074-9273; Hebert, Daniel/0000-0003-1537-4446; Clausen, Henrik/0000-0002-0915-5055; Yang, Zhang/0000-0002-4756-5813	National Institutes of Health [GM086874]; National Institutes of Health Chemistry-Biology Interface Program Training Grant [T32GM008515]; Danish National Research Foundation [DNRF107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM086874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Chemistry-Biology Interface Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM086874 (to D. N. H.), National Institutes of Health Chemistry-Biology Interface Program Training Grant T32GM008515 (to L. L.), and Danish National Research Foundation Grant DNRF107 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Braakman Ineke, 2017, Curr Protoc Protein Sci, V90, DOI 10.1002/cpps.43; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Ermonval M, 2001, GLYCOBIOLOGY, V11, P565, DOI 10.1093/glycob/11.7.565; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Gulow K, 2002, J CELL SCI, V115, P2443; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107371; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Jang BY, 2015, INT J MOL MED, V35, P870, DOI 10.3892/ijmm.2015.2109; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Khodayari N, 2017, J CELL BIOCHEM, V118, P3090, DOI 10.1002/jcb.26069; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Marin MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042998; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Ninagawa S, 2015, J CELL BIOL, V211, P775, DOI 10.1083/jcb.201504109; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Parodi A., 2015, ESSENTIALS GLYCOBIOL; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Reed BJ, 2015, J BIOL CHEM, V290, P20601, DOI 10.1074/jbc.M115.650952; Ronzoni R, 2016, HUM MOL GENET, V25, P642, DOI 10.1093/hmg/ddv501; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Schulz MA, 2018, GLYCOBIOLOGY, V28, P542, DOI 10.1093/glycob/cwy022; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sokolowska I, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0047-7; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yu SY, 2018, J BIOL CHEM, V293, P10663, DOI 10.1074/jbc.RA118.003129	48	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13932	13945		10.1074/jbc.RA118.004183	http://dx.doi.org/10.1074/jbc.RA118.004183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30021839	Green Published, hybrid			2022-12-26	WOS:000444070700019
J	Yin, RH; Zhou, LT; Gao, N; Li, Z; Zhao, LY; Shang, FN; Wu, MY; Zhao, JH				Yin, Ronghua; Zhou, Lutan; Gao, Na; Li, Zi; Zhao, Longyan; Shang, Feineng; Wu, Mingyi; Zhao, Jinhua			Oligosaccharides from depolymerized fucosylated glycosaminoglycan: Structures and minimum size for intrinsic factor Xase complex inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural product; carbohydrate chemistry; carbohydrate structure; chemical modification; drug discovery; oligosaccharide; thrombosis	CUCUMBER STICHOPUS-JAPONICUS; CHONDROITIN SULFATE; SEA-CUCUMBER; ANTICOAGULANT ACTIVITIES; FUCOSE BRANCHES; HOLOTHURIAN GLYCOSAMINOGLYCAN; TENASE COMPLEX; BODY-WALL; HEPARIN; POLYSACCHARIDE	Fucosylated glycosaminoglycan (FG), a structurally complex glycosaminoglycan found up to now exclusively in sea cucumbers, has distinct anticoagulant properties, notably a strong inhibitory activity of intrinsic factor Xase complex (FXase). Knowledge of the FG structures could facilitate the development of a clinically effective intrinsic FXase inhibitor for anticoagulant drugs. Here, a new fucosylated glycosaminoglycan was obtained from the widely traded sea cucumber Bohadschia argus. The precise structure was deduced as {4)-[l-Fuc3S4S--(13)-]-d-GlcA--(13)-d-GalNAc4S6S--(1} through analysis of its chemical properties and homogeneous oligosaccharides purified from its -eliminative depolymerized products. The B. argus FG with mostly 3,4-di-O-sulfated fucoses expands our knowledge on FG structural types. This -elimination process, producing oligosaccharides with well-defined structures, is a powerful tool for analyzing the structure of complex FGs. Among these oligosaccharides, an octasaccharide displayed potent FXase inhibitory activity. Compared with oligosaccharides with various degrees of polymerization (3n and 3n - 1), our analyses reveal that the purified octasaccharide is the minimum structural unit responsible for the potent selective FXase inhibition, because the d-talitol in the nonsaccharide is unnecessary. The octasaccharide with 2,4-di-O-sulfated fucoses is more potent than that of one with 3,4-di-O-sulfated fucoses. Thus, sulfation patterns can play an important role in the inhibition of intrinsic factor Xase complex.	[Yin, Ronghua; Zhou, Lutan; Gao, Na; Li, Zi; Zhao, Longyan; Shang, Feineng; Wu, Mingyi; Zhao, Jinhua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China; [Yin, Ronghua; Zhou, Lutan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, MY; Zhao, JH (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China.	mingyiwu_tju@yahoo.com; zhao.jinhua@yahoo.com	Zhao, Jinhua/GYV-4433-2022	Zhao, Longyan/0000-0001-9999-3433; Wu, Mingyi/0000-0002-7764-458X	National Natural Science Foundation of China [81673330, 81773737]; Yunnan Provincial Science and Technology Department [2016FA050, 2010CI116]; Kunming Institute of Botany [KIB2017011]; Chinese Academy of Sciences Youth Innovation Promotion Association [2017435]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department; Kunming Institute of Botany; Chinese Academy of Sciences Youth Innovation Promotion Association	This work was supported in part by National Natural Science Foundation of China Grants 81673330 and 81773737, Yunnan Provincial Science and Technology Department Grants 2016FA050 and 2010CI116, Kunming Institute of Botany Grant KIB2017011, and Chinese Academy of Sciences Youth Innovation Promotion Association Grant 2017435. The authors declare that they have no conflicts of interest with the contents of this article.	CASU B, 1975, CARBOHYD RES, V39, P168, DOI 10.1016/S0008-6215(00)82654-3; Chen SG, 2013, BBA-GEN SUBJECTS, V1830, P3054, DOI 10.1016/j.bbagen.2013.01.001; Chen SG, 2011, CARBOHYD POLYM, V83, P688, DOI 10.1016/j.carbpol.2010.08.040; Fonseca RJC, 2010, THROMB HAEMOSTASIS, V103, P994, DOI 10.1160/TH09-10-0734; Gao N, 2015, CARBOHYD POLYM, V127, P427, DOI 10.1016/j.carbpol.2015.04.002; Huang Y, 2015, ANAL CHEM, V87, P592, DOI 10.1021/ac503248k; Kariya Y, 1997, CARBOHYD RES, V297, P273, DOI 10.1016/S0008-6215(96)00258-3; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; Kitazato K, 1996, THROMB RES, V84, P111, DOI 10.1016/0049-3848(96)00166-1; KURACHI K, 1976, BIOCHEMISTRY-US, V15, P373, DOI 10.1021/bi00647a021; Li XM, 2017, J AGR FOOD CHEM, V65, P9315, DOI 10.1021/acs.jafc.7b03867; Liu J, 2017, INT J BIOL MACROMOL, V98, P786, DOI 10.1016/j.ijbiomac.2017.01.149; Luo L, 2013, MAR DRUGS, V11, P399, DOI 10.3390/md11020399; Mizumoto S, 2013, GLYCOBIOLOGY, V23, P155, DOI 10.1093/glycob/cws137; Mourao PAS, 1996, J BIOL CHEM, V271, P23973, DOI 10.1074/jbc.271.39.23973; Murase T, 2010, CARBOHYD RES, V345, P1702, DOI 10.1016/j.carres.2010.05.020; PHILIPS KD, 1973, CARBOHYD RES, V30, P281, DOI 10.1016/S0008-6215(00)81814-5; Pomin VH, 2014, MAR DRUGS, V12, P232, DOI 10.3390/md12010232; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Santos GRC, 2017, GLYCOBIOLOGY, V27, P625, DOI 10.1093/glycob/cwx031; Santos GRC, 2015, GLYCOBIOLOGY, V25, P1043, DOI 10.1093/glycob/cwv044; Shang FN, 2018, EUR J MED CHEM, V148, P423, DOI 10.1016/j.ejmech.2018.02.047; Sheehan JP, 2006, BLOOD, V107, P3876, DOI 10.1182/blood-2005-07-3043; Ustyuzhanina NE, 2017, CARBOHYD POLYM, V164, P8, DOI 10.1016/j.carbpol.2017.01.034; Ustyuzhanina NE, 2016, CARBOHYD POLYM, V153, P399, DOI 10.1016/j.carbpol.2016.07.076; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Wu MY, 2015, EUR J MED CHEM, V92, P257, DOI 10.1016/j.ejmech.2014.12.054; Wu MY, 2012, CARBOHYD POLYM, V87, P862, DOI 10.1016/j.carbpol.2011.08.082; YOSHIDA K, 1992, TETRAHEDRON LETT, V33, P4959, DOI 10.1016/S0040-4039(00)61245-5; Yu F, 2007, J AM CHEM SOC, V129, P13288, DOI 10.1021/ja075272h; Zhao LY, 2015, P NATL ACAD SCI USA, V112, P8284, DOI 10.1073/pnas.1504229112	31	34	35	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14089	14099		10.1074/jbc.RA118.003809	http://dx.doi.org/10.1074/jbc.RA118.003809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030375	hybrid, Green Published			2022-12-26	WOS:000444070700030
J	Tamayo, JCG; Olivella, M; Rios, S; Hoogstraat, M; Gonzalez, A; Mayol, E; Deupi, X; Campillo, M; Cordomi, A				Gomez Tamayo, Jose Carlos; Olivella, Mireia; Rios, Santiago; Hoogstraat, Marlous; Gonzalez, Angel; Mayol, Eduardo; Deupi, Xavier; Campillo, Mercedes; Cordomi, Arnau			GPCR-SAS: A web application for statistical analyses on G protein-coupled receptors sequences	PLOS ONE			English	Article							INFORMATION-SYSTEM; CRYSTAL-STRUCTURE; MOLECULAR SWITCHES; ALIGNMENT; FAMILY	G protein-coupled receptors (GPCRs) are one of the largest protein families in mammals. They mediate signal transduction across cell membranes and are important targets for the pharmaceutical industry. The G Protein-Coupled Receptors-Sequence Analysis and Statistics (GPCR-SAS) web application provides a set of tools to perform comparative analysis of sequence positions between receptors, based on a curated structural-informed multiple sequence alignment. The analysis tools include: (i) percentage of occurrence of an amino acid or motif and entropy at a position or range of positions, (ii) covariance of two positions, (iii) correlation between two amino acids in two positions (or two sequence motifs in two ranges of positions), and (iv) snake-plot representation for a specific receptor or for the consensus sequence of a group of selected receptors. The analysis of conservation of residues and motifs across transmembrane (TM) segments may guide the design of more selective ligands or help to rationalize activation mechanisms, among others. As an example, here we analyze the amino acids of the "transmission switch", that initiates receptor activation following ligand binding. The tool is freely accessible at http://lmc.uab.cat/gpcrsas/.	[Gomez Tamayo, Jose Carlos; Rios, Santiago; Gonzalez, Angel; Mayol, Eduardo; Campillo, Mercedes; Cordomi, Arnau] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Barcelona, Spain; [Olivella, Mireia] Univ Vic, Grp Rec Bioinformat & Estadist Med, Barcelona, Spain; [Hoogstraat, Marlous] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [Deupi, Xavier] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Deupi, Xavier] Paul Scherrer Inst, Condensed Matter Theory Grp, Villigen, Switzerland; [Gomez Tamayo, Jose Carlos] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Netherlands Cancer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Pompeu Fabra University	Cordomi, A (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Barcelona, Spain.	arnau.cordomi@uab.cat	Gonzalez, Angel/B-2492-2010; Rios, Santiago/GLU-4258-2022; Hoogstraat, Marlous/ABD-2968-2021; Deupi, Xavier/B-2424-2009; Gonzalez, Angel/AAU-5927-2020	Gonzalez, Angel/0000-0002-2284-8307; Rios, Santiago/0000-0003-2492-9247; Deupi, Xavier/0000-0003-4572-9316; Gonzalez, Angel/0000-0002-2284-8307; Hoogstraat, Marlous/0000-0002-4916-1177; Mayol, Eduardo/0000-0003-3120-8667	Spanish Ministerio de Economia y Competitividad; European Regional Development Fund [SAF2015-74627-JIN]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission)	This study was supported by the Spanish Ministerio de Economia y Competitividad and European Regional Development Fund (SAF2015-74627-JIN) (AC).	ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becu JM, 2013, METHOD ENZYMOL, V520, P49, DOI 10.1016/B978-0-12-391861-1.00003-4; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cvicek V, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004805; Davies MN, 2007, BIOINFORMATICS, V23, P3113, DOI 10.1093/bioinformatics/btm506; Deupi X, 2012, BIOCHEM SOC T, V40, P383, DOI 10.1042/BST20120001; Deville J, 2009, J MOL EVOL, V68, P475, DOI 10.1007/s00239-009-9214-9; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; George L, 2012, CURR PHARM DESIGN, V18, P175, DOI 10.2174/138161212799040529; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pele J, 2014, PROTEINS, V82, P2141, DOI 10.1002/prot.24570; Perez-Benito L, 2017, STRUCTURE, V25, P1153, DOI 10.1016/j.str.2017.05.021; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Spyridaki K, 2014, J BIOL CHEM, V289, P18966, DOI 10.1074/jbc.M113.544460; Sun Y, 2007, MOL BIOSYST, V3, P849, DOI 10.1039/b706343a; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199843	10.1371/journal.pone.0199843	http://dx.doi.org/10.1371/journal.pone.0199843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044824	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500020
J	He, JX; Yan, C; Holyoak, M; Wan, XR; Ren, GY; Hou, YF; Xie, Y; Zhang, ZB				He, Jinxing; Yan, Chuan; Holyoak, Marcel; Wan, Xinru; Ren, Guoyu; Hou, Yangfang; Xie, Yan; Zhang, Zhibin			Quantifying the effects of climate and anthropogenic change on regional species loss in China	PLOS ONE			English	Article							BIODIVERSITY LOSS; EXTINCTION RATES; GLOBAL CHANGE; HABITAT LOSS; BIRD; COMMUNITIES; IMPACTS; FRAGMENTATION; PRODUCTIVITY; ENVIRONMENT	Human-induced environmental and climate change are widely blamed for causing rapid global biodiversity loss, but direct estimation of the proportion of biodiversity lost at local or regional scales are still infrequent. This prevents us from quantifying the main and interactive effects of anthropogenic environmental and climate change on species loss. Here, we demonstrate that the estimated proportion of species loss of 252 key protected vertebrate species at a county level of China during the past half century was 27.2% for all taxa, 47.7% for mammals, 28.8% for amphibians and reptiles and 19.8% for birds. Both human population increase and species richness showed significant positive correlations with species loss of all taxa combined, mammals, birds, and amphibians and reptiles. Temperature increase was positively correlated with all-taxa and bird species loss. Precipitation increase was negatively correlated with species loss of birds. Human population change and species richness showed more significant interactions with the other correlates of species loss. High species richness regions had higher species loss under the drivers of human environmental and climate change than low-richness regions. Consequently, ongoing human environmental and climate changes are expected to perpetuate more negative effects on the survival of key vertebrate species, particularly in high-biodiversity regions.	[He, Jinxing; Yan, Chuan; Wan, Xinru; Xie, Yan; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [He, Jinxing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Holyoak, Marcel] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Ren, Guoyu] China Univ Geosci, Sch Environm Studies, Dept Atmospher Sci, Wuhan, Hubei, Peoples R China; [Ren, Guoyu] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Hou, Yangfang] Fudan Univ, Ctr Hist Geog Studies, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis; China University of Geosciences; China Meteorological Administration; Fudan University	Zhang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	zhangzb@ioz.ac.cn	Holyoak, Marcel/C-3475-2009; Ren, Guoyu/J-9953-2012; Yan, Chuan/ACA-0195-2022; xinru, wan/GPS-9515-2022	Holyoak, Marcel/0000-0001-9727-3627; Ren, Guoyu/0000-0002-9351-4179; xinru, wan/0000-0002-8189-2033; wan, xinru/0000-0002-1580-9692	National Key R&D Program of China [2017YFA0603300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB31000000]; scientific program of Biological Consequences of Global Change (BCGC) of International Society of Zoological Sciences (ISZS); International Union of Biological Sciences (IUBS); 13th Five-year Informatization Plan of Chinese Academy of Sciences [XXH13506]	National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); scientific program of Biological Consequences of Global Change (BCGC) of International Society of Zoological Sciences (ISZS); International Union of Biological Sciences (IUBS); 13th Five-year Informatization Plan of Chinese Academy of Sciences	Research was supported by National Key R&D Program of China (2017YFA0603300), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB31000000), the scientific program of Biological Consequences of Global Change (BCGC) of International Society of Zoological Sciences (ISZS) and International Union of Biological Sciences (IUBS), and the 13th Five-year Informatization Plan of Chinese Academy of Sciences (XXH13506).	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Boucher-Lalonde V, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2695; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buchmann CM, 2013, ECOL INFORM, V14, P90, DOI 10.1016/j.ecoinf.2012.11.015; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; China NGCo, CART NAT BAS GEOGR I; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Ducatez S, 2017, CONSERV LETT, V10, P186, DOI 10.1111/conl.12258; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Gu Lei, 2015, Biodiversity Science, V23, P583; He FL, 2013, ECOLOGY, V94, P1905, DOI 10.1890/12-1795.1; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Holyoak M, 2016, INTEGR ZOOL, V11, P40, DOI 10.1111/1749-4877.12167; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Keinath DA, 2017, GLOBAL ECOL BIOGEOGR, V26, P115, DOI 10.1111/geb.12509; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKee J, 2013, HUM ECOL, V41, P773, DOI 10.1007/s10745-013-9586-8; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2001, ANIM CONSERV, V4, P45, DOI 10.1017/S1367943001001056; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sciences TBCoCAo, 2015, CAT LIF CHIN 2015 AN; SFA, 2009, INV RES KEY TERR WIL; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245; Wu Qian-qian, 2017, Shengtaixue Zazhi, V36, P2605, DOI 10.13292/j.1000-4890.201709.012; Wu RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103783; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yan C, 2016, GLOBAL ECOL BIOGEOGR, V25, P455, DOI 10.1111/geb.12428; Zhang Lvbing, 2014, Biodiversity Science, V22, P696, DOI 10.3724/SP.J.1003.2014.14225	55	12	12	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199735	10.1371/journal.pone.0199735	http://dx.doi.org/10.1371/journal.pone.0199735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044787	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500018
J	Kerkhof, M; Tran, TN; van den Berge, M; Brusselle, GG; Gopalan, G; Jones, RCM; Kocks, JWH; Menzies-Gow, A; Nuevo, J; Pavord, ID; Rastogi, S; Price, DB				Kerkhof, Marjan; Tran, Trung N.; van den Berge, Maarten; Brusselle, Guy G.; Gopalan, Gokul; Jones, Rupert C. M.; Kocks, Janwillem W. H.; Menzies-Gow, Andrew; Nuevo, Javier; Pavord, Ian D.; Rastogi, Sarang; Price, David B.			Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study	PLOS ONE			English	Article							HOSPITAL READMISSIONS; 30-DAY READMISSIONS; HEALTH-CARE; EXACERBATIONS; ADULTS; CORTICOSTEROIDS; PREDICTORS; INSIGHTS; DATABASE; OUTCOMES	Background Recent studies have demonstrated an association between high blood eosinophil counts and greater risk of asthma exacerbations. We sought to determine whether patients hospitalized for an asthma exacerbation were at greater risk of readmission if they had a high blood eosinophil count documented before the first hospitalization. Methods This historical cohort study drew on 2 years of medical record data (Clinical Practice Research Datalink with Hospital Episode Statistics linkage) of patients (aged >= 5 years) admitted to hospital in England for asthma, with recorded blood eosinophil count within 1 baseline year before admission. We analyzed the association between high blood eosinophil count (>= 0.35x10(9) cells/L) and readmission risk during 1 year of follow-up after hospital discharge, with adjustment for predefined, relevant confounders using forward selection. Results We identified 2,613 eligible patients with asthma-related admission, of median age 51 years (interquartile range, 36-69) and 76% women (1,997/2,613). Overall, 835/2,613 (32.0%) had a preadmission high blood eosinophil count. During the follow-up year, 130/2,613 patients (5.0%) were readmitted for asthma, including 55/835 (6.6%) with vs. 75/1,778 (4.2%) without high blood eosinophil count at baseline (adjusted hazard ratio [HR] 1.49; 95% CI 1.04-2.13, p = 0.029). The association was strongest in never-smokers (n = 1,296; HR 2.16, 95% CI 1.27-3.68, p = 0.005) and absent in current smokers (n = 547; HR 1.00, 95% CI 0.49-2.04, p = 0.997). Conclusions A high blood eosinophil count in the year before an asthma-related hospitalization is associated with increased risk of readmission within the following year. These findings suggest that patients with asthma and preadmission high blood eosinophil count require careful follow-up, with treatment optimization, after discharge.	[Kerkhof, Marjan; Kocks, Janwillem W. H.; Price, David B.] Observat & Pragmat Res Inst Pte Ltd, Singapore, Singapore; [Tran, Trung N.; Gopalan, Gokul; Rastogi, Sarang] AstraZeneca, Gaithersburg, MD USA; [van den Berge, Maarten; Kocks, Janwillem W. H.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Brusselle, Guy G.] Ghent Univ Hosp, Ghent, Belgium; [Jones, Rupert C. M.] Peninsula Coll Med & Dent, Plymouth, Devon, England; [Menzies-Gow, Andrew] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Nuevo, Javier] AstraZeneca, Madrid, Spain; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Oxford Resp NIHR BRC, Oxford, England; [Price, David B.] Univ Aberdeen, Acad Primary Care, Aberdeen, Scotland	AstraZeneca; University of Groningen; Ghent University; Ghent University Hospital; University of Plymouth; Royal Brompton & Harefield NHS Foundation Trust; University of Oxford; University of Oxford; University of Aberdeen	Price, DB (corresponding author), Observat & Pragmat Res Inst Pte Ltd, Singapore, Singapore.; Price, DB (corresponding author), Univ Aberdeen, Acad Primary Care, Aberdeen, Scotland.	dprice@opri.sg	Price, David/H-2837-2019	Price, David/0000-0002-9728-9992; Brusselle, Guy/0000-0001-7021-8505; van den Berge, Maarten/0000-0002-9336-7340	AstraZeneca; Observational and Pragmatic Research Institute Pte Ltd (OPRI)	AstraZeneca(AstraZeneca); Observational and Pragmatic Research Institute Pte Ltd (OPRI)	Data acquisition and analyses were funded by AstraZeneca. This was a collaborative study involving both employees of the sponsor and an independent steering committee. The funder of the study participated in the study design, decision to publish, and preparation of the manuscript. In addition, the funder provided support in the form of salaries for authors TNT, GG, JN, and SR. Employees of the sponsor were part of the study steering committee and participated in the study design. Writing and editorial support was funded by the Observational and Pragmatic Research Institute Pte Ltd (OPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BOST COLL DRUG SURV; Beck AF, 2016, JAMA PEDIATR, V170, P695, DOI 10.1001/jamapediatrics.2016.0269; Buyantseva LV, 2016, J ASTHMA, V53, P684, DOI 10.3109/02770903.2016.1140773; Casciano J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0263-8; Couillard S, 2017, CHEST, V151, P366, DOI 10.1016/j.chest.2016.10.003; Delmas M-C, 2011, Rev Mal Respir, V28, pe115, DOI 10.1016/j.rmr.2011.09.023; FitzGerald JM, 2018, LANCET RESP MED, V6, P51, DOI 10.1016/S2213-2600(17)30344-2; Fleishaker DL, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1135-3; Global Initiative for Asthma (GINA) NHLaBI National Institutes of Health, GINA REP GLOB STRAT; Gonzalez-Barcala FJ, 2018, IRISH J MED SCI, V187, P155, DOI 10.1007/s11845-017-1633-9; Gonzalez-Barcala FJ, 2018, EUR J INTERN MED, DOI [10.1016/j.ejim.2018.02.034, DOI 10.1016/J.EJIM.2018.02.034PMID:29514744]; Hasegawa K, 2016, CHEST, V149, P1021, DOI 10.1016/j.chest.2015.12.039; KELLGREN JH, 1951, BRIT MED J, V2, P1183, DOI 10.1136/bmj.2.4741.1183; Kerkhof M, 2018, THORAX, V73, P116, DOI 10.1136/thoraxjnl-2017-210531; Makela MJ, 2018, EUR CLIN RESPIR J, V5, DOI 10.1080/20018525.2018.1458560; Mukherjee M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0657-8; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; Petsky HL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005603.pub3; Pola-Bibian B, 2017, J INVEST ALLERG CLIN, V27, P238, DOI 10.18176/jiaci.0128; Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Roche Nicolas, 2014, Ann Am Thorac Soc, V11 Suppl 2, pS99, DOI 10.1513/AnnalsATS.201309-300RM; Sadatsafavi M, 2015, RESP MED, V109, P320, DOI 10.1016/j.rmed.2014.12.014; Salamzadeh J, 2003, J ASTHMA, V40, P645, DOI 10.1081/JAS-120019035; Sheikh A, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0546-6; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; UK National Health Service, QUAL OUTC FRAM QOF; UK National Health Service, HOSP EP STAT HES; van den Berge M, 2016, J ASTHMA ALLERGY, V9, P27, DOI 10.2147/JAA.S78900; Veeranki SP, 2017, J ASTHMA, P1, DOI 10.1080/02770903.2017.1365888; Veeranki SP, 2016, CHEST, V150, P1162, DOI 10.1016/j.chest.2016.07.043; Westerhof GA, 2016, RESP MED, V118, P122, DOI 10.1016/j.rmed.2016.08.006; Yancey SW, 2017, J ALLERGY CLIN IMMUN, V139, P1167, DOI 10.1016/j.jaci.2016.08.008; Zeiger RS, 2017, J ALLER CL IMM-PRACT, V5, P144, DOI 10.1016/j.jaip.2016.07.015	36	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201143	10.1371/journal.pone.0201143	http://dx.doi.org/10.1371/journal.pone.0201143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044863	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500083
J	Pan, P; Jin, WF; Li, XH; Chen, Y; Jiang, JH; Wan, HT; Yu, DJ				Pan, Ping; Jin, Weifeng; Li, Xiaohong; Chen, Yi; Jiang, Jiahui; Wan, Haitong; Yu, Daojun			Optimization of multiplex quantitative polymerase chain reaction based on response surface methodology and an artificial neural network-genetic algorithm approach	PLOS ONE			English	Article							MINIMUM INFORMATION; EXPERIMENTAL-DESIGN; PCR; EXTRACTION; QUANTIFICATION; AMPLIFICATION; DIAGNOSIS; MODELS; VIRUS; RSM	Multiplex quantitative polymerase chain reaction (qPCR) has found an increasing range of applications. The construction of a reliable and dynamic mathematical model for multiplex qPCR that analyzes the effects of interactions between variables is therefore especially important. This work aimed to analyze the effects of interactions between variables through response surface method (RSM) for uni- and multiplex qPCR, and further optimize the parameters by constructing two mathematical models via RSM and back-propagation neural network-genetic algorithm (BPNN-GA) respectively. The statistical analysis showed that Mg2+ was the most important factor for both uni- and multiplex qPCR. Dynamic models of uni- and multiplex qPCR could be constructed using both RSM and BPNN-GA methods. But RSM was better than BPNN-GA on prediction performance in terms of the mean absolute error (MAE), the mean square error (MSE) and the Coefficient of Determination (R-2). Ultimately, optimal parameters of uni- and multiplex qPCR were determined by RSM.	[Pan, Ping; Chen, Yi; Jiang, Jiahui; Yu, Daojun] Zhejiang Chinese Med Univ, Hangzhou Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Jin, Weifeng; Li, Xiaohong] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Chen, Yi] Zhejiang Hosp, Hangzhou, Zhejiang, Peoples R China; [Wan, Haitong] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yu, Daojun] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Clin Lab, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang University	Yu, DJ (corresponding author), Zhejiang Chinese Med Univ, Hangzhou Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China.; Yu, DJ (corresponding author), Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Clin Lab, Sch Med, Hangzhou, Zhejiang, Peoples R China.	yudaojun98@163.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; wan, hai/GSM-9077-2022; jin, weifeng/C-7360-2017		Natural Science Foundation of Zhejiang Province [LY17H190001]; Health and Family Planning Commission of Zhejiang Province [2015ZDA025]; Health and Family Planning Commission of Hangzhou Manicipality [2018ZD001]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Health and Family Planning Commission of Zhejiang Province; Health and Family Planning Commission of Hangzhou Manicipality	This work was supported by Natural Science Foundation of Zhejiang Province (LY17H190001) grant to DJY, http://www.zjnsf.gov.cn/, Health and Family Planning Commission of Zhejiang Province (2015ZDA025) grant to DJY, http://www.zjwjw.gov.cn/, and Health and Family Planning Commission of Hangzhou Manicipality grant (2018ZD001) to DJY, http://wsjsw.hangzhou.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01526; Ayer T, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/832509; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buzaev Igor Vyacheslavovich, 2016, Chronic Dis Transl Med, V2, P166, DOI 10.1016/j.cdtm.2016.09.007; Chavali S, 2005, BIOINFORMATICS, V21, P3918, DOI 10.1093/bioinformatics/bti633; Chen Y, 2016, J MED MICROBIOL, V65, P590, DOI 10.1099/jmm.0.000266; Coelho S F., 2016, BIOCH ENG J, V109, P305; Denipitiya DTH, 2016, BIOLOGICALS, V44, P497, DOI 10.1016/j.biologicals.2016.09.004; Dil EA, 2016, ULTRASON SONOCHEM, V33, P129, DOI 10.1016/j.ultsonch.2016.04.031; Dubljanin E, 2014, BRIT J DERMATOL, V171, P1593, DOI 10.1111/bjd.13168; Ebrahimzadeh H, 2012, TALANTA, V97, P211, DOI 10.1016/j.talanta.2012.04.019; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Giordano PC, 2010, BIORESOURCE TECHNOL, V101, P7537, DOI 10.1016/j.biortech.2010.05.001; Hallenbeck PC, 2015, BIORESOURCE TECHNOL, V184, P161, DOI 10.1016/j.biortech.2014.09.022; Hamouda Hamed I, 2015, Biotechnol Res Int, V2015, P905792, DOI 10.1155/2015/905792; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Hwang SH, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1296-5; Jartti T, 2013, PAEDIATR RESPIR REV, V14, P38, DOI 10.1016/j.prrv.2012.04.002; Johnson G, 2014, METHODS MOL BIOL, V1160, P5, DOI 10.1007/978-1-4939-0733-5_2; Kim JY, 2014, J SCI FOOD AGR, V94, P2807, DOI 10.1002/jsfa.6699; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Li Y, 2010, APPL BIOCHEM BIOTECH, V160, P269, DOI 10.1007/s12010-009-8581-4; Li YQ, 2015, EUR J PHARM BIOPHARM, V94, P170, DOI 10.1016/j.ejpb.2015.04.028; Lim CW, 2015, BIOTECHNOL PROGR, V31, P35, DOI 10.1002/btpr.2009; Mohamed MS, 2013, SCI WORLD J, DOI 10.1155/2013/948940; Noda AA, 2013, ADV CLIN EXP MED, V22, P639; Pan HY, 2017, J SEP SCI, V40, P2062, DOI 10.1002/jssc.201601259; Qu WB, 2009, BIOINFORMATICS, V25, P276, DOI 10.1093/bioinformatics/btn614; Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Sarve A, 2015, ULTRASON SONOCHEM, V26, P218, DOI 10.1016/j.ultsonch.2015.01.013; Schoske R, 2003, ANAL BIOANAL CHEM, V375, P333, DOI 10.1007/s00216-002-1683-2; Shanmugaprakash M, 2013, BIORESOURCE TECHNOL, V148, P550, DOI 10.1016/j.biortech.2013.08.149; Taylor MJ, 2012, J IMMUNOL METHODS, V382, P220, DOI 10.1016/j.jim.2012.06.004; Vremera T., 2011, ARCH MICROBIOL IMMUN, V70, P69; Wadle S, 2016, Biomol Detect Quantif, V7, P1, DOI 10.1016/j.bdq.2015.12.002	37	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200962	10.1371/journal.pone.0200962	http://dx.doi.org/10.1371/journal.pone.0200962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044832	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500073
J	Sairanen, E; Lappalainen, P; Hiltunen, A				Sairanen, Essi; Lappalainen, Paivi; Hiltunen, Arto			Psychological inflexibility explains distress in parents whose children have chronic conditions	PLOS ONE			English	Article							COMMITMENT THERAPY; MINDFULNESS QUESTIONNAIRE; CONSTRUCT-VALIDITY; ACCEPTANCE; BURNOUT; STRESS; FLEXIBILITY; DEPRESSION; ANXIETY; DISABILITIES	Experiential avoidance, cognitive defusion, and mindfulness have all been associated with psychological disorders and well-being. This study investigates whether they predict psychological distress, i.e., symptoms of burnout, depression, stress and anxiety, in parents of children with chronic conditions. We hypothesized that these factors would exhibit a large degree of common variance, and that when compared to mindfulness and defusion, experiential avoidance on its own would predict a larger proportion of unique variance. 75 parents of children with chronic conditions having burnout symptoms who participated in an intervention study completed measures of burnout, stress, anxiety, depression, experiential avoidance, cognitive defusion, and mindfulness at the beginning of the intervention study (baseline). We ran several regression analyses to assess the predictive ability of these different constructs. Experiential avoidance on its own accounted for 28-48% of the variance in different psychological symptoms. Cognitive defusion and mindfulness did not make a significant contribution to explaining burnout, stress and anxiety, but cognitive defusion contributed to explaining depression. The results confirmed our hypothesis, supporting research on the importance of psychological flexibility as a central factor in understanding the occurrence of psychological distress.	[Sairanen, Essi; Hiltunen, Arto] Karlstad Univ, Dept Social & Psychol Studies, Karlstad, Sweden; [Lappalainen, Paivi] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	Karlstad University; University of Jyvaskyla	Sairanen, E (corresponding author), Karlstad Univ, Dept Social & Psychol Studies, Karlstad, Sweden.	essi.sairanen@kau.se		Hiltunen, Arto/0000-0001-7453-5399	County Council Varmland, Sweden	County Council Varmland, Sweden	The research was funded by County Council Varmland, Sweden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; Alfonsson S, 2017, J PSYCHIATR MENT HLT, V24, P154, DOI 10.1111/jpm.12363; Anclair M, 2009, J PEDIATR ONCOL NURS, V26, P68, DOI 10.1177/1043454208323912; APPELS A, 1991, BEHAV MED, V17, P53, DOI 10.1080/08964289.1991.9935158; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Boman KK, 2004, J PEDIATR-US, V145, P373, DOI 10.1016/j.jpeds.2004.05.043; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Burke K, 2015, CHILD PSYCHIAT HUM D, V46, P548, DOI 10.1007/s10578-014-0495-x; Burke K, 2014, FAM SYST HEALTH, V32, P122, DOI 10.1037/fsh0000012; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chong YY, 2017, J CHILD FAM STUD, V26, P2610, DOI 10.1007/s10826-017-0757-x; Evans T, 2012, INFANT BEHAV DEV, V35, P1, DOI 10.1016/j.infbeh.2011.10.002; Forman EM, 2007, BEHAV RES THER, V45, P2372, DOI 10.1016/j.brat.2007.04.004; Gifford EV, 2004, BEHAV THER, V35, P689, DOI 10.1016/S0005-7894(04)80015-7; Gillanders DT, 2014, BEHAV THER, V45, P83, DOI 10.1016/j.beth.2013.09.001; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Hastings RP, 2004, J CHILD PSYCHOL PSYC, V45, P1338, DOI 10.1111/j.1469-7610.2004.00357.x; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Kashdan TB, 2006, BEHAV RES THER, V44, P1301, DOI 10.1016/j.brat.2005.10.003; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Lilja Josefine L., 2011, Cognitive Behaviour Therapy, V40, P291, DOI 10.1080/16506073.2011.580367; Lindstrom C, 2010, ACTA PAEDIATR, V99, P427, DOI 10.1111/j.1651-2227.2009.01586.x; Lloyd T, 2008, J INTELL DISABIL RES, V52, P37, DOI 10.1111/j.1365-2788.2007.00974.x; Lundgren T, 2008, J BEHAV MED, V31, P225, DOI 10.1007/s10865-008-9151-x; Lundgren T, 2017, COGN BEHAV THERAPY, V46, P315, DOI 10.1080/16506073.2016.1250228; Lundgren-Nilsson A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; MELAMED S, 1992, BEHAV MED, V18, P53, DOI 10.1080/08964289.1992.9935172; Sairanen E., 2017, PUBLIC HEALTH NUTR, P1; Sairanen E, 2015, BEHAV MODIF; Shirom A., 2006, INT J STRESS MANAGE, V13, P176, DOI [10.1037/1072-5245.13.2.176, DOI 10.1037/1072-5245.13.2.176]; Singer GHS, 2007, MENT RETARD DEV D R, V13, P357, DOI 10.1002/mrdd.20175; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Wallace D., 2016, CLIN PRACT PEDIAT PS, V4, P405, DOI [10.1037/cpp0000160, DOI 10.1037/CPP0000160]; Wallace DP, 2015, J PAIN, V16, P235, DOI 10.1016/j.jpain.2014.11.013; Weiss JA, 2012, AUTISM, V16, P261, DOI 10.1177/1362361311422708; Whalen CK, 2011, J FAM PSYCHOL, V25, P402, DOI 10.1037/a0023473; Whittingham K, 2013, CHILD CARE HLTH DEV, V39, P366, DOI 10.1111/j.1365-2214.2012.01396.x	42	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201155	10.1371/journal.pone.0201155	http://dx.doi.org/10.1371/journal.pone.0201155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044852	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500085
J	Pospisilova, P; Grange, PA; Grillova, L; Mikalova, L; Martinet, P; Janier, M; Vermersch, A; Benhaddou, N; Del Giudice, P; Alcaraz, I; Truchetet, F; Dupin, N; Smajs, D				Pospisilova, Petra; Grange, Philippe Alain; Grillova, Linda; Mikalova, Lenka; Martinet, Pervenche; Janier, Michel; Vermersch, Annie; Benhaddou, Nadjet; Del Giudice, Pascal; Alcaraz, Isabelle; Truchetet, Francois; Dupin, Nicolas; Smajs, David			Multi-locus sequence typing of Treponema pallidum subsp pallidum present in clinical samples from France: Infecting treponemes are genetically diverse and belong to 18 allelic profiles	PLOS ONE			English	Article							SYPHILIS-CAUSING STRAINS; MACROLIDE RESISTANCE; IDENTIFIED GENOTYPES; GENE; PREVALENCE; MUTATIONS; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; SPIROCHETE	Treponema pallidum subsp. pallidum, the causative agent of sexually transmitted syphilis, detected in clinical samples from France, was subjected to molecular typing using the recently developed Multilocus Sequence Typing system. The samples (n = 133) used in this study were collected from 2010-2016 from patients with diagnosed primary or secondary syphilis attending outpatient centers or hospitals in several locations in France. Altogether, 18 different allelic profiles were found among the fully typed samples (n = 112). There were five allelic variants identified for TP0136, 12 for TP0548, and eight for TP0705. Out of the identified alleles, one, seven, and three novel alleles were identified in TP0136, TP0548, and TP0705, respectively. Partial allelic profiles were obtained from 6 samples. The majority of samples (n = 110) belonged to the SS14-like cluster of TPA isolates while 7 clustered with Nichols-like isolates. Patients infected with Nichols-like samples were more often older (p = 0.041) and more often diagnosed with secondary syphilis (p = 0.033) compared to patients infected with SS14-like samples. In addition, macrolide resistance caused by the A2058G mutation was found to be associated with allelic profile 1.3.1 or with strains belonging to the 1.3.1 lineage (p<0.001). The genetic diversity among TPA strains infecting the European population was surprisingly high, which suggests that additional studies are needed to reveal the full genetic diversity of TPA pathogens infecting humans.	[Pospisilova, Petra; Grillova, Linda; Mikalova, Lenka; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Grange, Philippe Alain; Benhaddou, Nadjet; Dupin, Nicolas] Univ Sorbonne Paris Descartes, Fac Med, Inst Cochin Equipe Batteux U1016, Lab Dermatol,CNR Syphilis, Paris, France; [Martinet, Pervenche] Serv Prevent Sante Conseil Dept Bouches Rhone, Marseille, France; [Janier, Michel] Hop St Louis, AP HP, Ctr MST, Paris, France; [Vermersch, Annie] Hop Jean Bernard, Serv Dermatol, Valenciennes, France; [Benhaddou, Nadjet] Grp Hosp Paris Ctr Cochin, Serv Bacteriol, Hotel Dieu Broca, Paris, France; [Del Giudice, Pascal] Ctr Hosp Inter Reg, Serv Dermatol Infectiol, Frejus, France; [Alcaraz, Isabelle] Hop Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Truchetet, Francois] Hop Belair, Serv Dermatol, Metz, France; [Dupin, Nicolas] Hop Cochin, AP HP, Serv Dermatol Venereol, Pavillon Tarnier, Paris, France	Masaryk University Brno; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.munu.cz	Grillova, Linda/AAA-8557-2020; Mikalová, Lenka/AAM-1068-2020; Grange, Philippe/W-3442-2017	Grillova, Linda/0000-0003-2371-3161; Pastekova, Lenka/0000-0003-4266-9952; Grange, Philippe/0000-0001-8151-748X	Grant Agency of the Czech Republic [GA17-25455S]; Ministry of Health of the Czech Republic [17-31333A]; Agence Nationale de Sante Publique (ANSP); Faculty of Medicine, Masaryk University	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Agence Nationale de Sante Publique (ANSP)(French National Research Agency (ANR)); Faculty of Medicine, Masaryk University	This work was supported by the Grant Agency of the Czech Republic (GA17-25455S) and by the Ministry of Health of the Czech Republic (17-31333A) to DS, by the Agence Nationale de Sante Publique (ANSP) to ND, NB and PAG and by funds from the Faculty of Medicine, Masaryk University to junior researcher PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.245; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Dai T, 2012, J CLIN MICROBIOL, V50, P3674, DOI 10.1128/JCM.01195-12; Flasarova M., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P105; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Florindo C, 2008, J CLIN MICROBIOL, V46, P3802, DOI 10.1128/JCM.00128-08; Vaulet LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172905; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Giacani L, 2018, SEX TRANSM DIS, V45, P237, DOI 10.1097/OLQ.0000000000000741; Grange PA, 2012, J CLIN MICROBIOL, V50, P546, DOI 10.1128/JCM.00702-11; Grange PA, 2016, SEX TRANSM DIS, V43, P517, DOI 10.1097/OLQ.0000000000000474; Grange PA, 2013, SEX TRANSM DIS, V40, P641, DOI 10.1097/OLQ.0000000000000006; Grillova A L, PLOS ONE; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Katz Kenneth A, 2010, Sex Transm Dis, V37, P660, DOI 10.1097/OLQ.0b013e3181e1a77a; Khairullin R, 2016, APMIS, V124, P595, DOI 10.1111/apm.12541; Knauf S, 2016, EBIOMEDICINE, V11, P85, DOI 10.1016/j.ebiom.2016.07.033; Li Z, 2017, APMIS, V125, P937, DOI 10.1111/apm.12724; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; Mikalova L, 2017, SEX TRANSM DIS, V44, P376, DOI 10.1097/OLQ.0000000000000600; Mikalova L, 2014, SEX TRANSM DIS, V41, P552, DOI 10.1097/OLQ.0000000000000165; Mikalova L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-178; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Mitja O, 2018, LANCET, V391, P1599, DOI 10.1016/S0140-6736(18)30204-6; Molini BJ, 2016, SEX TRANSM DIS, V43, P579, DOI 10.1097/OLQ.0000000000000486; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Noda AA, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.02.006; Oliver S, 2016, SEX TRANSM DIS, V43, P524, DOI 10.1097/OLQ.0000000000000478; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73; Peng RR, 2012, SEX TRANSM DIS, V39, P42, DOI 10.1097/OLQ.0b013e318232697d; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Pillay A, 2002, J CLIN MICROBIOL, V40, P256, DOI 10.1128/JCM.40.1.256-258.2002; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Prevention CfDCa, 1997, MMWR-MORBID MORTAL W, P1; Radolf JD, 2018, CURR TOP MICROBIOL, V415, P1, DOI 10.1007/82_2017_44; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Read P, 2016, J CLIN MICROBIOL, V54, P2172, DOI 10.1128/JCM.00959-16; Salado-Rasmussen K, 2015, DAN MED J, V62; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Smajs D., 2016, FORUM IMMUN DIS THER, V7, P181, DOI DOI 10.1615/F0RUMIMMUNDISTHER.2017020184; Smajs D, 2018, INFECT GENET EVOL, V61, P92, DOI 10.1016/j.meegid.2018.03.015; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; Strouhal M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005894; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tipple C, 2011, SEX TRANSM INFECT, V87, pA69, DOI 10.1136/sextrans-2011-050109.104; Tipple C, 2015, CURR OPIN INFECT DIS, V28, P53, DOI 10.1097/QCO.0000000000000124; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Woznicova V, 2007, J CLIN MICROBIOL, V45, P659, DOI 10.1128/JCM.02209-06; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Xiao YJ, 2016, SEX TRANSM DIS, V43, P310, DOI 10.1097/OLQ.0000000000000445; Zhang RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175477; Zhu BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159787; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838	61	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201068	10.1371/journal.pone.0201068	http://dx.doi.org/10.1371/journal.pone.0201068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024965	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000087
J	Chen, C; Yan, JB; Wang, HL; Li, P; Li, KF; Wu, B; Zhang, H				Chen, Can; Yan, Jian-Bo; Wang, Hong-Ling; Li, Peng; Li, Ke-Feng; Wu, Bing; Zhang, Hui			Molecular epidemiology and spatiotemporal dynamics of norovirus associated with sporadic acute gastroenteritis during 2013-2017, Zhoushan Islands, China	PLOS ONE			English	Article							GENETIC DIVERSITY; EMERGENCE; TRANSMISSION; STRAINS; EVOLUTION; OUTBREAK; WINTER	A total of 1 590 fecal swabs and stool samples from sporadic acute gastroenteritis patients of all ages were collected from January 2013 to March 2018 in the Zhoushan Islands, China, with 99 (6.23%) samples subsequently identified as human norovirus (HuNoV) positive. Phylogenetic analysis of partial RdRp and VP1 gene regions identified 10 genotypes of the GII genogroup and 3 genotypes of the GI genogroup. The predominant genotype was GII.P17-GII.17 (42.86%, 33/77), followed by GII.Pe-GII.4_Sydney 2012 (24.68%, 19/77) and GII.P16-G11.2 (12.96%, 10/77). However, the prevailing genotype in the Zhoushan Islands has shifted on three separate occasions. The GII.Pe-GII.4_Sydney_2012 strain was dominant in 2013-2014, the GII.P17-17 strain was dominant in 2015-2016, and the GII.P16GII.2 strain was dominant in 2017. Divergence analysis showed that the re-emerging GII.P16-GII.2 strains clustered with the Japanese 2010-2012 GII.P16-GII.2 strains, and the time of the most recent common ancestor was estimated to have occurred in 2012 to 2013. The evolutionary rates of the RdRp gene region of the GII.P16 genotype and the VP1 gene region of the GII.2 genotype were 2.64 x 10(-3) (95% HPD interval, 2.17-3.08 x 10(-3)) and 3.36 x 10(-3) (95% HPD interval, 2.66-4.04 x 10(-3)) substitutions/site/year, respectively. The migration pattern of the HuNoV GII.2 genotype in China demonstrated that the re-emerging GII.P16-GII.2 strains were first introduced into Hong Kong from Japan, and then spread from Hong Kong to other coastal areas. Our results also showed that the GII.P16-GII.2 strains in the Zhoushan Islands were likely introduced from Jiangsu Province, China, in 2016.	[Chen, Can; Yan, Jian-Bo] Nanchang Univ, Dept Publ Hlth, Nanchang, Jiangxi, Peoples R China; [Chen, Can; Yan, Jian-Bo; Wang, Hong-Ling; Li, Peng; Li, Ke-Feng; Wu, Bing; Zhang, Hui] Zhoushan Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China; [Chen, Can; Yan, Jian-Bo; Wang, Hong-Ling; Li, Peng; Li, Ke-Feng; Wu, Bing; Zhang, Hui] Zhoushan Ctr Dis Control & Prevent, Zhejiang Prov Key Lab Hlth Risk Factors Seafood, Zhoushan, Zhejiang, Peoples R China	Nanchang University	Yan, JB (corresponding author), Nanchang Univ, Dept Publ Hlth, Nanchang, Jiangxi, Peoples R China.; Yan, JB (corresponding author), Zhoushan Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China.; Yan, JB (corresponding author), Zhoushan Ctr Dis Control & Prevent, Zhejiang Prov Key Lab Hlth Risk Factors Seafood, Zhoushan, Zhejiang, Peoples R China.	yanjianbo02@163.com		Tong, Zhen-Dong/0000-0003-3309-0674; Li, Peng/0000-0002-2533-1864	Zhoushan Medical and Health Science Technology Project, Zhoushan, China [2017G03]; Special fund project of master innovation in Jiangxi Province, China [YC2017-S093]	Zhoushan Medical and Health Science Technology Project, Zhoushan, China; Special fund project of master innovation in Jiangxi Province, China	This work was supported by 1. Zhoushan Medical and Health Science Technology Project, Zhoushan, China (2017G03), http://www.zswsj.gov.cn/, Jian-Bo Yan received this funding and Contributed for study design, decision to publish. 2. Special fund project of master innovation in Jiangxi Province, China (YC2017-S093), http://yjsy.ncu.edu.cn/, Can Chen received this funding and Contributed for study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2001, AM J EPIDEMIOL, V154, P1013, DOI 10.1093/aje/154.11.1013; [Anonymous], 2014, RENEW ENERGY RESOUR; Ao Y, 2018, J INFECT DIS, V29, P1; Ao YY, 2017, EMERG INFECT DIS, V23, P1172, DOI 10.3201/eid2307.170034; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Bidalot M, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.15.30508; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061; Chen Can, 2018, Disease Surveillance, V33, P45; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Gong HX, 2016, ZHEJIANG PREV MED, V28, P510; Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lindesmith LC, 2017, J INFECT DIS, V216, P1227, DOI 10.1093/infdis/jix385; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Lu J, 2016, J INFECT DIS, V214, P556, DOI 10.1093/infdis/jiw208; Mathijs E, 2012, FOOD ENVIRON VIROL, V4, P131, DOI 10.1007/s12560-012-9091-z; Medici MC, 2018, NEW MICROBIOL, V41, P71; Motoya T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02399; Nagasawa K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00001; Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]; Qiao N, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0287-9; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Rasmussen LD, 2016, EMERG INFECT DIS, V22, P2024, DOI 10.3201/eid2211.161171; Ruis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179572; Ruvoen-Clouet N, 2013, REV MED VIROL, V23, P355, DOI 10.1002/rmv.1757; Sang SW, 2018, PEERJ, V6, DOI 10.7717/peerj.4333; Thanusuwannasak T, 2018, INFECT GENET EVOL, V61, P108, DOI 10.1016/j.meegid.2018.03.021; Thongprachum A, 2017, INFECT GENET EVOL, V51, P86, DOI 10.1016/j.meegid.2017.03.020; Treanor JJ, 2014, J INFECT DIS, V210, P1763, DOI 10.1093/infdis/jiu337; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Wu XF, 2015, ARCH VIROL, V160, P1705, DOI 10.1007/s00705-015-2440-0; Xue L, 2013, FOODBORNE PATHOG DIS, V10, P888, DOI 10.1089/fpd.2013.1521; Xue Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0922-z; Yu YX, 2015, APPL ENVIRON MICROB, V81, P7615, DOI 10.1128/AEM.01729-15; Yu YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196169; Zhang P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2033-x; Zhang XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17687; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	50	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200911	10.1371/journal.pone.0200911	http://dx.doi.org/10.1371/journal.pone.0200911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021022	Green Submitted, gold, Green Published			2022-12-26	WOS:000439022400088
J	De Vito, A; Lazzaro, M; Palmisano, I; Cittaro, D; Riba, M; Lazarevic, D; Bannai, M; Gabellini, D; Schiaffino, MV				De Vito, Annarosaria; Lazzaro, Massimo; Palmisano, Ilaria; Cittaro, Davide; Riba, Michela; Lazarevic, Dejan; Bannai, Makoto; Gabellini, Davide; Schiaffino, Maria Vittoria			Amino acid deprivation triggers a novel GCN2-independent response leading to the transcriptional reactivation of non-native DNA sequences	PLOS ONE			English	Article							EIF2-ALPHA KINASE GCN2; UNCHARGED TRANSFER-RNA; TRANSPOSABLE ELEMENTS; LIFE-SPAN; RIBOSOME BIOGENESIS; INTERFERON RESPONSE; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; GENE-EXPRESSION; STRESS-RESPONSE	In a variety of species, reduced food intake, and in particular protein or amino acid (AA) restriction, extends lifespan and healthspan. However, the underlying epigenetic and/or transcriptional mechanisms are largely unknown, and dissection of specific pathways in cultured cells may contribute to filling this gap. We have previously shown that, in mammalian cells, deprivation of essential AAs (methionine/cysteine or tyrosine) leads to the transcriptional reactivation of integrated silenced transgenes, including plasmid and retroviral vectors and latent HIV-1 provirus, by a process involving epigenetic chromatic remodeling and histone acetylation. Here we show that the deprivation of methionine/cysteine also leads to the transcriptional upregulation of endogenous retroviruses, suggesting that essential AA starvation affects the expression not only of exogenous non-native DNA sequences, but also of endogenous anciently-integrated and silenced parasitic elements of the genome. Moreover, we show that the transgene reactivation response is highly conserved in different mammalian cell types, and it is reproducible with deprivation of most essential AAs. The General Control Non-derepressible 2 (GCN2) kinase and the downstream integrated stress response represent the best candidates mediating this process; however, by pharmacological approaches, RNA interference and genomic editing, we demonstrate that they are not implicated. Instead, the response requires MEK/ERK and/or JNK activity and is reproduced by ribosomal inhibitors, suggesting that it is triggered by a novel nutrient-sensing and signaling pathway, initiated by translational block at the ribosome, and independent of mTOR and GCN2. Overall, these findings point to a general transcriptional response to essential AA deprivation, which affects the expression of non-native genomic sequences, with relevant implications for the epigenetic/transcriptional effects of AA restriction in health and disease.	[De Vito, Annarosaria; Lazzaro, Massimo; Palmisano, Ilaria; Gabellini, Davide; Schiaffino, Maria Vittoria] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy; [Cittaro, Davide; Riba, Michela; Lazarevic, Dejan] IRCCS San Raffaele Sci Inst, Ctr Translat Genom & Bioinformat, Milan, Italy; [Bannai, Makoto] Ajinomoto Co Inc, Inst Innovat, Frontier Res Labs, Tokyo, Japan; [Palmisano, Ilaria] Imperial Coll London, Dept Med, Div Brain Sci, London, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Ajinomoto Co Inc; Imperial College London	Schiaffino, MV (corresponding author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy.	schiaffino.mariavittoria@hsr.it	Riba, Michela/AAG-8955-2019; Schiaffino, Maria Vittoria/AAN-3313-2020; Gabellini, Davide/I-4551-2018; Cittaro, Davide/K-2405-2018; Palmisano, Ilaria/ABA-9513-2020; Lazarevic, Dejan/AAN-1861-2020	Schiaffino, Maria Vittoria/0000-0001-9744-7025; Gabellini, Davide/0000-0002-3811-4121; Cittaro, Davide/0000-0003-0384-3700; Palmisano, Ilaria/0000-0002-7139-8090; riba, michela/0000-0003-4857-2027; lazarevic, dejan/0000-0003-4527-290X	Ajinomoto Innovation Alliance Program, (AIAP)	Ajinomoto Innovation Alliance Program, (AIAP)	This study was funded by the Ajinomoto Innovation Alliance Program, (AIAP; https://www.ajinomoto.com/en/rd/AIAP/index.html#aiap) (to M.V.S and D.G), which is a joint research initiative of Ajinomoto Co., Inc., Japan. One of the authors [M.B.] is an employee of Ajinomoto Co., and his specific roles are articulated in the 'author contributions' section. The commercial funder provided support in the form of salary for author [M.B.] and some of the necessary research materials (medium for cell culture), but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript, and the authors had unrestricted access to the data. Due to a confidentiality agreement, the commercial funder participated only in the decision to publish the data obtained during the study, without any restriction.	Ball RO, 2006, J NUTR, V136, p1682S, DOI 10.1093/jn/136.6.1682S; Barres R, 2016, NAT REV ENDOCRINOL, V12, P441, DOI 10.1038/nrendo.2016.87; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bodega B, 2014, CURR OPIN CELL BIOL, V31, P67, DOI 10.1016/j.ceb.2014.09.002; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brown A, 2016, NATURE, V534, P277, DOI 10.1038/nature17675; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Bulut-Karslioglu A, 2018, CELL STEM CELL, V22, P369, DOI 10.1016/j.stem.2018.02.004; Buzdin AA, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00035; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Chaveroux C, 2010, BIOCHIMIE, V92, P736, DOI 10.1016/j.biochi.2010.02.020; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cuellar TL, 2017, J CELL BIOL, V216, P3535, DOI 10.1083/jcb.201612160; De Cecco M, 2013, AGING-US, V5, P867, DOI 10.18632/aging.100621; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lu ZG, 2017, NAT MED, V23, P79, DOI 10.1038/nm.4252; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; MURCHIE MJ, 1978, BIOCHIM BIOPHYS ACTA, V520, P233, DOI 10.1016/0005-2787(78)90024-2; ORENTREICH N, 1993, J NUTR, V123, P269; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Palmisano Ilaria, 2012, Mob Genet Elements, V2, P233; Palmisano I, 2012, P NATL ACAD SCI USA, V109, pE2284, DOI 10.1073/pnas.1202174109; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Reeds PJ, 2000, J NUTR, V130, p1835S; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sales VM, 2017, CELL METAB, V25, P559, DOI 10.1016/j.cmet.2017.02.016; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Shan JX, 2015, BBA-MOL CELL RES, V1853, P539, DOI 10.1016/j.bbamcr.2014.12.013; Shan JX, 2014, J BIOL CHEM, V289, P24665, DOI 10.1074/jbc.M114.565028; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Taya Y, 2016, SCIENCE, V354, P1152, DOI 10.1126/science.aag3145; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vernieri C, 2016, CANCER DISCOV, V6, P1315, DOI 10.1158/2159-8290.CD-16-0615; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001	75	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200783	10.1371/journal.pone.0200783	http://dx.doi.org/10.1371/journal.pone.0200783			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020994	gold, Green Submitted, Green Published			2022-12-26	WOS:000439022400075
J	Nam, DH; Kim, E; Benham, A; Park, HK; Soibam, B; Taffet, GE; Kaelber, JT; Suh, JH; Taegtmeyer, H; Entman, ML; Reineke, EL				Nam, Deok Hwa; Kim, Eunah; Benham, Ashley; Park, Hye-Kyung; Soibam, Benjamin; Taffet, George E.; Kaelber, Jason T.; Suh, Ji Ho; Taegtmeyer, Heinrich; Entman, Mark L.; Reineke, Erin L.			Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function	FASEB JOURNAL			English	Article						cardiac metabolism; cardiac stress; hypertrophy; fibrosis; heart failure	CARDIAC-HYPERTROPHY; REGULATOR; GROWTH	Coordinated changes in signaling pathways and gene expression in hearts subjected to prolonged stress maintain cardiac function. Loss of steroid receptor coactivator-2 (SRC-2) results in a reversal to the fetal gene program and disrupts the response to pressure overload, accompanied by prominent effects on metabolism and growth signaling, including increased AMPK activation. We proposed that early metabolic stress driven by AMPK activation induces contractile dysfunction in mice lacking SRC-2. We used 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to activate AMPK transiently before transverse aortic constriction (TAC) in wild-type and cardiomyocyte-specific SRC-2 knockout (CKO) animals. In contrast to AMPK activities during stress, in unstressed hearts, AICAR induced a mild activation of Akt signaling, and, in SRC-2-CKO mice, partially relieved an NAD(+) deficiency and increased antioxidant signaling. These molecular changes translated to a mild hypertrophic response to TAC with decreased maladaptive remodeling, including markedly decreased fibrosis. Additionally, preactivation of AMPK in SRC-2-CKO mice was accompanied by a dramatic improvement in cardiac function compared with saline-treated SRC-2-CKO mice. Our results show that altered molecular signaling before stress onset has extended effects on sustained cardiac stress responses, and prestress modulation of transient growth and metabolism pathways may control those effects.Nam, D. H., Kim, E., Benham, A., Park, H.-K., Soibam, B., Taffet, G. E., Kaelber, J. T., Suh, J. H., Taegtmeyer, H., Entman, M. L., Reineke, E. L. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.	[Nam, Deok Hwa; Kim, Eunah; Park, Hye-Kyung; Suh, Ji Ho; Reineke, Erin L.] Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA; [Benham, Ashley] Texas Heart Inst, Houston, TX 77025 USA; [Soibam, Benjamin] Univ Houston Downtown, Dept Comp Sci & Engn Technol, Houston, TX USA; [Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Taegtmeyer, Heinrich] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Texas Heart Institute; University of Houston System; University of Houston; University of Houston Downtown; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Reineke, EL (corresponding author), Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA.	elreineke@houstonmethodist.org		Kaelber, Jason/0000-0001-9426-1030	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [R00-HL118159-01]; Souki Mitochondrial Project Fund [R01-HL061483, R01-HL089792]; U.S. Army Department of Defense [68847MAREP/W911NF1610480]; NIH National Cancer Institute [P30-CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL118159, R01HL061483, R01HL089792] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); Souki Mitochondrial Project Fund; U.S. Army Department of Defense(United States Department of Defense); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Hong Chen (Houston Methodist Research Institute), and, Katherina Marcelo, Jennifer Pocius, Thuy Pham, and Alejandro Granillo Ibanez (all from Baylor College of Medicine) for technical assistance with surgery and cardiac imaging and molecular analysis. Histology was performed at the Pathology and Histology Core at Baylor College of Medicine with the assistance of Zahida Sayeeduddin. This work was supported by the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI; Grant R00-HL118159-01 to E.L.R.), the Souki Mitochondrial Project Fund (Grants R01-HL061483 to H.T. and R01-HL089792 to M.L.E.), and the U.S. Army Department of Defense (Grant 68847MAREP/W911NF1610480 to B.S.). The Pathology and Histology Core at Baylor College of Medicine is supported by funding from the NIH National Cancer Institute (Grant P30-CA125123). The authors declare no conflicts of interest.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baskin KK, 2011, TRENDS CARDIOVAS MED, V21, P124, DOI 10.1016/j.tcm.2012.03.010; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Cieslik KA, 2013, J MOL CELL CARDIOL, V63, P26, DOI 10.1016/j.yjmcc.2013.07.005; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li YH, 2003, ULTRASOUND MED BIOL, V29, P1281, DOI 10.1016/S0301-5629(03)00986-4; Meng RS, 2009, EUR J PHARMACOL, V620, P63, DOI 10.1016/j.ejphar.2009.08.024; Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Reineke EL, 2014, J BIOL CHEM, V289, P17721, DOI 10.1074/jbc.M113.539908; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Suh JH, 2017, J BIOL CHEM, V292, P21643, DOI 10.1074/jbc.M117.804740; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Taffet GE, 1996, AM J PHYSIOL-HEART C, V270, pH2204; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505	28	7	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					711	721		10.1096/fj.201800602R	http://dx.doi.org/10.1096/fj.201800602R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024790	Green Published, Bronze			2022-12-26	WOS:000457401500055
J	Li, WL; Wong, CC; Zhang, XM; Kang, W; Nakatsu, G; Zhao, QF; Chen, HR; Go, MYY; Chiu, PWY; Wang, XH; Ji, JF; Li, XN; Cai, ZW; Ng, EKW; Yu, J				Li, Weilin; Wong, Chi Chun; Zhang, Xiaoming; Kang, Wei; Nakatsu, Geicho; Zhao, Qinfu; Chen, Huarong; Go, Minnie Yin Yin; Chiu, Philip Wai Yan; Wang, Xiaohong; Ji, Jiafu; Li, Xiaona; Cai, Zongwei; Ng, Enders Kwok Wai; Yu, Jun			CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1 alpha axis to inhibit gastric tumorigenesis	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; CANCER GROWTH; AMPK; METABOLISM; REVEALS; HISTONE; METHYLATION; EPIGENETICS; REGULATOR; INTERPLAY	Metabolic dysfunction is a hallmark of gastric cancer (GC). In this study, we reported the identification of Calcium Binding Protein 39-Like (CAB39L) as a novel regulator of tumor metabolism in GC. CAB39L mRNA was frequently silenced by promoter methylation in GC cell lines and tissues. Functional studies suggested that CAB39L functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis. Mechanistically, CAB39L interacted with LKB1-STRAD complex and induced LKB1, leading to the phosphorylation and activation of AMPK alpha/beta. LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells. Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK. RNAseq and gene set enrichment analysis revealed that CAB39L was closely correlated with oxidative phosphorylation and mitochondrial biogenesis. Consistently, CAB39L-induced p-AMPK elicited PGC1 alpha phosphorylation and increased the expression of genes involved in mitochondrial respiration complexes. Accordingly, CAB39L reversed the Warburg effect in GC, as evidenced by enhanced oxygen consumption rate and reduced extracellular acidification rate; inversely, CAB39L knockdown promoted a metabolic shift towards the Warburg phenotype. In GC patients, CAB39L promoter hypermethylation was correlated with poor prognosis. Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 alpha axis, thereby preventing a metabolic shift that drives carcinogenesis. CAB39L methylation is a potential prognostic biomarker for GC patients.	[Li, Weilin; Wong, Chi Chun; Zhang, Xiaoming; Nakatsu, Geicho; Zhao, Qinfu; Chen, Huarong; Go, Minnie Yin Yin; Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China; [Li, Weilin; Wong, Chi Chun; Zhang, Xiaoming; Nakatsu, Geicho; Zhao, Qinfu; Chen, Huarong; Go, Minnie Yin Yin; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Peoples R China; [Li, Weilin; Chiu, Philip Wai Yan; Ng, Enders Kwok Wai] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China; [Kang, Wei] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China; [Wang, Xiaohong; Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Li, Xiaona; Cai, Zongwei] Hong Kong Baptist Univ, Dept Chem, State Key Lab Environm & Biol Anal, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University; Hong Kong Baptist University	Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Peoples R China.; Ng, EKW (corresponding author), Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China.	endersng@surgery.cuhk.edu.hk; junyu@cuhk.edu.hk	Chen, Huarong/ABZ-5810-2022; Li, Weilin/ABG-9032-2021; Chiu, Philip/ABB-1454-2020; KANG, Wei/C-5451-2016; Nakatsu, Geicho/AAU-3089-2021; Cai, Zongwei/ABD-4001-2020; chen, huarong/ABH-8561-2020; Ng, Enders Kwok-wai/E-8276-2016	Chiu, Philip/0000-0001-9292-112X; KANG, Wei/0000-0002-4651-677X; Cai, Zongwei/0000-0002-8724-7684; chen, huarong/0000-0003-2192-1864; Ng, Enders Kwok-wai/0000-0001-7219-5810	RGC/GRF Hong Kong [14114615, 14101917, 14111216, 14106145]; National Natural Science Foundation of China (NSFC) [81772501, 81502064]; HMRF Hong Kong [03140856]; Faculty of Medicine CUHK direct grant; Shenzhen Virtual University Park Support Scheme; Vice-Chancellor's Discretionary Fund CUHK	RGC/GRF Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); HMRF Hong Kong; Faculty of Medicine CUHK direct grant; Shenzhen Virtual University Park Support Scheme; Vice-Chancellor's Discretionary Fund CUHK	This project was supported by research funds from RGC/GRF Hong Kong (14114615, 14101917, 14111216, and 14106145); National Natural Science Foundation of China (NSFC) (81772501, 81502064); HMRF Hong Kong (03140856); Faculty of Medicine CUHK direct grant; Vice-Chancellor's Discretionary Fund CUHK; Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute.	Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Camacho L, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0598-8; Camargo MC, 2014, GUT, V63, P236, DOI 10.1136/gutjnl-2013-304531; Das M, 2017, LANCET ONCOL, V18, pE307, DOI 10.1016/S1470-2045(17)30321-2; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Garrido N, 2009, FERTIL STERIL, V91, P1307, DOI 10.1016/j.fertnstert.2008.01.078; Gupta V, 2014, CURR PHARM DESIGN, V20, P1706, DOI 10.2174/13816128113199990536; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jacome AA, 2016, WORLD J GASTROENTERO, V22, P1160, DOI 10.3748/wjg.v22.i3.1160; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; LeBleu VS, 2014, NAT CELL BIOL, P1001, DOI DOI 10.1038/NCB3039; Li XN, 2017, ONCOTARGET, V8; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mariotti S, 2016, ONCOTARGET, V7, P1808, DOI 10.18632/oncotarget.6577; Meng FQ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5063239; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morales DR, 2015, ANNU REV MED, V66, P17, DOI 10.1146/annurev-med-062613-093128; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Qian Y, 2017, CANCER RES, V77, P1968, DOI 10.1158/0008-5472.CAN-16-1595; Rahmioglu N, 2015, HUM MOL GENET, V24, P1185, DOI 10.1093/hmg/ddu516; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Selaru FM, 2009, AM J GASTROENTEROL, V104, P1910, DOI 10.1038/ajg.2008.145; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wang KN, 2016, GUT, V65, P1619, DOI 10.1136/gutjnl-2015-309276; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Whitburn J, 2017, CURR UROL REP, V18, DOI 10.1007/s11934-017-0693-8; William WN, 2012, ANN ONCOL, V23, P78, DOI 10.1093/annonc/mdr036; Wong CC, 2017, ONCOGENE, V36, P3359, DOI 10.1038/onc.2016.485; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xing F, 2017, CELL REP, V18, P468, DOI 10.1016/j.celrep.2016.12.037; Xu LX, 2012, GUT, V61, P977, DOI 10.1136/gutjnl-2011-300411; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	45	29	32	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 13	2018	37	50					6383	6398		10.1038/s41388-018-0402-1	http://dx.doi.org/10.1038/s41388-018-0402-1			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HE0WA	30054562	Green Published, hybrid			2022-12-26	WOS:000452989100001
J	Zhang, YJ; Tan, LR; Yang, QY; Li, CY; Liou, YE				Zhang, Yajun; Tan, Lora; Yang, Qiaoyun; Li, Chenyu; Liou, Yih-Cherng			The microtubule-associated protein HURP recruits the centrosomal protein TACC3 to regulate K-fiber formation and support chromosome congression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitotic spindle; microtubule-associated protein (MAP); chromosomes; kinetochore; cell division; chromosome congression; HURP; kinetochore fiber; mitotic spindle; TACC3	ENSURE SPINDLE STABILITY; GTP-BOUND RAN; AURORA-A; KINETOCHORE MICROTUBULES; MITOTIC SPINDLES; IMPORTIN-BETA; SOMATIC-CELLS; CLATHRIN; MITOSIS; PHOSPHORYLATION	Kinetochore fibers (K-fibers) are microtubule bundles attached to chromosomes. Efficient K-fiber formation is required for chromosome congression, crucial for faithful chromosome segregation in cells. However, the mechanisms underlying K-fiber formation before chromosome biorientation remain unclear. Depletion of hepatoma up-regulated protein (HURP), a RanGTP-dependent microtubule-associated protein localized on K-fibers, has been shown to result in low-efficiency K-fiber formation. Therefore, here we sought to identify critical interaction partners of HURP that may modulate this function. Using co-immunoprecipitation and bimolecular fluorescence complementation assays, we determined that HURP interacts directly with the centrosomal protein transforming acidic coiled coil-containing protein 3 (TACC3), a centrosomal protein, both in vivo and in vitro through the HURP1-625 region. We found that HURP is important for TACC3 function during kinetochore microtubule assembly at the chromosome region in prometaphase. Moreover, HURP regulates stable lateral kinetochore attachment and chromosome congression in early mitosis by modulation of TACC3. These findings provide new insight into the coordinated regulation of K-fiber formation and chromosome congression in prometaphase by microtubule-associated proteins.	[Zhang, Yajun; Tan, Lora; Yang, Qiaoyun; Li, Chenyu; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore	National University of Singapore; National University of Singapore	Liou, YE (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Liou, YE (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore.	dbslyc@nus.edu.sg		Liou, Yih-Cherng/0000-0003-0149-6856	NMRC of the Ministry of Education, Singapore [MOE-T2-1-113, R-154-000-A15-114]	NMRC of the Ministry of Education, Singapore	This work is supported in part by grants from NMRC, Tier2 (MOE-T2-1-113) and Tier 1 (R-154-000-A15-114) of the Ministry of Education, Singapore (to Y.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Albee AJ, 2006, J BIOL CHEM, V281, P38293, DOI 10.1074/jbc.M607203200; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; Burgess SG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005345; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Cheeseman LP, 2013, J CELL SCI, V126, P2102, DOI 10.1242/jcs.124834; Cheeseman Liam P, 2011, Commun Integr Biol, V4, P409, DOI 10.4161/cib.4.4.15250; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Foraker AB, 2012, J CELL BIOL, V198, P591, DOI 10.1083/jcb.201205116; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2011, CELL RES, V21, P1655, DOI 10.1038/cr.2011.106; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Iemura K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7447; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Li CY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10597; Li CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18773; Lin CH, 2010, J CELL BIOL, V189, P1097, DOI 10.1083/jcb.200911120; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Royle SJ, 2012, J CELL SCI, V125, P19, DOI 10.1242/jcs.094607; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Santarella RA, 2007, J MOL BIOL, V365, P1587, DOI 10.1016/j.jmb.2006.10.064; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Singh P, 2014, J BIOL CHEM, V289, P31719, DOI 10.1074/jbc.M114.575100; Song L, 2014, MOL CELL, V53, P179, DOI 10.1016/j.molcel.2013.12.022; Tan SJ, 2008, J CELL BIOL, V182, P27, DOI 10.1083/jcb.200712080; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Thakur HC, 2014, J BIOL CHEM, V289, P74, DOI 10.1074/jbc.M113.532333; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wu JM, 2013, P NATL ACAD SCI USA, V110, pE1779, DOI 10.1073/pnas.1220523110; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	63	3	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15733	15747		10.1074/jbc.RA118.003676	http://dx.doi.org/10.1074/jbc.RA118.003676			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30054275	Green Published, hybrid			2022-12-26	WOS:000446549200035
J	Liu, SX; Zhang, FF; Wang, Y; Wang, H; Chen, XJ; Hu, Y; Chen, M; Lan, SJ; Wang, CH; Cao, JX; Hu, X; Tan, F				Liu, Shuxian; Zhang, Fangfei; Wang, Yan; Wang, Han; Chen, Xiaojian; Hu, Yue; Chen, Ming; Lan, Shujue; Wang, Chenhong; Cao, Jiaxin; Hu, Xin; Tan, Feng			Characterization of the molecular mechanism of the autophagy-related Atg8-Atg3 protein interaction in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toxoplasma gondii; autophagy; protein complex; protein domain; protein-protein interaction; AlphaScreen; Atg3; Atg8; Atg8 family-interacting motif; peptide assay	CRYSTAL-STRUCTURE; ATG8; IDENTIFICATION; RECOGNITION; CYTOPLASM; SYSTEM; ENZYME	Toxoplasmosis is caused by an obligate intracellular parasite, the protozoan Toxoplasma gondii. Discovery of novel drugs against T. gondii infection could circumvent the toxicity of existing drugs and T. gondii resistance to current treatments. The autophagy-related protein 8 (Atg8)-Atg3 interaction in T. gondii is a promising drug target because of its importance for regulating Atg8 lipidation. We reported previously that TgAtg8 and TgAtg3 interact directly. Here we validated that substitutions of conserved residues of TgAtg8 interacting with the Atg8 family-interacting motif (AIM) in Atg3 disrupt the TgAtg8-TgAtg3 interaction and reduce TgAtg8 lipidation and autophagosome formation. These findings were consistent with results reported previously for Plasmodium Atg8, suggesting functional conservation of Atg8 in Toxoplasma and Plasmodium. Moreover, using peptide and AlphaScreen assays, we identified the AIM sequence in TgAtg3 that binds TgAtg8. We determined that the core TgAtg3 AIM contains a Phe(239)-Ala(240)-Asp(241)-Ile(242) ((239)FADI(242)) signature distinct from the (WLLP108)-W-105 signature in the AIM of Plasmodium Atg3. Furthermore, an alanine-scanning assay revealed that the TgAtg8-TgAtg3 interaction in T. gondii also depends strongly on several residues surrounding the core TgAtg3 AIM, such as Asn(238), Asp(243), and Cys(244). These results indicate that distinct AIMs in Atg3 contribute to differences between Toxoplasma and Plasmodium Atg8-Atg3 interactions. By elucidating critical residues involved in the TgAtg8-TgAtg3 interaction, our work paves the way for the discovery of potential anti-toxoplasmosis drugs. The quantitative and straightforward AlphaScreen assay developed here may enable high-throughput screening for small molecules disrupting the TgAtg8-TgAtg3 interaction.	[Liu, Shuxian; Wang, Yan; Wang, Han; Hu, Yue; Tan, Feng] Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou 325035, Zhejiang, Peoples R China; [Zhang, Fangfei] Wenzhou Med Univ, Renji Coll, Wenzhou 325035, Zhejiang, Peoples R China; [Chen, Xiaojian] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Lab, Wenzhou 325027, Zhejiang, Peoples R China; [Chen, Xiaojian] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Chen, Ming; Lan, Shujue] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Chem Biol Core Facil, Shanghai 200031, Peoples R China; [Wang, Chenhong] Wenzhou Med Univ, Sch Clin Med Sci 2, Wenzhou 325035, Zhejiang, Peoples R China; [Cao, Jiaxin] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325035, Zhejiang, Peoples R China; [Hu, Xin] Wenzhou Med Univ, Sch Med Lab Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Hu, Xin] Wenzhou Med Univ, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Tan, F (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou 325035, Zhejiang, Peoples R China.; Hu, X (corresponding author), Wenzhou Med Univ, Sch Med Lab Sci, Wenzhou 325035, Zhejiang, Peoples R China.; Hu, X (corresponding author), Wenzhou Med Univ, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China.	gail529@163.com; tanfengsong@163.com		Zhang, Fangfei/0000-0003-4806-1972	National Natural Science Foundation of China [81672052, 81702024]; Zhejiang Natural Science Funds for Distinguished Young Scientists Grant [LR17H190001]; Commonwealth Technology Application Project Program of Zhejiang Province [2015C33129]; Natural Science Foundation of Zhejiang Province Grant [LY16H190007]; Zhejiang Xinmiao Talent Plan Grant [2017R413062, 2017R413019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Funds for Distinguished Young Scientists Grant; Commonwealth Technology Application Project Program of Zhejiang Province; Natural Science Foundation of Zhejiang Province Grant(Natural Science Foundation of Zhejiang Province); Zhejiang Xinmiao Talent Plan Grant	This work was supported by National Natural Science Foundation of China Grant 81672052 and Zhejiang Natural Science Funds for Distinguished Young Scientists Grant LR17H190001 (to F. T.), National Natural Science Foundation of China Grant 81702024 and Commonwealth Technology Application Project Program of Zhejiang Province Grant 2015C33129 (to X. H.), Natural Science Foundation of Zhejiang Province Grant LY16H190007 (to X. C.), Zhejiang Xinmiao Talent Plan Grant 2017R413062 (to S. L.), as well as Zhejiang Xinmiao Talent Plan Grant 2017R413019 (to F. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Canon-Franco WA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-427; Besteiro S, 2012, MOL BIOCHEM PARASIT, V184, P1, DOI 10.1016/j.molbiopara.2012.04.001; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Chen D, 2016, ACTA TROP, V153, P79, DOI 10.1016/j.actatropica.2015.09.013; de Late PL, 2017, BIOMED J, V40, P23, DOI 10.1016/j.bj.2017.01.001; Dickson MA, 2013, ANN ONCOL, V24, P252, DOI 10.1093/annonc/mds275; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Hain AUP, 2016, CHEMMEDCHEM, V11, P900, DOI 10.1002/cmdc.201500515; Hain AUP, 2014, J MED CHEM, V57, P4521, DOI 10.1021/jm401675a; Hain AUP, 2012, J STRUCT BIOL, V180, P551, DOI 10.1016/j.jsb.2012.09.001; Ho KH, 2009, AUTOPHAGY, V5, P461, DOI 10.4161/auto.5.4.7696; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jayabalasingham B, 2014, AUTOPHAGY, V10, P269, DOI 10.4161/auto.27166; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Kong-Hap MA, 2013, AUTOPHAGY, V9, P1334, DOI 10.4161/auto.25189; Koopmann R, 2009, AUTOPHAGY, V5, P1085, DOI 10.4161/auto.5.8.9611; Lavine MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042107; Leveque MF, 2015, MBIO, V6, DOI 10.1128/mBio.01446-15; Li XZ, 2016, PARASITOLOGY, V143, P639, DOI 10.1017/S0031182015001985; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Luder CGK, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-116; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Reece SE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002320; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Sinai AP, 2012, TRENDS PARASITOL, V28, P358, DOI 10.1016/j.pt.2012.06.006; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tomlins AM, 2013, AUTOPHAGY, V9, P1540, DOI 10.4161/auto.25832; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Varberg JM, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01489-17; Walker DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067047; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670	44	5	5	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14545	14556		10.1074/jbc.RA118.002614	http://dx.doi.org/10.1074/jbc.RA118.002614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30026233	Green Published, hybrid			2022-12-26	WOS:000444671500031
J	Zinskie, JA; Ghosh, A; Trainor, BM; Shedlovskiy, D; Pestov, DG; Shcherbik, N				Zinskie, Jessica A.; Ghosh, Arnab; Trainor, Brandon M.; Shedlovskiy, Daniel; Pestov, Dimitri G.; Shcherbik, Natalia			Iron-dependent cleavage of ribosomal RNA during oxidative stress in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; RNA degradation; ribosome; reactive oxygen species (ROS); oxidative stress; iron; iron metabolism; cell death; yeast; Fenton reaction; glutaredoxin; iron homeostasis	GRX5 MONOTHIOL GLUTAREDOXIN; HYDROGEN-PEROXIDE; CELL-DEATH; FENTON REACTIONS; DNA-DAMAGE; VITAMIN-C; LIFE-SPAN; METAL-ION; KEY ROLE; APOPTOSIS	Stress-induced strand breaks in rRNA have been observed in many organisms, but the mechanisms by which they originate are not well-understood. Here we show that a chemical rather than an enzymatic mechanism initiates rRNA cleavages during oxidative stress in yeast (Saccharomyces cerevisiae). We used cells lacking the mitochondrial glutaredoxin Grx5 to demonstrate that oxidant-induced cleavage formation in 25S rRNA correlates with intracellular iron levels. Sequestering free iron by chemical or genetic means decreased the extent of rRNA degradation and relieved the hypersensitivity of grx5 cells to the oxidants. Importantly, subjecting purified ribosomes to an in vitro iron/ascorbate reaction precisely recapitulated the 25S rRNA cleavage pattern observed in cells, indicating that redox activity of the ribosome-bound iron is responsible for the strand breaks in the rRNA. In summary, our findings provide evidence that oxidative stress-associated rRNA cleavages can occur through rRNA strand scission by redox-active, ribosome-bound iron that potentially promotes Fenton reaction-induced hydroxyl radical production, implicating intracellular iron as a key determinant of the effects of oxidative stress on ribosomes. We propose that iron binding to specific ribosome elements primes rRNA for cleavages that may play a role in redox-sensitive tuning of the ribosome function in stressed cells.	[Zinskie, Jessica A.; Ghosh, Arnab; Trainor, Brandon M.; Shedlovskiy, Daniel; Pestov, Dimitri G.; Shcherbik, Natalia] Rowan Univ, Dept Cell Biol & Neurosci, Stratford, NJ 08084 USA; [Trainor, Brandon M.] Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University	Shcherbik, N (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	shcherna@rowan.edu	GHOSH, ARNAB/J-2299-2019	GHOSH, ARNAB/0000-0003-1952-1044; Pestov, Dimitri/0000-0002-1425-9879	National Institutes of Health [R01GM114308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114308 (to N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Alves R, 2004, PROTEINS, V57, P481, DOI 10.1002/prot.20228; Athavale SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038024; Belli G, 2002, J BIOL CHEM, V277, P37590, DOI 10.1074/jbc.M201688200; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berens C, 1998, CHEM BIOL, V5, P163, DOI 10.1016/S1074-5521(98)90061-8; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Bray M. S., 2018, FERROUS IRON FOLDS R, DOI [10.1101/256958, DOI 10.1101/256958]; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Cazzola M, 2003, BLOOD, V101, P1996, DOI 10.1182/blood-2002-07-2006; Chen XJ, 2017, J ORAL PATHOL MED, V46, P332, DOI 10.1111/jop.12502; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Ding QX, 2006, NEUROCHEM RES, V31, P705, DOI 10.1007/s11064-006-9071-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gomez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111585; GRAF E, 1984, J BIOL CHEM, V259, P3620; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; HOUGE G, 1993, FEBS LETT, V315, P16, DOI 10.1016/0014-5793(93)81123-H; Hsiao CL, 2013, NAT CHEM, V5, P525, DOI [10.1038/NCHEM.1649, 10.1038/nchem.1649]; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; KHAN MMT, 1967, J AM CHEM SOC, V89, P4176, DOI 10.1021/ja00992a036; Kim SJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0024-3; King KL, 2000, CELL DEATH DIFFER, V7, P994, DOI 10.1038/sj.cdd.4400731; Laporte D, 2012, J EXP BOT, V63, P503, DOI 10.1093/jxb/err301; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; LEE TS, 1948, J AM CHEM SOC, V70, P3596, DOI 10.1021/ja01191a015; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; Mahaseth T, 2017, MUTAT RES-REV MUTAT, V773, P274, DOI 10.1016/j.mrrev.2016.08.006; Mansour FH, 2013, ANAL BIOCHEM, V441, P18, DOI 10.1016/j.ab.2013.06.008; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; MORGAN AR, 1976, NUCLEIC ACIDS RES, V3, P1139, DOI 10.1093/nar/3.5.1139; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; Muhlenhoff U, 2015, EUR J CELL BIOL, V94, P292, DOI 10.1016/j.ejcb.2015.05.003; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Narendrula R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2197-1; Oikawa S, 1998, BBA-GENE STRUCT EXPR, V1399, P19, DOI 10.1016/S0167-4781(98)00092-X; Okafor CD, 2017, NUCLEIC ACIDS RES, V45, P3634, DOI 10.1093/nar/gkx171; Padmanabhan PK, 2012, CELL DEATH DIFFER, V19, P1972, DOI 10.1038/cdd.2012.85; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Petrov AS, 2011, RNA, V17, P291, DOI 10.1261/rna.2390311; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; Shcherbik N, 2016, NUCLEIC ACIDS RES, V44, P6840, DOI 10.1093/nar/gkw566; Shcherbik N, 2013, TRAFFIC, V14, P1209, DOI 10.1111/tra.12122; Shedlovskiy D, 2017, RNA BIOL, V14, P1722, DOI 10.1080/15476286.2017.1345417; Shedlovskiy D, 2017, J BIOL CHEM, V292, P18469, DOI 10.1074/jbc.M117.800003; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stefan L, 2012, NUCLEIC ACIDS RES, V40, P8759, DOI 10.1093/nar/gks581; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Martinez-Pastor MT, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2215-8; Topf U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02694-8; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Vilella F, 2004, COMP FUNCT GENOM, V5, P328, DOI 10.1002/cfg.406; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; WANG Y, 1989, NUCLEIC ACIDS RES, V17, P6915, DOI 10.1093/nar/17.17.6915; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	73	17	17	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14237	14248		10.1074/jbc.RA118.004174	http://dx.doi.org/10.1074/jbc.RA118.004174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30021840	hybrid, Green Published			2022-12-26	WOS:000444671500005
J	O'Neill, L; Park, SH; Rosinia, F				O'Neill, Liam; Park, Sae-Hwan; Rosinia, Frank			The role of the built environment and private rooms for reducing central line-associated bloodstream infections	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; PATIENT SAFETY INDICATORS; QUALITY IMPROVEMENT; FACILITY DESIGN; SINGLE ROOMS; ACQUISITION; PREVENTION; PERFORMANCE; OCCUPANCY; HOSPITALS	Private hospital rooms are believed to offer some protective effect against hospital-acquired infections, including central line-associated bloodstream infections. Yet a recent meta-analysis found the evidence-base to be lacking from a policy perspective. We sought to determine whether private rooms were associated with a lower risk of central-line infections. We examined the discharge records of more than one million inpatients from 335 Texas hospitals to determine patients that stayed in private rooms. Patients who stayed in bay rooms had 64 percent more central line infections than patients who stayed in private rooms. Even after adjusting for relevant covariates, patients assigned to bay rooms had a 21 percent greater relative risk of a central line infection (p = 0.005), compared with patients assigned to private rooms. At the hospital level, a 10% increase in private rooms was associated with an 8.6% decrease in central line infections (p<0.001), regardless of individual patients' room assignment. This study demonstrates and validates the use of private rooms as a structural measure and independent predictor of hospital quality.	[O'Neill, Liam; Park, Sae-Hwan] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA; [Rosinia, Frank] John Peter Smith Hosp, Dept Anesthesiol, Ft Worth, TX 76104 USA; [Rosinia, Frank] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	O'Neill, L (corresponding author), Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA.	liam.oneill@unthsc.edu		ONeill, Liam/0000-0003-1599-7774				[Anonymous], 2012, PSI 07 CENTRAL VENOU; Bartley J, 2010, CRIT CARE MED, V38, pS388, DOI 10.1097/CCM.0b013e3181e6d0c1; Bracco D, 2007, INTENS CARE MED, V33, P836, DOI 10.1007/s00134-007-0559-5; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Centers for Disease Control and Prevention (CDC), 2016, HEALTHC ASS INF HAI; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; Chaudhury H, 2006, APPL NURS RES, V19, P118, DOI 10.1016/j.apnr.2005.06.002; Datta R, 2011, ARCH INTERN MED, V171, P491, DOI 10.1001/archinternmed.2011.64; Detsky ME, 2008, JAMA-J AM MED ASSOC, V300, P954, DOI 10.1001/jama.300.8.954; Dettenkofer M, 2004, INFECT CONT HOSP EP, V25, P21, DOI 10.1086/502286; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Donabedian A., 1980, EXPLORATIONS QUALITY, P3; Edwards JN, 2011, ELIMINATING CENTRAL; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellison J, 2014, CAN J INFECT DIS MED, V25, P265, DOI 10.1155/2014/685402; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; Gallagher B, 2005, READMISSIONS SELECTE; Goldman DP, 2010, NEW ENGL J MED, V363, P2185, DOI 10.1056/NEJMp1009501; Hall KK, 2013, HERD-HEALTH ENV RES, V7, P13, DOI 10.1177/193758671300701S03; HCUP CCS. Healthcare Cost and Utilization Project (HCUP), 2017, CLIN CLASS SOFTW CCS; Hearld LR, 2008, MED CARE RES REV, V65, P259, DOI 10.1177/1077558707309613; Hendrich AL, 2004, AM J CRIT CARE, V13, P35, DOI 10.4037/ajcc2004.13.1.35; Lenfestey NF, 2013, HERD-HEALTH ENV RES, V7, P31, DOI 10.1177/193758671300701S05; Levin PD, 2011, CRIT CARE, V15, DOI 10.1186/cc10446; Liang SY, 2011, ANN EMERG MED, V58, P450; Marsteller JA, 2014, AM J INFECT CONTROL, V42, pS209, DOI 10.1016/j.ajic.2014.06.001; Moehring RW, 2013, INFECT CONT HOSP EP, V34, P238, DOI 10.1086/669527; National Conference of State Legislatures, 2017, CON CERT NEED STAT L; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P628, DOI 10.1377/hlthaff.2011.0047; Rivard PE, 2006, HEALTH SERV RES, V41, P1633, DOI 10.1111/j.1475-6773.2006.00569.x; Romano PS, 2003, HEALTH AFFAIR, V22, P154, DOI 10.1377/hlthaff.22.2.154; Rosen AK, 2012, MED CARE, V50, P74, DOI 10.1097/MLR.0b013e3182293edf; Stone PW, 2007, MED CARE, V45, P571, DOI 10.1097/MLR.0b013e3180383667; Studnicki J, 2013, AM J MED QUAL, V28, P525, DOI 10.1177/1062860613480826; Teltsch DY, 2011, ARCH INTERN MED, V171, P32, DOI 10.1001/archinternmed.2010.469; Texas Department of State Health Services center for health statistics Austin Texas, 2020, TEX INP PUBL US DAT; van de Glind I, 2007, HEALTH POLICY, V84, P153, DOI 10.1016/j.healthpol.2007.06.002; van Mourik MSM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008424; Weiner BJ, 2006, MED CARE RES REV, V63, P29, DOI 10.1177/1077558705283122; Winters BD, 2016, MED CARE, V55, P1105, DOI 10.1097/MLR.0000000000000550; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763; Zuberi D., 2013, CLEANING HOSP OUTS I	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201002	10.1371/journal.pone.0201002	http://dx.doi.org/10.1371/journal.pone.0201002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052672	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600021
J	Sala-Puigdollers, A; Figueras-Roca, M; Hereu, M; Hernandez, T; Morato, M; Adan, A; Zarranz-Ventura, J				Sala-Puigdollers, Anna; Figueras-Roca, Marc; Hereu, Mireia; Hernandez, Teresa; Morato, Montse; Adan, Alfredo; Zarranz-Ventura, Javier			Repeatability and reproducibility of retinal and choroidal thickness measurements in Diabetic Macular Edema using Swept-source Optical Coherence Tomography	PLOS ONE			English	Article							TIME-DOMAIN; RETINOPATHY; CONVERSION; METRICS; EYES	Purpose To evaluate the repeatability and reproducibility of retinal and choroidal thickness measured with Swept source Optical Coherence Tomography (SS-OCT) in eyes with Diabetic Macular Edema (DME). Methods 42 DME eyes were imaged using SS-OCT standard Macular scanning protocols. Retinal and choroidal thickness were measured in the Total macular circle (TMC) and foveal central subfield (FCS) using device-integrated specific software. The coefficient of repeatability (CR) and intraclass correlation coefficient (ICC) were determined as a measure of repeatability and relative reliability within graders. Reproducibility was assessed using Bland-Altman plots and 95% limits of agreement (LoA) were determined as a measure of interobserver variability. Results Intragrader CR of retinal and choroidal thickness were 8.37 and 12.20 microns for TMC and 22.24 and 32.40 microns for FCS, and intergrader 95% LoA were 7.37 +/- 8.69 and -27.2 +/- 27.71 microns for TMC and -34.21 +/- 41.93 and -30.46 +/- 24.84 for FCS, respectively. Retinal and choroidal thickness showed very good intraobserver reliability for both TMC and FCS (ICC 0.99, LoA 0.98 +/- 0.99 in all cases). Intraobserver and interobserver variability for retinal and choroidal thickness was not significantly different for TMC (p = 0.98 and p = 0.90, p = 0.98 and p = 0.91) or FCS (p = 0.97 and p = 0.85, p = 0.78 and p = 0.73), respectively. Conclusions Retinal and choroidal thickness in DME eyes can be quantified with good reliability, repeatability and reproducibility using new OCT devices that incorporate swept source technology. The technical advantages of this technology may provide new insights in the understanding of the choroidal changes related with DME.	[Sala-Puigdollers, Anna; Figueras-Roca, Marc; Hereu, Mireia; Hernandez, Teresa; Morato, Montse; Adan, Alfredo; Zarranz-Ventura, Javier] Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain; [Sala-Puigdollers, Anna; Figueras-Roca, Marc; Adan, Alfredo; Zarranz-Ventura, Javier] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Sala-Puigdollers, Anna] Ctr Med Teknon, Inst Macula, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sala-Puigdollers, A (corresponding author), Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain.; Sala-Puigdollers, A (corresponding author), August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.; Sala-Puigdollers, A (corresponding author), Ctr Med Teknon, Inst Macula, Barcelona, Spain.	ansala@clinic.cat	Figueras-Roca, Marc/G-9095-2017; Zarranz-Ventura, Javier/AAB-5390-2021	Figueras-Roca, Marc/0000-0002-0548-0539; Zarranz-Ventura, Javier/0000-0003-2338-8143; Hereu, Mireia/0000-0002-7179-2514; Sala-Puigdollers, Anna/0000-0001-5792-6937				Abadia B I, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0191977, DOI 10.1371/JOURNAL.PONE.0191977]; Abadia B, 2019, RETINA-J RET VIT DIS, V39, P786, DOI 10.1097/IAE.0000000000002022; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bressler SB, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.1.5; Bressler SB, 2014, JAMA OPHTHALMOL, V132, P1113, DOI 10.1001/jamaophthalmol.2014.1698; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Fiore T, 2013, CURR EYE RES, V38, P674, DOI 10.3109/02713683.2013.781191; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Hodzic-Hadzibegovic D, 2015, ACTA OPHTHALMOL, V93, P74, DOI 10.1111/aos.12494; Hua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083494; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Melancia D, 2016, GRAEF ARCH CLIN EXP, V254, P1453, DOI 10.1007/s00417-016-3360-8; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2893, DOI 10.1167/iovs.12-11085; Stanga PE, 2014, AM J OPHTHALMOL, V157, P397, DOI 10.1016/j.ajo.2013.10.008; Vujosevic S, 2012, RETINA-J RET VIT DIS, V32, P1781, DOI 10.1097/IAE.0b013e31825db73d; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836	20	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200819	10.1371/journal.pone.0200819	http://dx.doi.org/10.1371/journal.pone.0200819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048478	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400022
J	Zhang, W; Chen, KR; Zhang, XQ; Guo, CH; Chen, YS; Liu, XH				Zhang, Wei; Chen, Keren; Zhang, Xueqing; Guo, Chunhe; Chen, Yaosheng; Liu, Xiaohong			An integrated analysis of membrane remodeling during porcine reproductive and respiratory syndrome virus replication and assembly	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CORONAVIRUS REPLICATION; ULTRASTRUCTURAL CHARACTERIZATION; 3-DIMENSIONAL ARCHITECTURE; ARTERIVIRUS REPLICASE; SARS-CORONAVIRUS; RNA REPLICATION; LIFE-CYCLE; COMPLEX; PROTEIN	Background Recently, three-dimensional (3D) imaging techniques have been used to detect viral invasion and the appearance of specialized structures established in virus-infected cells. These methods have had a positive impact in the field of virology and helped to further our knowledge of how viruses invade cells. Nearly all positive-strand RNA viruses propagate their viral genomes in part through intracellular membranes. Porcine reproductive and respiratory syndrome virus (PRRSV), an Arterivirus, accumulates viral RNA that forms replication complexes (RCs) in infected cells. In this study, using immunofluorescence and electron microscopy (EM), we dissected PRRSV-induced membrane structures in infected cells and determined the correlations between PRRSV particles and vesicles stimulated by PRRSV to understand the structural and dynamic aspects of PRRSV infection. Methods We identified the appropriate time point by determining the 50% tissue culture infectious dose (TCID50) and using qRT-PCR and Western blotting. The co-localization of viruses and organelles was determined by immunofluorescence and immune-electron microscopy (IEM). The ultrastructure of cells infected by PRRSV was observed using EM and electron tomography (ET). Results In our study, we found that PRRSV dsRNA was located at the endoplasmic reticulum (ER) and autophagosomes; in addition, the N protein was located at the mitochondria, ER and autophagosomes. Vesicles induced by PRRSV appeared at 16 hours post-infection (h.p.i.) and increased in size with time during the infection period. In addition, our findings demonstrated that the virus vesicles originated from the ER, and these two organelle structures connected with each other to form a reticulovesicular network (RVN) that provided a site for virus replication and assembly. Conclusion Our results revealed that membrane vesicles induced by PRRSV were derived from the ER. The vesicles may provide a location for PRRSV replication and assembly.	[Zhang, Wei; Chen, Keren; Zhang, Xueqing; Guo, Chunhe; Chen, Yaosheng; Liu, Xiaohong] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei; Chen, Keren; Zhang, Xueqing; Guo, Chunhe; Chen, Yaosheng; Liu, Xiaohong] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, XH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Liu, XH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	xhliu@163.net	Guo, Chunhe/ABB-3754-2021	Guo, Chunhe/0000-0002-7859-1985; Wei, Zhang/0000-0002-8378-1142	Natural Science Foundation of Guangdong Province [2014A030312011]; National Natural Science Foundation of China [31601917]; Guangdong Sailing Program [2014YT02H042]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Sailing Program	This work was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the National Natural Science Foundation of China (31601917) and the Guangdong Sailing Program (2014YT02H042) (YC).	Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11; Blanchard E, 2015, CELL MICROBIOL, V17, P45, DOI 10.1111/cmi.12372; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; Dea S, 1995, Adv Exp Med Biol, V380, P95; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li SF, 2016, ONCOTARGET, V7, P56002, DOI 10.18632/oncotarget.10817; Maier HJ, 2013, MBIO, V4, DOI 10.1128/mBio.00801-13; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Metwally S, 2010, TRANSBOUND EMERG DIS, V57, P315, DOI 10.1111/j.1865-1682.2010.01152.x; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Misinzo G, ADV EXPT MED BIOL, P449; Molenkamp R, 2000, J GEN VIROL, V81, P2491, DOI 10.1099/0022-1317-81-10-2491; Oudshoorn D, 2016, MBIO, V7, DOI 10.1128/mBio.01991-16; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Peng L, 2010, STRUCTURE, V18, P47, DOI 10.1016/j.str.2009.10.017; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Spilman MS, 2009, J GEN VIROL, V90, P527, DOI 10.1099/vir.0.007674-0; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Suarez C, 2015, CELL MICROBIOL, V17, P1683, DOI 10.1111/cmi.12468; Ulasli M, 2010, CELL MICROBIOL, V12, P844, DOI 10.1111/j.1462-5822.2010.01437.x; Urakova N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169913; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; World Organization for Animal Health (OIE), 2001, WORLD AN HLTH 2000 1; Yoo D, 2003, J VIROL, V77, P12173, DOI 10.1128/JVI.77.22.12173-12183.2003; Zhang QF, 2004, J MED VIROL, V73, P332, DOI 10.1002/jmv.20095; Zhao HJ, 2014, THERIOGENOLOGY, V82, P790, DOI 10.1016/j.theriogenology.2014.06.003; Zhu HL, 2014, INT J MED MICROBIOL, V304, P577, DOI 10.1016/j.ijmm.2014.03.002	41	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200919	10.1371/journal.pone.0200919	http://dx.doi.org/10.1371/journal.pone.0200919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040832	gold, Green Submitted, Green Published			2022-12-26	WOS:000439749200016
J	Tai, YH; Chang, WK; Wu, HL; Chan, MY; Chen, HH; Chang, KY				Tai, Ying-Hsuan; Chang, Wen-Kuei; Wu, Hsiang-Ling; Chan, Min-Ya; Chen, Hsiu-Hsi; Chang, Kuang-Yi			The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study	PLOS ONE			English	Article							PERIOPERATIVE BLOOD-TRANSFUSIONS; LONG-TERM OUTCOMES; MU-OPIOID RECEPTOR; COLON-CANCER; CLINICAL-OUTCOMES; CELL TRANSFUSIONS; LIVER METASTASES; SURGERY; RECURRENCE; SURVIVAL	Retrospective clinical studies showed perioperative epidural analgesia (EA) was associated with better postoperative oncologic outcomes in patients with specific types of non-metastatic cancers. This study aimed to investigate the effects of EA on cancer prognosis after surgical intervention for stage IV colorectal cancer. In this retrospective study, patients with stage IV colorectal cancer undergoing primary tumor resection and metastasectomy between January 2005 and December 2014 were classified into two groups based on their use of perioperative EA or not and evaluated through August 2016. Primary and secondary endpoints were postoperative progression-free survival (PFS) and overall survival (OS), respectively. A total of 999 patients were included and 165 (16.5%) of them received EA. The median follow-up interval was 17.5 months and no significant difference in PFS or OS was noted between the EA and non-EA groups in the univariate analysis. Multivariable Cox proportional hazards model identified four independent risk factors both for disease progression and mortality, including American Society of Anesthesiologists (ASA) physical status >= 3, higher pretreatment carcinoembryonic antigen (CEA), multiple distant metastases, and pathologic lymphovascular invasion. After adjustment for the selected risk factors, the effects of EA on PFS and OS remained non-significant (hazard ratio: 1.06, 95% CI: 0.87 to 1.29, for PFS and 0.90, 95% CI: 0.68 to 1.20 for OS). Similar findings were demonstrated by propensity score analysis. Our results did not support the association between perioperative epidural analgesia and better progression-free or overall survival in patients following stage IV colorectal cancer surgery.	[Tai, Ying-Hsuan; Chang, Wen-Kuei; Wu, Hsiang-Ling; Chan, Min-Ya; Chang, Kuang-Yi] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tai, Ying-Hsuan] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Tai, Ying-Hsuan; Chang, Wen-Kuei; Wu, Hsiang-Ling; Chang, Kuang-Yi] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Tai, Ying-Hsuan] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Wu, Hsiang-Ling] Taipei Vet Gen Hosp, Dept Surg, Yuli Branch, Hualien, Taiwan; [Chan, Min-Ya] Natl Taiwan Normal Univ, Dept Technol Applicat & Human Resource Dev, Taipei, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Div Biostat, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Veterans General Hospital; National Taiwan Normal University; National Taiwan University	Chang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.; Chang, KY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	kychang@vghtpe.gov.tw	tai, yh/GRR-4574-2022	Chen, Hsiu-Hsi/0000-0002-5799-6705	Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C [V104C-096]; Ministry of Science and Technology, Taipei, Taiwan, R.O.C [MOST 104-2314-B-075-015]; Anesthesiology Research and Development Foundation, Taipei, Taiwan [ARDF10501]	Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C(Taipei Veterans General Hospital); Ministry of Science and Technology, Taipei, Taiwan, R.O.C; Anesthesiology Research and Development Foundation, Taipei, Taiwan	This study was supported by the grants from Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C (V104C-096; https://www.vghtpe.gov.tw), Ministry of Science and Technology, Taipei, Taiwan, R.O.C (MOST 104-2314-B-075-015; https://www.most.gov.tw) and Anesthesiology Research and Development Foundation, Taipei, Taiwan (ARDF10501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Aggarwal C, 2013, ANN ONCOL, V24, P420, DOI 10.1093/annonc/mds336; Amato A, 2006, COCHRANE DB SYST REV, DOI 10.1002/1465158.CD005033.pub2; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Buggy DJ, 1999, BMJ-BRIT MED J, V319, P530, DOI 10.1136/bmj.319.7209.530; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Edge SB, 2010, AJCC CANC STAGING MA; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hallet J, 2015, ANN SURG ONCOL, V22, P4038, DOI 10.1245/s10434-015-4477-4; Hiller JG, 2018, NAT REV CLIN ONCOL, V15, P205, DOI 10.1038/nrclinonc.2017.194; Hogan J, 2015, DIS COLON RECTUM, V58, P547, DOI 10.1097/DCR.0000000000000361; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Kawaraguchi Y, 2011, ANESTHESIOLOGY, V115, P499, DOI 10.1097/ALN.0b013e3182276d42; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lennon FE, 2012, ANESTHESIOLOGY, V116, P940, DOI 10.1097/ALN.0b013e31824b9512; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Nitsche U, 2013, ANN SURG, V258, P775, DOI 10.1097/SLA.0b013e3182a69f7e; Nylund G, 2008, DIGEST DIS SCI, V53, P461, DOI 10.1007/s10620-007-9897-y; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Singleton PA, 2015, CANCER-AM CANCER SOC, V121, P2681, DOI 10.1002/cncr.29460; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Sun YX, 2015, REGION ANESTH PAIN M, V40, P589, DOI 10.1097/AAP.0000000000000273; Thirunavukarasu P, 2015, JAMA SURG, V150, P747, DOI 10.1001/jamasurg.2015.0871; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Van Osdol AD, 2015, AM J SURG, V210, P990, DOI 10.1016/j.amjsurg.2015.06.026; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5; Wada H, 2007, ANESTHESIOLOGY, V106, P499, DOI 10.1097/00000542-200703000-00014; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zimmitti G, 2016, ANN SURG ONCOL, V23, P1003, DOI 10.1245/s10434-015-4933-1; Zylla D, 2013, CANCER-AM CANCER SOC, V119, P4103, DOI 10.1002/cncr.28345	40	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200893	10.1371/journal.pone.0200893	http://dx.doi.org/10.1371/journal.pone.0200893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028851	Green Published, gold			2022-12-26	WOS:000439396900023
J	Kim, DH; Lee, DI; Ahn, J; Lee, KN; Roh, SY; Shim, J; Choi, JI; Kim, YH				Kim, Dong-Hyeok; Lee, Dae-In; Ahn, Jinhee; Lee, Kwang-No; Roh, Seung-Young; Shim, Jaemin; Choi, Jong-Il; Kim, Young-Hoon			Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; THROMBOEMBOLIC EVENTS; ORAL ANTICOAGULATION; THERAPY; MULTICENTER; DEATH; TRIAL	The interruption of oral anticoagulation therapy (OAC) after CA of atrial fibrillation (AF) is controversial. The purpose of this study was to evaluate the relationship between successful long-term outcomes of catheter resection and SR maintenance and ischemic stroke risk in Korea. We studied 1,548 consecutive patients who were followed up for more than 2 years after CA of AF. We investigated the incidence of ischemic stroke during long-term follow-up. Compared to the AF recurrence group (n = 619), the sinus rhythm (SR) maintenance group (n = 929) had more paroxysmal AF (74.6% versus 44.4%, p<0.001), smaller LA size (39.9 +/- 5.7mm versus 42.3 +/- 6.0mm, p<0.001), and younger age (54.2 +/- 10.9 years versus 56.4 +/- 10.6 years, p<0.001). However, CHA(2)DS(2)-VASc scores were not significantly different between the two groups (0.9 vs. 1.1, p = 0.053). The overall incidence of ischemic stroke during the mean follow-up period of 54 months after CA was 0.6%, and was significantly lower in the SR group than the AF recurrence group (0.3% vs. 1.1%, log-rank test p<0.001). However, in sub-analysis in the SR group, the rate of ischemic stroke was significantly increasing in patients with a CHA(2)DS(2)-VASc score >= 4 compared to those with a CHA(2)DS(2)-VASc score < 4 (4.3% vs. 0.2%, log-rank test p<0.001). In conclusion, this long-term followup data in patients with AF who underwent successful CA showed that SR maintenance was correlated with a lower rate of ischemic stroke in Korea. However, it was only observed in patients with CHA(2)DS(2)-VASc score <= 3.	[Kim, Dong-Hyeok; Lee, Kwang-No; Shim, Jaemin; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Lee, Dae-In] Chungbuk Natl Univ Hosp, Div Cardiol, Cheongju, South Korea; [Ahn, Jinhee] Pusan Natl Univ Hosp, Div Cardiol, Busan, South Korea; [Roh, Seung-Young] Dongguk Univ, Coll Med, Div Cardiol, Goyang, South Korea; [Roh, Seung-Young] Dongguk Univ, Med Ctr, Goyang, South Korea	Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Chungbuk National University Hospital; Pusan National University; Pusan National University Hospital; Dongguk University; Dongguk University	Kim, YH (corresponding author), Korea Univ, Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea.	yhkmd@unitel.co.kr	Kim, Dong-Hyeok/N-7559-2018; Kim, Young-Hoon/AAO-5792-2021	Kim, Dong-Hyeok/0000-0002-6339-8496; Choi, Jong-Il/0000-0001-6617-508X; Kim, Young-Hoon/0000-0002-4254-647X				Bunch TJ, 2011, J CARDIOVASC ELECTR, V22, P839, DOI 10.1111/j.1540-8167.2011.02035.x; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Friberg L, 2016, EUR HEART J, V37, P2478, DOI 10.1093/eurheartj/ehw087; Hakalahti A, 2015, EUROPACE, V17, P370, DOI 10.1093/europace/euu376; Hindricks G, 2005, CIRCULATION, V112, P307, DOI 10.1161/CIRCULATIONAHA.104.518837; Holmqvist F, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001901; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Jons C, 2009, EUROPACE, V11, P917, DOI 10.1093/europace/eup122; Karasoy D, 2015, EUR HEART J, V36, P307, DOI 10.1093/eurheartj/ehu421; Kochhauser S, 2017, J CARDIOVASC ELECTR, V28, P273, DOI 10.1111/jce.13138; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Lickfett L, 2006, J CARDIOVASC ELECTR, V17, P1, DOI 10.1111/j.1540-8167.2005.00279.x; Nademanee K, 2008, J AM COLL CARDIOL, V51, P843, DOI 10.1016/j.jacc.2007.10.044; Oral H, 2006, CIRCULATION, V114, P759, DOI 10.1161/CIRCULATIONAHA.106.641225; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Potpara TS, 2015, EUROPACE, V17, P986, DOI 10.1093/europace/euv132; Saad EB, 2011, CIRC-ARRHYTHMIA ELEC, V4, P615, DOI 10.1161/CIRCEP.111.963231; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Themistoclakis S, 2010, J AM COLL CARDIOL, V55, P735, DOI 10.1016/j.jacc.2009.11.039; Verma A, 2013, JAMA INTERN MED, V173, P149, DOI 10.1001/jamainternmed.2013.1561; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093	21	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201061	10.1371/journal.pone.0201061	http://dx.doi.org/10.1371/journal.pone.0201061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024976	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000085
J	Park, AR; Jang, SW; Kim, JS; Park, YG; Koo, BS; Lee, HC				Park, Ah-Reum; Jang, Seung-Won; Kim, Jin-Sook; Park, Young-Gyun; Koo, Bong-Seong; Lee, Hyeon-Cheol			Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli	PLOS ONE			English	Article							TOXIN MUTANT CRM197; DIPHTHERIA-TOXIN; ESCHERICHIA-COLI; DEOXYRIBONUCLEASE ACTIVITY; PSEUDOMONAS-FLUORESCENS; CONJUGATE VACCINES; BODY PROTEINS; CANCER; SOLUBILIZATION; PURIFICATION	CRM197, which retains the same inflammatory and immune-stimulant properties as diphtheria toxin but with reduced toxicity, has been used as a safe carrier in conjugated vaccines. Expression of recombinant CRM197 in E. coli is limited due to formation of inclusion bodies. Soluble expression attempts in Bacillus subtilis, P. fluorescens, Pichia pastoris, and E. coli were partially unsuccessful or did not generate yields sufficient for industrial scale production. Multiple approaches have been attempted to produce CRM197 in E. coli, which has attractive features such as high yield, simplicity, fast growth, etc., including expression of oxidative host, concurrent expression of chaperones, or periplasmic export. Recently, alternative methods for recovery of insoluble proteins expressed in E. coliwere reported. Compared to traditional denaturation/refolding, these methods used the non-denaturing solubilization agent, N-lauroylsarkosine to obtain higher recovery yields of native proteins. Based on this work, here, we focused on solubilization of CRM197 from E. coli inclusion bodies. First, CRM197 was expressed as inclusion bodies by high-level expression of recombinant CRM197 in E. coli (126.8 mg/g dcw). Then bioactive CRM197 was isolated from these inclusion bodies with high yield (108.1 mg/g dcw) through solubilization with N-lauroylsarkosine including Triton X-100 and CHAPS, and purified by Ni-affinity chromatography and size-exclusion chromatography. In this study, we present a cost-effective alternative for the production of bioactive CRM197 and compare our recovery yield with yields in other production processes.	[Park, Ah-Reum; Jang, Seung-Won; Kim, Jin-Sook; Park, Young-Gyun; Koo, Bong-Seong; Lee, Hyeon-Cheol] ForBioKorea Co Ltd, Seoul, South Korea		Lee, HC (corresponding author), ForBioKorea Co Ltd, Seoul, South Korea.	hclee0609@gmail.com		Lee, Hyeon-Cheol/0000-0003-4324-8834	ForBioKorea Co., Ltd	ForBioKorea Co., Ltd	The author(s) received no specific funding for this work ForBioKorea Co., Ltd provided support in the form of salaries for authors [HL, AP, SJ, JK, YP, BK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ada G, 2003, CLIN MICROBIOL INFEC, V9, P79, DOI 10.1046/j.1469-0691.2003.00530.x; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BISHAI WR, 1987, J BACTERIOL, V169, P1554, DOI 10.1128/jb.169.4.1554-1563.1987; BISHAI WR, 1987, J BACTERIOL, V169, P5140, DOI 10.1128/jb.169.11.5140-5151.1987; BRUCE C, 1990, P NATL ACAD SCI USA, V87, P2995, DOI 10.1073/pnas.87.8.2995; Buzzi S, 2004, CANCER IMMUNOL IMMUN, V53, P1041, DOI 10.1007/s00262-004-0546-4; COX JC, 1975, APPL MICROBIOL, V29, P464, DOI 10.1128/AEM.29.4.464-468.1975; FISCHER B, 1992, PROTEIN ENG, V5, P593, DOI 10.1093/protein/5.6.593; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; Goffin P, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201700168; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Huang ZL, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-25; Jin HF, 2011, PROTEIN EXPRES PURIF, V78, P69, DOI 10.1016/j.pep.2011.03.002; Lee JW, 2005, BBA-PROTEINS PROTEOM, V1747, P121, DOI 10.1016/j.bbapap.2004.10.003; Mahamad P, 2016, APPL MICROBIOL BIOT, V100, P6319, DOI 10.1007/s00253-016-7453-4; Malito E, 2012, P NATL ACAD SCI USA, V109, P5229, DOI 10.1073/pnas.1201964109; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Nam SO, 2016, ANTICANCER RES, V36, P3651; Noe AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107764; Oganesyan N, 2015, Patent No. [WO2015117093 A1, 2015117093]; Park SY, 2012, ANAL BIOCHEM, V426, P63, DOI 10.1016/j.ab.2012.04.002; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Qin HM, 2017, PROTEIN EXPRES PURIF, V139, P1, DOI 10.1016/j.pep.2017.07.008; RAPPUOLI R, 1983, J BACTERIOL, V153, P1202, DOI 10.1128/JB.153.3.1202-1210.1983; RAPPUOLI R, 1983, APPL ENVIRON MICROB, V46, P560, DOI 10.1128/AEM.46.3.560-564.1983; Retallack DM, 2012, PROTEIN EXPRES PURIF, V81, P157, DOI 10.1016/j.pep.2011.09.010; Retallack DM, 2014, Patent No. [US 896636 B2, 896636]; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Shinefield HR, 2010, VACCINE, V28, P4335, DOI 10.1016/j.vaccine.2010.04.072; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Singh SM, 2012, PROTEIN EXPRES PURIF, V81, P75, DOI 10.1016/j.pep.2011.09.004; Stefan A, 2011, J BIOTECHNOL, V156, P245, DOI 10.1016/j.jbiotec.2011.08.024; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; TOKATLIDIS K, 1991, FEBS LETT, V282, P205, DOI 10.1016/0014-5793(91)80478-L; UCHIDA T, 1973, J BIOL CHEM, V248, P3838; UCHIDA T, 1973, J BIOL CHEM, V248, P3845; Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11; Wang X, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0270-0; Worrall D M, 1989, Aust J Biotechnol, V3, P28; Xu L, 2016, BIOTECHNOLOGY APPL B; Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022981; Yotsumoto F, 2017, ANTICANCER RES, V37, P3825, DOI 10.21873/anticanres.11761; Zhang YL, 2017, PREP BIOCHEM BIOTECH, V47, P934, DOI 10.1080/10826068.2017.1365242; Zhou J, 1999, J Tongji Med Univ, V19, P253	45	14	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0201060	10.1371/journal.pone.0201060	http://dx.doi.org/10.1371/journal.pone.0201060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021008	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400091
J	Wang, MX; Yuan, ZL; Xie, R; Ma, YL; Liu, XH; Yu, XC				Wang, Mengxi; Yuan, Zenglin; Xie, Rong; Ma, Yinliang; Liu, Xiuhua; Yu, Xiaochun			Structure-function analyses reveal the mechanism of the ARH3-dependent hydrolysis of ADP-ribosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; protein crystallization; structural biology; crystal structure; DNA damage; DNA damage response; DNA repair	POLY(ADP-RIBOSE); RIBOSE; FAMILY; REVERSIBILITY; INSIGHTS; SERINE	ADP-ribosylation of proteins plays key roles in multiple biological processes, including DNA damage repair. Recent evidence suggests that serine is an important acceptor for ADP-ribosylation, and that serine ADP-ribosylation is hydrolyzed by ADP-ribosylhydrolase 3 (ARH3 or ADPRHL2). However, the structural details in ARH3-mediated hydrolysis remain elusive. Here, we determined the structure of ARH3 in a complex with ADP-ribose (ADPR). Our analyses revealed a group of acidic residues in ARH3 that keep two Mg2+ ions at the catalytic center for hydrolysis of Ser-linked ADP-ribosyl group. In particular, dynamic conformational changes involving Glu(41) were observed in the catalytic center. Our observations suggest that Mg2+ ions together with Glu(41) and water351 are likely to mediate the cleavage of the glycosidic bond in the serine-ADPR substrate. Moreover, we found that ADPR is buried in a groove and forms multiple hydrogen bonds with the main chain and side chains of ARH3 residues. On the basis of these structural findings, we used site-directed mutagenesis to examine the functional roles of key residues in the catalytic pocket of ARH3 in mediating the hydrolysis of ADP-ribosyl from serine and DNA damage repair. Moreover, we noted that ADPR recognition is essential for the recruitment of ARH3 to DNA lesions. Taken together, our study provides structural and functional insights into the molecular mechanism by which ARH3 hydrolyzes the ADP-ribosyl group from serine and contributes to DNA damage repair.	[Wang, Mengxi; Xie, Rong; Ma, Yinliang; Liu, Xiuhua; Yu, Xiaochun] Hebei Univ, Coll Life Sci, Baoding 071000, Hebei, Peoples R China; [Yuan, Zenglin] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Xie, Rong; Ma, Yinliang; Yu, Xiaochun] Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA	Hebei University; Shandong University; City of Hope; Beckman Research Institute of City of Hope	Liu, XH; Yu, XC (corresponding author), Hebei Univ, Coll Life Sci, Baoding 071000, Hebei, Peoples R China.; Yu, XC (corresponding author), Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.	liuxiuhua_2004@163.com; xyu@coh.org	Yuan, Zenglin/M-8378-2016	Yuan, Zenglin/0000-0003-0517-8249	National Natural Science Foundation of China [81672794, 31570305, 31572269]; "100 Talents Plan" of Hebei Province [E2016100014]; Foundation of Hebei Educational committee [SLRC2017023]; NCI, National Institutes of Health [CA130899, CA132755, CA187209]; NIGMS, National Institutes of Health [GM108467]; Leukemia and Lymphoma Society [1325-15]; NATIONAL CANCER INSTITUTE [R01CA187209, R01CA132755, R01CA130899] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "100 Talents Plan" of Hebei Province; Foundation of Hebei Educational committee; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China Grants 81672794, 31570305, and 31572269, the "100 Talents Plan" of Hebei Province Grant E2016100014, Foundation of Hebei Educational committee Grant SLRC2017023, NCI, National Institutes of Health Grants CA130899, CA132755, and CA187209, NIGMS, National Institutes of Health Grant GM108467, and Leukemia and Lymphoma Society Grant 1325-15. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abplanalp J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02253-1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Berthold CL, 2009, P NATL ACAD SCI USA, V106, P14247, DOI 10.1073/pnas.0905906106; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Butepage M, 2015, CELLS-BASEL, V4, P569, DOI 10.3390/cells4040569; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Kasamatsu A, 2011, J BIOL CHEM, V286, P21110, DOI 10.1074/jbc.M111.237636; Kraus WL, 2015, MOL CELL, V58, P902, DOI 10.1016/j.molcel.2015.06.006; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leidecker O, 2016, NAT CHEM BIOL, V12, P998, DOI 10.1038/nchembio.2180; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mashimo M, 2016, CURR PROTEIN PEPT SC, V17, P633, DOI 10.2174/1389203717666160419144603; Mashimo M, 2014, DNA REPAIR, V23, P88, DOI 10.1016/j.dnarep.2014.03.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Palazzo L, 2017, FEBS J, V284, P2932, DOI 10.1111/febs.14078; Perina D, 2014, DNA REPAIR, V23, P4, DOI 10.1016/j.dnarep.2014.05.003; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Tucker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050889; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426	35	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14470	14480		10.1074/jbc.RA118.004284	http://dx.doi.org/10.1074/jbc.RA118.004284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30045870	Green Published, hybrid			2022-12-26	WOS:000444671500025
J	Andenaes, K; Lunde, IG; Mohammadzadeh, N; Dahl, CP; Aronsen, JM; Strand, ME; Palmero, S; Sjaastad, I; Christensen, G; Engebretsen, KVT; Tonnessen, T				Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Dahl, Christen P.; Aronsen, Jan Magnus; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis			The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; COLLAGEN CROSS-LINKING; MYOCARDIAL FIBROSIS; LYSYL OXIDASE; IMMUNE CELL; LUMICAN; HYPERTROPHY; EXPRESSION; SYNDECAN-4; FIBRILLOGENESIS	Pressure overload of the heart leads to cardiac remodeling that may progress into heart failure, a common, morbid and mortal condition. Increased mechanistic insight into remodeling is instrumental for development of novel heart failure treatment. Cardiac remodeling comprises cardiomyocyte hypertrophic growth, extracellular matrix alterations including fibrosis, and inflammation. Fibromodulin is a small leucine-rich proteoglycan that regulates collagen fibrillogenesis. Fibromodulin is expressed in the cardiac extracellular matrix, however its role in the heart remains largely unknown. We investigated fibromodulin levels in myocardial biopsies from heart failure patients and mice, subjected fibromodulin knock-out (FMOD-KO) mice to pressure overload by aortic banding, and overexpressed fibromodulin in cultured cardiomyocytes and cardiac fibroblasts using adenovirus. Fibromodulin was 3-10-fold upregulated in hearts of heart failure patients and mice. Both cardiomyocytes and cardiac fibroblasts expressed fibromodulin, and its expression was increased by pro-inflammatory stimuli. Without stress, FMOD-KO mice showed no cardiac phenotype. Upon aortic banding, left ventricles of FMOD-KO mice developed mildly exacerbated hypertrophic remodeling compared to wild-type mice, with increased cardiomyocyte size and altered infiltration of leukocytes. There were no differences in mortality, left ventricle dilatation, dysfunction or expression of heart failure markers. Although collagen amount and cross-linking were comparable in FMOD-KO and wild-type, overexpression of fibromodulin in cardiac fibroblasts in vitro decreased their migratory capacity and expression of fibrosis-associated molecules, i.e. the collagen-cross linking enzyme lysyl oxidase, transglutaminase 2 and periostin. In conclusion, despite a robust fibromodulin upregulation in clinical and experimental heart failure, FMOD-KO mice showed a relatively mild hypertrophic phenotype. In cultured cardiac fibroblasts, fibromodulin has anti-fibrotic effects.	[Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Aronsen, Jan Magnus; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway; [Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Aronsen, Jan Magnus; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Univ Oslo, Oslo, Norway; [Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Dahl, Christen P.; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Dahl, Christen P.; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Lunde, Ida G.] Oslo Univ Hosp, Ctr Mol Med Norway, Oslo, Norway; [Dahl, Christen P.] Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Dahl, Christen P.] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Engebretsen, Kristin V. T.] Vestre Viken Hosp, Dept Surg, Drammen, Norway; [Tonnessen, Theis] Oslo Univ Hosp, Dept Cardiothorac Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Tonnessen, T (corresponding author), Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway.; Tonnessen, T (corresponding author), Univ Oslo, Oslo, Norway.; Tonnessen, T (corresponding author), Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway.; Tonnessen, T (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.; Tonnessen, T (corresponding author), Oslo Univ Hosp, Dept Cardiothorac Surg, Oslo, Norway.	theis.tonnessen@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018; Lunde, Ida Gjervold/ABN-5567-2022	Lunde, Ida Gjervold/0000-0001-9502-6841	South-Eastern Regional Health Authority; Research Council of Norway; Norwegian Health Association; Kristian Gerhard Jebsen Foundation; Anders Jahre's Fund for the Promotion of Science; Olav Raagholt and Gerd Meidel Raagholt's Fund for Science; Rakel and Otto Kristian Bruun's Fund; Family Blix Fund; Inger Haldorsens Fund, Norway; Simon Fougner Hartmanns Family Fund, Denmark	South-Eastern Regional Health Authority; Research Council of Norway(Research Council of Norway); Norwegian Health Association; Kristian Gerhard Jebsen Foundation; Anders Jahre's Fund for the Promotion of Science; Olav Raagholt and Gerd Meidel Raagholt's Fund for Science; Rakel and Otto Kristian Bruun's Fund; Family Blix Fund; Inger Haldorsens Fund, Norway; Simon Fougner Hartmanns Family Fund, Denmark	This study was investigator initiated and performed, and the manuscript was written independently of the sponsors. This work was supported with unrestricted grants from the South-Eastern Regional Health Authority, the Research Council of Norway, the Norwegian Health Association, the Kristian Gerhard Jebsen Foundation, Anders Jahre's Fund for the Promotion of Science, the Olav Raagholt and Gerd Meidel Raagholt's Fund for Science, the Rakel and Otto Kristian Bruun's Fund, the Family Blix Fund, the Inger Haldorsens Fund, Norway, and the Simon Fougner Hartmanns Family Fund, Denmark. TT received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2017, CIRCULATION, V136; Bjornstad JL, 2011, EUR HEART J, V32, P236, DOI 10.1093/eurheartj/ehq166; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Christensen G, 2018, MATRIX BIOL; Dupuis LE, 2015, J MOL CELL CARDIOL, V84, P70, DOI 10.1016/j.yjmcc.2015.04.007; Engebretsen KVT, 2013, FEBS J, V280, P2382, DOI 10.1111/febs.12235; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Finsen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028302; Frantz S, 2018, EUR J HEART FAIL, V20, P445, DOI 10.1002/ejhf.1138; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Frieler RA, 2015, CIRCULATION, V131, P1019, DOI 10.1161/CIRCULATIONAHA.114.008788; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; Gyongyosi M, 2017, EUR J HEART FAIL, V19, P177, DOI 10.1002/ejhf.696; Herum KM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050053; Herum KM, 2015, CARDIOVASC RES, V106, P217, DOI 10.1093/cvr/cvv002; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jiang WL, 2018, J CELL MOL MED, V22, P2510, DOI 10.1111/jcmm.13516; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Karamanos NK, 2017, FEBS J, V284, P7, DOI 10.1111/febs.13945; Li L, 2018, MATRIX BIOL; Liu RJ, 2016, J MOL CELL CARDIOL, V101, P44, DOI 10.1016/j.yjmcc.2016.08.018; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lunde IG, 2016, CELL TISSUE RES, V365, P539, DOI 10.1007/s00441-016-2454-2; Malgija B, 2018, COMPUT BIOL CHEM, V73, P85, DOI 10.1016/j.compbiolchem.2018.01.011; Melleby AO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165079; Metra M, 2017, LANCET, V390, P1981, DOI 10.1016/S0140-6736(17)31071-1; Mormone E, 2012, GASTROENTEROLOGY, V142, P612, DOI 10.1053/j.gastro.2011.11.029; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ohmura H, 2012, HYPERTENS RES, V35, P1063, DOI 10.1038/hr.2012.92; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; Rydell-Tomaen K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06383; Schaefer L, 2011, J AM SOC NEPHROL, V22, P1200, DOI 10.1681/ASN.2010050570; Schirone L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3920195; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Strand ME, 2015, J MOL CELL CARDIOL, V88, P133, DOI 10.1016/j.yjmcc.2015.10.003; Strand ME, 2013, FEBS J, V280, P2228, DOI 10.1111/febs.12161; Suthahar Navin, 2017, Curr Heart Fail Rep, V14, P235, DOI 10.1007/s11897-017-0343-y; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Waehre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018668; Yu LL, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9874109; Zheng Z, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.50; Zheng Z, 2016, AM J PATHOL, V186, P2824, DOI 10.1016/j.ajpath.2016.07.023; Zheng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096011, 10.1371/journal.pone.0090817]; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	56	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201422	10.1371/journal.pone.0201422	http://dx.doi.org/10.1371/journal.pone.0201422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052659	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600044
J	Li, H; Zeitelhofer, M; Nilsson, I; Liu, XC; Allan, L; Gloria, B; Perani, A; Murone, C; Catimel, B; Neville, AM; Scott, FE; Scott, AM; Eriksson, U				Li, Hong; Zeitelhofer, Manuel; Nilsson, Ingrid; Liu, Xicong; Allan, Laura; Gloria, Benjamin; Perani, Angelo; Murone, Carmel; Catimel, Bruno; Neville, A. Munro; Scott, Fiona E.; Scott, Andrew M.; Eriksson, Ulf			Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFR alpha signalling in vivo	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR-CC; PLASMINOGEN ACTIVATOR; LOBULAR CARCINOMA; ISCHEMIC-STROKE; BREAST-CANCER; CELLS; RECEPTOR; TUMORS; IDENTIFICATION	PDGF-CC is a member of the platelet-derived growth factor (PDGF) family that stimulates PDGFR alpha phosphorylation and thereby activates intracellular signalling events essential for development but also in cancer, fibrosis and neuropathologies involving blood-brain barrier (BBB) disruption. In order to elucidate the biological and pathological role(s) of PDGF-CC signalling, we have generated high affinity neutralizing monoclonal antibodies (mAbs) recognizing human PDGF-CC. We determined the complementarity determining regions (CDRs) of the selected clones, and mapped the binding epitope for clone 6B3. Using the monoclonal 6B3, we determined the expression pattern for PDGF-CC in different human primary tumours and control tissues, and explored its ability to neutralize PDGF-CC-induced phosphorylation of PDGFR alpha. In addition, we showed that PDGF-CC induced disruption of the blood-retinal barrier (BRB) was significantly reduced upon intraperitoneal administration of a chimeric anti-PDGF-CC antibody. In summary, we report on high affinity monoclonal antibodies against PDGF-CC that have therapeutic efficacy in vivo.	[Li, Hong; Zeitelhofer, Manuel; Nilsson, Ingrid; Liu, Xicong; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Allan, Laura; Gloria, Benjamin; Perani, Angelo; Murone, Carmel; Catimel, Bruno; Scott, Fiona E.; Scott, Andrew M.] Ludwig Inst Canc Res, Melbourne Austin Branch, Melbourne, Vic, Australia; [Allan, Laura; Gloria, Benjamin; Murone, Carmel; Scott, Fiona E.; Scott, Andrew M.] La Trobe Univ, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia; [Allan, Laura; Gloria, Benjamin; Murone, Carmel; Scott, Fiona E.; Scott, Andrew M.] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia; [Neville, A. Munro] Ludwig Inst Canc Res, New York, NY USA	Karolinska Institutet; Ludwig Institute for Cancer Research; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; Ludwig Institute for Cancer Research	Li, H; Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Hong.li@ki.se; ulf.pe.erikssson@ki.se	Scott, Fiona E/K-8106-2013	CATIMEL, Bruno/0000-0002-4350-6875; Scott, Andrew/0000-0002-6656-295X; Zeitelhofer, Manuel/0000-0002-4324-2355	Swedish Heart and Lung Foundation [20110451, 20120077]; Swedish Research Council [2011-03861]; Swedish Cancer Foundation [CAN 2011/792, CAN 2014/630]; Karolinska Institutet; Australian National Health and Medical Research Council (NHMRC) Development Grants [1038334, 1075898]; Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship; Victorian Government, Australia	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Karolinska Institutet(Karolinska Institutet); Australian National Health and Medical Research Council (NHMRC) Development Grants(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government, Australia	This study was supported by the Swedish Heart and Lung Foundation (20110451 and 20120077, U.E.), the Swedish Research Council (2011-03861, U.E.), the Swedish Cancer Foundation (CAN 2011/792 and CAN 2014/630, U.E.), and the Karolinska Institutet. This work was supported in part by the Australian National Health and Medical Research Council (NHMRC) Development Grants 1038334 and 1075898 and Practitioner Fellowship to A.M.S. and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [HL, MZ, IN, XL, LA, BG, AP, CM, BC, AMN, FES, AMS and UE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Adzemovic MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056586; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Andrae J, 2002, BIOCHEM BIOPH RES CO, V296, P604, DOI 10.1016/S0006-291X(02)00917-8; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Dijkmans J, 2002, INT J BIOCHEM CELL B, V34, P414, DOI 10.1016/S1357-2725(01)00124-8; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Ehnman M, 2014, EXPERT OPIN INV DRUG, V23, P211, DOI 10.1517/13543784.2014.847086; Eitner F, 2002, NORMAL DISEASED RAT; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; Fredriksson L, 2005, J BIOL CHEM, V280, P26856, DOI 10.1074/jbc.M503388200; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fredriksson L, 2015, ANN CLIN TRANSL NEUR, V2, P722, DOI 10.1002/acn3.209; Grun K, 2005, EUR HEART J, V26, P728, DOI 10.1093/eurheartj/ehi168; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang YJ, 2014, CANCER RES, V74, P1011, DOI 10.1158/0008-5472.CAN-13-1072; Jiao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088191; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P639, DOI 10.1073/pnas.232686499; Lei H, 2008, INVEST OPHTH VIS SCI, V49, P42, DOI 10.1167/iovs.07-0776; Lewandowski SA, 2016, PHARMACOL THERAPEUT, V167, P108, DOI 10.1016/j.pharmthera.2016.07.016; Lewandowski SA, 2016, ACTA NEUROPATHOL, V131, P453, DOI 10.1007/s00401-015-1520-2; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2010, ONCOTARGET, V1, P309, DOI 10.18632/oncotarget.141; Lokker NA, 2002, CANCER RES, V62, P3729; Luo NA, 2014, INT J MOL SCI, V15, P20306, DOI 10.3390/ijms151120306; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Manzat-Saplacan RM, 2015, J BUON, V20, P1193; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Roswall P, 2018, NAT MED, V24, P463, DOI 10.1038/nm.4494; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; SILVERSTEIN MJ, 1994, CANCER-AM CANCER SOC, V73, P1673, DOI 10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Toikkanen S, 1997, BRIT J CANCER, V76, P1234, DOI 10.1038/bjc.1997.540; Wahlgren N, 2017, J INTERN MED, V281, P273, DOI 10.1111/joim.12576; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Zhan Y, 2015, J NEUROSCI RES, V93, P94, DOI 10.1002/jnr.23475; Zhang WS, 2013, J COMPUT AID MOL DES, V27, P539, DOI 10.1007/s10822-013-9661-7; Zhuo Y, 2004, AM J PHYSIOL-LUNG C, V286, pL182, DOI 10.1152/ajplung.00083.2003; Zwerner JP, 2001, ONCOGENE, V20, P626, DOI 10.1038/sj.onc.1204133; Zwerner JP, 2002, DOMINANT NEGATIVE PD	54	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201089	10.1371/journal.pone.0201089	http://dx.doi.org/10.1371/journal.pone.0201089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052660	Green Published, Green Submitted, gold			2022-12-26	WOS:000440006600023
J	Machablishvili, A; Chakhunashvili, G; Zakhashvili, K; Karseladze, I; Tarkhan-Mouravi, O; Gavashelidze, M; Jashiashvili, T; Sabadze, L; Imnadze, P; Daniels, RS; Ermetal, B; McCauley, JW				Machablishvili, Ann; Chakhunashvili, Giorgi; Zakhashvili, Khatuna; Karseladze, Irakli; Tarkhan-Mouravi, Olgha; Gavashelidze, Mari; Jashiashvili, Tamar; Sabadze, Lela; Imnadze, Paata; Daniels, Rodney S.; Ermetal, Burcu; McCauley, John W.			Overview of three influenza seasons in Georgia, 2014-2017	PLOS ONE			English	Article							VIRUSES; HEMAGGLUTININ; SURVEILLANCE; AFRICA	Background Influenza epidemiological and virologic data from Georgia are limited. We aimed to present Influenza Like Illness (ILI) and Severe Acute Respiratory Infection (SARI) surveillance data and characterize influenza viruses circulating in the country over three influenza seasons. Methods We analyzed sentinel site ILI and SARI data for the 2014-2017 seasons in Georgia. Patients' samples were screened by real-time RT-PCR and influenza viruses isolated were characterized antigenically by haemagglutination inhibition assay and genetically by sequencing of HA and NA genes. Results 32% (397/1248) of ILI and 29% (581/1997) of SARI patients tested were positive for influenza viruses. In 2014-2015 the median week of influenza detection was week 7/2015 with B/Yamagata lineage viruses dominating (79%); in 2015-2016-week 5/2016 was the median with A/H1N1pdm09 viruses prevailing (83%); and in 2016-2017 a bimodal distribution of influenza activity was observed-the first wave was caused by A/H3N2 (55%) with median week 51/2016 and the second by B/Victoria lineage viruses (45%) with median week 9/2017. For ILI, influenza virus detection was highest in children aged 5-14 years while for SARI patients most were aged >15 years and 27 (4.6%) of 581 SARI cases died during the three seasons. Persons aged 30-64 years had the highest risk of fatal outcome, notably those infected with A/H1N1pdm09 (OR 11.41, CI 3.94-33.04, p<0.001). A/H1N1pdm09 viruses analyzed by gene sequencing fell into genetic groups 6B and 6B.1; N H3N2 viruses belonged to genetic subclades 3C.3b, 3C.3a, 3C.2a and 3C.2a1; B/Yamagata lineage viruses were of Glade 3 and B/Victoria lineage viruses fell in clade1A. Conclusion In Georgia influenza virus activity occurred mainly from December through March in all seasons, with varying peak weeks and predominating viruses. Around one third of ILI/SARI cases were associated with influenza caused by antigenically and genetically distinct influenza viruses over the course of the three seasons.	[Machablishvili, Ann; Chakhunashvili, Giorgi; Zakhashvili, Khatuna; Karseladze, Irakli; Tarkhan-Mouravi, Olgha; Gavashelidze, Mari; Jashiashvili, Tamar; Sabadze, Lela; Imnadze, Paata] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Machablishvili, Ann; Imnadze, Paata] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia; [Daniels, Rodney S.; Ermetal, Burcu; McCauley, John W.] Francis Crick Inst, WHO Collaborating Ctr Reference & Res Influenza, Worldwide Influenza Ctr, London, England	National Center for Disease Control & Public Health - Georgia; Ivane Javakhishvili Tbilisi State University; Francis Crick Institute	Machablishvili, A (corresponding author), Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia.; Machablishvili, A (corresponding author), Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia.	a.machablishvili@ncdc.ge		Machablishvili, Ann/0000-0003-4779-9801	CDC, Atlanta, USA; Cancer Research UK [FC001030]; Medical Research Council [FC001030]; Wellcome Trust [FC001030]	CDC, Atlanta, USA; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	CDC, Atlanta, USA, provided financial support of influenza surveillance in Georgia. The work performed at the Worldwide Influenza Centre (WHO CC, London), the Francis Crick Institute was supported by core funding from Cancer Research UK (FC001030), the Medical Research Council (FC001030) and the Wellcome Trust (FC001030).; The authors wish to thank: (i) CDC, Atlanta, USA for financial support of influenza surveillance in Georgia; (ii) WRAIR, USA for providing sequencing primers; (iii) all sentinel clinic staff for sample and data collection; (iv) all WIC staff involved in virus characterization studies.	Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Altas AB, 2016, MIKROBIYOL BUL, V50, P401, DOI 10.5578/mb.27775; [Anonymous], 2015, FLU NEWS EUROPE; [Anonymous], 2016, FLU NEWS EUROPE; [Anonymous], 2017, FLU NEWS EUROPE; Bonmarin I, 2015, EUROSURVEILLANCE, V20, P30066, DOI DOI 10.2807/1560-7917.ES.2015.20.46.30066; Butsashvili Maia, 2012, Influenza Res Treat, V2012, P480763, DOI 10.1155/2012/480763; CDC, 2016, SEL VIR SEAS INFL VA; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Emukule GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180890; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Kandeel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161301; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Korsun N, 2017, INFECT GENET EVOL, V49, P241, DOI 10.1016/j.meegid.2017.01.027; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Machablishvili A, 2017, Georgian Med News, P71; McMorrow ML, 2015, J INFECT DIS, V212, P853, DOI 10.1093/infdis/jiv100; Meerhoff TJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0722-x; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Milne GJ, 2016, INFLUENZA OTHER RESP, V10, P324, DOI 10.1111/irv.12367; Moasser E, 2017, ARCH VIROL, V162, P1975, DOI 10.1007/s00705-017-3323-3; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Puig-Barbera J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3378-1; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Vestergaard LS, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.es.2017.22.14.30506, 10.2807/1560-7917.ES.2017.22.14.30506]; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, GLOB EP SURV STAND I; World Health Organization, 2015, REV 2014 2015 INFL S, P90; World Health Organization, 2016, INFL FACT SHEET; World Health Organization, CDC PROT REAL TIM RT; Worldwide Influenza Centre London, 2017, FEBR 2017 INT REP WH; Worldwide Influenza Centre London, 2017, SEPT 2016 INT REP WH; Wu P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01021-x; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279	37	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201207	10.1371/journal.pone.0201207	http://dx.doi.org/10.1371/journal.pone.0201207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052663	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600029
J	Yuille, S; Reichardt, N; Panda, S; Dunbar, H; Mulder, IE				Yuille, Samantha; Reichardt, Nicole; Panda, Suchita; Dunbar, Hayley; Mulder, Imke E.			Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; EPIGENETIC MODIFICATIONS; THERAPEUTIC TARGETS; MICROBIOTA; HOMEOSTASIS; ACTIVATION; DISORDERS; COLITIS; CANCER; CELLS	Overexpression of histone deacetylase (HDAC) isoforms has been implicated in a variety of disease pathologies, from cancer and colitis to cardiovascular disease and neurodegeneration, thus HDAC inhibitors have a long history as therapeutic targets. The gut microbiota can influence HDAC activity via microbial-derived metabolites. While HDAC inhibition (HDI) by gut commensals has long been attributed to the short chain fatty acid (SCFA) butyrate, the potent metabolic reservoir provided by the gut microbiota and its role in host physiology warrants further investigation in a variety of diseases. Cell-free supernatants (CFS) of 79 phylogenetically diverse gut commensals isolated from healthy human donors were screened for their SCFA profile and their total HDAC inhibitory properties. The three most potent HDAC inhibiting strains were further evaluated and subjected to additional analysis of specific class I and class II HDAC inhibition. All three HDAC inhibitors are butyrate producing strains, and one of these also produced substantial levels of valeric acid and hexanoic acid. Valeric acid was identified as a potential contributor to the HDAC inhibitory effects. This bacterial strain, Megasphaera massiliensis MRx0029, was added to a model microbial consortium to assess its metabolic activity in interaction with a complex community. M. massiliensis MRx0029 successfully established in the consortium and enhanced the total and specific HDAC inhibitory function by increasing the capacity of the community to produce butyrate and valeric acid. We here show that single bacterial strains from the human gut microbiota have potential as novel HDI therapeutics for disease areas involving host epigenetic aberrations.	[Yuille, Samantha; Reichardt, Nicole; Panda, Suchita; Dunbar, Hayley; Mulder, Imke E.] 4DPharma Res Ltd, Aberdeen, Scotland		Mulder, IE (corresponding author), 4DPharma Res Ltd, Aberdeen, Scotland.	imke.mulder@4dpharmaplc.com		, Imke/0000-0001-6468-4550	4D Pharma Research Ltd.	4D Pharma Research Ltd.	This work was funded by 4D Pharma Research Ltd. The funder provided support in the form of salaries for authors SY, NR, HD, SP, IEM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Bieliauskas AV, 2008, CHEM SOC REV, V37, P1402, DOI 10.1039/b703830p; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bultman SJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500902; Bultman SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/carcin/bgt392; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Felice C, 2015, ALIMENT PHARM THER, V41, P26, DOI 10.1111/apt.13008; Fellows R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02651-5; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Giloteaux L, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0171-4; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Glauben R, 2011, MOL MED, V17, P426, DOI 10.2119/molmed.2011.00069; Gonneaud A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0043-2; Gulden E, 2015, CLIN IMMUNOL, V159, P143, DOI 10.1016/j.clim.2015.05.013; Hegazi RAF, 2003, INFLAMM BOWEL DIS, V9, P230, DOI 10.1097/00054725-200307000-00003; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jacqueline C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11644-9; Johnsen LG, 2017, J CHROMATOGR A, V1503, P57, DOI 10.1016/j.chroma.2017.04.052; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Meng S, 1999, SURGERY, V126, P293, DOI 10.1067/msy.1999.98927; Minato T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187307; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sivaprakasam S, 2017, HLTH NUTRIENTS, V9; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Strati F, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0242-1; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tang Y, 2017, J AM HEART ASS, V6; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Wang CC, 2012, PROG NEURO-PSYCHOPH, V37, P111, DOI 10.1016/j.pnpbp.2012.01.017; Wang C, 2011, J NAT PROD, V74, P2031, DOI 10.1021/np200324x; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wilson AJ, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-12; Yoon Somy, 2016, Chonnam Med J, V52, P1, DOI 10.4068/cmj.2016.52.1.1; Zhang HL, 2012, J HEPATOL, V57, P803, DOI 10.1016/j.jhep.2012.06.011	46	92	95	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201073	10.1371/journal.pone.0201073	http://dx.doi.org/10.1371/journal.pone.0201073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052654	Green Published, Green Submitted, gold			2022-12-26	WOS:000440006600022
J	Kim, SK				Kim, Stuart K.			Identification of 613 new loci associated with heel bone mineral density and a polygenic risk score for bone mineral density, osteoporosis and fracture	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE ULTRASOUND; VERTEBRAL FRACTURES; OLDER WOMEN; HERITABILITY; METAANALYSIS; HIP; MEN; DEFORMITIES; PREDICTION	Low bone mineral density (BMD) leads to osteoporosis, and is a risk factor for bone fractures, including stress fractures. Using data from UK Biobank, a genome-wide association study identified 1,362 independent SNPs that clustered into 899 loci of which 613 are new. These data were used to train a genetic algorithm using 22,886 SNPs as predictors and showing a correlation with heel bone mineral density of 0.415. Combining this genetic algorithm with height, weight, age and sex resulted in a correlation with heel bone mineral density of 0.496. Individuals with low scores (2.2% of total) showed a change in BMD of - 1.16 Tscore units, an increase in risk for osteoporosis of 17.4 fold and an increase in risk for fracture of 1.87 fold. Genetic predictors could assist in the identification of individuals at risk for osteoporosis or fractures.	[Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu		kim, stuart/0000-0001-8887-5095	National Institutes of Aging, R01 grant [5R01 AG02594110]; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	National Institutes of Aging, R01 grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Aging, R01 grant number 5R01 AG02594110 to SKK. https://www.nia.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arden NK, 1996, J BONE MINER RES, V11, P530; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BURGER H, 1994, BRIT MED J, V309, P991, DOI 10.1136/bmj.309.6960.991; Bycroft CF, 2017, GENOME WIDE GENETIC; Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761; Compston J, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0324-5; Donaldson MG, 2009, J BONE MINER RES, V24, P1793, DOI 10.1359/jbmr.090511; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fredericson Michael, 2006, Top Magn Reson Imaging, V17, P309; Gluer CC, 2004, J BONE MINER RES, V19, P782, DOI 10.1359/JBMR.040304; Goolsby MA, 2017, SPORTS HEALTH, V9, P108, DOI 10.1177/1941738116677732; Hillier TA, 2011, J BONE MINER RES, V26, P1774, DOI 10.1002/jbmr.372; Howard GM, 1998, J BONE MINER RES, V13, P1318, DOI 10.1359/jbmr.1998.13.8.1318; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hunter DJ, 2001, OSTEOPOROSIS INT, V12, P406, DOI 10.1007/s001980170110; Jones BH, 1999, SPORTS MED, V27, P111, DOI 10.2165/00007256-199927020-00004; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Karasik D, 2002, OSTEOPOROSIS INT, V13, P796, DOI 10.1007/s001980200110; Kemp JP, 2017, NAT GENET; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lello L, BIORXIV; Liu CT, 2012, J BONE MINER RES, V27, P954, DOI 10.1002/jbmr.1537; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; McClung Michael R, 2005, Curr Osteoporos Rep, V3, P57, DOI 10.1007/s11914-005-0005-y; Moayyeri A, 2014, HUM MOL GENET, V23, P3054, DOI 10.1093/hmg/ddt675; Mullin BH, 2017, HUM MOL GENET, V26, P2791, DOI 10.1093/hmg/ddx174; Nattiv A, 2000, J Sci Med Sport, V3, P268, DOI 10.1016/S1440-2440(00)80036-5; Paterson R, 2017, EXPERT REV ANTICANC, V17, P991, DOI 10.1080/14737140.2017.1374175; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watts Nelson B, 2010, Endocr Pract, V16 Suppl 3, P1; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	44	80	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200785	10.1371/journal.pone.0200785	http://dx.doi.org/10.1371/journal.pone.0200785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048462	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400020
J	Wauters, J; Wilson, KS; Bouts, T; Valentine, I; Vanderschueren, K; Ververs, C; Howie, AF; Rae, MT; Van Soom, A; Li, RG; Li, DS; Zhang, HM; Vanhaecke, L				Wauters, Jella; Wilson, Kirsten S.; Bouts, Tim; Valentine, Iain; Vanderschueren, Koen; Ververs, Cyrillus; Howie, A. Forbes; Rae, Mick T.; Van Soom, Ann; Li, Rengui; Li, Desheng; Zhang, Hemin; Vanhaecke, Lynn			Urinary specific gravity as an alternative for the normalisation of endocrine metabolite concentrations in giant panda (Ailuropoda melanoleuca) reproductive monitoring	PLOS ONE			English	Article							PLASMA-CONCENTRATIONS; SERUM CERULOPLASMIN; PHYSICAL-ACTIVITY; HORMONE; CREATININE; PREGNANCY; PGFM; REFRACTOMETERS; PROGESTERONE; RELAXIN	Reproductive monitoring for captive breeding in giant pandas is based on behavioural observation and non-invasive hormone analysis. In urine, interpretation of results requires normalisation due to an animal's changing hydration. Correction of urinary concentrations based on creatinine is the gold standard. In this study, a largely unexplored, easy-to-perform normalisation technique, based on urinary specific gravity (USpG), was examined and compared to creatinine. To this extent, six cycles from two female pandas (SB741(1) and SB569 (5)) were monitored through urine analysis for oestrogen, progesterone, ceruloplasmin and 13,14-dihydro-15-keto-PGF2a (PGFM). The Pearson's correlation between creatinine and USpG was high (r = 0.805-0.894; p < 0.01), indicative for a similar performance of both normalisation methods. However, generally lower values were observed during pro-oestrus and primary (progesterone) rise. This could be associated with huge shifts in appetite, monitored by faecal output (kg) with an averaged > 50% decrease during oestrus and > 50% increase during primary progesterone rise. In parallel, respectively highest and lowest creatinine and USpG levels, were measured, with creatinine obviously more affected as a result of linkage with muscle tissue metabolism affected by reproductive hormones. As a consequence, metabolite levels were significantly different between both corrected datasets with significantly higher oestrogen peak levels during oestrus ranging from 2.13-86.93 and 31.61-306.45 ng/mL (USpG correction) versus 2.33-31.20 and 36.36-249.05 ng/mL Cr (creatinine correction) for SB569 and SB741 respectively, and significant lower progesterone levels during primary progesterone rise ranging from 0.35-3.21 and 0.85-6.80 ng/mL (USpG correction) versus 0.52-10.31 and 2.10-272.74 ng/mL Cr (creatinine correction) for SB569 and SB741 respectively. Consequently, USpG correction rendered unbiased profiles, less subject to variation and metabolic artefacts and therefore allowed a more straightforward identification of peak oestrogen and onset of secondary progesterone rise, being potentially advantageous for future studies unravelling key giant panda reproductive events, including (delayed) implantation. The alternative application of USpG as a normalisation factor was further supported by its easy application and environmental and technical robustness.	[Wauters, Jella; Vanhaecke, Lynn] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Chem Anal Lab, Merelbeke, Belgium; [Wauters, Jella; Bouts, Tim; Vanderschueren, Koen] Pairi Daiza Pairi Daiza Fdn, Brugelette, Belgium; [Wilson, Kirsten S.; Howie, A. Forbes] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Valentine, Iain] Edinburgh Zoo, Royal Zool Soc Scotland, Edinburgh, Midlothian, Scotland; [Ververs, Cyrillus; Van Soom, Ann] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, Merelbeke, Belgium; [Rae, Mick T.] Edinburgh Napier Univ, Sch Appl Sci, Sighthill Campus, Edinburgh, Midlothian, Scotland; [Li, Rengui; Li, Desheng; Zhang, Hemin] CCRCGP, Dujiangyan, Sichuan, Peoples R China	Ghent University; University of Edinburgh; Ghent University; Edinburgh Napier University	Wauters, J (corresponding author), Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Chem Anal Lab, Merelbeke, Belgium.; Wauters, J (corresponding author), Pairi Daiza Pairi Daiza Fdn, Brugelette, Belgium.	Jella.wauters@ugent.be	Vanhaecke, Lynn/N-1061-2017	Vanhaecke, Lynn/0000-0003-0400-2188; Wauters, Jella/0000-0002-7046-1764; Ververs, Cyriel/0000-0002-6994-7687	Pairi Daiza Foundation	Pairi Daiza Foundation	This study was partly funded by the Pairi Daiza Foundation (http://www.pairidaiza-foundation.org/fr). The funders had no role in the study design, data collection and analysis or preparation of the manuscript.	Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Bergfelt DR, 2014, THERIOGENOLOGY, V82, P1187, DOI 10.1016/j.theriogenology.2014.07.030; Bowen RS, 2011, SPORTS MED, V41, P73, DOI 10.2165/11536860-000000000-00000; Chadha V, 2001, PEDIATR NEPHROL, V16, P374, DOI 10.1007/s004670000551; COLLINS WP, 1979, ACTA ENDOCRINOL-COP, V90, P336, DOI 10.1530/acta.0.0900336; Dehnhard M, 2012, THERIOGENOLOGY, V77, P1088, DOI 10.1016/j.theriogenology.2011.10.011; DESHMUKH VK, 1985, PHARMACOL RES COMMUN, V17, P633, DOI 10.1016/0031-6989(85)90070-0; Drosdoff D, 2005, AM J PHYS, V73, P973, DOI 10.1119/1.2000974; FULLER NJ, 1988, CLIN CHIM ACTA, V175, P199, DOI 10.1016/0009-8981(88)90096-4; George JW, 2001, VET CLIN PATH, V30, P201, DOI 10.1111/j.1939-165X.2001.tb00432.x; Handler J, 2004, THERIOGENOLOGY, V61, P1573, DOI 10.1016/j.theriogenology.2003.09.005; Kersey DC, 2016, THERIOGENOLOGY, V85, P671, DOI 10.1016/j.theriogenology.2015.10.005; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; Kumar A, 2013, VET WORLD, V6, P59, DOI 10.5455/vetworld.2013.59-63; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Lovendahl P, 2010, J DAIRY SCI, V93, P249, DOI 10.3168/jds.2008-1721; Luz MR, 2006, THERIOGENOLOGY, V66, P1436, DOI 10.1016/j.theriogenology.2006.01.036; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Muscat JE, 2011, BIOMARKERS, V16, P206, DOI 10.3109/1354750X.2010.538084; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Rao P, 2015, INT J PHARM MED RES, V3, P57; Rishniw M, 2015, J FELINE MED SURG, V17, P329, DOI 10.1177/1098612X14541263; Roberts B, 2014, 3 ANN INT SOC WILDL; Roberts BM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195599; Samra Manpreet, 2012, Perm J, V16, P51; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Shrestha HK, 2011, BIOL REPROD, V85, P482, DOI 10.1095/biolreprod.111.092130; Spady TJ, 2007, MAMMAL REV, V37, P21, DOI 10.1111/j.1365-2907.2007.00096.x; Spierto FW, 1997, CLIN CHIM ACTA, V264, P227, DOI 10.1016/S0009-8981(97)00080-6; Steinetz BG, 2005, ANN NY ACAD SCI, V1041, P367, DOI 10.1196/annals.1282.057; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Swaisgood R., 2016, IUCN RED LIST THREAT; Tvedten HW, 2015, NEW ZEAL VET J, V63, P254, DOI 10.1080/00480169.2014.1002553; Wauters J, 2017, ANN C 2017 COMM BREE; Willis EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021159; Wyness Sara P, 2016, Pract Lab Med, V5, P65, DOI 10.1016/j.plabm.2016.06.001	38	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201420	10.1371/journal.pone.0201420	http://dx.doi.org/10.1371/journal.pone.0201420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048530	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400088
J	Fisher, CB; Fried, AL; Puri, LI; Macapagal, K; Mustanski, B				Fisher, Celia B.; Fried, Adam L.; Puri, Leah Ibrahim; Macapagal, Kathryn; Mustanski, Brian			"Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men	PLOS ONE			English	Article							PREVENTIVE MISCONCEPTION; HEALTH-CARE; PREEXPOSURE PROPHYLAXIS; HIV; BARRIERS; GAY; TRANSGENDER; EXPERIENCES; DISPARITIES; CONSENT	Background Adolescent men who have sex with men (AMSM) account for disproportionately high numbers of new HIV diagnoses. Non-adherence to daily use limiting the effectiveness of oral PrEP (Truvada) has led to current trials with adult MSM testing Cabotegravir, a long-term injectable medication. Once comparative studies with young adult MSM have established relative safety and efficacy of these medications, there will be a need for such comparative trials involving adolescents. Trends in state laws and IRB protocol review indicate that many of these studies will permit youth to provide independent consent for participation. Understanding the motivations of AMSM to participate in HIV biomedical prevention studies is important to ensure their agreement is voluntary without misunderstanding and undue influence. This study examined AMSM attitudes toward participation in oral/injectable PrEP RCTs to inform protections of youth's rights and welfare in future studies. Methods We administered to 198 ethnically diverse U.S. AMSM, 14-17 years, a web-based survey including demographic and sexual health questions, description of a year-long oral versus injectable PrEP RCT and 26 Likert-type and one open-ended item assessing motivations for and against participation including: perceived benefits and risks of PrEP; free HIV/STI testing and counseling; confidentiality concerns; random assignment; and benefit to others. Results Sixty-two percent indicated they were likely to participate in the study. The majority endorsed daily HIV protection, free HIV/STI testing, sexual health counseling, not having to rely on partner's condom use, and altruism as reasons to participate. Reasons against participation included medication side effects, concern taking the pill daily and clinic visits would reveal their sexual orientation and behaviors to parents. Over half erroneously assumed they would be assigned to the condition best for them and 39% indicated free access to services would lead them to participate even if they did not want to. Multiple regression indicated these factors accounted for 55% of the variance in participation choice. Nether age or ethnicity yielded significance. Conclusions Results suggest future biomedical HIV prevention research will need to develop procedures to address AMSM's confidentiality concerns, enhance youth's understanding of random assignment, the continued importance of medication adherence and partner condom use during trial participation, and availability of alternative sexual health services to avoid the potentially undue influence of access to free sexual health services.	[Fisher, Celia B.; Puri, Leah Ibrahim] Fordham Univ, Ctr Eth Educ, New York, NY 10023 USA; [Fried, Adam L.] Midwestern Univ, Clin Psychol Dept, Glendale, AZ USA; [Macapagal, Kathryn; Mustanski, Brian] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Fordham University; Midwestern University; Northwestern University; Feinberg School of Medicine	Fisher, CB (corresponding author), Fordham Univ, Ctr Eth Educ, New York, NY 10023 USA.	fisher@fordham.edu		Fisher, Celia/0000-0002-3849-7281	NIMHD [R01MD009561]; National Institute on Minority Health and Health Disparities [R01MD009561] Funding Source: NIH RePORTER	NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The research was funded by NIMHD #R01MD009561 to Celia B. Fisher and Brian Mustanski. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USFaD, 2012, FDA APPR 1 DRUG RED; Bauermeister JA, 2012, FIELD METHOD, V24, P272, DOI 10.1177/1525822X12443097; CDC, 2019, HIV GAY BIS MEN; Chin LJ, 2016, J EMPIRICAL RES HUMA, V11; Cohen S., 2015, J INT AIDS SOC S3, V18; Coker TR, 2010, ANNU REV PUBL HEALTH, V31, P457, DOI 10.1146/annurev.publhealth.012809.103636; Corneli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125458; D'Amico E, 2012, J GLBT FAM STUD, V8, P215, DOI 10.1080/1550428X.2012.677232; Dellar RC, 2014, AIDS BEHAV, V18, P1746, DOI 10.1007/s10461-014-0771-6; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; Emanuel E, 2004, JAMA-J AM MED ASSOC, V283, P2701; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Fisher CB, 2017, AIDS EDUC PREV, V29, P205, DOI 10.1521/aeap.2017.29.3.205; Fisher CB, 2016, J EMPIR RES HUM RES, V11, P3, DOI 10.1177/1556264616633963; Fisher CB, 2014, HASTINGS CENT REP, V44, pS28, DOI 10.1002/hast.367; Gilbert AL, 2015, J ADOLESCENT HEALTH, V57, P113, DOI 10.1016/j.jadohealth.2015.03.017; Gilead Sciences, 2018, US FOOD DRUG ADM APP; Grady Christine, 2016, AJOB Empir Bioeth, V7, P1; Grant RW, 2004, J MED PHILOS, V29, P717, DOI 10.1080/03605310490883046; Health NIo, 2015, NIH SUPP CLIN TRAILS; Heerman William J, 2016, IRB, V38, P8; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Herrick AL, 2011, J ADOLESCENT HEALTH, V48, P306, DOI 10.1016/j.jadohealth.2010.07.008; Hill B. J., 2012, J HEALTH CARE L PORV, V15, P37; HIV Prevention Trials Network, 2017, LONG ACT INJ CAB PRE; Hoffman LF, 2016, J ADOLESCENT HEALTH, V58, P576, DOI 10.1016/j.jadohealth.2016.01.007; Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Institute of Medicine Committee on Lesbian, 2011, BIS TRANSG HLTH ISS; Jackson CL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3467-1; Kann L, 2016, MORBIDITY MORTALITY, V65, P1, DOI DOI 10.15585/MMWR.SS6509A1; Kim Scott Y H, 2013, IRB, V35, P1; King NMP, 2000, J LAW MED ETHICS, V28, P332, DOI 10.1111/j.1748-720X.2000.tb00685.x; Kokolo MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022497; Konstan JA, 2005, J COMPUT-MEDIAT COMM, V10; Levy ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183521; Lidz CW, 2002, MED CARE, V40, P55, DOI 10.1097/01.MLR.0000023956.25813.18; Macapagal K, 2016, LGBT HEALTH, V3, P434, DOI 10.1089/lgbt.2015.0124; Macapagal K, 2016, ARCH SEX BEHAV, V45, P1513, DOI 10.1007/s10508-016-0698-2; Machado DM, 2017, ADOLESC HEALTH MED T, V8, P137, DOI 10.2147/AHMT.S112757; Meyers K, 2018, AIDS BEHAV, V22, P1209, DOI 10.1007/s10461-017-1871-x; Milhausen RR, 2013, CAN J HUM SEX, V22, P142, DOI DOI 10.3138/CJHS.2316; Miller Victoria A, 2016, IRB, V38, P1; Montgomery MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157742; Mustanski B, 2017, PERSPECT SEX REPRO H, V49, P111, DOI 10.1363/psrh.12027; Mustanski B, 2016, AM J PREV MED, V51, P249, DOI 10.1016/j.amepre.2016.02.026; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Napper LE, 2012, AIDS BEHAV, V16, P1075, DOI 10.1007/s10461-011-0003-2; NYS, 2016, GOV CUOM ANN PROP IN; Ott MA, 2013, J MED ETHICS, V39, P765, DOI 10.1136/medethics-2012-100821; Pace C, 2003, CRIT CARE MED, V31, pS121, DOI 10.1097/01.CCM.0000054907.33928.48; Pettifor A, 2015, J INT AIDS SOC, V18, P8, DOI 10.7448/IAS.18.2.19434; Philbin MM, 2014, AIDS BEHAV, V18, P1501, DOI 10.1007/s10461-013-0650-6; Phillips G, 2015, J ADOLESCENT HEALTH, V57, P407, DOI 10.1016/j.jadohealth.2015.06.014; Services DoHH, 2017, FED REGISTER, V83, P7149; Simon AE, 2007, AM J PREV MED, V32, P370, DOI 10.1016/j.amepre.2007.01.007; Smalley KB, 2016, HEALTH PSYCHOL, V35, P103, DOI 10.1037/hea0000231; Strutz KL, 2015, AM J PREV MED, V48, P76, DOI 10.1016/j.amepre.2014.07.038; Uusitalo S, 2017, AM J BIOETHICS, V17, P44, DOI 10.1080/15265161.2017.1388882; Vasgird D R, 2000, J Public Health Manag Pract, V6, P37; Wertheimer A, 2008, J MED ETHICS, V34, P389, DOI 10.1136/jme.2007.021857; Woodsong C, 2012, AIDS BEHAV, V16, P785, DOI 10.1007/s10461-011-0027-7	63	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200560	10.1371/journal.pone.0200560	http://dx.doi.org/10.1371/journal.pone.0200560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044845	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500060
J	Huda, N; Hosen, MI; Yasmin, T; Sarkar, PK; Hasan, AKMM; Nabi, AHMN				Huda, Nafiul; Hosen, Md. Ismail; Yasmin, Tahirah; Sarkar, Pankaj Kumar; Hasan, A. K. M. Mahbub; Nabi, A. H. M. Nurun			Genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LINEAGE; ACCELERATOR HYPOTHESIS; SUSCEPTIBILITY LOCI; POLYMORPHISM; VARIANTS; MELLITUS; OBESITY; MASS	Type 2 diabetes mellitus is a multifactorial metabolic disorder caused by environmental factors and has a strong association with hereditary issues. These hereditary issues result in an imbalance in CD4(+)T cells and a decreased level of naive CD4(+)T cells, which may be critical in the pathogenesis of type 2 diabetes. Transcription factors GATA3 and STAT4 mediate the cytokine-induced development of naive T cells into Th1 or Th2 types. In the present study, genetic analyses of GATA3 SNP rs3824662 and STAT4 SNP rs10181656 were performed to investigate the association of allelic and genotypic variations with the risk of T2D in the Bangladeshi population. A total of 297 unrelated Bangladeshi patients with type 2 diabetes and 247 healthy individuals were included in the study. The allelic and genotypic frequencies of rs10181656 located in the STAT4 gene were not found to be associated with risk of type 2 diabetes. The GATA3 rs3824662 T allele and mutant TT genotype had a significant association with the risk of T2D [OR: 1.52 (1.15-2.02), X-2 = 8.66, p = 0.003 and OR: 2.98 (1.36-6.55), X-2 = 7.98, p = 0.04, respectively]. Thus, the present study postulates that the genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population.	[Huda, Nafiul; Hosen, Md. Ismail; Yasmin, Tahirah; Hasan, A. K. M. Mahbub; Nabi, A. H. M. Nurun] Univ Dhaka, Dept Biochem & Mol Biol, Lab Populat Genet, Dhaka, Bangladesh; [Sarkar, Pankaj Kumar] Dinajpur Diabet O Swasthoseba Hosp, Dinajpur, Bangladesh	University of Dhaka	Nabi, AHMN (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Lab Populat Genet, Dhaka, Bangladesh.	nabi@du.ac.bd	Nabi, Ambreen/AED-3676-2022	Nabi, Ambreen/0000-0003-1899-363X; Yasmin, Tahirah/0000-0002-8143-2993; Nabi, AHM Nurun/0000-0002-0504-6556	World Academy of Sciences [15-167 RG/BIO/AS_G - FR3240287016]	World Academy of Sciences	This research work was partly supported by the research grant from The World Academy of Sciences, (Ref No. 15-167 RG/BIO/AS_G - FR3240287016) awarded to A.H.M. Nurun Nabi. Mr Nafiul Huda received a studentship from The World Academy of Sciences.	Afruza Rownock, 2014, J Genomics, V2, P45, DOI 10.7150/jgen.5193; Akther J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6973057; Ali A, 2007, HUM MOL GENET, V16, P265, DOI 10.1093/hmg/ddl454; [Anonymous], NON COMM DIS FACTSH; Bodhini D, 2007, INT J OBESITY, V31, P97, DOI 10.1038/sj.ijo.0803356; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Cunnion KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170500; Desai M, 2007, DIABETOLOGIA, V50, P68, DOI 10.1007/s00125-006-0513-z; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dobrian AD, 2015, J ENDOCRINOL, V227, P13, DOI 10.1530/JOE-15-0098; Dobrian AD, 2013, DIABETES, V62, P4109, DOI 10.2337/db12-1275; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; HITMAN GA, 1991, J MED GENET, V28, P97, DOI 10.1136/jmg.28.2.97; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hou QQ, 2017, ONCOTARGET, V8, P36040, DOI 10.18632/oncotarget.16424; Hypponen E, 2000, DIABETES CARE, V23, P1755, DOI 10.2337/diacare.23.12.1755; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kelley JM, 2010, ANN RHEUM DIS, V69, P778, DOI 10.1136/ard.2009.113183; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Kofteridis D, 2009, GENET TEST MOL BIOMA, V13, P281, DOI 10.1089/gtmb.2008.0128; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Mosaad YM, 2017, LEUKEMIA LYMPHOMA, V58, P689, DOI 10.1080/10428194.2016.1204656; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Nekoua MP, 2016, AFR HEALTH SCI, V16, P712, DOI 10.4314/ahs.v16i3.11; Perez-Andreu V, 2015, BLOOD, V125, P680, DOI 10.1182/blood-2014-09-595744; Pietropaolo M, 2000, DIABETES, V49, P32, DOI 10.2337/diabetes.49.1.32; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Sasaki Y, 2004, HUM GENET, V115, P177, DOI 10.1007/s00439-004-1146-2; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stoffers DA, 2004, HORM METAB RES, V36, P811, DOI 10.1055/s-2004-826168; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walsh KM, 2013, BLOOD, V122, P3385, DOI 10.1182/blood-2013-08-524124; Wang L, 2015, J BIOL CHEM, V290, P19458, DOI 10.1074/jbc.M115.641332; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069; Yi J, 2015, INT J CLIN EXP MED, V8, P3566; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5	56	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0198507	10.1371/journal.pone.0198507	http://dx.doi.org/10.1371/journal.pone.0198507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044774	Green Submitted, gold, Green Published			2022-12-26	WOS:000439942500006
J	Jin, S; Kang, M; Cho, H				Jin, Seokha; Kang, MungSoo; Cho, HyungJoon			Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note	PLOS ONE			English	Article							BRAIN-BARRIER BREAKDOWN; ULTRASHORT ECHO TIME; VASCULAR-PERMEABILITY; AGENT EXTRAVASATION; DCE-MRI; VOLUME; PARAMETERS; ISCHEMIA; STROKE; SIZE	In this study, we quantified perfusion deficits using dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) with an extravasating contrast agent (CA). We also investigated the efficacy of leakage compensation from CA pre-load in brains from post-ischemic rat models without significant dynamic contrast-enhanced MRI (DCE-MRI)-derived vessel wall permeability. DSC measurements were obtained using fast (0.3 s) echo-planar imaging in both normal rats and rats with transient middle carotid artery occlusion (MCAO) (1-h MCAO, 24-h reperfusion) after successive administrations of gadoterate meglumine (Dotarem) and intravascular superparamagnetic iron oxide nanoparticles (SPION). The relative cerebral blood volume (CBV) and cerebral blood flow (CBF) values acquired using Dotarem were significantly underestimated (similar to 20%) when compared to those acquired using SPION in ipsilesional post-ischemic brain regions. A slight overestimation of relative mean transit time was observed. Areas with underestimated CBV and CBF values from the corresponding error maps encompassed the area of infarcted tissue (apparent diffusion coefficient < 500 mu m(2)/s) and mostly coincided with the area wherein conspicuous longitudinal relaxation time differences were observed pre- vs. post-injection of Dotarem. The DSC measurements with significant pre-load (0.3 mmol.kg(-1)) of Dotarem displayed minimal perfusion deficits when compared to those determined using the reference intravascular SPION.	[Jin, Seokha; Kang, MungSoo; Cho, HyungJoon] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST)	Cho, H (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea.	hjcho@unist.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C0713]; Ulsan National Institute of Science and Technology (UNIST) [1.180063.01]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Ulsan National Institute of Science and Technology (UNIST)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0713 to SJ). This work was also supported by the 2018 Research Fund (grant number: 1.180063.01 to HC) of the Ulsan National Institute of Science and Technology (UNIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0713). This work was also supported by the 2018 Research Fund (grant number: 1.180063.01) of the Ulsan National Institute of Science and Technology (UNIST)	Bauman G, 2015, MAGN RESON MED, V73, P555, DOI 10.1002/mrm.25158; Boxerman JL, 2012, AM J NEURORADIOL, V33, P1081, DOI 10.3174/ajnr.A2934; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Dosa E, 2011, NEURO-ONCOLOGY, V13, P251, DOI 10.1093/neuonc/noq172; GARCIA JH, 1984, STROKE, V15, P5, DOI 10.1161/01.STR.15.1.5; GILL R, 1995, J CEREBR BLOOD F MET, V15, P1, DOI 10.1038/jcbfm.1995.1; Han SH, 2015, NEUROIMAGE, V112, P382, DOI 10.1016/j.neuroimage.2015.03.042; Heisen M, 2010, MAGN RESON MED, V63, P811, DOI 10.1002/mrm.22171; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; HOSSMANN KA, 1991, CEREBROVASC DIS, V1, P2, DOI 10.1159/000108875; Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570; Keston P, 2003, CLIN RADIOL, V58, P505, DOI 10.1016/S0009-9260(03)00130-2; Lee D, 2017, J MAGN RESON, V274, P57, DOI 10.1016/j.jmr.2016.11.004; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Nahirney PC, 2016, J CEREBR BLOOD F MET, V36, P413, DOI 10.1177/0271678X15608396; Quarles CC, 2005, MAGN RESON MED, V53, P1307, DOI 10.1002/mrm.20497; Reeson P, 2015, J NEUROSCI, V35, P5128, DOI 10.1523/JNEUROSCI.2810-14.2015; Roberts C, 2006, J MAGN RESON IMAGING, V23, P554, DOI 10.1002/jmri.20529; Shen Qiang, 2016, Brain Circ, V2, P20; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Simonsen CZ, 1999, JMRI-J MAGN RESON IM, V9, P342, DOI 10.1002/(SICI)1522-2586(199902)9:2<342::AID-JMRI29>3.3.CO;2-2; Tanaka Y, 2011, J CEREBR BLOOD F MET, V31, P1403, DOI 10.1038/jcbfm.2010.228; Uematsu H, 2006, EUR RADIOL, V16, P180, DOI 10.1007/s00330-005-2807-9; Vonken EJPA, 2000, MAGNET RESON MED, V43, P820, DOI 10.1002/1522-2594(200006)43:6<820::AID-MRM7>3.0.CO;2-F; ZIERLER KL, 1962, CIRC RES, V10, P393, DOI 10.1161/01.RES.10.3.393	27	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201076	10.1371/journal.pone.0201076	http://dx.doi.org/10.1371/journal.pone.0201076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044884	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500078
J	Weiss, G; Smith, DK; Newman, S; Wiener, J; Kitlas, A; Hoover, KW				Weiss, Gretchen; Smith, Dawn K.; Newman, Sarah; Wiener, Jeffrey; Kitlas, Alyssa; Hoover, Karen W.			PrEP implementation by local health departments in US cities and counties: Findings from a 2015 assessment of local health departments	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; INFECTION	Objective The United States Public Health Service released clinical practice guidelines for daily oral preexposure prophylaxis (PrEP) in May 2014. Local health departments (LHDs) are expected to play a critical role in PrEP implementation. We surveyed LHDs to assess awareness of and interest in supporting PrEP implementation, what roles they were taking, or believed they should take, in supporting PrEP, and what resources would be required to do so. Methods LHDs were surveyed in 2015 to assess their engagement in PrEP implementation (n = 500). The study employed a cross-sectional survey design with a randomly selected stratified sample. Results Among responding LHDs (n = 284), 109 (29%, weighted proportion) reported engagement in PrEP implementation. LHDs serving large jurisdictions (population 500,000+) and located in the West were more likely to be engaged in PrEP implementation. Making referrals for PrEP (74%) and conducting education and outreach to community members (51%) were the activities most frequently reported by LHDs engaged in PrEP implementation; 45% anticipated expanding their level of engagement. Among LHDs not engaged in PrEP implementation, 13% expected to become engaged over the next four years, 46% were undecided, and 41% reported it was unlikely. Information about PrEP for health care providers and information about PrEP for health department staff were the most frequently reported resource needs for LHDs engaged and not engaged in PrEP implementation, respectively. Conclusions PrEP implementation by LHDs was limited in 2015, three years after Food and Drug Administration approval and one year after the U.S. Public Health Service issued clinical practice guidelines. PrEP is a recently available intervention that is requiring LHDs to adjust existing HIV prevention efforts and service delivery models. Additional resources and implementation research is needed to effectively support PrEP scale-up by LHDs. Efforts must also be undertaken to increase PrEP awareness, knowledge, and implementation capacity among LHDs.	[Weiss, Gretchen; Newman, Sarah; Kitlas, Alyssa] Natl Assoc Cty & City Hlth Officials, Washington, DC 20005 USA; [Smith, Dawn K.; Wiener, Jeffrey; Hoover, Karen W.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Weiss, G (corresponding author), Natl Assoc Cty & City Hlth Officials, Washington, DC 20005 USA.	gweiss@naccho.org			Centers for Disease Control and Prevention [5U38OT000172-02-REVISED]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this research was provided by the Centers for Disease Control and Prevention (https://www.cdc.gov/) via Award Number 5U38OT000172-02-REVISED. The efforts of GW, SN, and AK were supported by the Centers for Disease Control and Prevention via Award Number 5U38OT000172-02-REVISED. The funder participated in study design, data analysis, decision to publish, and preparation of the manuscript.	Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Black AIDS Institute, 2015, WE KNOW BETT WE DO B; Bush S, 2015, IAPAC TREATMENT PREV; Centers for Disease Control and Prevention, 2017, PROJ PRID; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2017, AB THRIV; Centers for Disease Control and Prevention, 2018, FUND OPP ANN FOA PS1; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Crowley JS, 2015, AIDS EDUC PREV, V27, P84, DOI 10.1521/aeap.2015.27.1.84; District of Columbia Department of Health, 2016, MAYOR MUR BOWS 90 90; Green KR, 2015, SOC SOCIAL WORK RES; Hamel L., 2014, HIV AIDS LIVES GAY B; Kern County Public Health Services Department, 2017, COMMUNITY HLTH ASSES; King County, 2017, KING COUNT 1 NAT ACH; Krakower DS, 2016, CLIN INFECT DIS, V62, P99, DOI 10.1093/cid/civ736; Kuo I, 2016, DRUG ALCOHOL DEPEN, V164, P8, DOI 10.1016/j.drugalcdep.2016.02.044; Laufer FN, 2015, MMWR-MORBID MORTAL W, V64, P1296, DOI 10.15585/mmwr.mm6446a5; National Association of County City Health Officials, 2013, 2013 NAT PROF LOC HL; Smith DK, 2016, AIDS EDUC PREV, V28, P426, DOI 10.1521/aeap.2016.28.5.426; Smith DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156592; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; White House Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U	22	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200338	10.1371/journal.pone.0200338	http://dx.doi.org/10.1371/journal.pone.0200338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044820	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500043
J	Vasconcelos, R; Razgour, O; Tarroso, P; Fasola, M; Carranza, S; Alves, PC				Vasconcelos, Raquel; Razgour, Orly; Tarroso, Pedro; Fasola, Mauro; Carranza, Salvador; Alves, Paulo Cello			Combining molecular and landscape tools for targeting evolutionary processes in reserve design: An approach for islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HEMIDACTYLUS GECKOS; SOCOTRA ARCHIPELAGO; PROTECTED AREAS; CONSERVATION; DIVERSIFICATION; DIVERSITY; PATTERNS; GENETICS; POPULATIONS	The importance of targeting ecological and evolutionary processes in reserve design has been widely acknowledged in the literature but rarely implemented on islands. Using Socotran reptiles as models, we aim to relate richness of widespread and restricted-range species directly with landscape variables and to compare the impact of setting conservation targets for lineages versus species. Socotra Island is a UNESCO Natural World Heritage Site, containing high levels of endemism in relation to its area, especially of reptiles, the vertebrates with the most comprehensive available genetic data. We predicted the occurrences of reptile species using distribution models and used a novel approach to interpolate maps of spatial phylogenetic patterns. Patterns of intra and interspecifc diversity and differences between spatial outputs of lineage and species richness were related to eco-geographic variables. We evaluated differences in target achievement for each conservation unit within protected areas (PAs) under the current Zoning Plan (ZP) using gap and reserve design analyses. Although intraspecific richness was strongly correlated with interspecific richness, differences in their spatial distribution reached similar to 30% in some areas. Differences were more pronounced for wide-ranging than restricted-range taxa. Gap analysis indicates that most conservation units are under-represented in sanctuaries and that intra and interspecific richness were significantly higher outside PAs. This work will guide local-scale conservation planning as the ZP is due to be re-evaluated. This is one of the few studies on islands using genetic data from an entire class of vertebrates to incorporate lineage diversity in reserve design. This study provides an alternative methodological framework for supporting the use of landscape and genetic tools in reserve design, circumventing the use of phylogenetic distances and deterministic spatial interpolation of lineage diversity that can be widely applied to other systems.	[Vasconcelos, Raquel; Tarroso, Pedro; Alves, Paulo Cello] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBIO Lab Associado, CIBIO, Campus Agr Vairao, Vairao, Portugal; [Vasconcelos, Raquel; Tarroso, Pedro; Carranza, Salvador] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [Razgour, Orly] Univ Southampton, Biol Sci, Life Sci Bldg, Southampton, Hants, England; [Fasola, Mauro] Univ Pavia, Dipartimento Sci Terra & Ambiente, Pavia, Italy; [Alves, Paulo Cello] Univ Porto, Fac Ciencias, Dept Biol, Porto, Portugal	Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Southampton; University of Pavia; Universidade do Porto	Vasconcelos, R (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBIO Lab Associado, CIBIO, Campus Agr Vairao, Vairao, Portugal.; Vasconcelos, R (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain.	raquel.vasconcelos@cibio.up.pt	Razgour, Orly/X-3478-2019; Razgour, Orly/B-9646-2011; Tarroso, Pedro/I-3023-2012; Vasconcelos, Raquel/H-5524-2012; Carranza, Salvador/A-2126-2012; ALVES, Paulo Célio/B-5448-2009	Razgour, Orly/0000-0003-3186-0313; Razgour, Orly/0000-0003-3186-0313; Tarroso, Pedro/0000-0002-2694-1170; Vasconcelos, Raquel/0000-0002-4717-9429; Carranza, Salvador/0000-0002-5378-3008; ALVES, Paulo Célio/0000-0003-4797-0939	Fundacao para a Ciencia e Tecnologia - European Social Fund [SFRH/BPD/79913/2011, SFRH/BPD/93473/2013]; Human Potential Operational Program, POPH/FSE; Ministerio de Economia y Competitividad; FEDER [CGL2012-36970, CGL2015-70390-P]; Mohamed bin Zayed Species Conservation Fund [13055714, 1425991]; Natural Environment Research Council (NERC) Independent Research Fellowship [NE/M018660/1]; NERC [NE/M018660/2, NE/M018660/1] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia - European Social Fund; Human Potential Operational Program, POPH/FSE; Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); Mohamed bin Zayed Species Conservation Fund; Natural Environment Research Council (NERC) Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Fundacao para a Ciencia e Tecnologia (SFRH/BPD/79913/2011 fellowships to R.V. and SFRH/BPD/93473/2013 to P.T.), financed by The European Social Fund and the Human Potential Operational Program, POPH/FSE; Ministerio de Economia y Competitividad co-funded by FEDER (CGL2012-36970, CGL2015-70390-P); The Mohamed bin Zayed Species Conservation Fund (projects no 13055714, 1425991); and Natural Environment Research Council (NERC) Independent Research Fellowship (NE/M018660/1 to O.R.). Besides financial support, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, TECTONOPHYSICS, V637, P251, DOI 10.1016/j.tecto.2014.10.014; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Autin J, 2013, TECTONOPHYSICS, V607, P51, DOI 10.1016/j.tecto.2013.05.041; Badiane A, 2014, ZOOTAXA, V3835, P33, DOI 10.11646/zootaxa.3835.1.2; Bennett JR, 2014, BIOL CONSERV, V174, P47, DOI 10.1016/j.biocon.2014.03.013; Beydoun ZR, 1970, Q J GEOL SOC LOND, V125, P413, DOI DOI 10.1144/GSJGS.125.1.0413; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Chen YH, 2017, DIVERS DISTRIB, V23, P146, DOI 10.1111/ddi.12508; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; D'Amen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P93, DOI 10.1111/j.1466-8238.2012.00774.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Sanctis M, 2013, APPL VEG SCI, V16, P148, DOI 10.1111/j.1654-109X.2012.01212.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Porta J, 2017, J BIOGEOGR, V44, P1694, DOI 10.1111/jbi.12929; Garcia-Porta J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23729; Garcia-Porta J, 2016, MOL PHYLOGENET EVOL, V98, P288, DOI 10.1016/j.ympev.2016.02.007; Gillman LN, 2014, J BIOGEOGR, V41, P39, DOI 10.1111/jbi.12173; Gomez-Diaz E, 2012, MOL ECOL, V21, P4074, DOI 10.1111/j.1365-294X.2012.05672.x; Gray CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12306; Hammill E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11042; Hertz PE, 2013, EVOLUTION, V67, P2101, DOI 10.1111/evo.12072; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Laikre L, 2010, CONSERV GENET, V11, P349, DOI 10.1007/s10592-009-0037-4; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Malatesta L, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073527; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin N, 2017, ZOOL ANZ, V267, P69, DOI 10.1016/j.jcz.2017.01.005; Miraldo A, 2016, SCIENCE, V353, P1532, DOI 10.1126/science.aaf4381; Moilanen A., 2014, SPATIAL CONSERVATION, P288; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Myers N, 2003, BIOSCIENCE, V53, P916; Oliveira U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08707-2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pollock LJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0007; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porter R.F., 2016, Sandgrouse, V38, P169; Qu YH, 2014, MOL ECOL, V23, P705, DOI 10.1111/mec.12619; R-Core-Team, 2015, LANG ENV STAT COMP; Razgour O, 2013, ECOL LETT, V16, P1258, DOI 10.1111/ele.12158; Razgour O, 2011, OECOLOGIA, V167, P493, DOI 10.1007/s00442-011-1995-z; Razzetti E, 2011, ZOOTAXA, P1; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rijsdijk KF, 2014, J BIOGEOGR, V41, P1242, DOI 10.1111/jbi.12336; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Russo D, 2016, HYSTRIX, V27, P212, DOI DOI 10.4404/HYSTRIX-27.2-11788; Scholte P, 2011, ORYX, V45, P401, DOI 10.1017/S0030605310001535; Scoble J, 2010, DIVERS DISTRIB, V16, P343, DOI 10.1111/j.1472-4642.2010.00658.x; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Smid J, 2017, ORG DIVERS EVOL, V17, P267, DOI 10.1007/s13127-016-0293-3; Steinbauer MJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P1097, DOI 10.1111/geb.12469; Tarroso P, 2015, MOL ECOL RESOUR, V15, P349, DOI 10.1111/1755-0998.12312; Taylor C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169629; Thomassen HA, 2011, EVOL APPL, V4, P397, DOI 10.1111/j.1752-4571.2010.00172.x; Thomassen HA, 2010, MOL ECOL, V19, P3532, DOI 10.1111/j.1365-294X.2010.04737.x; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Vasconcelos R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149985; Vasconcelos R, 2014, ZOOTAXA, V3835, P501, DOI 10.11646/zootaxa.3835.4.4; Vasconcelos R, 2012, BIOL CONSERV, V153, P276, DOI 10.1016/j.biocon.2012.04.020; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wilson A, 2009, CONSERV GENET, V10, P419, DOI 10.1007/s10592-008-9612-3; Zhang YB, 2016, J NAT CONSERV, V31, P43, DOI 10.1016/j.jnc.2016.03.003	72	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200830	10.1371/journal.pone.0200830	http://dx.doi.org/10.1371/journal.pone.0200830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040840	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000439749200011
J	Karuppagounder, V; Bajpai, A; Meng, S; Arumugam, S; Sreedhar, R; Giridharan, VV; Guha, A; Bhimaraj, A; Youker, KA; Palaniyandi, SS; Karmouty-Quintana, H; Kamal, F; Spiller, KL; Watanabe, K; Thandavarayan, RA				Karuppagounder, Vengadeshprabhu; Bajpai, Anamika; Meng, Shu; Arumugam, Somasundaram; Sreedhar, Remya; Giridharan, Vijayasree V.; Guha, Ashrith; Bhimaraj, Arvind; Youker, Keith A.; Palaniyandi, Suresh S.; Karmouty-Quintana, Harry; Kamal, Fadia; Spiller, Kara L.; Watanabe, Kenichi; Thandavarayan, Rajarajan A.			Small molecule disruption of G protein beta gamma subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats	PLOS ONE			English	Article							DAUNORUBICIN-INDUCED NEPHROTOXICITY; COUPLED-RECEPTOR KINASES; HEART-FAILURE; ATOPIC-DERMATITIS; CARDIOVASCULAR-DISEASE; INFLAMMATION; HMGB1; MICE; POLARIZATION; PROGRESSION	The purpose of this study was to determine whether blocking of G protein beta gamma (G beta gamma) signaling halts heart failure (HF) progression by macrophage phenotype manipulation. Cardiac G beta gamma signaling plays a crucial role in HF pathogenesis. Previous data suggested that inhibiting G beta gamma signaling reprograms T helper cell 1 (Th1) and Th2 cytokines, suggesting that G beta gamma might be a useful drug target for treating HF. We investigated the efficacy of a small molecule G beta gamma inhibitor, gallein, in a clinically relevant, experimental autoimmune myocarditis (EAM) model of HF as well as in human macrophage phenotypes in vitro. In the myocardium of HF patients, we observed that G protein coupled receptor kinase (GRK)2 levels were down-regulated compared with healthy controls. In rat EAM, treatment with gallein effectively improved survival and cardiac function, suppressed cardiac remodeling, and further attenuated myocardial protein expression of GRK2 as well as high mobility group box (HMGB)1 and its cascade signaling proteins. Furthermore, gallein effectively inhibited M1 polarization and promoted M2 polarization in vivo in the EAM heart and in vitro in human monocyte-derived macrophages. Taken together, these data suggest that the small molecule G beta gamma inhibitor, gallein, could be an important pharmacologic therapy for HF as it can switch the phenotypic reprogramming from M1 to M2 phenotype in a rat model of EAM heart and in human macrophages.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Sreedhar, Remya; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata, Japan; [Karuppagounder, Vengadeshprabhu; Kamal, Fadia] Penn State Coll Med, Dept Orthopaed & Rehabil, Hershey, PA USA; [Bajpai, Anamika; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA; [Meng, Shu; Karmouty-Quintana, Harry] Univ Texas Houston, Dept Biochem & Mol Biol, Houston Med Sch, Houston, TX USA; [Giridharan, Vijayasree V.] McGovern Med Sch, Translat Psychiat Program, Dept Psychiat & Behav Sci, Houston, TX USA; [Guha, Ashrith; Bhimaraj, Arvind; Youker, Keith A.; Thandavarayan, Rajarajan A.] Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Palaniyandi, Suresh S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI USA	Niigata University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Drexel University; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Henry Ford Health System; Henry Ford Hospital	Watanabe, K (corresponding author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata, Japan.; Thandavarayan, RA (corresponding author), Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA.	wataken@med.niigata-u.ac.jp; atrajarajan@gmail.com	Arumugam, S./AAT-7570-2020; Vayalanellore Giridharan, Vijayasree/ABD-6290-2020; bajpai, Anamika/AAZ-4943-2021; Kamal, Fadia/AAP-1798-2021; Karmouty-Quintana, Harry/ABC-9144-2020; Karuppagounder, Vengadeshprabhu/AAC-6623-2019	Vayalanellore Giridharan, Vijayasree/0000-0003-3069-7139; Karmouty-Quintana, Harry/0000-0003-4753-9823; KARUPPA GOUNDER, VENGADESHPRABHU/0000-0003-1511-7810; Bajpai, Anamika/0000-0002-6943-3758; Youker, Keith/0000-0003-2535-7973; Arumugam, Somasundaram/0000-0002-2096-2552				Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Dorn GW, 2009, J MOL MED, V87, P455, DOI 10.1007/s00109-009-0450-7; Gao SS, 2015, J MOL CELL CARDIOL, V85, P131, DOI 10.1016/j.yjmcc.2015.04.025; Gounder VK, 2014, INT IMMUNOPHARMACOL, V18, P282, DOI 10.1016/j.intimp.2013.11.018; Hao QQ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/270930; Hynes Thomas R, 2015, J Mol Signal, V10, P1, DOI 10.5334/1750-2187-10-1; Kamal FA, 2014, J AM COLL CARDIOL, V63, P2549, DOI 10.1016/j.jacc.2014.02.587; Karuppagounder V, 2016, EXP DERMATOL, V25, P404, DOI 10.1111/exd.12962; Karuppagounder V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152922; Karuppagounder V, 2015, INT IMMUNOPHARMACOL, V28, P154, DOI 10.1016/j.intimp.2015.05.050; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lurier EB, 2017, IMMUNOBIOLOGY, V222, P847, DOI 10.1016/j.imbio.2017.02.006; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Mrro S, 2011, BIOL PHARM BULL, V34, P974, DOI 10.1248/bpb.34.974; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Reinkober J, 2012, GENE THER, V19, P686, DOI 10.1038/gt.2012.9; Schumacher-Bass Sarah M, 2012, Drug Discov Today Ther Strateg, V9, pe155; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Sreedhar R, 2016, BIOFACTORS, V42, P368, DOI 10.1002/biof.1280; Su ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21884; Su ZL, 2014, J CELL MOL MED, V18, P1740, DOI 10.1111/jcmm.12324; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Travers JG, 2016, CIRC RES, V118, P1049, DOI 10.1161/CIRCRESAHA.116.308542; Watanabe K, 2002, J NUCL MED, V43, P531; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173; Zhao XN, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017348	33	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200697	10.1371/journal.pone.0200697	http://dx.doi.org/10.1371/journal.pone.0200697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024944	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000042
J	Nizynski, B; Nieznanska, H; Dec, R; Boyko, S; Dzwolak, W; Nieznanski, K				Nizynski, Bartosz; Nieznanska, Hanna; Dec, Robert; Boyko, Solomiia; Dzwolak, Wojciech; Nieznanski, Krzysztof			Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; A-BETA OLIGOMERS; FRONTOTEMPORAL DEMENTIA; CONFORMATIONAL CONVERSION; ALZHEIMERS-DISEASE; REPEAT DOMAIN; AGGREGATION; PROPAGATION; PRINCIPLES; MUTATIONS	Amyloid aggregates of Tau protein have been implicated in etiology of many neurodegenerative disorders including Alzheimer's disease (AD). When amyloid growth is induced by seeding with preformed fibrils assembled from the same protein, structural characteristics of the seed are usually imprinted in daughter generations of fibrils. This so-called conformational memory effect may be compromised when the seeding involves proteins with nonidentical sequences leading to the emergence of distinct structural variants of fibrils (amyloid `strains). Here, we investigate cross-seeding of full-length human Tau (FL Tau) with fibrils assembled from K18 and K18 Delta K280 fragments of Tau in the presence of poly-L-glutamate (poly-Glu) as an enhancer of Tau aggregation. To study cross-seeding between Tau polypeptides and the role of the conformational memory effect in induction of Tau amyloid polymorphism, kinetic assays, transmission electron microscopy, infrared spectroscopy and limited proteolysis have been employed. The fastest fibrillization was observed for FL Tau monomers seeded with preformed K18 amyloid yielding daughter fibrils with unique trypsin digestion patterns. Morphological features of daughter FL Tau fibrils induced by K18 and K18AK280 seeds were reminiscent of the mother fibrils (i.e. straight paired fibrils and paired helical filaments (PHFs), respectively) but disappeared in the following generations which became similar to unpaired FL Tau amyloid fibrils formed de novo. The structural evolution observed in our study was accompanied by disappearance of the unique proteolysis profile originated from K18. Our findings may have implications for understanding molecular mechanisms of the emergence and stability of Tau amyloid strains.	[Nizynski, Bartosz] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, Banacha 2C, Warsaw, Poland; [Nizynski, Bartosz; Dec, Robert; Dzwolak, Wojciech] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland; [Nieznanska, Hanna; Boyko, Solomiia; Nieznanski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland	University of Warsaw; University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Dzwolak, W (corresponding author), Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland.; Nieznanski, K (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland.	wdzwolak@chem.uw.edu.pl; k.vandijki@nencki.gov.pl	Nieznanski, Krzysztof/R-4220-2016	Nieznanski, Krzysztof/0000-0003-0440-2632; Nieznanska, Hanna/0000-0001-7055-5018; Boyko, Solomiia/0000-0003-1867-7610; Dzwolak, Wojciech/0000-0002-1407-1497	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [665735]; Polish Ministry of Science and Higher Education [3548/H2020/COFUND/2016/2]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	S. B. and K. N. have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 665735 (Bio4Med) (https://cordis.europa.eu/project/rcn/196367_en.html) and the funding from Polish Ministry of Science and Higher Education within 2016-2020 funds for the implementation of international projects (agreement No 3548/H2020/COFUND/2016/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoury E, 2016, PROTEIN SCI, V25, P1010, DOI 10.1002/pro.2911; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Atsmon-Raz Y, 2016, J PHYS CHEM B, V120, P10649, DOI 10.1021/acs.jpcb.6b07731; Atsmon-Raz Y, 2016, ACS CHEM NEUROSCI, V7, P46, DOI 10.1021/acschemneuro.5b00204; Baram M, 2016, PHYS CHEM CHEM PHYS, V18, P2330, DOI 10.1039/c5cp03338a; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falsig J, 2008, HFSP J, V2, P332, DOI 10.2976/1.2990786; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fulara A, 2010, J PHYS CHEM B, V114, P8278, DOI 10.1021/jp102440n; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hernik A, 2015, LANGMUIR, V31, P10500, DOI 10.1021/acs.langmuir.5b02915; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kumar S, 2014, J BIOL CHEM, V289, P20318, DOI 10.1074/jbc.M114.554725; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Matsumoto SE, 2015, HUM MOL GENET, V24, P6403, DOI 10.1093/hmg/ddv351; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nizynski B, 2017, PROTEIN SCI, V26, P2126, DOI 10.1002/pro.3275; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raz Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073303; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sarell CJ, 2013, PRION, V7, P359, DOI 10.4161/pri.26415; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shammas SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8025; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Surmacz-Chwedoruk W, 2016, SCI REP-UK, V6, DOI 10.1038/srep32022; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wasiak T, 2012, MOL PHARMACEUT, V9, P458, DOI 10.1021/mp2005627; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	69	19	19	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201182	10.1371/journal.pone.0201182	http://dx.doi.org/10.1371/journal.pone.0201182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024984	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000095
J	Scheich, S; Koenig, R; Wilke, AC; Lindner, S; Reinheimer, C; Wichelhaus, TA; Hogardt, M; Kempf, VAJ; Kessel, J; Weber, S; Martin, H; Bug, G; Serve, H; Steffen, B				Scheich, Sebastian; Koenig, Rosalie; Wilke, Anne C.; Lindner, Sarah; Reinheimer, Claudia; Wichelhaus, Thomas A.; Hogardt, Michael; Kempf, Volkhard A. J.; Kessel, Johanna; Weber, Sarah; Martin, Hans; Bug, Gesine; Serve, Hubert; Steffen, Bjoern			Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETER; GRAM-NEGATIVE BACILLI; BONE-MARROW; RISK-FACTORS; MORTALITY; BACTEREMIA; SPECTRUM; EPIDEMIOLOGY; BACTERIAL	Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers potential cure to acute myeloid leukemia (AML) patients. However, infections with commensal bacteria are an important cause for non-relapse mortality (NRM). We have previously described the impact of multidrug-resistant organism (MDRO) colonization on the survival of allo-HSCT patients. In the aforementioned publication, according to consensus, we there did not consider the opportunistic gram-negative bacterium Stenotrophomonas maltophilia (S. maltophilia) to be an MDRO. Since rate of S. maltophilia colonization is increasing, and it is not known whether this poses a risk for allo-HSCT patients, we here analyzed here its effect on the previously described and now extended patient cohort. We report on 291 AML patients undergoing allo-HSCT. Twenty of 291 patients (6.9%) were colonized with S. maltophilia. Colonized patients did not differ from non-colonized patients with respect to their age, remission status before allo-HSCT, donor type and HSCT-comorbidity index. S. maltophilia colonized patients had a worse overall survival (OS) from 6 months up to 60 months (85% vs. 88.1% and 24.7% vs. 59.7%; p = 0.007) due to a higher NRM after allo-HSCT (6 months: 15% vs. 4.8% and 60 months: 40.1% vs. 16.2% p = 0.003). The main cause of mortality in colonized patients was infection (46.2% of all deaths) and in non-colonized patients relapse (58.8% of all deaths). 5/20 colonized patients developed an invasive infection with S. maltophilia. The worse OS after allo-HSCT due to higher infection related mortality might implicate the screening of allo-HSCT patients for S. maltophilia and a closer observation of colonized patients as outpatients.	[Scheich, Sebastian; Koenig, Rosalie; Wilke, Anne C.; Lindner, Sarah; Weber, Sarah; Martin, Hans; Bug, Gesine; Serve, Hubert; Steffen, Bjoern] Goethe Univ Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany; [Scheich, Sebastian; Wilke, Anne C.; Lindner, Sarah; Reinheimer, Claudia; Wichelhaus, Thomas A.; Hogardt, Michael; Kempf, Volkhard A. J.; Kessel, Johanna; Weber, Sarah; Martin, Hans; Bug, Gesine; Serve, Hubert; Steffen, Bjoern] Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany; [Reinheimer, Claudia; Wichelhaus, Thomas A.; Hogardt, Michael; Kempf, Volkhard A. J.] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Kessel, Johanna] Univ Hosp Frankfurt, Infect Dis Unit, Dept Med, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scheich, S (corresponding author), Goethe Univ Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany.; Scheich, S (corresponding author), Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany.	sebastian.scheich@kgu.de	Bug, Gesine/H-8827-2013					[Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Boktour M, 2006, CANCER-AM CANCER SOC, V106, P1967, DOI 10.1002/cncr.21846; Cappellano P, 2007, NEW MICROBIOL, V30, P89; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Corbella X, 1996, CLIN INFECT DIS, V23, P329, DOI 10.1093/clinids/23.2.329; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Elsabbagh EM, 2017, BIOL BLOOD MARROW TR, V23, pS231, DOI 10.1016/j.bbmt.2016.12.455; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Goerner M, 2002, BIOL BLOOD MARROW TR, V8, P47, DOI 10.1053/bbmt.2002.v8.pm11858190; Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001; Jones RN, 2003, INT J ANTIMICROB AG, V22, P551, DOI 10.1016/S0924-8579(03)00245-0; Kruger W, 1999, BONE MARROW TRANSPL, V23, P589, DOI 10.1038/sj.bmt.1701614; Labarca JA, 2000, CLIN INFECT DIS, V30, P195, DOI 10.1086/313591; Lai CH, 2006, CLIN MICROBIOL INFEC, V12, P986, DOI 10.1111/j.1469-0691.2006.01511.x; Liss BJ, 2012, INFECTION, V40, P613, DOI 10.1007/s15010-012-0269-y; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Mikulska M, 2012, INFECTION, V40, P271, DOI 10.1007/s15010-011-0229-y; Mori M, 2014, ANN HEMATOL, V93, P901, DOI 10.1007/s00277-014-2028-x; Ninin E, 2001, CLIN INFECT DIS, V33, P41, DOI 10.1086/320871; Norkin Maxim, 2017, F1000Res, V6, P870, DOI 10.12688/f1000research.11233.1; Nseir S, 2006, CRIT CARE, V10, DOI 10.1186/cc5063; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Poutsiaka DD, 2007, BONE MARROW TRANSPL, V40, P63, DOI 10.1038/sj.bmt.1705690; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sader HS, 2014, ANTIMICROB AGENTS CH, V58, P2274, DOI 10.1128/AAC.02684-13; Sader HS, 2005, INT J ANTIMICROB AG, V25, P95, DOI 10.1016/j.ijantimicag.2004.10.002; Samonis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037375; Scheich S, 2017, CANCER; Scheich S, 2017, BIOL BLOOD MARROW TR; Shiratori S, 2014, CLIN TRANSPLANT, V28, P656, DOI 10.1111/ctr.12356; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sostarich AM, 2008, INFECTION, V36, P31, DOI 10.1007/s15010-007-6316-4; US Department of Health and Human Services National Institutes of Health, 2010, COMM TERM CRIT ADV E; Wang L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001931; Waters VJ, 2007, INFECT IMMUN, V75, P1698, DOI 10.1128/IAI.01469-06; Yeshurun M, 2010, INFECTION, V38, P211, DOI 10.1007/s15010-010-0023-2	40	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201169	10.1371/journal.pone.0201169	http://dx.doi.org/10.1371/journal.pone.0201169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024969	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000093
J	Shimada, E; Ahsan, FM; Nili, M; Huang, D; Atamdede, S; TeSlaa, T; Case, D; Yu, X; Gregory, BD; Perrin, BJ; Koehler, CM; Teitell, MA				Shimada, Eriko; Ahsan, Fasih M.; Nili, Mahta; Huang, Dian; Atamdede, Sean; TeSlaa, Tara; Case, Dana; Yu, Xiang; Gregory, Brian D.; Perrin, Benjamin J.; Koehler, Carla M.; Teitell, Michael A.			PNPase knockout results in mtDNA loss and an altered metabolic gene expression program	PLOS ONE			English	Article							HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; RNA-IMPORT; INTERMEMBRANE SPACE; POLY(A) POLYMERASE; ESCHERICHIA-COLI; CULTURED-CELLS; MITOCHONDRIA; PROTEIN; FAMILY; DECAY	Polynucleotide phosphorylase (PNPase) is an essential mitochondria-localized exoribonuclease implicated in multiple biological processes and human disorders. To reveal role(s) for PNPase in mitochondria, we established PNPase knockout (PKO) systems by first shifting culture conditions to enable cell growth with defective respiration. Interestingly, PKO established in mouse embryonic fibroblasts (MEFs) resulted in the loss of mitochondrial DNA (mtDNA). The transcriptional profile of PKO cells was similar to rho(0) mtDNA deleted cells, with perturbations in cholesterol (FDR = 6.35 x 10(-13)), lipid (FDR = 3.21 x 10(-11)), and secondary alcohol (FDR = 1.04x10(-12)) metabolic pathway gene expression compared to wild type parental (TM6) MEFs. Transcriptome analysis indicates processes related to axonogenesis (FDR = 4.49 x 10(-3)), axon development (FDR = 4.74 x 10(-3)), and axonal guidance (FDR = 4.74 x 10(-3)) were overrepresented in PKO cells, consistent with previous studies detailing causative PNPase mutations in delayed myelination, hearing loss, encephalomyopathy, and chorioretinal defects in humans. Overrepresentation analysis revealed alterations in metabolic pathways in both PKO and rho(0) cells. Therefore, we assessed the correlation of genes implicated in cell cycle progression and total metabolism and observed a strong positive correlation between PKO cells and rho(0) MEFs compared to TM6 MEFs. We quantified the normalized biomass accumulation rate of PKO clones at 1.7% (SD +/- 2.0%) and 2.4% (SD +/- 1.6%) per hour, which was lower than TM6 cells at 3.3% (SD +/- 3.5%) per hour. Furthermore, PKO in mouse inner ear hair cells caused progressive hearing loss that parallels human familial hearing loss previously linked to mutations in PNPase. Combined, our study reports that knockout of a mitochondrial nuclease results in mtDNA loss and suggests that mtDNA maintenance could provide a unifying connection for the large number of biological activities reported for PNPase.	[Shimada, Eriko; TeSlaa, Tara; Case, Dana; Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Interdept Program, Los Angeles, CA 90024 USA; [Ahsan, Fasih M.; Nili, Mahta; Teitell, Michael A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Huang, Dian; Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Atamdede, Sean; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Yu, Xiang; Gregory, Brian D.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Perrin, Benjamin J.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Brd Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Koehler, CM; Teitell, MA (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Interdept Program, Los Angeles, CA 90024 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.; Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Koehler, CM; Teitell, MA (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Brd Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	koehlerc@chem.ucla.edu; mteitell@mednet.ucla.edu	Yu, Xiang/H-9666-2019; Gregory, Brian D/G-2890-2010	Yu, Xiang/0000-0002-5730-8802; Ahsan, Fasih/0000-0001-8031-7056; Koehler, Carla/0000-0001-8685-2412; TeSlaa, Tara/0000-0002-0504-0998	National Institutes of Health [CA90571, CA156674, GM073981, GM114188, CA185189, GM61721, CA009120, GM007185]; California Institute of Regenerative Medicine [RT307678]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [NS076228]; Whitcome Pre-doctoral Training Program (UCLA); MBI-IDP Special Award (UCLA); Air Force Office of Scientific Research [FA9550-15-1-0406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM114188, R01GM073981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Pre-doctoral Training Program (UCLA); MBI-IDP Special Award (UCLA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health awards CA90571 (MAT), CA156674 (MAT), GM073981 (MAT and CMK), GM114188 (MAT), CA185189 (MAT), and GM61721 (CMK); California Institute of Regenerative Medicine RT307678 (CMK and MAT); National Institutes of Health Ruth L. Kirschstein National Research Service Award NS076228 (ES); Whitcome Pre-doctoral Training Program (UCLA) (ES); and an MBI-IDP Special Award (UCLA) (ES). Air Force Office of Scientific Research FA9550-15-1-0406, National Institutes of Health CA009120, National Institutes of Health GM007185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alodaib A, 2017, EUR J HUM GENET, V25, P79, DOI 10.1038/ejhg.2016.128; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Bandyra KJ, 2016, RNA, V22, P360, DOI 10.1261/rna.052886.115; Becket E, 2012, J BACTERIOL, V194, P5613, DOI 10.1128/JB.00962-12; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Bralley P, 2014, GENE, V536, P177, DOI 10.1016/j.gene.2013.10.055; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Cameron TA, 2016, J BACTERIOL, V198, P3309, DOI 10.1128/JB.00624-16; Cardenas PP, 2011, NUCLEIC ACIDS RES, V39, P9250, DOI 10.1093/nar/gkr635; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Carzaniga T, 2014, BIOCHIMIE, V97, P49, DOI 10.1016/j.biochi.2013.09.018; Carzaniga T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-270; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; Goverde RLJ, 1998, MOL MICROBIOL, V28, P555, DOI 10.1046/j.1365-2958.1998.00816.x; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Gregory Warnes BB, 2016, BILL VENABLES GPLOTS; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Kettunen P, 2007, MECH DEVELOP, V124, P868, DOI 10.1016/j.mod.2007.09.003; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Kim SH, 2009, J FOOD PROTECT, V72, P1841, DOI 10.4315/0362-028X-72.9.1841; Kolde R, 2015, PACKAGE PHEATMAP PRE; Leszczyniecka M, 2003, GENE, V316, P143, DOI 10.1016/S0378-1119(03)00752-2; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Liu PP, 2017, PROTEIN CELL, V8, P735, DOI 10.1007/s13238-017-0448-9; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matilainen S, 2017, HUM MOL GENET, V26, P3352, DOI 10.1093/hmg/ddx221; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nishimura K, 2017, STEM CELL REP, V8, P787, DOI 10.1016/j.stemcr.2017.01.026; Oster SF, 2003, DEVELOPMENT, V130, P775, DOI 10.1242/dev.00299; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Pobre V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1237-6; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Rath D, 2012, MICROBIOL-SGM, V158, P1196, DOI 10.1099/mic.0.056309-0; REINER AM, 1969, J BACTERIOL, V97, P1437, DOI 10.1128/JB.97.3.1437-1443.1969; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rosenzweig JA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00081; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009; Sarkar D, 2004, CANCER RES, V64, P7473, DOI 10.1158/0008-5472.CAN-04-1772; Sarkar D, 2006, CELL DEATH DIFFER, V13, P1541, DOI 10.1038/sj.cdd.4401829; Sato R, 2018, CLIN GENET, V93, P242, DOI 10.1111/cge.13068; Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833; Slavotinek AM, 2015, CLIN GENET, V88, P468, DOI 10.1111/cge.12543; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Sokhi UK, 2014, J CELL PHYSIOL, V229, P1952, DOI 10.1002/jcp.24645; Sokhi UK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076284; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001; von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002; Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Wu JH, 2009, BIOCHEMISTRY-US, V48, P2012, DOI 10.1021/bi801752p; Yamanaka K, 2001, J BACTERIOL, V183, P2808, DOI 10.1128/JB.183.9.2808-2816.2001; Yip JW, 2000, P NATL ACAD SCI USA, V97, P8612, DOI 10.1073/pnas.150040497; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zangle TA, 2014, NAT METHODS, V11, P1221, DOI 10.1038/nmeth.3175; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307	86	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200925	10.1371/journal.pone.0200925	http://dx.doi.org/10.1371/journal.pone.0200925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024931	Green Published, gold			2022-12-26	WOS:000439120000068
J	Takagi, J; Ichikawa, K; Arai, N; Miyamoto, Y; Uchida, K; Shoji, J; Mitamura, H				Takagi, Junichi; Ichikawa, Kotaro; Arai, Nobuaki; Miyamoto, Yoshinori; Uchida, Keiichi; Shoji, Jun; Mitamura, Hiromichi			Simultaneous observation of intermittent locomotion of multiple fish by fine-scale spatiotemporal three-dimensional positioning	PLOS ONE			English	Article							ACOUSTIC TELEMETRY; MOVEMENT PATTERNS; LIGHT CONDITIONS; ACTIVITY RHYTHM; SITE FIDELITY; BEHAVIOR; HABITAT; SEARCH; SALMON; PSEUDOLABRUS	Recent advances in biotelemetry techniques, especially positioning methods, have revealed the detailed behaviour and movement of aquatic organisms. Behavioural intermittence in animal locomotion, such as the Levy walk, is a popular topic in the field of movement ecology. Previous attempts to describe intermittent locomotion quantitatively have been constrained by the spatial and temporal resolution possible with conventional biotelemetry systems. This study developed a fine-scale spatiotemporal three-dimensional positioning method using a new biotelemetry system with a positional precision of <10 cm and positioning interval of <10 s. Using this proposed positioning method, the intermittent stop-and-go locomotion of Siebold's wrasses (Pseudolabrus sieboldi) was observed during travel from an unsuitable to a suitable location following displacement. The fish displayed behavioural intermittence in relocating to a suitable location. Initially, their movement halted for reorientation, after which they moved intermittently yet in a straight line to the suitable location. To test the positioning ability of the proposed method, data sets were resampled at intervals of 5, 10, 30, 60, and 300 s. Longer sampling intervals failed to identify reorientations and underestimated the number of stops, distance travelled, and speed. Overall, the results highlighted the adequacy and ability of the proposed positioning method to observe the intermittent locomotion of fish, such as stop-and-go behaviour, in a natural environment.	[Takagi, Junichi; Mitamura, Hiromichi] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Takagi, Junichi; Ichikawa, Kotaro; Arai, Nobuaki; Miyamoto, Yoshinori; Uchida, Keiichi; Mitamura, Hiromichi] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Ichikawa, Kotaro; Arai, Nobuaki] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan; [Miyamoto, Yoshinori; Uchida, Keiichi] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Ocean Sci, Tokyo, Japan; [Shoji, Jun] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Tokyo University of Marine Science & Technology; Hiroshima University	Takagi, J (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.; Takagi, J (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.	takagi@bre.soc.i.kyoto-u.ac.jp	MIYAMOTO, Yoshinori/O-1920-2014	Shoji, Jun/0000-0003-2293-5707; Takagi, Junichi/0000-0002-6661-6065	JST CREST, Japan [JPMJCR13A5];  [17J10603];  [25712022]	JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST)); ; 	This study was supported by a Grant-in-Aid for JSPS (the Japan Society for the Promotion of Science, https://www.jsps.go.jp) Fellowship (17J10603 to JT); a Grant-in-Aids for Young Scientist (A) (25712022 to HM), Japan (https://www.jsps.go.jp); and JST CREST Grant Number JPMJCR13A5, Japan (http://www.jst.go.jp/kisoken/crest/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KS, 2011, MAR BIOL, V158, P2377, DOI 10.1007/s00227-011-1724-5; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arai N, 2016, J ADV MAR SCI TECHNO, V22, P5; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Berge J, 2012, FISH RES, V125, P1, DOI 10.1016/j.fishres.2012.02.008; Carlson H.R., 1995, Alaska Fishery Research Bulletin, V2, P76; Cooke SJ, 2005, MAR TECHNOL SOC J, V39, P31, DOI 10.4031/002533205787521659; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cote D, 1998, MAR TECHNOL SOC J, V32, P54; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Gjelland KO, 2013, METHODS ECOL EVOL, V4, P665, DOI 10.1111/2041-210X.12057; GOLD R, 1967, IEEE T INFORM THEORY, V13, P619, DOI 10.1109/TIT.1967.1054048; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Kessel ST, 2014, REV FISH BIOL FISHER, V24, P199, DOI 10.1007/s11160-013-9328-4; Kitahashi T, 2000, ZOOL SCI, V17, P1247, DOI 10.2108/zsj.17.1247; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; Langley R. B., 1999, GPS WORLD, P52; Lokkeborg S, 2002, HYDROBIOLOGIA, V483, P259, DOI 10.1023/A:1021312503220; Mabuchi K, 1997, ICHTHYOL RES, V44, P321, DOI 10.1007/BF02671984; Matsumoto K, 1997, ICHTHYOL RES, V44, P379, DOI 10.1007/BF02671989; Meckley TD, 2017, CAN J FISH AQUAT SCI, V74, P2045, DOI 10.1139/cjfas-2016-0412; Mitamura H, 2012, J EXP BIOL, V215, P2751, DOI 10.1242/jeb.065052; Mitamura H, 2009, FISHERIES SCI, V75, P1133, DOI 10.1007/s12562-009-0142-9; Miyamoto Y, 2011, J MAR ACOUST SOC JPN, V38, P110; Miyamoto Y., 2010, P ICA, P1; NISHI G, 1989, JPN J ICHTHYOL, V36, P350, DOI 10.1007/BF02905620; NISHI G, 1990, JPN J ICHTHYOL, V37, P170, DOI 10.1007/BF02905386; OBRIEN WJ, 1990, AM SCI, V78, P152; Pincock DG., 2008, UNDERSTANDING PERFOR; Roy R., 2014, ANIM BIOTELEM, V2, P1, DOI DOI 10.1186/2050-3385-2-1; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Ueda H, 1998, CHEM SENSES, V23, P207, DOI 10.1093/chemse/23.2.207; Voegeli FA, 1998, HYDROBIOLOGIA, V372, P35, DOI 10.1023/A:1017014903313; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Williams-Grove LJ, 2016, MAR ECOL PROG SER, V553, P233, DOI 10.3354/meps11778; Wolfe BW, 2015, MAR ENVIRON RES, V109, P69, DOI 10.1016/j.marenvres.2015.06.002; Zar JH., 2010, BIOSTAT ANAL, V5th	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201029	10.1371/journal.pone.0201029	http://dx.doi.org/10.1371/journal.pone.0201029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024958	Green Published, gold			2022-12-26	WOS:000439120000081
J	Sabella, E; Pierro, R; Luvisi, A; Panattoni, A; D'Onofrio, C; Scalabrelli, G; Nutricati, E; Aprile, A; De Bellis, L; Materazzi, A				Sabella, Erika; Pierro, Roberto; Luvisi, Andrea; Panattoni, Alessandra; D'Onofrio, Claudio; Scalabrelli, Giancarlo; Nutricati, Eliana; Aprile, Alessio; De Bellis, Luigi; Materazzi, Alberto			Phylogenetic analysis of viruses in Tuscan Vitis vinifera sylvestris (Gmeli) Hegi	PLOS ONE			English	Article							PITTING-ASSOCIATED-VIRUS; PCR TAQMAN(R) ASSAYS; RT-PCR; GENETIC DIVERSITY; CAPSID PROTEIN; GRAPEVINE; CALIFORNIA; TRANSCRIPTION; VARIABILITY; POPULATIONS	The health status of the native grapevine Vitis vinifera subsp. sylvestris (Gmeli) Hegi in natural areas in Europe has received little attention. A survey was carried out on wild grapevines in Tuscany (Italy), where isolates of the Grapevine rupestris stem pitting virus (GRSPaV), Grapevine leafroll-associated virus 1 and 3 (GLRaV-1 and GLRaV-3) and Grapevine virus A (GVA) were detected. The complete coat protein (CP) region of these isolates was sequenced to investigate the relationship of the viral variants from Tuscan wild grapevines with isolates from different geographical origins. According to the phylogenetic analyses, GLRaV-1 and GLRaV-3 isolates from Tuscan wild grapevines clustered with isolates from cultivated grapevines with nucleotide sequence identities ranging from 66% to 87% and from 72.5% to 99% respectively, without any correlation between the distribution and geographical origin. Conversely, GRSPaV and GVA isolates clustered together with other Italian isolates from V. vinifera with nucleotide sequence identities ranging from 71.14% to 96.12% and from 73.5% to 92%, respectively. Our analysis of the whole amino acid sequences revealed a high conservation level for the studied proteins explained by a selective pressure on this genomic region, probably due to functional constraints imposed on CP, such as specific interactions with cellular receptors in the insect vectors necessary for successful transmission. In addition, analyses of genetic recombination suggest no significant point mutations that might play a significant role in genetic diversification. The dN/dS ratio also estimated a low number of non-silent mutations, highlighting the purifying selective pressure. The widespread distribution of the Rugose wood complex (GRSPaV and GVA associated disease) in comparison with the Grapevine Leafroll associated viruses (GLRaV-1 and -3) could explain the major geographical correlation found for the viral variants detected in Tuscany.	[Sabella, Erika; Luvisi, Andrea; Nutricati, Eliana; Aprile, Alessio; De Bellis, Luigi] Univ Salento, Dept Biol & Environm Sci & Technol, Via Prov Le Monteroni, Lecce, Italy; [Pierro, Roberto; Luvisi, Andrea; Panattoni, Alessandra; D'Onofrio, Claudio; Scalabrelli, Giancarlo; Materazzi, Alberto] Univ Pisa, Dept Agr Food & Environm, Via Borghetto, Pisa, Italy	University of Salento; University of Pisa	Luvisi, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Via Prov Le Monteroni, Lecce, Italy.; Luvisi, A (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto, Pisa, Italy.	andrea.luvisi@unisalento.it	Pierro, Roberto/AFN-4127-2022; De Bellis, Luigi/I-2950-2019; Luvisi, Andrea/H-3790-2019; Aprile, Alessio/M-1343-2015	Pierro, Roberto/0000-0001-8305-9355; De Bellis, Luigi/0000-0002-6047-3526; Luvisi, Andrea/0000-0002-2207-7493; Sabella, Erika/0000-0003-4200-3894; Aprile, Alessio/0000-0002-3124-9146; D'ONOFRIO, CLAUDIO/0000-0003-2859-0201				Alabi OJ, 2014, PHYTOPATHOLOGY, V104, P548, DOI 10.1094/PHYTO-06-13-0179-R; Alabi OJ, 2011, PHYTOPATHOLOGY, V101, P1446, DOI 10.1094/PHYTO-04-11-0114; Alabi OJ, 2010, J GEN VIROL, V91, P265, DOI 10.1099/vir.0.014423-0; Bouyahia H, 2005, VITIS, V44, P133; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Cunha J, 2007, GENET RESOUR CROP EV, V54, P981, DOI 10.1007/s10722-006-9189-y; Dell'Orco M, 2002, ARCH VIROL, V147, P627, DOI 10.1007/s007050200012; Esteves F, 2013, J VIROL METHODS, V194, P258, DOI 10.1016/j.jviromet.2013.09.004; Faggioli F., 2013, Advances in Horticultural Science, V27, P107; Fajardo Thor V. M., 2007, Fitopatologia Brasileira, V32, P335, DOI 10.1590/S0100-41582007000400008; Gambino G, 2012, J EXP BOT, V63, P5919, DOI 10.1093/jxb/ers244; Garfi G, 2013, FLORA, V208, P538, DOI 10.1016/j.flora.2013.08.005; Goheen AC, 1988, COMPENDIUM GRAPE DIS, P53; Komar V, 2010, AM J ENOL VITICULT, V61, P68; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lima MF, 2006, ARCH VIROL, V151, P1889, DOI 10.1007/s00705-006-0742-y; Luvisi A, 2012, ACTA VIROL, V56, P159, DOI 10.4149/av_2012_02_159; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Mahfoudhi N, 2014, J PLANT PATHOL, V96, P431; Maree HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126819; Maree HJ, 2013, GRAPEVINE LEAFROLL A, P4, DOI [10.3389/fmicb.2013.00082, DOI 10.3389/FMICB.2013.00082]; Martelli GP, 2014, J PLANT PATHOL, V96, P1; Martelli GP, 1998, ARCH VIROL, V143, P1245, DOI 10.1007/s007050050372; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Meng B., 2007, PLANT VIRUSES, V1, P52; Meng B., 2017, GRAPEVINE VIRUSES MO, P257, DOI DOI 10.1007/978-3-319-57706-7; Meng B, 2009, 16 M ICVG DIJ FRANC, P331; Meng BZ, 2010, VIRUS RES, V153, P212, DOI 10.1016/j.virusres.2010.08.003; Meng BZ, 2006, J GEN VIROL, V87, P1725, DOI 10.1099/vir.0.81533-0; Minafra A, 2017, GRAPEVINE VIRUSES MO, P229; Nei M, 2000, MOL EVOLUTION PHYLOG; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nolasco G, 2006, ARCH VIROL, V151, P83, DOI 10.1007/s00705-005-0611-0; Nolasco G, 2000, EUR J PLANT PATHOL, V106, P311, DOI 10.1023/A:1008748924494; Osman F, 2008, J VIROL METHODS, V154, P69, DOI 10.1016/j.jviromet.2008.09.005; Osman F, 2008, J VIROL METHODS, V149, P292, DOI 10.1016/j.jviromet.2008.01.012; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Pacifico D, 2016, EUR J PLANT PATHOL, V145, P189, DOI 10.1007/s10658-015-0785-6; Regner F, 2004, VITIS, V43, P123; Rizzo D, 2015, J PLANT PATHOL, V97, P333; Rizzo D., 2012, Advances in Horticultural Science, V26, P148; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Sabanadzovic S., 2009, 16 M ICVG DIJ FRANC, P32; Santos M. T., 2003, 14 M INT COUNC STUD, P197; Sevin AF, 2012, 17 E M INT COUNC STU, P98; Sforza R, 2003, EUR J PLANT PATHOL, V109, P975, DOI 10.1023/B:EJPP.0000003750.34458.71; Terlizzi F, 2010, PLANT PATHOL, V59, P48, DOI 10.1111/j.1365-3059.2009.02156.x; Wei T, 2012, AUSTRALAS PLANT PATH, V41, P93, DOI 10.1007/s13313-011-0095-1	49	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200875	10.1371/journal.pone.0200875	http://dx.doi.org/10.1371/journal.pone.0200875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021001	Green Published, gold			2022-12-26	WOS:000439022400085
J	Li, LQ; Kolodziej, T; Jafari, N; Chen, J; Zhu, HN; Rajfur, Z; Huang, C				Li, Liqing; Kolodziej, Tomasz; Jafari, Naser; Chen, Jing; Zhu, Haining; Rajfur, Zenon; Huang, Cai			Cdk5-mediated phosphorylation regulates phosphatidylinositol 4-phosphate 5-kinase type I 90 activity and cell invasion	FASEB JOURNAL			English	Article						phosphatidylinositol kinase; cell migration; fibronectin; secretion; extracellular matrix protein	CYCLIN-DEPENDENT KINASE-5; FOCAL ADHESION DYNAMICS; EXOSOME SECRETION; PHOSPHATE KINASE; PLASMA-MEMBRANE; N-WASP; FIBRONECTIN; MIGRATION; CANCER; PROTEIN	Phosphatidylinositol 4-phosphate 5-kinase type I (PIPKI90) regulates cell migration, invasion, and metastasis. However, it is unknown how cellular signals regulate those processes. Here, we show that cyclin-dependent kinase 5 (Cdk5), a protein kinase that regulates cell migration and invasion, phosphorylates PIPKI90 at S453, and that Cdk5-mediated PIPKI90 phosphorylation is essential for cell invasion. Moreover, Cdk5-mediated phosphorylation down-regulates the activity of PIPKI90 and the secretion of fibronectin, an extracellular matrix protein that regulates cell migration and invasion. Furthermore, inhibition of PIPKI activity with the chemical inhibitor UNC3230 suppresses fibronectin secretion in a dose-dependent manner, whereas depletion of Cdk5 enhances fibronectin secretion. With total internal reflection fluorescence microscopy, we found that secreted fibronectin appears as round dots, which colocalize with Tks5 and CD9 but not with Zyxin. These data suggest that Cdk5-mediated PIPKI90 phosphorylation regulates cell invasion by controlling PIPKI90 activity and fibronectin secretion.Li, L., Koodziej, T., Jafari, N., Chen, J., Zhu, H., Rajfur, Z., Huang, C. Cdk5-mediated phosphorylation regulates phosphatidylinositol 4-phosphate 5-kinase type I 90 activity and cell invasion.	[Li, Liqing; Kolodziej, Tomasz; Jafari, Naser; Huang, Cai] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Chen, Jing; Zhu, Haining] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Kolodziej, Tomasz; Rajfur, Zenon] Jagiellonian Univ, Inst Phys, Fac Phys Astron & Appl Comp Sci, Krakow, Poland	University of Kentucky; University of Kentucky; University of Kentucky; Jagiellonian University	Rajfur, Z (corresponding author), Jagiellonian Univ, Inst Phys, Fac Phys Astron & Appl Comp Sci, Krakow, Poland.; Huang, C (corresponding author), Univ Kentucky, Markey Canc Ctr, Dept Pharmacol & Nutr Sci, BBSRB Room B359,741 South Limestone St, Lexington, KY 40506 USA.	zenon.rajfur@uj.edu.pl; cai-huang@uky.edu	LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Zhu, Haining/A-6076-2008; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020	Zhu, Haining/0000-0001-5498-6694; 	American Cancer Society [RSG-13-184-01CSM]; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01 GM122994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122994] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Research Scholar Grant RSG-13-184-01CSM (to C.H.) and U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM122994 (to C.H.). The authors declare no conflicts of interest.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Bhandari D, 2015, P NATL ACAD SCI USA, V112, pE4874, DOI 10.1073/pnas.1514157112; Bisht S, 2015, TRANSL ONCOL, V8, P295, DOI 10.1016/j.tranon.2015.06.002; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Durand N, 2016, SCI REP-UK, V6, DOI 10.1038/srep35963; Eggers JP, 2011, CLIN CANCER RES, V17, P6140, DOI 10.1158/1078-0432.CCR-10-2288; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; HONEYMAN TW, 1983, BIOCHEM J, V212, P489, DOI 10.1042/bj2120489; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jafari N, 2016, J BIOL CHEM, V291, P25729, DOI 10.1074/jbc.M116.742742; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jeon M, 2015, EXP CELL RES, V333, P116, DOI 10.1016/j.yexcr.2015.02.019; Ji C, 2017, CELL REP, V20, P1409, DOI 10.1016/j.celrep.2017.07.041; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Knowles LM, 2013, CANCER RES, V73, P6175, DOI 10.1158/0008-5472.CAN-13-0602; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Li H, 2017, ONCOGENE, V36, P5668, DOI 10.1038/onc.2017.166; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Liang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02932; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Ohshima T, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00458; Quintavalle M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002032; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sinha S, 2016, J CELL BIOL, V214, P197, DOI 10.1083/jcb.201601025; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Sung Bong Hwan, 2011, Bioarchitecture, V1, P257; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Thapa N, 2012, CELL ADHES MIGR, V6, P409, DOI 10.4161/cam.21192; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Wu CY, 2014, BRIT J PHARMACOL, V171, P5541, DOI 10.1111/bph.12777; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	63	5	5	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					631	642		10.1096/fj.201800296R	http://dx.doi.org/10.1096/fj.201800296R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30040488	Green Published			2022-12-26	WOS:000457401500049
J	Wang, Y; Jiang, JB; Gao, YC; Sun, Y; Dai, JF; Wu, Y; Qu, D; Ma, G; Fang, XY				Wang, Yan; Jiang, Jingbo; Gao, Yachao; Sun, Yang; Dai, Jianfeng; Wu, Yang; Qu, Di; Ma, Gang; Fang, Xianyang			Staphylococcus epidermidis small basic protein (Sbp) forms amyloid fibrils, consistent with its function as a scaffolding protein in biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; small-angle X-ray scattering (SAXS); electron microscopy (EM); atomic force microscopy (AFM); confocal microscopy; accumulated associated protein; biofilm formation; extracellular matrix protein; small basic protein; Staphylococcus epidermidis	INTRINSICALLY DISORDERED PROTEINS; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; INTERCELLULAR-ADHESION; STRUCTURAL BASIS; RESOLUTION; MECHANISMS; INFECTION; SYSTEM	Biofilms are communities of microbes embedded in a microbial extracellular matrix. Their formation is considered the main virulence mechanism enabling the opportunistic bacterial pathogen Staphylococcus epidermidis to cause devastating nosocomial, implant-associated infections. Biofilms often contain proteins, and an 18-kDa protein called small basic protein (Sbp) recently was discovered in the S. epidermidis biofilm matrix and may serve as a scaffolding protein in both polysaccharide intercellular adhesin (PIA)-dependent and accumulation-associated protein (Aap)-dependent biofilm formations. In Aap-mediated biofilm formation, Sbp colocalizes with Domain-B of Aap, implying that Sbp directly interacts with Aap's Domain-B. However, the structure of Sbp and its interaction with Aap, as well as the molecular mechanism underlying Sbp's roles in biofilm formation, are incompletely understood. In this work, we used small-angle X-ray scattering (SAXS), NMR, analytical size-exclusion chromatography, and isothermal titration calorimetry analyses to determine the Sbp structure and characterize its interaction with Aap's Domain-B. We found that Sbp is monomeric and partially folded in solution, and, unexpectedly, we observed no direct interactions between Sbp and Aap Domain-B. Instead, we noted that Sbp forms amyloid fibrils both in vitro and in vivo. Atomic force, transmission electron, and confocal fluorescence microscopy methods confirmed the formation of Sbp amyloid fibrils and revealed their morphology. Taken together, the Sbp amyloid fibril structures identified here may account for Sbp's role as a scaffolding protein in the S. epidermidis biofilm matrix.	[Wang, Yan; Jiang, Jingbo; Gao, Yachao; Sun, Yang; Fang, Xianyang] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Dai, Jianfeng] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Dai, Jianfeng] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Minist Publ Hlth, Dept Med Microbiol & Parasitol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China; [Ma, Gang] Hebei Univ, Coll Chem & Environm Sci, Key Lab Analyt Sci & Technol Hebei Prov, Minist Educ,Key Lab Med Chem & Mol Diag, Baoding 071002, Peoples R China	Tsinghua University; Soochow University - China; Soochow University - China; Fudan University; Fudan University; Hebei University	Fang, XY (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.	fangxy@tsinghua.edu.cn	Qu, Di/AAO-4590-2020; Dai, Jianfeng/ACP-1114-2022	Wang, Yan/0000-0002-0452-6750; Fang, Xianyang/0000-0001-9432-9736; dai, jianfeng/0000-0002-1871-8390	National Key Research and Development Program of China [2016YFA0500700]; China Youth 1000-Talent Program of the State Council of China; Beijing Advanced Innovation Center for Structural Biology; Tsinghua-Peking Joint Center for Life Sciences	National Key Research and Development Program of China; China Youth 1000-Talent Program of the State Council of China; Beijing Advanced Innovation Center for Structural Biology; Tsinghua-Peking Joint Center for Life Sciences	This work was supported by National Key Research and Development Program of China Grant 2016YFA0500700, the China Youth 1000-Talent Program of the State Council of China, the Beijing Advanced Innovation Center for Structural Biology, and the Tsinghua-Peking Joint Center for Life Sciences (to X. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilera P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00035; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Barbu EM, 2014, MOL MICROBIOL, V94, P172, DOI 10.1111/mmi.12750; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Buttner H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00014; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Cremades N, 2018, NEUROBIOL DIS, V109, P178, DOI 10.1016/j.nbd.2017.07.009; Decker R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004735; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Dragos A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030060; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Dutta A, 2016, BIOPHYS CHEM, V217, P32, DOI 10.1016/j.bpc.2016.07.006; Espargaro A, 2015, VIRUS RES, V207, P127, DOI 10.1016/j.virusres.2015.03.001; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fong JNC, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0004-2014; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Geoghegan JA, 2010, J BACTERIOL, V192, P5663, DOI 10.1128/JB.00628-10; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee G, 2015, SCI REP-UK, V5, DOI 10.1038/srep16220; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Missineo A, 2014, INFECT IMMUN, V82, P2448, DOI 10.1128/IAI.01542-14; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paharik AE, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P529, DOI 10.1128/microbiolspec.VMBF-0022-2015; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Romero D, 2014, INT MICROBIOL, V17, P65, DOI 10.2436/20.1501.01.208; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schaeffer CR, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00165-16; Schaeffer CR, 2015, INFECT IMMUN, V83, P214, DOI 10.1128/IAI.02177-14; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Sciacca MFM, 2012, BIOCHEMISTRY-US, V51, P7676, DOI 10.1021/bi3009888; Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taglialegna A, 2016, J BACTERIOL, V198, P2579, DOI 10.1128/JB.00122-16; Taglialegna A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005711; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36; Van Mellaert L, 2012, EXPERT REV VACCINES, V11, P319, DOI [10.1586/ERV.11.190, 10.1586/erv.11.190]; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	57	12	14	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14296	14311		10.1074/jbc.RA118.002448	http://dx.doi.org/10.1074/jbc.RA118.002448			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049797	Green Published, hybrid			2022-12-26	WOS:000444671500012
J	Lee, MF; Chiang, CH; Li, YL; Wang, NM; Song, PP; Lin, SJ; Chen, YH				Lee, Mey-Fann; Chiang, Chu-Hui; Li, Ying-Lan; Wang, Nancy M.; Song, Pei-Pong; Lin, Shyh-Jye; Chen, Yi-Hsing			Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model	PLOS ONE			English	Article							MOSAIC-VIRUS; IMMUNOTHERAPY; PROTEINS; MITE; HYPERSENSITIVITY; IDENTIFICATION; ETANERCEPT; CHALLENGE; EFFICACY	Background American cockroaches (Periplaneta americana) are an important indoor allergen source and a major risk factor for exacerbations and poor control of asthma. We previously reported that allergen components from American cockroaches exhibit varying levels of pathogenicity. Sensitization to major American cockroach allergen, Per a 2, correlated with more severe clinical phenotypes among patients with allergic airway diseases. Materials and methods In this study, we examined whether oral plant vaccine-encoding full-length Per a 2 clone-996 or its hypoallergenic clone-372 could exert a prophylactic role in Per a 2-sensitized mice. The cDNAs coding Per a 2-996 and Per a 2-372 were inserted into TuMV vector and expressed in Chinese cabbage. Adult female BALB/c mice were fed with the cabbage extracts for 21 days and subsequently underwent two-step sensitization with recombinant Per a 2. Results Per a 2-specific IgE measured by in-house ELISA in the sera of Per a 2-372-treated groups were significantly lower than in the control groups after allergen challenge but not the Per a 2-996-treated group. Moreover, Per a 2-372 vaccine markedly decreased airway hyper-responsiveness and infiltration of inflammatory cells into the lungs, as well as reduced mRNA expression of IL-4 and IL-13 in comparison with the control mice. Conclusion Our data suggest that oral administration of edible plant vaccine encoding Per a 2 hypoallergen may be used as a prophylactic strategy against the development of cockroach allergy.	[Lee, Mey-Fann; Song, Pei-Pong] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chiang, Chu-Hui] Natl Pingtung Univ Sci & Technol, Dept Plant Med, Pingtung, Taiwan; [Li, Ying-Lan; Wang, Nancy M.] Natl Changhua Univ Educ, Inst Biotechnol, Changhua, Taiwan; [Lin, Shyh-Jye] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Chen, Yi-Hsing] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan	Taichung Veterans General Hospital; National Pingtung University Science & Technology; National Changhua University of Education; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, YH (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.	ysanne@vghtc.gov.tw		Chen, Yi-Hsing/0000-0002-8135-9554; Wang, Nancy/0000-0002-8836-812X	Taichung Veterans General Hospital [TCVGH-1047314C, TCVGH-DYU1048304]	Taichung Veterans General Hospital	This study was supported by grants from Taichung Veterans General Hospital (TCVGH-1047314C and TCVGH-DYU1048304).	Beauchemin C, 2005, VIRUS RES, V112, P1, DOI 10.1016/j.virusres.2005.03.001; Bennett AN, 2005, RHEUMATOLOGY, V44, P1199, DOI 10.1093/rheumatology/keh676; Brenner BL, 2003, ENVIRON HEALTH PERSP, V111, P1649, DOI 10.1289/ehp.6069; Chen CC, 2007, VIRUS RES, V130, P210, DOI 10.1016/j.virusres.2007.06.014; Custovic A, 2002, ANN ALLERG ASTHMA IM, V88, P432, DOI 10.1016/S1081-1206(10)62378-2; Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029; Dubus JC, 2001, ALLERGY, V56, P351, DOI 10.1034/j.1398-9995.2001.00109.x; Fang Y, 2015, ALLERGY, V70, P1674, DOI 10.1111/all.12766; Focke M, 2010, CLIN EXP ALLERGY, V40, P385, DOI 10.1111/j.1365-2222.2009.03443.x; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; Hefferon KL, 2010, PHARM RES-DORDR, V27, P2040, DOI 10.1007/s11095-010-0168-9; Holgate ST, 2011, EUR RESPIR J, V37, P1352, DOI 10.1183/09031936.00063510; Hsu CH, 2004, J ALLERGY CLIN IMMUN, V113, P1079, DOI 10.1016/j.jaci.2004.02.047; Kohl T, 2006, CLIN VACCINE IMMUNOL, V13, P845, DOI 10.1128/CVI.00072-06; Kong QX, 2001, P NATL ACAD SCI USA, V98, P11539, DOI 10.1073/pnas.191617598; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; LAN JL, 1988, J ALLERGY CLIN IMMUN, V82, P736, DOI 10.1016/0091-6749(88)90072-3; Lee MF, 2016, ANN ALLERG ASTHMA IM, V117, P535, DOI 10.1016/j.anai.2016.09.432; Lee MF, 2015, ALLERGY ASTHMA IMMUN, V7, P376, DOI 10.4168/aair.2015.7.4.376; Lee MF, 2012, ANN ALLERG ASTHMA IM, V108, P243, DOI 10.1016/j.anai.2012.01.014; Lim JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182295; Margineanu Ioana, 2015, Pneumologia, V64, P28; Mascarell L, 2015, ALLERGY, V70, P408, DOI 10.1111/all.12576; Meteran H, 2017, J ASTHMA, V54, P991, DOI 10.1080/02770903.2017.1296157; Mett V, 2008, BIOLOGICALS, V36, P354, DOI 10.1016/j.biologicals.2008.09.001; Novak N, 2011, ALLERGY, V66, P733, DOI 10.1111/j.1398-9995.2010.02535.x; Pogrebnyak N, 2005, P NATL ACAD SCI USA, V102, P9062, DOI 10.1073/pnas.0503760102; Poynter ME, 2016, EUR RESPIR J, V48, P979, DOI 10.1183/13993003.01597-2016; Pumhirun P, 1997, ASIAN PAC J ALLERGY, V15, P183; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Santos ABR, 1999, J ALLERGY CLIN IMMUN, V104, P329, DOI 10.1016/S0091-6749(99)70375-1; Smart V, 2003, J IMMUNOL, V171, P2116, DOI 10.4049/jimmunol.171.4.2116; Sookrung N, 2010, ASIAN PAC J ALLERGY, V28, P95; Sudha VT, 2007, BIOLOGICALS, V35, P131, DOI 10.1016/j.biologicals.2006.07.004; Tacket CO, 2009, CURR TOP MICROBIOL, V332, P103, DOI 10.1007/978-3-540-70868-1_6; Tacket Carol O, 2007, Trans Am Clin Climatol Assoc, V118, P79; Takagi H, 2005, P NATL ACAD SCI USA, V102, P17525, DOI 10.1073/pnas.0503428102; Torres T, 2012, EUR J DERMATOL, V22, P696, DOI 10.1684/ejd.2012.1816; Tsai TC, 2010, PEDIATR NEONATOL, V51, P14, DOI 10.1016/S1875-9572(10)60004-6; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wilson NW, 1999, ANN ALLERG ASTHMA IM, V83, P27, DOI 10.1016/S1081-1206(10)63509-0; WU CH, 1988, J ALLERGY CLIN IMMUN, V82, P727, DOI 10.1016/0091-6749(88)90071-1; Yusibov V, 2008, EXPERT REV VACCINES, V7, P1173, DOI 10.1586/14760584.7.8.1173	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0201281	10.1371/journal.pone.0201281	http://dx.doi.org/10.1371/journal.pone.0201281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059516	Green Published, gold, Green Submitted			2022-12-26	WOS:000440251600031
J	Shipton, C; Blinkhorn, J; Breeze, PS; Cuthbertson, P; Drake, N; Groucutt, HS; Jennings, RP; Parton, A; Scerri, EML; Alsharekh, A; Petraglia, MD				Shipton, Ceri; Blinkhorn, James; Breeze, Paul S.; Cuthbertson, Patrick; Drake, Nick; Groucutt, Huw S.; Jennings, Richard P.; Parton, Ash; Scerri, Eleanor M. L.; Alsharekh, Abdullah; Petraglia, Michael D.			Acheulean technology and landscape use at Dawadmi, central Arabia	PLOS ONE			English	Article							STONE TOOL PRODUCTION; VARIABILITY SELECTION; PENINSULA; PLEISTOCENE; DISPERSALS; EUROPE; BIFACE; PERSPECTIVE; ADAPTATIONS; TRANSITION	Despite occupying a central geographic position, investigations of hominin populations in the Arabian Peninsula during the Lower Palaeolithic period are rare. The colonization of Eurasia below 55 degrees latitude indicates the success of the genus Homo in the Early and Middle Pleistocene, but the extent to which these hominins were capable of innovative and novel behavioural adaptations to engage with mid-latitude environments is unclear. Here we describe new field investigations at the Saffaqah locality (206-76) near Dawadmi, in central Arabia that aim to establish how hominins adapted to this region. The site is located in the interior of Arabia over 500 km from both the Red Sea and the Gulf, and at the headwaters of two major extinct river systems that were likely used by Acheulean hominins to cross the Peninsula. Saffaqah is one of the largest Acheulean sites in Arabia with nearly a million artefacts estimated to occur on the surface, and it is also the first to yield stratified deposits containing abundant artefacts. It is situated in the unusual setting of a dense and well-preserved landscape of Acheulean localities, with sites and isolated artefacts occurring regularly for tens of kilometres in every direction. We describe both previous and recent excavations at Saffaqah and its large lithic assemblage. We analyse thousands of artefacts from excavated and surface contexts, including giant andesite cores and flakes, smaller cores and retouched artefacts, as well as handaxes and cleavers. Technological assessment of stratified lithics and those from systematic survey, enable the reconstruction of stone tool life histories. The Acheulean hominins at Dawadmi were strong and skilful, with their adaptation evidently successful for some time. However, these biface-makers were also technologically conservative, and used least-effort strategies of resource procurement and tool transport. Ultimately, central Arabia was depopulated, likely in the face of environmental deterioration in the form of increasing aridity.	[Shipton, Ceri] Australian Natl Univ, Ctr Excellence Australian Biodivers & Heritage, Canberra, ACT, Australia; [Shipton, Ceri] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Blinkhorn, James] Royal Holloway Univ London, Dept Geog, London, England; [Blinkhorn, James; Groucutt, Huw S.; Scerri, Eleanor M. L.; Petraglia, Michael D.] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Breeze, Paul S.; Drake, Nick] Kings Coll London, Dept Geog, London, England; [Cuthbertson, Patrick; Groucutt, Huw S.; Scerri, Eleanor M. L.] Univ Oxford, Sch Archaeol, Oxford, England; [Jennings, Richard P.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Parton, Ash] Oxford Brookes Univ, Dept Social Sci, Oxford, England; [Parton, Ash] Univ Oxford, Mansfield Coll, Oxford, England; [Alsharekh, Abdullah] King Saud Univ, Dept Archaeol, Riyadh, Saudi Arabia	Australian National University; University of Cambridge; University of London; Royal Holloway University London; University of London; King's College London; University of Oxford; Liverpool John Moores University; Oxford Brookes University; University of Oxford; King Saud University	Shipton, C (corresponding author), Australian Natl Univ, Ctr Excellence Australian Biodivers & Heritage, Canberra, ACT, Australia.; Shipton, C (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England.	ceri.shipton@anu.edu.au	Alsharekh, Abdullah M/AAH-3718-2019; CABAH, ARC/T-6419-2019; Groucutt, Huw/GNM-5500-2022; Petraglia, Michael/ABA-9748-2021; Scerri, Eleanor/AHC-6769-2022	Scerri, Eleanor/0000-0002-7468-9977; Petraglia, Michael/0000-0003-2522-5727; Blinkhorn, James/0000-0002-9399-5515	Saudi Commission for Tourism and National Heritage; H2020 European Research Council Advanced Grant [295719]; Max Planck Society; SCTH	Saudi Commission for Tourism and National Heritage; H2020 European Research Council Advanced Grant; Max Planck Society(Max Planck Society); SCTH	This study was funded by the Saudi Commission for Tourism and National Heritage: https://scth.gov.sa/en/Pages/default.aspx; by a H2020 European Research Council Advanced Grant (295719) awarded to MDP: http://www.palaeodeserts.com/; and by the Max Planck Society: https://www.shh.mpg.de/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank HRH Prince Sultan bin Salman, President of the Saudi Commission for Tourism and National Heritage (SCTH) and Professor Ali I Al-Ghabban, Vice President, for permission to carry out this study. We are grateful for the support of the SCTH, in particular the staff who were with us in the field: Abdul-Aziz al-Omari, Sultan Al-Fageri, Khalid Al-Mura, and Abdul Rahman. We thank Laine Clark-Balzan, Oshan Wedage, Tom White, and Chris Stimpson for their assistance in the field. We thank Mary Ann Mullen for the consent to publish Fig 4 containing an image of her relative Norman Whalen. We thank Ian R. Cartwright (Institute of Archaeology, University of Oxford) for the lithic photographs shown in Figs 20 and 21. We thank Javier Baena and an anonymous reviewer for constructive feedback on a draft of this manuscript.	Preysler JB, 2018, QUATERNARY SCI REV, V190, P123, DOI 10.1016/j.quascirev.2018.04.015; del Cueto SB, 2016, QUATERN INT, V411, P329, DOI 10.1016/j.quaint.2016.01.041; Beshkani A, 2017, ARAB ARCHAEOL EPIGR, V28, P125, DOI 10.1111/aae.12101; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Breeze PS, 2015, QUATERN INT, V382, P98, DOI 10.1016/j.quaint.2015.01.022; Bridgland DR, 2015, J QUATERNARY SCI, V30, P623, DOI 10.1002/jqs.2805; Brooks AS, 2018, SCIENCE, V360, P90, DOI 10.1126/science.aao2646; Clarkson C, 2011, J ARCHAEOL SCI, V38, P1062, DOI 10.1016/j.jas.2010.12.001; Claud E, 2015, J ARCHAEOL SCI, V62, P105, DOI 10.1016/j.jas.2015.05.013; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; de la Torre I, 2018, GEOARCHAEOLOGY, V33, P218, DOI 10.1002/gea.21629; de la Torre I, 2014, J HUM EVOL, V76, P1, DOI 10.1016/j.jhevol.2014.06.008; DELFOUR J., 1982, SAUDI ARABIAN DEPUTY, V60, P36; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Foulds FWF, 2017, ANTIQUITY, V91, P1421, DOI 10.15184/aqy.2017.153; GALLART F, 1993, CATENA, V20, P529, DOI 10.1016/0341-8162(93)90015-H; Gallotti R, 2014, QUATERN INT, V343, P17, DOI 10.1016/j.quaint.2014.04.039; Gingerich JA, 2016, QUATERN INT, V466, P269; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 2006, AXE AGE ACHEULIAN TO, P111; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Groucutt HS, 2017, ARCHAEOL RES ASIA, V9, P44, DOI 10.1016/j.ara.2017.01.003; Groucutt HS, 2016, J FIELD ARCHAEOL, V41, P131, DOI 10.1080/00934690.2016.1156928; Groucutt HS, 2015, QUATERN INT, V382, P215, DOI 10.1016/j.quaint.2014.12.001; Groucutt HS, 2013, QUATERN INT, V300, P1, DOI 10.1016/j.quaint.2013.03.043; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Grove M, 2011, J HUM EVOL, V61, P306, DOI 10.1016/j.jhevol.2011.04.005; Hardaker T., 2011, NEW APPROACHES STUDY; Herzlinger G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188337; Hopkinson T, 2007, ANTIQUITY, V81, P294, DOI 10.1017/S0003598X00095181; Isaac G., 1972, CALIBRATION HOMINOID, P381; Isaac G.L., 1977, OLORGESAILIE ARCHEOL; Jennings RP, 2015, QUATERN INT, V382, P58, DOI 10.1016/j.quaint.2015.01.028; KELLY RL, 1988, AM ANTIQUITY, V53, P717, DOI 10.2307/281115; Key A, 2017, J ARCHAEOL SCI-REP, V12, P43, DOI 10.1016/j.jasrep.2017.01.023; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Movius H.L., 1948, T AM PHILOS SOC, V38, P329; Petraglia MD, 2005, GEOL SOC SPEC PUBL, V247, P305, DOI 10.1144/GSL.SP.2005.247.01.18; Petraglia MD, 2003, J WORLD PREHIST, V17, P141, DOI 10.1023/A:1025849206519; Petraglia MD, 2009, VERTEBR PALEOBIOL PA, P103, DOI 10.1007/978-90-481-2719-1_8; Pope M, 2005, HOMINID INDIVIDUAL C, P81; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Potts R, 2015, J HUM EVOL, V87, P5, DOI 10.1016/j.jhevol.2015.06.014; Proborukmi MS, 2018, PALAEOGEOGR PALAEOCL, V489, P166, DOI 10.1016/j.palaeo.2017.10.007; Rose Jeffrey I., 2018, 1 PEOPLES OMAN PALAE; Ruxton GD, 2011, J HUM EVOL, V61, P169, DOI 10.1016/j.jhevol.2011.02.012; Sampson CG., 2001, VERY REMOTE PERIOD I, P28; Scerri EML, 2015, QUATERN INT, V382, P200, DOI 10.1016/j.quaint.2014.09.036; Sharon G., 2010, PALEOANTHROPOLOGY, V2010, P79, DOI DOI 10.4207/PA.2010.ART35; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; Sharon G, 2010, QUATERN INT, V223, P226, DOI 10.1016/j.quaint.2009.11.023; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shipton C, 2016, CAMB ARCHAEOL J, V26, P599, DOI 10.1017/S095977431600041X; Shipton C, 2015, J ARCHAEOL SCI-REP, V2, P169, DOI 10.1016/j.jasrep.2015.01.013; Shipton C, 2013, J HUM EVOL, V65, P93, DOI 10.1016/j.jhevol.2013.03.007; Shipton C, 2018, AFRICAN ARCHAEOLOGIC; Shipton C., 2013, B MUJ; Shipton Ceri, 2014, Paleoanthropology, P446; Shipton C, 2011, AFR ARCHAEOL REV, V28, P141, DOI 10.1007/s10437-011-9089-1; Shipton C, 2010, VERTEBR PALEOBIOL PA, P49, DOI 10.1007/978-90-481-9094-2_5; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; WENBANSMITH FF, 1989, J ARCHAEOL SCI, V16, P17, DOI 10.1016/0305-4403(89)90053-8; Wendorf F., 1980, PREHISTORY E SAHARA; Whalen N., 1984, ATLAL, V8, P9; Whalen N.M., 1988, ATLAL, V11, P77; WHALEN NM, 1983, ATLAL, V7, P9; WHEELER PE, 1992, J HUM EVOL, V23, P379, DOI 10.1016/0047-2484(92)90086-O; Williams EM, 2014, J HUM EVOL, V72, P52, DOI 10.1016/j.jhevol.2014.03.004; ZARINS J, 1980, ATLAL, V4, P9	72	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200497	10.1371/journal.pone.0200497	http://dx.doi.org/10.1371/journal.pone.0200497			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052630	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000440006600008
J	Barretto, KT; Swanson, CM; Nguyen, CL; Annis, DS; Esnault, SJ; Mosher, DF; Johansson, MW				Barretto, Karina T.; Swanson, Calvin M.; Nguyen, Christopher L.; Annis, Douglas S.; Esnault, Stephane J.; Mosher, Deane F.; Johansson, Mats W.			Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IL-5 RECEPTOR-ALPHA; IL-5-STIMULATED EOSINOPHILS; AIRWAY EOSINOPHILS; NEWT EOSINOPHILS; GM-CSF; ASTHMA; ACTIVATION; EXPRESSION; ROLES	Periostin, which is induced by interleukin (IL)-13, is an extracellular matrix (ECM) protein that supports alpha(M)beta(2) integrin-mediated adhesion and migration of IL-5-stimulated eosinophils. Transforming growth factor (TGF)-beta-induced protein (TGFBI) is a widely expressed periostin paralog known to support monocyte adhesion. Our objective was to compare eosinophil adhesion and migration on TGFBI and periostin in the presence of IL-5-family cytokines. Eosinophil adhesion after 1 h and random motility over 20 h in the presence of various concentrations of IL-5, IL-3, or granulocyte macrophage-colony stimulating factor (GM-CSF) were quantified in wells coated with various concentrations of TGFBI or periostin. Results were compared to video microscopy of eosinophils. Cytokine-stimulated eosinophils adhered equivalently well to TGFBI or periostin in a coating concentration-dependent manner. Adhesion was blocked by anti-alpha(M)beta(2) and stimulated at the lowest concentration by GMCSF. In the motility assay, periostin was more potent than TGFBI, the coating-concentration effect was bimodal, and IL-3 was the most potent cytokine. Video microscopy revealed that under the optimal coating condition of 5 mu g/ml periostin, most eosinophils migrated persistently and were polarized and acorn-shaped with a ruffling forward edge and granules gathered together, in front of the nucleus. On 10 mu g/ml periostin or TGFBI, more eosinophils adopted a flattened pancake morphology with dispersed granules and nuclear lobes, and slower migration. Conversion between acorn and pancake morphologies were observed. We conclude that TGFBI or periostin supports two modes of migration by IL-5 family cytokine-activated eosinophils. The rapid mode is favored by intermediate protein coatings and the slower by higher coating concentrations. We speculate that eosinophils move by haptotaxis up a gradient of adhesive ECM protein and then slow down to surveil the tissue.	[Barretto, Karina T.; Swanson, Calvin M.; Nguyen, Christopher L.; Annis, Douglas S.; Mosher, Deane F.; Johansson, Mats W.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Esnault, Stephane J.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Johansson, MW (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	mwjohansson@wisc.edu	Esnault, Stephane/AAJ-4511-2020; Esnault, Stephane/AAO-4712-2020	Esnault, Stephane/0000-0001-7238-8671; Johansson, Mats/0000-0001-5699-978X	National Institutes of Health [P01 HL088594, R01 AI125390, UL1 RR025011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Program Project grant P01 HL088594 (NN Jarjour and DFM), research grant R01 AI125390 (DFM), and Clinical and Translational Science Award grant UL1 RR025011 (MK Drezner) from the National Institutes of Health (https://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfeld SK, 2016, AM J PATHOL, V186, P777, DOI 10.1016/j.ajpath.2015.11.024; Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Annis DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135374; Barthel SR, 2008, J LEUKOCYTE BIOL, V83, P1, DOI 10.1189/jlb.0607344; Barthel SR, 2006, AM J RESP CELL MOL, V35, P378, DOI 10.1165/rcmb.2006-0027OC; Billings PC, 2000, AM J RESP CELL MOL, V22, P352, DOI 10.1165/ajrcmb.22.3.3732; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Doran E, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00139; Esnault S, 2017, CLIN EXP ALLERGY, V47, P488, DOI 10.1111/cea.12876; Esnault S, 2018, J PROTEOME RES, V17, P2102, DOI 10.1021/acs.jproteome.8b00057; Esnault S, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00150; Esnault S, 2016, CRIT REV IMMUNOL, V36, P429, DOI 10.1615/CritRevImmunol.2017020172; Esnault S, 2015, J IMMUNOL, V195, P2529, DOI 10.4049/jimmunol.1500871; Esnault S, 2014, CLIN IMMUNOL, V150, P90, DOI 10.1016/j.clim.2013.11.009; GILBERT SH, 1994, J CELL BIOL, V127, P489, DOI 10.1083/jcb.127.2.489; Gregory B, 2003, J IMMUNOL, V170, P5359, DOI 10.4049/jimmunol.170.11.5359; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Han ST, 2014, AM J RESP CELL MOL, V50, P654, DOI 10.1165/rcmb.2013-0181OC; Hind LE, 2016, DEV CELL, V38, P161, DOI 10.1016/j.devcel.2016.06.031; Izuhara K, 2017, CELL MOL LIFE SCI, V74, P4293, DOI 10.1007/s00018-017-2648-0; Izuhara K, 2016, AM J RESP CRIT CARE, V193, P949, DOI 10.1164/rccm.201510-2032PP; Johansson MW, 2017, CLIN EXP ALLERGY, V47, P1263, DOI 10.1111/cea.12934; Johansson MW, 2014, CLIN EXP ALLERGY, V44, P482, DOI 10.1111/cea.12292; Johansson MW, 2008, J IMMUNOL, V180, P7622, DOI 10.4049/jimmunol.180.11.7622; Johansson MW, 2016, J ALLERGY CLIN IMMUN, V137, P1904, DOI 10.1016/j.jaci.2015.12.1346; Johansson Mats W, 2013, Front Pharmacol, V4, P33, DOI 10.3389/fphar.2013.00033; Johansson MW, 2013, AM J RESP CELL MOL, V48, P503, DOI 10.1165/rcmb.2012-0150OC; Kim HJ, 2008, INT J BIOCHEM CELL B, V40, P991, DOI 10.1016/j.biocel.2007.11.001; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; Liu AY, 2014, MATRIX BIOL, V37, P150, DOI 10.1016/j.matbio.2014.04.007; Liu LY, 2002, J IMMUNOL, V169, P6459, DOI 10.4049/jimmunol.169.11.6459; Lukassen MV, 2016, BIOCHEMISTRY-US, V55, P5610, DOI 10.1021/acs.biochem.6b00694; McBrien CN, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00093; Morra L, 2012, LUNG CANCER, V76, P183, DOI 10.1016/j.lungcan.2011.10.013; Mosher DF, 2015, CRIT REV BIOCHEM MOL, V50, P427, DOI 10.3109/10409238.2015.1069791; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Nakamura Y, 2015, ALLERGOL INT, V64, P209, DOI 10.1016/j.alit.2015.01.001; Nance T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092111; Nhu QM, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00128; Noguchi T, 2016, J ALLERGY CLIN IMMUN, V138, P1449, DOI 10.1016/j.jaci.2016.05.020; Schwanekamp JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181945; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Venge P, 2010, CLIN RESPIR J, V4, P15, DOI 10.1111/j.1752-699X.2010.00192.x; Viloria Katrina, 2016, BioMolecular Concepts, V7, P117, DOI 10.1515/bmc-2016-0004; Wang M, 2015, J ALLERGY CLIN IMMUN, V136, P1700, DOI 10.1016/j.jaci.2015.09.005; Wilkerson EM, 2016, J PROTEOME RES, V15, P1524, DOI 10.1021/acs.jproteome.6b00006; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yoshimura-Uchiyama C, 2003, BIOCHEM BIOPH RES CO, V309, P26, DOI 10.1016/S0006-291X(03)01526-2	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201320	10.1371/journal.pone.0201320	http://dx.doi.org/10.1371/journal.pone.0201320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048528	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400076
J	Calamnius, L; Lundin, M; Fjalling, A; Konigson, S				Calamnius, Linda; Lundin, Mikael; Fjalling, Arne; Konigson, Sara			Pontoon trap for salmon and trout equipped with a seal exclusion device catches larger salmons	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; BALTIC SEA; FISHERIES; MITIGATION; PREDATION; NET; MANAGEMENT; CONFLICT; QUALITY; BYCATCH	The growing seal populations of the Baltic have led to more frequent interactions with coastal fisheries. The motivation for seals to interact with fishing gear is high. It provides high densities of fish. A successful means of mitigating the conflict is the pontoon trap. Seal visits here have been frequent. Seals have access to most parts of the trap system including the middle chamber, which is an overhead environment. Concerns have been raised about seals possible entanglement in this specific part of the trap. As a means of keeping seals from entering the middle chamber, two different Seal Exclusion Devices (SEDs) were tested. A diamond mesh SED and a square mesh SED, which was rotated 45 degrees. The aim was to compare the functionality of the different SEDs with respect to seal deterrent abilities and catch composition. The hypothesis tested were (i) that seals would not be able to enter the middle chamber, (ii) that the catch would increase and (iii) that the SED would deter larger fish from swimming into the middle chamber. Catch data and underwater film were collected. Larger salmons were caught in traps equipped with SEDs. The SEDs did not affect the number of caught fish or the total catch per soak day.	[Calamnius, Linda] Univ Gavle, Fac Hlth & Occupat Studies, Dept Biol, Gavle, Sweden; [Calamnius, Linda; Fjalling, Arne] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Freshwater Res, Stangholmsvagen 2, Stockholm, Sweden; [Lundin, Mikael] Harmangers Machine & Marine, Stocka, Sweden; [Lundin, Mikael] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Skogsmarksgrand 9, Umea, Sweden; [Konigson, Sara] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Lysekil, Sweden	University of Gavle; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Calamnius, L (corresponding author), Univ Gavle, Fac Hlth & Occupat Studies, Dept Biol, Gavle, Sweden.; Calamnius, L (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Freshwater Res, Stangholmsvagen 2, Stockholm, Sweden.	linda.calamnius@hig.se			Operational Program for Fisheries in Sweden 2007 - 2013, Swedish Board of Agriculture; European Union, European Fisheries Fund Investing in sustainable fisheries [18-7965/11]; Harmangers Machine and Marine; The Wildlife Damage Centre, through the Swedish Agency for Marine and Water Management; County Administrative Board of Gavleborg [2342-15]; University of Gavle; Sven-Gunnar Lunneryd of Program Seals Fisheries	Operational Program for Fisheries in Sweden 2007 - 2013, Swedish Board of Agriculture; European Union, European Fisheries Fund Investing in sustainable fisheries; Harmangers Machine and Marine; The Wildlife Damage Centre, through the Swedish Agency for Marine and Water Management; County Administrative Board of Gavleborg; University of Gavle; Sven-Gunnar Lunneryd of Program Seals Fisheries	This research was supported in full by the Operational Program for Fisheries in Sweden 2007 - 2013, Swedish Board of Agriculture and was co-financed by the European Union, European Fisheries Fund Investing in sustainable fisheries, Dnr 18-7965/11, Harmangers Machine and Marine, The Wildlife Damage Centre, through the Swedish Agency for Marine and Water Management and the County Administrative Board of Gavleborg, Dnr 2342-15, LC, University of Gavle, and Sven-Gunnar Lunneryd of Program Seals & Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlin B-M, 2016, STOCKHOLM, P116; Bruckmeier K., 2013, HUMAN WILDLIFE CONFL, P15; Bruckmeier K, 2008, MAR POLICY, V32, P201, DOI 10.1016/j.marpol.2007.09.005; Butler JRA, 2011, MAR POLICY, V35, P317, DOI 10.1016/j.marpol.2010.10.011; Enivronmental Systems Research Institute (ESRI), 2017, ARCGIS DESKT; Fjalling A, 2005, ICES J MAR SCI, V62, P1630, DOI 10.1016/j.icesjms.2005.02.015; Fjalling Arne, 2007, NAMMCO Scientific Publications, V6, P215; Forrest KW, 2009, N AM J FISH MANAGE, V29, P885, DOI 10.1577/M08-083.1; Gearin PJ, 1988, 8830 NWAFC; Gotz T, 2010, J EXP BIOL, V213, P1536, DOI 10.1242/jeb.035535; Gordon J, 2002, POTENTIAL IMPACTS AC; Graham IM, 2011, ANIM CONSERV, V14, P604, DOI 10.1111/j.1469-1795.2011.00513.x; Hamer DJ, 2006, BIOL CONSERV, V130, P517, DOI 10.1016/j.biocon.2006.01.014; Harding KC, 1999, AMBIO, V28, P619; HELCOM, 2010, BALTIC SEA ENV P B, P116; Hemmingsson M, 2008, FISH RES, V93, P357, DOI 10.1016/j.fishres.2008.06.013; Hooper J, 2005, CCAMLR SCI, V12, P195; Hume F., 2002, Papers and Proceedings of the Royal Society of Tasmania, V136, P1; Jamieson GS, 2001, SALMON FARM PINNIPED; Jokikokko E, 2014, FISHERIES MANAG ECOL, V21, P250, DOI 10.1111/fme.12068; Jounela P, 2006, ICES J MAR SCI, V63, P936, DOI 10.1016/j.icesjms.2006.02.005; Konigson S., 2007, NAMMCO Scientific Publications, V6, P203; Konigson S, 2015, FISH RES, V167, P114, DOI 10.1016/j.fishres.2015.01.013; Konigson S, 2013, FISH RES, V148, P117, DOI 10.1016/j.fishres.2013.07.014; Lehtonen E, 2004, ICES J MAR SCI, V61, P1195, DOI 10.1016/j.icesjms.2004.06.012; Lehtonen E, 2010, FISH RES, V102, P214, DOI 10.1016/j.fishres.2009.10.007; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; LOWE TE, 1993, J FOOD SCI, V58, P770, DOI 10.1111/j.1365-2621.1993.tb09355.x; Lundin M, 2012, FISH RES, V127, P83, DOI 10.1016/j.fishres.2012.05.009; Lundin M, 2011, FISH RES, V108, P81, DOI 10.1016/j.fishres.2010.12.001; Lunneryd SG, 2003, ICES J MAR SCI, V60, P1194, DOI 10.1016/S1054-3139(03)00145-0; Lyle JM, 2016, CAN J FISH AQUAT SCI, V73, P436, DOI 10.1139/cjfas-2015-0273; Marine and Marine Industries Council, 2002, SEAL FISH INT MAN ST; Mate B.R., 1986, ACOUSTICAL DETERRENT, P23; Nelson ML, 2006, CAN J FISH AQUAT SCI, V63, P1710, DOI 10.1139/F06-067; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Prado J, 1990, FISHERMANS WORKBOOK, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Reeves R. R., 2002, NATL AUDUBON SOC GUI; Sepulveda M, 2005, AQUAC RES, V36, P1062, DOI 10.1111/j.1365-2109.2005.01320.x; Stansbury AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1595; Stewardson C, 2007, NATL ASSESSMENT HUMA; Stewardson C, 2003, SPEC SESSFEAG M RED; Suuronen P, 2006, FISH RES, V79, P129, DOI 10.1016/j.fishres.2006.02.014; Suuronen P, 2012, FISH RES, V119, P135, DOI 10.1016/j.fishres.2011.12.009; Swedish Agency for Marine and Water Management, 2014, SALP TILLV UTBR SAMT; Tilzey R., 2006, SEAL FISHERY INTERAC; Vanhatalo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113836; Varjopuro R., 2006, MAST, V5, P61; Varjopuro R, 2011, MAR POLICY, V35, P450, DOI 10.1016/j.marpol.2010.10.023; Westerberg H, 2007, RECONCILING FISHERIE, VI, P587; Wursig B, 2002, RESPONSIBLE MARINE AQUACULTURE, P45, DOI 10.1079/9780851996042.0045; Yurk H, 2000, T AM FISH SOC, V129, P1360, DOI 10.1577/1548-8659(2000)129<1360:EATRPB>2.0.CO;2	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201164	10.1371/journal.pone.0201164	http://dx.doi.org/10.1371/journal.pone.0201164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048493	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400056
J	Fathi, Z; Mousavi, SAJ; Roudi, R; Ghazi, F				Fathi, Zahra; Mousavi, Seyed Ali Javad; Roudi, Raheleh; Ghazi, Farideh			Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients	PLOS ONE			English	Article							JOINT-CONSENSUS-RECOMMENDATION; POLYMERASE-CHAIN-REACTION; SEQUENCE VARIANTS; P53; CARCINOMA; EGFR; ADENOCARCINOMA; ASSOCIATION; EXPRESSION; BRAF	Purpose Lung cancer is the deadliest known cancer in the world, with the highest number of mutations in proto-oncogenes and tumor suppressor genes. Therefore, this study was conducted to determine the status of hotspot regions in DDR2 and KRAS genes for the first time, as well as in TP53 gene, in lung cancer patients within the Iranian population. Experimental design The mutations in exon 2 of KRAS, exon 18 of DDR2, and exons 5-6 of TP53 genes were screened in lung cancer samples, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) using PCR and sequencing techniques. Results Analysis of the KRAS gene showed only a G12C variation in one large cell carcinoma (LCC) patient, whereas variants were not found in adenocarcinoma (ADC) and squamous cell carcinoma (SCC) cases. The Q808H variation in the DDR2 gene was detected in one SCC sample, while no variant was seen in the ADC and LCC subtypes. Variations in the TP53 gene were seen in all NSCLC subtypes, including six ADC (13.63%), seven SCC (15.9%) and two LCC (4.54%). Forty-eight variants were found in the TP53 gene. Of these, 15 variants were found in coding regions V147A, V157F, Q167Q, D186G, H193R, T211T, F212L and P222P, 33 variants in intronic regions rs1625895 (HGVS: c.672+62A>G), rs766856111 (HGVS: c.672+6G>A) and two new variants (c.560-12A>G and c.672+86T>C). Conclusions In conclusion, KRAS, DDR2, and TP53 variants were detected in 2%, 2.17% and 79.54% of all cases, respectively. The frequency of DDR2 mutation is nearly close to other studies, while KRAS and TP53 mutation frequencies are lower and higher than other populations, respectively. Three new putative pathogenic variants, for the first time, have been detected	[Fathi, Zahra; Ghazi, Farideh] Iran Univ Med Sci, Dept Med Genet & Mol Biol, Fac Med, Tehran, Iran; [Mousavi, Seyed Ali Javad] Iran Univ Med Sci, Minimally Invas Surg Res Ctr, Tehran, Iran; [Roudi, Raheleh] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Ghazi, F (corresponding author), Iran Univ Med Sci, Dept Med Genet & Mol Biol, Fac Med, Tehran, Iran.; Roudi, R (corresponding author), Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran.	Raheleroudi@gmail.com; Ghazi.f@iums.ac.ir	Roudi, Raheleh/J-2587-2018; mousavi, seyyed amin ayatollahi/Q-8504-2016	Roudi, Raheleh/0000-0001-5023-4743; mousavi, seyyed amin ayatollahi/0000-0002-5367-483X	Iran University of Medical Sciences [95-02-30-27795]	Iran University of Medical Sciences	This study was supported by a grant from Iran University of Medical Sciences (Grant #95-02-30-27795). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Andriani F, 2004, INT J CANCER, V108, P91, DOI 10.1002/ijc.11510; Ashktorab H, 2017, ONCOTARGET, V8, P7852, DOI 10.18632/oncotarget.13977; Bandoh N, 2002, CANCER, V94, P1968, DOI 10.1002/cncr.10388; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Baugh EH, 2018, CELL DEATH DIFFER, V25, P154, DOI 10.1038/cdd.2017.180; Chalela R, 2017, J THORAC DIS, V9, P2142, DOI 10.21037/jtd.2017.06.20; Chatziandreou I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133859; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; deAnta JM, 1997, ONCOGENE, V15, P2951, DOI 10.1038/sj.onc.1201475; Deben C, 2016, CRIT REV ONCOL HEMAT, V99, P63, DOI 10.1016/j.critrevonc.2015.11.019; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Ellard S, 2016, PRACTICE GUIDELINES; Fathi Z, 2018, J HUM GENET, V63, P783, DOI 10.1038/s10038-018-0450-y; Gobbini E, 2017, LUNG CANCER, V111, P30, DOI 10.1016/j.lungcan.2017.06.009; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Huang CL, 1998, INT J ONCOL, V12, P553; Jafari H, 2013, BIOIMPACTS, V3, P135, DOI 10.5681/bi.2013.018; Karami-Matin Behzad, 2016, Asian Pac J Cancer Prev, V17, P2131; Kenmotsu H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-786; Kim HJ, 2012, LUNG CANCER, V75, P321, DOI 10.1016/j.lungcan.2011.08.005; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lee HJ, 2013, KOREAN J PATHOL, V47, P52, DOI 10.4132/KoreanJPathol.2013.47.1.52; Lee MS, 2017, CANCER RES TREAT, V49, P1065, DOI 10.4143/crt.2016.347; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Lim SM, 2018, CANCER TREAT REV, V65, P1, DOI 10.1016/j.ctrv.2018.02.006; Liu DG, 2002, CANCER, V94, P2239, DOI 10.1002/cncr.10450; Liu X, 2014, CLIN ONCOL-UK, V26, P18, DOI 10.1016/j.clon.2013.09.003; Luthra R, 2015, CANCERS, V7, P2023, DOI 10.3390/cancers7040874; Ma XL, 2016, J THORAC ONCOL, V11, P850, DOI 10.1016/j.jtho.2016.02.002; Mardis ER, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0540-7; Martorell PM, 2017, CLIN LUNG CANCER, V18, pE395, DOI 10.1016/j.cllc.2017.04.006; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Matsumoto S, 2014, NEW NATIONWIDE GENOM; Miao LY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-369; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mitsudomi T, 2000, CLIN CANCER RES, V6, P4055; Mohammadi A, 2008, AM J BIOCH BIOTECHNO, V4, P1, DOI DOI 10.3844/AJBBSP.2008.1.6; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nadal E, 2014, J THORAC ONCOL, V9, P1513, DOI 10.1097/JTO.0000000000000305; Nicos M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0176-4; Pitini V, 2013, LUNG CANCER, V82, P171, DOI 10.1016/j.lungcan.2013.07.004; Poghosyan H, 2013, LUNG CANCER, V81, P11, DOI 10.1016/j.lungcan.2013.03.013; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richters A, 2014, J MED CHEM, V57, P4252, DOI 10.1021/jm500167q; Ricordel C, 2018, CLIN LUNG CANCER, V19, P163, DOI 10.1016/j.cllc.2017.10.006; Roudi R, 2015, CANCER INVEST, V33, P294, DOI 10.3109/07357907.2015.1034869; Roudi R, 2014, CANCER BIOMARK, V14, P457, DOI 10.3233/CBM-140424; Roviello G, 2018, CLIN EXP MED, V18, P15, DOI 10.1007/s10238-017-0460-7; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Terai H, 2015, ACS CHEM BIOL, V10, P2687, DOI 10.1021/acschembio.5b00655; Timar J, 2014, CURR OPIN ONCOL, V26, P138, DOI 10.1097/CCO.0000000000000051; Tsang H, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00214; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Viktorsson K, 2005, BIOCHEM BIOPH RES CO, V331, P868, DOI 10.1016/j.bbrc.2005.03.192; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Warth A, 2016, ONCOTARGET; Yang IS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2011-y; Yashima H, 2014, MOL CLIN ONCOL, V2, P714, DOI 10.3892/mco.2014.302; Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10; Zhu JW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011300.pub2	65	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200633	10.1371/journal.pone.0200633	http://dx.doi.org/10.1371/journal.pone.0200633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048458	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400011
J	Guo, J; Liu, C; Wang, W; Liu, Y; He, HW; Chen, C; Xiang, R; Luo, YP				Guo, Jian; Liu, Chen; Wang, Wei; Liu, Yan; He, Huiwen; Chen, Chong; Xiang, Rong; Luo, Yunping			Identification of serum miR-1915-3p and miR455-3p as biomarkers for breast cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; METASTASIS; ONCOGENE; GENOMICS; PATHWAY; CHINA	Breast cancer is one of the most malignant diseases in women worldwide. Serum microRNAs (miRNAs), with the characteristics of high sensitivity and specificity, have recently attracted more attentions to serve as potential biomarkers for tumor diseases. In this study, 194 breast cancer patients' serum samples were collected before surgery and enrolled into different groups based on their diagnostic information. To search for breast cancer diagnostic biomarkers, serum miRNAs were screened by microarray in pooled samples of healthy volunteers and breast cancer patients in different clinical stages. The miRNAs were further verified in each individual patient's serum samples in diagnostic and predictive sets. The serum level of miR-1915-3p was upregulated and miR-455-3p was downregulated significantly in breast cancer patients compared with healthy volunteers. Furthermore, the patients with infiltrating carcinoma or lymph node metastasis had a higher serum level of miR-1915-3p and lower serum level of miR-455-3p than patients with the carcinoma in situ or patients without lymph node metastasis. ROC analysis suggested that miR-1915-3p and miR-455-3p had the potential as a promising serum diagnostic and predictive biomarkers of breast cancer. miR-1915-3p was over-expressed in certain human breast cancer cells. Functional experiments in vitro showed that miR-1915-3p enhanced cell proliferative and migrational abilities. Overexpression of miR-1915-3p repressed target gene DUSP3 and activated ERK1/2. Collectively, this study provided a new insight that miR-1915-3p might play a role in the development of breast cancer and that serum miR-1915-3p and miR-4553p could serve as diagnostic and predictive biomarkers for breast cancer.	[Guo, Jian; Wang, Wei; Liu, Yan; He, Huiwen; Chen, Chong; Luo, Yunping] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Immunol,Inst Basic Med Sci, Beijing, Peoples R China; [Guo, Jian; Wang, Wei; Liu, Yan; He, Huiwen; Chen, Chong; Luo, Yunping] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Collaborat Innovat Ctr Biotherapy,Inst Basic Med, Beijing, Peoples R China; [Liu, Chen] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China; [Xiang, Rong] Nankai Univ, Coll Med, Collaborat Innovat Ctr Biotherapy, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chongqing Medical University; Nankai University	Luo, YP (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Immunol,Inst Basic Med Sci, Beijing, Peoples R China.; Luo, YP (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Collaborat Innovat Ctr Biotherapy,Inst Basic Med, Beijing, Peoples R China.	ypluo@ibms.pumc.edu.cn			National Natural Science Foundation of China [81472654, 81672914]; National Basic Research Program of China [2013CB967202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 81472654), http://www.nsfc.gov.cn/; the National Natural Science Foundation of China (No.81672914), http://www.nsfc.gov.cn/; the National Basic Research Program of China (No. 2013CB967202), http://program.most.gov.cn/.	Ali HEA, 2017, CLIN RES HEPATOL GAS, V41, pE51, DOI 10.1016/j.clinre.2017.06.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hua YQ, 2017, CANCER BIOMARK, V20, P95, DOI 10.3233/CBM-170231; Inamura K, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020012; Jia WH, 2015, MOL CLIN ONCOL, V3, P851, DOI 10.3892/mco.2015.560; Liu SN, 2017, CANCER BIOMARK, V20, P547, DOI 10.3233/CBM-170351; Markopoulos GS, 2017, CELL ONCOL, V40, P303, DOI 10.1007/s13402-017-0341-9; Matsuzaki J, 2017, INT J CLIN ONCOL, V22, P413, DOI 10.1007/s10147-017-1104-3; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Peng QL, 2017, ONCOTARGET, V8, P44893, DOI 10.18632/oncotarget.16488; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shi GL, 2017, CLIN LAB, V133; Takahashi RU, 2017, CLIN CHEM LAB MED, V55, P648, DOI 10.1515/cclm-2016-0708; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang W, 2015, J ZHEJIANG UNIV-SC B, V16, P18, DOI 10.1631/jzus.B1400184; Weng YX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0531-x; Zhu MX, 2017, ONCOTARGET, V8, P17081, DOI 10.18632/oncotarget.15059	30	39	42	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200716	10.1371/journal.pone.0200716	http://dx.doi.org/10.1371/journal.pone.0200716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048472	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400015
J	Laviola, M; Priori, R; D'Angelo, MG; Aliverti, A				Laviola, Marianna; Priori, Rita; D'Angelo, Maria Grazia; Aliverti, Andrea			Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients	PLOS ONE			English	Article							RESPIRATORY-FUNCTION ASSESSMENT; MUSCLE STRENGTH; 3-DIMENSIONAL RECONSTRUCTION; NEUROMUSCULAR DISORDERS; NORMAL VALUES; LUNG-VOLUMES; ULTRASOUND; CHILDREN; DISEASE; ADULTS	Introduction In Duchenne muscular dystrophy (DMD) the assessment of diaphragmatic function is crucial because respiratory muscle weakness can cause respiratory failure. We aimed to noninvasively assess diaphragmatic function in DMD by measuring diaphragmatic thickness by ultrasonography, under the hypothesis that the progressive decrease of lung function is related to alterations of diaphragmatic thickness. Methods Forty-four DMD patients and thirteen healthy controls were enrolled and subdivided into three age groups. Diaphragmatic thickness was measured during quiet breathing, inspiratory capacity, maximal inspiratory pressure and expiratory pressure maneuvers. Results In DMD, absolute values of diaphragmatic thickness were significantly lower than in controls in the majority of the manoeuvers and diaphragmatic thickness significantly decreased with age at end-expiration, remaining constant at end-inspiration and during maximal inspiratory pressure maneuvers. Comparing to controls, absolute values of diaphragmatic thickness and diaphragmatic thickness variations were significantly lower ( p<0.001), with the exception of quiet breathing and maximal expiratory pressure maneuvers in the youngest DMD. During maximal inspiratory pressure maneuver, variation of diaphragmatic thickness was not significantly different in the all groups, nevertheless maximal inspiratory pressure decreases with age. Conclusions The diaphragm is prone to pseudo-hypertrophy in the youngest DMD, and to progressive atrophy in middle-age and oldest DMD. Diaphragm impairment could be expressed as a dissociation between muscle drive and muscle developed force. Ultrasonography could be used as a noninvasive method to assess progressive diaphragmatic weakness.	[Laviola, Marianna; Priori, Rita; Aliverti, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [D'Angelo, Maria Grazia] Sci Inst IRCCS Eugenio Medea, Dept Neurorehabil, Bosisio Parini, Italy	Polytechnic University of Milan; IRCCS Eugenio Medea	Aliverti, A (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy.	andrea.aliverti@polimi.it	Andrea, Aliverti/A-3901-2015; Laviola, Marianna/M-5254-2019; D'Angelo, Maria Grazia/K-4685-2016	Andrea, Aliverti/0000-0002-2950-0231; Laviola, Marianna/0000-0001-6279-6137; D'Angelo, Maria Grazia/0000-0003-1241-4350	Fondo DMD "Amici di Emanuele" Onlus	Fondo DMD "Amici di Emanuele" Onlus	This work was supported by Fondo DMD "Amici di Emanuele" Onlus.	Baldwin CE, 2011, RESPIROLOGY, V16, P1136, DOI 10.1111/j.1440-1843.2011.02005.x; Beck J, 2006, NEUROMUSCULAR DISORD, V16, P161, DOI 10.1016/j.nmd.2006.01.003; Boon AJ, 2013, MUSCLE NERVE, V47, P884, DOI 10.1002/mus.23702; Boussuges A, 2009, CHEST, V135, P391, DOI 10.1378/chest.08-1541; Brown PI, 2013, EUR J APPL PHYSIOL, V113, P2849, DOI 10.1007/s00421-013-2726-4; Burns DP, 2017, J PHYSIOL-LONDON, V595, P6653, DOI 10.1113/JP274792; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Day JM, 2013, MANUAL THER, V18, P588, DOI 10.1016/j.math.2013.07.003; DeBruin PF, 1997, THORAX, V52, P472, DOI 10.1136/thx.52.5.472; Dube B-P, 2017, THORAX; Fromageot C, 2001, ARCH PHYS MED REHAB, V82, P123, DOI 10.1053/apmr.2001.18053; Gaeta M, 2015, NEUROMUSCULAR DISORD, V25, P852, DOI 10.1016/j.nmd.2015.09.003; GAUTHIER AP, 1994, J APPL PHYSIOL, V76, P495, DOI 10.1152/jappl.1994.76.2.495; Gottesman E, 1997, AM J RESP CRIT CARE, V155, P1570, DOI 10.1164/ajrccm.155.5.9154859; Kang SW, 2006, YONSEI MED J, V47, P184, DOI 10.3349/ymj.2006.47.2.184; Lee EP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183560; Li QL, 2013, ULTRASOUND MED BIOL, V39, P2194, DOI 10.1016/j.ultrasmedbio.2013.06.009; Lo Mauro A, 2010, EUR RESPIR J, V35, P1118, DOI 10.1183/09031936.00037209; LoMauro A, 2015, THER CLIN RISK MANAG, V11, P1475, DOI 10.2147/TCRM.S55889; LoMauro A, 2014, PEDIATR PULM, V49, P357, DOI 10.1002/ppul.22836; Matamis D, 2013, INTENS CARE MED, V39, P801, DOI 10.1007/s00134-013-2823-1; Mayer OH, 2017, ADV PULMONARY CARE D, V13, P7; Mead AF, 2014, J APPL PHYSIOL, V116, P807, DOI 10.1152/japplphysiol.00833.2013; Mellies U, 2005, CURR OPIN NEUROL, V18, P543, DOI 10.1097/01.wco.0000180662.03544.5f; NEWSOMDAVIS J, 1980, BRIT MED BULL, V36, P135, DOI 10.1093/oxfordjournals.bmb.a071628; Nicot F, 2006, AM J RESP CRIT CARE, V174, P67, DOI 10.1164/rccm.200512-1841OC; Pettiaux N, 1997, J APPL PHYSIOL, V82, P998, DOI 10.1152/jappl.1997.82.3.998; Romei M, 2012, RESP MED, V106, P276, DOI 10.1016/j.rmed.2011.10.010; Takahashi Y, 2013, J LOW FREQ NOISE V A, V32, P1; Taniguchi N MJ, 1991, J MED ULTRASON, V18, P93; Terzi N, 2008, EUR RESPIR J, V31, P93, DOI 10.1183/09031936.00094707; Testa A, 2011, ULTRASOUND MED BIOL, V37, P44, DOI 10.1016/j.ultrasmedbio.2010.10.004; Thibaud JL, 2017, NEUROMUSCULAR DISORD, V27, P315, DOI 10.1016/j.nmd.2017.02.003; UEKI J, 1995, THORAX, V50, P1157, DOI 10.1136/thx.50.11.1157; WAIT JL, 1989, J APPL PHYSIOL, V67, P1560, DOI 10.1152/jappl.1989.67.4.1560; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535	37	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200582	10.1371/journal.pone.0200582	http://dx.doi.org/10.1371/journal.pone.0200582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048455	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400009
J	Ofori, PA; Mizuno, A; Suzuki, M; Martinoia, E; Reuscher, S; Aoki, K; Shibata, D; Otagaki, S; Matsumoto, S; Shiratake, K				Ofori, Peter Amoako; Mizuno, Ayaka; Suzuki, Mami; Martinoia, Enrico; Reuscher, Stefan; Aoki, Koh; Shibata, Daisuke; Otagaki, Shungo; Matsumoto, Shogo; Shiratake, Katsuhiro			Genome-wide analysis of ATP binding cassette (ABC) transporters in tomato	PLOS ONE			English	Article							CADMIUM TOLERANCE; PROVIDES INSIGHTS; PROTEIN; PLANT; ACID; RESISTANCE; SUBFAMILY; GENE; COMATOSE; OVEREXPRESSION	ATP binding cassette (ABC) transporters are proteins that actively mediate the transport of a wide range of molecules, such as organic acids, metal ions, phytohormones and secondary metabolites. Therefore, ABC transporters must play indispensable roles in growth and development of tomato, including fruit development. Most ABC transporters have transmembrane domains (TMDs) and belong to the ABC protein family, which includes not only ABC transporters but also soluble ABC proteins lacking TMDs. In this study, we performed a genome-wide identification and expression analysis of genes encoding ABC proteins in tomato (Solanum lycopersicum), which is a valuable horticultural crop and a model plant for studying fleshy fruits. In the tomato genome, a total of 154 genes putatively encoding ABC transporters, including 9 ABCAs, 29 ABCBs, 26 ABCCs, 2 ABCDs, 2 ABCEs, 6 ABCFs, 70 ABCGs and 10 ABCIs, were identified. Gene expression data from the eFP Browser and reverse transcription-semi-quantitative PCR analysis revealed their tissue-specific and development-specific expression profiles. This work suggests physiological roles of ABC transporters in tomato and provides fundamental information for future studies of ABC transporters not only in tomato but also in other Solanaceae species.	[Ofori, Peter Amoako; Mizuno, Ayaka; Suzuki, Mami; Reuscher, Stefan; Otagaki, Shungo; Matsumoto, Shogo; Shiratake, Katsuhiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Martinoia, Enrico] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland; [Aoki, Koh] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan; [Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Japan	Nagoya University; University of Zurich; Osaka Metropolitan University; Kazusa DNA Research Institute	Shiratake, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.	shira@agr.nagoya-u.ac.jp	Martinoia, Enrico/AAH-8712-2021	SHIRATAKE, Katsuhiro/0000-0002-2608-7912	Programme for Promotion of Basic and Applied Researchers for Innovations from Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries (MAFF); Cross-ministerial Strategic Innovation Promotion Program (SIP) from the Cabinet Office; Japan Society for the Promotion of Science (JSPS)	Programme for Promotion of Basic and Applied Researchers for Innovations from Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries (MAFF); Cross-ministerial Strategic Innovation Promotion Program (SIP) from the Cabinet Office; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported partially by the Programme for Promotion of Basic and Applied Researchers for Innovations from Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (BRAIN), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries (MAFF), the Cross-ministerial Strategic Innovation Promotion Program (SIP) from the Cabinet Office, and the Grant-in-Aids for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS).	Andolfo G, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0323-2; Banasiak J, PLANT ABC TRANSPORTE, V22; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Bienert MD, 2014, SIGNAL COMMUN PLANTS, P137, DOI 10.1007/978-3-319-06511-3_8; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Borghi L, 2015, BIOCHEM SOC T, V43, P924, DOI 10.1042/BST20150106; Braz ASK, 2004, J MOL EVOL, V59, P20, DOI 10.1007/s00239-004-2600-4; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Bussell JD, 2014, PLANT PHYSIOL, V164, P48, DOI 10.1104/pp.113.229807; Cakir B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078860; Cerino Badone F, 2010, PLANTA, V231, P1189, DOI 10.1007/s00425-010-1123-z; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; Chen PJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02150; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; D'Agostino N, 2007, NUCLEIC ACIDS RES, V35, pD901, DOI 10.1093/nar/gkl921; Dave A, 2011, PLANT CELL, V23, P583, DOI 10.1105/tpc.110.081489; Davies TGE, 1997, GENE, V199, P195, DOI 10.1016/S0378-1119(97)00367-3; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Fernandez-Pozo N, 2017, BIOINFORMATICS, V33, P2397, DOI 10.1093/bioinformatics/btx190; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; Gaillard S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-22; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2017, PLANT CELL PHYSIOL, V58, P1601, DOI 10.1093/pcp/pcx104; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Hanikenne M, 2005, PLANT CELL ENVIRON, V28, P863, DOI 10.1111/j.1365-3040.2005.01335.x; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kato T, 2009, PLANT BIOTECHNOL-NAR, V26, P409, DOI 10.5511/plantbiotechnology.26.409; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kudo T, 2017, PLANT CELL PHYSL, V58, P1, DOI [10.1093/pcp/pcw227, DOI 10.1093/PCP/PCW227]; Kuromori T, 2016, PLANT SCI, V251, P75, DOI 10.1016/j.plantsci.2016.02.019; Kuromori T, 2011, J PLANT PHYSIOL, V168, P2001, DOI 10.1016/j.jplph.2011.05.014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen PB, 2007, PLANTA, V225, P1447, DOI 10.1007/s00425-006-0452-4; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lefevre F, 2015, BIOCHEM SOC T, V43, P931, DOI 10.1042/BST20150108; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Meissner R, 1997, PLANT J, V12, P1465, DOI 10.1046/j.1365-313x.1997.12061465.x; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Nie ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116857; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Remy E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00201; Reuscher S, 2014, PLANT CELL PHYSIOL, V55, P1123, DOI 10.1093/pcp/pcu052; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Russell L, 2000, DEVELOPMENT, V127, P3759; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Sarmiento C, 2006, PLANT MOL BIOL, V61, P153, DOI 10.1007/s11103-005-0001-8; Sasaki T, 2002, PLANT CELL PHYSIOL, V43, P177, DOI 10.1093/pcp/pcf025; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Shitan N, 2003, P NATL ACAD SCI USA, V100, P751, DOI 10.1073/pnas.0134257100; Sugiyama A, 2006, DNA RES, V13, P205, DOI 10.1093/dnares/dsl013; Tagashira Yusuke, 2015, Plants-Basel, V4, P196, DOI 10.3390/plants4020196; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; van den Brule S, 2002, PLANT J, V30, P649, DOI 10.1046/j.1365-313X.2002.01321.x; Vasiliou Vasilis, 2008, Hum Genomics, V3, P1; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wanke D, 2010, PLANT BIOLOGY, V12, P15, DOI 10.1111/j.1438-8677.2010.00380.x; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Wu GS, 2010, PLANT J, V62, P179, DOI 10.1111/j.1365-313X.2010.04137.x; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yano K, 2007, PLANT BIOTECHNOL-NAR, V24, P17, DOI 10.5511/plantbiotechnology.24.17; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Zhu YQ, 2003, PLANT PHYSIOL, V133, P580, DOI 10.1104/pp.103.027052; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	97	42	46	12	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200854	10.1371/journal.pone.0200854	http://dx.doi.org/10.1371/journal.pone.0200854			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048467	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400023
J	Duivenvoorden, HM; Spurling, A; O'Toole, SA; Parker, BS				Duivenvoorden, Hendrika M.; Spurling, Alex; O'Toole, Sandra A.; Parker, Belinda S.			Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; MYOSIN HEAVY-CHAIN; BREAST-CANCER; DUCTAL CARCINOMA; IN-SITU; MOLECULAR CHARACTERIZATION; TUMOR MICROENVIRONMENT; GLAND DEVELOPMENT; DEFICIENT MICE; CELLS	Mammographic screening has led to increased detection of breast cancer at a pre-invasive state, hence modelling the earliest stages of breast cancer invasion is important in defining candidate biomarkers to predict risk of relapse. Discrimination of pre-invasive from invasive lesions is critically important for such studies. Myoepithelial cells are the barrier between epithelial cells and the surrounding stroma in the breast ductal system. A number of myoepithelial immunohistochemistry markers have been identified and validated in human tissue for use by pathologists as diagnostic tools to distinguish in situ carcinoma from invasive breast cancer. However, robust myoepithelial markers for mouse mammary tissue have been largely under-utilised. Here, we investigated the utility of the myoepithelial markers smooth muscle actin (SMA), smooth muscle myosin heavy chain (SMMHC), cytokeratin-14 (CK14) and p63 to discriminate mammary intraepithelial neoplasia (MIN) from invasive disease in the C57BL/6J MMTV-PyMT transgenic model of mammary carcinoma. We identified that SMMHC and CK14 are retained in early in situ neoplasia and are appropriate markers for distinguishing MIN from invasive disease in this model. Additionally, the proliferation marker Ki67 is a superior marker for differentiating between normal and hyperplastic ducts, prior to the development of MIN. Based on this, we developed a scoring matrix for discriminating normal, hyperplasia, MIN and invasive lesions in this spontaneous mammary tumorigenesis model. This study demonstrates heterogeneous expression of myoepithelial proteins throughout tumour development, and highlights the need to characterise the most appropriate markers in other models of early breast cancer to allow accurate classification of disease state.	[Duivenvoorden, Hendrika M.; Spurling, Alex; Parker, Belinda S.] La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia; [O'Toole, Sandra A.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [O'Toole, Sandra A.] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [O'Toole, Sandra A.] Australian Clin Labs, Bella Vista, NSW, Australia	University of Sydney; Garvan Institute of Medical Research	Parker, BS (corresponding author), La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia.; O'Toole, SA (corresponding author), Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia.; O'Toole, SA (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW, Australia.; O'Toole, SA (corresponding author), Australian Clin Labs, Bella Vista, NSW, Australia.	s.otoole@garvan.org.au; Belinda.Parker@latrobe.edu.au		Parker, Belinda/0000-0002-8333-1926	National Health and Medical Research Council (NHMRC) [BSP 1047748, 1127754]; Victorian Cancer Agency; National Breast Cancer Foundation [PRAC-16-006]; Cancer Council Victoria; Sydney Breast Cancer Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; National Breast Cancer Foundation; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Sydney Breast Cancer Foundation	This work was supported by grant funding from the National Health and Medical Research Council (NHMRC) (BSP 1047748 and 1127754) to BSP; fellowship support to BSP from Victorian Cancer Agency, SAOT from National Breast Cancer Foundation (Practitioner Fellowship PRAC-16-006) and HMD from Cancer Council Victoria. Support from the Sydney Breast Cancer Foundation is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Clinical Labs provided support in the form of salaries for author SAOT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Cardiff RD, 2000, J MAMMARY GLAND BIOL, V5, P421, DOI 10.1023/A:1009534129331; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; DEANE HW, 1956, J APPL PHYSIOL, V9, P495, DOI 10.1152/jappl.1956.9.3.495; Downs-Holmes Catherine, 2011, Nurse Pract, V36, P20, DOI 10.1097/01.NPR.0000407602.29522.d7; Duivenvoorden HM, 2017, J PATHOL, V243, P496, DOI 10.1002/path.4990; Gudjonsson T, 2002, J CELL SCI, V115, P39; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hilson JB, 2009, AM J SURG PATHOL, V33, P227, DOI 10.1097/PAS.0b013e318180431d; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Kalof AN, 2004, J CLIN PATHOL, V57, P625, DOI 10.1136/jcp.2003.013227; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maglione JE, 2001, CANCER RES, V61, P8298; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; Medina D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004523; Mirtti T, 2003, PROSTATE, V54, P290, DOI 10.1002/pros.10196; Polyak K, 2005, J MAMMARY GLAND BIOL, V10, P231, DOI 10.1007/s10911-005-9584-6; Polyak Kornelia, 2010, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgq019; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Rautela J, 2015, CANCER IMMUNOL RES, V3, P1207, DOI 10.1158/2326-6066.CIR-15-0065; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Sameni M, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0847-0; Schurigt U, 2008, BIOL CHEM, V389, P1067, DOI 10.1515/BC.2008.115; Shousha S, 2016, J CLIN PATHOL, V69, P702, DOI 10.1136/jclinpath-2015-203408; TREISMAN R, 1981, NATURE, V292, P595, DOI 10.1038/292595a0; Van Cleef A, 2014, FACTS VIEWS VIS OBGY, V6, P210; Werling RW, 2003, AM J SURG PATHOL, V27, P82, DOI 10.1097/00000478-200301000-00009; World Health Organization, 2012, WHO CLASSIFICATION T	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201370	10.1371/journal.pone.0201370	http://dx.doi.org/10.1371/journal.pone.0201370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044853	gold, Green Published			2022-12-26	WOS:000439942500102
J	Dunn, VK; Gleason, E				Dunn, Vernon K.; Gleason, Evanna			Inhibition of endocytosis suppresses the nitric oxide-dependent release of Cl- in retinal amacrine cells	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; SYNTHASE-IMMUNOREACTIVE NEURONS; CLATHRIN TERMINAL DOMAIN; GUINEA-PIG RETINA; CALCIUM-CHANNELS; CYSTIC-FIBROSIS; TRANSMITTER RELEASE; ACTIN CYTOSKELETON; DYNAMIN INHIBITORS; GTPASE ACTIVITY	Our lab has previously shown that nitric oxide (NO) can alter the synaptic response properties of amacrine cells by releasing Cl- from internal acidic compartments. This alteration in the Cl- gradient brings about a positive shift in the reversal potential of the GABA-gated current, which can convert inhibitory synapses into excitatory synapses. Recently, we have shown that the cystic fibrosis transmembrane regulator (CFTR) Cl- channel is involved in the Cl- release. Here, we test the hypothesis that (acidic) synaptic vesicles are a source of NO-releasable Cl- in chick retinal amacrine cells. If SVs are a source of Cl-, then depleting synaptic vesicles should decrease the nitric oxide-dependent shift in the reversal potential of the GABA-gated current. The efficacy of four inhibitors of dynamin (dynasore, Dyngo 4a, Dynole 34-2, and MiTMAB) were evaluated. In order to deplete synaptic vesicles, voltagesteps were used to activate V-gated Ca2+ channels and stimulate the synaptic vesicle cycle either under control conditions or after treatment with the dynamin inhibitors. Voltage-ramps were used to measure the NO-dependent shift in the reversal potential of the GABA-gated currents under both conditions. Our results reveal that activating the synaptic vesicle cycle in the presence of dynasore or Dyngo 4a blocked the NO-dependent shift in EGABA. However, we also discovered that some dynamin inhibitors reduced Ca2+ signaling and L-type Ca2+ currents. Conversely, dynasore also increased neurotransmitter release at autaptic sites. To further resolve the mechanism underlying the inhibition of the NO-dependent shift in the reversal potential for the GABA-gated currents, we also tested the effects of the clathrin assembly inhibitor Pitstop 2 and found that this compound also inhibited the shift. These data provide evidence that dynamin inhibitors have multiple effects on amacrine cell synaptic transmission. These data also suggest that inhibition of endocytosis disrupts the ability of NO to elicit Cl- release from internal stores which may in part be due to depletion of synaptic vesicles.	[Dunn, Vernon K.; Gleason, Evanna] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Gleason, E (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	egleaso@lsu.edu			National Science Foundation, Division of Integrative Organismal Systems [IOS 1256782]; NIH [R25 Gm069743]; NSF [HRD-1141152]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069743] Funding Source: NIH RePORTER	National Science Foundation, Division of Integrative Organismal Systems(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Science Foundation, Division of Integrative Organismal Systems, IOS 1256782 to EG; https://www.nsf.gov/div/index.jsp?div=IOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was partially supported by NIH under award number R25 Gm069743 and NSF award number HRD-1141152 to Vernon K. Dunn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Cantiello HF, 1996, EXP PHYSIOL, V81, P505, DOI 10.1113/expphysiol.1996.sp003953; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao LX, 2001, VISUAL NEUROSCI, V18, P949, DOI 10.1017/S0952523801186128; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Castellani S, 2017, HISTOL HISTOPATHOL, V32, P445, DOI 10.14670/HH-11-842; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; COBCROFT M, 1989, NEUROSCI LETT, V103, P1, DOI 10.1016/0304-3940(89)90475-8; Cook T, 1996, J NEUROCHEM, V67, P927; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Edwards BS, 2016, ENDOCRINOLOGY, V157, P831, DOI 10.1210/en.2015-1575; El-Salem K, 2010, J CLIN NEUROPHYSIOL, V27, P216, DOI 10.1097/01.WNP.0b013e3181e0a9f9; Eldred WD, 2005, VISION RES, V45, P3469, DOI 10.1016/j.visres.2005.07.033; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Garthwaite J, 2016, J PHYSIOL-LONDON, V594, P9, DOI 10.1113/JP270297; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; GLEASON E, 1994, NEURON, V13, P1109, DOI 10.1016/0896-6273(94)90049-3; GLEASON E, 1989, J COMP NEUROL, V287, P213, DOI 10.1002/cne.902870205; GLEASON E, 1993, J NEUROSCI, V13, P2359, DOI 10.1523/JNEUROSCI.13-06-02359.1993; Habermann CJ, 2003, J NEUROSCI, V23, P6904; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoffpauir B, 2006, J NEUROPHYSIOL, V95, P2866, DOI 10.1152/jn.01317.2005; Hofmann ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174915; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Kim IB, 2000, MICROSC RES TECHNIQ, V50, P112, DOI 10.1002/1097-0029(20000715)50:2<112::AID-JEMT3>3.0.CO;2-S; KOISTINAHO J, 1993, NEUROSCIENCE, V57, P587, DOI 10.1016/0306-4522(93)90008-4; Krishnan V, 2017, J NEUROPHYSIOL; Krishnan V, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00213; Lemmon SK, 2012, TRAFFIC, V13, P511, DOI 10.1111/j.1600-0854.2011.01321.x; Linares-Clemente P, 2015, J PHYSIOL-LONDON, V593, P2867, DOI 10.1113/JP270112; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maddox JW, 2018, J NEUROPHYSIOL, V119, P262, DOI 10.1152/jn.00500.2017; Maddox JW, 2017, J NEUROPHYSIOL, V117, P1185, DOI 10.1152/jn.00803.2016; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Nguyen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036913; Oh SJ, 1999, CELL TISSUE RES, V297, P397, DOI 10.1007/s004410051367; ORIORDAN JI, 1995, IRISH J MED SCI, V164, P207, DOI 10.1007/BF02967830; OSBORNE NN, 1993, BRAIN RES, V610, P194, DOI 10.1016/0006-8993(93)91400-M; PEREZ MTR, 1995, EXP BRAIN RES, V104, P207; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rios H, 2000, DEV BRAIN RES, V120, P17, DOI 10.1016/S0165-3806(99)00166-2; SANDELL JH, 1985, J COMP NEUROL, V238, P466, DOI 10.1002/cne.902380410; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tekmen M, 2010, J NEUROPHYSIOL, V104, P1849, DOI 10.1152/jn.00031.2010; Tooker RE, 2015, J COMP NEUROL, V523, P2082, DOI 10.1002/cne.23780; Trippett TM, 2001, CANCER RES, V61, P1941; VACCARO TM, 1991, CELL TISSUE RES, V265, P371, DOI 10.1007/BF00398085; VANEY DI, 1988, BRAIN RES, V474, P380, DOI 10.1016/0006-8993(88)90455-6; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Vigh J, 2004, VISUAL NEUROSCI, V21, P129, DOI 10.1017/S095252380404204X; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang GY, 2003, J NEUROPHYSIOL, V90, P1304, DOI 10.1152/jn.00243.2003; WASSLE H, 1987, J COMP NEUROL, V265, P391, DOI 10.1002/cne.902650308; Willox AK, 2012, TRAFFIC, V13, P70, DOI 10.1111/j.1600-0854.2011.01289.x; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219	76	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201184	10.1371/journal.pone.0201184	http://dx.doi.org/10.1371/journal.pone.0201184			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044876	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500089
J	Eto, S; Goto, M; Soga, M; Kaneko, Y; Uehara, Y; Mizuta, H; Era, T				Eto, Shinya; Goto, Mizuki; Soga, Minami; Kaneko, Yumi; Uehara, Yusuke; Mizuta, Hiroshi; Era, Takumi			Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials	PLOS ONE			English	Article							PRESSURE ULCER; T-CELLS; MSC; PLURIPOTENCY; MECHANISMS	Mesenchymal stem cells (MSCs) isolated from adult human tissues are capable of proliferating in vitro and maintaining their multipotency, making them attractive cell sources for regenerative medicine. However, the availability and capability of self-renewal under current preparation regimes are limited. Induced pluripotent stem cells (iPSCs) now offer an alternative, similar cell source to MSCs. Herein, we established new methods for differentiating hiPSCs into MSCs via mesoderm-like and neuroepithelium-like cells. Both derived MSC populations exhibited self-renewal and multipotency, as well as therapeutic potential in mouse models of skin wounds, pressure ulcers, and osteoarthritis. Interestingly, the therapeutic effects differ between the two types of MSCs in the disease models, suggesting that the therapeutic effect depends on the cell origin. Our results provide valuable basic insights for the clinical application of such cells.	[Eto, Shinya; Goto, Mizuki; Soga, Minami; Kaneko, Yumi; Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto, Japan; [Goto, Mizuki] Oita Univ, Dept Dermatol, Fac Med, Yufu, Japan; [Uehara, Yusuke; Mizuta, Hiroshi] Kumamoto Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kumamoto, Japan	Kumamoto University; Oita University; Kumamoto University	Goto, M; Era, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto, Japan.; Goto, M (corresponding author), Oita Univ, Dept Dermatol, Fac Med, Yufu, Japan.	gotomizu@oita-u.ac.jp; tera@kumamoto-u.ac.jp			Japan Society for the Promotion Science (JSPS) [S2803]; Ministry of Health, Labor, and Welfare of Japan; Japan Agency for Medical Research and Development (A-MED); Core Research for Evolutional Science and Technology (CREST); KAKENHI [25505002, 18K06264]; Japan Science and Technology Agency (JST)	Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (A-MED)(Japan Agency for Medical Research and Development (AMED)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This study was supported, in part, by grants from Japan Society for the Promotion Science (JSPS, URLs: http://www.jsps.go.jp/english/) program on Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (Grant Number S2803), the Ministry of Health, Labor, and Welfare of Japan (URLs: http://www.mhlw.go.jp/english/), the Japan Agency for Medical Research and Development (A-MED, URLs: https://www.amed.go.jp/en/), Core Research for Evolutional Science and Technology (CREST, URLs: https://www.jst.go.jp/kisoken/crest/en/), Grant-in-Aid for Scientific Research (KAKENHI C, 25505002 and 18K06264, URLs: https://www.jsps.go.jp/english/e-grants/) and the Japan Science and Technology Agency (JST, URLs: https://www.jst.go.jp/EN/). T.E. received all of above grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Basiouny Hend Shafik, 2013, International Journal of Stem Cells, V6, P12; Bomsta BD, 2006, OSTEOARTHR CARTILAGE, V14, P477, DOI 10.1016/j.joca.2005.11.011; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bortolotti F, 2015, STEM CELL REP, V4, P332, DOI 10.1016/j.stemcr.2015.01.001; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Christiansen BA, 2015, OSTEOARTHR CARTILAGE, V23, P1627, DOI 10.1016/j.joca.2015.05.009; D'Antonio M, 2017, STEM CELL REP, V8, P1101, DOI 10.1016/j.stemcr.2017.03.011; de Rham C, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/518135; Fukuta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112291; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Hurley MM, 2016, J CELL BIOCHEM, V117, P721, DOI 10.1002/jcb.25357; Hynes K, 2012, PERIODONTOL 2000, V59, P203, DOI 10.1111/j.1600-0757.2012.00443.x; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kasuya A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04173; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Li JF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/470418; Li YY, 2014, BIO-MED MATER ENG, V24, pS47, DOI 10.3233/BME-140973; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mishra Pravin J, 2012, World J Stem Cells, V4, P35; Miwa H, 2018, DEVELOPMENT, V29, P145; Miwa H, 2014, METHODS MOL BIOL; Murphy WJ, 2012, CELL STEM CELL, V10, P485, DOI 10.1016/j.stem.2012.04.013; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pripuzova NS, 2015, STEM CELL RES, V14, P323, DOI 10.1016/j.scr.2015.01.009; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z; Resnick IB, 2013, AM J BLOOD RES, V3, P225; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Sheyn D, 2016, STEM CELL TRANSL MED, V5, P1447, DOI 10.5966/sctm.2015-0311; Soga M, 2014, STEM CELLS, V33, P1057; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; van Essen TH, 2015, PROG RETIN EYE RES, V46, P84, DOI 10.1016/j.preteyeres.2015.01.001; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wysocki A B, 1996, J Wound Ostomy Continence Nurs, V23, P283, DOI 10.1016/S1071-5754(96)90047-9; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Yang JJ, 2013, ANAT REC, V296, P1161, DOI 10.1002/ar.22676; Zhang JY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0417-0	51	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200790	10.1371/journal.pone.0200790	http://dx.doi.org/10.1371/journal.pone.0200790			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044827	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500066
J	Faoro, C; Wilkinson-White, L; Kwan, AH; Ataide, SF				Faoro, Camilla; Wilkinson-White, Lorna; Kwan, Ann H.; Ataide, Sandro F.			Discovery of fragments that target key interactions in the signal recognition particle (SRP) as potential leads for a new class of antibiotics	PLOS ONE			English	Article							GTPASE ACTIVATION; TRANSLATING RIBOSOME; CRYSTAL-STRUCTURE; RECEPTOR FTSY; DRUG DESIGN; PROTEIN; COMPLEX; NMR; RNA; BINDING	Given the increasing incidence of antibiotic resistance, antibiotics that employ new strategies are urgently needed. Bacterial survival is dependent on proper function of the signal recognition particle (SRP) and its receptor (FtsY). A unique set of interactions in FtsY:SRP-RNA represents a promising candidate for new antibiotic development as no antibiotic targets this complex and these interactions are functionally replaced by protein:protein interactions in eukaryotes. We used a Fragment Based Drug Design (FBDD) approach to search for new compounds that can bind FtsY, and have identified three lead fragments. In vitro and in vivo analyses have shown that despite a high micromolar binding affinity, one fragment has some antimicrobial properties. X-ray structures of E. coli FtsY:fragments reveal the fragments bind in the targeted RNA interaction site. Our results show that FBDD is a suitable approach for targeting FtsY:SRP-RNA for antibiotic development and opens the possibility of targeting protein:RNA interactions in general.	[Faoro, Camilla; Kwan, Ann H.; Ataide, Sandro F.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Wilkinson-White, Lorna] Univ Sydney, Sydney Analyt Core Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney	Kwan, AH; Ataide, SF (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	ann.kwan@sydney.edu.au; sandro.ataide@sydney.edu.au		Faoro, Camilla/0000-0002-6872-668X; F Ataide, Sandro/0000-0003-1807-5708; Kwan, Ann/0000-0002-1506-2226	ANSTO NDF [5132]; ARC LIEF [LE160100047]; University of Sydney; Faculties of Science and Medicine and School of Life and Environmental Sciences	ANSTO NDF; ARC LIEF(Australian Research Council); University of Sydney(University of Sydney); Faculties of Science and Medicine and School of Life and Environmental Sciences	This work was supported by internal University funding to SFA and AK, ANSTO NDF grant 5132 to SFA and AK as well as ARC LIEF grant LE160100047 to AK. We are grateful for financial contributions from the University of Sydney, including from the Faculties of Science and Medicine and School of Life and Environmental Sciences for support of the NMR and X-ray crystallography facilities that were used in this work. https://sydney.edu.au/; http://www.ansto. gov.au/; http://www.arc.gov.au/.	Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Baker M, 2013, NAT REV DRUG DISCOV, V12, P5, DOI 10.1038/nrd3926; Bange G, 2007, CURR BIOL, V17, pR980, DOI 10.1016/j.cub.2007.09.041; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; BROWN JD, 1994, EMBO J, V13, P4390, DOI 10.1002/j.1460-2075.1994.tb06759.x; Chavanieu A, 2016, EXPERT OPIN DRUG DIS, V11, P489, DOI 10.1517/17460441.2016.1160888; Costa EA, 2018, SCIENCE, V359, P689, DOI 10.1126/science.aar3607; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b; Doak BC, 2016, PHARMACOL THERAPEUT, V167, P28, DOI 10.1016/j.pharmthera.2016.07.003; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Huber S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175842; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Kalverda AP, 2014, MOL MEMBR BIOL, V31, P131, DOI 10.3109/09687688.2014.911980; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Retra K, 2010, ANAL BIOCHEM, V407, P58, DOI 10.1016/j.ab.2010.06.021; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; Sauer-Eriksson AE, 2003, CURR OPIN STRUC BIOL, V13, P64, DOI 10.1016/S0959-440X(02)00010-6; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Voigts-Hoffmann F, 2013, MOL CELL, V52, P643, DOI 10.1016/j.molcel.2013.10.005; Wild K, 2002, CURR OPIN STRUC BIOL, V12, P72, DOI 10.1016/S0959-440X(02)00292-0; Zhang DW, 2012, J BIOL CHEM, V287, P7652, DOI 10.1074/jbc.M111.325001	30	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200387	10.1371/journal.pone.0200387	http://dx.doi.org/10.1371/journal.pone.0200387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044812	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500050
J	Yu, WB; Wang, H; Liu, ML; Grabovskaya-Borodina, AE; Li, DZ				Yu, Wen-Bin; Wang, Hong; Liu, Min-Lu; Grabovskaya-Borodina, Alisa E.; Li, De-Zhu			Phylogenetic approaches resolve taxonomical confusion in Pedicularis (Orobanchaceae): Reinstatement of Pedicularis delavayi and discovering a new species Pedicularis milliana	PLOS ONE			English	Article							BAYESIAN POSTERIOR PROBABILITIES; HENGDUAN MOUNTAINS; SEED PRODUCTION; COROLLA TUBES; EVOLUTION; BOOTSTRAP; POLLINATION; ALGORITHM; SOFTWARE; BARCODE	Morphological identification of Pedicularis depends on floral characters. However, some important characters may be lost during the process of pressing the specimen. Pedicularis delavayi was described from northwestern Yunnan, and widely adopted as a variety of P. siphonantha. Unfortunately, the name "P. siphonantha var. delavayi incorrectly referred to P. milliana (a new species described in this study) or P. tenuituba in some herbarium specimens and publications. Moreover, phylogenetic relationships among P. delavayi, P. siphonantha and its allies (P. milliana and P. tenuituba) were not fully resolved. In this study, we sampled 76 individuals representing 56 taxa. Of them, 10 taxa were from P. siphonantha lineage, and 11 individuals of P. delavayi represented 9 populations. These species were named as P. siphonantha group on the basis of morphological similarity. Nuclear ribosomal internal transcribed spacer (nrITS) and four chloroplast genes/regions were used for phylogenetic analyses. Phylogenetic analyses showed that the P. siphonantha group was polyphyletic: P. delavayi was sister to P. obliquigaleata in Glade A; and the remaining species of P. siphonantha group were monophyletic in Glade B, named as P. siphonantha lineage. In the P. siphonantha lineage, P. milliana, P. siphonantha, and P. tenuituba were well supported as monophyletic, and P. dolichosiphon was sister to P. leptosiphon. Morphologically, P. de/avayidiffers from species of the P. siphonantha lineage in having a long petiole (similar to 50 mm) and pedicel (similar to 40 mm), a ridged corolla tube, and a folded lower-lip of the corolla. Therefore, both morphological characters and phylogenetic evidence strongly supported to reinstate P. delavayi as an independent species and describe P. milliana as new species. In addition, P. neolatituba was proposed to reduce as a new synonymy of P. delavayi.	[Yu, Wen-Bin] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China; [Yu, Wen-Bin] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Yezin, Nay Pyi Taw, Myanmar; [Wang, Hong; Liu, Min-Lu; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Wang, Hong; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Grabovskaya-Borodina, Alisa E.] Komarov Bot Inst, Prof Popov Str, St Petersburg, Russia	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Yu, WB (corresponding author), Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China.; Yu, WB (corresponding author), Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Yezin, Nay Pyi Taw, Myanmar.; Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.; Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.	yuwenbin@xtbg.ac.cn; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011; Yu, Wen-Bin/H-8339-2014	Li, De-Zhu/0000-0002-4990-724X; Yu, Wen-Bin/0000-0002-7643-2112	National Natural Science Foundation of China [31470323, 31200185]; National Key Basic Research Program of China [2014CB954100]; Major International Joint Research Project of National Natural Science Foundation of China [31320103919]; West Light Foundation of the Chinese Academy of Sciences [Y2227111W1]; Visiting Scholar Fellowship of Chinese Academy of Sciences; Komarov Botanical Institute of the Russian Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Major International Joint Research Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Visiting Scholar Fellowship of Chinese Academy of Sciences; Komarov Botanical Institute of the Russian Academy of Sciences	This study is supported by grants from the National Natural Science Foundation of China (grants 31470323, and 31200185), the National Key Basic Research Program of China (2014CB954100), the Major International Joint Research Project of National Natural Science Foundation of China (31320103919), the West Light Foundation of the Chinese Academy of Sciences (Y2227111W1), Visiting Scholar Fellowship of Chinese Academy of Sciences, and the research project of the Komarov Botanical Institute of the Russian Academy of Sciences: "Collections of vascular plants in BIN RAS (history, conservation, study and replenishment).	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Bonati G., 1921, NOTES ROY BOT GARD, V13, P103; Bonati G, 1904, RECORDS BOT SURVEY I, V4, P323; Bonati G., 1910, B SOC BOT FRANCE, V57, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Don D, 1825, PRODROMUS FLORAE NEP; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Gelman A, 1992, INFERENCE ITERATIVE, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guan KY, 1998, HIGHLAND FLOWERS YUN; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handel-Mazzetti HRE, 1923, AKAD WISSENSCHAFTEN, V60, P114; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hong W, 2005, ANN MO BOT GARD, V92, P127; Huang SQ, 2007, INT J PLANT SCI, V168, P325, DOI 10.1086/510209; Huang SQ, 2016, J INTEGR PLANT BIOL, V58, P698, DOI 10.1111/jipb.12460; Husain T, 2010, GENUS PEDICULARIS L; Jie C, 2004, CARYOLOGIA, V57, P337, DOI 10.1080/00087114.2004.10589817; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kolaczkowski B, 2007, MOL BIOL EVOL, V24, P2108, DOI 10.1093/molbev/msm141; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li H-L, 1948, P ACAD NAT SCI PHILA, V100, P205; LI HL, 1951, EVOLUTION, V5, P158, DOI 10.1111/j.1558-5646.1951.tb02771.x; LI HUI-LIN, 1949, PROC ACAD NAT SCI PHILADELPHIA, V101, P1; Li R, 2016, ORYX, V50, P204, DOI 10.1017/S0030605316000016; Limpricht W, 1924, REPERT SPEC NOV REGN, V20, P161, DOI DOI 10.1002/FEDR.19240200612; Liu ML, 2015, PHYTOTAXA, V217, P53, DOI 10.11646/phytotaxa.217.1.4; Liu Min-Lu, 2013, Plant Diversity and Resources, V35, P707, DOI 10.7677/ynzwyj201313168; MACIOR L W, 1991, Plant Species Biology, V6, P75, DOI 10.1111/j.1442-1984.1991.tb00212.x; Macior Lazarus Walter, 2001, Plant Species Biology, V16, P83, DOI 10.1046/j.1442-1984.2001.00048.x; Macior Lazarus Walter, 1997, Plant Species Biology, V12, P1, DOI 10.1111/j.1442-1984.1997.tb00150.x; Maximowicz CJ., 1888, B ACAD SCI ST PETERS, V32, P477; McNeil D, 2012, REGNUM VEGETABILE; Mill RR, 2001, FLORA BHUTAN, V2, P1156; Pennell Francis W, 1943, ACAD NAT SCI PHILADELPHIA MONOGR, V5, P1; Pennell FW, 1935, SCROPHULARIACEAE E T; Prain D., 1890, ANN ROYAL BOT GARDEN, V3, P1; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; Robart BW, 2015, SYST BOT, V40, P229, DOI 10.1600/036364415X686549; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tkach N, 2014, MOL PHYLOGENET EVOL, V76, P75, DOI 10.1016/j.ympev.2014.03.004; Tsoong P-C., 1955, ACTA PHYTOTAX SINICA, V4, P71; Tsoong P-C, 1956, ACTA PHYTOTAX SINICA, V5, P205; Tsoong P-C., 1961, ACTA BOT SIN, V9, P230; Tsoong P-C., 1963, FLORA REIPUBLICAE PO, V68, P1; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wang H., 2006, FLORA YUNNANICA, V16, P468; Wang W-T, 1994, VASCULAR PLANTS HE 2; [郁文彬 Wenbin Yu], 2008, [植物学通报, Chinese Bulletin of Botany], V25, P392; Xu B, 2013, SEED PLANTS ALPINE S; Yamazaki T, 1988, BULLETIN, V31, P91; Yang CF, 2005, BOT J LINN SOC, V147, P83, DOI 10.1111/j.1095-8339.2005.00363.x; Yang CF, 2002, PLANT SYST EVOL, V236, P89, DOI 10.1007/s00606-002-0223-z; Yang CF, 2015, BOT J LINN SOC, V179, P526, DOI 10.1111/boj.12331; Yang FS, 2007, PLANT SYST EVOL, V264, P251, DOI 10.1007/s00606-006-0510-1; Yang H-B, 1998, FLORA CHINA, V16, P97; Yu WB, 2008, NOVON, V18, P125, DOI 10.3417/2006032; Yu WB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0547-9; Yu WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074828; Yu WB, 2013, J SYST EVOL, V51, P435, DOI 10.1111/jse.12018; Yu WB, 2012, J SYST EVOL, V50, P218, DOI 10.1111/j.1759-6831.2012.00180.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x	66	1	2	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200372	10.1371/journal.pone.0200372	http://dx.doi.org/10.1371/journal.pone.0200372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044806	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500048
J	Williams, RA; Machin, LL				Williams, Richard A.; Machin, Laura L.			Rethinking gamete donor care: A satisfaction survey of egg and sperm donors in the UK	PLOS ONE			English	Article							OOCYTE DONATION; EMBRYO DONORS; FOLLOW-UP; MOTIVATION; ATTITUDES; GENDER; WOMEN	Objective Despite poor clinic communication and staff treatment being reported by donors, high rates of overall satisfaction are still reported in surveys. This study will evaluate the importance of communication and interaction between donors and fertility clinic staff in gamete donor care. Methods We report on 120 egg and sperm donors' responses to a UK-wide online satisfaction survey. The survey focused on donors' interactions with fertility clinic staff pre-, during, and post-donation. Basic cross-tabulation was performed on the data using online survey software. Textual data was read and extracts identified, which illustrated and expanded on the findings from the numerical data. Diagrammatic modeling was also utilised to analyse the textual data, with particular focus to relationships between the donors and clinic staff, the main activities within the gamete donation process, and how these activities may affect donor satisfaction with the gamete donation process. Results Donors expressed concern for the infertile couple and the resulting child; conveyed frustration at not receiving information on the expenses they could claim; felt lost in the system regarding the ease of making clinic appointments, and once made they were routinely not seen on time for these appointments. Donors also negatively commented on aftercare, the location and condition of the donation room, and information on contraception. In addition, Ovarian Hyperstimulation Syndrome was frequently reported, with these egg donors believing that clinic staff were not concerned with their physical or emotional well-being, but were instead disproportionately focused on extracting the eggs. Conclusions The multifaceted notion of donors highlights the complexity inherent to the gamete donation process, which comprises various aspects of uncertainty in the donation system, and ambiguity in the donation process. Categorising donors as Altruist, Customer, and Patient, conveys the particular importance of staff communication and treatment in donor care. These categories are not mutually exclusive however, in that an individual donor may experience more than one of these perspectives during the course of their gamete donation journey. Finally, there were a number of exemplar cases, where donors reported high satisfaction throughout, and these correlated with them being given a single point of contact at the clinic. Subject to resource constraints, we suggest that this practice should be implemented throughout clinics in the UK, so that donors have access to dedicated clinic staff who not only support them emotionally and physically throughout the gamete donation process, but also ensure that communication is open, clear, timely, and consistent.	[Williams, Richard A.] Univ Lancaster, Management Sch, Dept Management Sci, Lancaster, England; [Williams, Richard A.] Univ Lancaster, Data Sci Inst, Lancaster, England; [Machin, Laura L.] Univ Lancaster, Fac Hlth & Med, Med Sch, Lancaster, England	Lancaster University; Lancaster University; Lancaster University	Machin, LL (corresponding author), Univ Lancaster, Fac Hlth & Med, Med Sch, Lancaster, England.	l.machin@lancaster.ac.uk	Williams, Richard A/I-7883-2014; Williams, Richard/AAI-9331-2020	Williams, Richard A/0000-0001-6333-9448; Williams, Richard/0000-0001-6333-9448; Machin, Laura/0000-0002-6717-959X	National Gamete Donation Trust	National Gamete Donation Trust	The authors received funding from the National Gamete Donation Trust. Members of the Trust designed the questionnaire that was used for data collection, but have had no role in data analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their gratitude to the National Gamete Donation Trust who funded this study, and Kriss Fearon. Members of the Trust designed the questionnaire to collect the data used in this paper. However, the views expressed in this paper are the authors' own, and the Trust played no role in the data analysis or the writing of this paper.	Allan H, 2001, Nurs Inq, V8, P51, DOI 10.1046/j.1440-1800.2001.00090.x; Allan Helen T, 2005, Nurs Inq, V12, P175, DOI 10.1111/j.1440-1800.2005.00275.x; Allan HT, 2002, J ADV NURS, V38, P86, DOI 10.1046/j.1365-2648.2002.02149.x; Almeling R, 2006, NEW GENET SOC, V25, P143, DOI 10.1080/14636770600855184; Applegarth LD, 2006, INFERTILITY COUNSELING: A COMPREHENSIVE HANDBOOK FOR CLINICIANS, 2ND EDITION, P339; Arlow J, 2009, UML2 UN PROC PRACT O; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; AVIS M, 1995, J ADV NURS, V22, P316, DOI 10.1046/j.1365-2648.1995.22020316.x; BOOCH G, 1998, UNIFIED MODELING LAN; Braverman Andrea M., 2001, American Journal of Bioethics, V1, P16, DOI 10.1162/152651601317139234; Brett Sanora, 2008, Hum Fertil (Camb), V11, P101, DOI 10.1080/14647270801953109; Byrd Louise M, 2002, Hum Fertil (Camb), V5, P175, DOI 10.1080/1464727022000199082; Checkland P., 1999, RETHINKING MANAGEMEN; Crawshaw M, 2012, HUM FERTIL, V15, P82, DOI 10.3109/14647273.2012.687123; Fielding D, 1998, J COMMUNITY APPL SOC, V8, P273, DOI 10.1002/(SICI)1099-1298(199807/08)8:4<273::AID-CASP496>3.0.CO;2-Q; Fowler M., 2004, UML DISTILLED BRIEF, Vthird; Hamilton M, 2010, HUM FERTIL, V13, P257, DOI 10.3109/14647273.2010.518658; Human Fertilisation and Embryology Authority, FERT REG LAUNCH STRA; Jordan CB, 2004, J PSYCHOSOM OBST GYN, V25, P145, DOI 10.1080/1674820400002261; Kenney NJ, 2010, FERTIL STERIL, V93, P455, DOI 10.1016/j.fertnstert.2008.09.081; Klock SC, 1998, J WOMENS HEALTH, V7, P229, DOI 10.1089/jwh.1998.7.229; Klock SC, 2003, FERTIL STERIL, V79, P1312, DOI 10.1016/S0015-0282(03)00348-0; Machin LL, 2017, J INTERPROF CARE, V31, P342, DOI 10.1080/13561820.2016.1253546; Meerabeau L, 1998, J ADV NURS, V27, P721, DOI 10.1046/j.1365-2648.1998.00613.x; National Gamete Donation Trust, 2014, EGG SPERM DON UK 201; Object Management Group, UN MOD LANG SUP SPEC; Ockhuijsen HDL, 2012, J ADV NURS, V68, P1156, DOI 10.1111/j.1365-2648.2011.05829.x; Payne D, 2007, J ADV NURS, V60, P645, DOI 10.1111/j.1365-2648.2007.04451.x; Procter M., 2002, RES SOCIAL LIFE, P105; Purewal S, 2009, HUM REPROD UPDATE, V15, P499, DOI 10.1093/humupd/dmp018; Rapport F, 2003, J ADV NURS, V43, P28, DOI 10.1046/j.1365-2648.2003.02670.x; Redshaw M, 2008, BIRTH-ISS PERINAT C, V35, P73, DOI 10.1111/j.1523-536X.2007.00215.x; Royal College of Obstetricians and Gynaecologists, 2016, OV HYP SYNDR 2016; Seale C, 1998, RES SOC CULTURE, P146; Svanberg AS, 2013, ACTA OBSTET GYN SCAN, V92, P1049, DOI 10.1111/aogs.12156; Svanberg AS, 2012, ACTA OBSTET GYN SCAN, V91, P944, DOI 10.1111/j.1600-0412.2012.01430.x; Tomlinson MJ, 2010, HUM FERTIL, V13, P159, DOI 10.3109/14647273.2010.512654; Verdin H., 2018, OV HYP SYNDR 2016, P867; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5; Williams RA, 2017, P IEEE 2017 C EV COM, P249; Williams RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160834; Zhang L, 2016, BIOSYSTEMS, V139, P29, DOI 10.1016/j.biosystems.2015.12.006	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199971	10.1371/journal.pone.0199971	http://dx.doi.org/10.1371/journal.pone.0199971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036373	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000439429200009
J	Binderup, HG; Madsen, JS; Heegaard, NHH; Houlind, K; Andersen, RF; Brasen, CL				Binderup, Helle Glud; Madsen, Jonna Skov; Heegaard, Niels Henrik Helweg; Houlind, Kim; Andersen, Rikke Fredslund; Brasen, Claus Lohman			Quantification of microRNA levels in plasma - Impact of preanalytical and analytical conditions	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CIRCULATING MICRORNAS; ABSOLUTE QUANTIFICATION; CANCER-PATIENTS; EXPRESSION; CHALLENGES; SIGNATURE; BIOMARKER; MIRNAS	Numerous studies have reported a potential role for circulating microRNAs as biomarkers in a wide variety of diseases. However, there is a critical reproducibility challenge some of which might be due to differences in preanalytical and/or analytical factors. Thus, in the current study we systematically investigated the impact of selected preanalytical and analytical variables on the measured microRNA levels in plasma. Similar levels of microRNA were found in platelet-poor plasma obtained by dual compared to prolonged single centrifugation. In contrast, poor correlation was observed between measurements in standard plasma compared to platelet-poor plasma. The correlation between quantitative real-time PCR and droplet digital PCR was found to be good, contrary to TaqMan Low Density Array and single TaqMan assays where no correlation could be demonstrated. Dependent on the specific microRNA measured and the normalization strategy used, the intra- and inter-assay variation of quantitative real-time PCR were found to be 4.2-6.8% and 10.5-31.4%, respectively. Using droplet digital PCR the intra-assay variation was 4.4-20.1%, and the inter-assay variation 5.7-26.7%. Plasma preparation and microRNA purification were found to account for 39-73% of the total intra-assay variation, dependent on the microRNA measured and the normalization strategy used. In conclusion, our study highlighted the importance of reporting comprehensive methodological information when publishing, allowing others to perform validation studies where preanalytical and analytical variables as causes for divergent results can be minimized. Furthermore, if microRNAs are to become routinely used diagnostic or prognostic biomarkers, the differences in plasma microRNA levels between health and diseased subjects must exceed the high preanalytical and analytical variability.	[Binderup, Helle Glud; Madsen, Jonna Skov; Andersen, Rikke Fredslund; Brasen, Claus Lohman] Lillebaelt Hosp, Biochem & Immunol, Kolding, Denmark; [Binderup, Helle Glud; Madsen, Jonna Skov; Andersen, Rikke Fredslund; Brasen, Claus Lohman] Lillebaelt Hosp, Biochem & Immunol, Vejle, Denmark; [Binderup, Helle Glud; Madsen, Jonna Skov; Houlind, Kim; Brasen, Claus Lohman] Univ Southern Denmark, Dept Reg Hlth Res, Kolding, Denmark; [Heegaard, Niels Henrik Helweg] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen, Denmark; [Heegaard, Niels Henrik Helweg] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Houlind, Kim] Lillebaelt Hosp, Dept Vasc Surg, Kolding, Denmark	University of Southern Denmark; Statens Serum Institut; University of Southern Denmark; Odense University Hospital	Binderup, HG (corresponding author), Lillebaelt Hosp, Biochem & Immunol, Kolding, Denmark.; Binderup, HG (corresponding author), Lillebaelt Hosp, Biochem & Immunol, Vejle, Denmark.; Binderup, HG (corresponding author), Univ Southern Denmark, Dept Reg Hlth Res, Kolding, Denmark.	helle.glud.binderup@rsyd.dk	Madsen, Jonna Skov/AAF-7054-2019; Brasen, Claus/ABG-9421-2021; Andersen, Rikke/GRS-3064-2022	Madsen, Jonna Skov/0000-0001-6668-4714; Houlind, Kim/0000-0002-1600-4415; Binderup, Helle Glud/0000-0001-6698-9948; Andersen, Rikke Fredslund/0000-0002-5894-7745	Overlaege Jorgen Werner Schous og hustru Else Marie Schou, fodt Wonges fond [85832]; Faculty of Health Sciences, University of Southern Denmark	Overlaege Jorgen Werner Schous og hustru Else Marie Schou, fodt Wonges fond; Faculty of Health Sciences, University of Southern Denmark	This work was supported by Overlaege Jorgen Werner Schous og hustru Else Marie Schou, fodt Wonges fond, J.nr. 85832, no URL exists; PhD Scholarship, Faculty of Health Sciences, University of Southern Denmark, www.sdu.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qatati A, 2017, INT J CANCER, V141, P1231, DOI 10.1002/ijc.30815; Bandyopadhyay S, 2014, PLOS ONE; Binderup Helle Glud, 2016, Biochem Biophys Rep, V7, P195, DOI 10.1016/j.bbrep.2016.06.005; Binderup HG, 2016, CLIN BIOCHEM, V49, P1167, DOI 10.1016/j.clinbiochem.2016.04.017; Brunet-Vega A, 2015, ANAL BIOCHEM, V488, P28, DOI 10.1016/j.ab.2015.07.018; Campomenosi P, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0292-7; Cheng HH, 2013, PLOS ONE; Darvasi O, 2019, PATHOL ONCOL RES, V25, P169, DOI 10.1007/s12253-017-0330-3; Ferracin M, 2015, ONCOTARGET, V6, P14545, DOI 10.18632/oncotarget.3859; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gao XJ, 2016, ONCOTARGET, V7, P59664, DOI 10.18632/oncotarget.11198; Guttin Audrey, 2016, Microrna, V5, P201; Heegaard NHH, 2015, EXPERIENTIA SUPPL, V106, P171, DOI 10.1007/978-3-0348-0955-9_8; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Jiang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05026; Jorge KTOS, 2017, J CLIN MICROBIOL, V55, P1516, DOI 10.1128/JCM.02408-16; Liang HW, 2014, WIRES RNA, V5, P285, DOI 10.1002/wrna.1208; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Poel D, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.288; Sayed ASM, 2015, CLINICS, V70, P257, DOI 10.6061/clinics/2015(04)07; Scrutinio D, 2017, J HEART LUNG TRANSPL, V36, P616, DOI 10.1016/j.healun.2017.02.008; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Sourvinou IS, 2013, J MOL DIAGN, V15, P827, DOI 10.1016/j.jmoldx.2013.07.005; Sueta A, 2017, ONCOTARGET, V8, P69934, DOI 10.18632/oncotarget.19482; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Vigneron N, 2016, MOL ONCOL, V10, P981, DOI 10.1016/j.molonc.2016.03.005; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Yan SY, 2016, ACTA DIABETOL, V53, P693, DOI 10.1007/s00592-016-0837-1; Zheng XH, 2013, CHIN J CANCER, V32, P667, DOI 10.5732/cjc.012.10271	32	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201069	10.1371/journal.pone.0201069	http://dx.doi.org/10.1371/journal.pone.0201069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024941	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000088
J	Maraci, O; Ozkan, H; Bilgin, R				Maraci, Oncu; Ozkan, Hakan; Bilgin, Rasit			Phylogeny and genetic structure in the genus Secale	PLOS ONE			English	Article							CEREALE L.; POPULATION-STRUCTURE; MOLECULAR DIVERSITY; EVOLUTIONARY TRENDS; DNA-SEQUENCES; RYE; SOFTWARE; ORIGIN; PLANT; POLYMORPHISM	Secale L. is a small but important genus that includes cultivated rye. Although genetic diversity of cultivated rye is high, patterns of genetic diversity in the whole genus, and potential factors affecting the distribution of genetic diversity remain elusive. The population structure and distribution of genetic variation within Secale, and its correlation with taxonomic delimitation, cultivation status or spatial distribution in relation to geography and climate zones were analyzed in this study. A collection of 726 individual plants derived from 139 different accessions representing Secale cereale, S. vavilovii, S. strictum, and S. sylvestre were investigated using SSR analysis and sequence diversity analysis of a nuclear EST region. Our results indicated that perennial S. strictum subspecies are genetically divergent from annual forms of the genus. Existence of two distinct clusters within the annual taxa was observed, one corresponding to samples from Asia, and a second to those outside of Asia. No clear genetic structure was observed between different annual species/subspecies, indicating introgression between these taxa. The analysis of cultivated rye revealed that landrace populations from the Middle East have the highest genetic diversity, supporting the idea of the area being the center of origin for cultivated rye. Considering high adaptive potential of those populations, Middle Eastern landraces should be regarded as genetic resources reservoirs for new niches and future breeding programs.	[Maraci, Oncu] Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany; [Maraci, Oncu] Bielefeld Univ, Evolutionary Biol, Bielefeld, Germany; [Maraci, Oncu; Bilgin, Rasit] Bogazici Univ, Inst Environm Sci, Istanbul, Turkey; [Ozkan, Hakan] Univ Cukurova, Fac Agr, Dept Field Crops, Adana, Turkey	University of Bielefeld; University of Bielefeld; Bogazici University; Cukurova University	Maraci, O (corresponding author), Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany.; Maraci, O (corresponding author), Bielefeld Univ, Evolutionary Biol, Bielefeld, Germany.; Maraci, O (corresponding author), Bogazici Univ, Inst Environm Sci, Istanbul, Turkey.	oncu.maraci@uni-bielefeld.de	Bilgin, Rasit/A-3129-2016; ÖZKAN, Hakan/C-8510-2011	ÖZKAN, Hakan/0000-0003-3530-2626; Maraci, Oncu/0000-0001-8837-7766	Bogazici University in Istanbul [09S101, 1903]; German Research Foundation (DFG) [11Y00P2]; Bielefeld University; German Research Foundation (DFG)	Bogazici University in Istanbul(Bogazici University); German Research Foundation (DFG)(German Research Foundation (DFG)); Bielefeld University; German Research Foundation (DFG)(German Research Foundation (DFG))	Research Fund of Bogazici University in Istanbul to RB, Grant No: 09S101, 1903 and 11Y00P2 German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge to OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Dr. Emrah Coraman and Pahar Patlar for their support during the data analysis and production of figures. Seed materials were kindly provided by National Small Grains Collection of United States Department of Agriculture and Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany. We acknowledge the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge. We wish to express our sincere gratitude to the reviewers, for extremely valuable suggestions and comments.	Achrem M, 2014, TURK J BOT, V38, P213, DOI 10.3906/bot-1207-26; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Broda Zbigniew, 2016, Acta Agrobotanica, V69, P1652, DOI 10.5586/aa.1652; Burger JC, 2006, MOL ECOL, V15, P2527, DOI 10.1111/j.1365-294X.2006.02938.x; Ceccarelli S, 2009, J AGRIC ENVIRON INT, V103, P131; Chikmawati T, 2012, GENET RESOUR CROP EV, V59, P1743, DOI 10.1007/s10722-012-9796-8; Chikmawati T, 2005, GENOME, V48, P792, DOI 10.1139/g05-043; Chikmawati T., 2003, PHYLOGENETIC RELATIO; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Cuadrado A, 1997, GENOME, V40, P309, DOI 10.1139/g97-043; Cuadrado A, 2002, J HERED, V93, P339, DOI 10.1093/jhered/93.5.339; Cuevas HE, 2013, GENET RESOUR CROP EV, V60, P1817, DOI 10.1007/s10722-013-9956-5; De Bustos A, 2002, PLANT SYST EVOL, V235, P147, DOI 10.1007/s00606-002-0215-z; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falconer DS, 1996, INTROD TO QUANT GENE, V4, P43, DOI [10.1016/j.bbabio.2008.04.029, DOI 10.1016/J.BBABIO.2008.04.029]; Frederiksen S, 1997, NORD J BOT, V17, P185, DOI 10.1111/j.1756-1051.1997.tb00309.x; Frederiksen S, 1998, NORD J BOT, V18, P399, DOI 10.1111/j.1756-1051.1998.tb01517.x; Gailite Agnese, 2013, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V67, P264, DOI 10.2478/prolas-2013-0046; Goudet J., 2013, J HERED, V104, P586, DOI DOI 10.1093/JHERED/EST020; Grabowski R, 2011, VEG HIST ARCHAEOBOT, V20, P479, DOI 10.1007/s00334-011-0283-5; Gutierrez Juan, 2009, J HERED, V6, P718; Hagenblad J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0710-y; Hammer K, 2003, NATURWISSENSCHAFTEN, V90, P241, DOI 10.1007/s00114-003-0433-4; HAMMER K, 1990, BIOL ZBL, V109, P45; Hammer K., 1987, Kulturpflanze, V35, P135; Harris SA, 1999, SYST ASSOC SPEC VOL, V57, P211; Hawtin G, 1996, EUPHYTICA, V92, P255, DOI 10.1007/BF00022853; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jenabi T, 2011, GENET RESOUR CROP EV, V58, P497, DOI 10.1007/s10722-010-9593-1; JONES JDG, 1982, CHROMOSOMA, V86, P595, DOI 10.1007/BF00285606; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Khlestkina EK, 2004, THEOR APPL GENET, V109, P725, DOI 10.1007/s00122-004-1659-z; KHUSH G. S., 1963, Zeitschrift fur Pflanzenzuchtung, V50, P34; KHUSH GS, 1961, AM J BOT, V48, P723, DOI 10.2307/2439062; KHUSH GS, 1962, EVOLUTION, V16, P484, DOI 10.2307/2406180; KHUSH GURDEV S., 1963, ECON BOT, V17, P60, DOI 10.1007/BF02985354; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; LANTERI S, 2006, ROLE BIOTECHNOLOGY E, P55; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu KJ, 2003, GENETICS, V165, P2117; Matos M, 2001, HEREDITAS, V134, P229, DOI 10.1111/j.1601-5223.2001.00229.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Persson K, 2000, HEREDITAS, V132, P7, DOI 10.1111/j.1601-5223.2000.00007.x; Persson K, 2002, HEREDITAS, V136, P29, DOI 10.1034/j.1601-5223.2002.1360105.x; Pritchard JK, 2000, GENETICS, V155, P945; RAMIREZ L, 1986, GENETICA, V69, P209, DOI 10.1007/BF00133523; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Ren TH, 2011, GENOME, V54, P316, DOI [10.1139/G10-121, 10.1139/g10-121]; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saal B, 1999, GENOME, V42, P964, DOI 10.1139/gen-42-5-964; Santarnecchi E, 2017, BRAIN TOPOGR, V30, P502, DOI 10.1007/s10548-017-0565-z; Santos E, 2016, J GENET, V95, P273, DOI 10.1007/s12041-016-0632-3; Schlegel R, 2006, GEN RESOUR CHROM ENG, V2, P365; Schlegel R.H., 2013, RYE GENETICS BREEDIN; SENCER HA, 1980, BIOL J LINN SOC, V13, P299, DOI 10.1111/j.1095-8312.1980.tb00089.x; Shang HY, 2006, GENET MOL BIOL, V29, P685, DOI 10.1590/S1415-47572006000400018; Skuza L, 2007, ACTA BIOL CRACOV BOT, V49, P77; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STUTZ HC, 1972, AM J BOT, V59, P59, DOI 10.2307/2441230; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang SX, 2003, THEOR APPL GENET, V106, P990, DOI 10.1007/s00122-002-1127-6; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Targonska M, 2016, PLANT MOL BIOL REP, V34, P37, DOI 10.1007/s11105-015-0896-4; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Vavilov N. I, 1917, BULL APP BOT, V10, P561; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; VENCES FJ, 1987, PLANT BREEDING, V98, P281, DOI 10.1111/j.1439-0523.1987.tb01131.x; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237; Zhukovsky PM, 1933, LA TURGUIE AGRACOLE; ZOHARY D., 1971, Plant life of south-west Asia., P235; Zohary D, 2000, DOMESTICATION PLANTS, V531, P206; Zohary D, 1996, ORIGINS SPREAD AGR P, P142	80	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200825	10.1371/journal.pone.0200825	http://dx.doi.org/10.1371/journal.pone.0200825			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024916	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000056
J	Park, CK; Malinowski, DP; Cho, NH				Park, Cheol Keun; Malinowski, Douglas P.; Cho, Nam Hoon			Diagnostic algorithm for determining primary tumor sites using peritoneal fluid	PLOS ONE			English	Article							CANCER; EXPRESSION; CYTOLOGY; IMMUNOCYTOCHEMISTRY; CYTOKERATIN-20; TRIAGE; OVARY; WOMEN	This study was conducted to develop a novel algorithm for determining the origin of tumors by combining analysis of cluster patterns with immunocytochemistry (ICC) for markers in cells from fine-needle aspirates of ascites. We used LBC, based on SurePath (TM) (BD Diagnostics) technology, to screen 96 peritoneal fluid samples from patients with known malignancies and from 10 control patients with cirrhosis. Following dual ICC staining for cytokeratin 7 (CK7) and paired box gene 8 (PAX8), we developed an algorithm using immunoreactivity and three-dimensional (3D) cluster patterns to correlate staining and 3D cluster patterns with common primary origins that included stomach, ovarian, pancreatobiliary tract, colon, lung, and breast cancers. With the application of an automatic digitalized image analyzer, competence performance was analyzed using receiver operating characteristics (ROC) curve analysis. CK7 and PAX8 staining and 3D cluster patterns were used to differentiate primary origins. Samples from patients with stomach cancer were no 3D cluster /CK7(+)/PAX8(-) with area under the curve (AUC) of 0.8699 in ROC curve analysis. Samples from ovarian cancer patients were large 3D cluster/CK7(+)/PAX8(+) with AUC of 0.9812. Samples from pancreatobiliary tract cancer patients were small 3D cluster/CK7(+)/PAX8(-) with AUC of 0.8772. The remaining cancer samples, including breast, lung and colon cancer samples, had similar patterns of large 3D clusters/CK7(+)/PAX8(-) with AUC of 0.882, especially for lung cancer. SurePath (TM) technology, using 3D cluster patterns and dual ICC for CK7 and PAX8 in peritoneal fluid samples, can provide important information for determining specific primary origins in cases of unknown primary carcinoma.	[Park, Cheol Keun; Cho, Nam Hoon] Yonsei Univ, Severance hosp, Dept Pathol, Coll Med, Seoul, South Korea; [Park, Cheol Keun] Armed Forces Capital Hosp, Dept Pathol, Seongnam, South Korea; [Malinowski, Douglas P.] BD Life Sci, Womens Hlth & Canc, Durham, NC USA	Yonsei University; Yonsei University Health System	Cho, NH (corresponding author), Yonsei Univ, Severance hosp, Dept Pathol, Coll Med, Seoul, South Korea.	cho1988@yuhs.ac		jo, namhun/0000-0002-0045-6441	Mid-career Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2016R1A2B4011115]	Mid-career Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by the Mid-career Researcher Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: 2016R1A2B4011115; URL: https://www.nrf.re.kr/index).	Chen CC, 2016, ANN SAUDI MED, V36, P245, DOI 10.5144/0256-4947.2016.245; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Dadhich H, 2016, DIAGN CYTOPATHOL, V44, P874, DOI 10.1002/dc.23567; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gertych A, 2012, ANN BIOMED ENG, V40, P1192, DOI 10.1007/s10439-011-0498-8; Kaur G, 2017, DIAGN CYTOPATHOL, V45, P195, DOI 10.1002/dc.23659; Kawahara A, 2014, CANCER CYTOPATHOL, V122, P145, DOI 10.1002/cncy.21355; McCluggage WG, 2005, SEMIN DIAGN PATHOL, V22, P3, DOI 10.1053/j.semdp.2005.11.002; Morimoto A, 2014, ACTA CYTOL, V58, P461, DOI 10.1159/000367706; Ordi J, 2014, CANCER CYTOPATHOL, V122, P227, DOI 10.1002/cncy.21366; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P140, DOI 10.1097/PAP.0b013e318253465d; Park SY, 2002, HUM PATHOL, V33, P1078, DOI 10.1053/hupa.2002.129422; Piaton E, 2014, CANCER CYTOPATHOL, V122, P211, DOI 10.1002/cncy.21376; Shidham VB, 2010, CYTOJOURNAL, V7, DOI 10.4103/1742-6413.59887; Vang R, 2006, AM J SURG PATHOL, V30, P1130; Varadhachary GR, 2004, CANCER-AM CANCER SOC, V100, P1776, DOI 10.1002/cncr.20202	16	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199715	10.1371/journal.pone.0199715	http://dx.doi.org/10.1371/journal.pone.0199715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024911	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000009
J	Bhandari, S; Abdul, MKM; Hollabaugh, W; Sharma, K; Evans, DB; Guda, N				Bhandari, Sanjay; Abdul, Mubeen Khan Mohammed; Hollabaugh, Will; Sharma, Kanav; Evans, Douglas B.; Guda, Nalini			Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions	PLOS ONE			English	Article							MANAGEMENT; BURDEN; CARE	Background and aim Pancreatic cancer is one of the common cancers in US and is associated with high mortality and morbidity. The objectives of our study were to look at the recent trends in the number of hospitalizations with pancreatic cancer. Methods We identified patients with a discharge diagnosis of pancreatic cancer in the National Inpatient Sample from 2007 to 2011 using International Classification of Diseases-Clinical Modification, 9th revision (ICD-9-CM) codes. We looked at the yearly trend in the hospitalizations with pancreatic cancer and the outcomes which included length of stay (LOS), hospital charges and in-hospital mortality. We also performed multivariate analysis to look for the predictors of mortality. Results There were 450, 414 patients with discharge diagnosis of pancreatic cancer. There was 18% increase in hospitalizations with pancreatic cancer in 2011 compared to 2007. Most of the patients were Caucasian (63%) with the mean age of 68 +/- 0.14 years, had Medicare (57%) as primary insurance, were from Southern region (35%) and had higher Charlson Comorbidity Index (CCI) (87% with CCI > = 5). 6% underwent Whipple's procedure in the index hospitalization. After the adjustment for inflation, the mean hospital charges increased from $ 47,331 in 20007 to $ 53, 854 in 2011 (p = 0.01). LOS decreased from 7.31 +/- 0.11 days in 2007 to 6.70 +/- 0.09 days in 2011 (<0.001). Despite the increase in the number of hospitalizations of patients with pancreatic cancer, mortality decreased from 9.8% in 2007 to 8.1% in 2011 (p<0.001). On multivariate analysis, the independent factors associated with higher mortality were older age, male sex African-American race, insurance status other than Medicare, higher CCI and enrollment in palliative care. There was regional variation in mortality. Whipple's procedure conferred lower mortality. Conclusions Our study showed downward trends in LOS and in-hospital mortality despite increasing hospitalizations with pancreatic cancer.	[Bhandari, Sanjay; Sharma, Kanav] Med Coll Wisconsin, Dept Med, Div Gen Internal Med, Milwaukee, WI 53226 USA; [Abdul, Mubeen Khan Mohammed] Aurora St Lukes Med Ctr, Dept Med, Milwaukee, WI USA; [Hollabaugh, Will] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Evans, Douglas B.] Med Coll Wisconsin Milwaukee, Dept Surg, Div Surg Oncol, Milwaukee, WI USA; [Guda, Nalini] Aurora St Lukes Med Ctr, Div Gastroenterol, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Bhandari, S (corresponding author), Med Coll Wisconsin, Dept Med, Div Gen Internal Med, Milwaukee, WI 53226 USA.	sbhandari@mcw.edu						[Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P989, DOI 10.15585/mmwr.mm6536a10; [Anonymous], HEALTHC COST UT PROJ; Brunner TB, 2016, BEST PRACT RES CL GA, V30, P617, DOI 10.1016/j.bpg.2016.08.001; Cascinu S, 2010, ANN ONCOL, V21, pv55, DOI 10.1093/annonc/mdq165; Helm James F, 2008, Cancer Control, V15, P288; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Matrisian Lynn M, 2016, Am Soc Clin Oncol Educ Book, V35, pe205, DOI 10.14694/EDBK_159117; McDavid K, 2003, ARCH INTERN MED, V163, P2135, DOI 10.1001/archinte.163.18.2135; McKoy JM, 2009, J CLIN ONCOL, V27, P2745, DOI 10.1200/JCO.2009.22.4352; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mohammed S, 2014, WORLD J GASTROENTERO, V20, P9354, DOI 10.3748/wjg.v20.i28.9354; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh D, 2015, BBA-REV CANCER, V1856, P13, DOI 10.1016/j.bbcan.2015.04.003; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Spanknebel K, 2001, CANCER J, V7, P312; Sun Weixia, 2012, Dose Response, V11, P385, DOI 10.2203/dose-response.12-027.Cai; Wadhwa V, 2016, PANCREAS, V45, pE41, DOI 10.1097/MPA.0000000000000648; Wang Y, 2014, CANCER-AM CANCER SOC, V120, P1050, DOI 10.1002/cncr.28537; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Yeh NC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002293	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199909	10.1371/journal.pone.0199909	http://dx.doi.org/10.1371/journal.pone.0199909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020978	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400032
J	Fernandez, AB; Ballard, KD; Wong, TY; Guo, M; McClelland, RL; Burke, G; Cotch, MF; Klein, B; Allison, M; Klein, R				Fernandez, Antonio B.; Ballard, Kevin D.; Wong, Tien Y.; Guo, Mengye; McClelland, Robyn L.; Burke, Gregory; Cotch, Mary Frances; Klein, Barbara; Allison, Matthew; Klein, Ronald			Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTORS; EYE DISEASE; INTERVENTION; MORTALITY; ADULTS; PLAQUE; MESA; CT	Background Age-related macular degeneration (AMD) shares many similarities with cardiovascular disease (CVD) pathophysiology. We sought to determine the relationship of AMD to the progression of coronary artery calcium (CAC) using data from the Multi-Ethnic Study of Atherosclerosis (MESA). Methods Our cohort consisted of 5803 adults aged 45 to 84 years free of known cardiovascular disease (CVD). Retinal photographs were taken during visit 2 (Aug 2002-Jan 2004). CAC was measured with computed tomography at visit 1 (July 2000-Aug 2002) and visit 5 (April 2010-Dec 2011) and changes between visits were determined. Results Participants were categorized as with (n = 244) and without AMD (n = 5559) at visit 2. At visit 5, 92 participants with and 2684 without AMD had CAC scores. Among those with detectable CAC at baseline (>0 at visit 1), CAC progression was greater in persons with compared to those without AMD after multivariable adjustment (530 +/- 537 vs. 339 +/- 426 Agatston units, P<0.01). Conclusions The presence of AMD in a diverse population without known clinical CVD independently predicted higher 10-year CAC progression in participants with baseline CAC >0. The retinal exam might be a useful tool for pre-clinical assessment and prevention of CVD events.	[Fernandez, Antonio B.] Hartford Hosp, Inst Heart & Vasc, Div Cardiol, Hartford, CT 06115 USA; [Fernandez, Antonio B.] Univ Connecticut, Dept Med, Farmington, CT 06032 USA; [Ballard, Kevin D.] Miami Univ, Dept Kinesiol & Hlth, Oxford, OH 45056 USA; [Wong, Tien Y.] Natl Univ Singapore, Singapore Natl Eye Ctr, Duke NUS Med Sch, Singapore Eye Res Inst, Singapore, Singapore; [Guo, Mengye; McClelland, Robyn L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Burke, Gregory] Wake Forest Univ Hlth Sci, Dept Publ Hlth Sci, Winston Salem, NC USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Klein, Barbara; Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Allison, Matthew] Univ Calif San Diego, La Jolla, CA 92093 USA	Hartford Hospital; University of Connecticut; University System of Ohio; Miami University; National University of Singapore; Singapore National Eye Center; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest University School of Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Fernandez, AB (corresponding author), Hartford Hosp, Inst Heart & Vasc, Div Cardiol, Hartford, CT 06115 USA.; Fernandez, AB (corresponding author), Univ Connecticut, Dept Med, Farmington, CT 06032 USA.	antonio.fernandez@hhchealth.org	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Cotch, Mary Frances/0000-0002-2046-4350; Fernandez, Antonio/0000-0003-4517-9123; Klein, Ronald/0000-0002-4428-6237	National Heart, Lung, and Blood Institute [HL69979-03, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166]; NATIONAL EYE INSTITUTE [ZIAEY000403] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant #: HL69979-03 to Dr. Klein and Dr. Wong and by contracts N01-HC-95159 through N01-HC-95166 from the National Heart, Lung, and Blood Institute. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; Cheung CMG, 2014, J INTERN MED, V276, P140, DOI 10.1111/joim.12227; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; Criqui MH, 2014, JAMA-J AM MED ASSOC, V311, P271, DOI 10.1001/jama.2013.282535; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Fernandez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142968; Fernandez AB, 2012, OPHTHALMOLOGY, V119, P765, DOI 10.1016/j.ophtha.2011.09.044; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Hughes-Austin JM, 2014, VASC MED, V19, P264, DOI 10.1177/1358863X14537545; Ikram MK, 2012, STROKE, V43, P1681, DOI 10.1161/STROKEAHA.112.654632; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P1642, DOI 10.1001/archopht.122.11.1642; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2007, ARCH OPHTHALMOL-CHIC, V125, P534, DOI 10.1001/archopht.125.4.534; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; McClelland RL, 2015, J AM COLL CARDIOL, V66, P1643, DOI 10.1016/j.jacc.2015.08.035; McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038; Pulido JS, 2007, MAYO CLIN PROC, V82, P301, DOI 10.4065/82.3.301; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wong TY, 2009, AM J OPHTHALMOL, V148, P327, DOI 10.1016/j.ajo.2009.05.012; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yeboah J, 2016, J AM COLL CARDIOL, V67, P139, DOI 10.1016/j.jacc.2015.10.058	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0201000	10.1371/journal.pone.0201000	http://dx.doi.org/10.1371/journal.pone.0201000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020999	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400089
J	You, WP; Henneberg, M				You, Wenpeng; Henneberg, Maciej			Relaxed natural selection contributes to global obesity increase more in males than in females due to more environmental modifications in female body mass	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; WAIST CIRCUMFERENCE; SEX-DIFFERENCES; WEIGHT; FAT; PREVALENCE; COUNTRIES; MUTATION; INDEX	Objective Relaxed natural selection, measured by Biological State Index (I-bs), results in unfavourable genes/mutations accumulation in population. Obesity is partly heritable. We aim to examine and compare the effects of relaxed natural selection on male and female obesity prevalence. Methods Data for 191 countries of the world were captured for this ecological study. Curvilinear regressions, bivariate and partial correlations, linear mixed models and multivariate linear regression analyses were used to examine the relationship between I-bs and sex-specific obesity prevalence. Per capita GDP, urbanization and caloric intake were controlled for as the confounding factors. Fisher r-to-z transformation, R-2 increment in multivariate regression and F-test were used to compare the correlations. Results Curvilinear regressions, bivariate and partial correlations (controlled for GDP, urbanization and calories) revealed that I-bs was significantly correlated to obesity prevalence of both sexes, but significantly stronger to male than to female obesity prevalence. Curvilinear regression models also showed strong correlations. Mixed linear models, with effects of GDP, urbanisation and caloric intake controlled for, showed that male and female average obesity prevalence rates were significantly higher in countries with greater I-bs value than their equivalents in countries with lower I-bs. Between higher and lower I-bs countries, the gap of male obesity prevalence is 60% greater than the gap of female obesity prevalence. Stepwise multiple regression identified that I-bs was a significant predictor of obesity prevalence of both sexes. Multivariate regression showed that, adding I-bs as an obesity predictor, R-2 increment in male model was significantly greater than in female model. Conclusions Relaxed natural selection may drive males and females to accumulate metabolic faulty genes equally. Probably due to greater environmental, personal intervention in regulating female body mass, relaxed natural selection shows less contributing effects to female obesity prevalence than to male obesity prevalence. Gene therapy to prevent obesity may need to be also taken into account.	[You, Wenpeng; Henneberg, Maciej] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Henneberg, Maciej] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland	University of Adelaide; University of Zurich	You, WP (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.	Wenpeng.you@adelaide.edu.au		You, Wenpeng/0000-0002-6229-1064; Henneberg, Maciej/0000-0003-1941-2286	MaExi Foundation, Zurich, Switzerland	MaExi Foundation, Zurich, Switzerland	This work was supported by the MaExi Foundation, Zurich, Switzerland awarded to Professor Maciej Henneberg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Eisa ES, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/642187; Al-Habsi Azza, 2015, Sultan Qaboos Univ Med J, V15, pe257; Al-Kandari YY, 2006, OBES REV, V7, P147, DOI 10.1111/j.1467-789X.2006.00231.x; Al-Riyami AA, 2003, SAUDI MED J, V24, P641; Aranceta J, 2009, NUTR REV, V67, pS83, DOI 10.1111/j.1753-4887.2009.00166.x; Astrup A, 2012, LANCET, V379, P1100, DOI 10.1016/S0140-6736(12)60456-5; Blair SN, 2013, INT J EPIDEMIOL, V42, P1836, DOI 10.1093/ije/dyt160; Bleich SN, 2008, WHY IS DEV WORLD OBE, P273; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Budnik A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170098; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Courtiol A, 2012, P NATL ACAD SCI USA, V109, P8044, DOI 10.1073/pnas.1118174109; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Darwin C., 1901, DESCENT MAN SELECTIO; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; FAO, 2001, FOOD BAL SHEETS HDB; Fezeu L, 2010, INT J OBESITY, V34, P446, DOI 10.1038/ijo.2009.256; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gallagher J., 2017, GENE THERAPY GLYBERA; GHO, 2015, CAT INS PHYS ACT; Giskes K, 2008, OBESITY, V16, P1377, DOI 10.1038/oby.2008.54; Grantham JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099776; Hall B, 2008, STRICKBERGERS EVOLUT; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; HENNEBERG M, 1976, J HUM EVOL, V5, P41, DOI 10.1016/0047-2484(76)90098-1; Henneberg M., 2004, STUD HIST ANTHR, V4, P49; Henneberg M, 1975, PRZEGLAD ANTROPOLOGI, VXLI, P191; Henneberg W.Y.A.M, 2016, J NUTR FOOD SCI, V6, P517, DOI [10.4172/2155-9600.1000517, DOI 10.4172/2155-9600.1000517]; Hill JO, 2013, INT J EPIDEMIOL, V42, P1840, DOI 10.1093/ije/dyt161; Howe LD, 2010, INT J EPIDEMIOL, V39, P404, DOI 10.1093/ije/dyp366; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Kahan David, 2015, Prev Med Rep, V2, P71, DOI 10.1016/j.pmedr.2014.12.007; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kjellstrom I, 2007, SCAND J PUBLIC HEALT, V35, P2; Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159; Lynch M, 2016, GENETICS, V202, P869, DOI 10.1534/genetics.115.180471; Mabry RM, 2010, OBES REV, V11, P457, DOI 10.1111/j.1467-789X.2009.00655.x; MCGARVEY ST, 1991, AM J CLIN NUTR, V53, pS1586, DOI 10.1093/ajcn/53.6.1586S; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Medawar P. B., 1971, NATURAL SELECTION HU, P300; Miles C, 2016, SPORT EDUC SOC, V21, P723, DOI 10.1080/13573322.2014.942623; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Nargund G, 2009, FACTS VIEWS VIS OBGY, V1, P191; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nestle M, 2003, J AM DIET ASSOC, V103, P39, DOI 10.1053/jada.2003.50007; Nettle D, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16000947; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Park LE, 2009, PSYCHOL WOMEN QUART, V33, P108, DOI 10.1111/j.1471-6402.2008.01478.x; Pearson S, 2004, NAT BIOTECHNOL, V22, P3, DOI 10.1038/nbt0104-3; Pirgon O, 2015, J CLIN RES PEDIATR E, V7, P163, DOI 10.4274/jcrpe.1984; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Prentice AM, 2005, P NUTR SOC, V64, P153, DOI 10.1079/PNS2005421; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Ruhli F, 2017, ON HUMAN NATURE: BIOLOGY, PSYCHOLOGY, ETHICS, POLITICS, AND RELIGION, P263, DOI 10.1016/B978-0-12-420190-3.00017-X; Saniotis A, 2011, MED HYPOTHESES, V77, P560, DOI 10.1016/j.mehy.2011.06.031; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Schreiner PJ, 1996, AM J EPIDEMIOL, V144, P335, DOI 10.1093/oxfordjournals.aje.a008934; Sellayah D, 2014, ENDOCRINOLOGY, V155, P1573, DOI 10.1210/en.2013-2103; Snodgrass J Josh, 2006, J Physiol Anthropol, V25, P75, DOI 10.2114/jpa2.25.75; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Staub K, 2018, EVOLUTION MED PUBLIC; Stephan CN, 2001, MED HYPOTHESES, V57, P633, DOI 10.1054/mehy.2001.1431; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Swinburn B, 2013, INT J EPIDEMIOL, V42, P1838, DOI 10.1093/ije/dyt162; The United Nations, 2015, WORLD FERT DAT 2008; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2010, URB HLTH WHO; WHO, 2017, GHO CAT OB BOD MASS; WHO, 2009, WHO PHYS ACT WOM; WOMERSLEY J, 1977, BRIT J NUTR, V38, P271, DOI 10.1079/BJN19770088; World Bank, 2022, GIN IND; World Bank, 2015, INT COMP PROGR DAT W; World Health Organisation, 2004, WHO TECHN REP SER; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2016, BMI CLASSIFICATION; World Health Organization,, 2015, OB OV; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2022, GLOB HLTH OBS; World Health Organization, 2015, OBESITY; You W, 2018, ADV BREAST CANC RES, V7, P1, DOI DOI 10.4236/ABCR.2018.71001; You W, 2016, BMC NUTR, V2, P22, DOI [DOI 10.1186/S40795-016-0063-9, 10.1186/s40795-016-0063-9, 10.1186/s40795-015-0041-7]; You WP, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000161; You WP, 2018, EVOL APPL, V11, P140, DOI 10.1111/eva.12523; You WenPeng, 2016, Journal of Nutrition and Food Sciences, V6, P517; You WP, 2016, AIMS PUBLIC HEALTH, V3, P313, DOI 10.3934/publichealth.2016.2.313	96	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199594	10.1371/journal.pone.0199594	http://dx.doi.org/10.1371/journal.pone.0199594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30021019	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000439022400022
J	Engjom, T; Kavaliauskiene, G; Tjora, E; Erchinger, F; Wathle, G; Laerum, BN; Njolstad, PR; Frokjaer, JB; Gilja, OH; Dimcevski, G; Haldorsen, IS				Engjom, Trond; Kavaliauskiene, Giedre; Tjora, Erling; Erchinger, Friedemann; Wathle, Gaute; Laerum, Birger Norderud; Njolstad, Pal Rasmus; Frokjaer, Jens Brondum; Gilja, Odd Helge; Dimcevski, Georg; Haldorsen, Ingfrid Salvesen			Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI	PLOS ONE			English	Article							SYSTEM; LIVER; ULTRASONOGRAPHY; IDENTIFICATION; GUIDELINES; PATHOLOGY; CHILDREN; ADULTS; WATER; GENE	Objective Fatty infiltration of the pancreas is a dominating feature in cystic fibrosis (CF). We evaluate the association between pancreatic fat content assessed by Dixon magnetic resonance imaging (MRI), pancreatic echogenicity at ultrasonography (US) and exocrine function in CF patients and healthy controls (HC). Material and methods Transabdominal US, pancreatic Dixon-MRI and diffusion-weighted imaging (DWI) were performed in 21 CF patients and 15 HCs. Exocrine function was assessed by endoscopic secretin test and fecal elastase. Results CF patients were grouped according to exocrine pancreatic function as subjects with normal (CFS: n = 11) or reduced (CFI: n = 10) function. Among CFI 90% (9/10) had visual hypere-chogenicity. CFI also had increased echo-level values (p<0.05 vs others). All CFI (10/10) had markedly increased pancreatic fat content estimated by MRI compared to sufficient groups, p<0.001). Among CFS patients and HC, 27% (3/11) and 33% (5/15), respectively, had hyperechoic pancreas. However, all these had low pancreatic fat-content at MRI compared to CFI. In CFI, pancreatic fat content was correlated to ADC (r = -0.93, p<0.001). Conclusion Pancreas insufficient CF patients exhibit severe pancreatic fatty-infiltration at MRI and hyperechoic pancreas at US. Pancreas hyperechogenicity in pancreatic sufficient subjects does not co-exist with fatty infiltration at MRI. MRI evaluates pancreatic fatty infiltration more accurately than US and fat infiltration estimated by MRI outperforms sonographic hyperechogenicity as a marker for exocrine pancreatic failure in CF.	[Engjom, Trond; Erchinger, Friedemann; Gilja, Odd Helge; Dimcevski, Georg; Haldorsen, Ingfrid Salvesen] Univ Bergen, Dept Clin Med, Bergen, Norway; [Engjom, Trond] Haukeland Hosp, Dept Med, Bergen, Norway; [Kavaliauskiene, Giedre; Wathle, Gaute; Haldorsen, Ingfrid Salvesen] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Tjora, Erling; Njolstad, Pal Rasmus] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Tjora, Erling; Laerum, Birger Norderud; Njolstad, Pal Rasmus] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Erchinger, Friedemann] Voss Hosp, Dept Med, Voss, Norway; [Frokjaer, Jens Brondum] Aalborg Univ Hosp, Dept Radiol, Aalborg, Denmark; [Frokjaer, Jens Brondum] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Gilja, Odd Helge] Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Aalborg University; Aalborg University Hospital; Aalborg University; University of Bergen; Haukeland University Hospital	Engjom, T; Haldorsen, IS (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.; Engjom, T (corresponding author), Haukeland Hosp, Dept Med, Bergen, Norway.; Haldorsen, IS (corresponding author), Haukeland Hosp, Dept Radiol, Bergen, Norway.	trond.engjom@helse-bergen.no; ingfrid.haldorsen@uib.no		Engjom, Trond/0000-0002-2207-5455	University of Bergen; Norwegian Gastroenterology Association; Norwegian cystic fibrosis Association	University of Bergen; Norwegian Gastroenterology Association; Norwegian cystic fibrosis Association	This study has received funding from the University of Bergen (TE, PhD scholarship), the Norwegian Gastroenterology Association (TE, FE, GD, Limited grants) and The Norwegian cystic fibrosis Association (TE, Limited grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Borowitz D, 2004, J PEDIATR-US, V145, P322, DOI 10.1016/j.jpeds.2004.04.049; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dietrich CF, 2002, J ULTRAS MED, V21, P409, DOI 10.7863/jum.2002.21.4.409; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; DURIE PR, 1989, J ROY SOC MED, V82, P2; Engjom T, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0259-3; Engjom T, 2015, PANCREAS, V44, P1266, DOI 10.1097/MPA.0000000000000425; Engjom T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121121; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Feigelson J, 2000, J PEDIATR GASTR NUTR, V30, P145, DOI 10.1097/00005176-200002000-00010; FIEL SB, 1987, CHEST, V91, P181, DOI 10.1378/chest.91.2.181; Friedrich-Rust M, 2013, J CYST FIBROS, V12, P431, DOI 10.1016/j.jcf.2012.12.013; Frokjaer JB, 2013, PANCREAS, V42, P1182, DOI 10.1097/MPA.0b013e31829628f4; Glaser J, 2000, GERONTOLOGY, V46, P93, DOI 10.1159/000022141; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; GRAHAM N, 1985, CLIN RADIOL, V36, P199, DOI 10.1016/S0009-9260(85)80120-3; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; KOPITO LE, 1976, PEDIATR RES, V10, P742, DOI 10.1203/00006450-197610080-00010; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Madzak A, 2017, PANCREATOLOGY, V17, P228, DOI 10.1016/j.pan.2017.01.009; Manning P, 2017, J MAGN RESON IMAGING, V46, P1149, DOI 10.1002/jmri.25663; MARKS WM, 1980, RADIOLOGY, V137, P475, DOI 10.1148/radiology.137.2.7433680; MURAYAMA S, 1990, PEDIATR RADIOL, V20, P536, DOI 10.1007/BF02011384; O'Sullivan BP, 2013, J PEDIATR-US, V162, P808, DOI 10.1016/j.jpeds.2012.10.008; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; THAM RTOTA, 1991, RADIOLOGY, V179, P183, DOI 10.1148/radiology.179.1.2006275; Wathle GK, 2013, JMAGN RESONIMAGING; WILSONSHARP RC, 1984, ARCH DIS CHILD, V59, P923, DOI 10.1136/adc.59.10.923; WMA general assembly, 2015, WORLD MED ASS DECL H; WORTHEN NJ, 1982, AM J ROENTGENOL, V139, P1095, DOI 10.2214/ajr.139.6.1095; Yoon JH, 2016, RADIOLOGY, V279, P140, DOI 10.1148/radiol.2015142254	36	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201019	10.1371/journal.pone.0201019	http://dx.doi.org/10.1371/journal.pone.0201019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048483	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400040
J	Serrano-Oviedo, L; Ortega-Muelas, M; Garcia-Cano, J; Valero, MLI; Cimas, FJ; Pascual-Serra, R; Fernandez-Aroca, DM; Roche, O; Ruiz-Hidalgo, MJ; Belandia, B; Gimenez-Bachs, JM; Salinas, AS; Sanchez-Prieto, R				Serrano-Oviedo, Leticia; Ortega-Muelas, Marta; Garcia-Cano, Jesus; Valero, Maria L. I.; Cimas, Francisco J.; Pascual-Serra, Raquel; Fernandez-Aroca, Diego M.; Roche, Olga; Ruiz-Hidalgo, Maria J.; Belandia, Borja; Gimenez-Bachs, Jose M.; Salinas, Antonio S.; Sanchez-Prieto, Ricardo			Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LUNG-CANCER CELLS; ACQUIRED-RESISTANCE; IN-VITRO; ANTITUMOR-ACTIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; TYROSINE KINASE; LEUKEMIA CELLS; GROWTH	Objectives To fully clarify the role of Mitogen Activated Protein Kinase in the therapeutic response to Sorafenib in Renal Cell Carcinoma as well as the cell death mechanism associated to this kinase inhibitor, we have evaluated the implication of several Mitogen Activated Protein Kinases in Renal Cell Carcinoma-derived cell lines. Materials and methods An experimental model of Renal Cell Carcinoma-derived cell lines (ACHN and 786-O cells) was evaluated in terms of viability by MTT assay, induction of apoptosis by caspase 3/7 activity, autophagy induction by LC3 lipidation, and p62 degradation and kinase activity using phospho-targeted antibodies. Knock down of ATG5 and ERK5 was performed using lentiviral vector coding specific shRNA Results Our data discard Extracellular Regulated Kinase 1/2 and 5 as well as p38 Mitogen Activated Protein Kinase pathways as mediators of Sorafenib toxic effect but instead indicate that the inhibitory effect is exerted through the PI3K/Akt signalling pathway. Furthermore, we demonstrate that inhibition of Akt mediates cell death associated to Sorafenib without caspase activation, and this is consistent with the induction of autophagy, as indicated by the use of pharmacological and genetic approaches. Conclusion The present report demonstrates that Sorafenib exerts its toxic effect through the induction of autophagy in an Akt-dependent fashion without the implication of Mitogen Activated Protein Kinase. Therefore, our data discard the use of inhibitors of the RAF-MEK-ERK1/2 signalling pathway in RCC and support the use of pro-autophagic compounds, opening new therapeutic opportunities for Renal Cell Carcinoma.	[Serrano-Oviedo, Leticia; Ortega-Muelas, Marta; Garcia-Cano, Jesus; Valero, Maria L. I.; Cimas, Francisco J.; Pascual-Serra, Raquel; Fernandez-Aroca, Diego M.; Roche, Olga; Ruiz-Hidalgo, Maria J.] UCLM, Unidad Asociada Biomed, Unidad Asociada, Lab Oncol,Unidad Med Mol,Ctr Reg Invest Biomed,CS, Albacete, Spain; [Roche, Olga; Sanchez-Prieto, Ricardo] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain; [Ruiz-Hidalgo, Maria J.] Univ Castilla La Mancha, Fac Med, Area Bioquim & Biol Mol, Albacete, Spain; [Belandia, Borja; Sanchez-Prieto, Ricardo] UCLM, Unidad Asociada Biomed, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Biol Canc,Unidad Asociada,CSIC, Madrid, Spain; [Gimenez-Bachs, Jose M.; Salinas, Antonio S.] Complejo Hosp Albacete, Fac Med, Unidad Invest, Serv Urol, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Castilla-La Mancha	Sanchez-Prieto, R (corresponding author), Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain.; Sanchez-Prieto, R (corresponding author), UCLM, Unidad Asociada Biomed, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Biol Canc,Unidad Asociada,CSIC, Madrid, Spain.	rsprieto@iib.uam.es	García-Cano, Jesús/J-3581-2012; Sanchez-Prieto, Ricardo/AAY-4271-2021; Prieto, Ricardo/AAZ-7221-2021; Fernandez Aroca, Diego Manuel/AAB-7423-2022; Roche, UCLM/F-5697-2019; García-Cano, Jesús/AAA-9257-2020; Sanchez-Prieto, Ricardo/B-6877-2008; Ruiz-Hidalgo, Maria J/L-1956-2014	García-Cano, Jesús/0000-0002-8312-2622; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Fernandez Aroca, Diego Manuel/0000-0003-2699-7374; Roche, UCLM/0000-0003-1884-8256; García-Cano, Jesús/0000-0002-8312-2622; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Ruiz-Hidalgo, Maria J/0000-0003-2508-8398; Serrano Oviedo, Leticia/0000-0003-3876-2919; Cimas, Francisco J./0000-0001-9241-331X	Fundacion Leticia Castillejo Castillo, Ministerio de Economia y Competitividad [SAF2012-30862, SAF2015-64215R]; European Community through the Regional Development Funding Program (FEDER); University of Castilla La Mancha (UCLM)	Fundacion Leticia Castillejo Castillo, Ministerio de Economia y Competitividad; European Community through the Regional Development Funding Program (FEDER); University of Castilla La Mancha (UCLM)	This work was supported by grants from Fundacion Leticia Castillejo Castillo, Ministerio de Economia y Competitividad (SAF2012-30862, SAF2015-64215R) to RSP and MJRH. RSP and MJRH Research Institutes, and the work carried out in their laboratories received support from the European Community through the Regional Development Funding Program (FEDER). OR has a contract for accessing the Spanish System of Science, Technology and Innovation (SECTI) funded by the University of Castilla La Mancha (UCLM).	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; Ahmad T, 2004, CLIN CANCER RES, V10, p6388S, DOI 10.1158/1078-0432.CCR-040028; Arias-Gonzalez L, 2013, NEOPLASIA, V15, P649, DOI 10.1593/neo.121896; Buonato JM, 2014, CANCER RES, V74, P309, DOI 10.1158/0008-5472.CAN-12-4721; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; Cho D, 2013, CANCER J, V19, P311, DOI 10.1097/PPO.0b013e31829d5cea; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Deschenes-Simard X, 2014, CANCER RES, V74, P412, DOI 10.1158/0008-5472.CAN-13-2381; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fecteau JF, 2012, MOL MED, V18, P19, DOI 10.2119/molmed.2011.00164; Fouladi F, 2015, LEUKEMIA LYMPHOMA, V56, P2690, DOI 10.3109/10428194.2014.1003055; Fukazawa H, 2000, CANCER RES, V60, P2104; Gadaleta-Caldarola G, 2015, FUTURE ONCOL, V11, P1863, DOI [10.2217/fon.15.85, 10.2217/FON.15.85]; Garcia-Cano J, 2015, ONCOTARGET, V6, P15551, DOI 10.18632/oncotarget.3902; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Grimaldi A, 2015, CANCER BIOL THER, V16, P567, DOI 10.1080/15384047.2015.1018494; Harada K, 2014, CLIN TRANSL ONCOL, V16, P801, DOI 10.1007/s12094-013-1151-9; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Katz SI, 2009, CANCER BIOL THER, V8, P2406, DOI 10.4161/cbt.8.24.10824; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kiprianova I, 2015, NEOPLASIA, V17, P564, DOI 10.1016/j.neo.2015.07.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lin JC, 2013, INT IMMUNOPHARMACOL, V15, P333, DOI 10.1016/j.intimp.2013.01.006; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu XY, 2016, CELL MOL NEUROBIOL, V36, P1197, DOI 10.1007/s10571-015-0318-z; Valero ML, 2014, CELL CYCLE, V13, P52, DOI 10.4161/cc.26754; Lohmeyer J, 2018, CLIN EXP IMMUNOL, V193, P64, DOI 10.1111/cei.13128; Lu XC, 2010, J SURG ONCOL, V102, P821, DOI 10.1002/jso.21661; Martin-Liberal J, 2014, EXPERT OPIN DRUG SAF, V13, P483, DOI 10.1517/14740338.2014.892578; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pignochino Y, 2013, CLIN CANCER RES, V19, P2117, DOI 10.1158/1078-0432.CCR-12-2293; Piscazzi A, 2012, J CLIN ENDOCR METAB, V97, pE898, DOI 10.1210/jc.2011-3269; Porta C, 2014, CANCER MED-US, V3, P1517, DOI 10.1002/cam4.302; Prieto-Dominguez N, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00151; Rosenberg L, 2018, CARCINOGENESIS, V39, P681, DOI 10.1093/carcin/bgy038; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Rusconi P, 2012, CURR MED CHEM, V19, P1164; Sakai I, 2013, BJU INT, V112, pE211, DOI 10.1111/j.1464-410X.2012.11655.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Spirli C, 2012, HEPATOLOGY, V56, P2363, DOI 10.1002/hep.25872; Tai WT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.18; Takahashi M, 2003, HEPATOL RES, V26, P232, DOI 10.1016/S1386-6346(03)00112-8; Tei H, 2015, HUM CELL, V28, P114, DOI 10.1007/s13577-015-0112-8; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2010, BIOCHEM PHARMACOL, V80, P561, DOI 10.1016/j.bcp.2010.03.019; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xargay-Torrent S, 2013, CLIN CANCER RES, V19, P586, DOI 10.1158/1078-0432.CCR-12-1935; Yi HQ, 2016, CRIT REV ONCOL HEMAT, V100, P137, DOI 10.1016/j.critrevonc.2016.02.006; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J; Yuen JSP, 2011, BRIT J CANCER, V104, P941, DOI 10.1038/bjc.2011.55; Yuen JSP, 2012, INT J ONCOL, V41, P712, DOI 10.3892/ijo.2012.1494; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043; Zhang YN, 2014, MOL MED REP, V9, P365, DOI 10.3892/mmr.2013.1782; Zhang ZG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-23	69	20	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200878	10.1371/journal.pone.0200878	http://dx.doi.org/10.1371/journal.pone.0200878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048489	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400026
J	Lachmann, R; Loenenbach, A; Waterboer, T; Brenner, N; Pawlita, M; Michel, A; Thamm, M; Poethko-Muller, C; Wichmann, O; Wiese-Posselt, M				Lachmann, Raskit; Loenenbach, Anna; Waterboer, Tim; Brenner, Nicole; Pawlita, Michael; Michel, Angelika; Thamm, Michael; Poethko-Mueller, Christina; Wichmann, Ole; Wiese-Posselt, Miriam			Cytomegalovirus (CMV) seroprevalence in the adult population of Germany	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS; SOCIOECONOMIC DISPARITIES; PREGNANT-WOMEN; RISK-FACTORS; INFECTION; DISEASE; PREVENTION; VACCINE; BURDEN; SEROCONVERSION	Background Infection with cytomegalovirus (CMV) remains asymptomatic in most immunocompetent hosts, but is the leading cause of congenital viral infection worldwide and can be life-threatening in immunocompromised individuals. We aimed to assess CMV seroprevalence in a nationally representative sample of adults in Germany and to identify sociodemographic factors associated with CMV seropositivity. Methods Blood samples from 6552 participants (18-79 years) of the "German National Health Interview and Examination Survey 1998", a population-based sample of the adult population in Germany, were tested for the presence of CMV antibodies using an Ig-multiplex assay. Weighted seroprevalence was calculated and weighted binomial regression was used to identify factors associated with CMV seropositivity. Results Overall CMV seroprevalence was 56.7% (95%CI: 54.8-58.7%), with a higher seroprevalence in women (62.3%) than in men (51.0%). Seroprevalence increased with age: from 31.8% to 63.7% in men and from 44.1% to 77.6% in women when comparing the 18-29 with the 70-79 year age-group, respectively. CMV seroprevalence in women of childbearing age (18-45 years) was 51.7%. Factors significantly associated with CMV seropositivity were age, country of birth, smoking status, education, living in northern Germany and number of household members. In addition, having attended child care was associated with seropositivity in men, and number of siblings and living in East Germany in women. Conclusion Our results indicate that half the women of childbearing age were susceptible for primary CMV infection during pregnancy. CMV screening during pregnancy and informing seronegative women about CMV risk reduction measures could prevent congenital CMV infections with its serious consequences.	[Lachmann, Raskit; Loenenbach, Anna; Wichmann, Ole; Wiese-Posselt, Miriam] Robert Koch Inst, Immunizat Unit, Berlin, Germany; [Lachmann, Raskit] Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany; [Lachmann, Raskit] ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Loenenbach, Anna] Charite Univ Med Berlin, Berlin, Germany; [Waterboer, Tim; Brenner, Nicole; Pawlita, Michael; Michel, Angelika] German Canc Res Ctr, Div Mol Diagnost Oncogen infect, Infect Inflammat & Canc Program, Heidelberg, Germany; [Thamm, Michael; Poethko-Mueller, Christina] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Robert Koch Institute	Lachmann, R (corresponding author), Robert Koch Inst, Immunizat Unit, Berlin, Germany.; Lachmann, R (corresponding author), Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany.; Lachmann, R (corresponding author), ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden.	LachmannR@rki.de		Wiese-Posselt, Miriam/0000-0001-9300-2563; , Raskit/0000-0003-0915-5968	German Ministry of Health; German Ministry of Education and Research; Robert Koch Institute (Berlin, Germany); Molecular Diagnostics of Oncogenic Infections Division at the German Cancer Research Center (DKFZ, Heidelberg)	German Ministry of Health; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute (Berlin, Germany); Molecular Diagnostics of Oncogenic Infections Division at the German Cancer Research Center (DKFZ, Heidelberg)	The German National Health Interview and Examination Survey 1998 was funded by the German Ministry of Health, the German Ministry of Education and Research, and the Robert Koch Institute (Berlin, Germany). Laboratory testing for CMV-specific Ig by multiplex assay was funded by the German Ministry of Health and the Robert Koch Institute (Berlin, Germany), and in-house funding from the Molecular Diagnostics of Oncogenic Infections Division at the German Cancer Research Center (DKFZ, Heidelberg).	Adler SP, 2004, J PEDIATR-US, V145, P485, DOI 10.1016/j.jpeds.2004.05.041; Alfaro-Murillo JA, 2016, VACCINE, V34, P225, DOI 10.1016/j.vaccine.2015.11.039; Antona D., 2017, EPIDEMIOL INFECT, P1; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Basha J, 2014, J PAEDIATR CHILD H, V50, P368, DOI 10.1111/jpc.12502; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bernstein DI, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00491-16; Bernstein DI, 2016, VACCINE, V34, P313, DOI 10.1016/j.vaccine.2015.11.056; Binda S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1861-z; Buxmann H, 2017, DTSCH ARZTEBL INT, V114, P45, DOI 10.3238/arztebl.2017.0045; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Deutsche Vereinigung zur Beka E mpfung der Viruskrankheiten Virologie Gf., LAB SCHWAN GERSCH VI; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Hamer M, 2016, J CLIN ENDOCR METAB, V101, P1680, DOI 10.1210/jc.2015-4208; Hecker M, 2004, VOX SANG, V86, P41, DOI 10.1111/j.0042-9007.2004.00388.x; Hyde TB, 2010, REV MED VIROL, V20, P311, DOI 10.1002/rmv.659; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Korndewal MJ, 2015, J CLIN VIROL, V63, P53, DOI 10.1016/j.jcv.2014.11.033; Lancini D, 2014, MED J AUSTRALIA, V201, P578, DOI 10.5694/mja14.00183; Loewendorf A, 2010, J INTERN MED, V267, P483, DOI 10.1111/j.1365-2796.2010.02220.x; Lopo S, 2011, EUROSURVEILLANCE, V16, P2002; Ludwig A, 2009, EUROSURVEILLANCE, V14, P26; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Marshall GS, 2005, AM J PERINAT, V22, P371, DOI 10.1055/s-2005-872590; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; Modrow S, 2018, FRAUENARZT, V59, P394; Odland ML, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003066; Olsson J, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0093-4; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Picone O, 2009, BJOG-INT J OBSTET GY, V116, P818, DOI 10.1111/j.1471-0528.2009.02139.x; Qiu FF, 2017, ONCOTARGET, V8, P268, DOI 10.18632/oncotarget.13613; Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47; Reichman O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/135416; Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003; Smith LR, 2013, VACCINES-BASEL, V1, DOI 10.3390/vaccines1040398; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Taniguchi K, 2014, J CLIN VIROL, V59, P192, DOI 10.1016/j.jcv.2013.12.013; Thackeray Rosemary, 2016, Prev Med Rep, V4, P517; Thefeld W., 1999, GESUNDHEITSWESEN, V61, pS57; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003; Vilibic-Cavlek T, 2017, WIEN KLIN WOCHENSCHR, V129, P129, DOI 10.1007/s00508-016-1069-7; Voigt S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv193; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Willame A, 2015, INT J ENV RES PUB HE, V12, P15285, DOI 10.3390/ijerph121214982	48	58	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200267	10.1371/journal.pone.0200267	http://dx.doi.org/10.1371/journal.pone.0200267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044826	gold, Green Submitted, Green Published			2022-12-26	WOS:000439942500037
J	Hanson, EA; Sandmann, C; Malyshev, A; Lundervold, A; Modersitzki, J; Hodneland, E				Hanson, Erik A.; Sandmann, Constantin; Malyshev, Alexander; Lundervold, Arvid; Modersitzki, Jan; Hodneland, Erlend			Estimating the discretization dependent accuracy of perfusion in coupled capillary flow measurements	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; STROKE PATIENTS; BOLUS TRACKING; MRI; CT; FRAMEWORK; BRAIN; MAPS	One-compartment models are widely used to quantify hemodynamic parameters such as perfusion, blood volume and mean transit time. These parameters are routinely used for clinical diagnosis and monitoring of disease development and are thus of high relevance. However, it is known that common estimation techniques are discretization dependent and values can be erroneous. In this paper we present a new model that enables systematic quantification of discretization errors. Specifically, we introduce a continuous flow model for tracer propagation within the capillary tissue, used to evaluate state-of-the-art one-compartment models. We demonstrate that one-compartment models are capable of recovering perfusion accurately when applied to only one compartment, i.e. the whole region of interest. However, substantial overestimation of perfusion occurs when applied to fractions of a compartment. We further provide values of the estimated overestimation for various discretization levels, and also show that overestimation can be observed in real-life applications. Common practice of using compartment models for fractions of tissue violates model assumptions and careful interpretation is needed when using the computed values for diagnosis and treatment planning.	[Hanson, Erik A.; Malyshev, Alexander] Univ Bergen, Dept Math, Bergen, Norway; [Sandmann, Constantin; Modersitzki, Jan] Univ Lubeck, Inst Math & Image Comp, Lubeck, Germany; [Lundervold, Arvid] Univ Bergen, Dept Biomed, Bergen, Norway; [Lundervold, Arvid] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Hodneland, Erlend] Christian Michelsen Res AS, Bergen, Norway	University of Bergen; University of Lubeck; University of Bergen; University of Bergen; Haukeland University Hospital	Hodneland, E (corresponding author), Christian Michelsen Res AS, Bergen, Norway.	erlend.hodneland@cmr.no			MedViz Research Cluster; Christian Michelsen Research; University of Lubeck; University of Bergen; Research Council of Norway [262203]	MedViz Research Cluster; Christian Michelsen Research; University of Lubeck; University of Bergen; Research Council of Norway(Research Council of Norway)	The work has partly been financed by MedViz Research Cluster as well through in-kind contributions from Christian Michelsen Research, University of Lubeck and University of Bergen. The authors Hanson, E, Lundervold, A. and Hodneland, E. received funding from the Research Council of Norway project #262203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnes JE, 2007, AN INTRODUCTION TO T; Boutelier T, 2012, IEEE T MED IMAGING, V31, P1381, DOI 10.1109/TMI.2012.2189890; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Cho YI, 2011, KOREAN CIRC J, V41, P287, DOI 10.4070/kcj.2011.41.6.287; Cookson AN, 2012, J BIOMECH, V45, P850, DOI 10.1016/j.jbiomech.2011.11.026; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; Evans LC, 1996, PARTIAL DIFFERENTIAL; Feng Q, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-33; Gruner R, 2006, J MAGN RESON IMAGING, V23, P273, DOI 10.1002/jmri.20505; Guibert R, 2013, J CEREBR BLOOD F MET, V33, P669, DOI 10.1038/jcbfm.2013.39; HENKELMAN RM, 1990, MAGNET RESON MED, V16, P470, DOI 10.1002/mrm.1910160313; Kickingereder P, 2015, RADIOLOGY, P542; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Mendrik AM, 2011, PHYS MED BIOL, V56, P3857, DOI 10.1088/0031-9155/56/13/008; Michler C, 2013, INT J NUMER METH BIO, V29, P217, DOI 10.1002/cnm.2520; Mokin M, 2015, INTERV NEUROL, V4, P104, DOI 10.1159/000442717; Mori S, 1998, PROCEEDINGS OF INTER; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Patankar S.V., 2018, NUMERICAL HEAT TRANS; Rosencranz R, 2006, AM J CLIN PATHOLOG S, V125, P78, DOI DOI 10.1309/FFF7U8RRPK26VAPY; Smith AM, 2000, J MAGN RESON IMAGING, V12, P400, DOI 10.1002/1522-2586(200009)12:3<400::AID-JMRI5>3.0.CO;2-C; Sourbron S, 2014, IEEE T MED IMAGING, V33, P935, DOI 10.1109/TMI.2014.2300450; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Townsley MI, 2012, COMPR PHYSL; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Zierler K, 2000, ANN BIOMED ENG, V28, P836, DOI 10.1114/1.1308496	29	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200521	10.1371/journal.pone.0200521	http://dx.doi.org/10.1371/journal.pone.0200521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028854	Green Published, gold, Green Submitted			2022-12-26	WOS:000439396900007
J	Prestigiacomo, V; Suter-Dick, L				Prestigiacomo, Vincenzo; Suter-Dick, Laura			Nrf2 protects stellate cells from Smad-dependent cell activation	PLOS ONE			English	Article							I RECEPTOR KINASE; OXIDATIVE STRESS; LIVER-INJURY; KNOCKOUT MICE; FIBROSIS; PATHWAY; ACETAMINOPHEN; ANTIOXIDANT; MECHANISMS; INHIBITION	Hepatic stellate cells (HSC) orchestrate the deposition of extracellular matrix (ECM) and are the primary effector of liver fibrosis. Several factors, including TGF-beta 1, PDGF and oxidative stress, have been shown to trigger HSC activation. However, the involvement of cellular defence mechanisms, such as the activation of antioxidant response by Nrf2/Keap1 in the modulation of HSC activation is not known. The aim of this work was to elucidate the role of Nrf2 pathway in HSC trans-differentiation involved in the development of fibrosis. To this end, we repressed Nrf2 and Keap1 expression in HSC with specific siRNAs. We then assessed activation markers, as well as proliferation and migration, in both primary and immortalised human HSCs exposed to Smad inhibitors (SB-431542 hydrate and SB525334), TGF-beta 1 and/or PDGF. Our results indicate that knocking down Nrf2 induces HSC activation, as shown by an increase in alpha SMA-positive cells and by gene expression induction of ECM components (collagens and fibronectin). HSC with reduced Nrf2-levels also showed an increase in migration and a decrease in proliferation. We could also demonstrate that the activation of Nrf2-deficient HSC involves the TGF-beta 1/Smad pathway, as the activation was successfully inhibited with the two tested Smad inhibitors. Moreover, TGF-beta 1 elicited a stronger induction of HSC activation markers in Nrf2 deficient cells than in wild type cells. Thus, our data suggest that Nrf2 limits HSCs activation, through the inhibition of the TGF-beta 1/Smad pathway in HSCs.	[Prestigiacomo, Vincenzo; Suter-Dick, Laura] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland; [Prestigiacomo, Vincenzo] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland	FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Basel	Prestigiacomo, V (corresponding author), Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland.; Prestigiacomo, V (corresponding author), Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland.	vincenzo.prestigiacomo@fhnw.ch	Suter-Dick, Laura/A-9093-2019	Suter-Dick, Laura/0000-0002-1449-3913	School of Life Sciences (University of Applied Sciences Northwestern Switzerland)	School of Life Sciences (University of Applied Sciences Northwestern Switzerland)	This work was partly founded by the Swiss Centre for Applied Human Toxicology (SCAHT), and partly funded by the School of Life Sciences (University of Applied Sciences Northwestern Switzerland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Cai CX, 2017, DIGEST DIS SCI, V62, P968, DOI 10.1007/s10620-017-4470-9; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chien MH, 2015, CLIN CANCER RES, V21, P4719, DOI 10.1158/1078-0432.CCR-14-2880; Churchman AT, 2009, J CELL MOL MED, V13, P2282, DOI 10.1111/j.1582-4934.2009.00874.x; Cuadrado A, 2014, J BIOL CHEM, V289, P15244, DOI 10.1074/jbc.M113.540633; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Fan Z, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.65; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Hauck PM, 2017, MOL CANCER RES, V15, P1598, DOI 10.1158/1541-7786.MCR-17-0174; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16552; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Mormone E, 2012, GASTROENTEROLOGY, V142, P612, DOI 10.1053/j.gastro.2011.11.029; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Pall Martin L., 2015, Shengli Xuebao, V67, P1; Pennock R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13113; Potteti HR, 2016, AM J PHYSIOL-RENAL, V311, pF1025, DOI 10.1152/ajprenal.00362.2016; Prestigiacomo V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179995; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Ryoo IG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093265; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Shen H, 2014, DIS ESOPHAGUS, V27, P685, DOI 10.1111/dote.12124; Sison-Young RLC, 2015, TOXICOL SCI, V147, P412, DOI 10.1093/toxsci/kfv136; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang Y, 2008, WORLD J GASTROENTERO, V14, P5186, DOI 10.3748/wjg.14.5186; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang JJ, 2014, CELL SIGNAL, V26, P2381, DOI 10.1016/j.cellsig.2014.07.016	44	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201044	10.1371/journal.pone.0201044	http://dx.doi.org/10.1371/journal.pone.0201044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028880	gold, Green Published, Green Submitted			2022-12-26	WOS:000439396900034
J	Hage-Hulsmann, J; Grunberger, A; Thies, S; Santiago-Schubel, B; Klein, AS; Pietruszka, J; Binder, D; Hilgers, F; Domrose, A; Drepper, T; Kohlheyer, D; Jaeger, KE; Loeschcke, A				Hage-Huelsmann, Jennifer; Gruenberger, Alexander; Thies, Stephan; Santiago-Schuebel, Beatrix; Klein, Andreas Sebastian; Pietruszka, Joerg; Binder, Dennis; Hilgers, Fabienne; Domroese, Andreas; Drepper, Thomas; Kohlheyer, Dietrich; Jaeger, Karl-Erich; Loeschcke, Anita			Natural biocide cocktails: Combinatorial antibiotic effects of prodigiosin and biosurfactants	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SERRATIA-MARCESCENS; ANTIMICROBIAL ACTIVITY; CORYNEBACTERIUM-GLUTAMICUM; BACILLUS-SUBTILIS; SERRAWETTIN W1; SINGLE; BIOSYNTHESIS; PROTEIN; CELLS	Bacterial secondary metabolites are naturally produced to prevail amongst competitors in a shared habitat and thus represent a valuable source for antibiotic discovery. The transformation of newly discovered antibiotic compounds into effective drugs often requires additional surfactant components for drug formulation. Nature may also provide blueprints in this respect: A cocktail of two compounds consisting of the antibacterial red pigment prodigiosin and the biosurfactant serrawettin W1 is naturally produced by the bacterium Serratia marcescens, which occurs in highly competitive habitats including soil. We show here a combinatorial antibacterial effect of these compounds, but also of prodigiosin mixed with other (bio)surfactants, against the soil-dwelling bacterium Corynebacterium glutamicum taken as a model target bacterium. Prodigiosin exerted a combinatorial inhibitory effect with all tested surfactants in a disk diffusion assay which was especially pronounced in combination with N-myristoyltyrosine. Minimal inhibitory and bactericidal concentrations (MIC and MBC) of the individual compounds were 2.56 mu g/mL prodigiosin and 32 mu g/mL N-myristoyltyrosine, and the MIC of prodigiosin was decreased by 3 orders of magnitude to 0.005 mu g/mL in the presence of 16 mu g/mL N-myristoyltyrosine, indicative of synergistic interaction. Investigation of bacterial survival revealed similar combinatorial effects; moreover, antagonistic effects were observed at higher compound concentrations. Finally, the investigation of microcolony formation under combined application of concentrations just below the MBC revealed heterogeneity of responses with cell death or delayed growth. In summary, this study describes the combinatorial antibacterial effects of microbial biomolecules, which may have ecological relevance by inhibiting cohabiting species, but shall furthermore inspire drug development in the combat of infectious disease.	[Hage-Huelsmann, Jennifer; Thies, Stephan; Binder, Dennis; Hilgers, Fabienne; Domroese, Andreas; Drepper, Thomas; Jaeger, Karl-Erich; Loeschcke, Anita] Heinrich Heine Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany; [Gruenberger, Alexander; Pietruszka, Joerg; Kohlheyer, Dietrich; Jaeger, Karl-Erich] Forschungszentrum Julich, IBG Biotechnol 1, Julich, Germany; [Gruenberger, Alexander] Bielefeld Univ, Multiscale Bioengn, Bielefeld, Germany; [Thies, Stephan; Loeschcke, Anita] Forschungszentrum Julich, Bioecon Sci Ctr BioSC, Julich, Germany; [Santiago-Schuebel, Beatrix] Forschungszentrum Julich, Cent Div Analyt Chem ZEA Analyt Biospec 3, Julich, Germany; [Klein, Andreas Sebastian; Pietruszka, Joerg] Heinrich Heine Univ Dusseldorf, Inst Bioorgan Chem, Forschungszentrum Julich, Julich, Germany; [Kohlheyer, Dietrich] Rhein Westfal TH Aachen, Aachener Verfahrenstech AVT MSB, Aachen, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Bielefeld; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; RWTH Aachen University	Loeschcke, A (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany.	a.loeschcke@fz-juelich.de	Knapp, Fabienne/AAD-5729-2022; Kohlheyer, Dietrich/A-9645-2012; Thies, Stephan/H-3749-2015; Drepper, Thomas/ABA-8291-2020; drepper, thomas/ABB-4717-2020; jaeger, karl/ABB-1955-2020	Knapp, Fabienne/0000-0002-8749-284X; Kohlheyer, Dietrich/0000-0001-6215-1857; Thies, Stephan/0000-0003-4240-9149; Drepper, Thomas/0000-0002-0096-8084; drepper, thomas/0000-0002-0096-8084; Domrose, Andreas/0000-0003-4274-1432; Klein, Andreas Sebastian/0000-0001-8075-3480	Forschungsgemeinschaft via CEPLAS-Cluster of Excellence on Plant Science [EXC1028]; Ministry of Culture and Science of the German Federal State of North Rhine-Westphalia; Heinrich-Heine-University DuEsseldorf (CLIB Graduate Cluster Industrial Biotechnology); German Helmholtz Association [VH-NG-1029]; Ministry of Culture and Science of the German State of North Rhine-Westphalia (NRW Strategieprojekt BioSC) [313/323-400-00213]; Helmholtz Association [PD-311]	Forschungsgemeinschaft via CEPLAS-Cluster of Excellence on Plant Science; Ministry of Culture and Science of the German Federal State of North Rhine-Westphalia; Heinrich-Heine-University DuEsseldorf (CLIB Graduate Cluster Industrial Biotechnology); German Helmholtz Association(Helmholtz Association); Ministry of Culture and Science of the German State of North Rhine-Westphalia (NRW Strategieprojekt BioSC); Helmholtz Association(Helmholtz Association)	JHH was funded by the Deutsche Forschungsgemeinschaft via CEPLAS-Cluster of Excellence on Plant Science (EXC1028). We gratefully acknowledge the Ministry of Culture and Science of the German Federal State of North Rhine-Westphalia and the Heinrich-Heine-University DuEsseldorf (scholarships within the CLIB Graduate Cluster Industrial Biotechnology for AD and ASK). DK work was supported by the German Helmholtz Association (VH-NG-1029). ST and AL are funded by the Ministry of Culture and Science of the German State of North Rhine-Westphalia (through NRW Strategieprojekt BioSC (No. 313/323-400-00213). AG is supported by a postdoctoral grant provided by the Helmholtz Association (PD-311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Abu-Ghunmi L, 2014, J SURFACTANTS DETERG, V17, P833, DOI 10.1007/s11743-014-1584-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2012, AGENCY TOXIC SUBSTAN; BARNESS R, 1988, J BACTERIOL, V170, P4361, DOI 10.1128/jb.170.9.4361-4364.1988; Barraud O, 2011, EMERG INFECT DIS, V17, P2078, DOI 10.3201/eid1711.110282; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Baumgart M, 2016, J BACTERIOL, V198, P3045, DOI 10.1128/JB.00406-16; Belda E, 2016, ENVIRON MICROBIOL, V18, P3403, DOI 10.1111/1462-2920.13230; Ben Khedher S, 2017, J INVERTEBR PATHOL, V144, P11, DOI 10.1016/j.jip.2017.01.006; Bhadoriya SS, 2013, BIOCHEM PHARMACOL, DOI [DOI 10.4172/2167-0501.1000113, 10.4172/2167-0501.1000113]; Binder D, 2014, INTEGR BIOL-UK, V6, P755, DOI 10.1039/c4ib00027g; Bnyan R, 2018, J PHARM SCI-US, V107, P1237, DOI 10.1016/j.xphs.2018.01.005; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; Brady SF, 2004, APPL ENVIRON MICROB, V70, P6865, DOI 10.1128/AEM.70.11.6865-6870.2004; Brady SF, 2000, J AM CHEM SOC, V122, P12903, DOI 10.1021/ja002990u; Brothers KM, 2015, INFECT IMMUN, V83, P4373, DOI 10.1128/IAI.00466-15; Burkovski A, 2003, FEMS MICROBIOL REV, V27, P617, DOI 10.1016/S0168-6445(03)00067-6; Busschaert N, 2013, ANGEW CHEM INT EDIT, V52, P1374, DOI 10.1002/anie.201207535; Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006; Cassella M, 2005, J BIOL CONTRL, Patent No. 6926892; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Charlop-Powers Z, 2016, P NATL ACAD SCI USA, V113, P14811, DOI 10.1073/pnas.1615581113; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; D'aes J, 2010, ENV MICROBIOL REP, V2, P359, DOI 10.1111/j.1758-2229.2009.00104.x; Danevcic T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162412; Danevcic T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00027; Darshan N, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0222-z; Das Ghatak P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19175-7; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deziel E, 2000, BBA-MOL CELL BIOL L, V1485, P145, DOI 10.1016/S1388-1981(00)00039-1; Domrose A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00972; Dwivedi D, 2008, J NAT PROD, V71, P637, DOI 10.1021/np7007126; Escobar-Diaz E, 2005, LEUKEMIA, V19, P572, DOI 10.1038/sj.leu.2403679; FENG JS, 1982, APPL ENVIRON MICROB, V43, P850, DOI 10.1128/AEM.43.4.850-853.1982; Fischbach MA, 2011, CURR OPIN MICROBIOL, V14, P519, DOI 10.1016/j.mib.2011.08.003; Fischbach MA, 2009, CURR OPIN MICROBIOL, V12, P520, DOI 10.1016/j.mib.2009.07.002; FRACCHIA L, 2014, BIOSURFACTANTS PRODU, P245, DOI DOI 10.1201/B17599-15; Giri AV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-11; Grunberger A, 2015, CYTOM PART A, V87A, P1101, DOI 10.1002/cyto.a.22779; Gruenberger A, 2013, JOVE-J VIS EXP, DOI 10.3791/50560; Grunberger A, 2014, CURR OPIN BIOTECH, V29, P15, DOI 10.1016/j.copbio.2014.02.008; Grunberger A, 2012, LAB CHIP, V12, P2060, DOI [10.1039/c2lc40156h, 10.1039/c21c40156h]; Gudina EJ, 2010, LETT APPL MICROBIOL, V50, P419, DOI 10.1111/j.1472-765X.2010.02818.x; Gudina EJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14020038; Guo XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14720; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; HORREVORTS AM, 1987, EUR J CLIN MICROBIOL, V6, P502, DOI 10.1007/BF02013128; Jadon PS, 2009, AAPS PHARMSCITECH, V10, P1186, DOI 10.1208/s12249-009-9325-z; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Kadouri DE, 2013, RES MICROBIOL, V164, P821, DOI 10.1016/j.resmic.2013.06.002; Kalam MA, 2016, DRUG DELIV, V23, P896, DOI 10.3109/10717544.2014.920432; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Khanafari A, 2006, INT J BIOL SCI, DOI [10.3844/ojbsci.2006.1.13, DOI 10.3844/OJBSCI.2006.1.13]; Klein AS, 2017, ACS SYNTH BIOL, V6, P1757, DOI 10.1021/acssynbio.7b00099; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lapenda JC, 2015, WORLD J MICROB BIOT, V31, P399, DOI 10.1007/s11274-014-1793-y; Leao PN, 2010, P NATL ACAD SCI USA, V107, P11183, DOI 10.1073/pnas.0914343107; Li H, 2005, MICROBIOL IMMUNOL, V49, P303, DOI 10.1111/j.1348-0421.2005.tb03734.x; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Majik MS, 2014, BIOORG MED CHEM LETT, V24, P2863, DOI 10.1016/j.bmcl.2014.04.097; MATSUYAMA T, 1985, FEMS MICROBIOL LETT, V28, P125, DOI 10.1111/j.1574-6968.1985.tb00777.x; Matsuyama T, 2011, MICROBIOL MONOGR, V20, P93, DOI 10.1007/978-3-642-14490-5_4; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Muller H, 2009, FEMS MICROBIOL ECOL, V67, P468, DOI 10.1111/j.1574-6941.2008.00635.x; Munck C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009940; Nasiri MJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00681; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Perez-Tomas R, 2010, CURR MED CHEM, V17, P2222, DOI 10.2174/092986710791331103; Perneel M, 2008, ENVIRON MICROBIOL, V10, P778, DOI 10.1111/j.1462-2920.2007.01501.x; Probst C, 2015, ANAL METHODS-UK, V7, P91, DOI 10.1039/c4ay02257b; Roberts DP, 2007, SOIL BIOL BIOCHEM, V39, P2275, DOI 10.1016/j.soilbio.2007.03.029; Rodriguez H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-127; Rossi CC, 2016, LETT APPL MICROBIOL, V63, P215, DOI 10.1111/lam.12611; Sambrook J., 2001, MOL CLONING LAB MANU; Shanks RMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057634; SHEMYAKIMM, 1965, EXPERIENTIA, V21, P548, DOI DOI 10.1007/BF02138991; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Siliakus MF, 2017, EXTREMOPHILES, V21, P651, DOI 10.1007/s00792-017-0939-x; Sotirova A, 2012, CURR MICROBIOL, V65, P534, DOI 10.1007/s00284-012-0191-7; Soto-Cerrato V, 2005, BIOCHEM PHARMACOL, V71, P32, DOI 10.1016/j.bcp.2005.10.020; Stella NA, 2015, J BACTERIOL, V197, P2468, DOI 10.1128/JB.00136-15; Stokes JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.28; Straight PD, 2006, J BACTERIOL, V188, P4918, DOI 10.1128/JB.00162-06; Su C, 2017, J BIOTECHNOL, V245, P9, DOI 10.1016/j.jbiotec.2017.01.011; Su C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3171-7; Suryawanshi RK, 2017, NAT PROD RES, V31, P572, DOI 10.1080/14786419.2016.1195380; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Thies S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27035; Thies S, 2014, J BIOTECHNOL, V181, P27, DOI 10.1016/j.jbiotec.2014.03.037; Till Tiso, 2017, CONSEQUENCES MICROBI, V35, P1, DOI [10.1007/978-3-319-31421-1_388-1, DOI 10.1007/978-3-319-31421-1_388-1]; Troeschel SC, 2010, METHODS MOL BIOL, V668, P117, DOI 10.1007/978-1-60761-823-2_8; Van Der Voort M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00693; Vijay S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00463; Voget S, 2015, J BIOTECHNOL, V204, P3, DOI 10.1016/j.jbiotec.2015.03.022; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; WANG F, 2013, ELECTRON J BIOTECHN, V16, DOI DOI 10.2225/V0L16-ISSUE4-FULLTEXT-7; Wang XD, 2004, BIOTECHNOL APPL BIOC, V40, P277; WASSERMAN HH, 1962, J AM CHEM SOC, V84, P2978, DOI 10.1021/ja00874a028; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Yin Xihou, 2014, US Patent Application for Formulations combining ramoplanin and rhamnolipids for combating bacterial infection, Patent No. [20,140,294,925, 20140294925]	107	30	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200940	10.1371/journal.pone.0200940	http://dx.doi.org/10.1371/journal.pone.0200940			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024935	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000071
J	Kahaki, SMM; Arshad, H; Nordin, MJ; Ismail, W				Kahaki, Seyed M. M.; Arshad, Haslina; Nordin, Md Jan; Ismail, Waidah			Geometric feature descriptor and dissimilarity-based registration of remotely sensed imagery	PLOS ONE			English	Article							POINT DISTANCE ACCUMULATION; SPACE CORNER DETECTOR; CLASSIFICATION; CURVATURE; TRANSLATION; REGION	Image registration of remotely sensed imagery is challenging, as complex deformations are common. Different deformations, such as affine and homogenous transformation, combined with multimodal data capturing can emerge in the data acquisition process. These effects, when combined, tend to compromise the performance of the currently available registration methods. A new image transform, known as geometric mean projection transform, is introduced in this work. As it is deformation invariant, it can be employed as a feature descriptor, whereby it analyzes the functions of all vertical and horizontal signals in local areas of the image. Moreover, an invariant feature correspondence method is proposed as a point matching algorithm, which incorporates new descriptor's dissimilarity metric. Considering the image as a signal, the proposed approach utilizes a square Eigenvector correlation (SEC) based on the Eigenvector properties. In our experiments on standard test images sourced from "Featurespace" and "IKONOS" datasets, the proposed method achieved higher average accuracy relative to that obtained from other state of the art image registration techniques. The accuracy of the proposed method was assessed using six standard evaluation metrics. Furthermore, statistical analyses, including t-test and Friedman test, demonstrate that the method developed as a part of this study is superior to the existing methods.	[Kahaki, Seyed M. M.; Arshad, Haslina; Nordin, Md Jan] Natl Univ Malaysia UKM, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Bangi, Selangor, Malaysia; [Ismail, Waidah] Univ Sains Islam Malaysia, Fac Sci & Technol, Nilai, Negeri Sembilan, Malaysia	Universiti Kebangsaan Malaysia; Universiti Sains Islam Malaysia	Kahaki, SMM (corresponding author), Natl Univ Malaysia UKM, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Bangi, Selangor, Malaysia.	kahaki@siswa.ukm.edu.my	Kahaki, Seyed Mostafa Mousavi/H-3906-2015; Ismail, Waidah/AAF-3346-2019; arshad, haslina/AAF-8737-2019; Ismail, Waidah/AAP-2575-2020; Nordin, Jan/B-9579-2011	Kahaki, Seyed Mostafa Mousavi/0000-0002-0249-3238; Ismail, Waidah/0000-0002-4544-636X; Nordin, Jan/0000-0002-7524-5665	national university of Malaysia [TD-2016-003, DIP-2016-018]	national university of Malaysia	This work was supported by TD-2016-003 and DIP-2016-018 from the national university of Malaysia (www.ukm.edu.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtari AH, 2015, IEEE T IMAGE PROCESS, V24, P3370, DOI 10.1109/TIP.2015.2440763; Awrangjeb M, 2008, IEEE T IMAGE PROCESS, V17, P2425, DOI 10.1109/TIP.2008.2006441; Awrangjeb M, 2008, IEEE T MULTIMEDIA, V10, P1059, DOI 10.1109/TMM.2008.2001384; BROWN LG, 1992, COMPUT SURV, V24, P325, DOI 10.1145/146370.146374; Chen HM, 2003, INT J REMOTE SENS, V24, P3701, DOI 10.1080/0143116031000117047; Chen TZ, 2014, IEEE GEOSCI REMOTE S, V11, P906, DOI 10.1109/LGRS.2013.2281729; Cole-Rhodes AA, 2003, IEEE T IMAGE PROCESS, V12, P1495, DOI 10.1109/TIP.2003.819237; Cui CH, 2013, IEEE T IMAGE PROCESS, V22, P2876, DOI 10.1109/TIP.2013.2246521; Dutta A, 2011, PATTERN RECOGN LETT, V32, P712, DOI 10.1016/j.patrec.2010.12.006; Eugenio F, 2002, INT GEOSCI REMOTE SE, P3390, DOI 10.1109/IGARSS.2002.1027192; GFDRD, 2016, GEOM FEAT DESCR IM R; GOSHTASBY A, 1985, IEEE T PATTERN ANAL, V7, P338, DOI 10.1109/TPAMI.1985.4767663; Goshtasby AA, 2011, IMAGE REGISTRATION FOR REMOTE SENSING, P153; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Han JH, 2001, PATTERN RECOGN LETT, V22, P1133, DOI 10.1016/S0167-8655(01)00063-0; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; He XC, 2004, INT C PATT RECOG, P791, DOI 10.1109/ICPR.2004.1334377; Ji R. R., 2014, ACM T INTELLIGENT SY, V6, P1; Jia Y-B, 2013, TRANSFORMATIONS HOMO; Kahaki SMM, 2016, NEUROCOMPUTING, V175, P1009, DOI 10.1016/j.neucom.2015.09.106; Kahaki SMM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149710; Kahaki SMM, 2014, SENSORS-BASEL, V14, P4126, DOI 10.3390/s140304126; Li W, 2004, IEEE T IMAGE PROCESS, V13, P1115, DOI 10.1109/TIP.2004.828435; Liu Z., 2014, SENS TRANSDUCERS, V163, P82; Ma JY, 2015, IEEE T GEOSCI REMOTE, V53, P6469, DOI 10.1109/TGRS.2015.2441954; Ma JY, 2015, IEEE T SIGNAL PROCES, V63, P1115, DOI 10.1109/TSP.2014.2388434; Ma JY, 2014, IEEE T IMAGE PROCESS, V23, P1706, DOI 10.1109/TIP.2014.2307478; Mattes D, 2001, PROC SPIE, V4322, P1609, DOI 10.1117/12.431046; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mokhtarian F, 2006, COMPUT VIS IMAGE UND, V102, P81, DOI 10.1016/j.cviu.2005.11.001; Mokhtarian F, 1998, IEEE T PATTERN ANAL, V20, P1376, DOI 10.1109/34.735812; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Orchard J, 2005, LECT NOTES COMPUT SC, V3656, P116, DOI 10.1007/11559573_15; Palenichka RM, 2010, IEEE T GEOSCI REMOTE, V48, P2864, DOI 10.1109/TGRS.2010.2043677; Reddy BS, 1996, IEEE T IMAGE PROCESS, V5, P1266, DOI 10.1109/83.506761; Scott DW, 2001, TECHNOMETRICS, V43, P274, DOI 10.1198/004017001316975880; Shui PL, 2013, IEEE T IMAGE PROCESS, V22, P3204, DOI 10.1109/TIP.2013.2259834; Srivastava R., 2013, RES DEV COMPUTER VIS; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Sun WH, 2012, BIOMED SIGNAL PROCES, V7, P599, DOI 10.1016/j.bspc.2012.05.006; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195; Wei ZQ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090904; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wu Z, 2012, IEEE T IMAGE PROCESS, V21, P2464, DOI 10.1109/TIP.2012.2185941; Yang K, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060581; Zhang XH, 2007, PATTERN RECOGN LETT, V28, P545, DOI 10.1016/j.patrec.2006.10.006; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zhang YD, 2011, SENSORS-BASEL, V11, P4721, DOI 10.3390/s110504721; Zhang YD, 2009, SENSORS-BASEL, V9, P7516, DOI 10.3390/s90907516; Zhou DX, 2004, IEEE INT CONF ROBOT, P2730; Zhu Min, 2014, PLOS ONE, V9; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	53	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200676	10.1371/journal.pone.0200676	http://dx.doi.org/10.1371/journal.pone.0200676			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024921	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000040
J	Matsuda, Y; Hashimoto, R; Takemoto, S; Yoshioka, Y; Uehara, T; Kawasaki, Y				Matsuda, Yukihisa; Hashimoto, Reiko; Takemoto, Sachiko; Yoshioka, Yuka; Uehara, Takashi; Kawasaki, Yasuhiro			Educational benefits for nurses and nursing students of the dementia supporter training program in Japan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SCALE DEVELOPMENT; KNOWLEDGE; ATTITUDES; PEOPLE; CARE	In Japan, which is thought to be a rapidly growing super-aging society, a national campaign named "the Dementia Supporter Caravan" has been deployed. The aim of this study was to assess the educational benefits of the dementia supporter training program for nurses and nursing students. We conducted dementia supporter training, and measured knowledge and attitudes regarding people with dementia as educational benefits pre- and post-training. Data sets of 134 nursing students and 63 nurses were analyzed. The results indicated that the two groups gained knowledge, understanding, and the confidence to care for people with dementia after attending the dementia supporter training program. Moreover, the two groups derived different benefits from the program. Nursing students gained substantial knowledge and learnt the importance of early detection and treatment, to levels similar to those of nurses prior to training. The training program reduced the difficulties of nurses to interact with and care for people with dementia. We can conclude that the dementia supporter training program has considerable educational benefits for nurses and nursing students.	[Matsuda, Yukihisa] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima, Japan; [Matsuda, Yukihisa; Hashimoto, Reiko; Takemoto, Sachiko; Yoshioka, Yuka; Uehara, Takashi; Kawasaki, Yasuhiro] Kanazawa Med Univ, Dept Neuropsychiat, Uchinada, Ishikawa, Japan	Fukuyama University; Kanazawa Medical University	Matsuda, Y (corresponding author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima, Japan.; Matsuda, Y (corresponding author), Kanazawa Med Univ, Dept Neuropsychiat, Uchinada, Ishikawa, Japan.	y-matsuda@fupharm.fukuyama-u.ac.jp		Matsuda, Yukihisa/0000-0003-0030-6918	National Key R&D Program of China [2016YFC0401601, 2017YFC0804607]; National Natural Science Foundation of China [51739003, 51479054, 51779086, 51579086, 51379068, 51579083, 51579085, 51609074]; Priority Academic Program Development of Jiangsu Higher Education Institutions [YS11001]; Jiangsu Natural Science Foundation [BK20160872]; Special Project Funded of National Key Laboratory [20145027612, 20165042112]; Key R&D Program of Guangxi [AB17195074]; Central University Basic Research Project [2017B11114]; Fundamental Research Funds for the Central Universities [2017B617X14]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYZZ16_0283, KYCX17_0424]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Special Project Funded of National Key Laboratory; Key R&D Program of Guangxi; Central University Basic Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported by National Key R&D Program of China (2016YFC0401601, 2017YFC0804607), National Natural Science Foundation of China (Grant Nos. 51739003, 51479054, 51779086, 51579086, 51379068, 51579083, 51579085, and 51609074), Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (YS11001), Jiangsu Natural Science Foundation (Grant No. BK20160872), Special Project Funded of National Key Laboratory (20145027612, 20165042112), Key R&D Program of Guangxi (AB17195074), Central University Basic Research Project (2017B11114), the Fundamental Research Funds for the Central Universities (Grant No. 2017B617X14), Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant Nos. KYZZ16_0283, KYCX17_0424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Disease International, 2016, DEM FRIENDL COMM GLO; Annear MJ, 2015, J AM GERIATR SOC, V63, P2375, DOI 10.1111/jgs.13707; Austrom MG, 2015, DEMENTIA-LONDON, V14, P682, DOI 10.1177/1471301214544338; Buffington ALH, 2013, J AM OSTEOPATH ASSOC, V113, P768, DOI 10.7556/jaoa.2013.046; Carpenter BD, 2009, GERONTOLOGIST, V49, P236, DOI 10.1093/geront/gnp023; Community-Care Policy Network, 2016, NUMB DEM SUPP CUM 20; Eccleston CEA, 2015, NURS EDUC TODAY, V35, P800, DOI 10.1016/j.nedt.2015.02.019; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; GILLEARD C, 1994, BRIT J CLIN PSYCHOL, V33, P529, DOI 10.1111/j.2044-8260.1994.tb01149.x; Goldberg LR, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0344-z; Hattink B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4025; Kang Y, 2017, SCAND J CARING SCI, V31, P631, DOI 10.1111/scs.12377; Kimzey M, 2016, NURS EDUC TODAY, V46, P57, DOI 10.1016/j.nedt.2016.08.031; Kitwood Tom, 1992, Ageing Soc, V12, P269, DOI 10.1017/S0144686X0000502X; Korczyn AD, 2002, ANN NY ACAD SCI, V977, P129, DOI 10.1111/j.1749-6632.2002.tb04807.x; KOROLEV IO, 2014, MED STUDENT RES J, V4, P24, DOI DOI 10.3402/MSRJ.V3I0.201333; Kuhn Daniel, 2005, Am J Alzheimers Dis Other Demen, V20, P41, DOI 10.1177/153331750502000108; McCurry J, 2015, LANCET, V386, P1523, DOI 10.1016/S0140-6736(15)00525-5; Ministry of Health Labour and Welfare, 2012, 5 YEAR PLAN PROM MEA; Ministry of Health Labour and Welfare, 2016, LONG TERM CAR INS SY; Ministry of Health Labour and Welfare, 2015, COMPR STRAT ACC DEM; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; Organization WH, 2015, SUMM WORLD REP AG HL; Saito Miki, 2015, Journal of the Acarological Society of Japan, V24, P19, DOI 10.2300/acari.24.19; Shin JH, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0116-4; Statistics Bureau, 2016, MONTHL REP; Sugawara H., 2014, NINCHISHO DEMENTIA S; Toye C, 2014, DEMENTIA-LONDON, V13, P248, DOI 10.1177/1471301212471960; Warren JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4827; World Health Organization, 2017, GLOB ACT PLAN PUB HL GLOB ACT PLAN PUB HL; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190	32	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200586	10.1371/journal.pone.0200586	http://dx.doi.org/10.1371/journal.pone.0200586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024922	gold, Green Submitted, Green Published			2022-12-26	WOS:000439120000031
J	Vijay, A; Becker, JE; Ross, JS				Vijay, Aishwarya; Becker, Jessica E.; Ross, Joseph S.			Patterns and predictors of off-label prescription of psychiatric drugs	PLOS ONE			English	Article							ANTIPSYCHOTIC MEDICATIONS; PRIMARY-CARE; ANTIDEPRESSANTS; ASSOCIATION; GABAPENTIN; PHYSICIANS; TRAZODONE; MEDICAID; INSOMNIA; SYSTEM	Off-label prescribing of psychiatric drugs is common, despite lacking strong scientific evidence of efficacy and potentially increasing risk for adverse events. The goal of this study was to characterize prevalence of off-label prescriptions of psychiatric drugs and examine patient and clinician predictors of off-label use. This manuscript presents a retrospective, cross-sectional study using data from the 2012 and 2013 National Ambulatory Medical Care Surveys (NAMCS). The study examined all adult outpatient visits to psychiatric practices for chronic care management with a single listed visit diagnosis in which at least one psychiatric drug was prescribed. The main outcome measure was off-label prescribing of at least one psychiatric drug, defined as prescription for a condition for which it has not been approved for use by the FDA. Among our sample representative of 1.85 billion outpatient visits, 18.5 million (1.3%) visits were to psychiatrists for chronic care management in which at least one psychiatric drug was prescribed. Overall, the rate of off-label use was 12.9% (95% CI: 12.215.7). The most common off-label uses were for manic-depressive psychosis treated with citalopram and primary insomnia treated with trazodone. Several patient and clinician characteristics were positively associated with off-label prescribing, including seeing a psychiatrist (OR: 1.06, 95% CI, 1.01-1.12; p = 0.03) instead of another type of clinician, the office visit taking place in the Western region of the country (OR: 1.09, 95% CI, 1.01-1.17; p = 0.02), and the patient having 3 or more chronic conditions (OR: 1.12, 95% CI, 1.02-1.14; p = 0.003). In contrast, having Medicare coverage (OR: 0.93, 95% CI, 0.84-0.97; p = 0.04) and receiving payment assistance from a medical charity (OR: 0.91, 95% CI, 0.88-0.96; p = 0.03) instead of private insurance were negatively associated with off-label prescribing. These results suggest that certain classes of psychiatric medications are being commonly prescribed to treat conditions for which they have not been determined by the FDA to be clinically efficacious and/or safe.	[Vijay, Aishwarya] Yale Univ, Sch Med, New Haven, CT USA; [Becker, Jessica E.] Massachusetts Gen Hosp, MGH McLean Psychiat Residency Program, Boston, MA 02114 USA; [Becker, Jessica E.] Harvard Med Sch, Boston, MA USA; [Ross, Joseph S.] Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Sch Med, Natl Clinician Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA	Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University; Yale University; Yale University	Ross, JS (corresponding author), Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA.; Ross, JS (corresponding author), Yale Sch Med, Natl Clinician Scholars Program, New Haven, CT 06510 USA.; Ross, JS (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.; Ross, JS (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.	joseph.ross@yale.edu		Ross, Joseph/0000-0002-9218-3320; Becker, Jessica/0000-0003-0522-2836	NIMH NIH HHS [R25 MH094612] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams C, 2003, NEWSPAPER ARTICLE SE; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2013, LEXICON PLUS; [Anonymous], 2016, ABILIFY ARIPIPRAZOLE; Anxiety Disorders Association America, 2009, ANX DIS MED; Canada H., 2013, GOOD PHARMACOVIGILAN; Chen H, 2006, J CLIN PSYCHIAT, V67, P972, DOI 10.4088/JCP.v67n0615; CMS, 2013, ANT MED US FOOD DRUG; Eguale T, 2016, JAMA INTERN MED, V176, P55, DOI 10.1001/jamainternmed.2015.6058; Eguale T, 2012, ARCH INTERN MED, V172, P781, DOI 10.1001/archinternmed.2012.340; FDA, 2015, PED EXP ADV PAN GUID; FLEISCHMAN W, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I4189; Fukada Christine, 2012, Can Pharm J (Ott), V145, P280, DOI 10.3821/145.6.cpj280; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Grundy Q, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001561; Horen B, 2002, BRIT J CLIN PHARMACO, V54, P665, DOI 10.1046/j.1365-2125.2002.t01-3-01689.x; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jaffer KY, 2017, INNOVATIONS CLIN NEU, V14; James SP, 2004, J CLIN PSYCHIAT, V65, P752; Kamble P, 2010, PSYCHIAT SERV, V61, P130, DOI 10.1176/ps.2010.61.2.130; Kapczynski A, 2016, JAMA INTERN MED, V176, P295, DOI 10.1001/jamainternmed.2015.8155; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Lai LL, 2011, DRUG HEALTHC PATIENT, V3, P27, DOI 10.2147/DHPS.S21079; Lamy FX, 2017, CURR MED RES OPIN, V33, P891, DOI 10.1080/03007995.2017.1294055; Leslie DL, 2009, PSYCHIAT SERV, V60, P1174, DOI 10.1176/ps.2009.60.9.1175; Leslie DL, 2012, AM J MANAG CARE, V18, pE109; McInerney SJ, 2014, PRIMARY CARE COMPANI, V16; Neubert A, 2004, DRUG SAFETY, V27, P1059, DOI 10.2165/00002018-200427130-00006; Patwardhan AR, 2016, PHYS PHARM SALES REP; Pena E., 2003, PHARMAVOICE; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P884; Schappert SM, 2008, AMBULATORY MED CARE; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; Wallach JD, 2018, JAMA-J AM MED ASSOC, V319, P776, DOI 10.1001/jama.2017.21897; Walton SN, 2008, PHARMACOTHERAPY, V28, P1443, DOI 10.1592/phco.28.12.1443; Wiegand MH, 2008, DRUGS, V68, P2411, DOI 10.2165/0003495-200868170-00001; Wijkstra J, 2017, BJPSYCH ADV, V23, P2; Wiktorowicz M, 2012, SOC SCI MED, V75, P165, DOI 10.1016/j.socscimed.2011.11.046; Wong J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j603; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	43	20	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0198363	10.1371/journal.pone.0198363	http://dx.doi.org/10.1371/journal.pone.0198363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024873	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000003
J	Justin, C; Samrot, AV; Sruthi, PD; Sahithya, CS; Bhavya, KS; Saipriya, C				Justin, C.; Samrot, Antony V.; Sruthi, Durga P.; Sahithya, Chamarthy Sai; Bhavya, Karanam Sai; Saipriya, C.			Preparation, characterization and utilization of coreshell super paramagnetic iron oxide nanoparticles for curcumin delivery	PLOS ONE			English	Article							ANTICANCER ACTIVITY; CHITOSAN; SPIONS; TUMOR	In this study, super paramagnetic iron oxide nanoparticles (SPIONs) were produced by chemical co-precipitation method, then it was constructed to be a core shell nanoparticle by functionalizing with SDS, loading with curcumin and coating with a biopolymer i.e. chitosan. Each step was analyzed microscopically and spectroscopically. The produced coreshell particles were between 40 and 45nm and these coreshell particles were utilized for drug delivery studies against cervical cancer cell line-HeLa cells. The coreshell SPIONs were found to be releasing curcumin in between 6 and 12 h, which was evidenced by increased apoptotic cells and increased caspase 3 expression in HeLa cells.	[Justin, C.; Samrot, Antony V.; Sruthi, Durga P.; Sahithya, Chamarthy Sai; Bhavya, Karanam Sai; Saipriya, C.] Sathyabama Inst Sci & Technol, Dept Biotechnol, Chennai, Tamil Nadu, India	Sathyabama Institute of Science & Technology	Samrot, AV (corresponding author), Sathyabama Inst Sci & Technol, Dept Biotechnol, Chennai, Tamil Nadu, India.	antonysamrot@gmail.com	samrot, antony Vincent/C-1509-2011	samrot, antony Vincent/0000-0001-9536-0567				Allegra A, 2017, CANCER INVEST, V35, P1, DOI 10.1080/07357907.2016.1247166; Biosciences B. D., 2011, DETECTION APOPTOSIS; Bolden NW, 2008, NSTI NANOTECH 2008, VOL 2, TECHNICAL PROCEEDINGS, P390; Cortajarena Aitziber L, 2014, Nanobiomedicine (Rij), V1, P2, DOI 10.5772/58841; Disch S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013025; Griffiths D, 2011, NANOTECHNOLOGY 2011: ADVANCED MATERIALS, CNTS, PARTICLES, FILMS AND COMPOSITES, NSTI-NANOTECH 2011, VOL 1, P4; Gupta AK, 2007, NANOMEDICINE-UK, V2, P23, DOI 10.2217/17435889.2.1.23; Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/anie.200200546; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hazra K., 2015, INT J PHARMACOL, V2, P127, DOI [10.13040/IJPSR.0975-8232.IJP.2(3).127-30, DOI 10.13040/IJPSR.0975-8232.IJP.2(3).127-30, DOI 10.13040/IJPSR.0975-8232]; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hong SC, 2011, INT J NANOMED, V6, P3219, DOI 10.2147/IJN.S26355; Justin C, 2017, APPL NANOSCI, V7, P463, DOI 10.1007/s13204-017-0583-x; Kievit FM, 2011, ACCOUNTS CHEM RES, V44, P853, DOI 10.1021/ar2000277; Klein S, 2014, J PHYS CHEM B, V118, P6159, DOI 10.1021/jp5026224; Kolev TM, 2005, INT J QUANTUM CHEM, V102, P1069, DOI 10.1002/qua.20469; Laurent S, 2014, EXPERT OPIN DRUG DEL, V11, P1449, DOI 10.1517/17425247.2014.924501; Layek S., 2010, INT J ENG SCI TECHNO, V2; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Magro M, 2014, CHEM-EUR J, V20, P11913, DOI 10.1002/chem.201402820; Martinez-Boubeta C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01652; Mitchell E, 2015, POWDER TECHNOL, V272, P295, DOI 10.1016/j.powtec.2014.12.021; Mohammad F, 2010, J PHYS CHEM C, V114, P19194, DOI 10.1021/jp105807r; Mohan PRK, 2012, VIB SPECTROSC, V62, P77, DOI 10.1016/j.vibspec.2012.05.002; Morsy S.M.I., 2014, INT J CURR MICROBIOL, V3, P237, DOI DOI 10.1007/978-3-319-13596-0_10; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Narang AS, 2007, INT J PHARM, V345, P9, DOI 10.1016/j.ijpharm.2007.08.057; Onyishi V. I., 2013, African Journal of Pharmacy and Pharmacology, V7, P809; PICQUART M, 1986, J PHYS CHEM-US, V90, P243, DOI 10.1021/j100274a008; Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091; Qin CQ, 2006, CARBOHYD POLYM, V63, P367, DOI 10.1016/j.carbpol.2005.09.023; Rajan M, 2017, RSC ADV, V7, P46271, DOI 10.1039/c7ra06615e; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Rudakovskaya PG, 2010, MENDELEEV COMMUN, V20, P158, DOI 10.1016/j.mencom.2010.05.012; Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b; Scialabba C, 2014, EUR J PHARM BIOPHARM, V88, P695, DOI 10.1016/j.ejpb.2014.09.008; Shang HS, 2016, ONCOL REP, V36, P2207, DOI 10.3892/or.2016.5002; Sweetman SC, 2011, COMPLETE DRUG REFERE; Tombacz E, 2013, COLLOID SURFACE A, V435, P91, DOI 10.1016/j.colsurfa.2013.01.023; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; VILLA S, 2016, MATERIALS, V9; Wang LY, 2005, J PHYS CHEM B, V109, P21593, DOI 10.1021/jp0543429; Wright JS, 2002, J MOL STRUC-THEOCHEM, V591, P207, DOI 10.1016/S0166-1280(02)00242-7; Yallapu MM, 2014, BIOMATERIALS, V35, P8635, DOI 10.1016/j.biomaterials.2014.06.040; Zhang Jin, 2006, Cancer Genomics & Proteomics, V3, P147	47	33	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200440	10.1371/journal.pone.0200440	http://dx.doi.org/10.1371/journal.pone.0200440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021002	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400049
J	Miyazaki, R; Ando, H; Hamasaki, T; Higuchi, Y; Oshita, K; Tashiro, T; Sakane, N				Miyazaki, Ryo; Ando, Hitoshi; Hamasaki, Tomoko; Higuchi, Yukito; Oshita, Kazushige; Tashiro, Tomoki; Sakane, Naoki			Development and initial validation of the Morningness-Eveningness Exercise Preference Questionnaire (MEEPQ) in Japanese university students	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CIRCADIAN-RHYTHM; CHRONOTYPE	The aim of this study was to develop a questionnaire to conveniently assess the diurnal preferences of physical activity (PA) in Japanese university students. A total of 219 subjects completed our novel Morningness-eveningness Exercise Preference Questionnaire (MEEPQ). The MEEPQ consisted of 30 items (15 items for the morning and the same 15 items for the evening) rated on a 5-point Likert scale concerning their preference for participating in PA in the morning and evening. The morning score (MS) and evening score (ES) were determined by summing each of the respective 15 items. The internal consistency and construct validity were assessed, and a factor analysis was conducted. To examine the external validity of the MEEPQ, participants wore an accelerometer for seven consecutive days to measure their PA levels objectively. Finally, the test-retest reliability was evaluated at a one-month interval. The MEEPQ showed excellent internal consistency (Cronbach's alpha = 0.896) and construct validity (morning KMO = 0.913, evening KMO = 0.875). A factor analysis showed a three-factor structure involving Physical Wellness (MEEPQ-W), Psychological Well-Being (MEEPQ-P) and Exercise Barrier (MEEPQ-B). The percent of variance was largest for MEEPQ-W in the morning (45.2%) and MEEPQ-P in the evening (40.8%). Test-retest showed that MEEPQ scores had fair repeatability. Significant and positive associations between scores and objectively measured PA levels were found in the MS and 6-9 AM PA and in the ES and 6-9 PM and 9 PM- 0 AM PA (all p<0.05). In summary, the novel MEEPQ showed relatively good agreement and thus can be used for Japanese university student samples. In the MEEPQ, three factors (the physical wellness, psychological well-being and exercise barrier) contributed to a morning or evening PA preference. The summed scores were significantly associated with the objectively measured PA levels in both the morning and evening. Therefore the MEEPQ appears to be a suitable tool for assessing diurnal PA preferences.	[Miyazaki, Ryo] Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan; [Miyazaki, Ryo] Univ East Asia, Fac Human Sci, Dept Sports & Hlth Sci, Yamaguchi, Japan; [Ando, Hitoshi] Kanagawa Univ, Grad Sch Med Sci, Dept Cellular & Mol Funct Anal, Yokohama, Ishikawa, Japan; [Hamasaki, Tomoko] Kyushu Womens Univ, Fac Home Econ, Dept Nutr, Fukuoka, Fukuoka, Japan; [Higuchi, Yukito; Oshita, Kazushige; Tashiro, Tomoki] Kyushu Kyoritsu Univ, Dept Sports Sci, Fukuoka, Fukuoka, Japan; [Sakane, Naoki] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med, Kyoto, Japan	Shimane University; Kanagawa University	Miyazaki, R (corresponding author), Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan.; Miyazaki, R (corresponding author), Univ East Asia, Fac Human Sci, Dept Sports & Hlth Sci, Yamaguchi, Japan.	miyazaki@hmn.shimane-u.ac.jp	ANDO, Hitoshi/O-8199-2016; Miyazaki, Ryo/GPW-7412-2022	ANDO, Hitoshi/0000-0001-6179-9993; Miyazaki, Ryo/0000-0002-1996-709X; OSHITA, Kazushige/0000-0002-8049-1174	Ministry of Education and Science of Japan [26750351]	Ministry of Education and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for Science Research from the Ministry of Education and Science of Japan (26750351), URL: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26750351/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Kelly C, 2008, Eat Behav, V9, P62, DOI 10.1016/j.eatbeh.2007.03.007; Arvidsson D, 2013, MED SCI SPORT EXER, V45, P698, DOI 10.1249/MSS.0b013e31827a1d05; Bonato M, 2017, J SPORT SCI MED, V16, P286; Brace N., 2012, SPSS PSYCHOL; Chourou H., 2014, SPORT SCI HLTH, V10, P143, DOI [10.1007/s11332-014-0185-x, DOI 10.1007/S11332-014-0185-X]; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hatcher L., 1994, STEP BY STEP APPROAC; Henst RHP, 2015, CHRONOBIOL INT, V32, P858, DOI 10.3109/07420528.2015.1048870; Hisler GC, 2017, ANN BEHAV MED, V51, P391, DOI 10.1007/s12160-016-9862-0; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; ISHIHARA K, 1986, JPN J PSYCHOL, V57, P87, DOI 10.4992/jjpsy.57.87; Jansen FM, 2018, J PUBLIC HEALTH-UK, V40, P787, DOI 10.1093/pubmed/fdx146; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Kunorozva L, 2014, J SPORT SCI, V32, P917, DOI 10.1080/02640414.2013.873139; Kunorozva L, 2012, CHRONOBIOL INT, V29, P1004, DOI 10.3109/07420528.2012.719966; Laborde S, 2015, CHRONOBIOL INT, V32, P942, DOI 10.3109/07420528.2015.1055755; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lastella M, 2016, J HUM KINET, V54, P219, DOI 10.1515/hukin-2016-0049; Antunez JM, 2013, CHRONOBIOL INT, V30, P981, DOI 10.3109/07420528.2013.790397; Ministry of Health Labour and Welfare, 2010, RES STEP COUNT NAT H; Pedisic Z, 2014, EUR J SPORT SCI, V14, P492, DOI 10.1080/17461391.2013.844861; Rae DE, 2015, EUR J APPL PHYSIOL, V115, P1339, DOI 10.1007/s00421-015-3109-9; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2015, J BIOL RHYTHM, V30, P487, DOI 10.1177/0748730415603835; Roveda E, 2017, CHRONOBIOL INT, V34, P551, DOI 10.1080/07420528.2016.1276928; Schondube A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01414; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; Suh S, 2017, BEHAV SLEEP MED, V15, P361, DOI 10.1080/15402002.2016.1141768; Tanaka C, 2016, J PHYS ACT HEALTH, V13, pS189, DOI 10.1123/jpah.2016-0296; Vitale JA, 2015, CHRONOBIOL INT, V32, P405, DOI 10.3109/07420528.2014.986273; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Yu JH, 2015, J CLIN ENDOCR METAB, V100, P1494, DOI 10.1210/jc.2014-3754	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200870	10.1371/journal.pone.0200870	http://dx.doi.org/10.1371/journal.pone.0200870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021011	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400083
J	Mund, T; Masuda-Suzukake, M; Goedert, M; Pelham, HR				Mund, Thomas; Masuda-Suzukake, Masami; Goedert, Michel; Pelham, Hugh R.			Ubiquitination of alpha-synuclein filaments by Nedd4 ligases	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOMAIN; ARCHITECTURE; DEGRADATION; FAMILY; ITCH	Alpha-synuclein can form beta-sheet filaments, the accumulation of which plays a key role in the development of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. It has previously been shown that alpha-synuclein is a substrate for the HECT domain-containing ubiquitin ligase Nedd4, and is subject to ubiquitin-mediated endosomal degradation. We show here that alpha-synuclein filaments are much better substrates for ubiquitination in vitro than monomeric alpha-synuclein, and that this increased susceptibility cannot be mimicked by the mere clustering of monomers. Recognition by Nedd4 family enzymes is not through the conventional binding of PPxY-containing sequences to WW domains of the ligase, but it also involves C2 and HECT domains. The disease-causing alpha-synuclein mutant A53T is a much less efficient substrate for Nedd4 ligases than the wild-type protein. We suggest that preferential recognition, ubiquitination and degradation of beta-sheet-containing filaments may help to limit toxicity, and that A53T alpha-synuclein may be more toxic, at least in part because it avoids this fate.	[Mund, Thomas; Masuda-Suzukake, Masami; Goedert, Michel; Pelham, Hugh R.] MRC Lab Mol Biol, Cambridge, England; [Masuda-Suzukake, Masami] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo, Japan	MRC Laboratory Molecular Biology; Tokyo Metropolitan Institute of Medical Science	Pelham, HR (corresponding author), MRC Lab Mol Biol, Cambridge, England.	hp@mrc-lmb.cam.ac.uk		Mund, Thomas/0000-0002-3957-1105	UK Medical Research Council [MC_U105178788, MC_U105184291]; MRC [MC_U105184291, MC_U105178788] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (https://mrc.ukri.org) through awards MC_U105178788 (H.P) and MC_U105184291 (M.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hospenthal MK, 2015, NAT PROTOC, V10, P349, DOI 10.1038/nprot.2015.018; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Mund T, 2018, J BIOL CHEM, V293, P5200, DOI 10.1074/jbc.RA117.000934; Mund T, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150185; Mund T, 2014, P NATL ACAD SCI USA, V111, P16736, DOI 10.1073/pnas.1412152111; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	25	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200763	10.1371/journal.pone.0200763	http://dx.doi.org/10.1371/journal.pone.0200763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021006	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400074
J	El Motiam, A; Vidal, S; de la Cruz-Herrera, CF; Da Silva-Alvarez, S; Baz-Martinez, M; Seoane, R; Vidal, A; Rodriguez, MS; Xirodimas, DP; Carvalho, AS; Beck, HC; Matthiesen, R; Collado, M; Rivas, C				El Motiam, Ahmed; Vidal, Santiago; de la Cruz-Herrera, Carlos F.; Da Silva-Alvarez, Sabela; Baz-Martinez, Maite; Seoane, Rocio; Vidal, Anxo; Rodriguez, Manuel S.; Xirodimas, Dimitris P.; Carvalho, Ana Sofia; Beck, Hans Christian; Matthiesen, Rune; Collado, Manuel; Rivas, Carmen			Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function	FASEB JOURNAL			English	Article						SUMO; NEDD8; p53; ARF	RIBOSOMAL-PROTEIN L11; SUMO-1 MODIFICATION; ONCOPROTEIN MDM2; P53; PROMOTES; UBIQUITINATION; ACCUMULATION; DEGRADATION; CONJUGATION; INHIBITION	The ribosomal protein L11 (RPL11) integrates different types of stress into a p53-mediated response. Here, we analyzed the impact of the ubiquitin-like protein SUMO on the RPL11-mouse double-minute 2 homolog-p53 signaling. We show that small ubiquitin-related modifier (SUMO)1 and SUMO2 covalently modify RPL11. We find that SUMO negatively modulates the conjugation of the ubiquitin-like protein neural precursor cell-expressed developmentally downregulated 8 (NEDD8) to RPL11 and promotes the translocation of the RP outside of the nucleoli. Moreover, the SUMO-conjugating enzyme, Ubc9, is required for RPL11-mediated activation of p53. SUMOylation of RPL11 is triggered by ribosomal stress, as well as by alternate reading frame protein upregulation. Collectively, our data identify SUMO protein conjugation to RPL11 as a new regulator of the p53-mediated cellular response to different types of stress and reveal a previously unknown SUMO-NEDD8 interplay.El Motiam, A., Vidal, S., de la Cruz-Herrera, C. F., Da Silva-alvarez, S., Baz-Martinez, M., Seoane, R., Vidal, A., Rodriguez, M. S., Xirodimas, D. P., Carvalho, A. S., Beck, H. C., Matthiesen, R., Collado, M., Rivas, C. Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function.	[El Motiam, Ahmed; Vidal, Santiago; Baz-Martinez, Maite; Seoane, Rocio; Vidal, Anxo; Rivas, Carmen] Univ Santiago de Compostela, Ctr Invest Med Mol & Enfermedades Cron CIMUS, Santiago De Compostela, Spain; [El Motiam, Ahmed; Vidal, Santiago; Baz-Martinez, Maite; Seoane, Rocio; Vidal, Anxo; Rivas, Carmen] Inst Invest Sanitarias, Santiago De Compostela, Spain; [de la Cruz-Herrera, Carlos F.; Rivas, Carmen] CNB, CSIC, Dept Biol Mol & Celular, Madrid, Spain; [de la Cruz-Herrera, Carlos F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Da Silva-Alvarez, Sabela; Collado, Manuel] Complexo Hosp Univ Santiago De Compostela, Inst Invest Sanitaria Santiago Compostela, Serv Gallego Salud, Santiago De Compostela, Spain; [Rodriguez, Manuel S.] CNRS, USR 3505, Adv Technol Inst Life Sci ITAV, Toulouse, France; [Rodriguez, Manuel S.] Univ Toulouse III Paul Sabatier, Inst Pharmacol & Biol Struct, Toulouse, France; [Xirodimas, Dimitris P.] Univ Montpellier, CNRS, UMR 5237, Montpellier Cell Biol Res Ctr CRBM, Montpellier, France; [Carvalho, Ana Sofia; Matthiesen, Rune] Univ Nova Lisboa, Univ Nova Lisboa NOVA, Med Sch Fac, Fac Ciencias Med,Ctr Estudos Doencas Cron CEDOC, Lisbon, Portugal; [Beck, Hans Christian] Odense Univ Hosp, Ctr Clin Prote, Odense, Denmark	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Toronto; Complexo Hospitalario Universitario de Santiago de Compostela; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universidade Nova de Lisboa; University of Southern Denmark; Odense University Hospital	Rivas, C (corresponding author), Univ Santiago de Compostela, CIMUS, Avda Barcelona, Santiago De Compostela 15706, Spain.	crivas@cnb.csic.es	Vidal, Santiago/AAA-5646-2019; Rivas, Carmen/AAB-6278-2019; Rivas, Carmen/L-3162-2017; Beck, Hans Christian/AAK-9147-2021; Seoane, Rocio/AAA-8330-2019; Collado, Manuel/K-8140-2014; Matthiesen, Rune/AAF-2167-2020; Baz-Martínez, Maite/L-4626-2017; elmotiam, ahmed/AAB-6287-2019; Vidal, Anxo/B-5010-2015	Vidal, Santiago/0000-0002-0105-4583; Rivas, Carmen/0000-0002-0518-7199; Rivas, Carmen/0000-0002-0518-7199; Seoane, Rocio/0000-0002-7536-8702; Collado, Manuel/0000-0002-0330-0880; Matthiesen, Rune/0000-0002-6353-2616; Baz-Martínez, Maite/0000-0001-9160-7833; elmotiam, ahmed/0000-0003-2855-1368; Vidal, Anxo/0000-0002-0866-4202; Carvalho, Ana Sofia/0000-0003-0657-1907; de la Cruz-Herrera, Carlos/0000-0002-7493-5154; Da Silva Alvarez, Sabela/0000-0003-2702-8524; Xirodimas, Dimitris/0000-0001-9275-1140; Beck, Hans Christian/0000-0002-7763-3637	Ministry of Ecomony and Competitiveness; Fondos Europeos de Desarrollo Regional (FEDER) [BFU-2014-58530]; Xunta de Galicia; Institut National du Cancer (INCa) [PLBIO16-251]	Ministry of Ecomony and Competitiveness; Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	The authors thank Dr. Yue Xong for depositing the RPL11 plasmid at Addgene. Funding at the laboratory of C.R. is provided by the Ministry of Ecomony and Competitiveness, Fondos Europeos de Desarrollo Regional (FEDER) (BFU-2014-58530), and Xunta de Galicia. A.E.M. is a fellow of the Spanish Formacion de Personal Investigador (FPI) Program. S.V. is a fellow of the "Iniciacion a la Investigacion" Program of Centro de Investigacion en Medicina Molecular (CIMUS), Universidade de Santiago de Compostela (USC). Funding at the laboratory of D.P.X. and M.S.R. is provided by Institut National du Cancer (INCa; PLBIO16-251). The authors declare no conflicts of interest.	Bailly A, 2016, ONCOGENE, V35, P415, DOI 10.1038/onc.2015.104; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2012, J BIOL CHEM, V287, P17120, DOI 10.1074/jbc.M111.311902; de la Cruz-Herrera CF, 2015, ONCOGENE, V34, P1442, DOI 10.1038/onc.2014.48; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Domingues P, 2015, CELL REP, V13, P1467, DOI 10.1016/j.celrep.2015.10.001; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Guo C, 2014, IUBMB LIFE, V66, P71, DOI 10.1002/iub.1244; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Nishimura K, 2015, CELL REP, V10, P1310, DOI 10.1016/j.celrep.2015.01.055; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Rizos H, 2005, CELL CYCLE, V4, P597, DOI 10.4161/cc.4.4.1588; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Wang S, 2015, J MOL CELL BIOL, V7, P154, DOI 10.1093/jmcb/mjv010; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	37	15	15	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					643	651		10.1096/fj.201800341RR	http://dx.doi.org/10.1096/fj.201800341RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024791	Green Submitted			2022-12-26	WOS:000457401500050
J	Zhang, XS; Lu, Y; Wu, Q; Dai, HB; Li, W; Lv, SY; Zhou, XM; Zhang, X; Hang, CH; Wang, J				Zhang, Xiangsheng; Lu, Yue; Wu, Qi; Dai, Haibin; Li, Wei; Lv, Shengyin; Zhou, Xiaoming; Zhang, Xin; Hang, Chunhua; Wang, Jian			Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway	FASEB JOURNAL			English	Article						early brain injury; inflammation; microglia; neuroprotection	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MOUSE MODEL; POSSIBLE INVOLVEMENT; ISCHEMIC-STROKE; OXIDATIVE STRESS; CEREBRAL EDEMA; ACTIVATION; NEUROPROTECTION; INFLAMMATION	Inflammation plays a key role in the progression of subarachnoid hemorrhage (SAH). Here, we examined the effects of astaxanthin (ATX) on the inflammatory response and secondary damage after SAH and the underlying mechanisms of action. In vivo, a prechiasmatic cistern injection model was established in rats and mice. In addition, neuron-microglia cocultures were exposed to oxyhemoglobin to mimic SAH in vitro. Western blotting revealed that protein expression of TLR4 was markedly increased in microglia at 24 h after SAH, with consequent increases in the downstream molecules myeloid differentiation factor 88 and NF-kB. Treatment with ATX significantly inhibited the TLR4 activation, increased sirtuin 1 expression, and inhibited the subsequent inflammatory response both in vivo and in vitro. ATX also significantly decreased high-mobility group box 1 nuclear translocation and secretion in neurons, an effect that was reversed by the sirtuin 1-specific inhibitor sirtinol. ATX administered 4 h after SAH ameliorated cerebral inflammation, brain edema, and neuronal death and improved neurologic function. ATX reduced neuronal death but did not improve neurologic function in TLR4 knockout mice. These results suggest that ATX reduces the proinflammatory response and secondary brain injury after SAH, primarily by increasing sirtuin 1 levels and inhibiting the TLR4 signaling pathway.Zhang, X., Lu, Y., Wu, Q., Dai, H., Li, W., Lv, S., Zhou, X., Zhang, X., Hang, C., Wang, J. Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway.	[Zhang, Xiangsheng; Lu, Yue; Dai, Haibin; Li, Wei; Hang, Chunhua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Qi; Lv, Shengyin; Zhang, Xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Xiangsheng; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Zhou, Xiaoming] Second Mil Med Univ, Changzheng Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China	Nanjing University; Nanjing University; Johns Hopkins University; Naval Medical University	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zhang, X (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	zhangxsp@163.com; hang_neurosurgery@163.com	Wang, Jian/I-4874-2019; Li, Wei/ABE-4301-2021	Wang, Jian/0000-0003-2291-640X; LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of China [81471183, 81501022, 81771292]; American Heart Association [17GRNT33660766]; Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University; China Scholarship Council(China Scholarship Council)	The authors thank Dr. Bo Yu and YanLing Han (both from Jinling Hospital) for their generous assistance with pathologic examinations. The authors also thank Claire Levine, M.S., ELS, for assistance with manuscript preparation and the J.W. laboratory team members for insightful input. This work was supported by the National Natural Science Foundation of China (Grants 81471183 to Xin Zhang, 81501022 to Xiangsheng Zhang, and 81771292 to C.H.), the American Heart Association Grant-in-Aid (17GRNT33660766), and a Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University. Xiangsheng Zhang is a recipient of the China Scholarship Council Joint Ph.D. training award. The authors declare no conflicts of interest.	Alhadidi Q, 2018, MOL NEUROBIOL, V55, P1676, DOI 10.1007/s12035-017-0432-7; Brea D, 2011, REV NEUROLOGIA, V52, P12, DOI 10.33588/rn.5201.2010494; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng YY, 2015, J BIOCHEM, V158, P299, DOI 10.1093/jb/mvv041; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Dzaye ODA, 2016, J NEUROPATH EXP NEUR, V75, P429, DOI 10.1093/jnen/nlw016; Fadakar K, 2014, REV NEUROSCIENCE, V25, P699, DOI 10.1515/revneuro-2013-0069; Gong LL, 2016, EUR J NEUROSCI, V43, P1674, DOI 10.1111/ejn.13257; Han XN, 2019, J CEREBR BLOOD F MET, V39, P1531, DOI 10.1177/0271678X18762645; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Hwang J. S., 2015, TUMOR BIOL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128014; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lan KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12285-8; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Q, 2017, NEUROBIOL DIS, V108, P173, DOI 10.1016/j.nbd.2017.08.011; Lin QQ, 2017, LIFE SCI, V170, P100, DOI 10.1016/j.lfs.2016.11.026; Lv SY, 2018, WORLD NEUROSURG, V111, pE355, DOI 10.1016/j.wneu.2017.12.076; Pan LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099526; Raghavan A, 2012, NEURODEGENER DIS, V9, P1, DOI 10.1159/000329724; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Sakai S, 2009, J BIOL CHEM, V284, P28172, DOI 10.1074/jbc.M109.001099; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Siler DA, 2015, STROKE, V46, P1916, DOI 10.1161/STROKEAHA.114.008560; Siler DA, 2014, TRANSL STROKE RES, V5, P227, DOI 10.1007/s12975-014-0329-y; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sukumari-Ramesh S, 2016, TRANSL STROKE RES, V7, P141, DOI 10.1007/s12975-015-0421-y; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sun XB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-157; Tian XD, 2017, CURR DRUG DELIV, V14, P785, DOI 10.2174/1567201813666160808111933; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2015, BRAIN BEHAV IMMUN, V45, P98, DOI 10.1016/j.bbi.2014.12.015; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Wu H, 2015, NEUROBIOL AGING, V36, P1439, DOI 10.1016/j.neurobiolaging.2014.12.029; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Wu QJ, 2017, INFLAMMATION, V40, P1245, DOI 10.1007/s10753-017-0567-8; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Ye QY, 2013, MAR DRUGS, V11, P1019, DOI 10.3390/md11041019; Zhang J, 2017, BBA-GEN SUBJECTS, V1861, P1715, DOI 10.1016/j.bbagen.2017.03.007; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhang XS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081331; Zhang XS, 2014, J SURG RES, V192, P206, DOI 10.1016/j.jss.2014.05.029; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zhang XS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00611; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005; Zhao D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1007-2; Zheng D, 2014, NEUROPHARMACOLOGY, V84, P13, DOI 10.1016/j.neuropharm.2014.04.013; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	74	44	49	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					722	737		10.1096/fj.201800642RR	http://dx.doi.org/10.1096/fj.201800642RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30048156				2022-12-26	WOS:000457401500056
J	Salgado-Polo, F; Fish, A; Matsoukas, MT; Heidebrecht, T; Keune, WJ; Perrakis, A				Salgado-Polo, Fernando; Fish, Alex; Matsoukas, Minos-Timotheos; Heidebrecht, Tatjana; Keune, Willem-Jan; Perrakis, Anastassis			Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; lysophospholipid; phosphodiesterases; enzyme kinetics; molecular dynamics; ATX; ENPP2; LPA; allostery; phospholipase; phospholipid turnover; autotaxin	LYSOPHOSPHOLIPASE-D; SPHINGOSINE 1-PHOSPHATE; STRUCTURAL BASIS; KINETIC-DATA; BINDING; INHIBITORS; PHOSPHODIESTERASE; DISCOVERY; SUBSTRATE; ACTIVATION	Autotaxin (ATX) is a secreted glycoprotein and the only member of the ectonucleotide pyrophosphatase/phosphodiesterase family that converts lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). LPA controls key responses, such as cell migration, proliferation, and survival, implicating ATX-LPA signaling in various (patho)physiological processes and establishing it as a drug target. ATX structural and functional studies have revealed an orthosteric and an allosteric site, called the pocket and the tunnel, respectively. However, the mechanisms in allosteric modulation of ATX's activity as a lysophospholipase D are unclear. Here, using the physiological LPC substrate, a new fluorescent substrate, and diverse ATX inhibitors, we revisited the kinetics and allosteric regulation of the ATX catalytic cycle, dissecting the different steps and pathways leading to LPC hydrolysis. We found that ATX activity is stimulated by LPA and that LPA activates ATX lysophospholipase D activity by binding to the ATX tunnel. A consolidation of all experimental kinetics data yielded a comprehensive catalytic model supported by molecular modeling simulations and suggested a positive feedback mechanism that is regulated by the abundance of the LPA products activating hydrolysis of different LPC species. Our results complement and extend the current understanding of ATX hydrolysis in light of the allosteric regulation by ATX-produced LPA species and have implications for the design and application of both orthosteric and allosteric ATX inhibitors.	[Salgado-Polo, Fernando; Fish, Alex; Matsoukas, Minos-Timotheos; Heidebrecht, Tatjana; Keune, Willem-Jan; Perrakis, Anastassis] Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Matsoukas, Minos-Timotheos] Univ Patras, Dept Pharm, Patras 26504, Greece	Netherlands Cancer Institute; University of Patras	Perrakis, A (corresponding author), Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl	Matsoukas, Minos-Timotheos/B-8746-2012; Perrakis, Anastassis/E-8704-2013	Matsoukas, Minos-Timotheos/0000-0002-4642-8163; Salgado-Polo, Fernando/0000-0001-8362-5281; Perrakis, Anastassis/0000-0002-1151-6227	NWO-TOP Grant [700.10.354]	NWO-TOP Grant	The early part of this work was supported by NWO-TOP Grant 700.10.354 (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Albers HMHG, 2012, CHEM REV, V112, P2593, DOI 10.1021/cr2003213; Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Barbayianni E, 2015, PROG LIPID RES, V58, P76, DOI 10.1016/j.plipres.2015.02.001; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Cavalli S, 2010, CHEMBIOCHEM, V11, P2311, DOI 10.1002/cbic.201000349; Desroy N, 2017, J MED CHEM, V60, P3580, DOI 10.1021/acs.jmedchem.7b00032; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Hausmann J, 2016, J STRUCT BIOL, V195, P199, DOI 10.1016/j.jsb.2016.06.002; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hausmann J, 2010, ACTA CRYSTALLOGR F, V66, P1130, DOI 10.1107/S1744309110032938; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joncour A, 2017, J MED CHEM, V60, P7371, DOI 10.1021/acs.jmedchem.7b00647; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kato K, 2016, NAT STRUCT MOL BIOL, V23, P395, DOI 10.1038/nsmb.3200; Keune WJ, 2017, J MED CHEM, V60, P2006, DOI 10.1021/acs.jmedchem.6b01743; Keune WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11248; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lynch K. R., 2013, Patent No. [US8,378,100, 8378100]; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; MUNDER PG, 1979, SPRINGER SEMIN IMMUN, V2, P187, DOI 10.1007/BF01891668; Nikitopoulou I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070941; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Saunders LP, 2011, J BIOL CHEM, V286, P30130, DOI 10.1074/jbc.M111.246884; Shah P, 2016, BIOORG MED CHEM LETT, V26, P5403, DOI 10.1016/j.bmcl.2016.10.036; Stein AJ, 2015, MOL PHARMACOL, V88, P982, DOI 10.1124/mol.115.100404; Takakusa H, 2002, J AM CHEM SOC, V124, P1653, DOI 10.1021/ja011251q; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wu T, 2014, FASEB J, V28, P861, DOI 10.1096/fj.13-232868	43	21	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14312	14327		10.1074/jbc.RA118.004450	http://dx.doi.org/10.1074/jbc.RA118.004450			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30026231	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000444671500013
J	Gao, X; Zhang, SX; Zhao, XJ; Wu, QH				Gao, Xiang; Zhang, Shuxiang; Zhao, Xiujuan; Wu, Qihua			Potassium-induced plant resistance against soybean cyst nematode via root exudation of phenolic acids and plant pathogen-related genes	PLOS ONE			English	Article							HETERODERA-GLYCINES; DISEASE RESISTANCE; AGRICULTURE; EXPRESSION; DENSITY	Soybean cyst nematode (SCN) is a severe soil borne disease. The control of this disease is still a worldwide problem in agriculture. In this study, we found that application of potassium (K) fertilizer could decrease the occurrence of SCN at two field sites. Furthermore, the application of K could suppress Heterodera glycines with the activation of Phenylalanine Ammonia Lyase (PAL) and Polyphenol Oxidase (PPO) expression via pot experiments in a greenhouse. The release of cinnamic, ferulic and salicylic acids was significantly enhanced by K application of 3 mM, and each of three acids can dramatically constrain Heterodera glycines in vitro. This research indicated that K induce multiple mechanisms to improve the resistance of soybean against SCN and provide a new strategy to control SCN in fields with nutrient application.	[Gao, Xiang; Zhang, Shuxiang; Zhao, Xiujuan; Wu, Qihua] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Zhang, SX (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China.	zhangshuxiang@caas.cn	gao, xiang/AFP-7274-2022	gao, xiang/0000-0003-0359-9533	Special Fund for Agro-scientific Research in the Public Interest of China [201503120]; project "Modulation Technology for Water and Nutrients in the Soil Environment for Plant Growth" [2013AA102901]	Special Fund for Agro-scientific Research in the Public Interest of China; project "Modulation Technology for Water and Nutrients in the Soil Environment for Plant Growth"	This work was financially supported by the Special Fund for Agro-scientific Research in the Public Interest of China (201503120) and by the project "Modulation Technology for Water and Nutrients in the Soil Environment for Plant Growth" (2013AA102901) to SZ. The funders had no role in the study, data collection and analysis, decision to publish, or preparation of the manuscript. grant numbers: 201503120 URL: http://www.moa.gov.cn/zwllm/tzgg/tz/201304/t20130416_3435699.htmand. 2013AA102901 URL: http://www.most.gov.cn/kjjh/xmsb/xmys/.	Amtmann A, 2008, PHYSIOL PLANTARUM, V133, P682, DOI 10.1111/j.1399-3054.2008.01075.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2005, NATURE, V434, P217, DOI 10.1038/nature03356; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Dicko MH, 2005, J CHEM ECOL, V31, P2671, DOI 10.1007/s10886-005-7619-5; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Gao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095031; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033977; Hao WY, 2010, PLANT SOIL, V336, P485, DOI 10.1007/s11104-010-0505-0; Holzmueller EJ, 2007, PLANT SOIL, V290, P189, DOI 10.1007/s11104-006-9151-y; Huber D.M., 1999, MINERAL NUTR CROPS F, P205; Klink VP, 2009, PLANT PHYSIOL, V151, P1017, DOI 10.1104/pp.109.144006; Li W., 2009, P INT PLANT NUTR C 1; Li WJ, 2010, AGR SCI CHINA, V9, P1467, DOI 10.1016/S1671-2927(09)60239-X; Ling N, 2011, PLANT SOIL, V341, P485, DOI 10.1007/s11104-010-0660-3; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Maafi ZT, 2008, NEMATOLOGY, V10, P919, DOI 10.1163/156854108786161535; Midiwo J. Ogweno, 2002, Phytochemistry Reviews, V1, P311; Niblack TL, 2005, PLANT DIS, V89, P1020, DOI 10.1094/PD-89-1020; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Ntalli NG, 2012, J AGR FOOD CHEM, V60, P9929, DOI 10.1021/jf303107j; Qiao K, 2011, J AGR FOOD CHEM, V59, P2362, DOI 10.1021/jf104553f; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; Shaukat Syed Shahid, 2003, Phytopathologia Mediterranea, V42, P71; Shivashankar S, 2015, ANN APPL BIOL, V166, P420, DOI 10.1111/aab.12194; Song YAYA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013324; Upchurch RG, 2010, PHYSIOL MOL PLANT P, V75, P64, DOI 10.1016/j.pmpp.2010.08.007; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang J, 2003, PLANT DIS, V87, P623, DOI 10.1094/PDIS.2003.87.6.623; Wang M, 2013, INT J MOL SCI, V14, P7370, DOI 10.3390/ijms14047370; Wu HS, 2008, CHEMOSPHERE, V74, P45, DOI 10.1016/j.chemosphere.2008.09.027; Wuyts N, 2006, NEMATOLOGY, V8, P89, DOI 10.1163/156854106776179953; Zhou Y, 2017, PLOS ONE, V8; Zhu YB, 2013, EUR J SOIL BIOL, V58, P32, DOI 10.1016/j.ejsobi.2013.05.001; Zorb C, 2014, J PLANT PHYSIOL, V171, P656, DOI 10.1016/j.jplph.2013.08.008	36	18	20	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0200903	10.1371/journal.pone.0200903	http://dx.doi.org/10.1371/journal.pone.0200903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059518	Green Published, gold, Green Submitted			2022-12-26	WOS:000440251600019
J	Ideno, Y; Hayashi, K; Nakajima-Shimada, J; Onizuka, Y; Kishi, M; Ueno, T; Uchiyama, S				Ideno, Yuki; Hayashi, Kunihiko; Nakajima-Shimada, Junko; Onizuka, Yoko; Kishi, Mikiko; Ueno, Tomomi; Uchiyama, Shigeto			Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey	PLOS ONE			English	Article							SOY ISOFLAVONES; HABITUAL DIET; METABOLISM; EXCRETION	Equol is one of the most active soy isoflavones. When the association between soy food intake in daily life and health outcomes is examined in epidemiological studies, it is important to define the equol-producing status of each individual. However, few studies have assessed equol-producing status without a soy challenge test. To determine a robust cutoff criterion for equol producer classification in observational studies, we conducted a urinary isoflavone concentration survey in daily life among women. Furthermore, we examined the association between eating habits regarding soy foods and equol-producing status. A total of 4,412 participants were included in the analyses. Urinary isoflavones were analyzed using a high-performance liquid chromatography method. We examined the distribution of the log(10) equol/daidzein ratios, finding a mixture of two normal distributions, corresponding to equol producer and non-producer subpopulations. Applying a finite mixture model, we estimated the means, standard deviations, and mixing proportions of these two distributions. The estimation was carried out using the SAS NLIN procedure. The optimal cutoff point for the log(10) equol/daidzein ratio in the study population was determined to be -1.42, according to the estimated parameters of the mixture distribution. Based on this criterion, 1,830 (41.5%) of the participants were identified as equol producers. Compared with non-consumers of soy foods, consumers of soy foods had significantly higher odds of being equol producers. Using log(10)-transformed equol/daidzein ratios >= -1.42 to define equol producers among Japanese women is reasonable and suitable for determining equol-producing status in epidemiological studies. We found that soy food eating habits were associated with equol-producing status. Further investigation is required to evaluate associations between equol-producing status in daily life and health outcomes. The results of this study suggest the best cutoff point to use in the definition of equol-producing status in daily life.	[Ideno, Yuki] Gunma Univ, Initiat Adv Res, Maebashi, Gunma, Japan; [Hayashi, Kunihiko; Nakajima-Shimada, Junko; Onizuka, Yoko] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan; [Kishi, Mikiko] Gunma Univ, Ctr Med Educ, Maebashi, Gunma, Japan; [Ueno, Tomomi; Uchiyama, Shigeto] Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan	Gunma University; Gunma University; Gunma University; Otsuka Pharmaceutical	Hayashi, K (corresponding author), Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan.	khayashi@gunma-u.ac.jp		Hayashi, Kunihiko/0000-0003-4648-3936	JSPS by the Ministry of Education, Culture, Sports, Science and Technology [16K09049]; Otsuka Pharmaceutical Co., Ltd	JSPS by the Ministry of Education, Culture, Sports, Science and Technology; Otsuka Pharmaceutical Co., Ltd(Otsuka Pharmaceutical)	This work was partly supported by JSPS KAKENHI (grant number 16K09049) to YI by the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Otsuka Pharmaceutical Co., Ltd provided support in the form of salaries for authors TU and SU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; Arai Y, 2000, J Epidemiol, V10, P127; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; AXELSON M, 1982, BIOCHEM J, V201, P353, DOI 10.1042/bj2010353; Cassidy A, 2005, NURS STAND, V19, P54, DOI DOI 10.7748/NS2005.03.19.29.44; Cassidy Aedin, 2005, Nurs Stand, V19, P44; Du JX, 2004, STAT MED, V23, P2049, DOI 10.1002/sim.1797; Franke AA, 2012, J NUTR BIOCHEM, V23, P573, DOI 10.1016/j.jnutbio.2011.03.002; Ko TF, 2010, J FOOD SCI, V75, pH306, DOI 10.1111/j.1750-3841.2010.01860.x; Kobayashi A, 2015, KITAKANTO MED J, V65, P29; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Lampe JW, 1998, P SOC EXP BIOL MED, V217, P335; Liu BH, 2010, J EPIDEMIOL, V20, P377, DOI 10.2188/jea.JE20090185; Liu WY, 2013, ENVIRON HEALTH PREV, V18, P394, DOI 10.1007/s12199-013-0338-6; Messina M, 2002, J NUTR, V132, p547S, DOI 10.1093/jn/132.3.547S; Nagata C, 2008, NUTR CANCER, V60, P49, DOI 10.1080/01635580701525885; Newton KM, 2015, MENOPAUSE, V22, P489, DOI [10.1097/gme.0000000000000363, 10.1097/GME.0000000000000363]; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2003, J NUTR, V133, P1027, DOI 10.1093/jn/133.4.1027; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; YAN L, 2004, INT J CANC PREV, V1, P281; Yoshikata R, 2017, MENOPAUSE, V24, P216, DOI 10.1097/GME.0000000000000743	24	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201318	10.1371/journal.pone.0201318	http://dx.doi.org/10.1371/journal.pone.0201318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048499	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400074
J	Kao, PC; Pierro, MA; Booras, K				Kao, Pei-Chun; Pierro, Michaela A.; Booras, Konstantina			Effects of motor fatigue on walking stability and variability during concurrent cognitive challenges	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; POSITION SENSE; MUSCLE FATIGUE; DESTABILIZING ENVIRONMENTS; MUSCULAR FATIGUE; POSTURAL CONTROL; GAIT; ATTENTION; INTERFERENCE; HUMANS	Cognitive-motor interference, a negative influence on the performance of one or both tasks, is manifested when simultaneously performing a cognitive and a motor task. Motor fatigue reduces the ability of generating a required force level. However, little is known about the effects of motor fatigue on the cognitive-motor dual-tasking performance, an important capability during our daily lives. This study investigated how motor fatigue affects dual-task walking performance. Eighteen healthy younger adults walked on a treadmill under three different conditions: walking only, walking while receiving the Paced Auditory Serial Addition Test (PASAT) or a modified Stroop test before and after a lower-extremity fatiguing exercise. We computed dynamic margins of stability (MOS), step and joint kinematic variability, and short-term local divergence exponent (LDE) of the trunk motion. We found that subjects had similar values of short-term LDE during all conditions, indicating that local stability was not affected by the motor fatigue or dual-task conditions. Compared to the baseline, subjects had significantly greater mean MOS after the fatiguing exercise by walking with greater step length and width while having significantly greater gait variability. In contrast, subjects walked with similar mean MOS but significantly less gait variability during the dual-task conditions, indicating that subjects used different adaptive strategies when walking with motor fatigue and during dual-task conditions. There were no significant differences in the number of errors for the two cognitive tests before and after the fatiguing exercise. The current findings demonstrate that motor fatigue does not affect cognitive but motor performance in younger adults.	[Kao, Pei-Chun; Booras, Konstantina] Univ Massachusetts Lowell, Dept Phys Therapy, Lowell, MA 01854 USA; [Pierro, Michaela A.] Univ Massachusetts Lowell, Biomed Engn & Biotechnol Program, Lowell, MA USA	University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell	Kao, PC (corresponding author), Univ Massachusetts Lowell, Dept Phys Therapy, Lowell, MA 01854 USA.	PeiChun_Kao@uml.edu		Kao, Pei-Chun/0000-0001-8603-3898				Abd-Elfattah HM, 2015, J ADV RES, V6, P351, DOI 10.1016/j.jare.2015.01.011; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Arvin M, 2015, GAIT POSTURE, V42, P545, DOI 10.1016/j.gaitpost.2015.08.011; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Barbieri FA, 2013, J BACK MUSCULOSKELET, V26, P125, DOI 10.3233/BMR-130371; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-12; Ellis RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141694; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Gates DH, 2011, EXP BRAIN RES, V209, P525, DOI 10.1007/s00221-011-2580-8; Gates DH, 2010, J BIOMECH, V43, P913, DOI 10.1016/j.jbiomech.2009.11.001; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Kao PC, 2015, GAIT POSTURE, V41, P947, DOI 10.1016/j.gaitpost.2015.03.347; Knudson D, 2009, SPORT BIOMECH, V8, P96, DOI 10.1080/14763140802629966; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; Lorist MM, 2002, J PHYSIOL-LONDON, V545, P313, DOI 10.1113/jphysiol.2002.027938; Milanese C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192046; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Ribeiro F, 2007, EUR J APPL PHYSIOL, V99, P379, DOI 10.1007/s00421-006-0357-8; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Torres R, 2010, INT J SPORTS MED, V31, P410, DOI 10.1055/s-0030-1248285; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; WILKIE DA, 1990, J AM VET MED ASSOC, V196, P1831; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201433	10.1371/journal.pone.0201433	http://dx.doi.org/10.1371/journal.pone.0201433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048551	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400089
J	Ho, KT; Wang, X; Chen, L				Ho, Kiti; Wang, Xia; Chen, Lei			Reasons for parental withdrawal of care in a pediatric intensive care unit in China	PLOS ONE			English	Article							ACCESS	Background The past decade saw the establishment of pediatric intensive care units (PICU) across China. This occurred in the context of increasing private shares of medical costs. Payment schemes have not kept pace with the increased availability and demand. As a result a substantial number of parents, in the face of financial constraints, choose to withdraw the medical care of children even when recovery is expected. Objective We set out to describe the experience of one PICU in Changsha, an industrialized city near the center of the country with a population of 7.3 million. Results During the two-year period 883 patients were admitted to the PICU. One hundred one (11%) patients died during their hospital stay. Of these 69 (68%) died after parents elected to withdraw care. A large proportion (33 out of 69 48%) cited economic factors as a reason behind the decision. Compared with the non-withdrawal group the cases had lower disease severity at admission and on the day of death. On the day of death 34% in the withdrawal group had lower disease severity than at admission, showing clinical improvement. The mean hospital charge for the ICU stay was RMB35,000 (similar to$5600). Conclusion A substantial proportion of patients in a Chinese urban PICU died after parents chose to withdraw their care in the face of financial hardship, even while some were showing clinical improvement. The society has an obligation, and, likely, an economic incentive, to share this burden.	[Ho, Kiti; Chen, Lei] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Wang, Xia] Cent S Univ, Xiangya Sch Med, Dept Pediat, Changsha, Hunan, Peoples R China	Yale University; Central South University	Chen, L (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	Lei.chen@yale.edu						Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Li Z, 2012, BMC PUBLIC HLTH S1, V12, P59; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ren XX., 2006, APPL CLIN PEDIAT, V21, P382; Wang HL, 2007, JAMA-J AM MED ASSOC, V298, P1928, DOI 10.1001/jama.298.16.1928; Wang XF, 2012, PEDIATR CARDIOL, V33, P677, DOI 10.1007/s00246-012-0177-z; Yip W, 2014, LANCET, V384, P805, DOI 10.1016/S0140-6736(14)61120-X; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	8	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e199419	10.1371/journal.pone.0199419	http://dx.doi.org/10.1371/journal.pone.0199419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044777	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500012
J	Ptaszynska, AA; Gancarz, M; Hurd, PJ; Borsuk, G; Wiacek, D; Nawrocka, A; Strachecka, A; Zaluski, D; Paleolog, J				Ptaszynska, Aneta A.; Gancarz, Marek; Hurd, Paul J.; Borsuk, Grzegorz; Wiacek, Dariusz; Nawrocka, Agnieszka; Strachecka, Aneta; Zaluski, Daniel; Paleolog, Jerzy			Changes in the bioelement content of summer and winter western honeybees (Apis mellifera) induced by Nosema ceranae infection	PLOS ONE			English	Article							ENERGETIC STRESS; BEE; SUPPLEMENTATION; GLANDS; GROWTH; BORON; ACID; LEAD	Proper bioelement content is crucial for the health and wellness of all organisms, including honeybees. However, the situation is more complicated in these important pollinators due to the fact that they change their physiology during winter in order to survive the relatively harsh climatic conditions. Additionally, honeybees are susceptible to many diseases such as nosemosis, which during winter can depopulate an entire colony. Here we show that summer bees have a markedly higher content of important bioelements such as: Al, Cu, P, V, (physiologically essential); Ca, K, Mg, (electrolytic); Cr, Se, Zn, (enzymatic); As, Hg, (toxic). In contrast, a markedly higher content of: Fe (physiologically essential); Mn, Ni, (enzymatic); Cd (exclusively toxic) were present in winter bees. Importantly, N. ceranae infection resulted in an increased honeybee bioelement content of: S, Sr (physiologically essential) and Pb (exclusively toxic), whereas the Nosema-free worker-bees had higher amounts of B and Si (physiologically essential). We propose that the shortages of Fe, Mn, Ni, and Na observed in Nosema-infected bees, could be the reason for the higher mortality of Nosema-infected bees throughout overwintering. In addition, a shortage of bioelements such as B and Si may be a reason for accelerated aging in foragers that is observed following N. ceranae infection. Therefore, in winter, bioelement content was more strongly affected by N. ceranae infection than during summer. We found a strong correlation between the bioelement content of bees and seasons (summer or winter) and also with Nosema infection. We conclude that the balance of bioelements in the honeybee is altered by both seasonal affects and by Nosema infection.	[Ptaszynska, Aneta A.] Marie Curie Sklodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Bot & Mycol, Lublin, Poland; [Gancarz, Marek; Wiacek, Dariusz; Nawrocka, Agnieszka] Polish Acad Sci, Inst Agrophys, Lublin, Poland; [Hurd, Paul J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Borsuk, Grzegorz; Strachecka, Aneta] Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Inst Biol Basis Anim Prod, Lab Environm Biol & Apidol, Lublin, Poland; [Zaluski, Daniel] Nicolaus Copernicus Univ, Dept Pharmacognosy, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Paleolog, Jerzy] Life Sci Univ Lublin, Dept Zool Ecol & Wildlife Management, Lublin, Poland	Maria Curie-Sklodowska University; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; University of London; Queen Mary University London; University of Life Sciences in Lublin; Nicolaus Copernicus University	Ptaszynska, AA (corresponding author), Marie Curie Sklodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Bot & Mycol, Lublin, Poland.	aneta.ptaszynska@poczta.umcs.lublin.pl	Ptaszynska, Aneta/AAG-7172-2021; Gancarz, Marek/AAF-5498-2019; Paleolog, Jerzy/U-5290-2018; Borsuk, Grzegorz/AAD-3268-2021; Gancarz, Marek/W-3118-2019	Ptaszynska, Aneta/0000-0001-6413-6028; Gancarz, Marek/0000-0003-4719-2954; Paleolog, Jerzy/0000-0002-4447-4318; Borsuk, Grzegorz/0000-0002-8407-3383; Gancarz, Marek/0000-0003-4719-2954; Hurd, Paul/0000-0003-1112-9347; Wiacek, Dariusz/0000-0001-9043-6163; Strachecka, Aneta/0000-0003-1313-9880; Nawrocka, Agnieszka/0000-0001-8618-2092	Vice-rector for Research and International Relations of UMCS (Lublin, Poland); BBSRC [BB/L023164/1]	Vice-rector for Research and International Relations of UMCS (Lublin, Poland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Individual Research Grant of the Vice-rector for Research and International Relations of UMCS (Lublin, Poland) granted to AAP. Work in the Hurd lab is funded by the BBSRC (BB/L023164/1) granted to PJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alina M., 2012, International Food Research Journal, V19, P135; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Black J., 2006, USITC PUBL; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; Bonoan RE, 2018, J INSECT PHYSIOL, V107, P23, DOI 10.1016/j.jinsphys.2018.02.002; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Charbonneau LR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22626; Cohen AC, 2004, INSECT DIETS SCI TEC; Copley TR, 2012, J APPL MICROBIOL, V112, P15, DOI 10.1111/j.1365-2672.2011.05192.x; De Groot AP, 1953, PHYSL COMP ECOLOGIA, V3, P197; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Dzugan M, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6474-0; Eiri DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126330; Filipiak M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183236; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Ghanati F, 2005, PLANT SOIL, V276, P133, DOI 10.1007/s11104-005-3697-y; Ghosh S, 2016, J ASIA-PAC ENTOMOL, V19, P487, DOI 10.1016/j.aspen.2016.03.008; Golubkina NA, 2016, ECOL INDIC, V66, P452, DOI 10.1016/j.ecolind.2016.01.042; Hamdan K., 2010, Bee World, V87, P52, DOI 10.1080/0005772X.2010.11417360; Hunt CD, 2003, J TRACE ELEM EXP MED, V16, P291, DOI 10.1002/jtra.10041; Jack CJ, 2016, J INSECT PHYSIOL, V87, P12, DOI 10.1016/j.jinsphys.2016.01.004; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Jugdaohsingh Ravin, 2015, Bone Rep, V1, P9; Kowalczyk-Pecka D, 2017, ENVIRON POLLUT, V222, P138, DOI 10.1016/j.envpol.2016.12.068; Kowalczyk-Pecka D, 2017, ECOTOX ENVIRON SAFE, V138, P223, DOI 10.1016/j.ecoenv.2016.12.033; Kurze C, 2016, PARASITOL RES, V115, P2381, DOI 10.1007/s00436-016-4988-3; Lamson Davis W, 2002, Altern Med Rev, V7, P218; Li YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121884; Markert B., 2015, CHEM EVOLUTION BIOLO, DOI [10.1007/978-3-319-14355-2_2, DOI 10.1007/978-3-319-14355-2_2]; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meana A, 2010, J APICULT RES, V49, P212, DOI 10.3896/IBRA.1.49.2.12; Michels HT, 2006, ASTM STAND NEWS, V34, P28; Milanino R, 1989, COPPER ZINC INFLAMMA; Mulholland Grace E., 2012, Insects, V3, P1143, DOI 10.3390/insects3041143; Nation J. L, 1971, J Apic Res, V10, P35; Naug D, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0731; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP, DOI [10.17226/13039, DOI 10.17226/13039]; Patrick Lyn, 2002, Altern Med Rev, V7, P456; Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004; Ptaszynska AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164477; Ptaszynska AA, 2012, MED WETER, V68, P618; Ritter W., 2006, 4 FAO AGR FOOD ENG; Safaee S, 2014, PERIOD BIOL, V116, P259; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schwartz K, 1959, ARCH BIOCH BIOPHYS; Skalny AV, 2011, J TRACE ELEM MED BIO, V25, pS3, DOI 10.1016/j.jtemb.2010.10.005; Skalny AV, 2014, PHARM NUTR FUNDAMENT, DOI [10.5772/57368, DOI 10.5772/57368]; Smart MD, 2012, J INVERTEBR PATHOL, V109, P148, DOI 10.1016/j.jip.2011.09.009; Tacon AGJ, 1987, GCPRLA075ITA FAO FIL; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Underwood EA, 1977, TRACE ELEMENTS HUMAN; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Wainwright M, 1997, MYCOL RES, V101, P933, DOI 10.1017/S0953756297003560; WANG DI, 1971, J INVERTEBR PATHOL, V17, P308, DOI 10.1016/0022-2011(71)90002-4; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; Williams LR, 1990, 901448 IRGIWP; WOODS WG, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3431956; Zhai HB, 2000, CONTACT DERMATITIS, V42, P98, DOI 10.1034/j.1600-0536.2000.042002098.x; Zhelyazkova I, 2012, BULG J AGRIC SCI, V18, P435; Zhou XT, 2018, ENVIRON SCI TECHNOL, V52, P991, DOI 10.1021/acs.est.7b04084	66	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200410	10.1371/journal.pone.0200410	http://dx.doi.org/10.1371/journal.pone.0200410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044811	Green Submitted, gold, Green Published			2022-12-26	WOS:000439942500051
J	Desoubeaux, G; Chauvin, D; Piqueras, MD; Bronson, E; Bhattacharya, SK; Sirpenski, G; Bailly, E; Cray, C				Desoubeaux, Guillaume; Chauvin, David; Piqueras, Maria del Carmen; Bronson, Ellen; Bhattacharya, Sanjoy K.; Sirpenski, Gayle; Bailly, Eric; Cray, Carolyn			Translational proteomic study to address host protein changes during aspergillosis	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; SIGNALING PATHWAY; FUNGAL-INFECTIONS; MASS-SPECTROMETRY; RISK-FACTORS; DIAGNOSIS; ELECTROPHORESIS; FUMIGATUS; DISEASE; CELLS	Aspergillosis is a fungal disease due to Aspergillus molds that can affect both humans and animals. As routine diagnosis remains difficult, improvement of basic knowledge with respect to its pathophysiology is critical to search for new biomarkers of infection and new therapeutic targets. Large-scale proteomics allows assessment of protein changes during various disease processes. In the present study, mass spectrometry iTRAQ (R) (isobaric tags for relative and absolute quantitation) protocol was used for direct identification and relative quantitation of host proteins in diseased fluids and tissues collected from an experimental rat model challenged with Aspergillus, as well as in blood obtained from naturally-infected penguins. In all, mass spectrometry analysis revealed that proteome during aspergillosis was mostly represented by proteins that usually express role in metabolic processes and biological process regulation. Ten and 17 proteins were significantly >= 4.0-fold over-represented in blood of Aspergillus-diseased rats and penguins, respectively, while five and 39 were negatively >= 4.0-fold depleted within the same samples. In rat lungs, 33 proteins were identified with positive or negative relative changes versus controls and were quite different from those identified in the blood. Except for some zinc finger proteins, kinases, and histone transferases, and while three pathways were common (Wnt, cadherin and FGF), great inter-species variabilities were observed regarding the identity of the differentially-represented proteins. Thus, this finding confirmed how difficult it is to define a unique biomarker of infection. iTRAQ (R) protocol appears as a convenient proteomic tool that is greatly suited to ex vivo exploratory studies and should be considered as preliminary step before validation of new diagnostic markers and new therapeutic targets in humans.	[Desoubeaux, Guillaume; Cray, Carolyn] Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Div Comparat Pathol, Miami, FL 33136 USA; [Desoubeaux, Guillaume; Bailly, Eric] CHU Tours, Parasitol, Mycol, Med Trop, Tours, France; [Desoubeaux, Guillaume; Chauvin, David] Univ Tours, CEPR INSERM U1100, Equipe 3, Fac Med, Tours, France; [Piqueras, Maria del Carmen; Bhattacharya, Sanjoy K.] Univ Miami, Miller Sch Med, Mass Spectrometry Core Facil, Miami, FL 33136 USA; [Bronson, Ellen] Maryland Zoo Baltimore, Baltimore, MD USA; [Sirpenski, Gayle] Mystic Aquarium, Mystic, CT USA; [Desoubeaux, Guillaume] Hop Bretonneau, Serv Parasitol Mycol Med Trop, Tours, France	University of Miami; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Miami; CHU Tours	Desoubeaux, G (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Div Comparat Pathol, Miami, FL 33136 USA.; Desoubeaux, G (corresponding author), CHU Tours, Parasitol, Mycol, Med Trop, Tours, France.; Desoubeaux, G (corresponding author), Univ Tours, CEPR INSERM U1100, Equipe 3, Fac Med, Tours, France.; Desoubeaux, G (corresponding author), Hop Bretonneau, Serv Parasitol Mycol Med Trop, Tours, France.	guillaume.desoubeaux@univ-tours.fr	DESOUBEAUX, Guillaume/J-5026-2015	DESOUBEAUX, Guillaume/0000-0001-7945-9890	NIH center grant [P30-EY14801]; African penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program	NIH center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); African penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program	This work was supported by internal laboratory funding and partly by NIH center grant P30-EY14801.; The authors are very grateful to Dr. Sophie Guyetant (CHU de Tours, France) for her precious assistance with the ethics and customs regulations, and to Parastou Moshiri for her technical help with beta-D-glucan measurement, and to Emilie Dalloneau for the rat protocol. We also thank the African penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program for supporting this study, as well as all institutions that enrolled their patients: California Academy of Sciences (San Francisco, CA, U.S.A.), Minnesota Zoo (Apple Valley, MN, U.S.A.), Busch Gardens (Tampa, FL, U.S.A.), Maryland Zoo (Baltimore, MA, U.S.A.), Tulsa Zoo, (Tulsa, OK, U.S.A.), Fort Wayne Children's Zoo (Fort Wayne, IN, U.S.A.), Georgia Aquarium (Atlanta, GA, U.S.A.), Mystic Aquarium (Mystic, CT, U.S.A.), and Cincinnati Zoo and Botanical Garden (Cincinnati, OH, U.S.A.).	Arendrup MC, 2012, BONE MARROW TRANSPL, V47, P1030, DOI 10.1038/bmt.2011.246; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Bonnet S, 2017, CURR RES TRANSL MED, V65, P77, DOI 10.1016/j.retram.2017.05.003; Bourassa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125934; Brasier AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143165; Bruser L, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029140; Chandenier J, 2009, MYCOSES, V52, P239, DOI 10.1111/j.1439-0507.2009.01695.x; COULOT P, 1994, INFECT IMMUN, V62, P2169, DOI 10.1128/IAI.62.6.2169-2177.1994; Cray C, 2011, J AVIAN MED SURG, V25, P102, DOI 10.1647/2010-019.1; Cray C, 2009, AVIAN DIS, V53, P491, DOI 10.1637/8673-030209-Reg.1; Cray C, 2009, J AVIAN MED SURG, V23, P125, DOI 10.1647/2007-041.1; Cray C, 2009, J ZOO WILDLIFE MED, V40, P64, DOI 10.1638/2007-0138.1; Csokai J, 2009, VET PARASITOL, V163, P18, DOI 10.1016/j.vetpar.2009.03.057; da Silva RP, 2015, J ZOO WILDLIFE MED, V46, P667, DOI 10.1638/2013-0092.1; Day MJ, 2009, MED MYCOL, V47, pS315, DOI 10.1080/13693780802056038; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Desoubeaux G, 2014, MED MALADIES INFECT, V44, P89, DOI 10.1016/j.medmal.2013.11.006; Desoubeaux G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177961; Desoubeaux G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00841; Desoubeaux G, 2014, INT J MED MICROBIOL, V304, P327, DOI 10.1016/j.ijmm.2013.11.015; Desoubeaux Guillaume, 2012, Methods Mol Biol, V845, P511, DOI 10.1007/978-1-61779-539-8_36; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Heldt S, 2017, CURR FUNGAL INFECT R, V11, P45, DOI 10.1007/s12281-017-0275-8; Hennigan Stephanie, 2008, Ther Clin Risk Manag, V4, P767; Jolink H, 2017, J INFECTION, V74, P81, DOI 10.1016/j.jinf.2016.10.010; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Komiya Yuko, 2008, Organogenesis, V4, P68; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Kuncewitch M, 2015, J TRAUMA ACUTE CARE, V78, P793, DOI 10.1097/TA.0000000000000566; Li GK, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017254; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Melloul E, 2014, COMP IMMUNOL MICROB, V37, P271, DOI 10.1016/j.cimid.2014.07.005; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moghaddam A, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0111-x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Oliva A, 2015, J CLIN MICROBIOL, V53, P248, DOI 10.1128/JCM.02690-14; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Patterson KC, 2014, CHEST, V146, P1358, DOI 10.1378/chest.14-0917; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schreml J, 2017, CURR PHARM DESIGN, V23, P1562, DOI 10.2174/1381612823666170125160108; Schweppe RE, 2003, ACCOUNTS CHEM RES, V36, P453, DOI 10.1021/ar020143l; Seyedmousavi S, 2015, MED MYCOL, V53, P765, DOI 10.1093/mmy/myv067; Speth C, 2004, MYCOSES, V47, P93, DOI 10.1111/j.1439-0507.2004.00979.x; Sulahian A, 2003, NEW ENGL J MED, V349, P2366, DOI 10.1056/NEJM200312113492424; Tang XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15119; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200; Winther Malene, 2014, Adv Neurobiol, V8, P315; Zhong X, 2017, AM J TRANSL RES, V9, P2920	57	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200843	10.1371/journal.pone.0200843	http://dx.doi.org/10.1371/journal.pone.0200843			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040865	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200014
J	Hollenbach, M; Kloting, N; Sommerer, I; Lorenz, J; Heindl, M; Kern, M; Mossner, J; Bluher, M; Hoffmeister, A				Hollenbach, Marcus; Kloeting, Nora; Sommerer, Ines; Lorenz, Jana; Heindl, Mario; Kern, Matthias; Moessner, Joachim; Blueher, Matthias; Hoffmeister, Albrecht			p8 deficiency leads to elevated pancreatic beta cell mass but does not contribute to insulin resistance in mice fed with high-fat diet	PLOS ONE			English	Article							NUCLEAR-PROTEIN P8; GLUCOSE-INTOLERANCE; IN-VIVO; EXPRESSION; SENSITIVITY; GENE; METABOLISM; APOPTOSIS; CLONING; RAT	Background p8 was initially described as being overexpressed in acute pancreatitis and encoding a ubiquitous stress protein. Analysis of insulin sensitivity and glucose tolerance in p8-knockout and haplodeficient mice revealed counterintuitive results. Thus, we determined glycemic control of p8 in mice fed with standard (SD) and high-fat diet (HFD). Methods p8(-/-) and wild type (p8(+/+)) mice were used for analysis of glucagon (immunohistochemistry), insulin levels (ELISA) and beta cell mass. Hyperinsulinemic-euglycemic glucose clamp technique, i.p. glucose tolerance test (ipGTT), i.p. insulin tolerance test (ipITT) and metabolic chamber analysis were performed in SD (4% fat) and HFD (55% fat) groups. Results p8(-/-) mice showed no differences in glucagon or insulin content but higher insulin secretion from pancreatic islets upon glucose stimulation. p8 deficiency resulted in elevated beta cell mass but was not associated with increased insulin resistance in ipGTT or ipITT. Glucose clamp tests also revealed no evidence of association of p8 deficiency with insulin resistance. Metabolic chamber analysis showed equal energy expenditure in p8(-/-) mice and wild type animals. Conclusion p8 depletion may contribute to glucose metabolism via stress-induced insulin production and elevated beta cell mass. Nevertheless, p8 knockout showed no impact on insulin resistance in SD and HFD-fed mice.	[Hollenbach, Marcus; Sommerer, Ines; Lorenz, Jana; Heindl, Mario; Moessner, Joachim; Hoffmeister, Albrecht] Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Med Neurol & Dermatol, Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Kern, Matthias] Univ Leipzig, German Diabet Ctr Leipzig, Leipzig, Germany; [Blueher, Matthias] Univ Leipzig, Dept Med Neurol & Dermatol, Div Endocrinol & Nephrol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Hollenbach, M (corresponding author), Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Med Neurol & Dermatol, Leipzig, Germany.	marcus.hollenbach@medizin.uni-leipzig.de	Hollenbach, Marcus/ABF-7452-2021		Deutsche Forschungsgemeinschaft [SFB 1052, SFB1052:B1, SFB1052:B4]; Federal Ministry of Education and Research (BMBF) [FKZ: 01EO1501, DZD82DZD00601]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work received support from "Deutsche Forschungsgemeinschaft", Grant SFB 1052, SFB1052:B1 and :B4, www.dfg.de; "Federal Ministry of Education and Research (BMBF)", www.bmbf.de, Grants FKZ: 01EO1501 and DZD82DZD00601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barbosa-Sampaio HC, 2015, BBA-MOL BASIS DIS, V1852, P962, DOI 10.1016/j.bbadis.2015.01.013; Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Beguinot Francesco, 2012, Methods Mol Biol, V933, P219, DOI 10.1007/978-1-62703-068-7_14; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler AE, 2016, J CLIN ENDOCR METAB, V101, P523, DOI 10.1210/jc.2015-3566; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Hoffmeister A, 2002, J BIOL CHEM, V277, P22314, DOI 10.1074/jbc.M201657200; Jia Q, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.29; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Kallwellis K, 2006, HORM METAB RES, V38, P570, DOI 10.1055/s-2006-950503; Kern M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038744; Li J, 2017, J NEURO-ONCOL, V132, P15, DOI 10.1007/s11060-016-2337-0; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Malicet Cedric, 2003, Mol Cancer, V2, P37, DOI 10.1186/1476-4598-2-37; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Mu Yanchao, 2018, Autophagy, V14, P654, DOI 10.1080/15548627.2017.1338556; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005; Path G, 2004, DIABETES, V53, pS82, DOI 10.2337/diabetes.53.2007.S82; PEREZ VJ, 1980, PHYSIOL BEHAV, V24, P1185, DOI 10.1016/0031-9384(80)90070-0; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Pommier RM, 2012, BIOCHEM J, V445, P285, DOI 10.1042/BJ20120368; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Tiraby C, 2007, DIABETOLOGIA, V50, P2190, DOI 10.1007/s00125-007-0765-2; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222; Weis S, 2015, ARCH BIOCHEM BIOPHYS, V565, P89, DOI 10.1016/j.abb.2014.11.007; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Zeng Chensi, 2017, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V33, P1240	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201159	10.1371/journal.pone.0201159	http://dx.doi.org/10.1371/journal.pone.0201159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040846	Green Published, Green Submitted, gold			2022-12-26	WOS:000439749200028
J	Lou, H; Wang, LM; Duan, DB; Yang, C; Mammadov, M				Lou, Hua; Wang, Limin; Duan, Dingbo; Yang, Cheng; Mammadov, Musa			RDE: A novel approach to improve the classification performance and expressivity of KDB	PLOS ONE			English	Article								Bayesian network classifiers (BNCs) have demonstrated competitive classification performance in a variety of real-world applications. A highly scalable BNC with high expressivity is extremely desirable. This paper proposes Redundant Dependence Elimination (RDE) for improving the classification performance and expressivity of k-dependence Bayesian classifier (KDB). To demonstrate the unique characteristics of each case, RDE identifies redundant conditional dependencies and then substitute/remove them. The learned personalized k-dependence Bayesian Classifier (PKDB) can achieve high-confidence conditional probabilities, and graphically interpret the dependency relationships between attributes. Two thyroid cancer datasets and four other cancer datasets from the UCI machine learning repository are selected for our experimental study. The experimental results prove the effectiveness of the proposed algorithm in terms of zero-one loss, bias, variance and AUC.	[Lou, Hua; Duan, Dingbo; Yang, Cheng] Changzhou Coll Informat Technol, Changzhou, Peoples R China; [Wang, Limin] Jilin Univ, Coll Comp Sci & Technol, Changchun, Jilin, Peoples R China; [Mammadov, Musa] Federat Univ, Fac Sci & Technol, Ballarat, Vic, Australia	Changzhou College of Information Technology; Jilin University; Federation University Australia	Lou, H (corresponding author), Changzhou Coll Informat Technol, Changzhou, Peoples R China.	ccit-louhua@139.com		Mammadov, Musa/0000-0002-2600-3379				Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Blanco R, 2005, J BIOMED INFORM, V38, P376, DOI 10.1016/j.jbi.2005.05.004; Bouckaert RR, 2006, LECT NOTES COMPUT SC, V4304, P243; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen SL, 2017, IEEE T KNOWL DATA EN, V29, P172, DOI 10.1109/TKDE.2016.2608881; Chen SL, 2013, J MACH LEARN RES, P1; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; CHURCH KW, 1990, 27TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P76; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fayyad UM, MULTIINTERVAL DISCRE; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Jiang LX, 2012, KNOWL-BASED SYST, V26, P239, DOI 10.1016/j.knosys.2011.08.010; Kittler J., 1986, HDB PATTERN RECOGNIT; Kohavi R., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P275; Louzada F, 2012, EXPERT SYST APPL, V39, P11583, DOI 10.1016/j.eswa.2012.04.024; Murphy PM., 1995, UCI REPOSITORY MACHI; Park SH, 2014, MACH LEARN, V96, P295, DOI 10.1007/s10994-013-5430-z; Pearl J., 1988, PROBABILISTIC REASON; Sahami M., 1996, P 2 INT C KNOWL DISC, P335; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Taheri S, 2015, OPTIM LETT, V9, P931, DOI 10.1007/s11590-014-0803-1; Wang LM, 2015, ENTROPY-SWITZ, V17, P4134, DOI 10.3390/e17064134; Wu J, 2014, J INTELL INF SYST, V42, P671, DOI 10.1007/s10844-013-0279-y; Zheng F., 2006, P 23 INT C MACH LEAR, P1113, DOI DOI 10.1007/S10994-011-5263-6; Zheng F, 2011, MACH LEARN, V87, P1947	26	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199822	10.1371/journal.pone.0199822	http://dx.doi.org/10.1371/journal.pone.0199822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036402	Green Published, Green Submitted, gold			2022-12-26	WOS:000439429200007
J	Johnson, WL; Ramachandran, A; Torres, NJ; Nicholson, AC; Whitney, AM; Bell, M; Villarma, A; Humrighouse, BW; Sheth, M; Dowd, SE; McQuiston, JR; Gustafson, JE				Johnson, William L.; Ramachandran, Akhilesh; Torres, Nathaniel J.; Nicholson, Ainsley C.; Whitney, Anne M.; Bell, Melissa; Villarma, Aaron; Humrighouse, Ben W.; Sheth, Mili; Dowd, Scot E.; McQuiston, John R.; Gustafson, John E.			The draft genomes of Elizabethkingia anophelis of equine origin are genetically similar to three isolates from human clinical specimens	PLOS ONE			English	Article							CHRYSEOBACTERIUM-MENINGOSEPTICUM OUTBREAK; MULTIPLE-ANTIBIOTIC-RESISTANCE; INFECTIOUS-DISEASES SOCIETY; HEALTH-SYSTEM PHARMACISTS; MULTIDRUG EFFLUX PUMP; FLAVOBACTERIUM-MENINGOSEPTICUM; BETA-LACTAMASE; STAPHYLOCOCCUS-AUREUS; GYRA GENE; CONSENSUS RECOMMENDATIONS	We report the isolation and characterization of two Elizabethkingia anophelis strains (OSUVM-1 and OSUVM-2) isolated from sources associated with horses in Oklahoma. Both strains appeared susceptible to fluoroquinolones and demonstrated high MICs to all cell wall active antimicrobials including vancomycin, along with aminoglycosides, fusidic acid, chloramphenicol, and tetracycline. Typical of the Elizabethkingia, both draft genomes contained multiple copies of beta-lactamase genes as well as genes predicted to function in antimicrobial efflux. Phylogenetic analysis of the draft genomes revealed that OSUVM-1 and OSUVM-2 differ by only 6 SNPs and are in a Glade with 3 strains of Elizabethkingia anophelis that were responsible for human infections. These findings therefore raise the possibility that Elizabethkingia might have the potential to move between humans and animals in a manner similar to known zoonotic pathogens.	[Johnson, William L.; Torres, Nathaniel J.; Gustafson, John E.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Ramachandran, Akhilesh] Oklahoma State Univ, Ctr Vet Hlth Sci, Oklahoma Anim Dis Diagnost Lab, Stillwater, OK 74078 USA; [Nicholson, Ainsley C.; Whitney, Anne M.; Bell, Melissa; Villarma, Aaron; Humrighouse, Ben W.; McQuiston, John R.] Ctr Dis Control & Prevent, Special Bacteriol Reference Lab, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Sheth, Mili] Ctr Dis Control & Prevent, Div Sci Resources, Atlanta, GA USA; [Dowd, Scot E.] Mol Res DNA Lab, Shallowater, TX USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Gustafson, JE (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.; Ramachandran, A (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Oklahoma Anim Dis Diagnost Lab, Stillwater, OK 74078 USA.	rakhile@okstate.edu; john.gustafson@okstate.edu		Johnson, William/0000-0003-2616-2553	Oklahoma Agricultural Experiment Station; Advanced Molecular Detection (AMD) initiative	Oklahoma Agricultural Experiment Station; Advanced Molecular Detection (AMD) initiative	WLJ, NJT and JEG acknowledge support from the Oklahoma Agricultural Experiment Station (http://oaes.okstate.edu/). CDC research was supported by the Advanced Molecular Detection (AMD) initiative (https://www.cdc.gov/amd/index.html). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER RC, 1978, ANTIMICROB AGENTS CH, V14, P483, DOI 10.1128/AAC.14.3.483; Agarwal S, 2017, J CLIN DIAGN RES, V11, pDC4, DOI 10.7860/JCDR/2017/24023.9317; ALTMANN G, 1971, J MED MICROBIOL, V4, P296, DOI 10.1099/00222615-4-2-296; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BAQUERO F, 1990, EUR UROL, V17, P3; BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507; Bordelo J, 2016, CAN VET J, V57, P994; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Cambau E, 1993, Drugs, V45 Suppl 3, P15; Centers for Disease Control and Prevention, 2016, RECENT OUTBREAKS; Ceyhan M, 2008, AM J INFECT CONTROL, V36, P453, DOI 10.1016/j.ajic.2007.09.008; Chang JC, 1997, ANTIMICROB AGENTS CH, V41, P1301, DOI 10.1128/AAC.41.6.1301; Chung Y. J., 2001, CURRENT OPINION DRUG, V4, P237; Damborg P, 2004, J CLIN MICROBIOL, V42, P1363, DOI 10.1128/JCM.42.3.1363-1364.2004; de Carvalho Filho E. B., 2017, New Microbes and New Infections, V20, P27, DOI 10.1016/j.nmni.2017.09.002; Di Pentima MC, 1998, CLIN INFECT DIS, V26, P1169, DOI 10.1086/520309; Dias M, 2010, Indian J Nephrol, V20, P203, DOI 10.4103/0971-4065.73460; Doijad S, 2016, INT J SYST EVOL MICR, V66, P4555, DOI 10.1099/ijsem.0.001390; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Dziuban EJ, 2018, CLIN INFECT DIS, V67, P144, DOI 10.1093/cid/cix1052; FASS RJ, 1980, REV INFECT DIS, V2, P841; Finch NA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01293-17, 10.1128/aac.01293-17]; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Frank T, 2013, LANCET, V381, P1876, DOI 10.1016/S0140-6736(13)60318-9; Fraser SL, 1997, ANTIMICROB AGENTS CH, V41, P2738, DOI 10.1128/AAC.41.12.2738; Garay JAR, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00084-16; Gonzalez LJ, 2012, ANTIMICROB AGENTS CH, V56, P1686, DOI 10.1128/AAC.05835-11; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Guardabassi L, 2004, VET MICROBIOL, V98, P23, DOI 10.1016/j.vetmic.2003.09.021; GUMP DW, 1981, REV INFECT DIS, V3, pS289; Gungor S, 2003, INFECT CONT HOSP EP, V24, P613, DOI 10.1086/502261; Gupta P, 2017, WORLD J CLIN CASES, V5, P187, DOI 10.12998/wjcc.v5.i5.187; HAZUKA BT, 1977, J CLIN MICROBIOL, V6, P450; Hu RX, 2017, EMERG INFECT DIS, V23, P2055, DOI 10.3201/eid2312.170942; Jacobs A, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-16; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Jean SS, 2014, J HOSP INFECT, V86, P244, DOI 10.1016/j.jhin.2014.01.009; Jean SS, 2017, INT J ANTIMICROB AG, V50, P507, DOI 10.1016/j.ijantimicag.2017.06.021; Jiang HY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02073; Kampfer P, 2015, INT J SYST EVOL MICR, V65, P2187, DOI 10.1099/ijs.0.000236; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kenna DTD, 2018, DIAGN MICR INFEC DIS, V90, P109, DOI 10.1016/j.diagmicrobio.2017.10.014; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; KING EO, 1959, AM J CLIN PATHOL, V31, P241; Kukutla P, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01030-13; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lau SKP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26045; Lee D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01181-15; LEWIN CS, 1990, J MED MICROBIOL, V31, P153, DOI 10.1099/00222615-31-3-153; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14841-8; Lin PY, 2004, J CLIN MICROBIOL, V42, P3353, DOI 10.1128/JCM.42.7.3353-3355.2004; Lin XH, 2012, INT J ANTIMICROB AG, V40, P186, DOI 10.1016/j.ijantimicag.2012.03.020; Lothuvachai T, 2006, AM J KIDNEY DIS, V48, pE49, DOI 10.1053/j.ajkd.2006.07.010; Lozano C, 2011, CLIN MICROBIOL INFEC, V17, P923, DOI 10.1111/j.1469-0691.2010.03437.x; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Matsumoto T, 2012, ANTIMICROB AGENTS CH, V56, P588, DOI 10.1128/AAC.05165-11; Matyi SA, 2013, J DAIRY SCI, V96, P3535, DOI 10.3168/jds.2013-6590; Mee PT, 2017, EMERG INFECT DIS, V23, P1409, DOI 10.3201/eid2308.161565; Mine T, 1999, ANTIMICROB AGENTS CH, V43, P415, DOI 10.1128/AAC.43.2.415; Mirza HC, 2018, MICROB DRUG RESIST, V24, P816, DOI 10.1089/mdr.2017.0206; Montrucchio G, 2018, INFECTION, V46, P123, DOI 10.1007/s15010-017-1055-7; Moore LSP, 2016, EMERG INFECT DIS, V22, P9, DOI 10.3201/eid2201.150139; Moran-Barrio J, 2016, ANTIMICROB AGENTS CH, V60, P6013, DOI 10.1128/AAC.01067-16; Navon L, 2016, MMWR-MORBID MORTAL W, V65, P1380, DOI 10.15585/mmwr.mm6548a6; Neuner EA, 2012, J ANTIMICROB CHEMOTH, V67, P1558, DOI 10.1093/jac/dks053; Nicholson AC, 2018, ANTON LEEUW INT J G, V111, P55, DOI 10.1007/s10482-017-0926-3; Nicholson AC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00045-16; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Opota O, 2017, INT J ANTIMICROB AG, V49, P93, DOI 10.1016/j.ijantimicag.2016.09.031; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pei D, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01359-17, 10.1128/genomea.01359-17]; Perrin A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15483; PLOTKIN SA, 1966, J AMER MED ASSOC, V198, P662, DOI 10.1001/jama.198.6.662; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Pumbwe L, 2002, FEMS MICROBIOL LETT, V206, P185, DOI 10.1111/j.1574-6968.2002.tb11007.x; Rossolini GM, 1999, ANTIMICROB AGENTS CH, V43, P2193, DOI 10.1128/AAC.43.9.2193; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; RUIZ J, 1995, J ANTIMICROB CHEMOTH, V36, P737, DOI 10.1093/jac/36.4.737; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2009, PHARMACOTHERAPY, V29, P1275, DOI 10.1592/phco.29.11.1275; SADER HS, 1995, CLIN INFECT DIS, V21, P997, DOI 10.1093/clinids/21.4.997; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schindler BD, 2015, ANTIMICROB AGENTS CH, V59, P747, DOI 10.1128/AAC.04678-14; Schmitz FJ, 2002, EUR J CLIN MICROBIOL, V21, P647, DOI 10.1007/s10096-002-0788-z; Sebastiampillai BS, 2018, TROP DOCT, V48, P62, DOI 10.1177/0049475517717135; SMITH JT, 1986, J ANTIMICROB CHEMOTH, V18, P21, DOI 10.1093/jac/18.Supplement_D.21; Soman Rajeev, 2016, J Assoc Physicians India, V64, P98; Tai IC, 2017, J HOSP INFECT, V96, P168, DOI 10.1016/j.jhin.2016.11.018; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tekerekoglu MS, 2003, MICROBIOLOGICA, V26, P57; Teo J, 2014, GENOME BIOL EVOL, V6, P1158, DOI 10.1093/gbe/evu094; Teo J, 2013, LANCET, V382, P855, DOI 10.1016/S0140-6736(13)61858-9; TIZER KB, 1995, PEDIATR INFECT DIS J, V14, P916; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Tseng MH, 2009, CLIN KIDNEY J, V2, P433, DOI 10.1093/ndtplus/sfp080; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; WOLFSON JS, 1989, REV INFECT DIS, V11, pS960; YOSHIDA H, 1988, MOL GEN GENET, V211, P1, DOI 10.1007/BF00338386; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA T, 1994, ANTIMICROB AGENTS CH, V38, P1466, DOI 10.1128/AAC.38.7.1466	109	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200731	10.1371/journal.pone.0200731	http://dx.doi.org/10.1371/journal.pone.0200731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024943	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000044
J	Xu, YM; Zhang, K; Miao, JL; Zhao, P; Lv, MH; Li, J; Fu, XH; Luo, X; Zhu, P				Xu, Yingming; Zhang, Kui; Miao, Jinlin; Zhao, Peng; Lv, Minghua; Li, Jia; Fu, Xianghui; Luo, Xing; Zhu, Ping			The spinal NR2BR/ERK2 pathway as a target for the central sensitization of collagen-induced arthritis pain	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; NEUROPATHIC PAIN; DORSAL-HORN; RECEPTORS; TRAMADOL; HYPERSENSITIVITY; PHOSPHORYLATION; HYPERALGESIA; INFLAMMATION; CONTRIBUTES	Objective Pain management is a huge challenge in the treatment of rheumatoid arthritis (RA), and central sensitization is reportedly involved in the development of pain. The current study was undertaken to explore the possible role of N-methyl-D-aspartate receptors (NMDARs) in the spinal mechanism of central sensitization in RA using a collagen-induced arthritis (CIA) model. Methods Mechanical hypersensitivity was assessed in C57BL/6 mice, before and after the induction of CIA via administration of chick type II collagen. Analgesic drugs, receptor antagonist, and kinase inhibitor were administrated intrathecally in the spinal cord. Protein expression and phosphorylation changes were detected via immunoblotting. Results CIA mice developed significant mechanical hypersensitivity, and spinal administration of the NMDAR antagonist D-2-amino-5-phosphonovaleric acid (D-APV) effectively attenuated peripheral pain hypersensitivity. There was specific enhancement of synaptic NR2B-containing NMDAR (NR2BR) expression in the spinal dorsal horns of the mice. Both the increased total protein expression of NR2B subunit and the enhanced total phosphorylation level of NR2B subunit at 1472 tyrosine promoted the synaptic expression of NMDAR in the mice. Intrathecal injection of tramadol suppressed synaptic NMDAR expression mainly by changing the synaptic phosphorylation state of NR2B subunit at Tyr1472. Extracellular signal-regulated protein kinases 2 (ERK2) activity synchronized with the synaptic expression of NR2BR, which was downregulated by the action of tramadol. Conclusion Specific enhancement of NR2BR in the spinal dorsal horn may be vital for central sensitization in the CIA model of RA. The NR2BR/ERK2 pathway may be a promising target for pain management in RA patients.	[Xu, Yingming; Zhang, Kui; Miao, Jinlin; Zhao, Peng; Lv, Minghua; Li, Jia; Fu, Xianghui; Luo, Xing; Zhu, Ping] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian, Shaanxi, Peoples R China; [Zhao, Peng] Hanzhong 3201 Hosp, Dept Hematol & Rheumatol, Hanzhong, Peoples R China	Air Force Military Medical University	Zhu, P (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian, Shaanxi, Peoples R China.	zhuping@fmmu.edu.cn		Zhu, Ping/0000-0002-8391-4945	National Basic Research Program of China [2015CB553704]; National Natural Science Foundation of China [81701640]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China (NO. 2015CB553704) and the National Natural Science Foundation of China (no. 81701640).	Alter BJ, 2010, J NEUROSCI, V30, P11537, DOI 10.1523/JNEUROSCI.6103-09.2010; Bameri B, 2018, INT J TOXICOL, V37, P164, DOI 10.1177/1091581817753607; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Hama A, 2003, EUR J PHARMACOL, V459, P49, DOI 10.1016/S0014-2999(02)02828-5; Hara K, 2005, ANESTH ANALG, V100, P1400, DOI 10.1213/01.ANE.0000150961.24747.98; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Inglis JJ, 2007, ARTHRITIS RHEUM-US, V56, P4015, DOI 10.1002/art.23063; Jesse CR, 2010, PHARMACOLOGY, V85, P36, DOI 10.1159/000265551; Konig C, 2014, ARTHRITIS RHEUMATOL, V66, P599, DOI 10.1002/art.38271; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Li C, 2012, J ANESTH, V26, P230, DOI 10.1007/s00540-011-1267-4; Li S, 2011, J NEUROSCI RES, V89, P1869, DOI 10.1002/jnr.22719; Li YL, 2018, EUR J PHARMACOL, V818, P167, DOI 10.1016/j.ejphar.2017.10.041; Liu HP, 2017, J PHYSIOL SCI, V67, P197, DOI 10.1007/s12576-016-0456-1; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Luo JG, 2014, ARTHRITIS RHEUMATOL, V66, P896, DOI 10.1002/art.38328; Mannelli LD, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/905360; Nieto FR, 2015, ARTHRITIS RHEUMATOL, V67, P1668, DOI 10.1002/art.39082; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sarantis K, 2015, J NEUROCHEM, V135, P714, DOI 10.1111/jnc.13291; ten Klooster PM, 2007, ANN RHEUM DIS, V66, P1485, DOI 10.1136/ard.2007.069765; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vazquez E, 2012, ARTHRITIS RHEUM-US, V64, P2233, DOI 10.1002/art.34384; Walsh DA, 2014, NAT REV RHEUMATOL, V10, P581, DOI 10.1038/nrrheum.2014.64; Wang D, 2016, ONCOTARGET, V7, P85564, DOI 10.18632/oncotarget.9447; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Xu YM, 2015, EUR J PAIN, V19, P1298, DOI 10.1002/ejp.660; Yamasaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125147; Yanarates O, 2010, ANESTHESIOLOGY, V112, P696, DOI 10.1097/ALN.0b013e3181cd7920; Yang HB, 2011, J NEUROCHEM, V116, P93, DOI 10.1111/j.1471-4159.2010.07088.x; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Yang X, 2009, PAIN, V144, P162, DOI 10.1016/j.pain.2009.04.005	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201021	10.1371/journal.pone.0201021	http://dx.doi.org/10.1371/journal.pone.0201021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024967	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000077
J	Coll, M; Ferrer-Costa, C; Pich, S; Allegue, C; Rodrigo, E; Fernandez-Fresnedo, G; Barreda, P; Mates, J; de Francisco, ALM; Ortega, I; Iglesias, A; Campuzano, O; Salas, E; Arias, M; Brugada, R				Coll, Monica; Ferrer-Costa, Carles; Pich, Sara; Allegue, Catarina; Rodrigo, Emilio; Fernandez-Fresnedo, Gema; Barreda, Paloma; Mates, Jesus; Martinez de Francisco, Angel Luis; Ortega, Israel; Iglesias, Anna; Campuzano, Oscar; Salas, Eduardo; Arias, Manuel; Brugada, Ramon			Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients	PLOS ONE			English	Article							HEMODIALYSIS; DISPERSION; PREVALENCE; CHANNELS	Background Patients with end-stage renal disease have very high mortality. In individuals on hemodialysis, cardiovascular deaths account for similar to 50% of all deaths in this population, mostly due to arrhythmia. To determine the causes of these arrhythmic deaths is essential in order to adopt preventive strategies. The main objective of this study was to investigate whether, the presence of QTc interval alterations, from electrolyte abnormalities or presence of rare genetic variants, could have a relationship with sudden arrhythmogenic deaths in end-stage renal disease patients. Methods We recorded the pre- and post-dialysis QTc interval in 111 patients undergoing hemodialysis. In 47 of them, we analyzed 24 SCD-related genes including the most prevalent genes associated with long QT syndrome using a custom resequencing panel. Results We found a positive although not significant association between the presence of long QTc and mortality in a subset of end-stage renal disease patients. In addition, in five patients with long QTc only after dialysis (21.7%) we detected rare potentially pathogenic genetic variants. Three out of these five carriers subsequently died suddenly. Conclusions Genetic background may be determinant in the risk of sudden cardiac death in these patients. We recommend evaluating the QTc interval before and after hemodialysis, and performing a genetic analysis of individuals with long QTc after hemodialysis.	[Coll, Monica; Allegue, Catarina; Mates, Jesus; Iglesias, Anna; Campuzano, Oscar; Brugada, Ramon] Dr Trueta Univ Hosp, IDIBGI, Cardiovasc Genet Ctr, Parc Hosp Mart & Julia,Edifici M2, Salt, Spain; [Ferrer-Costa, Carles; Pich, Sara; Ortega, Israel; Salas, Eduardo] Gendiag Exe, Sci Dept, Barcelona, Spain; [Rodrigo, Emilio; Fernandez-Fresnedo, Gema; Barreda, Paloma; Martinez de Francisco, Angel Luis; Arias, Manuel] Hosp Univ Marques Valdecilla, IFIMAV, Serv Nefrol, Santander, Spain; [Brugada, Ramon] Dr Trueta Univ Hosp, Cardiol Serv, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Hospital Universitario Marques de Valdecilla (HUMV)	Brugada, R (corresponding author), Dr Trueta Univ Hosp, IDIBGI, Cardiovasc Genet Ctr, Parc Hosp Mart & Julia,Edifici M2, Salt, Spain.; Brugada, R (corresponding author), Dr Trueta Univ Hosp, Cardiol Serv, Girona, Spain.	rbrugada@idibgi.org	Salas, Eduardo/AAL-4836-2020; campuzano, oscar/J-1968-2014; Rodrigo, Emilio/AAX-2050-2021; Coll, Monica/H-3176-2015	Salas, Eduardo/0000-0002-6837-2471; campuzano, oscar/0000-0001-5298-5276; Rodrigo, Emilio/0000-0002-2845-5272; Coll, Monica/0000-0003-1214-803X; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Fondo de Desarrollo Regional Europeo (Red de Investigacion Cardiovascular) [RD12/0042/0013-0061]; Fondo de Investigacion Sanitaria [FIS PI12/00232]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009 SGR 1195]; Ferrer-InCode, a biotechnological services company	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Fondo de Desarrollo Regional Europeo (Red de Investigacion Cardiovascular); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ferrer-InCode, a biotechnological services company	This work was supported by Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, Fondo de Desarrollo Regional Europeo (Red de Investigacion Cardiovascular RD12/0042/0013-0061); Fondo de Investigacion Sanitaria (FIS PI12/00232); Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009 SGR 1195). The author Ramon Brugada receives salary in compensation for his work as a consultant for Ferrer-InCode, a biotechnological services company. The specific roles of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2017, HEART RHYTHM, V14, pE41, DOI 10.1016/j.hrthm.2016.09.012; Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Alabd MA, 2011, NEPHRON EXTRA, V1, P1, DOI 10.1159/000328930; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Franczyk-Skora B, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-162; Genovesi S, 2008, EUROPACE, V10, P771, DOI 10.1093/europace/eun028; Genovesi S, 2013, EUROPACE, V15, P1025, DOI 10.1093/europace/eus412; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Gray B, 2016, HEART RHYTHM, V13, P1652, DOI 10.1016/j.hrthm.2016.05.004; Hamilton KL, 2012, AM J PHYSIOL-RENAL, V302, pF1069, DOI 10.1152/ajprenal.00646.2011; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Howse M, 2002, POSTGRAD MED J, V78, P273, DOI 10.1136/pmj.78.919.273; Kanbay M, 2010, BLOOD PURIFICAT, V30, P135, DOI 10.1159/000320370; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; LANG F, 1992, PHYSIOL REV, V72, P1, DOI 10.1152/physrev.1992.72.1.1; Lorincz I, 1999, J AM SOC NEPHROL, V10, P1297; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Malhis M, 2010, SAUDI J KIDNEY DIS T, V21, P460; Mueller C, 2016, EUR HEART J, V37, pE15, DOI 10.1093/eurheartj/ehv409; Otero A, 2010, NEFROLOGIA, V30, P78, DOI 10.3265/Nefrologia.pre2009.Dic.5732; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Vallon V, 2001, J AM SOC NEPHROL, V12, P2003, DOI 10.1681/ASN.V12102003; Willis BC, 2016, CIRCULATION, V133, P2348, DOI 10.1161/CIRCULATIONAHA.116.021936; Wu VC, 2005, NEPHROLOGY, V10, P109, DOI 10.1111/j.1440-1797.2005.00391.x; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200756	10.1371/journal.pone.0200756	http://dx.doi.org/10.1371/journal.pone.0200756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020974	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400072
J	Luo, RF; Hu, S; Liu, QJ; Han, MK; Wang, FF; Qiu, MJ; Li, SC; Li, XS; Yang, TX; Fu, XD; Wang, WD; Li, CL				Luo, Renfei; Hu, Shan; Liu, Qiaojuan; Han, Mengke; Wang, Feifei; Qiu, Miaojuan; Li, Suchun; Li, Xiaosa; Yang, Tianxin; Fu, Xiaodong; Wang, Weidong; Li, Chunling			Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration	FASEB JOURNAL			English	Article						kidney; water channel; gasotransmitter; cAMP	CYSTATHIONINE BETA-SYNTHASE; AQUAPORIN-2 WATER CHANNEL; NA-K-2CL COTRANSPORTER; GAMMA-LYASE; MOLECULAR-MECHANISMS; PHYSIOLOGY; PROPARGYLGLYCINE; INHIBITION; H2S	Increasing evidence supports the important role of H2S in renal physiology and the pathogenesis of kidney injury. Whether H2S regulates water metabolism in the kidney and the potential mechanism are still unknown. The present study was conducted to determine the role of H2S in urine concentration. Inhibition of both cystathionine--lyase (CSE) and cystathionine--synthase (CBS), 2 major enzymes for endogenous H2S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla. Mice treated with both PPG and AOAA developed a urine concentration defect in response to dehydration that was accompanied by reduced AQP-2 protein expression. Inhibition of CSE alone was associated with a mild decrease in AQP-2 protein level in the renal medulla of heterozygous CBS mice. GYY4137, a slow H2S donor, markedly improved urine concentration and prevented the down-regulation of renal AQP-2 protein expression in mice with lithium-induced nephrogenic diabetes insipidus (NDI). GYY4137 significantly increased cAMP levels in cell lysates prepared from inner medullary collecting duct (IMCD) suspensions. AQP-2 protein expression was also upregulated, but was significantly inhibited by the adenyl cyclase inhibitor MDL12330A or the PKA inhibitor H89, but not the vasopressin 2 receptor (V2R) antagonist tolvaptan. Inhibition of endogenous H2S production impaired urine concentration in mice, whereas an exogenous H2S donor improved urine concentration in lithium-induced NDI by increasing AQP-2 expression in the collecting duct principal cells. H2S upregulated AQP-2 protein expression, probably via the cAMP-PKA pathway.Luo, R., Hu, S., Liu, Q., Han, M., Wang, F., Qiu, M., Li, S., Li, X., Yang, T., Fu, X., Wang, W., Li, C. Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.	[Luo, Renfei; Hu, Shan; Liu, Qiaojuan; Han, Mengke; Wang, Feifei; Qiu, Miaojuan; Li, Suchun; Yang, Tianxin; Wang, Weidong; Li, Chunling] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Li, Xiaosa; Fu, Xiaodong] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Tianxin] Univ Utah, Dept Med, Vet Affairs Med Ctr, Salt Lake City, UT 84112 USA	Sun Yat Sen University; Guangzhou Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Wang, WD; Li, CL (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	wangwd6@mail.sysu.edu.cn; lichl3@mail.sysu.edu.cn		Li, Suchun/0000-0002-5748-681X; Wang, Weidong/0000-0003-2523-3145	Natural Science Foundation of China [81570635, 81670646, 81370822]; Natural Science Foundation of Guangdong Province [2014A020212623, 2014A030313168, 2016A020215034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104072] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002817] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Natural Science Foundation of China Grants 81570635, 81670646, and 81370822, and Natural Science Foundation of Guangdong Province Grants 2014A020212623, 2014A030313168, and 2016A020215034. The authors declare no conflicts of interest.	Altaany Z, 2013, J CELL MOL MED, V17, P879, DOI 10.1111/jcmm.12077; Bankir L, 2017, J INTERN MED, V282, P284, DOI 10.1111/joim.12645; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Cao X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00385; Castrop H, 2014, AM J PHYSIOL-RENAL, V307, pF991, DOI 10.1152/ajprenal.00432.2014; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Christ-Crain M, 2016, NAT REV ENDOCRINOL, V12, P168, DOI 10.1038/nrendo.2015.224; Feliers D, 2016, ANTIOXID REDOX SIGN, V25, P720, DOI 10.1089/ars.2015.6596; Ge SN, 2014, ANTIOXID REDOX SIGN, V21, P2061, DOI 10.1089/ars.2013.5304; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Jin S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00682; Jung HJ, 2018, J AM SOC NEPHROL, V29, P1490, DOI 10.1681/ASN.2017050545; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Knepper MA, 2015, NEW ENGL J MED, V373, P196, DOI 10.1056/NEJMc1505505; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Koning AM, 2015, NITRIC OXIDE-BIOL CH, V46, P37, DOI 10.1016/j.niox.2015.01.005; Konno R, 2000, ARCH TOXICOL, V74, P473, DOI 10.1007/s002040000156; Kwong RWM, 2015, AM J PHYSIOL-CELL PH, V309, pC60, DOI 10.1152/ajpcell.00053.2015; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li C, 2008, J AM SOC NEPHROL, V19, P225, DOI 10.1681/ASN.2007010029; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Li CL, 2011, AM J PHYSIOL-RENAL, V300, pF1255, DOI 10.1152/ajprenal.00469.2010; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Olson KR, 2008, AM J PHYSIOL-REG I, V295, pR669, DOI 10.1152/ajpregu.00807.2007; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Perniss A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03742-5; Roy A, 2012, AM J HYPERTENS, V25, P74, DOI 10.1038/ajh.2011.149; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Tang GH, 2013, ANTIOXID REDOX SIGN, V19, P1634, DOI 10.1089/ars.2012.4805; Triguero A, 1997, BRIT J NUTR, V78, P823, DOI 10.1079/BJN19970198; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang WD, 2015, AM J PHYSIOL-RENAL, V308, pF910, DOI 10.1152/ajprenal.00649.2014; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WORK J, 1985, AM J PHYSIOL, V249, pF698, DOI 10.1152/ajprenal.1985.249.5.F698; Xia M, 2009, J PHARMACOL EXP THER, V329, P1056, DOI 10.1124/jpet.108.149963; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420	43	22	22	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					469	483		10.1096/fj.201800436R	http://dx.doi.org/10.1096/fj.201800436R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30036087	Green Published			2022-12-26	WOS:000457401500037
J	Lu, CH; Yeh, DW; Lai, CY; Liu, YL; Huang, LR; Lee, AYL; Jin, SLC; Chuang, TH				Lu, Chih-Hao; Yeh, Da-Wei; Lai, Chao-Yang; Liu, Yi-Ling; Huang, Li-Rung; Lee, Alan Yueh-Luen; Jin, S-L Catherine; Chuang, Tsung-Hsien			USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation	ONCOGENE			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME USP17; TUMOR-ASSOCIATED MACROPHAGES; ACTIVATION; TRAF2; METASTASIS; MECHANISMS; EXPRESSION; INHIBITORS	Macrophage accumulation and inflammation in the lung owing to stresses and diseases is a cause of lung cancer development. However, molecular mechanisms underlying the interaction between macrophages and cancer cells, which drive inflammation and stemness in cancers, are poorly understood. In this study, we investigated the expression of ubiquitin-specific peptidase 17 (USP17) in lung cancers, and role of elevated USP17 in the interaction between macrophages and lung cancer cells. USP17 expression in lung cancers was associated with poor prognosis, macrophage, and inflammatory marker expressions. Macrophages promoted USP17 expression in cancer cells. TNFR-associated factor (TRAF) 2-binding and TRAF3-binding motifs were identified in USP17, through which it interacted with and disrupted the TRAF2/TRAF3 complex. This stabilized its client proteins, enhanced inflammation and stemness in cancer cells, and promoted macrophage recruitment. In different animal studies, co-injection of macrophages with cancer cells promoted USP17 expression in tumors and tumor growth. Conversely, depletion of macrophages in host animals by clodronate liposomes reduced USP17 expression and tumor growth. In addition, overexpression of USP17 in cancer cells promoted tumor growth and inflammation-associated and stemness-associated gene expressions in tumors. These results suggested that USP17 drives a positive-feedback interaction between macrophages and cancer cells to enhance inflammation and stemness in cancer cells, and promotes lung cancer growth.	[Lu, Chih-Hao; Yeh, Da-Wei; Lai, Chao-Yang; Liu, Yi-Ling; Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan; [Lu, Chih-Hao; Jin, S-L Catherine] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Huang, Li-Rung] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Lee, Alan Yueh-Luen] Natl Inst Canc Res, Natl Hlth Res Inst, Miaoli, Taiwan; [Chuang, Tsung-Hsien] Kaohsiung Med Univ, Program Environm & Occupat Med, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Central University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University	Chuang, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan.; Chuang, TH (corresponding author), Kaohsiung Med Univ, Program Environm & Occupat Med, Kaohsiung, Taiwan.	thchuang@nhri.org.tw	Chuang, Tsung-Hsien/F-9679-2010	Lee, Alan Yueh-Luen/0000-0003-0252-0571	National Health Research Institutes, Taiwan [IM-106-PP-02, NHRI-EX106-10630SI]; Ministry of Science and Technology of Taiwan [MOST 105-2314-B-400-006, MOST 105-2320-B-400-013-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	We thank the Laboratory Animal Center of the National Health Research Institutes, Taiwan, for assistance with animal work. This work was supported by grants from National Health Research Institutes, Taiwan (IM-106-PP-02, NHRI-EX106-10630SI) and Ministry of Science and Technology of Taiwan (MOST 105-2314-B-400-006, and MOST 105-2320-B-400-013-MY3).	Bolli E, 2017, CURR OPIN ONCOL, V29, P55, DOI 10.1097/CCO.0000000000000344; Borbely G, 2015, ONCOTARGET, V6, P33623, DOI 10.18632/oncotarget.5601; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Conway EM, 2016, AM J RESP CRIT CARE, V193, P116, DOI 10.1164/rccm.201508-1545CI; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Farshi P, 2015, EXPERT OPIN THER PAT, V25, P1191, DOI 10.1517/13543776.2015.1056737; Goswami KK, 2017, CELL IMMUNOL, V316, P1, DOI 10.1016/j.cellimm.2017.04.005; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lim KH, 2013, CYTOKINE GROWTH F R, V24, P427, DOI 10.1016/j.cytogfr.2013.05.007; Liu TZ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13923; MacDonagh L, 2016, CANCER LETT, V372, P147, DOI [10.1016/j.canlet.2016,01.012, 10.1016/j.canlet.2016.01.012]; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McFarlane C, 2013, ONCOTARGET, V4, P1836, DOI 10.18632/oncotarget.1282; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Ni YM, 2015, INT J MOL SCI, V16, P27956, DOI 10.3390/ijms161126063; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pal A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0461-3; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Popovic D, 1998, CLIN EXP METASTAS, V16, P623, DOI 10.1023/A:1006508413070; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Ramakrishna S, 2015, BBA-REV CANCER, V1855, P83, DOI 10.1016/j.bbcan.2014.11.006; Ramakrishna S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037772; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Sainz B, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9012369; Shigdar S, 2014, CANCER LETT, V345, P271, DOI 10.1016/j.canlet.2013.07.031; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sica A, 2017, CANCER IMMUNOL IMMUN, V66, P1025, DOI 10.1007/s00262-017-1997-8; Suarez-Carmona M, 2017, MOL ONCOL, V11, P805, DOI 10.1002/1878-0261.12095; Suresh R, 2016, ADV EXP MED BIOL, V890, P57, DOI 10.1007/978-3-319-24932-2_4; Todoric J, 2016, CANCER PREV RES, V9, P895, DOI 10.1158/1940-6207.CAPR-16-0209; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Valavanidis A, 2013, INT J ENV RES PUB HE, V10, P3886, DOI 10.3390/ijerph10093886; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Won M, 2016, ARCH PHARM RES, V39, P1075, DOI 10.1007/s12272-016-0772-2; Wu YD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14228; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yang XD, 2015, IMMUNOL REV, V266, P56, DOI 10.1111/imr.12311; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yeh DW, 2016, CELL DEATH DIFFER, V23, P841, DOI 10.1038/cdd.2015.147; Yeh DW, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4368101; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang S, 2016, ONCOL RES, V24	57	43	43	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 6	2018	37	49					6327	6340		10.1038/s41388-018-0411-0	http://dx.doi.org/10.1038/s41388-018-0411-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HD3AP	30038267	hybrid, Green Published			2022-12-26	WOS:000452384400004
J	Kemp, JP; Brieher, WM				Kemp, James Peter, Jr.; Brieher, William M.			The actin filament bundling protein -actinin-4 actually suppresses actin stress fibers by permitting actin turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; tropomyosin; epithelial cell; migration; kidney; focal adhesions; -actinin; contractility; motility; paxillin; stress fibers	FOCAL ADHESION MATURATION; ALPHA-ACTININ; F-ACTIN; IN-VITRO; EXTRACELLULAR-MATRIX; STRUCTURAL PROTEIN; ENDOTHELIAL-CELLS; BINDING AFFINITY; PROXIMAL TUBULES; BOWMANS CAPSULE	Cells organize actin filaments into contractile bundles known as stress fibers that resist mechanical stress, increase cell adhesion, remodel the extracellular matrix, and maintain tissue integrity. -actinin is an actin filament bundling protein that is thought to be essential for stress fiber formation and stability. However, previous studies have also suggested that -actinin might disrupt fibers, making the true function of this biomolecule unclear. Here we use fluorescence imaging to show that kidney epithelial cells depleted of -actinin-4 via shRNA or CRISPR/Cas9, or expressing a disruptive mutant make more massive stress fibers that are less dynamic than those in WT cells, leading to defects in cell motility and wound healing. The increase in stress fiber mass and stability can be explained, in part, by increased loading of the filament component tropomyosin onto stress fibers in the absence of -actinin, as monitored via immunofluorescence. We show using imaging and cosedimentation that -actinin and tropomyosin compete for binding to F-actin and that tropomyosin shields actin filaments from cofilin-mediated disassembly in vitro and in cells. Perturbing tropomyosin in cells lacking -actinin-4 results in a complete loss of stress fibers. Our results with -actinin-4 on stress fiber organization are the opposite of what might have been predicted from previous in vitro biochemistry and further highlight how the complex interactions of multiple proteins competing for filament binding lead to unexpected functions for actin-binding proteins in cells.	[Kemp, James Peter, Jr.; Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Kemp, James Peter, Jr.] Univ N Carolina, Integrat Program Biol & Genome Sci IBGS, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill	Brieher, WM (corresponding author), MC-123,601 S Goodwin Ave, Urbana, IL 61801 USA.	wbrieher@illinois.edu		Brieher, William/0000-0002-3168-6688; Kemp, James/0000-0003-1975-1149	National Institutes of Health [R01-GM106106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM106106 (to W. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BADLEY R A, 1980, Journal of Muscle Research and Cell Motility, V1, P5, DOI 10.1007/BF00711922; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Bonet C, 2010, EUR BIOPHYS J BIOPHY, V39, P1143, DOI 10.1007/s00249-009-0566-2; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; DRABIKOWSKI W, 1968, EUR J BIOCHEM, V5, P209, DOI 10.1111/j.1432-1033.1968.tb00359.x; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Ennomani H, 2016, CURR BIOL, V26, P616, DOI 10.1016/j.cub.2015.12.069; Feng YF, 2013, EXP CELL RES, V319, P1124, DOI 10.1016/j.yexcr.2013.02.009; Fukumoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120616; GABBIANI G, 1975, LAB INVEST, V32, P227; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; GOLL DE, 1972, J MOL BIOL, V67, P469, DOI 10.1016/0022-2836(72)90464-0; Goto K, 1998, CELL STRUCT FUNCT, V23, P73, DOI 10.1247/csf.23.73; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; HERMAN IM, 1981, J CELL BIOL, V90, P84, DOI 10.1083/jcb.90.1.84; Hiraiwa T, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.188101; Hu SQ, 2017, NAT CELL BIOL, V19, P133, DOI 10.1038/ncb3466; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; ISENBERG G, 1976, CELL TISSUE RES, V166, P427; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Katoh K, 1998, MOL BIOL CELL, V9, P1919, DOI 10.1091/mbc.9.7.1919; KAWAMURA M, 1970, J BIOCHEM-TOKYO, V68, P577, DOI 10.1093/oxfordjournals.jbchem.a129388; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; KREIS TE, 1980, CELL, V22, P555, DOI 10.1016/0092-8674(80)90365-7; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Lenz M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238107; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MARUYAMA K, 1965, J BIOCHEM-TOKYO, V58, P13, DOI 10.1093/oxfordjournals.jbchem.a128158; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McFadden WM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005811; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Meacci G, 2016, MOL BIOL CELL, V27, P3471, DOI 10.1091/mbc.E16-02-0107; Mulholland DJ, 1999, TISSUE CELL, V31, P610, DOI 10.1054/tice.1999.0075; MURAKAMI T, 1991, CELL STRUCT FUNCT, V16, P231, DOI 10.1247/csf.16.231; Murrell M, 2015, NAT REV MOL CELL BIO, V16, P486, DOI 10.1038/nrm4012; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Piccinini F, 2016, BIOINFORMATICS, V32, P955, DOI 10.1093/bioinformatics/btv686; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Stam S, 2017, P NATL ACAD SCI USA, V114, pE10037, DOI 10.1073/pnas.1708625114; TANAKA K, 1977, JPN CIRC J, V41, P1329; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; WILLINGHAM MC, 1977, CELL, V10, P375, DOI 10.1016/0092-8674(77)90024-1; WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yu-Kemp HC, 2016, J BIOL CHEM, V291, P658, DOI 10.1074/jbc.C115.689265	76	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14520	14533		10.1074/jbc.RA118.004345	http://dx.doi.org/10.1074/jbc.RA118.004345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049798	hybrid, Green Published			2022-12-26	WOS:000444671500029
J	Nguyen, TQ; Aumont-Nicaise, M; Andreani, J; Velours, C; Chenon, M; Vilela, F; Geneste, C; Varela, PF; Llinas, P; Menetrey, J				Nguyen, T. Quyen; Aumont-Nicaise, Magali; Andreani, Jessica; Velours, Christophe; Chenon, Melanie; Vilela, Fernando; Geneste, Clementine; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie			Characterization of the binding mode of JNK-interacting protein 1 (JIP1) to kinesin-light chain 1 (KLC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						isothermal titration calorimetry (ITC); protein-protein interaction; kinesin; protein engineering; site-directed mutagenesis; alcadein; MST; SH2D6; TPR domain; Y-acidic motif; JNK-interacting protein 1; kinesin light chain; TorsinA; autoinhibitory LFP-acidic motif; motor protein	SEQUENCE; CARGO; PERFORMANCE; TRANSPORT; DATABASE	JIP1 was first identified as scaffold protein for the MAP kinase JNK and is a cargo protein for the kinesin1 molecular motor. JIP1 plays significant and broad roles in neurons, mainly as a regulator of kinesin1-dependent transport, and is associated with human pathologies such as cancer and Alzheimer disease. JIP1 is specifically recruited by the kinesin-light chain 1 (KLC1) of kinesin1, but the details of this interaction are not yet fully elucidated. Here, using calorimetry, we extensively biochemically characterized the interaction between KLC1 and JIP1. Using various truncated fragments of the tetratricopeptide repeat (TPR) domain of KLC1, we narrowed down its JIP1-binding region and identified seven KLC1 residues critical for JIP1 binding. These isothermal titration calorimetry (ITC)-based binding data enabled us to footprint the JIP1-binding site on KLC1-TPR. This footprint was used to uncover the structural basis for the marginal inhibition of JIP1 binding by the autoinhibitory LFP-acidic motif of KLC1, as well as for the competition between JIP1 and another cargo protein of kinesin1, the W-acidic motif-containing alcadein-. Also, we examined the role of each of these critical residues of KLC1 for JIP1 binding in light of the previously reported crystal structure of the KLC1-TPR:JIP1 complex. Finally, sequence search in eukaryotic genomes identified several proteins, among which is SH2D6, that exhibit a motif similar to the KLC1-binding motif of JIP1. Overall, our extensive biochemical characterization of the KLC:JIP1 interaction, as well as identification of potential KLC1-binding partners, improves the understanding of how this growing family of cargos is recruited to kinesin1 by KLC1.	[Nguyen, T. Quyen; Velours, Christophe; Chenon, Melanie; Vilela, Fernando; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie] Univ Paris Sud, CNRS, LEBS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France; [Nguyen, T. Quyen; Aumont-Nicaise, Magali; Andreani, Jessica; Velours, Christophe; Chenon, Melanie; Vilela, Fernando; Geneste, Clementine; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, Commissariat Energie Atom,CNRS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Llinas, P; Menetrey, J (corresponding author), Univ Paris Sud, CNRS, LEBS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.; Llinas, P; Menetrey, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, Commissariat Energie Atom,CNRS, F-91198 Gif Sur Yvette, France.	paola.llinas@i2bc.paris-saclay.fr; julie.menetrey@i2bc.paris-saclay.fr	Ménétrey, Julie/AAM-6408-2021; Varela, Paloma/AFT-0478-2022	Varela, Paloma/0000-0001-5078-7102; Andreani, Jessica/0000-0003-4435-9093; MENETREY, Julie/0000-0003-0091-8842; Vilela, Fernando/0000-0002-1593-5648	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; ARC [SFI20121205592, DOC20160603834]; Canceropole Ile-de-France Grant [2013-2-AD-06-UP 6-1]	French Infrastructure for Integrated Structural Biology (FRISBI); ARC(Australian Research Council); Canceropole Ile-de-France Grant	This work was supported by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01 and by ARC Grant SFI20121205592 (to J. M.) as well as Canceropole Ile-de-France Grant 2013-2-AD-06-UP 6-1 and ARC Grant DOC20160603834 (to T.Q.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dey G, 2015, CELL REP, V10, P993, DOI 10.1016/j.celrep.2015.01.025; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faure G, 2012, NUCLEIC ACIDS RES, V40, pD847, DOI 10.1093/nar/gkr845; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2001, J NEUROSCI, V21, P6597; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Morfini G, 2016, BRAIN RES BULL, V126, P347, DOI 10.1016/j.brainresbull.2016.06.009; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pernigo S., 2018, BIORXIV, DOI [10.1101/322057, DOI 10.1101/322057]; Pernigo S, 2013, SCIENCE, V340, P356, DOI 10.1126/science.1234264; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Nguyen TQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186354; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Yip YY, 2016, P NATL ACAD SCI USA, V113, P2418, DOI 10.1073/pnas.1520817113; Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14; Zhu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052393	39	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13946	13960		10.1074/jbc.RA118.003916	http://dx.doi.org/10.1074/jbc.RA118.003916			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30026235	hybrid, Green Published			2022-12-26	WOS:000444070700020
J	Feyissa, GT; Lockwood, C; Woldie, M; Munn, Z				Feyissa, Garumma Tolu; Lockwood, Craig; Woldie, Mirkuzie; Munn, Zachary			Evaluation of a guideline developed to reduce HIV-related stigma and discrimination in healthcare settings and establishing consensus	PLOS ONE			English	Article							DELPHI TECHNIQUE; FORMAL CONSENSUS; CRITERIA; STABILITY; TOOL	Background Developing guidelines and policies is critical to address HIV-related stigma and discrimination (SAD) in healthcare settings. To this end, a multidisciplinary panel developed a guideline to reduce SAD. This project evaluated the appropriateness of implementing the guideline in the Ethiopian context. Methods A consensus of the expert panel was established through a modified Delphi technique which was followed by a panel meeting. Initial tentative recommendations were distributed to experts through e-mails to be evaluated using the modified guideline implementability appraisal (GLIA) v.2.0 checklist. Results In the first round of the Delphi survey, all (13) panel members evaluated the guideline. The overall score for the general domain of the modified GLIA checklist was 96.56%. The scores for individual recommendations ranged from 68.33% to 92.76%. Maximum and minimum scores were attained for measurability (97.71%) and flexibility (59.77%) domains respectively. Percentages mean score lower than 75% was obtained for flexibility and validity domains. Participants suggested that additional tools and training should be added to the guideline. In the second round of the survey, all the recommendations received endorsement with scores above 75%. Maximum and minimum scores were attained for measurability (100%) and flexibility (86.88%) domains respectively. During the panel meeting, issues of responsibility for implementing the guideline were discussed. Conclusion The project evaluated implementability of a guideline developed to reduce HIV-related SAD in healthcare settings. The Delphi survey was followed by a half-day meeting that helped in further clarification of points.	[Feyissa, Garumma Tolu; Woldie, Mirkuzie] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia; [Feyissa, Garumma Tolu; Woldie, Mirkuzie] Jimma Univ, JBI Ctr Excellence, Ethiopian Evidence Based Hlth Care Ctr, Jimma, Ethiopia; [Feyissa, Garumma Tolu; Lockwood, Craig; Munn, Zachary] Univ Adelaide, Joanna Briggs Inst, Adelaide, SA, Australia; [Woldie, Mirkuzie] Jimma Univ, Dept Hlth Econ Management & Policy, Jimma, Ethiopia	Jimma University; Jimma University; University of Adelaide; Jimma University	Feyissa, GT (corresponding author), Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia.; Feyissa, GT (corresponding author), Jimma Univ, JBI Ctr Excellence, Ethiopian Evidence Based Hlth Care Ctr, Jimma, Ethiopia.; Feyissa, GT (corresponding author), Univ Adelaide, Joanna Briggs Inst, Adelaide, SA, Australia.	garummatolu@yahoo.com	Munn, Zachary/AAV-9760-2021; Woldie, Mirkuzie/S-4086-2017; Feyissa, Garumma/AAP-9097-2020	Munn, Zachary/0000-0002-7091-5842; Woldie, Mirkuzie/0000-0002-1777-0816; Feyissa, Garumma/0000-0001-6179-0024	Adelaide scholarship International (ASI) - University of Adelaide	Adelaide scholarship International (ASI) - University of Adelaide	This study was conducted as part of GTF's PhD project which was supported by the Adelaide scholarship International (ASI) granted by the University of Adelaide. The authors did not receive any funding for this research.	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; [Anonymous], 1998, HEALTH TECHNOL ASSES, DOI DOI 10.1186/s12888-014-0241-8; Brosseau L, 2015, CLIN REHABIL; Carr D, 2015, ACHIEVING STIGMA FRE; Catalan J, 2011, PSYCHOL HEALTH MED, V16, P588, DOI 10.1080/13548506.2011.582125; CHAFFIN WW, 1980, TECHNOL FORECAST SOC, V16, P67, DOI 10.1016/0040-1625(80)90074-8; Chibanda D, 2014, JAIDS-J ACQ IMM DEF, V67, pS54, DOI 10.1097/QAI.0000000000000258; Ciliska D, 2008, INTRO EVIDENCE INFOR; Cole F L, 1988, Clin Nurse Spec, V2, P53, DOI 10.1097/00002800-198800210-00025; DAJANI JS, 1979, TECHNOL FORECAST SOC, V13, P83, DOI 10.1016/0040-1625(79)90007-6; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Day J., 2005, ELECT J BUS RES METH, V3, P103; Egon G., 1981, ED COMMUNICATION TEC, V29, P75; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Franklin KK, 2006, INNOVATIVE HIGHER ED, V31, P237; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Halkitis PN, 2017, INTERD T GERONT GERI, V42, P187, DOI 10.1159/000448564; Harrison MB, 2012, CAN IMPLEMENT GUIDEL; Hsu CC, 2007, PARE, V12, P1; Hsu CC, 2007, PRACTICAL ASSESSMENT, V12, P62; Human SP, 2007, HLTH SA GESONDHEID, V12; James D, 2015, NURSE RES, V22, P35, DOI 10.7748/nr.22.3.35.e1297; Jordan Z, 2016, UPDATED JBI MODEL EV; Kalaian S.A., 2012, PRACT ASSESS RES EVA, V17, P5, DOI [DOI 10.7275/G48Q-JE05, 10.7275/g48q-je05]; Kashyap N, 2005, GUIDELINE IMPLEMENTA; Kastner M, 2011, EXPERT REV PHARM OUT, V11, P315, DOI [10.1586/ERP.11.32, 10.1586/erp.11.32]; Loblaw DA, 2012, J CLIN ONCOL, V30, P3136, DOI 10.1200/JCO.2012.42.0489; Loo R, 2002, POLICING, V25, P762, DOI 10.1108/13639510210450677; McMillan SS, 2016, INT J CLIN PHARM; MURRY JW, 1995, REV HIGH EDUC, V18, P423, DOI 10.1353/rhe.1995.0008; Nair R, 2011, SEMIN ARTHRITIS RHEU, V41, P95, DOI 10.1016/j.semarthrit.2010.12.001; National Institute for Health Care Excellence, 2020, DEV NICE GUID MAN; NCCMT, 2011, CRIT APPR PRACT GUID; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Phillips Kenneth D, 2011, Issues Ment Health Nurs, V32, P374, DOI 10.3109/01612840.2011.568273; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Sharkey SB, 2001, NURS EDUC TODAY, V21, P398, DOI 10.1054/nedt.2001.0573; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Shiffman RN, 2005, BMC MED INFORM DECIS, V5; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; van der Linde H, 2005, J REHABIL RES DEV, V42, P693, DOI 10.1682/JRRD.2003.11.0172; Vernon W, 2009, INT J THER REHABIL, V16, P69, DOI 10.12968/ijtr.2009.16.2.38892; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Yang Y.N., 2003, TESTING STABILITY EX; Yousuf M.I., 2007, PRACT ASSESS RES EVA, V12, P8, DOI [10.7275/rrph-t210, DOI 10.7275/RRPH-T210]; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	56	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0198781	10.1371/journal.pone.0198781	http://dx.doi.org/10.1371/journal.pone.0198781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052634	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600004
J	Oliveras, A; Baro, A; Montesinos, L; Badosa, E; Montesinos, E; Feliu, L; Planas, M				Oliveras, Angel; Baro, Aina; Montesinos, Laura; Badosa, Esther; Montesinos, Emilio; Feliu, Lidia; Planas, Marta			Antimicrobial activity of linear lipopeptides derived from BP100 towards plant pathogens	PLOS ONE			English	Article							CATIONIC LIPOPEPTIDES; CYCLIC LIPOPEPTIDES; PEPTIDES; ANTIFUNGAL; ANTIBACTERIAL; CONJUGATION; BACTERIAL; BACILLUS; FUNGAL; UNDECAPEPTIDES	A collection of 36 lipopeptides were designed from the cecropin A-melittin hybrid peptide BP100 (H-Lys-Lys-Leu-Phe-Lys-Lys-Ile-Leu-Lys-Tyr-Leu-NH2) previously described with activity against phytopathogenic bacteria. These lipopeptides were synthesized on solid-phase and screened for their antimicrobial activity, toxicity and proteolytic stability. They incorporated a butanoyl, a hexanoyl or a lauroyl group at the N-terminus or at the side chain of a lysine residue placed at each position of the sequence. Their antimicrobial activity and hemolysis depended on the fatty acid length and its position. In particular, lipopeptides containing a butanoyl or a hexanoyl chain exhibited the best biological activity profile. In addition, we observed that the incorporation of the acyl group did not induce the overexpression of defense-related genes in tomato. Best lipopeptides were BP370, BP378, BP381, BP387 and BP389, which were highly active against all the pathogens tested (minimum inhibitory concentration of 0.8 to 12.5 mu M), low hemolytic, low phytotoxic and significantly stable to protease degradation. This family of lipopeptides might be promising functional peptides useful for plant protection.	[Oliveras, Angel; Feliu, Lidia; Planas, Marta] Univ Girona, LIPPSO, Dept Chem, Campus Montilivi, Girona, Spain; [Baro, Aina; Montesinos, Laura; Badosa, Esther; Montesinos, Emilio] Univ Girona, Inst Food & Agr Technol CIDSAV XaRTA, Lab Plant Pathol, Campus Montilivi, Girona, Spain	Universitat de Girona; Universitat de Girona	Feliu, L; Planas, M (corresponding author), Univ Girona, LIPPSO, Dept Chem, Campus Montilivi, Girona, Spain.	lidia.feliu@udg.edu; marta.planas@udg.edu	Planas, Marta/E-4145-2015; Feliu, Lidia/H-8285-2015; Romañó, Esther Badosa/H-3342-2015; MONTESINOS, EMILIO/H-5246-2015	Planas, Marta/0000-0003-4988-4970; Feliu, Lidia/0000-0001-9792-6106; Romañó, Esther Badosa/0000-0001-7776-8286; MONTESINOS, EMILIO/0000-0003-4455-8332	Ministerio de Economia y Competitividad [AGL2012-39880-C02-02, AGL2015-69876-C2-2-R]; University of Girona [MPCUDG2016/038]	Ministerio de Economia y Competitividad(Spanish Government); University of Girona	The work was supported by the following: Ministerio de Economia y Competitividad (ES); AGL2012-39880-C02-02; LM, EB, EM, LF, MP; Ministerio de Economia y Competitividad (ES); AGL2015-69876-C2-2-R; AO, LM, EB, EM, LF, MP; University of Girona (ES); MPCUDG2016/038; AO, LF, MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Badosa E, 2017, J PLANT PATHOL, V99, P65, DOI 10.4454/jpp.v99i0.3915; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Badosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085515; Badosa E, 2009, APPL ENVIRON MICROB, V75, P5563, DOI 10.1128/AEM.00711-09; Bektas Y, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00804; Bionda N, 2016, EUR J MED CHEM, V108, P354, DOI 10.1016/j.ejmech.2015.11.032; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Brotman Y, 2009, APPL ENVIRON MICROB, V75, P5373, DOI 10.1128/AEM.00724-09; Camo C, 2017, MOLECULES, V22, DOI 10.3390/molecules22111817; Chu-Kung AF, 2004, BIOCONJUGATE CHEM, V15, P530, DOI 10.1021/bc0341573; Cochrane SA, 2016, MED RES REV, V36, P4, DOI 10.1002/med.21321; Dalboge LS, 2015, J PEPT SCI, V21, P85, DOI 10.1002/psc.2727; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Goodwin D, 2012, CURR MED CHEM, V19, P4451, DOI 10.2174/092986712803251548; Guell I, 2017, BIOPOLYMERS, V108, DOI 10.1002/bip.23012; Guryanov I, 2016, J PEPT SCI, V22, P471, DOI 10.1002/psc.2890; HAZEL W J, 1980, Plant Disease, V64, P178; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohan S, 2013, CHEM BIOL DRUG DES, V82, P557, DOI 10.1111/cbdd.12182; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Malmsten M, 2016, CURR TOP MED CHEM, V16, P16, DOI 10.2174/1568026615666150703121518; Mandal SM, 2013, BIOTECHNOL ADV, V31, P338, DOI 10.1016/j.biotechadv.2013.01.004; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Meena KR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/473050; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Montesinos E, 2012, ACS SYM SER, V1095, P235; Ng-Choi I, 2014, PROTEIN PEPTIDE LETT, V21, P357, DOI 10.2174/09298665113206660103; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Patel S, 2015, WORLD J MICROB BIOT, V31, P1177, DOI 10.1007/s11274-015-1880-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Rajasekaran K., 2012, ACS S SERIES; Schmidtchen A, 2014, ADV COLLOID INTERFAC, V205, P265, DOI 10.1016/j.cis.2013.06.009; Shai Y, 2006, CURR PROTEIN PEPT SC, V7, P479, DOI 10.2174/138920306779025620; Slootweg JC, 2013, BIOORG MED CHEM LETT, V23, P3749, DOI 10.1016/j.bmcl.2013.05.002; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Strieker M, 2009, CHEMBIOCHEM, V10, P607, DOI 10.1002/cbic.200800546; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; Thennarasu S, 2005, BBA-BIOMEMBRANES, V1711, P49, DOI 10.1016/j.bbamem.2005.02.010; Humpola MV, 2017, J PEPT SCI, V23, P45, DOI 10.1002/psc.2958; Vidaver AK, 2002, CLIN INFECT DIS, V34, pS107, DOI 10.1086/340247; Vila S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151639	53	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201571	10.1371/journal.pone.0201571	http://dx.doi.org/10.1371/journal.pone.0201571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052685	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600050
J	Chabanon, A; Seferian, AM; Daron, A; Pereon, Y; Cances, C; Vuillerot, C; De Waele, L; Cuisset, JM; Laugel, V; Schara, U; Gidaro, T; Gilabert, S; Hogrel, JY; Baudin, PY; Carlier, P; Fournier, E; Lowes, LP; Hellbach, N; Seabrook, T; Toledano, E; Annoussamy, M; Servais, L				Chabanon, Aurelie; Seferian, Andreea Mihaela; Daron, Aurore; Pereon, Yann; Cances, Claude; Vuillerot, Carole; De Waele, Liesbeth; Cuisset, Jean-Marie; Laugel, Vincent; Schara, Ulrike; Gidaro, Teresa; Gilabert, Stephanie; Hogrel, Jean-Yves; Baudin, Pierre-Yves; Carlier, Pierre; Fournier, Emmanuel; Lowes, Linda Pax; Hellbach, Nicole; Seabrook, Timothy; Toledano, Elie; Annoussamy, Melanie; Servais, Laurent		NatHis-SMA Study Grp	Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study	PLOS ONE			English	Article							NASAL INSPIRATORY PRESSURE; MOTOR FUNCTION MEASURE; 6-MINUTE WALK TEST; OUTCOME MEASURES; NEUROMUSCULAR DISEASES; HEALTHY-SUBJECTS; MUSCLE STRENGTH; CLINICAL-TRIALS; CHILDREN; VALUES	Spinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutations in the survival motor neuron 1 gene, which results in a broad range of disease severity, from neonatal to adult onset. There is currently a concerted effort to define the natural history of the disease and develop outcome measures that accurately capture its complexity. As several therapeutic strategies are currently under investigation and both the FDA and EMA have recently approved the first medical treatment for SMA, there is a critical need to identify the right association of responsive outcome measures and biomarkers for individual patient follow-up. As an approved treatment becomes available, untreated patients will soon become rare, further intensifying the need for a rapid, prospective and longitudinal study of the natural history of SMA Type 2 and 3. Here we present the baseline assessments of 81 patients aged 2 to 30 years of which 19 are non-sitter SMA Type 2, 34 are sitter SMA Type 2, 9 non-ambulant SMA Type 3 and 19 ambulant SMA Type 3. Collecting these data at nine sites in France, Germany and Belgium established the feasibility of gathering consistent data from numerous and demanding assessments in a multicenter SMA study. Most assessments discriminated between the four groups well. This included the Motor Function Measure (MFM), pulmonary function testing, strength, electroneuromyography, muscle imaging and workspace volume. Additionally, all of the assessments showed good correlation with the MFM score. As the untreated patient population decreases, having reliable and valid multi-site data will be imperative for recruitment in clinical trials. The pending two-year study results will evaluate the sensitivity of the studied outcomes and biomarkers to disease progression.	[Chabanon, Aurelie; Seferian, Andreea Mihaela; Gidaro, Teresa; Gilabert, Stephanie; Hogrel, Jean-Yves; Carlier, Pierre; Fournier, Emmanuel; Annoussamy, Melanie; Servais, Laurent] GH Pitie Salpetriere, Inst Myol, Paris, France; [Daron, Aurore; Servais, Laurent] CHU Liege, Ctr Reference Malad Neuromusculaires, Liege, Belgium; [Pereon, Yann] Hop Hotel Dieu, Ctr Reference Malad Neuromusculaires Atlantique O, Nantes, France; [Cances, Claude] Hop Enfants, Ctr Reference Malad Neuromusculaires, Toulouse, France; [Cances, Claude] Hop Enfants, Unite Neurol Pediat, Toulouse, France; [Vuillerot, Carole] CHU Lyon, Hop Mere Enfant, Serv Reeduc Pediat Infantile LEscale, Lyon, France; [De Waele, Liesbeth] Univ Hosp Leuven, Dept Pediat Neurol, Leuven, Belgium; [De Waele, Liesbeth] KU Leuven Kulak Kortijk, Dept Dev & Regenerat, Kortrijk, Belgium; [Cuisset, Jean-Marie] Hop Roger Salengro, Ctr Reference Malad Neuromusculaires, Lille, France; [Cuisset, Jean-Marie] Hop Roger Salengro, Serv Neuropediat, Lille, France; [Laugel, Vincent] CHU Strasbourg Hautepierre, INSERM, CIC 1434, Neuropediat, Strasbourg, France; [Schara, Ulrike] Univ Essen Gesamthsch, Paediat Neurol & Neuromuscular Ctr, Essen, Germany; [Baudin, Pierre-Yves] CRIS, Tournai, Belgium; [Lowes, Linda Pax] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA; [Hellbach, Nicole; Seabrook, Timothy] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Basel, Switzerland; [Toledano, Elie] Inst Roche, Paris, France; [Servais, Laurent] CHU Liege, Serv Pediat, Liege, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Liege; Nantes Universite; CHU de Nantes; CHU de Toulouse; CHU de Toulouse; CHU Lyon; KU Leuven; University Hospital Leuven; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Duisburg Essen; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Roche Holding; University of Liege	Servais, L (corresponding author), GH Pitie Salpetriere, Inst Myol, Paris, France.; Servais, L (corresponding author), CHU Liege, Ctr Reference Malad Neuromusculaires, Liege, Belgium.; Servais, L (corresponding author), CHU Liege, Serv Pediat, Liege, Belgium.	l.servais@institut-myologie.org	Servais, Laurent/AAL-7384-2020; Lowes, Linda Pax/C-9471-2009	laugel, vincent/0000-0002-5782-6538; Servais, Laurent/0000-0001-9270-4061; Hogrel, Jean-Yves/0000-0003-0045-7505; Chabanon, Aurelie/0000-0001-8740-6924; Toledano, Elie/0000-0002-7190-0052	Institut Roche; Association Institut de Myologie	Institut Roche; Association Institut de Myologie	The NatHis-SMA study is co-funded by Institut Roche and Association Institut de Myologie. Both funders played a role in the study design, data analysis, decision to publish and preparation of the manuscript. Among the authors, Nicole Hellbach, Timothy Seabrook and Elie Toledano are employees of the F. Hoffmann-La Roche group, whereas Pierre-Yves Baudin is employee of Consultants for Research in Imaging and Spectroscopy (CRIS). We confirm these authors contributions reflects the respective roles they had in the study.	Azzabou N, 2015, J MAGN RESON IMAGING, V41, P645, DOI 10.1002/jmri.24613; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Bertini E, 2017, LANCET NEUROL; Bianchi C, 2008, AM J PHYS MED REHAB, V87, P461, DOI 10.1097/PHM.0b013e318174e4c7; Bonati U, 2017, ANN CLIN TRANSL NEUR, V4, P292, DOI 10.1002/acn3.406; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; Carlier PG, 2014, NEUROMUSCULAR DISORD, V24, P390, DOI 10.1016/j.nmd.2014.02.009; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; de Lattre C, 2013, ARCH PHYS MED REHAB, V94, P2218, DOI 10.1016/j.apmr.2013.04.001; Dunaway S, 2016, J PEDIATR REHAB MED, V9, P35, DOI 10.3233/PRM-160360; Farrar MA, 2013, J PEDIATR-US, V162, P155, DOI 10.1016/j.jpeds.2012.05.067; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Fujak Albert, 2005, Ortop Traumatol Rehabil, V7, P175; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hogrel JY, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0612-4; Iannaccone ST, 2003, ARCH NEUROL-CHICAGO, V60, P1130, DOI 10.1001/archneur.60.8.1130; Kang PB, 2014, MUSCLE NERVE, V49, P636, DOI 10.1002/mus.23967; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Khirani S, 2013, EUR J PAEDIATR NEURO, V17, P552, DOI 10.1016/j.ejpn.2013.04.004; Kobayashi DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060113; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Le Moing AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156696; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Lowes LP, 2015, MUSCLE NERVE, V52, P356, DOI 10.1002/mus.24557; Mazzone E, 2014, NEUROMUSCULAR DISORD, V24, P347, DOI 10.1016/j.nmd.2014.01.003; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P126, DOI 10.1016/j.nmd.2015.10.006; Merlini L, 2004, MUSCLE NERVE, V29, P548, DOI 10.1002/mus.20018; Montes J, 2010, NEUROLOGY, V74, P833, DOI 10.1212/WNL.0b013e3181d3e308; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Neve V, 2013, EUR RESPIR J, V42, P671, DOI 10.1183/09031936.00127712; Pereira AC, 2016, ARCH DIS CHILD, V101, P147, DOI 10.1136/archdischild-2014-307396; Ramsey D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172346; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Russman BS, 1996, NEUROLOGY, V47, P973, DOI 10.1212/WNL.47.4.973; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Stefanutti D, 1999, AM J RESP CRIT CARE, V159, P107; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; Vuillerot C, 2013, ARCH PHYS MED REHAB, V94, P1555, DOI 10.1016/j.apmr.2013.01.014; Wadman RI, 2012, NEUROLOGY, V79, P2050, DOI 10.1212/WNL.0b013e3182749eca; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Yonekawa T, 2013, BRAIN DEV-JPN, V35, P165, DOI 10.1016/j.braindev.2012.03.009; Young SD, 2016, MUSCLE NERVE, V54, P836, DOI 10.1002/mus.25120; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	60	81	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201004	10.1371/journal.pone.0201004	http://dx.doi.org/10.1371/journal.pone.0201004			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048507	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400038
J	Wang, ZC; Sha, QY; Fang, SR; Zhang, K; Zhang, SL				Wang, Zhenchuan; Sha, Qiuying; Fang, Shurong; Zhang, Kui; Zhang, Shuanglin			Testing an optimally weighted combination of common and/or rare variants with multiple traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; DETECTING ASSOCIATION; CORRELATED TRAITS; CONTINUOUS PHENOTYPES; QUANTITATIVE TRAITS; JOINT ANALYSIS; BREAST-CANCER; SEQUENCE DATA; SUSCEPTIBILITY	Recently, joint analysis of multiple traits has become popular because it can increase statistical power to identify genetic variants associated with complex diseases. In addition, there is increasing evidence indicating that pleiotropy is a widespread phenomenon in complex diseases. Currently, most of existing methods test the association between multiple traits and a single genetic variant. However, these methods by analyzing one variant at a time may not be ideal for rare variant association studies because of the allelic heterogeneity as well as the extreme rarity of rare variants. In this article, we developed a statistical method by testing an optimally weighted combination of variants with multiple traits (TOWmuT) to test the association between multiple traits and a weighted combination of variants (rare and/or common) in a genomic region. TOWmuT is robust to the directions of effects of causal variants and is applicable to different types of traits. Using extensive simulation studies, we compared the performance of TOWmuT with the following five existing methods: gene association with multiple traits (GAMuT), multiple sequence kernel association test (MSKAT), adaptive weighting reverse regression (AWRR), single-TOW, and MANOVA. Our results showed that, in all of the simulation scenarios, TOWmuT has correct type I error rates and is consistently more powerful than the other five tests. We also illustrated the usefulness of TOWmuT by analyzing a whole-genome genotyping data from a lung function study.	[Wang, Zhenchuan; Sha, Qiuying; Zhang, Kui; Zhang, Shuanglin] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Fang, Shurong] John Carroll Univ, Dept Math & Comp Sci, University Hts, OH USA	Michigan Technological University; John Carroll University	Zhang, SL (corresponding author), Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA.	shuzhang@mtu.edu		WANG, ZHENCHUAN/0000-0002-6247-2156	National Human Genome Research Institute of the National Institutes of Health [R15HG008209]; NIH from the National Institute of General Medical Sciences [R01 GM031575]; NIH [R01 MH059490, U01HL089856, U01HL089897]; COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089897, U01HL089856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH from the National Institute of General Medical Sciences(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R15HG008209 to QS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Genetic Analysis workshops are supported by NIH grant R01 GM031575 from the National Institute of General Medical Sciences. Preparation of the Genetic Analysis Workshop 17 Simulated Exome Data Set was supported in part by NIH R01 MH059490 and used sequencing data from the 1000 Genomes Project (www.1000genomes.org). This research used data generated by the COPDGene study, which was supported by NIH grants U01HL089856 and U01HL089897. The COPDGene project is also supported by the COPD Foundation through contributions made by an Industry Advisory Board comprised of Pfizer, AstraZeneca, Boehringer Ingelheim, Novartis, and Sunovion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AM, 2007, GENET EPIDEMIOL, V31, P659, DOI 10.1002/gepi.20185; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Broadaway KA, 2016, AM J HUM GENET, V98, P525, DOI 10.1016/j.ajhg.2016.01.017; Capanu M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00176; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Chu JH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-78; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Fang SR, 2013, ANN HUM GENET, V77, P524, DOI 10.1111/ahg.12038; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Figarska SM, 2014, PHYSIOL GENOMICS, V46, P411, DOI 10.1152/physiolgenomics.00178.2013; Greco B, 2016, EUR J HUM GENET, V24, P767, DOI 10.1038/ejhg.2015.194; Gur RE, 2007, AM J PSYCHIAT, V164, P813, DOI 10.1176/appi.ajp.164.5.813; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34323; Lin WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21824; Lutz SM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0299-4; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nazir SA, 2009, DRUG AGING, V26, P813, DOI 10.2165/11316760-000000000-00000; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sha QY, 2014, GENET EPIDEMIOL, V38, P494, DOI 10.1002/gepi.21834; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Sun JP, 2016, EUR J HUM GENET, V24, P1344, DOI 10.1038/ejhg.2016.8; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang YF, 2015, GENET EPIDEMIOL, V39, P259, DOI 10.1002/gepi.21895; Wang ZC, 2016, ANN HUM GENET, V80, P162, DOI 10.1111/ahg.12149; Wang ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150975; Wu BL, 2016, GENET EPIDEMIOL, V40, P91, DOI 10.1002/gepi.21945; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yang XL, 2017, GENET EPIDEMIOL, V41, P233, DOI 10.1002/gepi.22034; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; Zhang YW, 2014, NEUROIMAGE, V96, P309, DOI 10.1016/j.neuroimage.2014.03.061; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]; Zhu HH, 2015, HUM HERED, V80, P144, DOI 10.1159/000446239; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	64	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201186	10.1371/journal.pone.0201186	http://dx.doi.org/10.1371/journal.pone.0201186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048520	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400058
J	Dale, R; Guo, BB				Dale, Renee; Guo, BeiBei			Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statistics	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; UNITED-STATES; ART ADHERENCE; DEEP SOUTH; INFECTION; ACCESS; AIDS; CARE; TRANSMISSION; PREVENTION	Current estimates of the HIV epidemic indicate a decrease in the incidence of the disease in the undiagnosed subpopulation over the past 10 years. However, a lack of access to care has not been considered when modeling the population. Populations at high risk for contracting HIV are twice as likely to lack access to reliable medical care. In this paper, we consider three contributors to the HIV population dynamics: at-risk population exhaustion, lack of access to care, and usage of anti-retroviral therapy (ART) by diagnosed individuals. An extant problem in the mathematical study of this system is deriving parameter estimates due to a portion of the population being unobserved. We approach this problem by looking at the proportional change in the infected subpopulations. We obtain conservative estimates for the proportional change of the infected subpopulations using hierarchical Bayesian statistics. The estimated proportional change is used to derive epidemic parameter estimates for a system of stochastic differential equations (SDEs). Model fit is quantified to determine the best parametric explanation for the observed dynamics in the infected subpopulations. Parameter estimates derived using these methods produce simulations that closely follow the dynamics observed in the data, as well as values that are generally in agreement with prior understanding of transmission and diagnosis rates. Simulations suggest that the undiagnosed population may be larger than currently estimated without significantly affecting the population dynamics.	[Dale, Renee; Guo, BeiBei] Louisiana State Univ, Dept Expt Stat, Baton Rouge, LA 70803 USA; [Dale, Renee] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Dale, R (corresponding author), Louisiana State Univ, Dept Expt Stat, Baton Rouge, LA 70803 USA.; Dale, R (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	rdale1@lsu.edu	Dale, Renee/AAG-8754-2021	Dale, Renee/0000-0002-1674-1247	National Institute of Health [R01 AI12125903]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was partially funded by National Institute of Health (nih.gov) R01 AI12125903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amico KR, 2009, AIDS BEHAV, V13, P66, DOI 10.1007/s10461-007-9311-y; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], R2016B MATLAB MATHWO; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2002, J GEN INTERN MED, V17, P812, DOI 10.1046/j.1525-1497.2002.20812.x; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Centers for Disease Control and Prevention, 2014, 17 HIV CTR DIS CONTR; Centers for Disease Control and Prevention, 2016, 4 CDCP; Chen Y., 2017, J SENSORS, V2017, P1, DOI DOI 10.1155/2017/1591504; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Davey DJ, 2017, JAIDS-J ACQ IMM DEF, V74, pE97, DOI [10.1097/QAI.0000000000001233, 10.1097/qai.0000000000001233]; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Arroyo MJH, 2013, PATIENT PREFER ADHER, V7, P729, DOI 10.2147/PPA.S47519; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Lanoy E, 2007, ANTIVIR THER, V12, P89; MacDowell M., 2013, NATL VIEW RURAL HLTH, P16; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Michigan Department of Health and Human Services, 2015, ANN HIV SURV REP; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pinkerton SD, 2012, AIDS BEHAV, V16, P791, DOI 10.1007/s10461-011-0042-8; Rasmussen DA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003570; Reif S, 2006, AM J PUBLIC HEALTH, V96, P970, DOI 10.2105/AJPH.2005.063149; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Sayles JN, 2009, J GEN INTERN MED, V24, P1101, DOI 10.1007/s11606-009-1068-8; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Schoen C, 2008, HEALTH AFFAIR, V27, pW298, DOI 10.1377/hlthaff.27.4.w298; Sherman S.G., 2008, SO STATES MANIFESTO; Simoni JM, 2012, JAIDS-J ACQ IMM DEF, V60, P466, DOI 10.1097/QAI.0b013e31825db0bd; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Stein JA, 2000, AIDS CARE, V12, P343, DOI 10.1080/09540120050043007; Swihart B, 2017, rmutil: Utilities for Nonlinear Regression and Repeated Measurements Models; Valdiserri R. O., 2013, MEASURING WHAT MATTE; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568	39	2	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200126	10.1371/journal.pone.0200126	http://dx.doi.org/10.1371/journal.pone.0200126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044818	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500029
J	Espinoza-Romo, BA; Sainz-Hernandez, JC; Ley-Quinonez, CP; Hart, CE; Leal-Moreno, R; Aguirre, AA; Zavala-Norzagaray, AA				Espinoza-Romo, B. A.; Sainz-Hernandez, J. C.; Ley-Quinonez, C. P.; Hart, C. E.; Leal-Moreno, R.; Aguirre, A. A.; Zavala-Norzagaray, A. A.			Blood biochemistry of olive ridley (Lepidochelys olivacea) sea turtles foraging in northern Sinaloa, Mexico	PLOS ONE			English	Article							BAJA-CALIFORNIA-SUR; CHELONIA-MYDAS; GREEN TURTLES; CARETTA-CARETTA; BODY CONDITION; REFERENCE INTERVALS; PLASMA CHEMISTRY; HEALTH INDEXES; PACIFIC COAST; JUVENILE	Blood parameters provide an excellent tool to evaluate the health status of wildlife. However, there are few studies about health parameters of sea turtles in Mexico. For olive ridley turtles (Lepidochelys olivacea), no information was available to establish the health baseline for the species. The objective of this study was to establish reference blood biochemistry values for olive ridley turtles in the northern Sinaloa foraging area. Between 2013 and 2015, 82 olive ridley turtles were captured. Body condition index (BCI) presented a mean of 1.46 +/- 0.14 (1.17-2.02) that categorized the population with excellent body condition; in addition, 99% of the turtles captured had a good physical appearance. Blood was collected for biochemistry analysis from 60 turtles. Significantly higher values of total protein, albumin, A/G ratio (albumin/globulin) and PCV (packed cell volume or hematocrit) were observed in adult when compared to subadult turtles. On the other hand, no significant differences were found when females and males were compared. Based on the BCI, physical assessment, and blood parameters, and compared to other sea turtle species, olive ridley turtles in northern Sinaloa were considered in excellent health. To the best of our knowledge, this is the first study to establish normal blood biochemistry values of foraging olive ridley turtles in northern Sinaloa.	[Espinoza-Romo, B. A.; Sainz-Hernandez, J. C.; Ley-Quinonez, C. P.; Leal-Moreno, R.; Zavala-Norzagaray, A. A.] Inst Politecn Nacl, CIIDIR SINALOA, Guasave, Sinaloa, Mexico; [Espinoza-Romo, B. A.; Ley-Quinonez, C. P.; Hart, C. E.; Leal-Moreno, R.; Zavala-Norzagaray, A. A.] Grp Tortuguero Californias AC, La Paz, Bcs, Mexico; [Ley-Quinonez, C. P.; Hart, C. E.; Leal-Moreno, R.; Zavala-Norzagaray, A. A.] Invest Capacitac & Soluc Ambientas & Sociales AC, Tepic, Nayarit, Mexico; [Aguirre, A. A.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	Instituto Politecnico Nacional - Mexico; George Mason University	Zavala-Norzagaray, AA (corresponding author), Inst Politecn Nacl, CIIDIR SINALOA, Guasave, Sinaloa, Mexico.; Zavala-Norzagaray, AA (corresponding author), Grp Tortuguero Californias AC, La Paz, Bcs, Mexico.; Zavala-Norzagaray, AA (corresponding author), Invest Capacitac & Soluc Ambientas & Sociales AC, Tepic, Nayarit, Mexico.	anorzaga@ipn.mx	Zavala-Norzagaray, Alan/ABA-3734-2020; Hart, Catherine E./AAD-5944-2022; Ley-Quiñónez, Cesar P./AAV-6746-2020	Hart, Catherine E./0000-0002-0833-2523; Ley-Quiñónez, Cesar P./0000-0003-1043-7276	IPN-CIIDIR SINALOA; GRUPO TORTUGUERO DE LAS CALIFORNIAS; Department of Environmental Science and Policy, George Mason University; Instituto Politecnico Nacional [SIP 20141052]	IPN-CIIDIR SINALOA; GRUPO TORTUGUERO DE LAS CALIFORNIAS; Department of Environmental Science and Policy, George Mason University; Instituto Politecnico Nacional	This work was supported by IPN-CIIDIR SINALOA, GRUPO TORTUGUERO DE LAS CALIFORNIAS and Department of Environmental Science and Policy, George Mason University. Grant number SIP 20141052, Instituto Politecnico Nacional http://www.ipn.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois A, 2014, LEPIDOCHELYS OLIVACE; Aguilar-Gonzalez ME, 2009, EVALUACION IMPACTO A; Aguirre AA, 1999, J AQUAT ANIM HEALTH, V11, P283, DOI 10.1577/1548-8667(1999)011&lt;0283:POFIOR&gt;2.0.CO;2; AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Anderson E, 2010, SOCIAL MEDIA MARKETING: GAME THEORY AND THE EMERGENCE OF COLLABORATION, P1, DOI 10.1007/978-3-642-13299-5_1; Anderson ET, 2013, J ZOO WILDLIFE MED, V44, P62, DOI 10.1638/1042-7260-44.1.62; Anderson Eric T., 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/890829; Barrios-Garrido H, 2015, 35 ANN S SEA TURTL B; Bjorndal KA, 2000, TECNICAS INVESTIGACI, V4, P13; BOLTEN A., 2000, PUBL, V4, P126; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; BOLTEN AB, 1992, AM J VET RES, V53, P2224; Brenes-Chaves L, 2013, REV MAR COST, V5, P16; Camacho M, 2013, MAR ENVIRON RES, V92, P15, DOI 10.1016/j.marenvres.2013.08.002; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Santos MRD, 2015, DIS AQUAT ORGAN, V115, P193, DOI 10.3354/dao02883; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Delgado C, 2011, J WILDLIFE DIS, V47, P523, DOI 10.7589/0090-3558-47.3.523; Ehsanpour M., 2015, Comparative Clinical Pathology, V24, P561, DOI 10.1007/s00580-014-1945-3; Fazio Esterina, 2012, Comparative Clinical Pathology, V21, P105, DOI 10.1007/s00580-010-1070-x; Flint M, 2010, VET J, V185, P299, DOI 10.1016/j.tvjl.2009.06.011; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Fong ChiaLing, 2010, Journal of Veterinary Medicine and Animal Health, V2, P008; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Goldberg DW, 2011, CIENC RURAL, V41, P143, DOI 10.1590/S0103-84782011000100023; Graciano-Obeso A., 2013, CARACTERIZACION AMBI; Gregory LF, 2001, GEN COMP ENDOCR, V124, P66, DOI 10.1006/gcen.2001.7683; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M, 2003, CRC MAR BIOL SER, P135; Hofer H, 2012, NEW DIRECTIONS CONSE, P82; IDEXX, 2014, IDEXX VETTEST CHEM A; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jessop TS, 2004, MAR ECOL PROG SER, V276, P281, DOI 10.3354/meps276281; Kakizoe Y, 2007, J ZOO WILDLIFE MED, V38, P77, DOI 10.1638/05-096.1; Labrada-Martagon V, 2010, CHELONIAN CONSERV BI, V9, P162, DOI 10.2744/CCB-0806.1; Labrada-Martagon V, 2010, CHELONIAN CONSERV BI, V9, P173, DOI 10.2744/CCB-0807.1; Limpus C. J., 1985, STUDY LOGGERHEAD TUR; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Marquez M. R., 1996, TORTUGAS MARINAS NUE; Najera-Hillman E, 2012, REV MEX BIODIVERS, V83, P1171, DOI 10.7550/rmb.27444; Norton T., 2015, BODY CONDITION SCORI; Nunez L, 2007, PATOLOGIA CLIN VET; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Munoz-Perez JP, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox028; Ley-Quinonez CP, 2017, ENVIRON SCI POLLUT R, V24, P9530, DOI 10.1007/s11356-017-8556-x; Perrault JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031841; Price ER, 2016, BIOL REV; Prieto-Torres DA, 2013, S AM J HERPETOL, V8, P147, DOI 10.2994/SAJH-D-13-00010.1; Ramos M, 2007, 27 ANN S SEA TURTL B; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Santoro M, 2007, VET REC, V161, P818; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Seminoff JA, 2003, J MAR BIOL ASSOC UK, V83, P1355, DOI 10.1017/S0025315403008816; Seminoff Jeffrey A., 2010, P135; Sibaja-cordero J.A., 2008, REV BIOL TROP, V56, P49; Snoddy JE, 2009, J WILDLIFE MANAGE, V73, P1394, DOI 10.2193/2008-472; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Swimmer JY, 2000, J WILDLIFE DIS, V36, P102, DOI 10.7589/0090-3558-36.1.102; Sykes John M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P481, DOI 10.1016/j.cvex.2008.03.005; Thomson JA, 2009, COPEIA, P251, DOI 10.1643/CE-07-227; Voigt GL., 2011, HEMATOLOGY TECHNIQUE; Whiting Scott D., 2007, Comparative Clinical Pathology, V16, P109, DOI 10.1007/s00580-006-0646-y; Wibbels T, 2000, PUBLICACION GRUPO ES, V4, P160; Zavala-Norzagaray AA, 2014, B ENVIRON CONTAM TOX, V93, P536, DOI 10.1007/s00128-014-1320-8; Zavala-Norzagaray AA., 2014, MED CONSERVACION MET	68	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199825	10.1371/journal.pone.0199825	http://dx.doi.org/10.1371/journal.pone.0199825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044783	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500019
J	Kefale, B; Tadesse, Y; Alebachew, M; Engidawork, E				Kefale, Belayneh; Tadesse, Yewondwossen; Alebachew, Minyahil; Engidawork, Ephrem			Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; DRUG-THERAPY; MEDICATION; IMPACT; PREVALENCE; CARE; CKD; INTERVENTIONS	Introduction Chronic kidney disease (CKD) has a complicated interrelationship with other diseases and major risk factor for cardiovascular disease. Therapeutic management for CKD patients is complicated due to co-morbidities and dominant risk factors of CKD. Non-adherence to treatment is an increasing problem for patients with CKD and it has not been extensively studied in patients with CKD. Hence, the present study was carried out to assess the management practice, medication adherence and factors affecting medication adherence in CKD patients at Tikur Anbessa Specialized Hospital (TASH). Methods A hospital-based cross-sectional study was conducted at the nephrology clinic of TASH. A total of 256 patients were recruited through systematic random sampling. Data were collected from medical records and interviewing patients. The degree of adherence was determined using eight-item Morisky Medication Adherence Scale. The data were entered into Epi Info 7.2.2.2 and analyzed using SPSS version 20.0 statistical software. Descriptive statistics such as frequency, percent, mean and standard deviation were used to summarize patients' baseline characteristics. Univariable and multivariable binary logistic regression were used to investigate the potential predictors of medication non-adherence. Results About 55% patients with hypertension only were treated with non-angiotensin converting enzyme inhibition based regimens; 57.3% of diabetes mellitus with hypertension treated with combination of insulin and ACEI based regimens. About three-fourth of patients with anemia and osteodystrophy complications were treated with iron preparations and calcium based phosphate binder. Only 61.3% of the study population were adherent to their treatment regimens. Forgetfulness (79.8%) was the major reason for medication non-adherence. Patients who had an average and high monthly income were 4.14 (AOR = 4.14, 95% CI: 1.45-11.84, p = 0.008) and 6.17 times (AOR = 6.17, 95% CI: 1.02-37.46, p = 0.048) more likely to adhere as compared to those who had very low income. Patients who were prescribed with >= 5 drugs were 0.46 times (AOR = 0.54, 95% CI: 0.27-1.10, p = 0.049) less likely to adhere compared to their counterpart. Patients who were students, drivers, teachers working in private school were about 7.46 times (AOR = 7.46, 95% CI: 1.49-37.26, p = 0.014) more likely to adhere compared with patients who were farmers. Conclusion Insulin and ACEIs based regimens were the most frequently used regimens in the treatment of diabetes mellitus and hypertension co-morbidities. Very low income, increased number of prescribed medications and being a farmer were the predictors of medication non-adherence.	[Kefale, Belayneh] Ambo Univ, Dept Pharm, Coll Med & Hlth Sci, Ambo, Ethiopia; [Tadesse, Yewondwossen] Addis Ababa Univ, Sch Med, Dept Internal Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Alebachew, Minyahil; Engidawork, Ephrem] Addis Ababa Univ, Sch Pharm, Dept Pharmacol & Clin Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia	Ambo University; Addis Ababa University; Addis Ababa University	Kefale, B (corresponding author), Ambo Univ, Dept Pharm, Coll Med & Hlth Sci, Ambo, Ethiopia.	Belayneh.kefale@yahoo.com	Kefale, Belayneh/AAK-7367-2020; Woldu, Minyahil/ABD-9452-2020; Engidawork, Ephrem/K-7551-2019	Woldu, Minyahil/0000-0002-3163-0326; Engidawork, Ephrem/0000-0002-9931-6421	Addis Ababa University	Addis Ababa University	This work was supported by Addis Ababa University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Rajiv, 2012, J Am Soc Hypertens, V6, P299, DOI 10.1016/j.jash.2012.07.004; Ahlawat R, 2016, J PHARMA CARE HLTH S, V3, P2376, DOI DOI 10.4172/2376-0419.1000152; Ahmed AK, 2010, NEPHROL DIAL TRANSPL, V25, P3977, DOI 10.1093/ndt/gfp511; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Awuah KT, 2013, KIDNEY INT SUPPL, V3, P227, DOI 10.1038/kisup.2013.20; Bilo H, 2015, NEPHROL DIAL TRANSPL, V30, P1, DOI 10.1093/ndt/gfv100; Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207; Burnier M, 2015, NEPHROL DIAL TRANSPL, V30, P39, DOI 10.1093/ndt/gfu015; Chiu YW, 2009, CLIN J AM SOC NEPHRO, V4, P1089, DOI 10.2215/CJN.00290109; Covic A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-153; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; Dasari P, 2014, INT J PHARM PHARM SC, V6, P363; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Arenas MD, 2010, J NEPHROL, V23, P525; Drenth-van Maanen AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128237; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Fiseha T, 2014, AJHR, V2, P216, DOI [10.11648/j.ajhr.20140204.28, DOI 10.11648/J.AJHR.20140204.28, 10.11648/j. ajhr.20140204.28]; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Garcia GG, 2011, ACTA NEPHROLOGICA, V25, P155; Ghimire S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0583-9; Ghimire S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144119; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Hsu KL, 2015, AM J KIDNEY DIS, V66, P621, DOI 10.1053/j.ajkd.2015.03.026; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Johnson CA, 2004, AM FAM PHYSICIAN, V70, P823; Johnson DW, 2013, NEPHROLOGY, V18, P340, DOI 10.1111/nep.12052; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Koro CE, 2009, CLIN THER, V31, P2608, DOI 10.1016/j.clinthera.2009.10.020; Kugler C, 2011, J NEPHROL, V24, P366, DOI 10.5301/JN.2010.5823; Lessan Pezeshki M, 2009, INT J NEPHROL UROL, V1, P129; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lindberg M, 2008, PHARM WORLD SCI, V30, P571, DOI 10.1007/s11096-008-9212-9; Liu BC, 2008, CLIN CHIM ACTA, V387, P128, DOI 10.1016/j.cca.2007.09.020; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Magacho EJC, 2011, BRAZ J MED BIOL RES, V44, P258, DOI 10.1590/S0100-879X2011007500013; Malluche HH, 2008, CLIN J AM SOC NEPHRO, V3, pS157, DOI 10.2215/CJN.02500607; Manley HJ, 2004, NEPHROL DIAL TRANSPL, V19, P1842, DOI 10.1093/ndt/gfh280; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mason NA, 2011, CURR OPIN NEPHROL HY, V20, P492, DOI 10.1097/MNH.0b013e328349c261; Mathew S, 2007, J AM SOC NEPHROL, V18, P122, DOI 10.1681/ASN.2006050490; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Miller PD., 2014, BONEKEY REPORTS, V3, P1; Molnar MZ, 2014, J AM COLL CARDIOL, V63, P650, DOI 10.1016/j.jacc.2013.10.050; Muntner P, 2010, AM J KIDNEY DIS, V56, P447, DOI 10.1053/j.ajkd.2010.02.348; Nazar CMJ, 2014, J RENAL INJ PREV, V3, P61, DOI 10.12861/jrip.2014.20; Neri L, 2011, AM J NEPHROL, V34, P71, DOI 10.1159/000328391; Okpechi IG, 2017, SEMIN NEPHROL, V37, P260, DOI 10.1016/j.semnephrol.2017.02.006; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Padhi S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2258; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Raymond Colette B, 2011, CANNT J, V21, P47; Rifkin DE, 2010, AM J KIDNEY DIS, V56, P439, DOI 10.1053/j.ajkd.2010.04.021; Rivera JA, 2012, AM FAM PHYSICIAN, V86, P749; Roy L, 2013, KIDNEY INT, V84, P570, DOI 10.1038/ki.2013.103; Salini A, 2013, IJRPC, V3, P2231; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schieppati A, 2003, KIDNEY INT, V63, P1948, DOI 10.1046/j.1523-1755.2003.00926.x; Schmid H, 2009, EUR J MED RES, V14, P185, DOI 10.1186/2047-783X-14-5-185; Singh AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-114; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Sontakke S, 2015, INDIAN J PHARMACOL, V47, P668, DOI 10.4103/0253-7613.169597; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tomson C, 2011, MEDICINE, V39, P407, DOI DOI 10.1016/J.MPMED.2011.04.006; Toto RD, 2005, SEMIN NEPHROL, V25, P435, DOI 10.1016/j.semnephrol.2005.05.016; Tuso Philip J, 2009, Perm J, V13, P51; Vassalotti JA, 2016, AM J MED, V129, P153, DOI 10.1016/j.amjmed.2015.08.025; Victoria A., 2015, AM J NURS SCI, V4, P60, DOI [10.11648/j.ajns.s.2015040201.21, DOI 10.11648/j.ajns.s.2015040201.21]	73	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200415	10.1371/journal.pone.0200415	http://dx.doi.org/10.1371/journal.pone.0200415			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044830	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500053
J	Kowalik, A; Siolek, M; Kopczynski, J; Krawiec, K; Kalisz, J; Zieba, S; Kozak-Klonowska, B; Wypiorkiewicz, E; Furmanczyk, J; Nowak-Ozimek, E; Chlopek, M; Macek, P; Smok-Kalwat, J; Gozdz, S				Kowalik, Artur; Siolek, Monika; Kopczynski, Janusz; Krawiec, Kamila; Kalisz, Joanna; Zieba, Sebastian; Kozak-Klonowska, Beata; Wypiorkiewicz, Elzbieta; Furmanczyk, Jowita; Nowak-Ozimek, Ewelina; Chlopek, Matgorzata; Macek, Pawel; Smok-Kalwat, Jolanta; Gozdz, Stanislaw			BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study	PLOS ONE			English	Article							OVARIAN-CANCER FAMILIES; BREAST-CANCER; GERMLINE MUTATIONS; VARIANTS; CARRIERS; POLAND; ASSOCIATION; PATHOLOGY; RISKS; GENE	Hereditary mutations in BRCA1/2 genes increase the risk of breast cancer by 60-80% and ovarian cancer by about 20-40% in female carriers. Detection of inherited mutations in asymptomatic carriers allows for the implementation of appropriate preventive measures. BRCA1/2 genotyping is also important for poly(adenosine diphosphate)-ribose polymerase (PARP) inhibitor administration. This work addresses the need for next-generation sequencing (NGS) technology for the detection of BRCA1/2 mutations in Poland where until recently mostly founder mutations have been tested, and whether BRCA diagnostics should be extended beyond the panel of founder mutations in this population. The study comprises 2931 patients who were referred for genetic counseling and tested for founder and recurrent mutations in BRCA1 (5382insC (c.5266dupC; p.Gln1756Profs), c.5370C>T (c.5251C>T; p.R1751*), 300T>G (c.181T>G; p.Cys61Gly), 185delAG (c.68_69delAG; p.Glu23Valfs), and 4153delA (c.4035delA; p.Glu1346Lysfs)) by high-resolution melting/Sanger sequencing. A total of 103 (3.5%) mutations were detected, including 53 (51%) in healthy subjects and 50 (49%) in cancer patients. Then, based on more stringent clinical and pedigree criteria, sequencing of all BRCA1/2 exons was performed in 454 (16%) patients without founder mutations by NGS, which detected 58 mutations (12.8%), 40 (8.8%) of which were pathogenic. In 14 (3.1%) subjects, variants of uncertain significance (VUS) were detected, and in four (0.9%) subjects, the detected mutations were benign. In total, 161 mutations were detected using our two-step algorithm (founder test and NGS), of which 64% were founder mutations, 25% were NGS-detected pathogenic mutations, 9% were VUS, and 2% were benign. In addition, 38 mutations not yet reported in the Polish population were detected. In total, founder mutations accounted for only 64% of all detected mutations, and the remaining mutations (36%) were dispersed across the BRCA1/2 gene sequences. Thus, in Poland, testing for constitutional mutations in BRCA1/2 should be carried out in two stages, where NGS is performed in qualifying subjects if founder mutations are not identified.	[Kowalik, Artur; Krawiec, Kamila; Kalisz, Joanna; Zieba, Sebastian; Wypiorkiewicz, Elzbieta; Furmanczyk, Jowita; Nowak-Ozimek, Ewelina; Chlopek, Matgorzata] Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland; [Siolek, Monika; Kozak-Klonowska, Beata] Holycross Canc Ctr, Genet Clin, Kielce, Poland; [Kopczynski, Janusz] Holycross Canc Ctr, Dept Surg Pathol, Kielce, Poland; [Macek, Pawel] Holycross Canc Ctr, Dept Canc Epidemiol & Canc Control, Kielce, Poland; [Smok-Kalwat, Jolanta; Gozdz, Stanislaw] Holycross Canc Ctr, Oncol Clin, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland	Jan Kochanowski University	Kowalik, A (corresponding author), Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland.	arturko@onkol.kielce.pl	Kowalik, Artur/AAB-5690-2020; Zięba, Sebastian/AAB-7487-2020; Kowalik, Artur/K-2111-2017; Gozdz, Stanislaw/D-3300-2013	Kowalik, Artur/0000-0002-3718-999X; Kowalik, Artur/0000-0002-3718-999X; Gozdz, Stanislaw/0000-0001-6902-3807; Macek, Pawel/0000-0001-9755-7507	Holycross Cancer Centre	Holycross Cancer Centre	The study was supported by the Holycross Cancer Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Biswas K, 2011, BLOOD, V118, P2430, DOI 10.1182/blood-2010-12-324541; Claes K, 2004, BRIT J CANCER, V90, P1244, DOI 10.1038/sj.bjc.6601656; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Eccles DM, 2015, ANN ONCOL, V26, P2057, DOI 10.1093/annonc/mdv278; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Feliubadalo L, 2013, EUR J HUM GENET, V21, P864, DOI 10.1038/ejhg.2012.270; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Gorski B, 2004, INT J CANCER, V110, P683, DOI 10.1002/ijc.20162; Gronwald J, 2006, J MED GENET, V43, P424, DOI 10.1136/jmg.2005.036921; Grzybowska E, 2002, ACTA BIOCHIM POL, V49, P351; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kluska A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0092-2; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Kwiatkowska E, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<73::AID-HUMU12>3.3.CO;2-F; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lubinski J, 2006, BREAST CANCER RES TR, V99, P71, DOI 10.1007/s10549-006-9182-3; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meeks HD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv315; Moghadasi S, 2018, J MED GENET, V55, P15, DOI 10.1136/jmedgenet-2017-104560; Neveling K, 2017, CLIN CHEM, V63, P503, DOI 10.1373/clinchem.2016.263897; Perkowska M, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9139; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Ratajska M, 2008, ONCOL REP, V19, P263; Ratajska M, 2015, J APPL GENET, V56, P193, DOI 10.1007/s13353-014-0254-5; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Rhiem K, 2007, CANCER GENET CYTOGEN, V176, P76, DOI 10.1016/j.cancergencyto.2007.03.006; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Surowy HM, 2014, BREAST CANCER RES TR, V145, P451, DOI 10.1007/s10549-014-2943-5; Suthers GK, 2007, ANZ J SURG, V77, P314, DOI 10.1111/j.1445-2197.2007.04050.x; Szwiec M, 2015, CLIN GENET, V87, P288, DOI 10.1111/cge.12360; Tonin PN, 2007, FAM CANCER, V6, P491, DOI 10.1007/s10689-007-9152-x; van Der Looij M, 2000, Hum Mutat, V15, P480, DOI 10.1002/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G; Wojcik P, 2016, HERED CANCER CLIN PR, V14, DOI 10.1186/s13053-016-0046-5; Wong-Brown MW, 2015, BREAST CANCER RES TR, V150, P71, DOI 10.1007/s10549-015-3293-7	37	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201086	10.1371/journal.pone.0201086	http://dx.doi.org/10.1371/journal.pone.0201086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040829	gold, Green Published, Green Submitted			2022-12-26	WOS:000439749200023
J	Matsuo, M; Katahata, A; Satoh, S; Matsuzaki, M; Nomura, M; Ishida, K; Inagaki, Y; Obokata, J				Matsuo, Mitsuhiro; Katahata, Atsushi; Satoh, Soichirou; Matsuzaki, Motomichi; Nomura, Mami; Ishida, Ken-ichiro; Inagaki, Yuji; Obokata, Junichi			Characterization of spliced leader trans-splicing in a photosynthetic rhizarian amoeba, Paulinella micropora, and its possible role in functional gene transfer	PLOS ONE			English	Article							CHROMATOPHORE GENOME SEQUENCE; MESSENGER-RNA; TRYPANOSOMA-BRUCEI; C-ELEGANS; TRANSCRIPTION; EVOLUTION; SM; IDENTIFICATION; EUKARYOTES; METAZOA	Paulinella micropora is a rhizarian thecate amoeba, belonging to a photosynthetic Paulinella species group that has a unique organelle termed chromatophore, whose cyanobacterial origin is distinct from that of plant and algal chloroplasts. Because acquisition of the chromatophore was quite a recent event compared with that of the chloroplast ancestor, the Paulinella species are thought to be model organisms for studying the early process of primary endosymbiosis. To obtain insight into how endosymbiotically transferred genes acquire expression competence in the host nucleus, here we analyzed the 5' end sequences of the mRNAs of P. micropora MYN1 strain with the aid of a cap-trapper cDNA library. As a result, we found that mRNAs of 27 genes, including endosymbiotically transferred genes, possessed the common 5' end sequence of 28-33 bases that were posttranscriptionally added by spliced leader (SL) trans-splicing. We also found two subtypes of SL RNA genes encoded by the P. micropora MYN1 genome. Differing from the other SL trans-splicing organisms that usually possess poly(A)-less SL RNAs, this amoeba has polyadenylated SL RNAs. In this study, we characterize the SL trans-splicing of this unique organism and discuss the putative merits of SL trans-splicing in functional gene transfer and genome evolution.	[Matsuo, Mitsuhiro; Katahata, Atsushi; Satoh, Soichirou; Obokata, Junichi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Matsuzaki, Motomichi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan; [Nomura, Mami; Ishida, Ken-ichiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan	Kyoto Prefectural University; University of Tokyo; University of Tsukuba; University of Tsukuba	Obokata, J (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan.	Obokata@kpu.ac.jp	Matsuzaki, Motomichi/D-4043-2016	Matsuzaki, Motomichi/0000-0001-5811-798X; Obokata, Junichi/0000-0002-2973-0109; Inagaki, Yuji/0000-0003-0101-8483; Satoh, Soichirou/0000-0002-7622-1868	Japan Society for the Promotion of Sciences [15K14554, 16K14788]; Ministry of Education, Culture, Sports, Science and Technology of Japan [3308]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Sciences (http://www.jsps.go.jp) Grants 15K14554 (to J.O.), 16K14788 (to M.M.); Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp) Grant-in-Aid for Scientific Research on Innovative Areas 3308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Bitar Maina, 2013, Frontiers in Genetics, V4, P199, DOI 10.3389/fgene.2013.00199; BRUZIK JP, 1992, NATURE, V360, P692, DOI 10.1038/360692a0; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Cheng GF, 2006, J BIOL CHEM, V281, P733, DOI 10.1074/jbc.M506963200; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Davis RE, 1996, PARASITOL TODAY, V12, P33, DOI 10.1016/0169-4758(96)80643-0; Delaye L, 2016, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.e68a099364bb1a1e129a17b4e06b0c6b; Denker JA, 1996, RNA, V2, P746; Derelle R, 2010, RNA, V16, P696, DOI 10.1261/rna.1975210; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Ferguson KC, 1996, GENE DEV, V10, P1543, DOI 10.1101/gad.10.12.1543; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Gibson W, 2000, MOL BIOCHEM PARASIT, V107, P269, DOI 10.1016/S0166-6851(00)00193-6; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Glockner G, 2014, CURR BIOL, V24, P11, DOI 10.1016/j.cub.2013.11.027; HANNON GJ, 1992, SCIENCE, V258, P1775, DOI 10.1126/science.1465612; HANNON GJ, 1990, EMBO J, V9, P1915, DOI 10.1002/j.1460-2075.1990.tb08318.x; HANNON GJ, 1991, J BIOL CHEM, V266, P22792; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lall S, 2004, J BIOL CHEM, V279, P45573, DOI 10.1074/jbc.M407475200; Lamontagne J, 1999, J BIOL CHEM, V274, P6602, DOI 10.1074/jbc.274.10.6602; Lasda E. L., 2011, RNA, V2, P417, DOI [DOI 10.1002/WRNA.71, 10.1002/wrna.71]; Lhee D, 2017, PROTIST, V168, P155, DOI 10.1016/j.protis.2017.01.003; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; Maroney PA, 1996, RNA, V2, P735; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; NILSEN TW, 1989, MOL CELL BIOL, V9, P3543, DOI 10.1128/MCB.9.8.3543; Nomura M, 2014, J EUKARYOT MICROBIOL, V61, P317, DOI 10.1111/jeu.12102; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Nowack ECM, 2016, P NATL ACAD SCI USA, V113, P12214, DOI 10.1073/pnas.1608016113; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; PELLE R, 1993, MOL BIOCHEM PARASIT, V59, P277, DOI 10.1016/0166-6851(93)90225-M; Pouchkina-Stantcheva NN, 2005, MOL BIOL EVOL, V22, P1482, DOI 10.1093/molbev/msi139; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; Schwelm A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11153; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Song B, 2017, GENOME BIOL EVOL, V9, P2037, DOI 10.1093/gbe/evx144; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stangegaard M, 2006, BIOTECHNIQUES, V40, P649, DOI 10.2144/000112153; Stover NA, 2001, P NATL ACAD SCI USA, V98, P5693, DOI 10.1073/pnas.101049998; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; THOMAS JD, 1988, CELL, V54, P533, DOI 10.1016/0092-8674(88)90075-X; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x; Vandenberghe AE, 2001, GENE DEV, V15, P294, DOI 10.1101/gad.865401; Wang PP, 2006, EMBO J, V25, P4513, DOI 10.1038/sj.emboj.7601328; Yang FF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17411; Yoon HS, 2006, CURR BIOL, V16, pR670, DOI 10.1016/j.cub.2006.08.018; Zeiner GM, 2003, J BIOL CHEM, V278, P38269, DOI 10.1074/jbc.M304295200; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019933; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200961	10.1371/journal.pone.0200961	http://dx.doi.org/10.1371/journal.pone.0200961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024971	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000073
J	Daukantaite, D; Tellhed, U; Maddux, RE; Svensson, T; Melander, O				Daukantaite, Daiva; Tellhed, Una; Maddux, Rachel E.; Svensson, Thomas; Melander, Olle			Five-week yin yoga-based interventions decreased plasma adrenomedullin and increased psychological health in stressed adults: A randomized controlled trial	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; ACUTE MYOCARDIAL-INFARCTION; HOSPITAL ANXIETY; POPULATION; PEPTIDES; EXERCISE; INSOMNIA; PROGRAM	Background Non-communicable diseases (NCDs, e.g. cardiovascular disease) are responsible for high rates of morbidity and the majority of premature deaths worldwide. It is necessary to develop preventative interventions that can reduce the associated risk factors of NCDs. Researchers have found that the biomarker adrenomedullin (ADM) becomes elevated years before the onset of NCDs and might play an important role in their development. ADM has also been linked to psychological problems such as stress, anxiety, and depression, which are known risk factors of NCDs. In this randomized controlled trial, we examined whether participating in a five-week yoga intervention reduces ADM and increases psychological health in middle-aged adults who self-report as moderately to highly stressed, but who otherwise exhibit no physical complaints. Methods One hundred and five adults (78% women; mean age = 53.5, SD = 6.7) were randomly assigned to (1) a five-week Yin yoga intervention, (2) a five-week intervention combining Yin yoga with psychoeducation and mindfulness practice (called the YOMI program), or (3) a control group who did not practice yoga or mindfulness for five weeks. Results Compared to the control group, we observed significantly greater pre-post reductions in plasma ADM levels (p < .001), anxiety (p <= .002), and sleep problems (p <= .003) in both intervention groups. Furthermore, the YOMI group exclusively showed significantly greater pre-post reductions in stress (p = .012) and depression (p = .021) compared to the control group. Significant correlations (p < .05) were found between pre-post reductions in ADM and anxiety symptoms (p = .02) and depression (p = .04) in the entire sample. Conclusion The five-week Yin yoga-based interventions appeared to reduce both the physiological and psychological risk factors known to be associated with NCDs. The study suggests that incorporating Yin yoga could be an easy and low-cost method of limiting the negative health effects associated with high stress.	[Daukantaite, Daiva; Tellhed, Una; Maddux, Rachel E.] Lund Univ, Dept Psychol, Lund, Sweden; [Svensson, Thomas; Melander, Olle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Svensson, Thomas] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Clin Biotechnol, Tokyo, Japan; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; Lund University; University of Tokyo; Lund University; Skane University Hospital	Melander, O (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.; Melander, O (corresponding author), Skane Univ Hosp, Dept Internal Med, Malmo, Sweden.	Olle.Melander@med.lu.se	Svensson, Thomas/AAJ-4578-2020	Svensson, Thomas/0000-0003-1283-358X; Daukantaite, Daiva/0000-0002-1994-041X; Tellhed, Una/0000-0002-7283-6021; Melander, Olle/0000-0002-2581-484X	Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Swedish Heart- and Lung Foundation; Swedish Research Council; Novo Nordisk Foundation; Ernhold Lundstroms Stiftelse	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Swedish Heart- and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ernhold Lundstroms Stiftelse	The study was supported by Knut and Alice Wallenberg Foundation, Goran Gustafsson Foundation, the Swedish Heart- and Lung Foundation, the Swedish Research Council, the Novo Nordisk Foundation, and Ernhold Lundstroms Stiftelse. None of them had any role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Akpinar A, 2013, PROG NEURO-PSYCHOPH, V46, P120, DOI 10.1016/j.pnpbp.2013.07.003; Al-Ayadhi LY, 2005, ANN SAUDI MED, V25, P36, DOI 10.5144/0256-4947.2005.36; American Psychological Association, STRESS AM OUR HLTH R; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Batelaan NM, 2016, BRIT J PSYCHIAT, V208, P223, DOI 10.1192/bjp.bp.114.156554; Belting M, 2012, CANCER EPIDEM BIOMAR, V21, P513, DOI 10.1158/1055-9965.EPI-11-0840; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Booth J, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0456-4; Bussing A, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/165410, 10.1155/2012/219402]; Chu P, 2016, EUR J PREV CARDIOL, V23, P291, DOI 10.1177/2047487314562741; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cramer H, 2014, INT J CARDIOL, V173, P170, DOI 10.1016/j.ijcard.2014.02.017; European Agency for Safety and Health at Work, 2009, OSH FIG STRESS WORK; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Grilley P., 2002, YIN YOGA OUTLINE QUI; HARTLEY HO, 1971, BIOMETRICS, V27, P783, DOI 10.2307/2528820; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hughes MF, 2016, PSYCHOSOM MED, V78, P401, DOI 10.1097/PSY.0000000000000289; Hylander F, 2017, ANXIETY STRESS COPIN, V30, P365, DOI 10.1080/10615806.2017.1301189; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Innes KE, 2007, ALTERN THER HEALTH M, V13, P44; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kato J, 2002, HYPERTENS RES, V25, P887; Khan S, 1999, NEUROREPORT, V10, P2829, DOI 10.1097/00001756-199909090-00024; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kong DG, 2014, CLIN EXP HYPERTENS, V36, P27, DOI 10.3109/10641963.2013.783049; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Maddux RE, 2018, ANXIETY STRESS COPIN, V31, P121, DOI 10.1080/10615806.2017.1405261; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Meyer T, 2015, PSYCHONEUROENDOCRINO, V62, P227, DOI 10.1016/j.psyneuen.2015.08.007; Mithoefer B., 2006, YIN YOGA KIT PRACTIC; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Muktibodhananda S., 2012, HATHA YOGA PRADIPIKA; Nomura I, 2009, REGUL PEPTIDES, V158, P127, DOI 10.1016/j.regpep.2009.08.003; Nordin M, 2013, SCAND J PSYCHOL, V54, P502, DOI 10.1111/sjop.12071; Purdy RA, 2013, CAN J NEUROL SCI, V40, P139, DOI 10.1017/S0317167100013640; Riley KE, 2015, HEALTH PSYCHOL REV, V9, P224, DOI 10.1080/17437199.2014.895928; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Ross A, 2010, J ALTERN COMPLEM MED, V16, P3, DOI 10.1089/acm.2009.0044; Rossler A, 1999, HYPERTENSION, V34, P1147, DOI 10.1161/01.HYP.34.5.1147; Saoji AA, 2016, N AM J MED SCI, V8, P200, DOI 10.4103/1947-2714.179962; Sengupta P, 2012, INT J PREVENTIVE MED, V3, P444; TANAKA M, 1995, INTERNAL MED, V34, P728, DOI 10.2169/internalmedicine.34.728; Urbaniak G.C., 2015, RES RANDOMIZER VERSI; Valenzuela-Sanchez F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.65; World Health Organization, 2015, NONCOMMUNICABLE DIS; Yuyun MF, 2015, AM J CARDIOL, V115, P986, DOI 10.1016/j.amjcard.2015.01.027; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200518	10.1371/journal.pone.0200518	http://dx.doi.org/10.1371/journal.pone.0200518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020987	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400052
J	Dhar, SK; Bakthavatchalu, V; Dhar, B; Chen, J; Tadahide, I; Zhu, HN; Gao, TY; St Clair, DK				Dhar, Sanjit K.; Bakthavatchalu, Vasudevan; Dhar, Bithika; Chen, Jing; Tadahide, Izumi; Zhu, Haining; Gao, Tianyan; St Clair, Daret K.			DNA polymerase gamma (Pol gamma) deficiency triggers a selective mTORC2 prosurvival autophagy response via mitochondria-mediated ROS signaling	ONCOGENE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; KAPPA-B; SURVIVAL; IDENTIFICATION; TUMORIGENESIS; MECHANISMS; PROTEIN; DAMAGE; CELLS	Autophagy is a highly regulated evolutionarily conserved metabolic process induced by stress and energy deprivation. Here, we show that DNA polymerase gamma (Pol gamma) deficiency activates a selective prosurvival autophagic response via mitochondria-mediated reactive oxygen species (ROS) signaling and the mammalian target of rapamycin complex 2 (mTORC2) activities. In keratinocytes, Pol gamma deficiency causes metabolic adaptation that triggers cytosolic sensing of energy demand for survival. Knockdown of Pol gamma causes mitochondrial stress, decreases mitochondrial energy production, increases glycolysis, increases the expression of autophagy-associated genes, and enhances AKT phosphorylation and cell proliferation. Deficiency of Pol gamma preferentially activates mTORC2 formation to increase autophagy and cell proliferation, and knocking down Rictor abrogates these responses. Overexpression of Rictor, but not Raptor, reactivates autophagy in Pol gamma-deficient cells. Importantly, inhibition of ROS by a mitochondria-selective ROS scavenger abolishes autophagy and cell proliferation. These results identify Rictor as a critical link between mitochondrial stress, ROS, and autophagy. They represent a major shift in our understanding of the prosurvival role of the mTOR complexes and highlight mitochondria-mediated ROS as a prosurvival autophagy regulator during cancer development.	[Dhar, Sanjit K.; Dhar, Bithika; Tadahide, Izumi; St Clair, Daret K.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Bakthavatchalu, Vasudevan] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Chen, Jing; Zhu, Haining; Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; Massachusetts Institute of Technology (MIT); University of Kentucky	St Clair, DK (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.	dstcl00@uky.edu	Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694	National Institutes of Health [CA 49797, CA 73599]; NCI Cancer Center Support Grant [P30 CA177558]; NATIONAL CANCER INSTITUTE [R01CA214638, P30CA177558, R01CA073599, R01CA049797, R01CA133429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in part, by National Institutes of Health Grants CA 49797 and CA 73599 to Daret K. St. Clair, and the NCI Cancer Center Support Grant P30 CA177558 to B. Mark Evers.	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Bakthavatchalu V, 2012, ONCOGENE, V31, P2129, DOI 10.1038/onc.2011.407; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; BOLDEN A, 1977, J BIOL CHEM, V252, P3351; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Copeland William C, 2003, ScientificWorldJournal, V3, P34; Dangi A, 2016, J CELL PHYSIOL, V231, P94, DOI 10.1002/jcp.25055; Dhar SK, 2010, J BIOL CHEM, V285, P9835, DOI 10.1074/jbc.M109.060715; Dhar SK, 2014, ANTIOXID REDOX SIGN, V20, P1550, DOI 10.1089/ars.2012.4984; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Duan HY, 2015, EXP CELL RES, V335, P99, DOI 10.1016/j.yexcr.2015.05.003; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HUBSCHER U, 1979, P NATL ACAD SCI USA, V76, P2316, DOI 10.1073/pnas.76.5.2316; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kovalenko O.A., 2009, CURR PROTOC HUM GENE, V62; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202; Maglio DHG, 2005, PHOTODERMATOL PHOTO, V21, P311, DOI 10.1111/j.1600-0781.2005.00185.x; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Matsuzawa Y, 2015, AUTOPHAGY, V11, P1052, DOI 10.1080/15548627.2015.1055439; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Petersson AS, 2001, J MASS SPECTROM, V36, P616, DOI 10.1002/jms.161; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Szczesny B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075201; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wang P, 2013, MOL CELL BIOCHEM, V372, P161, DOI 10.1007/s11010-012-1457-x; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wu SY, 2010, PHOTOCHEM PHOTOBIOL, V86, P389, DOI 10.1111/j.1751-1097.2009.00682.x	46	11	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 29	2018	37	48					6225	6242		10.1038/s41388-018-0404-z	http://dx.doi.org/10.1038/s41388-018-0404-z			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HC2HE	30038268	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000451622100003
J	Poudel, S; Yao, JH; Kemp, MG; Leffak, M				Poudel, Sumeet; Yao, Jianhong; Kemp, Michael G.; Leffak, Michael			Interaction between DUE-B and Treslin is required to load Cdc45 on chromatin in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; checkpoint control; chromatin regulation; DNA-protein interaction; DNA damage response	ELEMENT-BINDING PROTEIN; REPLICATION CHECKPOINT CONTROL; CHROMOSOMAL DNA-REPLICATION; CYCLIN-DEPENDENT KINASE; INITIATION; TOPBP1; DAMAGE; YEAST; SLD3; RECRUITMENT	A key step in the initiation of eukaryotic DNA replication is the binding of the activator protein Cdc45 to promote MCM helicase unwinding of the origin template. We show here that the c-myc origin DNA unwinding element-binding protein, DUE-B, interacts in HeLa cells with the replication initiation protein Treslin to allow Cdc45 loading onto chromatin. The chromatin loading of DUE-B and Treslin are mutually dependent, and the DUE-B-Treslin interaction is cell cycle-regulated to peak as cells exit G(1) phase prior to the initiation of replication. The conserved C-terminal domain of DUE-B is required for its binding to TopBP1, Treslin, Cdc45, and the MCM2-7 complex, as well as for the efficient loading of Treslin, Cdc45, and TopBP1 on chromatin. These results suggest that DUE-B acts to identify origins by MCM binding and serves as a node for replication protein recruitment and Cdc45 transfer to the prereplication complex.	[Poudel, Sumeet; Yao, Jianhong; Leffak, Michael] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Kemp, Michael G.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Leffak, M (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	michael.leffak@wright.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745	Wright State University Biomedical Sciences Ph.D. Program; National Institutes of Health, NIGMS [GM099874, GM122976]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122976, R01GM099874] Funding Source: NIH RePORTER	Wright State University Biomedical Sciences Ph.D. Program; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wright State University Biomedical Sciences Ph.D. Program and by grants GM099874 and GM122976 from the National Institutes of Health, NIGMS (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Casper JM, 2005, J BIOL CHEM, V280, P13071, DOI 10.1074/jbc.M404754200; Chowdhury A, 2010, MOL CELL BIOL, V30, P1495, DOI 10.1128/MCB.00710-09; Douglas ME, 2018, NATURE, V555, P265, DOI 10.1038/nature25787; Fu YV, 2010, CURR BIOL, V20, pR515, DOI 10.1016/j.cub.2010.05.033; Gao YZ, 2014, J BIOL CHEM, V289, P35987, DOI 10.1074/jbc.M114.589119; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hassan BH, 2013, J BIOL CHEM, V288, P18903, DOI 10.1074/jbc.M113.475517; Jares P, 2000, GENE DEV, V14, P1528; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kumagai A, 2017, MOL BIOL CELL, V28, P2998, DOI 10.1091/mbc.E17-07-0448; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Leung CCY, 2013, STRUCTURE, V21, P1450, DOI 10.1016/j.str.2013.06.015; Liu K, 2017, P NATL ACAD SCI USA, V114, pE3766, DOI 10.1073/pnas.1619832114; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Mu RL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00344-17; Noguchi Y, 2017, P NATL ACAD SCI USA, V114, pE9529, DOI 10.1073/pnas.1712537114; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sansam CG, 2018, GENE DEV, V32, P224, DOI 10.1101/gad.306464.117; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076	33	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14497	14506		10.1074/jbc.RA118.004519	http://dx.doi.org/10.1074/jbc.RA118.004519			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30037903	Green Published, hybrid			2022-12-26	WOS:000444671500027
J	Yuan, JM; Ng, WH; Yap, JJ; Chia, B; Huang, XC; Wang, M; Hu, JC				Yuan, Jimin; Ng, Wan Hwa; Yap, Jiajun; Chia, Brandon; Huang, Xuchao; Wang, Mei; Hu, Jiancheng			The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho-Ser-621 in the C terminus of CRAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cancer therapy; cell signaling; drug resistance; cancer biology; 14-3-3; AMP-activated protein kinase; paradoxical activation; RAF inhibitor; RAF kinase	ACTIVATED PROTEIN-KINASE; WILD-TYPE; DEPENDENT MECHANISM; RAF/MEK/ERK PATHWAY; B-RAF; BRAF; CANCER; HETERODIMERIZATION; PHOSPHORYLATION; OLIGOMERIZATION	The dimerization-driven paradoxical activation of RAF proto-oncogene Ser/Thr kinase (RAF) is the predominant cause of drug resistance and toxicity in cancer therapies with RAF inhibitors. The scaffold protein 14-3-3, which binds to the RAF C terminus, is essential for RAF activation under physiological conditions, but the molecular basis is unclear. Here we investigated whether and how 14-3-3 regulates the dimerization-driven transactivation of the RAF isoform CRAF by RAF inhibitors and affects drug resistance and toxicity by virtue of the dominant role of CRAF in these processes. We demonstrated that 14-3-3 enhances the dimerization-driven transactivation of CRAF by stabilizing CRAF dimers. Further, we identified AMP-activated protein kinase (AMPK) and CRAF itself as two putative kinases that redundantly phosphorylate CRAF's C terminus and thereby control its association with 14-3-3. Next, we determined whether the combinatory inhibition of AMPK and CRAF could overcome the paradoxical effect of RAF inhibitors. We found that the AMPK inhibitor (AMPKi) not only blocked the RAF inhibitor-driven paradoxical activation of ERK signaling and cellular overgrowth in Ras-mutated cancer cells by blocking phosphorylation of Ser-621 in CRAF but also reduced the formation of drug-resistant clones of BRAF(V600E)-mutated cancer cells. Last, we investigated whether 14-3-3 binding to the C terminus of CRAF is required for CRAF catalytic activity and observed that it was dispensable in vivo. Altogether, our study unravels the molecular mechanism by which 14-3-3 regulates dimerization-driven RAF activation and identified AMPKi as a potential agent to counteract drug resistance and adverse effects of RAF inhibitors in cancer therapies.	[Yuan, Jimin; Ng, Wan Hwa; Yap, Jiajun; Chia, Brandon; Huang, Xuchao; Hu, Jiancheng] Natl Canc Ctr Singapore, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore; [Wang, Mei; Hu, Jiancheng] Duke NUS Med Sch, Canc & Stem Cell Program, 8 Coll Rd, Singapore 169857, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore	Hu, JC (corresponding author), Natl Canc Ctr Singapore, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore.; Hu, JC (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Program, 8 Coll Rd, Singapore 169857, Singapore.	hu.jiancheng@nccs.com.sg	Hu, Jiancheng/ABE-8133-2021	Hu, Jiancheng/0000-0003-1615-0030; Wang, Mei/0000-0001-6887-6840	National Cancer Centre Singapore Research Fund (NCCRF) Startup Grant NCCRF-SUG-JH; National Cancer Centre Singapore Research Fund (NCCRF) Bridging Grant [NCCRF-YR2016-JUL-BG1]; National Cancer Centre Singapore Research Fund (NCCRF) Pilot/Exploratory Project [NCCRF-YR2017-JULPG3]; Duke-NUS Khoo Bridge Funding Award [Duke-NUS-KBrFA/2017/0003]; SingHealth Foundation Startup Grant [SHF/FG692S/2016]; Asia Fund for Cancer Research Grant [AFCR2017/2019-JH]	National Cancer Centre Singapore Research Fund (NCCRF) Startup Grant NCCRF-SUG-JH; National Cancer Centre Singapore Research Fund (NCCRF) Bridging Grant; National Cancer Centre Singapore Research Fund (NCCRF) Pilot/Exploratory Project; Duke-NUS Khoo Bridge Funding Award; SingHealth Foundation Startup Grant; Asia Fund for Cancer Research Grant	This study was supported by National Cancer Centre Singapore Research Fund (NCCRF) Startup Grant NCCRF-SUG-JH, Bridging Grant NCCRF-YR2016-JUL-BG1, and Pilot/Exploratory Project Grant NCCRF-YR2017-JULPG3, Duke-NUS Khoo Bridge Funding Award Duke-NUS-KBrFA/2017/0003, SingHealth Foundation Startup Grant SHF/FG692S/2016, and Asia Fund for Cancer Research Grant AFCR2017/2019-JH. The authors declare that they have no conflicts of interest with the contents of this article.	Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Cseh B, 2014, FEBS LETT, V588, P2398, DOI 10.1016/j.febslet.2014.06.025; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hu JC, 2014, J IMMUNOL, V193, P85, DOI 10.4049/jimmunol.1300429; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Sprenkle AB, 1997, FEBS LETT, V403, P254, DOI 10.1016/S0014-5793(97)00062-8; Taylor SS, 2013, BIOCHEM SOC T, V41, P981, DOI 10.1042/BST20130120; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan J., 2017, 101101229849 BOIRXIV, DOI [10. 1101/229849, DOI 10.1101/229849]; Yuan JM, 2018, ONCOGENE, V37, P5719, DOI 10.1038/s41388-018-0365-2	38	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14276	14284		10.1074/jbc.RA118.004597	http://dx.doi.org/10.1074/jbc.RA118.004597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30030377	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000444671500009
J	Liu, Y; Peng, WQ; Guo, YY; Liu, Y; Tang, QQ; Guo, L				Liu, Yuan; Peng, Wan-Qiu; Guo, Ying-Ying; Liu, Yang; Tang, Qi-Qun; Guo, Liang			Kruppel-like factor 10 (KLF10) is transactivated by the transcription factor C/EBP and involved in early 3T3-L1 preadipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; Kruppel-like factor (KLF); CCAAT-enhancer-binding protein (C; EBP); cell proliferation; transcription regulation; histone deacetylase 1 (HDAC1); adipose tissue; 3T3-L1 preadipocytes; adipocyte differentiation; C; EBP; Kruppel-like factor (KLF); mitotic clonal expansion	MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; ADIPOGENESIS; BETA; OBESITY; ALPHA; GENE; EXPRESSION; CELL; ACTIVATION	Adipose tissue stores energy and plays an important role in energy homeostasis. CCAAT/enhancer-binding protein (C/EBP) is an important early transcription factor for 3T3-L1 preadipocyte differentiation, facilitating mitotic clonal expansion (MCE) and transactivating C/EBP and peroxisome proliferator-activated receptor- (PPAR) to promote adipogenesis. C/EBP is induced early, but the expression of antimitotic C/EBP and PPAR is not induced until approximate to 48 h. The delayed expression of C/EBP and PPAR is thought to ensure MCE progression, but the molecular mechanism for this delay remains elusive. Here, we show that the zinc-finger transcription factor Kruppel-like factor 10 (KLF10) is induced after adipogenic induction and that its expression positively correlates with that of C/EBP but inversely correlates with expression of C/EBP and PPAR. C/EBP bound to the KLF10 promoter and transactivated its expression during MCE. KLF10 overexpression in 3T3-L1 preadipocyte repressed adipogenesis and decreased C/EBP and PPAR expression, whereas siRNA-mediated down-regulation of KLF10 enhanced adipogenesis and increased C/EBP and PPAR expression. Luciferase assays revealed an inhibitory effect of KLF10 on C/EBP promoter activity. Using promoter deletion and mutation analysis, we identified a KLF10-binding site within the proximal promoter region of C/EBP. Furthermore, KLF10 interacted with and recruited histone deacetylase 1 (HDAC1) to the C/EBP promoter, decreasing acetylated histone H4 on the C/EBP promoter and inactivating C/EBP transcription. Because C/EBP can transactivate PPAR, our results suggest a mechanism by which expression of C/EBP and PPAR is delayed via KLF10 expression and shed light on the negative feedback loop for C/EBP-regulated adipogenesis in 3T3-L1 preadipocyte.	[Tang, Qi-Qun; Guo, Liang] Fudan Univ, Key Lab Metab & Mol Med, Minist Educ,Dept Biochem & Mol Biol,Sch Basic Med, Inst Stem Cell Res & Regenerat Med,Inst Biomed Sc, Shanghai 200032, Peoples R China; Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Tang, QQ; Guo, L (corresponding author), Fudan Univ, Key Lab Metab & Mol Med, Minist Educ,Dept Biochem & Mol Biol,Sch Basic Med, Inst Stem Cell Res & Regenerat Med,Inst Biomed Sc, Shanghai 200032, Peoples R China.	qqtang@shmu.edu.cn; liangguo@fudan.edu.cn		Guo, Liang/0000-0001-7353-8336	National Natural Science Foundation [81730021, 31571471, 31370027]; Ministry of Science and Technology of the People's Republic of China [2013CB530601]; 985 Project [985 III-YFX0302]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); 985 Project(Jilin UniversityXiamen University)	This work was supported by the National Natural Science Foundation Grants 81730021 (to Q.-Q. T.), 31571471 (to Q.-Q. T.), and 31370027 (to L. G.) and the Ministry of Science and Technology of the People's Republic of China Grant 2013CB530601 (to Q.-Q. T.). The department is supported by 985 Project 985 III-YFX0302. The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brey CW, 2009, INT J BIOL SCI, V5, P622; Chen JL, 2018, INT NURS REV, V65, P217, DOI 10.1111/inr.12371; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 2016, J INVEST MED, V64, P1082, DOI 10.1136/jim-2016-000155; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Guo L, 2013, MOL CELL BIOL, V33, P3180, DOI 10.1128/MCB.00193-13; Hawse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019429; Hopwood B, 2009, BONE, V44, P87, DOI 10.1016/j.bone.2008.08.120; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Kuzmochka C, 2014, ENDOCRINOLOGY, V155, P4762, DOI 10.1210/en.2014-1565; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; Li Z, 2018, OSTEOARTHR CARTILAGE, V26, P966, DOI 10.1016/j.joca.2018.04.002; Mishra VK, 2017, CANCER RES, V77, P2387, DOI 10.1158/0008-5472.CAN-16-2589; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shukla AP, 2015, J CARDIOPULM REHABIL, V35, P81, DOI 10.1097/HCR.0000000000000112; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Subramaniam M, 2010, BIOFACTORS, V36, P8, DOI 10.1002/biof.67; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xiao TF, 2015, STEM CELL REP, V5, P856, DOI 10.1016/j.stemcr.2015.09.007; Xiong YN, 2014, AM J PHYSIOL-REG I, V307, pR608, DOI 10.1152/ajpregu.00085.2014; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Yang XY, 2017, DIABETOLOGIA, V60, P2443, DOI 10.1007/s00125-017-4412-2; Yu JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13884; Zhang YY, 2012, MOL ENDOCRINOL, V26, P798, DOI 10.1210/me.2011-1287; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912; Zhang ZW, 2013, ACTA BIOCH BIOPH SIN, V45, P280, DOI 10.1093/abbs/gmt010	42	20	24	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14012	14021		10.1074/jbc.RA118.004401	http://dx.doi.org/10.1074/jbc.RA118.004401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30026232	hybrid, Green Published			2022-12-26	WOS:000444070700025
J	Javanmardi, A; Ibrahim, Z; Ghaedi, K; Khan, NB; Ghadim, HB				Javanmardi, Ahad; Ibrahim, Zainah; Ghaedi, Khaled; Khan, Niaz Bahadur; Ghadim, Hamed Benisi			Seismic isolation retrofitting solution for an existing steel cable-stayed bridge	PLOS ONE			English	Article							1988 SAGUENAY EARTHQUAKE; PASSIVE CONTROL; SYSTEMS; DAMAGE; VIBRATION	This paper investigated the seismic retrofitting of an existing cable-stayed bridge through the use of a seismic isolation system. The bridge is situated in a high seismic zone. During the Saguenay earthquake 1988, one of the anchorage plates of the bridge supports failed. Herein, several configurations of seismic isolation system were considered to identify an appropriate solution for the seismic retrofitting of the bridge in both the longitudinal and transverse directions. A three-dimensional model of the bridge was created, and its seismic behavior studied through nonlinear dynamic time-history analysis. The comparative performance study among the five retrofitting configurations showed that the partial seismic isolation of the bridge led to an enhancement of the seismic response of the bridge in one direction only. However, the overall seismic response of the cable-stayed bridge substantially improved in the longitudinal and transverse directions in cases where the isolation systems were utilized between the supports and the deck-tower connection of the bridge.	[Javanmardi, Ahad; Ibrahim, Zainah; Ghaedi, Khaled] Univ Malaya, Fac Engn, Civil Engn Dept, Kuala Lumpur, Malaysia; [Khan, Niaz Bahadur] Natl Univ Sci & Technol, Sch Mech & Mfg Engn, Islamabad, Pakistan; [Ghadim, Hamed Benisi] Fuzhou Univ, Fac Civil Engn, SIBERC, Fuzhou, Fujian, Peoples R China	Universiti Malaya; National University of Sciences & Technology - Pakistan; Fuzhou University	Javanmardi, A; Ibrahim, Z (corresponding author), Univ Malaya, Fac Engn, Civil Engn Dept, Kuala Lumpur, Malaysia.	ahadjavanmardi@gmail.com; zainah@um.edu.my	Khan, Niaz B/C-5539-2016; IBRAHIM, ZAINAH/GQU-0237-2022; IBRAHIM, ZAINAH/R-5259-2019; Khan, Niaz Bahadur/ACU-7263-2022; IBRAHIM, ZAINAH/C-1117-2010; Javanmardi, Ahad/AAH-7594-2019; Ghaedi, Khaled/J-3643-2015	Khan, Niaz B/0000-0003-4141-5600; IBRAHIM, ZAINAH/0000-0002-0748-9190; IBRAHIM, ZAINAH/0000-0002-0748-9190; Khan, Niaz Bahadur/0000-0003-4141-5600; IBRAHIM, ZAINAH/0000-0002-0748-9190; Javanmardi, Ahad/0000-0003-0678-5227; Ghaedi, Khaled/0000-0002-3919-1479	University Malaya Research Grant (UMRG) [RP004A/13AET]; University Malaya Postgraduate Research Fund (PPP) [PG242-2015B]; Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS) [FP028/2013A]	University Malaya Research Grant (UMRG); University Malaya Postgraduate Research Fund (PPP); Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS)	The authors gratefully acknowledge the support given by University Malaya Research Grant (UMRG - Project No. RP004A/13AET), University Malaya Postgraduate Research Fund (PPP - Project No. PG242-2015B) and Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS - Project No. FP028/2013A).	AASHTO, 2010, GUID SPEC SEISM ISOL; ALI HEM, 1995, SHOCK VIB, V2, P259, DOI 10.1155/1995/918721; ALI HEM, 1994, EARTHQUAKE ENG STRUC, V23, P877, DOI 10.1002/eqe.4290230805; ALI HM, 1995, COMPUT STRUCT, V54, P461, DOI 10.1016/0045-7949(94)00353-5; [Anonymous], 2017, 39 IABSE S ENG FUT I; [Anonymous], 2017, EARTHQUAKES TECTON H, DOI DOI 10.5772/65511; [Anonymous], NONLINEAR TEST PRECA; [Anonymous], 2012, LRFD BRIDG DES SPEC; Atmaca B, 2017, ADV COMPUT DES, V2, P43, DOI 10.12989/acd.2017.2.1.043; Atmaca B, 2012, STEEL COMPOS STRUCT, V12, P413; Bruno D, 2008, ENG STRUCT, V30, P1160, DOI 10.1016/j.engstruct.2007.07.001; Built SM, 1982, LEAD RUBBER DISSIPAT, DOI [10.1061/(ASCE)0733-9445(2003)129:(857), DOI 10.1061/(ASCE)0733-9445(2003)129:(857)]; Camara A, 2012, ENG STRUCT, V41, P444, DOI 10.1016/j.engstruct.2012.03.059; Casciati F, 2008, COMPUT STRUCT, V86, P1769, DOI 10.1016/j.compstruc.2008.01.012; Chang CM, 2006, J EARTHQ ENG, V10, P481, DOI 10.1142/S1363246906002839; Computers and Structures Inc, 2015, CI AN REF MAN; Cunha A, 2001, J BRIDGE ENG, V6, P54, DOI DOI 10.1061/(ASCE)1084-0702(2001)6:1(54); Dicleli M, 2003, ENG STRUCT, V25, P1139, DOI 10.1016/S0141-0296(03)00062-2; Dolce M, 2007, B EARTHQ ENG, V5, P491, DOI 10.1007/s10518-007-9044-3; Dyke SJ, 2003, J STRUCT ENG-ASCE, V129, P857, DOI 10.1061/(ASCE)0733-9445(2003)129:7(857); Felber AJ, 1992, CAN SOC CIV EN ANN C, P375; FILIATRAULT A, 1993, J STRUCT ENG-ASCE, V119, P1432, DOI 10.1061/(ASCE)0733-9445(1993)119:5(1432); FILIATRAULT A, 1993, J STRUCT ENG-ASCE, V119, P1450, DOI 10.1061/(ASCE)0733-9445(1993)119:5(1450); Ghaedi K, 2018, ADV CIV ENG, V2018, DOI 10.1155/2018/4517940; Ghaedi K, 2017, J VIBROENG, V19, P3564, DOI 10.21595/jve.2017.18900; He M, 2015, P I CIVIL ENG-STR B, V168, P890, DOI 10.1680/jstbu.14.00038; He WL, 2007, STRUCT CONTROL HLTH, V14, P1, DOI 10.1002/stc.81; Iemura H, 2002, J STRUCT CONTROL, V9, P189, DOI DOI 10.1002/STC.12; Javanmardi Ahad, 2015, Applied Mechanics and Materials, V735, P141, DOI 10.4028/www.scientific.net/AMM.735.141; Javanmardi A, 2017, ARCH CIV MECH ENG, V17, P419, DOI 10.1016/j.acme.2016.12.002; Karalar M, 2012, ENG STRUCT, V40, P276, DOI 10.1016/j.engstruct.2012.02.023; Li H, 2009, J EARTHQ TSUNAMI, V3, P227, DOI 10.1142/S1793431109000524; Martinez-Rodrigo MD, 2015, ENG STRUCT, V99, P232, DOI 10.1016/j.engstruct.2015.04.048; Mozos CM, 2010, ENG STRUCT, V32, P3288, DOI 10.1016/j.engstruct.2010.07.003; NAZMY AS, 1992, EARTHQUAKE ENG STRUC, V21, P1, DOI 10.1002/eqe.4290210101; Park K-S, 2014, SOIL DYN EARTHQ ENG, V66, P314; PARK YJ, 1986, EARTHQUAKE ENG STRUC, V14, P543, DOI 10.1002/eqe.4290140405; Ren W-X, 1999, J BRIDGE ENG, V4, P1404; Robinson W. H., 1977, B NZ NATL SOC EARTHQ, V10, P151, DOI 10.5459/bnzsee.10.3.151-153; Sharabash AM, 2009, ENG STRUCT, V31, P607, DOI 10.1016/j.engstruct.2008.11.007; Tuladhar R, 1999, CAN J CIVIL ENG, V26, P631; Wang PH, 1996, COMPUT STRUCT, V60, P243, DOI 10.1016/0045-7949(95)00382-7; Wesolowsky MJ, 2003, EARTHQ ENG STRUCT D, V32, P2107, DOI 10.1002/eqe.318; Xi Y, 2000, P I CIVIL ENG-STR B, V140, P227, DOI 10.1680/stbu.2000.140.3.227	44	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0200482	10.1371/journal.pone.0200482	http://dx.doi.org/10.1371/journal.pone.0200482			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059506	Green Published, gold, Green Submitted			2022-12-26	WOS:000440251600010
J	Kundu, S; Cheng, YC; Shin, M; Manyam, G; Mallick, BK; Baladandayuthapani, V				Kundu, Suprateek; Cheng, Yichen; Shin, Minsuk; Manyam, Ganiraju; Mallick, Bani K.; Baladandayuthapani, Veerabhadran			Bayesian variable selection with graphical structure learning: Applications in integrative genomics	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; COPY NUMBER; HUMAN-COLON; GENE; CANCER; REGRESSION; MODELS; LASSO; INFORMATION; ACTIVATION	Significant advances in biotechnology have allowed for simultaneous measurement of molecular data across multiple genomic, epigenomic and transcriptomic levels from a single tumor/patient sample. This has motivated systematic data-driven approaches to integrate multi-dimensional structured datasets, since cancer development and progression is driven by numerous co-ordinated molecular alterations and the interactions between them. We propose a novel multi-scale Bayesian approach that combines integrative graphical structure learning from multiple sources of data with a variable selection framework D to determine the key genomic drivers of cancer progression. The integrative structure learning is first accomplished through novel joint graphical models for heterogeneous (mixed scale) data, allowing for flexible and interpretable incorporation of prior existing knowledge. This subsequently informs a variable selection step to identify groups of co-ordinated molecular features within and across platforms associated with clinical outcomes of cancer progression, while according appropriate adjustments for multicollinearity and multiplicities. We evaluate our methods through rigorous simulations to establish superiority over existing methods that do not take the network and/or prior information into account. Our methods are motivated by and applied to a glioblastoma multiforme (GBM) dataset from The Cancer Genome Atlas to predict patient survival times integrating gene expression, copy number and methylation data. We find a high concordance between our selected prognostic gene network modules with known associations with GBM. In addition, our model discovers several novel cross-platform network interactions (both cis and trans acting) between gene expression, copy number variation associated gene dosing and epigenetic regulation through promoter methylation, some with known implications in the etiology of GBM. Our framework provides a useful tool for biomedical researchers, since clinical prediction using multi-platform genomic information is an important step towards personalized treatment of many cancers.	[Kundu, Suprateek] Emory Univ, Dept Biostat & Bioinformat, 1518 Clifton Rd, Atlanta, GA 30322 USA; [Cheng, Yichen] Georgia State Univ, Robinson Coll Business, 35 Brd St NW, Atlanta, GA 30303 USA; [Shin, Minsuk; Mallick, Bani K.] Texas A&M, Dept Stat, 155 Ireland St, College Stn, TX 77843 USA; [Manyam, Ganiraju; Baladandayuthapani, Veerabhadran] MD Anderson Canc Res Ctr, Dept Biostat, Houston, TX 77030 USA	Emory University; University System of Georgia; Georgia State University; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center	Kundu, S (corresponding author), Emory Univ, Dept Biostat & Bioinformat, 1518 Clifton Rd, Atlanta, GA 30322 USA.	suprateek.kundu@emory.edu	Manyam, Ganiraju C/B-5890-2014; Manyam, Ganiraju/E-9150-2012; Shin, Minsuk/R-1270-2019	Manyam, Ganiraju/0000-0001-6006-8961; Kundu, Suprateek/0000-0002-1767-4875	NIH [R01CA160736]; Cancer Center Support Grant (CCSG) [P30 CA016672]; National Cancer Institute of the National Institutes of Health [R01CA194391]; NATIONAL CANCER INSTITUTE [R01CA160736, R01CA194391, P30CA016672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant (CCSG); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	VB was partially supported by NIH grant R01CA160736 and the Cancer Center Support Grant (CCSG, P30 CA016672). BKM and VB were also supported by National Cancer Institute of the National Institutes of Health under award number R01CA194391.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Anjum S, 2009, BIOINFORMATICS, V25, P2929, DOI 10.1093/bioinformatics/btp485; Baladandayuthapani V, 2010, J AM STAT ASSOC, V105, P1358, DOI 10.1198/jasa.2010.ap09250; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Bondell HD, 2012, J AM STAT ASSOC, V107, P1610, DOI 10.1080/01621459.2012.716344; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Buschges R, 1999, BRAIN PATHOL, V9, P435; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Canale A, 2011, J AM STAT ASSOC, V106, P1528, DOI 10.1198/jasa.2011.tm10552; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen X, 2012, ANN APPL STAT, V6, P719, DOI 10.1214/11-AOAS514; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Choi HW, 2010, J COMPUT BIOL, V17, P121, DOI 10.1089/cmb.2009.0019; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DAWID AP, 1993, ANN STAT, V21, P1272, DOI 10.1214/aos/1176349260; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Hamid JS, 2009, HUMAN GENOMICS PROTE, V1, P1, DOI [10.4061/2009/869093, DOI 10.4061/2009/869093]; Huang PH, 2009, ONCOGENIC EGFR SIGNA, V2, DOI [10.1126/scisignal.287re6, DOI 10.1126/SCISIGNAL.287RE6]; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Isci S, 2014, BIOINFORMATICS, V30, P860, DOI 10.1093/bioinformatics/btt643; Jennings EM, 2013, EURASIP J BIOINFORMA, V1, P1687; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Li F., 2010, J AM STAT ASSOC, V105, P1978; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Melott JM, 2016, BIOINFORMATICS, V32, P312, DOI 10.1093/bioinformatics/btv554; Pan W, 2010, BIOMETRICS, V66, P474, DOI 10.1111/j.1541-0420.2009.01296.x; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Praveen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067410; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Rockova V, 2014, BAYESIAN ANAL, V9, P221, DOI 10.1214/13-BA846; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Solomon DA, 2008, CANCER RES, V68, P8657, DOI 10.1158/0008-5472.CAN-08-2084; Stingo FC, 2011, ANN APPL STAT, V5, P1978, DOI 10.1214/11-AOAS463; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Sun SW, 2016, PHYS LETT A, V380, P1912, DOI 10.1016/j.physleta.2016.03.048; Sun SW, 2015, APPL MATH COMPUT, V252, P249, DOI 10.1016/j.amc.2014.12.044; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Veronika Rockova, 2017, J AM STAT ASS; Wang H, 2012, BAYESIAN ANAL, V7, P867, DOI 10.1214/12-BA729; Wang WT, 2013, BIOINFORMATICS, V29, P149, DOI 10.1093/bioinformatics/bts655; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0195070	10.1371/journal.pone.0195070	http://dx.doi.org/10.1371/journal.pone.0195070			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059495	gold, Green Published, Green Submitted			2022-12-26	WOS:000440251600002
J	Avet, C; Denoyelle, C; L'Hote, D; Petit, F; Guigon, CJ; Cohen-Tannoudji, J; Simon, V				Avet, Charlotte; Denoyelle, Chantal; L'Hote, David; Petit, Florence; Guigon, Celine J.; Cohen-Tannoudji, Joelle; Simon, Violaine			GnRH regulates the expression of its receptor accessory protein SET in pituitary gonadotropes	PLOS ONE			English	Article							ACTIVATING FACTOR-I; ACUTE UNDIFFERENTIATED LEUKEMIA; PHOSPHATASE 2A; ABNORMAL HYPERPHOSPHORYLATION; NEGATIVE REGULATION; HORMONE RECEPTOR; GENE PROMOTER; CANCER-CELLS; BETA; TRANSCRIPTION	Reproductive function is under the control of the neurohormone GnRH, which activates a G-protein-coupled receptor (GnRHR) expressed in pituitary gonadotrope cells. GnRHR activates a complex signaling network to regulate synthesis and secretion of the two gonadotropin hormones, luteinizing hormone and follicle-stimulating hormone, both regulating gametogenesis and steroidogenesis in gonads. Recently, in an attempt to identify the mechanisms underlying GnRHR signaling plasticity, we identified the first interacting partner of GnRHR, the proto-oncogene SET. We showed that SET binds to intracellular domains of GnRHR to enhance its coupling to cAMP pathway in alpha T3-1 gonadotrope cells. Here, we demonstrate that SET protein is rapidly regulated by GnRH, which increases SET phosphorylation state and decreases dose-dependently SET protein level. Our results highlight a post-translational regulation of SET protein involving the proteasome pathway. We determined that SET phosphorylation upon GnRH stimulation is mediated by PKC and that PKC mediates GnRH-induced SET down-regulation. Phosphorylation on serine 9 targets SET for degradation into the proteasome. Furthermore, a non-phosphorylatable SET mutant on serine 9 is resistant to GnRH-induced down-regulation. Altogether, these data suggest that GnRH-induced SET phosphorylation on serine 9 mediates SET protein down-regulation through the proteasome pathway. Noteworthy, SET down-regulation was also observed in response to pulsatile GnRH stimulation in L beta T2 gonadotrope cells as well as in vivo in prepubertal female mice supporting its physiological relevance. In conclusion, this study highlights a regulation of SET protein by the neurohormone GnRH and identifies some of the mechanisms involved.	[Avet, Charlotte; Denoyelle, Chantal; L'Hote, David; Petit, Florence; Guigon, Celine J.; Cohen-Tannoudji, Joelle; Simon, Violaine] Univ Paris Diderot, Sorbonne Paris Cite, CNRS,Biol Fonct & Adaptat Physiol Axe Gonadotrope, INSERM,UMR 8251,U1133, Paris, France; [Avet, Charlotte] Univ Montreal, Inst Res Immunol & Canc, Dept Biochem & Mol Med, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	Simon, V (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS,Biol Fonct & Adaptat Physiol Axe Gonadotrope, INSERM,UMR 8251,U1133, Paris, France.	violaine.simon@univ-paris-diderot.fr	LHOTE, David/AAD-5390-2020; L'Hote, David/L-2653-2017; guigon, celine/L-3518-2017	PETIT, Florence/0000-0002-0363-280X; simon, violaine/0000-0002-4417-127X; L'Hote, David/0000-0001-5658-5018; guigon, celine/0000-0002-4489-4304	Paris 7 University; CNRS; INSERM	Paris 7 University; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from Paris 7 University, CNRS and INSERM.	ADACHI Y, 1994, FEBS LETT, V340, P231, DOI 10.1016/0014-5793(94)80144-4; Aguilar-Rojas A, 2009, ONCOL REP, V22, P981, DOI 10.3892/or_00000525; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; Avet C, 2013, J BIOL CHEM, V288, P2641, DOI 10.1074/jbc.M112.388876; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bergstralh DT, 2007, EXP CELL RES, V313, P65, DOI 10.1016/j.yexcr.2006.09.016; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chambon JP, 2013, CURR BIOL, V23, P485, DOI 10.1016/j.cub.2013.02.004; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Cohen-Tannoudji Joelle, 2012, Front Endocrinol (Lausanne), V3, P107, DOI 10.3389/fendo.2012.00107; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Dulka EA, 2017, ENDOCRINOLOGY, V158, P3943, DOI 10.1210/en.2017-00768; Ekmekci SS, 2012, TUMORI J, V98, P252, DOI 10.1700/1088.11938; Farrell AS, 2014, MOL CANCER RES, V12, P924, DOI 10.1158/1541-7786.MCR-13-0542; Francois CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46222; Fukukawa C, 2005, INT J ONCOL, V26, P751; Granger A, 2004, ENDOCRINOLOGY, V145, P983, DOI 10.1210/en.2003-0881; Hung MH, 2016, ONCOTARGET, V7, P638, DOI 10.18632/oncotarget.6313; Ichijo T, 2008, MOL CELL ENDOCRINOL, V283, P19, DOI 10.1016/j.mce.2007.10.014; Irie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051242; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; Kandilci A, 2004, LEUKEMIA, V18, P337, DOI 10.1038/sj.leu.2403227; Karetsou Z, 2005, BIOCHEM BIOPH RES CO, V335, P322, DOI 10.1016/j.bbrc.2005.06.210; Kato K, 2011, J CELL SCI, V124, P3254, DOI 10.1242/jcs.083139; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Kim DW, 2010, BIOCHEM BIOPH RES CO, V400, P419, DOI 10.1016/j.bbrc.2010.08.093; Lam BD, 2012, CYTOM PART A, V81A, P81, DOI 10.1002/cyto.a.21153; Leopoldino AM, 2012, MOL CELL BIOCHEM, V363, P65, DOI 10.1007/s11010-011-1158-x; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu GP, 2012, NEUROBIOL AGING, V33, P254, DOI 10.1016/j.neurobiolaging.2010.01.016; Loganathan J, 2014, INT J ONCOL, V44, P2009, DOI 10.3892/ijo.2014.2375; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Poulin B, 2009, NEUROENDOCRINOLOGY, V89, P252, DOI 10.1159/000164694; Qi ST, 2013, J CELL SCI, V126, P1595, DOI 10.1242/jcs.116541; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schang AL, 2011, ENDOCRINOLOGY, V152, P568, DOI 10.1210/en.2010-0840; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Simon V, 2012, MOL PHARMACOL, V82, P17, DOI 10.1124/mol.111.075523; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Thompson JW, 2014, J BIOL CHEM, V289, P28942, DOI 10.1074/jbc.M114.573352; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Yang XF, 2012, TOXICOL LETT, V209, P232, DOI 10.1016/j.toxlet.2011.12.019; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648; Zhang PL, 2001, DNA CELL BIOL, V20, P613, DOI 10.1089/104454901753340604; Zhang Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00146; Zhang WP, 2015, MOL MED REP, V12, P1506, DOI 10.3892/mmr.2015.3468	63	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201494	10.1371/journal.pone.0201494	http://dx.doi.org/10.1371/journal.pone.0201494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052687	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600048
J	Zhou, M; Aziz, M; Ochani, M; Yang, WL; Sharma, A; Wang, P				Zhou, Mian; Aziz, Monowar; Ochani, Manhendar; Yang, Weng-Lang; Sharma, Archna; Wang, Ping			The protective role of human ghrelin in sepsis: Restoration of CD4 T cell proliferation	PLOS ONE			English	Article							PROFOUND DEPLETION; UP-REGULATION; SEPTIC SHOCK; FAS-LIGAND; APOPTOSIS; IMMUNOSUPPRESSION; ACTIVATION; RATS; SECRETAGOGUE; LYMPHOCYTES	Decrease of CD4 T cell numbers causes immunosuppression in sepsis. We previously showed the beneficial role of ghrelin in sepsis. We hypothesize that the protective outcome of ghrelin in sepsis is mediated partially through the restoration of CD4 T cells' proliferation. Sepsis was induced in mice by cecal ligation and puncture (CLP). The percentage of CD4 T cells in spleen was assessed by flow cytometry and their proliferation was determined by carboxyfluorescein succinimidyl ester (CSFE). Compared to sham mice, the percentages of splenic CD4 T cells were reduced by 20%, 21%, and 29% at day 1, 2 and 3 after CLP, respectively. Human ghrelin was given to 3 day septic mice by s.c. injection at 5 and 24 h after CLP. Treatment with ghrelin restored the loss of CD4 T cells by increasing their proliferation in septic mice. The expression of cyclin D1 and B1 was significantly increased, while the expression of p57 was decreased in ghrelin-treated mice compared to vehicle-treated mice in sepsis. Treatment with human ghrelin significantly increased the p-AKT levels in the spleen compared to vehicle-treated septic mice. Human ghrelin plays an important role in reestablishing the proliferation of CD4 T cells and serves as a promising therapeutic agent in sepsis.	[Zhou, Mian; Aziz, Monowar; Ochani, Manhendar; Yang, Weng-Lang; Sharma, Archna; Wang, Ping] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA; [Yang, Weng-Lang; Wang, Ping] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Dept Surg & Mol Med, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA.; Wang, P (corresponding author), Hofstra Northwell, Donald & Barbara Zucker Sch Med, Dept Surg & Mol Med, Manhasset, NY 11030 USA.	pwang@northwell.edu		Aziz, Monowar/0000-0002-8195-4505; Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R35GM118337]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) grant R35GM118337 to Ping Wang.	Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Ayala A, 2003, SCAND J INFECT DIS, V35, P593, DOI 10.1080/00365540310015656; Ayala A, 1999, IMMUNOLOGY, V97, P45; Aziz M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.488; Aziz M, 2014, J IMMUNOL, V192, P2305, DOI 10.4049/jimmunol.1302160; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Balivada S, 2016, AUTON NEUROSCI-BASIC, V201, P68, DOI 10.1016/j.autneu.2016.08.011; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369; Dembinski A, 2003, J PHYSIOL PHARMACOL, V54, P561; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Garin MC, 2013, J CLIN ENDOCR METAB, V98, P1826, DOI 10.1210/jc.2012-4247; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, SCAND J INFECT DIS, V35, P585, DOI 10.1080/00365540310015692; Hu D, 2015, CELL IMMUNOL, V295, P92, DOI 10.1016/j.cellimm.2015.03.009; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Koo GC, 2001, J IMMUNOL, V166, P4195, DOI 10.4049/jimmunol.166.6.4195; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Narula T, 2015, AM J RESP CELL MOL, V53, P437, DOI 10.1165/rcmb.2014-0226TR; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Sharma A, 2015, IMMUNOL LETT, V168, P41, DOI 10.1016/j.imlet.2015.09.005; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stieglitz D, 2015, IMMUN INFLAMM DIS, V3, P374, DOI 10.1002/iid3.75; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Taub DD, 2010, CURR OPIN PHARMACOL, V10, P408, DOI 10.1016/j.coph.2010.04.015; Theil MM, 2009, J IMMUNOL, V183, P2859, DOI 10.4049/jimmunol.0803362; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Wang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118213; Ward PA, 2014, TRENDS MOL MED, V20, P189, DOI 10.1016/j.molmed.2014.02.003; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Wirth T, 2014, BRAIN BEHAV IMMUN, V38, P100, DOI 10.1016/j.bbi.2014.01.007; Wu JT, 2004, ANN SURG, V239, P464, DOI 10.1097/01.sla.0000118561.54919.61; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1296, DOI 10.1152/ajpheart.00852.2003; Yang WL, 2016, MOL MED, V22, P124, DOI 10.2119/molmed.2015.00255; Zhou M, 2017, BBA-MOL BASIS DIS, V1863, P2584, DOI 10.1016/j.bbadis.2017.01.014; Zukerberg LR, 1996, BLOOD, V88, P268, DOI 10.1182/blood.V88.1.268.bloodjournal881268	56	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201139	10.1371/journal.pone.0201139	http://dx.doi.org/10.1371/journal.pone.0201139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052667	gold, Green Published, Green Submitted			2022-12-26	WOS:000440006600024
J	Cho, U; Park, HS; Im, SY; Yoo, CY; Jung, JH; Suh, YJ; Choi, HJ				Cho, Uiju; Park, Hong Sik; Im, So Young; Yoo, Chang Young; Jung, Ji Han; Suh, Young Jin; Choi, Hyun Joo			Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer	PLOS ONE			English	Article							PLATELET-LYMPHOCYTE RATIO; PANCREATIC DUCTAL ADENOCARCINOMA; PRETREATMENT NEUTROPHIL; RADICAL CYSTECTOMY; BLADDER-CANCER; POOR-PROGNOSIS; SURVIVAL; CARCINOMA; OUTCOMES; LYMPHOPENIA	Systemic inflammatory markers derived from peripheral blood cell, such as the neutrophil-lymphocyte ratio (NLR), derived neutrophil-lymphocyte ratio (dNLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR), have been demonstrated as prognostic markers in several types of malignancy. Here, we investigated and compared the association between systemic inflammatory markers and survival and developed a prognostic nomogram in breast cancer patients. We reviewed the clinical and pathological records of 661 patients diagnosed with invasive breast carcinoma between 1993 and 2011. The NLR, dNLR, PLR and LMR in the immediate preoperative period were assessed. We analyzed the relationship between these inflammatory markers and clinicopathologic variables, disease-specific survival (DSS), and disease-free survival (DFS) in patients. A nomogram was developed to predict 3-and 5-year DSS for breast cancer. In the univariate analysis, high NLR, dNLR, PLR and low LMR were all significantly associated with poor DSS and DFS. In the multivariate analysis, only the PLR (HR 3.226, 95% CI 1.768-5.885 for DSS and HR 1.824, 95% CI 1.824-6.321 for DFS) was still identified as an independent predictor of outcomes. A subgroup analysis revealed that the PLR was the sole independent marker predicting poor DSS in patients with lymph node metastasis (HR 2.294, 95% CI 1.102-4.777) and with luminal subtype (HR 4.039, 95% CI 1.905-8.562). The proposed nomogram, which includes the PLR, shows good accuracy in predicting DSS with a concordance index of 0.82. PLR is an indicator of systemic inflammation as a part of the host immune response. As an independent prognostic factor, an elevated preoperative PLR is superior to the NLR, dNLR, and LMR in predicting clinical outcomes in patients with breast cancer. Moreover, the nomogram incorporating the PLR could accurately predict individualized survival probability in breast cancer.	[Cho, Uiju; Park, Hong Sik; Im, So Young; Yoo, Chang Young; Jung, Ji Han; Choi, Hyun Joo] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Hosp Pathol, Seoul, South Korea; [Suh, Young Jin] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Surg, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Choi, HJ (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Hosp Pathol, Seoul, South Korea.	chj0103@catholic.ac.kr		CHOI, HYUN JOO/0000-0003-2292-424X; Cho, Uiju/0000-0002-6229-8418				Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allred DC, 1998, MODERN PATHOL, V11, P155; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Bhindi B, 2016, BRIT J CANCER, V114, P207, DOI 10.1038/bjc.2015.432; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Dolan RD, 2017, CRIT REV ONCOL HEMAT, V116, P134, DOI 10.1016/j.critrevonc.2017.06.002; Dominguez I, 2008, WORLD J SURG, V32, P1051, DOI 10.1007/s00268-007-9423-6; Edge SB, 2010, AJCC CANC STAGING MA; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hermanns T, 2014, BRIT J CANCER, V111, P444, DOI 10.1038/bjc.2014.305; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Howlader N., 2016, SEER CANC STAT REV 1; Ishii Y, 2017, PATHOL INT, V67, P235, DOI 10.1111/pin.12530; Jia WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143061; Jiang K, 2017, J SURG ONCOL, V116, P281, DOI 10.1002/jso.24683; Kano S, 2017, HEAD NECK-J SCI SPEC, V39, P247, DOI 10.1002/hed.24576; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Kou FR, 2016, CANCER MED-US, V5, P778, DOI 10.1002/cam4.638; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Papouchado BG, 2010, AM J SURG PATHOL, V34, P767, DOI 10.1097/PAS.0b013e3181d96231; Pistelli M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1204-2; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Radziwon-Balicka A, 2012, BRIT J PHARMACOL, V167, P787, DOI 10.1111/j.1476-5381.2012.01991.x; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Song X, 2016, ONCOTARGETS THER, V9, P1399, DOI 10.2147/OTT.S97520; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Szkandera J, 2014, INT J CANCER, V135, P362, DOI 10.1002/ijc.28677; Templeton AJ, 2014, CANCER EPIDEM BIOMAR, V23, P1204, DOI 10.1158/1055-9965.EPI-14-0146; Teng JJ, 2016, ONCOTARGETS THER, V9, DOI 10.2147/OTT.S94458; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Wariss BR, 2017, MATURITAS, V101, P51, DOI 10.1016/j.maturitas.2017.04.015; Yao MY, 2014, ONCOTARGETS THER, V7, P1743, DOI 10.2147/OTT.S69657; Ying HQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0305-0; Zhang GM, 2015, TUMOR BIOL, V36, P8537, DOI 10.1007/s13277-015-3613-x; Zhang M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9503025; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101119; Zhu YY, 2017, ONCOTARGET, V8, P1023, DOI 10.18632/oncotarget.13714; Zou ZY, 2016, ONCOL LETT, V11, P2241, DOI 10.3892/ol.2016.4216	52	69	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200936	10.1371/journal.pone.0200936	http://dx.doi.org/10.1371/journal.pone.0200936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048474	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400033
J	Hakak, S; Kamsin, A; Shivakumara, P; Idris, MYI; Gilkar, GA				Hakak, Saqib; Kamsin, Amirrudin; Shivakumara, Palaiahnakote; Idris, Mohd Yamani Idna; Gilkar, Gulshan Amin			A new split based searching for exact pattern matching for natural texts	PLOS ONE			English	Article								Exact pattern matching algorithms are popular and used widely in several applications, such as molecular biology, text processing, image processing, web search engines, network intrusion detection systems and operating systems. The focus of these algorithms is to achieve time efficiency according to applications but not memory consumption. In this work, we propose a novel idea to achieve both time efficiency and memory consumption by splitting query string for searching in Corpus. For a given text, the proposed algorithm split the query pattern into two equal halves and considers the second (right) half as a query string for searching in Corpus. Once the match is found with second halves, the proposed algorithm applies brute force procedure to find remaining match by referring the location of right half. Experimental results on different S1 Dataset, namely Arabic, English, Chinese, Italian and French text databases show that the proposed algorithm outperforms the existing S1 Algorithm in terms of time efficiency and memory consumption as the length of the query pattern increases.	[Hakak, Saqib; Kamsin, Amirrudin; Shivakumara, Palaiahnakote; Idris, Mohd Yamani Idna] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Gilkar, Gulshan Amin] Shaqra Univ, Coll Comp & Informat Technol, Shaqraa, Saudi Arabia	Universiti Malaya; Shaqra University	Hakak, S; Kamsin, A (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	saqibhakak@ieee.org; amir@um.edu.my	Idris, Mohd. Yamani Idna/B-5232-2010; Palaiahnakote, Shivakumara/B-6261-2013; KAMSIN, AMIRRUDIN/B-8220-2010; Hakak, Saqib/AAC-5134-2021; Idris, Mohd. Yamani Idna/GPP-2401-2022	Idris, Mohd. Yamani Idna/0000-0003-4894-0838; KAMSIN, AMIRRUDIN/0000-0003-2796-3459; hakak, saqib/0000-0002-8718-0336	Fundamental Research Grant (FRGS) through the University Malaya [FP003-2016]; IPPP research fund [PG017-2015B]	Fundamental Research Grant (FRGS) through the University Malaya; IPPP research fund	This work was supported by the Fundamental Research Grant (FRGS) through the University Malaya under Project No. FP003-2016 and IPPP research fund (PG017-2015B) (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MK., 2014, ENHANCED BOYER MOORE; Al-Ssulami AM, 2015, J INF SCI, V41, P82, DOI 10.1177/0165551514555668; Berry TaR S., 2001, P PRAG STR CLUB WORK; Bobroff N, 2016, US Patent, Patent No. [20,160,110,225, 206010225]; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; CROCHEMORE M, 1994, ALGORITHMICA, V12, P247, DOI 10.1007/BF01185427; Faro S, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431212; Frakes WB, 1992, INFORM RETRIEVAL DAT; HORSPOOL RN, 1980, SOFTWARE PRACT EXPER, V10, P501, DOI 10.1002/spe.4380100608; Kim J-S, 2000, ACM SIGMETRICS PERFO; Lecroq T, 2007, INFORM PROCESS LETT, V102, P229, DOI 10.1016/j.ipl.2007.01.002; Lin J, 2014, ALGORITHMS, V7, DOI 10.3390/a7020253; Michailidis PD, 2002, INT J COMPUT MATH, V79, P867, DOI 10.1080/00207160212111; Rafiq ANME, 2004, COMPUT COMMUN, V27, P1524, DOI 10.1016/j.comcom.2004.06.005; Shaham R, 2001, ACM SIGPLAN NOTICES; SUNDAY DM, 1990, COMMUN ACM, V33, P132, DOI 10.1145/79173.79184; Yang T, 2004, P 4 INT S MEM MAN	18	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200912	10.1371/journal.pone.0200912	http://dx.doi.org/10.1371/journal.pone.0200912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048486	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400029
J	Rathod, J; Tu, HP; Chang, YI; Chu, YH; Tseng, YY; Jean, JS; Wu, WS				Rathod, Jagat; Tu, Hao-Ping; Chang, Yung-I; Chu, Yu-Han; Tseng, Yan-Yuan; Jean, Jiin-Shuh; Wu, Wei-Sheng			YARG: A repository for arsenic-related genes in yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CADMIUM TOLERANCE; TOXICITY; EXPRESSION; TUSC1; IDENTIFICATION; TARGET; CANCER	Arsenic is a toxic metalloid. Moderate levels of arsenic exposure from drinking water can cause various human health problems such as skin lesions, circulatory disorders and cancers. Thus, arsenic toxicity is a key focus area for environmental and toxicological investigations. Many arsenic-related genes in yeast have been identified by experimental strategies such as phenotypic screening and transcriptional profiling. These identified arsenic-related genes are valuable information for studying arsenic toxicity. However, the literature about these identified arsenic-related genes is widely dispersed and cannot be easily acquired by researchers. This prompts us to develop YARG (Yeast Arsenic-Related Genes) database, which comprehensively collects 3396 arsenic-related genes in the literature. For each arsenic-related gene, the number and types of experimental evidence (phenotypic screening and/or transcriptional profiling) are provided. Users can use both search and browse modes to query arsenic-related genes in YARG. We used two case studies to show that YARG can return biologically meaningful arsenic-related information for the query gene(s). We believe that YARG is a useful resource for arsenic toxicity research.	[Rathod, Jagat; Jean, Jiin-Shuh] Natl Cheng Kung Univ, Dept Earth Sci, Tainan, Taiwan; [Tu, Hao-Ping; Chang, Yung-I; Chu, Yu-Han; Wu, Wei-Sheng] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan; [Tseng, Yan-Yuan] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA	National Cheng Kung University; National Cheng Kung University; Wayne State University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019	Rathod, Jagat/0000-0002-5235-835X	National Cheng Kung University; Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2, MOST-106-2628-E-006-006-MY2]	National Cheng Kung University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2 and MOST-106-2628-E-006-006-MY2]. Funding for open access charge: Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar062; Chen Y, 2009, TOXICOL APPL PHARM, V239, P184, DOI 10.1016/j.taap.2009.01.010; Cherry JM, 2015, COLD SPRING HARB PRO, V2015; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Farrugia G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00064; Fuchs SM, 2014, DRUG DISCOV TODAY DI, V12, P1, DOI DOI 10.1016/J.DDMOD.2014.04.004; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Guo L, 2016, G3-GENES GENOM GENET, V6, P3317, DOI 10.1534/g3.116.033829; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hosiner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083330; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Jo WJ, 2009, TOXICOL SCI, V111, P424, DOI 10.1093/toxsci/kfp162; Johnson AJ, 2016, METALLOMICS, V8, P228, DOI 10.1039/c5mt00261c; Kanda M, 2014, J SURG ONCOL, V110, P136, DOI 10.1002/jso.23614; Kumar NV, 2016, MOL CELL BIOL, V36, P913, DOI 10.1128/MCB.00842-15; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Pan XW, 2010, GENETICS, V186, P725, DOI 10.1534/genetics.110.117655; Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201; Serero A, 2008, DNA REPAIR, V7, P1262, DOI 10.1016/j.dnarep.2008.04.005; Shan ZH, 2004, ONCOGENE, V23, P6612, DOI 10.1038/sj.onc.1207857; Shimizu D, 2014, ONCOL REP, V31, P1305, DOI 10.3892/or.2013.2939; Thorsen M, 2007, PHYSIOL GENOMICS, V30, P35, DOI 10.1152/physiolgenomics.00236.2006; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; van Leeuwen JS, 2012, CURR DRUG METAB, V13, P1464; Vujcic M, 2007, CANCER RES, V67, P9740, DOI 10.1158/0008-5472.CAN-07-1962; Wu WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-522; Wysocki R, CELLULAR EFFECTS HEA; Zhang R, 2017, CELL MOL NEUROBIOL, V37, P37, DOI 10.1007/s10571-016-0339-2; Zhou X, 2009, GENOMICS, V94, P294, DOI 10.1016/j.ygeno.2009.07.003	30	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201204	10.1371/journal.pone.0201204	http://dx.doi.org/10.1371/journal.pone.0201204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048518	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400061
J	Adler, FR; Stockmann, C; Ampofo, K; Pavia, AT; Byington, CL				Adler, Frederick R.; Stockmann, Chris; Ampofo, Krow; Pavia, Andrew T.; Byington, Carrie L.			( )Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure	PLOS ONE			English	Article							RESPIRATORY VIRUSES; PULMONARY EXACERBATIONS; VIRAL-INFECTIONS; 1ST YEAR; CHILDREN; ILLNESS; EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; TRACT	Background Common cold viruses create significant health and financial burdens, and understanding key loci of transmission would help focus control strategies. This study (1) examines factors that influence when individuals transition from a negative to positive test (acquisition) or a positive to negative test (loss) of rhinovirus (HRV) and other respiratory tract viruses in 26 households followed weekly for one year, (2) investigates evidence for intrahousehold and interhousehold transmission and the characteristics of individuals implicated in transmission, and (3) builds data-based simulation models to identify factors that most strongly affect patterns of prevalence. Methods We detected HRV, coronavirus, paramyxovirus, influenza and bocavirus with the FilmArray polymerase chain reaction (PCR) platform (BioFire Diagnostics, LLC). We used logistic regression to find covariates affecting acquisition or loss of HRV including demographic characteristics of individuals, their household, their current infection status, and prevalence within their household and across the population. We apply generalized linear mixed models to test robustness of results. Results Acquisition of HRV was less probable in older individuals and those infected with a coronavirus, and higher with a higher proportion of other household members infected. Loss of HRV is reduced with a higher proportion of other household members infected. Within households, only children and symptomatic individuals show evidence for transmission, while between households only a higher number of infected older children (ages 5-19) increases the probability of acquisition. Coronaviruses, paramyxoviruses and bocavirus also show evidence of intrahousehold transmission. Simulations show that age-dependent susceptibility and transmission have the largest effects on mean HRV prevalence. Conclusions Children are most likely to acquire and most likely to transmit HRV both within and between households, with infectiousness concentrated in symptomatic children. Simulations predict that the spread of HRV and other respiratory tract viruses can be reduced but not eliminated by practices within the home.	[Adler, Frederick R.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Adler, Frederick R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Stockmann, Chris; Ampofo, Krow; Pavia, Andrew T.] Univ Utah, Dept Pediat Med, Salt Lake City, UT USA; [Byington, Carrie L.] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Adler, FR (corresponding author), Univ Utah, Dept Math, Salt Lake City, UT 84112 USA.; Adler, FR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	adler@math.utah.edu	PAN, ZEQIANG/X-6341-2018		21st Century Science Initiative Grant from the James S McDonnell Foundation; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [5U01AI082482]; NIH/National Institute of Child Health and Human Development [K24HD047249]; NIH/National Center for Advancing Translational Sciences [1UL1TR001067]; HA and Edna Benning Presidential Endowment; Primary Children's Hospital Foundation; Pediatric Clinical and Translational Scholars Program; NIH/NAID [1R01AI125642-01]; NIH [R01 HL125520]; NIH-CSBC [U54 CA209978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD047249] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA209978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125520] Funding Source: NIH RePORTER	21st Century Science Initiative Grant from the James S McDonnell Foundation; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/National Center for Advancing Translational Sciences; HA and Edna Benning Presidential Endowment; Primary Children's Hospital Foundation; Pediatric Clinical and Translational Scholars Program; NIH/NAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-CSBC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a 21st Century Science Initiative Grant from the James S McDonnell Foundation (F.R.A.); the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases 5U01AI082482 (C.L.B., K.A., C.S.); NIH/National Institute of Child Health and Human Development K24HD047249 (C.L.B.); NIH/National Center for Advancing Translational Sciences 1UL1TR001067 (C.L.B.); The HA and Edna Benning Presidential Endowment (C.L.B.); The Primary Children's Hospital Foundation (K.A.); and the Pediatric Clinical and Translational Scholars Program (K.A.). Additional support comes from NIH/NAID 1R01AI125642-01 (K.A., A.T.P.), NIH R01 HL125520 (F.R.A.), and NIH-CSBC: U54 CA209978 (F.R.A.).	Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arden KE, 2010, REV MED VIROL, V20, P156, DOI 10.1002/rmv.644; Asner S, 2012, J CYST FIBROS, V11, P433, DOI 10.1016/j.jcf.2012.04.006; BADGER GF, 1953, AM J HYG, V58, P41, DOI 10.1093/oxfordjournals.aje.a119589; BADGER GF, 1953, AM J HYG, V58, P31, DOI 10.1093/oxfordjournals.aje.a119588; Bolker B., 2020, BBMLE TOOLS GEN MAXI; Brostrom G., 2011, GLMMML GEN LINEAR MO; Byington CL, 2015, CLIN INFECT DIS, V61, P1217, DOI 10.1093/cid/civ486; Canini L, 2016, SCI REPORTS, P6; Cauchemez S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004310; Cousin M, 2016, INFLUENZA OTHER RESP, V10, P109, DOI 10.1111/irv.12353; DOUGLAS RG, 1966, AM REV RESPIR DIS, V94, P159; FOX JP, 1975, AM J EPIDEMIOL, V101, P122, DOI 10.1093/oxfordjournals.aje.a112078; Gern JE, 2015, CLIN EXP ALLERGY, V45, P32, DOI 10.1111/cea.12428; Glass K, 2011, EPIDEMICS-NETH, V3, P152, DOI 10.1016/j.epidem.2011.05.001; Granados A, 2015, DIAGN MICR INFEC DIS, V82, P292, DOI 10.1016/j.diagmicrobio.2015.05.001; Greenberg SB, 2016, SEMIN RESP CRIT CARE, V37, P555, DOI 10.1055/s-0036-1584797; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Harris JM, 1996, CLIN INFECT DIS, V23, P1287, DOI 10.1093/clinids/23.6.1287; Hastie T, 2013, GAM GEN ADDITIVE MOD; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; HENDLEY JO, 1969, AM J EPIDEMIOL, V89, P184, DOI 10.1093/oxfordjournals.aje.a120928; Hendley JO, 1999, ADV VIRUS RES, V54, P453, DOI 10.1016/S0065-3527(08)60375-9; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; Hershenson MB, 2006, AM J RESP CRIT CARE, V174, P1284, DOI 10.1164/rccm.200609-1387ED; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howard LM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw001; Hung IFN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020259; Ironmonger, 1999, J POPULATION RES, V16, P65, DOI DOI 10.1007/BF03029455; Jackson DJ, 2008, J ALLERGY CLIN IMMUN, V121, P667, DOI 10.1016/j.jaci.2007.12.249; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Karppinen S, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.002; KETLER A, 1969, AM J EPIDEMIOL, V90, P244, DOI 10.1093/oxfordjournals.aje.a121067; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Kwok KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022089; Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132; Louie JK, 2005, CLIN INFECT DIS, V41, P262, DOI 10.1086/430915; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCaw JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-345; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; MONTO AS, 1987, J INFECT DIS, V156, P43, DOI 10.1093/infdis/156.1.43; Monto AS, 2014, J INFECT DIS; Peltola V, 2013, CLIN MICROBIOL INFEC, V19, pE322, DOI 10.1111/1469-0691.12193; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Piotrowska Z, 2009, PEDIATR INFECT DIS J, V28, P25, DOI 10.1097/INF.0b013e3181861da0; R Core Team, 2013, R LANG ENV STAT COMP; Sacri AS, 2014, PEDIATR INFECT DIS J, V33, P583, DOI 10.1097/INF.0000000000000220; Taylor S, 2017, J INFECTION, V74, P29, DOI 10.1016/j.jinf.2016.09.003; Tsang TK, 2016, TRENDS MICROBIOL, V24, P123, DOI 10.1016/j.tim.2015.10.012; van der Zalm MM, 2011, J CLIN VIROL, V52, P317, DOI 10.1016/j.jcv.2011.09.003; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Yang Y, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21056; [No title captured]	58	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199388	10.1371/journal.pone.0199388	http://dx.doi.org/10.1371/journal.pone.0199388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044794	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500011
J	Boteon, YL; Wallace, L; Boteon, APCS; Mirza, DF; Mergental, H; Bhogal, RH; Afford, S				Boteon, Yuri L.; Wallace, Lorraine; Boteon, Amanda P. C. S.; Mirza, Darius F.; Mergental, Hynek; Bhogal, Ricky H.; Afford, Simon			An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; PEROXISOME PROLIFERATOR; MOLECULAR-MECHANISMS; ACTIVATED RECEPTORS; HEPATIC STEATOSIS; LIPID-METABOLISM; DRUG-METABOLISM; HEPG2 CELLS; CULTURE; INJURY	Introduction Pharmacological defatting of rat hepatocytes and hepatoma cell lines suggests that the same method could be used to ameliorate macrovesicular steatosis in moderate to severely fatty livers. However there is no data assessing the effects of those drugs on primary human liver cells. We aimed to determine the effectiveness of a pharmacological cocktail in reducing the in vitro lipid content of primary human hepatocytes (PHH). In addition we sought to determine the cytotoxicity of the cocktail towards non-parenchymal liver cells. Methods Steatosis was induced in PHH by supplementation with a combination of saturated and unsaturated free fatty acids. This was followed by addition of a defatting drug cocktail for up to 48 hours. The same experimental method was used with human intra-hepatic endothelial cells (HIEC) and human cholangiocytes. MTT assay was used to assess cell viability, triglyceride quantification and oil red 0 staining were used to determine intracellular lipids content whilst ketone bodies were measured in the supernatants following experimentation. Results Incubation of fat loaded PHH with the drugs over 48 hours reduced the intracellular lipid area by 54%, from 12.85% to 5.99% (p = 0.002) (percentage of total oil red O area), and intracellular triglyceride by 35%, from 28.24 to 18.30 nmol/million of cells (p<0.001). Total supernatant ketone bodies increased 1.4-fold over 48 hours in the defatted PHH compared with vehicle controls (p = 0.002). Moreover incubation with the drugs for 48 hours increased the viability of PHH by 11%, cholangiocytes by 25% whilst having no cytotoxic effects on HIEC. Conclusion These data demonstrate that pharmacological intervention can significantly decrease intracellular lipid content of PHH, increase fatty acids beta-oxidation whilst being non-toxic to PHH, HIEC or cholangiocytes.	[Boteon, Yuri L.; Boteon, Amanda P. C. S.; Mirza, Darius F.; Mergental, Hynek] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Boteon, Yuri L.; Wallace, Lorraine; Bhogal, Ricky H.; Afford, Simon] Univ Birmingham, Coll Med & Dent Sci, NIHR Birmingham Biomed Res Ctr, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Afford, S (corresponding author), Univ Birmingham, Coll Med & Dent Sci, NIHR Birmingham Biomed Res Ctr, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.	s.c.afford@bham.ac.uk	Mergental, Hynek/AAY-7122-2021; Boteon, Yuri/J-1940-2019; Mergental, Hynek/H-9485-2013	Mergental, Hynek/0000-0001-5480-9380; Boteon, Yuri/0000-0002-1709-9284; Mergental, Hynek/0000-0001-5480-9380	National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre; NIHR Birmingham Biomedical Research Centre based at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham	National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre; NIHR Birmingham Biomedical Research Centre based at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham	YLB, LW, and SA have received support from the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre based at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Chang TKH, 2009, AAPS J, V11, P590, DOI 10.1208/s12248-009-9135-y; Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; de Graaf EL, 2012, J GASTROEN HEPATOL, V27, P540, DOI 10.1111/j.1440-1746.2011.06844.x; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fuchs CD, 2014, TRENDS ENDOCRIN MET, V25, P576, DOI 10.1016/j.tem.2014.08.001; Gaddipati R, 2010, ANN HEPATOL, V9, P266, DOI 10.1016/S1665-2681(19)31635-7; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Gomez-Lechon MJ, 2004, CURR DRUG METAB, V5, P443, DOI 10.2174/1389200043335414; Gomez-Lechon MJ, 2014, EXPERT OPIN DRUG MET, V10, P1553, DOI 10.1517/17425255.2014.967680; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; LI SJ, 1989, J SURG RES, V46, P557, DOI 10.1016/0022-4804(89)90020-6; Lin G, 2010, ASIAN BIOMED, V4, P757, DOI 10.2478/abm-2010-0098; Liu Q, 2018, LIVER TRANSPLANT, V24, P233, DOI 10.1002/lt.24972; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Nagrath D, 2009, METAB ENG, V11, P274, DOI 10.1016/j.ymben.2009.05.005; Nativ NI, 2012, AM J TRANSPLANT, V12, P3176, DOI 10.1111/j.1600-6143.2012.04288.x; Nativ NI, 2014, LIVER TRANSPLANT, V20, P1000, DOI 10.1002/lt.23905; Nativ NI, 2013, J HEPATOL, V59, P1307, DOI 10.1016/j.jhep.2013.07.019; NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001; Nocito A, 2006, J HEPATOL, V45, P494, DOI 10.1016/j.jhep.2006.07.017; Oh KS, 2006, BIOCHEM BIOPH RES CO, V345, P1232, DOI 10.1016/j.bbrc.2006.04.182; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Perez-Daga JA, 2006, TRANSPLANT P, V38, P2468, DOI 10.1016/j.transproceed.2006.08.077; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Seifalian AM, 1998, LIVER TRANSPLANT SUR, V4, P71, DOI 10.1002/lt.500040110; Seifalian AM, 1999, TRANSPLANTATION, V68, P780, DOI 10.1097/00007890-199909270-00009; Sharma Shruti, 2009, Drug Discov Today Dis Mech, V6, pe31; Sison-Young RLC, 2015, TOXICOL SCI, V147, P412, DOI 10.1093/toxsci/kfv136; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014; Yarmush G, 2017, BIOMECH MODEL MECHAN, V16, P1095, DOI 10.1007/s10237-017-0882-x; Yarmush G, 2016, METABOLITES, V6, DOI 10.3390/metabo6010001	39	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201419	10.1371/journal.pone.0201419	http://dx.doi.org/10.1371/journal.pone.0201419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044872	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500103
J	Holldobler, B; Kwapich, CL; Haight, KL				Hoelldobler, Bert; Kwapich, Christina L.; Haight, Kevin L.			Behavior and exocrine glands in the myrmecophilous beetle Lomechusoides strumosus (Fabricius, 1775) (formerly called Lomechusa strumosa) (Coleoptera: Staphylinidae: Aleocharinae)	PLOS ONE			English	Article							ATEMELES; COMMUNICATION; MORPHOLOGY; BIOLOGY; ANTS	To become integrated into an ant society, myrmecophilous parasites must overcome both the defenses and the communication system of their hosts. Some aleocharine staphylinid beetles employ chemical and tactile strategies to invade colonies, where they later consume ant brood and participate in parasitic trophallaxis with host ants. By producing compounds that both appease their hosts and stimulate adoption, the beetles are able to live in and deposit their own eggs in the well defended ant nest. In the current paper, previous findings on the myrmecophilous behavior and morphological features of the staphylinid beetle Lomechusoides (formerly Lomechusa) strumosus are reviewed and re-evaluated. Hitherto unpublished results concerning the beetles' ability to participate in the social food flow of their host ants are reported. Furthermore, we present an analysis and documentation of the behavioral interactions between beetles and host ants during the adoption process, and we report new histological and scanning electron microscopic analyses of the exocrine glands and morphological adaptations that underlie the myrmecophilous behavior of L. strumosus. The main features of L. strumosus are compared with those of the staphilinid myrmecophile Lomechusa (formerly Atemeles) pubicollis. The paper concludes with a description of the life trajectory of L. strumosus and presents a brief history and discussion of the hypotheses concerning the evolution of myrmecophily in L. strumosus and other highly adapted myrmecophilous parasites.	[Hoelldobler, Bert; Kwapich, Christina L.; Haight, Kevin L.] Arizona State Univ, Social Insect Res Grp, Sch Life Sci, Tempe, AZ 85281 USA; [Hoelldobler, Bert] Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B; Kwapich, CL (corresponding author), Arizona State Univ, Social Insect Res Grp, Sch Life Sci, Tempe, AZ 85281 USA.; Holldobler, B (corresponding author), Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany.	bert.hoelldobler@asu.edu; ckwapich@asu.edu		Kwapich, Christina/0000-0001-5141-7605				[Anonymous], 1971, INSECT SOC; Billen Johan, 2011, Formosan Entomologist, V31, P75; BLUM MS, 1971, ANN ENTOMOL SOC AM, V64, P975, DOI 10.1093/aesa/64.4.975; Donisthorpe HSJK., 1927, GUESTS BRIT ANTS THE; Escherich K, 1898, ZOOLOGISCHE JB SGBT, V12, P27; GACK C, 1994, ZOOMORPHOLOGY, V114, P227, DOI 10.1007/BF00416861; Hlavac P, 2005, SOCIOBIOLOGY, V46, P203; Holldobler B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180847; HOLLDOBL.B, 1967, Z VERGL PHYSIOL, V56, P1, DOI 10.1007/BF00333561; HOLLDOBLER B, 1970, Z VERGL PHYSIOL, V66, P215, DOI 10.1007/BF00297780; Holldobler B., 1990, pi; HOLLDOBLER B, 1971, SCI AM, V224, P86; Holldobler B., 1972, VERHANDLUNGEN DTSCH, V65, P137; Holldobler K, 1948, Z PARASITENKD, V14, P3; HOLLDOLBER B, 1981, Psyche (Cambridge), V88, P347, DOI 10.1155/1981/75317; Jordan KHC, 1913, Z WISS ZOOL ABT A, V107, P346; Kloft W., 1960, ZOOL BEITR, V5, P519; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Parker J, 2016, MYRMECOL NEWS, V22, P65; PASTEELS J M, 1968, Archives de Biologie, V79, P381; RATHMAYER W, 1962, NATURE, V196, P1148, DOI 10.1038/1961148a0; ROMEIS B, 1948, MIKROSKOPISCHE TECHN; Sawada Kohei, 1994, Contributions from the Biological Laboratory Kyoto University, V28, P357; SCHILOW W F, 1981, Reichenbachia, V19, P213; Schilow WF., 1977, REICHENBACHIA, V16, P323; Schilow WF, 1997, DTSCH ENTOMOLOGISCHE, V24, P371; Wasmann E, 1915, Z WISS ZOOL ABT A, V114, P233; Wasmann E., 1903, Biologisches Zentralblatt, Vxxiii, P63; Wasmann E., 1897, Zoologischer Anzeiger, P463; Wasmann E., 1920, GASTPFLEGE AMEISEN; Wasmann E, 1903, BIOLISCHES ZENTRALBL, V23, P61; Wasmann E, 1903, BIOLISCHES ZENTRALBL, V23, P98; Wasmann E, 1903, BIOLISCHES ZENTRALBL, V23, P32; Wasmann E, 1903, BIOL ZENTRALBL, V23, P195; Wheeler W. M, 1910, ANTS	35	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200309	10.1371/journal.pone.0200309	http://dx.doi.org/10.1371/journal.pone.0200309			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044803	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500040
J	Narita, K; Asano, K; Morimoto, Y; Igarashi, T; Nakane, A				Narita, Kouji; Asano, Krisana; Morimoto, Yukihiro; Igarashi, Tatsushi; Nakane, Akio			Chronic irradiation with 222-nm UVC light induces neither DNA damage nor epidermal lesions in mouse skin, even at high doses	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTION; SURGICAL SITE INFECTIONS; ULTRAVIOLET-RADIATION; PREVENTION; SURGERY; MICE	Surgical site infections (SSIs) represent an important clinical problem associated with increased levels of surgical morbidity and mortality. UVC irradiation during surgery has been considered to represent a possible strategy to prevent the development of SSI. 254-nm UVC induces marked levels of DNA damage by generating cyclobutyl pyrimidine dimers (CPD) in microorganisms. However, this effect is elicited not only in microorganisms, but also in human cells, and chronic exposure to 254-nm UVC has been established to represent a human health hazard. In contrast, despite short wavelength-UVC light, especially 222-nm UVC, having been demonstrated to elicit a bactericidal effect, single irradiation with a high dose of 222-nm UVC energy has been reported to not induce mutagenic or cytotoxic DNA lesions in mammalian cells. However, the effect of chronic irradiation with a high dose of 222-nm UVC to mammalian cells has not been determined. In this study, it was demonstrated that large numbers of CPD-expressing cells were induced in the epidermis of mice following treatment with a small amount of single exposure 254-nm UVC, and then less than half of these cells reduced within 24 h. Chronic 254-nm UVC irradiation was revealed to induce sunburn and desquamation in mouse skin. Histological analysis demonstrated that small numbers of CPD-expressing cells were detected only in hyperkeratotic stratum corneum after chronic irradiation with a high dose of 254-nm UVC, and that significant hyperplasia and intercellular edema were also induced in the epidermis of mice. In contrast, chronic irradiation with 222-nm UVC light was revealed not to induce mutagenic or cytotoxic effects in the epidermis of mice. These results indicated that 222-nm UVC light emitted from the lamp apparatus (or device), which was designed to attenuate harmful light present in wave-lengths of more than 230 nm, represents a promising tool for the reduction of SSI incidence in patients and hospital staff.	[Narita, Kouji; Asano, Krisana; Nakane, Akio] Hirosaki Univ, Dept Microbiol & Immunol, Grad Sch Med, Hirosaki, Aomori, Japan; [Narita, Kouji] Hirosaki Univ, Inst Anim Experimentat, Grad Sch Med, Hirosaki, Aomori, Japan; [Asano, Krisana; Nakane, Akio] Hirosaki Univ, Dept Biopolymer & Hlth Sci, Grad Sch Med, Hirosaki, Aomori, Japan; [Morimoto, Yukihiro; Igarashi, Tatsushi] Ushio Inc, Chiyoda Ku, Tokyo, Japan	Hirosaki University; Hirosaki University; Hirosaki University	Nakane, A (corresponding author), Hirosaki Univ, Dept Microbiol & Immunol, Grad Sch Med, Hirosaki, Aomori, Japan.; Nakane, A (corresponding author), Hirosaki Univ, Dept Biopolymer & Hlth Sci, Grad Sch Med, Hirosaki, Aomori, Japan.	a27k03n0@hirosaki-u.ac.jp			USHIO Inc., Tokyo, Japan	USHIO Inc., Tokyo, Japan	This work was supported by USHIO Inc., Tokyo, Japan. The funder provided support in the form of salaries for authors [Y. M. and T. I.] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEMEIER WA, 1968, SURG CLIN N AM, V48, P227; Anderson DJ, 2009, INFECT DIS CLIN N AM, V23, P53, DOI 10.1016/j.idc.2008.10.004; Berton TR, 1997, J INVEST DERMATOL, V109, P340, DOI 10.1111/1523-1747.ep12335984; Buonanno M, 2017, RADIAT RES, V187, P483, DOI 10.1667/RR0010CC.1; Buonanno M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138418; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; CHANG JCH, 1985, APPL ENVIRON MICROB, V49, P1361, DOI 10.1128/AEM.49.6.1361-1365.1985; Dai TH, 2012, ANTIMICROB AGENTS CH, V56, P3841, DOI 10.1128/AAC.00161-12; GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; Gupta A, 2013, ADV WOUND CARE, V2, P422, DOI 10.1089/wound.2012.0366; HOWORTH FH, 1985, LANCET, V1, P386; Kaye KS, 2008, CLIN INFECT DIS, V46, P1568, DOI 10.1086/587673; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Lee CH, 2013, INT J MOL SCI, V14, P6414, DOI 10.3390/ijms14036414; Mallet JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162212; Narita K, 2018, J PHOTOCH PHOTOBIO B, V178, P10, DOI 10.1016/j.jphotobiol.2017.10.030; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Ponnaiya B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192053; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Reichman David E, 2009, Rev Obstet Gynecol, V2, P212; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; STERENBORG HJCM, 1988, PHOTOCHEM PHOTOBIOL, V47, P245, DOI 10.1111/j.1751-1097.1988.tb02722.x; VINK AA, 1991, CARCINOGENESIS, V12, P861, DOI 10.1093/carcin/12.5.861; Welch D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21058-w	27	56	60	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201259	10.1371/journal.pone.0201259	http://dx.doi.org/10.1371/journal.pone.0201259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044862	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500096
J	Ohmichi, T; Kasai, T; Kosaka, T; Shikata, K; Tatebe, H; Ishii, R; Shinomoto, M; Mizuno, T; Tokuda, T				Ohmichi, Takuma; Kasai, Takashi; Kosaka, Tadashi; Shikata, Keisuke; Tatebe, Harutsugu; Ishii, Ryotaro; Shinomoto, Makiko; Mizuno, Toshiki; Tokuda, Takahiko			Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease	PLOS ONE			English	Article							CAFFEINE; NEUROPROTECTION; PROGRESSION; VALIDATION; CRITERIA; MODEL; TIME; CSF	Caffeine has been considered a neuroprotective agent against Parkinson's disease (PD). Recent metabolomic analysis showed that levels of caffeine and its metabolites were decreased in sera from patients with PD compared with those from healthy controls. We focused on theophylline, which is one of the primary caffeine metabolites, as a candidate biomarker of PD because: (1) its serum level can be measured in hospital laboratories by standardized immunoassay kits for therapeutic drug monitoring and (2) because it is less markedly affected by caffeine intake. This was a pilot study to measure the levels of theophylline in sera of 31 patients with PD and 33 age-matched disease controls using an immunoassay kit. We confirmed the previous finding of significantly lower levels of serum theophylline in the PD group compared with control group (PD: 0.07 +/- 0.09 mu g/mL, control: 0.18 +/- 0.24 mu g/mL, p<0.05). Using such an approach of applying known medical biomarkers for neurodegenerative diseases may allow us to skip the process from the discovery phase to clinical application, and subsequently shorten the period of time necessary for biomarker development.	[Ohmichi, Takuma; Kasai, Takashi; Tatebe, Harutsugu; Ishii, Ryotaro; Shinomoto, Makiko; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Kosaka, Tadashi; Shikata, Keisuke] Kyoto Prefectural Univ Med, Univ Hosp, Dept Pharm, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare Med, Kyoto, Japan; [Ishii, Ryotaro] Kyoto Prefectural Univ Med, North Med Ctr, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan; [Tokuda, Takahiko] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	kasaita@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020; Ishii, Ryotaro/K-4595-2019		Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/ MINDS)); Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09319, 18K07506]; Dainippon Sumitomo Pharma Research grant; Dainippon Sumitomo Pharma	Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/ MINDS))(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dainippon Sumitomo Pharma Research grant; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.)	This work was supported in part by a grant from the Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/ MINDS)) (to T.T.) and by a Grant-in-Aid (Nos. 15K09319 and 18K07506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.K. and Dainippon Sumitomo Pharma Research grant (2017 to TK and 2018 to TO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a grant from the Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)) (to T.T.), by a Grant-in-Aid (Nos. 15K09319 and 18K07506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.K, and research grants from Dainippon Sumitomo Pharma in 2018 (to T.O.) and 2017 (to T.K.).	Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Chen F, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3900; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Daly J W, 1987, Prog Clin Biol Res, V230, P41; del Campo M, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00202; Fujimaki M, 2018, NEUROLOGY, V90, pE404, DOI 10.1212/WNL.0000000000004888; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hatano T, 2016, J NEUROL NEUROSUR PS, V87, P295, DOI 10.1136/jnnp-2014-309676; Ko D-H, 2016, J LAB MED QUAL ASSUR, V38, P11; Kruse N, 2015, NEUROBIOL AGING, V36, P2587, DOI 10.1016/j.neurobiolaging.2015.05.003; LeWitt PA, 2017, NEUROLOGY, V88, P862, DOI 10.1212/WNL.0000000000003663; Lue LF, 2017, NEUROL THER, V6, pS25, DOI 10.1007/s40120-017-0074-8; Molinuevo JL, 2014, ALZHEIMERS DEMENT, V10, P808, DOI 10.1016/j.jalz.2014.03.003; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Mizuno Y, 2013, MOVEMENT DISORD, V28, P1138, DOI 10.1002/mds.25418; Moccia M, 2016, PARKINSONISM RELAT D, V32, P116, DOI 10.1016/j.parkreldis.2016.08.005; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Postuma RB, 2012, NEUROLOGY, V79, P651, DOI 10.1212/WNL.0b013e318263570d; Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Schwarzschild Michael A., 2003, Neurology, V61, pS55; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006; Yamazaki H, 1998, CHEM RES TOXICOL, V11, P659, DOI 10.1021/tx970217f; Zhou B, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/567386	27	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201260	10.1371/journal.pone.0201260	http://dx.doi.org/10.1371/journal.pone.0201260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044870	gold, Green Submitted, Green Published			2022-12-26	WOS:000439942500097
J	Wang, JB; Olgin, JE; Nah, G; Vittinghoff, E; Cataldo, JK; Pletcher, MJ; Marcus, GM				Wang, Julie B.; Olgin, Jeffrey E.; Nah, Gregory; Vittinghoff, Eric; Cataldo, Janine K.; Pletcher, Mark J.; Marcus, Gregory M.			Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study	PLOS ONE			English	Article							TERM E-CIGARETTE; ELECTRONIC CIGARETTES; SMOKING-CESSATION; RESPIRATORY HEALTH; UNITED-STATES; NICOTINE; PREFERENCES; RELIABILITY; VALIDITY; ADULTS	E-cigarettes are promoted as healthier alternatives to conventional cigarettes. Many cigarette smokers use both products. It is unknown whether the additional use of e-cigarettes among cigarette smokers (dual users) is associated with reduced exposure to tobaccorelated health risks. Cross-sectional analysis was performed using baseline data from the Health eHeart Study, among English-speaking adults, mostly from the United States. Cigarette use (# cigarettes/day) and/or e-cigarette use (# days, # cartridges, and # puffs) were compared between cigarette only users vs. dual users. Additionally, we examined cardiopulmonary symptoms/ conditions across product use: no product (neither), e-cigarettes only, cigarettes only, and dual use. Among 39,747 participants, 573 (1.4%) reported e-cigarette only use, 1,693 (4.3%) reported cigarette only use, and 514 (1.3%) dual use. Dual users, compared to cigarette only users, reported a greater median (IQR) number of cigarettes per day, 10.0 (4.0-20.0) vs. 9.0 (3.0-15.0) (p < .0001), a lower (worse) median (IQR) SF-12 general health score, 3.3 (2.8-3.8) vs. 3.5 (2.8-3.9) (p = .0014), and a higher (worse) median (IQR) breathing difficulty score in the past month, 2.0 (1.0-2.0) vs. 1.0 (1.0-2.0) (p = .1). Of the 19 cardiopulmonary symptoms/ conditions, having a history of arrhythmia was significantly different between cigarette only users (14.2%) and dual users (17.8%) (p= .2). In this sample, dual use was not associated with reduced exposure to either (i) cigarettes, compared to cigarette only users or (ii) e-cigarettes, compared to e-cigarette only users. E-cigarette only use, compared to no product use, was associated with lower general health scores, higher breathing difficulty scores (typically and past month), and greater proportions of those who responded 'yes' to having chest pain, palpitations, coronary heart disease, arrhythmia, COPD, and asthma. These data suggest the added use of e-cigarettes alone may have contributed to cardiopulmonary health risks particularly respiratory health risks.	[Wang, Julie B.] 24K Data, Washington, DC USA; [Wang, Julie B.; Olgin, Jeffrey E.; Nah, Gregory; Marcus, Gregory M.] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA; [Wang, Julie B.; Cataldo, Janine K.] Univ Calif San Francisco, Sch Nursing, Physiol Nursing, San Francisco, CA 94143 USA; [Vittinghoff, Eric; Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA.	greg.marcus@ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Wang, Julie/0000-0001-7039-6061	Office of Behavioral and Social Sciences Research of the National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health; National Institute of Neurological Disorders and Stroke of the National Institutes of Health; National Heart, Lung, and Blood Institute of the National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [1U2CEB021881]; National Institutes of Health/National Cancer Institute [2T32CA113710-11]; Patient Centered Outcomes Research Institute [PPRN-1306-04709]; 24K Data	Office of Behavioral and Social Sciences Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); 24K Data	This study was supported by Office of Behavioral and Social Sciences Research, National Institute of Biomedical Imaging and Bioengineering, National Institute of Neurological Disorders and Stroke, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health (1U2CEB021881), National Institutes of Health/National Cancer Institute (2T32CA113710-11), the Patient Centered Outcomes Research Institute (PPRN-1306-04709), and 24K Data (http://24Kdata.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant information: 1U2CEB021881: JO, MP, GM (http://grantome.com/grant/NIH/U2C-EB021881-01), 2T32CA113710-11: JW (via PL) (http://grantome.com/grant/NIH/T32-CA113710-11), PPRN-1306-04709: JO, MP, GM (URL not available).	Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; [Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1177, DOI 10.15585/mmwr.mm6542a7; Ayers JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170702; Barrington-Trimis JL, 2014, JAMA-J AM MED ASSOC, V312, P2493, DOI 10.1001/jama.2014.14830; Benowitz NL, 2017, NAT REV CARDIOL, V14, P447, DOI 10.1038/nrcardio.2017.36; Benowitz NL, 2017, ADDICTION, V112, P6, DOI 10.1111/add.13534; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Borland R, 2010, NICOTINE TOB RES, V12, pS45, DOI 10.1093/ntr/ntq038; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Clapp PW, 2017, AM J PHYSIOL-LUNG C, V313, pL278, DOI 10.1152/ajplung.00452.2016; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Douglas CE, 1998, TOB CONTROL, V7, P215, DOI 10.1136/tc.7.3.215; Etter JF, 2014, ADDICT BEHAV, V39, P491, DOI 10.1016/j.addbeh.2013.10.028; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Farsalinos KE, 2016, ADDICTION, V111, P2032, DOI 10.1111/add.13506; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Flower M, 2017, RESPIROL CASE REP, V5, DOI 10.1002/rcr2.230; Food and Drug Administration (FDA), 2010, FED REGISTER, V75, P13225; Foulds J, 2011, INT J CLIN PRACT, V65, P1037, DOI 10.1111/j.1742-1241.2011.02751.x; Gerloff Janice, 2017, Appl In Vitro Toxicol, V3, P28, DOI 10.1089/aivt.2016.0030; Goniewicz ML, 2013, DRUG ALCOHOL REV, V32, P133, DOI 10.1111/j.1465-3362.2012.00512.x; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grana RA, 2014, JAMA INTERN MED, V174, P812, DOI 10.1001/jamainternmed.2014.187; Guo XF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02232-y; Hagstromer M, 2017, INT PHYS ACTIVITY QU, DOI [10.1079/PHN2005898, DOI 10.1079/PHN2005898]; Heydari G, 2017, LUNG INDIA, V34, P25, DOI 10.4103/0970-2113.197119; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lippi G, 2014, SEMIN THROMB HEMOST, V40, P60, DOI 10.1055/s-0033-1363468; Moazed F, 2017, AM J RESP CRIT CARE, V195, P974, DOI 10.1164/rccm.201611-2259ED; Popova L, 2013, AM J PUBLIC HEALTH, V103, P923, DOI 10.2105/AJPH.2012.301070; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; Schoenborn CA, 2014, ELECT CIGARETTE USE; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Sherwood CL, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0369-9; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Vansickel AR, 2010, CANCER EPIDEM BIOMAR, V19, P1945, DOI 10.1158/1055-9965.EPI-10-0288; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Vickerman KA, 2013, NICOTINE TOB RES, V15, P1787, DOI 10.1093/ntr/ntt061; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Warren GW, 2014, CANCER-AM CANCER SOC, V120, P1914, DOI 10.1002/cncr.28695; Zhu SH, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3262; Zhuang YL, 2016, TOB CONTROL, V25, pi90, DOI 10.1136/tobaccocontrol-2016-053096	49	107	109	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0198681	10.1371/journal.pone.0198681	http://dx.doi.org/10.1371/journal.pone.0198681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044773	gold, Green Published			2022-12-26	WOS:000439942500008
J	Wang, XH; Jiao, Y; Li, LH				Wang, Xun-Heng; Jiao, Yun; Li, Lihua			Mapping individual voxel-wise morphological connectivity using wavelet transform of voxel-based morphology	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; LOW-FREQUENCY; SMALL-WORLD; BRAIN; MORPHOMETRY; ORGANIZATION; RELIABILITY; NETWORKS; HUBS; MRI	Mapping individual brain networks has drawn significant research interest in recent years. Most individual brain networks developed to date have been based on fMRI or diffusion MRI. Given recent concerns regarding confounding artifacts, various preprocessing steps are generally included in functional or structural brain networks. Notably, voxel-based morphometry (VBM) derived from anatomical MRI exhibits high signal-to-noise ratios and has been applied to individual interregional morphological networks. To the best of our knowledge, individual voxel-wise morphological networks remain unexplored. The goal of this research is twofold: to build novel metrics for individual voxel-wise morphological networks and to test the reliability of the proposed morphological connectivity. To this end, anatomical scans of a cohort of healthy subjects were obtained from a public database. The anatomical datasets were preprocessed and normalized to the standard brain space. For each individual, wavelet-transform was applied on the VBM measures to obtain voxel-wise hierarchical features. The voxel-wise morphological connectivity was computed based on the wavelet features. Reliable brain hubs were detected by the z-scores of degree centrality. High reliability was discovered by test-retest analysis. No effects of wavelet scale, network threshold or network type were found on hubs of group-level degree centrality. However, significant effects of wavelet scale, network threshold and network type were found on individual-level degree centrality. Significant effects of network threshold and network type were found on reliability of degree centrality. The results suggested that the voxel-wise morphological connectivity was reliable and exhibited a hub structure. Moreover, the voxel-wise morphological connectivity could reflect individual differences. In summary, individual voxel-wise wavelet-based features can probe morphological connectivity and may be beneficial for investigating the brain morphological connectomes.	[Wang, Xun-Heng; Li, Lihua] Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Peoples R China; [Jiao, Yun] Southeast Univ, Zhongda Hosp, Dept Radiol, Jiangsu Key Lab Mol & Funct Imaging,Med Sch, Nanjing, Jiangsu, Peoples R China	Hangzhou Dianzi University; Southeast University - China	Wang, XH; Li, LH (corresponding author), Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Peoples R China.	xhwang@hdu.edu.cn; lilh@hdu.edu.cn		Wang, Xun-Heng/0000-0002-0094-6862	National Natural Science Foundation of China [61601155, 81501453, 61731008, 61271063]; 973 Program [2013CB329502]; National Distinguished Young Research Scientist Award [60788101]; Zhejiang Provincial Natural Science Foundation of China [LZ15F010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Distinguished Young Research Scientist Award; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by grants from the National Natural Science Foundation of China (61601155, 81501453, 61731008, and 61271063), http://www.nsfc.gov.cn, 973 Program (2013CB329502), http://program.most.gov.cn, the National Distinguished Young Research Scientist Award (60788101), http://www.nsfc.gov.cn, and the Zhejiang Provincial Natural Science Foundation of China (LZ15F010001), http://www.zjnsf.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baum GL, 2018, NEUROIMAGE, V173, P275, DOI 10.1016/j.neuroimage.2018.02.041; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Dai Z., 2014, CEREB CORTEX, V25, P3723, DOI [10.1093/cercor/bhu246, DOI 10.1093/CERCOR/BHU246]; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Guo XJ, 2015, J MAGN RESON IMAGING, V42, P261, DOI 10.1002/jmri.24780; Hackmack K, 2012, NEUROIMAGE, V62, P48, DOI 10.1016/j.neuroimage.2012.05.022; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Canales-Rodriguez EJ, 2013, NEUROIMAGE, V72, P214, DOI 10.1016/j.neuroimage.2013.01.058; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Kong XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141840; Kong XZ, 2014, J NEUROSCI METH, V237, P103, DOI 10.1016/j.jneumeth.2014.09.003; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Pantazatos SP, 2014, NEUROIMAGE, V88, P61, DOI 10.1016/j.neuroimage.2013.11.011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schnack HG, 2010, HUM BRAIN MAPP, V31, P1967, DOI 10.1002/hbm.20991; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wang H, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.448; Wang X, 2013, NEUROSCIENCE, V254, P404, DOI 10.1016/j.neuroscience.2013.09.009; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	39	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201243	10.1371/journal.pone.0201243	http://dx.doi.org/10.1371/journal.pone.0201243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040855	gold, Green Submitted, Green Published			2022-12-26	WOS:000439749200033
J	Sander, S; Kappenstein, O; Ebner, I; Fritsch, KA; Schmidt, R; Pfaff, K; Luch, A				Sander, Stefan; Kappenstein, Oliver; Ebner, Ingo; Fritsch, Kai-Andre; Schmidt, Roman; Pfaff, Karla; Luch, Andreas			Release of aluminium and thallium ions from uncoated food contact materials made of aluminium alloys into food and food simulant	PLOS ONE			English	Article							DISSOLUTION; INCLUSIONS; FOIL	In order to investigate the release of aluminium ions from food contact materials, three different types of uncoated aluminium menu trays for single use were tested with the foodstuffs sauerkraut juice, apple sauce and tomato puree, as well as with the food simulants 5 g/L citric acid solution and artificial tap water. To mimic a consumer relevant exposure scenario, the aluminium trays were studied using time and temperature gradients according to the Cook & Chill method, also taking into account storage time at elevated temperatures during the delivery period. The release of aluminium was found to exceed the specific release limit (SRL) of 5 mg aluminium per kilogram of food specified by the Council of Europe by up to six times. Furthermore, a release of thallium was also detected unexpectedly. Kinetic studies showed a comparable behaviour in the release of aluminium, manganese and vanadium as components of the aluminium alloy itself. In contrast, thallium could be identified as a surface contaminant or impurity because of an entirely different kinetic curve. Kinetic studies also allowed activation energy calculations. Additional camping saucepans were tested as an article for repeated use. In three subsequent release experiments with citric acid (5 g/L), artificial tap water and tomato puree as benchmark foodstuffs, the results were comparable to those of the uncoated wrought alloy aluminium trays.	[Sander, Stefan; Kappenstein, Oliver; Ebner, Ingo; Fritsch, Kai-Andre; Schmidt, Roman; Pfaff, Karla; Luch, Andreas] Natl Reference Lab Food Contact Mat, Dept Chem & Prod Safety, German Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment	Kappenstein, O (corresponding author), Natl Reference Lab Food Contact Mat, Dept Chem & Prod Safety, German Fed Inst Risk Assessment, Berlin, Germany.	oliver.kappenstein@bfr.bund.de	Kappenstein, Oliver/GQH-4523-2022; Kappenstein, Oliver/AAB-4365-2020; Oliver, Kappenstein/L-1573-2019	Kappenstein, Oliver/0000-0003-0857-460X; Ebner, Ingo/0000-0003-1418-6312	Bundesinstitut fur Risikobewertung (BfR) [SFP 1322-513]	Bundesinstitut fur Risikobewertung (BfR)	This work was funded by Bundesinstitut fur Risikobewertung (BfR), project no. SFP 1322-513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.754; [Anonymous], 2008, 32645200811 DIN; [Anonymous], 2016, 10536 DIN; BfR, 2017, UNV AL MEN ERST FORS; BfR, THALL NAT MIN; BfR, 2015, SICH VERPFL BES EMPF; Brunner B, 1999, FLEISCHWIRTSCHAFT, V79, P110; Charles E., 2010, CHEMIE THIEME; CoE, 2004, VER EG NR 1935 2004; Czeslik HS C., 2010, BASISWISSEN PHYSIKAL; Davis J.R., 1999, CORROSION ALUMINIUM; DIN DIfNeV, 2004, 602 DIN EN, P2004; DIN DIfNeV, 2012, 10508 DIN; DIN DIfNeV, 2011, 10531 DIN; EDQM, 2013, MET ALL US FOOD CONT; Ewender J, 2014, PACKAG TECHNOL SCI, V27, P963, DOI 10.1002/pts.2085; Fekete V, 2012, FOOD ADDIT CONTAM A, V29, P1322, DOI 10.1080/19440049.2012.688068; Holleman A. F., 1995, WIBERG LEHRBUCH ANOR; JOHNSON E, 1993, PHIL MAG LETT, V68, P131, DOI 10.1080/09500839308240954; Karbouj R., 2008, TRANSFERT ALUMINIUM; Karbouj R, 2009, FOOD CHEM TOXICOL, V47, P571, DOI 10.1016/j.fct.2008.12.028; PALRECHA MM, 1986, ANALYST, V111, P375, DOI 10.1039/an9861100375; Poonam Rajwanshi VS, 1997, ENVIRON GEOCHEM HLTH, V19, P1; Rajwanshi P, 1997, ENVIRON GEOCHEM HLTH, V19, P1; Scancar J, 2004, FOOD CHEM, V85, P151, DOI 10.1016/j.foodchem.2003.07.028; Sorensen AH, 1997, PHILOS MAG A, V75, P1533, DOI 10.1080/01418619708223742; Stahl T., 2017, MIGRATION ALUMINUM 3; Stahl T, 2011, ALUMINIUM CONTENT SE, P1; Takeda Y, 1998, J FOOD HYG SOC JPN, V39, P178; Takeda Y, 1998, J FOOD HYG SOC JPN, V39, P266, DOI 10.3358/shokueishi.39.4_266	30	11	11	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200778	10.1371/journal.pone.0200778	http://dx.doi.org/10.1371/journal.pone.0200778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036389	Green Published, gold, Green Submitted			2022-12-26	WOS:000439429200015
J	Wu, JMT; Zhan, J; Chobe, S				Wu, Jimmy Ming-Tai; Zhan, Justin; Chobe, Sanket			Mining Association rules for Low-Frequency itemsets	PLOS ONE			English	Article							HIGH UTILITY ITEMSETS; ALGORITHM; PATTERNS; DISCOVERY	High utility itemset mining has become an important and critical operation in the Data Mining field. High utility itemset mining generates more profitable itemsets and the association among these itemsets, to make business decisions and strategies. Although, high utility is important, it is not the sole measure to decide efficient business strategies such as discount offers. It is very important to consider the pattern of itemsets based on the frequency as well as utility to predict more profitable itemsets. For example, in a supermarket or restaurant, beverages like champagne or wine might generate high utility (profit), but also sell less frequently compared to other beverages like soda or beer. In previous studies, it is observed that people who buy milk, bread, or diapers from a supermarket, also tend to buy beer or soda. But the items like milk, diapers, beer, or soda generate less utility (profit value) compared to beverages like champagne or wine. If we combine items like champagne or wine having high utility but less frequency, with the frequently sold items like milk, diaper, or beer, we can increase the utility of the transaction by providing some discount offers on champagne or wine. In this paper, we are integrating low-frequency itemsets with high-frequency itemsets, both having low or high utility, and provide different association rules for this combination of itemsets. In this way, we can generate a more accurate measure of pattern mining for various business strategies.	[Wu, Jimmy Ming-Tai; Zhan, Justin; Chobe, Sanket] Univ Nevada, Dept Comp Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Zhan, J (corresponding author), Univ Nevada, Dept Comp Sci, Las Vegas, NV 89154 USA.	justin.zhan@unlv.edu			United States Department of Defense [W91 1 NF-13-1-0130, 72140-NS-RIP]; National Science Foundation [1625677, 1560625, 1710716]; United Healthcare Foundation [1592]	United States Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); United Healthcare Foundation	This work was supported in part by the United States Department of Defense under Grant W91 1 NF-13-1-0130 and Grant 72140-NS-RIP, in part by the National Science Foundation under Grant 1625677, Grant 1560625, and Grant 1710716, and in part by the United Healthcare Foundation under Grant 1592. We gratefully acknowledge all the organizations for their support.r This work was supported in part by the United States Department of Defense under Grant W91 1 NF-13-1-0130 and Grant 72140-NS-RIP, in part by the National Science Foundation under Grant 1625677, Grant 1560625, and Grant 1710716, and in part by the United Healthcare Foundation under Grant 1592. We gratefully acknowledge all the organizations for their support.	Adinarayanareddy B, 2012, INT J COMPUTER APPL, V58, P25; Agrawal R., 1994, P 20 INT C VER LARG, P487; Ahmed CF, 2009, IEEE T KNOWL DATA EN, V21, P1708, DOI 10.1109/TKDE.2009.46; Vo B, 2013, EXPERT SYST APPL, V40, P1256, DOI 10.1016/j.eswa.2012.08.065; Chan R, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P19; Chen MS, 1996, IEEE T KNOWL DATA EN, V8, P866, DOI 10.1109/69.553155; Chu CJ, 2009, APPL MATH COMPUT, V215, P767, DOI 10.1016/j.amc.2009.05.066; Fournier-Viger Philippe, 2014, Foundations of Intelligent Systems. 21st International Symposium, ISMIS 2014. Proceedings: LNCS 8502, P83, DOI 10.1007/978-3-319-08326-1_9; Fournier-Viger P, 2016, LECT NOTES ARTIF INT, V9853, P36, DOI 10.1007/978-3-319-46131-1_8; Fournier-Viger P, 2016, LECT NOTES ARTIF INT, V9648, P53, DOI 10.1007/978-3-319-32034-2_5; Han JW, 2000, SIGMOD RECORD, V29, P1; Li YC, 2005, LECT NOTES ARTIF INT, V3614, P551; Lin CW, 2014, APPL INTELL, V40, P343, DOI 10.1007/s10489-013-0467-z; Liu JQ, 2012, IEEE DATA MINING, P984, DOI 10.1109/ICDM.2012.20; Liu Y, 2005, LECT NOTES ARTIF INT, V3518, P689; Mengchi Liu, 2012, P 21 ACM INT C INF K; Nathiarasan AS, 2014, 2014 INTERNATIONAL CONFERENCE ON CIRCUITS, COMMUNICATION, CONTROL AND COMPUTING (I4C), P317, DOI 10.1109/CIMCA.2014.7057815; Shankar S., 2010, INT J COMPUTER APPL, V1, P87; Shao JY, 2016, 2016 IEEE/CSAA INTERNATIONAL CONFERENCE ON AIRCRAFT UTILITY SYSTEMS (AUS), P1164, DOI 10.1109/AUS.2016.7748234; Shao JY, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (IEEE DSAA 2015), P549; Song W, 2014, APPL INTELL, V40, P29, DOI 10.1007/s10489-013-0443-7; Tseng V. S., 2010, KDD, P253, DOI [DOI 10.1145/1835804.1835839, 10.1145/1835804.1835839]; Tseng VS, 2013, IEEE T KNOWL DATA EN, V25, P1772, DOI 10.1109/TKDE.2012.59; Tzung-Pei Hong, 2001, Intelligent Data Analysis, V5, P111; Wang J, 2007, LECT NOTES COMPUT SC, V4489, P685; Xing S, 2015 8 INT S COMP IN; Yao H, 2004, SIAM PROC S, P482; Yao H, 2006, DATA KNOWL ENG, V59, P603, DOI 10.1016/j.datak.2005.10.004; Yen SJ, 2007, LECT NOTES COMPUT SC, V4654, P283; Yun U, 2014, KNOWL-BASED SYST, V55, P49, DOI 10.1016/j.knosys.2013.10.011; Yun U, 2013, INTELL DATA ANAL, V17, P917, DOI 10.3233/IDA-130612; Zida S, 2015, ADV ARTIFICIAL INTEL	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0198066	10.1371/journal.pone.0198066	http://dx.doi.org/10.1371/journal.pone.0198066			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036359	Green Published, gold			2022-12-26	WOS:000439429200001
J	Hernandez-Candia, CN; Casas-Flores, S; Gutierrez-Medina, B				Noemi Hernandez-Candia, Carmen; Casas-Flores, Sergio; Gutierrez-Medina, Braulio			Light induces oxidative damage and protein stability in the fungal photoreceptor Vivid	PLOS ONE			English	Article							LOV2 DOMAIN; AVENA-SATIVA; OXYGEN; FLAVOPROTEIN; AGGREGATION; PHOTOADAPTATION; PHOTOTROPIN; ARABIDOPSIS; NEUROSPORA; SCATTERING	Flavin-binding photoreceptor proteins sense blue-light (BL) in diverse organisms and have become core elements in recent optogenetic applications. The light-oxygen-voltage (LOV) protein Vivid (VVD) from the filamentous fungus Neurospora crassa is a classic BL photoreceptor, characterized by effecting a photocycle based on light-driven formation and subsequent spontaneous decay of a flavin-cysteinyl adduct. Here we report that VVD presents alternative outcomes to light exposure that result in protein self-oxidation and, unexpectedly, rise of stability through kinetic control. Using optical absorbance and mass spectrometry we show that purified VVD develops amorphous aggregates with the presence of oxidized residues located at the cofactor binding pocket. Light exposure increases oxidative levels in VVD and specific probe analysis identifies singlet oxygen production by the flavin. These results indicate that VVD acts alternatively as a photosensitizer, inducing self-oxidative damage and subsequent aggregation. Surprisingly, BL illumination has an additional, opposite effect in VVD. We show that light-induced adduct formation establishes a stable state, delaying protein aggregation until photoadduct decay occurs. In accordance, repeated BL illumination suppresses VVD aggregation altogether. Furthermore, photoadduct formation confers VVD stability against chemical denaturation. Analysis of the aggregation kinetics and testing of stabilizers against aggregation reveal that aggregation in VVD proceeds through light-dependent kinetic control and dimer formation. These results uncover the aggregation pathway of a photosensor, where light induces a remarkable interplay between protein damage and stability.	[Noemi Hernandez-Candia, Carmen; Casas-Flores, Sergio; Gutierrez-Medina, Braulio] Inst Potosino Invest Cient & Tecnol, Div Mol Biol, San Luis Potosi, Mexico; [Gutierrez-Medina, Braulio] Inst Potosino Invest Cient & Tecnol, Div Adv Mat, San Luis Potosi, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; Instituto Potosino Investigacion Cientifica y Tecnologica	Gutierrez-Medina, B (corresponding author), Inst Potosino Invest Cient & Tecnol, Div Mol Biol, San Luis Potosi, Mexico.; Gutierrez-Medina, B (corresponding author), Inst Potosino Invest Cient & Tecnol, Div Adv Mat, San Luis Potosi, Mexico.	bgutierrez@ipicyt.edu.mx	Casas-Flores, Sergio/S-6985-2019	Casas-Flores, Sergio/0000-0002-9612-9268; Gutierrez-Medina, Braulio/0000-0003-2810-6774	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico) [SEP-CB-2013-01-223377, IFC-2015-2/1144, SEP-CB-2013-01-220791, LINAN-56787, INFRA-2013-01-204373]; CONACYT [CVU-330541]	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico, www.conacyt.gob.mx), grants SEP-CB-2013-01-223377 and IFC-2015-2/1144 to B.G.-M., SEP-CB-2013-01-220791 to S.C.-F., LINAN-56787 and INFRA-2013-01-204373. C.N.H.-C. is indebted to CONACYT for a Ph.D. scholarship, CVU-330541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Borgia MB, 2013, J AM CHEM SOC, V135, P6456, DOI 10.1021/ja308852b; Buckley AM, 2015, CURR OPIN CHEM BIOL, V27, P39, DOI 10.1016/j.cbpa.2015.05.011; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Conrad KS, 2014, NAT CHEM BIOL, V10, P801, DOI [10.1038/NCHEMBIO.1633, 10.1038/nchembio.1633]; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Finn TE, 2012, J BIOL CHEM, V287, P21530, DOI 10.1074/jbc.M112.372961; Gin E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.24; Grewal RK, 2015, BIOINFORMATICS, V31, P3608, DOI 10.1093/bioinformatics/btv429; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hunt SM, 2007, GENE DEV, V21, P1964, DOI 10.1101/gad.437107; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Lee CT, 2014, J MOL BIOL, V426, P601, DOI 10.1016/j.jmb.2013.10.035; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Losi A, 2017, PHOTOCHEM PHOTOBIOL, V93, P141, DOI 10.1111/php.12674; Massey V, 2002, INT CONGR SER, V1233, P3, DOI 10.1016/S0531-5131(02)00519-8; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Penzkofer A, 2007, CHEM PHYS, V342, P55, DOI 10.1016/j.chemphys.2007.09.014; Schuttrigkeit TA, 2003, CHEM PHYS, V294, P501, DOI 10.1016/S0301-0104(03)00390-2; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Vaidya AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001945; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; Yee EF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10079; Zoltowski B. D., 2009, THESIS; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201028	10.1371/journal.pone.0201028	http://dx.doi.org/10.1371/journal.pone.0201028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028876	Green Submitted, gold, Green Published			2022-12-26	WOS:000439396900033
J	Biswas, C; Rao, S; Slade, K; Hyman, D; Dersh, D; Mantegazza, AR; Zoltick, PW; Marks, MS; Argon, Y; Behrens, EM				Biswas, Chhanda; Rao, Sheila; Slade, Katharine; Hyman, David; Dersh, Devin; Mantegazza, Adriana R.; Zoltick, Philip W.; Marks, Michael S.; Argon, Yair; Behrens, Edward M.			Tyrosine 870 of TLR9 is critical for receptor maturation rather than phosphorylation-dependent ligand-induced signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOPLASMIC-RETICULUM; GENE-REGULATION; TETRACYCLINE RESISTANCE; PROTEOLYTIC CLEAVAGE; ADAPTER PROTEIN-3; MASTER CHAPERONE; STRUCTURAL BASIS; INNATE IMMUNITY; TET REPRESSOR	Toll like receptors (TLRs) share a conserved structure comprising the N-terminal ectodomain, a transmembrane segment and a C-terminal cytoplasmic Toll/IL-1 receptor (TIR) domain. Proper assembly of the TIR domain is crucial for signal transduction; however, the contribution of individual motifs within the TIR domain to TLR trafficking and signaling remains unclear. We targeted a highly conserved tyrosine (Y870) located in the box 1 region of the TIR domain of most TLRs, including TLR9, previously described to be a critical site of phosphorylation in TLR4. We reconstituted bone marrow-derived dendritic cells (BMDC) from Tlr9(-/-) mice WT TLR9 or Y870F or Y870A mutants. Despite normal interactions with the luminal chaperones GRP94 and UNC93B1, Y870F conferred only partial responsiveness to CpG, and Y870A had no activity and functioned as a dominant negative inhibitor when coexpressed with endogenous TLR9. This loss of function correlated with reduction or absence, respectively, of the 80 kDa mature form of TLR9. In Y870E-expressing cells, CpG-dependent signaling correlated directly with levels of the mature form, suggesting that signaling did not require tyrosine phosphorylation but rather that the Y870F mutation conferred reduced receptor levels due to defective processing or trafficking. Microscopy revealed targeting of the mutant protein to an autophagolysosome-like structure for likely degradation. Collectively we postulate that the conserved Y870 in the TIR domain does not participate in phosphorylation-induced signaling downstream of ligand recognition, but rather is crucial for proper TIR assembly and ER egress, resulting in maturation-specific stabilization of TLR9 within endolysosomes and subsequent pro-inflammatory signaling.	[Biswas, Chhanda; Rao, Sheila; Slade, Katharine; Hyman, David; Zoltick, Philip W.; Behrens, Edward M.] Childrens Hosp Philadelphia, Div Pediat Rheumatol, Philadelphia, PA 19104 USA; [Dersh, Devin; Mantegazza, Adriana R.; Marks, Michael S.; Argon, Yair] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Behrens, EM (corresponding author), Childrens Hosp Philadelphia, Div Pediat Rheumatol, Philadelphia, PA 19104 USA.	Behrens@email.chop.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262; Mantegazza, Adriana/0000-0002-7583-0231	Nancy Taylor Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121323] Funding Source: NIH RePORTER	Nancy Taylor Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Nancy Taylor Foundation to EMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dennis MK, 2015, J CELL BIOL, V209, P563, DOI 10.1083/jcb.201410026; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Hasan M, 2016, J LEUKOCYTE BIOL, V100, P525, DOI 10.1189/jlb.2A0815-337R; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Mantegazza AR, 2012, IMMUNITY, V36, P782, DOI 10.1016/j.immuni.2012.02.018; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medvedev AE, 2013, J INTERF CYTOK RES, V33, P467, DOI 10.1089/jir.2012.0140; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sinha SS, 2016, J IMMUNOL, V197, P1343, DOI 10.4049/jimmunol.1502357; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200913	10.1371/journal.pone.0200913	http://dx.doi.org/10.1371/journal.pone.0200913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024926	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000066
J	De Leon, MP; Montecillo, AD; Pinili, DS; Siringan, MAT; Park, DS				De Leon, Marian P.; Montecillo, Andrew D.; Pinili, Dale S.; Siringan, Maria Auxilia T.; Park, Doo-Sang			Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RESERVOIR HOSTS; ECOLOGY; HISTOPLASMOSIS; ENVIRONMENTS; PATHOGENS; CARRIAGE; GENOMICS; TRINIDAD; VIRUSES	Bats are highly diverse and ecologically valuable mammals. They serve as host to bacteria, viruses and fungi that are either beneficial or harmful to its colony as well as to other groups of cave organisms. The bacterial diversity of two bat guano samples, C1 and C2, from Cabalyorisa Cave, Mabini, Pangasinan, Philippines were investigated using 16S rRNA gene amplicon sequencing. V3-V4 hypervariable regions were amplified and then sequenced using Illumina MiSeq 250 PE system. Reads were processed using Mothur and QIIME pipelines and assigned 12,345 OTUs for C1 and 5,408 OTUs for C2. The most dominant OTUs in C1 belong to the Proteobacteria (61.7%), Actinobacteria (19.4%), Bacteroidetes (4.2%), Firmicutes (2.7%), Chloroflexi (2.5%), candidate phylum TM7 (2.3%) and Planctomycetes (1.9%) while Proteobacteria (61.7%) and Actinobacteria (34.9%) dominated C2. Large proportion of sequence reads mainly associated with unclassified bacteria indicated possible occurrence of novel bacteria in both samples. XRF spectrophotometric analyses of C1 and C2 guano revealed significant differences in the composition of both major and trace elements. C1 guano recorded high levels of Si, Fe, Mg, Al, Mn, Ti and Cu while C2 samples registered high concentrations of Ca, P, S, Zn and Cr. Community structure of the samples were compared with other published community profiling studies from Finland (SRR868695), Meghalaya, Northeast India (SRR1793374) and Maharashtra State, India (CGS). Core microbiome among samples were determined for comparison. Variations were observed among previously studied guano samples and the Cabalyorisa Cave samples were attributed to either bat sources or age of the guano. This is the first study on bacterial diversity of guano in the Philippines through high-throughput sequencing.	[De Leon, Marian P.] Univ Philippines Los Banos, Museum Nat Hist, Microbial Culture Collect, Laguna, Philippines; [Montecillo, Andrew D.] Univ Philippines Los Banos, Coll Arts & Sci, Inst Biol Sci, Microbiol Div, Laguna, Philippines; [Pinili, Dale S.] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Laguna, Philippines; [Siringan, Maria Auxilia T.] Univ Philippines Diliman, Nat Sci Res Inst, Microbiol Res & Serv Lab, Quezon City, Philippines; [Park, Doo-Sang] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Korean Collect Type Cultures, Jeongeup, South Korea	University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos; CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Diliman; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	De Leon, MP (corresponding author), Univ Philippines Los Banos, Museum Nat Hist, Microbial Culture Collect, Laguna, Philippines.	mpdeleon1@up.edu.ph		Pulido De Leon, Marian/0000-0002-7542-6175	Department of Agriculture-Bureau of Agricultural Research (DA-BAR); University of the Philippines Diliman, Natural Sciences Research Institute (UP NSRI); Next Generation Sequencing by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea [NRF-2016M3A9A5919255]; University of the Philippines Diliman Natural Sciences Research Institute (UP NSRI)	Department of Agriculture-Bureau of Agricultural Research (DA-BAR); University of the Philippines Diliman, Natural Sciences Research Institute (UP NSRI); Next Generation Sequencing by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea; University of the Philippines Diliman Natural Sciences Research Institute (UP NSRI)	The post-doctoral research fellowship was funded by the Department of Agriculture-Bureau of Agricultural Research (DA-BAR) and University of the Philippines Diliman, Natural Sciences Research Institute (UP NSRI) and the Next Generation Sequencing by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea (NRF-2016M3A9A5919255).; The authors acknowledge the Department of Agriculture-Bureau of Agricultural Research (DA-BAR) and University of the Philippines Diliman Natural Sciences Research Institute (UP NSRI) for providing the Post-Doctoral Fellowship to Dr. Marian P. De Leon. The fellowship host scientist, Dr. Maria Auxilia T. Siringan, Curator of the University of the Philippines Culture Collection (UPCC) and Head of Microbiological Research and Services Laboratory (MRSL) and the MRSL Researchers and Administrative staff for the assistance in the conduct of the laboratory experiments. The Next Generation Sequencing was funded by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea (NRF-2016M3A9A5919255). Mr. James DV. Alvarez, Mr. Edison A. Cosico and Mr. Manuel M. Baldovino of the UPLB Museum of Natural History and Mr. John Mark A. Encinares of Institute of Biological Science, UPLB provided the technical and field assistance during the sample collection and identification of bats in Cabalyorisa Cave. The Balincaguin Conservancy, Inc. (BC), especially to Mr. Rawen Balmana, Mr. Guillermo Rendon, Mr. Oliver Barao and his son, Mr. Russel Barao, who accompanied Dr. De Leon in the fieldwork, conducted photo documentation and ensured the safety of the team. The local government of Mabini, headed by the former Honorable Mayor Carlitos Reyes, for the provision of technical and manpower assistance during the fieldwork and the Department of Environment and Natural Resources for the issuance of gratuitous permit.	Adesiyun AA, 2009, J WILDLIFE DIS, V45, P952, DOI 10.7589/0090-3558-45.4.952; Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Allocati N, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.48; Banskar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36948; Banskar S, 2016, MICROBIOL RES, V182, P99, DOI 10.1016/j.micres.2015.10.006; Reyes AWB, 2011, ACTA SCI VET, V39; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; BROWN D, 1988, JAMA-J AM MED ASSOC, V260, P2510, DOI 10.1001/jama.1988.03410170058033; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrillo-Araujo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00447; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Cooper Lisa Noelle, 2013, P3; D'Auria SRN, 2010, VECTOR-BORNE ZOONOT, V10, P459, DOI 10.1089/vbz.2009.0070; De Mandal S, 2015, GENOM DATA, V4, P99, DOI 10.1016/j.gdata.2015.04.001; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Encinares JMA, 2016, THESIS; Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348; Fenton MB, 2003, WILDLIFE SOC B, V31, P6; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Goodman SM, 2006, ORYX, V40, P225, DOI 10.1017/S0030605306000354; Groth I, 1999, GEOMICROBIOL J, V16, P1, DOI 10.1080/014904599270703; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hazeleger W. C., 2010, 15 BAT RES C PRAQ CZ, P72; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hoyt JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121329; Ingle NR, 1992, FIELDIANA; IUCN SSC, 2014, IUCN SSC GUID MIN NE; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Jones G., 2009, ENDANGER SPECIES RES, V8, P3; Kasso M, 2013, ECOLOGICAL EC IMPORT, V2013, P1; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Kobayashi Y, 2006, J VET MED SCI, V68, P1097, DOI 10.1292/jvms.68.1097; Kuzmin IV, 2011, VECTOR-BORNE ZOONOT, V11, P1465, DOI 10.1089/vbz.2011.0663; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee S, 2014, ISME J, V8, P493, DOI 10.1038/ismej.2013.167; Lei BNR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002738; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lyon GM, 2004, AM J TROP MED HYG, V70, P438, DOI 10.4269/ajtmh.2004.70.438; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Municipal Government of Mabini [LGU-Mabini], 2014, MUN COMP LAND USE PL; Niyomvong N, 2012, CHIANG MAI J SCI, V39, P373; Northup DE, 1997, NATL SPELEO SOC NEW, V55, P11; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; Poisot T, 2013, ECOL EVOL, V3, P1125, DOI 10.1002/ece3.508; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rahuma N, 2005, ANN TROP MED PARASIT, V99, P795, DOI 10.1179/136485905X65134; Rapin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112285; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHACKLETTE MH, 1962, SCIENCE, V135, P1135, DOI 10.1126/science.135.3509.1135; Smythe LD, 2002, J WILDLIFE DIS, V38, P182, DOI 10.7589/0090-3558-38.1.182; Tomova I, 2013, INT J SPELEOL, V42, P65, DOI 10.5038/1827-806X.42.1.8; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Wales AD, 2010, ZOONOSES PUBLIC HLTH, V57, P299, DOI 10.1111/j.1863-2378.2008.01222.x; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zdanowski MK, 2004, FEMS MICROBIOL ECOL, V50, P163, DOI 10.1016/j.femsec.2004.06.012	66	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200095	10.1371/journal.pone.0200095	http://dx.doi.org/10.1371/journal.pone.0200095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024917	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000015
J	Luan, HX; Weng, LY; Luan, YZ				Luan, Hengxuan; Weng, Liyuan; Luan, Yuanzhong			Numerical simulation of unsteady aerodynamic interactions of contra-rotating axial fan	PLOS ONE			English	Article							NAVIER-STOKES SIMULATIONS; ROTOR-STATOR INTERACTION; PERFORMANCE; COMPRESSOR; FLOW; OPTIMIZATION; STAGE; NOISE	This paper describes the investigations performed to better understand unsteady effect that develop in a contra-rotating axial fan. More specifically, this study focuses on rotor-rotor interactions effects on unsteady characteristic and blade aerodynamic force. The investigation method is based on three-dimensional URANS simulations, in conjunction with SST turbulence model. At first, the experimental measurements are compared to evaluate ability of the numerical method in estimation of unsteady flows. The results show that rotor-rotor interaction in the contra-rotating fan played an important role in aerodynamic efficiency. Unsteady effect increased flow losses of rotor 1, but effectively inhibited flow losses of rotor 2. The inhibition effect was mainly caused by wake recovery effect of upstream wakes in the flow passage of rotor 2. Meanwhile, negative jet flow enhanced boundary layer energy of the blade of rotor 2, so that flow separation was postponed. Different configurations consider five sets of axial spacing dimensions. Specific survey of flows under the same operation conditions indicates that axial spacing is responsible for the unsteady interaction effect. The blade aerodynamics analysis shows that the influence of the downstream potential flow disturbance on rotor 1 is greater than the effect of the upstream wake on rotor 2.	[Luan, Hengxuan] Shandong Univ Sci & Technol, Dept Mech & Elect Engn, Tai An, Shandong, Peoples R China; [Weng, Liyuan; Luan, Yuanzhong] Shandong Univ Sci & Technol, Coll Geomat, Qingdao, Shandong, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology	Luan, HX (corresponding author), Shandong Univ Sci & Technol, Dept Mech & Elect Engn, Tai An, Shandong, Peoples R China.	hengxuanluan@163.com		luan, hengxuan/0000-0001-8168-8924; Weng, liyuan/0000-0001-8381-2474	Scientific Research Foundation of Shandong University of Science and Technology for Recruited Talents [2017RCJJ078]; Key Research and Development Plan of Shandong Province [2017GSF220010]	Scientific Research Foundation of Shandong University of Science and Technology for Recruited Talents; Key Research and Development Plan of Shandong Province	The authors would like to acknowledge the support of the Scientific Research Foundation of Shandong University of Science and Technology for Recruited Talents (Grant No. 2017RCJJ078), the support of the Key Research and Development Plan of Shandong Province (Grant No. 2017GSF220010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone A, 1995, AM SOC MECH ENG, DOI [10.1115/95-GT-177, DOI 10.1115/95-GT-177]; Blandeau VP, 2010, AIAA J, V48, P2674, DOI 10.2514/1.J050566; Castellani F, 2013, APPL ENERG, V101, P432, DOI 10.1016/j.apenergy.2012.04.039; Chen YY, 2008, P I MECH ENG G-J AER, V222, P985, DOI 10.1243/09544100JAERO364; Crasto G, 2012, ENRGY PROCED, V24, P385, DOI 10.1016/j.egypro.2012.06.122; DRING RP, 1991, J TURBOMACH, V113, P600, DOI 10.1115/1.2929121; El-Behery SM, 2011, COMPUT FLUIDS, V44, P248, DOI 10.1016/j.compfluid.2011.01.009; Furukawa A, 2007, J THERM SCI, V16, P7, DOI 10.1007/s11630-007-0007-4; Gao Limin, 2014, Acta Aeronautica et Astronautica Sinica, V35, P1874, DOI 10.7527/S1000-6893.2013.0509; Gourdain N, 2012, J TURBOMACH, V134, DOI 10.1115/1.4003815; Holmes DG, 2008, PROCEEDINGS OF THE ASME TURBO EXPO 2008, VOL 6, PT A, P2649; Key NL, 2010, J PROPUL POWER, V26, P344, DOI 10.2514/1.45715; Loureiro JBR, 2008, J WIND ENG IND AEROD, V96, P540, DOI 10.1016/j.jweia.2008.01.011; Luan HX, 2017, J VIBROENG, V19, P4630, DOI 10.21595/jve.2017.17863; Luan HX, 2016, J VIBROENG, V18, P5605, DOI 10.21595/jve.2016.17926; Mailach R, 2008, J TURBOMACH, V130, DOI 10.1115/1.2812330; Mao XC, 2016, P I MECH ENG A-J POW, V230, P289, DOI 10.1177/0957650915627061; Mayorca MA, 2011, J TURBOMACH, V133, DOI 10.1115/1.4000579; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Meyer R, 2010, PROCEEDINGS OF THE ASME TURBO EXPO 2010: TURBOMACHINERY: AXIAL FLOW FAN AND COMPRESSOR AERODYNAMICS DESIGN METHODS, AND CFD MODELING FOR TURBOMACHINERY, VOL 7, PTS A-C, P247; Mistry C, 2013, P I MECH ENG A-J POW, V227, P138, DOI 10.1177/0957650912467453; Mortazavi F, 2017, J FLUID ENG-T ASME, V139, DOI 10.1115/1.4037281; Nouri H, 2012, J FLUID ENG-T ASME, V134, DOI 10.1115/1.4007591; RAI MM, 1989, J PROPUL POWER, V5, P312, DOI 10.2514/3.51296; RAI MM, 1989, J PROPUL POWER, V5, P305, DOI 10.2514/3.23154; Ricouard J., 2010, 16 AIAACEAS AEROACOU, DOI [10.2514/6.2010-3795, DOI 10.2514/6.2010-3795]; Schimming P, 2003, J THERM SCI, V12, P97, DOI 10.1007/s11630-003-0049-1; SHARMA PB, 1988, P I MECH ENG A-J POW, V202, P15; Shigemitsu T, 2010, J THERM SCI, V19, P1, DOI 10.1007/s11630-010-0001-0; SMITH LH, 1966, J BASIC ENG-T ASME, V88, P688, DOI 10.1115/1.3645942; Untaroiu CD, 2010, J ENG GAS TURB POWER, V132, DOI 10.1115/1.4001811; Untaroiu CD, 2008, J VIB ACOUST, V130, DOI 10.1115/1.2730535; Van Zante D.E., 1997, 97GT535 ASME, DOI [10.1115/97-GT-535, DOI 10.1115/97-GT-535]; Younsi M, 2016, 12 INT C HEAT TRANSF; Zhao B, 2014, J THERM SCI, V23, P22, DOI 10.1007/s11630-014-0673-y	36	7	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200510	10.1371/journal.pone.0200510	http://dx.doi.org/10.1371/journal.pone.0200510			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024892	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000024
J	Mazzeo, MF; Cacace, G; Iovieno, P; Massarelli, I; Grillo, S; Siciliano, RA				Mazzeo, Maria Fiorella; Cacace, Giuseppina; Iovieno, Paolo; Massarelli, Immacolata; Grillo, Stefania; Siciliano, Rosa Anna			Response mechanisms induced by exposure to high temperature in anthers from thermo-tolerant and thermo-sensitive tomato plants: A proteomic perspective	PLOS ONE			English	Article							HEAT-STRESS RESPONSE; MALE REPRODUCTIVE DEVELOPMENT; ADENOSYL-L-METHIONINE; ORYZA-SATIVA L.; LYCOPERSICON-ESCULENTUM; RICE ANTHERS; PHYSIOLOGICAL PROCESSES; SOLANUM-LYCOPERSICON; MOLECULAR-MECHANISMS; POLLEN DEVELOPMENT	Constant global warming is one of the most detrimental environmental factors for agriculture causing significant losses in productivity as heat stress (HS) conditions damage plant growth and reproduction. In flowering plants such as tomato, HS has drastic repercussions on development and functionality of male reproductive organs and pollen. Response mechanisms to HS in tomato anthers and pollen have been widely investigated by transcriptomics; on the contrary, exhaustive proteomic evidences are still lacking. In this context, a differential proteomic study was performed on tomato anthers collected from two genotypes (thermo-tolerant and thermo-sensitive) to explore stress response mechanisms and identify proteins possibly associated to thermo-tolerance. Results showed that HS mainly affected energy and amino acid metabolism and nitrogen assimilation and modulated the expression of proteins involved in assuring protein quality and ROS detoxification. Moreover, proteins potentially associated to thermo-tolerant features, such as glutamine synthetase, S-adenosylmethionine synthase and polyphenol oxidase, were identified.	[Mazzeo, Maria Fiorella; Cacace, Giuseppina; Siciliano, Rosa Anna] Natl Res Council Italy, CNR ISA, Inst Food Sci, Avellino, Italy; [Iovieno, Paolo; Massarelli, Immacolata; Grillo, Stefania] Natl Res Council Italy, CNR IBBR, Inst Biosci & Bioresources, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Mazzeo, MF (corresponding author), Natl Res Council Italy, CNR ISA, Inst Food Sci, Avellino, Italy.	fmazzeo@isa.cnr.it	Iovieno, Paolo/ABF-2160-2020; Mazzeo, Maria Fiorella/AAX-7262-2020; Siciliano, Rosa Anna/G-9822-2013; Iovieno, Paolo/P-2747-2018	Mazzeo, Maria Fiorella/0000-0003-1542-0027; Iovieno, Paolo/0000-0002-6938-2735	Italian Ministry of Education, University and Scientific Research (GenoPOM Project) [12 DM 593/00]	Italian Ministry of Education, University and Scientific Research (GenoPOM Project)	This work was supported by funding from the Italian Ministry of Education, University and Scientific Research (GenoPOM Project, art 12 DM 593/00) to RAS and SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz A, 2009, PEPTIDES, V30, P1600, DOI 10.1016/j.peptides.2009.06.005; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bita CE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-384; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; Brukhin V, 2003, SEX PLANT REPROD, V15, P311, DOI 10.1007/s00497-003-0167-7; Chaturvedi P, 2016, PLANT REPROD, V29, P119, DOI 10.1007/s00497-016-0283-9; Chaturvedi P, 2015, J PROTEOME RES, V14, P4463, DOI 10.1021/pr501240n; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P1881, DOI 10.1111/pce.12396; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Ghatak A, 2017, J PROTEOMICS, V169, P41, DOI 10.1016/j.jprot.2017.05.016; Giorno Filomena, 2013, Plants-Basel, V2, P489, DOI 10.3390/plants2030489; Giorno F, 2010, J EXP BOT, V61, P453, DOI 10.1093/jxb/erp316; Gong B, 2014, PLANT BIOTECHNOL J, V12, P694, DOI 10.1111/pbi.12173; Gonzalez-Schain N, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv174; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; HURKMAN WJ, 1988, ELECTROPHORESIS, V9, P781, DOI 10.1002/elps.1150091114; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; IWAHORI S., 1966, Engei Gakkai Zasshi = Journal of the Japanese Society of Horticultural Science, V35, P379; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jang SJ, 2012, MOL CELLS, V34, P251, DOI 10.1007/s10059-012-0067-5; Johnova P, 2016, BBA-PROTEINS PROTEOM, V1864, P916, DOI 10.1016/j.bbapap.2016.02.007; Kim M, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/238704; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kosova K, 2015, INT J MOL SCI, V16, P20913, DOI 10.3390/ijms160920913; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Liu JX, 2011, MOL PLANT, V4, P59, DOI 10.1093/mp/ssq039; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Mazzeo MF, 2014, PLANT PHYSIOL BIOCH, V74, P42, DOI 10.1016/j.plaphy.2013.10.031; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mu QL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091811; Muller F, 2016, PLANT REPROD, V29, P107, DOI 10.1007/s00497-016-0282-x; Nguyen TN, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0717-4; Paupiere MJ, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1927-z; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Pucciariello C, 2012, PLANT PHYSIOL BIOCH, V59, P3, DOI 10.1016/j.plaphy.2012.02.016; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Robbins ML, 2013, J PROTEOMICS, V93, P254, DOI 10.1016/j.jprot.2013.06.018; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Sarhadi E, 2012, PLANT PHYSIOL BIOCH, V58, P280, DOI 10.1016/j.plaphy.2012.07.013; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; Sato S, 2002, J EXP BOT, V53, P1187, DOI 10.1093/jexbot/53.371.1187; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; Singh RP, 2013, ADV AGRON, V118, P49, DOI 10.1016/B978-0-12-405942-9.00002-5; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Uvackova L, 2012, J PROTEOMICS, V75, P1886, DOI 10.1016/j.jprot.2011.12.033; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; XU JM, 2017, EUPHYTICA, V213; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zhang ZB, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600458; Zhou SP, 2011, J AM SOC HORTIC SCI, V136, P219, DOI 10.21273/JASHS.136.3.219	53	17	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201027	10.1371/journal.pone.0201027	http://dx.doi.org/10.1371/journal.pone.0201027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024987	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000080
J	Tang, JF; Lee, CH; Hsu, TH; Lo, HC				Tang, Ju-Fang; Lee, Chien-Hsing; Hsu, Tai-Hao; Lo, Hui-Chen			Potential activities and mechanisms of extracellular polysaccharopeptides from fermented Trametes versicolor on regulating glucose homeostasis in insulin-resistant HepG2 cells	PLOS ONE			English	Article							MEDICINAL MUSHROOMS; POLYSACCHARIDES; CULTURE; METABOLISM; MANAGEMENT; 2-NBDG	Polysaccharides derived from mushrooms have potential to control blood sugar, reduce insulin resistance and prevent diabetic complications. The intracellular polysaccharopeptides of Trametes versicolor (TV) have been used as immunologic and oncologic adjuvants. The aim of this study was to investigate the potential activities and mechanisms of extracellular polysaccharopeptides (ePSP) obtained from TV strain LH-1 on regulating glucose homeostasis. Human hepatoma HepG2 cells incubated with normal glucose (5.5 mM, NG model), high glucose (33 mM, HG model), or high glucose (33 mM) plus high insulin (10(-7) M, HGI model) concentrations were administered with TV LH-1 ePSP (50, 100, and 1000 mu g/ml) for 24 hr. Glucose uptake of HepG2 cells, determined by flow cytometry, was significantly decreased in the HG and HGI models with insulin stimulation, suggesting insulin resistance of these cells; however, ePSP reversed this decrease in a dose-dependent manner (one-way ANOVA, p<0.05). In the HG and HGI models, ePSP significantly increased glycogen content, insulin receptor substrate-2 protein and phosphorylated AMP-activated protein kinase (AMPK), as determined by western blot analysis. In addition, ePSP significantly increased glucokinase in the NG and HG models, increased membrane glucose transporter-1 and decreased glycogen synthase kinase-3 beta in the HGI model, and increased glucose-6-phosphatase in the NG and HGI models (one-way ANOVA, p<0.05). In summary, TV LH-1 ePSP may elevate cellular glucose uptake to regulate glucose homeostasis via the activation of AMPK and glycogen synthesis in an insulin-independent manner. These results suggest that TV LH-1 ePSP may be a nutraceutical with anti-hyperglycemic activity.	[Tang, Ju-Fang; Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei, Taiwan; [Lee, Chien-Hsing] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Lee, Chien-Hsing] China Med Univ, Dept Surg, Div Pediat Surg, Childrens Hosp, Taichung, Taiwan; [Hsu, Tai-Hao] Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan; [Hsu, Tai-Hao] Da Yeh Univ, Dept Med Bot & Hlth Care, Changhua, Taiwan	Fu Jen Catholic University; China Medical University Taiwan; China Medical University Taiwan; Da Yeh University; Da Yeh University	Lo, HC (corresponding author), Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei, Taiwan.	041663@mail.fju.edu.tw	Lo, Hui-Chen/AAN-5906-2021		Ministry of Economic Affairs of Taiwan [97-EC-17-A-17-S1-115]	Ministry of Economic Affairs of Taiwan(Ministry of Economic Affairs, Taiwan)	This study was supported by a grant from the Ministry of Economic Affairs (97-EC-17-A-17-S1-115) of Taiwan.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Chang TJ, 2012, J FORMOS MED ASSOC, V111, P605, DOI 10.1016/j.jfma.2012.09.011; Chang YJ, 2017, DISCOV MED, V23, P207; Chay WY, 2017, J ALTERN COMPLEM MED, V23, P648, DOI 10.1089/acm.2016.0136; Chen CH, 2015, J AGR FOOD CHEM, V63, P9232, DOI 10.1021/acs.jafc.5b02668; Donatini B, 2014, INT J MED MUSHROOMS, V16, P497, DOI 10.1615/IntJMedMushrooms.v16.i5.80; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Guo W, 2006, AM J PHYSIOL-GASTR L, V290, pG528, DOI 10.1152/ajpgi.00386.2005; Hsu WK, 2013, CARBOHYD POLYM, V92, P297, DOI 10.1016/j.carbpol.2012.10.001; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jhan MH, 2016, MOLECULES, V21, DOI 10.3390/molecules21091215; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Knezevic A., 2015, SCI WORLD J, P1, DOI DOI 10.1155/2015/146378; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Lai CH, 2011, INT J MED MUSHROOMS, V13, P227, DOI 10.1615/IntJMedMushr.v13.i3.20; Lin FY, 2008, FOOD CHEM, V110, P446, DOI 10.1016/j.foodchem.2008.02.023; Lo HC, 2011, INT J MED MUSHROOMS, V13, P401, DOI 10.1615/IntJMedMushr.v13.i5.10; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Otsuka Y., 2013, INT J NUTR FOOD SCI, V2, P85, DOI DOI 10.11648/j.ijnfs.20130202.19; Pandey A, 2011, J PHARM BIOALLIED SC, V3, P504, DOI 10.4103/0975-7406.90103; Julian MT, 2015, WORLD J DIABETES, V6, P321, DOI 10.4239/wjd.v6.i2.321; Yang JP, 2012, CARBOHYD POLYM, V90, P174, DOI 10.1016/j.carbpol.2012.05.011; Yeung JHK, 2012, PHYTOMEDICINE, V19, P457, DOI 10.1016/j.phymed.2011.09.077; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yu ZT, 2013, PLANT FOOD HUM NUTR, V68, P107, DOI 10.1007/s11130-013-0342-4; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang HJ, 2009, J FOOD SCI, V74, pH1, DOI 10.1111/j.1750-3841.2008.00976.x; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	31	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201131	10.1371/journal.pone.0201131	http://dx.doi.org/10.1371/journal.pone.0201131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024975	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000091
J	Yang, TW; Moon, J; Kim, TJ; Jun, JS; Lim, JA; Lee, ST; Jung, KH; Park, KI; Jung, KY; Chu, K; Lee, SK				Yang, Tae-Won; Moon, Jangsup; Kim, Tae-Joon; Jun, Jin-Sun; Lim, Jung-Ah; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Chu, Kon; Lee, Sang Kun			HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events	PLOS ONE			English	Article							REFRACTORY PARTIAL SEIZURES; ANTIEPILEPTIC DRUGS; KOREAN POPULATION; DOUBLE-BLIND; NEGATIVE ASSOCIATION; TRANSGENIC MICE; HLA-B; SCHIZOPHRENIA; GENE; EPILEPSY	Levetiracetam (LEV) is effective for focal and generalized epilepsy and is used worldwide because of its relatively few drug interactions and favorable tolerability. However, some psychiatric adverse events (PAEs) have been reported, resulting in drug withdrawal. The pathophysiology of LEV-induced PAE has not yet been elucidated. In this study, we investigated the relationship between PAEs and human leukocyte antigen (HLA) genes. Eleven epilepsy patients, who developed PAEs after the administration of LEV and spontaneously improved after drug withdrawal, were enrolled retrospectively. Genomic DNA from the peripheral blood was extracted, and four-digit allele genotyping of HLA genes was performed. The genotype frequencies of HLA genes were compared to those of 80 patients in which LEV was well tolerated, as well as to 485 individuals from the general Korean population. The frequency of the HLA-A*1101 allele was significantly higher in the LEV-induced PAEs group compared to both the LEV-tolerant group (p = 0.021, OR 4.80, 95% CI 1.30-17.74) and the general Korean population (p = 0.015, OR 4.62, 95% CI 1.38-15.45). This study is the first attempt at investigating the relationship between the HLA system and LEV-induced PAE. The results of this study suggest that the HLA-A*1101 allele could be a risk factor for the development of PAEs.	[Yang, Tae-Won] Gyeongsang Natl Univ, Gyeongsang Natl Univ Changwon Hosp, Coll Med, Dept Neurol, Jinju, South Korea; [Moon, Jangsup; Kim, Tae-Joon; Lee, Soon-Tae; Jung, Keun-Hwa; Jung, Ki-Young; Chu, Kon; Lee, Sang Kun] Seoul Natl Univ Hosp, Comprehens Epilepsy Ctr, Biomed Res Inst, Dept Neurol,Lab Neurotherapeut, Seoul, South Korea; [Moon, Jangsup; Kim, Tae-Joon; Lee, Soon-Tae; Jung, Keun-Hwa; Jung, Ki-Young; Chu, Kon; Lee, Sang Kun] Seoul Natl Univ, Coll Med, Program Neurosci, Seoul, South Korea; [Moon, Jangsup] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Jun, Jin-Sun] Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea; [Lim, Jung-Ah] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Kyung-Il] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Neurol, Seoul, South Korea	Changwon National University; Gyeongsang National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Hallym University; Seoul National University (SNU); Seoul National University Hospital	Chu, K; Lee, SK (corresponding author), Seoul Natl Univ Hosp, Comprehens Epilepsy Ctr, Biomed Res Inst, Dept Neurol,Lab Neurotherapeut, Seoul, South Korea.; Chu, K; Lee, SK (corresponding author), Seoul Natl Univ, Coll Med, Program Neurosci, Seoul, South Korea.	stemcell.snu@gmail.com; sangkun2923@gmail.com		Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302; Moon, Jangsup/0000-0003-1282-4528; Yang, Tae-Won/0000-0002-8113-2384; Park, Kyung-Il/0000-0001-8064-6749; Jung, Keun-Hwa/0000-0003-1433-8005	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1C1B2016275]; Dong-A ST [0620154110]; Seoul National University Hospital [0420170820]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Dong-A ST; Seoul National University Hospital	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1C1B2016275). S.K.L. was supported by Dong-A ST (0620154110). J.M. was supported by Seoul National University Hospital (0420170820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKA A, 1981, BRIT J PSYCHIAT, V138, P498, DOI 10.1192/bjp.138.6.498; Bedetti C, 2017, EUR J NEUROL, V24, P1283, DOI 10.1111/ene.13375; Belcastro V, 2017, J NEUROL, V264, P921, DOI 10.1007/s00415-017-8463-6; Ben-Menachem E, 2000, EPILEPSIA, V41, P1276, DOI 10.1111/j.1528-1157.2000.tb04605.x; Berkovic SF, 2007, NEUROLOGY, V69, P1751, DOI 10.1212/01.wnl.0000268699.34614.d3; Bloch KM, 2014, PHARMACOGENOMICS, V15, P857, DOI [10.2217/PGS.14.65, 10.2217/pgs.14.65]; Cereghino JJ, 2000, NEUROLOGY, V55, P236, DOI 10.1212/WNL.55.2.236; Crepeau AZ, 2010, EXPERT REV NEUROTHER, V10, P159, DOI [10.1586/ern.10.5, 10.1586/ERN.10.3]; De Smedt T, 2007, CNS DRUG REV, V13, P57, DOI 10.1111/j.1527-3458.2007.00005.x; El Bissati K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85955; Franciotta D, 2009, CURR OPIN NEUROL, V22, P144, DOI 10.1097/WCO.0b013e328328f276; French J, 2001, EPILEPSY RES, V47, P77, DOI 10.1016/S0920-1211(01)00296-0; French JA, 2008, NEW ENGL J MED, V359, P166, DOI 10.1056/NEJMcp0801738; Helmstaedter C, 2013, EPILEPSIA, V54, P36, DOI 10.1111/j.1528-1167.2012.03603.x; Huang M., 2016, SCI REPORTS, V6; Jun TY, 2002, PSYCHIAT CLIN NEUROS, V56, P453, DOI 10.1046/j.1440-1819.2002.01035.x; Kim SH, 2011, EPILEPSY RES, V97, P190, DOI 10.1016/j.eplepsyres.2011.08.010; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Lo BWY, 2011, CAN J NEUROL SCI, V38, P475, DOI 10.1017/S0317167100011902; Lyseng-Williamson KA, 2011, DRUGS, V71, P489, DOI 10.2165/11204490-000000000-00000; Mokhtari R, 2016, J CLIN CELLULAR IMMU, V7; Moon J, 2016, EPILEPSIA, V57, P1879, DOI 10.1111/epi.13566; Moon J, 2015, EPILEPSIA, V56, pE161, DOI 10.1111/epi.13087; Mula M, 2003, NEUROLOGY, V61, P704, DOI 10.1212/01.WNL.0000078031.32904.0D; Mula M, 2007, EPILEPSIA, V48, P2322; Mula M, 2015, EPILEPSY BEHAV, V45, P64, DOI 10.1016/j.yebeh.2015.03.018; Nimgaonkar VL, 1995, SCHIZOPHR RES, V18, P43, DOI 10.1016/0920-9964(95)00023-2; NIMGAONKAR VL, 1993, SCHIZOPHR RES, V8, P199, DOI 10.1016/0920-9964(93)90018-E; Nimgaonkar VL, 1997, SCHIZOPHR RES, V23, P81, DOI 10.1016/S0920-9964(96)00086-2; Nunes SOV, 2005, SCHIZOPHR RES, V76, P195, DOI 10.1016/j.schres.2005.02.005; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; Sasaki T, 1999, AM J PSYCHIAT, V156, P771; Shorvon SD, 2000, EPILEPSIA, V41, P1179, DOI 10.1111/j.1528-1157.2000.tb00323.x; Song HR, 2014, GEN HOSP PSYCHIAT, V36, DOI 10.1016/j.genhosppsych.2013.12.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ventura T, 1990, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V18, P339; Verrotti A, 2015, SEIZURE-EUR J EPILEP, V31, P49, DOI 10.1016/j.seizure.2015.07.004; Wei CY, 2012, J ALLERGY CLIN IMMUN, V129, P1562, DOI 10.1016/j.jaci.2011.12.990; Yun J, 2012, ALLERGY, V67, P1338, DOI 10.1111/all.12008; Zeng Y, 2016, HUM VACC IMMUNOTHER, V12, P829, DOI 10.1080/21645515.2015.1103405; Zheng Y, 2015, CANCER IMMUNOL RES, V3, P1138, DOI 10.1158/2326-6066.CIR-14-0203-T	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200812	10.1371/journal.pone.0200812	http://dx.doi.org/10.1371/journal.pone.0200812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020991	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400078
J	Hu, F; Liu, HC; Su, DQ; Chen, HJ; Chan, SO; Wang, Y; Wang, J				Hu, Fang; Liu, Huai-Cun; Su, Dong-Qiang; Chen, Hai-Jing; Chan, Sun-On; Wang, Yun; Wang, Jun			Nogo-A promotes inflammatory heat hyperalgesia by maintaining TRPV-1 function in the rat dorsal root ganglion neuron	FASEB JOURNAL			English	Article						RTN4A; inflammatory pain; cytoskeleton	PRIMARY SENSORY NEURONS; NEURITE OUTGROWTH INHIBITOR; MYELIN-ASSOCIATED INHIBITOR; AXON REGENERATION; MESSENGER-RNA; MICE LACKING; SPINAL-CORD; RECEPTOR; PROTEIN; KINASE	Nogo-A is a key inhibitory molecule of axon regeneration in oligodendrocytes. However, little is known about its role in adult neurons. In this study, we showed an important function of Nogo-A on regulation of inflammatory pain in dorsal root ganglion (DRG) neurons. In adult rats with complete Freund's adjuvant (CFA) hind paw inflammation, DRG neurons showed a significant increase in Nogo-A expression. Disruption of Nogo-A signaling with Nogo-66 receptor antagonist peptide, Nogo-A blocking antibody, Nogo-A short hairpin RNA, or Nogo-A gene knockout attenuated CFA-induced inflammatory heat hyperalgesia. Moreover, disruption of Nogo-A signaling suppressed the function and expression in DRG neurons of the transient receptor potential vanilloid subfamily member (TRPV)-1 channel, which is known to be the endogenous transducer of noxious heat during inflammation. These effects were accompanied with a reduction in LIM domain kinase (LIMK)/cofilin phosphorylation and actin polymerization. Similar disruption of actin filament architecture by direct action of Latrunculin A reduced the TRPV-1 activity and up-regulation of TRPV-1 protein caused by CFA. We conclude that Nogo-A plays an essential role in the development of inflammatory heat hyperalgesia, partly through maintaining TRPV-1 function via activation of the LIMK/cofilin pathway, which regulates actin filament dynamics. These findings support a therapeutic potential of modulating Nogo-A signaling in pain management.Hu, F., Liu, H.-C., Su, D.-Q., Chen, H.-J., Chan, S.-O., Wang, Y., Wang, J. Nogo-A promotes inflammatory heat hyperalgesia by maintaining TRPV-1 function in the rat dorsal root ganglion neuron.	[Hu, Fang; Chen, Hai-Jing; Wang, Yun] Peking Univ, Hlth Sci Ctr,Dept Neurobiol, Natl Hlth Commiss,Neurosci Res Inst, Key Lab Neurosci,Minist Educ & Neurosci, Beijing, Peoples R China; [Hu, Fang] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China; [Liu, Huai-Cun; Su, Dong-Qiang; Wang, Jun] Peking Univ, Sch Basic Med Sci, Dept Anat & Histol, 38 Xueyuan Rd, Beijing 100083, Peoples R China; [Chan, Sun-On] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Wang, Yun] Peking Univ, McGovern Inst Brain Res, Peking Univ Int Data Grp PKU IDG, Beijing, Peoples R China	Peking University; Qingdao University; Peking University; Chinese University of Hong Kong; Peking University	Wang, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Anat & Histol, 38 Xueyuan Rd, Beijing 100083, Peoples R China.; Wang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Neurosci Res Inst, Dept Neurobiol, Beijing 100083, Peoples R China.	wangy66@bjmu.edu.cn; wangjun74008@bjmu.edu.cn	Chan, Sun-On/R-6547-2018	Chan, Sun-On/0000-0002-3221-3786	National Natural Science Foundation of China [31471119, 31720103908, 31530028]; Beijing Natural Science Foundation [7132130]; Ministry of Science and Technology of China 973 Program [2014CB542204]; National Science and Technology Support Project Grant [2015BAI08B02]; General Research Fund of Hong Kong Research Grant Council [CUHK461612, CUHK14113815]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Science and Technology Support Project Grant; General Research Fund of Hong Kong Research Grant Council	This work was supported by National Natural Science Foundation of China Grants 31471119 (to J.W.), and 31720103908 and 31530028 (to Y.W.); Beijing Natural Science Foundation Grant 7132130 (to J.W.); Ministry of Science and Technology of China 973 Program Grant 2014CB542204 (to Y.W.); National Science and Technology Support Project Grant 2015BAI08B02 (to Y. W.); and General Research Fund of Hong Kong Research Grant Council Project Grants CUHK461612 and CUHK14113815 (to S.-O.C.). The authors declare no conflicts of interest.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Diaz-Franulic I, 2016, MOL PHARMACOL, V90, P300, DOI 10.1124/mol.116.104430; Dina OA, 2003, NEURON, V39, P613, DOI 10.1016/S0896-6273(03)00473-2; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Fukiage C, 1997, BBA-MOL BASIS DIS, V1361, P304, DOI 10.1016/S0925-4439(97)00043-4; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; HOUGH C, 1994, J NEUROCHEM, V62, P421; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Hu FH, 2005, J NEUROSCI, V25, P5298, DOI 10.1523/JNEUROSCI.5235-04.2005; Huber AB, 2002, J NEUROSCI, V22, P3553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; IGWE OJ, 1994, PAIN, V58, P63, DOI 10.1016/0304-3959(94)90185-6; Iobbi C, 2017, CEREB CORTEX, V27, P2779, DOI 10.1093/cercor/bhw122; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Li Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005353; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Nyatia E, 2007, RES VET SCI, V83, P287, DOI 10.1016/j.rvsc.2007.01.011; O'Neill P, 2004, DEV DYNAM, V231, P109, DOI 10.1002/dvdy.20116; Oertle T, 2003, J NEUROSCI, V23, P5393; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Sousa-Valente J, 2014, BRIT J PHARMACOL, V171, P2508, DOI 10.1111/bph.12532; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Vajda F, 2015, CELL DEATH DIFFER, V22, P323, DOI 10.1038/cdd.2014.147; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Wang J, 2008, J NEUROSCI RES, V86, P2581, DOI 10.1002/jnr.21717; Wang J, 2010, BRAIN RES, V1306, P8, DOI 10.1016/j.brainres.2009.10.018; Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhu HH, 2008, PAIN, V137, P574, DOI 10.1016/j.pain.2007.10.025	48	10	12	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					668	682		10.1096/fj.201800382RR	http://dx.doi.org/10.1096/fj.201800382RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024789				2022-12-26	WOS:000457401500052
J	Huang, XJ; Xie, XH; Liu, P; Yang, L; Chen, B; Song, CL; Tang, HL; Xie, XM				Huang, Xiaojia; Xie, Xinhua; Liu, Peng; Yang, Lu; Chen, Bo; Song, Cailu; Tang, Hailin; Xie, Xiaoming			Adam12 and Inc015192 act as ceRNAs in breast cancer by regulating miR-34a	ONCOGENE			English	Article							LONG NONCODING RNA; FEEDBACK LOOP; METASTASIS; EXPRESSION; INVASION; CELLS; MICRORNAS; EMT	Long non-coding RNAs (lncRNAs) are reported to play vital roles in the progress of multiple cancers. However, the functions of lncRNAs in breast cancer remain to be discovered. We performed microarrays to identify the differentially expressed mRNAs and lncRNAs in breast tissues with or without miR-34a knockout. To explore the functions of the differentially expressed mRNA and lncRNA in breast cancer, we conducted a series of experiments. We found that Adam12 and lnc015192 were significantly upregulated in miR-34a knockout breast tissues. Knockdown of Adam12 and lnc015192 inhibited breast cancer cell migration, invasion, and epithelial-mesenchymal transition (EMT). Further experiments revealed that lnc015192 regulated Adam12 expression by functioning as a competing endogenous RNA (ceRNA) for miR-34a. In summary, our study demonstrate that Adam12 and lnc015192 promote breast cancer metastasis partly by sponging miR-34a through the ceRNA mechanism.	[Huang, Xiaojia; Xie, Xinhua; Liu, Peng; Yang, Lu; Chen, Bo; Song, Cailu; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Tang, HL; Xie, XM (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	tanghl@sysucc.org.cn; xiexm@sysucc.org.cn	Chen, Bo/GRS-7546-2022		National Natural Science Foundation of China [81672598, 81772961]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Natural Science Foundation of China (81672598 and 81772961).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Dong R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.143; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Eckert MA, 2017, J CELL SCI, V130, P2036, DOI 10.1242/jcs.198200; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Grelet S, 2017, NAT CELL BIOL, V19, P1105, DOI 10.1038/ncb3595; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jang E, 2016, BIOMATERIALS, V105, P12, DOI 10.1016/j.biomaterials.2016.07.036; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Li LS, 2012, MOL THER, V20, P2326, DOI 10.1038/mt.2012.201; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu LF, 2017, ONCOTARGET, V8, P31386, DOI 10.18632/oncotarget.15607; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Song YX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00304-1; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang JW, 2016, INT J CANCER, V139, P1327, DOI 10.1002/ijc.30173; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang LH, 2016, ELIFE, V5, DOI 10.7554/eLife.14620; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Xiao XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21735; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhu M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14718	34	36	36	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 6	2018	37	49					6316	6326		10.1038/s41388-018-0410-1	http://dx.doi.org/10.1038/s41388-018-0410-1			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HD3AP	30042416				2022-12-26	WOS:000452384400003
J	Shi, L; Tang, XL; Qian, MX; Liu, ZJ; Meng, FB; Fu, L; Wang, ZM; Zhu, WG; Huang, JD; Zhou, ZJ; Liu, BH				Shi, Lei; Tang, Xiaolong; Qian, Minxian; Liu, Zuojun; Meng, Fanbiao; Fu, Li; Wang, Zimei; Zhu, Wei-Guo; Huang, Jian-Dong; Zhou, Zhongjun; Liu, Baohua			A SIRT1-centered circuitry regulates breast cancer stemness and metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-CELLS; SIRT1; EXPRESSION; PROTEIN; IDENTIFICATION; DEACETYLASE; INDUCTION; HETEROGENEITY; LOCALIZATION	Cancer stem cell (CSC)-dictated intratumor heterogeneity accounts for the majority of drug-resistance and distant metastases of breast cancers. Here, we identify a SIRT1-PRRX1-KLF4-ALDH1 circuitry, which couples CSCs, chemo-resistance, metastasis and aging. Pro-longevity protein SIRT1 deacetylates and stabilizes the epithelial-to-mesenchymal-transition (EMT) inducer PRRX1, which inhibits the transcription of core stemness factor KLF4. Loss of SIRT1 destabilizes PRRX1, disinhibits KLF4, and activates the transcription of ALDH1, which induces and functionally marks CSCs, resulting in chemo-resistance and metastatic relapse. Clinically, the level of PRRX1 is positively linked to SIRT1, whereas KLF4 is reversely correlated. Importantly, KLF4 inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects. Our findings delineate a SIRT1-centered circuitry that regulates CSC origination, and targeting this pathway might be a promising therapeutic strategy.	[Shi, Lei; Tang, Xiaolong; Qian, Minxian; Liu, Zuojun; Meng, Fanbiao; Fu, Li; Wang, Zimei; Zhu, Wei-Guo; Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, Guangdong Key Lab Genome Stabil & Human Dis Preve, Shenzhen 518060, Peoples R China; [Shi, Lei; Tang, Xiaolong; Qian, Minxian; Liu, Zuojun; Meng, Fanbiao; Fu, Li; Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, MRC, Shenzhen 518060, Peoples R China; [Shi, Lei; Huang, Jian-Dong; Zhou, Zhongjun] Univ Hong Kong, Sch Biomed Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tang, Xiaolong; Qian, Minxian; Liu, Zuojun; Wang, Zimei; Zhu, Wei-Guo; Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China; [Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, Carson Int Canc Ctr, Shenzhen 518060, Peoples R China	Shenzhen University; Shenzhen University; University of Hong Kong; Shenzhen University; Shenzhen University	Liu, BH (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Guangdong Key Lab Genome Stabil & Human Dis Preve, Shenzhen 518060, Peoples R China.; Liu, BH (corresponding author), Shenzhen Univ, Hlth Sci Ctr, MRC, Shenzhen 518060, Peoples R China.; Liu, BH (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China.; Liu, BH (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Carson Int Canc Ctr, Shenzhen 518060, Peoples R China.	ppliew@szu.edu.cn	Liu, Baohua/AAH-3685-2020; Fu, Li/F-7182-2010; Liu, Baohua/C-9594-2014; Zhou, Zhongjun/C-4476-2009; /C-4277-2009	Liu, Baohua/0000-0002-1599-8059; Fu, Li/0000-0003-2643-6278; Liu, Baohua/0000-0002-1599-8059; Zhou, Zhongjun/0000-0001-7092-8128; Shi, Lei/0000-0002-6043-8819; /0000-0001-7531-2816; Zhu, Wei-Guo/0000-0001-8385-6581	National Natural Science Foundation of China [81422016, 91439133, 81571374, 81501206, 81702909]; National Key R&D Program of China [2017YFA0503900, 2016YFC0904600]; Research Grant Council of Hong Kong [773313, HKU2/CRF/13G]; Natural Science Foundation of Guangdong Province [2014A030308011, 2015A030308007]; Shenzhen Science and Technology Innovation Commission [CXZZ20140903103747568, JCYJ20160226191451487, JCYJ20130329104732074]; Discipline Construction Funding of Shenzhen (2016); China Postdoctoral Science Foundation [2015M582419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Commission; Discipline Construction Funding of Shenzhen (2016); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Dr Qi-Wei Zhai (Shanghai Institutes for Biological Sciences, China) for EGFP-SIRT1 construct and Dr Zhen-Kun Lou (Mayo Clinic College of Medicine, USA) for FLAG-SIRT1 construct. This project is supported by research grants from National Natural Science Foundation of China (81422016, 91439133, 81571374, 81501206 and 81702909), National Key R&D Program of China (2017YFA0503900 and 2016YFC0904600), Research Grant Council of Hong Kong (773313 and HKU2/CRF/13G), Natural Science Foundation of Guangdong Province (2014A030308011 and 2015A030308007), Shenzhen Science and Technology Innovation Commission (CXZZ20140903103747568, JCYJ20160226191451487 and JCYJ20130329104732074), Discipline Construction Funding of Shenzhen (2016) and China Postdoctoral Science Foundation (2015M582419).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Byles V, 2010, INT J BIOL SCI, V6, P599; Cao YW, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0097-2; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Ellsworth RE, 2017, SEMIN CELL DEV BIOL, V64, P65, DOI 10.1016/j.semcdb.2016.08.025; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Finicelli M, 2014, ONCOTARGET, V5, P9678, DOI 10.18632/oncotarget.1936; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Giordano SH, 2012, J CLIN ONCOL, V30, P2232, DOI 10.1200/JCO.2011.40.1273; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Islam F, 2015, EXP MOL PATHOL, V98, P184, DOI 10.1016/j.yexmp.2015.02.002; Jang SH, 2012, J CLIN PATHOL, V65, P735, DOI 10.1136/jclinpath-2012-200685; Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Li P, 2014, EXP BIOL MED, V239, P813, DOI 10.1177/1535370214538727; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nishi M, 2014, ONCOGENE, V33, P643, DOI 10.1038/onc.2012.614; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren RT, 2017, CELL METAB, V26, P460, DOI 10.1016/j.cmet.2017.07.019; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Tang XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00396-9; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zhao D, 2014, J CLIN INVEST, V124, P5453, DOI 10.1172/JCI76611	51	41	43	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 6	2018	37	49					6299	6315		10.1038/s41388-018-0370-5	http://dx.doi.org/10.1038/s41388-018-0370-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HD3AP	30038266	Green Published, hybrid			2022-12-26	WOS:000452384400002
J	Gubbiotti, MA; Seifert, E; Rodeck, U; Hoek, JB; Iozzo, RV				Gubbiotti, Maria A.; Seifert, Erin; Rodeck, Ulrich; Hoek, Jan B.; Iozzo, Renato V.			Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						decorin; autophagy; metabolomics; proteoglycan; extracellular matrix; heart; O-GlcNAcylation; cardiac function; fasting; nutrient sensing	ACTIVATED PROTEIN-KINASE; HYALURONAN SYNTHASE 2; O-GLCNACYLATION; VII COLLAGEN; GROWTH; INHIBITION; BIOLOGY; ROLES; CELLS; PROTEOGLYCAN	The extracellular matrix is a master regulator of tissue homeostasis in health and disease. Here we examined how the small, leucine-rich, extracellular matrix proteoglycan decorin regulates cardiomyocyte metabolism during fasting in vivo. First, we validated in Dcn(-/-) mice that decorin plays an essential role in autophagy induced by fasting. High-throughput metabolomics analyses of cardiac tissue in Dcn(-/-) mice subjected to fasting revealed striking differences in the hexosamine biosynthetic pathway resulting in aberrant cardiac O--N-acetylglycosylation as compared with WT mice. Functionally, Dcn(-/-) mice maintained cardiac function at a level comparable with nonfasted animals whereas fasted WT mice showed reduced ejection fraction. Collectively, our results suggest that reduced sensing of nutrient deprivation in the absence of decorin preempts functional adjustments of cardiac output associated with metabolic reprogramming.	[Gubbiotti, Maria A.; Seifert, Erin; Rodeck, Ulrich; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Gubbiotti, Maria A.; Seifert, Erin; Rodeck, Ulrich; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Seifert, Erin; Hoek, Jan B.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr, Philadelphia, PA 19107 USA; [Rodeck, Ulrich] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.; Iozzo, RV (corresponding author), Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020		National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462]; National Institutes of Health Training Grant [T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA164462, R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.) and National Institutes of Health Training Grant T32 AA07463 (to M. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreuzzi E, 2017, MATRIX BIOL, V64, P40, DOI 10.1016/j.matbio.2017.04.002; Barallobre-Barreiro J, 2016, CIRCULATION, V134, P817, DOI 10.1161/CIRCULATIONAHA.115.016423; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Ghadiali RS, 2017, MATRIX BIOL, V59, P54, DOI 10.1016/j.matbio.2016.07.007; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jahania SM, 2013, J AM COLL SURGEONS, V216, P719, DOI 10.1016/j.jamcollsurg.2012.12.034; Karousou E, 2017, MATRIX BIOL, V59, P3, DOI 10.1016/j.matbio.2016.10.001; Lavandero S, 2015, J CLIN INVEST, V125, P55, DOI 10.1172/JCI73943; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrione A, 2013, FEBS J, V280, P2138, DOI 10.1111/febs.12149; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Park S, 2014, BIOCHEM BIOPH RES CO, V453, P208, DOI 10.1016/j.bbrc.2014.05.047; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Prockop DJ, 2016, MATRIX BIOL, V51, P7, DOI 10.1016/j.matbio.2016.01.010; Randles MJ, 2017, MATRIX BIOL, V57-58, P12, DOI 10.1016/j.matbio.2016.08.006; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Suzuki J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1115, DOI 10.1152/ajpendo.91031.2008; Troncoso R, 2014, TRENDS ENDOCRIN MET, V25, P128, DOI 10.1016/j.tem.2013.12.002; Uitto J, 2017, MATRIX BIOL, V57-58, P76, DOI 10.1016/j.matbio.2016.07.009; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Yang SL, 2006, SHOCK, V25, P600, DOI 10.1097/01.shk.0000209563.07693.db; Yao T, 2016, FEBS OPEN BIO, V6, P707, DOI 10.1002/2211-5463.12076; Young MF, 2016, MATRIX BIOL, V52-54, P1, DOI 10.1016/j.matbio.2016.04.003; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	54	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16940	16950		10.1074/jbc.RA118.004563	http://dx.doi.org/10.1074/jbc.RA118.004563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30049794	Green Published, hybrid			2022-12-26	WOS:000448515100033
J	Hussain, MS; Kwon, M; Oh, DH				Hussain, Mohammad Shakhawat; Kwon, Minyeong; Oh, Deog-Hwan			Impact of manganese and heme on biofilm formation of Bacillus cereus food isolates	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; MASTER REGULATOR; STRAINS; SPORULATION; RESISTANCE; SUBTILIS; PROTEIN; GROWTH; ACID	The objective of this study was to determine the impact of manganese (Mn2+) and heme on the biofilm formation characteristics of six B. cereus food isolates and two reference strains (ATCC 10987 and ATCC 14579). The data obtained from the crystal violet assay revealed that addition of a combination of Mn2+ and heme to BHI growth medium induced B. cereus biofilm formation. However, the induction of biofilm formation was strictly strain-dependent. In all of the induced strains, the impact of Mn2+ was greater than that of heme. The impact of these two molecules on the phenotypic characteristics related to biofilm formation, such as cell density, sporulation and swarming ability, was determined in a selected food isolate (GIHE 72-5). Addition of Mn2+ and heme to BHI significantly (p < 0.05) increased the number of cells, which was correlated with the results of crystal violet assays as well as scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) analyses. In addition, induced biofilms showed higher numbers of spores and greater resistance to benzalkonium chloride. The swarming ability of B. cereus planktonic cells was increased in the presence of Mn2+ and heme in BHI. The expression levels of a number of selected genes, which are involved in mobility and extracellular polymeric substances (EPS) formation in B. cereus, were positively correlated with biofilm formation in the presence of Mn2+ and heme in BHI. These results further confirming the role of these molecules in swarming mobility and making matrix components related to B. cereus biofilm formation. These data indicate that signaling molecules present in the food environment might substantially trigger B. cereus biofilm formation, which could pose a threat to the food industry.	[Hussain, Mohammad Shakhawat; Kwon, Minyeong; Oh, Deog-Hwan] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, Gangwon, South Korea	Kangwon National University	Oh, DH (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, Gangwon, South Korea.	deoghwa@kangwon.ac.kr		DeogHwan, Oh/0000-0002-7472-0436; Hussain, Mohammad/0000-0003-1538-1451	Brain Korea (BK) 21 Plus project - Korean Government [22A20153713433]; Kangwon National University	Brain Korea (BK) 21 Plus project - Korean Government; Kangwon National University	This work was supported by a grant from the Brain Korea (BK) 21 Plus project (grant no. 22A20153713433) funded by the Korean Government. It was also supported by a grant from Kangwon National University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bojsen R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21874; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Caro-Astorga Joaquin, 2014, Front Microbiol, V5, P745, DOI 10.3389/fmicb.2014.00745; Castelijn GAA, 2012, BIOFOULING, V28, P51, DOI 10.1080/08927014.2011.648927; Chai YR, 2011, EMBO J, V30, P1402, DOI 10.1038/emboj.2011.36; CHARNEY J, 1951, J BACTERIOL, V62, P145, DOI 10.1128/JB.62.2.145-148.1951; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Forghani F, 2016, J FOOD PROTECT, V79, P810, DOI 10.4315/0362-028X.JFP-15-428; Gao TT, 2015, MICROBIOLOGYOPEN, V4, P452, DOI 10.1002/mbo3.251; Gopal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01418; Granger AC, 2011, APPL ENVIRON MICROB, V77, P32, DOI 10.1128/AEM.01965-10; Halstead FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136190; Hayrapetyan H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00842; Hayrapetyan H, 2015, INT J FOOD MICROBIOL, V200, P72, DOI 10.1016/j.ijfoodmicro.2015.02.005; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Huecker M.R., 2017, BIOCH IRON ABSORPTIO; Hussain MS, 2017, FOOD CONTROL, V77, P270, DOI 10.1016/j.foodcont.2017.02.014; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lucking G, 2009, MICROBIOL-SGM, V155, P922, DOI 10.1099/mic.0.024125-0; Ma WT, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0013-6; Majed R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01054; McLoon AL, 2011, J BACTERIOL, V193, P679, DOI 10.1128/JB.01186-10; Mhatre E, 2016, MICROBIOL-SGM, V162, P1468, DOI 10.1099/mic.0.000320; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; Poimenidou SV, 2016, INT J FOOD MICROBIOL, V237, P164, DOI 10.1016/j.ijfoodmicro.2016.08.029; Radolf J.D., 2011, CLIN INFECT DIS, V52, P965, DOI [10.1093/cid/cir083, DOI 10.1093/CID/CIR528]; Ryu JH, 2005, J FOOD PROTECT, V68, P1734, DOI 10.4315/0362-028X-68.8.1734; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; VASANTHA N, 1979, J GEN MICROBIOL, V112, P329, DOI 10.1099/00221287-112-2-329; Wani AM, 2007, J FOOD SCI TECH MYS, V44, P138; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Xu SD, 2017, MOL PLANT MICROBE IN, V30, P603, DOI [10.1094/MPMI-02-17-0042-R, 10.1094/mpmi-02-17-0042-r]; Yan F, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00561-17	37	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200958	10.1371/journal.pone.0200958	http://dx.doi.org/10.1371/journal.pone.0200958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048488	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400037
J	Loturco, I; Contreras, B; Kobal, R; Fernandes, V; Moura, N; Siqueira, F; Winckler, C; Suchomel, T; Pereira, LA				Loturco, Irineu; Contreras, Bret; Kobal, Ronaldo; Fernandes, Victor; Moura, Neilton; Siqueira, Felipe; Winckler, Ciro; Suchomel, Timothy; Pereira, Lucas Adriano			Vertically and horizontally directed muscle power exercises: Relationships with top-level sprint performance	PLOS ONE			English	Article							SOCCER PLAYERS; RUNNING PERFORMANCE; JUMP SQUATS; STRENGTH; SPEED; LOAD; TESTS; PHASE	The capacity to rapidly generate and apply a great amount of force seems to play a key role in sprint running. However, it has recently been shown that, for sprinters, the technical ability to effectively orient the force onto the ground is more important than its total amount. The force-vector theory has been proposed to guide coaches in selecting the most adequate exercises to comprehensively develop the neuromechanical qualities related to the distinct phases of sprinting. This study aimed to compare the relationships between vertically-directed (loaded and unloaded vertical jumps, and half-squat) and horizontally-directed (hip-thrust) exercises and the sprint performance of top-level track and field athletes. Sixteen sprinters and jumpers (including three Olympic athletes) executed vertical jumps, loaded jump squats and hip-thrusts, and sprinting speed tests at 10-, 20-, 40-, 60-, 100-, and 150-m. Results indicated that the hip-thrust is more associated with the maximum acceleration phase (i.e., from zero to 10-m; r = 0.93), whereas the loaded and unloaded vertical jumps seem to be more related to top-speed phases (i.e., distances superior to 40-m; r varying from 0.88 to 0.96). These findings reinforce the mechanical concepts supporting the force-vector theory, and provide coaches and sport scientists with valuable information about the potential use and benefits of using vertically-or horizontally-based training exercises.	[Loturco, Irineu; Kobal, Ronaldo; Pereira, Lucas Adriano] NAR Nucleus High Performance Sport, Sao Paulo, Brazil; [Contreras, Bret] Auckland Univ Technol, Sport Performance Res Inst New Zealand, Auckland, New Zealand; [Fernandes, Victor; Moura, Neilton] B3 Track & Field Club, Sao Paulo, Brazil; [Fernandes, Victor; Siqueira, Felipe] ADAPT Assoc High Performance Training & Sports De, Sao Paulo, Brazil; [Siqueira, Felipe] Pinheiros Sport Club, Sao Paulo, Brazil; [Winckler, Ciro] Brazilian Paralymp Comm, Sao Paulo, Brazil; [Suchomel, Timothy] Carroll Univ, Dept Human Movement Sci, Waukesha, WI USA	Auckland University of Technology	Loturco, I (corresponding author), NAR Nucleus High Performance Sport, Sao Paulo, Brazil.	irineu.loturco@terra.com.br	Kobal, Ronaldo/AAU-8415-2021; PEREIRA, LUCAS/HHZ-5877-2022; Loturco, Irineu/AAH-4916-2019; Winckler, Ciro/G-2220-2012; Pereira, Lucas/S-3110-2019	Kobal, Ronaldo/0000-0003-0243-2133; Loturco, Irineu/0000-0003-1309-2568; Winckler, Ciro/0000-0002-9595-8144; Pereira, Lucas/0000-0003-1079-2446	B3 Track & Field Club, Sao Paulo, Brazil; ADAPT - Association of High-Performance Training & Sports Development, Sao Paulo, Brazil; Pinheiros Sport Club, Sao Paulo, Brazil; Brazilian Paralympic Committee, Sao Paulo, Brazil	B3 Track & Field Club, Sao Paulo, Brazil; ADAPT - Association of High-Performance Training & Sports Development, Sao Paulo, Brazil; Pinheiros Sport Club, Sao Paulo, Brazil; Brazilian Paralympic Committee, Sao Paulo, Brazil	The researchers Victor Fernandes, Neilton Moura, Felipe Siqueira, and Ciro Winckler of the study entitled: Vertically and horizontally directed muscle power exercises: relationships with top-level sprint performance, declare that they have commercial affiliation with the following funders: B3 Track & Field Club, Sao Paulo, Brazil; ADAPT - Association of High-Performance Training & Sports Development, Sao Paulo, Brazil; Pinheiros Sport Club, Sao Paulo, Brazil; Brazilian Paralympic Committee, Sao Paulo, Brazil. The funder provided support in the form of salaries for authors VF, NM, FS, CW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Baker D, 2001, J STRENGTH COND RES, V15, P92; Baker D., 1995, STRENGTH COND COACH, V3, P8; Bishop C, 2017, J STRENGTH COND RES; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Contreras B, 2017, J STRENGTH COND RES, V31, P999, DOI 10.1519/JSC.0000000000001510; Cronin J, 2005, SPORTS MED, V35, P213, DOI 10.2165/00007256-200535030-00003; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Delecluse C, 1997, SPORTS MED, V24, P147, DOI 10.2165/00007256-199724030-00001; Harris NK, 2008, J STRENGTH COND RES, V22, P691, DOI 10.1519/JSC.0b013e31816d8d80; Hopkins WG., 2005, SPORTSCIENCE, V9, P17, DOI DOI 10.1123/SSJ.20.1.17; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kale M, 2009, J STRENGTH COND RES, V23, P2272, DOI 10.1519/JSC.0b013e3181b3e182; Loturco I, 2016, INT J SPORTS MED, V37, P1051, DOI 10.1055/s-0042-107249; Loturco I, 2017, J STRENGTH COND RES; Loturco I, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01034; Loturco I, 2017, J STRENGTH COND RES, V31, P2579, DOI 10.1519/JSC.0000000000002086; Loturco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140102; Loturco I, 2015, J STRENGTH COND RES, V29, P2771, DOI 10.1519/JSC.0000000000000951; Loturco I, 2015, J STRENGTH COND RES, V29, P1966, DOI 10.1519/JSC.0000000000000849; Loturco I, 2015, J SPORT SCI, V33, P1283, DOI 10.1080/02640414.2015.1022574; Loturco I, 2015, J STRENGTH COND RES, V29, P758, DOI 10.1519/JSC.0000000000000660; Loturco I, 2013, J SPORT SCI MED, V12, P109; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; MERO A, 1992, SPORTS MED, V13, P376, DOI 10.2165/00007256-199213060-00002; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Randell AD, 2010, STRENGTH COND J, V32, P100, DOI 10.1519/SSC.0b013e3181e91eec; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Slawinski J, 2017, SCAND J MED SCI SPOR, V27, P45, DOI 10.1111/sms.12627	30	45	47	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201475	10.1371/journal.pone.0201475	http://dx.doi.org/10.1371/journal.pone.0201475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048538	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400091
J	Wheeler, AC; Ventura, CV; Ridenour, T; Toth, D; Nobrega, LALL; Dantas, LCSD; Rocha, C; Bailey, DB; Ventura, LO				Wheeler, Anne C.; Ventura, Camila V.; Ridenour, Ty; Toth, Danielle; Nobrega, Lucelia Lima; Silva de Souza Dantas, Lana Claudia; Rocha, Camilla; Bailey, Donald B., Jr.; Ventura, Liana O.			Skills attained by infants with congenital Zika syndrome: Pilot data from Brazil	PLOS ONE			English	Article							VIRUS; AGE; NORMS; SLEEP	The recent Zika outbreak and its link to microcephaly and other birth defects in infants exposed in utero have garnered widespread international attention. Based on the severity of birth defects the extent of impairment in these infants is expected to be profound; however, virtually nothing is known regarding the developmental and behavioral sequela of congenital Zika syndrome. This pilot study collected parent-reported patterns of development and sleep in 47 infants with confirmed congenital Zika syndrome who are being followed for clinical services at the Altino Ventura Foundation (FAV) in Recife, Brazil. With assistance from clinicians at FAV, caregivers completed Brazilian Portuguese versions of the Ages and Stages Questionnaire, 3 rd edition (ASQ-3) and the Brief Infant Sleep Questionnaire (BISQ). All infants were between 13-22 months of age at the time of the assessment. At 16 months of age, none of the children displayed age appropriate developmental skills. Most (similar to 75%) mastered some communication and gross motor skills at around a 6-8-month level. Communication and gross motor skills were relative strengths for the sample, while problem-solving and fine motor skills were relative weaknesses. Sleep was noted to be a problem for around 18% of the sample. In utero exposure to the Zika virus will have lifelong consequences for affected children and their families. Understanding the developmental and behavioral trajectories of affected infants will help identify appropriate family supports to improve quality of life.	[Wheeler, Anne C.; Ridenour, Ty; Toth, Danielle; Bailey, Donald B., Jr.] RTI Int, RTI Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC USA; [Ventura, Camila V.; Nobrega, Lucelia Lima; Silva de Souza Dantas, Lana Claudia; Rocha, Camilla; Ventura, Liana O.] Altino Ventura Fdn FAV, Rehabil Ctr Menina dos Olhos, Recife, PE, Brazil	Research Triangle Institute	Wheeler, AC (corresponding author), RTI Int, RTI Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC USA.	acwheeler@rti.org	Ventura, Liana Vieira O/N-6151-2018; Ventura, Camila/N-2654-2018	Ventura, Liana Vieira O/0000-0001-6529-6883; Wheeler, Anne/0000-0003-2693-5616; Ridenour, Ty/0000-0002-9709-6808; Ventura, Camila/0000-0002-2927-4684; Bailey, Donald/0000-0002-0513-9330	NICHD [1R01HD093572-01]; RTI International; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD093572] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); RTI International; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NICHD 1R01HD093572-01 to DB, CV, and AW; RTI International to DB and AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Center on the Developing Child, 2007, SCI EARL CHILDH DEV; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004; Filgueiras A, 2013, EARLY HUM DEV, V89, P561, DOI 10.1016/j.earlhumdev.2013.02.005; Mindell JA, 2015, INFANT BEHAV DEV, V41, P102, DOI 10.1016/j.infbeh.2015.08.004; Moore CA, 2016, JAMA PEDIAT; Nunes ML, 2012, SLEEP SCI, V5, P89; Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16; Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009; Salomao SR, 2008, ARQ BRAS OFTALMOL, V71, P475, DOI 10.1590/S0004-27492008000400002; SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Squires J, 2009, AGES STAGES QUESTION; Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]	14	25	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201495	10.1371/journal.pone.0201495	http://dx.doi.org/10.1371/journal.pone.0201495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048541	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400096
J	Hao, Y; Purtha, W; Cortesio, C; Rui, H; Gu, Y; Chen, H; Sickmier, EA; Manzanillo, P; Huang, X				Hao, Yue; Purtha, Whitney; Cortesio, Christa; Rui, Huan; Gu, Yan; Chen, Hao; Sickmier, E. Allen; Manzanillo, Paolo; Huang, Xin			Crystal structures of human procathepsin H	PLOS ONE			English	Article							PARTICLE MESH EWALD; HUMAN CATHEPSIN-H; MINI-CHAIN; IN-VITRO; AMINOPEPTIDASE ACTIVITY; STRUCTURE REFINEMENT; MOLECULAR-DYNAMICS; ENDOPEPTIDASE; ACTIVATION; PARAMETERS	Cathepsin H is a member of the papain superfamily of lysosomal cysteine proteases. It is the only known aminopeptidase in the family and is reported to be involved in cancer and other major diseases. Like many other proteases, it is synthesized as an inactive proenzyme. Although the crystal structure of mature porcine cathepsin H revealed the binding of the mini-chain and provided structural basis for the aminopeptidase activity, detailed structural and functional information on the inhibition and activation of procathepsin H has been elusive. Here we present the crystal structures of human procathepsin H at 2.00 angstrom and 1.66 angstrom resolution. These structures allow us to explore in detail the molecular basis for the inhibition of the mature domain by the prodomain. Comparison with cathepsin H structure reveals how mini-chain reorients upon activation. We further demonstrate that procathepsin H is not auto-activated but can be trans-activated by cathepsin L.	[Hao, Yue; Rui, Huan; Sickmier, E. Allen; Huang, Xin] Amgen Inc, Dept Mol Engn, Cambridge, MA 02141 USA; [Hao, Yue] Amgen Inc, Amgen Postdoctoral Fellow Program, Cambridge, MA USA; [Purtha, Whitney; Manzanillo, Paolo] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA USA; [Cortesio, Christa] Amgen Inc, Dept Prot Technol, San Francisco, CA USA; [Gu, Yan; Chen, Hao] Amgen Inc, Dept Prot Technol, Cambridge, MA USA	Amgen; Amgen; Amgen; Amgen; Amgen	Huang, X (corresponding author), Amgen Inc, Dept Mol Engn, Cambridge, MA 02141 USA.	hxin@amgen.com	Hao, Yue/AAA-3530-2022; Hao, Yue/O-6107-2019	Hao, Yue/0000-0003-0943-0499; 	Amgen Discovery Research. Amgen Inc	Amgen Discovery Research. Amgen Inc	This work was supported by Amgen Discovery Research. Amgen Inc provided funding for all research. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAUDYS M, 1991, BIOMED BIOCHIM ACTA, V50, P569; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Case RMBDA, 2016, AMBER 2016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Crowley MF, 1997, J SUPERCOMPUT, V11, P255, DOI 10.1023/A:1007907925007; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; del Re EC, 2000, BRIT J CANCER, V82, P1317; Dodt J, 2003, BIOL CHEM, V384, P1327, DOI 10.1515/BC.2003.149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Guncar G, 1998, STRUCTURE, V6, P51; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOGA H, 1992, CHEM PHARM BULL, V40, P965; Kos J, 1997, CLIN CANCER RES, V3, P1815; MACH L, 1994, J BIOL CHEM, V269, P13030; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rojnik M, 2012, EUR J CELL BIOL, V91, P757, DOI 10.1016/j.ejcb.2012.05.004; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; TAKAHASHI T, 1988, J BIOL CHEM, V263, P10952; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vasiljeva O, 2003, BIOCHEMISTRY-US, V42, P13522, DOI 10.1021/bi035355k; Verma S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00107; Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woods RJ, GA20052018	38	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200374	10.1371/journal.pone.0200374	http://dx.doi.org/10.1371/journal.pone.0200374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044821	gold, Green Submitted, Green Published			2022-12-26	WOS:000439942500049
J	Li, M; Zhao, LZ; Zhang, C; Wang, X; Hong, WX; Sun, J; Liu, R; Yu, L; Wang, JH; Zhang, FC; Jin, X				Li, Min; Zhao, Lingzhai; Zhang, Chao; Wang, Xin; Hong, Wenxin; Sun, Jin; Liu, Ran; Yu, Lei; Wang, Jianhua; Zhang, Fuchun; Jin, Xia			Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; PRINCIPAL TARGET-CELLS; IN-VITRO; MONONUCLEAR-CELLS; CROSS-REACTIVITY; T-CELLS; B-CELLS; TRANSMISSION; PATHOGENESIS; REPLICATION	Antibody dependent enhancement (ADE) has most often been associated with dengue virus (DENV). Studies using leukemia cell lines suggest that DENV specific antibodies can enhance Zika virus (ZIKV) infectivity, and vice versa. To examine the mechanisms of ADE of ZIKV infection in primary human cells, we assessed 40 serum samples obtained from convalescent DENV-1 or DENV-3 infected subjects. All sera tested exhibited high binding potency, while modest or none neutralization activities against ZIKV. Primary CD14+ monocytes, rather than B and T cells in peripheral blood mononuclear cells (PBMCs), were found to be the mediators of the enhancement of ZIKV infectivity by DENV immune sera. Monocyte-derived immature dendritic cells (DCs), but not mature DCs were highly permissive to ZIKV infection, whereas neither immature nor mature DCs could mediate enhanced ZIKV infection in the presence of DENV immune sera. In addition, antibody blocking of either Fc gamma RI (CD64), or Fc gamma RII (CD32), or Fc gamma RIII (CD16) resulted in diminished ADE of ZIKV infection. Our findings provide an improved understanding of the pathogenesis of ZIKV infection, and inform rational vaccine design.	[Li, Min; Zhang, Chao; Wang, Xin; Sun, Jin; Liu, Ran; Wang, Jianhua; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Li, Min; Zhang, Chao; Wang, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Lingzhai; Hong, Wenxin; Yu, Lei; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China; [Wang, Xin] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Medical University; Shanghai University	Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Zhang, FC (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.	gz8hzfc@126.com; xjin@ips.ac.cn			Chinese Ministry of Science and Technology (National Key Program Project Grant) [2016YFC1201000, 2016YFE0133500]; National Science Foundation of China [31670941, 31370870]; Guangzhou Science and Technology Program for Public Wellbeing [2014Y2-00185, 2014Y2-00550, 201508020263]; Special Program of Guangdong Provincial Department of Science and Technology [2016A020248001, S201302001300]; Chinese Academy of Sciences (STS Grant) [KFJEWSTS098]	Chinese Ministry of Science and Technology (National Key Program Project Grant); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Program for Public Wellbeing; Special Program of Guangdong Provincial Department of Science and Technology; Chinese Academy of Sciences (STS Grant)	This project was supported by grants from Chinese Ministry of Science and Technology (National Key Program Project Grant, #2016YFC1201000 and #2016YFE0133500), National Science Foundation of China (General Grant, #31670941 and #31370870), Guangzhou Science and Technology Program for Public Wellbeing (#2014Y2-00185, #2014Y2-00550 and #201508020263), the Special Program of Guangdong Provincial Department of Science and Technology (#2016A020248001 and #S201302001300), and Chinese Academy of Sciences (STS Grant, #KFJEWSTS098).	Bardina SV, 2017, SCIENCE; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638; Charles AS, 2016, PLOS CURR; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014; Jin X, 2009, ANTIVIR THER, V14, P739, DOI 10.3851/IMP1288; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pan American Health Organization, 2016, NUMB REP CAS DENG SE; Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674; Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; ROBINSON JE, 1990, J IMMUNOL METHODS, V132, P63, DOI 10.1016/0022-1759(90)90399-G; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006; Wei HY, 2016, AM J TROP MED HYG, V95, P322, DOI 10.4269/ajtmh.15-0905; WHO, 2017, ZIK VIR COMPL 2016 P	46	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200478	10.1371/journal.pone.0200478	http://dx.doi.org/10.1371/journal.pone.0200478			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044839	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500055
J	Garcia, PJ; Hernandez-Cordova, G; Pourjavaheri, P; Gomez-Paredes, HJ; Sudar, S; Bayer, AM				Garcia, Patricia J.; Hernandez-Cordova, Gustavo; Pourjavaheri, Paria; Gomez-Paredes, Hilbert J.; Sudar, Samuel; Bayer, Angela M.			Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; LIMA; CARE; INTERVENTION; HYPERTENSION; INFECTIONS; PREVENTION; MANAGEMENT; DISTRICT	Introduction Although the worldwide incidence of tuberculosis (TB) is slowly decreasing, annual infection rates in Peru remain among the highest in the Americas. Pharmacies could play an important role in facilitating early detection of TB. However, the awareness, expertise and cooperation of pharmacy workers is fundamental. This study explored the TB-related knowledge, attitudes and practices of pharmacy workers in a district with one of the highest incidences of TB in Peru. Methods This cross-sectional study applied a questionnaire that was administered face to face using smartphones with one pharmacy worker at each of 45 randomly selected pharmacies in the El Agustino district of Lima, Peru. Results Participants were primarily female (78%) and had an average age of 31.3 years old (range 18-57 years old). Only 11% of participants were pharmacists with complete university training. The pharmacy workers' knowledge was adequate; however, workers had important knowledge gaps and myths regarding prevention of TB transmission. Most pharmacy workers (77%) reported they would send a client with a history of cough for more than two weeks to a healthcare center, while 23% reported they would offer them antitussive medication or antibiotics. Almost all workers reported talking with clients about diseases and reported respiratory symptoms as one of the most common causes for consultation (60%). Most participants expressed interest in learning more about TB and expanding their involvement in the fight against TB in their community. Conclusion Pharmacy workers have adequate knowledge about TB. However, we identified gaps in knowledge with respect to prevention of TB transmission. Pharmacy workers commonly see patients with respiratory symptoms and some offer recommendations, including for treatment. Pharmacy workers are willing to learn more and contribute to TB control and could be a valuable asset in the control and prevention of TB in Peru. To achieve this integration of pharmacy workers into TB control and prevention, more research is needed.	[Garcia, Patricia J.; Hernandez-Cordova, Gustavo; Pourjavaheri, Paria; Gomez-Paredes, Hilbert J.; Sudar, Samuel; Bayer, Angela M.] Univ Peruana Cayetano Heredia, Epidemiol STI & HIV Res Unit, Sch Publ Hlth & Adm, Lima, Peru; [Bayer, Angela M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Universidad Peruana Cayetano Heredia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bayer, AM (corresponding author), Univ Peruana Cayetano Heredia, Epidemiol STI & HIV Res Unit, Sch Publ Hlth & Adm, Lima, Peru.; Bayer, AM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	angelabayerx@gmail.com		Hernandez-Cordova, Gustavo/0000-0001-5258-2952	Fogarty International Center of the U.S. National Institutes of Health; KUSKAYA: AN INTERDISCIPLINARY TRAINING PROGRAM FOR INNOVATION IN GLOBAL HEALTH [5D43TW009375-02]	Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); KUSKAYA: AN INTERDISCIPLINARY TRAINING PROGRAM FOR INNOVATION IN GLOBAL HEALTH	This study was funded by the Fogarty International Center of the U.S. National Institutes of Health, through a grant to PJG. The grant title is KUSKAYA: AN INTERDISCIPLINARY TRAINING PROGRAM FOR INNOVATION IN GLOBAL HEALTH and the grant number is 5D43TW009375-02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Faham Z, 2011, J INFECT DEV COUNTR, V5, P396, DOI 10.3855/jidc.1248; Alarcon Valentina, 2017, Rev Peru Med Exp Salud Publica, V34, P299, DOI 10.17843/rpmesp.2017.342.2384; Bell CA, 2012, INT J TUBERC LUNG D, V16, P1086, DOI 10.5588/ijtld.11.0669; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Castañeda-Hernández Diana M, 2013, Rev. perú. med. exp. salud publica, V30, P560; Cheema E, 2014, BRIT J CLIN PHARMACO, V78, P1238, DOI 10.1111/bcp.12452; De Blasio Francesco, 2011, Cough, V7, P7, DOI 10.1186/1745-9974-7-7; Dongo Víctor, 2009, Rev. perú. med. exp. salud publica, V26, P517; Pham DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074882; Fathima Mariam, 2013, Pharmacy Practice (Internet), V11, P228, DOI 10.4321/s1886-36552013000400008; Garcia PJ, 2007, SEX TRANSM INFECT, V83, P142, DOI 10.1136/sti.2006.022657; Garcia PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047750; Garcia PJ, 2012, LANCET, V379, P1120, DOI 10.1016/S0140-6736(11)61846-1; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Islam QS, 2014, INT HEALTH, V6, P225, DOI 10.1093/inthealth/ihu025; Jakeman B, 2015, J AM PHARM ASSOC, V55, P307, DOI 10.1331/JAPhA.2015.14141; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783, DOI 10.3855/jidc.335; Lambert ML, 2005, TROP MED INT HEALTH, V10, P246, DOI 10.1111/j.1365-3156.2004.01383.x; Larsson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166019; McGuire TR, 2007, J EVAL CLIN PRACT, V13, P146, DOI 10.1111/j.1365-2753.2007.00677.x; Ministerio de Salud del Peru A (MINSA), 2013, NORM TECN CONTR TUB; Ministerio de Salud (MINSA), 2014, AN SIT SAL DISA 4 LI; MINSA, 2011, SIT TUB PER; Munayco CV, 2015, REV PANAM SALUD PUBL, V38, P177; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Said K, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0276-4; Saldarriaga EM, 2017, ANN GLOB HEALTH, V83, P394, DOI 10.1016/j.aogh.2017.03.514; Sarker M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2181-8; Soumya R, 2016, INDIAN J PHARMACOL, V48, P360, DOI 10.4103/0253-7613.186204; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625; WHO, 2017, GLOB TUB REP 2017; WHO, 2008, PHARMAFORUM 0121	36	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0196648	10.1371/journal.pone.0196648	http://dx.doi.org/10.1371/journal.pone.0196648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040825	gold, Green Published			2022-12-26	WOS:000439749200001
J	Ma, H; Lee, Y; Hayama, T; Van Dyken, C; Marti-Gutierrez, N; Li, Y; Ahmed, R; Koski, A; Kang, E; Darby, H; Gonmanee, T; Park, Y; Wolf, DP; Kim, CJ; Mitalipov, S				Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Marti-Gutierrez, Nuria; Li, Ying; Ahmed, Riffat; Koski, Amy; Kang, Eunju; Darby, Hayley; Gonmanee, Thanasup; Park, Younjung; Wolf, Don P.; Kim, Chong Jai; Mitalipov, Shoukhrat			Germline and somatic mtDNA mutations in mouse aging	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; POINT MUTATIONS; CLONAL EXPANSION; HUMAN BRAIN; MUTATOR MICE; DELETIONS; DISEASE; HETEROPLASMY; ACCUMULATION; REPLICATION	The accumulation of acquired mitochondrial genome (mtDNA) mutations with aging in somatic cells has been implicated in mitochondrial dysfunction and linked to age-onset diseases in humans. Here, we asked if somatic mtDNA mutations are also associated with aging in the mouse. MtDNA integrity in multiple organs and tissues in young and old (2 +/- 34 months) wild type (wt) mice was investigated by whole genome sequencing. Remarkably, no acquired somatic mutations were detected in tested tissues. However, we identified several non-synonymous germline mtDNA variants whose heteroplasmy levels (ratio of normal to mutant mtDNA) increased significantly with aging suggesting clonal expansion of inherited mtDNA mutations. Polg mutator mice, a model for premature aging, exhibited both germline and somatic mtDNA mutations whose numbers and heteroplasmy levels increased significantly with age implicating involvement in premature aging. Our results suggest that, in contrast to humans, acquired somatic mtDNA mutations do not accompany the aging process in wt mice.	[Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Marti-Gutierrez, Nuria; Li, Ying; Ahmed, Riffat; Koski, Amy; Kang, Eunju; Darby, Hayley; Gonmanee, Thanasup; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97201 USA; [Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Marti-Gutierrez, Nuria; Li, Ying; Ahmed, Riffat; Koski, Amy; Kang, Eunju; Darby, Hayley; Gonmanee, Thanasup; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Lee, Yeonmi; Kang, Eunju; Park, Younjung; Kim, Chong Jai] ASAN Med Ctr, ASAN Inst Life Sci, Stem Cell Ctr, Seoul, South Korea	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of Ulsan; Asan Medical Center	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97201 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu		Gonmanee, Thanasup/0000-0001-9108-6476; Koski, Amy/0000-0003-1918-528X	National Institutes of Health [R56AG045137, P51OD011092]; Burroughs Wellcome Fund; OHSU Institutional Funds; National Research Foundation of Korea [NRF-2015K1A4A3046807]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); OHSU Institutional Funds; National Research Foundation of Korea(National Research Foundation of Korea); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by grants from the National Institutes of Health R56AG045137 and P51OD011092, Burroughs Wellcome Fund, OHSU Institutional Funds, and National Research Foundation of Korea (NRF-2015K1A4A3046807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004; Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje; Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Keogh M, 2013, CELL METAB, V18, P463, DOI 10.1016/j.cmet.2013.09.015; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040; Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8; Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Morris J, 2017, CELL REP, V21, P2706, DOI 10.1016/j.celrep.2017.11.031; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990	60	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201304	10.1371/journal.pone.0201304	http://dx.doi.org/10.1371/journal.pone.0201304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040856	gold, Green Published, Green Submitted			2022-12-26	WOS:000439749200036
J	Wang, HL; Du, HM; Li, HY; Huang, Y; Ding, JZ; Liu, C; Wang, N; Lan, H; Zhang, SZ				Wang, Hongling; Du, Hanmei; Li, Hongyou; Huang, Ying; Ding, Jianzhou; Liu, Chan; Wang, Ning; Lan, Hai; Zhang, Suzhi			Identification and functional characterization of the ZmCOPT copper transporter family in maize	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR MECHANISMS; ARABIDOPSIS-THALIANA; GENE FAMILY; YEAST; HOMEOSTASIS; EXPRESSION; COMPLEMENTATION; METALS	Copper (Cu) is an essential micronutrient for plant growth and development; Cu homeostasis in plant is maintained by the important functions of Ctr/COPT-type Cu transporters. Although the COPT genes have been identified in Arabidopsis thaliana and rice, little is known about Cu transporters in maize. In this study, three-members of putative maize Cu transporters (ZmCOPT 1, 2 and 3) are identified. ZmCOPT genes have expression in all of the tested tissues, including roots, stems, leaves and flowers (male and female), and their expression levels vary responding to stress due to Cu-deficiency and excess. Functional complementation and overexpression together with Cu uptake measurements in ZmCOPTs-transformed ctr1 Delta ctr2 Delta mutant strain or the wild type strain of Saccharomyces cerevisiae show that the three ZmCOPT members possess the ability to be Cu transporters. Among these, ZmCOPT1 and ZmCOPT2 have high-affinity while ZmCOPT3 has low-affinity. In addition, ZmCOPT2 tend to specifically transport Cu (I) but no other bivalent metal ions.	[Wang, Hongling; Du, Hanmei; Li, Hongyou; Huang, Ying; Ding, Jianzhou; Liu, Chan; Wang, Ning; Lan, Hai; Zhang, Suzhi] Sichuan Agr Univ, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Agr Dept,Maize Res Inst, Chengdu, Sichuan, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Zhang, SZ (corresponding author), Sichuan Agr Univ, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Agr Dept,Maize Res Inst, Chengdu, Sichuan, Peoples R China.	suzhi1026@163.com			National High Technology Research and Development Program of China [2016YFD0101206]; National Natural Science Foundation of China [30800687, 31071434]; Major Project of Education Department in Sichan [15ZA0022]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Education Department in Sichan	This work was supported by the National High Technology Research and Development Program of China (2016YFD0101206); the National Natural Science Foundation of China [No. 30800687, 31071434], Major Project of Education Department in Sichan [No. 15ZA0022].SZ received the funding.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Koch KA, 1996, MOL CELL BIOL, V16, P724; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Li H, 2016, PLANT CELL PHYSL; Li HX, 2014, PLANT CELL ENVIRON, V37, P1561, DOI 10.1111/pce.12263; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Liu LH, 2012, BIOCHEM BIOPH RES CO, V420, P600, DOI 10.1016/j.bbrc.2012.03.040; Martins V, 2014, PLANTA, V240, P91, DOI 10.1007/s00425-014-2067-5; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Puig S., 2014, ADV BOT, V2014, DOI DOI 10.1155/2014/476917; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Sancenon V, 2004, J BIOL CHEM, V279, P15348, DOI 10.1074/jbc.M313321200; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vatansever R., 2016, INTERDISCIPLINARY SC, P1, DOI DOI 10.1007/S12539-015-0014-1; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012; Yuan M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-69; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	43	13	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199081	10.1371/journal.pone.0199081	http://dx.doi.org/10.1371/journal.pone.0199081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036360	Green Published, Green Submitted, gold			2022-12-26	WOS:000439429200002
J	Batista, DFA; Neto, OCD; de Almeida, AM; Maboni, G; de Carvalho, TF; de Carvalho, TP; Barrow, PA; Berchieri, A				Alves Batista, Diego Felipe; de Freitas Neto, Oliveiro Caetano; de Almeida, Adriana Maria; Maboni, Grazieli; de Carvalho, Tatiane Furtado; de Carvalho, Thaynara Parente; Barrow, Paul Andrew; Berchieri Junior, Angelo			Evaluation of pathogenicity of Salmonella Gallinarum strains harbouring deletions in genes whose orthologues are conserved pseudogenes in S. Pullorum	PLOS ONE			English	Article							ENTERICA SEROVARS; HOST ADAPTATION; INFECTION; EXPRESSION; METABOLISM; MICE; IDENTIFICATION; EVOLUTIONARY; ENTERITIDIS; MACROPHAGES	The diseases caused by Salmonella Gallinarum and S. Pullorum in chickens known as fowl typhoid and pullorum disease, respectively, pose a great threat to the poultry industry mainly in developing countries, since they have already been controlled in the developed ones. These bacteria are very similar at the genomic level but develop distinct host-pathogen relationships with chickens. Therefore, a deep understanding of the molecular mechanisms whereby S. Gallinarum and S. Pullorum interact with the host could lead to the development of new approaches to control and, perhaps, eradicate both diseases from the chicken flocks worldwide. Based on our previous study, it was hypothesised that metabolism-related pseudogenes, fixed in S. Pullorum genomes, could play a role in the distinct host-pathogen interaction with susceptible chickens. To test this idea, three genes (idnT, idnO and ccmH) of S. Gallinarum str. 287/91, which are pseudogenes on the S. Pullorum chromosomes, were inactivated by mutations. These genetically engineered strains grew well on the solid media without any colony morphology difference. In addition, similar growth curves were obtained by cultivation in M9 minimal medium containing D-gluconate as the sole carbon source. Infection of chickens with idnTO mutants led to increased numbers of bacteria in the livers and spleens at 5 days post-infection, but with slightly decreased heterophil infiltration in the spleens when compared to the wild-type strain. On the other hand, no significant phenotypic change was caused by mutation to ccmH genes. Apart from the above-mentioned alterations, all S. Gallinarum strains provoked similar infections, since mortality, clinical signs, macroscopic alterations and immune response were similar to the infected chickens. Therefore, according to the model applied to this study, mutation to the idnTO and ccmH genes showed minor impact on the fowl typhoid pathogenesis and so they may be relics from the ancestor genome. Our data hints at a more complex mechanism driving the distinct host-pathogen interaction of S. Gallinarum/Pullorum with chickens than differential inactivation of a few genes.	[Alves Batista, Diego Felipe; de Freitas Neto, Oliveiro Caetano; de Almeida, Adriana Maria; Berchieri Junior, Angelo] Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Post Grad Program Agr & Livestock Microbiol, Dept Vet Pathol, Campus Jaboticabal, Sao Paulo, Brazil; [de Freitas Neto, Oliveiro Caetano] Univ Fed Paraiba, Dept Vet Sci, Areia, Paraiba, Brazil; [Maboni, Grazieli; Barrow, Paul Andrew] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [de Carvalho, Tatiane Furtado; de Carvalho, Thaynara Parente] Fed Univ Minas Gerais UFMG, Sch Vet, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil	Universidade Estadual Paulista; Universidade Federal da Paraiba; University of Nottingham; Universidade Federal de Minas Gerais	Neto, OCD (corresponding author), Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Post Grad Program Agr & Livestock Microbiol, Dept Vet Pathol, Campus Jaboticabal, Sao Paulo, Brazil.; Neto, OCD (corresponding author), Univ Fed Paraiba, Dept Vet Sci, Areia, Paraiba, Brazil.	oliveirocaetano@yahoo.com.br	de, Freitas Neto O. C./E-8713-2012; Batista, Diego F. A./F-3467-2012; Berchieri Junior, Angelo/ABA-2618-2021	de, Freitas Neto O. C./0000-0002-1437-069X; Berchieri Junior, Angelo/0000-0003-2522-6500; MABONI, GRAZIELI/0000-0002-6952-1598	Sao Paulo Research Foundation [2013/26127-7, 2013/22920-4]; National Council of Technological and Scientific Development (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES); Sao Paulo Research Foundation (FAPESP), Brazil; Coordination of Improvement of Higher Education Personnel (CAPES), Brazil; Council of Technological and Scientific Development (CNPq), Brazil	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination of Improvement of Higher Education Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Council of Technological and Scientific Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by Sao Paulo Research Foundation: http://www.fapesp.br/en/ (Grant numbers 2013/26127-7 and 2013/22920-4) AB and DB; The National Council of Technological and Scientific Development (CNPq) and the Coordination of Improvement of Higher Education Personnel (CAPES), Dr. Oliveiro Caetano de Freitas Neto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like thank the Sao Paulo Research Foundation (FAPESP), the National Council of Technological and Scientific Development (CNPq) and the Coordination of Improvement of Higher Education Personnel (CAPES), Brazil, for funding this research. We are also grateful to Dr. Denadai, J. and to the Avian Diseases laboratory team (Unesp), for their technical support, and to Dr. Santos, R. L. from the School of Veterinary D Federal University of Minas Gerais (UFMG) for allowing us to use his laboratory to perform histopathology analysis.	Batista DFA, 2015, INFECT GENET EVOL, V30, P74, DOI 10.1016/j.meegid.2014.12.007; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrow PA, 2011, AVIAN PATHOL, V40, P1, DOI 10.1080/03079457.2010.542575; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berchieri A, 2001, AVIAN PATHOL, V30, P221, DOI 10.1080/03079450120054631; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brinsmade SR, 2017, CURR GENET, V63, P417, DOI 10.1007/s00294-016-0656-5; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Choby JE, 2016, CELL CHEM BIOL, V23, P1351, DOI 10.1016/j.chembiol.2016.09.012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Neto OCD, 2013, VET MICROBIOL, V165, P425, DOI 10.1016/j.vetmic.2013.04.015; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Ezema WS, 2009, COMP CLIN PATHOL, V18, P395, DOI DOI 10.1007/S00580-009-0812-0; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059427; Grove J, 1996, MOL MICROBIOL, V19, P467, DOI 10.1046/j.1365-2958.1996.383914.x; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Henderson SC, 1999, INFECT IMMUN, V67, P3580, DOI 10.1128/IAI.67.7.3580-3586.1999; Jelsbak L, 2016, INFECT IMMUN, V84, P2076, DOI 10.1128/IAI.00182-16; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; Kogut MH, 2008, INNATE IMMUN-LONDON, V14, P213, DOI 10.1177/1753425908094416; Langridge GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/pnas.1416707112; LI J, 1993, J MED MICROBIOL, V38, P129, DOI 10.1099/00222615-38-2-129; Lopes PD, 2016, VET J, V214, P40, DOI 10.1016/j.tvjl.2016.05.006; Njoroge JW, 2012, MBIO, V3, DOI 10.1128/mBio.00280-12; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; Okon E, 2017, INT J MED MICROBIOL, V307, P83, DOI 10.1016/j.ijmm.2016.09.007; Peekhaus N, 1997, FEMS MICROBIOL LETT, V147, P233, DOI 10.1111/j.1574-6968.1997.tb10247.x; Sambrook J., 2001, MOL CLONING LAB MANU; Setta A, 2012, VET IMMUNOL IMMUNOP, V146, P212, DOI 10.1016/j.vetimm.2012.03.008; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; Shivaprasad HL, 2004, DIS POULTRY; Tanapongpipat S, 1998, BIOCHEM J, V334, P355, DOI 10.1042/bj3340355; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wigley P, 2005, INFECT IMMUN, V73, P2986, DOI 10.1128/IAI.73.5.2986-2990.2005; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	38	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200585	10.1371/journal.pone.0200585	http://dx.doi.org/10.1371/journal.pone.0200585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028856	gold, Green Published, Green Submitted			2022-12-26	WOS:000439396900008
J	Thyagarajan, HM; Lancaster, JN; Lira, SA; Ehrlich, LIR				Thyagarajan, Hiran M.; Lancaster, Jessica N.; Lira, Sergio A.; Ehrlich, Lauren I. R.			CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction	PLOS ONE			English	Article							REGULATORY T-CELLS; CHEMOKINE RECEPTOR CCR8; HEMATOPOIETIC PROGENITORS; NEGATIVE SELECTION; MEDULLA MIGRATION; GENE-EXPRESSION; DENDRITIC CELLS; DIFFERENTIATION; ACTIVATION; SURVIVAL	Following positive selection, thymocytes migrate into the medulla where they encounter diverse self-antigens that induce central tolerance. Thymocytes expressing T cell receptors (TCRs) with high affinity for self-antigens displayed by medullary antigen presenting cells (APCs) undergo either negative selection or diversion to the regulatory T cell (Treg) lineage, thus ensuring maturation of non-autoreactive T cells. Because many self-antigens are expressed by only a small percentage of medullary thymic epithelial cells, thymocytes must enter the medulla and efficiently scan APCs therein to encounter the full array of self-antigens that induce central tolerance. Chemokine receptors play a critical role in promoting medullary entry and rapid motility of post-positive selection thymocytes. We found that the chemokine receptor CCR8 is expressed by post-positive selection CD4(+) single positive (SP) thymocytes in mice, while the corresponding chemokine ligands are expressed by medullary APCs, and thus hypothesized that CCR8 would promote thymocyte medullary entry and/or rapid motility to induce negative selection. However, despite a subtle decline in thymocyte medullary accumulation and the presence of autoantibodies in aged CCR8-deficient mice, CCR8 was not required for thymocyte differentiation, rapid motility, or negative selection.	[Thyagarajan, Hiran M.; Lancaster, Jessica N.; Ehrlich, Lauren I. R.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Lira, Sergio A.] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Ehrlich, Lauren I. R.] Univ Texas Austin, Livestrong Canc Inst, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Austin	Ehrlich, LIR (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.; Ehrlich, LIR (corresponding author), Univ Texas Austin, Livestrong Canc Inst, Dell Med Sch, Austin, TX 78712 USA.	lehrlich@austin.utexas.edu	Lancaster, Jessica Naomi/O-7762-2019	Lancaster, Jessica Naomi/0000-0003-0398-9988; Lira, Sergio/0000-0002-6742-3089; Ehrlich, Lauren/0000-0002-1697-1755	National Institute of Allergy and Infectious Disease [R01AI104870]; Cancer Research Institute of Texas [R1003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104870] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Disease (https://www.niaid.nih.gov) R01AI104870 to L.I.R.E., and by a grant from the Cancer Research Institute of Texas (http://www.cprit.state.tx.us) R1003 to L.I.R.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Barsheshet Y, 2017, P NATL ACAD SCI USA, V114, P6086, DOI 10.1073/pnas.1621280114; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Coghill JM, 2013, BLOOD, V122, P825, DOI 10.1182/blood-2012-06-435735; Cowan JE, 2014, J IMMUNOL, V193, P1204, DOI 10.4049/jimmunol.1400993; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hu ZC, 2017, CELL REP, V21, P168, DOI 10.1016/j.celrep.2017.09.016; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Ki S, 2017, EUR J IMMUNOL, V14, P377; Ki S, 2014, CELL REP, V9, P402, DOI 10.1016/j.celrep.2014.08.070; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kozai M, 2017, J EXP MED, V214, P1925, DOI 10.1084/jem.20161864; Kremer L, 2001, J IMMUNOL, V166, P218, DOI 10.4049/jimmunol.166.1.218; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Lancaster JN, 2018, TRENDS IMMUNOL, V39, P86, DOI 10.1016/j.it.2017.10.007; Lancaster JN, 2017, METHODS MOL BIOL, V1591, P9, DOI 10.1007/978-1-4939-6931-9_2; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Spinetti G, 2003, J LEUKOCYTE BIOL, V73, P201, DOI 10.1189/jlb.0302105; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Trampont PC, 2009, NAT IMMUNOL, V11, P162, DOI 10.1038/blood-2009-07-235721; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; VanSnick J, 1996, J IMMUNOL, V157, P2570; Wang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030793; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Yabe R, 2015, INT IMMUNOL, V27, P169, DOI 10.1093/intimm/dxu098; Zingoni A, 1998, J IMMUNOL, V161, P547; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200765	10.1371/journal.pone.0200765	http://dx.doi.org/10.1371/journal.pone.0200765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024927	Green Submitted, gold, Green Published			2022-12-26	WOS:000439120000049
J	Ferrandino, F; Bernardini, G; Tsaouli, G; Grazioli, P; Campese, AF; Noce, C; Ciuffetta, A; Vacca, A; Besharat, ZM; Bellavia, D; Screpanti, I; Felli, MP				Ferrandino, Francesca; Bernardini, Giovanni; Tsaouli, Georgia; Grazioli, Paola; Campese, Antonio Francesco; Noce, Claudia; Ciuffetta, Ambra; Vacca, Alessandra; Besharat, Zein Mersini; Bellavia, Diana; Screpanti, Isabella; Felli, Maria Pia			Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation	ONCOGENE			English	Article							NF-KAPPA-B; ACUTE LYMPHOBLASTIC-LEUKEMIA; PRE-TCR; ACTIVATING MUTATIONS; ADRENERGIC-RECEPTOR; SIGNALING PATHWAYS; BONE; EXPRESSION; PROTEIN; BETA	Notch hyperactivation dominates T-cell acute lymphoblastic leukemia development, but the mechanisms underlying "pre-leukemic" cell dissemination are still unclear. Here we describe how deregulated Notch3 signaling enhances CXCR4 cell-surface expression and migratory ability of CD4(+)CD8(+) thymocytes, possibly contributing to "pre-leukemic" cell propagation, early in disease progression. In transgenic mice overexpressing the constitutively active Notch3 intracellular domain, we detect the progressive increase in circulating blood and bone marrow of CD4(+)CD8(+) cells, characterized by high and combined surface expression of Notch3 and CXCR4. We report for the first time that transplantation of such CD4(+)CD8(+) cells reveals their competence in infiltrating spleen and bone marrow of immunocompromised recipient mice. We also show that CXCR4 surface expression is central to the migratory ability of CD4(+)CD8(+) cells and such an expression is regulated by Notch3 through beta-arrestin in human leukemia cells. De novo, we propose that hyperactive Notch3 signaling by boosting CXCR4-dependent migration promotes anomalous egression of CD4(+)CD8(+) cells from the thymus in early leukemia stages. In fact, in vivo CXCR4 antagonism prevents bone marrow colonization by such CD4(+)CD8(+) cells in young Notch3 transgenic mice. Therefore, our data suggest that combined therapies precociously counteracting intrathymic Notch3/CXCR4 crosstalk may prevent dissemination of "pre-leukemic" CD4(+)CD8(+ )cells, by a "thymus-autonomous" mechanism.	[Ferrandino, Francesca; Grazioli, Paola; Vacca, Alessandra; Besharat, Zein Mersini; Felli, Maria Pia] Sapienza Univ, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy; [Bernardini, Giovanni; Tsaouli, Georgia; Campese, Antonio Francesco; Noce, Claudia; Ciuffetta, Ambra; Bellavia, Diana; Screpanti, Isabella] Sapienza Univ, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy; [Bernardini, Giovanni] IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, IS, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Neuromed	Felli, MP (corresponding author), Sapienza Univ, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy.; Screpanti, I (corresponding author), Sapienza Univ, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy.	isabella.screpanti@uniroma1.it; mariapia.felli@uniroma1.it	BERNARDINI, Giovanni/AAA-8160-2019; Bellavia, Diana/AAO-6348-2021; Ferrandino, Francesca/AAA-4905-2020; Besharat, Zein Mersini/G-5413-2013; Bernardini, Giovanni/GRJ-0070-2022	BERNARDINI, Giovanni/0000-0002-3705-2598; Besharat, Zein Mersini/0000-0003-0317-9854; Bellavia, Diana/0000-0001-5728-2537; FELLI, MARIA PIA/0000-0002-5765-2611	Sapienza University; Ateneo 2015 [C26A15MHEL]; Ateneo 2016 [RP116154CE3A9FA1]	Sapienza University; Ateneo 2015; Ateneo 2016	Dedicated to Alberto Gulino. We thank Maria Pelullo, Giulia Diluvio, and Rebeka Popovic for skillful assistance in experiments, Mr. Alessandro Martini for mouse husbandry and Mr. Fernando Duranti for technical assistance, and Sarah Sturman for help in editing the manuscript. Funding was provided by Sapienza University, Ateneo 2015 (C26A15MHEL), and Ateneo 2016 (RP116154CE3A9FA1) to MPF.	Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Ben-Baruch A, 2009, CELL ADHES MIGR, V3, P328, DOI 10.4161/cam.3.4.9211; Bernardini G, 2005, FASEB J, V19, P1305, DOI 10.1096/fj.04-3352fje; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Bernasconi-Elias P, 2016, ONCOGENE, V35, P6077, DOI 10.1038/onc.2016.133; Campese AF, 2003, SEMIN CELL DEV BIOL, V14, P151, DOI 10.1016/S1084-9521(02)00184-2; Campese AF, 2006, BLOOD, V108, P305, DOI 10.1182/blood-2006-01-0143; Campese AF, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113803; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Checquolo S, 2010, ONCOGENE, V29, P1463, DOI 10.1038/onc.2009.446; Cyster JG, 2002, J CLIN INVEST, V109, P1011, DOI 10.1172/JCI200215511; Felli MP, 2005, ONCOGENE, V24, P992, DOI 10.1038/sj.onc.1208302; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Franciosa G, 2016, ONCOGENE, V35, P4741, DOI 10.1038/onc.2016.5; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Goertzen CG, 2016, CELL SIGNAL, V28, P165, DOI 10.1016/j.cellsig.2015.12.010; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Jost TR, 2016, J LEUKOCYTE BIOL, V99, P1077, DOI 10.1189/jlb.5MA0915-394R; Kuksin CA, 2015, BLOOD, V125, P2087, DOI 10.1182/blood-2014-08-594796; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Liu T, 2016, EXP HEMATOL ONCOL, V5, DOI 10.1186/s40164-016-0050-5; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Massimi I, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/607957; Mirandola L, 2012, J PATHOL, V226, P713, DOI 10.1002/path.3015; Parretta E, 2008, J IMMUNOL, V180, P7230, DOI 10.4049/jimmunol.180.11.7230; Passaro D, 2015, CANCER CELL, V27, P769, DOI 10.1016/j.ccell.2015.05.003; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pelullo M, 2014, NEOPLASIA, V16, P1007, DOI 10.1016/j.neo.2014.10.004; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Puca L, 2014, J CELL SCI, V127, P1359, DOI 10.1242/jcs.142539; Quaranta R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.326; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Scupoli MT, 2008, HAEMATOLOGICA, V93, P524, DOI 10.3324/haematol.12098; Talora C, 2006, BLOOD, V107, P3313, DOI 10.1182/blood-2005-07-2823; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Uckun FM, 1998, BLOOD, V91, P735; Vacca A, 2006, EMBO J, V25, P1000, DOI 10.1038/sj.emboj.7600996; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	57	24	24	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 6	2018	37	49					6285	6298		10.1038/s41388-018-0401-2	http://dx.doi.org/10.1038/s41388-018-0401-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HD3AP	30038265	Green Published, hybrid			2022-12-26	WOS:000452384400001
J	Crousilles, A; Dolan, SK; Brear, P; Chirgadze, DY; Welch, M				Crousilles, Audrey; Dolan, Stephen K.; Brear, Paul; Chirgadze, Dimitri Y.; Welch, Martin			Gluconeogenic precursor availability regulates flux through the glyoxylate shunt in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; bacterial pathogenesis; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); metabolic regulation; enzyme structure; allosteric regulation; post-translational modification (PTM); gluconeogenesis; acetyl coenzyme A (acetyl-CoA); glyoxylate shunt; isocitrate dehydrogenase; isocitrate lyase; Pseudomonas aeruginosa; enzyme regulation; bacterial virulence; metabolic adaptation	COLI ISOCITRATE DEHYDROGENASE; TRICARBOXYLIC-ACID CYCLE; ESCHERICHIA-COLI; BRANCH POINT; MYCOBACTERIUM-TUBERCULOSIS; MALATE SYNTHASE; LYASE; PHOSPHORYLATION; PATHOGENESIS; PERSISTENCE	The glyoxylate shunt bypasses the oxidative decarboxylation steps of the tricarboxylic acid (TCA) cycle, thereby conserving carbon skeletons for gluconeogenesis and biomass production. In Escherichia coli, carbon flux is redirected through the first enzyme of the glyoxylate shunt, isocitrate lyase (ICL), following phosphorylation and inactivation of the TCA cycle enzyme, isocitrate dehydrogenase (ICD), by the kinase/phosphatase, AceK. In contrast, mycobacterial species lack AceK and employ a phosphorylation-insensitive isocitrate dehydrogenase (IDH), which is allosterically activated by the product of ICL activity, glyoxylate. However, Pseudomonas aeruginosa expresses IDH, ICD, ICL, and AceK, raising the question of how these enzymes are regulated to ensure proper flux distribution between the competing pathways. Here, we present the structure, kinetics, and regulation of ICL, IDH, and ICD from P. aeruginosa. We found that flux partitioning is coordinated through reciprocal regulation of these enzymes, linking distribution of carbon flux to the availability of the key gluconeogenic precursors, oxaloacetate and pyruvate. Specifically, a greater abundance of these metabolites activated IDH and inhibited ICL, leading to increased TCA cycle flux. Regulation was also exerted through AceK-dependent phosphorylation of ICD; high levels of acetyl-CoA (which would be expected to accumulate when oxaloacetate is limiting) stimulated the kinase activity of AceK, whereas high levels of oxaloacetate stimulated its phosphatase activity. In summary, the TCA cycle-glyoxylate shunt branch point in P. aeruginosa has a complex enzymology that is profoundly different from those in other species characterized to date. Presumably, this reflects its predilection for consuming fatty acids, especially during infection scenarios.	[Crousilles, Audrey; Dolan, Stephen K.; Brear, Paul; Chirgadze, Dimitri Y.; Welch, Martin] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England	University of Cambridge	Welch, M (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mw240@cam.ac.uk	Dolan, Stephen K/O-6542-2018; Welch, Martin/A-6186-2016	Dolan, Stephen K/0000-0002-7391-2137; Welch, Martin/0000-0003-3646-1733; Chirgadze, Dimitri/0000-0001-9942-0993; Brear, Paul/0000-0002-4045-0474; Crousilles, Audrey/0000-0002-3003-3490	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M019411/1]; BBSRC [BB/M019411/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/M019411/1. The authors declare that they have no conflicts of interest with the contents of this article.	Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Britton KL, 2000, STRUCTURE, V8, P349, DOI 10.1016/S0969-2126(00)00117-9; Britton KL, 2001, ACTA CRYSTALLOGR D, V57, P1209, DOI 10.1107/S0907444901008642; Chung JCS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120131; DEAN AM, 1989, J BIOL CHEM, V264, P20482; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahnoe KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051732; Hayes D. B., 1995, SEDNTERP; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; KORNBERG HL, 1957, BIOCHIM BIOPHYS ACTA, V24, P651, DOI 10.1016/0006-3002(57)90268-8; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; Lassek C, 2016, PROTEOMICS, V16, P1381, DOI 10.1002/pmic.201500228; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McVey AC, 2017, BIOCHEMISTRY-US, V56, P5539, DOI 10.1021/acs.biochem.7b00852; Murima P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12527; NIMMO GA, 1984, EUR J BIOCHEM, V141, P409, DOI 10.1111/j.1432-1033.1984.tb08206.x; NIMMO HG, 1986, BIOCHEM J, V234, P317, DOI 10.1042/bj2340317; RITTENHOJW, 1974, ARCH BIOCHEM BIOPHYS, V163, P79, DOI DOI 10.1016/0003-9861(74)90456-1; SCHLOSS JV, 1982, BIOCHEMISTRY-US, V21, P4420, DOI 10.1021/bi00261a035; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Stoddard BL, 1998, NAT STRUCT BIOL, V5, P891, DOI 10.1038/2331; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yasutake Y, 2002, STRUCTURE, V10, P1637, DOI 10.1016/S0969-2126(02)00904-8; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	36	27	27	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14260	14269		10.1074/jbc.RA118.004514	http://dx.doi.org/10.1074/jbc.RA118.004514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30030382	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000444671500007
J	Mathews, CK				Mathews, Christopher K.			Still the most interesting enzyme in the world	FASEB JOURNAL			English	Editorial Material						ribonucleotide reductase; dNTPs; deoxyribonucleotide biosynthesis	HUMAN RIBONUCLEOTIDE REDUCTASE; STRUCTURAL BASIS		[Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, 2011 Ag & Life Sci Bldg, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Ag & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@oregonstate.edu						Ahmad MF, 2017, P NATL ACAD SCI USA, V114, P8241, DOI 10.1073/pnas.1620220114; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Brignole EJ, 2018, ELIFE, V7, DOI [10.7554/eLife.3150, 10.7554/eLife.31502]; Chen PYT, 2018, J BIOL CHEM, V293, P10404, DOI 10.1074/jbc.RA118.002569; Dassama LMK, 2013, BIOCHEMISTRY-US, V52, P6424, DOI 10.1021/bi400819x; Dragicevic I, 2015, CHEM-EUR J, V21, P6132, DOI 10.1002/chem.201405741; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Foskolou IP, 2017, MOL CELL, V66, P206, DOI 10.1016/j.molcel.2017.03.005; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Huff SE, 2018, J MED CHEM, V61, P666, DOI 10.1021/acs.jmedchem.7b00530; Johansson R, 2016, STRUCTURE, V24, P906, DOI 10.1016/j.str.2016.03.025; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Mathews CK, 2016, STRUCTURE, V24, P843, DOI 10.1016/j.str.2016.05.006; Nazaretyan SA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00713-17; Parker MJ, 2018, P NATL ACAD SCI USA, V115, pE4594, DOI 10.1073/pnas.1800356115; Song Y, 2017, DEV CELL, V42, P301, DOI 10.1016/j.devcel.2017.06.013; STUBBE JA, 1990, J BIOL CHEM, V265, P5329	17	5	5	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4067	4069		10.1096/fj.201800790R	http://dx.doi.org/10.1096/fj.201800790R			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	30059250	Bronze			2022-12-26	WOS:000439325400001
J	Bove, RM; Patrick, E; McCabe, C; Srivastava, G; Schneider, JA; Bennett, DA; De Jager, PL; Chibnik, LB				Bove, Riley M.; Patrick, Ellis; McCabe, Cristin; Srivastava, Gyan; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.; Chibnik, Lori B.			Reproductive period and epigenetic modifications of the oxidative phosphorylation pathway in the human prefrontal cortex	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DNA-METHYLATION CHANGES; ALZHEIMERS-DISEASE; GENE-EXPRESSION; HUMAN BRAIN; TRANSCRIPTOME ANALYSIS; BIPOLAR DISORDER; MENOPAUSE; WOMEN; AGE	Purpose Human females have a unique duration of post-reproductive longevity, during which sex-specific mechanisms ma influence later-life mechanisms of neuronal resilience and vulnerability. The maintenance of energy metabolism, through the oxidative phosphorylation (OXPHOS) apparatus, is essential for brain health. Given the known association between reproductive period (years from menarche to menopause) and cognitive aging, we examined the hypothesis that cumulative estrogen exposure across the lifetime may be associated with differential methylation of genes in the OXPHOS pathway. Methods Using DNA methylation patterns in the post-mortem dorsolateral prefrontal cortex (DLPFC) of 426 women prospectively followed until death in the Religious Orders Study and Rush Memory and Aging Project, we examined the relationship between reproductive period (subtracting age at menarche from age at menopause) and DNA methylation of a published set of autosomal OXPHOS genes previously implicated in stroke susceptibility. We then performed an unsupervised analysis of methylation levels across the Hallmark pathways from the Molecular Signatures Database. Results We observed a strong association between reproductive period and DNA methylation status across OXPHOS CpGs. We replicated this association between reproductive period and DNA methylation in a much larger set of OXPHOS genes in our unsupervised analysis. Here, reproductive period also showed associations with methylation in genes related to E2F, MYC and MTORC1 signaling, fatty acid metabolism and DNA repair. Conclusion This study provides evidence from both a supervised and unsupervised analyses, that lifetime cumulative endogenous steroid exposures may play a role in maintenance of postmenopausal cellular balance, including in brain tissue.	[Bove, Riley M.] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Bove, Riley M.; Patrick, Ellis; De Jager, Philip L.; Chibnik, Lori B.] Harvard Med Sch, Boston, MA 02115 USA; [Patrick, Ellis; Srivastava, Gyan; De Jager, Philip L.; Chibnik, Lori B.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Patrick, Ellis; Srivastava, Gyan; De Jager, Philip L.; Chibnik, Lori B.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Patrick, Ellis; McCabe, Cristin; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Patrick, Ellis] Univ Sydney, Sch Math & Stat, Westmead, NSW, Australia; [Patrick, Ellis] Univ Sydney, Westmead Inst Med Res, Westmead, NSW, Australia; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [De Jager, Philip L.] Columbia Univ, Med Ctr, Dept Neurol, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [Srivastava, Gyan] Abbvie Pharmaceut, Cambridge, MA USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Rush University; Columbia University; AbbVie	Bove, RM (corresponding author), Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Bove, RM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Riley.Bove@ucsf.edu	Patrick, Ellis/B-1763-2013	Patrick, Ellis/0000-0002-5253-4747; Chibnik, Lori/0000-0001-6293-806X	National Institutes of Health [R01 AG036042, R01AG036836, R01 AG17917, R01AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, K25 AG041906-01, K12 HD051959]; National Multiple Sclerosis Society Career Transition Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036042, K25AG041906, RC2AG036547, RF1AG015819, RF1AG036042, R01AG036836, P30AG010161, P50AG016574, R01AG032990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Career Transition Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants: R01 AG036042, R01AG036836, R01 AG17917, R01AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, K25 AG041906-01 and K12 HD051959; as well as by the National Multiple Sclerosis Society Career Transition Grant (R.B.). GS is currently employed by Abbvie; however was not affiliated with this employer at the time of the study. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CD, 2013, STROKE, V44, P612, DOI 10.1161/STROKEAHA.112.672089; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976, DOI 10.2741/E434; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Boulware Marissa I, 2012, Curr Top Behav Neurosci, V10, P165, DOI 10.1007/7854_2011_122; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carrard A, 2011, J AFFECT DISORDERS, V132, P450, DOI 10.1016/j.jad.2011.03.018; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Connor CM, 2008, EPIGENETICS-US, V3, P55, DOI 10.4161/epi.3.2.5938; Coppus AMW, 2010, J ALZHEIMERS DIS, V19, P545, DOI 10.3233/JAD-2010-1247; Corbo RM, 2011, DEMENT GERIATR COGN, V32, P63, DOI 10.1159/000330472; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Geerlings MI, 2001, JAMA-J AM MED ASSOC, V285, P1475, DOI 10.1001/jama.285.11.1475; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Henderson VW, 2007, MENOPAUSE, V14, P572, DOI 10.1097/gme.0b013e31803df49c; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kirsch-Volders M, 2010, MUTAGENESIS, V25, P213, DOI 10.1093/mutage/geq008; Lai JC, 2005, INT J CANCER, V117, P974, DOI 10.1002/ijc.21278; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Lim ASP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004792; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Lopez-Gallardo E, 2011, MUTAT RES-REV MUTAT, V728, P98, DOI 10.1016/j.mrrev.2011.06.004; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pregelj P, 2009, PSYCHIAT DANUB, V21, P128; Qureshi IA, 2010, PROG BRAIN RES, V186, P77, DOI 10.1016/B978-0-444-53630-3.00006-3; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Yang JY, 2015, INT J BIOCHEM CELL B, V67, P58, DOI 10.1016/j.biocel.2015.05.009; Yu L, 2016, ALZHEIMERS DEMENT, V12, P942, DOI 10.1016/j.jalz.2016.02.009; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0199073	10.1371/journal.pone.0199073	http://dx.doi.org/10.1371/journal.pone.0199073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052629	Green Published, gold			2022-12-26	WOS:000440006600006
J	Ramirez-Paz, J; Saxena, M; Delinois, LJ; Joaquin-Ovalle, FM; Lin, S; Chen, ZF; Rojas-Nieves, VA; Griebenow, K				Ramirez-Paz, Josell; Saxena, Manoj; Delinois, Louis J.; Joaquin-Ovalle, Freisa M.; Lin, Shiru; Chen, Zhongfang; Rojas-Nieves, Virginia A.; Griebenow, Kai			Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis	PLOS ONE			English	Article							COLI L-ASPARAGINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; SITE-SPECIFIC PEGYLATION; CRYSTALLINE L-ASPARAGINASE; ESCHERICHIA-COLI; POLYETHYLENE-GLYCOL; THERAPEUTIC PROTEINS; MONOMETHOXYPOLYETHYLENE GLYCOL; BINDING ABILITY; DISULFIDE BONDS	L-Asparaginase is an enzyme successfully being used in the treatment of acute lymphoblastic leukemia, acute myeloid leukemia, and non-Hodgkin's lymphoma. However, some disadvantages still limit its full application potential, e.g., allergic reactions, pancreatitis, and blood clotting impairment. Therefore, much effort has been directed at improving its performance. A popular strategy is to randomly conjugate L-asparaginase with mono-methoxy polyethylene glycol, which became a commercial FDA approved formulation widely used in recent years. To improve this formulation by PEGylation, herein we performed cysteine-directed conjugation of the L-asparaginase subunits to prevent dissociation-induced loss of activity. The recombinant cysteine conjugation sites were introduced by mutagenesis at surface-exposed positions on the protein to avoid affecting the catalytic activity. Three conjugates were obtained using different linear PEGs of 1000, 2000, and 5000 g/mol, with physical properties ranging from a semi-solid gel to a fully soluble state. The soluble-conjugate exhibited higher catalytic activity than the non-conjugated mutant, and the same activity than the native enzyme. The cysteine-directed crosslinking of the L-asparaginase subunits produced a higher molecular weight conjugate compared to the native tetrameric enzyme. This strategy might improve L-asparaginase efficiency for leukemia treatment by reducing glomerular filtration due to the increase in hydrodynamic size thus extending half-live, while at the same time retaining full catalytic activity.	[Ramirez-Paz, Josell; Saxena, Manoj; Delinois, Louis J.; Joaquin-Ovalle, Freisa M.; Lin, Shiru; Chen, Zhongfang; Rojas-Nieves, Virginia A.; Griebenow, Kai] Univ Puerto Rico Rio Piedras, Fac Nat Sci, Dept Chem, San Juan, PR 00931 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras	Griebenow, K (corresponding author), Univ Puerto Rico Rio Piedras, Fac Nat Sci, Dept Chem, San Juan, PR 00931 USA.	kai.griebenow@gmail.com	Lin, Shiru/B-9209-2018; Griebenow, Kai H/AAS-2754-2021; Griebenow, Kai/AGK-1725-2022; Chen, Zhongfang/A-3397-2008	Lin, Shiru/0000-0002-0159-2269; Griebenow, Kai H/0000-0003-0495-9932; Chen, Zhongfang/0000-0002-1445-9184	RISE Program at the University of Puerto Rico Rio Piedras Campus, NIH Grant [5R25GM061151-16]; RISE Program at UPR Rio Piedras NIH Grant [5R25GM061151-16]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151] Funding Source: NIH RePORTER	RISE Program at the University of Puerto Rico Rio Piedras Campus, NIH Grant; RISE Program at UPR Rio Piedras NIH Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Materials, instrumentation and research facilities provided by Kai Griebenow's laboratory at Facundo Bueso Building at the University of Puerto Rico Rio Piedras campus. Instrumentation and research facilities provided by the Molecular Sciences Research Center at the University of Puerto Rico. Research materials and student stipend provided by the RISE Program at the University of Puerto Rico Rio Piedras Campus, NIH Grant No. 5R25GM061151-16.; This work was developed with materials, instrumentation and facilities provided by Kai Griebenow's research laboratory at Facundo Bueso building at the University of Puerto Rico Rio Piedras campus, the Molecular Sciences Research Center at the UPR, and RISE Program at UPR Rio Piedras NIH Grant No. 5R25GM061151-16. We like to thank Arthur D. Tinoco for his help with the mass spectroscopy instrumentation.	Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; ASHIHARA Y, 1978, BIOCHEM BIOPH RES CO, V83, P385, DOI 10.1016/0006-291X(78)91002-1; ASSELIN BL, 1991, CANCER RES, V51, P6568; Avramis VI, 2006, INT J NANOMED, V1, P241; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Balan S, 2007, BIOCONJUGATE CHEM, V18, P61, DOI 10.1021/bc0601471; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brocchini S, 2008, ADV DRUG DELIVER REV, V60, P3, DOI 10.1016/j.addr.2007.06.014; CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418; Dozier JK, 2015, INT J MOL SCI, V16, P25831, DOI 10.3390/ijms161025831; Farkas D., 2009, GAUSSIAN 09 REVISION; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; Gesto DS, 2013, J AM CHEM SOC, V135, P7146, DOI 10.1021/ja310165u; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HANDSCHUMACHER RE, 1972, MOL PHARMACOL, V8, P59; Hashimoto Y, 2014, TOXICOL APPL PHARM, V277, P30, DOI 10.1016/j.taap.2014.03.002; HO PPK, 1969, SCIENCE, V165, P510, DOI 10.1126/science.165.3892.510; HO PPK, 1970, J BIOL CHEM, V245, P3708; JACKSON CJC, 1987, ANAL BIOCHEM, V165, P114, DOI 10.1016/0003-2697(87)90208-9; JENNINGS MP, 1990, J BACTERIOL, V172, P1491, DOI 10.1128/jb.172.3.1491-1498.1990; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; KAMISAKI Y, 1981, J PHARMACOL EXP THER, V216, P410; Khushoo A, 2005, APPL MICROBIOL BIOT, V68, P189, DOI 10.1007/s00253-004-1867-0; Khushoo A, 2004, PROTEIN EXPRES PURIF, V38, P29, DOI 10.1016/j.pep.2004.07.009; KODERA Y, 1994, BIOCONJUGATE CHEM, V5, P283, DOI 10.1021/bc00028a001; Krishnapura PR, 2016, CRIT REV MICROBIOL, V42, P720, DOI 10.3109/1040841X.2015.1022505; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Lanvers-Kaminsky C, 2017, CANCER CHEMOTH PHARM, V79, P439, DOI 10.1007/s00280-016-3236-y; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; MATSUSHIMA A, 1980, CHEM LETT, P773, DOI 10.1246/cl.1980.773; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Mishra P, 2016, ASIAN J PHARM SCI, V11, P337, DOI 10.1016/j.ajps.2015.08.011; Muharram M, 2014, AFRICAN J MICROBIOL, V8, P1610; Nair DP, 2014, CHEM MATER, V26, P724, DOI 10.1021/cm402180t; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Patel N, 2009, J CLIN INVEST, V119, P1964, DOI 10.1172/JCI37977; Qian GQ, 1997, POLYM ADVAN TECHNOL, V8, P581, DOI 10.1002/(SICI)1099-1581(199710)8:10<581::AID-PAT689>3.0.CO;2-#; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; ROBERTS J, 1968, J BACTERIOL, V95, P2117, DOI 10.1128/JB.95.6.2117-2123.1968; Rodriguez-Martinez JA, 2008, BIOTECHNOL BIOENG, V101, P1142, DOI 10.1002/bit.22014; Rodriguez-Martinez JA, 2009, BIOTECHNOL LETT, V31, P883, DOI 10.1007/s10529-009-9947-y; Sharkey I, 2001, BRIT J CANCER, V85, P23, DOI 10.1054/bjoc.2001.1859; Shaunak S, 2006, NAT CHEM BIOL, V2, P312, DOI 10.1038/nchembio786; SHIFRIN S, 1974, J BIOL CHEM, V249, P1335; Shrivastava A, 2016, CRIT REV ONCOL HEMAT, V100, P1, DOI 10.1016/j.critrevonc.2015.01.002; Soares AL, 2002, INT J PHARMACEUT, V237, P163, DOI 10.1016/S0378-5173(02)00046-7; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Stecher A L, 1999, Pharm Acta Helv, V74, P1, DOI 10.1016/S0031-6865(99)00009-6; SUTOW WW, 1971, CANCER, V28, P819, DOI 10.1002/1097-0142(1971)28:4<819::AID-CNCR2820280403>3.0.CO;2-9; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Swierczewska M, 2015, EXPERT OPIN EMERG DR, V20, P531, DOI 10.1517/14728214.2015.1113254; TALLAL L, 1970, Cancer, V25, P306, DOI 10.1002/1097-0142(197002)25:2<306::AID-CNCR2820250206>3.0.CO;2-H; TODOKORO K, 1975, FEBS LETT, V60, P259, DOI 10.1016/0014-5793(75)80726-5; Ulu A, 2017, BIOCONJUGATE CHEM, V28, P1598, DOI 10.1021/acs.bioconjchem.7b00217; Upadhyay AK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00486; van den Berg H, 2011, LEUKEMIA LYMPHOMA, V52, P168, DOI 10.3109/10428194.2010.537796; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Vidya J, 2011, FOOD TECHNOL BIOTECH, V49, P286; Vreven T, 2001, J CHEM PHYS, V115, P62, DOI 10.1063/1.1376127; Wang BC, 2012, Z NATURFORSCH C, V67, P312, DOI 10.5560/ZNC.2012.67c0312; WRISTON JC, 1985, METHOD ENZYMOL, V113, P608; Zhang C, 2012, BIODRUGS, V26, P209, DOI 10.2165/11633350-000000000-00000	65	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0197643	10.1371/journal.pone.0197643	http://dx.doi.org/10.1371/journal.pone.0197643			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052638	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600001
J	Zheng, J; Sadot, E; Vigidal, JA; Klimstra, DS; Balachandran, VP; Kingham, TP; Allen, PJ; D'Angelica, MI; DeMatteo, RP; Jarnagin, WR; Ventura, A				Zheng, Jian; Sadot, Eran; Vigidal, Joana A.; Klimstra, David S.; Balachandran, Vinod P.; Kingham, T. Peter; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Jarnagin, William R.; Ventura, Andrea			Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing	PLOS ONE			English	Article							FOCAL NODULAR HYPERPLASIA; TUMORIGENESIS; CANCER; CELLS; CLASSIFICATION; EXPRESSION; MANAGEMENT; TUMORS; PROLIFERATION; PROGRESSION	Background Hepatocellular adenomas (HCA) are benign liver tumors that may transform into hepatocellular carcinoma (HCC), but the molecular drivers of this transformation remain ill-defined. This study evaluates the molecular changes in HCA and HCC and in comparison to their adjacent non-neoplastic liver. Methods 11 patients with HCA and 10 patients with HCC without underlying hepatitis or cirrhosis were included in this pilot study. Tumor and non-tumor liver tissues were selected for immunohistochemical staining, small RNA sequencing, and targeted gene sequencing. We compared microRNA expressions and mutations between HCA and HCC and non-neoplastic liver. Results HCA were classified as inflammatory (n = 6), steatotic (n = 4), or beta-catenin activated (n = 1) subtypes. MicroRNA profile of all 3 HCA subtypes clustered between that of normal liver and HCC in principal component analysis. In both HCA and HCC, miR-200a, miR-429, and miR-490-3p were significantly downregulated compared to normal liver, whereas miR-452, miR-766, and miR-1180 were significantly upregulated. In addition, compared to HCA, HCC had significantly higher expression of members of the chromosome 19 miRNA cluster (C19MC), including miR-515-5p, miR-517a, miR-518b, and miR-520c-3p. Conclusions This study indicates that while there are significant differences in the molecular profile between HCA and HCC, several miRNAs are similarly deregulated in HCA and HCC compared to adjacent normal liver. These results may provide insights into the drivers of hepato-carcinogenesis and warrant further investigations.	[Zheng, Jian; Sadot, Eran; Balachandran, Vinod P.; Kingham, T. Peter; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Sadot, Eran] Rabin Med Ctr, Dept Surg, Petah Tiqwa, Israel; [Sadot, Eran] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Vigidal, Joana A.; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Vigidal, Joana A.] NCI, Lab Biochem & Mol Biol, Bethesda, MD 20892 USA; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rabin Medical Center; Tel Aviv University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center	Jarnagin, WR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Ventura, A (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	jarnagiw@mskcc.org; venturaa@mskcc.org		Ventura, Andrea/0000-0003-4320-9907; Zheng, Jian/0000-0003-3600-0742	NIH/NCI [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH/NCI P30 CA008748 Cancer Center Support Grant to WRJ, and there was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, CLIN GASTROENTEROL H, V13, P1221, DOI 10.1016/j.cgh.2014.05.023; Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Alberti N, 2015, CLIN RES HEPATOL GAS, V39, DOI 10.1016/j.clinre.2014.08.007; Augello C, 2012, LIVER INT, V32, P772, DOI 10.1111/j.1478-3231.2012.02795.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barthelmes Ludger, 2005, HPB (Oxford), V7, P186, DOI 10.1080/13651820510028954; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bioulac-Sage P, 2012, AM J SURG PATHOL, V36, P1691, DOI 10.1097/PAS.0b013e3182653ece; Bioulac-Sage P, 2009, HEPATOLOGY, V50, P481, DOI 10.1002/hep.22995; Bioulac-Sage P, 2009, LIVER INT, V29, P459, DOI 10.1111/j.1478-3231.2008.01849.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen S, 2015, CANCER LETT, V362, P122, DOI 10.1016/j.canlet.2015.03.029; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu HH, 2014, BIOCHEM BIOPH RES CO, V444, P104, DOI 10.1016/j.bbrc.2014.01.020; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hung CS, 2013, ANN SURG ONCOL, V20, pS360, DOI 10.1245/s10434-012-2482-4; Karkar AM, 2013, HPB, V15, P235, DOI 10.1111/j.1477-2574.2012.00584.x; Khemlina G, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0712-x; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li XL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-159; Li YC, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S89459; Nault JC, 2013, GASTROENTEROLOGY, V144, P888, DOI 10.1053/j.gastro.2013.02.032; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pinho FG, 2013, CANCER RES, V73, P5936, DOI 10.1158/0008-5472.CAN-13-0158; Rebouissou S, 2016, HEPATOLOGY, V64, P2047, DOI 10.1002/hep.28638; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roncalli M, 2016, CLIN MOL HEPATOL, V22, P199, DOI 10.3350/cmh.2016.0101; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen J, 2015, CANCER RES, V75, P754, DOI 10.1158/0008-5472.CAN-14-1301; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Wojcicka A, 2014, INT J BIOCHEM CELL B, V53, P208, DOI 10.1016/j.biocel.2014.05.020; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Wong CM, 2015, ONCOTARGET, V6, P13658, DOI 10.18632/oncotarget.3700; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhao L, 2016, ONCOTARGETS THER, V9, P4505, DOI 10.2147/OTT.S100037; Zheng QL, 2014, MOL CELL BIOCHEM, V389, P187, DOI 10.1007/s11010-013-1940-z; Zhou X, 2016, BIOMED PHARMACOTHER, V79, P315, DOI 10.1016/j.biopha.2016.02.025; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	49	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200776	10.1371/journal.pone.0200776	http://dx.doi.org/10.1371/journal.pone.0200776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052636	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600014
J	Dumont, L; Larochelle-Brunet, F; Theoret, H; Riedl, R; Senecal, S; Leger, PM				Dumont, Laurence; Larochelle-Brunet, Felix; Theoret, Hugo; Riedl, Rene; Senecal, Sylvain; Leger, Pierre-Majorique			Non-invasive brain stimulation in information systems research: A proof-of-concept study	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; COGNITIVE NEUROSCIENCE; RISK-TAKING; TDCS; HEALTHY; NEUROIS; ACCEPTANCE; PERCEPTION; ACTIVATION; INCREASES	One of the founding experiments in the field of Neuro-Information-Systems (NeuroIS), which aims at exploring the neural correlates of the technology acceptance model, suggests that perceived ease of use (PEoU) is associated with activity in the dorsolateral prefrontal cortex (DLPFC) while perceived usefulness is associated with activity in the insula, caudate nucleus and anterior cingulate cortex. To further assess the link between DLPFC and PEoU, transcranial direct current stimulation (tDCS) was applied over bilateral DLPFC (F3 and F4) immediately before an online shopping task. Forty-two participants were divided in three stimulation groups: left anodal/right cathodal, left cathodal/right anodal and sham. No change in PEoU was observed post stimulation but participants in the left anodal/right cathodal stimulation group took longer to make a purchase compared to sham stimulation and had different visual fixation patterns over the buy buttons. This is, to our knowledge, the first use of non-invasive brain stimulation in the field of NeuroIS. Although the involvement of DLPFC in PEoU could not be confirmed, the present study suggests that non-invasive brain stimulation may be a useful research tool in NeuroIS.	[Dumont, Laurence; Larochelle-Brunet, Felix; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Dumont, Laurence; Senecal, Sylvain; Leger, Pierre-Majorique] HEC Montreal, Tech3Lab, Montreal, PQ, Canada; [Riedl, Rene] Univ Linz, Dept Business Informat Informat Engn, Linz, Austria; [Riedl, Rene] Univ Appl Sci Upper Austria, Sch Management, Digital Business, Steyr, Austria	Universite de Montreal; Universite de Montreal; HEC Montreal; Johannes Kepler University Linz	Dumont, L (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Dumont, L (corresponding author), HEC Montreal, Tech3Lab, Montreal, PQ, Canada.	laurence.dumont@hec.ca		Theoret, Hugo/0000-0002-7458-8797; Dumont, Laurence/0000-0002-8081-7525	Social Sciences and Humanities Research Council [435-2012-1232]	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by a grant from the Social Sciences and Humanities Research Council (http://www.sshrc-crsh.gc.ca/) (435-2012-1232). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASB, 2008, PROJ MANAG J, V39, P5, DOI 10.1002/pmj.20041; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Benwell CSY, 2015, CORTEX, V69, P152, DOI 10.1016/j.cortex.2015.05.007; Berryhill ME, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00800; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Boggio PS, 2010, DRUG ALCOHOL DEPEN, V112, P220, DOI 10.1016/j.drugalcdep.2010.06.019; Boonstra TW, 2016, FRONT HUM NEUROSCI, V10, P1; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; DAVIS FD, 1993, INT J MAN MACH STUD, V38, P475, DOI 10.1006/imms.1993.1022; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; Dimoka A, 2011, INFORM SYST RES, V22, P687, DOI 10.1287/isre.1100.0284; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fecteau Shirley, 2012, Front Psychiatry, V3, P97, DOI 10.3389/fpsyt.2012.00097; Fregni F, 2008, APPETITE, V51, P34, DOI 10.1016/j.appet.2007.09.016; Hecht D, 2010, J NEUROSCI, V30, P4241, DOI 10.1523/JNEUROSCI.2924-09.2010; Hornbak Kasper, 2017, ACM Transactions on Computer-Human Interaction, V24, DOI 10.1145/3127358; Hortensius R, 2012, SOC COGN AFFECT NEUR, V7, P342, DOI 10.1093/scan/nsr012; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Kable Joseph W, 2011, J Neurosci Psychol Econ, V4, P63; Keinanen H, 2015, J BUS IND MARK, V30, P711, DOI 10.1108/JBIM-04-2013-0095; Kuo M-F, 2016, PHYSL TRANSCRANIAL D, P29, DOI [10.1007/978-3-319-33967-2_3, DOI 10.1007/978-3-319-33967-2_3]; Lauro LJR, 2014, CORTEX, V58, P99, DOI 10.1016/j.cortex.2014.05.003; Leite J, 2013, BRAIN STIMUL, V6, P660, DOI 10.1016/j.brs.2012.10.006; Loiacono ET, 2007, INT J ELECTRON COMM, V11, P51, DOI 10.2753/JEC1086-4415110302; Loos P, 2010, BUS INFORM SYST ENG+, V2, P395, DOI 10.1007/s12599-010-0130-8; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mancuso LE, 2016, J COGNITIVE NEUROSCI, V28, P1063, DOI 10.1162/jocn_a_00956; Minati L, 2012, COGN NEUROSCI-UK, V3, P80, DOI 10.1080/17588928.2011.628382; Mylius V, 2013, NEUROIMAGE, V78, P224, DOI 10.1016/j.neuroimage.2013.03.061; Mylius V, 2012, EUR J PAIN, V16, P974, DOI 10.1002/j.1532-2149.2011.00105.x; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Pechmann C, 1988, J CURRENT ISSUES RES, V11, P285, DOI DOI 10.1080/01633392.1988.10504936; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Riedl R, 2017, P INT C INF SYST; Riedl R., 2016, FUNDAMENTALS NEUROIS, DOI [10.1007/978-3-662-450 91-8, DOI 10.1007/978-3-662-45091-8, 10.1007/978-3-662-45091-8]; Riedl R, 2010, COMMUN ASSOC INF SYS, V27, P243; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schestatsky P, 2013, JOVE-J VIS EXP, DOI 10.3791/50426; Sela T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00022; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247	57	5	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201128	10.1371/journal.pone.0201128	http://dx.doi.org/10.1371/journal.pone.0201128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048490	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400052
J	Mahapatra, C; Brain, KL; Manchanda, R				Mahapatra, Chitaranjan; Brain, Keith L.; Manchanda, Rohit			A biophysically constrained computational model of the action potential of mouse urinary bladder smooth muscle	PLOS ONE			English	Article							POTASSIUM CHANNELS; SMALL-CONDUCTANCE; CA2+ CHANNELS; BK CHANNEL; PHARMACOLOGICAL ACTIVATION; EXCITATION-CONTRACTION; ELECTRICAL-ACTIVITY; MATHEMATICAL-MODEL; ION CHANNELS; K+ CHANNEL	Urinary incontinence is associated with enhanced spontaneous phasic contractions of the detrusor smooth muscle (DSM). Although a complete understanding of the etiology of these spontaneous contractions is not yet established, it is suggested that the spontaneously evoked action potentials (sAPs) in DSM cells initiate and modulate the contractions. In order to further our understanding of the ionic mechanisms underlying sAP generation, we present here a biophysically detailed computational model of a single DSM cell. First, we constructed mathematical models for nine ion channels found in DSM cells based on published experimental data: two voltage gated Ca2+ ion channels, an hyperpolarization-activated ion channel, two voltage-gated K+ ion channels, three Ca2+-activated K+ ion channels and a nonspecific background leak ion channel. The ion channels' kinetics were characterized in terms of maximal conductances and differential equations based on voltage or calcium-dependent activation and inactivation. All ion channel models were validated by comparing the simulated currents and current-voltage relations with those reported in experimental work. Incorporating these channels, our DSM model is capable of reproducing experimentally recorded spiketype sAPs of varying configurations, ranging from sAPs displaying after-hyperpolarizations to sAPs displaying after-depolarizations. The contributions of the principal ion channels to spike generation and configuration were also investigated as a means of mimicking the effects of selected pharmacological agents on DSM cell excitability. Additionally, the features of propagation of an AP along a length of electrically continuous smooth muscle tissue were investigated. To date, a biophysically detailed computational model does not exist for DSM cells. Our model, constrained heavily by physiological data, provides a powerful tool to investigate the ionic mechanisms underlying the genesis of DSM electrical activity, which can further shed light on certain aspects of urinary bladder function and dysfunction.	[Mahapatra, Chitaranjan; Manchanda, Rohit] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Brain, Keith L.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Birmingham	Manchanda, R (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	rmanch@iitb.com	Brain, Keith L./AFU-7168-2022	Brain, Keith L./0000-0002-0906-7012	Department of Biotechnology (DBT), India [BT/PR14326/MED/30/483/2010, BT/PR12973/MED/122/47/2016]; UK-India Education and Research Initiative (UKIERI), UK [number UKUTP 20110055]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); UK-India Education and Research Initiative (UKIERI), UK	This work is supported in part by Department of Biotechnology (DBT), India (grant number BT/PR14326/MED/30/483/2010), BT/PR12973/MED/122/47/2016 and the UK-India Education and Research Initiative (UKIERI), UK (grant number UKUTP 20110055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V62, P28, DOI 10.1016/j.urology.2003.09.050; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Afeli SAY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075875; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Aliev RR, 2000, J THEOR BIOL, V204, P21, DOI 10.1006/jtbi.2000.1069; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Anderson UA, 2009, J UROLOGY, V182, P330, DOI 10.1016/j.juro.2009.02.108; Andrej-Nikolai Spiess, 2010, BMC PHARM, V10, P6, DOI DOI 10.1186/1471-2210-10-6; [Anonymous], 2008, N-S ARCH PHARMACOL, V376, P309, DOI [10.1007/s00210-007-0241-z, DOI 10.1007/S00210-007-0241-Z]; Appukuttan S, 2015, J COMPUT NEUROSCI, V38, P167, DOI 10.1007/s10827-014-0532-6; Aydin M, 2012, BJU INT, V110, pE402, DOI 10.1111/j.1464-410X.2012.11137.x; BONEV AD, 1993, AM J PHYSIOL, V264, pC1190, DOI 10.1152/ajpcell.1993.264.5.C1190; Bootman MD, 2001, J CELL SCI, V114, P2213; Brading A F, 2011, Handb Exp Pharmacol, P375, DOI 10.1007/978-3-642-16499-6_18; Brading AF, 2006, J PHYSIOL-LONDON, V570, P13, DOI 10.1113/jphysiol.2005.097311; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; Cha CY, 2008, PROG BIOPHYS MOL BIO, V96, P399, DOI 10.1016/j.pbiomolbio.2007.07.007; Chen MY, 2009, J UROLOGY, V182, P374, DOI 10.1016/j.juro.2009.02.109; Chow KY, 2003, NEUROUROL URODYNAM, V22, P77, DOI 10.1002/nau.10081; Corrias A, 2008, AM J PHYSIOL-GASTR L, V294, pG989, DOI 10.1152/ajpgi.00528.2007; Corrias A, 2007, ANN BIOMED ENG, V35, P1595, DOI 10.1007/s10439-007-9324-8; Cox DH, 2014, BIOPHYS J, V107, P2797, DOI 10.1016/j.bpj.2014.10.069; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Ekman M, 2009, BJU INT, V104, P690, DOI 10.1111/j.1464-410X.2009.08576.x; Fry CH, 2004, UROLOGY, V63, P3, DOI 10.1016/j.urology.2003.11.005; Fry CH, 1999, J UROLOGY, V161, P660, DOI 10.1016/S0022-5347(01)61990-6; Fujii K, 1990, BRIT J PHARM, V99; Green ME, 1996, BRIT J PHARMACOL, V119, P1509, DOI 10.1111/j.1476-5381.1996.tb16066.x; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hashitani H, 2003, BRIT J PHARMACOL, V140, P159, DOI 10.1038/sj.bjp.0705320; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heppner TJ, 2009, J PHYSIOL-LONDON, V587, P5275, DOI 10.1113/jphysiol.2009.178806; Herrera GM, 2005, AM J PHYSIOL-REG I, V289, pR402, DOI 10.1152/ajpregu.00488.2004; Herrera GM, 2003, J PHYSIOL-LONDON, V551, P893, DOI 10.1113/jphysiol.2003.045914; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; Hines M. L., 2006, NEURON, V9; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hristov KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068052; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC1632, DOI 10.1152/ajpcell.00417.2011; Hristov KL, 2011, AM J PHYSIOL-CELL PH, V301, pC903, DOI 10.1152/ajpcell.00495.2010; Hristov KL, 2008, AM J PHYSIOL-CELL PH, V295, pC1344, DOI 10.1152/ajpcell.00001.2008; Hudman D, 2000, EUR J PHARMACOL, V397, P169, DOI 10.1016/S0014-2999(00)00229-6; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jacobsen JCB, 2007, AM J PHYSIOL-HEART C, V293, pH229, DOI 10.1152/ajpheart.00727.2006; John J, 2011, J BIOSCIENCES, V36, P309, DOI 10.1007/s12038-011-9039-8; Kajioka S, 2002, EUR J PHARMACOL, V443, P19, DOI 10.1016/S0014-2999(02)01593-5; Kapela A, 2008, J THEOR BIOL, V253, P238, DOI 10.1016/j.jtbi.2008.03.004; KLOCKNER U, 1985, PFLUG ARCH EUR J PHY, V405, P329, DOI 10.1007/BF00595685; Koenigsberger M, 2004, BIOPHYS J, V87, P92, DOI 10.1529/biophysj.103.037853; Korogod SM, 2014, NEUROPHYSIOLOGY+, V46, P293, DOI 10.1007/s11062-014-9447-0; Layne JJ, 2010, AM J PHYSIOL-REG I, V298, pR378, DOI 10.1152/ajpregu.00458.2009; Li LK, 2007, NEUROUROL URODYNAM, V26, P870, DOI 10.1002/nau.20392; Li N, 2018, IEEE T CONTR SYST T, V26, P1782, DOI 10.1109/TCST.2017.2723574; Mahapatra C, 2016, NEUROUROL URODYNAM, V35, pS332; Mahapatra C, 2017, J UROLOGY, V197, pE544, DOI 10.1016/j.juro.2017.02.1290; Mahapatra C, 2015, BIOPHYS J, V108, p588A, DOI 10.1016/j.bpj.2014.11.3204; Mahapatra C, 2015, I IEEE EMBS C NEUR E, P832, DOI 10.1109/NER.2015.7146752; Malysz J, 2014, AM J PHYSIOL-CELL PH, V306, pC45, DOI 10.1152/ajpcell.00047.2013; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; Miftakhov RN, 1996, BIOL CYBERN, V74, P167, DOI 10.1007/BF00204205; Morimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC388, DOI 10.1152/ajpcell.00409.2005; Nausch B, 2010, AM J PHYSIOL-REG I, V299, pR878, DOI 10.1152/ajpregu.00180.2010; Ohya S, 2001, JAPANESE J PHARM, V84, P97; Okinami T, 2014, ALTERED DETRUSOR GAP; Padmakumar M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190016; Parajuli SP, 2013, BRIT J PHARMACOL, V168, P1611, DOI 10.1111/bph.12049; Parajuli SP, 2012, J PHARMACOL EXP THER, V340, P114, DOI 10.1124/jpet.111.186213; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2001, AM J PHYSIOL-REG I, V280, pR1427, DOI 10.1152/ajpregu.2001.280.5.R1427; Poh YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042385; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; Schulson E. M., 2009, CREEP FRACTURE ICE, P101; SIBLEY GNA, 1984, J PHYSIOL-LONDON, V354, P431, DOI 10.1113/jphysiol.1984.sp015386; Soder RP, 2013, AM J PHYSIOL-REG I, V304, pR155, DOI 10.1152/ajpregu.00363.2012; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Sui GP, 2003, BJU INT, V92, P476, DOI 10.1046/j.1464-410X.2003.04356.x; Sui GP, 2001, J UROLOGY, V165, P621, DOI 10.1097/00005392-200102000-00084; Sui GP, 2001, J UROLOGY, V165, P627, DOI 10.1097/00005392-200102000-00085; Sui GP, 2007, BJU INT, V99, P436, DOI 10.1111/j.1464-410X.2006.06568.x; Svalo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117350; Svalo J, 2012, BASIC CLIN PHARMACOL, V110, P145, DOI 10.1111/j.1742-7843.2011.00765.x; Takagi H, 2016, EUR J PHARMACOL, V789, P179, DOI 10.1016/j.ejphar.2016.07.041; Thorneloe KS, 2008, AM J PHYSIOL-REG I, V294, pR1737, DOI 10.1152/ajpregu.00840.2006; Thorneloe KS, 2004, AM J PHYSIOL-CELL PH, V286, pC1246, DOI 10.1152/ajpcell.00501.2003; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Turner WH, 1997, PHARMACOL THERAPEUT, V75, P77, DOI 10.1016/S0163-7258(97)00038-7; Vogalis F, 1998, BBA-BIOMEMBRANES, V1371, P309, DOI 10.1016/S0005-2736(98)00029-7; Yanai Y, 2006, BJU INT, V97, P182, DOI 10.1111/j.1464-410X.2006.05894.x; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040	97	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200712	10.1371/journal.pone.0200712	http://dx.doi.org/10.1371/journal.pone.0200712			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048468	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400014
J	Walker, IF; Khanal, S; Hicks, JP; Lamichhane, B; Thapa, A; Elsey, H; Baral, SC; Newell, JN				Walker, Ian F.; Khanal, Sudeepa; Hicks, Joe P.; Lamichhane, Bikash; Thapa, Anil; Elsey, Helen; Baral, Sushil C.; Newell, James N.			Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study	PLOS ONE			English	Article							MENTAL-HEALTH; SEVERE DEPRESSION; PRIMARY-CARE; TRIAL; INDIA	Background and objectives People receiving treatment for multidrug-resistant tuberculosis (MDR-TB) have high rates of depression. Psychosocial support in general, and treatments for depression in particular, form an important but neglected area of patient-centred care, and a key pillar in the global End TB strategy. We assessed the feasibility and acceptability of a psychosocial support package for people receiving treatment for MDR-TB in Nepal. Methods This feasibility study used a mixed quantitative and qualitative approach. We implemented the intervention package in two National Tuberculosis Programme (NTP) MDR-TB treatment centres and 8 sub-centres. We screened patients monthly for depression and anxiety (cut-off >= 24 and >= 17 respectively on the Hopkins Symptom Checklist) and also for low social support (cut-off <= 3 on the Multidimensional Scale of Perceived Social Support). Those who screened positive on either screening tool received the Healthy Activity Program (HAP), which uses brief counselling based on behavioural activation theory. Other aspects of the psychosocial package were information/education materials and group interactions with other patients. Results We screened 135 patients, of whom 12 (9%) received HAP counselling, 115 (85%) received information materials, 80 (59%) received an education session and 49 (36%) received at least one group session. Eight group sessions were conducted in total. All aspects of the intervention package were acceptable to patients, including the screening, information, group work and counselling. Patients particularly valued having someone to talk to about their concerns and worries. We were able to successfully train individuals with no experience of psychological counselling to deliver HAP. Conclusion This psychosocial support package is acceptable to patients. The information materials we developed are feasible to deliver in the current NTP. However, the structured psychological counselling (HAP), is not feasible in the current NTP due to time constraints. This requires additional investment of counsellors in TB clinics.	[Walker, Ian F.; Hicks, Joe P.; Elsey, Helen; Newell, James N.] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Khanal, Sudeepa; Baral, Sushil C.] Hlth Res & Social Dev Forum HERD, Kathmandu, Nepal; [Lamichhane, Bikash; Thapa, Anil] Govt Nepal, Natl TB Ctr, Kathmandu, Nepal	University of Leeds	Walker, IF (corresponding author), Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England.	i.walker@leeds.ac.uk	Elsey, Helen/AAZ-1121-2020	Elsey, Helen/0000-0003-4724-0581; Walker, Ian/0000-0001-5707-6389	COMDIS-HSD, a research consortium - UK aid from the UK government (Department for International Development)	COMDIS-HSD, a research consortium - UK aid from the UK government (Department for International Development)	This study was funded by COMDIS-HSD, a research consortium funded by UK aid from the UK government (Department for International Development): however, the views expressed do not necessarily reflect the UK government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha J, 2007, Glob Public Health, V2, P404, DOI 10.1080/17441690701191610; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; Chowdhary N, 2016, BRIT J PSYCHIAT, V208, P381, DOI 10.1192/bjp.bp.114.161075; Cresswell J., 2014, CONCISE INTRO MIXED; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Government of Nepal, 2016, ANN TUB REP 2014 15; Government of Nepal, 2016, NAT STRAT APPL 2016; Jordans MJD, 2016, BRIT J PSYCHIAT, V208, pS21, DOI 10.1192/bjp.bp.114.153718; Khanal S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167559; Kohrt BA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0768-y; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Richards DA, 2016, LANCET, V388, P871, DOI 10.1016/S0140-6736(16)31140-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Thapa SB, 2005, SOC PSYCH PSYCH EPID, V40, P672, DOI 10.1007/s00127-005-0943-9; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147397; Walker IF, 2017, INT J TUBERC LUNG D, V21, P603, DOI 10.5588/ijtld.17.0135; *WHO, 2015, THE END TB STRAT; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2015, GLOB TUB REP 2015; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	25	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201163	10.1371/journal.pone.0201163	http://dx.doi.org/10.1371/journal.pone.0201163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048495	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000439952400055
J	Santaus, TM; Li, S; Ladd, P; Harvey, A; Cole, S; Stine, OC; Geddes, CD				Santaus, Tonya M.; Li, Shan; Ladd, Paula; Harvey, Amanda; Cole, Shannon; Stine, O. Colin; Geddes, Chris D.			Rapid sample preparation with Lyse-It (R) for Listeria monocytogenes and Vibrio cholerae	PLOS ONE			English	Article							METAL-ENHANCED FLUORESCENCE; ULTRA-FAST; MICROWAVE; DNA; GROWTH; EXTRACTION; CELLS; ASSAY	Sample preparation is a leading bottleneck in rapid detection of pathogenic bacteria. Here, we use Lyse-It (R) for bacterial cellular lysis, genomic DNA fragmentation, and protein release and degradation for both Listeria monocytogenes and Vibrio cholerae. The concept of Lyse-It (R) employs a conventional microwave and Lyse-It (R) slides for intensely focused microwave irradiation onto the sample. High microwave power and a <60 second irradiation time allow for rapid cellular lysis and subsequent intracellular component release. The pathogenic bacteria are identified by quantitative polymerase chain reaction (qPCR), which subsequently demonstrates the viability of DNA for amplification post microwave-induced lysis. Intracellular component release, degradation, and detection of L. monocytogenes and V. cholerae has been performed and shown in this paper. These results demonstrate a rapid, low-cost, and efficient way for bacterial sample preparation on both food and water-borne Gram-positive and -negative organisms alike.	[Santaus, Tonya M.; Ladd, Paula; Harvey, Amanda; Cole, Shannon; Geddes, Chris D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Santaus, Tonya M.; Geddes, Chris D.] Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA; [Li, Shan; Stine, O. Colin] Univ Maryland, Sch Med, Epidemiol & Publ Hlth Dept, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.; Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA.	geddes@umbc.edu		Cole, Shannon/0000-0003-1805-1407; Santaus, Tonya/0000-0002-8643-2343; Stine, O. Colin/0000-0003-3974-3752	UMBC-UMB Cholera joint training grant; National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship [T32GM066706-14]; Institute of Fluorescence; University of Maryland School Medicine departments of Public Health and Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	UMBC-UMB Cholera joint training grant; National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship; Institute of Fluorescence; University of Maryland School Medicine departments of Public Health and Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the UMBC-UMB Cholera joint training grant and the National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship (T32GM066706-14). We would also like to thank the Institute of Fluorescence and the University of Maryland School Medicine departments of Public Health and Epidemiology for their support, advice, and funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CONTR CFD; [Anonymous], KEY PHRASE HEADINGS, DOI [10.1007/s10895-005-0026-z, DOI 10.1007/S10895-005-0026-Z]; [Anonymous], 2016, VIBRIO CHOLERA; [Anonymous], 2015, CONTR CFD; Aslan K, 2006, J FLUORESC, V16, P3, DOI 10.1007/s10895-005-0026-z; Aslan K, 2008, PLASMONICS, V3, P89, DOI 10.1007/s11468-008-9059-x; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Aslan K, 2007, ANALYST, V132, P1130, DOI 10.1039/b707876e; BiologyWise, 2018, GRAM NEG GRAM POS BA; Cecchini F, 2016, TRAC-TREND ANAL CHEM, V79, P199, DOI 10.1016/j.trac.2016.01.017; Chen MW, 2004, SCANNING, V26, pI113; Diffen, 2018, GRAM POS GRAM NEG BA; Dragan A, 2014, J FLUORESC, V24, P1715, DOI 10.1007/s10895-014-1458-0; Dragan AI, 2012, ANAL BIOCHEM, V425, P54, DOI 10.1016/j.ab.2012.02.040; FARBER JM, 1988, CAN MED ASSOC J, V138, P413; FARBER JM, 1992, LETT APPL MICROBIOL, V15, P103, DOI 10.1111/j.1472-765X.1992.tb00737.x; Friedlander T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004055; Hasan D, 2016, ADV OPT MATER, V4, P943, DOI 10.1002/adom.201600014; Hu SR, 2016, ACS PHOTONICS, V3, P1647, DOI 10.1021/acsphotonics.6b00219; Javid A, 2017, PHYS CHEM CHEM PHYS, V19, P237, DOI 10.1039/c6cp06955j; Joshi LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104334; Kumar M, 2016, ARCH BIOCHEM BIOPHYS, V605, P41, DOI 10.1016/j.abb.2016.03.026; Melendez JH, 2016, ANAL BIOCHEM, V510, P33, DOI 10.1016/j.ab.2016.06.017; Melendez JH, 2013, J CLIN MICROBIOL, V51, P2913, DOI 10.1128/JCM.00980-13; Previte MJR, 2007, OPT EXPRESS, V15, P11640, DOI 10.1364/OE.15.011640; Previte MJR, 2007, J FLUORESC, V17, P279, DOI 10.1007/s10895-007-0170-8; Rodriguez-Lazaro D, 2005, APPL ENVIRON MICROB, V71, P9008, DOI 10.1128/AEM.71.12.9008-9012.2005; Rodriguez-Lazaro D, 2006, J RAPID METH AUT MIC, V14, P395, DOI 10.1111/j.1745-4581.2006.00058.x; Silva S, 2008, J FOOD PROTECT, V71, P1379, DOI 10.4315/0362-028X-71.7.1379; Sung HJ, 2014, LWT-FOOD SCI TECHNOL, V59, P754, DOI 10.1016/j.lwt.2014.05.058; Tennant SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018700; Woo IS, 2000, APPL ENVIRON MICROB, V66, P2243, DOI 10.1128/AEM.66.5.2243-2247.2000; Zhang YX, 2011, IEEE T BIO-MED ENG, V58, P781, DOI 10.1109/TBME.2010.2066275	33	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201070	10.1371/journal.pone.0201070	http://dx.doi.org/10.1371/journal.pone.0201070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044836	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500077
J	Sin, S; Lee, KH; Hur, JH; Lee, SH; Lee, YJ; Cho, YJ; Yoon, HI; Lee, JH; Lee, CT; Park, JS				Sin, Sooim; Lee, Kyung Hee; Hur, Jee Hye; Lee, Sang-Hoon; Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon Taek; Park, Jong Sun			Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis	PLOS ONE			English	Article							USUAL INTERSTITIAL PNEUMONITIS; DISEASE SEVERITY; SCORING SYSTEM; LUNG; CLASSIFICATION; INDEX; LYMPHANGIOGENESIS; PREVALENCE; VALIDATION; PHYSIOLOGY	Background Mediastinal lymph node enlargement (LNE) is common in idiopathic pulmonary fibrosis (IPF) and is known to be associated with the severity of lung fibrosis. However, the relationship between mediastinal LNE and the prognosis of IPF has not been determined to date. Methods This study included patients with IPF from the interstitial lung disease registry at Seoul National University Bundang Hospital, from January 2012 to March 2016. Two thoracic radiologists independently reviewed mediastinal LNE and lung parenchymal fibrosis and ground glass opacities in chest computed tomography scans of each patient, which were obtained upon diagnosis. Mortality and admission rates were analyzed. Results In total, 132 patients (104 [78.8%] male; median age, 72 years; range, 51-84 years) were enrolled and 73 (55.3%) patients had mediastinal LNE (short axis >= 10 mm in diameter). Mortality was significantly higher among patients with LNE than among those without LNE (hazard ratio 2.26 [95% confidence interval 1.20-4.23], p = 0.011). Of the patients with LNE, 24.7% experienced acute exacerbation and 43.8% experienced hospital admission for respiratory causes, in comparison with 16.9% and 40.0% of patients without LNE respectively. Although patients with LNE had a tendency to have increased rate of acute exacerbation, it was not statistically significant. Conclusion Mediastinal LNE in IPF is associated with increased mortality and its occurrence may be considered a poor prognostic factor in patients with IPF.	[Sin, Sooim] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea; [Lee, Kyung Hee] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea; [Hur, Jee Hye] Hanil Gen Hosp, Dept Radiol, Seoul, South Korea; [Lee, Sang-Hoon; Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon Taek; Park, Jong Sun] Seoul Natl Univ, Bundang Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Coll Med, Seongnam Si, Gyeonggi Do, South Korea; [Lee, Sang-Hoon] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Inst Chest Dis,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Park, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Coll Med, Seongnam Si, Gyeonggi Do, South Korea.	jspark.im@gmail.com	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462; Lee, Sang Hoon/0000-0002-7706-5318; Hur, Jee Hye/0000-0001-5718-8647	Seoul National University Bundang Hospital Research Fund [11-2011-036]	Seoul National University Bundang Hospital Research Fund	This study was supported by a grant (grant No. 11-2011-036) from the Seoul National University Bundang Hospital Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili AK, 2006, J THORAC IMAG, V21, P288, DOI 10.1097/01.rti.0000213562.55914.9a; BERGIN C, 1990, AM J ROENTGENOL, V154, P251, DOI 10.2214/ajr.154.2.2105008; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Cui Y, 2014, LYMPHAT RES BIOL, V12, P238, DOI 10.1089/lrb.2014.0012; Daccord C., 2016, F1000RESEARCH, V5; El-Chemaly Souheil, 2009, Lymphatic Research and Biology, V7, P197, DOI 10.1089/lrb.2009.0014; El-Chemaly S, 2009, P NATL ACAD SCI USA, V106, P3958, DOI 10.1073/pnas.0813368106; GARBER SJ, 1992, BRIT J RADIOL, V65, P983, DOI 10.1259/0007-1285-65-779-983; Johannson KA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0403-7; Jung JI, 2000, J COMPUT ASSIST TOMO, V24, P706, DOI 10.1097/00004728-200009000-00007; Kim ES, 2015, CHEST, V147, P430, DOI 10.1378/chest.14-0453; Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Kolb M, 2014, EUR RESPIR REV, V23, P220, DOI 10.1183/09059180.00002114; Kondoh S, 2016, RESPIR INVESTIG, V54, P327, DOI 10.1016/j.resinv.2016.02.009; Lara AR, 2012, CHEST, V142, P1569, DOI 10.1378/chest.12-0029; Ley B, 2014, RADIOLOGY, V273, P570, DOI 10.1148/radiol.14130216; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Mh S, 2015, LYMPHANGIOGENESIS IT; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Pathak RR, 2014, CELL PHYSIOL BIOCHEM, V33, P1239, DOI 10.1159/000358693; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Salisbury ML, 2016, CHEST, V149, P491, DOI 10.1378/chest.15-0530; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Souza CA, 2006, AM J ROENTGENOL, V186, P995, DOI 10.2214/AJR.04.1663; Spagnolo P, 2015, CURR OPIN PULM MED, V21, P470, DOI 10.1097/MCP.0000000000000187; Stump B, 2017, AM J RESP CELL MOL, V57, P272, DOI 10.1165/rcmb.2016-0290TR; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; WATTERS LC, 1986, AM REV RESPIR DIS, V133, P97, DOI 10.1164/arrd.1986.133.1.97; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201154	10.1371/journal.pone.0201154	http://dx.doi.org/10.1371/journal.pone.0201154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044866	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500084
J	Watanabe, H; Nakamura, I; Mizutani, S; Kurokawa, Y; Mori, H; Kurokawa, K; Yamada, T				Watanabe, Hikaru; Nakamura, Issei; Mizutani, Sayaka; Kurokawa, Yumiko; Mori, Hiroshi; Kurokawa, Ken; Yamada, Takuji			Minor taxa in human skin microbiome contribute to the personal identification	PLOS ONE			English	Article							RNA GENE DATABASE; DIVERSITY; DISEASE; SEQUENCES; PROJECT; SEARCH	The human skin microbiome can vary over time, and inter-individual variability of the microbiome is greater than the temporal variability within an individual. The skin microbiome has become a useful tool to identify individuals, and one type of personal identification using the skin microbiome has been reported in a community of less than 20 individuals. However, identification of individuals based on the skin microbiome has shown low accuracy in communities larger than 80 individuals. Here, we developed a new approach for personal identification, which considers that minor taxa are one of the important factors for distinguishing between individuals. We originally established a human skin microbiome for 66 samples from 11 individuals over two years (33 samples each year). Our method could classify individuals with 85% accuracy beyond a one-year sampling period. Moreover, we applied our method to 837 publicly available skin microbiome samples from 89 individuals and succeeded in identifying individuals with 78% accuracy. In short, our results investigate that (i) our new personal identification method worked well with two different communities (our data: 11 individuals; public data: 89 individuals) using the skin microbiome, (ii) defining the personal skin microbiome requires samples from several time points, (iii) inclusion of minor skin taxa strongly contributes to the effectiveness of personal identification.	[Watanabe, Hikaru; Nakamura, Issei; Kurokawa, Ken; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, Tokyo, Japan; [Mizutani, Sayaka] Japan Soc Promot Sci, Meguro Ku, Tokyo, Japan; [Kurokawa, Yumiko] Tokyo Inst Technol, Educ Acad Computat Life Sci, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan; [Mori, Hiroshi; Kurokawa, Ken] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan; [Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Tokyo Institute of Technology; Japan Society for the Promotion of Science; Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Yamada, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, Tokyo, Japan.; Yamada, T (corresponding author), Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.	takuji@bio.titech.ac.jp		Mori, Hiroshi/0000-0003-0806-7704	Education Academy of Computational Life Sciences, Tokyo Institute of Technology	Education Academy of Computational Life Sciences, Tokyo Institute of Technology	This study was supported by the Education Academy of Computational Life Sciences, Tokyo Institute of Technology.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Clarke TH, 2017, FORENSIC SCI INT-GEN, V30, P141, DOI 10.1016/j.fsigen.2017.06.008; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2018, BIOINFORMATICS, V34, P2371, DOI 10.1093/bioinformatics/bty113; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Mukherjee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36062; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ross AA, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00043-17; Salzberg S., 2014, F1000 POSTPUBLICATIO, DOI [10.3410/f.725233607.793501834, DOI 10.3410/F.725233607.793501834]; Schmedes SE, 2018, FORENSIC SCI INT-GEN, V32, P50, DOI 10.1016/j.fsigen.2017.10.004; Schmedes SE, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01672-17; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shibagaki N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10834-9; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; van Rensburg JJ, 2015, MBIO, V6, DOI 10.1128/mBio.01315-15; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkins D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0209-7; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	43	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e019947	10.1371/journal.pone.0199947	http://dx.doi.org/10.1371/journal.pone.0199947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044822	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500023
J	Crabb, HK; Allen, JL; Devlin, JM; Firestone, SM; Wilks, CR; Gilkerson, JR				Crabb, Helen Kathleen; Allen, Joanne Lee; Devlin, Joanne Maree; Firestone, Simon Matthew; Wilks, Colin Reginald; Gilkerson, James Rudkin			Salmonella spp. transmission in a vertically integrated poultry operation: Clustering and diversity analysis using phenotyping (serotyping, phage typing) and genotyping (MLVA)	PLOS ONE			English	Article							NUMBER TANDEM-REPEATS; RISK-FACTORS; SAMPLE-SIZE; DRAG SWABS; BROILER; TYPHIMURIUM; DISSEMINATION; SIMILARITY; PCR; IDENTIFICATION	The transmission of Salmonella enterica within a vertically integrated poultry operation was investigated longitudinally over an 18-month period (2013-2014). Thirty six percent of all samples collected (1503 of 4219) were positive for salmonellae with seven Salmonella enterica subsp. enterica serovars, and one Salmonella enterica subsp. salamae serovar detected. Both Salmonella enterica subsp. enterica serovars Infantis and Typhimurium were detected in all locations sampled. Salmonella Typhimurium was the most frequently detected serovar (63% of serotyped samples) with 8 phage types (PT) and 41 multiple-locus variable-number tandem-repeats analysis (MLVA) profiles identified. The most frequently identified phage types were PT135a and DT135. A total of 62 PT/MLVA combinations were observed. MLVA profiles 03-14-10-09-525 and 03-15-11-11-525 were the most frequently identified and 83% of the isolates shared at least one MLVA profile with an isolate from another phage type. The use of phage typing and MLVA profiling, on their own or in combination, were insufficient to understand the complexity of the epidemiological relationships between locations within this production system. Despite the high level of apparent diversity, cluster analysis was unable to differentiate the transmission pathways of all S. Typhimurium variants detected within the integrated enterprise. Using additional epidemiological information, the parent breeder rearing site was identified as the most likely point of introduction of two S. Typhimurium isolates into the production system with subsequent dissemination to the broiler flocks via the hatchery. This complexity is unable to be resolved in the absence of intensive sampling programs at all generations of the production system.	[Crabb, Helen Kathleen; Allen, Joanne Lee; Devlin, Joanne Maree; Firestone, Simon Matthew; Wilks, Colin Reginald; Gilkerson, James Rudkin] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia	University of Melbourne	Crabb, HK (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia.	helen.crabb@unimelb.edu.au	Allen, Joanne L/L-2354-2015	Allen, Joanne L/0000-0003-4740-9404; Devlin, Joanne/0000-0003-0400-9670; Firestone, Simon/0000-0002-3239-1419; Crabb, Helen/0000-0001-5550-3834; Gilkerson, James/0000-0003-1801-4817	Cybec Foundation, Victoria, Australia; Australian Government Research Training Program Scholarship	Cybec Foundation, Victoria, Australia; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by funding from the Cybec Foundation, Victoria, Australia, http://cybec.com.au, HKC; Australian Government Research Training Program Scholarship, https://www.education.gov.au/research-training-program, HKC. The funding body had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or the decision to submit the article for publication.	ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; [Anonymous], 2002, MODEL CODE PRACTICE, P83; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; Arzey G., 2002, NSW VIC ACCREDITATIO; Bailey JS, 2002, J FOOD PROTECT, V65, P742, DOI 10.4315/0362-028X-65.5.742; BAINS BS, 1974, POULTRY SCI, V53, P1114, DOI 10.3382/ps.0531114; Biosecurity Australia, 2008, GEN IMP RISK AN REP; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; CASON JA, 1994, AVIAN DIS, V38, P583, DOI 10.2307/1592082; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chen H P, 2016, APPL SCI, V179, P1, DOI DOI 10.1038/SREP28902; Choi SW, 2014, POULTRY SCI, V93, P1251, DOI 10.3382/ps.2013-03558; Chriel M, 1999, PREV VET MED, V40, P1, DOI 10.1016/S0167-5877(99)00016-1; Crabb HK, 2018, FOOD MICROBIOL, V71, P73, DOI 10.1016/j.fm.2017.03.008; Cutcher Z., 2015, APPL EPIDEMIOLOGY VI; Dimovski K, 2014, J BACTERIOL, V196, P3036, DOI 10.1128/JB.01820-14; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzsimmons G, 2012, COMMUN DIS INTELL, V36, pE213; Food Regulation Standing Committee, 2005, 12006 FRSC; FSANZ, 2012, PRIM PROD PROC STAND; Gan E, 2011, MICROBIOL-SGM, V157, P1056, DOI 10.1099/mic.0.047001-0; Gilbert Gwendolyn L, 2008, N S W Public Health Bull, V19, P29, DOI 10.1071/NB07116; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; HARVEY RWS, 1967, J HYG-CAMB, V65, P423, DOI 10.1017/S0022172400045939; HARVEY RWS, 1979, J APPL BACTERIOL, V46, P27, DOI 10.1111/j.1365-2672.1979.tb02580.x; Heuzenroeder MW, 2013, PRJ003419 ACT RUR IN, P1; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Humphry RW, 2004, PREV VET MED, V65, P173, DOI 10.1016/j.prevetmed.2004.07.003; IMVS, 2011, AUSTR SALM REF CTR M, P7; JACKSON CAW, 1971, AUST VET J, V47, P485, DOI 10.1111/j.1751-0813.1971.tb02029.x; Jeoffreys NJ, 2001, PATHOLOGY, V33, P66, DOI 10.1080/00313020120034939; Kardos G, 2007, LETT APPL MICROBIOL, V45, P421, DOI 10.1111/j.1472-765X.2007.02220.x; Kassambara A., FACTOEXTRA EXTRACT V; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; Kim A, 2007, J VET SCI, V8, P155, DOI 10.4142/jvs.2007.8.2.155; Kindt R., 2005, WORLD; KINGSTON DJ, 1981, AVIAN DIS, V25, P513, DOI 10.2307/1589943; Kuijpers AFA, 2014, EU INTERLABORATORY C; Kuijpers AFA, 2011, EU INTERLABORATORY C; Kuijpers AFA, 2012, EU INTERLABORATORY C; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee YJ, 2007, J VET MED SCI, V69, P399, DOI 10.1292/jvms.69.399; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Liebana E, 2002, BRIT POULTRY SCI, V43, P38, DOI 10.1080/00071660120109872; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; MACKENZIE MA, 1976, POULTRY SCI, V55, P957, DOI 10.3382/ps.0550957; Malorny B, 2003, APPL ENVIRON MICROB, V69, P290, DOI 10.1128/AEM.69.1.290-296.2003; McCrea BA, 2005, J APPL POULTRY RES, V14, P694, DOI 10.1093/japr/14.4.694; MORRIS GK, 1969, AM J VET RES, V30, P1413; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Oksansen J, 2017, VEGAN COMMUNITY ECOL; Powling J., 2014, NATL ENTERIC PATHOGE; RCore Team, 2020, R LANG ENV STAT COMP; Research ethics and integrity, 2017, RES ETH INT AN ETH W; Rose N, 1999, PREV VET MED, V39, P265, DOI 10.1016/S0167-5877(99)00002-1; Shanmugasundaram M, 2009, WORLD J MICROB BIOT, V25, P1385, DOI 10.1007/s11274-009-0025-3; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; Singer RS, 2000, J VET DIAGN INVEST, V12, P118, DOI 10.1177/104063870001200203; Skov MN, 1999, POULTRY SCI, V78, P848, DOI 10.1093/ps/78.6.848; Standards Australia, 2009, 5013102009 SAI; Suzuki R., 2015, PVCLUST HIERARCHICAL; Thrusfield M., 2007, VET EPIDEMIOLOGY, V3rd; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Volkova VV, 2010, ZOONOSES PUBLIC HLTH, V57, P463, DOI 10.1111/j.1863-2378.2009.01263.x; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055	67	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201031	10.1371/journal.pone.0201031	http://dx.doi.org/10.1371/journal.pone.0201031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024964	gold, Green Published			2022-12-26	WOS:000439120000082
J	Rothenbacher, D; Braig, S; Logan, CA; Feike, G; Muller, M; Koenig, W; Reister, F; Genuneit, J				Rothenbacher, Dietrich; Braig, Stefanie; Logan, Chad A.; Feike, Gertrud; Mueller, Miriam; Koenig, Wolfgang; Reister, Frank; Genuneit, Jon			Association of maternal uric acid and cystatin C serum concentrations with maternal and neonatal cardiovascular risk markers and neonatal body composition: The Ulm SPATZ Health Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PREGNANCY; PREECLAMPSIA; CREATININE; WOMEN	Purpose In utero exposure to cardiometabolic risk factors may determine health related outcomes at birth and in later life. The aim of this analysis was to describe the relationship of maternal serum uric acid (SUA) and cystatin C with maternal and neonatal cardiometabolic risk markers and with birth weight and risk of small-for-gestational age (SGA) as well as large-for gestational age (LGA). Material and methods In the Ulm SPATZ Health Study, 934 singleton newborns and their mothers were recruited during their hospital stay in the University Medical Center Ulm between 04/2012 and 05/ 2013 (overall response 49%). The association between SUA and cystatin C (both in quartiles and as continuous measures) with risk for SGA as well as with LGA was quantified by means of multivariable logistic regression. Results Overall, n = 885 mother-newborn pairs were included in the final analysis. Most of the mothers were of German nationality (85%) and were between 26 and 35 years of age at delivery (69%). Maternal SUA was associated with maternal age, body mass index, alcohol consumption and history of hypertension as well as with many other maternal and neonate cardiovascular risk markers. Cystatin C was associated with parity. No clear association of SUA with SGA and LGA was observed in fully adjusted models. However, cystatin C was negatively associated with SGA with an odds ratio (OR) of 0.35 (95% CI: 0.16-0.77; p for trend 0.04) comparing the top quartile vs. the bottom quartile and was positively associated with LGA with an OR of 5.92 (95% CI: 2.27-15.44; p for trend <0.0001) after adjustment for covariates. Conclusions We found a positive association of cystatin C with birth weight and a clearly increased risk for LGA with maternal increased cystatin C values in a population with fairly normal renal function.	[Rothenbacher, Dietrich; Braig, Stefanie; Logan, Chad A.; Feike, Gertrud; Mueller, Miriam; Genuneit, Jon] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Univ Med Ctr Ulm, Dept Internal Med Cardiol 2, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Reister, Frank] Univ Med Ctr Ulm, Dept Gynecol & Obstet, Ulm, Germany; [Genuneit, Jon] WUN, In FLAME Int Inflammat Network, West New York, NJ USA	Ulm University; Ulm University; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University	Rothenbacher, D (corresponding author), Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany.	dietrich.rothenbacher@uni-ulm.de	Genuneit, Jon/I-9323-2012	Genuneit, Jon/0000-0001-5764-1528; Logan, Chad/0000-0002-6157-3641; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603	Medical Faculty of Ulm University	Medical Faculty of Ulm University	The study was funded through an unrestricted grant by the Medical Faculty of Ulm University.	Akahori Y, 2012, GYNECOL OBSTET INVES, V73, P162, DOI 10.1159/000332391; Amini E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-104; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; Filler G, 2014, PEDIATR NEPHROL, V29, P183, DOI 10.1007/s00467-013-2426-7; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Hawkins TLA, 2012, BJOG-INT J OBSTET GY, V119, P484, DOI 10.1111/j.1471-0528.2011.03232.x; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kang DH, 2004, J HYPERTENS, V22, P229, DOI 10.1097/00004872-200402000-00001; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Laughon SK, 2009, AM J OBSTET GYNECOL, V201, P1; Logan CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149918; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Morken NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101897; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Paula LG, 2008, HYPERTENS PREGNANCY, V27, P413, DOI 10.1080/10641950801955709; Rothenbacher D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045907; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P825; Strevens H, 2001, SCAND J CLIN LAB INV, V61, P575; Yalamati Padma, 2015, Int J Reprod Contracept Obstet Gynecol, V4, P1505	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200470	10.1371/journal.pone.0200470	http://dx.doi.org/10.1371/journal.pone.0200470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024915	gold, Green Submitted, Green Published			2022-12-26	WOS:000439120000021
J	Wakil, W; Yasin, M; Qayyum, MA; Ghazanfar, MU; Al-Sadi, AM; Bedford, GO; Kwon, YJ				Wakil, Waqas; Yasin, Muhammad; Qayyum, Mirza Abdul; Ghazanfar, Muhammad Usman; Al-Sadi, Abdullah M.; Bedford, Geoffrey O.; Kwon, Yong Jung			Resistance to commonly used insecticides and phosphine fumigant in red palm weevil, Rhynchophorus ferrugineus (Olivier) in Pakistan	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; SPODOPTERA-LITURA LEPIDOPTERA; FIELD POPULATIONS; DATE PALM; NOCTUIDAE; COLEOPTERA; ORGANOPHOSPHATE; CURCULIONIDAE	The red palm weevil Rhynchophorus ferrugineus (Olivier) is an important pest of date palms in many regions of the world. This paper reports the first survey of insecticide resistance in field populations of R. ferrugineus in Pakistan which were collected from seven date palm growing areas across Punjab and Khyber Pakhtunkhwa (KPK) provinces, Pakistan. The resistance was assessed by the diet incorporation method against the formulated commonly used chemical insecticides profenophos, imidacloprid, chlorpyrifos, cypermethrin, deltamethrin, spinosad, lambda-cyhalothrin and a fumigant phosphine. Elevated levels of resistance were recorded for cypermethrin, deltamethrin and phosphine after a long history of insecticide use in Pakistan. Resistance Ratios (RRs) were 63- to 79-fold for phosphine, 16- to 74-fold for cypermethrin, 13- to 58-fold for deltamethrin, 2.6- to 44-fold for profenophos, 3- to 24-fold for chlorpyrifos, 2- to 12-fold for lambda-cyhalothrin and 1- to 10-fold for spinosad compared to a susceptible control line. Resistant R. ferrugineus populations were mainly found in southern Punjab and to some extent in KPK. The populations from Bahawalpur, Vehari, Layyah and Dera Ghazi Khan were most resistant to chemical insecticides, while all populations exhibited high levels of resistance to phosphine. Of the eight agents tested, lower LC50 and LC90 values were recorded for spinosad and lambda-cyhalothrin. These results suggest that spinosad and lambda-cyhalothrin exhibit unique modes of action and given their better environmental profile, these two insecticides could be used in insecticide rotation or assist in phasing out the use of older insecticides. A changed pattern of both insecticides can be used sensibly be recommended without evidence of dose rates and frequencies used.	[Wakil, Waqas; Yasin, Muhammad; Qayyum, Mirza Abdul] Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan; [Yasin, Muhammad] Bahauddin Zakariya Univ, Coll Agr, Bahadur Subcampus, Layyah, Pakistan; [Qayyum, Mirza Abdul] Muhammad Nawaz Shareef Univ Agr, Dept Entomol, Multan, Pakistan; [Ghazanfar, Muhammad Usman] Univ Sargodha, Coll Agr, Dept Plant Pathol, Sargodha, Pakistan; [Al-Sadi, Abdullah M.] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Crop Sci, Al Khoud, Oman; [Bedford, Geoffrey O.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Kwon, Yong Jung] Kyungpook Natl Univ, Coll Agr & Life Sci, Daegu, South Korea	University of Agriculture Faisalabad; University of Sargodha; Sultan Qaboos University; Macquarie University; Kyungpook National University	Wakil, W (corresponding author), Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan.	arid1972@yahoo.com	Ghazanfar, Muhammad Usman/ABD-4903-2021; Qayyum, Mirza Abdul/AGX-6138-2022; Qayyum, Mirza Abdul/AAH-2455-2021; Qayyum, Mirza Abdul/Q-6363-2018; Al-Sadi, Abdullah M./D-6766-2012; Wakil, Waqas/AAQ-2870-2020	Ghazanfar, Muhammad Usman/0000-0001-6503-2108; Qayyum, Mirza Abdul/0000-0001-5043-987X; Qayyum, Mirza Abdul/0000-0001-5043-987X; Qayyum, Mirza Abdul/0000-0001-5043-987X; Al-Sadi, Abdullah M./0000-0002-3419-8268; Wakil, Waqas/0000-0002-4765-3637	Higher Education Commission, Islamabad, Pakistan [2AV1-263]	Higher Education Commission, Islamabad, Pakistan(Higher Education Commission of Pakistan)	This study was financially supported (2AV1-263) by Higher Education Commission, Islamabad, Pakistan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abdulsalam K., 2001, J PEST CONT ENV SCI, V9, P63; Abdulsalam K. S., 2001, Annals of Agricultural Science (Cairo), V46, P841; Ahmad M, 2002, PEST MANAG SCI, V58, P203, DOI 10.1021/ps.440; Ahmad M, 2003, CROP PROT, V22, P539, DOI 10.1016/S0261-2194(02)00219-3; Ahmad M, 2008, PESTIC BIOCHEM PHYS, V91, P24, DOI 10.1016/j.pestbp.2007.12.003; Ahmad M, 2015, J ECON ENTOMOL, V108, P1279, DOI 10.1093/jee/tov085; Ahmad M, 2013, J ECON ENTOMOL, V106, P954, DOI 10.1603/EC12233; Ahmad M, 2009, PEST MANAG SCI, V65, P433, DOI 10.1002/ps.1702; Ajlann AM, 2002, RHYNCHOPHORUS FERRUG, V1, P15; Al-Ayedh H, 2015, INT J AGRIC BIOL, V17, P1; Al-Rajhy DiefAlla H., 2005, Pakistan Journal of Biological Sciences, V8, P679, DOI 10.3923/pjbs.2005.679.682; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; Avand F. A, 1996, APPL ENTOMOL PHYTOPA, V63, P16; Azam KM, 1997, 2 INT C DAT PALMS AL, V18, P6; Azam KM, 2000, P 1 WORKSH CONTR DAT, P26; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Dembilio O, 2015, SUST PLANT CROP PRO, P13, DOI 10.1007/978-3-319-24397-9_2; Faleiro J. R., 2006, International Journal of Tropical Insect Science, V26, P135, DOI 10.1079/IJT2006113; Faleiro J.R., 2012, Arab Journal of Plant Protection, V30, P274; Ferry M., 2002, Palms, V46, P172; Hussain A, 2013, J FOOD AGRIC ENVIRON, V11, P456; IRAC, 2017, IRAC SUSC TEST METH; Ishtiaq M, 2012, CROP PROT, V33, P13, DOI 10.1016/j.cropro.2011.11.014; Kaakeh W, 2006, CROP PROT, V25, P432, DOI 10.1016/j.cropro.2005.07.006; Khalifa O, 2001, 2 INT C DAT PALMS AL, P25; LeOra, 2003, POLO PLUS USERS GUID; Llacer E, 2010, SPAN J AGRIC RES, V8, P775, DOI 10.5424/sjar/2010083-1278; Martin M.M., 2006, Boletin de Sanidad Vegetal Plagas, V32, P631; Milne D., 1918, DATE PALM ITS CULTIV, P153; Opit GP, 2012, J ECON ENTOMOL, V105, P1107, DOI 10.1603/EC12064; Qayyum MA, 2015, J ECON ENTOMOL, V108, P286, DOI 10.1093/jee/tou037; Rajamanickam K, 1995, MEDEDELINGEN VAN DE FACULTEIT LANDBOUWWETENSCHAPPEN - UNIVERSITEIT GENT, VOL 60, NOS 2A-3B, 1995, P803; Sayyed AH, 2008, J ECON ENTOMOL, V101, P472, DOI 10.1603/0022-0493(2008)101[472:CAGORT]2.0.CO;2; Shar M. U., 2012, African Journal of Agricultural Research, V7, P1666; Wakil W, 2015, SUST PLANT CROP PRO, P1, DOI 10.1007/978-3-319-24397-9	36	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0192628	10.1371/journal.pone.0192628	http://dx.doi.org/10.1371/journal.pone.0192628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024882	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000001
J	Messina, F; Di Corcia, T; Ragazzo, M; Mellado, CS; Contini, I; Malaspina, P; Ciminelli, BM; Rickards, O; Jodice, C				Messina, Francesco; Di Corcia, Tullia; Ragazzo, Michele; Sanchez Mellado, Cesar; Contini, Irene; Malaspina, Patrizia; Ciminelli, Bianca Maria; Rickards, Olga; Jodice, Carla			Signs of continental ancestry in urban populations of Peru through autosomal STR loci and mitochondrial DNA typing	PLOS ONE			English	Article							TANDEM REPEAT LOCI; GENETIC-STRUCTURE; ALLELE FREQUENCIES; AMERICAN POPULATION; AFRICAN-AMERICANS; ADMIXTURE; MARKERS; INDIVIDUALS; REVEALS; AMAZON	The human genetic diversity around the world was studied through several high variable genetic markers. In South America the demic consequences of admixture events between Native people, European colonists and African slaves have been displayed by uniparental markers variability. The mitochondrial DNA (mtDNA) has been the most widely used genetic marker for studying American mixed populations, although nuclear markers, such as microsatellite loci (STRs) commonly used in forensic science, showed to be genetically and geographically structured. In this work, we analyzed DNA from buccal swab samples of 296 individuals across Peru: 156 Native Amazons (Ashaninka, Cashibo and Shipibo from Ucayali, Huambiza from Loreto and Moche from Lambayeque) and 140 urban Peruvians from Lima and other 33 urban areas. The aim was to evaluate, through STRs and mtDNA variability, recent migrations in urban Peruvian populations and to gain more information about their continental ancestry. STR data highlighted that most individuals (67%) of the urban Peruvian sample have a strong similarity to the Amazon Native population, whereas 22% have similarity to African populations and only similar to 1% to European populations. Also the maternally-transmitted mtDNA confirmed the strong Native contribution (-90% of Native American haplogroups) and the lower frequencies of African (similar to 6%) and European (similar to 3%) haplogroups. This study provides a detailed description of the urban Peruvian genetic structure and proposes forensic STRs as a useful tool for studying recent migrations, especially when coupled with mtDNA.	[Messina, Francesco; Di Corcia, Tullia; Contini, Irene; Malaspina, Patrizia; Ciminelli, Bianca Maria; Rickards, Olga; Jodice, Carla] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Ragazzo, Michele] Cent Lab Natl DNA Database, Dept Penitentiary Adm, Italian Minist Justice, Rome, Italy; [Sanchez Mellado, Cesar] Natl Intercultural Univ Amazon, Fac Intercultural Educ & Human, Ucayali, Coronel Portill, Peru	University of Rome Tor Vergata	Messina, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	francesco.messina@uniroma2.it	Messina, Francesco/AAC-1816-2019; Messina, Francesco/AAC-1675-2019; Messina, Francesco/AAB-5363-2022; RICKARDS, OLGA/L-7878-2015	Messina, Francesco/0000-0001-8076-7217; RICKARDS, OLGA/0000-0003-2880-7466	Italian Ministry of Justice [CUP E81J10001270005]; Italian Ministry of Justice	Italian Ministry of Justice; Italian Ministry of Justice	This work was supported by grants of the Italian Ministry of Justice (grant number CUP E81J10001270005) to C.J., P.M. and B.M.C. F.M. was supported by a fellowship from the Italian Ministry of Justice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar VRC, 2014, FORENSIC SCI INT-GEN, V13, pE6, DOI 10.1016/j.fsigen.2014.04.015; Algee-Hewitt BFB, 2016, CURR BIOL, V26, P935, DOI 10.1016/j.cub.2016.01.065; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Baeta M, 2012, INT J LEGAL MED, V126, P299, DOI 10.1007/s00414-011-0656-4; Barbieri C, 2014, AM J PHYS ANTHROPOL, V155, P600, DOI 10.1002/ajpa.22616; Barbieri C, 2011, AM J HUM BIOL, V23, P89, DOI 10.1002/ajhb.21107; Borosky A, 2014, FORENSIC SCI INT-GEN, V13, pE20, DOI 10.1016/j.fsigen.2014.07.008; Branham A, 2012, FORENSIC SCI INT-GEN, V6, pE3, DOI 10.1016/j.fsigen.2010.11.001; Bravo ML, 2001, INT J LEGAL MED, V115, P102, DOI 10.1007/s004140100223; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Budowle B, 1999, J FORENSIC SCI, V44, P1277; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Butler JM, 2012, ADV TOPICS FORENSIC, pxvii; Callegari-Jacques SM, 2011, AM J PHYS ANTHROPOL, V145, P371, DOI 10.1002/ajpa.21505; Di Corcia T, 2017, AM J PHYS ANTHROPOL, V163, P328, DOI 10.1002/ajpa.23209; Duran R, 2001, AM J HUM BIOL, V13, P374; Emery LS, 2015, AM J HUM GENET, V96, P183, DOI 10.1016/j.ajhg.2014.12.015; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez WMZ, 2005, AM J HUM BIOL, V17, P451, DOI 10.1002/ajhb.20409; Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144; Gomez-Carballa A, 2016, FORENSIC SCI INT-GEN, V20, P81, DOI 10.1016/j.fsigen.2015.10.002; Guha Pokhraj, 2013, Frontiers in Genetics, V4, P155, DOI 10.3389/fgene.2013.00155; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Healy ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185503; Heinz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134129; Heinz T, 2013, FORENSIC SCI INT-GEN, V7, P537, DOI 10.1016/j.fsigen.2013.05.012; Hill CR, 2013, FORENSIC SCI INT-GEN, V7, pE82, DOI 10.1016/j.fsigen.2012.12.004; Iannacone GC, 2011, FORENS SCI INT-GEN S, V3, pE291, DOI 10.1016/j.fsigss.2011.09.008; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kling D, 2014, FORENSIC SCI INT-GEN, V13, P121, DOI 10.1016/j.fsigen.2014.07.004; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Messina F, 2018, ANN HUM BIOL, V45, P77, DOI 10.1080/03014460.2017.1409365; Messina F, 2017, ANN HUM BIOL, V44, P53, DOI 10.3109/03014460.2016.1155646; Messina F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167065; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Ng J, 2016, FORENSIC SCI INT-GEN, V24, pE12, DOI 10.1016/j.fsigen.2016.06.014; Pemberton TJ, 2014, HUM HERED, V77, P37, DOI 10.1159/000362878; Pemberton TJ, 2013, G3-GENES GENOM GENET, V3, P891, DOI 10.1534/g3.113.005728; Pritchard JK, 2000, GENETICS, V155, P945; Ramallo V, 2013, AM J PHYS ANTHROPOL, V150, P453, DOI 10.1002/ajpa.22219; Rodrigues EMR, 2007, FORENSIC SCI INT, V168, P244, DOI 10.1016/j.forsciint.2006.03.003; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Rickards O, 2001, INT J LEGAL MED, V114, P141, DOI 10.1007/s004149900119; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Sala A, 2014, MOL BIOL REP, V41, P1533, DOI 10.1007/s11033-013-2999-z; Sandoval JR, 2013, J HUM GENET, V58, P627, DOI 10.1038/jhg.2013.73; Santos HC, 2016, EUR J HUM GENET, V24, P725, DOI 10.1038/ejhg.2015.187; Silva NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049666; Taboada-Echalar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058980; TAJIMA F, 1989, GENETICS, V123, P585; Talledo M, 2010, FORENSIC SCI INT-GEN, V4, pE109, DOI 10.1016/j.fsigen.2009.09.003; Tomas C, 2014, FORENSIC SCI INT-GEN, V11, pE18, DOI 10.1016/j.fsigen.2014.04.004; Tomas C, 2001, HUM BIOL, V73, P349, DOI 10.1353/hub.2001.0042; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vergara IA, 2012, FORENSIC SCI INT-GEN, V6, pE83, DOI 10.1016/j.fsigen.2011.07.002; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wealker TJ, 2017, EXQUISITE SLAVES RAC; Yunis JJ, 2001, FORENSIC SCI INT, V117, P235, DOI 10.1016/S0379-0738(00)00414-X; Zhou AJ, 2013, INT J LEGAL MED, V127, P377, DOI 10.1007/s00414-012-0781-8	67	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200796	10.1371/journal.pone.0200796	http://dx.doi.org/10.1371/journal.pone.0200796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020992	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400076
J	Bhattacharya, S; Iglesias, PA				Bhattacharya, Sayak; Iglesias, Pablo A.			The threshold of an excitable system serves as a control mechanism for noise filtering during chemotaxis	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; ACTIN CYTOSKELETON; CELL-MIGRATION; NETWORKS; MODELS; SWITCH; DISCOIDEUM; AMEBAS; MOTION	Chemotaxis, the migration of cells in the direction of a chemical gradient, is of utmost importance in various biological processes. In recent years, research has demonstrated that the underlying mechanism that controls cell migration is an excitable network. One of the properties that characterizes excitability is the presence of a threshold for activation. Here, we show that excitable systems possess noise filtering capabilities that enable faster and more efficient directed migration compared to other systems that also include a threshold, such as ultrasensitive switches. We demonstrate that this filtering ability is a consequence of the varying responses of excitable systems to step and pulse stimuli. Whereas the response to step inputs is determined solely by the magnitude of the stimulus, for pulse stimuli, the response depends on both the magnitude and duration of the stimulus. We then show that these two forms of threshold behavior can be decoupled from one another, allowing finer control in chemotaxis. Finally, we use a simple model of chemotaxis to demonstrate that cells that rely on an excitable system display faster and more effective directed migration that a hypothetical cell guided by an ultra-sensitive switch.	[Bhattacharya, Sayak; Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Whiting Sch Engn, Baltimore, MD 21218 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Iglesias, PA (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Whiting Sch Engn, Baltimore, MD 21218 USA.; Iglesias, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	pi@jhu.edu	Bhattacharya, Sayak/ABF-1644-2020; Iglesias, Pablo A/A-5202-2008	Bhattacharya, Sayak/0000-0002-0957-7530; Iglesias, Pablo A/0000-0002-0840-155X	Defense Advanced Research Project Administration [HR0011-16-C-0139]	Defense Advanced Research Project Administration	This work was supported by Defense Advanced Research Project Administration under contract number HR0011-16-C-0139 (https://www.darpa.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2016, IFAC PAPERSONLINE, V49, P357, DOI 10.1016/j.ifacol.2017.03.001; Bhowmik A, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/1/016002; Cooper RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033528; Devreotes PN, 2017, ANNU REV CELL DEV BI, V33, P103, DOI 10.1146/annurev-cellbio-100616-060739; Edwards M, 2018, P NATL ACAD SCI USA, V115, pE3722, DOI 10.1073/pnas.1710480115; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerhardt M, 2014, J CELL SCI, V127, P4507, DOI 10.1242/jcs.156000; Graziano BR, 2017, J CELL BIOL, V216, P2515, DOI 10.1083/jcb.201604113; Graziano BR, 2014, CURR OPIN CELL BIOL, V30, P60, DOI 10.1016/j.ceb.2014.06.007; Hecht I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002044; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Iglesias Pablo A, 2002, Sci STKE, V2002, pre12, DOI 10.1126/stke.2002.148.re12; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Kostova T, 2004, INT J BIFURCAT CHAOS, V14, P913, DOI 10.1142/S0218127404009685; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; MATO JM, 1975, P NATL ACAD SCI USA, V72, P4991, DOI 10.1073/pnas.72.12.4991; Miao YC, 2017, NAT CELL BIOL, V19, P329, DOI 10.1038/ncb3495; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Naoki H, 2008, J THEOR BIOL, V255, P259, DOI 10.1016/j.jtbi.2008.08.012; Nishikawa M, 2014, BIOPHYS J, V106, P723, DOI 10.1016/j.bpj.2013.12.023; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Samoilov M, 2002, J PHYS CHEM A, V106, P10205, DOI 10.1021/jp025846z; Seaton D, 2011, IET SYST BIOL, V5, P81, DOI 10.1049/iet-syb.2009.0061; Shi CJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003122; Shi CJ, 2013, WIRES SYST BIOL MED, V5, P631, DOI 10.1002/wsbm.1230; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Tang M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6175; van Haastert PJM, 2017, MOL BIOL CELL, V28, P922, DOI 10.1091/mbc.E16-10-0733; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Yang L, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-68	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0201283	10.1371/journal.pone.0201283	http://dx.doi.org/10.1371/journal.pone.0201283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059517	Green Submitted, Green Published, gold			2022-12-26	WOS:000440251600032
J	Banon, JA; Fiorentino, R; Gabriele, A				Banon, Jose Aleman; Fiorentino, Robert; Gabriele, Alison			Using event-related potentials to track morphosyntactic development in second language learners: The processing of number and gender agreement in Spanish	PLOS ONE			English	Article							BRAIN POTENTIALS; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; LANGUAGE COMPREHENSION; GRAMMATICAL GENDER; NONNATIVE SPANISH; ERP EVIDENCE; L2; ACQUISITION; PROFICIENCY	We used event-related potentials to investigate morphosyntactic development in 78 adult English-speaking learners of Spanish as a second language (L2) across the proficiency spectrum. We examined how development is modulated by the similarity between the native language (L1) and the L2, by comparing number (a feature present in English) and gender agreement (novel feature). We also investigated how development is impacted by structural distance, manipulating the distance between the agreeing elements by probing both within-phrase (fruta muy jugosa"fruit(-FEM-SG) very juicy(-FEM-SG)") and across-phrase agreement (fresa es acida "strawberry(-FEM-SG) is tart(-FEM-SG)"). Regression analyses revealed that the learners' overall proficiency, as measured by a standardized test, predicted their accuracy with the target properties in the grammaticality judgment task (GJT), but did not predict P600 magnitude to the violations. However, a relationship emerged between immersion in Spanish-speaking countries and P600 magnitude for gender. Our results also revealed a correlation between accuracy in the GJT and P600 magnitude, suggesting that behavioral sensitivity to the target property predicts neurophysiological sensitivity. Subsequent group analyses revealed that the highest-proficiency learners showed equally robust P600 effects for number and gender. This group also elicited more positive waveforms for within- than across-phrase agreement overall, similar to the native controls. The lowest-proficiency learners showed a P600 for number overall, but no effects for gender. Unlike the highest-proficiency learners, they also showed no sensitivity to structural distance, suggesting that sensitivity to such linguistic factors develops over time. Overall, these results suggest an important role for proficiency in morphosyntactic development, although differences emerged between behavioral and electrophysiological measures. While L2 proficiency predicted behavioral sensitivity to agreement, development with respect to the neurocognitive mechanisms recruited in processing only emerged when comparing the two extremes of the proficiency spectrum. Importantly, while both L1-L2 similarity and hierarchical structure impact development, they do not constrain it.	[Banon, Jose Aleman] Stockholm Univ, Dept Swedish & Multilingualism, Ctr Res Bilingualism, Stockholm, Sweden; [Fiorentino, Robert] Univ Kansas, Dept Linguist, Neurolinguist & Language Proc Lab, Lawrence, KS 66045 USA; [Gabriele, Alison] Univ Kansas, Dept Linguist, Language Acquisit Lab 2, Lawrence, KS 66045 USA	Stockholm University; University of Kansas; University of Kansas	Banon, JA (corresponding author), Stockholm Univ, Dept Swedish & Multilingualism, Ctr Res Bilingualism, Stockholm, Sweden.	jose.aleman.banon@biling.su.se	Aleman Banon, Jose/H-6787-2015	Aleman Banon, Jose/0000-0003-4210-3174	National Science Foundation [BCS-0951900]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (BCS-0951900) to AG and RF.	Aleman Banon J, 2016, LANG COGN NEUROSCI; Banon JA, 2017, J EXP PSYCHOL LEARN, V43, P1509, DOI 10.1037/xlm0000394; Aleman Banon J, 2014, SECOND LANG RES, V30, P275, DOI 10.1177/0267658313515671; Banon JA, 2012, BRAIN RES, V1456, P49, DOI 10.1016/j.brainres.2012.03.057; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Bowden HW, 2013, NEUROPSYCHOLOGIA, V51, P2492, DOI 10.1016/j.neuropsychologia.2013.09.004; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Caffarra S, 2015, NEUROSCI BIOBEHAV R, V51, P31, DOI 10.1016/j.neubiorev.2015.01.010; Carrasco-Ortiz H, 2017, INT J PSYCHOPHYSIOL, V117, P91, DOI 10.1016/j.ijpsycho.2017.04.008; Clahsen H, 2006, APPL PSYCHOLINGUIST, V27, P107, DOI 10.1017/S0142716406060206; Clahsen H, 2010, LANG LEARN, V60, P21, DOI 10.1111/j.1467-9922.2009.00550.x; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; DeKeyser R. M., 1997, STUD SECOND LANG ACQ, V19, P195, DOI DOI 10.1017/S0272263197002040; Diaz B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00133; Drury J, 2007, J COGNITIVE NEUROS S, V249, DOI DOI 10.1016/J.NEUBIOREV.2015.01.010; Dussias PE, 2013, STUD SECOND LANG ACQ, V35, P353, DOI 10.1017/S0272263112000915; Field A, 2013, DISCOVERING STAT USI; Foote R, 2011, APPL PSYCHOLINGUIST, V32, P187, DOI 10.1017/S0142716410000342; Foucart A, 2012, J MEM LANG, V66, P226, DOI 10.1016/j.jml.2011.07.007; Franceschina F., 2005, FOSSILIZED 2 LANGUAG; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gabriele A, 2013, LINGUIST APPROACH BI, V3, P213, DOI 10.1075/lab.3.2.04gab; Dowens MG, 2010, J COGNITIVE NEUROSCI, V22, P1870, DOI 10.1162/jocn.2009.21304; Gillon-Dowens M, 2010, NEUROPSYCHOLOGIA, V22, P1870, DOI DOI 10.1016/J.NEUR0PSYCH0L0GIA.2011.02.034; Gruter T, 2012, SECOND LANG RES, V28, P191, DOI 10.1177/0267658312437990; Hagoort P, 1999, J PSYCHOLINGUIST RES, V28, P715, DOI 10.1023/A:1023277213129; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; HARRIS JW, 1991, LINGUIST INQ, V22, P27; Hawkins R., 1997, SECOND LANG RES, V13, P187; Hopp H, 2010, LINGUA, V120, P901, DOI 10.1016/j.lingua.2009.06.004; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2016, BILING-LANG COGN, V19, P1, DOI 10.1017/S1366728914000844; Keating GD, 2009, LANG LEARN, V59, P503, DOI 10.1111/j.1467-9922.2009.00516.x; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Liszka S., 2003, LEXICON SYNTAX INTER, V30, P21, DOI DOI 10.1075/LALD.30.03HAW; LONG MH, 1990, TESOL QUART, V24, P649, DOI 10.2307/3587113; Mancini S, 2011, BRAIN RES, V1410, P64, DOI 10.1016/j.brainres.2011.06.055; Marinis T, 2005, STUD SECOND LANG ACQ, V27, P53, DOI 10.1017/S0272263105050035; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; McCarthy C, 2008, SECOND LANG RES, V24, P459, DOI 10.1177/0267658308095737; McLaughlin J, 2010, LANG LEARN, V60, P123, DOI 10.1111/j.1467-9922.2010.00604.x; Molinaro N, 2015, CORTEX, V66, P156, DOI 10.1016/j.cortex.2014.06.009; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Molinaro N, 2011, J MEM LANG, V64, P211, DOI 10.1016/j.jml.2010.12.002; Montrul S, 2008, LANG LEARN, V58, P503, DOI 10.1111/j.1467-9922.2008.00449.x; Morgan-Short K, 2010, LANG LEARN, V60, P154, DOI 10.1111/j.1467-9922.2009.00554.x; Nevins A, 2007, BRAIN RES, V1164, P81, DOI 10.1016/j.brainres.2007.05.058; Nicol JL, 1997, J MEM LANG, V36, P569, DOI 10.1006/jmla.1996.2497; O'Grady W., 2005, SYNTACTIC CARPENTRY; O'Grady W, 2015, LANG LEARN, V65, P6, DOI 10.1111/lang.12091; O'Rourke PL, 2011, BRAIN RES, V1392, P62, DOI 10.1016/j.brainres.2011.03.071; Ojima S, 2005, J COGNITIVE NEUROSCI, V17, P1212, DOI 10.1162/0898929055002436; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Osterhout L, 2006, LANG LEARN, V56, P199, DOI 10.1111/j.1467-9922.2006.00361.x; Pakulak E, 2010, J COGNITIVE NEUROSCI, V22, P2728, DOI 10.1162/jocn.2009.21393; Pearlmutter NJ, 1999, J MEM LANG, V41, P427, DOI 10.1006/jmla.1999.2653; Pienemann M, 2005, STUD BILINGUAL, V30, P1; Pienemann M, 2015, LANG LEARN, V65, P123, DOI 10.1111/lang.12095; Pienemann Manfred., 1998, LANGUAGE PROCESSING; Prego BL, 2014, LINGUIST APPROACH BI, V4, P192, DOI 10.1075/lab.4.2.03lop; Rossi E, 2014, NEUROPSYCHOLOGIA, V62, P11, DOI 10.1016/j.neuropsychologia.2014.07.002; Rossi S, 2005, NEUROSCI LETT, V384, P228, DOI 10.1016/j.neulet.2005.04.077; Rossi S, 2006, J COGNITIVE NEUROSCI, V18, P2030, DOI 10.1162/jocn.2006.18.12.2030; Sagarra N, 2010, LINGUA, V120, P2022, DOI 10.1016/j.lingua.2010.02.004; SAPORTA S, 1965, LANGUAGE, V41, P218, DOI 10.2307/411875; Schwartz Bonnie., 1994, LANG ACQUIS, P317, DOI DOI 10.1075/LALD.8.14SCH; Sprouse R.A., 1996, SECOND LANG RES, V12, P40, DOI DOI 10.1177/026765839601200103; Steinhauer K, 2009, SECOND LANG RES, V25, P13, DOI 10.1177/0267658308098995; Tagliaferri B., 2005, PARADIGM VERSION 1; Tanner D, 2014, BILING-LANG COGN, V17, P277, DOI 10.1017/S1366728913000370; Tanner D, 2014, NEUROPSYCHOLOGIA, V56, P289, DOI 10.1016/j.neuropsychologia.2014.02.002; Tanner D, 2013, BILING-LANG COGN, V16, P367, DOI 10.1017/S1366728912000302; Teschner R.V., 1984, HISPANIC LINGUISTICS, V1, P115; Tokowicz N, 2005, STUD SECOND LANG ACQ, V27, P173, DOI 10.1017/S0272263105050102; Tsimpli IM, 2007, SECOND LANG RES, V23, P215, DOI 10.1177/0267658307076546; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman M. T., 2013, ROUTLEDGE ENCY 2 LAN, P160; Ullman M.T., 2001, BILING-LANG COGN, V4, P105, DOI [10.1017/S1366728901000220, DOI 10.1017/S1366728901000220]; Vainikka A., 1996, SECOND LANG RES, V12, P7, DOI DOI 10.1177/026765839601200102; Vainikka A., 1994, LANG ACQUIS, P265; VanPatten B., 2012, ROUTLEDGE HDB 2 LANG, P268; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; White EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052318; White L, 2004, APPL PSYCHOLINGUIST, V25, P105, DOI 10.1017/S0142716404001067; White L, 2007, THEORIES 2 LANGUAGE, P37; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE	98	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200791	10.1371/journal.pone.0200791	http://dx.doi.org/10.1371/journal.pone.0200791			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052686	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600016
J	Amado-Azevedo, J; de Menezes, RX; Amerongen, GPV; van Hinsbergh, VWM; Hordijk, PL				Amado-Azevedo, Joana; de Menezes, Renee X.; Amerongen, Geerten P. van Nieuw; van Hinsbergh, Victor W. M.; Hordijk, Peter L.			A functional siRNA screen identifies RhoGTPase-associated genes involved in thrombin-induced endothelial permeability	PLOS ONE			English	Article							ATYPICAL RHO-GTPASES; NUCLEOTIDE EXCHANGE FACTOR; BARRIER DYSFUNCTION; VASCULAR-PERMEABILITY; CELL PERMEABILITY; SEMAPHORIN 5A; P115 RHOGEF; PROTEIN; RAC; ACTIVATION	Thrombin and other inflammatory mediators may induce vascular permeability through the disruption of adherens junctions between adjacent endothelial cells. If uncontrolled, hyper-permeability leads to an impaired barrier, fluid leakage and edema, which can contribute to multi-organ failure and death. RhoGTPases control cytoskeletal dynamics, adhesion and migration and are known regulators of endothelial integrity. Knowledge of the precise role of each RhoGTPase, and their associated regulatory and effector genes, in endothelial integrity is incomplete. Using a combination of a RNAi screen with electrical impedance measurements, we quantified the effect of individually silencing 270 Rho-associated genes on the barrier function of thrombin-activated, primary endothelial cells. Known and novel RhoGT-Pase-associated regulators that modulate the response to thrombin were identified (RTKN, TIAM2, MLC1, ARPC1B, SEPT2, SLC9A3R1, RACGAP1, RAPGEF2, RHOD, PREX1, ARHGEF7, PLXNB2, ARHGAP45, SRGAP2, ARHGEF5). In conclusion, with this siRNA screen, we confirmed the roles of known regulators of endothelial integrity but also identified new, potential key players in thrombin-induced endothelial signaling.	[Amado-Azevedo, Joana; Amerongen, Geerten P. van Nieuw; van Hinsbergh, Victor W. M.; Hordijk, Peter L.] Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Physiol, Amsterdam, Netherlands; [de Menezes, Renee X.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Hordijk, PL (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Physiol, Amsterdam, Netherlands.	p.hordijk@vumc.nl	Menezes, Renee/L-2182-2019	Hordijk, Peter/0000-0002-3348-078X	Dutch Heart Foundation (Nederlands hartstichting) [2011T072]	Dutch Heart Foundation (Nederlands hartstichting)	This work was supported by the Dutch Heart Foundation (Nederlands hartstichting) grant number 2011T072 to Geerten P. van Nieuw Amerongen.	Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; Amado-Azevedo J, 2018, VASC PHARMACOL, V101, P38, DOI 10.1016/j.vph.2017.11.007; Amado-Azevedo J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10392-0; Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Amsellem V, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-12; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Aspenstrom Pontus, 2020, Small GTPases, V11, P248, DOI 10.1080/21541248.2017.1391365; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Blom M, 2017, EXP CELL RES, V352, P255, DOI 10.1016/j.yexcr.2017.02.013; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Breslin JW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003336; Buul JDV, 2014, CONTROLING SWITCHES, P1; Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Das S, 2015, P NATL ACAD SCI USA, V112, pE267, DOI 10.1073/pnas.1409667112; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Durkin CH, 2017, DEV CELL, V41, P315, DOI 10.1016/j.devcel.2017.04.010; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flynt AS, 2010, CELL CYCLE, V9, P235, DOI 10.4161/cc.9.2.10434; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Fritz Rafael Dominik, 2016, F1000Res, V5, DOI 10.12688/f1000research.7370.1; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gottesbuhren U, 2013, BIOL OPEN, V2, P210, DOI 10.1242/bio.20123574; Hall A, 2008, CURR OPIN CELL BIOL, V20, P117, DOI 10.1016/j.ceb.2008.02.006; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Li XH, 2010, J BIOL CHEM, V285, P32436, DOI 10.1074/jbc.M110.120451; McColl B, 2016, J CELL SCI, V129, P4046, DOI 10.1242/jcs.192211; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Minshall RD, 2010, MICROVASC RES, V80, P240, DOI 10.1016/j.mvr.2010.04.007; Naikawadi RP, 2012, CIRC RES, V111, P1517, DOI 10.1161/CIRCRESAHA.112.273078; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Pronk Manon C A, 2019, Small GTPases, V10, P466, DOI 10.1080/21541248.2017.1339767; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; R Core Team, 2019, R LANG ENV STAT COMP; Reinhard NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25502; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Roney KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024795; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Song GJ, 2012, J MOL CELL CARDIOL, V53, P809, DOI 10.1016/j.yjmcc.2012.08.022; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wylie T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185899; Xie XZ, 2005, CELL SIGNAL, V17, P461, DOI 10.1016/j.cellsig.2004.09.012	72	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201231	10.1371/journal.pone.0201231	http://dx.doi.org/10.1371/journal.pone.0201231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048510	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400063
J	Ayele, BGK; Gebregzabher, TG; Hailu, TT; Assefa, BA				Ayele, Brhane G. Kidan; Gebregzabher, Tesfay Gebrehiwot; Hailu, Tesfay Tekle; Assefa, Belete Abera			Determinants of teenage pregnancy in Degua Tembien District, Tigray, Northern Ethiopia: A community-based case-control study	PLOS ONE			English	Article							ADOLESCENT	Background Approximately 16 million teenagers aged 15-19 years and 2 million teenagers under the age of 15 years give birth annually, with 95% of these births occurring in developing countries. Ethiopia has one of the highest teenage fertility rates in Sub-Saharan Africa; however determinants of teenage pregnancy are not well studied. Therefore, this study aimed to identify determinants of teenage pregnancy among female teenagers in Degua Tembien district, Tigray, Northern Ethiopia, in 2015. Methods A community-based case-control study was conducted in Degua' Tembien district from February 01, 2015 to March 15, 2015 with a randomly selected total sample size of 414 females (with a ratio of 1:2 case to control, 138 and 276 respectively). Data were entered in to Epi-Info and analyzed using SPSS software. Multivariable logistic regression was used to assess predictors of the outcome variable; variables with a p-value <0.25 in bivariable analysis were included in the model. Statistically significance was considered at a p-value <= 0.05 in both bivariable and multivariable logistic regression analyses. Result The mean ages (plus or minus standard deviation (+/- SD)) of cases and controls were 18.47 (0.72) and 17.09 (1.2) years, respectively. After adjustment for other variables, predictors of teenage pregnancy included: lower monthly income below similar to$25 and similar to$25-50 (adjusted odds ratio (AOR) = 23.96; 95% confidence interval (95%CI) 4.89-117.29 and AOR = 4.91; 95%CI 1.64-14.66, respectively); aged 18-19 years (AOR = 16.75; 95%Cl 6.45-43.47); being married (AOR = 15.91; 95%CI 7.43-34.04); not communicating with parents on reproductive health issues (AOR = 6.52; 95%CI 3.12-13.64) and having a history of maternal teenage pregnancy (AOR = 4.14; 95%CI 1.84-9.33). Conclusion The factors associated with teenage pregnancy in our study were lower family monthly income, being married, being in the 18-19 year age group, not communicating with parents on reproductive health issues and having a maternal history of teenage pregnancy. Programs that encourage parent-teenage communication of reproductive health issues, starting from early adolescence, in order to build skills to prevent pregnancy in the late teenage years, are very important. In addition, multi-pronged activities across sectors that encourage delayed marriage and improve health service utilizations for girls are essential.	[Ayele, Brhane G. Kidan; Assefa, Belete Abera] Tigray Hlth Res Inst, Publ Hlth Dept, Publ Hlth Emergency Management Directorate, Mekelle, Ethiopia; [Gebregzabher, Tesfay Gebrehiwot; Hailu, Tesfay Tekle] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia	Mekelle University	Ayele, BGK (corresponding author), Tigray Hlth Res Inst, Publ Hlth Dept, Publ Hlth Emergency Management Directorate, Mekelle, Ethiopia.	brhane3127@gmail.com		Ayele, Brhane/0000-0003-4749-4629	Mekelle University; Degua Tembien district Health Office	Mekelle University; Degua Tembien district Health Office	The author(s) received funding support for this work from Mekelle University and Degua Tembien district Health Office. However the manuscripts contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alemayehu T, 2010, ETHIOP J HEALTH DEV, V24, P30; Ayalew M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-77; Beguy D, 2013, J BIOSOC SCI, V45, P721, DOI 10.1017/S0021932013000199; Dulitha F, 2013, J HLTH SCI, V7; East Patricia L., 2013, NIH PUBLIC ACCESS PM; Emily J., 2007, GUTTMACHER I, V39; Gideon R., 2013, AM J SOCIOL RES, V3, P30, DOI DOI 10.5923/J.SOCIOLOGY.20130302.03; Goicolea I, 2009, PAN AM J PUBLIC HLTH; Grossman JM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010107; Hyde A, 2009, PARENTS APPROACHES E; Isa AI., 2012, OPEN J OBSTET GYNECO, V2, P239, DOI [DOI 10.4236/OJOG.2012.23049, 10.4236/ojog.2012.23049]; Jones N., 2014, EARLY MARRIAGE ED CO; Mangiaterra V, 2008, MAKE PREGNANCY SAFER; Manu AA, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0003-1; Mchunu G, 2012, AFR HEALTH SCI, V12, P426; Mekonnen WA., 2013, DIFFERENTIALS EARLY; Omar K, 2010, INT J GYNECOL OBSTET, V111, P220, DOI 10.1016/j.ijgo.2010.06.023; ONER S, 2012, ASIAN PAC J REPROD, V1, P135, DOI DOI 10.1016/S2305-0500(13)60064-0; Perezieto P, 2013, SOCIAL JUSTICE ADOLE; Peter N., 2008, FACTORS ASS ADOLESCE; Raghav R, 2013, INDIAN MED GAZETTE; Rutgers and the Government of Ethiopia, 2017, FACT SHEET DEV HIGH; Santos MI, 2011, FAMILY PRACTICE INT; Sofia L, 2014, PAN AM J PUBLIC HLTH; Tigray Regional Health Bureau (TRHB), 2013, TIGR REG HLTH BUR AN; Unicef Fact Sheet, 2008, YOUNG E PEOPL FAM PL; United Nations Population Fund (UNFPA), 2012, STAT REP AD YOUNG PE; Vincent G, 2016, S SUDAN MED J, V9; Vundule C, 2001, AFRICA J, V91; Wall-Wieler E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0911-2; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-6; *WHO, 2004, AD PREGN; Woodward LJ, 2001, NEW ZEAL MED J, V114, P301; World Health Organization, 2012, EARL MARR AD YOUNG P; World Health Organization (WHO), 2008, MAK PREGN SAF; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4	36	30	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200898	10.1371/journal.pone.0200898	http://dx.doi.org/10.1371/journal.pone.0200898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044850	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500069
J	Azuma, T; Sato, Y; Ohno, T; Azuma, M; Kume, H				Azuma, Takeshi; Sato, Yujiro; Ohno, Tetsukuni; Azuma, Miyuki; Kume, Haruki			Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; SUPPRESSOR-CELLS; GASTRIC-CANCER; LUNG-CANCER; EXPRESSION; SURVIVAL; MELANOMA	Background B7-H4 is a member of the B7 family of immune-regulatory ligands and is considered to be a negative regulator of the immune response. We investigated the clinical significance of serum soluble B7-H4 in patients with non-metastatic clear cell renal cell carcinoma. Methods We analyzed 108 patients in whom non-metastatic clear cell renal cancer was diagnosed at Tokyo Metropolitan Tama Medical Center between 2008 and 2013. We measured the serum soluble B7-H4 level using the Enzyme-Linked ImmunoSorbent Assay (ELISA) and evaluated the association between the peripheral blood neutrophil count and sB7-H4 as well as the utility of soluble B7-H4 as a prognostic biomarker for clear cell renal cancer. The Cox proportional hazards regression model was used to assess the PFS and OS with the soluble B7-H4 level. Results We detected high levels of soluble B7-H4 in the sera of 56% of patients with non-metastatic clear cell renal cell carcinoma versus only 10% of healthy donors. Elevated soluble B7-H4 levels were associated with changes in an elevated peripheral blood neutrophil count. The increase of soluble B7-H4 also was significantly associated with poor PFS and OS. Multivariate analysis showed that the elevation of the soluble B7-H4 level was an independent prognostic factor for PFS and OS. Conclusions Our data suggest that the association between serum soluble B7-H4 and peripheral blood neutrophil count, as well as the evaluation of serum soluble B7-H4 expression is a useful tool for predicting the prognosis of patients with non-metastatic clear cell renal cell carcinoma.	[Azuma, Takeshi; Sato, Yujiro] Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan; [Azuma, Takeshi; Ohno, Tetsukuni; Azuma, Miyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Tokyo, Japan; [Azuma, Takeshi; Kume, Haruki] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Azuma, T (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Tokyo, Japan.; Azuma, T (corresponding author), Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo, Japan.	tazuma-tky@umin.ac.jp	Azuma, Miyuki/AAT-8928-2021	Azuma, Miyuki/0000-0002-3529-4585; Azuma, Takeshi/0000-0002-4921-2122	JSPS KAKENHI [16K11037, 17K11169]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI, Grant Number 16K11037 to Y. Sato and JSPS KAKENHI, Grant Number 17K11169 to T. Azuma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadallah NS, 2008, PANCREAS, V36, P200, DOI 10.1097/MPA.0b013e318150e4e0; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P337, DOI 10.1016/j.clgc.2013.04.003; Azuma T, 2012, CLIN GENITOURIN CANC, V10, P180, DOI 10.1016/j.clgc.2012.03.006; Azuma T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000166; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Dong H, 2016, BIOMARKERS, V21, P129, DOI 10.3109/1354750X.2015.1118544; Dong Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/156432; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Ilie M, 2012, CANCER-AM CANCER SOC, V118, P1726, DOI 10.1002/cncr.26456; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Jiang JT, 2010, CANCER IMMUNOL IMMUN, V59, P1707, DOI 10.1007/s00262-010-0900-7; Ko JS, 2009, CURR ONCOL REP, V11, P87, DOI 10.1007/s11912-009-0014-6; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Leung J, 2013, J IMMUNOL, V190, P6651, DOI 10.4049/jimmunol.1201242; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Mugler KC, 2007, APPL IMMUNOHISTO M M, V15, P363, DOI 10.1097/01.pai.0000213159.79557.71; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Ohki S, 2012, ONCOL REP, V28, P453, DOI 10.3892/or.2012.1812; Shi HB, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-188; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang C, 2015, J SURG RES, V197, P301, DOI 10.1016/j.jss.2015.04.034; Zhu GF, 2009, BLOOD, V113, P1759, DOI 10.1182/blood-2008-01-133223	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e199719	10.1371/journal.pone.0199719	http://dx.doi.org/10.1371/journal.pone.0199719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044793	gold, Green Published			2022-12-26	WOS:000439942500017
J	Civita, P; Menicagli, M; Scopelliti, C; Lessi, F; Millanta, F; Borsacchi, S; Parisi, F; Freer, G; Pistellon, M; Mazzanti, CM; Poli, A				Civita, Prospero; Menicagli, Michele; Scopelliti, Claudia; Lessi, Francesca; Millanta, Francesca; Borsacchi, Sara; Parisi, Francesca; Freer, Giulia; Pistellon, Mauro; Mazzanti, Chiara Maria; Poli, Alessandro			Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions	PLOS ONE			English	Article							HUMAN BREAST-CANCER; GENE-SEQUENCES; PARTICLES; CLASSIFICATION; IDENTIFICATION; RETROVIRUSES; CELLS	Mouse mammary tumour virus-like (MMTV-like) is suspected to be involved in human breast cancer and it has been hypothesized that companion animals might have a role in viral transmission. The aim of our study was to investigate the presence of MMTV-like nucleotide sequences and viral protein in a larger number of feline (FMCs) and canine mammary carcinomas (CMCs) by nested PCR and immunohistochemistry. Results showed that the presence of MMTV-like env sequence in FMCs was 7% (6/86), while all the CMCs and canine dysplastic lesions scored negative. All PCR-positive FMCs scored positive for the MMTV p14 signal peptide of the envelope precursor protein of the virus. In contrast, all PCR-negative FMCs and canine mammary lesions were also negative for immunohistochemistry analysis. Canine and feline normal mammary gland tissues scored negative for both PCR and MMTV-p14 protein. Multiple nucleotide alignment of MMTV-like env gene sequences isolated from cat showed 97% and 99% similarity with HMTV and MMTV, respectively, while the others two presented some polimorphisms. Particularly the sequences of one of these two tumors showed a polymorphism (c. 7575 A> G), that causes a previously unreported amino acid substitution (Thr > Ala). In conclusion, the results of our study showed the presence of MMTV-like sequences and viral protein in some FMCs. Further studies are needed to understand whether this virus does play a role in the development of FMCs, if MMTV-like is an exogenous virus as these data suggest and, in such a case, how and from whom this virus was acquired.	[Civita, Prospero; Menicagli, Michele; Scopelliti, Claudia; Lessi, Francesca; Mazzanti, Chiara Maria] Fdn Pisana Sci, Pisa, Italy; [Millanta, Francesca; Borsacchi, Sara; Parisi, Francesca; Poli, Alessandro] Univ Pisa, Dipartimento Sci Vet, Pisa, Italy; [Freer, Giulia; Pistellon, Mauro] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy	University of Pisa; University of Pisa	Poli, A (corresponding author), Univ Pisa, Dipartimento Sci Vet, Pisa, Italy.	alessandro.poli@unipi.it	Civita, Prospero/AAU-6170-2020; Lessi, Francesca/AAE-6812-2022; Parisi, Francesca/AEI-3375-2022; Mazzanti, Chiara/AAX-6539-2021	Lessi, Francesca/0000-0002-3346-4296; Parisi, Francesca/0000-0001-5635-9360; Civita, Prospero/0000-0002-8313-1094	Universita di Pisa [599999_2017_Neoplasie_Mammarie]	Universita di Pisa	This work was supported by Universita di Pisa grant no. 599999_2017_Neoplasie_Mammarie to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSUMIDAIE AM, 1988, LANCET, V1, P5; Bittner JJ, 1936, SCIENCE, V84, P162, DOI 10.1126/science.84.2172.162; Coffin John M., 1996, P763; Etkind P, 2000, CLIN CANCER RES, V6, P1273; Feldman D, 2012, MOL CANCER RES, V10, P1077, DOI 10.1158/1541-7786.MCR-11-0581; Goedert JJ, 2006, BRIT J CANCER, V94, P548, DOI 10.1038/sj.bjc.6602977; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; HOWARD DK, 1980, INT J CANCER, V25, P647, DOI 10.1002/ijc.2910250515; Hsu WL, 2010, J CLIN MICROBIOL, V48, P4354, DOI 10.1128/JCM.01157-10; Lawson JS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00141; Mazzanti CM, 2015, ONCOTARGET, V6, P18355, DOI 10.18632/oncotarget.4567; Mazzanti CM, 2011, AM J PATHOL, V179, P2083, DOI 10.1016/j.ajpath.2011.06.046; Melana SM, 2007, CANCER RES, V67, P8960, DOI 10.1158/0008-5472.CAN-06-3892; Melana SM, 2010, J VIROL METHODS, V163, P157, DOI 10.1016/j.jviromet.2009.09.015; Misdorp W., 1999, HISTOLOGIC CLASSIFIC, V7; MOORE DH, 1969, TEX REP BIOL MED, V27, P1027; Nandi S., 1973, ADV CANCER RES, V17, P353; Riester M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000777; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar NH, 1980, ROLE VIRUSES HUMAN C, P207; SCHLOM J, 1971, SCIENCE, V174, P840, DOI 10.1126/science.174.4011.840; SCHOCHETMAN G, 1979, VIROLOGY, V97, P342, DOI 10.1016/0042-6822(79)90345-3; Song N, 2013, J GEN VIROL, V94, P1587, DOI 10.1099/vir.0.051862-0; Stewart AFR, 2002, ARCH VIROL, V147, P577, DOI 10.1007/s007050200007; Stewart THM, 2000, BRIT J CANCER, V82, P446, DOI 10.1054/bjoc.1999.0941; Szabo S, 2005, MICROSC RES TECHNIQ, V68, P209, DOI 10.1002/jemt.20233; WANG Y, 1995, CANCER RES, V55, P5173; Wang Y, 2001, INT J ONCOL, V18, P1041; Wang Y, 2001, ARCH VIROL, V146, P171, DOI 10.1007/s007050170201; YANAGAWA SI, 1993, J VIROL, V67, P112, DOI 10.1128/JVI.67.1.112-118.1993; Zammarchi F, 2006, J PATHOL, V209, P436, DOI 10.1002/path.1997; Zappulli V, 2015, VET PATHOL, V52, P46, DOI 10.1177/0300985814528221	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200839	10.1371/journal.pone.0200839	http://dx.doi.org/10.1371/journal.pone.0200839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040851	gold, Green Published, Green Submitted			2022-12-26	WOS:000439749200013
J	Roy, SK; Meng, QH; Sadowitz, BD; Kollisch-Singule, M; Yepuri, N; Satalin, J; Gatto, LA; Nieman, GF; Cooney, RN; Clark, D				Roy, Shreyas K.; Meng, Qinghe; Sadowitz, Benjamin D.; Kollisch-Singule, Michaels; Yepuri, Natesh; Satalin, Joshua; Gatto, Louis A.; Nieman, Gary F.; Cooney, Robert N.; Clark, David			Enteral administration of bacteria fermented formula in newborn piglets: A high fidelity model for necrotizing enterocolitis (NEC)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL MUCOSAL INJURY; BIRTH-WEIGHT INFANTS; ESCHERICHIA-COLI; IN-VITRO; PATHOGENESIS; NUTRITION; RATS; EPIDEMIOLOGY; MILK	Objective To develop an animal model which replicates neonatal NEC and characterizes the importance of bacterial fermentation of formula and short chain fatty acids (SCFAs) in its pathogenesis. Background NEC is a severe form of intestinal inflammation in preterm neonates and current models do not reproduce the human condition. Methods Three groups of newborn piglets: Formula alone (FO), Bacteria alone (E.coli: BO) and E. coli-fermented formula (FF) were anesthetized, instrumented and underwent post-pyloric injection of formula, bacteria or fermented-formula. SCFA levels were measured by gas chromatography-mass spectrometry. At 6 h bowel appearance was assessed, histologic and molecular analysis of intestine were performed. Gut inflammation (p65 NF-kappa B, TLR4, TNF-alpha, IL-1 beta), apoptosis (cleaved caspase-3, BAX, apoptosis) and tight junction proteins (claudin-2, occludin) were measured. Results SCFAs were increased in FF. Small bowel from FF piglet's demonstrated inflammation, coagulative necrosis and pneumatosis resembling human NEC. Histologic gut injury (injury score, mast cell activation) were increased by Bacteria, but more severe in FF piglets. Intestinal expression of p65 NF-kappa B, NF-kappa B activation, TNF-alpha and IL-1 beta were increased in BO and markedly increased in the FF group (P<0.05 vs. FO). Intestine from Bacteria piglets demonstrated increased apoptotic index, pro-apoptotic protein expression and decreased tight junction proteins. These changes were more severe in FF piglets. Conclusions Our piglet model demonstrates the findings of NEC in human neonates: systemic acidosis, intestinal inflammation, pneumatosis and portal venous gas. Bacteria alone can initiate intestinal inflammation, injury and apoptosis, but bacterial fermentation of formula generates SCFAs which contribute to the pathogenesis of NEC.	[Roy, Shreyas K.; Meng, Qinghe; Sadowitz, Benjamin D.; Kollisch-Singule, Michaels; Yepuri, Natesh; Satalin, Joshua; Nieman, Gary F.; Cooney, Robert N.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Gatto, Louis A.] SUNY Coll Cortland, Dept Biol, Cortland, NY 13045 USA; [Clark, David] Albany Med Ctr, Dept Pediat, Albany, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; SUNY Cortland; Albany Medical College	Cooney, RN (corresponding author), SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA.	cooneyr@upstate.edu	Nieman, Gary/ABA-9469-2020	Cooney, Robert/0000-0002-8901-3638; Satalin, Joshua/0000-0002-7582-2493	Upstate Medical University HSC Foundation account	Upstate Medical University HSC Foundation account	This project was supported by the Upstate Medical University HSC Foundation account. Voluntary donations were accepted into this fund. Donors waived rights to determine how and to which projects the funds were allocated. Donations were accepted under the condition that ownership of intellectual property rights were waived and donor approval not required for publication. These funds were not provided for goods or services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bizzarro MJ, 2014, J PEDIATR-US, V164, P61, DOI 10.1016/j.jpeds.2013.09.020; Boccia D, 2001, EUR J PEDIATR, V160, P385, DOI 10.1007/s004310100749; CARBONARO CA, 1988, MICROB PATHOGENESIS, V5, P427, DOI 10.1016/0882-4010(88)90004-6; Carlisle EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018084; CLARK DA, 1988, AM J PATHOL, V130, P537; Clark David A, 2014, Pathophysiology, V21, P29, DOI 10.1016/j.pathophys.2013.11.006; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; CUSHING AH, 1983, PEDIATRICS, V71, P626; DILORENZO M, 1995, J PEDIATR SURG, V30, P1138, DOI 10.1016/0022-3468(95)90006-3; Feng JX, 2006, J PEDIATR SURG, V41, P144, DOI 10.1016/j.jpedsurg.2005.10.018; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Hunter Catherine J, 2014, Pathophysiology, V21, P55, DOI 10.1016/j.pathophys.2013.11.010; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; KLIEGMAN RM, 1993, PEDIATR RES, V34, P701, DOI 10.1203/00006450-199312000-00001; KLIEGMAN RM, 1982, J PEDIATR-US, V100, P440, DOI 10.1016/S0022-3476(82)80456-3; KOSLOSKE AM, 1980, J PEDIATR SURG, V15, P558, DOI 10.1016/S0022-3468(80)80773-1; Lambert DK, 2007, J PERINATOL, V27, P437, DOI 10.1038/sj.jp.7211738; Lin J, 2005, J PEDIATR GASTR NUTR, V41, P607, DOI 10.1097/01.mpg.0000179659.09210.ff; Lin J, 2004, MED HYPOTHESES, V62, P291, DOI 10.1016/S0306-9877(03)00333-5; Lin J, 2002, J PEDIATR GASTR NUTR, V35, P545, DOI 10.1097/00005176-200210000-00016; Lu Peng, 2014, Pathophysiology, V21, P81, DOI 10.1016/j.pathophys.2013.11.007; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; MILLER MJS, 1991, SCAND J GASTROENTERO, V26, P379, DOI 10.3109/00365529108996498; Moore SA, 2016, J PEDIATR SURG, V51, P1907, DOI 10.1016/j.jpedsurg.2016.09.011; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Nafday SM, 2005, PEDIATR RES, V57, P201, DOI 10.1203/01.PDR.0000150721.83224.89; Neu J, 2015, CURR OPIN CLIN NUTR, V18, P285, DOI 10.1097/MCO.0000000000000169; Neu J, 2012, JPEN-PARENTER ENTER, V36, p30S, DOI 10.1177/0148607111422068; NEWPORT MJ, 1984, PEDIATR RES, V18, P658, DOI 10.1203/00006450-198407000-00019; NOWICKI P, 1990, J PEDIATR-US, V117, pS14, DOI 10.1016/S0022-3476(05)81125-4; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Penn AH, 2012, PEDIATR RES, V72, P560, DOI 10.1038/pr.2012.125; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; Sachdev AH, 2013, THER ADV CHRONIC DIS, V4, P223, DOI 10.1177/2040622313496126; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; SANTULLI TV, 1975, PEDIATRICS, V55, P376; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Shea-Donohue Terez, 2010, Curr Gastroenterol Rep, V12, P349, DOI 10.1007/s11894-010-0132-1; Sodhi C, 2008, DIS MODEL MECH, V1, P94, DOI 10.1242/dmm.000315; Sonntag J, 1998, J PEDIATR SURG, V33, P481, DOI 10.1016/S0022-3468(98)90092-6; SPEER ME, 1976, J PEDIATR-US, V89, P91, DOI 10.1016/S0022-3476(76)80939-0; STOLL BJ, 1980, J PEDIATR-US, V96, P447; Tatum PM, 2010, J PEDIATR SURG, V45, P1246, DOI 10.1016/j.jpedsurg.2010.02.093; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; VanderKolk WE, 1996, J PEDIATR SURG, V31, P1063, DOI 10.1016/S0022-3468(96)90088-3; Waligora-Dupriet AJ, 2009, ANAEROBE, V15, P138, DOI 10.1016/j.anaerobe.2009.02.001; Young Christopher M, 2011, J Pediatr, V158, pe25, DOI 10.1016/j.jpeds.2010.11.009	54	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201172	10.1371/journal.pone.0201172	http://dx.doi.org/10.1371/journal.pone.0201172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036384	Green Submitted, Green Published, gold			2022-12-26	WOS:000439429200032
J	Claxton, DP; Gouaux, E				Claxton, Derek P.; Gouaux, Eric			Expression and purification of a functional heteromeric GABA(A) receptor for structural studies	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; GATED ION-CHANNEL; GREEN FLUORESCENT PROTEIN; X-RAY STRUCTURES; MAMMALIAN-CELL LINES; HAMSTER OVARY CELLS; MEMBRANE-PROTEINS; A RECEPTORS; BENZODIAZEPINE BINDING; SUBUNIT ARRANGEMENT	The GABA-gated chloride channels of the Cys-loop receptor family, known as GABA(A) receptors, function as the primary gatekeepers of fast inhibitory neurotransmission in the central nervous system. Formed by the pentameric arrangement of five identical or homologous subunits, GABA(A) receptor subtypes are defined by the subunit composition that shape ion channel properties. An understanding of the structural basis of distinct receptor properties has been hindered by the absence of high resolution structural information for heteromeric assemblies. Robust heterologous expression and purification protocols of high expressing receptor constructs are vital for structural studies. Here, we describe a unique approach to screen for well-behaving and functional GABA(A) receptor subunit assemblies by using the Xenopus oocyte as an expression host in combination with fluorescence detection size exclusion chromatography (FSEC). To detect receptor expression, GFP fusions were introduced into the alpha 1 subunit isoform. In contrast to expression of alpha 1 alone, co-expression with the beta subunit promoted formation of monodisperse assemblies. Mutagenesis experiments suggest that the alpha and beta subunits can tolerate large truncations in the non-conserved M3/M4 cytoplasmic loop without compromising oligomeric assembly or GABA-gated channel activity, although removal of N-linked glycosylation sites is negatively correlated with expression level. Additionally, we report methods to improve GABA(A) receptor expression in mammalian cell culture that employ recombinant baculovirus transduction. From these methods we have identified a well-behaving minimal functional construct for the alpha 1/beta 1 GABA(A) receptor subtype that can be purified in milligram quantities while retaining high affinity agonist binding activity.	[Claxton, Derek P.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; [Claxton, Derek P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Vanderbilt University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Claxton, Derek P/0000-0002-1374-7176	NIH grant from the National Institute of General Medical Sciences [R01-GM100400]; NRSA from the National Institute of General Medical Sciences [F32-GM100584]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100400, F32GM100584] Funding Source: NIH RePORTER	NIH grant from the National Institute of General Medical Sciences; NRSA from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant from the National Institute of General Medical Sciences (R01-GM100400) to E.G., who is also an Investigator with the Howard Hughes Medical Institute, and by an NRSA postdoctoral fellowship from the National Institute of General Medical Sciences (F32-GM100584) to D.P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Anderson KN, 2009, J CLIN SLEEP MED, V5, P235; Andrell J, 2013, MOL MEMBR BIOL, V30, P52, DOI 10.3109/09687688.2012.703703; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Ashikawa Y, 2011, PROTEIN SCI, V20, P1720, DOI 10.1002/pro.707; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; BIRNIR B, 1992, P ROY SOC B-BIOL SCI, V250, P307, DOI 10.1098/rspb.1992.0163; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Campagna-Slater V, 2007, J MOL GRAPH MODEL, V25, P721, DOI 10.1016/j.jmgm.2006.06.001; CARTER DB, 1992, BIO-TECHNOL, V10, P679, DOI 10.1038/nbt0692-679; CASALOTTI SO, 1986, J BIOL CHEM, V261, P5013; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connor JX, 1998, J BIOL CHEM, V273, P28906, DOI 10.1074/jbc.273.44.28906; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dibbens LM, 2009, NEUROSCI LETT, V453, P162, DOI 10.1016/j.neulet.2009.02.038; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Ferris MM, 2011, J VIROL METHODS, V171, P111, DOI 10.1016/j.jviromet.2010.10.010; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Hsu CS, 2004, BIOTECHNOL BIOENG, V88, P42, DOI 10.1002/bit.20213; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Luckow Verne A., 1993, Current Opinion in Biotechnology, V4, P564, DOI 10.1016/0958-1669(93)90078-B; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mitte K, 2005, J CLIN PSYCHOPHARM, V25, P141, DOI 10.1097/01.jcp.0000155821.74832.f9; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PALERMO DP, 1991, J BIOTECHNOL, V19, P35, DOI 10.1016/0168-1656(91)90073-5; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PREGENZER JF, 1993, MOL PHARMACOL, V43, P801; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; Puthenkalam R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00044; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reeves PJ, 1999, BIOCHEM SOC T, V27, P950, DOI 10.1042/bst0270950; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; SMART TG, 1990, BRIT J PHARMACOL, V99, P643, DOI 10.1111/j.1476-5381.1990.tb12984.x; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; Smart TG, 2012, COLD SPRING HARB PER, V4; Tan KR, 2011, TRENDS NEUROSCI; Tierney ML, 1996, J MEMBRANE BIOL, V154, P11, DOI 10.1007/s002329900128; Tretter V, 1997, J NEUROSCI, V17, P2728; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vijayan RSK, 2012, J CHEM INF MODEL, V52, P2958, DOI [10.1021/ci300189a, 10.1021/ci3001092]; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Wilkins MR, 1999, METH MOL B, V112, P531; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Xie HB, 2013, BIOPHYS CHEM, V180, P1, DOI 10.1016/j.bpc.2013.05.004; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782	89	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201210	10.1371/journal.pone.0201210	http://dx.doi.org/10.1371/journal.pone.0201210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028870	Green Published, Green Submitted, gold			2022-12-26	WOS:000439396900046
J	Alfajaro, MM; Cho, EH; Park, JG; Kim, JY; Soliman, M; Baek, YB; Kang, MI; Park, SI; Cho, KO				Alfajaro, Mia Madel; Cho, Eun-Hyo; Park, Jun-Gyu; Kim, Ji-Yun; Soliman, Mahmoud; Baek, Yeong-Bin; Kang, Mun-Il; Park, Sang-Ik; Cho, Kyoung-Oh			Feline calicivirus- and murine norovirus-induced COX-2/PGE(2) signaling pathway has proviral effects	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; NF-KAPPA-B; NITRIC-OXIDE; PROSTAGLANDIN E-2; CYTOMEGALOVIRUS REPLICATION; IMMUNE-RESPONSES; COX-2 EXPRESSION; VIRAL-INFECTION; BINDING-PROTEIN; H5N1 INFECTION	Cyclooxygenases (COXs)/prostaglandin E-2 (PGE(2)) signaling pathways are known to modulate a variety of homeostatic processes and are involved in various pathophysiological conditions. COXs/PGE(2) signaling pathways have also been demonstrated to have proviral or antiviral effects, which appeared different even in the same virus family. A porcine sapovirus Cowden strain, a member of genus Sapovirus within the Caliciviridae family, induces strong COX-2/PGE(2) but transient COX-1/PGE(2) signaling to enhance virus replication. However, whether infections of other viruses in the different genera activate COXs/PGE(2) signaling, and thus affect the replication of viruses, remains unknown. In the present study, infections of cells with the feline calicivirus (FCV) F9 strain in the genus Vesivirus and murine norovirus (MNV) CW-1 strain in the genus Norovirus only activated the COX-2/PGE(2) signaling in a time-dependent manner. Treatment with pharmacological inhibitors or transfection of small interfering RNAs (siRNAs) against COX-2 enzyme significantly reduced the production of PGE(2) as well as FCV and MNV replications. The inhibitory effects of these pharmacological inhibitors against COX-2 enzyme on the replication of both viruses were restored by the addition of PGE(2). Silencing of COX-1 via siRNAs and inhibition of COX-1 via an inhibitor also decrease the production of PGE(2) and replication of both viruses, which can be attributed to the inhibition COX-1/PGE(2) signaling pathway. These data indicate that the COX-2/PGE(2) signaling pathway has proviral effects for the replication of FCV and MNV, and pharmacological inhibitors against these enzymes serve as potential therapeutic candidates for treating FCV and MNV infections.	[Alfajaro, Mia Madel; Cho, Eun-Hyo; Park, Jun-Gyu; Kim, Ji-Yun; Soliman, Mahmoud; Baek, Yeong-Bin; Kang, Mun-Il; Park, Sang-Ik; Cho, Kyoung-Oh] Chonnam Natl Univ, Coll Vet Med, Lab Vet Pathol, Gwangju, South Korea	Chonnam National University	Park, SI; Cho, KO (corresponding author), Chonnam Natl Univ, Coll Vet Med, Lab Vet Pathol, Gwangju, South Korea.	sipark@chonnam.ac.kr; choko@chonnam.ac.kr	Park, Jun-Gyu/C-1298-2014; Soliman, Mahmoud/GRX-5174-2022	Soliman, Mahmoud/0000-0003-4110-3703	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Republic of Korea [2017R1A2B3002971]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Republic of Korea	This study was supported by a grant (2017R1A2B3002971) of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x; Alfajaro MM, 2017, J VIROL, V91, DOI 10.1128/JVI.01656-16; Alvarez S, 2007, NEUROMOL MED, V9, P170; Ayukekbong JA, 2015, J GEN VIROL, V96, P1983, DOI 10.1099/vir.0.000194; Bi YM, 2014, J VIROL, V88, P2810, DOI 10.1128/JVI.03205-13; BI ZB, 1995, J VIROL, V69, P2208, DOI 10.1128/JVI.69.4.2208-2213.1995; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Carey MA, 2003, PROSTAG LEUKOTR ESS, V69, P157, DOI 10.1016/S0952-3278(03)00076-0; Carey MA, 2003, AM J RESP CRIT CARE, V167, P1509, DOI 10.1164/rccm.200211-1383OC; Carey MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011610; Chen CJ, 2002, J GEN VIROL, V83, P1897, DOI 10.1099/0022-1317-83-8-1897; Chen N, 2000, VIROLOGY, V276, P44, DOI 10.1006/viro.2000.0562; Clarke I., 2012, CALICIVIRIDAE, P977; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; DOREDUFFY P, 1982, PROSTA LEUKOTR MED, V8, P73, DOI 10.1016/0262-1746(82)90129-9; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; FLOWERS M, 1994, TRANSPLANTATION, V58, P183; Foley J, 2006, J FELINE MED SURG, V8, P55, DOI 10.1016/j.jfms.2005.08.002; Gandhi J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00538; Gebhardt BM, 2005, J OCUL PHARMACOL TH, V21, P114, DOI 10.1089/jop.2005.21.114; Green KY, 2014, FIELDS VIROLOGY, P582; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; Herulf M, 1999, J INFECT DIS, V180, P542, DOI 10.1086/314908; Hwang S., 2014, CURR PROTOC MICROBIO, V33, p15K21, DOI DOI 10.1002/9780471729259.MC15K02S33; Hyman A, 1999, J VIRAL HEPATITIS, V6, P329, DOI 10.1046/j.1365-2893.1999.00161.x; Janelle ME, 2002, J BIOL CHEM, V277, P30665, DOI 10.1074/jbc.M203041200; Jeong C, 2007, VET MICROBIOL, V122, P246, DOI 10.1016/j.vetmic.2007.02.008; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; KHYATTI M, 1990, ANTIVIR RES, V14, P161, DOI 10.1016/0166-3542(90)90032-3; Kim DS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004267; Kim DS, 2016, J VIROL, V90, P4067, DOI 10.1128/JVI.02449-15; Kim HJ, 2011, VET MICROBIOL, V152, P291, DOI 10.1016/j.vetmic.2011.05.017; Kim Y, 2018, ANTIVIR RES, V152, P76, DOI 10.1016/j.antiviral.2018.02.009; KUNO S, 1986, P NATL ACAD SCI USA, V83, P3487, DOI 10.1073/pnas.83.10.3487; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Lee SMY, 2011, ANTIVIR RES, V91, P330, DOI 10.1016/j.antiviral.2011.07.011; Liao QF, 2014, ARCH VIROL, V159, P2529, DOI 10.1007/s00705-014-2083-6; Lin CK, 2017, SCI REP-UK, V7, DOI 10.1038/srep44701; Lin CK, 2015, BRIT J PHARMACOL, V172, P4481, DOI 10.1111/bph.13233; Lin YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054466, 10.1371/journal.pone.0069722]; Lu L, 2015, CANC LETT, V356, DOI [10.1016/j.canlet.2014.09, DOI 10.1016/J.CANLET.2014.09]; Lu LL, 2008, VIROLOGY, V371, P61, DOI 10.1016/j.virol.2007.09.025; LUCZAK M, 1975, ARCH VIROL, V49, P377, DOI 10.1007/BF01318248; Mikalsen AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107132; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; Ongradi J, 1994, Acta Microbiol Immunol Hung, V41, P173; Park JG, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-88; Park SI, 2008, VET MICROBIOL, V130, P371, DOI 10.1016/j.vetmic.2008.01.017; Park SI, 2007, VET MICROBIOL, V124, P125, DOI 10.1016/j.vetmic.2007.03.010; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Paul AG, 2013, TRANSL RES, V162, P77, DOI 10.1016/j.trsl.2013.03.004; Pesavento PA, 2008, VET CLIN N AM-SMALL, V38, P775, DOI 10.1016/j.cvsm.2008.03.002; Pyeon D, 2000, J VIROL, V74, P5740, DOI 10.1128/JVI.74.12.5740-5745.2000; Radford AD, 2007, VET RES, V38, P319, DOI 10.1051/vetres:2006056; Ray N, 2004, J VIROL, V78, P12964, DOI 10.1128/JVI.78.23.12964-12974.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rott D, 2003, J AM COLL CARDIOL, V41, P1812, DOI 10.1016/S0735-1097(03)00304-8; Scherk MA, 2013, J FELINE MED SURG, V15, P785, DOI 10.1177/1098612X13500429; Sowmyanarayanan TV, 2009, T ROY SOC TROP MED H, V103, P849, DOI 10.1016/j.trstmh.2009.05.003; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Taube S, 2009, J VIROL, V83, P4092, DOI 10.1128/JVI.02245-08; Tung WH, 2010, J CELL PHYSIOL, V224, P376, DOI 10.1002/jcp.22133; Tung WH, 2010, CELL SIGNAL, V22, P234, DOI 10.1016/j.cellsig.2009.09.018; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang FM, 2017, ARCH VIROL, V162, P2115, DOI 10.1007/s00705-017-3302-8; Wang HQ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0264-x; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Wolf S, 2012, ARCH VIROL, V157, P1499, DOI 10.1007/s00705-012-1326-7; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; YAMAMOTO N, 1986, AIDS RES HUM RETROV, V2, pS183; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Zaki MH, 2005, J PHARMACOL SCI, V98, P117, DOI 10.1254/jphs.CRJ05004X; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zheng J, 2018, CURR OPIN VIROL, V28, P43, DOI 10.1016/j.coviro.2017.11.002; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	82	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200726	10.1371/journal.pone.0200726	http://dx.doi.org/10.1371/journal.pone.0200726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021004	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400069
J	Bystrom, A; Roepstorff, L; Rhodin, M; Braganca, FS; Engell, MT; Hernlund, E; Persson-Sjodin, E; van Weeren, R; Weishaupt, MA; Egenvall, A				Bystrom, A.; Roepstorff, L.; Rhodin, M.; Braganca, F. Serra; Engell, M. T.; Hernlund, E.; Persson-Sjodin, E.; van Weeren, R.; Weishaupt, M. A.; Egenvall, A.			Lateral movement of the saddle relative to the equine spine in rising and sitting trot on a treadmill	PLOS ONE			English	Article							HORSES; KINEMATICS; LAMENESS; RIDER; BACK; SLIP	Saddle slip, defined as a progressive lateral displacement of the saddle during ridden exercise, has recently been given attention in the scientific press as a potential sign of lameness. The aim of this study was to objectively quantify the normal lateral movement (oscillations) of the saddle relative to the horse in non-lame horses, and associate this movement to the movements of the horse and rider. Data from seven Warmblood dressage horses competing at Grand Prix (n = 6) or FEI Intermediate (n = 1) level, ridden by their usual riders, were used. Simultaneous kinetic, kinematic and saddle pressure measurements were conducted during sitting and rising trot on a force-measuring treadmill. The maximum lateral movement of the caudal part of the saddle relative to the horse's spine (MAX) was determined for each diagonal step. A mixed model was applied, with MAX as outcome, and T6 and S3 vertical position, rigid body rotation angles (roll, pitch, yaw) of the horse's and rider's pelvis, vertical ground reaction forces, saddle force, and rider position (rising in rising trot, sitting in rising trot or sitting in sitting trot) as explanatory variables. The least square means for MAX were 14.3 (SE 4.7) mm and 23.9 (SE 4.7) mm for rising and sitting in rising trot, and 20.3 (SE 4.7) mm for sitting trot. A 10 mm increase in maximum pelvic height at push off increased MAX by 1.4 mm (p<0.0001). One degree increase in rider pelvis roll decreased MAX 1.1 mm, and one degree increase in rider pelvis yaw increased MAX 0.7 mm (both p<0.0001). The linear relationships found between MAX and movements of both horse and rider implies that both horse and rider movement asymmetries are reflected in the lateral movements or oscillations of the saddle in non-lame horses.	[Bystrom, A.; Roepstorff, L.; Engell, M. T.; Hernlund, E.] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Rhodin, M.; Hernlund, E.; Persson-Sjodin, E.; Egenvall, A.] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden; [Braganca, F. Serra; van Weeren, R.] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Weishaupt, M. A.] Univ Zurich, Vetsuisse Fac, Equine Dept, Zurich, Switzerland	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Utrecht University; University of Zurich	Bystrom, A (corresponding author), Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	anna.bystrom@slu.se	Rhodin, Marie/AAD-7266-2020; Bystrom, Anna/H-1525-2017	Bystrom, Anna/0000-0002-2008-8244; Weishaupt, Michael/0000-0001-7314-162X; Hernlund, Elin/0000-0002-5769-3958; Rhodin, Marie/0000-0003-0575-2765; Roepstorff, Lars/0000-0002-4109-9284				Bell RP, 2016, AM J VET RES, V77, P337, DOI 10.2460/ajvr.77.4.337; Bystrom A, 2010, EQUINE VET J, V42, P502, DOI 10.1111/j.2042-3306.2010.00173.x; Bystrom A, 2009, EQUINE VET J, V41, P280, DOI 10.2746/042516409X394454; de Cocq P, 2010, J BIOMECH, V43, P627, DOI 10.1016/j.jbiomech.2009.10.036; Galloux P, 1994, EQUINE VET J, V26, P44, DOI [DOI 10.1111/J.2042-3306.1994.TB04872.X, 10.1111/j.2042-3306.1994.tb04872.x]; Greve L, 2017, VET J, V220, P95, DOI 10.1016/j.tvjl.2017.01.003; Greve L, 2015, EQUINE VET J, V47, P415, DOI 10.1111/evj.12304; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Greve L, 2013, EQUINE VET J, V45, P570, DOI 10.1111/evj.12029; Kramer J, 2004, AM J VET RES, V65, P741, DOI 10.2460/ajvr.2004.65.741; Licka T, 2001, Equine Vet J Suppl, P150; Rhodin M, 2009, EQUINE VET J, V41, P274, DOI 10.2746/042516409X394436; Roepstorff L, 2009, EQUINE VET J, V41, P292, DOI 10.2746/042516409X397127; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; von Peinen K, 2009, EQUINE VET J, V41, P285, DOI 10.2746/042516409X397136; Weishaupt M A, 2006, Equine Vet J Suppl, P387; Weishaupt MA, 2002, AM J VET RES, V63, P520, DOI 10.2460/ajvr.2002.63.520	17	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200534	10.1371/journal.pone.0200534	http://dx.doi.org/10.1371/journal.pone.0200534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020982	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000439022400053
J	Marcucci, L; Canato, M; Protasi, F; Stienen, GJM; Reggiani, C				Marcucci, Lorenzo; Canato, Marta; Protasi, Feliciano; Stienen, Ger J. M.; Reggiani, Carlo			A 3D diffusional-compartmental model of the calcium dynamics in cytosol, sarcoplasmic reticulum and mitochondria of murine skeletal muscle fibers	PLOS ONE			English	Article							BINDING PROTEIN; CA2+ RELEASE; INTRACELLULAR CA2+; CARDIAC-MUSCLE; TWITCH FIBERS; MOUSE MUSCLE; CALSEQUESTRIN; MICE; SIMULATION; CONTRACTION	Variations of free calcium concentration ([Ca2+]) are powerful intracellular signals, controlling contraction as well as metabolism in muscle cells. To fully understand the role of calcium redistribution upon excitation and contraction in skeletal muscle cells, the local [Ca2+] in different compartments needs to be taken into consideration. Fluorescent probes allow the determination of [Ca2+] in the cytosol where myofibrils are embedded, the lumen of the sarcoplasmic reticulum (SR) and the mitochondrial matrix. Previously, models have been developed describing intracellular calcium handling in skeletal and cardiac muscle cells. However, a comprehensive model describing the kinetics of the changes in free calcium concentration in these three compartments is lacking. We designed a new 3D compartmental model of the half sarcomere with radial symmetry, which accounts for diffusion of Ca2+ into the three compartments and simulates its dynamics at rest and at various rates of stimulation in mice skeletal muscle fibers. This model satisfactorily reproduces both the amplitude and time course of the variations of [Ca2+] in the three compartments in mouse fast fibers. As an illustration of the applicability of the model, we investigated the effects of Calsequestrin (CSQ) ablation. CSQ is the main Ca2+ buffer in the SR, localized in close proximity of its calcium release sites and near to the mitochondria. CSQ knock-out mice muscles still preserve a near-normal contractile behavior, but it is unclear whether this is caused by additional SR calcium buffering or a significant contribution of calcium entry from extracellular space, via stored-operated calcium entry (SOCE). The model enabled quantitative assessment of these two scenarios by comparison to measurements of local calcium in the cytosol, the SR and the mitochondria. In conclusion, the model represents a useful tool to investigate the impact of protein ablation and of pharmacological interventions on intracellular calcium dynamics in mice skeletal muscle.	[Marcucci, Lorenzo; Canato, Marta; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Protasi, Feliciano] CeSI Met Ctr Res Ageing & Translat Med, Chieti, Italy; [Protasi, Feliciano] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Stienen, Ger J. M.] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands	University of Padua; G d'Annunzio University of Chieti-Pescara; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Marcucci, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	lorenzo.marcucci@gmail.com	Marcucci, Lorenzo/AAD-5771-2020	Marcucci, Lorenzo/0000-0002-9542-4417	Telethon [GGP13213]; Italian Ministry of Instruction, University and Research [PRIN 2015ZZR4W3]	Telethon(Fondazione Telethon); Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR))	LM, CR and FP were supported by Telethon GGP13213. CR and FP were also supported by Italian Ministry of Instruction, University and Research PRIN 2015ZZR4W3.	[Anonymous], ACCELERATED ACTIVATI; Baylor SM, 1998, J GEN PHYSIOL, V112, P297, DOI 10.1085/jgp.112.3.297; Baylor SM, 2007, J GEN PHYSIOL, V130, P283, DOI 10.1085/jgp.200709827; Boncompagni S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14134-0; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Boyman L, 2014, BIOPHYS J, V107, P1289, DOI 10.1016/j.bpj.2014.07.045; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; CANNELL MB, 1984, BIOPHYS J, V45, P913, DOI 10.1016/S0006-3495(84)84238-1; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Crank J., 1979, MATH DIFFUSION; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; Divet A, 2007, J CELL PHYSIOL, V213, P464, DOI 10.1002/jcp.21121; Fenelon K, 2012, J GEN PHYSIOL, V140, P403, DOI 10.1085/jgp.201110730; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hatano A, 2011, BIOPHYS J, V101, P2601, DOI 10.1016/j.bpj.2011.10.020; Hollingworth S, 2000, J PHYSIOL-LONDON, V526, P551, DOI 10.1111/j.1469-7793.2000.t01-1-00551.x; Hollingworth S, 2012, J PHYSIOL-LONDON, V590, P575, DOI 10.1113/jphysiol.2011.220780; Jiang YH, 1999, BIOPHYS J, V77, P2333, DOI 10.1016/S0006-3495(99)77072-4; Lamboley CRH, 2015, J GEN PHYSIOL, V145, P127, DOI 10.1085/jgp.201411250; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; LUFF AR, 1971, J CELL BIOL, V51, P369, DOI 10.1083/jcb.51.2.369; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michelucci A, 2017, FASEB J, V31, P3649, DOI 10.1096/fj.201601292R; MOBLEY BA, 1975, J GEN PHYSIOL, V66, P31, DOI 10.1085/jgp.66.1.31; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Novo D, 2003, BIOPHYS J, V85, P1080, DOI 10.1016/S0006-3495(03)74546-9; OSTWALD TJ, 1974, J BIOL CHEM, V249, P974; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/634075; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Protasi F, 2011, J MUSCLE RES CELL M, V32, P257, DOI 10.1007/s10974-011-9277-2; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Reane DV, 2016, MOL CELL, V64, P760, DOI 10.1016/j.molcel.2016.10.001; Rios E, 2015, J GEN PHYSIOL, V145, P459, DOI 10.1085/jgp.201411321; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Scorzeto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074919; Selvin D, 2015, AM J PHYSIOL-REG I, V308, pR467, DOI 10.1152/ajpregu.00144.2014; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; Tran K, 2009, BIOPHYS J, V96, P2029, DOI 10.1016/j.bpj.2008.11.045; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WESTERBLAD H, 1994, J PHYSIOL-LONDON, V474, P291, DOI 10.1113/jphysiol.1994.sp020022; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Wust RCI, 2017, J PHYSIOL-LONDON, V595, P2001, DOI 10.1113/JP273589; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200	56	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201050	10.1371/journal.pone.0201050	http://dx.doi.org/10.1371/journal.pone.0201050			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048500	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400044
J	Qu, Z; Ju, FR; Guo, Y; Bai, L; Chen, K				Qu, Zhong; Ju, Fang-Rong; Guo, Yang; Bai, Ling; Chen, Kuo			Concrete surface crack detection with the improved pre-extraction and the second percolation processing methods	PLOS ONE			English	Article							ALGORITHM; IMAGES	Monitoring the instantaneous and changing concrete surface condition is paramount to cost-effectively managing tunnel assets. In practice, detecting cracks efficiently and accurately is a very challenging task due to concrete blebs, stains, and illumination over the concrete surface. Unclear and tiny cracks cannot be detected effectively. In this paper, we proposed an ultra-efficient crack detection algorithm (CrackHHP) and an improved pre-extraction and second percolation process based on the percolation model to address these issues. Our contributions are shown as follows: 1) apply the overlapping grids and weight-based, redefined pixel value to obtain the candidate dark pixel image while preserving the cracks. 2) introduce the second percolation processing to generate a high-accuracy crack detection algorithm, which can connect the tiny fractures and detect the tiny cracks. 3) construct a high-efficiency and high-accuracy crack detection algorithm combining the improved pre-extraction and the second percolation process. The experimental results demonstrate that CrackHHP can significantly improve the efficiency and accuracy of crack detection.	[Qu, Zhong; Ju, Fang-Rong; Chen, Kuo] Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China; [Qu, Zhong; Guo, Yang; Bai, Ling] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; Chongqing University of Posts & Telecommunications	Qu, Z (corresponding author), Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China.; Qu, Z (corresponding author), Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China.	quzhong@cqupt.edu.cn		Qu, Zhong/0000-0001-7013-4854; Bai, Ling/0000-0002-2135-5404	Chongqing Basic and Frontier Research Project [cstc2015jcyjBX0090, cstc2014jcyjA40033, cstc2014 jcyjA10051, cstc2015jcyjA40034]; Outstanding Achievements Transformation Projects of University in Chongqing [KJZH14219]	Chongqing Basic and Frontier Research Project; Outstanding Achievements Transformation Projects of University in Chongqing	This work was supported by Chongqing Basic and Frontier Research Project under Grant No. cstc2015jcyjBX0090, cstc2014jcyjA40033, cstc2014 jcyjA10051, and cstc2015jcyjA40034 (ZQ), and Outstanding Achievements Transformation Projects of University in Chongqing under Grant No. KJZH14219.	Amhaz R, 2016, IEEE T INTELL TRANSP, V17, P2718, DOI 10.1109/TITS.2015.2477675; Annum R, 2011, SIGNAL IMAGE VIDEO P, P1; Barazzetti L, 2009, ISPRS J PHOTOGRAMM, V64, P285, DOI 10.1016/j.isprsjprs.2009.02.004; Cabaleiro M, 2017, CONSTR BUILD MATER, V130, P41, DOI 10.1016/j.conbuildmat.2016.11.032; Cha YJ, 2017, COMPUT-AIDED CIV INF, V32, P361, DOI 10.1111/mice.12263; Chambon S, 2011, INT J GEOPHYS, V2011, DOI 10.1155/2011/989354; Cui LM, 2015, LECT NOTES COMPUT SC, V9208, P95, DOI 10.1007/978-3-319-24474-7_14; Lee BY, 2013, STRUCT INFRASTRUCT E, V9, P567, DOI 10.1080/15732479.2011.593891; Lu S, 2016, J COMPUT CIVIL ENG, V30, P1; Niharika N, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION CONTROL AND COMPUTING TECHNOLOGIES (ICACCCT), P809, DOI 10.1109/ICACCCT.2014.7019204; Nouri F, 2017, SIGNAL IMAGE VIDEO P, P1; Oliveira H, 2013, IEEE T INTELL TRANSP, V14, P155, DOI 10.1109/TITS.2012.2208630; Prasanna P, 2016, IEEE T AUTOM SCI ENG, V13, P591, DOI 10.1109/TASE.2014.2354314; Qu Z, 2016, IMAGING SCI J, V64, P119, DOI 10.1080/13682199.2016.1146816; Qu Z, 2015, IEEJ T ELECTR ELECTR, V10, P214, DOI 10.1002/tee.22056; Schnebele E, 2015, EUR TRANSP RES REV, V7, DOI 10.1007/s12544-015-0156-6; Shi Y, 2016, IEEE T INTELL TRANSP, V17, P3434, DOI 10.1109/TITS.2016.2552248; Sinha SK, 2006, AUTOMAT CONSTR, V15, P47, DOI 10.1016/j.autcon.2005.02.007; Nguyen TS, 2011, IEEE IMAGE PROC, P1069, DOI 10.1109/ICIP.2011.6115610; Tsai YC, 2010, J TRANSP ENG, V136, P11, DOI 10.1061/(ASCE)TE.1943-5436.0000051; Tsai Y, 2014, IEEE IMAGE PROC, P773, DOI 10.1109/ICIP.2014.7025155; Valenca J, 2017, CONSTR BUILD MATER, V146, P668, DOI 10.1016/j.conbuildmat.2017.04.096; Valenca J, 2013, MEASUREMENT, V46, P433, DOI 10.1016/j.measurement.2012.07.019; Valenca J, 2012, CONSTR BUILD MATER, V28, P607, DOI 10.1016/j.conbuildmat.2011.08.082; Xu W, 2013, IEEE IMAGE PROC, P4093, DOI 10.1109/ICIP.2013.6738843; Yamaguchi T, 2010, MACH VISION APPL, V21, P797, DOI 10.1007/s00138-009-0189-8; Yokoyama S, 2017, PROCEDIA ENGINEER, V171, P1250, DOI 10.1016/j.proeng.2017.01.418; Zhang B, 2015, MATER RES INNOV, V19, P144; Zou Q, 2012, PATTERN RECOGN LETT, V33, P227, DOI 10.1016/j.patrec.2011.11.004	29	14	15	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201109	10.1371/journal.pone.0201109	http://dx.doi.org/10.1371/journal.pone.0201109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048514	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400050
J	Rossi, A; Pappalardo, L; Cintia, P; Iaia, FM; Fernandez, J; Medina, D				Rossi, Alessio; Pappalardo, Luca; Cintia, Paolo; Iaia, F. Marcello; Fernandez, Javier; Medina, Daniel			Effective injury forecasting in soccer with GPS training data and machine learning	PLOS ONE			English	Article							PLAYERS; MODEL; RISK; LOADS	Injuries have a great impact on professional soccer, due to their large influence on team performance and the considerable costs of rehabilitation for players. Existing studies in the literature provide just a preliminary understanding of which factors mostly affect injury risk, while an evaluation of the potential of statistical models in forecasting injuries is still missing. In this paper, we propose a multi-dimensional approach to injury forecasting in professional soccer that is based on GPS measurements and machine learning. By using GPS tracking technology, we collect data describing the training workload of players in a professional soccer club during a season. We then construct an injury forecaster and show that it is both accurate and interpretable by providing a set of case studies of interest to soccer practitioners. Our approach opens a novel perspective on injury prevention, providing a set of simple and practical rules for evaluating and interpreting the complex relations between injury risk and training performance in professional soccer.	[Rossi, Alessio; Pappalardo, Luca] Univ Pisa, Dept Comp Sci, Pisa, Italy; [Pappalardo, Luca; Cintia, Paolo] CNR, ISTI, Pisa, Italy; [Iaia, F. Marcello] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Fernandez, Javier] FC Barcelona, Sports Sci & Hlth Dept, Barcelona, Spain; [Medina, Daniel] Philadelphia 76Ers, Athlet Care Dept, Philadelphia, PA USA	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" (ISTI-CNR); University of Milan	Rossi, A (corresponding author), Univ Pisa, Dept Comp Sci, Pisa, Italy.	alessio.rossi2@gmail.com	Iaia, F. Marcello/L-6067-2015; Pappalardo, Luca/F-7726-2018; Rossi, Alessio/AAN-4755-2020; Cintia, Paolo/AAV-4068-2020; Cintia, Paolo/AFU-4998-2022	Iaia, F. Marcello/0000-0003-0981-6471; Pappalardo, Luca/0000-0002-1547-6007; ROSSI, ALESSIO/0000-0002-6400-5914; Cintia, Paolo/0000-0002-8085-9338	European Community's H2020 Program [INFRAIA-1-2014-2015, 654024]	European Community's H2020 Program	This work is partially supported by the European Community's H2020 Program under the funding scheme "INFRAIA-1-2014-2015: Research Infrastructures" grant agreement 654024, www.sobigdata.eu, "SoBigData". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson L, 2003, J STRENGTH COND RES, V17, P734; Brink MS, 2010, BRIT J SPORT MED, V44, P809, DOI 10.1136/bjsm.2009.069476; Cintia P, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (IEEE DSAA 2015), P392; Duncan MJ, 2009, J SCI MED SPORT, V12, P549, DOI 10.1016/j.jsams.2008.10.010; Ehrmann FE, 2016, J STRENGTH COND RES, V30, P360, DOI 10.1519/JSC.0000000000001093; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P953, DOI 10.1519/JSC.0b013e3182302023; Gabbett TJ, 2010, J STRENGTH COND RES, V24, P2593, DOI 10.1519/JSC.0b013e3181f19da4; Gabbett TJ, 2004, BRIT J SPORT MED, V38, P743, DOI 10.1136/bjsm.2003.008391; Gudmundsson J, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3054132; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Hagglund M, 2013, BRIT J SPORT MED, DOI [10.1136/bjsports-2013-092215, DOI 10.1136/BJSPORTS-2013-092215,2013]; He H., 2008, IEEE INT JOINT C NEU; Hulin BT, 2014, BRIT J SPORT MED, V48, P708, DOI 10.1136/bjsports-2013-092524; Hurley OA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00807; James G., 2014, INTRO STAT LEARNING; Kampakis S., 2016, PREDICTIVE MODELLING; Kazemitabar J, 31 C NEUR INF PROC S; Kirkendall DT, 2010, PHYSICIAN SPORTSMED, V38, P147, DOI 10.3810/psm.2010.04.1772; Lehmann E.E., 2008, APPL EC Q, V54, P59, DOI DOI 10.3790/AEQ.54.1.59; Murray NB, 2017, BRIT J SPORT MED, V51, P749, DOI 10.1136/bjsports-2016-097152; Pappalardo L, 2018, ADV COMPLEX SYST, V21, DOI 10.1142/S021952591750014X; Pastor-Barrn I, 2010, 15 ANN C EUR COLL SP; Rogalski B, 2013, J SCI MED SPORT, V16, P499, DOI 10.1016/j.jsams.2012.12.004; Rossi A, 2016, INT CONF DAT MIN WOR, P160, DOI 10.1109/ICDMW.2016.0030; Stein M, 2017, DATA, V2, DOI 10.3390/data2010002; Talukder H, 2016, MIT SLOAN AN C BOST; Venturelli M, 2011, J SCI MED SPORT, V14, P293, DOI 10.1016/j.jsams.2011.02.013	30	85	85	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201264	10.1371/journal.pone.0201264	http://dx.doi.org/10.1371/journal.pone.0201264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044858	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500098
J	Zhan, YH; Qu, YC; Zhu, LJ; Shen, CJ; Feng, XP; Yu, CL				Zhan, Yihua; Qu, Yinchao; Zhu, Longjing; Shen, Chenjia; Feng, Xuping; Yu, Chenliang			Transcriptome analysis of tomato (Solanum lycopersicum L.) shoots reveals a crosstalk between auxin and strigolactone	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; GENE FAMILY; REPRODUCTIVE DEVELOPMENT; BIOSYNTHESIS; INDUCTION; RECEPTOR; DYNAMICS; HOMOLOG; ACID; PEA	Auxin and strigolactone (SL) are two important phytohormones involved in shoot branching and morphology. Tomato (Solanum lycopersicum L.), a member of the Solanaceae family, is one of the most popular food crops with high economic value in the world. To seek a better understanding of the responses to exogenous hormones, transcriptome analyses of the tomato shoots treated with exogenous auxin and SL, separately or together, were performed. A total of 2326, 260 and 1379 differential expressed genes (DEGs) were identified under the IAA, GR24 and IAA+GR24 treatments, respectively. Network analysis pointed out two enriched interaction clusters, including "ethylene biosynthesis" and "photosynthesis". Several ethylene biosynthesis and metabolism-related genes were up-regulated under both IAA and IAA+GR24 treatments, suggesting their involvement in the regulation of ethylene biosynthesis. Besides, auxin-SLs-triggered the expression of several CAB genes may lead to systemic increases in the induction of photosynthesis. Several auxin-activated metabolic pathways could be reduced by the GR24 treatment, indicated that the crosstalk between auxin and SLs may be involved in the metabolic regulation of tomato. Further analysis showed that SLs affect the responses of tomato shoots to auxin by inducing the expression of a series of auxin downstream genes. On the other hand, auxin regulated the biosynthesis of SLs by affecting the genes in the "Carotenoid biosynthesis" pathway. Our data will give us an opportunity to reveal the crosstalk between auxin and SLs in the shoots of tomato.	[Zhan, Yihua] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou, Zhejiang, Peoples R China; [Qu, Yinchao; Yu, Chenliang] Zhejiang Acad Agr Sci, Vegetable Res Inst, Hangzhou, Zhejiang, Peoples R China; [Zhu, Longjing] Wenzhou Vocat Coll Sci & Technol, Wenzhou, Zhejiang, Peoples R China; [Shen, Chenjia] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Feng, Xuping] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Hangzhou Normal University; China Jiliang University	Yu, CL (corresponding author), Zhejiang Acad Agr Sci, Vegetable Res Inst, Hangzhou, Zhejiang, Peoples R China.; Feng, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	pimmmx@163.com; 21007030@zju.edu.cn			National Natural Science Foundation of China [31701967]; Natural Science Foundation of Zhejiang Province, China [LQ17C150003]; young talent training project of Zhejiang Academy of Agricultural Sciences [2016R23R08E05]; Research Project of seed and seedling of Wenzhou City [Z20160009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); young talent training project of Zhejiang Academy of Agricultural Sciences; Research Project of seed and seedling of Wenzhou City	This work was supported by the National Natural Science Foundation of China (Grant no. 31701967) (CY), the Natural Science Foundation of Zhejiang Province, China (Grant No. LQ17C150003) (CY), the young talent training project of Zhejiang Academy of Agricultural Sciences (2016R23R08E05) (CY), and the Research Project of seed and seedling of Wenzhou City (No. Z20160009) (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant no. 31701967), the Natural Science Foundation of Zhejiang Province, China (Grant No. LQ17C150003), the young talent training project of Zhejiang Academy of Agricultural Sciences (2016R23R08E05), and the Research Project of seed and seedling of Wenzhou City (No. Z20160009).	Albacete A, 2009, PLANT CELL ENVIRON, V32, P928, DOI 10.1111/j.1365-3040.2009.01973.x; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Boureau L, 2016, PLANT MOL BIOL, V90, P485, DOI 10.1007/s11103-016-0436-0; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Cheng X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00392; Chersicola M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00464; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Dixit R, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1113363; Ercolano MR, 2012, PLANT CELL REP, V31, P973, DOI 10.1007/s00299-012-1234-z; Estan MT, 2005, J EXP BOT, V56, P703, DOI 10.1093/jxb/eri027; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Foo E, 2013, J PLANT PHYSIOL, V170, P523, DOI 10.1016/j.jplph.2012.11.002; French E, 2017, MOL PLANT MICROBE IN, V2018, P31; Goldental-Cohen S, 2017, PLANT CELL PHYSIOL, V58, P1661, DOI 10.1093/pcp/pcx102; Guillotin B, 2017, NEW PHYTOL, V213, P1124, DOI 10.1111/nph.14246; Guo ZX, 2016, PLANT PHYSIOL, V172, P1259, DOI 10.1104/pp.16.01202; Hao YW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005649; Hao YW, 2014, J EXP BOT, V65, P1013, DOI 10.1093/jxb/ert440; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Ito S, 2017, PLANT PHYSIOL, V174, P1250, DOI 10.1104/pp.17.00301; Kharshiing EV, 2010, PLANT SIGNAL BEHAV, V5, P1379, DOI 10.4161/psb.5.11.13035; Khatun K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051056; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kohlen W, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22785; Kohlen W, 2012, NEW PHYTOL, V196, P535, DOI 10.1111/j.1469-8137.2012.04265.x; Koltai H, 2015, J EXP BOT, V66, P4855, DOI 10.1093/jxb/erv178; Koltai H, 2010, J EXP BOT, V61, P1739, DOI 10.1093/jxb/erq041; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Z, 2014, J PROTEOME RES, V13, P1359, DOI 10.1021/pr400925t; Liu W, 2011, PLANT CELL, V23, P3853, DOI 10.1105/tpc.111.089771; Lopez-Raez JA, 2010, NEW PHYTOL, V187, P343, DOI 10.1111/j.1469-8137.2010.03291.x; Lopez-Raez JA, 2008, PLANT SIGNAL BEHAV, V3, P963, DOI 10.4161/psb.6126; Ma N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01671; Matsuoka K, 2016, PLANT CELL PHYSIOL, V57, P2620, DOI 10.1093/pcp/pcw177; Mayzlish-Gati E, 2010, J EXP BOT, V61, P3129, DOI 10.1093/jxb/erq138; Pandya-Kumar N, 2014, NEW PHYTOL, V202, P1184, DOI 10.1111/nph.12744; Qiu LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3182-4; Ren ZX, 2011, J EXP BOT, V62, P2815, DOI 10.1093/jxb/erq455; Sang DJ, 2014, P NATL ACAD SCI USA, V111, P11199, DOI 10.1073/pnas.1411859111; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shaharuddin NA, 2006, FEBS LETT, V580, P6579, DOI 10.1016/j.febslet.2006.11.005; Shen CJ, 2016, J EXP BOT, V67, P4179, DOI 10.1093/jxb/erw196; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0495-4; Sun WH, 2014, BIOL PLANTARUM, V58, P99, DOI 10.1007/s10535-013-0360-y; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168287; Wu J, 2012, GENE, V509, P38, DOI 10.1016/j.gene.2012.08.002; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu YL, 2017, PLANTA, V245, P583, DOI 10.1007/s00425-016-2625-0; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xu DB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00676; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yu CN, 2017, TREE PHYSIOL, V37, P1659, DOI 10.1093/treephys/tpx091; Yuan HW, 2017, IND CROP PROD, V108, P814, DOI 10.1016/j.indcrop.2017.07.026; Zhou T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00836	59	8	8	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201124	10.1371/journal.pone.0201124	http://dx.doi.org/10.1371/journal.pone.0201124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044859	gold, Green Submitted, Green Published			2022-12-26	WOS:000439942500082
J	Kelner, A; Tinti, M; Guther, MLS; Foth, BJ; Chappell, L; Berriman, M; Cowling, VH; Ferguson, MAJ				Kelner, Anna; Tinti, Michele; Guther, Maria Lucia S.; Foth, Bernardo J.; Chappell, Lia; Berriman, Matthew; Cowling, Victoria Haigh; Ferguson, Michael A. J.			The mRNA cap methyltransferase gene TbCMT1 is not essential in vitro but is a virulence factor in vivo for bloodstream form Trypanosoma brucei	PLOS ONE			English	Article							TSETSE-FLY; METHYLATION; EXPRESSION; GROWTH; DONOR	Messenger RNA is modified by the addition of a 50 methylated cap structure, which protects the transcript and recruits protein complexes that mediate RNA processing and/or the initiation of translation. Two genes encoding mRNA cap methyltransferases have been identified in T. brucei: TbCMT1 and TbCGM1. Here we analysed the impact of TbCMT1 gene deletion on bloodstream form T. brucei cells. TbCMT1 was dispensable for parasite proliferation in in vitro culture. However, significantly decreased parasitemia was observed in mice inoculated with TbCMT1 null and conditional null cell lines. Using RNA-Seq, we observed that several cysteine peptidase mRNAs were downregulated in TbCMT1 null cells lines. The cysteine peptidase Cathepsin-L was also shown to be reduced at the protein level in TbCMT1 null cell lines. Our data suggest that TbCMT1 is not essential to bloodstream form T. brucei growth in vitro or in vivo but that it contributes significantly to parasite virulence in vivo.	[Kelner, Anna; Tinti, Michele; Guther, Maria Lucia S.; Ferguson, Michael A. J.] Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Dundee, Scotland; [Foth, Bernardo J.; Chappell, Lia; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Cowling, Victoria Haigh] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland	University of Dundee; Wellcome Trust Sanger Institute; University of Dundee	Ferguson, MAJ (corresponding author), Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Dundee, Scotland.; Cowling, VH (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland.	v.h.cowling@dundee.ac.uk; ma.a.j.ferguson@dundee.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Chappell, Lia/0000-0002-2317-3524; Ferguson, Michael/0000-0003-1321-8714; Cowling, Victoria/0000-0001-7638-4870; Tinti, Michele/0000-0002-0051-017X	Wellcome Trust [101842/Z13/Z, 093712/Z/10/Z]; Medical Research Council (U.K.) [MR/K024213/1]; MRC [MR/K024213/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (U.K.)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust 101842/Z13/Z to MAJF and Wellcome Trust 093712/Z/10/Z to AK and Medical Research Council (U.K.) MR/K024213/1 to VHC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004130; Aregger M, 2016, MOL CELL, V61, P734, DOI 10.1016/j.molcel.2016.02.008; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Cox FEG, 2004, INFECT DIS CLIN N AM, V18, P231, DOI 10.1016/j.idc.2004.01.004; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Denise H, 2003, INFECT IMMUN, V71, P3190, DOI 10.1128/IAI.71.6.3190-3195.2003; Fernandez-Cortes F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06501-8; FREISTADT MS, 1987, NUCLEIC ACIDS RES, V15, P9861, DOI 10.1093/nar/15.23.9861; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Grasso L, 2016, CELL REP, V16, P1352, DOI 10.1016/j.celrep.2016.06.089; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guther MLS, 2001, EMBO J, V20, P4923, DOI 10.1093/emboj/20.17.4923; Hall MP, 2006, RNA, V12, P488, DOI 10.1261/rna.2250606; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; Mottram JC, 2004, CURR OPIN MICROBIOL, V7, P375, DOI 10.1016/j.mib.2004.06.010; MOTTRAM JC, 1989, MOL BIOCHEM PARASIT, V37, P115, DOI 10.1016/0166-6851(89)90108-4; Pina-Vazquez Carolina, 2012, Journal of Parasitology Research, P748206, DOI 10.1155/2012/748206; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; Silva E, 1998, MOL CELL BIOL, V18, P4612, DOI 10.1128/MCB.18.8.4612; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Takagi Y, 2007, J BIOL CHEM, V282, P15995, DOI 10.1074/jbc.M701569200; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201263	10.1371/journal.pone.0201263	http://dx.doi.org/10.1371/journal.pone.0201263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040830	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200034
J	Shao, JX; Haider, I; Xiong, LZ; Zhu, XY; Hussain, RMF; Overnas, E; Meijer, AH; Zhang, GS; Wang, M; Bouwmeester, HJ; Ouwerkerk, PBF				Shao, Jingxia; Haider, Imran; Xiong, Lizhong; Zhu, Xiaoyi; Hussain, Rana Muhammad Fraz; Overnas, Elin; Meijer, Annemarie H.; Zhang, Gaisheng; Wang, Mei; Bouwmeester, Harro J.; Ouwerkerk, Pieter B. F.			Functional analysis of the HD-Zip transcription factor genes Oshox12 and Oshox14 in rice	PLOS ONE			English	Article							CLASS-I; SALT TOLERANCE; HOMEODOMAIN; ARABIDOPSIS; EXPRESSION; GROWTH; PROTEINS; IDENTIFICATION; DROUGHT; FAMILY	The homeodomain-leucine zipper (HD-Zip) transcription factor family plays vital roles in plant development and morphogenesis as well as responses to biotic and abiotic stresses. In barley, a recessive mutation in Vrs1 (HvHox1) changes two-rowed barley to six-rowed barley, which improves yield considerably. The Vrs1 gene encodes an HD-Zip subfamily I transcription factor. Phylogenetic analysis has shown that the rice HD-Zip I genes Oshox12 and Oshox14 are the closest homologues of Vrs1. Here, we show that Oshox12 and Oshox14 are ubiquitously expressed with higher levels in developing panicles. Trans-activation assays in yeast and rice protoplasts demonstrated that Oshox12 and Oshox14 can bind to a specific DNA sequence, AH1 (CAAT(A/T)ATTG), and activate reporter gene expression. Overexpression of Oshox12 and Oshox14 in rice resulted in reduced panicle length and a dwarf phenotype. In addition, Oshox14 overexpression lines showed a deficiency in panicle exsertion. Our findings suggest that Oshox12 and Oshox14 may be involved in the regulation of panicle development. This study provides a significant advancement in understanding the functions of HD-Zip transcription factors in rice.	[Shao, Jingxia] Northwest A&F Univ, Coll Life Sci, Xianyang, Shaanxi, Peoples R China; [Shao, Jingxia; Haider, Imran; Hussain, Rana Muhammad Fraz; Meijer, Annemarie H.; Wang, Mei; Ouwerkerk, Pieter B. F.] Leiden Univ, Inst Biol IBL, Leiden, Netherlands; [Haider, Imran; Bouwmeester, Harro J.] Wageningen Univ & Res Ctr, Lab Plant Physiol, Wageningen, Netherlands; [Xiong, Lizhong] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Zhu, Xiaoyi] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Overnas, Elin] Uppsala Univ, Dept Physiol Bot, EBC, Uppsala, Sweden; [Zhang, Gaisheng] Northwest A&F Univ, Coll Agron, Xianyang, Shaanxi, Peoples R China; [Wang, Mei] Leiden Univ, European Ctr Chinese Med & Nat Cpds, Leiden, Netherlands; [Haider, Imran] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Bouwmeester, Harro J.] Univ Amsterdam, Swammerdam Inst Life Sci, Plant Hormone Biol Grp, Amsterdam, Netherlands	Northwest A&F University - China; Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Uppsala University; Northwest A&F University - China; Leiden University; Leiden University - Excl LUMC; King Abdullah University of Science & Technology; University of Amsterdam	Ouwerkerk, PBF (corresponding author), Leiden Univ, Inst Biol IBL, Leiden, Netherlands.	p.b.f.ouwerkerk.2@gmail.com	Xiong, Lizhong/AAE-6984-2019; Haider, Imran/ABG-1774-2021; Bouwmeester, Harro J/C-1414-2008; Meijer, Annemarie/W-3726-2019	Haider, Imran/0000-0002-0100-2513; Meijer, Annemarie H./0000-0002-1325-0725; Bouwmeester, Harro/0000-0003-0907-2732	China Scholarship Council (CSC) [2007U27088]; National Natural Science Foundation of China [31770345]; Higher Education Commission (HEC) of Pakistan; King Abdullah University of Science and Technology (KAUST); KNAW Program Scientific Alliance [04-PSA-BD-04]; TF-STRESS [QLK3-CT-2000-00328]; CEDROME [INCO-CT-2005-015468]; TNO, the Netherlands; KNAW project	China Scholarship Council (CSC)(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); KNAW Program Scientific Alliance; TF-STRESS; CEDROME; TNO, the Netherlands; KNAW project	This work was supported by funding to JS from China Scholarship Council (CSC, 2007U27088, http.//www.csc.edu.cn/) and National Natural Science Foundation of China (31770345, littpliwww.nsfc.gov.cn/). This work was supported by the Higher Education Commission (HEC) of Pakistan and the King Abdullah University of Science and Technology (KAUST) to IH. MW and PBFO were supported by the KNAW Program Scientific Alliance (04-PSA-BD-04, www.knaw.nI). AHM was supported by TF-STRESS (QLK3-CT-2000-00328). PBFO was also supported by CEDROME (INCO-CT-2005-015468). TNO, the Netherlands (https://mmtno.nlien/) provided funding in the form of salary for MW; MW was also supported by the KNAW projects via a subsidy allowing travel and purchasing consumables for the PhD students working on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank all the contributing members of the Rice Research Group of the IBL, Leiden University. This work was supported by funding to JS from China Scholarship Council (CSC, 2007U27088) and National Natural Science Foundation of China (31770345). This work was supported by the Higher Education Commission (HEC) of Pakistan and the King Abdullah University of Science and Technology (KAUST) to IH. MW and PBFO were supported by the KNAW Program Scientific Alliance (04-PSA-BD-04). AHM was supported by TF-STRESS (QLK3-CT-2000-00328). PBFO was also supported by CEDROME (INCO-CT-2005-015468).	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Arce AL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-42; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Ariel FD, 2010, PLANT SIGNAL BEHAV, V5, P1666, DOI 10.4161/psb.5.12.14020; Bhattacharjee A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00628; Bhattacharjee A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00627; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt R, 2014, J INTEGR PLANT BIOL, V56, P518, DOI 10.1111/jipb.12185; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Capella M, 2014, PLANT CELL REP, V33, P955, DOI 10.1007/s00299-014-1576-9; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dai MQ, 2008, PLANT MOL BIOL, V66, P289, DOI 10.1007/s11103-007-9270-8; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Perotti MF, 2017, IUBMB LIFE, V69, P280, DOI 10.1002/iub.1619; Gao SP, 2016, PLANT CELL, V28, P680, DOI 10.1105/tpc.15.01021; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Hur YS, 2015, NEW PHYTOL, V205, P316, DOI 10.1111/nph.12998; Jain M, 2008, PLANT SIGNAL BEHAV, V3, P1024, DOI 10.4161/psb.6770; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; KAO KN, 1975, PLANTA, V126, P105, DOI 10.1007/BF00380613; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kuijt SJH, 2014, PLANT PHYSIOL, V164, P1952, DOI 10.1104/pp.113.222836; Li Q, 2015, J EXP BOT, V66, P2515, DOI 10.1093/jxb/erv046; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Liu W, 2013, GENE, V531, P279, DOI 10.1016/j.gene.2013.08.089; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Meijer AH, 1998, YEAST, V14, P1407, DOI 10.1002/(SICI)1097-0061(199811)14:15<1407::AID-YEA325>3.0.CO;2-M; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Meijer AH, 2000, MOL GEN GENET, V263, P12, DOI 10.1007/PL00008671; Memelink J, 1994, PLANT MOL BIOL MANUA, pF1; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Ohgishi M, 2001, PLANT J, V25, P389, DOI 10.1046/j.1365-313x.2001.00966.x; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Ouwerkerk P B, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1212s55; Ouwerkerk PBF, 2011, METHODS MOL BIOL, V678, P211, DOI 10.1007/978-1-60761-682-5_16; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pereira A, 1998, METH MOL B, V82, P329; Re DA, 2011, J EXP BOT, V62, P155, DOI 10.1093/jxb/erq252; Ren XF, 2014, GENOME, V57, P239, DOI 10.1139/gen-2014-0039; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Sakuma S, 2010, FUNCT INTEGR GENOMIC, V10, P123, DOI 10.1007/s10142-009-0134-y; Scarpella E, 2000, DEVELOPMENT, V127, P3655; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Shen SH, 2003, BIOL PHARM BULL, V26, P129, DOI 10.1248/bpb.26.129; Skinner DJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-29; Son O, 2005, BIOCHEM BIOPH RES CO, V326, P203, DOI 10.1016/j.bbrc.2004.11.014; Takada K, 1977, GAMMA FIELD S, V16, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang QQ, 2017, J PLANT BIOL, V60, P207, DOI 10.1007/s12374-016-0413-9; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang SX, 2012, PLANT MOL BIOL, V80, P571, DOI 10.1007/s11103-012-9967-1; Zhao Y, 2014, PLANT CELL PHYSIOL, V55, P1142, DOI 10.1093/pcp/pcu054; Zhu L, 2011, PLANT MOL BIOL, V77, P475, DOI 10.1007/s11103-011-9825-6	65	20	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0199248	10.1371/journal.pone.0199248	http://dx.doi.org/10.1371/journal.pone.0199248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028850	Green Published, gold, Green Submitted			2022-12-26	WOS:000439396900004
J	Yoo, B; Greninger, P; Stein, GT; Egan, RK; McClanaghan, J; Moore, A; Benes, CH; Medarova, Z				Yoo, Byunghee; Greninger, Patricia; Stein, Giovanna T.; Egan, Regina K.; McClanaghan, Joseph; Moore, Anna; Benes, Cyril H.; Medarova, Zdravka			Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin	PLOS ONE			English	Article							MICRORNA-B-10; METASTASIS; EXPRESSION; INVASION; OVEREXPRESSION; PROLIFERATION; GLIOBLASTOMA; MIGRATION; THERAPY	Since microRNAs (miRNAs, miRs) have been implicated in oncogenesis, many of them have been identified as therapeutic targets. Previously we have demonstrated that miRNA-10b acts as a master regulator of the viability of metastatic tumor cells and represents a target for therapeutic intervention. We designed and synthesized an inhibitor of miR-10b, termed MN-anti-miR10b. We showed that treatment with MN-anti-miR10b led to durable regression/elimination of established metastases in murine models of metastatic breast cancer. Since miRNA-10b has been associated with various metastatic and non-metastatic cancers, in the present study, we investigated the effect of MN-anti-miR10b in a panel of over 600 cell lines derived from a variety of human malignancies. We observed an effect on the viability of multiple cell lines within each cancer type and a mostly dichotomous response with cell lines either strongly responsive to MN-anti-miR10b or not at all even at maximum dose tested, suggesting a very high specificity of the effect. Genomic modeling of the drug response showed enrichment of genes associated with the proto-oncogene, c-Jun.	[Yoo, Byunghee; Moore, Anna; Medarova, Zdravka] Massachusetts Gen Hosp, Mol Imaging Lab, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Boston, MA 02114 USA; [Yoo, Byunghee; Greninger, Patricia; Stein, Giovanna T.; Egan, Regina K.; McClanaghan, Joseph; Moore, Anna; Benes, Cyril H.; Medarova, Zdravka] Harvard Med Sch, Boston, MA 02115 USA; [Greninger, Patricia; Stein, Giovanna T.; Egan, Regina K.; McClanaghan, Joseph; Benes, Cyril H.] Massachusetts Gen Hosp, Ctr Mol Therapeut, Canc Ctr, Boston, MA 02114 USA; [Moore, Anna] Michigan State Univ, Radiol & Physiol, E Lansing, MI 48824 USA; [Moore, Anna] Michigan State Univ, Precis Hlth Program, E Lansing, MI 48824 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Michigan State University; Michigan State University	Moore, A; Medarova, Z (corresponding author), Massachusetts Gen Hosp, Mol Imaging Lab, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Boston, MA 02114 USA.; Moore, A; Benes, CH; Medarova, Z (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Benes, CH (corresponding author), Massachusetts Gen Hosp, Ctr Mol Therapeut, Canc Ctr, Boston, MA 02114 USA.; Moore, A (corresponding author), Michigan State Univ, Radiol & Physiol, E Lansing, MI 48824 USA.; Moore, A (corresponding author), Michigan State Univ, Precis Hlth Program, E Lansing, MI 48824 USA.	moorea57@msu.edu; cbenes@mgh.harvard.edu; zmedarova@mgh.harvard.edu			Burroughs Wellcome Fund [102696]; National Cancer Institute [R01CA16346101A1]; NATIONAL CANCER INSTITUTE [R01CA163461] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Anna Moore and Zdravka Medarova are Founders, Members of the Board of Directors and Scientific Advisory Board Members of TransCode Therapeutics, Inc. However, they received no funding support from TransCode Therapeutics, Inc. in the form of authors' salaries and/or research materials. Also, TransCode Therapeutics, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The study was funded by the Burroughs Wellcome Fund 102696 to CB and National Cancer Institute R01CA16346101A1 to ZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmaksoud-Dammak R, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695916; Ahmad A, 2014, AM J TRANSL RES, V6, P384; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Chen WJ, 2013, TUMOR BIOL, V34, P455, DOI 10.1007/s13277-012-0570-5; Guessous F, 2013, J NEURO-ONCOL, V112, P153, DOI 10.1007/s11060-013-1047-0; Hou R, 2017, ONCOL LETT, V13, P5009, DOI 10.3892/ol.2017.6033; Huang JC, 2015, MOL BIOSYST, V11, P2051, DOI 10.1039/c4mb00752b; Hur K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju492; Jiang H, 2016, CANCER MED-US, V5, P2934, DOI 10.1002/cam4.789; Jikuzono T, 2013, INT J ONCOL, V42, P1858, DOI 10.3892/ijo.2013.1879; Kim JC, 2016, CANCER RES, V76, P6424, DOI 10.1158/0008-5472.CAN-16-1571; Knirsh R, 2016, ONCOTARGET, V7, P59932, DOI 10.18632/oncotarget.11000; Li G, 2010, CANCER LETT, V299, P29, DOI 10.1016/j.canlet.2010.07.021; Li QJ, 2012, TUMOR BIOL, V33, P1455, DOI 10.1007/s13277-012-0396-1; Li YW, 2016, CANCER BIOL THER, V17, P272, DOI 10.1080/15384047.2016.1139242; Liu Y, 2012, MED SCI MONITOR, V18, pBR299, DOI 10.12659/MSM.883262; Liu Zhisheng, 2012, REFRIGERATION AIR CO, V01, P24; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Meseguer S, 2011, J BIOL CHEM, V286, P4150, DOI 10.1074/jbc.M110.167817; Min WL, 2014, MED SCI MONIT BASIC, V20, P97, DOI 10.12659/MSMBR.891246; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Parrella P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-142; Preis M, 2011, CLIN CANCER RES, V17, P5812, DOI 10.1158/1078-0432.CCR-11-0695; Saldanha G, 2016, MODERN PATHOL, V29, P112, DOI 10.1038/modpathol.2015.149; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Tian Wenhong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P809; Tong P, 2015, BIOINFORMATICS, V31, P1692, DOI 10.1093/bioinformatics/btv028; Wang R, 2015, AM J CANCER RES, V5, P32; Wang YF, 2015, ONCOL REP, V33, P1275, DOI 10.3892/or.2015.3737; Xiao HB, 2014, ONCOL REP, V31, P1832, DOI 10.3892/or.2014.3048; Yang YL, 2015, TUMOR BIOL, V36, P7069, DOI 10.1007/s13277-015-3366-6; Yigit MV, 2013, ONCOGENE, V32, P1530, DOI 10.1038/onc.2012.173; Yoo B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45060; Yoo B, 2015, CANCER RES, V75, P4407, DOI 10.1158/0008-5472.CAN-15-0888; Yoo B, 2014, J BIOMED NANOTECHNOL, V10, P1114, DOI 10.1166/jbn.2014.1795; Zhang J, 2015, CLIN TRANSL ONCOL, V17, P209, DOI 10.1007/s12094-014-1213-7; Zhao FL, 2012, J INT MED RES, V40, P859, DOI 10.1177/147323001204000304	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201046	10.1371/journal.pone.0201046	http://dx.doi.org/10.1371/journal.pone.0201046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028875	gold, Green Published, Green Submitted			2022-12-26	WOS:000439396900035
J	Shahba, AAW; Alanazi, FK; Abdel-Rahman, SI				Shahba, Ahmad Abdul-Wahhab; Alanazi, Fars Kaed; Abdel-Rahman, Sayed Ibrahim			Stabilization benefits of single and multi-layer self-nanoemulsifying pellets: A poorly-water soluble model drug with hydrolytic susceptibility	PLOS ONE			English	Article							BETA-CYCLODEXTRIN COMPLEX; IN-VITRO RELEASE; ORAL BIOAVAILABILITY; DELIVERY-SYSTEMS; FLUID-BED; BEAGLE DOGS; COMPETING AGENT; CINNARIZINE; FORMULATION; OPTIMIZATION	Solidified self-nanoemulsifying drug delivery systems (SNEDDS) offer strong option to enhance both drug aqueous solubility and stability. The current study was designed to evaluate the potential stabilization benefits of solidifying cinnarizine (CN) liquid SNEDDS into single and multi-layer self-nanoemulsifying pellets (SL-SNEP and ML-SNEP, respectively). The selected formulations were enrolled into accelerated, intermediate and long-term stability studies. The chemical stability was assessed based on the % of intact CN remaining in formulation. The physical stability was assessed by monitoring the in-vitro dissolution and physical appearance of the formulations. The degradation pathway of CN within lipid-based formulation was proposed to involve a hydroxylation reaction of CN molecule. The chemical stability study revealed significant CN degradation in liquid SNEDDS, SL-SNEP and ML-SNEP (lacking moisture-sealing) within all the storage conditions. In contrast, the moisture sealed ML-SNEP showed significant enhancement of CN chemical stability within the formulation. In particular, ML-SNEP coated with Kollicoat Smartseal 30D showed superior CN stabilization and no significant decrease in dissolution efficiency, at all the storage conditions. The observed stability enhancement is owing to the complete isolation between CN and SNEDDS layer as well as the effective moisture protection provided by Kollicoat Smartseal 30D. Hence, the degradation problem could be eradicated completely. The incorporation of silicon dioxide had an important role in the inhibition of pellet agglomeration upon storage. Accordingly, ML-SNEP coated with Kollicoat Smart-seal 30D and/or silicon dioxide could be an excellent dosage form that combine dual enhancement of CN solubilization and stabilization.	[Shahba, Ahmad Abdul-Wahhab; Alanazi, Fars Kaed] King Saud Univ, Coll Pharm, Dept Pharmaceut, Kayyali Chair Pharmaceut Ind, Riyadh, Saudi Arabia; [Abdel-Rahman, Sayed Ibrahim] Assiut Univ, Fac Pharm, Dept Ind Pharm, Assiut, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Assiut University	Shahba, AAW (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Kayyali Chair Pharmaceut Ind, Riyadh, Saudi Arabia.	shahba@ksu.edu.sa	alanazi, Fars/AAI-6391-2020; shahba, Ahmad Abdul-Wahhab/D-2412-2012; Alanazi, Fars/AAR-9338-2020	alanazi, Fars/0000-0002-0757-3245; shahba, Ahmad Abdul-Wahhab/0000-0003-4509-8219; Alanazi, Fars/0000-0002-0757-3245	King Saud University, Kayyali Chair for Pharmaceutical Industries [A-2017]; National Plan for science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [11NAN1953-02]	King Saud University, Kayyali Chair for Pharmaceutical Industries; National Plan for science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This work was hosted and financially supported by King Saud University, Vice Deanship of Research Chairs, Kayyali Chair for Pharmaceutical Industries through the grant number A-2017. This work was also a part of a research project funded by National Plan for science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (11NAN1953-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 2012, ASIAN J CHEM, V24, P595; Alhnan MA, 2011, INT J PHARMACEUT, V416, P55, DOI 10.1016/j.ijpharm.2011.05.079; Altamimi MA, 2018, ADV POWDER TECHNOL, V29, P1676, DOI 10.1016/j.apt.2018.04.002; Amer SM, 2017, RSC ADV, V7, P4479, DOI 10.1039/c6ra25767d; [Anonymous], 2003, ICH HARM TRIP GUID Q; [Anonymous], 2011, KOLLICOAT SMARTSEAL; [Anonymous], [No title captured]; Arora S, 2005, AAPS PHARMSCITECH, V6, pE372, DOI 10.1208/pt060347; Atef E, 2008, EUR J PHARM SCI, V35, P257, DOI 10.1016/j.ejps.2008.07.004; Basu B, 2011, J ADV PHARM TECHNOL, V2, P266, DOI 10.4103/2231-4040.90885; Byrn SR, 2001, ADV DRUG DELIVER REV, V48, P115, DOI 10.1016/S0169-409X(01)00102-8; Christiansen ML, 2014, EUR J PHARM SCI, V57, P164, DOI 10.1016/j.ejps.2013.11.003; Date AA, 2008, INT J PHARMACEUT, V355, P19, DOI 10.1016/j.ijpharm.2008.01.004; Date AA, 2010, NANOMEDICINE-UK, V5, P1595, DOI 10.2217/NNM.10.126; El Maghraby GM, 2012, DRUG DEV IND PHARM, V38, P971, DOI 10.3109/03639045.2011.634811; Gu CH, 2005, J PHARM SCI-US, V94, P199, DOI 10.1002/jps.20242; JARVINEN T, 1995, J PHARM SCI, V84, P295, DOI 10.1002/jps.2600840306; Kablitz CD, 2006, EUR J PHARM SCI, V27, P212, DOI 10.1016/j.ejps.2005.10.001; Kayaert P, 2011, J PHARM PHARMACOL, V63, P1446, DOI 10.1111/j.2042-7158.2011.01351.x; Kossena GA, 2004, J PHARM SCI-US, V93, P332, DOI 10.1002/jps.10554; Larsen Anne T, 2012, Pharmaceutics, V4, P641, DOI 10.3390/pharmaceutics4040641; Larsen AT, 2013, EUR J PHARM SCI, V48, P339, DOI 10.1016/j.ejps.2012.11.004; Lei Y, 2012, J BIOMED NANOTECHNOL, V8, P515, DOI 10.1166/jbn.2012.1400; Lei Y, 2011, INT J NANOMED, V6, P795, DOI 10.2147/IJN.S17711; Machida Y, 1989, Drug Des Deliv, V4, P155; Mehta D.M., 2012, ASIAN J PHARM SCI, V7, P193; Mukherjee T, 2012, PHARM DEV TECHNOL, V17, P511, DOI 10.3109/10837450.2010.550625; Nagarwal RC, 2010, AAPS PHARMSCITECH, V11, P294, DOI 10.1208/s12249-010-9380-5; Patel RP, 2009, PHARM TECH, V33, P53; Raghuvanshi S, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/479246; Shahba AAW, 2017, PHARMAZIE, V72, P143, DOI 10.1691/ph.2017.6089; Shahba AA, 2012, LAT AM J PHARM, V31, P549; Shahba AAW, 2018, AAPS PHARMSCITECH, V19, P2087, DOI 10.1208/s12249-018-0990-7; Shahba AAW, 2016, BRAZ J PHARM SCI, V52, P653, DOI [10.1590/S1984-82502016000400009, 10.1590/s1984-82502016000400009]; Shahba AAW, 2012, AAPS PHARMSCITECH, V13, P967, DOI 10.1208/s12249-012-9821-4; Shi S, 2009, INT J PHARMACEUT, V373, P147, DOI 10.1016/j.ijpharm.2009.02.006; Shravani D, 2011, ACTA PHARM SIN B, V1, P56, DOI 10.1016/j.apsb.2011.04.005; TOKUMURA T, 1986, CHEM PHARM BULL, V34, P1275; TOKUMURA T, 1985, CHEM PHARM BULL, V33, P2069; TOKUMURA T, 1986, J PHARM SCI, V75, P391, DOI 10.1002/jps.2600750415; TOKUMURA T, 1987, J PHARM SCI, V76, P286, DOI 10.1002/jps.2600760404; Varshosaz J, 2007, J MICROENCAPSUL, V24, P253, DOI 10.1080/02652040601162723	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0198469	10.1371/journal.pone.0198469	http://dx.doi.org/10.1371/journal.pone.0198469			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024877	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000004
J	Perkins, MJ; Mak, YKY; Tao, LSR; Wong, ATL; Yau, JKC; Baker, DM; Leung, KMY				Perkins, Matthew J.; Mak, Yanny K. Y.; Tao, Lily S. R.; Wong, Archer T. L.; Yau, Jason K. C.; Baker, David M.; Leung, Kenneth M. Y.			Short-term tissue decomposition alters stable isotope values and C:N ratio, but does not change relationships between lipid content, C:N ratio, and Delta delta C-13 in marine animals	PLOS ONE			English	Article							MIXING MODELS; FOOD WEBS; NITROGEN; CARBON; PRESERVATION; FRACTIONATION; DELTA-N-15; ENRICHMENT; SIGNATURES	Measures (e.g. delta N-15, delta C-13, %C, %N and C:N) derived from animal tissues are commonly used to estimate diets and trophic interactions. Since tissue samples are often exposed to air or kept chilled in ice over a short-term during sample preparation, they may degrade. Herein, we hypothesize that tissue decomposition will cause changes in these measures. In this study, we kept marine fish, crustacean and mollusc tissues in air or ice over 120 h (5 days). We found that tissue decomposition in air enriched delta N-15 (range 0.6 parts per thousand to 1.3 parts per thousand) and delta C-13 (0.2 parts per thousand to 0.4 parts per thousand), decreased %N (0.47 to 3.43 percentage points from staring values of similar to 13%) and %C (4.53 to 8.29 percentage points from starting values of similar to 43%), and subsequently increased C:N ratio (0.14 to 0.75). In air, while such changes to delta C-13 were relatively minor and therefore likely tolerable, changes in delta N-15, %N, %C and C:N ratio should be interpreted with caution. Ice effectively reduced the extent to which decomposition enriched delta N-15 (<= 0.4%.) and delta C-13 (<= 0.2%.), and eliminated decomposition in C:N ratio, %N and %C. In our second experiment, for fish tissues in either air or ice over 120 h, we observed no effects of decomposition on relationships between lipid content, C:N ratio, and Delta delta C-13 (change in delta C-13 after lipid removal), which are employed to correct delta C-13 for samples containing lipid. We also confirmed that lipid in tissues caused large errors when estimating delta C-13 (mean +/- standard error = -1.8 parts per thousand +/- 0.1 parts per thousand, range -0.6 parts per thousand to -3.8 parts per thousand), and showed both lipid extraction and mathematical correction performed equally well to correct for lipids when estimating delta C-13. We, therefore, recommend that specimens of marine animals should be kept in ice during sample preparation for a short-term, as it is an effective means for minimizing changes of the stable isotope measures in their tissue.	[Perkins, Matthew J.; Leung, Kenneth M. Y.] Univ Hong Kong, Swire Inst Marine Sci, Pokfulam, Hong Kong, Peoples R China; [Perkins, Matthew J.; Leung, Kenneth M. Y.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Perkins, MJ; Leung, KMY (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Pokfulam, Hong Kong, Peoples R China.; Perkins, MJ; Leung, KMY (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	matthewjperkins@outlook.com; kmyleung@hku.hk	Baker, David/B-2512-2010; Leung, Kenneth Mei Yee/C-1055-2009	Baker, David/0000-0002-0308-4954; Leung, Kenneth Mei Yee/0000-0002-2164-4281	Research Grants Council of the Government of the Hong Kong Special Administrative Region (HKSAR) via a Collaborative Research Fund (CRF) [HKU5/CRF/12G]; University of Hong Kong (HKU) [201611159133]	Research Grants Council of the Government of the Hong Kong Special Administrative Region (HKSAR) via a Collaborative Research Fund (CRF); University of Hong Kong (HKU)(University of Hong Kong)	This research was substantially funded by a Research Grants Council of the Government of the Hong Kong Special Administrative Region (HKSAR) via a Collaborative Research Fund (CRF Project No. HKU5/CRF/12G) to KMYL, and partially supported by a Seed Fund for Basic Research (Project Code: 201611159133) by the University of Hong Kong (HKU) to KMYL and MJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer A, 1997, ARCHAEOMETRY, V39, P415, DOI 10.1111/j.1475-4754.1997.tb00817.x; Barrow LM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P688, DOI 10.1086/588172; Barton K., 2013, MUMIN MULTI MODEL IN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Burrows DG, 2014, MAR MAMMAL SCI, V30, P747, DOI 10.1111/mms.12076; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Dannheim J, 2007, J EXP MAR BIOL ECOL, V351, P37, DOI 10.1016/j.jembe.2007.06.001; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; FENTON GE, 1988, ESTUAR COAST SHELF S, V26, P429, DOI 10.1016/0272-7714(88)90023-6; Fernandez I, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/GB001834; Feuchtmayr H, 2003, RAPID COMMUN MASS SP, V17, P2605, DOI 10.1002/rcm.1227; Gonzalez-Bergonzoni I, 2015, METHODS ECOL EVOL, V6, P307, DOI 10.1111/2041-210X.12313; Hill JM, 2009, ESTUAR COAST SHELF S, V82, P397, DOI 10.1016/j.ecss.2009.02.001; Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Lau DCP, 2012, LIMNOL OCEANOGR-METH, V10, P75, DOI 10.4319/lom.2012.10.75; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Machas R, 2006, ESTUAR COAST SHELF S, V66, P21, DOI 10.1016/j.ecss.2005.07.018; Macko S.A., 1984, ORG GEOCHEM, V6, P787, DOI DOI 10.1016/0146-6380(84)90100-1; Mateo MA, 2008, OECOLOGIA, V157, P105, DOI 10.1007/s00442-008-1052-8; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Norderhaug KM, 2003, MAR ECOL PROG SER, V255, P135, DOI 10.3354/meps255135; Passi S, 2005, BIOFACTORS, V25, P241, DOI 10.1002/biof.5520250130; Payo-Payo A, 2013, AQUAT BIOL, V18, P141, DOI 10.3354/ab00497; Perkins MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093281; Perkins MJ, 2013, METHODS ECOL EVOL, V4, P944, DOI 10.1111/2041-210X.12098; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2021, R LANGUAGE ENV STAT; Syvaranta J, 2011, HYDROBIOLOGIA, V658, P383, DOI 10.1007/s10750-010-0512-4; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wilder SM, 2013, ECOL LETT, V16, P895, DOI 10.1111/ele.12116; Woitchik AF, 1997, BIOGEOCHEMISTRY, V39, P15, DOI 10.1023/A:1005850032254; Yurkowski DJ, 2017, RAPID COMMUN MASS SP, V31, P389, DOI 10.1002/rcm.7802; ZIEMAN JC, 1984, B MAR SCI, V35, P380	41	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199680	10.1371/journal.pone.0199680	http://dx.doi.org/10.1371/journal.pone.0199680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020988	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400023
J	Fleischmann-Struzek, C; Thomas-Ruddel, DO; Schettler, A; Schwarzkopf, D; Stacke, A; Seymour, CW; Haas, C; Dennler, U; Reinhart, K				Fleischmann-Struzek, Carolin; Thomas-Rueddel, Daniel O.; Schettler, Anna; Schwarzkopf, Daniel; Stacke, Angelika; Seymour, Christopher W.; Haas, Christoph; Dennler, Ulf; Reinhart, Konrad			Comparing the validity of different ICD coding abstraction strategies for sepsis case identification in German claims data	PLOS ONE			English	Article							30-DAY MORTALITY-RATES; UNITED-STATES; DEFINITIONS; FRAMEWORK	Introduction Administrative data are used to generate estimates of sepsis epidemiology and can serve as source for quality indicators. Aim was to compare estimates on sepsis incidence and mortality based on different ICD-code abstraction strategies and to assess their validity for sepsis case identification based on a patient sample not pre-selected for presence of sepsis codes. Materials and methods We used the national DRG-statistics for assessment of population-level sepsis incidence and mortality. Cases were identified by three previously published International Statistical Classification of Diseases (ICD) coding strategies for sepsis based on primary and secondary discharge diagnoses (clinical sepsis codes (R-codes), explicit coding (all sepsis codes) and implicit coding (combined infection and organ dysfunction codes)). For the validation study, a stratified sample of 1120 adult patients admitted to a German academic medical center between 2007 +/- 2013 was selected. Administrative diagnoses were compared to a gold standard of clinical sepsis diagnoses based on manual chart review. Results In the validation study, 151/937 patients had sepsis. Explicit coding strategies performed better regarding sensitivity compared to R-codes, but had lower PPV. The implicit approach was the most sensitive for severe sepsis; however, it yielded a considerable number of false positives. R-codes and explicit strategies underestimate sepsis incidence by up to 3.5-fold. Between 2007 +/- 2013, national sepsis incidence ranged between 231-1006/100,000 person-years depending on the coding strategy. Conclusions In the sample of a large tertiary care hospital, ICD-coding strategies for sepsis differ in their accuracy. Estimates using R-codes are likely to underestimate the true sepsis incidence, whereas implicit coding overestimates sepsis cases. Further multi-center evaluation is needed to gain better understanding on the validity of sepsis coding in Germany.	[Fleischmann-Struzek, Carolin; Thomas-Rueddel, Daniel O.; Schwarzkopf, Daniel; Reinhart, Konrad] Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany; [Thomas-Rueddel, Daniel O.; Schettler, Anna; Stacke, Angelika; Reinhart, Konrad] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Seymour, Christopher W.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Seymour, Christopher W.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Haas, Christoph; Dennler, Ulf] Jena Univ Hosp, Div Med Controlling, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Friedrich Schiller University of Jena	Reinhart, K (corresponding author), Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany.; Reinhart, K (corresponding author), Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany.	konrad.reinhart@med.uni-jena.de	Thomas-Rüddel, Daniel/B-4380-2013; Schwarzkopf, Daniel/F-8287-2018	Thomas-Rüddel, Daniel/0000-0001-9143-8566; Schwarzkopf, Daniel/0000-0002-1568-8202; Fleischmann, Carolin/0000-0002-1104-3191	German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC) [FKZ: 01EO1002, 01EO1502]; National Institutes of Health [R35GM119519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119519] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KR, DTR, CF and DS receive grants from the German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC; FKZ: 01EO1002 and 01EO1502). KR is unpaid chairman of the Global Sepsis Alliance and shareholder of InflaRx Jena, a University spin-off that develops adjunctive therapies for systemic inflammation. CWS was supported in part by a grant from the National Institutes of Health (R35GM119519). The funding agencies played no role in the study design or analysis of data.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2016, CRIT CARE MED, V44, pE113, DOI 10.1097/CCM.0000000000001730; Bloos F, 2014, CRIT CARE, V18, DOI 10.1186/cc13755; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Falotico R., 2010, ITAL J APPL STAT, V22, P151; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Jolley RJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0847-3; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lagu T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.004; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mellhammar L., 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw207, DOI 10.1093/OFID/OFW207]; Mikolajetz A, 2018, 38 INT S INT CAR EM; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Qualita E, 2015, G IQI GERM INP QUAL, V1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reinhart K, 2010, Ger Med Sci, V8, pDoc14, DOI 10.3205/000103; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; RHEE C, 2017, AM J RESP CRIT CARE, V195; Seymour CW, 2016, CRIT CARE MED, V44, pE122, DOI 10.1097/CCM.0000000000001724; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Team RDC, 2014, R LANG ENV STAT COMP; Walkey AJ, 2015, ANN AM THORAC SOC, V12, P216, DOI 10.1513/AnnalsATS.201411-498BC; Weiner Mark G, 2006, AMIA Annu Symp Proc, P1140; Whittaker SA, 2013, CRIT CARE MED, V41, P945, DOI 10.1097/CCM.0b013e31827466f1; World Health Organization, 2017, IMPR PREV DIAGN CLIN	34	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0198847	10.1371/journal.pone.0198847	http://dx.doi.org/10.1371/journal.pone.0198847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059504	Green Published, gold, Green Submitted			2022-12-26	WOS:000440251600003
J	Aesoy, R; Muwonge, H; Asrud, KS; Sabir, M; Witsoe, SL; Bjornstad, R; Kopperud, RK; Hoivik, EA; Doskeland, SO; Bakke, M				Aesoy, Reidun; Muwonge, Haruna; Asrud, Kathrine S.; Sabir, Misbah; Witsoe, Solveig L.; Bjornstad, Ronja; Kopperud, Reidun K.; Hoivik, Erling A.; Doskeland, Stein Ove; Bakke, Marit			Deletion of exchange proteins directly activated by cAMP (Epac) causes defects in hippocampal signaling in female mice	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR TRANSCRIPTION; PITUITARY-ADRENAL AXIS; IMMEDIATE-EARLY GENES; CYCLIC-AMP; NUCLEAR TRANSLOCATION; CHRONIC STRESS; EXPRESSION; DEPRESSION; CELLS; BRAIN	Previous studies demonstrate essential roles for the exchange proteins directly activated by cAMP 1 and 2 (Epac1 and Epac2; here collectively referred to as Epac) in the brain. In the hippocampus, Epac contributes to the control of neuronal growth and differentiation and has been implicated in memory and learning as well as in anxiety and depression. In the present study we address the hypothesis that Epac affects hippocampal cellular responses to acute restraint stress. Stress causes activation of the hypothalamus-pituitary-adrenal (HPA)-axis, and glucocorticoid receptor (GR) signaling is essential for proper feedback regulation of the stress response, both in the brain and along the HPA axis. In the hippocampus, GR expression is regulated by cAMP and the brain enriched micro RNA miR-124. Epac has been associated with miR-124 expression in hippocampal neurons, but not in regulation of GR. We report that hippocampal expression of Epac1 and Epac2 increased in response to acute stress in female wild type mice. In female mice genetically deleted for Epac, nuclear translocation of GR in response to restraint stress was significantly delayed, and moreover, miR124 expression was decreased in these mice. Male mice lacking Epac also showed abnormalities in miR-124 expression, but the phenotype was less profound than in females. Serum corticosterone levels were slightly altered immediately after stress in both male and female mice deleted for Epac. The presented data indicate that Epac1 and Epac2 are involved in controlling cellular responses to acute stress in the mouse hippocampus and provide novel insights into the underlying transcriptional and signaling networks. Interestingly, we observe sex specific differences when Epac is deleted. As the incidence and prevalence of stress-related diseases are higher in women than in men, the Epac knockout models might serve as genetic tools to further elucidate the cellular mechanisms underlying differences between male and female with regard to regulation of stress.	[Aesoy, Reidun; Sabir, Misbah; Bjornstad, Ronja; Kopperud, Reidun K.; Hoivik, Erling A.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Muwonge, Haruna; Asrud, Kathrine S.; Doskeland, Stein Ove; Bakke, Marit] Univ Bergen, Dept Biomed, Bergen, Norway; [Witsoe, Solveig L.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Muwonge, Haruna] Makerere Univ, Coll Hlth Sci, Dept Physiol, Kampala, Uganda	University of Bergen; University of Bergen; University of Bergen; Makerere University	Bakke, M (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Marit.Bakke@uib.no	Muwonge, Haruna/AAT-7275-2020	Muwonge, Haruna/0000-0003-3964-2169; Sivertsen Nordhus, Kathrine/0000-0001-7951-4044; Aesoey, Reidun/0000-0001-7660-8678; Doskeland, Stein Ove/0000-0002-4009-4756	Research Council of Norway [183451/S10]; Regional Health Authorities of Western Norway [911979]	Research Council of Norway(Research Council of Norway); Regional Health Authorities of Western Norway	This work was supported by The Research Council of Norway (Grant no 183451/S10; MB) and The Regional Health Authorities of Western Norway (Grant no. 911979; SOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumo L, 2010, ENDOCRINOLOGY, V151, P2151, DOI 10.1210/en.2009-1139; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Banerjee U, 2015, GENE, V570, P157, DOI 10.1016/j.gene.2015.06.063; Bourke CH, 2013, PSYCHONEUROENDOCRINO, V38, P84, DOI 10.1016/j.psyneuen.2012.05.001; Bourke CH, 2012, HORM BEHAV, V62, P210, DOI 10.1016/j.yhbeh.2012.02.024; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Kloet ER, 1979, STRESS RES PAST PRES; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Djordjevic A, 2009, NEUROPSYCHOBIOLOGY, V59, P213, DOI 10.1159/000223733; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dwivedi Y, 2006, ARCH GEN PSYCHIAT, V63, P639, DOI 10.1001/archpsyc.63.6.639; Edland F, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0147-1; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fernandes HB, 2015, J NEUROSCI, V35, P6544, DOI 10.1523/JNEUROSCI.0314-14.2015; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fuchsl AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153164; Gloerich M, 2011, J CELL BIOL, V193, P1009, DOI 10.1083/jcb.201011126; Gray JD, 2014, MOL PSYCHIATR, V19, P1171, DOI 10.1038/mp.2013.175; Green MR, 2016, PSYCHONEUROENDOCRINO, V73, P32, DOI 10.1016/j.psyneuen.2016.07.210; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; Han QQ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00287; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Higuchi F, 2016, J NEUROSCI, V36, P7253, DOI 10.1523/JNEUROSCI.0319-16.2016; Hoivik EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067925; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Kai AKL, 2013, FASEB J, V27, P4122, DOI 10.1096/fj.13-230433; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kleppe R, 2015, CRC SERIES METHODS S; Kolber BJ, 2009, BRAIN RES, V1293, P85, DOI 10.1016/j.brainres.2009.03.061; Kopperud RK, 2017, ACTA PHYSIOL, V219, P441, DOI 10.1111/apha.12697; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Laryea G, 2015, FRONT NEUROENDOCRIN, V36, P150, DOI 10.1016/j.yfrne.2014.09.002; Laryea G, 2013, MOL ENDOCRINOL, V27, P1655, DOI 10.1210/me.2013-1187; Lee K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0130-1; Lewis AE, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00063; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannironi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073385; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; McPhee I, 2005, BIOCHEM SOC T, V33, P1330, DOI 10.1042/BST0331330; Mediero A, 2014, FASEB J, V28, P4901, DOI 10.1096/fj.14-255703; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; Mentzel CMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131650; Mifsud KR, 2017, NEUROENDOCRINOLOGY, V104, P157, DOI 10.1159/000445875; Munoz-Llancao P, 2015, J NEUROSCI, V35, P11315, DOI 10.1523/JNEUROSCI.3645-14.2015; Myers B, 2012, CELL MOL NEUROBIOL, V32, P683, DOI 10.1007/s10571-012-9801-y; Nakamura NH, 2011, NEUROSCIENCE, V187, P15, DOI 10.1016/j.neuroscience.2011.04.031; Newson MJF, 2013, J ENDOCRINOL, V216, P99, DOI 10.1530/JOE-12-0375; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Noguchi T, 2010, ENDOCRINOLOGY, V151, P4344, DOI 10.1210/en.2010-0266; Nygaard G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08975-y; Ostroveanu A, 2010, HIPPOCAMPUS, V20, P1018, DOI 10.1002/hipo.20700; Parnell E, 2015, TRENDS PHARMACOL SCI, V36, P203, DOI 10.1016/j.tips.2015.02.003; Peace AG, 2011, BRAIN RES BULL, V84, P280, DOI 10.1016/j.brainresbull.2010.09.002; Pereira L, 2015, P NATL ACAD SCI USA, V112, P3991, DOI 10.1073/pnas.1416163112; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Real FM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110957; Roper JA, 2010, J NEUROENDOCRINOL, V22, P1173, DOI 10.1111/j.1365-2826.2010.02070.x; Ryabinin AE, 1999, ALCOHOL CLIN EXP RES, V23, P1272, DOI 10.1111/j.1530-0277.1999.tb04288.x; Schwede F, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002038; Sewer MB, 2003, MICROSC RES TECHNIQ, V61, P300, DOI 10.1002/jemt.10339; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Suzuki S, 2010, J BIOL CHEM, V285, P24248, DOI 10.1074/jbc.M109.094581; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang B, 2016, EXP CELL RES, V347, P360, DOI 10.1016/j.yexcr.2016.08.018; Wang PY, 2017, BIOORG MED CHEM LETT, V27, P1633, DOI 10.1016/j.bmcl.2017.02.065; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xu JJ, 2017, J PSYCHIATR RES, V95, P102, DOI 10.1016/j.jpsychires.2017.08.010; Yan JB, 2013, MOL CELL BIOL, V33, P918, DOI 10.1128/MCB.01227-12; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003; Zhang XW, 2017, MOL NEUROBIOL, V54, P2498, DOI 10.1007/s12035-016-9845-y; Zhou L, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.129	87	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200935	10.1371/journal.pone.0200935	http://dx.doi.org/10.1371/journal.pone.0200935			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048476	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400032
J	Gerofke, A; Ulbig, E; Martin, A; Muller-Graf, C; Selhorst, T; Gremse, C; Spolders, M; Schafft, H; Heinemeyer, G; Greiner, M; Lahrssen-Wiederholt, M; Hensel, A				Gerofke, Antje; Ulbig, Ellen; Martin, Annett; Mueller-Graf, Christine; Selhorst, Thomas; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Heinemeyer, Gerhard; Greiner, Matthias; Lahrssen-Wiederholt, Monika; Hensel, Andreas			Lead content in wild game shot with lead or non-lead ammunition - Does "state of the art consumer health protection" require non-lead ammunition?	PLOS ONE			English	Article							BOAR SUS-SCROFA; DEER CAPREOLUS-CAPREOLUS; RED DEER; HEAVY-METALS; RIFLE AMMUNITION; MEAT; CADMIUM; MUSCLE; LIVER; CONSUMPTION	The toxicity of lead has been known for a long time, and no safe uptake level can be derived for humans. Consumers' intake via food should therefore be kept as low as possible. Game meat can contain elevated levels of lead due to the use of lead ammunition for hunting. A risk assessment conducted in 2010 by the German Federal Institute for Risk Assessment including various consumption scenarios revealed a possible health risk for extreme consumers of game meat hunted with lead ammunition (i.e. hunters and members of hunters' households). Babies, infants, children and women of childbearing age were identified as vulnerable group with regards to the developmental neurotoxicity of lead. It was noted, that a sound data base was required in order to refine the assessment. Therefore, the research project "Safety of game meat obtained through hunting" (LEMISI) has been conducted in Germany, with the aims of determining the concentrations of lead (as well as of copper and zinc) brought into the edible parts of game meat (roe deer (Capreolus capreolus) and wild boar (Sus scrofa)) due to using either lead or non-lead hunting ammunition, whilst concurrently taking geogenic (i.e. "background") levels of lead into account. Compared to non-lead ammunition, lead ammunition significantly increased lead concentrations in the game meat. The use of both lead and non-lead ammunition deposited copper and zinc in the edible parts of game meat, and the concentrations were in the range of those detected regularly in meat of farm animals. For the average consumer of game meat in Germany the additional uptake of lead only makes a minor contribution to the average alimentary lead exposure. However, for consumers from hunters' households the resulting uptake of lead-due to lead ammunition D can be several times higher than the average alimentary lead exposure. Non-lead bullets in combination with suitable game meat hygienic measures are therefore recommended in order to ensure "state of the art consumer health protection".	[Gerofke, Antje; Ulbig, Ellen; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Lahrssen-Wiederholt, Monika] German Fed Inst Risk Assessment, Dept Safety Food Chain, Berlin, Germany; [Martin, Annett; Mueller-Graf, Christine; Selhorst, Thomas; Heinemeyer, Gerhard; Greiner, Matthias] German Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany; [Hensel, Andreas] German Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment; Federal Institute for Risk Assessment; Federal Institute for Risk Assessment	Gerofke, A (corresponding author), German Fed Inst Risk Assessment, Dept Safety Food Chain, Berlin, Germany.	antje.gerofke@bfr.bund.de	; Greiner, Matthias/D-2812-2013	Muller-Graf, Christine/0000-0002-0122-7528; Greiner, Matthias/0000-0003-4974-5970	Federal Ministry of Food and Agriculture (BMEL) in Germany; Mecklenburg-Western Pomerania; Lower Saxony; Saxony-Anhalt; Bavaria; Hesse; North Rhine-Westphalia; Hamburg; Bremen; European Poultry; Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen und Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	Federal Ministry of Food and Agriculture (BMEL) in Germany; Mecklenburg-Western Pomerania; Lower Saxony; Saxony-Anhalt; Bavaria; Hesse; North Rhine-Westphalia; Hamburg; Bremen; European Poultry; Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen und Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	The study was supported mainly by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen und Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; Alimentarius C, 2007, CODEX ALIMENTARIUS C, P177; Amici A, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e65; [Anonymous], 2014, 138052014 EN; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF MERC; BfR, 2005, BFR ENTW NEUES VERZ; BfR, 2010, BLEIB WILDBR DURCH V; BfR, 2014, FORSCH LEB JAGDL GEW; Bilandzic N, 2010, B ENVIRON CONTAM TOX, V84, P738, DOI 10.1007/s00128-010-9999-7; Bilandzic N, 2009, SCI TOTAL ENVIRON, V407, P4243, DOI 10.1016/j.scitotenv.2009.04.009; Birgisdottir BE, 2013, SCI TOTAL ENVIRON, V463, P836, DOI 10.1016/j.scitotenv.2013.06.078; Blume K, 2010, AUFNAHME UMWELTKONTA; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Buenz EJ, 2018, AM J MED, V131, pE181, DOI 10.1016/j.amjmed.2017.11.031; BVL, 2012, BER LEB 2012 LEB MON; BVL, 2012, BER LEB 2012 D LEB M; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Chiari M, 2015, FOOD ADDIT CONTAM A, V32, P1867, DOI 10.1080/19440049.2015.1087058; Danieli PP, 2012, ARCH ENVIRON CON TOX, V63, P612, DOI 10.1007/s00244-012-9791-2; Garcia MHD, 2011, J ENVIRON SCI HEAL A, V46, P109, DOI 10.1080/10934529.2011.532422; Dobrowolska A, 2008, EUR J WILDLIFE RES, V54, P231, DOI 10.1007/s10344-007-0134-y; Ehlscheid N, 2014, 51 WISSENSCHAFTLICHE; Ertl K, 2016, FOOD ADDIT CONTAM B, V9, P120, DOI 10.1080/19393210.2016.1151464; European Food Safety Authority, 2012, EFSA Journal, V10, P2831; Fustinoni S, 2017, ENVIRON RES, V155, P36, DOI 10.1016/j.envres.2017.01.041; Gasparik J, 2017, BIOL TRACE ELEM RES, V177, P258, DOI 10.1007/s12011-016-0884-z; Gottlein A, 2013, S FORSCHUNGSVORHABEN; Gremse F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102015; Gulson BL, 2003, SCI TOTAL ENVIRON, V303, P79, DOI 10.1016/S0048-9697(02)00355-8; Hacklander K., 2015, EIGNUNG BLEIFREIER B; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hecht H, 2000, AUSWIRKUNG GESCHOSSW; Hecht H., 1984, UNTERSUCHUNG KONTAMI; Human Biomonitoring Commission (HBM Commission) of the German EnvironmentAgency, 2009, BUNDESGESUNDHEITSBLA, V52, P983, DOI [10.1007/s00103-009-0936-z, DOI 10.1007/S00103-009-0936-Z]; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Kanstrup N, 2016, EUR J WILDLIFE RES, V62, P333, DOI 10.1007/s10344-016-1006-0; Knott Jeff, 2009, Conservation Evidence, V6, P71; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lehel J, 2016, ENVIRON SCI POLLUT R, V23, P4465, DOI 10.1007/s11356-015-5658-1; Lorimer MF, 2007, INT J FOOD MICROBIOL, V116, P313, DOI 10.1016/j.ijfoodmicro.2007.02.001; Makri A, 2004, J TOXICOL ENV HEAL B, V7, P417, DOI 10.1080/10937400490512465; Martin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185029; Mateo R, 2007, ECOTOX ENVIRON SAFE, V66, P119, DOI 10.1016/j.ecoenv.2005.12.010; Mateo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015892; MRI, 2008, NAT VERZ 2 NVS 2; Muller-Graf C, 2017, GAME MEAT HYGIENE: FOOD SAFETY AND SECURITY, P201, DOI 10.3920/978-90-8686-840-7_12; Nardi EP, 2009, FOOD CHEM, V112, P727, DOI 10.1016/j.foodchem.2008.06.010; Piskorova L, 2003, CZECH J ANIM SCI, V48, P134; Rudy M, 2010, FOOD ADDIT CONTAM A, V27, P464, DOI 10.1080/19440040903493785; Sager M., 2005, Ernahrung, V29, P199; Schlichting D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184946; Srebocan E, 2011, CZECH J FOOD SCI, V29, P624, DOI 10.17221/249/2010-CJFS; Taggart MA, 2011, ENVIRON INT, V37, P18, DOI 10.1016/j.envint.2010.06.007; Thomas VG, 2016, EUR J WILDLIFE RES, V62, P633, DOI 10.1007/s10344-016-1044-7; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Ulbig E., 2013, S FORSCHUNGSVORHABEN; Morales JSV, 2011, FOOD ADDIT CONTAM A, V28, P1021, DOI 10.1080/19440049.2011.583282; WHO, 10 CHEM MAJ PUBL HLT; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm M, 2004, HOCHSTGEHALTE UMWELT; World Health Organization, 2010, CHILDH LEAD POIS	62	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200792	10.1371/journal.pone.0200792	http://dx.doi.org/10.1371/journal.pone.0200792			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048463	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400021
J	Reddi, G; Pruss, K; Cottingham, KL; Taylor, RK; Almagro-Moreno, S				Reddi, Geethika; Pruss, Kali; Cottingham, Kathryn L.; Taylor, Ronald K.; Almagro-Moreno, Salvador			Catabolism of mucus components influences motility of Vibrio cholerae in the presence of environmental reservoirs	PLOS ONE			English	Article							CHITIN UTILIZATION; EASTERN OYSTER; COLONIZATION; CHEMOTAXIS; VIRULENCE; O1; OLIGOSACCHARIDES; SELECTION; PATHWAY; BLOOMS	Vibrio cholerae O1, the etiological agent of cholera, is a natural inhabitant of aquatic ecosystems. Motility is a critical element for the colonization of both the human host and its environmental reservoirs. In this study, we investigated the molecular mechanisms underlying the chemotactic response of V. cholerae in the presence of some of its environmental reservoirs. We found that, from the several oligosaccharides found in mucin, two specifically triggered motility of V. cholerae O1:N-acetylneuraminic acid (Neu5Ac) and N-acetylglucosamine (GlcNAc). We determined that the compounds need to be internally catabolized in order to trigger motility of V. cholerae. Interestingly, the catabolism of Neu5Ac and GlcNAc converges and the production of one molecule common to both pathways, glucosamine-6-phosphate (GlcN-6P), is essential to induce motility in the presence of both compounds. Mutants unable to produce GlcN-6P show greatly reduced motility towards mucin. Furthermore, we determined that the production of GlcN-6P is necessary to induce motility of V. cholerae in the presence of some of its environmental reservoirs such as crustaceans or cyanobacteria, revealing a molecular link between the two distinct modes of the complex life cycle of V. cholerae. Finally, cross-species comparisons revealed varied chemotactic responses towards mucin, GlcNAc, and Neu5Ac for environmental (non-pathogenic) strains of V. cholerae, clinical and environmental isolates of the human pathogens Vibrio vulnificus and Vibrio parahaemolyticus, and fish and squid isolates of the symbiotic bacterium Vibrio fischeri. The data presented here suggest nuance in convergent strategies across species of the same bacterial family for motility towards suitable substrates for colonization.	[Reddi, Geethika; Almagro-Moreno, Salvador] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Pruss, Kali] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Cottingham, Kathryn L.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Taylor, Ronald K.] Dartmouth Coll, Geisel Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Almagro-Moreno, Salvador] Univ Cent Florida, Natl Ctr Integrated Coastal Res, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; Stanford University; Dartmouth College; Dartmouth College; State University System of Florida; University of Central Florida	Almagro-Moreno, S (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.; Almagro-Moreno, S (corresponding author), Univ Cent Florida, Natl Ctr Integrated Coastal Res, Orlando, FL 32816 USA.	samoreno@ucf.edu	Almagro-Moreno, Salvador/L-3036-2019; Cottingham, Kathryn L./AAV-3934-2021	Almagro-Moreno, Salvador/0000-0002-1121-1204; Cottingham, Kathryn L./0000-0003-3169-5047	Burnett School of Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025096] Funding Source: NIH RePORTER	Burnett School of Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Startup Funds from Burnett School of Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2013, CHOLERA ENV RESERVOI, V1, P149; Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; Almagro-Moreno S, 2010, GUT MICROBES, V1, P45, DOI 10.4161/gmic.1.1.10386; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BASSLER BL, 1991, J BIOL CHEM, V266, P24268; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Ceccarelli D, 2015, APPL ENVIRON MICROB, V81, P1909, DOI 10.1128/AEM.03540-14; Ceccarelli D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00256; Chaturvedi P, 2015, ECOTOX ENVIRON SAFE, V115, P67, DOI 10.1016/j.ecoenv.2015.02.001; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; EPSTEIN PR, 1993, BIOSYSTEMS, V31, P209, DOI 10.1016/0303-2647(93)90050-M; Ghosh S, 2011, MOL MICROBIOL, V80, P1549, DOI 10.1111/j.1365-2958.2011.07664.x; GUENTZEL MN, 1975, INFECT IMMUN, V11, P890, DOI 10.1128/IAI.11.5.890-897.1975; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; HOOD MA, 1981, APPL ENVIRON MICROB, V41, P559, DOI 10.1128/AEM.41.2.559-560.1981; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; HUQ A, 1986, APPL ENVIRON MICROB, V52, P586, DOI 10.1128/AEM.52.3.586-588.1986; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Islam MS, 2006, EPIDEMIOL INFECT, V134, P645, DOI 10.1017/S0950268805005297; ISLAM MS, 1994, J DIARRHOEAL DIS RES, V12, P87; ISLAM S, 1990, J TROP MED HYG, V93, P133; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004; Lee SH, 2001, P NATL ACAD SCI USA, V98, P6889, DOI 10.1073/pnas.111581598; Liu ZY, 2015, INFECT IMMUN, V83, P1114, DOI 10.1128/IAI.02841-14; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Mandel MJ, 2012, APPL ENVIRON MICROB, V78, P4620, DOI 10.1128/AEM.00377-12; Martinez RM, 2009, J BACTERIOL, V191, P5669, DOI 10.1128/JB.00632-09; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Millet YA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004405; MURPHREE RL, 1995, APPL ENVIRON MICROB, V61, P3656, DOI 10.1128/AEM.61.10.3656-3660.1995; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nahar S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00260; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Napolitano MG, 2011, INFECT GENET EVOL, V11, P423, DOI 10.1016/j.meegid.2010.12.003; O'Toole R, 1999, J BACTERIOL, V181, P4308; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Sakib SN, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00795-17; Schuster BM, 2011, APPL ENVIRON MICROB, V77, P7568, DOI 10.1128/AEM.00378-11; Shapiro BJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.240; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Sun Y, 2015, FRONT MICROBIOL, V6, P17284; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; TWEDT RM, 1981, APPL ENVIRON MICROB, V41, P1475, DOI 10.1128/AEM.41.6.1475-1478.1981; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x	56	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201383	10.1371/journal.pone.0201383	http://dx.doi.org/10.1371/journal.pone.0201383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048543	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400083
J	Tentori, K; Pighin, S; Divan, C; Crupi, V				Tentori, Katya; Pighin, Stefania; Divan, Claudio; Crupi, Vincenzo			Mind the gap: Physicians' assessment of patients' importance weights in localized prostate cancer	PLOS ONE			English	Article							SHARED DECISION-MAKING; VALUES CLARIFICATION METHODS; DESIGN-FEATURES; PREFERENCES; CARE; COMMUNICATION; DIAGNOSIS; RISK; RECOMMENDATIONS; SATISFACTION	Background The management of localized prostate cancer is challenging because of the many therapeutic options available, none of which is generally acknowledged as superior to the others in every respect. The selection of the most appropriate treatment should therefore reflect patients' preferences. Objective The purpose of the following study was to pilot a new approach for investigating whether urologists who had previously provided patients with therapeutic advice actually knew their patients' importance weights concerning the relevant aspects of the treatments at issue. Method Participants were patients recently diagnosed with localized prostate cancer (n = 20), urologists (n = 10), and non-medical professionals (architects, n = 10). These last served as a control group for the urologists and were matched to them for age and gender. Patients' importance weights were elicited by two standard methods (Direct Rating and Value Hierarchy). Each urologist was asked to estimate (with Direct Rating) his/her patient's importance weights. The same task was performed by a corresponding architect, who never met the patient and knew only the patient's age. Univariate and bivariate statistical analyses were performed to investigate the association between importance weights as elicited from patients and as estimated by urologists and architects, as well as to assess whether such agreement was attribute-dependent. Results Participants found both elicitation methods easy to use. The correlation between patients' actual importance weights and urologists' estimates was poor and comparable to that obtained between patients and architects. This result did not depend on the attribute considered, with the sole exception of the attribute "Effectiveness in curing the cancer", which was evaluated as the most important attribute by the majority of participants. Conclusion These findings demonstrate the feasibility of the employed methodology and highlight the need to support preference-sensitive decisions in clinical practice by facilitating the elicitation of patients' importance weights, as well as their communication to physicians.	[Tentori, Katya; Pighin, Stefania] Univ Trento, Ctr Mind Brain Sci, Trento, Italy; [Divan, Claudio] Santa Chiara Hosp, Div Urol, Trento, Italy; [Crupi, Vincenzo] Univ Torino, Dept Philosophy & Educ Sci, Turin, Italy	University of Trento; Santa Chiara Hospital; University of Turin	Tentori, K (corresponding author), Univ Trento, Ctr Mind Brain Sci, Trento, Italy.	katya.tentori@unitn.it	Crupi, Vincenzo/I-1190-2012; Crupi, Vincenzo/U-2446-2019	Crupi, Vincenzo/0000-0002-8727-5001; Tentori, Katya/0000-0002-5968-9936	Cassa di Risparmio of Trento and Rovereto (SMC) [40102595]; DFG as part of the priority program New Frameworks of Rationality [SPP 1516, CR 409/1-2]	Cassa di Risparmio of Trento and Rovereto (SMC); DFG as part of the priority program New Frameworks of Rationality(German Research Foundation (DFG))	Financial support for this study was provided by the Cassa di Risparmio of Trento and Rovereto (SMC, grant 40102595 to KT) and by the DFG as part of the priority program New Frameworks of Rationality (SPP 1516, grant CR 409/1-2 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2015, OPER RES, V63, P378, DOI 10.1287/opre.2015.1350; Alfandre David, 2016, J Clin Ethics, V27, P21; [Anonymous], CANC STAT REG; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; BARRY MJ, 1988, JAMA-J AM MED ASSOC, V259, P3010, DOI 10.1001/jama.259.20.3010; Bottomley PA, 2000, J MARKETING RES, V37, P508, DOI 10.1509/jmkr.37.4.508.18794; Brabers AEM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173316; Brom L, 2017, HEALTH EXPECT, V20, P69, DOI 10.1111/hex.12434; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; Chi WC, 2017, ANN FAM MED, V15, P546, DOI 10.1370/afm.2106; Chiu C, 2016, J PAIN SYMPTOM MANAG, V51, P33, DOI 10.1016/j.jpainsymman.2015.07.018; Christie DRH, 2015, PSYCHO-ONCOLOGY, V24, P1002, DOI 10.1002/pon.3776; Combs MP, 2013, MAYO CLIN PROC, V88, P666, DOI 10.1016/j.mayocp.2013.05.013; Cuypers M, 2019, HEALTH INFORM J, V25, P701, DOI 10.1177/1460458217720393; Cuypers M, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.06.015; Davison BJ, 2012, PATIENT EDUC COUNS, V87, P369, DOI 10.1016/j.pec.2011.11.009; Ellis PM, 1999, ANN MED, V31, P336, DOI 10.3109/07853899908995900; Elstein AS, 2005, HEALTH PSYCHOL, V24, pS85, DOI 10.1037/0278-6133.24.4.S85; Elstein AS, 2004, HEALTH EXPECT, V7, P115, DOI 10.1111/j.1369-7625.2004.00267.x; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Epstein RM, 2013, MED CARE RES REV, V70, p94S, DOI 10.1177/1077558712459216; Fried TR, 2016, NEW ENGL J MED, V374, P104, DOI 10.1056/NEJMp1510020; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hoffman KE, 2014, JAMA INTERN MED, V174, P1450, DOI 10.1001/jamainternmed.2014.3021; Holmes-Rovner M, 2015, MED DECIS MAKING, V35, P999, DOI 10.1177/0272989X15597226; Hurwitz LM, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.11.014; Johnson DC, 2016, J UROLOGY, V196, P1640, DOI 10.1016/j.juro.2016.06.082; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016; Mottet N, 2017, EUR UROL, V71, P618, DOI 10.1016/j.eururo.2016.08.003; Moulton B, 2013, J ROY SOC MED, V106, P391, DOI 10.1177/0141076813490686; National Cancer Institute, CANC TRENDS PROGR RE; OConnor AM, 2014, HLTH AFF, V23; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Pighin S, 2018, ANN BEHAV MED, V52, P909, DOI 10.1093/abm/kax065; Pighin S, 2015, PRENATAL DIAG, V35, P777, DOI 10.1002/pd.4606; Poyhonen M, 2001, EUR J OPER RES, V129, P569, DOI 10.1016/S0377-2217(99)00467-1; Raiffa H., 1976, DECISION ANAL MULTIP; Reamer E, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1467056; Sanda MG, 2018, J UROLOGY, V199, P683, DOI 10.1016/j.juro.2017.11.095; Scherr KA, 2017, MED DECIS MAKING, V37, P56, DOI 10.1177/0272989X16662841; Seo J, 2016, MED DECIS MAKING, V36, P550, DOI 10.1177/0272989X16632197; Sevdalis N, 2006, HEALTH EXPECT, V9, P245, DOI 10.1111/j.1369-7625.2006.00391.x; Showalter TN, 2015, PATIENT PREFER ADHER, V9, DOI 10.2147/PPA.S83333; Smith RA, 2016, CA-CANCER J CLIN, V66, P96, DOI 10.3322/caac.21336; Sommers BD, 2008, CANCER, V113, P2058, DOI 10.1002/cncr.23807; SRIVASTAVA J, 1995, ORGAN BEHAV HUM DEC, V63, P112, DOI 10.1006/obhd.1995.1066; Stalmeier PFM, 2007, J CLIN ONCOL, V25, P3096, DOI 10.1200/JCO.2006.07.4955; Stiggelbout AM, 2015, PATIENT EDUC COUNS, V98, P1172, DOI 10.1016/j.pec.2015.06.022; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; SVENSON O, 1992, ACTA PSYCHOL, V80, P143, DOI 10.1016/0001-6918(92)90044-E; Tamirisa NP, 2017, HEALTH EXPECT, V20, P1248, DOI 10.1111/hex.12564; Underwood W, 2010, CAN J UROL, V17, P5346; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Violette PD, 2015, CA-CANCER J CLIN, V65, P239, DOI 10.3322/caac.21272; Wang LL, 2017, AJIS, V21, DOI [10.3127/ajis.v21i0.1382, DOI 10.3127/AJIS.V21I0.1382]; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Witteman HO, 2016, MED DECIS MAKING, V36, P760, DOI 10.1177/0272989X16634085; Witteman HO, 2016, MED DECIS MAKING, V36, P453, DOI 10.1177/0272989X15626397; Zhong WJ, 2018, UROLOGY, V114, P1, DOI 10.1016/j.urology.2017.10.022; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200780	10.1371/journal.pone.0200780	http://dx.doi.org/10.1371/journal.pone.0200780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048485	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400019
J	Zhao, R; Gu, XX; Xue, B; Zhang, JQ; Ren, WX				Zhao, Rui; Gu, Xinxin; Xue, Bing; Zhang, Jianqiang; Ren, Wanxia			Short period PM2.5 prediction based on multivariate linear regression model	PLOS ONE			English	Article							AEROSOL OPTICAL DEPTH; GROUND-LEVEL PM2.5; UNITED-STATES; AIR-QUALITY; MITIGATION; EMISSIONS; POLLUTION; CHINA; LAND; VARIABILITY	A multivariate linear regression model was proposed to achieve short period prediction of PM2.5 (fine particles with an aerodynamic diameter of 2.5 mu m or less). The main parameters for the proposed model included data on aerosol optical depth (AOD) obtained through remote sensing, meteorological factors from ground monitoring (wind velocity, temperature, and relative humidity), and other gaseous pollutants (SO2, NO2, CO, and O-3). Beijing City was selected as a typical region for the case study. Data on the aforementioned variables for the city throughout 2015 were used to construct two regression models, which were discriminated by annual and seasonal data, respectively. The results indicated that the regression model based on annual data had (R-2 = 0.766) goodness-of-fit and (R-2 = 0.875) cross-validity. However, the regression models based on seasonal data for spring and winter were more effective, achieving 0.852 and 0.874 goodness-of-fit, respectively. Model uncertainties were also given, with the view of laying the foundation for further study.	[Zhao, Rui; Gu, Xinxin; Zhang, Jianqiang] Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu, Sichuan, Peoples R China; [Xue, Bing] Inst Adv Sustainabil Studies eV, Potsdam, Germany; [Ren, Wanxia] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Liaoning, Peoples R China	Southwest Jiaotong University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Xue, B (corresponding author), Inst Adv Sustainabil Studies eV, Potsdam, Germany.	bing.xue@iass-potsdam.de			National Natural Science Foundation of China [41571520, 41471116]; Sichuan Provincial Key Technology Support [2014GZ0168]; Fundamental Research Funds for the Central Universities [A0920502051408]; BMBF Kopernikus Project for the Energy Transition-Thematic Field No. 4 "System Integration and Networks for the Energy Supply" (ENavi); Youth Innovation Promotion Association CAS [2016181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Key Technology Support; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); BMBF Kopernikus Project for the Energy Transition-Thematic Field No. 4 "System Integration and Networks for the Energy Supply" (ENavi)(Federal Ministry of Education & Research (BMBF)); Youth Innovation Promotion Association CAS	This study is sponsored by National Natural Science Foundation of China (No. 41571520; No. 41471116), Sichuan Provincial Key Technology Support (No. 2014GZ0168), The Fundamental Research Funds for the Central Universities (No. A0920502051408), BMBF Kopernikus Project for the Energy Transition-Thematic Field No. 4 "System Integration and Networks for the Energy Supply" (ENavi), and the Youth Innovation Promotion Association CAS (Xue Bing, 2016181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boys BL, 2014, ENVIRON SCI TECHNOL, V48, P11109, DOI 10.1021/es502113p; Chang YH, 2012, ENVIRON SCI TECHNOL, V46, P7069, DOI 10.1021/es3022705; Chen W, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020110; Di Q, 2016, ATMOS ENVIRON, V131, P390, DOI 10.1016/j.atmosenv.2016.02.002; Engel-Cox J A, 2004, ATMOS ENVIRON, V38, P11118, DOI [10.1021/es502113p, DOI 10.1021/ES502113P]; Engel-Cox J, 2013, ATMOS ENVIRON, V80, P584, DOI 10.1016/j.atmosenv.2013.08.016; Grigas T., 2017, THESIS; Guan DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024010; Guo JP, 2009, ATMOS ENVIRON, V43, P5876, DOI 10.1016/j.atmosenv.2009.08.026; He XD, 2015, BUILD ENVIRON, V92, P668, DOI 10.1016/j.buildenv.2015.05.044; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Hu XF, 2014, REMOTE SENS ENVIRON, V140, P220, DOI 10.1016/j.rse.2013.08.032; Hu XF, 2013, ENVIRON RES, V121, P1, DOI 10.1016/j.envres.2012.11.003; Just AC, 2015, ENVIRON SCI TECHNOL, V49, P8576, DOI 10.1021/acs.est.5b00859; Kloog I, 2012, ENVIRON SCI TECHNOL, V46, P11913, DOI 10.1021/es302673e; Kloster S, 2008, ATMOS CHEM PHYS, V8, P6405, DOI 10.5194/acp-8-6405-2008; Kumar N, 2007, ATMOS ENVIRON, V41, P4492, DOI 10.1016/j.atmosenv.2007.01.046; Langrish JP, 2012, ENVIRON HEALTH PERSP, V120, P367, DOI 10.1289/ehp.1103898; Lee HJ, 2011, ATMOS CHEM PHYS, V11, P7991, DOI 10.5194/acp-11-7991-2011; Leibensperger EM, 2011, ATMOS ENVIRON, V45, P3318, DOI 10.1016/j.atmosenv.2011.02.023; Leitte AM, 2011, ENVIRON HEALTH PERSP, V119, P508, DOI 10.1289/ehp.1002203; Levy R. C., 2010, ATMOSPHERIC CHEM PHY, V10, P14815, DOI DOI 10.5194/ACPD-10-14815-2010; Li J, 2015, ATMOS ENVIRON, V102, P260, DOI 10.1016/j.atmosenv.2014.12.010; Liu Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI [10.1029/2004JD005025, 10.1029/2003JD003981]; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Lv BL, 2016, ENVIRON SCI TECHNOL, V50, P4752, DOI 10.1021/acs.est.5b05940; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Munchak LA, 2013, ATMOS MEAS TECH, V6, P1747, DOI 10.5194/amt-6-1747-2013; Pavese G, 2016, ENVIRON SCI POLLUT R, V23, P6546, DOI 10.1007/s11356-015-5860-1; Qu LL, 2017, ENVIRON SCI POLLUT R, V24, P2578, DOI 10.1007/s11356-016-7995-0; Rae JGL, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007826; Rogula-Kozlowska W, 2014, AIR QUAL ATMOS HLTH, V7, P41, DOI 10.1007/s11869-013-0222-y; Schaap M, 2009, ATMOS CHEM PHYS, V9, P909, DOI 10.5194/acp-9-909-2009; Shindell D, 2008, ATMOS CHEM PHYS, V8, P7101, DOI 10.5194/acp-8-7101-2008; Song WZ, 2014, REMOTE SENS ENVIRON, V154, P1, DOI 10.1016/j.rse.2014.08.008; Unger N, 2006, P NATL ACAD SCI USA, V103, P4377, DOI 10.1073/pnas.0508769103; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Walsh MP, 2014, FRONT ENV SCI ENG, V8, P1, DOI 10.1007/s11783-014-0634-4; Wang JM, 2016, ENVIRON SCI POLLUT R, V23, P8827, DOI 10.1007/s11356-016-6127-1; Xie YY, 2015, PARTICUOLOGY, V20, P141, DOI 10.1016/j.partic.2015.01.003; Xie YY, 2015, ENVIRON SCI TECHNOL, V49, P12280, DOI 10.1021/acs.est.5b01413; Xue B, 2017, P I CIVIL ENG D, P1; Yuan Y, 2012, ENVIRON SCI TECHNOL, V46, P3627, DOI 10.1021/es300984j; Zhang H, 2009, J AIR WASTE MANAGE, V59, P1358, DOI 10.3155/1047-3289.59.11.1358; Zheng YX, 2016, ATMOS ENVIRON, V124, P232, DOI 10.1016/j.atmosenv.2015.06.046; Zhou Y, 2010, ENVIRON HEALTH PERSP, V118, P1204, DOI 10.1289/ehp.1001991; Zhuang XL, 2014, J ENVIRON SCI, V26, P2, DOI 10.1016/S1001-0742(13)60376-9	47	27	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201011	10.1371/journal.pone.0201011	http://dx.doi.org/10.1371/journal.pone.0201011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048475	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400039
J	Rogalska, A; Gajek, A; Lukawska, M; Oszczapowicz, I; Marczak, A				Rogalska, Aneta; Gajek, Arkadiusz; Lukawska, Malgorzata; Oszczapowicz, Irena; Marczak, Agnieszka			Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE DEATH; OXIDATIVE STRESS; IN-VITRO; DOXORUBICIN; MECHANISMS; RESISTANCE; 3-METHYLADENINE; SENSITIVITY; CALCIUM; PATHWAY	Chemical modification of known, effective drugs are one method to improve the chemotherapy of tumors. We reported ability of oxazoline analogs of doxorubicin (O-DOX) and daunorubicin (O-DAU) to induce apoptosis and autophagy in ovarian and liver cancer cells. Reactive oxygen and nitrogen species (ROS and RNS, respectively), together with intracellular calcium-mediated downstream signaling, are essential for the anticancer effect of these new anthracycline analogs. The changes of mitochondrial membrane potential and induction of the ceramide pathway suggests that these compounds induce cell death by apoptosis. In addition, a significant increase of autophagosome formation was observed by fluorescence assay and acridine orange staining, indicating that the new analogs also induce autophagic cell death. Compared to free DOX-and DAU-treated cells, we observed inhibition of colony formation and migration, a time-dependency between ROS/RNS levels and a greater fall in mitochondrial membrane potential. Altogether, our research broadens the base of molecular oxazolinoanthracyclines targets and reveals that derivatives mediated oxidative stress, ceramide production and increase in intracellular calcium level by mitochondria. Furthermore, our data highlight the importance of mitochondria that simultaneously assume the role of activator of autophagy and apoptosis signals.	[Rogalska, Aneta; Gajek, Arkadiusz; Marczak, Agnieszka] Univ Lodz, Fac Biol & Environm Protect, Inst Biophys, Dept Med Biophys, Lodz, Poland; [Lukawska, Malgorzata; Oszczapowicz, Irena] Inst Biotechnol & Antibiot, Dept Modified Antibiot, Warsaw, Poland	University of Lodz; Institute of Biotechnology & Antibiotics (IBA)	Rogalska, A (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Inst Biophys, Dept Med Biophys, Lodz, Poland.	aneta.rogalska@biol.uni.lodz.pl		Rogalska, Aneta/0000-0002-4170-1693; Gajek, Arkadiusz/0000-0003-3475-441X; Marczak, Agnieszka/0000-0003-3439-9032	 [B1611000000190.01]		The investigation was supported by a statutory research admitted for Department of Medical Biophysics (B1611000000190.01).	Barraud L, 2005, J HEPATOL, V42, P736, DOI 10.1016/j.jhep.2004.12.035; Breton-Romero R, 2014, REDOX BIOL, V2, P529, DOI 10.1016/j.redox.2014.02.005; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Denel-Bobrowska M, 2017, LIFE SCI, V178, P1, DOI 10.1016/j.lfs.2017.04.009; Denel-Bobrowska M, 2016, TOXICOL APPL PHARM, V313, P159, DOI 10.1016/j.taap.2016.10.018; Failli P, 2002, NITRIC OXIDE-BIOL CH, V7, P277, DOI 10.1016/S1089-8603(02)00120-9; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Fulbright JM, 2015, CANCER CHEMOTH PHARM, V76, P1297, DOI 10.1007/s00280-015-2879-4; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Gong XL, 2016, WORLD J GASTROENTERO, V22, P6582, DOI 10.3748/wjg.v22.i29.6582; Hajj C, 2015, BIOL CHEM, V396, P669, DOI 10.1515/hsz-2014-0302; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jana A, 2007, J NEUROIMMUNE PHARM, V2, P184, DOI 10.1007/s11481-007-9066-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Lanceley A, 2017, INT J GYNECOL CANCER, V27, P59, DOI 10.1097/IGC.0000000000000877; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li L, 2007, OTOLARYNG HEAD NECK, V137, P659, DOI 10.1016/j.otohns.2007.04.026; Liu J, 2015, ONCOL REP, V33, P1551, DOI 10.3892/or.2015.3730; Lukawska M, 2012, ANTICANCER RES, V32, P2959; Lukawska M, 2010, INVEST NEW DRUG, V28, P600, DOI 10.1007/s10637-009-9299-4; Mordente A, 2017, CURR MED CHEM, V24, P1607, DOI 10.2174/0929867323666161214120355; Nussler AK, 2006, NAT PROTOC, V1, P2223, DOI 10.1038/nprot.2006.341; Oh SH, 2017, ANAL BIOCHEM, V530, P57, DOI 10.1016/j.ab.2017.05.003; Oyama K, 2009, J CLIN BIOCHEM NUTR, V45, P361, DOI 10.3164/jcbn.09-47; Parra V, 2013, BBA-MOL BASIS DIS, V1832, P1334, DOI 10.1016/j.bbadis.2013.04.009; Patel AG, 2012, ELIFE, V1, DOI 10.7554/eLife.00387; Pedrini I, 2014, MOL PHARMACEUT, V11, P3068, DOI 10.1021/mp500257s; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Ren F, 2016, BBA-REV CANCER, V1866, P266, DOI 10.1016/j.bbcan.2016.10.001; Sagi JC, 2016, PHARMACOGENOMICS, V17, P1075, DOI 10.2217/pgs-2016-0036; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sikora Adam, 2005, Acta Pol Pharm, V62, P31; Sishi BJN, 2013, BIOCHEM PHARMACOL, V85, P124, DOI 10.1016/j.bcp.2012.10.005; Srankova J, 2016, BASIC CLIN PHARMACOL, V119, P443, DOI 10.1111/bcpt.12606; Su WT, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0460-z; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Valcovici M, 2016, ARCH MED SCI, V12, P428, DOI 10.5114/aoms.2016.59270; Wang YD, 2017, MOL PHARMACEUT, V14, P2323, DOI 10.1021/acs.molpharmaceut.7b00184; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xiao Y, 2014, LIFE SCI, V112, P33, DOI 10.1016/j.lfs.2014.07.016; Xu JH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0487-8; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Xu XM, 2012, J PHARMACOL EXP THER, V341, P183, DOI 10.1124/jpet.111.189589; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhao DX, 2014, MOL MED REP, V9, P1975, DOI 10.3892/mmr.2014.2055	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201296	10.1371/journal.pone.0201296	http://dx.doi.org/10.1371/journal.pone.0201296			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040861	gold, Green Submitted, Green Published			2022-12-26	WOS:000439749200035
J	Atreya, CE; Kubo, A; Borno, HT; Rosenthal, B; Campanella, M; Rettger, JP; Joseph, G; Allen, IE; Venook, AP; Altschuler, A; Dhruva, A				Atreya, Chloe E.; Kubo, Ai; Borno, Hala T.; Rosenthal, Blake; Campanella, Matthew; Rettger, John P.; Joseph, Galen; Allen, I. Elaine; Venook, Alan P.; Altschuler, Andrea; Dhruva, Anand			Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ALTERNATIVE MEDICINE USE; EXPRESSIVE GROUP-THERAPY; BREAST-CANCER; STRESS REDUCTION; PSYCHOLOGICAL DISTRESS; FAMILY CAREGIVERS; LUNG-CANCER; DEPRESSIVE SYMPTOMS	A metastatic cancer diagnosis is associated with high levels of distress in patients and caregivers. Mindfulness interventions can reduce distress and improve quality of life in cancer patients. However, standard mindfulness training relies on in-person instruction, which is often not practical for either patients receiving chemotherapy or their caregivers. In the Being Present single arm pilot study, we designed and tested an 8-week audio-based mindfulness meditation program for patients with metastatic colorectal cancer receiving chemotherapy with or without a participating caregiver. The study accrued 33 of 74 (45%) eligible patients consenting together with 20 family caregivers (53 participants total) within nine months. Forty-one participants were evaluable (77%); 10 of 12 cases of attrition were attributable to hospitalization or death. Median participant age was 51 (range 21-78 years); 38% were men. Baseline levels of distress were similar in patients and caregivers. The top reasons for participation cited in pre-intervention interviews were to increase relaxation/calm, improve mood/emotions, and reduce stress/anxiety. In measures of adherence, 59% of responses to weekly texts asking: "Have you practiced today?" were "Yes" and 59% of interviewees reported practicing >50% of the time. Compared to baseline, post-intervention surveys demonstrated significantly reduced distress (p = 0.01) and anxiety (p = 0.03); as well as increased non-reactivity (p<0.01), and feeling at peace (p<0.01). Post-intervention qualitative interviews, where 71% of participants reported benefit, were consistent with quantitative findings. In the interviews, participants spontaneously described reduced stress/anxiety and increased relaxation/calm. Benefits appeared to be accentuated in patient-caregiver pairs as compared to unpaired patients. Seventy-nine percent of participants reported plans for continued practice after study completion. We conclude that the Being Presentaudio-based mindfulness meditation program is of interest to, feasible, and acceptable for patients with metastatic colorectal cancer and caregivers, with initial evidence of efficacy. These results will guide plans for a follow-up study.	[Atreya, Chloe E.; Borno, Hala T.; Rosenthal, Blake; Campanella, Matthew; Venook, Alan P.; Dhruva, Anand] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Atreya, Chloe E.; Borno, Hala T.; Rosenthal, Blake; Campanella, Matthew; Venook, Alan P.; Dhruva, Anand] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr HFCCC, San Francisco, CA 94143 USA; [Kubo, Ai; Altschuler, Andrea] Kaiser Permanente, Div Res, Oakland, CA USA; [Rettger, John P.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Joseph, Galen] UCSF, Dept Anthropol Hist & Social Med, San Francisco, CA USA; [Allen, I. Elaine] UCSF, Dept Epidemiol & Biostat, San Francisco, CA USA; [Dhruva, Anand] UCSF, Osher Ctr Integrat Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Atreya, CE (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Atreya, CE (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr HFCCC, San Francisco, CA 94143 USA.	chloe.atreya@ucsf.edu		Atreya, Chloe/0000-0003-2954-1727	Mount Zion Health Fund; NIH; NCI [KL2TR000143, K08CA175143, K07CA166143]; UCSF Open Access Publishing Fund; NATIONAL CANCER INSTITUTE [K07CA166143, K08CA175153, K08CA127143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER	Mount Zion Health Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCSF Open Access Publishing Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a grant from the Mount Zion Health Fund and the NIH and NCI under Award Numbers KL2TR000143 (CEA and AK); K08CA175143 (CEA) and K07CA166143 (AK), and the UCSF Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We extend gratitude to all Being Present study participants; to Kameron Allen, graphic design; Michael Starita, sound engineer; Lucid Dawn, female voice; Mark Silva, male voice; Hilary Chan, RedCap surveys; Emily Mitchell, back-up research coordinator; Amy J. Markowitz, editorial assistance; as well as to Christopher Webb for inspiration; and to Andrew Avins and James Mitchell for guidance. We also acknowledge the UCSF Open Access Publishing Fund.	Altschuler A, 2012, SUPPORT CARE CANCER, V20, P1291, DOI 10.1007/s00520-011-1216-7; Atreya CE, 2016, J NATL COMPR CANC NE, V14, P1536, DOI 10.6004/jnccn.2016.0165; Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108; Bidstrup PE, 2015, ACTA ONCOL, V54, P789, DOI 10.3109/0284186X.2014.1002571; Birnie K, 2010, PSYCHO-ONCOLOGY, V19, P1004, DOI 10.1002/pon.1651; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Braun M, 2007, J CLIN ONCOL, V25, P4829, DOI 10.1200/JCO.2006.10.0909; Broderick Joan E, 2013, EGEMS (Wash DC), V1, P1015, DOI 10.13063/2327-9214.1015; Brown KW, 2003, PSYCHOSOM MED, V65, P636, DOI 10.1097/01.PSY.0000077503.96903.A6; Carlson LE, 2004, PSYCHO-ONCOL, V13, P837, DOI 10.1002/pon.832; Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Carlson LE, 2013, J CLIN ONCOL, V31, P3119, DOI 10.1200/JCO.2012.47.5210; Carney S, 2011, J CLIN ONCOL, V29, P1001, DOI 10.1200/JCO.2010.30.9104; Chambers SK, 2017, J CLIN ONCOL, V35, P291, DOI 10.1200/JCO.2016.68.8788; Elwert F, 2008, AM J PUBLIC HEALTH, V98, P2092, DOI 10.2105/AJPH.2007.114348; Fang CY, 2001, HEALTH PSYCHOL, V20, P452, DOI 10.1037//0278-6133.20.6.452; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; Fish J, 2016, MINDFULNESS, V7, P1011, DOI 10.1007/s12671-016-0548-2; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Giese-Davis J, 2011, J CLIN ONCOL, V29, P413, DOI 10.1200/JCO.2010.28.4455; GIVEN CW, 1993, HEALTH PSYCHOL, V12, P277, DOI 10.1037/0278-6133.12.4.277; Golant M, 2008, CANCER J, V14, P420, DOI 10.1097/PPO.0b013e31818d894a; Greenlee H, 2009, BREAST CANCER RES TR, V117, P653, DOI 10.1007/s10549-009-0315-3; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Huebner J, 2014, ONCOL RES TREAT, V37, DOI 10.1159/000362616; Johannsen M, 2016, J CLIN ONCOL, V34, P3390, DOI 10.1200/JCO.2015.65.0770; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Kim Y, 2015, PSYCHO-ONCOLOGY, V24, P95, DOI 10.1002/pon.3580; Kissane D, 2009, PSYCHO-ONCOLOGY, V18, P1, DOI 10.1002/pon.1493; Lengacher CA, 2018, PSYCHO-ONCOLOGY, V27, P524, DOI 10.1002/pon.4491; Lengacher CA, 2016, J CLIN ONCOL, V34, P2827, DOI 10.1200/JCO.2015.65.7874; Lengacher CA, 2012, J HOLIST NURS, V30, P170, DOI 10.1177/0898010111435949; Morrison EJ, 2017, CLIN LUNG CANCER, V18, P497, DOI 10.1016/j.cllc.2017.02.008; Musial F, 2011, FORSCH KOMPLEMENTMED, V18, P192, DOI 10.1159/000330714; National Cancer Institute, PALL CAR CANC; National Comprehensive Cancer Network, 2018, DISTR MAN CLIN PRACT; National Comprehensive Cancer Network (NCCN), NCCN DISTR THERM PRO; Nipp RD, 2017, CANCER-AM CANCER SOC, V123, P4720, DOI 10.1002/cncr.30912; Piet J, 2012, J CONSULT CLIN PSYCH, V80, P1007, DOI 10.1037/a0028329; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pirl WF, 2014, CANCER-AM CANCER SOC, V120, P2946, DOI 10.1002/cncr.28750; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Ringdal GI, 2004, PALLIATIVE MED, V18, P108, DOI 10.1191/0269216304pm878oa; Roscoe JA, 2002, SUPPORT CARE CANCER, V10, P329, DOI 10.1007/s00520-001-0317-0; Schellekens MPJ, 2017, PSYCHO-ONCOLOGY, V26, P2118, DOI 10.1002/pon.4430; Schellekens MPJ, 2017, J BEHAV MED, V40, P414, DOI 10.1007/s10865-016-9799-6; Schellekens MPJ, 2016, SUPPORT CARE CANCER, V24, P1813, DOI 10.1007/s00520-015-2954-8; Segal Z. V., 2002, MINDFULNESS BASED CO; Segrin C, 2012, HEALTH PSYCHOL, V31, P70, DOI 10.1037/a0025394; Shaw JM, 2016, SUPPORT CARE CANCER, V24, P585, DOI 10.1007/s00520-015-2817-3; Shumay DM, 2002, J ALTERN COMPLEM MED, V8, P661, DOI 10.1089/107555302320825183; Steinhauser KE, 2006, ARCH INTERN MED, V166, P101, DOI 10.1001/archinte.166.1.101; Trevino KM, 2018, PSYCHO-ONCOLOGY, V27, P243, DOI 10.1002/pon.4441; Venook AP, 2017, JAMA-J AM MED ASSOC, V317, P2392, DOI 10.1001/jama.2017.7105; Walker MS, 2006, PSYCHO-ONCOLOGY, V15, P684, DOI 10.1002/pon.997; Yates JS, 2005, SUPPORT CARE CANCER, V13, P806, DOI 10.1007/s00520-004-0770-7; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y; Zernicke KA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-34	59	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199423	10.1371/journal.pone.0199423	http://dx.doi.org/10.1371/journal.pone.0199423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036361	Green Published, gold			2022-12-26	WOS:000439429200004
J	Nad'o, L; Kanuch, P				Nad'o, Ladislav; Kanuch, Peter			Why sampling ratio matters: Logistic regression and studies of habitat use	PLOS ONE			English	Article							CHALINOLOBUS-TUBERCULATUS; ROOSTING BEHAVIOR; NYCTALUS-NOCTULA; SELECTION; VESPERTILIONIDAE; CONSERVATION; CHIROPTERA; BATS; FOREST; LONG	Logistic regression (LR) models are among the most frequently used statistical tools in ecology. With LR one can infer if a species' habitat use is related to environmental factors and estimate the probability of species occurrence based on the values of these factors. However, studies often use inadequate sampling with regards to the arbitrarily chosen ratio between occupied and unoccupied (or available) locations, and this has a profound effect on the inference and predictive power of LR models. To demonstrate the effect of various sampling strategies/efforts on the quality of LR models, we used a unique census dataset containing all the used roosting cavities of the tree-dwelling bat Nyctalus leisleri and all cavities where the species was absent. We compared models constructed from randomly selected data subsets with varying ratios of occupied and unoccupied cavities (1:1, 1:5, 1:10) with a full dataset model (ratio 1:31). These comparisons revealed that the power of LR models was low when the sampling did not reflect the population ratio of occupied and unoccupied cavities. The use of weights improved the subsampled models. Thus, this study warns against inadequate data sampling and highly encourages a randomized sampling procedure to estimate the true ratio of occupied:unoccupied locations, which can then be used to optimize a manageable sampling effort and apply weights to improve the LR model. Such an approach may provide robust and reliable models suitable for both inference and prediction.	[Nad'o, Ladislav; Kanuch, Peter] Slovak Acad Sci, Inst Forest Ecol, Zvolen, Slovakia; [Kanuch, Peter] PJ Safar Univ Kosice, Fac Sci, Inst Biol & Ecol, Kosice, Slovakia	Slovak Academy of Sciences	Nad'o, L (corresponding author), Slovak Acad Sci, Inst Forest Ecol, Zvolen, Slovakia.	ladislav.nado@gmail.com	Kanuch, Peter/A-5416-2011; Naďo, Ladislav/G-5699-2013	Kanuch, Peter/0000-0003-2001-4541; Nado, Ladislav/0000-0002-1718-901X	Ministerstvo skolstva, vedy, vyskumu a sportu Slovenskej republiky [VEGA - 2/0131/17]	Ministerstvo skolstva, vedy, vyskumu a sportu Slovenskej republiky	This work was funded by the Ministerstvo skolstva, vedy, vyskumu a sportu Slovenskej republiky, VEGA - 2/0131/17, to Dr. Ladislav Nado. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, BIOL CONSERV, V111, P435, DOI 10.1016/S0006-3207(02)00313-0; Bihari Z, 2004, MAMMALIA, V68, P329, DOI 10.1515/mamm.2004.032; Campbell S, 2009, AUST J ZOOL, V57, P89, DOI 10.1071/ZO09006; Dietz C., 2009, BATS BRITAIN EUROPE; Drew CA, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7390-0; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Menard S., 2002, APPL LOGISTIC REGRES; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pullin AS, 2003, J NAT CONSERV, V11, P83, DOI 10.1078/1617-1381-00040; R Development Core Team, 2016, R LANG ENV STAT COMP; Ruczynski I, 2005, J MAMMAL, V86, P921, DOI 10.1644/1545-1542(2005)86[921:RCSBNN]2.0.CO;2; Russo D, 2004, BIOL CONSERV, V117, P73, DOI 10.1016/S0006-3207(03)00266-0; Sedgeley JA, 2003, NEW ZEAL J ZOOL, V30, P227, DOI 10.1080/03014223.2003.9518341; Sedgeley JA, 2001, J APPL ECOL, V38, P425, DOI 10.1046/j.1365-2664.2001.00607.x; Swarming P., 2015, BEHAV PROCESS, V120, P80	17	12	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200742	10.1371/journal.pone.0200742	http://dx.doi.org/10.1371/journal.pone.0200742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036369	gold, Green Published, Green Submitted			2022-12-26	WOS:000439429200014
J	Rhyasen, GW; Yao, Y; Zhang, JW; Dulak, A; Castriotta, L; Jacques, K; Zhao, W; Gharandaghi, F; Hattersley, MM; Lyne, PD; Clark, E; Zinda, M; Fawell, SE; Mills, GB; Che, HW				Rhyasen, Garrett W.; Yao, Yi; Zhang, Jingwen; Dulak, Austin; Castriotta, Lillian; Jacques, Kelly; Zhao, Wei; Gharandaghi, Farzin; Hattersley, Maureen M.; Lyne, Paul D.; Clark, Edwin; Zinda, Michael; Fawell, Stephen E.; Mills, Gordon B.; Che, Huawei			BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors	PLOS ONE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; DRUG-SENSITIVITY; REVEALS; MUTATIONS; CHROMATIN; RECURRENT; BINDING; SWI/SNF; NUMBER	BRD4 is a transcriptional co-activator functioning to recruit regulatory complexes to acety-lated chromatin. A subset of High-grade Serous Ovarian Cancer (HGSOC) patients are typified by focal, recurrent BRD4 gene amplifications. Despite previously described cancer dependencies, it is unclear whether BRD4 amplification events are oncogenic in HGSOC. We find that physiologically relevant levels of expression of BRD4 isoforms in non-transformed ovarian cells result in cellular transformation. Transcriptional profiling of BRD4-transformed ovarian cells, and BRD4-amplified HGSOC patient samples revealed shared expression patterns, including enriched MYC, and E2F1 gene signatures. Furthermore, we demonstrate that a novel BET inhibitor, AZD5153, is highly active in BRD4-amplified patient derived xenografts and uncover Neuregulin-1 as a novel BRD4 effector. Experiments involving Neuregulin-1 inhibition and exogenous addition, demonstrate Neuregulin-1 as necessary and sufficient for BRD4-mediated transformation. This study demonstrates the oncogenic potential of BRD4 amplification in cancer and establishes BRD4-amplified HGSOC as a potential patient population that could benefit from BET inhibitors.	[Rhyasen, Garrett W.; Yao, Yi; Zhang, Jingwen; Dulak, Austin; Castriotta, Lillian; Jacques, Kelly; Gharandaghi, Farzin; Hattersley, Maureen M.; Lyne, Paul D.; Clark, Edwin; Zinda, Michael; Fawell, Stephen E.; Che, Huawei] AstraZeneca, IMED Biotech Unit, Biosci, Oncol, Boston, MA USA; [Zhao, Wei; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	AstraZeneca; University of Texas System; UTMD Anderson Cancer Center	Che, HW (corresponding author), AstraZeneca, IMED Biotech Unit, Biosci, Oncol, Boston, MA USA.	raymond.chen@astrazeneca.com	Zhang, Jing/GWZ-7332-2022	Mills, Gordon/0000-0002-0144-9614	AstraZeneca Pharmaceuticals; NCI [P50CA083639]; NATIONAL CANCER INSTITUTE [P50CA083639] Funding Source: NIH RePORTER	AstraZeneca Pharmaceuticals(AstraZeneca); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is funded mainly by AstraZeneca Pharmaceuticals LP and also partially by grant P50CA083639 from NCI: https://www. cancer.gov/ (GBM). AstraZeneca provided support in the form of salaries for authors G.W.R., Y.Y., A. D., L.C, K.J., J.Z., F.G., M.H., P.L., E.C., M.Z., S.F., and H.C, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alsarraj J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080746; Baratta MG, 2015, P NATL ACAD SCI USA, V112, P232, DOI 10.1073/pnas.1422165112; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dhanasekaran SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6893; Duygu UaL, 2015, MOL CLIN ONCOLOGY, V3, P1291, DOI [10.3892/mco.2015.622, DOI 10.3892/MCO.2015.622]; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Goundiam O, 2015, INT J CANCER, V137, P1890, DOI 10.1002/ijc.29568; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Itzen F, 2014, NUCLEIC ACIDS RES, V42, P7577, DOI 10.1093/nar/gku449; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Rhyasen GW, 2016, MOL CANCER THER, V15, P2563, DOI 10.1158/1535-7163.MCT-16-0141; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart HJS, 2013, CANCER MED-US, V2, P826, DOI 10.1002/cam4.146; Sung CO, 2014, GYNECOL ONCOL, V132, P343, DOI 10.1016/j.ygyno.2013.11.036; Therapeutics T., DOSE ESCALATION COHO; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yu J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3248-y; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	39	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200826	10.1371/journal.pone.0200826	http://dx.doi.org/10.1371/journal.pone.0200826			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036377	Green Published, gold, Green Submitted			2022-12-26	WOS:000439429200018
J	van Rijn, S				van Rijn, Sophie			Salivary testosterone in relation to social cognition and social anxiety in children and adolescents with 47,XXY (Klinefelter syndrome)	PLOS ONE			English	Article							SPECTRUM DISORDERS; SERUM TESTOSTERONE; FETAL TESTOSTERONE; DIURNAL-VARIATION; SHORT-FORMS; MEN; AUTISM; BEHAVIOR; PUBERTY; BOYS	Background Approximately 1 in 650 boys are born with an extra X chromosome. Boys and men with 47, XXY (Klinefelter syndrome) are at risk for neurodevelopmental disorders and specific cognitive impairments. This study was focused on social anxiety and social cognition. The aim was to assess if these aspects of the phenotype are related to testosterone deficiency, which is typically seen in 47,XXY from puberty onwards. Methods In the study 20 boys with 47,XXY and 25 non-clinical controls between 8 and 19 years participated. None had ever used testosterone supplements. Cognitive tests measuring the labeling of facial expressions and perspective taking (Theory of Mind) were administered. Self-report questionnaires were used to assess social anxiety. Testosterone was measured in saliva. Results Within the 47,XXY group lower levels of salivary testosterone were significantly associated with higher levels of social anxiety. The correlation was strong, andindependent of age and pubertal development. However, salivary levels of testosterone were uncorrelated to social cognitive skills. Discussion These findings point out that lower testosterone levels might contribute to high social anxiety in 47,XXY, suggesting that anxiety should be monitored in pubertal boys with XXY presenting with testosterone deficiency. This should be done in addition to exploring cognitive behavioral therapy or psychopharmacologic treatments targeting anxiety, which are more evidence based. In contrast, testosterone levels were not associated with social cognitive functioning, suggesting that other mechanisms are driving vulnerabilities in this domain.	[van Rijn, Sophie] Leiden Univ, Clin Child & Adolescent Studies, Leiden, Netherlands; [van Rijn, Sophie] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	van Rijn, S (corresponding author), Leiden Univ, Clin Child & Adolescent Studies, Leiden, Netherlands.; van Rijn, S (corresponding author), Leiden Inst Brain & Cognit, Leiden, Netherlands.	srijn@fsw.leidenuniv.nl		van rijn, sophie/0000-0002-9179-7515	VENI grant from the Netherlands Organization for Scientific Research [016.095.060, 016.165.397]	VENI grant from the Netherlands Organization for Scientific Research	This work was supported by a VENI grant (grant number 016.095.060 to SvR) and VIDI grant (grant number 016.165.397 to SvR) from the Netherlands Organization for Scientific Research (www.nwo.nl).	Aksglaede L, 2013, EUR J ENDOCRINOL, V168, pR67, DOI 10.1530/EJE-12-0934; [Anonymous], 1991, MANUAL CHILD BEHAV C; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bialek M, 2004, POL J PHARMACOL, V56, P509; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; BUTLER GE, 1989, CLIN ENDOCRINOL, V30, P587, DOI 10.1111/j.1365-2265.1989.tb01431.x; Campbell JM, 1998, PSYCHOL ASSESSMENT, V10, P431, DOI 10.1037/1040-3590.10.4.431; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Cederlof M, 2014, J PSYCHIATR RES, V48, P128, DOI 10.1016/j.jpsychires.2013.10.001; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Coleman L, 2002, J ADOLESCENCE, V25, P535, DOI 10.1006/jado.2002.0494; Coleman N, 2008, J INTELLECT DISABILI, V12, P49, DOI 10.1177/1744629507086608; Cordeiro L, 2012, RES DEV DISABIL, V33, P1254, DOI 10.1016/j.ridd.2012.02.013; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P191, DOI 10.1111/j.2044-8260.1992.tb00983.x; Dekking YM., 1983, HANDLEIDING SOCIALE; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Granger DA, 2003, DEV PSYCHOPATHOL, V15, P431, DOI 10.1017/S0954579403000233; HANDA RJ, 1994, PHYSIOL BEHAV, V55, P117, DOI 10.1016/0031-9384(94)90018-3; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Host C, 2014, ASIAN J ANDROL, V16, P185, DOI 10.4103/1008-682X.122201; Knickmeyer R, 2006, HORM BEHAV, V49, P282, DOI 10.1016/j.yhbeh.2005.08.010; Lee NR, 2011, INT REV RES DEV DISA, V40, P139, DOI 10.1016/B978-0-12-374478-4.00006-X; Lee NR, 2011, J INT NEUROPSYCH SOC, V17, P522, DOI 10.1017/S1355617711000312; McHenry J, 2014, FRONT NEUROENDOCRIN, V35, P42, DOI 10.1016/j.yfrne.2013.09.001; Mohatt J, 2014, AM J PSYCHIAT, V171, P741, DOI 10.1176/appi.ajp.2014.13101337; Morley JE, 2006, AGING MALE, V9, P165, DOI 10.1080/13685530600907993; Oates RD, 2012, FERTIL STERIL, V98, P266, DOI 10.1016/j.fertnstert.2012.06.024; Rilling JK, 1996, STEROIDS, V61, P374, DOI 10.1016/0039-128X(96)00043-8; Ross JL, 2017, J PEDIATR-US, V185, P193, DOI 10.1016/j.jpeds.2017.02.036; Samango-Sprouse CA, 2013, AM J MED GENET A, V161A, P501, DOI 10.1002/ajmg.a.35769; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Ung D, 2015, CHILD PSYCHIAT HUM D, V46, P533, DOI 10.1007/s10578-014-0494-y; Van Manen TG., 2009, MANUAL SOCIAL COGNIT; van Rijn S, 2006, SCHIZOPHR RES, V84, P194, DOI 10.1016/j.schres.2006.02.020; van Rijn S, 2015, GENES BRAIN BEHAV, V14, P200, DOI 10.1111/gbb.12203; van Rijn S, 2014, GENES BRAIN BEHAV, V13, P459, DOI 10.1111/gbb.12134; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; van Rijn S, 2014, J AUTISM DEV DISORD, V44, P310, DOI 10.1007/s10803-013-1860-5; van Rijn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084721; van Wingen G, 2010, PSYCHONEUROENDOCRINO, V35, P105, DOI 10.1016/j.psyneuen.2009.09.007; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; Viau V, 1996, J NEUROSCI, V16, P1866; Visootsak J, 2009, DEV DISABIL RES REV, V15, P328, DOI 10.1002/ddrr.76; WANG C, 1981, J CLIN ENDOCR METAB, V53, P1021, DOI 10.1210/jcem-53-5-1021; Wechsler D., 2005, WECHSLER ADULT INTEL; Wosnitzer MS, 2013, AM J MED GENET C, V163C, P16, DOI 10.1002/ajmg.c.31350	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200882	10.1371/journal.pone.0200882	http://dx.doi.org/10.1371/journal.pone.0200882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036387	gold, Green Published			2022-12-26	WOS:000439429200021
J	Bossier, S; Palacz, AP; Nielsen, JR; Christensen, A; Hoff, A; Maar, M; Gislason, H; Bastardie, F; Gorton, R; Fulton, EA				Bossier, Sieme; Palacz, Artur P.; Nielsen, J. Rasmus; Christensen, Asbjorn; Hoff, Ayoe; Maar, Marie; Gislason, Henrik; Bastardie, Francois; Gorton, Rebecca; Fulton, Elizabeth A.			The Baltic Sea Atlantis: An integrated end-to-end modelling framework evaluating ecosystem-wide effects of human-induced pressures	PLOS ONE			English	Article							SOUTHERN BENGUELA; TROPHIC CASCADES; FOOD-WEB; MANAGEMENT; FISHERIES; NITROGEN; IMPACT; FISH; EUTROPHICATION; COMMUNITIES	Achieving good environmental status in the Baltic Sea region requires decision support tools which are based on scientific knowledge across multiple disciplines. Such tools should integrate the complexity of the ecosystem and enable exploration of different natural and anthropogenic pressures such as climate change, eutrophication and fishing pressures in order to compare alternative management strategies. We present a new framework, with a Baltic implementation of the spatially-explicit end-to-end Atlantis ecosystem model linked to two external models, to explore the different pressures on the marine ecosystem. The HBM-ERGOM initializes the Atlantis model with high-resolution physical-chemical-biological and hydrodynamic information while the FISHRENT model analyses the fisheries economics of the output of commercial fish biomass for the Atlantis terminal projection year. The Baltic Atlantis model composes 29 subareas, 9 vertical layers and 30 biological functional groups. The balanced calibration provides realistic levels of biomass for, among others, known stock sizes of top predators and of key fish species. Furthermore, it gives realistic levels of phytoplankton biomass and shows reasonable diet compositions and geographical distribution patterns for the functional groups. By simulating several scenarios of nutrient load reductions on the ecosystem and testing sensitivity to different fishing pressures, we show that the model is sensitive to those changes and capable of evaluating the impacts on different trophic levels, fish stocks, and fisheries associated with changed benthic oxygen conditions. We conclude that the Baltic Atlantis forms an initial basis for strategic management evaluation suited for conducting medium to long term ecosystem assessments which are of importance for a number of pan-Baltic stakeholders in relation to anthropogenic pressures such as eutrophication, climate change and fishing pressure, as well as changed biological interactions between functional groups.	[Bossier, Sieme; Nielsen, J. Rasmus; Christensen, Asbjorn; Gislason, Henrik; Bastardie, Francois] Tech Univ Denmark, Natl Inst Aquat Resources, Lyngby, Denmark; [Palacz, Artur P.] Polish Acad Sci, Inst Oceanol, Int Ocean Carbon Coordinat Project, Sopot, Poland; [Hoff, Ayoe] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark; [Maar, Marie] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Gorton, Rebecca; Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Fulton, Elizabeth A.] Univ Tasmania, Ctr Marine Socioecol, Battery Point, Tas, Australia	Technical University of Denmark; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; University of Copenhagen; Aarhus University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Bossier, S (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Lyngby, Denmark.	siebo@aqua.dtu.dk	Maar, Marie/C-5837-2008; Nielsen, J. Rasmus/AAG-2647-2021; Gislason, Henrik/C-1357-2008; Fulton, Beth/A-2871-2008; Gislason, Henrik/R-9567-2019	Maar, Marie/0000-0001-8594-2993; Nielsen, J. Rasmus/0000-0002-2833-3873; Gislason, Henrik/0000-0003-0242-3333; Fulton, Beth/0000-0002-5904-7917; Bastardie, Francois/0000-0002-2669-6179; Hoff, Ayoe/0000-0002-3679-3431; Christensen, Asbjorn/0000-0002-4286-7409; Palacz, Artur/0000-0002-1634-7880; Bossier, Sieme/0000-0003-2548-0410	Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE) [09-067259]; EU [266445]; EU-H2020 Climate change and European Aquatic RESources (CERES) [678193]; Cooperation. in Fisheries, Aquaculture and Sea Food Processing (European Commission FP7 ERA-NET PRIME TRADEOFFS) [321553]	Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE); EU(European Commission); EU-H2020 Climate change and European Aquatic RESources (CERES); Cooperation. in Fisheries, Aquaculture and Sea Food Processing (European Commission FP7 ERA-NET PRIME TRADEOFFS)	This work was supported by (i) The Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE, Grant no. 09-067259), author receiving funding: RN; (ii) the EU "Vectors of Change in Oceans and Seas, Marine Life, Impact and Economic Sectors"(Vectors, FP7/2010-2013, Grant Agreement no. 266445), http://www.marinevectors.eu/, author receiving funding: RN; (iii) the EU-H2020 Climate change and European Aquatic RESources (CERES, Grant agreement no. 678193), http.//ceresprojecteu, author receiving funding: RN; (iv) Cooperation. in Fisheries, Aquaculture and Sea Food Processing (European Commission FP7 ERA-NET PRIME TRADEOFFS, Grant agreement no. 321553), http://old.uefscdi.ro/artcole/3275/COFASP Cooperation- in-Fisheries-Aquaculture-and -Sea-foodProcessng.html, Stefan Neuenfeldt, DTU Aqua is main receiver of the funding, but Sieme Bossier also received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the extensive cooperation we have had on this work from research under: (i) The Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE, Grant no. 09-067259), (ii) the EU "Vectors of Change in Oceans and Seas, Marine Life, Impact and Economic Sectors" (Vectors, FP7/2010-2013, Grant Agreement no. 266445), (iii) the EU-H2020 CERES (Grant agreement no. 678193) Project and (iv) the COFASP ERA-NET PRIME-TRA-DEOFFS project (Grant agreement no. 321553, EU-FP7).	Al-Hamdani K. Z., 2007, GEOLOGICAL SURVEY DE, V13, P61; Audzijonyte A., 2017, ATLANTIS USERS GUI 1; BADEN SP, 1990, AMBIO, V19, P113; Bastardie F, 2015, 2015M03 ICES ASC CM; Bastardie F, 2015, ICES J MAR SCI, V72, P824, DOI 10.1093/icesjms/fsu215; Bastardie F, 2014, CAN J FISH AQUAT SCI, V71, P366, DOI 10.1139/cjfas-2013-0126; Bergstom S., 1992, SMHI REPORTS RV; BEVERTON RJH, 1957, DYNAMICS EXPLOITED F, V2; Bonsdorff E, 1999, AUST J ECOL, V24, P312, DOI 10.1046/j.1442-9993.1999.00986.x; Bonsdorff E, 2002, HYDROBIOLOGIA, V475, P371, DOI 10.1023/A:1020395526898; Borja A, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00072; Bostrom C, 2014, AQUAT CONSERV, V24, P410, DOI 10.1002/aqc.2424; Bucas M, 2009, OCEANOLOGIA, V51, P341, DOI 10.5697/oc.51-3.359; Cerco CF, 2010, ENVIRON MODELL SOFTW, V25, P562, DOI 10.1016/j.envsoft.2009.09.008; Deutsch B, 2010, BIOGEOSCIENCES, V7, P3259, DOI 10.5194/bg-7-3259-2010; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dutz J, 2012, MAR ECOL PROG SER, V462, P51, DOI 10.3354/meps09830; Eilola K, 2011, J MARINE SYST, V88, P267, DOI 10.1016/j.jmarsys.2011.05.004; Eriksson BK, 2005, ESTUAR COAST SHELF S, V62, P109, DOI 10.1016/j.ecss.2004.08.009; Fleming-Lehtinen V, 2015, ECOL INDIC, V48, P380, DOI 10.1016/j.ecolind.2014.08.022; Frost H., 2009, EIAA MODEL METHODOLO; Frost H, 2013, CAN J AGR ECON, V61, P283, DOI 10.1111/cjag.12014; Fulton E. A., 2004, R991546 AUSTR FISH M, P116, DOI DOI 10.1017/CBO9781107415324.004; Fulton EA, 2015, ENVIRON SCI POLICY, V48, P44, DOI 10.1016/j.envsci.2014.12.006; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gardmark A, 2013, ECOL APPL, V23, P742, DOI 10.1890/12-0267.1; Girardin R, 2018, ESTUAR COAST SHELF S, V201, P208, DOI 10.1016/j.ecss.2016.10.016; Hagerman L, 1998, HYDROBIOLOGIA, V375-76, P241, DOI 10.1023/A:1017033711985; Hallfors H, 2013, HYDROBIOLOGIA, V707, P109, DOI 10.1007/s10750-012-1414-4; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen C, 2016, SET UP NORDIC BARENT, P1; Hansen J., 2013, NOVANA VIDENSKABELIG; Harvey CJ, 2003, ICES J MAR SCI, V60, P939, DOI 10.1016/S1054-3139(03)00098-5; Hasler B., 2015, MODELLERING OMKOSTNI; HELCOM, 2010, HELCOM BALT SEA ENV; HELCOM, 2007, HELCOM ENV P, V111; HELCOM, 2014, BALT SEA ENV P; HELCOM, 2013, BALT SEA ENV P, P1; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2015, CAN J FISH AQUAT SCI, V72, P1433, DOI 10.1139/cjfas-2015-0062; Hilborn R, 2011, FISH RES, V108, P235, DOI 10.1016/j.fishres.2010.12.030; Horne P.J., 2010, TECHNICAL REPORT; ICES, 2013, BALT SEA COD SUBD 22; ICES, 2012, STOCK SUMM ADV JUN 2; ICES, 2013, 2013ACOM06 ICES CM; ICES, 2013, 20133 ICES WGNSSK; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jorgensen L, 2014, BIOGEOCHEMISTRY, V117, P455, DOI 10.1007/s10533-013-9890-9; Kahru M, 1997, MONITORING ALGAL BLOOMS: NEW TECHNIQUES FOR DETECTING LARGE-SCALE ENVIRONMENTAL CHANGE, P43; Kaplan IC, 2014, ICES J MAR SCI, V71, P308, DOI 10.1093/icesjms/fst114; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kaplan IC, 2009, FISH FISH SER, V31, P77, DOI 10.1007/978-1-4020-9210-7_5; Karlson B, 2001, SKAGERRAK ENV STATE; Korpinen S, 2012, ECOL INDIC, V15, P105, DOI 10.1016/j.ecolind.2011.09.023; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Laane A, 2005, GIWA REGIONAL ASSESS, V17; Lewy P, 2004, STOCHASTIC AGE LENGT, P33; Link J. S., 2010, ECOSYSTEM BASED FISH; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; Lundstrom K, 2010, ICES J MAR SCI, V67, P1230, DOI 10.1093/icesjms/fsq022; Lyngsgaard MM, 2014, LIMNOL OCEANOGR, V59, P1679, DOI 10.4319/lo.2014.59.5.1679; Maar M, 2016, ECOL MODEL, V320, P258, DOI 10.1016/j.ecolmodel.2015.09.023; Maar M, 2011, ECOL MODEL, V222, P1696, DOI 10.1016/j.ecolmodel.2011.03.006; MacKenzie BR, 2000, MAR ECOL PROG SER, V193, P143, DOI 10.3354/meps193143; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; Morzaria-Luna HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042917; Murawski SA, 2010, ICES J MAR SCI, V67, P1, DOI 10.1093/icesjms/fsp221; Nehring D., 1991, ACTA ICHTHYOL PISCAT, V21, P152; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Neumann T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001450; Nielsen JR, 2018, FISH FISH, V19, P1, DOI 10.1111/faf.12232; Nielsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070668; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Osterblom H, 2017, ECOSYSTEMS, V20, P54, DOI 10.1007/s10021-016-9998-6; Osterblom H, 2013, BIOSCIENCE, V63, P735, DOI 10.1093/bioscience/63.9.735; Pecuchet L, 2015, ICES J MAR SCI, V72, P1323, DOI 10.1093/icesjms/fsu220; Petersen ME, 2017, J MARINE SYST, V169, P25, DOI 10.1016/j.jmarsys.2017.01.006; Plaganyi E.E., 2007, FAO FISH TECH PAP; Ramos J, 2015, ICES J MAR SCI, V72, P720, DOI 10.1093/icesjms/fsu095; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Ross SD, 2016, MAR MAMMAL SCI, V32, P1491, DOI 10.1111/mms.12318; Rumohr H, 1996, ARCH FISH MAR RES, V44, P179; Savchuk OP, 2009, HYDROBIOLOGIA, V629, P209, DOI 10.1007/s10750-009-9775-z; Savchuk OP, 2005, J MARINE SYST, V56, P1, DOI 10.1016/j.jmarsys.2004.08.005; Savchuk OP, 2012, 5 BALT NEST I; Schinke H, 1998, CONT SHELF RES, V18, P67, DOI 10.1016/S0278-4343(97)00071-X; Siegel H, 2015, SEA SURFACE TEMPERAT; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Smith ADM, 2008, FISH RES, V94, P373, DOI 10.1016/j.fishres.2008.06.006; Smith MD, 2015, AFR J MAR SCI, V37, P65, DOI 10.2989/1814232X.2015.1013501; Smith MD, 2015, ENVIRON MODELL SOFTW, V69, P23, DOI 10.1016/j.envsoft.2015.03.002; Soma K., 2010, STUDY REMUNERATION S; Soma K, 2014, ICES J MAR SCI, V71, P2630, DOI 10.1093/icesjms/fst193; Timmermann K, 2012, J MARINE SYST, V105, P60, DOI 10.1016/j.jmarsys.2012.06.001; Timmermann K, 2010, J MARINE SYST, V82, P111, DOI 10.1016/j.jmarsys.2010.04.008; Tomczak MT, 2012, ECOL MODEL, V230, P123, DOI 10.1016/j.ecolmodel.2011.12.014; Tomczak MT, 2009, PROG OCEANOGR, V81, P111, DOI 10.1016/j.pocean.2009.04.017; Unverzagt S., 2001, GREIFSWALDER GEOGRAP, V19, P99; UZARS D, 1994, ICES MAR SC, V198, P612; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Wan Z, 2012, OCEAN SCI, V8, P683, DOI 10.5194/os-8-683-2012; Weijerman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144165; Wennhage H, 2007, MAR ECOL PROG SER, V335, P187, DOI 10.3354/meps335187; Windolf J, 2011, J ENVIRON MONITOR, V13, P2645, DOI 10.1039/c1em10139k; Winterhalter B., 1981, BALTIC SEA, P105; Wulff FV, 2013, SYSTEMS ANAL BALTIC, V148	107	25	25	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0199168	10.1371/journal.pone.0199168	http://dx.doi.org/10.1371/journal.pone.0199168			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028849	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000439396900003
J	Margaryan, S; Witkowicz, A; Arakelyan, A; Partyka, A; Karabon, L; Manukyan, G				Margaryan, Sona; Witkowicz, Agata; Arakelyan, Arsen; Partyka, Anna; Karabon, Lidia; Manukyan, Gayane			sFasL-mediated induction of neutrophil activation in patients with type 2 diabetes mellitus	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; SOLUBLE FAS LIGAND; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; NLRP3 INFLAMMASOME; EXPRESSION; OBESITY; DEATH; FORM; MACROPHAGES	Fas/Fas ligand system was shown to be related to insulin resistance and type 2 diabetes mellitus (T2DM). However, the role of soluble Fas ligand (sFasL) in functioning of immune cells in type 2 diabetes mellitus (T2DM) has not been studied yet. The aim of the present study was to determine in vitro effects of sFasL on neutrophil activation and apoptosis. We demonstrate here that sFasL exhibited proinflammatory effect and induced mRNA levels of caspase-1, NF-kappa B, IL-1 beta and CD18 expression. At the same time, sFasL induced reactive oxygen species (ROS) production. Activation of caspase-1 activity abolished sFasL-dependent apoptosis, and suppressed Fas expression and mRNA levels of caspase-3 in neutrophils from T2DM patients. Collectively, our findings identify a novel proinflammatory role of sFasL in T2DM neutrophils that is dependent of caspase activity. Thus, sFasL enhances inflammatory response of neutrophils from T2DM patients without increasing apoptosis suggesting its triggering role in T2DM inflammation.	[Margaryan, Sona; Arakelyan, Arsen; Manukyan, Gayane] Russian Armenian Univ, Yerevan, Armenia; [Margaryan, Sona; Manukyan, Gayane] Inst Mol Biol, Lab Mol & Cellular Immunol, Yerevan, Armenia; [Witkowicz, Agata; Partyka, Anna; Karabon, Lidia] Polish Acad Sci, L Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Therapy, Wroclaw, Poland; [Arakelyan, Arsen] Inst Mol Biol, Bioinformat Grp, Yerevan, Armenia	Russian Armenian Slavonic University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA	Manukyan, G (corresponding author), Russian Armenian Univ, Yerevan, Armenia.; Manukyan, G (corresponding author), Inst Mol Biol, Lab Mol & Cellular Immunol, Yerevan, Armenia.	gaya.manukyan@gmail.com	Karabon, Lidia/J-1148-2019; Manukyan, Gayane/AAR-7421-2020	Karabon, Lidia/0000-0001-8172-0971; Manukyan, Gayane/0000-0001-7541-5743; Arakelyan, Arsen/0000-0002-6851-1056	U-GENE, 7. PR UE PEOPLE Marie Curie International Research Staff Exchange Scheme (IRSES) [319010]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation	U-GENE, 7. PR UE PEOPLE Marie Curie International Research Staff Exchange Scheme (IRSES); Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation	This work was supported by the U-GENE, 7. PR UE PEOPLE Marie Curie International Research Staff Exchange Scheme (IRSES) number 319010, and Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, as well as Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation. The cost of publication was covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Bamri-Ezzine S, 2003, LAB INVEST, V83, P1069, DOI 10.1097/01.LAB.0000078687.21634.69; Bluher M, 2014, J CLIN ENDOCR METAB, V99, pE36, DOI 10.1210/jc.2013-2488; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cosson E, 2005, DIABETES METAB, V31, P47, DOI 10.1016/S1262-3636(07)70166-0; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Engstrom G, 2003, DIABETES, V52, P442, DOI 10.2337/diabetes.52.2.442; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Guillot R, 2001, DIABETES METAB, V27, P315; Hatanaka E, 2006, CLIN EXP IMMUNOL, V146, P443, DOI 10.1111/j.1365-2249.2006.03229.x; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Hou HW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29410; Item F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00566-9; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje; Keane KN, 2017, EUR J CLIN NUTR, V71, P904, DOI 10.1038/ejcn.2017.45; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lee CTC, 2014, CLIN ENDOCRINOL, V81, P536, DOI 10.1111/cen.12390; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maedler K, 2002, P NATL ACAD SCI USA, V99, P8236, DOI 10.1073/pnas.122686299; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mitsiades N, 1998, AM J PATHOL, V153, P1947, DOI 10.1016/S0002-9440(10)65708-2; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mogi M, 2001, LAB INVEST, V81, P177, DOI 10.1038/labinvest.3780225; Mondal Avijit, 2012, Indian J Endocrinol Metab, V16, pS465, DOI 10.4103/2230-8210.104133; Niinobu T, 2000, AM J PHYSIOL-CELL PH, V279, pC504, DOI 10.1152/ajpcell.2000.279.2.C504; O'Donnell JA, 2015, J LEUKOCYTE BIOL, V97, P321, DOI 10.1189/jlb.3AB1113-594RR; Ottonello L, 1999, J IMMUNOL, V162, P3601; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Ristic T, 2010, VOJNOSANIT PREGL, V67, P537, DOI 10.2298/VSP1007537R; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; Shimizu M, 2002, J AM COLL CARDIOL, V39, P585, DOI 10.1016/S0735-1097(01)01800-9; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tomita T, 2016, BOSNIAN J BASIC MED, V16, P162, DOI 10.17305/bjbms.2016.919; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yamaguchi S, 1999, AM J CARDIOL, V83, P1500, DOI 10.1016/S0002-9149(99)00133-2; Zhang HM, 2017, J DIABETES COMPLICAT, V31, P31, DOI 10.1016/j.jdiacomp.2016.10.029	46	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201087	10.1371/journal.pone.0201087	http://dx.doi.org/10.1371/journal.pone.0201087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024959	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000090
J	Wagner, AC; Jaworsky, D; Logie, CH; Conway, T; Pick, N; Wozniak, D; Rana, J; Tharao, W; Kaida, A; de Pokomandy, A; Ion, A; Chambers, LA; Webster, K; MacGillivray, SJ; Loutfy, M				Wagner, Anne C.; Jaworsky, Denise; Logie, Carmen H.; Conway, Tracey; Pick, Neora; Wozniak, Denise; Rana, Jesleen; Tharao, Wangari; Kaida, Angela; de Pokomandy, Alexandra; Ion, Allyson; Chambers, Lori A.; Webster, Kath; MacGillivray, S. Jay; Loutfy, Mona		CHIWOS Res Team	High rates of posttraumatic stress symptoms in women living with HIV in Canada	PLOS ONE			English	Article							RURAL RESIDENCE; SOCIAL SUPPORT; SUBSTANCE USE; TRAUMA; DISORDER; INSTRUMENT; DEPRESSION; INFECTION; RISK; PTSD	Purpose Women living with HIV experience high levels of trauma exposure before and after diagnosis. One of the most challenging outcomes following trauma exposure is posttraumatic stress disorder. Despite high exposure to traumatic events, the presence and contributors to posttraumatic stress disorder symptoms have not been examined in women living with HIV in Canada. Methods The current study examines the presence of, contributors to, and geographical regions associated with self-reported posttraumatic stress symptoms (PTSS) among 1405 women enrolled in the Canadian HIV Women's Sexual & Reproductive Health Cohort Study (CHIWOS). Results Separate linear regression models were run for the three provinces in the cohort: British Columbia, Ontario and Quebec. Scores consistent with posttraumatic stress disorder were reported by 55.9%, 39.1% and 54.1% of the participants in each province, respectively (F(2, 1402) = 13.53, p < .001). Conclusions The results demonstrate that women living with HIV have high rates of PTSS, and that rates and variables associated with these symptoms vary by province. These results suggest the need for trauma-informed practices and care for women living with HIV in Canada, which may need to be tailored for the community and identities of the women.	[Wagner, Anne C.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Jaworsky, Denise; Pick, Neora] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Logie, Carmen H.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Logie, Carmen H.; Conway, Tracey; Loutfy, Mona] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Pick, Neora] BC Womens Hosp, Oak Tree Clin, Vancouver, BC, Canada; [Wozniak, Denise] CHIWOS Community Advisory Board, Mission, BC, Canada; [Rana, Jesleen; Tharao, Wangari] Womens Hlth Womens Hands Community Hlth Ctr, Toronto, ON, Canada; [Rana, Jesleen; Loutfy, Mona] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaida, Angela; Webster, Kath] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [de Pokomandy, Alexandra] McGill Univ, Chron Viral Illness Serv, Hlth Ctr, Montreal, PQ, Canada; [de Pokomandy, Alexandra] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Ion, Allyson; Chambers, Lori A.] McMaster Univ, Sch Social Work, Hamilton, ON, Canada; [MacGillivray, S. Jay] St Michaels Hosp, Toronto, ON, Canada	Toronto Metropolitan University; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of British Columbia; University of Toronto; Simon Fraser University; McGill University; McGill University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wagner, AC (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	anne.wagner@psych.ryerson.ca			Canadian Institutes of Health Research (CIHR) [MOP-111041]; CIHR Canadian HIV Trials Network [CTN 262]; Ontario HIV Treatment Network (OHTN); Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; CIHR; Clinician Investigator Program at UBC; Canada Research Chair program; Fonds de Recherche Sante Quebec; Federation des Omnipracticiens du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN); Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; CIHR(Canadian Institutes of Health Research (CIHR)); Clinician Investigator Program at UBC; Canada Research Chair program(Canada Research Chairs); Fonds de Recherche Sante Quebec; Federation des Omnipracticiens du Quebec	CHIWOS is funded by a Canadian Institutes of Health Research (CIHR) Operating Grant (grant #MOP-111041), the CIHR Canadian HIV Trials Network (CTN 262), the Ontario HIV Treatment Network (OHTN), and the Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund. The following authors received salary support awards: CIHR Postdoctoral Fellowship (Anne C. Wagner), Clinician Investigator Program at UBC (Denise Jaworsky), Canada Research Chair program (Angela Kaida), Fonds de Recherche Sante Quebec and Federation des Omnipracticiens du Quebec (Alexandra de Pokomondy). Neora Pick is on the boards of VIIV Healthcare and Gilead Sciences. Alexandra de Pokomandy is a site principal investigator for several VIIV Healthcare HIV trials, is a site co-investigator for Gilead Sciences and Merck HIV trials, and received honoraria for participating on the advisory board for VIIV Healthcare. Mona Loutfy has been a site principal investigator and sub-investigator on Merck, VIIV Healthcare, and Gilead Sciences clinical trials and has been on Advisory Boards for these three pharmaceutical companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African and Caribbean Council on HIV/AIDS in Ontario (ACCHO), 2013, ONT HIV AIDS STRAT A; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BC Centre for Disease Control, 2010, VANC REP HIV SEX TRA; Brief DJ, 2004, AIDS CARE, V16, pS97, DOI 10.1080/09540120412301315259; Cohen J, 2002, APPL MULTIPLE REGRES; De Reus L.A., 2005, SOURCEBOOK FAMILY TH, P447, DOI [DOI 10.4135/9781412990172.N18, 10.4135/9781412990172.n18]; Elliott DE, 2005, J COMMUNITY PSYCHOL, V33, P461, DOI 10.1002/jcop.20063; Gjesfjeld CD, 2008, RES SOCIAL WORK PRAC, V18, P231, DOI 10.1177/1049731507309830; Harris M, 2001, New Dir Ment Health Serv, P3; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Hilerio CM, 2005, ETHNIC DIS, V15, pS47; Holmes WC, 1998, MED CARE, V36, P138, DOI 10.1097/00005650-199802000-00004; Institut national de sante publique Quebec, 2012, SURV INF TRANSM SEX; Jaworsky D, RURAL REMOTE HLTH; Katz S, 2005, AIDS PATIENT CARE ST, V19, P110, DOI 10.1089/apc.2005.19.110; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Litz BT, 2002, CLIN PSYCHOL-SCI PR, V9, P112, DOI 10.1093/clipsy/9.2.112; Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296; Logie CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162826; Loutfy M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184708; Machtinger EL, 2012, AIDS BEHAV, V16, P2091, DOI 10.1007/s10461-011-0127-4; McKeown Iris, 2004, Int J Circumpolar Health, V63 Suppl 2, P399; Norris F. H., 2002, J CLIN GEROPSYCHOLOG, V8, P153, DOI DOI 10.1023/A:1015940126474; O'Cleirigh C, 2009, J BEHAV MED, V32, P466, DOI 10.1007/s10865-009-9217-4; Ohl M, 2013, AIDS BEHAV, V17, P250, DOI 10.1007/s10461-011-0107-8; Ohl M, 2010, MED CARE, V48, P1064, DOI 10.1097/MLR.0b013e3181ef60c2; Public Health Agency of Canada, 2010, HIV AIDS EPI UPD JUL; Public Health Agency of Canada, 2014, HIV AIDS EPI UPD NAT; Public Health Agency of Canada, 2012, AT A GLANCE HIV AND; Remis RS, 2013, TORONTO REPORT HIV A; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Simoni JM, 2004, AIDS BEHAV, V8, P33, DOI 10.1023/B:AIBE.0000017524.40093.6b; Sternthal MJ, 2011, DU BOIS REV, V8, P95, DOI 10.1017/S1742058X11000087; Vranceanu AM, 2008, AIDS PATIENT CARE ST, V22, P313, DOI 10.1089/apc.2007.0069; Wagner AC, 2010, ARCH WOMEN MENT HLTH, V13, P207, DOI 10.1007/s00737-010-0158-2; Wagnild G M, 1993, J Nurs Meas, V1, P165; Weems CF, 2007, BEHAV RES THER, V45, P2295, DOI 10.1016/j.brat.2007.04.013; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040793; Zierler S, 1996, AM J PREV MED, V12, P304, DOI 10.1016/S0749-3797(18)30283-6	43	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200526	10.1371/journal.pone.0200526	http://dx.doi.org/10.1371/journal.pone.0200526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024901	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000026
J	Chiurchiu, V; Leuti, A; Saracini, S; Fontana, D; Finamore, P; Giua, R; Padovini, L; Incalzi, RA; Maccarrone, M				Chiurchiu, Valerio; Leuti, Alessandro; Saracini, Stefano; Fontana, Davide; Finamore, Panaiotis; Giua, Renato; Padovini, Lucia; Incalzi, Raffaele Antonelli; Maccarrone, Mauro			Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes	FASEB JOURNAL			English	Article						resolvins; chronic inflammation; adaptive immunity	NECROSIS-FACTOR-ALPHA; RESOLVIN D1; CELLS; MEDIATORS; ACTIVATION; EXPRESSION; INFECTION; CYTOKINES; IMMUNITY	Chronic heart failure (CHF) is characterized by an ongoing nonresolving inflammatory status, where T lymphocytes seem critical. It has been recently recognized that transition from acute to chronic inflammation could be caused by defects in resolving inflammation, the resolution of which is mediated by a novel family of -3-derived specialized proresolving lipid mediators such as resolvins. We analyzed 27 elderly patients with CHF and 23 healthy age-matched control subjects, and we reported significantly lower levels of D-series resolvin (RvD)1 in plasma of patients with CHF that were associated with a reduced ability of their leukocytes to produce this lipid via its biosynthetic enzyme 15-lipoxygenase and that correlated with gas exchange dysfunction. Furthermore, when pretreating ex vivo peripheral blood mononuclear cells of patients with CHF with RvD1 or RvD2, we found that neither of them was able to modulate the immune response of CD8(+) and CD4(+) T cells in terms of proinflammatory cytokine production, namely TNF-, IFN-, IL-17, and IL-2. Such impaired T-cell responsiveness in patients with CHF was associated with a significant reduction in mRNA and protein expression of RvD1 receptor GPR32, suggesting a defective signaling in the proresolving pathway. We conclude that patients with CHF show alterations in producing proresolving mediator RvD1 and a failure of adaptive immune cells in responding to the anti-inflammatory actions of RvDs that may contribute to the progression of chronic inflammation. Thus, the proresolution pathway might be a potential candidate to design better treatments for CHF aimed at reducing T cell-mediated chronic inflammation.ChiurchiU, V., Leuti, A., Saracini, S., Fontana, D., Finamore, P., Giua, R., Padovini, L., Incalzi, R. A., Maccarrone, M. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes.	[Chiurchiu, Valerio; Leuti, Alessandro; Incalzi, Raffaele Antonelli; Maccarrone, Mauro] Univ Rome, Dept Med, Biomed Campus, Rome, Italy; [Saracini, Stefano; Fontana, Davide; Finamore, Panaiotis; Giua, Renato; Padovini, Lucia] Univ Rome, Unit Geriatr Med, Biomed Campus, Rome, Italy; [Saracini, Stefano; Fontana, Davide; Finamore, Panaiotis; Giua, Renato; Padovini, Lucia] Teaching Hosp, Rome, Italy; [Chiurchiu, Valerio; Leuti, Alessandro; Maccarrone, Mauro] Inst Res & Hlth Care IRCCS Santa Lucia Fdn, European Ctr Brain Res, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Maccarrone, M (corresponding author), Univ Rome, Dept Med, Biomed Campus, Rome, Italy.; Chiurchiu, V (corresponding author), IRCCS Sana Lucia Fdn, Via Fosso Fiorano 64, I-00143 Rome, Italy.	v.chiurchiu@hsantalucia.it; m.maccarrone@unicampus.it	Finamore, Panaiotis/ABH-2693-2021; Chiurchiu, Valerio/G-6227-2011	Finamore, Panaiotis/0000-0002-8608-9223; Leuti, Alessandro/0000-0002-5982-0682; Chiurchiu, Valerio/0000-0002-0316-7311; Fontana, Davide Onofrio/0000-0003-4262-8368				Agostoni P, 2007, PULM PHARMACOL THER, V20, P130, DOI 10.1016/j.pupt.2006.03.001; Moro-Garcia MA, 2014, INT J CARDIOL, V174, P590, DOI 10.1016/j.ijcard.2014.04.128; Ayoub KF, 2017, CARDIOVASC DRUG THER, V31, P593, DOI 10.1007/s10557-017-6752-z; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Cai YH, 2016, ASIAN PAC J TROP MED, V9, P672, DOI 10.1016/j.apjtm.2016.05.006; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Corsonello A, 2013, CURR MED CHEM, V20, P1103, DOI 10.2174/0929867311320090002; Fildes JE, 2009, J AM COLL CARDIOL, V53, P1013, DOI 10.1016/j.jacc.2008.11.046; Fredman G, 2017, MOL ASPECTS MED, V58, P65, DOI 10.1016/j.mam.2017.02.003; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fukunaga T, 2007, HEART VESSELS, V22, P178, DOI 10.1007/s00380-006-0955-8; Gilbert K, 2015, EUR J PHARMACOL, V769, P147, DOI 10.1016/j.ejphar.2015.11.010; Gilbert K, 2015, J CARDIOVASC PHARM, V66, P72, DOI 10.1097/FJC.0000000000000245; Gilbert K, 2014, MAR DRUGS, V12, P5396, DOI 10.3390/md12115396; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; Koller L, 2013, ATHEROSCLEROSIS, V230, P414, DOI 10.1016/j.atherosclerosis.2013.08.008; Li N, 2010, CLIN CHIM ACTA, V411, P1963, DOI 10.1016/j.cca.2010.08.013; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Ogata H, 2016, EUR J PHARMACOL, V777, P26, DOI 10.1016/j.ejphar.2016.02.058; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Reina-Couto M, 2014, EUR J CLIN INVEST, V44, P527, DOI 10.1111/eci.12265; Sanchez-Trujillo L, 2017, ARCH MED RES, V48, P1, DOI 10.1016/j.arcmed.2016.12.008; Satoh S, 2006, INT J CARDIOL, V111, P405, DOI 10.1016/j.ijcard.2005.08.021; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Torre-Amione G, 2005, AM J CARDIOL, V95, p3C, DOI 10.1016/j.amjcard.2005.03.006; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6	33	37	39	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					909	916		10.1096/fj.201801017R	http://dx.doi.org/10.1096/fj.201801017R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052486				2022-12-26	WOS:000457401500071
J	Zhang, BY; Lyu, JF; Liu, YF; Wu, CJ; Yang, EJ; Pardeshi, L; Tan, KL; Wong, KH; Chen, Q; Xu, XL; Deng, CX; Shim, JS				Zhang, Baoyuan; Lyu, Junfang; Liu, Yifan; Wu, Changjie; Yang, Eun Ju; Pardeshi, Lakhansing; Tan, Kaeling; Wong, Koon Ho; Chen, Qiang; Xu, Xiaoling; Deng, Chu-Xia; Shim, Joong Sup			BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition	ONCOGENE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; UP-REGULATED PROTEIN-1; DNA-DAMAGE; CYCLE; GENE; MYC; SUPPRESSION; EXPRESSION; RESISTANCE; APOPTOSIS	BRCA1 is a tumor suppressor frequently mutated in breast and ovarian cancer, serving it as a target for therapeutic exploitation. Here, we show that BRCA1 has a synthetic lethality interaction with an epigenetics regulator, bromodomain and extra-terminal domain (BET). BET inhibition led to gene expression changes reversing MYC-dependent transcription repression of a redox regulator, thioredoxin-interacting protein (TXNIP), via switching the promoter occupant from MYC to MondoA:MLX complex. Reversing the MYC-TXNIP axis inhibited thioredoxin activity and elevated cellular oxidative stress, causing DNA damages that are detrimental to BRCA1-deficient breast cancer cells. Tumor xenograft models and breast cancer clinical data analyses further demonstrated an in vivo synthetic lethality interaction and clinical association between BET/TXNIP and BRCA1 deficiency in the survival of breast cancer patients.	[Zhang, Baoyuan; Lyu, Junfang; Liu, Yifan; Wu, Changjie; Yang, Eun Ju; Pardeshi, Lakhansing; Tan, Kaeling; Wong, Koon Ho; Chen, Qiang; Xu, Xiaoling; Deng, Chu-Xia; Shim, Joong Sup] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa 999078, Macau, Peoples R China	University of Macau	Shim, JS (corresponding author), Univ Macau, Fac Hlth Sci, Ave Univ, Taipa 999078, Macau, Peoples R China.	jsshim@umac.mo	Wong, Koon Ho/P-3685-2018; wong, chris/GSN-0962-2022; Wong, Koon/AAH-3021-2020; LIU, Yifan/AAV-1994-2020	Wong, Koon Ho/0000-0002-9264-5118; Wong, Koon/0000-0002-9264-5118; Pardeshi, Lakhansing/0000-0003-0702-5465; Tan, Kaeling/0000-0002-3347-7628	Multi-Year Research Grant of the University of Macau [MYRG2015-00181-FHS, MYRG2017-00176-FHS]; Science and Technology Development Fund (FDCT) of Macau SAR [FDCT/024/2015/A1]	Multi-Year Research Grant of the University of Macau; Science and Technology Development Fund (FDCT) of Macau SAR	We thank to the members of the Genomics and Bioinformatics Core of FHS at UM for experimental and technical supports for the RNA-sequencing and data analyses and to Jacky Chan and William Pang from ICTO at UM for supporting the High Performance Computing cluster. We are also grateful to the members of FHS Animal Facility at UM for arranging and maintaining experimental animals for this study. This work was supported by the Multi-Year Research Grant of the University of Macau (MYRG2015-00181-FHS and MYRG2017-00176-FHS to J.S.S) and the Science and Technology Development Fund (FDCT) of Macau SAR (FDCT/024/2015/A1 to J.S.S).	Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cadenas C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2599; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Deng CX, 2000, BIOESSAYS, V22, P728; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Greenup R, 2013, ANN SURG ONCOL, V20, P3254, DOI 10.1245/s10434-013-3205-1; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kalinin A, 2001, J CELL SCI, V114, P3069; Karakashev S, 2017, CELL REP, V21, P3398, DOI 10.1016/j.celrep.2017.11.095; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morrison JA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-62; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; O'Shea JM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014258; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Schafer M, 2011, J INVEST DERMATOL, V131, P1409, DOI 10.1038/jid.2011.119; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Sun CY, 2018, CANCER CELL, V33, P401, DOI 10.1016/j.ccell.2018.01.019; Tome ME, 2005, BLOOD, V106, P3594, DOI 10.1182/blood-2005-02-0487; Tomlinson GE, 1998, CANCER RES, V58, P3237; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vazquez-Ortiz G, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3682; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Wilde BR, 2015, BRIT J CANCER, V113, P1529, DOI 10.1038/bjc.2015.360; Woolston CM, 2013, REDOX BIOL, V1, P285, DOI 10.1016/j.redox.2013.04.006; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yang L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1645; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983	54	11	11	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 6	2018	37	49					6341	6356		10.1038/s41388-018-0408-8	http://dx.doi.org/10.1038/s41388-018-0408-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HD3AP	30042414				2022-12-26	WOS:000452384400005
J	Shin, SH; Ye, MK; Lee, DW; Che, MH				Shin, Seung-Heon; Ye, Mi-Kyung; Lee, Dong-Won; Che, Mi-Hyun			Effect of microencapsulated essential oil form Chamaecyparis obtusa on monocyte-derived dendritic cell activation and CD4(+) T cell polarization	PLOS ONE			English	Article							ALTERNARIA; LIPOPOLYSACCHARIDE; ANTIBACTERIAL; INFLAMMATION; MACROPHAGES; ANTIFUNGAL; CYTOKINES; PATHWAY; ASTHMA; FUNGUS	The essential oil of Chamaecyparis obtusa (C. obtusa), which is used in soap, toothpaste, and aromatic agents, has been known to have anti-inflammatory properties. In this study, we investigated the effects of microencapsulated C. obtusa essential oil on airborne fungus-induced dendritic cell (DC) activation and Th immune responses. We stimulated monocyte-derived DCs with Alternaria alternate and lipopolysaccharide (LPS). To determine the anti-inflammatory effects, we pre-treated DCs with various concentrations of microencapsulated C. obtusa essential oil and collected the supernatants to measure interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), and we determined the expression of cell surface molecules. The effects of the essential oil on CD4(+) T cells polarization was determine by culturing stimulated DCs and autologous CD4(+ )T cells. Alternaria enhanced the production of IL-6 and TNF-alpha from DCs, and pretreating DCs with 0.001, 0.01, and 0.05% of the essential oil significantly inhibited their production. Increased CD80 and CD86 expression by Alternaria was significantly inhibited with 0.05% of the essential oil. Alternaria-induced IL-5, IL-10, and interferon-gamma from CD4(+) T cells were significantly inhibited with C. obtusa essential oil in a dose dependent manner. C. obtusa influenced both Alternaria- and LPS-induced Th1 and Th2 polarization of CD4(+) T cells. These results suggest a novel pharmacological use for C. obtusa essential oil to treat inflammatory airway diseases.	[Shin, Seung-Heon; Ye, Mi-Kyung; Lee, Dong-Won; Che, Mi-Hyun] Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea	Catholic University of Daegu	Shin, SH (corresponding author), Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea.	hsseung@cu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931622]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03931622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, MED MYCOL, V49, pS150, DOI 10.3109/13693786.2010.504752; An BS, 2013, MOL MED REP, V8, P255, DOI 10.3892/mmr.2013.1459; Andersson M, 2003, PEDIAT ALLERG IMM-UK, V14, P100, DOI 10.1034/j.1399-3038.2003.00031.x; Carvalho IT, 2016, INT J COSMETIC SCI, V38, P109, DOI 10.1111/ics.12232; Chou ST, 2013, INT J MOL SCI, V14, P12978, DOI 10.3390/ijms140712978; Guimaraes AG, 2013, PHYTOTHER RES, V27, P1, DOI 10.1002/ptr.4686; Gupta SK, 2013, RES VET SCI, V95, P930, DOI 10.1016/j.rvsc.2013.07.015; Joo SS, 2010, J DERMATOL SCI, V60, P122, DOI 10.1016/j.jdermsci.2010.08.008; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Lai XL, 2008, INT J PHARM, V352, P66, DOI 10.1016/j.ijpharm.2007.10.011; Lima DKS, 2012, J ETHNOPHARMACOL, V142, P274, DOI 10.1016/j.jep.2012.05.016; Marchese A, 2016, FOOD CHEM, V210, P402, DOI 10.1016/j.foodchem.2016.04.111; Matsuwaki Y, 2011, INT ARCH ALLERGY IMM, V155, P123, DOI 10.1159/000327498; Mohammadi A, 2015, BIOTECH HISTOCHEM, V90, P445, DOI 10.3109/10520295.2015.1017536; Park HS, 2010, MOLECULES, V15, P6810, DOI 10.3390/molecules15106810; Park Y, 2016, MOL MED REP, V13, P3335, DOI 10.3892/mmr.2016.4905; Park Y, 2015, INT IMMUNOPHARMACOL, V29, P320, DOI 10.1016/j.intimp.2015.10.034; Reichling J, 2009, FORSCH KOMPLEMENTMED, V16, P79, DOI 10.1159/000207196; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Yang JK, 2007, FITOTERAPIA, V78, P149, DOI 10.1016/j.fitote.2006.09.026	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201233	10.1371/journal.pone.0201233	http://dx.doi.org/10.1371/journal.pone.0201233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052657	Green Published, Green Submitted, gold			2022-12-26	WOS:000440006600031
J	Ongwandee, S; Lertpiriyasuwat, C; Khawcharoenporn, T; Chetchotisak, P; Thiansukhon, E; Leerattanapetch, N; Leungwaranan, B; Manopaiboon, C; Phoorisri, T; Visavakum, P; Jetsawang, B; Poolsawat, M; Nookhai, S; Vasanti-Uppapokakorn, M; Karuchit, S; Kittinunvorakoon, C; Mock, P; Prybylski, D; Sukkul, AC; Roels, T; Martin, M				Ongwandee, Sumet; Lertpiriyasuwat, Cheewanan; Khawcharoenporn, Thana; Chetchotisak, Ploenchan; Thiansukhon, Ekkachai; Leerattanapetch, Niramon; Leungwaranan, Banlang; Manopaiboon, Chomnad; Phoorisri, Thanongsri; Visavakum, Prin; Jetsawang, Bongkoch; Poolsawat, Monsicha; Nookhai, Somboon; Vasanti-Uppapokakorn, Monthinee; Karuchit, Samart; Kittinunvorakoon, Chonticha; Mock, Philip; Prybylski, Dimitri; Sukkul, Ake-Chittra; Roels, Thierry; Martin, Michael			Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; PREEXPOSURE PROPHYLAXIS; BANGKOK TENOFOVIR; DRUG-USERS; YOUNG MEN; INFECTION; THERAPY; ADHERENCE; EPIDEMIC; TRIAL	Introduction Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at five hospitals in four provinces of Thailand to increase HIV testing, help those who test positive start antiretroviral therapy, and increase access to pre-exposure prophylaxis (PrEP). Methods We implemented rapid HIV testing and trained staff on immediate antiretroviral initiation at the five hospitals and offered PrEP at two hospitals. We recruited MSM and transgender women who walked-in to clinics and used a peer-driven intervention to expand recruitment. We used logistic regression to determine factors associated with prevalent HIV infection and the decision to start antiretroviral therapy and PrEP. Results During 2015 and 2016, 1880 people enrolled. Participants recruited by peers were younger (p<0.0001), less likely to be HIV-infected (p<0.0001), and those infected had higher CD4 counts (p = 0.04) than participants who walked-in to the clinics. Overall, 16% were HIV-positive: 18% of MSM and 9% of transgender women; 86% started antiretroviral therapy and 46% of eligible participants started PrEP. A higher proportion of participants at hospitals with one-stop HIV services started antiretroviral therapy than other hospitals. Participants who started PrEP were more likely to report sex with an HIV-infected partner (p = 0.002), receptive anal intercourse (p = 0.02), and receiving PrEP information from a hospital (p<0.0001). Conclusions We implemented a Test, Treat, and Prevent HIV Program offering rapid HIV testing and immediate access to antiretroviral therapy and PrEP. Peer-driven recruitment reached people at high risk of HIV and people early in HIV illness, providing an opportunity to promote HIV prevention services including PrEP and early antiretroviral therapy. Sites with one-stop HIV services had a higher uptake of antiretroviral therapy and PrEP.	[Ongwandee, Sumet; Lertpiriyasuwat, Cheewanan; Phoorisri, Thanongsri; Vasanti-Uppapokakorn, Monthinee] Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Khawcharoenporn, Thana] Thammasat Univ Hosp, Pathum Thani, Thailand; [Chetchotisak, Ploenchan] Srinagarind Univ Hosp, Khon Kaen, Thailand; [Thiansukhon, Ekkachai] Udon Thani Hosp, Udon Thani, Thailand; [Leerattanapetch, Niramon] Khon Kaen Hosp, Khon Kaen, Thailand; [Leungwaranan, Banlang] Lerdsin Hosp, Bangkok, Thailand; [Manopaiboon, Chomnad; Visavakum, Prin; Jetsawang, Bongkoch; Poolsawat, Monsicha; Nookhai, Somboon; Karuchit, Samart; Kittinunvorakoon, Chonticha; Mock, Philip; Prybylski, Dimitri; Sukkul, Ake-Chittra; Roels, Thierry; Martin, Michael] US Ctr Dis Control & Prevent, Div HIV AIDS & TB Thailand, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Thammasat University	Manopaiboon, C (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS & TB Thailand, Nonthaburi, Thailand.	hpy0@cdc.gov		Roels, Thierry/0000-0002-0886-5645	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5U2GGH000616]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of 5U2GGH000616.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Broadhead RS, 1999, PUBLIC HEALTH, V113, P42; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; FHI360, 2008, AS EP MOD AEM PROJ H; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Institute for Population and Social Research, 2013, EV NAT HIV PREV PROG; James S. E., 2016, REPORT US TRANSGENDE; Johnston LG, 2016, AIDS BEHAV, V20, P2023, DOI 10.1007/s10461-016-1336-7; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, 90 90 90 AMB TREATM; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Martin M, 2017, LANCET HIV, V4, pE59, DOI 10.1016/S2352-3018(16)30207-7; Pawa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077113; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Siraprapasiri T, 2013, JOURNEY UNIVERSAL AC; Thailand Ministry of Public Health, 2014, NAT OP PLAN END AIDS; Thailand Ministry of Public Health, 2013, GUID HIV COUNS TEST; Thailand Ministry of Public Health Thai AIDS Society., 2014, THAIL NAT GUID HIV A; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, GLOB AIDS RESP PROGR; van Griensven F, 2015, LANCET HIV, V2, pE64, DOI 10.1016/S2352-3018(14)00031-9; van Griensven F, 2014, SEX HEALTH, V11, P180, DOI 10.1071/SH13119; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e	32	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201171	10.1371/journal.pone.0201171	http://dx.doi.org/10.1371/journal.pone.0201171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044867	gold, Green Submitted, Green Published			2022-12-26	WOS:000439942500087
J	Patel, U; Gingerich, A; Widman, L; Sarr, D; Tripp, RA; Rada, B				Patel, Urmi; Gingerich, Aaron; Widman, Lauren; Sarr, Demba; Tripp, Ralph A.; Rada, Balazs			Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system	PLOS ONE			English	Article							A VIRUS; EPITHELIAL-CELLS; DUAL OXIDASE; B VIRUS; AIRWAY; IODIDE; HEMAGGLUTININ; INACTIVATION	Lactoperoxidase (LPO) is an enzyme found in several exocrine secretions including the airway surface liquid producing antimicrobial substances from mainly halide and pseudohalide substrates. Although the innate immune function of LPO has been documented against several microbes, a detailed characterization of its mechanism of action against influenza viruses is still missing. Our aim was to study the antiviral effect and substrate specificity of LPO to inactivate influenza viruses using a cell-free experimental system. Inactivation of different influenza virus strains was measured in vitro system containing LPO, its substrates, thiocyanate (SCN-) or iodide (I-), and the hydrogen peroxide (H2O2)-producing system, glucose and glucose oxidase (GO). Physiologically relevant concentrations of the components of the LPO/H2O2/(SCN-I-) antimicrobial system were exposed to twelve different strains of influenza A and B viruses in vitro and viral inactivation was assessed by determining plaque-forming units of non-inactivated viruses using Madin-Darby canine kidney cells (MDCK) cells. Our data show that LPO is capable of inactivating all influenza virus strains tested: H1N1, H1N2 and H3N2 influenza A viruses (IAV) and influenza B viruses (IBV) of both, Yamagata and Victoria lineages. The extent of viral inactivation, however, varied among the strains and was in part dependent on the LPO substrate. Inactivation of H1N1 and H1N2 viruses by LPO showed no substrate preference, whereas H3N2 influenza strains were inactivated significantly more efficiently when iodide, not thiocyanate, was the LPO substrate. Although LPO-mediated inactivation of the influenza B strains tested was strain-dependent, it showed slight preference towards thiocyanate as the substrate. The results presented here show that the LPO/H2O2/(SCN-/I-) cell-free, in vitro experimental system is a functional tool to study the specificity, efficiency and the molecular mechanism of action of influenza inactivation by LPO. These studies tested the hypothesis that influenza strains are all susceptible to the LPO-based antiviral system but exhibit differences in their substrate specificities. We propose that a LPO-based antiviral system is an important contributor to anti-influenza virus defense of the airways.	[Patel, Urmi; Gingerich, Aaron; Widman, Lauren; Sarr, Demba; Tripp, Ralph A.; Rada, Balazs] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Rada, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	radab@uga.edu	Sarr, Demba/GOG-9376-2022; Sarr, Demba/AAP-7125-2020	Sarr, Demba/0000-0002-8306-0433; Gingerich, Aaron/0000-0002-8139-611X	National Institutes of Health, National Institute of Allergy and Infectious Diseases [R21AI124189-01A1]; startup funds by the Office of Vice President for Research; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124189] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); startup funds by the Office of Vice President for Research; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was mainly supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases R21AI124189-01A1 (Rada, Tripp), URL: https://www.niaid.nih.gov; startup funds (Rada) provided by the Office of Vice President for Research, URL: https://research.uga.edu; and the Georgia Research Alliance (Tripp), URL: http://gra.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahariz M, 2010, CLIN COSMET INVESTIG, V2, P69; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P281; Bafort F, 2014, ENZYME RES, V2014, DOI DOI 10.1155/2014/517164; Belongia Edward A, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334554; Burnham AJ, 2013, ANTIVIR RES, V100, P520, DOI 10.1016/j.antiviral.2013.08.023; Cegolon L, 2014, INT J HYG ENVIR HEAL, V217, P17, DOI 10.1016/j.ijheh.2013.03.001; Clark AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188267; Conner GE, 2002, AM J RESP CRIT CARE, V166, pS57, DOI 10.1164/rccm.2206018; DAS D, 1995, BIOCHEM J, V305, P59, DOI 10.1042/bj3050059; Derscheid RJ, 2014, AM J RESP CELL MOL, V50, P389, DOI 10.1165/rcmb.2012-0529OC; Dlugolenski D, 2015, J VIROL, V89, P5651, DOI 10.1128/JVI.00087-15; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gerson C, 2000, AM J RESP CELL MOL, V22, P665, DOI 10.1165/ajrcmb.22.6.3980; Gingerich A, 2016, INFLAMM RES, V65, P71, DOI 10.1007/s00011-015-0892-z; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473; Jackson D, 2011, J GEN VIROL, V92, P1, DOI 10.1099/vir.0.026187-0; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; KEMBLE GW, 1992, J VIROL, V66, P4940, DOI 10.1128/JVI.66.8.4940-4950.1992; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P7782, DOI 10.1073/pnas.85.20.7782; Kordyukova LV, 2019, J BIOMOL STRUCT DYN, V37, P671, DOI 10.1080/07391102.2018.1436089; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Leonard AS, 2016, J VIROL, V90, P11247, DOI 10.1128/JVI.01657-16; Li HYS, 2007, ENDOCRINOLOGY, V148, P2747, DOI 10.1210/en.2007-0082; Liang X, 2018, J TRACE ELEM MED BIO, V47, P89, DOI 10.1016/j.jtemb.2018.01.018; Londino JD, 2017, AM J PHYSIOL-LUNG C, V313, pL845, DOI 10.1152/ajplung.00244.2017; Lowen AC, 2017, ANNU REV VIROL, V4, P105, DOI 10.1146/annurev-virology-101416-041726; Mandelboim M, 2016, ONCOTARGET, V7, P1185, DOI 10.18632/oncotarget.6746; MOGABGAB WJ, 1955, P SOC EXP BIOL MED, V89, P654, DOI 10.3181/00379727-89-21907; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; Ogata N, 2012, J GEN VIROL, V93, P2558, DOI 10.1099/vir.0.044263-0; Peng WJ, 2017, CELL HOST MICROBE, V21, P23, DOI 10.1016/j.chom.2016.11.004; Pinsent A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-015-1298-9; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025; Rada B, 2009, IMMUNOL RES, V43, P198, DOI 10.1007/s12026-008-8071-8; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Retamal M, 2014, J GEN VIROL, V95, P2377, DOI 10.1099/vir.0.067819-0; Ross GR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6302869; Sakudo Akikazu, 2014, Front Biosci (Elite Ed), V6, P69; Schlorke D, 2016, FREE RADICAL RES, V50, P1287, DOI 10.1080/10715762.2016.1235789; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Spanakis N, 2014, EXPERT REV ANTI-INFE, V12, P1325, DOI 10.1586/14787210.2014.966083; Sriwilaijaroen N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-124; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Sundararajan A, 2010, ANTIVIR RES, V88, P1, DOI 10.1016/j.antiviral.2010.06.014; Verma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175733; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC	50	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199167	10.1371/journal.pone.0199167	http://dx.doi.org/10.1371/journal.pone.0199167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044776	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500009
J	Vloeberghs, V; Verheyen, G; Santos-Ribeiro, S; Staessen, C; Verpoest, W; Gies, I; Tournaye, H				Vloeberghs, Veerle; Verheyen, Greta; Santos-Ribeiro, Samuel; Staessen, Catherine; Verpoest, Willem; Gies, Inge; Tournaye, Herman			Is genetic fatherhood within reach for all azoospermic Klinefelter men?	PLOS ONE			English	Article							TESTICULAR SPERM EXTRACTION; NONOBSTRUCTIVE AZOOSPERMIA; ICSI; INFERTILITY; RETRIEVAL; RECOVERY; MEIOSIS; CELLS; IVF	Background Multidisciplinary management of Klinefelter cases is now considered good clinical practice in order to ensure optimal quality of life. Reproductive performance of Klinefelter men is an important issue however literature in this domain is limited and prone to bias. Study design This was a retrospective longitudinal cohort study performed at a tertiary referral University Centre for Reproductive Medicine and Genetics. One hundred thirty-eight non-mosaic azoospermic Klinefelter patients undergoing their first testicular biopsy (TESE) between 1994 and 2013, followed by intracytoplasmic sperm injection (ICSI) with fresh or frozen-thawed testicular sperm in the female partner, were followed-up longitudinally. The main outcome measure was cumulative live birth rate per Klinefelter patient embarking on TESE-ICSI. Findings In forty-eight men (48/138) sperm were successfully retrieved at the first TESE (34.8%). The mean age of the patients was 32.4 years. Younger age at first TESE was associated with a higher sperm retrieval rate (p<0.001). Overall 39 couples underwent 62 ICSI cycles and 13 frozen embryo transfer cycles resulting in in 20 pregnancies and 14 live birth deliveries (16 children). The mean age of the female partner was 28.1 years. The crude cumulative delivery rate after four ICSI cycles was 35.9%. Per intention-to-treat however, only 10.1% (14/138) of the Klinefelter men starting treatment succeeded in having their biologically own child(ren). Conclusion Non-mosaic Klinefelter patients with azoospermia seeking treatment by TESE-ICSI should be counseled that by intention-to-treat the chance of retrieving sperm is fair, however only a minority will eventually father genetically own children.	[Vloeberghs, Veerle; Verheyen, Greta; Santos-Ribeiro, Samuel; Verpoest, Willem; Tournaye, Herman] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium; [Staessen, Catherine] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Med Genet, Brussels, Belgium; [Gies, Inge] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Pediat, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	Vloeberghs, V (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium.	veerle.vloeberghs@uzbrussel.be	Santos-Ribeiro, Samuel/Q-1203-2017; Gies, Inge/D-5870-2016	Santos-Ribeiro, Samuel/0000-0003-2476-7858; verpoest, willem/0000-0002-5020-2888; Verheyen, Greta/0000-0003-4677-2084; Vloeberghs, Veerle/0000-0002-7095-3996; Gies, Inge/0000-0002-8571-0858				Aksglaede L, 2013, EUR J ENDOCRINOL, V168, pR67, DOI 10.1530/EJE-12-0934; Bakircioglu ME, 2011, FERTIL STERIL, V95, P1696, DOI 10.1016/j.fertnstert.2011.01.005; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Corona G, 2017, HUM REPROD UPDATE, V23, P265, DOI 10.1093/humupd/dmx008; COZZI J, 1994, HUM GENET, V93, P32; Crabbe E, 1998, HUM REPROD, V13, P2791, DOI 10.1093/humrep/13.10.2791; Foresta C, 1999, J CLIN ENDOCR METAB, V84, P3807, DOI 10.1210/jc.84.10.3807; Fullerton G, 2010, HUM REPROD, V25, P588, DOI 10.1093/humrep/dep431; Griesinger G, 2016, HUM REPROD, V31, P249, DOI 10.1093/humrep/dev322; Groth KA, 2013, J CLIN ENDOCR METAB, V98, P20, DOI 10.1210/jc.2012-2382; HULL MGR, 1992, BRIT MED J, V304, P1465, DOI 10.1136/bmj.304.6840.1465; Kitamura M, 2000, INT J UROL, V7, P88, DOI 10.1046/j.1442-2042.2000.00145.x; Kolibianakis EM, 2004, HUM REPROD, V19, P2550, DOI 10.1093/humrep/deh447; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; Plotton I, 2015, J CLIN ENDOCR METAB, V100, P961, DOI 10.1210/jc.2014-3083; Raheem AA, 2013, BJU INT, V112, P258, DOI 10.1111/j.1464-410X.2012.11714.x; Rohayem J, 2016, ANDROLOGY-US, V4, P1178, DOI 10.1111/andr.12249; Sabbaghian M, 2014, UROLOGY, V83, P107, DOI 10.1016/j.urology.2013.09.021; Samango-Sprouse C, 2017, PRENAT DIAGN, V37, P487; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Staessen C, 1996, HUM REPROD, V11, P1650; Tournaye H, 1996, HUM REPROD, V11, P1644; Van Landuyt L, 2006, REPROD BIOMED ONLINE, V13, P765, DOI 10.1016/S1472-6483(10)61022-X; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Verheyen G, 2004, HUM REPROD, V19, P2822, DOI 10.1093/humrep/deh490; Vloeberghs V, 2015, HUM REPROD, V30, P1790, DOI 10.1093/humrep/dev139; Wikstrom AM, 2008, HORM RES, V69, P317, DOI 10.1159/000117387	28	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200300	10.1371/journal.pone.0200300	http://dx.doi.org/10.1371/journal.pone.0200300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044810	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500039
J	Tso, FY; Kang, GB; Kwon, EH; Julius, P; Li, QS; West, JT; Wood, C				Tso, For Yue; Kang, Guobin; Kwon, Eun Hee; Julius, Peter; Li, Qingsheng; West, John T.; Wood, Charles			Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; COMBINED ANTIRETROVIRAL THERAPY; PROVIRAL DNA LOAD; CD4(+) T-CELLS; INFECTED PATIENTS; VIRUS; AIDS; TISSUES; INFLAMMATION; INDIVIDUALS	Subtype C HIV-1 is responsible for the largest proportion of people living with HIV-1 infection. However, there is limited information about the roles of the brain and its cell types as a potential sanctuary for this subtype and how the sanctuary may be affected by the administration of anti-retroviral therapy (ART). To address this issue, we collected postmortem brain tissues from ART treated HIV-1 infected Zambian individuals who experienced complete viral suppression and those who did not. Tissues from various brain compartments were collected from each individual as frozen and formalin-fixed paraffin embedded brain specimens, for detection and quantification of HIV-1 genomes and identification of the infected cell type. Genomic DNA and RNA were extracted from frozen brain tissues. The extracted DNA and RNA were then subjected to droplet digital PCR for HIV-1 quantification. RNA/DNAscope in situ hybridization (ISH) for HIV-1 was performed on formalin-fixed paraffin embedded brain tissues in conjugation with immunohistochemistry to identify the infected cell types. Droplet digital PCR revealed that HIV-1 gag DNA and RNA were detectable in half of the cases studied regardless of ART success or failure. The presence of HIV-1 lacked specific tissue compartmentalization since detection was random among various brain tissues. When combined with immunohistochemistry, RNA/DNAscope ISH demonstrated colocalization of HIV-1 DNA with CD68 expressing cells indicative of microglia or peripheral macrophage. Our study showed that brain is a potential sanctuary for subtype C HIV-1, as HIV-1 can be detected in the brain of infected individuals irrespective of ART treatment outcome and no compartmentalization of HIV-1 to specific brain compartments was evident.	[Tso, For Yue; Kang, Guobin; Kwon, Eun Hee; Li, Qingsheng; West, John T.; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Tso, For Yue; Kang, Guobin; Kwon, Eun Hee; Li, Qingsheng; West, John T.; Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Julius, Peter] Univ Teaching Hosp, Dept Pathol & Microbiol, Nationalist Rd, Lusaka, Zambia	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Zambia	Wood, C (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.; Wood, C (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	cwood1@unl.edu	Tso, For Yue/AAF-1131-2019; Wood, Charles/AAH-4536-2021	Wood, Charles/0000-0002-4256-1530	American Foundation for AIDS Research [109123-57-RGR]; National Institutes of Health (NIH) [NS074903, CA75903, P30 GM103509, Fogarty D43 TW01492, TW010354]; NIAID [UM1AI126620 BEAT-HIV]; FOGARTY INTERNATIONAL CENTER [D43TW010354] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074903] Funding Source: NIH RePORTER	American Foundation for AIDS Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by American Foundation for AIDS Research (109123-57-RGR), and the National Institutes of Health (NIH) Grants (NS074903, CA75903, P30 GM103509 and Fogarty D43 TW01492 and TW010354) to C.W; NIAID UM1AI126620 BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy to Q.L.; P.J. is a Fogarty Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the families of all tissue donors for their participation in this study. This work is supported in part by American Foundation for AIDS Research (109123-57-RGR), and the National Institutes of Health (NIH) Grants (NS074903, CA75903, P30 GM103509 and Fogarty D43 TW01492 and TW010354) to C.W; NIAID UM1AI126620 BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy to Q.L.; P.J. is a Fogarty Fellow.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Cysique LA, 2011, J NEUROVIROL, V17, P176, DOI 10.1007/s13365-011-0021-x; Dahl V, 2014, J INFECT DIS, V209, P1618, DOI 10.1093/infdis/jit805; De Pablo-Bernal RS, 2014, J ANTIMICROB CHEMOTH, V69, P3041, DOI 10.1093/jac/dku263; Deleage Claire, 2016, Pathog Immun, V1, P68; Fujimura RK, 1997, J ACQ IMMUN DEF SYND, V16, P146, DOI 10.1097/00042560-199711010-00002; Gama L, 2017, AIDS, V31, P5, DOI 10.1097/QAD.0000000000001267; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Letendre Scott, 2011, Top Antivir Med, V19, P137; Li QS, 2015, JAIDS-J ACQ IMM DEF, V69, P519, DOI 10.1097/QAI.0000000000000687; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mahadevan A, 2007, J NEUROPATH EXP NEUR, V66, P799, DOI 10.1097/NEN.0b013e3181461d3e; Mishra M, 2015, J NEUROVIROL, V21, P399, DOI 10.1007/s13365-015-0328-0; Mouton JP, 2016, EXPERT REV CLIN PHAR, V9, P1493, DOI 10.1080/17512433.2016.1221760; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Strazielle N, 2005, REV MED VIROL, V15, P105, DOI 10.1002/rmv.454; Sturdevant CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003094; Tavazzi E, 2014, CURR HIV RES, V12, P97, DOI 10.2174/1570162X12666140526114956; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Wiley CA, 1998, BRAIN PATHOL, V8, P277; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Zhao L, 2009, SCI CHINA SER C, V52, P651, DOI 10.1007/s11427-009-0085-5	40	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201325	10.1371/journal.pone.0201325	http://dx.doi.org/10.1371/journal.pone.0201325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040863	Green Published, gold			2022-12-26	WOS:000439749200037
J	Spengler, JR; McElroy, AK; Harmon, JR; Coleman-McCray, JD; Welch, SR; Keck, JG; Nichol, ST; Spiropoulou, CF				Spengler, Jessica R.; McElroy, Anita K.; Harmon, Jessica R.; Coleman-McCray, JoAnn D.; Welch, Stephen R.; Keck, James G.; Nichol, Stuart T.; Spiropoulou, Christina F.			Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice	PLOS ONE			English	Article							VIRUS-INFECTION; TRANSCRIPTION; RESPONSES; PROTEIN; DISEASE; MODELS; NSS	Rift Valley fever (RVF) in humans is usually mild, but, in a subset of cases, can progress to severe hepatic and neurological disease. Rodent models of RVF generally develop acute severe clinical disease. Here, we inoculated humanized NSG-SGM3 mice with Rift Valley fever virus (RVFV) to investigate whether the presence of human immune cells in mice would alter the progression of RVFV infection to more closely model human disease. Despite increased human cytokine expression, including responses mirroring those seen in human disease, and decreased hepatic viral RNA levels at terminal euthanasia, both high-and low-dose RVFV inoculation resulted in lethal disease in all mice with comparable time-to-death as unengrafted mice.	[Spengler, Jessica R.; McElroy, Anita K.; Harmon, Jessica R.; Coleman-McCray, JoAnn D.; Welch, Stephen R.; Nichol, Stuart T.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [McElroy, Anita K.] Emory Univ, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [McElroy, Anita K.] Univ Pittsburgh, Div Pediat Infect Dis, Pittsburgh, PA USA; [Keck, James G.] Jackson Lab, Vivo Serv, Sacramento, CA USA	Centers for Disease Control & Prevention - USA; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory	Spengler, JR (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	JSpengler@cdc.gov	Spengler, Jessica R./AAN-9099-2020	Spengler, Jessica R./0000-0002-5383-0513; McElroy, Anita/0000-0001-6764-7536; Welch, Stephen/0000-0002-6905-8521	Burroughs Wellcome Career Award [1013362.01]; NIH [K08 AI 119448]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI119448] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by a Burroughs Wellcome Career Award (1013362.01) and NIH K08 AI 119448 [AKM].	Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2007, J CLIN MICROBIOL, V45, P3506, DOI 10.1128/JCM.00936-07; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Dodd KA, 2013, J VIROL, V87, P6161, DOI 10.1128/JVI.00337-13; Erickson AK, 2015, J GEN VIROL, V96, P1328, DOI 10.1099/vir.0.000075; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020; McElroy AK, 2012, VIROLOGY, V422, P6, DOI 10.1016/j.virol.2011.09.023; Njenga MK, 2009, J CLIN MICROBIOL, V47, P1166, DOI 10.1128/JCM.01905-08; Ross TM, 2012, VIRUS RES, V163, P417, DOI 10.1016/j.virusres.2011.10.023; Smith DR, 2010, VIROLOGY, V407, P256, DOI 10.1016/j.virol.2010.08.016; Spengler JR, 2017, J INFECT DIS, V216, P1386, DOI 10.1093/infdis/jix215; Spengler JR, 2017, CURR OPIN VIROL, V25, P90, DOI 10.1016/j.coviro.2017.07.028; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; van Vuren PJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0392-3; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Zivcec M, 2013, J INFECT DIS, V207, P1909, DOI 10.1093/infdis/jit061	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201104	10.1371/journal.pone.0201104	http://dx.doi.org/10.1371/journal.pone.0201104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028878	Green Submitted, Green Published, gold			2022-12-26	WOS:000439396900039
J	Cardenas-Lopez, FA; Lamata, L; Retamal, JC; Solano, E				Cardenas-Lopez, F. A.; Lamata, L.; Retamal, J. C.; Solano, E.			Multiqubit and multilevel quantum reinforcement learning with quantum technologies	PLOS ONE			English	Article							CIRCUITS; MEMORY; GATES	We propose a protocol to perform quantum reinforcement learning with quantum technologies. At variance with recent results on quantum reinforcement learning with superconducting circuits, in our current protocol coherent feedback during the learning process is not required, enabling its implementation in a wide variety of quantum systems. We consider diverse possible scenarios for an agent, an environment, and a register that connects them, involving multiqubit and multilevel systems, as well as open-system dynamics. We finally propose possible implementations of this protocol in trapped ions and superconducting circuits. The field of quantum reinforcement learning with quantum technologies will enable enhanced quantum control, as well as more efficient machine learning calculations.	[Cardenas-Lopez, F. A.; Retamal, J. C.] Univ Santiago Chile USACH, Dept Fis, Santiago, Chile; [Cardenas-Lopez, F. A.; Retamal, J. C.] Estn Cent, Ctr Dev Nanosci & Nanotechnol, Santiago, Chile; [Lamata, L.; Solano, E.] Univ Basque Country, UPV EHU, Dept Phys Chem, Bilbao, Spain; [Solano, E.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Solano, E.] Shanghai Univ, Dept Phys, Shanghai, Peoples R China	Universidad de Santiago de Chile; University of Basque Country; Basque Foundation for Science; Shanghai University	Cardenas-Lopez, FA (corresponding author), Univ Santiago Chile USACH, Dept Fis, Santiago, Chile.; Cardenas-Lopez, FA (corresponding author), Estn Cent, Ctr Dev Nanosci & Nanotechnol, Santiago, Chile.	francisco.cardenas@usach.cl	Retamal, Juan Carlos/G-6425-2010; Lamata, Lucas/CAG-6488-2022; Lamata, Lucas/B-2439-2009	Retamal, Juan Carlos/0000-0002-7174-7879; Lamata, Lucas/0000-0002-9504-8685; Lamata, Lucas/0000-0002-9504-8685; SOLANO VILLANUEVA, ENRIQUE LEONIDAS/0000-0002-8602-1181; Cardenas, Francisco/0000-0002-2916-2826	CEDENNA basal grant [FB0807]; Direccion de Postgrado USACH; FONDECYT [1140194]; Spanish MINECO/FEDER [FIS2015-69983-P]; Basque Government [IT986-16]; Ramon y Cajal Grant [RYC-2012-11391]	CEDENNA basal grant; Direccion de Postgrado USACH; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish MINECO/FEDER; Basque Government(Basque Government); Ramon y Cajal Grant(Spanish Government)	We acknowledge support from CEDENNA basal grant No. FB0807 and Direccion de Postgrado USACH (FAC-L), FONDECYT under grant No. 1140194 (JCR), Spanish MINECO/FEDER FIS2015-69983-P and Basque Government IT986-16 (LL and ES), and Ramon y Cajal Grant RYC-2012-11391 (LL).	Adcock J., 2015, ARXIV PREPRINT ARXIV; Aimeur E, 2013, MACH LEARN, V90, P261, DOI 10.1007/s10994-012-5316-5; Alber G, 2000, QUANTPH0008022 ARXIV; Alvarez-Rodriguez U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13378-0; Ballance CJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060504; Barends R, 2016, NATURE, V534, P222, DOI 10.1038/nature17658; Barends R, 2014, NATURE, V508, P500, DOI 10.1038/nature13171; Barends R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080502; Benedetti M, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aabd98; Benedetti M, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.022308; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Biamonte J, 2017, NATURE, V549, P195, DOI 10.1038/nature23474; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Blais A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032329; Bonner R., 2003, QUANTUM COMPUTATION, P106; Brown KR, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.030303; Cai XD, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.110504; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Crawford D, 2016, ARXIV161205695; Paparo GD, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031002; Dong DY, 2008, IEEE T SYST MAN CY B, V38, P1207, DOI 10.1109/TSMCB.2008.925743; Dunjko V, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/2/023006; Dunjko V, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aab406; Friis N, 2015, SCI REP-UK, V5, DOI 10.1038/srep18036; Gaebler JP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060505; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; Harty TP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140501; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Lamata L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01711-6; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Lee K.-F., 1989, ICASSP-89: 1989 International Conference on Acoustics, Speech and Signal Processing (IEEE Cat. No.89CH2673-2), P445, DOI 10.1109/ICASSP.1989.266459; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Li ZK, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.140504; Lloyd S., 2013, ARXIV13070411; Michalski R S., 2013, MACHINE LEARNING ART; Myerson AH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.200502; Noek R, 2013, OPT LETT, V38, P4735, DOI 10.1364/OL.38.004735; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Perdomo-Ortiz A, 2017, ARXIV170809757; Pfeiffer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29507; Plamondon R, 2000, IEEE T PATTERN ANAL, V22, P63, DOI 10.1109/34.824821; Rebentrost P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.130503; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Riste D., 2015, ARXIV150801385; Russell S. J., 2010, ARTIF INTELL, V3rd; Salmilehto J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42044; Sanz M, 2018, APL PHOTONICS, V3, DOI 10.1063/1.5036596; Schuld M, 2015, CONTEMP PHYS, V56, P172, DOI 10.1080/00107514.2014.964942; Shevchenko SN, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.014006; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sriarunothai T., ARXIV170901366; Wendin G, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa7e1a	55	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200455	10.1371/journal.pone.0200455	http://dx.doi.org/10.1371/journal.pone.0200455			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024914	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000020
J	Mah, RL; Connolly, JF				Mah, Richard L.; Connolly, John F.			A framework for the extended monitoring of levels of cognitive function in unresponsive patients	PLOS ONE			English	Article							SUBJECTS OWN NAME; BRAIN POTENTIAL ERP; MISMATCH NEGATIVITY; IMPAIRED CONSCIOUSNESS; SELECTIVE-ATTENTION; COMATOSE PATIENTS; NEURAL RESPONSES; P300; DISORDERS; N400	Generally, prognostication of coma outcome currently combines behavioral, reflex, and possibly neuroimaging tests that are interpreted by an attending physician. Electroencephalography, particularly, event-related brain potentials (ERP) have received attention due to evidence demonstrating the positive predictive value of certain ERP including the mismatch negativity (MMN) and the P3a, for coma emergence. We describe a set of ERP paradigms designed to require and reflect increasing levels of cognitive processing with the added objective of determining the influence of each paradigm's context strength on its ability to elicit ERPs. These paradigms were then used without explicit instructions to participants to attend to the stimuli to determine which paradigms possessed sufficient context "strength" to elicit ERPs in the absence of active participation on the part of the subject; a circumstance often encountered in brain injury patients. These paradigms were then validated on two groups of adults-younger and older, and the difference due to active participation was validated on another group of younger adults. Results show that paradigms with stronger stimulus context features performed better than those with weaker contexts, and that older adults generally had significantly attenuated and delayed responses compared to younger adults. Based on these findings, it is recommended the use of the auditory oddball paradigm that includes novel stimuli to elicit the mismatch negativity and P300, and semantic violation sentences to elicit the N400. These findings also reinforce the procedure of instructing participants about the requirements of a protocol-regardless of the patient's diagnosis or apparent state-in order to help those who are able to attend to show the most robust responses possible.	[Mah, Richard L.; Connolly, John F.] McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada; [Mah, Richard L.; Connolly, John F.] McMaster Univ, Ctr Adv Res Expt & Appl Linguist, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Mah, RL; Connolly, JF (corresponding author), McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada.; Mah, RL; Connolly, JF (corresponding author), McMaster Univ, Ctr Adv Res Expt & Appl Linguist, Hamilton, ON, Canada.; Connolly, JF (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.; Connolly, JF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.	mahrl@mcmaster.ca; jconnol@mcmaster.ca		Connolly, John/0000-0001-8869-5369; Mah, Richard/0000-0003-2121-5185	Canada Foundation for Innovation [20889]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	JFC was supported by an infrastructure grant from the Canada Foundation for Innovation (#20889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V38, P55, DOI 10.1016/S0167-8760(00)00130-6; Connolly JF, 1999, J CLIN EXP NEUROPSYC, V21, P444, DOI 10.1076/jcen.21.4.444.879; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Cooper RJ, 2006, NEUROBIOL AGING, V27, P752, DOI 10.1016/j.neurobiolaging.2005.03.012; Cruse D, 2014, NEUROIMAGE-CLIN, V4, P788, DOI 10.1016/j.nicl.2014.05.001; DEGIORGIO CM, 1993, ACTA NEUROL SCAND, V87, P423; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gabriel D, 2016, BRAIN, V139, pE30, DOI 10.1093/brain/aww065; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; Harrison AH, 2013, NEUROSCI BIOBEHAV R, V37, P1403, DOI 10.1016/j.neubiorev.2013.05.004; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Howell DC., 2012, STAT METHODS PSYCHOL; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Morlet D, 2017, PSYCHOPHYSIOLOGY, V54, P1644, DOI 10.1111/psyp.12954; Muller HM, 1996, NEUROREPORT, V8, P221; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1995, EAR HEARING, V16, P6; Naccache L, 2016, BRAIN, V139, pE31, DOI 10.1093/brain/aww060; NEMO Consortium, 2012, TR2012008 NEMO CONS; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekkonen E, 1996, EXP AGING RES, V22, P171, DOI 10.1080/03610739608254005; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1994, INT J PSYCHOPHYSIOL, V17, P25, DOI 10.1016/0167-8760(94)90052-3; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Public Health Agency of Canada, 2017, CAN CHRON DIS SURV; Rohaut B, 2015, NEUROPSYCHOLOGIA, V66, P279, DOI 10.1016/j.neuropsychologia.2014.10.014; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schroeder MM, 1995, ANN NY ACAD SCI, V769, P399, DOI 10.1111/j.1749-6632.1995.tb38155.x; Sculthorpe LD, 2011, CLIN NEUROPHYSIOL, V122, P2236, DOI 10.1016/j.clinph.2011.04.018; Statland B.E., 1987, CLIN DECISION LEVELS, V2nd; TEASDALE G, 1974, LANCET, V2, P81; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Wechsler D., 1991, WISC 3 WECHSLER INTE; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; WOODS DL, 1992, ELECTROEN CLIN NEURO, V84, P456, DOI 10.1016/0168-5597(92)90033-8; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; Zeelenberg R, 2003, PSYCHON B REV, V10, P653, DOI 10.3758/BF03196528	55	3	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200793	10.1371/journal.pone.0200793	http://dx.doi.org/10.1371/journal.pone.0200793			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024945	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000053
J	Manalil, S; Ali, HH; Chauhan, BS				Manalil, Sudheesh; Ali, Hafiz Haider; Chauhan, Bhagirath Singh			Germination ecology of turnip weed (Rapistrum rugosum (L.) All.) in the northern regions of Australia	PLOS ONE			English	Article							MUSTARD SISYMBRIUM-ORIENTALE; AFFECTING SEED-GERMINATION; SOUTHERN AUSTRALIA; ENVIRONMENTAL-FACTORS; MYAGRUM-PERFOLIATUM; GRAIN REGION; EMERGENCE; WATER; DORMANCY; MANAGEMENT	In Australia, turnip weed has been rapidly emerging as one of the major weeds in conservation agricultural systems. Germination and emergence of turnip weed were examined for two populations collected from Gatton and St George regions of Australia; two locations with high and low rainfall, respectively. The seeds of turnip weed germinated at all the tested temperatures, but germination was the lowest at 15/5 degrees C, intermediate at 20/10 degrees C and highest at 25/15 degrees C and 30/20 degrees C. The results indicated a high adaptability of turnip weed to warm environmental conditions, although it is a major problem in the winter season. Germination was higher in dark than light/dark regimes except at 30/20 degrees C. Three was a concomitant reduction in germination as the osmotic potential values decreased from 0 to -1.0 MPa. There was 2 and 4% germination at -0.8 MPa for Gatton and St George populations, respectively, and no germination occurred at an osmotic potential of -1.0 MPa. There was a reduction in germination when the sodium chloride (NaCl) concentration was increased from 0 to 150 mM, and no germination was observed at 200 and 250 mM of NaCl. Turnip weed germinated over a broad range of pH (4 to 10). Seedling emergence was higher at 1 cm depth compared to 0.5 cm or at the soil surface. There was 28 and 33% emergence at the surface for the Gatton and St George populations, respectively, compared to 48 and 56% emergence from 1 cm depth for the Gatton and St George populations, respectively and no emergence was observed from 6 cm depth. The results indicated that tillage leading to shallow burial would promote the emergence of turnip weed; on the contrary, tillage that could bury seeds deep into the soil profile might minimise the emergence. Under ideal conditions and lack of integrated weed management programmes, this weed will emerge, set seeds and enrich the soil seed bank and thereby continue to be a problem in the northern grain region of Australia.	[Manalil, Sudheesh; Chauhan, Bhagirath Singh] Univ Queensland, QAAFI, Ctr Crop Sci, Gatton, Qld, Australia; [Manalil, Sudheesh] Univ Western Australia, Inst Agr, Sch Plant Biol, Perth, Crawley, Australia; [Manalil, Sudheesh] Amrita Univ, Coimbatore, Tamil Nadu, India; [Ali, Hafiz Haider] Univ Sargodha, Univ Coll Agr, Dept Agron, Sargodha, Punjab, Pakistan	University of Queensland; University of Western Australia; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Coimbatore; Bahauddin Zakariya University; University of Sargodha	Manalil, S (corresponding author), Univ Queensland, QAAFI, Ctr Crop Sci, Gatton, Qld, Australia.; Manalil, S (corresponding author), Univ Western Australia, Inst Agr, Sch Plant Biol, Perth, Crawley, Australia.; Manalil, S (corresponding author), Amrita Univ, Coimbatore, Tamil Nadu, India.	s.manalil@uq.edu.au	Manalil, Sudheesh/GQR-0450-2022; Ali, Hafiz Haider/ABE-6457-2021; Chauhan, Bhagirath/G-8892-2014	Ali, Hafiz Haider/0000-0002-8262-6327; Chauhan, Bhagirath/0000-0003-1540-4668	Grains Research Development Corporation (GRDC), Australia [UA00156]	Grains Research Development Corporation (GRDC), Australia(Grains R&D Corp)	This work was supported by a grant from Grains Research Development Corporation (GRDC), Australia under project UA00156.	Adkins SW, 1997, WEED RES, V37, P343, DOI 10.1046/j.1365-3180.1997.d01-56.x; Ahmed S, 2015, WEED SCI, V63, P491, DOI 10.1614/WS-D-14-00115.1; [Anonymous], JORDAN J BIOL SCI; ASRIS, 2017, NAT SOIL GRIDS; Australia Government, 2017, CLIM STAT AUSTR LOC; Boutsalis P, 1998, WEED RES, V38, P389, DOI 10.1046/j.1365-3180.1998.00109.x; Chauhan BS, 2008, WEED SCI, V56, P567, DOI 10.1614/WS-07.200.1; Chauhan BS, 2006, WEED SCI, V54, P1032, DOI 10.1614/WS-06-060R1.1; Chauhan BS, 2006, WEED SCI, V54, P1025, DOI 10.1614/WS-06-092.1; Chauhan BS, 2006, WEED SCI, V54, P854, DOI 10.1614/WS-06-047R.1; Chauhan BS, 2006, WEED SCI, V54, P891, DOI 10.1614/WS-06-053R.1; Chauhan BS, 2009, WEED SCI, V57, P36, DOI 10.1614/WS-08-015.1; CottonInfo, 2016, STEW RED RISK RES; COUSENS R, 1994, WEED RES, V34, P127, DOI 10.1111/j.1365-3180.1994.tb01980.x; Dalal RC, 2004, AUST J EXP AGR, V44, P1013, DOI 10.1071/EA03166; Dang YP, 2006, AUST J AGR RES, V57, P983, DOI 10.1071/AR05268; Dang YP, 2015, SOIL TILL RES, V152, P104, DOI 10.1016/j.still.2015.03.009; Dang YP, 2016, AGRONOMY-BASEL, V6, DOI 10.3390/agronomy6040055; Eslami SV, 2010, INT J PLANT PROD, V4, P159; Gorecki MJ, 2012, ANN BOT-LONDON, V109, P1369, DOI 10.1093/aob/mcs067; GRDC, 2017, GROW REG; Hatami ZM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00169; Honarmand SJ, 2016, WEED BIOL MANAG, V16, P186, DOI 10.1111/wbm.12110; Karimmojeny H, 2014, BRAZ J BOT, V37, P121, DOI 10.1007/s40415-014-0058-1; Kleemann SGL, 2007, WEED SCI, V55, P481, DOI 10.1614/WS-06-197.1; Kleemann SGL, 2013, WEED SCI, V61, P222, DOI 10.1614/WS-D-12-00083.1; Lu P, 2006, WEED SCI, V54, P452, DOI 10.1614/WS-05-174R1.1; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Nandula VK, 2006, WEED SCI, V54, P898, DOI 10.1614/WS-06-006R2.1; Nosratti I, 2017, WEED BIOL MANAG, V17, P144, DOI 10.1111/wbm.12128; Ohadi S, 2011, WEED SCI, V59, P483, DOI 10.1614/WS-D-10-00153.1; Opena JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092261; Osten VA, 2007, AUST J EXP AGR, V47, P57, DOI 10.1071/EA05141; R Development Core Team, R LANG ENV STAT COMP; Ramesh K., ADV AGRON, V131, P251; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Simmons MT, 2005, RESTOR ECOL, V13, P609, DOI 10.1111/j.1526-100X.2005.00078.x; Whish JPM, 2002, AUST J AGR RES, V53, P1335, DOI 10.1071/AR01168; Widderick M., 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P535; Wilson BJ, 1981, 6 AUSTR WEEDS C GOLD	40	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201023	10.1371/journal.pone.0201023	http://dx.doi.org/10.1371/journal.pone.0201023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024963	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000078
J	Mendes, MD; da Silva, I; Ramires, V; Reichert, F; Martins, R; Ferreira, R; Tomasi, E				Mendes, Marcio de Almeida; da Silva, Inacio; Ramires, Virgilio; Reichert, Felipe; Martins, Rafaela; Ferreira, Rodrigo; Tomasi, Elaine			Metabolic equivalent of task (METs) thresholds as an indicator of physical activity intensity	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; EPIDEMIOLOGIC RESEARCH; PUBLIC-HEALTH; EXERCISE; FITNESS; RECOMMENDATION; ACCELEROMETER; PREVENTION; ADULTS; OUTPUT	The purpose of the study was to identify and compare validity parameters of different absolute intensity thresholds in METs, using relative intensity classification as criterion measure. Convenience sampling was used to recruit total of 112 adults. The participants carried out an incremental maximal cycle ergometer test and asked to perform nine free-living activities. The oxygen uptake was measured by a VO2000 (R) gas analyser throughout the tests. The intensity thresholds were identified using Receiver Operator Characteristic (ROC) curve analysis, having relative intensity categories as criterion measure. A total of 103 participants attended the two visits. Among 54 men and 49 women, the mean (+/- SD) ages were 36.1 (+/- 11.1) and 33.9 (+/- 10.6) years, respectively. The intensity thresholds identified were 4.9 METs for moderate and 6.8 METs for vigorous physical activity. In conclusion, the physical activity thresholds, generated according to the entire sample, were higher and presented improved specificity when compared to thresholds currently recommended. Moreover, these parameters presented relatively high accuracy, even when applied to specific groups such as sex, age, nutritional status and physical fitness.	[Mendes, Marcio de Almeida; Martins, Rafaela; Tomasi, Elaine] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [da Silva, Inacio; Reichert, Felipe; Ferreira, Rodrigo] Univ Fed Pelotas, Phys Educ Sch, Pelotas, Brazil; [Ramires, Virgilio] Sul Rio Grandense Fed Inst Educ Sci & Technol, Camaqua, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Mendes, MD (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	marciopenha.esef@yahoo.com.br	Tomasi, Elaine/AAH-2226-2021; Silva, Inacio C M/L-9896-2017; Martins, Rafaela C/E-2819-2014	Silva, Inacio C M/0000-0001-5390-8360; Costa Martins, Rafaela/0000-0003-3538-7228; de Almeida Mendes, Marcio/0000-0002-5590-5750				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; du Prel JB, 2009, DTSCH ARZTEBL INT, V106, P335, DOI 10.3238/arztebl.2009.0335; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Ferguson B, 2014, J CAN CHIROPR ASS, V58, P328; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Guedes DP, 2006, PRACTICAL GUIDE PHYS; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Midgley AW, 2009, APPL PHYSIOL NUTR ME, V34, P115, DOI 10.1139/H08-146; Neder JA, CLIN PHYSL EXERCISE; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Phillips LRS, 2013, J SCI MED SPORT, V16, P124, DOI 10.1016/j.jsams.2012.05.013; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Shephard RJ, 2001, MED SCI SPORT EXER, V33, pS400, DOI 10.1097/00005768-200106001-00008; Shephard RJ, 2015, J PHYS ACT HEALTH, V12, P454, DOI 10.1123/jpah.2013-0473; Sterne JAC, 2001, PHYS THER, V81, P1464, DOI 10.1093/ptj/81.8.1464; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Wahrlich V, 2006, CLIN NUTR, V25, P687, DOI 10.1016/j.clnu.2006.01.002; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; World OH, 2000, WHO TECHN REP SER	25	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200701	10.1371/journal.pone.0200701	http://dx.doi.org/10.1371/journal.pone.0200701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024953	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000043
J	Romagnoli, N; Pagnanelli, G; Lambertini, C; Drayton, E; Buonacucina, A; Peli, A				Romagnoli, Noemi; Pagnanelli, Giacomo; Lambertini, Carlotta; Drayton, Emily; Buonacucina, Alessandra; Peli, Angelo			Cardiorespiratory effects of medetomidine and dexmedetomidine combined with tiletamine-zolazepam for the immobilization of Asiatic black bears (Ursus thibetanus) under isoflurane general anesthesia	PLOS ONE			English	Article							KETAMINE	The aim of this paper was to compare the cardiorespiratory effects of the two combinations (medetomidine-tiletamine-zolazepam (MTZ) or dexmedetomidine-tiletamine-zolazepam (DTZ)) used for Asiatic black bear (Ursus thibetanus) immobilization. A retrospective analysis was carried out, reviewing the anesthetic records of captive bears. Sixty-six records were reviewed. The bears were immobilized, and general anesthesia was maintained with isoflurane vaporized in 100% oxygen. The mean sedation time and score were evaluated. The cardiorespiratory parameters were recorded every 10 minutes from intubation until extubation. Mean sedation time was 26.1 +/- 14.5 minutes for the MTZ group and 25.6 +/- 19.4 minutes for the DTZ group. The heart rate and the respiratory rate were higher in the bears immobilized with DTZ (66 +/- 19 beats/min; 13 +/- 5.2 breaths/min) as compared with the bears immobilized with MTZ (57 +/- 14.5 beats/min; 10 +/- 4.7 breaths/min) whereas the mean arterial pressure did not differ significantly between the groups. The body temperature was in the normal range throughout the procedures in all bears (MTZ 36.3 +/- 0.9 degrees C; DTZ 37 +/- 1 degrees C). In conclusion, the two protocols used in this study have been proven to be safe and reliable for the immobilization of Asiatic black bears, and the DTZ combination seemed to be associated with less cardiorespiratory depression than the MTZ one.	[Romagnoli, Noemi; Pagnanelli, Giacomo; Lambertini, Carlotta; Peli, Angelo] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Buonacucina, Alessandra] Univ Bologna, Centralized Vet Serv, Bologna, Italy; [Drayton, Emily] Chengdu Bear Rescue Ctr, Chengdu, Sichuan, Peoples R China	University of Bologna; University of Bologna	Lambertini, C (corresponding author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	carlotta.lambertini2@unibo.it	Lambertini, Carlotta/AAY-7825-2020; PELI, ANGELO/AAX-8423-2021	Lambertini, Carlotta/0000-0002-3604-5337; PELI, ANGELO/0000-0003-3488-2948				Asano M, 2007, J VET MED SCI, V69, P433, DOI 10.1292/jvms.69.433; Cattet MRL, 1999, J ZOO WILDLIFE MED, V30, P354; Caulkett N, 2002, ZOOL RESTRAINT ANEST, P2; Caulkett NA, 1997, J WILDLIFE DIS, V33, P618, DOI 10.7589/0090-3558-33.3.618; Caulkett NA, 1999, J ZOO WILDLIFE MED, V30, P504; Coltrane JA, 2015, WILDLIFE SOC B, V39, P378, DOI 10.1002/wsb.538; Fahlman A, 2014, J WILDLIFE DIS, V50, P574, DOI 10.7589/2013-06-148; Fahlman A, 2011, J ZOO WILDLIFE MED, V42, P1, DOI 10.1638/2008-0117.1; Fandos Esteruelas N, 2017, PLOS ONE, V12, P83, DOI [10.7589/2012-11-273, DOI 10.7589/2012-11-273]; IUCN, IUCN RED LIST THREAT; Jeong DH, 2017, J VET MED SCI, V79, P153, DOI 10.1292/jvms.16-0290; Laricchiuta P, 2008, J ZOO WILDLIFE MED, V39, P558, DOI 10.1638/2007-0130.1; Onuma M, 2003, J ZOO WILDLIFE MED, V34, P202, DOI 10.1638/1042-7260(2003)034[0202:IOSBHM]2.0.CO;2; Teisberg JE, 2014, J WILDLIFE DIS, V50, P74, DOI 10.7589/2012-11-273; White TH, 1996, WILDLIFE SOC B, V24, P521	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200833	10.1371/journal.pone.0200833	http://dx.doi.org/10.1371/journal.pone.0200833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024923	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000057
J	Wohlfahrt, A; Campos, A; Iversen, MD; Gagne, JJ; Massarotti, E; Solomon, DH; Feldman, CH				Wohlfahrt, Alyssa; Campos, Anarosa; Iversen, Maura D.; Gagne, Joshua J.; Massarotti, Elena; Solomon, Daniel H.; Feldman, Candace H.			Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; UNINTENTIONAL NONADHERENCE; ARTHRITIS; MORTALITY	Objective Adherence to medications among patients with rheumatic diseases is often suboptimal. Patient navigators, individuals trained in care coordination, motivational interviewing and basic rheumatology and pharmacology, have not been employed to explore and address this issue. We piloted a single-site, single arm intervention to determine the feasibility and acceptability of using rheumatology-specific navigators to understand and reduce barriers to adherence to oral disease modifying anti-rheumatic drugs (DMARDs). We analyzed our qualitative findings from navigator-patient interactions as well as patient satisfaction with the intervention. Methods We recruited patients >= 18 years with a systemic rheumatic disease who initiated an oral DMARD within the prior 6 months. Navigators conducted baseline needs assessments and 2-4 week follow-up calls to understand and address issues related to medication adherence. We analyzed patient-navigator encounters qualitatively using content analysis to identify key themes related to barriers to adherence and navigator actions performed in response to the barriers described. We also categorized intentional and unintentional nonadherent behavior and assessed satisfaction with the navigator experience (range 0-5,5 = most satisfied). Results 107 rheumatology patients were followed for up to 6 months. Mean patient age was 55 years (+/- 17) and 93% were female; 36% described one or more episode of intentional or unintentional nonadherence. The three most common themes identified as barriers to adherence were fear of adverse events (raised by 54%), concerns about medication effectiveness (43%), and challenges with medication acquisition (32%). 86% of participants described at least one adherence-related barrier. Frequent navigator actions included facilitation of patient-doctor communication (38%), medication and diagnosis education (27%), and development of individualized strategies to improve adherence (16%). Patients were satisfied with the navigator experience (mean 4.4 +/- 0.9). Conclusion Navigators uncovered and addressed a number of medication adherence-related concerns and patients were satisfied with the services provided.	[Wohlfahrt, Alyssa; Campos, Anarosa; Iversen, Maura D.; Massarotti, Elena; Solomon, Daniel H.; Feldman, Candace H.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Iversen, Maura D.] Northeastern Univ, Dept Phys Therapy, Movement & Rehabil Sci, Boston, MA 02115 USA; [Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Northeastern University; Harvard University; Brigham & Women's Hospital	Feldman, CH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	chfeldman@partners.org	iversen, maura daly/O-5388-2015	iversen, maura daly/0000-0003-4708-9914	Pfizer Pharmaceuticals (PI: DHS); NIH/NIAMS [K23 AR071500]; Rheumatology Research Foundation Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR071500] Funding Source: NIH RePORTER	Pfizer Pharmaceuticals (PI: DHS); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by Pfizer Pharmaceuticals (PI: DHS). Funding was also received from NIH/NIAMS K23 AR071500 (CHF) and the Rheumatology Research Foundation Investigator Award (CHF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259; Brandstetter S, 2016, PSYCHOL HEALTH, V31, P675, DOI 10.1080/08870446.2016.1139111; Cannon GW, 2011, ARTHRIT CARE RES, V63, P1680, DOI 10.1002/acr.20629; Cho JY, 2014, QUAL REP, V19, DOI 10.7838/jsebs.2014.19.1.001; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Conn DL, 2013, CLIN RHEUMATOL, V32, P49, DOI 10.1007/s10067-012-2090-5; Daleboudt GMN, 2011, ARTHRIT CARE RES, V63, P342, DOI 10.1002/acr.20411; de Achaval S, 2010, J MUSCULOSKELET MED, V27; Feldman CH, 2015, ARTHRIT CARE RES, V67, P1712, DOI 10.1002/acr.22636; Feldman CH, 2017, ARTHRITIS CARE RES H, DOI [10.1002/acr, DOI 10.1002/ACR]; Galo JS, 2016, ANN RHEUM DIS, V75, P667, DOI 10.1136/annrheumdis-2014-206593; Innala L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3442; Julian LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P240, DOI 10.1002/art.24236; Kelly E, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0019-1; Lasser Karen E, 2013, J Ethn Subst Abuse, V12, P374, DOI 10.1080/15332640.2013.819311; Lehane E, 2007, INT J NURS STUD, V44, P1468, DOI 10.1016/j.ijnurstu.2006.07.010; Lehane E, 2007, J CLIN NURS, V16, P698, DOI 10.1111/j.1365-2702.2005.01538.x; Lowry KP, 2005, ANN PHARMACOTHER, V39, P1198, DOI 10.1345/aph.1E594; Mathijssen EGE, 2018, PATIENT PREFER ADHER, V12, P349, DOI 10.2147/PPA.S152759; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pasma A, 2015, J RHEUMATOL, V42, P379, DOI 10.3899/jrheum.140693; Rapoff MA, 2002, HEALTH PSYCHOL, V21, P620, DOI 10.1037//0278-6133.21.6.620; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; van den Bemt BJF, 2009, J RHEUMATOL, V36, P2164, DOI 10.3899/jrheum.081204; Waimann CA, 2013, ARTHRITIS RHEUM-US, V65, P1421, DOI 10.1002/art.37917; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Wroe AL, 2002, J BEHAV MED, V25, P355, DOI 10.1023/A:1015866415552	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200886	10.1371/journal.pone.0200886	http://dx.doi.org/10.1371/journal.pone.0200886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024938	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000064
J	Sukeri, S; Idris, Z; Zahiruddin, WM; Shafei, MN; Idris, N; Hamat, RA; Jamaluddin, TZT; Osman, M; Wahab, ZA; Daud, A				Sukeri, Surianti; Idris, Zawaha; Zahiruddin, Wan Mohd; Shafei, Mohd Nazri; Idris, Norazlin; Hamat, Rukman Awang; Jamaluddin, Tengku Zetty Tengku; Osman, Malina; Wahab, Zainudin Abdul; Daud, Aziah			A qualitative exploration of the misconceptions, knowledge gaps and constructs of leptospirosis among rural and urban communities in Malaysia	PLOS ONE			English	Article								This qualitative study aimed to explore the misconceptions, knowledge gaps and constructs of leptospirosis among 72 respondents from rural and urban districts in two states of Malaysia. We conducted focus group discussions and data were examined using thematic analyses. The layman term of 'rat urine disease' contributed the most to the misconceptions regarding leptospirosis. There were gaps in the knowledge among urban and rural respondents in the two states, with the majority of subjects demonstrating a poor understanding of the disease. Construction of knowledge about leptospirosis relied mostly on the information provided by mass and social media; reading materials; word-of-mouth publicity; observations; experiences; and knowledge sharing among families, friends, and communities. The study findings may provide the foundation for the development of educational materials that may reduce the gaps in knowledge, and thereby improve health literacy and enhance preventive health behaviours for avoiding leptospirosis.	[Sukeri, Surianti; Zahiruddin, Wan Mohd; Shafei, Mohd Nazri; Idris, Norazlin; Daud, Aziah] Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kubang Kerian, Kelantan, Malaysia; [Idris, Zawaha] Penang State Hlth Dept, Hlth Promot Unit, Jalan Anson, George Town, Malaysia; [Hamat, Rukman Awang; Jamaluddin, Tengku Zetty Tengku; Osman, Malina] Univ Putra Malaysia, Fac Med, Dept Med Microbiol & Parasitol, Serdang, Selangor, Malaysia; [Wahab, Zainudin Abdul] Fed Terr Kuala Lumpur & Putrajaya, Hlth Dept, Jalan Cenderasari, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; Universiti Putra Malaysia	Sukeri, S (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kubang Kerian, Kelantan, Malaysia.	surianti@usm.my	DAUD, AZIAH/ABC-2347-2020; Osman, Malina/U-5389-2019; Mohammad, Wan Mohd Zahiruddin Wan/B-1916-2018; SHAFEI, MOHD NAZRI/R-8993-2019; Awang Hamat, Rukman/K-1232-2014; Sukeri, Surianti/L-5691-2016	Osman, Malina/0000-0001-5591-3315; Mohammad, Wan Mohd Zahiruddin Wan/0000-0002-5564-6111; SHAFEI, MOHD NAZRI/0000-0002-7023-9717; Awang Hamat, Rukman/0000-0001-6288-3791; Sukeri, Surianti/0000-0003-0974-7074; Jamaluddin, Tengku Zetty Maztura Tengku/0000-0002-8269-5699	Ministry of Higher Education Malaysia [203/PPSP/6770003]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	The research was funded by the Long-Term Research Grant (203/PPSP/6770003), Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, HUM LEPT GUID DIAGN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown A., 2012, THESIS; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Department of Statistics, POPULATION HOUSING C; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Mason MR, 2016, THESIS; Mohan ARM, 2011, INT HEALTH, V3, P131, DOI 10.1016/j.inhe.2011.03.002; Molineri AI, 2014, REV ARGENT MICROBIOL, V46, P7, DOI 10.1016/S0325-7541(14)70041-0; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Nozmi N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040693; Prabhu N, 2014, INT J PHARM RES HLTH, V2; Quina C.R., 2014, AM J PUBLIC HLTH RES, V2, P91, DOI DOI 10.12691/ajphr-2-3-5; Rafizah AAN, 2013, INT J INFECT DIS, V17, pE394, DOI 10.1016/j.ijid.2012.12.012; RAHIM SM, 2012, BRUNEI DARUSSALAM J, V5, P1; Sakinah SNS, 2015, INT J PUBLIC HLTH CL, V2, P92; Samarakoon YM, 2013, RURAL REMOTE HEALTH, V13; Sapian M, 2012, Med J Malaysia, V67, P293; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Stull JW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-553; STYCOS JM, 1981, STUD FAMILY PLANN, V12, P450, DOI 10.2307/1965657; Tan WL, 2016, SE ASIAN J TROP MED, V47, P434; Vinetz Joseph M., 2005, EcoHealth, V2, P291, DOI 10.1007/s10393-005-8638-y; Wahab ZA., 2015, LOCAL AUTHORITY C EN; Zanzi C, 2014, J INFECT PUBLIC HEAL, V7, P314, DOI [10.1016/j.jiph.2014.03.004, DOI 10.1016/J.JIPH.2014.03.004]; Zhang HL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004476	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200871	10.1371/journal.pone.0200871	http://dx.doi.org/10.1371/journal.pone.0200871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021013	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400084
J	Garza-Lopez, E; Lopez, JA; Hagen, J; Sheffer, R; Meiner, V; Lee, A				Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Sheffer, Ruth; Meiner, Vardiella; Lee, Amy			Role of a conserved glutamine in the function of voltage-gated Ca2+ channels revealed by a mutation in human CACNA1D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; gating; ion channel; autism; epilepsy; CACNA1D; calcium voltage-gated channel subunit alpha1 D; Ca2+ channel; modulation; inactivation; intellectual disability; hearing impairment	AUTISM SPECTRUM DISORDERS; INNER HAIR-CELLS; CALCIUM-CHANNELS; DEPENDENT INACTIVATION; CA(V)1.3 CHANNELS; TIMOTHY-SYNDROME; MOLECULAR DETERMINANTS; CONGENITAL DEAFNESS; ALPHA(1A) SUBUNIT; MODULATION	Voltage-gated Ca-v Ca2+ channels play crucial roles in regulating gene transcription, neuronal excitability, and synaptic transmission. Natural or pathological variations in Ca-v channels have yielded rich insights into the molecular determinants controlling channel function. Here, we report the consequences of a natural, putatively disease-associated mutation in the CACNA1D gene encoding the pore-forming Ca(v)1.3 (1) subunit. The mutation causes a substitution of a glutamine residue that is highly conserved in the extracellular S1-S2 loop of domain II in all Ca-v channels with a histidine and was identified by whole-exome sequencing of an individual with moderate hearing impairment, developmental delay, and epilepsy. When introduced into the rat Ca(v)1.3 cDNA, Q558H significantly decreased the density of Ca2+ currents in transfected HEK293T cells. Gating current analyses and cell-surface biotinylation experiments suggested that the smaller current amplitudes caused by Q558H were because of decreased numbers of functional Ca(v)1.3 channels at the cell surface. The substitution also produced more sustained Ca2+ currents by weakening voltage-dependent inactivation. When inserted into the corresponding locus of Ca(v)2.1, the substitution had similar effects as in Ca(v)1.3. However, the substitution introduced in Ca(v)3.1 reduced current density, but had no effects on voltage-dependent inactivation. Our results reveal a critical extracellular determinant of current density for all Ca-v family members and of voltage-dependent inactivation of Ca(v)1.3 and Ca(v)2.1 channels.	[Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Mol Physiol, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Biophys, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Iowa Neurosci Inst, Iowa City, IA 52242 USA; [Sheffer, Ruth; Meiner, Vardiella] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Hebrew University of Jerusalem; Hadassah University Medical Center	Lee, A (corresponding author), PBDB 5318,169 Newton RD, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu		Lopez, Josue A./0000-0003-0232-4407; Garza Lopez-Hinton, Edgar/0000-0003-0243-0816; Sheffer, Ruth/0000-0002-3623-8016	Karl Kahane Foundation; Conacyt (Mexico) postdoctoral fellowship; National Institutes of Health [NS084190, DC009433]; Carver Research Program of Excellence Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	Karl Kahane Foundation; Conacyt (Mexico) postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Karl Kahane Foundation (to V. M. and R. S.), Conacyt (Mexico) postdoctoral fellowship (to E. G. L.), and National Institutes of Health Grants NS084190 and DC009433 and Carver Research Program of Excellence Award (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Bett Glenna Cl, 2012, N Am J Med Sci (Boston), V5, P135; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Brandt A, 2003, J NEUROSCI, V23, P10832; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; Ehlinger DG, 2017, EUR J NEUROSCI, V46, P2416, DOI 10.1111/ejn.13707; Full Y, 2013, PFLUG ARCH EUR J PHY, V465, P797, DOI 10.1007/s00424-012-1184-x; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; Graybiel AM, 2016, RES PER NEUROSCI, P81, DOI 10.1007/978-3-319-28802-4_6; Gregory FD, 2013, J PHYSIOL-LONDON, V591, P3253, DOI 10.1113/jphysiol.2013.254367; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; Harel T, 2017, AM J MED GENET A, V173, P2539, DOI 10.1002/ajmg.a.38347; Hennessey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106982; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; Joensuu M, 2018, PROG NEURO-PSYCHOPH, V84, P362, DOI 10.1016/j.pnpbp.2017.08.023; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Mckeown L, 2008, J BIOL CHEM, V283, P30421, DOI 10.1074/jbc.M708921200; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Palovcak E, 2014, J GEN PHYSIOL, V143, P145, DOI 10.1085/jgp.201311103; Pantazis A, 2014, P NATL ACAD SCI USA, V111, P18381, DOI 10.1073/pnas.1411127112; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Pinggera A, 2017, HUM MOL GENET, V26, P2923, DOI 10.1093/hmg/ddx175; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Schraders M, 2012, AM J HUM GENET, V91, P883, DOI 10.1016/j.ajhg.2012.09.012; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stanika R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34528; Stawarski M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00068; Stotz SC, 2001, J BIOL CHEM, V276, P33001, DOI 10.1074/jbc.M104387200; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Wang SY, 2017, J NEUROSCI, V37, P4679, DOI 10.1523/JNEUROSCI.2583-16.2017; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wehrens XHT, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9136; WEI XY, 1994, J BIOL CHEM, V269, P1635; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	53	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14444	14454		10.1074/jbc.RA118.003681	http://dx.doi.org/10.1074/jbc.RA118.003681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30054272	Green Published, hybrid			2022-12-26	WOS:000444671500023
J	Bhowmick, SS; Saha, I; Bhattacharjee, D; Genovese, LM; Geraci, F				Bhowmick, Shib Sankar; Saha, Indrajit; Bhattacharjee, Debotosh; Genovese, Loredana M.; Geraci, Filippo			Genome- wide analysis of NGS data to compile cancer- specific panels of miRNA biomarkers	PLOS ONE			English	Article							FEATURE-SELECTION; DIFFERENTIAL EVOLUTION; TARGET INTERACTIONS; MUTUAL INFORMATION; COMPONENT ANALYSIS; CLASSIFICATION; MICRORNAS; IDENTIFICATION; ALGORITHMS; INJURY	MicroRNAs are small non-coding RNAs that influence gene expression by binding to the 3' UTR of target mRNAs in order to repress protein synthesis. Soon after discovery, microRNA dysregulation has been associated to several pathologies. In particular, they have often been reported as differentially expressed in healthy and tumor samples. This fact suggested that microRNAs are likely to be good candidate biomarkers for cancer diagnosis and personalized medicine. With the advent of Next-Generation Sequencing (NGS), measuring the expression level of the whole miRNAome at once is now routine. Yet, the collaborative effort of sharing data opens to the possibility of population analyses. This context motivated us to perform an in-silico study to distill cancer-specific panels of microRNAs that can serve as biomarkers. We observed that the problem of finding biomarkers can be modeled as a twoclass classification task where, given the miRNAomes of a population of healthy and cancerous samples, we want to find the subset of microRNAs that leads to the highest classification accuracy. We fulfill this task leveraging on a sensible combination of data mining tools. In particular, we used: differential evolution for candidate selection, component analysis to preserve the relationships among miRNAs, and SVM for sample classification. We identified 10 cancer-specific panels whose classification accuracy is always higher than 92%. These panels have a very little overlap suggesting that miRNAs are not only predictive of the onset of cancer, but can be used for classification purposes as well. We experimentally validated the contribution of each of the employed tools to the selection of discriminating miRNAs. Moreover, we tested the significance of each panel for the corresponding cancer type. In particular, enrichment analysis showed that the selected miRNAs are involved in oncogenesis pathways, while survival analysis proved that miRNAs can be used to evaluate cancer severity. Summarizing: results demonstrated that our method is able to produce cancerspecific panels that are promising candidates for a subsequent in vitro validation.	[Bhowmick, Shib Sankar; Bhattacharjee, Debotosh] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, India; [Bhowmick, Shib Sankar] Heritage Inst Technol, Dept Elect & Commun Engn, Kolkata, India; [Saha, Indrajit] Natl Inst Tech Teachers Training & Res, Dept Comp Sci & Engn, Kolkata, India; [Genovese, Loredana M.; Geraci, Filippo] CNR, Inst Informat & Telemat, Pisa, Italy	Jadavpur University; Heritage Institute of Technology (HITK); National Institute of Technical Teachers Training & Research, Kolkata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR)	Saha, I (corresponding author), Natl Inst Tech Teachers Training & Res, Dept Comp Sci & Engn, Kolkata, India.	indrajit@nitttrkol.ac.in	Bhattacharjee, Debotosh/Q-4065-2019	Bhattacharjee, Debotosh/0000-0002-1163-6413; GERACI, FILIPPO/0000-0001-6993-6761	Department of Science and Technology, India [DST/INT/POL/P-36/2016]; Istituto Toscano Tumori	Department of Science and Technology, India(Department of Science & Technology (India)); Istituto Toscano Tumori	The authors declare the following funding: Department of Science and Technology, India, DST/INT/POL/P-36/2016 (Dr. Indrajit Saha); Istituto Toscano Tumori, "Eligibility of miRNAs modified by docetaxel in prostate cancer cells to plasma biomarkers in patients responsive or no more responsive to docetaxel (Dr Filippo Geraci). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bickel P. J., 2015, MATH STAT BASIC IDEA, VI; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Carbonell J, 2012, GENOME MED, V4, DOI 10.1186/gm363; Church RJ, 2014, TOXICOL RES-UK, V3, P384, DOI 10.1039/c4tx00051j; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Fabbri M, 2013, CURR MOL MED, V13, P751, DOI 10.2174/1566524011313050006; Gao XJ, 2016, ONCOTARGET, V7, P81670, DOI 10.18632/oncotarget.13164; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hollander M, 1999, NONPARAMETRIC STAT M, V2; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Jenssen R, 2010, IEEE T PATTERN ANAL, V32, P847, DOI 10.1109/TPAMI.2009.100; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kok MGM, 2015, FASEB J, V29, P3853, DOI 10.1096/fj.15-271312; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu Huiqing, 2002, Genome Inform, V13, P51; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Maulik U, 2009, PATTERN RECOGN, V42, P2135, DOI 10.1016/j.patcog.2009.01.011; Miao JY, 2016, PROCEDIA COMPUT SCI, V91, P919, DOI 10.1016/j.procs.2016.07.111; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Sethi S, 2014, CLIN GENET, V86, P68, DOI 10.1111/cge.12362; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sourvinou IS, 2013, J MOL DIAGN, V15, P827, DOI 10.1016/j.jmoldx.2013.07.005; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Uncu O, 2007, INFORM SCIENCES, V177, P449, DOI 10.1016/j.ins.2006.03.022; Wu L, 2015, CHEM SOC REV, V44, P2963, DOI 10.1039/c4cs00370e; Yang H., 1999, P INT ICSC S ADV INT, P22; Zhou H, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0167-0	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200353	10.1371/journal.pone.0200353	http://dx.doi.org/10.1371/journal.pone.0200353			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048452	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400006
J	Huppi, R; Felber, R; Krauss, M; Six, J; Leifeld, J; Fuss, R				Huppi, Roman; Felber, Raphael; Krauss, Maike; Six, Johan; Leifeld, Jens; Fuss, Roland			Restricting the nonlinearity parameter in soil greenhouse gas flux calculation for more reliable flux estimates	PLOS ONE			English	Article							NITROUS-OXIDE FLUXES; N2O EMISSIONS; CHAMBERS; ATMOSPHERE; EXCHANGE; BIOCHAR; IMPACT; CARBON; MODEL	The static chamber approach is often used for greenhouse gas (GHG) flux measurements, whereby the flux is deduced from the increase of species concentration after closing the chamber. Since this increase changes diffusion gradients between chamber air and soil air, a nonlinear increase is expected. Lateral gas flow and leakages also contribute to non linearity. Several models have been suggested to account for this non linearity, the most recent being the Hutchinson-Mosier regression model (HMR). However, the practical application of these models is challenging because the researcher needs to decide for each flux whether a nonlinear fit is appropriate or exaggerates flux estimates due to measurement artifacts. In the latter case, a flux estimate from the linear model is a more robust solution and introduces less arbitrary uncertainty to the data. We present the new, dynamic and reproducible flux calculation scheme, KAPPA. MAX, for an improved trade-off between bias and uncertainty (i.e. accuracy and precision). We develop a tool to simulate, visualise and optimise the flux calculation scheme for any specific static N2O chamber measurement system. The decision procedure and visualisation tools are implemented in a package for the R software. Finally, we demonstrate with this approach the performance of the applied flux calculation scheme for a measured flux dataset to estimate the actual bias and uncertainty. The KAPPA. MAX method effectively improved the decision between linear and nonlinear flux estimates reducing the bias at a minimal cost of uncertainty.	[Huppi, Roman; Six, Johan] Swiss Fed Inst Technol, Inst Agr Sci, Dept Environm Sci, Zurich, Switzerland; [Huppi, Roman; Felber, Raphael; Leifeld, Jens] Agroscope, Climate & Agr Grp, Zurich, Switzerland; [Krauss, Maike] Res Inst Organ Agr FiBL, Dept Soil Sci, Frick, Switzerland; [Fuss, Roland] Thunen Inst Climate Smart Agr, Braunschweig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; Johann Heinrich von Thunen Institute	Huppi, R (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Dept Environm Sci, Zurich, Switzerland.; Huppi, R (corresponding author), Agroscope, Climate & Agr Grp, Zurich, Switzerland.	roman.hueppi@usys.ethz.ch	Leifeld, Jens/GYR-0349-2022; Leifeld, Jens/A-3298-2014; Krauss, Maike/AAR-4252-2021; Fuß, Roland/F-3866-2011; six, johan/J-5228-2015	Leifeld, Jens/0000-0002-7245-9852; Leifeld, Jens/0000-0002-7245-9852; Fuß, Roland/0000-0002-0274-0809; six, johan/0000-0001-9336-4185; Felber, Raphael/0000-0002-0285-2894	Swiss National Science Foundation (SNF) [200021_140448]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (SNF) Project ID 200021_140448.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANTHONY WH, 1995, SOIL SCI SOC AM J, V59, P1308, DOI 10.2136/sssaj1995.03615995005900050015x; Bain WG, 2005, AGR FOREST METEOROL, V131, P225, DOI 10.1016/j.agrformet.2005.06.004; Cambareri G, 2017, CAN J SOIL SCI, V97, P532, DOI 10.1139/cjss-2016-0108; Collier SM, 2014, JOVE-J VIS EXP, DOI 10.3791/52110; Conen F, 2000, EUR J SOIL SCI, V51, P111, DOI 10.1046/j.1365-2389.2000.00292.x; De Klein C, 2013, NITROUS OXIDE CHAMBE; Deppe M, 2016, AGR ECOSYST ENVIRON, V219, P138, DOI 10.1016/j.agee.2015.12.015; FLESSA H, 1995, J GEOPHYS RES-ATMOS, V100, P23115, DOI 10.1029/95JD02270; Fuss R, 2017, FUNCTION VERSION 0 3; Huppi R, 2015, SOIL DISCUSSIONS, V2, P793, DOI [10.5194/soild-2-793-2015, DOI 10.5194/SOILD-2-793-2015]; Huppi R, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/8/084013; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Kandel TP, 2016, ATMOS ENVIRON, V141, P245, DOI 10.1016/j.atmosenv.2016.06.062; Krauss M, 2017, AGR ECOSYST ENVIRON, V239, P324, DOI 10.1016/j.agee.2017.01.029; Leiber-Sauheitl K, 2014, BIOGEOSCIENCES, V11, P749, DOI 10.5194/bg-11-749-2014; Levy PE, 2011, EUR J SOIL SCI, V62, P811, DOI 10.1111/j.1365-2389.2011.01403.x; Livingston GP, 2006, SOIL SCI SOC AM J, V70, P1459, DOI 10.2136/sssaj2005.0322; Parkin TB, 2012, J ENVIRON QUAL, V41, P705, DOI 10.2134/jeq2011.0394; Pedersen AR, 2010, EUR J SOIL SCI, V61, P888, DOI 10.1111/j.1365-2389.2010.01291.x; Pedersen AR, 2017, FLUX ESTIMATION STAT; Rochette P, 2008, SOIL SCI SOC AM J, V72, P331, DOI 10.2136/sssaj2007.0215; Ruser R, 2017, AGR ECOSYST ENVIRON, V249, P57, DOI 10.1016/j.agee.2017.07.039; Venterea RT, 2008, SOIL SCI SOC AM J, V72, P1410, DOI 10.2136/sssaj2008.0019; Venterea RT, 2013, SOIL SCI SOC AM J, V77, P709, DOI 10.2136/sssaj2013.01.0010; Venterea RT, 2010, J ENVIRON QUAL, V39, P126, DOI 10.2134/jeq2009.0231; Venterea RT, 2009, SOIL SCI SOC AM J, V73, P1087, DOI 10.2136/sssaj2008.0307; Verhoeven E, 2014, AGR ECOSYST ENVIRON, V191, P27, DOI 10.1016/j.agee.2014.03.008; Walter K, 2015, BIOMASS BIOENERG, V81, P556, DOI 10.1016/j.biombioe.2015.08.011	30	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200876	10.1371/journal.pone.0200876	http://dx.doi.org/10.1371/journal.pone.0200876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048522	Green Published, gold			2022-12-26	WOS:000439952400025
J	Kim, S; Yang, HK; Hwang, JM				Kim, Seonghwan; Yang, Hee Kyung; Hwang, Jeong-Min			Surgical outcomes of unilateral recession and resection in intermittent exotropia according to forced duction test results	PLOS ONE			English	Article							LATERAL RECTUS RECESSION; SURGERY; OVERCORRECTION; CHILDREN; ANGLE	Purpose To compare the surgical outcomes of unilateral lateral rectus recession-medial rectus resection (RR) according to forced duction test (FDT) results with those of conventional RR in intermittent exotropia. Methods A total of 129 patients aged 3 to 10 years with intermittent exotropia who underwent RR between 2006 and 2011 were included. The operator compared the tension of the lateral rectus (LR) between both eyes. When FDT results were asymmetric, RR was performed on the eye with more LR tension. RR was performed on the nondominant eye when FDT results were symmetric. Patients were divided into two groups; one group (n = 64) underwent RR without FDT (RR group) and the other group (n = 65) underwent RR considering FDT results (RR-FDT group). Success, recurrence, reoperation rates and cumulative probabilities of success were evaluated in both groups. Surgical outcome was considered satisfactory if the distance deviation in the primary position was between <= 10 PD of exophoria/tropia and <= 10 PD of esophoria/tropia. Recurrence was defined as an alignment of > 10 PD of exophoria/tropia, and overcorrection defined as > 10 PD of esophoria/tropia. Reoperation for recurrence was recommended for constant exotropia >= 14 PD at distance. Results The total follow-up periods were 4.4 +/- 2.3 years in the RR group, and 3.9 +/- 2.0 years in the RR-FDT group (P =.310). In the RR group, 50 patients (78.1%) were successful, 13 patients (20.3%) had recurrence, and 1 patient (1.6%) had overcorrection at 2 years after surgery. In the RR-FDT group, 58 patients (89.2%) were successful, 5 patients (7.7%) had recurrence, and 2 patients (3.1%) were overcorrected. The recurrence rate at 2 years after operation was significantly lower in the RR-FDT group (P =.045). Recurrence rates during the followup period were 5.6% per person-year in the RR group and 2.7% per person-year in the RR-FDT group. Reoperation for recurrence was performed on 7 patients ( 10.8%) in the RR- FDT group and 16 patients ( 25.0%) in the RR group ( P =.035). Postoperative sensory outcomes were similar between both groups. Conclusions The forced duction test was useful in reducing the risk of recurrence at 2 years after surgery when RR was performed on the eye with more passive tension of the LR. Intraoperative FDT may be considered to choose which eye to operate on when planning RR in intermittent	[Kim, Seonghwan; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea.	hjm@snu.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A2B4011450]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2B4011450) (JMH).	Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; CLARKE WN, 1981, CAN J OPHTHALMOL, V16, P66; Dell R, 1999, BRIT J ANAESTH, V82, P761, DOI 10.1093/bja/82.5.761; Duane A., 1897, ANN OPHTHALMOL OTOLA, V84, P247, DOI [10.1016/S0002-9394(42)92411-5, DOI 10.1016/S0002-9394(42)92411-5]; Govindan M, 2005, OPHTHALMOLOGY, V112, P104, DOI 10.1016/j.ophtha.2004.07.033; Heo H, 2013, JPN J OPHTHALMOL, V57, P475, DOI 10.1007/s10384-013-0260-x; Jampolsky A, 1986, Trans New Orleans Acad Ophthalmol, V34, P201; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Kim C, 2005, EYE, V19, P637, DOI 10.1038/sj.eye.6701604; Kim H, 2016, AM J OPHTHALMOL, V163, P11, DOI 10.1016/j.ajo.2015.12.003; Kim KE, 2014, AM J OPHTHALMOL, V157, P1214, DOI 10.1016/j.ajo.2014.02.038; Kim TW, 2005, OPHTHALMOLOGICA, V219, P237, DOI 10.1159/000085734; Lee SY, 2007, J AAPOS, V11, P266, DOI 10.1016/j.jaapos.2007.02.014; Maruo T, 2001, Binocul Vis Strabismus Q, V16, P265; METZ HS, 1985, INT OPHTHALMOL CLIN, V25, P13, DOI 10.1097/00004397-198502540-00004; Nusz KJ, 2006, OPHTHALMOLOGY, V113, P1154, DOI 10.1016/j.ophtha.2006.01.033; Preslan MW, 1996, OPHTHALMOLOGY, V103, P105, DOI 10.1016/S0161-6420(96)30753-7; ROSENBAUM AL, 1980, OPHTHALMOLOGY, V87, P158; Stephens K F, 1967, Trans Am Acad Ophthalmol Otolaryngol, V71, P324; Vishwanath M, 2009, STRABISMUS, V17, P41, DOI 10.1080/09273970802678354; von Noorden GK, 1996, BINOCULAR VISION OCU, P343; Wright KJ., 2000, COLOR ATLAS STRABISM, V2, P249; Zou LL, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/828919	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200741	10.1371/journal.pone.0200741	http://dx.doi.org/10.1371/journal.pone.0200741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048470	Green Published, gold			2022-12-26	WOS:000439952400017
J	Strang, BL; Asquith, CRM; Moshrif, HF; Ho, CMK; Zuercher, WJ; Al-Ali, H				Strang, Blair L.; Asquith, Christopher R. M.; Moshrif, Hanan F.; Ho, Catherine M-K; Zuercher, William J.; Al-Ali, Hassan			Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data	PLOS ONE			English	Article							STRUCTURE-BASED DESIGN; VIRUS ENTRY REQUIRES; WEST-NILE-VIRUS; GENETIC SCREEN; HOST FACTORS; HIV-1 REPLICATION; PROTEIN-KINASE; POTENT; MUTATIONS; MARIBAVIR	Chemogenomic approaches involving highly annotated compound sets and cell based high throughput screening are emerging as a means to identify novel drug targets. We have previously screened a collection of highly characterized kinase inhibitors (Khan et al., Journal of General Virology, 2016) to identify compounds that increase or decrease expression of a human cytomegalovirus (HCMV) protein in infected cells. To identify potential novel anti-HCMV drug targets we used a machine learning approach to relate our phenotypic data from the aforementioned screen to kinase inhibition profiling of compounds used in this screen. Several of the potential targets had no previously reported role in HCMV replication. We focused on one potential anti-HCMV target, MAPK4K, and identified lead compounds inhibiting MAP4K4 that have anti-HCMV activity with little cellular cytotoxicity. We found that treatment of HCMV infected cells with inhibitors of MAP4K4, or an siRNA that inhibited MAP4K4 production, reduced HCMV replication and impaired detection of IE2-60, a viral protein necessary for efficient HCMV replication. Our findings demonstrate the potential of this machine learning approach to identify novel anti-viral drug targets, which can inform the discovery of novel anti-viral lead compounds.	[Strang, Blair L.; Moshrif, Hanan F.; Ho, Catherine M-K] St Georges Univ London, Inst Infect & Immun, London, England; [Asquith, Christopher R. M.; Zuercher, William J.] Univ N Carolina, UNC Eshelman Sch Pharm, Struct Genom Consortium, Chapel Hill, NC 27515 USA; [Zuercher, William J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Al-Ali, Hassan] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Dept Neurol Surg, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Katz Drug Discovery Ctr, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Dept Med, Miami, FL USA	St Georges University London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Strang, BL (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	bstrang@sgul.ac.uk	Moshrif, Hanan F/L-1892-2017	Asquith, Christopher/0000-0001-5871-3458; Al-Ali, Hassan/0000-0002-8899-3443; Strang, Blair/0000-0001-9407-1974	St George's, University of London; PARK/WestFocus Award; Kingdom of Saudi Arabia; Miami Project to Cure Paralysis; The Wallace H Coulter Foundation; NINDS [R01 NS100531-01A1]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA) [115766]; Janssen; Merck KGaA Darmstadt Germany; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome [106169/ZZ14/Z]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100531] Funding Source: NIH RePORTER	St George's, University of London; PARK/WestFocus Award; Kingdom of Saudi Arabia; Miami Project to Cure Paralysis; The Wallace H Coulter Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA Darmstadt Germany; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BLS and CMKH were supported by New Investigator funds from St George's, University of London and a PARK/WestFocus Award. HFM was supported by a studentship from the Kingdom of Saudi Arabia. HAA was supported by The Miami Project to Cure Paralysis, The Wallace H Coulter Foundation, and NINDS R01 NS100531-01A1. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z]. The funders had no role in experimental design, data collection, data interpretation or the decision to submit the work for publication.	Al-Ali H, 2015, ACS CHEM BIOL, V10, P1939, DOI 10.1021/acschembio.5b00289; Ammirati M, 2015, ACS MED CHEM LETT, V6, P1128, DOI 10.1021/acsmedchemlett.5b00215; Beelontally R, 2017, ANTIVIR RES, V138, P61, DOI 10.1016/j.antiviral.2016.12.006; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chou SW, 2007, J INFECT DIS, V196, P91, DOI 10.1086/518514; Chou SW, 2017, ANTIVIR RES, V148, P1, DOI 10.1016/j.antiviral.2017.10.019; Chou SW, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01325-17; Chou SW, 2015, ANTIMICROB AGENTS CH, V59, P6588, DOI 10.1128/AAC.01623-15; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; Chou SW, 2004, J VIROL, V78, P7124, DOI 10.1128/JVI.78.13.7124-7130.2004; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Crawford TD, 2014, J MED CHEM, V57, P3484, DOI 10.1021/jm500155b; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Fusco DN, 2013, GASTROENTEROLOGY, V144, P1438, DOI 10.1053/j.gastro.2013.02.026; Gao X, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0121-7; Gaspar M, 2006, P NATL ACAD SCI USA, V103, P2821, DOI 10.1073/pnas.0511148103; Haas DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003737; Heaton BE, 2017, CELL REP, V20, P1503, DOI 10.1016/j.celrep.2017.07.060; Ho CMK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150339; Hoffmann HH, 2017, CELL HOST MICROBE, V22, P460, DOI 10.1016/j.chom.2017.09.002; Huang HB, 2012, ACS MED CHEM LETT, V3, P1059, DOI 10.1021/ml300278f; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Hutterer C, 2017, ANTIVIR RES, V143, P113, DOI 10.1016/j.antiviral.2017.04.003; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Khan AS, 2017, J GEN VIROL, V98, P754, DOI 10.1099/jgv.0.000713; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Koyuncu E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003333; Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lin YT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006329; Martinez GJ, 2017, J EXP MED, V214, P1205, DOI 10.1084/jem.20170571; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Mocarski E. S., 2015, FIELDS VIROLOGY, P1960; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P913, DOI 10.1021/acsmedchemlett.5b00174; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Polachek WS, 2016, J VIROL, V90, P8360, DOI 10.1128/JVI.01134-16; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Raaben M, 2017, CELL HOST MICROBE, V22, P688, DOI 10.1016/j.chom.2017.10.002; Reitsma JM, 2013, ANTIVIR RES, V100, P321, DOI 10.1016/j.antiviral.2013.09.011; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Strang BL, 2017, ANTIVIR RES, V144, P21, DOI 10.1016/j.antiviral.2017.05.004; Tan XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132148; Terry LJ, 2012, P NATL ACAD SCI USA, V109, P3071, DOI 10.1073/pnas.1200494109; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Virbasius JV, 2016, TRENDS ENDOCRIN MET, V27, P484, DOI 10.1016/j.tem.2016.04.006; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; White EA, 2007, J VIROL, V81, P2573, DOI 10.1128/JVI.02454-06; Wilkinson GWG, 2015, MED MICROBIOL IMMUN, V204, P273, DOI 10.1007/s00430-015-0411-4; Xuan BQ, 2009, J VIROL, V83, P3463, DOI 10.1128/JVI.02307-08; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	62	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201321	10.1371/journal.pone.0201321	http://dx.doi.org/10.1371/journal.pone.0201321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048526	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000439952400077
J	Ferreira, RC; Ribeiro, MTD; Vargas-Ferreira, F; Sampaio, AA; Pereira, ACM; Vargas, AMD; de Jesus, RM; Ferreira, EFE				Ferreira, Raquel Conceicao; de Freitas Ribeiro, Marco Tulio; Vargas-Ferreira, Fabiana; Sampaio, Aline Araujo; Marinho Pereira, Ana Cristina; Duarte Vargas, Andrea Maria; de Jesus, Rafaella Mendes; Ferreira e Ferreira, Efigenia			Assistive technologies for improving the oral hygiene of leprosy patients residing in a former leprosy colony in Betim, Minas Gerais, Brazil	PLOS ONE			English	Article							DEVICES; HEALTH; NEED	Background This study deals with management of a group of elderly patients with a history of leprosy and hand deformities by a multidisciplinary team of dentists and occupational therapists. Assistive technology devices have been developed to allow such patients to obtain independence in oral self-care and can be a cost-effective approach to improving oral care in this population. The objective of this study was to describe the development of assistive devices to facilitate daily oral hygiene in older people with enduring leprosy-related impairments. Methodology Case study realized among elders with a history of leprosy residents in a former isolation colony in Betim, Minas Gerais, Brazil. The elders were evaluated for dependence on others for denture hygiene and mouthwash using the Daily Oral Hygiene Activity Index (ADOH). Those deemed partially or completely dependent on others were eligible for an intervention based on assistive technology. We adopted a personalized approach to each case, taking into account medical history, physical impairment and living environment. Six months after the intervention, the participants were assessed again using the ADOH and an unstructured interview about use of the devices. Principal findings Assistive devices for denture hygiene and mouthwash were developed for 16 elders. These devices facilitated oral hygiene in most patients and there was no worsening in any of the cases. Patients' report suggested they were satisfied with the devices provided. Conclusions This study demonstrated that assistive devices can facilitate oral hygiene activities in leprosy patients. It also reinforces the importance of using a multidisciplinary team for the rehabilitation of these patients.	[Ferreira, Raquel Conceicao; Vargas-Ferreira, Fabiana; Sampaio, Aline Araujo; Duarte Vargas, Andrea Maria; de Jesus, Rafaella Mendes; Ferreira e Ferreira, Efigenia] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil; [de Freitas Ribeiro, Marco Tulio; Marinho Pereira, Ana Cristina] Fundacao Hosp Estado Minas Gerais, Casa Sau Santa Isabel, Betim, Brazil	Universidade Federal de Minas Gerais	Vargas-Ferreira, F (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil.	fabivfer@yahoo.com.br	Ferreira, Efigenia/AAF-5226-2021; Ferreira, Raquel Conceição/J-5236-2015; De Freitas Ribeiro, Marco Túlio/AAF-9938-2020; Vargas-Ferreira, Fabiana/V-6274-2017	Ferreira, Efigenia/0000-0002-0665-211X; Ferreira, Raquel Conceição/0000-0001-8897-9345; Araujo Sampaio, Aline/0000-0002-8704-5994; Vargas-Ferreira, Fabiana/0000-0003-3567-4737	Minas Gerais State Research Foundation - FAPEMIG in Brazil [APQ 03462-14]; Minas Gerais State Research Foundation - FAPEMIG in Brazil (Programa Pesquisador Mineiro) [PPM 00686 - 16]	Minas Gerais State Research Foundation - FAPEMIG in Brazil; Minas Gerais State Research Foundation - FAPEMIG in Brazil (Programa Pesquisador Mineiro)	This study was supported by Minas Gerais State Research Foundation - FAPEMIG (http://www.fapemig.br) located in Brazil - (Award numbers - APQ 03462-14 and Programa Pesquisador Mineiro PPM 00686 - 16). Both of them were received by the author RCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P501; [Anonymous], 2015, Wkly Epidemiol Rec, V91, P405; Araújo Marcelo Grossi, 2003, Rev. Soc. Bras. Med. Trop., V36, P373, DOI 10.1590/S0037-86822003000300010; Bauer J G, 2001, Spec Care Dentist, V21, P63, DOI 10.1111/j.1754-4505.2001.tb00227.x; Boku N, 2010, LEPROSY REV, V81, P111; Borg J, 2009, LEPROSY REV, V80, P13; Carmona IT, 2003, ARCH GERONTOL GERIAT, V36, P49, DOI 10.1016/S0167-4943(02)00054-7; Chen TY, 2000, OCCUP THER J RES, V20, P179, DOI 10.1177/153944920002000303; Cheng SP, 2012, REHABIL NURS, V37, P88, DOI 10.1002/RNJ.00015; Almeida JRDS, 2013, CIENC SAUDE COLETIVA, V18, P817, DOI 10.1590/S1413-81232013000300027; Hartmann KD, 2010, WORK, V36, P399, DOI 10.3233/WOR-2010-1048; Hirota K, 2017, J APPL MICROBIOL, V122, P321, DOI 10.1111/jam.13330; Maia FB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004644; Matsumoto M. C., 2008, VERSAO BRASILEIRA IN, P98; Mojon Philippe, 2002, J Can Dent Assoc, V68, P340; Montandon Andreia A B, 2006, J Dent Educ, V70, P1261; Savassi LCM, 2014, QUAL LIFE RES, V23, P1345, DOI 10.1007/s11136-013-0590-7; Muniz LD, 2016, REV SOC BRAS MED TRO, V49, P644, DOI 10.1590/0037-8682-0097-2016; Orellano-Colon EM, 2016, J RACIAL ETHN HEALTH, V3, P676, DOI 10.1007/s40615-015-0186-8; Peek STM, 2014, INT J MED INFORM, V83, P235, DOI 10.1016/j.ijmedinf.2014.01.004; Phillips B, 1993, Assist Technol, V5, P36; Pinto DM, 2011, TEXTO CONTEXTO ENFER, V3, P493; Price V E, 1980, Dent Hyg (Chic), V54, P467; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Santos VS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003900; Scherer MJ, 2011, DISABIL REHABIL, V33, P811, DOI 10.3109/09638288.2010.511418; Shay K, 2002, CLIN INFECT DIS, V34, P1215, DOI 10.1086/339865; Silva AD, 2014, REV SOC BRAS MED TRO, V47, P212, DOI 10.1590/0037-8682-0012-2014; Silva EP, 2013, REV BRAS CIENC SAUDE, V17, P197; van Brakel WH, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18394; Verza R, 2006, MULT SCLER J, V12, P88, DOI 10.1191/1352458506ms1233oa; WASSON JH, 1990, J GEN INTERN MED, V5, P46, DOI 10.1007/BF02602309; White C, 2015, CLIN MICROBIOL REV, V28, P80, DOI 10.1128/CMR.00079-13; World Health Organisation, 2006, GLOB STRAT FURTH RED; World Health Organization, 2008, ENH GLOB STRAT FURTH; World Health Organization Regional Office for South-East Asia New Delhi, 2006, GLOB STRAT FURTH RED, V77, P1	36	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200503	10.1371/journal.pone.0200503	http://dx.doi.org/10.1371/journal.pone.0200503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044849	Green Submitted, gold, Green Published			2022-12-26	WOS:000439942500058
J	Jeon, HM; Lee, JY; Jeong, GM; Choi, SI				Jeon, Hong-Min; Lee, Je-Yeol; Jeong, Gu-Min; Choi, Sang-Il			Data reconstruction using iteratively reweighted L1-principal component analysis for an electronic nose system	PLOS ONE			English	Article							GAS SENSOR; FACE RECOGNITION; CLASSIFICATION; EIGENFACES; SELECTION; ARRAY; LDA	We propose a method to reconstruct damaged data based on statistical learning during data acquisition. In the process of measuring the data using a sensor, the damage of the data caused by the defect of the sensor or the environmental factor greatly degrades the performance of data classification. Instead of the traditional PCA based on L2-norm, the PCA features were extracted based on L1-norm and updated by iteratively reweighted fitting using the generalized objective function to obtain robust features for the outlier data. The damaged data samples were reconstructed using weighted linear combination using these features and the projection vectors of L1-norm based PCA. The experimental results on various types of volatile organic compounds (VOCs) data show that the proposed method can be used to reconstruct the damaged data to the original form of the undamaged data and to prevent degradation of classification performance due to data corruption through data reconstruction.	[Jeon, Hong-Min] Dankook Univ, Dept Data Sci, 152 Jukjeon Ro, Yongin 16890, Gyeonggi Do, South Korea; [Lee, Je-Yeol; Choi, Sang-Il] Dankook Univ, Dept Comp Sci & Engn, 152 Jukjeon Ro, Yongin 16890, Gyeonggi Do, South Korea; [Jeong, Gu-Min] Kookmin Univ, Elect Engn, 861-1 Jeongneung Dong, Seoul 02707, South Korea	Dankook University; Dankook University; Kookmin University	Choi, SI (corresponding author), Dankook Univ, Dept Comp Sci & Engn, 152 Jukjeon Ro, Yongin 16890, Gyeonggi Do, South Korea.	choisi@dankook.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2018R1A2B6001400]; Human Resources Program in Energy Technology of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy, Republic of Korea [20174030201740]	National Research Foundation of Korea (NRF) - Korea government (MSIT); Human Resources Program in Energy Technology of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy, Republic of Korea	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1A2B6001400) and was also supported by the Human Resources Program in Energy Technology of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry and Energy, Republic of Korea (20174030201740).	Ampuero S, 2003, SENSOR ACTUAT B-CHEM, V94, P1, DOI 10.1016/S0925-4005(03)00321-6; Barsan N, 2007, SENSOR ACTUAT B-CHEM, V121, P18, DOI 10.1016/j.snb.2006.09.047; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Cevikalp H, 2005, IEEE T PATTERN ANAL, V27, P4, DOI 10.1109/TPAMI.2005.9; Chen LF, 2000, PATTERN RECOGN, V33, P1713, DOI 10.1016/S0031-3203(99)00139-9; Choi SI, 2017, IEEE SENS J, V17, P5954, DOI 10.1109/JSEN.2017.2716967; Choi SI, 2014, SENSORS-BASEL, V14, P6938, DOI 10.3390/s140406938; Choi SI, 2010, SENSORS-BASEL, V10, P10387, DOI 10.3390/s101110387; Duda R. O., 1973, PATTERN CLASSIFICATI; Fonollosa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037809; Fukunaga K., 2013, INTRO STAT PATTERN R; GARDNER JW, 1994, SENSOR ACTUAT B-CHEM, V18, P211; Ha SC, 2005, SENSOR ACTUAT B-CHEM, V105, P549, DOI 10.1016/j.snb.2004.01.019; Janata J, 2003, NAT MATER, V2, P19, DOI 10.1038/nmat768; Kim C, 2007, PATTERN RECOGN, V40, P2958, DOI 10.1016/j.patcog.2007.02.008; Kim YS, 2005, SENSOR ACTUAT B-CHEM, V108, P285, DOI 10.1016/j.snb.2004.11.067; Kwak N, 2008, IEEE T PATTERN ANAL, V30, P1672, DOI 10.1109/TPAMI.2008.114; Li S., 2014, P SIAM INT C DATA MI, P163, DOI DOI 10.1137/1.9781611973440.19; Li S, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P989, DOI 10.1145/2983323.2983780; Li S, 2016, IEEE T NEUR NET LEAR, V27, P2160, DOI 10.1109/TNNLS.2015.2464090; Liu L., 2009, ENCY DATABASE SYSTEM, V6; Martinez A.M., 1998, CVC TECHNICAL REPORT; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Martnez A., 1998, 24 CVC; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vergara A, 2012, SENSOR ACTUAT B-CHEM, V166, P320, DOI 10.1016/j.snb.2012.01.074; Wang ZM, 2007, CIS WORKSHOPS 2007: INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY WORKSHOPS, P304, DOI 10.1109/CIS.Workshops.2007.33; WATSON J, 1984, SENSOR ACTUATOR, V5, P29, DOI 10.1016/0250-6874(84)87004-3; Yang YS, 2005, SENSOR ACTUAT B-CHEM, V106, P263, DOI 10.1016/j.snb.2004.08.008; Zhang Z. Q., 2016, IEEE T CYBERNETICS, V10, P1109, DOI DOI 10.1109/TIP.2016.2547180; Zuo WM, 2006, LECT NOTES COMPUT SC, V4261, P844	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200605	10.1371/journal.pone.0200605	http://dx.doi.org/10.1371/journal.pone.0200605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044840	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500063
J	Usman, MS; Hussein, MZ; Fakurazi, S; Masarudin, MJ; Saad, FFA				Usman, Muhammad Sani; Hussein, Mohd Zobir; Fakurazi, Sharida; Masarudin, Mas Jaffri; Saad, Fathinul Fikri Ahmad			A bimodal theranostic nanodelivery system based on [graphene oxide-chlorogenic acid-gadolinium/gold] nanoparticles	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TARGETED DELIVERY; CARRIER	We have synthesized a bimodal theranostic nanodelivery system (BIT) that is based on graphene oxide (GO) and composed of a natural chemotherapeutic agent, chlorogenic acid (CA) used as the anticancer agent, while gadolinium (Gd) and gold nanoparticles (AuNPs) were used as contrast agents for magnetic resonance imaging (MRI) modality. The CA and Gd guest agents were simultaneously loaded on the GO nanolayers using chemical interactions, such as hydrogen bonding and rr-rr non-covalent interactions to form GOGCA nano-composite. Subsequently, the AuNPs were doped on the surface of the GOGCA by means of electrostatic interactions, which resulted in the BIT. The physico-chemical studies of the BIT affirmed its successful development. The X-ray diffractograms (XRD) collected of the various stages of BIT synthesis showed the successive development of the hybrid system, while 90% of the chlorogenic acid was released in phosphate buffer solution (PBS) at pH 4.8. This was further reaffirmed by the in vitro evaluations, which showed stunted HepG2 cancer cells growth against the above 90% cell growth in the control cells. A reverse case was recorded for the 3T3 normal cells. Further, the acquired T1-weighted image of the BIT doped samples obtained from the MRI indicated contrast enhancement in comparison with the plain Gd and water references. The abovementioned results portray our BIT as a promising future chemotherapeutic for anticancer treatment with diagnostic modalities.	[Usman, Muhammad Sani; Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol ITMA, Mat Synth & Characterizat Lab, Serdang, Selangor, Malaysia; [Fakurazi, Sharida] Univ Putra Malaysia, Dept Human Anat, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Masarudin, Mas Jaffri] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [Saad, Fathinul Fikri Ahmad] Univ Putra Malaysia, Ctr Diagnost & Nucl Imaging, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Usman, MS; Hussein, MZ (corresponding author), Univ Putra Malaysia, Inst Adv Technol ITMA, Mat Synth & Characterizat Lab, Serdang, Selangor, Malaysia.	muhusma@gmail.com; mzobir@upm.edu.my	Saad, Fathinul Fikri Ahmad/C-4116-2014	Saad, Fathinul Fikri Ahmad/0000-0002-0499-7747; MASARUDIN, MAS JAFFRI/0000-0003-0695-2136; FAKURAZI, SHARIDA/0000-0001-8986-876X; USMAN, MUHAMMAD/0000-0002-3211-6310	Universiti Putra Malaysia (UPM) [5526300]; Ministry of Higher Education of Malaysia (MOHE) [5526300]	Universiti Putra Malaysia (UPM); Ministry of Higher Education of Malaysia (MOHE)	Universiti Putra Malaysia (UPM) and the Ministry of Higher Education of Malaysia (MOHE) provided the funds for the research under a NanoMITe grant Vot No. 5526300.	Akhavan O, 2014, RSC ADV, V4, P20441, DOI 10.1039/c4ra01550a; Balcioglu M, 2013, J MATER CHEM B, V1, P6187, DOI 10.1039/c3tb20992j; Baradaran S, 2014, CARBON, V69, P32, DOI 10.1016/j.carbon.2013.11.054; Barahuie F, 2017, MAT SCI ENG C-MATER, V74, P177, DOI 10.1016/j.msec.2016.11.114; Begum A, 2014, CHEM-EUR J, V20, P16657, DOI 10.1002/chem.201404461; Bullo S., 2015, INT J NANOMED, V10; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Dorniani D, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1712-2; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Ehrlich P., THE COLLECTED PAPERS; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Guo YQ, 2012, CARBON, V50, P2513, DOI 10.1016/j.carbon.2012.01.074; Hancock Y, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/47/473001; He H, 2011, BIOMATERIALS, V32, P478, DOI 10.1016/j.biomaterials.2010.09.002; Hedlund A, 2011, INT J NANOMED, V6, P3233, DOI 10.2147/IJN.S23940; Huang YS, 2017, J MAGN MAGN MATER, V427, P34, DOI 10.1016/j.jmmm.2016.10.042; Kim KS, 2014, BIOMATERIALS, V35, P337, DOI 10.1016/j.biomaterials.2013.10.004; Kolodynska D, 2016, NANOSCALE RES LETT, V11, P1, DOI 10.1186/s11671-016-1371-3; Kuila T, 2011, COMPOS PART A-APPL S, V42, P1856, DOI 10.1016/j.compositesa.2011.08.014; Kura AU, 2014, CHEM CENT J, V8; Le WJ, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040065; Lu YY, 2013, J SEP SCI, V36, P2210, DOI 10.1002/jssc.201300260; Luo K, 2010, J NANOSCI NANOTECHNO, V10, P540, DOI 10.1166/jnn.2010.1742; Muhulet A, 2018, FUNDAMENTALS SCOPES, V30, P154; Nasir S, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7070182; Nguyen Ngoc L., 2009, J PHYS C SER, V187; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ovid'ko IA, 2013, REV ADV MATER SCI, V34, P1; Rana VK, 2011, MACROMOL MATER ENG, V296, P131, DOI 10.1002/mame.201000307; Shen AJ, 2012, J BIOMED MATER RES A, V100A, P2499, DOI 10.1002/jbm.a.34148; Shen AJ, 2012, J BIOMED MAT RES A, V100; Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642; Sun X, 2008, NANO RES, V1; Tang LAL, 2012, SMALL, V8, P423, DOI 10.1002/smll.201101690; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Usman MS, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7090244; Usman MS, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0275-3; Verma S, 2011, CHEM COMMUN, V47, P12673, DOI 10.1039/c1cc15230k; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wang L, 2013, BIOMATERIALS, V34; Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c; Zhang BM, 2017, MAT SCI ENG C-MATER, V75, P198, DOI 10.1016/j.msec.2017.02.048; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200760	10.1371/journal.pone.0200760	http://dx.doi.org/10.1371/journal.pone.0200760			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044841	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500065
J	Patel, A; Patel, S; Gregg, R; O'Connor, L				Patel, Ajay; Patel, Sumaiya; Gregg, Rebecca; O'Connor, Laura			A qualitative analysis of the enforcement of the regulation of nutrition and health claims made for foods and its implications for health	PLOS ONE			English	Article							MARKET; POLICY	In common with local government organisations across the world, local authorities in the UK have responsibility for promoting health. A key part of this function is the frontline enforcement activities of officers responsible for compliance with health and nutrition claims. This study identifies attitudes, values and practices of enforcers: namely trading standards and environmental health officers, when faced with the problem of non-compliance with the Regulation. Semi-structured interviews with frontline enforcers from local authority regulatory services to investigate challenges with the enforcement of Regulation (EC) 1924/2006. Twenty participants were interviewed; sixteen were based in North West England and two in the North and two in the South of England. The participants were selected for their specialist knowledge and experience of enforcement of nutrition and health claims. Regulation (EC) No. 1924/2006 on nutrition and health claims presents particular challenges for enforcers seeking to apply an optimal strategy to flawed regulatory design. As with other regulations, when faced with non-compliance, enforcers, specifically trading standards and environmental health officers have a wide discretion to determine their response: ranging from the deterrent or accommodative styles of enforcement. The participants reported using advice rather than action and by doing so confronting their bifurcating identity of prosecutor and advisor. Enforcers used advice as a regulatory tool in enforcing the law relating to nutrition and health claims.	[Patel, Ajay; Patel, Sumaiya; Gregg, Rebecca; O'Connor, Laura] Manchester Metropolitan Univ, Dept Hlth Profess, Fac Hlth Psychol & Social Care, Cavendish Bldg, Manchester, Lancs, England	Manchester Metropolitan University	Patel, A (corresponding author), Manchester Metropolitan Univ, Dept Hlth Profess, Fac Hlth Psychol & Social Care, Cavendish Bldg, Manchester, Lancs, England.	a.k.patel@mmu.ac.uk	O'Connor, Laura/ABD-7999-2021	O'Connor, Laura/0000-0002-6022-2022; Patel, Ajay/0000-0001-5978-117X				AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Ayres I, 1992, RESPONSIVE REGULATIO, P21; Baldwin R., 2012, UNDERSTANDING REGULA, V2nd ed.; BEESLEY ME, 1989, RAND J ECON, V20, P454, DOI 10.2307/2555582; Black J, 2010, LAW POLICY, V32, P181, DOI 10.1111/j.1467-9930.2010.00318.x; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Braithwaite J, 2002, J LAW SOC, V29, P12, DOI 10.1111/1467-6478.00209; Braithwaite J, 1987, LAW POLICY, V9, P323, DOI DOI 10.1111/J.1467-9930.1987.TB00414.X; BRDO, 2016, EXT SIMPL PRIM AUTH; Caraher M, 2004, PUBLIC HEALTH NUTR, V7, P591, DOI 10.1079/PHN2003575; Caswell J, 1998, AGR RESOURCE EC REV, V27; Caswell JA, 1996, AM J AGR ECON, V78, P1248, DOI 10.2307/1243501; Cranston R, 1979, REGULATING BUSINESS; Harrison M, 1997, T I BRIT GEOGR, V22, P473, DOI 10.1111/j.0020-2754.1997.00473.x; Hawkins K., 1993, LAW POLICY, V15, P199, DOI DOI 10.1111/J.1467-9930.1993.TB00103.X; Hawkins K., 2002, LAW LAST RESORT PROS; Healy J, 2006, MED J AUSTRALIA, V184, pS56; HELM D, 1994, OXFORD REV ECON POL, V10, P17, DOI 10.1093/oxrep/10.3.17; Helm D, 2006, OXFORD REV ECON POL, V22, P169, DOI 10.1093/oxrep/grj011; Hillary R, 1995, SMALL FIRMS ENV GROU; Hutter BM, 1997, COMPLIANCE REGULATIO; Law MT, 2006, J LAW ECON ORGAN, V22, P459, DOI 10.1093/jleo/ewj014; LEGRAND J, 1991, BRIT J POLIT SCI, V21, P423, DOI 10.1017/S0007123400006244; Patel A, 2012, TRENDS FOOD SCI TECH, V28, P15, DOI 10.1016/j.tifs.2012.06.006; Reiss A.J., 1984, ENFORCING REGULATION, P23; STIGLER GJ, 1961, J POLIT ECON, V69, P213, DOI 10.1086/258464; Tansey O, 2007, PS-POLIT SCI POLIT, V40, P765, DOI 10.1017/S1049096507071211; Yapp C, 2006, FOOD CONTROL, V17, P42, DOI 10.1016/j.foodcont.2004.08.007	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201178	10.1371/journal.pone.0201178	http://dx.doi.org/10.1371/journal.pone.0201178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040857	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200030
J	Trivedi, MS; Oltra, E; Sarria, L; Rose, N; Beljanski, V; Fletcher, MA; Klimas, NG; Nathanson, L				Trivedi, Malay S.; Oltra, Elisa; Sarria, Leonor; Rose, Natasha; Beljanski, Vladimir; Fletcher, Mary Ann; Klimas, Nancy G.; Nathanson, Lubov			Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns	PLOS ONE			English	Article							RESEARCH CASE-DEFINITION; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; CYSTEINE UPTAKE; HYPOMETHYLATION; EPIGENETICS; PREVALENCE; DISCOVERY; SEQUENCES; CRITERIA	Background Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex condition involving multiple organ systems and characterized by persistent/relapsing debilitating fatigue, immune dysfunction, neurological problems, and other symptoms not curable for at least 6 months. Disruption of DNA methylation patterns has been tied to various immune and neurological diseases; however, its status in ME/CFS remains uncertain. Our study aimed at identifying changes in the DNA methylation patterns that associate with ME/CFS. Methods We extracted genomic DNA from peripheral blood mononuclear cells from 13 ME/CFS study subjects and 12 healthy controls and measured global DNA methylation by ELISA-like method and site-specific methylation status using Illumina MethylationEPIC microarrays. Pyrosequencing validation included 33 ME/CFS cases and 31 controls from two geographically distant cohorts. Results Global DNA methylation levels of ME/CFS cases were similar to those of controls. However, microarray-based approach allowed detection of 17,296 differentially methylated CpG sites in 6,368 genes across regulatory elements and within coding regions of genes. Analysis of DNA methylation in promoter regions revealed 307 differentially methylated promoters. Ingenuity pathway analysis indicated that genes associated with differentially methylated promoters participated in at least 15 different pathways mostly related to cell signaling with a strong immune component. Conclusions This is the first study that has explored genome-wide epigenetic changes associated with ME/CFS using the advanced Illumina MethylationEPIC microarrays covering about 850,000 CpG sites in two geographically distant cohorts of ME/CFS cases and matched controls. Our results are aligned with previous studies that indicate a dysregulation of the immune system in ME/CFS. They also suggest a potential role of epigenetic de-regulation in the pathobiology of ME/CFS. We propose screening of larger cohorts of ME/CFS cases to determine the external validity of these epigenetic changes in order to implement them as possible diagnostic markers in clinical setting.	[Trivedi, Malay S.; Rose, Natasha] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA; [Oltra, Elisa] Catholic Univ Valencia, Sch Med & Dent, Valencia, Spain; [Sarria, Leonor; Fletcher, Mary Ann; Klimas, Nancy G.; Nathanson, Lubov] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA; [Beljanski, Vladimir] Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Cell Therapy Inst, Ft Lauderdale, FL 33314 USA; [Fletcher, Mary Ann; Klimas, Nancy G.] Miami VAMC, Miami, FL USA	Nova Southeastern University; Universidad Catolica de Valencia San Vicente Martir; Nova Southeastern University; Nova Southeastern University	Nathanson, L (corresponding author), Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA.	lnathanson@nova.edu	Nathanson, Lubov/ABC-2642-2021; Oltra, Elisa/I-3642-2015	Oltra, Elisa/0000-0003-0598-2907; Nathanson, Lubov/0000-0003-1038-9083	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R15NS087604-01A1]; Presidential Faculty Research and Development Grant from Nova Southeastern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS087604] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Presidential Faculty Research and Development Grant from Nova Southeastern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the grant R15NS087604-01A1 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and by Presidential Faculty Research and Development Grant from Nova Southeastern University (both awarded to LN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola A, 2015, EUR J HUM GENET, V23, P1308, DOI 10.1038/ejhg.2015.26; An Y, 2017, J CELL MOL MED, V21, P185, DOI 10.1111/jcmm.12952; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Brenu EW, 2012, J AFFECT DISORDERS, V141, P261, DOI 10.1016/j.jad.2012.03.037; Brenu EW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-1; Brenu EW, 2014, J CLIN CELL IMMUNOL, V5, P228, DOI [10.4172/2155-9899.1000228, DOI 10.4172/2155-9899.1000228]; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Castelein H, 1997, BIOCHEM BIOPH RES CO, V233, P91, DOI 10.1006/bbrc.1997.6395; Chandler HK, 2008, DISABIL REHABIL, V30, P1185, DOI 10.1080/09638280701500109; Cheekatla SS, 2017, J IMMUNOL, V199, P2815, DOI 10.4049/jimmunol.1601231; Christopher MA, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0150-4; de Andrade DC, 2017, PAIN, V158, P1473, DOI 10.1097/j.pain.0000000000000932; de Vega WC, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0248-3; de Vega WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104757; Demitrack MA, 1997, J PSYCHIATR RES, V31, P69, DOI 10.1016/S0022-3956(96)00059-3; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Falkenberg VR, 2013, GENET EPIGENETICS, V5, P1, DOI 10.4137/GEG.S10944; Fluge O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129898; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Galicia JC, 2014, GENES IMMUN, V15, P333, DOI 10.1038/gene.2014.24; Gambuzza ME, 2015, CNS NEUROL DISORD-DR, V14, P903, DOI 10.2174/1871527314666150325235247; Hardie DL, 2011, IMMUNOLOGY, V133, P288, DOI 10.1111/j.1365-2567.2011.03437.x; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jason LA, 2017, FATIGUE, V5, P89, DOI 10.1080/21641846.2017.1299077; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lattie EG, 2013, FATIGUE, V1, P210, DOI 10.1080/21641846.2013.843255; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lee Y, 2015, J CLIN INVEST, V125, P4011, DOI 10.1172/JCI75933; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003; Mahurkar S, 2016, NEUROGASTROENT MOTIL, V28, P410, DOI 10.1111/nmo.12741; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ospelt C, 2017, SEMIN IMMUNOPATHOL, V39, P409, DOI 10.1007/s00281-017-0621-5; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; PATARCA R, 1994, CLIN INFECT DIS, V18, pS147, DOI 10.1093/clinids/18.Supplement_1.S147; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Rowe PC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00121; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P935, DOI 10.2214/ajr.162.4.8141020; SEMLER G, 1987, EUR ARCH PSY CLIN N, V236, P214, DOI 10.1007/BF00383851; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stepanov GA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/206849; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Trivedi MS, 2014, J NUTR BIOCHEM, V25, P1011, DOI 10.1016/j.jnutbio.2014.05.004; Vangeel E, 2015, PSYCHOSOM MED, V77, P853, DOI 10.1097/PSY.0000000000000224; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weil AF, 2013, P NATL ACAD SCI USA, V110, pE448, DOI 10.1073/pnas.1219702110; Zandi S, 2012, P NATL ACAD SCI USA, V109, P15871, DOI 10.1073/pnas.1210144109; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	68	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201066	10.1371/journal.pone.0201066	http://dx.doi.org/10.1371/journal.pone.0201066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036399	Green Published, gold, Green Submitted			2022-12-26	WOS:000439429200025
J	Barisnikov, K; Lejeune, F				Barisnikov, Koviljka; Lejeune, Fleur			Social knowledge and social reasoning abilities in a neurotypical population and in children with Down syndrome	PLOS ONE			English	Article							EXECUTIVE FUNCTION; EARLY-CHILDHOOD; COGNITION; AUTISM; ADULTS; SKILLS; MIND; ADOLESCENCE; BEHAVIOR; PRETERM	Social knowledge refers to the ability to analyze and reason about social situations in relation to social rules which are essential to the development of social skills and social behavior. The present research aimed to assess these abilities with the "Social resolution task" in a neurotypical population of 351 children (4 to 12 years) and 39 young adults, and in 20 participants (10 to 18 years) with Down syndrome. Results showed that young children aged 4 to 6 were well able to distinguish between appropriate and inappropriate social behavior but they had significantly more difficulties in judging and identifying social cues for the transgression of conventional rules than for moral ones. Between age 4 and 8, their social reasoning was mainly based on factual answers, while older children showed significantly more social awareness, making more reference to emotional and social consequences for the "victims". The representation of a more universal applicability of social rules seemed to develop later in childhood, as of age 8. In contrast, participants with Down syndrome exhibited significantly more difficulties in judging, identifying and reasoning about transgression of social rules without social awareness. In conclusion, the results have shown that social reasoning abilities develop throughout childhood. Social awareness seems to have a long developmental course, which includes a sensibility about welfare and intersubjectivity, critical for the development of prosocial behavior. The clinical population with difficulties in social interaction and socio-emotional behavior could benefit from an early assessment and from learning social reasoning abilities to improve social skills.	[Barisnikov, Koviljka; Lejeune, Fleur] Univ Geneva, Child Clin Neuropsychol Unit, FPSE, Geneva, Switzerland	University of Geneva	Barisnikov, K (corresponding author), Univ Geneva, Child Clin Neuropsychol Unit, FPSE, Geneva, Switzerland.	Koviljka.Barisnikov@unige.ch			Swiss National Science Foundation [100014-120657/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant No 100014-120657/1 from the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx) awarded to the first author, KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Baillargeon R, 2016, ANNU REV PSYCHOL, V67, P159, DOI 10.1146/annurev-psych-010213-115033; Barisnikov K, 2005, TA CHE RE SOLUTION S; Barisnikov K, 2012, BASIC EXECUTIVE FUNC, P372; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Bornstein MH, 2010, DEV PSYCHOPATHOL, V22, P717, DOI 10.1017/S0954579410000416; Cebula KR, 2010, J INTELL DISABIL RES, V54, P113, DOI 10.1111/j.1365-2788.2009.01215.x; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; COOK ET, 1994, J ABNORM CHILD PSYCH, V22, P205, DOI 10.1007/BF02167900; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Dunn L. M., 1993, PEABODY PICTURE VOCA; Fenning RM, 2011, CHILD DEV, V82, P717, DOI 10.1111/j.1467-8624.2010.01569.x; Fine SE, 2003, DEV PSYCHOPATHOL, V15, P331, DOI 10.1017/S095457940300018X; Fischi-Gomez E, 2015, CEREB CORTEX, V25, P2793, DOI 10.1093/cercor/bhu073; Freeman SFN, 2002, AM J MENT RETARD, V107, P16, DOI 10.1352/0895-8017(2002)107<0016:CAQOTP>2.0.CO;2; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Grant CM, 2005, AUTISM, V9, P317, DOI 10.1177/1362361305055418; Gunbey HP, 2017, EUR RADIOL, V27, P3013, DOI 10.1007/s00330-016-4626-6; Guralnick MJ, 2011, J APPL RES INTELLECT, V24, P310, DOI 10.1111/j.1468-3148.2010.00619.x; Guralnick MJ, 2009, AJIDD-AM J INTELLECT, V114, P340, DOI 10.1352/1944-7558-114.5.340; Helwig C. C., 2011, WILEY BLACKWELL HDB, P567; Hippolyte L, 2010, J INTELL DISABIL RES, V54, P714, DOI 10.1111/j.1365-2788.2010.01299.x; Houssa M., 2014, J ED TRAINING STUDIE, V2, P139; Houssa M, 2016, J PSYCHOL ABNORM S; Houssa M, 2016, J ED TRAIN STUD, V5, P110; Hughes C., 2011, SOCIAL UNDERSTANDING; Jambon M, 2017, CHILD DEV, P1; KASARI C, 1995, AM J MENT RETARD, V100, P128; Kasari C, 2003, J CHILD PSYCHOL PSYC, V44, P424, DOI 10.1111/1469-7610.00132; Lachavanne A, 2013, EUR REV APPL PSYCHOL, V63, P345, DOI 10.1016/j.erap.2013.09.002; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lejeune F, 2016, EARLY HUM DEV, V103, P49, DOI 10.1016/j.earlhumdev.2016.07.010; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Loveland KA, 2001, J AUTISM DEV DISORD, V31, P367, DOI 10.1023/A:1010608518060; Margoni F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01478; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Nucci L, 2001, ED MORAL DOMAIN, DOI DOI 10.1017/CBO9780511605987; Parker JG, 2006, DEV PSYCHOPATHOL, P419, DOI DOI 10.1002/9780470939383.CH12; Peterson CC, 2012, CHILD DEV, V83, P469, DOI 10.1111/j.1467-8624.2011.01728.x; Pujol J, 2015, CORTEX, V64, P148, DOI 10.1016/j.cortex.2014.10.012; Revermann M, 2017, CULT HISTOR, P1; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shulman C, 2012, J AUTISM DEV DISORD, V42, P1364, DOI 10.1007/s10803-011-1369-8; SMETANA JG, 1990, MERRILL PALMER QUART, V36, P329; SMETANA JG, 1985, DEV PSYCHOL, V21, P18, DOI 10.1037/0012-1649.21.1.18; Tanaka C, 2012, DEV NEUROSCI-BASEL, V34, P477, DOI 10.1159/000345152; Turiel E, 1998, HDB CHILD PSYCHOL, V3, P863, DOI [10.1002/9780470147658.chpsy0313, DOI 10.1002/9780470147658.CHPSY0313]; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Turiel E, 2008, COGNITIVE DEV, V23, P136, DOI 10.1016/j.cogdev.2007.04.001; van Gameren-Oosterom HBM, 2013, J PEDIATR-US, V163, P1396, DOI 10.1016/j.jpeds.2013.06.054; Wainryb CE., 2008, SOCIAL DEV SOCIAL IN; Wellman H. M, 1990, CHILDS THEORY MIND; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; White SF, 2017, COGN AFFECT BEHAV NE; Wishart JG, 2007, J INTELL DISABIL RES, V51, P996, DOI 10.1111/j.1365-2788.2007.01007.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126; Zalla T, 2011, COGNITION, V121, P115, DOI 10.1016/j.cognition.2011.06.004	61	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200932	10.1371/journal.pone.0200932	http://dx.doi.org/10.1371/journal.pone.0200932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028865	Green Published, Green Submitted, gold			2022-12-26	WOS:000439396900026
J	Peiravan, A; Bertolini, F; Rothschild, MF; Simpson, KW; Jergens, AE; Allenspach, K; Werling, D				Peiravan, Atiyeh; Bertolini, Francesca; Rothschild, Max F.; Simpson, Kenneth W.; Jergens, Albert E.; Allenspach, Karin; Werling, Dirk			Genome-wide association studies of inflammatory bowel disease in German shepherd dogs	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; POLYMERASE-CHAIN-REACTION; CROHNS-DISEASE; ULCERATIVE-COLITIS; T-CELLS; CHRONIC ENTEROPATHIES; DUODENAL MUCOSA; COLONIC-MUCOSA; HEALTHY DOGS; CYTOKINE	Canine Inflammatory Bowel Disease (IBD) is considered a multifactorial disease caused by complex interactions between the intestinal immune system, intestinal microbiota and environmental factors in genetically susceptible individuals. Although IBD can affect any breed, German shepherd dogs (GSD) in the UK are at increased risk of developing the disease. Based on previous evidence, the aim of the present study was to identify single nucleotide polymorphisms (SNPs), which may confer genetic susceptibility or resistance to IBD using a genome-wide association study (GWAS). Genomic DNA was extracted from EDTA blood or saliva samples of 96 cases and 98 controls. Genotyping of cases and controls was performed on the Canine lllumina HD SNP array and data generated was analyzed using PLINK. Several SNPs and regions on chromosomes 7,9,11 and 13 were detected to be associated with IBD using different SNP-by-SNP association methods and F-ST windows approach. Searching one Mb up-and down-stream of the most significant SNPs, as identified by single SNP analysis as well as 200Kb before and after the start and the end position of the associated regions identified by F-ST windows approach, we identified 63 genes. Using a combination of pathways analysis and a list of genes that have been reported to be involved in human IBD, we identified 16 candidate genes potentially associated with IBD in GSD.	[Peiravan, Atiyeh; Werling, Dirk] Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, England; [Bertolini, Francesca; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Jergens, Albert E.; Allenspach, Karin] Iowa State Univ, Coll Vet Med, Ames, IA USA	University of London; University of London Royal Veterinary College; Iowa State University; Cornell University; Iowa State University	Peiravan, A (corresponding author), Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, England.	apeiravan@rvc.ac.uk	bertolini, francesca/AAX-3836-2021; Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Bertolini, Francesca/0000-0003-4181-3895	BBSRC [BB/J01236X/1]; Laboklin GmBH; Bad Kissingen, GE	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Laboklin GmBH; Bad Kissingen, GE	We declare that the work described in this manuscript was funded through a BBSRC iCase PhD studentship stipend (BB/J01236X/1 to DW) and part-funded by Laboklin GmBH, Bad Kissingen, GE. Funding was also provided by the Ensminger fund, State of Iowa and Hatch funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahenspach K, 2006, J COMP PATHOL, V134, P1, DOI 10.1016/j.jcpa.2005.06.003; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2006, J VET INTERN MED, V20, P239, DOI 10.1892/0891-6640(2006)20[239:PACEOC]2.0.CO;2; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bhan AK, 1999, CURR OPIN GASTROEN, V15, P285, DOI 10.1097/00001574-199907000-00002; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; De Majo M, 2008, VET RES COMMUN, V32, pS275, DOI 10.1007/s11259-008-9127-x; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garside P, 1999, CLIN EXP IMMUNOL, V118, P337; German AJ, 2003, J VET INTERN MED, V17, P33, DOI 10.1111/j.1939-1676.2003.tb01321.x; German AJ, 2000, DIGEST DIS SCI, V45, P7, DOI 10.1023/A:1005436721798; Gunawardana SC, 1997, J AM VET MED ASSOC, V211, P318; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Iijima H, 1999, J EXP MED, V190, P607, DOI 10.1084/jem.190.5.607; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Jergens AE, 1996, AM J VET RES, V57, P697; Jergens AE, 1999, VET CLIN N AM-SMALL, V29, P501, DOI 10.1016/S0195-5616(99)50032-6; Jergens AE, 2009, COMPARATIVE MED, V59, P153; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Junginger J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-23; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kathrani A, 2014, VET IMMUNOL IMMUNOP, V161, P32, DOI 10.1016/j.vetimm.2014.06.003; Kathrani A, 2011, VET REC, V169, P635, DOI 10.1136/vr.d5380; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Kimmel SE, 2000, J AM VET MED ASSOC, V217, P703, DOI 10.2460/javma.2000.217.703; Luckschander N, 2006, J VET INTERN MED, V20, P221, DOI 10.1892/0891-6640(2006)20[221:PACAAR]2.0.CO;2; Maeda S, 2016, VET PATHOL, V53, P102, DOI 10.1177/0300985815591081; Mandigers PJJ, 2010, J VET INTERN MED, V24, P1350, DOI 10.1111/j.1939-1676.2010.0632.x; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; MULLIN GE, 1992, GASTROENTEROLOGY, V102, P1620, DOI 10.1016/0016-5085(92)91722-G; NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428; OGarra A., 1998, J IMMUNOL, V161, P547; Papadakis KA, 1999, GASTROENTEROL CLIN N, V28, P283, DOI 10.1016/S0889-8553(05)70057-1; Peiravan A, 2016, VET IMMUNOL IMMUNOP, V182, P101, DOI 10.1016/j.vetimm.2016.10.012; Peters IR, 2005, J VET INTERN MED, V19, P644, DOI 10.1892/0891-6640(2005)19[644:CMQIDM]2.0.CO;2; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; Plevy SE, 1997, J IMMUNOL, V159, P6276; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridyard AE, 2002, VET IMMUNOL IMMUNOP, V86, P205, DOI 10.1016/S0165-2427(02)00039-9; Roberts RL, 2012, J GASTROEN HEPATOL, V27, P1546, DOI 10.1111/j.1440-1746.2012.07220.x; Sandborn WJ, 2004, INFLAMM BOWEL DIS, V10, pS35, DOI 10.1097/00054725-200402001-00008; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Stonehewer J, 1998, RES VET SCI, V65, P59, DOI 10.1016/S0034-5288(98)90028-5; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Volkmann M, 2014, VET J, V202, P630, DOI 10.1016/j.tvjl.2014.10.012; Westermarck E, 2005, J VET INTERN MED, V19, P177, DOI 10.1892/0891-6640(2005)19&lt;177:TCDID&gt;2.0.CO;2; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	57	19	19	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200685	10.1371/journal.pone.0200685	http://dx.doi.org/10.1371/journal.pone.0200685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028859	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000439396900012
J	Radenkovic, S; Velickovic, N; Ssymank, A; Vidakovic, DO; Djan, M; Stahls, G; Veselic, S; Vujic, A				Radenkovic, Snezana; Velickovic, Nevena; Ssymank, Axel; Vidakovic, Dragana Obreht; Djan, Mihajla; Stahls, Gunilla; Veselic, Sanja; Vujic, Ante			Close relatives of Mediterranean endemorelict hoverflies (Diptera, Syrphidae) in South Africa: Morphological and molecular evidence in the Merodon melanocerus subgroup	PLOS ONE			English	Article							RUFICORNIS GROUP DIPTERA; MEIGEN; DIVERSITY; EVOLUTION; REVISION	An ongoing study of the genus Merodon Meigen, 1803 in the Republic of South Africa (RSA) has revealed the existence of new species related to M. melanocerus Bezzi, 1915. The M. melanocerus subgroup belongs to the Afrotropical lineage of the M. desuturinus group. Revision of all available material from museums and detailed analyses of newly -collected specimens from our own expeditions to RSA resulted in delimitation of five species: M. capensis Hurkmans sp. n., M. commutabilis Radenkovic et Vujic sp. n., M. drakonis Vujic et Radenkovic sp. n., M. flavocerus Hurkmans sp. n. and M. melanocerus. In addition to classical morphological characters, sequences of the mitochondrial COI gene are provided for four related taxa. Results of molecular phylogenetic analyses supports monophyly of the M. desuturinus group and confirmed delimitation between species. Links between Palaearctic and Afrotropical faunas of this group, as well as possible evolutionary paths, are discussed. Based on phylogenetic analyses, four lineages (putative subgenera) have been recognized within the genus Merodon; besides the three previously established ones, albifrons+desuturinus, aureus (sensu lato) and avidus-nigritarsis, one new lineage named natans is distinguished.	[Radenkovic, Snezana; Velickovic, Nevena; Vidakovic, Dragana Obreht; Djan, Mihajla; Veselic, Sanja; Vujic, Ante] Univ Novi Sad, Dept Biol & Ecol, Novi Sad, Serbia; [Ssymank, Axel] Bundesamt Nat Schutz, Bonn, Germany; [Stahls, Gunilla] Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland	University of Novi Sad; University of Helsinki	Velickovic, N (corresponding author), Univ Novi Sad, Dept Biol & Ecol, Novi Sad, Serbia.	nevena.velickovic@dbe.uns.ac.rs	Velickovic, Nevena/ABG-4787-2020; Vujic, Ante/AAG-2996-2020	Velickovic, Nevena/0000-0003-0797-269X; Djan, Mihajla/0000-0002-2427-0676; Radenkovic, Snezana/0000-0002-7805-9614; Vujic, Ante/0000-0002-8819-8079; Stahls, Gunilla/0000-0003-0505-0691	European Union [645636]; RSA SAEON network, a member of International Long-Term Ecological Research Network (ILTER); Ministry of Education, Science and Technological Development of the Republic of Serbia [OI173002, III43002]	European Union(European Commission); RSA SAEON network, a member of International Long-Term Ecological Research Network (ILTER); Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was funded by a project of the European Union: Horizon 2020, Marie Sklodowska-Curie action, Research and Innovation Staff Exchange (RISE) Programme: FlyHigh - Insect-plant relationships: insights into biodiversity and new applications (project number 645636, 2015-2018); and partially by the RSA SAEON network, a member of International Long-Term Ecological Research Network (ILTER) and Ministry of Education, Science and Technological Development of the Republic of Serbia (OI173002 to AV and III43002).	Andric A, 2014, ACTA ENT MUS NAT PRA, V54, P741; Marcos-Garcia MA, 2011, CAN ENTOMOL, V143, P332, DOI 10.4039/n11-013; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Doczkal D, 2009, SYST ENTOMOL, V34, P559, DOI 10.1111/j.1365-3113.2009.00478.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francuski L, 2011, J INSECT CONSERV, V15, P379, DOI 10.1007/s10841-010-9311-5; Francuski L, 2009, ZOOL SCI, V26, P301, DOI 10.2108/zsj.26.301; Gaston KJ, 2004, PHILOS T R SOC B, V359, P655, DOI 10.1098/rstb.2003.1442; Goloboff P. A, 1999, NONA COMPUTER PROGRA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hijmans RJ, 2012, DIVA GIS VSN 7 5 GEO; Hippa H, 2005, MORPHOLOGICAL CHARAC; Hurkmans Willem, 1993, Tijdschrift voor Entomologie, V136, P147; Jordaens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140264; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Manning J., 2002, The color encyclopedia of Cape bulbs; Marcos-Garcia MA, 2007, EUR J ENTOMOL, V104, P531, DOI 10.14411/eje.2007.073; Martinez-Azorin M, 2011, ANN BOT-LONDON, V107, P1, DOI 10.1093/aob/mcq207; Mengual Ximo, 2006, Zootaxa, V1377, P1; Milankov V, 2008, J ZOOL SYST EVOL RES, V46, P143, DOI 10.1111/j.1439-0469.2007.00448.x; Milankov V, 2005, EUR J ENTOMOL, V102, P125, DOI 10.14411/eje.2005.020; Milankov V, 2008, EUR J ENTOMOL, V105, P197, DOI 10.14411/eje.2008.028; Nedeljkovic Z, 2015, CONTRIB ZOOL, V84, P285, DOI 10.1163/18759866-08404002; Nixon K.C., 2002, WINCLADA VERSION 1 0; Petanidou T, 2011, ANN SOC ENTOMOL FR, V47, P168, DOI 10.1080/00379271.2011.10697709; Pfosser MF, 2004, PLANT SYST EVOL, V246, P245, DOI 10.1007/s00606-004-0153-z; Preradovic J, 2018, ZOOTAXA, V4420, P229, DOI 10.11646/zootaxa.4420.2.5; R/gl F., 1998, ANN NATURHIST MUS A, V99A, P279, DOI DOI 10.2307/41702129; Radenkovic S, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2735.1.5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ricarte A, 2008, ENTOMOL FENNICA, V19, P129, DOI 10.33338/ef.84424; Ricarte A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189852; Ricarte Antonio, 2012, Zootaxa, V3175, P1; Rotheray G. E., 2011, NATURAL HIST HOVERFL; Sasic L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160001; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stahls G, 2009, MOL ECOL RESOUR, V9, P1431, DOI 10.1111/j.1755-0998.2009.02592.x; Stahls G, 2008, ANN ZOOL FENN, V45, P149, DOI 10.5735/086.045.0206; Stahls G, 2016, ECOL EVOL, V6, P2226, DOI 10.1002/ece3.2021; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Thompson F. C., 1999, Contributions on Entomology, International, V3, P321; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vujic A., 1995, EKOLOGIYA, V30, P65; Vujic A, 2007, ANN SOC ENTOMOL FR, V43, P319, DOI 10.1080/00379271.2007.10697527; Vujic A, 2018, ZOOKEYS, P105, DOI 10.3897/zookeys.771.20481; Vujic A, 2015, ZOOTAXA, V4006, P439, DOI 10.11646/zootaxa.4006.3.2; Vujic A, 2013, ZOOTAXA, V3640, P442, DOI 10.11646/zootaxa.3640.3.7; Vujic A, 2012, SYST ENTOMOL, V37, P578, DOI 10.1111/j.1365-3113.2012.00631.x; Vujic A, 2011, ANN SOC ENTOMOL FR, V47, P78, DOI 10.1080/00379271.2011.10697699; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	54	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200805	10.1371/journal.pone.0200805	http://dx.doi.org/10.1371/journal.pone.0200805			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028840	Green Submitted, Green Published, gold			2022-12-26	WOS:000439396900015
J	Ore, RMC; Caceda, RE; Huaman, AA; Williams, M; Hang, J; Juarez, DE; Kocherl, TJ; Halsey, ES; Forshey, BM				Castillo Ore, Roger M.; Caceda, Roxana E.; Huaman, Alfredo A.; Williams, Maya; Hang, Jun; Juarez, Diana E.; Kocherl, Tadeusz J.; Halsey, Eric S.; Forshey, Brett M.			Molecular and antigenic characterization of group C orthobunyaviruses isolated in Peru	PLOS ONE			English	Article							ARTHROPOD-BORNE VIRUSES; BIOLOGY; REGION; BASIN	Group C orthobunyaviruses (GRCVs) are a complex of viruses in the genus Orthobunyavirus and are associated with human febrile disease in tropical and subtropical areas of South and Central America. While numerous GRCVs have been isolated from mosquitoes, animals, and humans, genetic analysis of these viruses is limited. In this study, we characterized 65 GRCV isolates from febrile patients identified through clinic-based surveillance in the northern and southern Peruvian Amazon. A 500 base pair region of the S segment and 750 base pair regions of the M and L segments were sequenced. Pairwise sequence analysis of the clinical isolates showed nucleotide identities ranging from 68% to 100% and deduced amino acid sequence identities ranging from 72% to 100%. Sequences were compared with reference strains of the following GRCVs: Caraparu virus (CARV), Murutucu virus (MURV), Oriboca virus (ORIV), Marituba virus (MTBV), Itaqui virus (ITQV), Apeu virus (APEUV), and Madrid virus (MADV). Sequence comparison of clinical isolates with the prototype strains based on the S and L segments identified two clades; Glade I included isolates with high genetic association with CARV-MADV, and Glade II included isolates with high genetic association with MURV, ORIV, APEUV, and MTBV. Genetic relationships based on the M segment were at time inconsistent with those based on the S and L segments. However, Glade groupings based on the M segment were highly consistent with relationships based on microneutralization assays. These results advance our understanding of the genetic and serologic relationships of GRCVs circulating in the Peruvian Amazon.	[Castillo Ore, Roger M.; Caceda, Roxana E.; Huaman, Alfredo A.; Juarez, Diana E.; Kocherl, Tadeusz J.; Halsey, Eric S.; Forshey, Brett M.] US Naval Med Res Unit 6, Iquitos, Peru; [Castillo Ore, Roger M.; Caceda, Roxana E.; Huaman, Alfredo A.; Juarez, Diana E.; Kocherl, Tadeusz J.; Halsey, Eric S.; Forshey, Brett M.] US Naval Med Res Unit 6, Lima, Peru; [Williams, Maya] US Naval Med Res Ctr, Silver Spring, MD USA; [Hang, Jun] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA; [Kocherl, Tadeusz J.] Natl Biodef Anal & Countermeasures Ctr, Forens Virol, Frederick, MD USA; [Halsey, Eric S.] Ctr Dis Control & Prevent, Malaria Branch, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA USA; [Forshey, Brett M.] Armed Forces Hlth Surveillance Branch, Global Emerging Infect Surveillance Sect, Silver Spring, MD USA	Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA	Ore, RMC (corresponding author), US Naval Med Res Unit 6, Iquitos, Peru.; Ore, RMC (corresponding author), US Naval Med Res Unit 6, Lima, Peru.	roger.m.castillo8.ln@mail.mil	Halsey, Eric/AAC-8110-2022	Halsey, Eric/0000-0001-6291-8923; CASTILLO, Roger/0000-0002-5828-9252; Juarez, Diana/0000-0001-5599-4653	United States Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [847705.82000.25GB.B0016]	United States Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center(United States Department of Defense)	The study was supported by the United States Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center Work Unit Number: 847705.82000.25GB.B0016.	Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; Calisher CH, 1998, OVERVIEW ARBOVIROLOG, P32; CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250; CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227; DERODANICHE E, 1964, AM J TROP MED HYG, V13, P839, DOI 10.4269/ajtmh.1964.13.839; Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092114; Hang Jun, 2012, J Biomol Tech, V23, P4, DOI 10.7171/jbt.12-2301-001; Hontz RD, 2015, EMERG INFECT DIS, V21, P781, DOI 10.3201/eid2105.141368; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; REED L. J., 1938, AMER JOUR HYG, V27, P493; SARTORELLI AC, 1966, J IMMUNOL, V96, P676; Scherer W F, 1975, Bull Pan Am Health Organ, V9, P19; Shope R. E., 1988, The arboviruses: epidemiology and ecology. Volume III., P37; SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283; SHOPE RE, 1961, AM J TROP MED HYG, V10, P264, DOI 10.4269/ajtmh.1961.10.264; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIKASINGH E. S., 1966, AMER J TROP MED HYG, V15, P219; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148; Woodall J. P., 1979, Arctic and tropical arboviruses., P123	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200576	10.1371/journal.pone.0200576	http://dx.doi.org/10.1371/journal.pone.0200576			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024910	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000029
J	Meyers, K; Wu, YM; Brill, A; Sandfort, T; Golub, SA				Meyers, Kathrine; Wu, Yumeng; Brill, Atrina; Sandfort, Theodorus; Golub, Sarit A.			To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; SEXUAL-BEHAVIOR; PREVENTION; ACCEPTABILITY; BARRIERS; PARTICIPANTS; PREFERENCES; MOTIVATIONS; INFECTIONS; ADHERENCE	Background Phase III trials of long-acting injectable (LAI) PrEP, currently underway, have great potential for expanding the menu of HIV prevention options. Imagining a future in which multiple PrEP modalities are available to potential users of biomedical HIV prevention, we investigated which factors might help direct a patient-physician shared-decision making process to optimize the choice of biomedical HIV prevention method. Methods Participants (n = 105; ages 19-63; 46.7% men of color) were former participants in a PrEP demonstration project and had taken daily oral PrEP for >= 12 months. Participants were given information about LAI PrEP and asked whether they would be interested in switching from oral to LAI PrEP. Participants were also asked about specific pros/cons of LAI PrEP, PrEP attitudes and experiences, and personality factors. Results Two-thirds (66.7%) of current oral PrEP users would switch to LAI PrEP. Intention to switch was associated with product-level and psychosocial factors. Attitudes towards logistical factors (i.e. getting to regular clinic visits for recurring shots) featured more prominently than factors related to the physical experience of PrEP modality (i.e., concerns about injection pain) as motivators for switching. In a multivariate regression model, psychosocial factors including the emotional burden of daily pill taking, deriving a sense of responsibility from PrEP use, and self-identifying as an early adopter, were the strongest predictors of switching. Conclusions These data underscore the importance of attending not only to product-level factors, but also to the logistical and psychological experience of prevention methods for users. Findings have significant implications for the development of patient education materials and patient-provider shared decision aids.	[Meyers, Kathrine; Wu, Yumeng] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Brill, Atrina; Golub, Sarit A.] CUNY, Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Sandfort, Theodorus] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY USA; [Golub, Sarit A.] CUNY, Grad Ctr, Dept Psychol, New York, NY 10021 USA	Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY); Columbia University; City University of New York (CUNY) System	Golub, SA (corresponding author), CUNY, Grad Ctr, Dept Psychol, New York, NY 10021 USA.	sgolub@hunter.cuny.edu	Wu, Yumeng/AAT-4764-2021; Sandfort, Theo/D-1796-2011	Sandfort, Theo/0000-0002-4986-1739; Wu, Yumeng/0000-0002-4586-0675	National Institute of Health [R01MH106380]; National Institute of Mental Health [P30-MH43520]; NIH [R01MH106380]; NIMH [P30-MH43520]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106380] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	READY is funded by National Institute of Health (Grant number: R01MH106380; Golub, PI; URL: https://www.nih.gov/) and funded the contributions of Drs. Golub and Meyers and Ms. Wu and Ms. Brill. Dr. Sandfort's contribution to this manuscript was supported by National Institute of Mental Health center grant P30-MH43520 (P.I.: Robert Remien, PhD; URL: https://www.nimh.nih.gov/index.shtml) to the HIV Center for Clinical and Behavioral Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; READY is funded by NIH (R01MH106380; Golub, PI) and funded the contributions of Drs. Golub and Meyers and Ms. Wu and Ms. Brill. Dr. Sandfort's contribution to this manuscript was supported by NIMH center grant P30-MH43520 (P.I.: Robert Remien, PhD) to the HIV Center for Clinical and Behavioral Studies. We gratefully acknowledge the efforts of Dr. Asa Radix, Stephanie Pena, and Anthony Surace, who all contributed to the success of this project. We also appreciate the contributions of two anonymous reviewers, whose critique and comments enhanced the quality of the final manuscript. Finally, we are grateful to the participants who gave their time and energy to READY.	Alfonso V, 2006, AIDS PATIENT CARE ST, V20, P848, DOI 10.1089/apc.2006.20.848; [Anonymous], 2017, MY BIRTHCONTROL; [Anonymous], 2005, DECISION MAKING TOOL; Auerbach JD, 2015, J INT AIDS SOC, V18, P30, DOI 10.7448/IAS.18.4.19983; Baeten JM, 2014, LANCET INFECT DIS, V14, P443, DOI 10.1016/S1473-3099(14)70070-2; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Curran K, 2014, AIDS, V28, P227, DOI 10.1097/QAD.0000000000000025; Deacon B, 2006, J ANXIETY DISORD, V20, P946, DOI 10.1016/j.janxdis.2006.01.004; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Gamarel KE, 2014, ANN BEHAV MED, V47, pS18, DOI 10.1007/s12160-014-9646-3; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2016, CURR OPIN HIV AIDS, V11, P3, DOI 10.1097/COH.0000000000000216; Greene GJ, 2017, AIDS BEHAV, V21, P1336, DOI 10.1007/s10461-016-1565-9; Hahm MI, 2011, CANCER EPIDEMIOL, V35, P90, DOI 10.1016/j.canep.2010.08.009; Hojilla JC, 2016, AIDS BEHAV, V20, P1461, DOI 10.1007/s10461-015-1055-5; Jackson T, 2013, AIDS CARE, V25, P601, DOI 10.1080/09540121.2012.726341; Jackson T, 2012, AIDS BEHAV, V16, P1853, DOI 10.1007/s10461-012-0188-z; John SA, 2018, AIDS BEHAV, V22, P1184, DOI 10.1007/s10461-017-1907-2; Kim YM, 2005, INT FAM PLAN PERSPEC, V31, P162, DOI 10.1363/3116205; Koester K, 2014, 20 INT AIDS C; Koester KA, 2015, AIDS CARE, V27, P1199, DOI 10.1080/09540121.2015.1039958; Kojima N, 2016, AIDS, V30, P2251, DOI 10.1097/QAD.0000000000001185; Kozyrskyj A., 2017, EUROPEAN J CLIN PHAR, V63, P597; Lazarus R, 2010, J PEDIATR HEALTH CAR, V24, P176, DOI 10.1016/j.pedhc.2009.07.006; Levy ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183521; Liu A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001613; Magazi B, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-88; McMahon JM, 2014, AIDS PATIENT CARE ST, V28, P462, DOI 10.1089/apc.2013.0302; Meyers K, 2018, AIDS BEHAV, V22, P1209, DOI 10.1007/s10461-017-1871-x; Meyers K, 2018, AIDS BEHAV, V22, P1217, DOI 10.1007/s10461-017-1845-z; Meyers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114700; Mugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3; Noble LM, 2014, J TRAVEL MED, V21, P86, DOI 10.1111/jtm.12081; O'Cathain Alicia, 2004, BMC Med Res Methodol, V4, P25, DOI 10.1186/1471-2288-4-25; Oldenburg CE, 2016, SEX HEALTH, V13, P465, DOI 10.1071/SH15144; Parsons JT, 2016, AIDS BEHAV, V20, P1390, DOI 10.1007/s10461-016-1370-5; Perez-Figueroa RE, 2015, AIDS EDUC PREV, V27, P112, DOI 10.1521/aeap.2015.27.2.112; Rohrer JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182156; Taylor SW, 2014, AIDS BEHAV, V18, P871, DOI 10.1007/s10461-013-0617-7; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; Wyatt KD, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-28	45	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200296	10.1371/journal.pone.0200296	http://dx.doi.org/10.1371/journal.pone.0200296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024903	gold, Green Published			2022-12-26	WOS:000439120000018
J	Yu, ZH; Wang, X; Bien, HY; Jiao, L; Wu, WB; Dai, HQ				Yu, Zhihuai; Wang, Xiu; Bien, Huiyang; Jiao, Liang; Wu, Weibing; Dai, Hongqi			Enhancement of the heat conduction performance of boron nitride/cellulosic fibre insulating composites	PLOS ONE			English	Article							POLYMER NANOCOMPOSITES; THERMAL-CONDUCTIVITY; NITRIDE; FUNCTIONALIZATION; DEGRADATION; POLYIMIDE; FILMS	The continuous development of high electrical equipment towards high power output requires better heat dissipation performance of internal insulation structure. It challenges the traditional paper-based insulating materials, with poor thermal conductivity. Introducing thermally conductive and electrically insulating filler into cellulose-based insulating material can enhance heat conduction performance. This work provided a method to prepare thermally conductive and electrically insulating BN/cellulosic fibre composites. And the thermal conductivity of the composites was remarkably increased via grafting APTES and adding dual-sized fillers. The thermal conductivity of the composite reached 0.682 W/(m.k) that increased by 387% with h-BN loading of 41.08 wt%. Simultaneously, BN fillers improved the insulating properties of the resultant composites. The dielectric constant, breaking strength of and volume resistivity of the composites reached 4.75, 9.2 kV/mm(-1) and 4.72x10(14) Omega.m, respectively. The resultant insulating material which has better heat conduction property may have a vast potential for future development in electrical equipment.	[Yu, Zhihuai; Wang, Xiu; Bien, Huiyang; Jiao, Liang; Wu, Weibing; Dai, Hongqi] Nanjing Forestry Univ, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat F, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Dai, HQ (corresponding author), Nanjing Forestry Univ, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat F, Nanjing, Jiangsu, Peoples R China.	hgdhq@njfu.edu.cn		Wu, Weibing/0000-0003-2786-9585	National Natural Science of China [31470599]; Priority Academic Program Development of Jiangsu Higher Education Institutions in China	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions in China	The authors were funded by National Natural Science of China (Project No.31470599) and the Priority Academic Program Development of Jiangsu Higher Education Institutions in China.r The authors were funded by National Natural Science of China (Project No.31470599) and the Priority Academic Program Development of Jiangsu Higher Education Institutions in China.	AGARI Y, 1991, J APPL POLYM SCI, V42, P1665, DOI 10.1002/app.1991.070420621; Chen J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604754; Chen L, 2017, PLOS ONE, V12; Chowdhury ZZ, 2014, BIORESOURCES, V9, P1787; Fofana I, 2010, ELECTR POW SYST RES, V80, P91, DOI 10.1016/j.epsr.2009.08.008; Han ZD, 2011, PROG POLYM SCI, V36, P914, DOI 10.1016/j.progpolymsci.2010.11.004; Hollertz R, 2015, IEEE T DIELECT EL IN, V22, P2339, DOI 10.1109/TDEI.2015.005017; Hollertz R, 2015, ADV FUNCTIONAL MAT, V22, P2339, DOI 10.1103/PhysRevE.86.011912; Hou J, 2014, RSC ADV, V4, P44282, DOI 10.1039/c4ra07394k; Huang M, 2015, J POLYM SCI B, V37, P2360; Huang XY, 2011, IEEE ELECTR INSUL M, V27, P8, DOI 10.1109/MEI.2011.5954064; Jin WQ, 2013, APPL SURF SCI, V270, P561, DOI 10.1016/j.apsusc.2013.01.086; Karim MZ, 2016, SCI ADV MATER, V8, P534, DOI 10.1166/sam.2016.2712; Kim K, 2014, POLYM ADVAN TECHNOL, V25, P791, DOI 10.1002/pat.3291; Kumari S, 2016, RSC ADV, V6, P21119, DOI 10.1039/c5ra28037k; Latini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105788; Li Q, 2015, NATURE, V523, P576, DOI 10.1038/nature14647; Li Qing, 2014, Science & Technology Review, V32, P51; Liao RJ, 2012, J APPL POLYM SCI, V126, pE290, DOI 10.1002/app.36891; Marconnett AM, 2011, ACS NANO, V5, P4818, DOI 10.1021/nn200847u; Moore AL, 2014, MATER TODAY, V17, P163, DOI 10.1016/j.mattod.2014.04.003; [秦丽丽 Qin Lili], 2013, [高分子材料科学与工程, Polymer Materials Science & Engineering], V29, P175; Sato K, 2010, J MATER CHEM, V20, P2749, DOI 10.1039/b924997d; Tang CC, 2006, J PHYS CHEM B, V110, P10354, DOI 10.1021/jp0607014; Thakur VK, 2012, POLYM CHEM-UK, V3, P962, DOI 10.1039/c2py00612j; Tsai MH, 2014, ACS APPL MATER INTER, V6, P8639, DOI 10.1021/am501323m; Verma P, 2004, J POLYM MATER, V21, P361; Wang FF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19394; Wroblewska-Krepsztul J, 2018, INT J POLYM ANAL CH, V23, P383, DOI 10.1080/1023666X.2018.1455382; Yung KC, 2007, J APPL POLYM SCI, V106, P3587, DOI 10.1002/app.27027; Zeng XL, 2013, J APPL POLYM SCI, V128, P1353, DOI 10.1002/app.38276; Zhou LH, 2016, ACS APPL MATER INTER, V8, P28838, DOI 10.1021/acsami.6b09471	32	16	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200842	10.1371/journal.pone.0200842	http://dx.doi.org/10.1371/journal.pone.0200842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024928	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000058
J	Jennings, E; Esposito, D; Rittinger, K; Thurston, TLM				Jennings, Elliott; Esposito, Diego; Rittinger, Katrin; Thurston, Teresa L. M.			Structure-function analyses of the bacterial zinc metalloprotease effector protein GtgA uncover key residues required for deactivating NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Salmonella enterica; bacterial pathogenesis; metalloprotease; type III secretion system (T3SS); NF-B; substrate specificity; bacterial effectors; GtgA; virulence factor	KAPPA-B; SECRETION SYSTEM; SUBSTRATE RECOGNITION; HOMODIMER; NLEC; SPECIFICITY; REFINEMENT; MECHANISM; ASTACIN; PHENIX	The closely related type III secretion system zinc metalloprotease effector proteins GtgA, GogA, and PipA are translocated into host cells during Salmonella infection. They then cleave nuclear factor -light-chain-enhancer of activated B cells (NF-B) transcription factor subunits, dampening activation of the NF-B signaling pathway and thereby suppressing host immune responses. We demonstrate here that GtgA, GogA, and PipA cleave a subset of NF-B subunits, including p65, RelB, and cRel but not NF-B1 and NF-B2, whereas the functionally similar type III secretion system effector NleC of enteropathogenic and enterohemorrhagic Escherichia coli cleaved all five NF-B subunits. Mutational analysis of NF-B subunits revealed that a single nonconserved residue in NF-B1 and NF-B2 that corresponds to the P1 residue Arg-41 in p65 prevents cleavage of these subunits by GtgA, GogA, and PipA, explaining the observed substrate specificity of these enzymes. Crystal structures of GtgA in its apo-form and in complex with the p65 N-terminal domain explained the importance of the P1 residue. Furthermore, the pattern of interactions suggested that GtgA recognizes NF-B subunits by mimicking the shape and negative charge of the DNA phosphate backbone. Moreover, structure-based mutational analysis of GtgA uncovered amino acids that are required for the interaction of GtgA with p65, as well as those that are required for full activity of GtgA in suppressing NF-B activation. This study therefore provides detailed and critical insight into the mechanism of substrate recognition by this family of proteins important for bacterial virulence.	[Jennings, Elliott; Thurston, Teresa L. M.] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Sect Microbiol, London SW7 2AZ, England; [Esposito, Diego; Rittinger, Katrin] Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England	Imperial College London; Francis Crick Institute	Thurston, TLM (corresponding author), Imperial Coll London, Ctr Mol Bacteriol & Infect, Med Res Council, Microbiol Sect, London SW7 2AZ, England.	t.thurston@imperial.ac.uk	Thurston, Teresa/AAZ-9938-2020; Rittinger, Katrin/N-3344-2019	Thurston, Teresa/0000-0001-6139-3723; Rittinger, Katrin/0000-0002-7698-4435; Jennings, Elliott/0000-0002-3118-2375	Francis Crick Institute Grant from Cancer Research UK [FC001142]; UK Medical Research Council; Wellcome Trust; Wellcome Trust [102410/Z/13/ZR]; Imperial College London [RSRO_P50016]; Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship [BB/R011834/1]; BBSRC [BB/R011834/1] Funding Source: UKRI; MRC [MR/P028225/1] Funding Source: UKRI	Francis Crick Institute Grant from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust(Wellcome Trust); Imperial College London(General Electric); Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Francis Crick Institute Grant FC001142, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Wellcome Trust Ph.D. Studentship 102410/Z/13/ZR.; Supported by Imperial College London Junior Research Fellowship RSRO_P50016 and Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship BB/R011834/1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito D, 2018, J BIOL CHEM, V293, P5064, DOI 10.1074/jbc.RA118.001796; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Giogha C, 2015, CELL MICROBIOL, V17, P1766, DOI 10.1111/cmi.12469; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hodgson A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004705; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Li WQ, 2014, ACTA CRYSTALLOGR D, V70, P40, DOI 10.1107/S1399004713024619; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Mulero MC, 2017, J BIOL CHEM, V292, P18821, DOI 10.1074/jbc.M117.813980; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nahar K, 2014, MOL PLANT PATHOL, V15, P297, DOI 10.1111/mpp.12079; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Silva DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003128; Sun H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005484; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Turco MM, 2014, BIOCHEMISTRY-US, V53, P5131, DOI 10.1021/bi500593e; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231	44	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15316	15329		10.1074/jbc.RA118.004255	http://dx.doi.org/10.1074/jbc.RA118.004255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30049795	Green Published, hybrid			2022-12-26	WOS:000445998400030
J	Hintaran, AD; Kliffen, SJ; Lodder, W; Pijnacker, R; Brandwagt, D; van der Bij, AK; Siedenburg, E; Sonder, GJB; Fanoy, EB; Joosten, RE				Hintaran, A. D.; Kliffen, S. J.; Lodder, W.; Pijnacker, R.; Brandwagt, D.; van der Bij, A. K.; Siedenburg, E.; Sonder, G. J. B.; Fanoy, E. B.; Joosten, R. E.			Infection risks of city canal swimming events in the Netherlands in 2016	PLOS ONE			English	Article							WATER-QUALITY INDICATORS; NOROVIRUS; OUTBREAK; EXPOSURE; ILLNESS	Introduction Swimming events in city canals are gaining popularity in the Netherlands, even though canal water is usually not officially designated for recreational use. Knowledge regarding the risk of infection after swimming in canals is limited. An outbreak was reported in 2015 following a canal swimming event in Utrecht, the Netherlands. Local governments were concerned about the health risks of such events. In order to assess the safety of canal swimming, the Public Health Service (PHS) prospectively investigated two city canal swimming events in 2015. In 2016, we repeated this study, aiming to prospectively determine the risks of infection during two urban swimming events, the Utrecht SingelSwim 2016 (USS) and the Amsterdam City Swim 2016 (ACS). Methods We sent online questionnaires to 271 USS participants and 2697 ACS participants, concerning personal characteristics, symptoms, and exposure. Participants were asked to forward the questionnaire to three relatives, i.e., non-exposed. We analyzed water samples from the USS venue taken during the event, as well as stool samples of USS participants with acute gastrointestinal illness (AGI). AGI was defined as diarrhea and/or vomiting within seven days after the event. We calculated adjusted risk ratios (RR) for AGI in the exposed group compared with non-exposed respondents, using binomial regression models. Results The questionnaire was returned by 160 USS participants (exposed) (59%) and 40 non-exposed relatives. Five percent of the exposed (n = 17) and 3% of non-exposed (n =1) reported AGI (RR = 1.69; 95% CI: 0.23-12.46). Norovirus genogroup II was detected in of six USS water samples and in none of the three stool samples. In one of three stool samples, rotavirus was detected. The questionnaire was returned by 1169 ACS participants (exposed) (43%) and 410 non-exposed relatives. Six percent of the exposed (n = 71) and 1% of non-exposed (n = 5) reported AGI (RR 4.86; 95% CI: 1.98-11.97). Conclusion Results of the ACS event showed a higher risk for AGI among the exposed, indicating that participants of events in urban canals in the Netherlands could be at a higher risk for AGI than those not participating. The inconclusive results from the USS are likely due to the small sample size. Swimming in non-monitored open water can bring health risks and more knowledge about environmental and human risk factors helps reduce the risk by being able to more specifically advise organizations and governments.	[Hintaran, A. D.; Brandwagt, D.; Fanoy, E. B.; Joosten, R. E.] Publ Hlth Serv Utrecht Reg, Zeist, Netherlands; [Kliffen, S. J.; Siedenburg, E.; Sonder, G. J. B.] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Kliffen, S. J.; Joosten, R. E.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Preparedness & Response Unit, Bilthoven, Netherlands; [Lodder, W.; Pijnacker, R.; Brandwagt, D.; Fanoy, E. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control Epidemiol & Surveillance, Bilthoven, Netherlands; [van der Bij, A. K.] Diakonessen Hosp, Dept Med Microbiol & Immunol, Utrecht, Netherlands; [Sonder, G. J. B.] Univ Amsterdam, AMC, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [Fanoy, E. B.] Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands	Public Health Service Amsterdam; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Diakonessenhuis; University of Amsterdam; Academic Medical Center Amsterdam	Hintaran, AD (corresponding author), Publ Hlth Serv Utrecht Reg, Zeist, Netherlands.	phintaran@ggdru.nl	fanoy, Eb/ABE-8382-2020					Arnold BF, 2013, EPIDEMIOLOGY, V24, P845, DOI 10.1097/01.ede.0000434431.06765.4a; CABELLI VJ, 1982, AM J EPIDEMIOL, V115, P606, DOI 10.1093/oxfordjournals.aje.a113342; CABELLI VJ, 1979, AM J PUBLIC HEALTH, V69, P690, DOI 10.2105/AJPH.69.7.690; Colford JM, 2007, EPIDEMIOLOGY, V18, P27, DOI 10.1097/01.ede.0000249425.32990.b9; Dorevitch S, 2012, WATER RES, V46, P4961, DOI 10.1016/j.watres.2012.06.030; European Centre for Disease Prevention and Control, 2016, SYST REV INC INF SHE; Fewtrell Lorna, 2015, Curr Environ Health Rep, V2, P85, DOI 10.1007/s40572-014-0036-6; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Haile RW, 1999, EPIDEMIOLOGY, V10, P355, DOI 10.1097/00001648-199907000-00004; Hall V, 2017, EPIDEMIOL INFECT, V145, P1246, DOI 10.1017/S0950268816003393; Harder-Lauridsen NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078371; International Organization for Standardization, 1998, 78991 ISO; International Organization for Standardization, 1998, 930831998 ISO; International Organization for Standardization, 2000, 789922000 ISO; ISO, 2014, 930812014 ISO; Joosten R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174732; KWR Watercycle Research Institute, 2006, CONTR ZWEMW CONF EUR; Lee RM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-446; Magill-Collins A, 2015, WILD ENVIRON MED, V26, P312, DOI 10.1016/j.wem.2015.02.007; Marion JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112029; Parker S, 2019, EPIDEMIOL PSYCH SCI, V28, P408, DOI [10.1017/S2045796017000749, 10.1017/S0950268817001017]; Pruss A, 1998, INT J EPIDEMIOL, V27, P1, DOI 10.1093/ije/27.1.1; Sartorius B, 2007, SCAND J INFECT DIS, V39, P323, DOI 10.1080/00365540601053006; Schets FM, 2011, EPIDEMIOL INFECT, V139, P1114, DOI 10.1017/S0950268810002347; Schets FM van Wijnen J. H, 2007, MICROBIOLOGICAL QUAL; Schets Franciska M, 2014, Ned Tijdschr Geneeskd, V158, pA7969; Schuurman T, 2007, J CLIN MICROBIOL, V45, P3692, DOI 10.1128/JCM.00896-07; StataCorp, 2013, STATA STAT SOFTW REL; Stuurgroep Water, 2013, BESL WERKW IND MET M; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Verhaelen K, 2012, INT J FOOD MICROBIOL, V160, P137, DOI 10.1016/j.ijfoodmicro.2012.10.008; Zlot A, 2015, MMWR-MORBID MORTAL W, V64, P485	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200616	10.1371/journal.pone.0200616	http://dx.doi.org/10.1371/journal.pone.0200616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052633	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600010
J	Jiang, MH; Leung, NH; Ip, M; You, JHS				Jiang, Minghuan; Leung, Nok-Hang; Ip, Margaret; You, Joyce H. S.			Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection	PLOS ONE			English	Article							VANCOMYCIN; GUIDELINES; MORTALITY; DISEASE; CARE; PCR; METRONIDAZOLE; DIARRHEA; ROUTE	Background Clostridium difficile infection (CDI) caused by ribotype 002 strain is associated with poor outcomes in Chinese patients. Fecal microbiota transplantation (FMT) is an effective but costly treatment for CDI. We aimed to examine potential cost-effectiveness of ribotype-guided FMT in Chinese patients with severe CDI. Methods A decision-analytic model was designed to simulate outcomes of ribotype 002-guided FMT versus vancomycin treatment in Chinese patients with severe CDI in the hospital setting. Outcome measures included mortality rate; direct medical cost; and quality-adjusted life year (QALY) loss for CDI. Sensitivity analysis was performed to examine robustness of base-case results. Results Comparing to vancomycin treatment, ribotype-guided FMT group reduced mortality (11.6% versus 17.1%), cost (USD8,807 versus USD9,790), and saved 0.472 QALYs in base-case analysis. One-way sensitivity analysis found the ribotype-guided FMT group to remain cost-effective when patient acceptance rate of FMT was >0.6% and ribotype 002 prevalence was >0.07%. In probabilistic sensitivity analysis, ribotype-guided FMT gained higher QALYs at 100% of simulations with mean QALY gain of 0.405 QALYs (95% CI: 0.400-0.410; p<0.001). The ribotype-guided group was less costly in 97.9% of time, and mean cost-saving was USA679 (95% CI: 670 - 688;p<0.001). Conclusions In the present model, ribotype-guided FMT appears to be a potential option to save QALYs and cost when comparing with vancomycin. The cost-effectiveness of ribotype-guided FMT is subject to the patient acceptance to FMT and prevalence of ribotype 002.	[Jiang, Minghuan] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Shaanxi, Peoples R China; [Jiang, Minghuan] Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Shaanxi, Peoples R China; [Jiang, Minghuan] Xi An Jiao Tong Univ, Global Hlth Inst, Xian, Shaanxi, Peoples R China; [Jiang, Minghuan] Shaanxi Ctr Hlth Reform & Dev Res, Xian, Shaanxi, Peoples R China; [Leung, Nok-Hang; You, Joyce H. S.] Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China; [Ip, Margaret] Chinese Univ Hong Kong, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Chinese University of Hong Kong; Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	Ip, Margaret/K-1096-2013; You, Joyce H. S./C-2984-2008	Ip, Margaret/0000-0003-1291-6537; You, Joyce H. S./0000-0002-5763-7403				Aitken SL, 2015, INFECT CONT HOSP EP, V36, P1318, DOI 10.1017/ice.2015.187; Barbieri M, 2010, VALUE HEALTH, V13, P1028, DOI 10.1111/j.1524-4733.2010.00771.x; Baro E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170258; Bidet P, 2000, J CLIN MICROBIOL, V38, P2484, DOI 10.1128/JCM.38.7.2484-2487.2000; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Census and Statistics Department Hong Kong SAR, HONG KONG LIF TABL 2; Census and Statistics Department The Government of Hong Kong SAR, NAT INC; Cheng VCC, 2011, EUR J CLIN MICROBIOL, V30, P1371, DOI 10.1007/s10096-011-1231-0; Drekonja D, 2015, ANN INTERN MED, V162, P630, DOI 10.7326/M14-2693; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Gundacker ND, 2017, J HOSP INFECT, V96, P349, DOI 10.1016/j.jhin.2017.05.004; Hocquart M, 2018, CLIN INFECT DIS, V66, P645, DOI 10.1093/cid/cix762; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Kim J, 2014, CLIN MICROBIOL INFEC, V20, P1198, DOI 10.1111/1469-0691.12704; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Lagier JC, 2015, EUR J CLIN MICROBIOL, V34, P1597, DOI 10.1007/s10096-015-2394-x; Lapointe-Shaw L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149521; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; Martinson JNV, 2015, J CLIN MICROBIOL, V53, P1192, DOI 10.1128/JCM.03591-14; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; Merlo G, 2016, J GASTROEN HEPATOL, V31, P1927, DOI 10.1111/jgh.13402; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Rao K, 2015, CLIN INFECT DIS, V61, P233, DOI 10.1093/cid/civ254; Ridley S, 2007, ANAESTHESIA, V62, P547, DOI 10.1111/j.1365-2044.2007.04997.x; Shah DN, 2016, J HOSP INFECT, V93, P286, DOI 10.1016/j.jhin.2016.04.004; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Varier R U, 2014, Clin Microbiol Infect, V20, P1343, DOI 10.1111/1469-0691.12805; Varier RU, 2015, INFECT CONT HOSP EP, V36, P438, DOI 10.1017/ice.2014.80; Wang SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161174; Wong SH, 2016, J INFECTION, V73, P115, DOI 10.1016/j.jinf.2016.05.010; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; You JHS, 2009, J EPIDEMIOL COMMUN H, V63, P906, DOI 10.1136/jech.2008.081885; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763; Zipursky JS, 2012, CLIN INFECT DIS, V55, P1652, DOI 10.1093/cid/cis809	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201539	10.1371/journal.pone.0201539	http://dx.doi.org/10.1371/journal.pone.0201539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048534	Green Submitted, gold, Green Published			2022-12-26	WOS:000439952400097
J	Lee, I; Kim, D; Park, GL; Jeon, TJ; Kim, SM				Lee, Insu; Kim, Daegyu; Park, Ga-Lahm; Jeon, Tae-Joon; Kim, Sun Min			Investigation of wound healing process guided by nano-scale topographic patterns integrated within a microfluidic system	PLOS ONE			English	Article							ORGANS-ON-CHIPS; CONTACT GUIDANCE; CELL-MIGRATION; HUMAN SKIN; IN-VITRO; DECISION-MAKING; SOFT-TISSUE; REPAIR; MECHANOTRANSDUCTION; REGENERATION	When living tissues are injured, they undergo a sequential process of homeostasis, inflammation, proliferation and maturation, which is called wound healing. The working mechanism of wound healing has not been wholly understood due to its complex environments with various mechanical and chemical factors. In this study, we propose a novel in vitro wound healing model using a microfluidic system that can manipulate the topography of the wound bed. The topography of the extracellular matrix (ECM) in the wound bed is one of the most important mechanical properties for rapid and effective wound healing. We focused our work on the topographical factor which is one of crucial mechanical cues in wound healing process by using various nano-patterns on the cell attachment surface. First, we analyzed the cell morphology and dynamic cellular behaviors of NIH-3T3 fibroblasts on the nano-patterned surface. Their morphology and dynamic behaviors were investigated for relevance with regard to the recovery function. Second, we developed a highly reproducible and inexpensive research platform for wound formation and the wound healing process by combining the nano-patterned surface and a microfluidic channel. The effect of topography on wound recovery performance was analyzed. This in vitro wound healing research platform will provide well-controlled topographic cue of wound bed and contribute to the study on the fundamental mechanism of wound healing.	[Lee, Insu; Park, Ga-Lahm; Kim, Sun Min] Inha Univ, Dept Mech Engn, Incheon, South Korea; [Kim, Daegyu; Jeon, Tae-Joon] Inha Univ, Dept Biol Engn, Incheon, South Korea; [Jeon, Tae-Joon; Kim, Sun Min] Inha Univ, WCSL Integrated Human Airway On A Chip, Incheon, South Korea	Inha University; Inha University; Inha University	Kim, SM (corresponding author), Inha Univ, Dept Mech Engn, Incheon, South Korea.; Jeon, TJ (corresponding author), Inha Univ, Dept Biol Engn, Incheon, South Korea.; Jeon, TJ; Kim, SM (corresponding author), Inha Univ, WCSL Integrated Human Airway On A Chip, Incheon, South Korea.	tjjeon@inha.ac.kr; sunmk@inha.ac.kr	Kim, Sun Min/A-1208-2007; Jeon, Tae-Joon/D-4725-2013	Kim, Sun Min/0000-0001-8420-637X; Jeon, Tae-Joon/0000-0002-4882-9040	INHA UNIVERSITY	INHA UNIVERSITY	This work was supported by INHA UNIVERSITY Research Grant; http://www.inha.ac.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/18/183001; Briquez PS, 2015, ADV WOUND CARE, V4, P479, DOI 10.1089/wound.2014.0603; Chan CY, 2013, LAB CHIP, V13, P4697, DOI 10.1039/c3lc90115g; Choi S, 2013, CELLS TISSUES ORGANS, V198, P349, DOI 10.1159/000358755; DEMARCHEZ M, 1992, TRANSPLANTATION, V54, P317, DOI 10.1097/00007890-199208000-00023; Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x; Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160; Hu MS, 2014, ANN BIOMED ENG, V42, P1494, DOI 10.1007/s10439-014-1010-z; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Jarbrink K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0400-8; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038; Kreeger PK, 2018, ANNU REV BIOMED ENG, V20, P49, DOI 10.1146/annurev-bioeng-062117-121011; Latifi-Pupovci H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0676-9; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Marmaras A, 2012, SOFT MATTER, V8, P6922, DOI 10.1039/c2sm00030j; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Murrell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024283; Nie FQ, 2007, BIOMATERIALS, V28, P4017, DOI 10.1016/j.biomaterials.2007.05.037; Paul CD, 2016, FASEB J, V30, P2161, DOI 10.1096/fj.201500199R; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Ray A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14923; Saito AC, 2014, EXP CELL RES, V327, P1, DOI 10.1016/j.yexcr.2014.05.002; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Silver FH, 2003, SKIN RES TECHNOL, V9, P3, DOI 10.1034/j.1600-0846.2003.00358.x; Stamm A., 2016, BIONANOMATERIALS, V17, P79, DOI [10.1515/bnm-2016-0002, DOI 10.1515/BNM-2016-0002]; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Sutherland J, 2005, J ANAT, V206, P581, DOI 10.1111/j.1469-7580.2005.00415.x; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Ud-Din S, 2017, WOUND REPAIR REGEN, V25, P164, DOI 10.1111/wrr.12513; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212	36	10	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201418	10.1371/journal.pone.0201418	http://dx.doi.org/10.1371/journal.pone.0201418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048525	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400087
J	Luo, WT; Gao, XB; Zhang, X				Luo, Wenting; Gao, Xubo; Zhang, Xin			Geochemical processes controlling the groundwater chemistry and fluoride contamination in the Yuncheng Basin, China-An area with complex hydrogeochemical conditions	PLOS ONE			English	Article							WATER-QUALITY; AQUEOUS GEOCHEMISTRY; NALGONDA DISTRICT; SURFACE-WATER; THAR DESERT; SALT LAKE; CL-OH; F-OH; NORTHERN; ENRICHMENT	Hydrogeochemical and stable isotope analyses and geochemical modeling were carried out to identify the major geochemical processes controlling the groundwater chemistry and fluoride contamination in the aquifers of the Yuncheng Basin, China, an area with complex hydrogeochemical conditions and severe fluoride contamination of the groundwater. The major findings of this case study include the following: 1) Cation exchange and salt effects are vital controls on the enrichment of fluoride in groundwater in the area by reducing the activity of Ca2+/F- in groundwater via ion complexation. Cation exchange increased the fluoride concentration by 2.7 mg/L when the Na/Ca molar ratio increased from 0.24 to 9.0, while the salt effect led to a ca. 5-10% increase in complex F- in groundwater due to the further dissolution of fluoride-bearing minerals in the aquifers, as suggested by a model calculation. 2) Anthropogenic contamination from pesticide and fertilizer use and industrial waste discharge is also a main source of fluoride in the groundwater. 3) Evaporation and ion effects favor the enrichment of fluoride in groundwater by encouraging the removal of Ca via precipitation. 4) The desorption of fluoride from mineral/organic matter surfaces is enhanced under alkaline conditions and a high HCO3 content in groundwater.	[Luo, Wenting; Gao, Xubo; Zhang, Xin] China Univ Geosci, Sch Environm Studies, Wuhan, Hubei, Peoples R China	China University of Geosciences	Gao, XB (corresponding author), China Univ Geosci, Sch Environm Studies, Wuhan, Hubei, Peoples R China.	xubo.gao.cug@gmail.com	gao, xubo/F-2289-2010	gao, xubo/0000-0003-2458-3063	National Natural Science Foundation of China [41521001, 41372251]; Natural Science Foundation of Hubei Province of China [2013CFB410]; Specialized Research Fund for the Doctoral Program of Higher Education [20130145120014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funded by "National Natural Science Foundation of China (41521001)-YW. National Natural Science Foundation of China (41372251)-XG. Natural Science Foundation of Hubei Province of China (2013CFB410)-XG Specialized Research Fund for the Doctoral Program of Higher Education, 20130145120014, XG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE HJ, 1987, CONTRIB MINERAL PETR, V97, P305, DOI 10.1007/BF00371994; Adams S, 2011, J HYDROL, V241, P91; Alagumuthu G., 2010, ARCH APPL SCI RES, V2, P170; Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; Apambire WB, 1997, ENVIRON GEOL, V33, P13, DOI 10.1007/s002540050221; BACK W, 1983, GEOL SOC AM BULL, V94, P1415, DOI 10.1130/0016-7606(1983)94<1415:PARODM>2.0.CO;2; Banerjee A, 2015, GEOSCI FRONT, V6, P277, DOI 10.1016/j.gsf.2014.03.003; BARNES CJ, 1988, J HYDROL, V100, P143, DOI 10.1016/0022-1694(88)90184-9; Berger T, 2016, SCI TOTAL ENVIRON, V569, P948, DOI 10.1016/j.scitotenv.2016.06.002; BISCHOFF JL, 1994, GEOLOGY, V22, P995, DOI 10.1130/0091-7613(1994)022<0995:KWCABD>2.3.CO;2; Boujelben N, 2008, J HAZARD MATER, V151, P103, DOI 10.1016/j.jhazmat.2007.05.057; Brahman KD, 2014, CHEMOSPHERE, V100, P182, DOI 10.1016/j.chemosphere.2013.11.035; Brahman KD, 2013, WATER RES, V47, P1005, DOI 10.1016/j.watres.2012.10.042; Brindha K, 2016, ENVIRON SCI POLLUT R, V23, P8302, DOI 10.1007/s11356-016-6069-7; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Carillo-Rivera J.J., 2002, MEXICO J HYDRO, V261, P24; Chae GT, 2007, SCI TOTAL ENVIRON, V385, P272, DOI 10.1016/j.scitotenv.2007.06.038; Chae GT, 2006, GEOCHEM J, V40, P95, DOI 10.2343/geochemj.40.95; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P519, DOI 10.1107/S0021889874010375; COLEMAN ML, 1982, ANAL CHEM, V54, P993, DOI 10.1021/ac00243a035; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; Cronin SJ, 2000, NEW ZEAL J AGR RES, V43, P295, DOI 10.1080/00288233.2000.9513430; Currell M, 2011, APPL GEOCHEM, V26, P540, DOI 10.1016/j.apgeochem.2011.01.012; Currell MJ, 2012, HYDROL PROCESS, V26, P4050, DOI 10.1002/hyp.9208; Currell MJ, 2010, J HYDROL, V385, P216, DOI 10.1016/j.jhydrol.2010.02.022; Datta PS, 1996, J CONTAM HYDROL, V24, P85, DOI 10.1016/0169-7722(96)00004-6; Dissanayake C. B., 1991, International Journal of Environmental Studies, V38, P137, DOI 10.1080/00207239108710658; Domenico P.A., 1998, PHYS CHEM HYDROGEOLO, V506; Dreybrodt W, 2014, GEOCHIM COSMOCHIM AC, V125, P433, DOI 10.1016/j.gca.2013.10.004; Edmunds WM, 2001, ESSENTIALS MED GEOLO, P311; El-Said GF, 2016, ENVIRON SCI POLLUT R, V23, P14240, DOI 10.1007/s11356-016-6552-1; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Farooqi A, 2007, ENVIRON POLLUT, V145, P839, DOI 10.1016/j.envpol.2006.05.007; Farooqi A, 2009, ARCH ENVIRON CON TOX, V56, P693, DOI 10.1007/s00244-008-9239-x; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Gao XB, 2007, ENVIRON GEOL, V53, P795, DOI 10.1007/s00254-007-0692-z; Gao XB, 2016, SCI TOTAL ENVIRON, V545, P1, DOI 10.1016/j.scitotenv.2015.09.109; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; Hallett BM, 2015, J HYDROL-REG STUD, V4, P111, DOI 10.1016/j.ejrh.2014.10.003; Handa B.K., 1975, GROUNDWATER, V13, P275, DOI [DOI 10.1111/J.1745-6584.1975.TB03086.X, 10.1111/j.1745-6584.1975.tb03086.x]; HEATON THE, 1984, J HYDROL, V67, P249, DOI 10.1016/0022-1694(84)90244-0; Heikens A, 2005, SCI TOTAL ENVIRON, V346, P56, DOI 10.1016/j.scitotenv.2004.12.007; Jacks G, 2005, APPL GEOCHEM, V20, P221, DOI 10.1016/j.apgeochem.2004.07.002; Jia YQ, 2000, J YUNCHENG ADV TRAIN, V3, P12; JONES BF, 1977, GEOCHIM COSMOCHIM AC, V41, P53, DOI 10.1016/0016-7037(77)90186-7; Kim K, 2005, HYDROL PROCESS, V19, P493, DOI 10.1002/hyp.5551; KLUMPP A, 1994, ENVIRON POLLUT, V85, P109, DOI 10.1016/0269-7491(94)90244-5; Kumar M, 2016, CHEMOSPHERE, V150, P227, DOI 10.1016/j.chemosphere.2016.02.019; Li CC, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5260-y; Li CC, 2015, SCI TOTAL ENVIRON, V508, P155, DOI 10.1016/j.scitotenv.2014.11.045; Li DN, 2018, ENVIRON POLLUT, V237, P430, DOI 10.1016/j.envpol.2018.02.072; Li Y, 2015, J ENVIRON SCI-CHINA, V31, P21, DOI 10.1016/j.jes.2014.10.016; Machender G, 2014, ENVIRON EARTH SCI, V72, P4017, DOI 10.1007/s12665-014-3291-9; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Moore RB, 2004, 20045093 US GEOL SUR, P30; MUNOZ JL, 1984, REV MINERAL, V13, P469; NANYARO JT, 1984, J AFR EARTH SCI, V2, P129, DOI 10.1016/S0731-7247(84)80007-5; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Olaka LA, 2016, SCI TOTAL ENVIRON, V545, P641, DOI 10.1016/j.scitotenv.2015.11.161; Ozsvath DL, 2006, ENVIRON GEOL, V50, P132, DOI 10.1007/s00254-006-0192-6; Pathak RP, 2012, INT J ENG SCI, V1, P44; Rafique T, 2015, SCI TOTAL ENVIRON, V530, P271, DOI 10.1016/j.scitotenv.2015.05.038; RAO NVR, 1993, ENVIRON GEOL, V21, P84; Ravichandran B, 2012, INT J ENVIRON POLLUT, V49, P55, DOI 10.1504/IJEP.2012.049774; Reyes-Gomez VM, 2015, ARCH ENVIRON CON TOX, V68, P292, DOI 10.1007/s00244-014-0082-y; ROBINSON GR, 2003, GEN LITHOLOGY LITHOG; Rosi M, 2003, VOLCANOES, P335; Samal AC, 2015, ENVIRON SCI POLLUT R, V22, P6220, DOI 10.1007/s11356-014-3817-4; Saxena VK, 2001, ENVIRON GEOL, V40, P1084, DOI 10.1007/s002540100290; SCHOEMAN JJ, 1987, WATER SA, V13, P229; Sharma R, 2010, PLOS ONE, V5; Singh CK, 2015, ENVIRON SCI POLLUT R, V22, P2668, DOI 10.1007/s11356-014-3504-5; Singh CK, 2013, HYDROL PROCESS, V27, P2462, DOI 10.1002/hyp.9247; Stormer JC, 1970, AM MINERAL, V55, P126; Su CL, 2013, J GEOCHEM EXPLOR, V135, P79, DOI 10.1016/j.gexplo.2012.09.003; Susheela AK, 1999, CURR SCI INDIA, V77, P1250; Taylor RP, 1997, TERRA NOVA, V9, P105; Temminghoff EJM, 1997, ENVIRON SCI TECHNOL, V31, P1109, DOI 10.1021/es9606236; Voigt M, 2016, CHEM GEOL, V430, P70, DOI 10.1016/j.chemgeo.2016.03.012; Wallin B, 2015, COMPILATION REV 87SR; Wang YX, 2009, APPL GEOCHEM, V24, P641, DOI 10.1016/j.apgeochem.2008.12.015; Yang CX, 1989, LATE CENOZOIC STRATA; Yin XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125369; Zabala ME, 2016, J HYDROL, V541, P1067, DOI [10.1016/j.jhydrol.2016.08,023, 10.1016/j.jhydrol.2016.08.023]; Zhang J, 1998, GEOLOGICAL J CHINA U, V4, P140; Zhang Jian-jie, 2016, Yingyong Shengtai Xuebao, V27, P207; ZHU C, 1991, GEOCHIM COSMOCHIM AC, V55, P1837, DOI 10.1016/0016-7037(91)90028-4	87	67	71	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0199082	10.1371/journal.pone.0199082	http://dx.doi.org/10.1371/journal.pone.0199082			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048448	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400003
J	Schakel, L; Veldhuijzen, DS; van Middendorp, H; Van Dessel, P; De Houwer, J; Bidarra, R; Evers, AWM				Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Van Dessel, Pieter; De Houwer, Jan; Bidarra, Rafael; Evers, Andrea W. M.			The effects of a gamified approach avoidance training and verbal suggestions on food outcomes	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; PLACEBO ANALGESIA; APPROACH BIAS; HEALTH; EXPECTATION; BEHAVIOR; INTERVENTION; EXPECTANCIES; METAANALYSIS; OVERWEIGHT	There is initial support for the effectiveness of approach-avoidance trainings in altering food-related health behaviors. Furthermore, outcome expectancies induced by verbal suggestions might optimize the effectiveness of these interventions, as shown in placebo research. The present study investigated the effectiveness of a gamified approach-avoidance training on food-related outcomes and whether verbal suggestions could strengthen those effects. A total of 120 participants were randomly assigned to 1 of 4 conditions: serious gaming only, verbal suggestions only, serious gaming combined with verbal suggestions, or a gaming control condition. Virtual food preference and food choice were assessed with a food choice task, with pairs differing in healthiness or in healthiness and attractiveness. Implicit food preference was assessed with an Implicit Association Test and food intake with a bogus taste test. Participants in both serious gaming conditions made healthier food choices for pairs differing in healthiness and attractiveness and had healthier implicit food preferences compared to gaming control. No effects were found on food intake. These findings provide the first preliminary support for the effects of a gamified approach-avoidance training on virtual food choice and implicit food preference. Future studies should further elucidate these effects, also in other health domains such as physical activity.	[Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Fac Social & Behav Sci, Inst Psychol, Hlth Med & Neuropsychol Unit, Leiden, Netherlands; [Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Van Dessel, Pieter; De Houwer, Jan] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Bidarra, Rafael] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Evers, Andrea W. M.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schakel, L (corresponding author), Leiden Univ, Fac Social & Behav Sci, Inst Psychol, Hlth Med & Neuropsychol Unit, Leiden, Netherlands.; Schakel, L (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	l.schakel@fsw.leidenuniv.nl	Evers, Andrea/GWV-9705-2022; Van Dessel, Pieter/Q-1917-2019; De Houwer, Jan/ABF-6866-2021; van Middendorp, Henriet/B-8300-2013; Evers, Andrea/U-8983-2019	Van Dessel, Pieter/0000-0002-3401-780X; De Houwer, Jan/0000-0003-0488-5224; Evers, Andrea/0000-0002-0090-5091; Veldhuijzen, Dieuwke S. (Judy)/0000-0001-9046-1019; Bidarra, Rafael/0000-0003-4281-6019	European Research Council [617700]; Scientific Research Foundation, Flanders (FWO-Vlaanderen) [FWO16/PDO/201]	European Research Council(European Research Council (ERC)European Commission); Scientific Research Foundation, Flanders (FWO-Vlaanderen)(FWO)	This study is funded by a European Research Council Consolidator Grant (ID: 617700, granted to A Evers; https://ec.europa.eu/commission/index_en). P Van Dessel is supported by a Post-Doctoral fellowship of the Scientific Research Foundation, Flanders (FWO-Vlaanderen, ID: FWO16/PDO/201; http://www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00444; Bartels DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091727; Beard C, 2012, BEHAV COGN PSYCHOTH, V40, P618, DOI 10.1017/S1352465811000671; Becker D, 2015, APPETITE, V85, P58, DOI 10.1016/j.appet.2014.11.017; Blackburne T, 2016, JMIR SERIOUS GAMES, V4, DOI 10.2196/games.5708; Boendermaker WJ, 2016, JMIR SERIOUS GAMES, V4, DOI 10.2196/games.6464; Cohen Deborah, 2008, Prev Chronic Dis, V5, pA23; Cohen-Kdoshay O, 2009, EXP PSYCHOL, V56, P128, DOI 10.1027/1618-3169.56.2.128; Colloca L, 2014, Z PSYCHOL, V222, P124, DOI 10.1027/2151-2604/a000177; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761; Dassen FCM, 2018, APPETITE, V124, P89, DOI 10.1016/j.appet.2017.05.009; DeSmet A, 2014, PREV MED, V69, P95, DOI 10.1016/j.ypmed.2014.08.026; Dickson H, 2016, APPETITE, V99, P46, DOI 10.1016/j.appet.2015.12.026; Drenowatz C, 2015, ADV NUTR, V6, P592, DOI 10.3945/an.115.008615; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Havermans RC, 2013, CURR OBES REP, V2, P165, DOI 10.1007/s13679-013-0053-z; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Horwath CC, 2010, AM J HEALTH PROMOT, V24, P324, DOI 10.4278/ajhp.071218138; Kakoschke N, 2017, J BEHAV THER EXP PSY, V55, P99, DOI 10.1016/j.jbtep.2017.01.002; Kakoschke N, 2014, EAT BEHAV, V15, P120, DOI 10.1016/j.eatbeh.2013.11.001; Kato PM, 2010, REV GEN PSYCHOL, V14, P113, DOI 10.1037/a0019441; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; O'Donnell S, 2014, J NUTR EDUC BEHAV, V46, P570, DOI 10.1016/j.jneb.2014.03.005; Pearson ES, 2012, PATIENT EDUC COUNS, V87, P32, DOI 10.1016/j.pec.2011.07.018; Peerdeman KJ, 2017, EUR J PAIN, V21, P1366, DOI 10.1002/ejp.1035; Peerdeman KJ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01270; Peerdeman KJ, 2016, PAIN, V157, P1179, DOI 10.1097/j.pain.0000000000000540; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Robinson E, 2017, APPETITE, V116, P223, DOI 10.1016/j.appet.2017.05.002; Salmon SJ, 2014, HEALTH PSYCHOL, V33, P103, DOI 10.1037/a0031785; Sardi L, 2017, J BIOMED INFORM, V71, P31, DOI 10.1016/j.jbi.2017.05.011; Schakel L, OPTIMIZING HLT UNPUB; Schumacher SE, 2016, APPETITE, V96, P219, DOI 10.1016/j.appet.2015.09.014; Shiyko M, 2016, JMIR SERIOUS GAMES, V4, pE8, DOI 10.2196/games.4977; Spagnolo PA, 2015, ALCOHOL ALCOHOLISM, V50, P282, DOI 10.1093/alcalc/agv015; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; van den Akker K, 2016, CONTEMP CLIN TRIALS, V49, P85, DOI 10.1016/j.cct.2016.06.008; Van Dessel P, DO ACTIONS INF UNPUB; Van Dessel P, 2018, ACTA PSYCHOL, V184, P137, DOI 10.1016/j.actpsy.2017.03.016; Van Dessel P, 2017, J EXP SOC PSYCHOL, V69, P23, DOI 10.1016/j.jesp.2016.10.004; Van Dessel P, 2016, PERS SOC PSYCHOL B, V42, P81, DOI 10.1177/0146167215615335; Van Dessel P, 2015, EXP PSYCHOL, V62, P161, DOI 10.1027/1618-3169/a000282; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Wilson-Barlow L, 2014, EAT BEHAV, V15, P490, DOI 10.1016/j.eatbeh.2014.06.004	48	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201309	10.1371/journal.pone.0201309	http://dx.doi.org/10.1371/journal.pone.0201309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048511	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400073
J	Sood, A; Suryaprasad, A; Trickey, A; Kanchi, S; Midha, V; Foster, MA; Bennett, E; Kamili, S; Alvarez-Bognar, F; Shadaker, S; Surlikar, V; Garg, R; Mittal, P; Sharma, S; May, MT; Vickerman, P; Averhoff, F				Sood, Ajit; Suryaprasad, A.; Trickey, A.; Kanchi, S.; Midha, V.; Foster, M. A.; Bennett, E.; Kamili, S.; Alvarez-Bognar, F.; Shadaker, S.; Surlikar, V.; Garg, R.; Mittal, P.; Sharma, S.; May, M. T.; Vickerman, P.; Averhoff, F.			The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NORTHERN INDIA; GLOBAL EPIDEMIOLOGY; NATURAL-HISTORY; PREVALENCE; SURVEILLANCE; GENOTYPE; DISEASE; COHORT	Introduction Hepatitis C virus (HCV) infection prevalence is believed to be elevated in Punjab, India; however, state-wide prevalence data are not available. An understanding of HCV prevalence, risk factors and genotype distribution can be used to plan control measures in Punjab.\ Methods A cross-sectional, state-wide, population-based serosurvey using a multi-stage stratified cluster sampling design was conducted October 2013 to April 2014. Children aged >= 5 years and adults were eligible to participate. Demographic and risk behavior data were collected, and serologic specimens were obtained and tested for anti-HCV antibody, HCV Ribonucleic acid (RNA) on anti-HCV positive samples, and HCV genotype. Prevalence estimates and adjusted odds ratios for risk factors were calculated from weighted data and stratified by urban/rural residence. Results 5,543 individuals participated in the study with an overall weighted anti-HCV prevalence of 3.6% (95% Confidence Interval [ CI]: 3.0%-4.2%) and chronic infection (HCV Ribonucleic acid test positive) of 2.6% (95% CI: 2.0%-3.1%). Anti-HCV was associated with being male (adjusted odds ratio 1.52; 95% CI: 1.08-2.14), living in a rural area (adjusted odds ratio 2.53; 95% CI: 1.62-3.95) and was most strongly associated with those aged 40-49 (adjusted odds ratio 40-49 vs. 19-29-year-olds 3.41; 95% CI: 1.90-6.11). Anti-HCV prevalence increased with each blood transfusion received (adjusted odds ratio 1.36; 95% CI: 1.10-1.68) and decreased with increasing education, (adjusted odds ratio 0.37 for graduate-level vs. primary school/no education; 95% CI: 0.16-0.82). Genotype 3 (58%) was most common among infected individuals. Discussion The study findings, including the overall prevalence of chronic HCV infection, associated risk factors and demographic characteristics, and genotype distribution can guide prevention and control efforts, including treatment provision. In addition to high-risk populations, efforts targeting rural areas and adults aged >= 40 would be the most effective for identifying infected individuals.	[Sood, Ajit; Midha, V.] Dayanand Med Coll, Ludhiana, Punjab, India; [Suryaprasad, A.; Foster, M. A.; Bennett, E.; Kamili, S.; Averhoff, F.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Trickey, A.; May, M. T.; Vickerman, P.] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Kanchi, S.; Surlikar, V.] MSD India Pvt Ltd, Bombay, Maharashtra, India; [Alvarez-Bognar, F.] Merck & Co Inc, Kenilworth, NJ USA; [Shadaker, S.] CDC Fdn, Atlanta, GA USA; [Garg, R.] Guru Gobind Singh Med Coll & Hosp, Faridkot, Punjab, India; [Mittal, P.] Mittal Liver & Gastroenterol Ctr, Patiala, Punjab, India; [Sharma, S.] All India Inst Med Sci, Coll Nursing, Rishikesh, Uttarakhand, India	Dayanand Medical College & Hospital; Centers for Disease Control & Prevention - USA; University of Bristol; Merck & Company; All India Institute of Medical Sciences (AIIMS) Rishikesh	Trickey, A (corresponding author), Univ Bristol, Populat Hlth Sci, Bristol, Avon, England.	adam.trickey@bristol.ac.uk	Sharma, Suresh K/T-1696-2019	Vickerman, Peter/0000-0002-8291-5890; Trickey, Adam/0000-0003-3462-2898; Sharma, Suresh/0000-0003-1214-8865	Merck Sharp & Dohme (MSD) Pharmaceuticals India Private Limited, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA; Merck	Merck Sharp & Dohme (MSD) Pharmaceuticals India Private Limited, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA; Merck(Merck & Company)	This population survey was sponsored by Merck Sharp & Dohme (MSD) Pharmaceuticals India Private Limited, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA. S Kanchi, F Alvarez-Bognar, and V Surlikar are, or have been, employees of Merck. The specific roles of these authors are articulated in the "author contributions" section. Ajit Sood has also received funding from Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoramoorthy G, 2017, DIGEST DIS SCI, V62, P550, DOI 10.1007/s10620-016-4436-3; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Ara A Kardashian, 2015, Gastroenterol Hepatol (N Y), V11, P458; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Balogun MA, 2002, J INFECTION, V45, P219, DOI 10.1053/jinf.2002.1059; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Dhiman RK, 2016, J CLIN EXP HEPATOL, V6, P224, DOI 10.1016/j.jceh.2016.09.005; Duseja A, 2002, Trop Gastroenterol, V23, P125; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Iles JC, 2013, INFECT GENET EVOL, V19, P386, DOI 10.1016/j.meegid.2013.01.021; Jindal N, 2008, JPN J INFECT DIS, V61, P79; Kumar T, 2015, MMWR-MORBID MORTAL W, V64, P758, DOI 10.15585/mmwr.mm6428a3; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Mahajan R, 2017, J GASTROEN HEPATOL, DOI [10.1111/jgh, DOI 10.1111/JGH]; Minhas Sukhmeet, 2011, Med J Armed Forces India, V67, P7, DOI 10.1016/S0377-1237(11)80003-1; Munjal A, 2015, J VIRAL HEPATITIS, V22, P28, DOI 10.1111/jvh.17_12425; Nadeem Ahmad, 2009, Pravara Medical Review, V4, P4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NANDI J, 1994, VOX SANG, V67, P406, DOI 10.1111/j.1423-0410.1994.tb01284.x; Nave RL, 2013, ANN EMERG MED, V62, p19A, DOI 10.1016/j.annemergmed.2013.10.013; Panda S, 2014, INT J STD AIDS, V25, P596, DOI 10.1177/0956462413515659; Petruzziello Arnolfo, 2018, Open Virol J, V12, P26, DOI 10.2174/1874357901812010026; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rajasekaran M, 2003, PUBLIC HEALTH, V117, P208, DOI 10.1016/S0033-3506(03)00065-9; Rehan HS, 2011, SAUDI J GASTROENTERO, V17, P241, DOI 10.4103/1319-3767.82576; Schietroma Ivan, 2018, Open Virol J, V12, P16, DOI 10.2174/1874357901812010016; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Singh Paramdeep, 2014, J Nat Sci Biol Med, V5, P56, DOI 10.4103/0976-9668.127288; Singh S, 2010, AIP CONF PROC, V1276, P37, DOI 10.1063/1.3504330; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sood A, 2002, Trop Gastroenterol, V23, P198; Sood A, 2017, J GASTROEN HEPATOL, V32, P894, DOI 10.1111/jgh.13628; Sood A, 2012, INDIAN J GASTROENTER, V31, P232, DOI 10.1007/s12664-012-0251-8; Strickland GT, 2010, J VIRAL HEPATITIS, V17, P305, DOI 10.1111/j.1365-2893.2010.01285.x; The Indian Express, 2017, WORLD HEP DAY PUNJ S; Wait S, 2016, LANCET GASTROENTEROL, V1, P248, DOI 10.1016/S2468-1253(16)30031-0; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; World Health Organization, 2016, COMB HEP B C REACH E	39	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200461	10.1371/journal.pone.0200461	http://dx.doi.org/10.1371/journal.pone.0200461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048454	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400008
J	Clahsen, H; Paulmann, S; Budd, MJ; Barry, C				Clahsen, Harald; Paulmann, Silke; Budd, Mary-Jane; Barry, Christopher			Morphological encoding beyond slots and fillers: An ERP study of comparative formation in English	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; LANGUAGE PRODUCTION; WORD PRODUCTION; PAST-TENSE; ELECTROPHYSIOLOGICAL EVIDENCE; COGNITIVE CONTROL; SINGLE WORD; TIME-COURSE; ADJECTIVES	One important organizational property of morphology is competition. Different means of expression are in conflict with each other for encoding the same grammatical function. In the current study, we examined the nature of this control mechanism by testing the formation of comparative adjectives in English during language production. Event-related brain potentials (ERPs) were recorded during cued silent production, the first study of this kind for comparative adjective formation. We specifically examined the ERP correlates of producing synthetic relative to analytic comparatives, e.g. angriervs. more angry. A frontal, bilaterally distributed, enhanced negative-going waveform for analytic comparatives (vis-a-vis synthetic ones) emerged approximately 300ms after the (silent) production cue. We argue that this ERP effect reflects a control mechanism that constrains grammatically-based computational processes (viz. more comparative formation). We also address the possibility that this particular ERP effect may belong to a family of previously observed negativities reflecting cognitive control monitoring, rather than morphological encoding processes per se.	[Clahsen, Harald] Univ Potsdam, PRIM, Potsdam, Germany; [Paulmann, Silke; Barry, Christopher] Univ Essex, Dept Psychol, Colchester, Essex, England; [Paulmann, Silke; Barry, Christopher] Univ Essex, Ctr Brain Sci, Colchester, Essex, England; [Budd, Mary-Jane] Univ East London, Sch Psychol, London, England	University of Potsdam; University of Essex; University of Essex; University of East London	Paulmann, S (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.; Paulmann, S (corresponding author), Univ Essex, Ctr Brain Sci, Colchester, Essex, England.	paulmann@essex.ac.uk		Clahsen, Harald/0000-0002-6190-1318; Budd, Mary-Jane/0000-0002-9964-7351	Leverhulme Trust [F/00213/U]; Alexander-von-Humboldt Professorship	Leverhulme Trust(Leverhulme Trust); Alexander-von-Humboldt Professorship(Alexander von Humboldt Foundation)	This project has been supported by a grant to H.C. and C.B. from the Leverhulme Trust (F/00213/U) and an Alexander-von-Humboldt Professorship to H.C.	Abutalebi J, 2016, BILING-LANG COGN, V19, P689, DOI 10.1017/S1366728916000225; Aronoff M., 2015, P 8 DEC TOUL CLLE ER, P1; Aronoff Mark, 2016, ATTI 47 C INT SOC LI, P39; Baayen R. H., 1993, CELEX LEXICAL DATA B; Barber C., 1964, LINGUISTIC CHANGE PR; Bolte J, 2010, NEUROSCI LETT, V469, P107, DOI 10.1016/j.neulet.2009.11.054; Bosch S, 2017, BILING-LANG COGN, V20, P435, DOI 10.1017/S1366728916000055; Boyd Jeremy Kenyon, 2007, COMPARATIVELY SPEAKI; Budd MJ, 2015, DEV COGN NEUROS-NETH, V12, P51, DOI 10.1016/j.dcn.2014.11.002; Budd MJ, 2013, BRAIN LANG, V127, P345, DOI 10.1016/j.bandl.2012.12.010; Burki A, 2016, COGNITION, V146, P90, DOI 10.1016/j.cognition.2015.09.002; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dunbar E, 2016, GLOSSA-UK, V1, DOI 10.5334/gjgl.9; Elston-Guttler KE, 2005, J COGNITIVE NEUROSCI, V17, P1593, DOI 10.1162/089892905774597245; Emonds Joseph., 1976, TRANSFORMATIONAL APP; Festman J, 2016, APPL PSYCHOLINGUIST, V37, P487, DOI 10.1017/S0142716415000089; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frank M, 1972, MODERN ENGLISH PRACT; Ganushchak LY, 2008, J COGNITIVE NEUROSCI, V20, P927, DOI 10.1162/jocn.2008.20514; GATHERCOLE VC, 1985, J EXP CHILD PSYCHOL, V40, P73, DOI 10.1016/0022-0965(85)90066-9; Giraudo H, 2000, LANG COGNITIVE PROC, V15, P421, DOI 10.1080/01690960050119652; Giraudo H, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01778; Graziano-King J, 2005, J CHILD LANG, V32, P345, DOI 10.1017/S0305000904006828; Graziano-King J., 2003, ENGLISH COMPARATIVES; Guo TM, 2011, NEUROIMAGE, V56, P2300, DOI 10.1016/j.neuroimage.2011.03.049; Hilpert M, 2008, ENGL LANG LINGUIST, V12, P395, DOI 10.1017/S1360674308002694; Hirschfeld G, 2008, NEUROREPORT, V19, P1227, DOI 10.1097/WNR.0b013e328309ecd1; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Janssen DP, 2002, LANG COGNITIVE PROC, V17, P209, DOI 10.1080/01690960143000182; Jessen A, 2017, J CHILD LANG, V44, P427, DOI 10.1017/S0305000916000118; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kunter G., 2015, NETWORDS, P32; LaFave N, 2015, U PENNSYLVANIA WORKI, V21, P1; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Lavric A, 2001, CLIN NEUROPHYSIOL, V112, P1833, DOI 10.1016/S1388-2457(01)00615-0; Leminen A, 2014, BRAIN RES, V1543, P223, DOI 10.1016/j.brainres.2013.10.038; Levy Y., LANGUAGE COMPETENCE, P323; Misra M, 2012, J MEM LANG, V67, P224, DOI 10.1016/j.jml.2012.05.001; Muller O, 2006, J COGNITIVE NEUROSCI, V18, P84, DOI 10.1162/089892906775249997; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S., 1999, WORDS RULES INGREDIE; Poser W., 1992, LEXICAL MATTERS, P111; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Runnqvist E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00379; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Scliffler NO, 2006, BRAIN RES, V1112, P201, DOI 10.1016/j.brainres.2006.07.027; Sierpowska J, 2015, BRAIN LANG, V142, P54, DOI 10.1016/j.bandl.2015.01.005; Spalek K, 2013, LANG COGNITIVE PROC, V28, P597, DOI 10.1080/01690965.2012.718088; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Verhoef K, 2009, COGNITION, V110, P84, DOI 10.1016/j.cognition.2008.10.013; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199897	10.1371/journal.pone.0199897	http://dx.doi.org/10.1371/journal.pone.0199897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044825	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000439942500022
J	Cornet, L; Meunier, L; Van Vlierberghe, M; Leonard, RR; Durieu, B; Lara, Y; Misztak, A; Sirjacobs, D; Javaux, EJ; Philippe, H; Wilmotte, A; Baurain, D				Cornet, Luc; Meunier, Loic; Van Vlierberghe, Mick; Leonard, Raphael R.; Durieu, Benoit; Lara, Yannick; Misztak, Agnieszka; Sirjacobs, Damien; Javaux, Emmanuelle J.; Philippe, Herve; Wilmotte, Annick; Baurain, Denis			Consensus assessment of the contamination level of publicly available cyanobacterial genomes	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MULTIPLE SEQUENCE ALIGNMENT; BACTERIAL DIVERSITY; EVOLUTION; ORIGIN; TOOL; QUANTIFICATION; ANNOTATION; CONSISTENT; QUALITY	Publicly available genomes are crucial for phylogenetic and metagenomic studies, in which contaminating sequences can be the cause of major problems. This issue is expected to be especially important for Cyanobacteria because axenic strains are notoriously difficult to obtain and keep in culture. Yet, despite their great scientific interest, no data are currently available concerning the quality of publicly available cyanobacterial genomes. As reliably detecting contaminants is a complex task, we designed a pipeline combining six methods in a consensus strategy to assess the contamination level of 440 genome assemblies of Cyanobacteria. Two methods are based on published reference databases of ribosomal genes (SSU rRNA 16S and ribosomal proteins), one is indirectly based on a reference database of marker genes (CheckM), and three are based on complete genome analysis. Among those genome-wide methods, Kraken and DIAMOND blastx share the same reference database that we derived from Ensembl Bacteria, whereas CONCOCT does not require any reference database, instead relying on differences in DNA tetramer frequencies. Given that all the six methods appear to have their own strengths and limitations, we used the consensus of their rankings to infer that >5% of cyanobacterial genome assemblies are highly contaminated by foreign DNA (i.e., contaminants were detected by 5 or 6 methods). Our results will help researchers to check the quality of publicly available genomic data before use in their own analyses. Moreover, we argue that journals should make mandatory the submission of raw read data along with genome assemblies in order to facilitate the detection of contaminants in sequence databases.	[Cornet, Luc; Meunier, Loic; Van Vlierberghe, Mick; Leonard, Raphael R.; Misztak, Agnieszka; Sirjacobs, Damien; Baurain, Denis] Univ Liege, InBioS PhytoSYST, Eukaryot Phylogen, Liege, Belgium; [Cornet, Luc; Javaux, Emmanuelle J.] Univ Liege, UR Geol Palaeobiogeol Palaeobot Palaeopalynol, Liege, Belgium; [Leonard, Raphael R.] Univ Liege, InBioS CIP, Macromol Crystallog, Liege, Belgium; [Durieu, Benoit; Lara, Yannick; Wilmotte, Annick] Univ Liege, Ctr Prot Engn, InBioS CIP, Liege, Belgium; [Misztak, Agnieszka] Intercollegiate Fac Biotechnol UG MUG, Gdansk, Poland; [Philippe, Herve] Ctr Biodivers Theory & Modelling, Moulis, France	University of Liege; University of Liege; University of Liege; University of Liege	Baurain, D (corresponding author), Univ Liege, InBioS PhytoSYST, Eukaryot Phylogen, Liege, Belgium.	denis.baurain@uliege.be	Baurain, Denis/S-4048-2019	Baurain, Denis/0000-0003-2388-6185; Cornet, Luc/0000-0002-3420-4488; Leonard, Raphael/0000-0003-3098-8876; Wilmotte, Annick/0000-0003-3546-3489; Misztak, Agnieszka/0000-0001-5977-3532	F.R.S.-FNRS (National Fund for Scientific Research of Belgium); European Research Council Stg ELITE [FP7/308074]; BELSPO project CCAMBIO [SD/BA/03A]; BELSPO Interuniversity Attraction Pole Planet TOPERS; TULIP Laboratory of Excellence [ANR-10-LABX-41]; Republic of Poland and Belgium (Federation Wallonie-Bruxelles); F.R.S.-FNRS [2.5020.11]; University of Liege "Credit de demarrage 2012" [SFRD-12/04]; F.R.S.-FNRS "Credit de recherche 2014" [CDR J.0080.15]	F.R.S.-FNRS (National Fund for Scientific Research of Belgium)(Fonds de la Recherche Scientifique - FNRS); European Research Council Stg ELITE(European Research Council (ERC)); BELSPO project CCAMBIO; BELSPO Interuniversity Attraction Pole Planet TOPERS; TULIP Laboratory of Excellence; Republic of Poland and Belgium (Federation Wallonie-Bruxelles); F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege "Credit de demarrage 2012"; F.R.S.-FNRS "Credit de recherche 2014"(Fonds de la Recherche Scientifique - FNRS)	This work was supported by operating funds from F.R.S.-FNRS (National Fund for Scientific Research of Belgium) (AW), the European Research Council Stg ELITE FP7/308074 (EJJ), the BELSPO project CCAMBIO (SD/BA/03A) (AW), the BELSPO Interuniversity Attraction Pole Planet TOPERS (EJJ and LC), and the TULIP Laboratory of Excellence (ANR-10-LABX-41) (HP). LC, LM, MVV, RRL and BD are all FRIA (Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture) fellows of the FRS-FNRS. AW is a Research Associate of the FRS-FNRS. AM's stay in University of Liege was partially financed by a bilateral cooperation [ARTHRO-ARN: Functional genomics-based approach for the design of genetic engineering tools in the edible cyanobacterium Arthrospira. Scientific and technical cooperation between Republic of Poland and Belgium (Federation Wallonie-Bruxelles) (2014-2016)]. Computational resources were provided by the Consortium des Equipements de Calcul Intensif (CECI), funded by the F.R.S.-FNRS (2.5020.11), and through two grants to DB (University of Liege "Credit de demarrage 2012" SFRD-12/04; F.R.S.-FNRS "Credit de recherche 2014" CDR J.0080.15).	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Alvarenga DO, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00809; Andam CP, 2011, FEMS MICROBIOL REV, V35, P756, DOI 10.1111/j.1574-6976.2011.00274.x; Ballenghien M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0366-6; Ben Hania W, 2017, ENVIRON MICROBIOL, V19, P1134, DOI 10.1111/1462-2920.13639; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Brown MW, 2018, GENOME BIOL EVOL, V10, P427, DOI 10.1093/gbe/evy014; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Christie-Oleza JA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.100; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; Darriba D, 2018, MOL BIOL EVOL, V35, P1037, DOI 10.1093/molbev/msy014; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Engene N, 2011, FOTTEA, V11, P17, DOI 10.5507/fot.2011.003; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jauffrit F, 2016, MOL BIOL EVOL, V33, P2170, DOI 10.1093/molbev/msw088; Lima ARJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01200-13; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan MA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1268-2; Khayrullina GA, 2012, CURR MED CHEM, V19, P5187, DOI 10.2174/092986712803530485; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klassen JL, 2009, J BACTERIOL, V191, P7500, DOI 10.1128/JB.01060-09; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Komarek J, 2016, EUR J PHYCOL, V51, P346, DOI 10.1080/09670262.2016.1163738; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kozlov AM, 2016, NUCLEIC ACIDS RES, V44, P5022, DOI 10.1093/nar/gkw396; Laczny CC, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0066-1; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laurin-Lemay S, 2012, CURR BIOL, V22, pR593, DOI 10.1016/j.cub.2012.06.013; Lee JZ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00061; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Lux M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1397-7; Manen JF, 2002, INT J SYST EVOL MICR, V52, P861, DOI [10.1099/ijs.0.01981-0, 10.1099/00207713-52-3-861]; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675; Mikalsen B, 2003, J BACTERIOL, V185, P2774, DOI 10.1128/JB.185.9.2774-2785.2003; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; de Alda JAGO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5937; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Paver SF, 2013, ENVIRON MICROBIOL, V15, P2489, DOI 10.1111/1462-2920.12131; Peeters K, 2012, POLAR BIOL, V35, P543, DOI 10.1007/s00300-011-1100-4; Philippe H, 2017, EUR J TAXON, V283, P1, DOI 10.5852/ejt.2017.283; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Ponce-Toledo RI, 2017, CURR BIOL, V27, P386, DOI 10.1016/j.cub.2016.11.056; Popa O, 2017, ISME J, V11, P543, DOI 10.1038/ismej.2016.116; Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Schierwater Bernd, 2009, Communicative & Integrative Biology, V2, P403; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simion P, 2017, CURR BIOL, V27, P958, DOI 10.1016/j.cub.2017.02.031; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuart RK, 2016, ISME J, V10, P1240, DOI 10.1038/ismej.2015.180; Tennessen K, 2016, ISME J, V10, P269, DOI 10.1038/ismej.2015.100; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Tooming-Klunderud A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-256; Vinh LS, 2004, MOL BIOL EVOL, V21, P1565, DOI 10.1093/molbev/msh176; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Whitton BA, 2012, ECOLOGY CYANOBACTERI, VII, P1, DOI [10.1007/978-94-007-3855-3_1, DOI 10.1007/978-94-007-3855-3_1]; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu YW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-26; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	80	23	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200323	10.1371/journal.pone.0200323	http://dx.doi.org/10.1371/journal.pone.0200323			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044797	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500042
J	Hoffmann, CJ; Milovanovic, M; Kinghorn, A; Kim, HY; Motlhaoleng, K; Martinson, NA; Variava, E				Hoffmann, Christopher J.; Milovanovic, Minja; Kinghorn, Anthony; Kim, Hae-Young; Motlhaoleng, Katlego; Martinson, Neil A.; Variava, Ebrahim			Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MIDDLE-INCOME COUNTRIES; OPTION B PLUS; ANTIRETROVIRAL THERAPY; INITIATION; IMPROVE; LINKAGE; TIME; METAANALYSIS; MOZAMBIQUE	Introduction Inefficient clinic-level delivery of HIV services is a barrier to linkage and engagement in care. We used value stream mapping to quantify time spent on each component of a clinic visit while receiving care following a hospital admission in South Africa. Methods We described time for each clinic service ("process time") and time spent waiting for that service ("lead time"). We also determined time and patient costs associated with travel to the clinic and expenditures during the clinic visits for 15 clinic visits in South Africa. Participants were selected consecutively based on timing of scheduled clinic visit from a cohort of HIV-positive patients recently discharged from inpatient hospital care. During the mapping we asked the participants to assess challenges faced at the clinic visit. We subsequently conducted in depth interviews and included themes from the care experience in this analysis. Results The 15 clinic visits occurred at five clinics; four primary care and one hospital-based specialty clinic. Nine (64%) of the participants were women, the median age was 44 years (IQR: 32-49), three of the participants had one or more clinic visit in the prior 14 days, all but one participant was on antiretroviral therapy (ART) at the time of the clinic visit (ART was stopped following the hospital visit for that participant). The median time since hospital discharge was 131 days (interquartile range; IQR: 121-183) for the observed visits. The median travel time to and from the clinic to a place of residence was 60 minutes. The median time spent at the clinic was 3.5 hours (IQR: 2.5-5.3) of which 2.9 hours was lead time and 25 minutes was process time (registration, vital signs, clinician assessment, laboratory, and check-out). The median patient cost for transport and food while at the clinic was ZAR43/USD2.8 (median monthly household income in the district was ZAR2450/USD157). Participants highlighted long queues, repeat clinic visits, and multiple queues during the visit (median of 5 queues) as challenges. Conclusions Accessing HIV care in South Africa is time consuming, complicated by multiple queues and frequent visits. A more patient-centered approach to care may decrease the burden of receiving care and improve outcomes.	[Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Hoffmann, Christopher J.; Kim, Hae-Young] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Milovanovic, Minja; Kinghorn, Anthony; Motlhaoleng, Katlego; Martinson, Neil A.] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp Complex, Dept Internal Med, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp, South Africa	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; University of Witwatersrand	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.; Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	choffmann@jhmi.edu	Variava, Ebrahim/AAO-5717-2020; Milovanovic, Minja/J-9832-2017	Variava, Ebrahim/0000-0003-2888-789X; Milovanovic, Minja/0000-0002-4654-8755; Hoffmann, Christopher/0000-0002-9422-0519	Johns Hopkins University Center for AIDS Research [P30AI094189]; Provincial Department of Health in North West; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research; Provincial Department of Health in North West; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Johns Hopkins University Center for AIDS Research (P30AI094189) through a faculty development award to Christopher J Hoffmann.; We express our appreciation to participants for agreeing to be part of the value stream mapping and for answering our questions, the Johns Hopkins University Center for AIDS Research (P30AI094189) for a Faculty Development Award, and the Provincial Department of Health in North West who approved our work in the public clinics. We also acknowledge the hard work and dedication of the study field team: Nkateko Makwarela, Hilda Mosia, and Tlhompho Gaoshebe.	Amolloh MM A, 2012, FACTORS ASS EARLY UP; Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Carter PM, 2012, ACAD EMERG MED, V19, P338, DOI 10.1111/j.1553-2712.2012.01311.x; Colebunders R, 2007, AIDS CARE, V19, P149, DOI 10.1080/09540120600762078; Cowan JF, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0249-6; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Franse CB, 2017, AIDS CARE, V29, P326, DOI 10.1080/09540121.2016.1220475; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hoffmann CJ, 2016, AIDS EDUC PREV, V28, P351, DOI 10.1521/aeap.2016.28.4.351; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Kwena ZA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19876; Layer EH, 2014, AIDS PATIENT CARE ST, V28, P483, DOI 10.1089/apc.2014.0077; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; MacKellar DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150086; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; Martin K., 2014, VALUE STREAM MAPPING; Monroe-Wise A, 2017, INT J STD AIDS, V28, P1410, DOI 10.1177/0956462417711624; Napua M, 2016, JAIDS-J ACQ IMM DEF, V72, pS181, DOI 10.1097/QAI.0000000000001061; Rother M, 2009, LEARNING SEE; Sherr K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-55; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Wagenaar BH, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31980; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wazimap, 2017, 2011 S AFR CENS DAT	28	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201032	10.1371/journal.pone.0201032	http://dx.doi.org/10.1371/journal.pone.0201032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040836	Green Submitted, Green Published, gold			2022-12-26	WOS:000439749200022
J	Junaidi, J; Kallenbach, CM; Byrne, PF; Fonte, SJ				Junaidi, Junaidi; Kallenbach, Cynthia M.; Byrne, Patrick F.; Fonte, Steven J.			Root traits and root biomass allocation impact how wheat genotypes respond to organic amendments and earthworms	PLOS ONE			English	Article							MICROBIAL BIOMASS; SOIL CARBON; NITROGEN AVAILABILITY; PLANT DOMESTICATION; CROP PLANTS; SYSTEMS; GROWTH; COMMUNITIES; BACTERIAL; NUTRIENT	Plant-soil biological interactions are increasingly recognized as a key feature of agroecosystems, promoting both crop and soil health. However, the effectiveness of plant-soil synergies is likely modulated by both root system characteristics and soil management impacts on soil biological communities. To successfully manage for plant-soil interactions, we need to better understand how crops respond to changes in soil management, especially in terms of belowground investment. Specifically, crop genotypes that exhibit reduced plasticity in root growth and investment may not be able to take full advantage of changes in soil biological activity associated with soil health promoting practices. We hypothesized that genotypes with greater belowground investment respond more, in terms of plant growth and crop nitrogen (N) uptake, to compost and earthworm additions, agronomic factors commonly associated with soil health. We evaluated four spring wheat (Triticum aestivum) genotypes with distinct breeding and environmental histories, and one progenitor of wheat (Aegilops tauschii) under low soil fertility conditions in the greenhouse for differences in belowground root biomass and architecture. We then determined how these below-ground traits influenced genotype response to additions of compost and earthworms. Measurements included plant growth, biomass, grain yield, root characteristics, plant N uptake, and soil N. Overall, in unamended soils, genotypes differed in above and below-ground phenotypic traits. In general, Ae. tauschii had three times greater root: shoot (R:S) ratio, root length, and root biomass relative to wheat genotypes. We found that genotypes with higher R:S ratios responded more positively to compost additions compared to those with lower R:S ratios, particularly in terms of plant aboveground biomass, N uptake and soil N-cycling, and also exhibited greater plasticity in root morphology. Consequently, while higher R:S genotypes had relatively poorer yields in unamended soils, they outperformed lower R:S genotypes in total seed weight under compost treatments. Our findings suggest that genotypes with greater belowground investment may be better able to take advantage of soil health promoting practices, such as the use of organic amendments. These results highlight the need to consider soil management practices (and associated biological communities) in parallel with root phenotypic plasticity when evaluating wheat lines for improvements in plant-soil synergies.	[Junaidi, Junaidi; Kallenbach, Cynthia M.; Byrne, Patrick F.; Fonte, Steven J.] Colorado State Univ, Soil & Crop Sci Dept, Ft Collins, CO 80523 USA; [Junaidi, Junaidi] Indonesian Rubber Res Inst, Bogor, Jawa Barat, Indonesia	Colorado State University; Riset Perkebunan Nusantara; Indonesian Rubber Research Institute (IRRI)	Kallenbach, CM (corresponding author), Colorado State Univ, Soil & Crop Sci Dept, Ft Collins, CO 80523 USA.	kallenbachcm@gmail.com	Junaidi, Junaidi/U-7915-2019; Byrne, Patrick/AFP-4228-2022; , Junaidi/AAX-2747-2020	Junaidi, Junaidi/0000-0002-4968-5528; Byrne, Patrick/0000-0003-0173-3161; , Junaidi/0000-0003-2294-040X; Fonte, Steven/0000-0002-3727-2304	Institute of International Education as a Fulbright Scholarship; Department of Soil and Crop Sciences at Colorado State University	Institute of International Education as a Fulbright Scholarship; Department of Soil and Crop Sciences at Colorado State University	Funding and support for this work was provided to JJ by the Institute of International Education as a Fulbright Scholarship and to SJF from the Department of Soil and Crop Sciences at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2017, SCI HORTIC-AMSTERDAM, V216, P256, DOI 10.1016/j.scienta.2017.01.019; Araujo Y, 2004, BIOL FERT SOILS, V39, P146, DOI 10.1007/s00374-003-0696-0; Awad W, 2018, AGRON J; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baldi E, 2013, PLANT SOIL ENVIRON, V59, P221, DOI 10.17221/857/2012-PSE; Bardgett RD, 2014, TRENDS ECOL EVOL, V29, P692, DOI 10.1016/j.tree.2014.10.006; Becker SR, 2016, EUPHYTICA, V207, P213, DOI 10.1007/s10681-015-1574-1; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Bernard L, 2012, ISME J, V6, P213, DOI 10.1038/ismej.2011.87; Binet F, 1998, BIOL FERT SOILS, V27, P79, DOI 10.1007/s003740050403; Bossuyt H, 2004, EUR J SOIL SCI, V55, P393, DOI 10.1111/j.1351-0754.2004.00603.x; Brown GG, 2000, EUR J SOIL BIOL, V36, P177, DOI 10.1016/S1164-5563(00)01062-1; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Celik I, 2004, SOIL TILL RES, V78, P59, DOI 10.1016/j.still.2004.02.012; CGIAR WHEAT, 2014, CGIAR WHEAT 2013 ANN; Chaparro JM, 2012, BIOL FERT SOILS, V48, P1; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Clark JA, 1922, FARMERS B, V1301-1325, P3; Costa C, 2001, CAN J BOT, V79, P23, DOI 10.1139/cjb-79-1-23; de Graaff MA, 2013, SOIL BIOL BIOCHEM, V58, P198, DOI 10.1016/j.soilbio.2012.11.015; de Vries FT, 2017, J ECOL, V105, P913, DOI 10.1111/1365-2745.12783; de Vries FT, 2012, FRONT ECOL ENVIRON, V10, P425, DOI 10.1890/110162; Dijkstra FA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00216; Eriksen-Hamel NS, 2008, SOIL BIOL BIOCHEM, V40, P1004, DOI 10.1016/j.soilbio.2007.11.013; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Fess TL, 2011, SUSTAINABILITY-BASEL, V3, P1742, DOI 10.3390/su3101742; Fonte SJ, 2007, SOIL BIOL BIOCHEM, V39, P1014, DOI 10.1016/j.soilbio.2006.11.011; Fonte SJ, 2012, PLANT SOIL, V359, P205, DOI 10.1007/s11104-012-1199-2; Gardner JB, 2009, ECOL APPL, V19, P2167, DOI 10.1890/08-1122.1; Gaudin ACM, 2011, CROP SCI, V51, P2780, DOI 10.2135/cropsci2010.12.0686; Genesys, ACC PROF TA2374; Gioia T, 2015, J EXP BOT, V66, P5519, DOI 10.1093/jxb/erv289; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Grossman JD, 2012, EVOL APPL, V5, P850, DOI 10.1111/j.1752-4571.2012.00263.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Halvorson AD, 2015, AGRON J, V107, P1504, DOI 10.2134/agronj15.0074; HETRICK BAD, 1995, CAN J BOT, V73, P891, DOI 10.1139/b95-097; Iannucci A, 2017, FRONT PLANT SCI, P8; Inselsbacher E, 2010, SOIL BIOL BIOCHEM, V42, P360, DOI 10.1016/j.soilbio.2009.11.019; Jackson LE, 2012, CURR OPIN ENV SUST, V4, P517, DOI 10.1016/j.cosust.2012.08.003; Jain N, 2014, CEREAL RES COMMUN, V42, P426, DOI 10.1556/CRC.42.2014.3.6; Kallenbach C, 2011, AGR ECOSYST ENVIRON, V144, P241, DOI 10.1016/j.agee.2011.08.020; KAPULNIK Y, 1991, EUPHYTICA, V56, P27; Kell DB, 2011, ANN BOT-LONDON, V108, P407, DOI 10.1093/aob/mcr175; Kimball S, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1602; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; Lanning SP, 2012, CROP SCI, V52, P1145, DOI 10.2135/cropsci2011.11.0625; Lanning SP, 2000, CROP SCI, V40, P861; Leff JW, 2017, NEW PHYTOL, V214, P412, DOI 10.1111/nph.14323; Litvinenko M., 2001, WORLD WHEAT BOOK HIS, P351; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Martin-Robles N, 2018, NEW PHYTOL, V218, P322, DOI 10.1111/nph.14962; Mason HE, 2006, CAN J PLANT SCI, V86, P333, DOI 10.4141/P05-051; McCormack ML, 2015, NEW PHYTOL, V207, P505, DOI 10.1111/nph.13363; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Milla R, 2015, TRENDS ECOL EVOL, V30, P463, DOI 10.1016/j.tree.2015.06.006; Morris CF, 2001, CROP SCI, V41, P218, DOI 10.2135/cropsci2001.411218x; Muller A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01410-w; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Nie M, 2016, AGR ECOSYST ENVIRON, V224, P50, DOI 10.1016/j.agee.2016.03.032; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; Paez-Garcia Ana, 2015, Plants-Basel, V4, P334, DOI 10.3390/plants4020334; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Piovanelli C, 2006, SOIL TILL RES, V90, P84, DOI 10.1016/j.still.2005.08.013; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; Powlson DS, 2011, FOOD POLICY, V36, pS72, DOI 10.1016/j.foodpol.2010.11.025; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Reynolds John Warren, 2011, Megadrilogica, V14, P159; SATTELMACHER B, 1994, Z PFLANZ BODENKUNDE, V157, P215, DOI 10.1002/jpln.19941570309; Schmidtke J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00678; Schultz MJ, 2008, THESIS; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Soudzilovskaia NA, 2013, P NATL ACAD SCI USA, V110, P18180, DOI 10.1073/pnas.1310700110; Speratti AB, 2008, APPL SOIL ECOL, V38, P27, DOI 10.1016/j.apsoil.2007.08.009; Symko S., 2002, SINGLE SEED TRACING; Szoboszlay M, 2015, SOIL BIOL BIOCHEM, V80, P34, DOI 10.1016/j.soilbio.2014.09.001; van Bueren ETL, 2011, NJAS-WAGEN J LIFE SC, V58, P193, DOI 10.1016/j.njas.2010.04.001; van Groenigen JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06365; Verbon EH, 2016, TRENDS PLANT SCI, V21, P218, DOI 10.1016/j.tplants.2016.01.013; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Wallenstein MD, 2017, RHIZOSPHERE-NETH, V3, P230, DOI 10.1016/j.rhisph.2017.04.004; Willer H, 2021, WORLD ORGANIC AGR ST; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Wu MN, 2011, BIOL FERT SOILS, V47, P397, DOI 10.1007/s00374-010-0535-z; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhu B, 2014, SOIL BIOL BIOCHEM, V76, P183, DOI 10.1016/j.soilbio.2014.04.033; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	91	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200646	10.1371/journal.pone.0200646	http://dx.doi.org/10.1371/journal.pone.0200646			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040842	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200007
J	Barrera, N; Guerrero, L; Debut, A; Santa-Cruz, P				Barrera, Nicole; Guerrero, Lizeth; Debut, Alexis; Santa-Cruz, Petrus			Printable nanocomposites of polymers and silver nanoparticles for antibacterial devices produced by DoD technology	PLOS ONE			English	Article							ARTEMIA-FRANCISCANA; TOXICITY; RESISTANCE	Silver nanoparticles (Ag-NPs) are known for their efficient bactericidal activity and are widely used in industry. This study aims to produce printable antibacterial devices by drop-ondemand (DoD) inkjet technology, using Ag-NPs as the active part in complex printable fluids. The synthesis of this active part is described using two methods to obtain monodisperse NPs: chemical and microwave irradiation. The synthesized NPs were characterized by UV-VIS, STEM, TEM, DLS and XRD. Two printable fluids were produced based: one with Ag-NPs and a second one, a polymeric nanocomposite, using silver nanoparticles and polyvinyl butyral (Ag-NPs/PVB). Cellulose acetate was used as a flexible substrate. The ecotoxicity analysis of fluids and substrate was performed with Artemia franciscana nauplii. Optimized electric pulse waveforms for drop formation of the functional fluids were obtained for the piezoelectric-based DoD printing. Activity of printed antibacterial devices was evaluated using the Kirby-Bauer method with Staphylococcus aureus and Escherichia coll. The results show that the printed device with Ag-NP fluids evidenced a bacterial inhibition. An important advantage in using the DoD process is the possibility of printing, layer by layer or side by side, more than one active principle, allowing an interleaved or simultaneous release of silver NP and other molecules of interest as for example with a second functional fluid to ensure effectiveness of Ag activity.	[Barrera, Nicole; Guerrero, Lizeth; Debut, Alexis] Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador; [Barrera, Nicole; Guerrero, Lizeth; Santa-Cruz, Petrus] Univ Fed Pernambuco UFPE, Dept Quim Fundamental, Recife, PE, Brazil	Escuela Politecnica Superior del Ejercito; Universidade Federal de Pernambuco	Debut, A (corresponding author), Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador.	apdebut@espe.edu.ec	Barrera, Nicole/Y-1879-2019; Santa-Cruz, Petrus/C-7413-2011; Debut, Alexis/H-8424-2019	Barrera, Nicole/0000-0002-8377-5092; Santa-Cruz, Petrus/0000-0003-2475-7764; Debut, Alexis/0000-0002-8269-7619	"Laboratorio de Arquitetura de Nanodispositivos Fotonicos e Bioinspirados" LANDFOTON-UFPE (Recife-Brazil) Group; FINEP (CT-HIDRO/NAMICRO); CNPq; FACEPE; CAPES [36]; CENCINAT "Centro de Nanociencia y Nanotecnologia" (Quito-Ecuador)	"Laboratorio de Arquitetura de Nanodispositivos Fotonicos e Bioinspirados" LANDFOTON-UFPE (Recife-Brazil) Group; FINEP (CT-HIDRO/NAMICRO); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CENCINAT "Centro de Nanociencia y Nanotecnologia" (Quito-Ecuador)	This work was funded by the "Laboratorio de Arquitetura de Nanodispositivos Fotonicos e Bioinspirados" LANDFOTON-UFPE (Recife-Brazil) Group, supported by the Brazilian Research Agencies FINEP (CT-HIDRO/NAMICRO), CNPq, FACEPE, and CAPES (Nanobiotec-Brasil Network 36), for the financing of the project carried out, the CETENE Research Center (MCTIC) and the CENCINAT "Centro de Nanociencia y Nanotecnologia" (Quito-Ecuador), for their research support in the characterization of the nanoparticles (PS-C).	Abbasi E, 2016, CRIT REV MICROBIOL, V42, P173, DOI 10.3109/1040841X.2014.912200; Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; Amutha M, 2014, J NANOTECHNOL, V2014, DOI 10.1155/2014/860875; Arroyo CR, 2016, BIOL MED, V8; Assis M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19270-9; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Belluco S, 2018, CRIT REV FOOD SCI, V58, P1084, DOI 10.1080/10408398.2016.1237468; Bergami E, 2017, AQUAT TOXICOL, V189, P159, DOI 10.1016/j.aquatox.2017.06.008; Bergami E, 2016, ECOTOX ENVIRON SAFE, V123, P18, DOI 10.1016/j.ecoenv.2015.09.021; Biswas K.R.P., 2015, INT J RECENT SCI RES, V6, P5880; Borroto Janetsy, 2011, Rev Cubana Plant Med, V16, P34; Callister WD, 2018, MAT SCI ENG INTRO, V9; Cao H., 2017, SILVER NANOPARTICLES; Chinnasamy A, 2014, SCI WORLD J, P1, DOI [10.1155/2014/256919, DOI 10.1155/2014/256919]; de Sa GF, 2000, COORDIN CHEM REV, V196, P165, DOI 10.1016/S0010-8545(99)00054-5; Dell'Erba IE, 2017, LANGMUIR, V33, P10248, DOI 10.1021/acs.langmuir.7b01936; FAO, 2017, GEN RES MICR CURR PO; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gameiro CG, 1999, MATER SCI FORUM, V315-3, P249, DOI 10.4028/www.scientific.net/MSF.315-317.249; Hadjispyrou S, 2001, ECOTOX ENVIRON SAFE, V49, P179, DOI 10.1006/eesa.2001.2059; Hong XS, 2016, ENVIRON SCI POLLUT R, V23, P4489, DOI 10.1007/s11356-015-5668-z; Icten E, 2016, AAPS PHARMSCITECH, V17, P284, DOI 10.1208/s12249-015-0348-3; Kaweeteerawat C, 2017, J TOXICOL ENV HEAL A, V80, P1276, DOI 10.1080/15287394.2017.1376727; Kumar B, 2016, BIONANOSCIENCE, V6, P15, DOI 10.1007/s12668-016-0193-1; Kumar B, 2016, SYNTH REACT INORG M, V46, P1265, DOI 10.1080/15533174.2015.1004451; Lopes NA, 2018, CRIT REV FOOD SCI, V58, P2202, DOI 10.1080/10408398.2017.1308915; Malegowd G, 2015, INT J BIOL MACROMOL, DOI [10.1016/j.ijbiomac.2015.12.026, DOI 10.1016/J.IJBIOMAC.2015.12.026]; Marslin G, 2017, INT J NANO MED, V10, P5955; Mehr FP, 2015, ORIENT J CHEM, V31, P1831; Mishra Y.K., 2018, MAT TODAY; Mogensen KB, 2014, J PHYS CHEM C, V118, P28075, DOI 10.1021/jp505632n; Naranjo LP, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2143135; Naser MN, 2016, J ENVIRON SCI ENG, V5, P261; Ng WL, 2017, MATERIALS, V10, DOI 10.3390/ma10020190; Panacek A, 2018, NAT NANOTECHNOL, V13, P65, DOI 10.1038/s41565-017-0013-y; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Podolsky SH, 2015, EMERG INFECT DIS, V21, P1093, DOI [10.3201/eid2106.150212, DOI 10.3201/EID2106.150212]; Poulose S, 2014, J NANOSCI NANOTECHNO, V14, P2038, DOI 10.1166/jnn.2014.9019; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Pradeep T., 2012, TXB NANOSCIENCE NANO, P887; Pulit-Prociak J, 2016, OPEN CHEM, V14, P76, DOI 10.1515/chem-2016-0005; Quirino W, 2011, SYNTHETIC MET, V161, P964, DOI 10.1016/j.synthmet.2011.03.001; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rajabi S, 2015, DARU, V23, DOI 10.1186/s40199-015-0105-x; Ramesh S, 2016, BIOMATER SCI-UK, V4, P1713, DOI 10.1039/c6bm00688d; Ranoszek-Soliwoda K, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-017-3973-9; Santa-Cruz PA, 2016, Patent BR, Patent No. 1020160184355; Santa-Cruz PA, 2004, BR Patent, Patent No. [PI 0403087-7, 0403087]; Schneider R, 2017, RSC ADV, V7, P41479, DOI 10.1039/c7ra07434d; Sousa FLN, 2016, MATER RES EXPRESS, V3, DOI 10.1088/2053-1591/3/4/045701; Souza F. Z., 2015, THESIS; Thakur NS, 2017, BIOINSPIRED SYNTHESI, P11; Valenti LE, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-017-3860-4; Velasco S. J., 2016, INT J FISHERIES AQUA, V3, P247; Velayudhannair Krishnakumar, 2017, International Journal of Aquatic Biology-IJAB, V5, P246, DOI 10.22034/ijab.v5i4.316; Wolny-Koladka KA, 2017, MICRO NANO LETT, V12, P772, DOI 10.1049/mnl.2017.0129	56	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200918	10.1371/journal.pone.0200918	http://dx.doi.org/10.1371/journal.pone.0200918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024925	Green Submitted, gold, Green Published			2022-12-26	WOS:000439120000067
J	Chagnon, M; O'Loughlin, J; Engert, JC; Karp, I; Sylvestre, MP				Chagnon, Miguel; O'Loughlin, Jennifer; Engert, James C.; Karp, Igor; Sylvestre, Marie-Pierre			Missing single nucleotide polymorphisms in Genetic Risk Scores: A simulation study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENOTYPE IMPUTATION; ASSOCIATION; PREDICTION	Using a genetic risk score (GRS) to predict a phenotype in a target sample can be complicated by missing data on the single nucleotide polymorphisms (SNPs) that comprise the GRS. This is usually addressed by imputation, omission of the SNPs or by replacing the missing SNPs with proxy SNPs. To assess the impact of the omission and proxy approaches on effect size estimation and predictive ability of weighted and unweighted GRS with small numbers of SNPs, we simulated a dichotomous phenotype conditional on real genotype data. We considered scenarios in which the proportion of missing SNPs ranged from 20-70%. We assessed the impact of omitting or replacing missing SNPs on the association between the GRS and phenotype, the corresponding statistical power and the area under the receiver operating curve. Omission resulted in a larger bias towards the null value of the effect size, a smaller predictive ability and greater loss of statistical power than proxy approaches. The predictive ability of a weighted GRS that includes SNPs with large weights depends of the availability of these large-weight SNPs.	[Chagnon, Miguel; O'Loughlin, Jennifer; Sylvestre, Marie-Pierre] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada; [Chagnon, Miguel; O'Loughlin, Jennifer; Karp, Igor; Sylvestre, Marie-Pierre] Univ Montreal, Sch Publ Hlth, Dept Social & Prevent Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Karp, Igor] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University; Western University (University of Western Ontario)	Sylvestre, MP (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada.; Sylvestre, MP (corresponding author), Univ Montreal, Sch Publ Hlth, Dept Social & Prevent Med, Montreal, PQ, Canada.	marie-pierre.sylvestre@umontreal.ca	Sylvestre, Marie-Pierre/CAF-5219-2022; Chagnon, Miguel/ABB-6996-2020	Sylvestre, Marie-Pierre/0000-0001-5803-4615; Chagnon, Miguel/0000-0002-2291-9566; Engert, James/0000-0001-8411-4790	Fonds de Recherche du Quebec (FRSQ) [32123]	Fonds de Recherche du Quebec (FRSQ)	This work was supported by Fonds de Recherche du Quebec (FRSQ), URL: http://www.frqs.gouv.qc.ca. Grant number: 32123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2009, EUR J EPIDEMIOL, V24, P585, DOI 10.1007/s10654-009-9387-y; Arabkhazaeli A, 2018, PEDIAT ALLERG IMM-UK, V29, P72, DOI 10.1111/pai.12824; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Beaney KE, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0457-7; Belsky DW, 2013, JAMA PSYCHIAT, V70, P534, DOI 10.1001/jamapsychiatry.2013.736; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dudbridge F, 2016, GENET EPIDEMIOL, V40, P268, DOI 10.1002/gepi.21966; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Goldstein BA, 2015, GENET EPIDEMIOL, V39, P439, DOI 10.1002/gepi.21912; Gottsater M, 2018, J HYPERTENS, V36, P809, DOI 10.1097/HJH.0000000000001646; Halperin E, 2009, NAT BIOTECHNOL, V27, P349, DOI 10.1038/nbt0409-349; Hung CF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0334-3; Iwasaki M, 2017, CANCER PREV RES, V10, P535, DOI 10.1158/1940-6207.CAPR-17-0141; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Labos C, 2015, ATHEROSCLEROSIS, V242, P261, DOI 10.1016/j.atherosclerosis.2015.07.029; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reddon H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18672; Smith CJ, 2016, AM J HYPERTENS, V29, P17, DOI 10.1093/ajh/hpv069; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; WATSON JD, 1990, JAMA-J AM MED ASSOC, V263, P3322, DOI 10.1001/jama.263.24.3322; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200630	10.1371/journal.pone.0200630	http://dx.doi.org/10.1371/journal.pone.0200630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024900	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000036
J	Corp, N; Jordan, JL; Croft, PR				Corp, Nadia; Jordan, Joanne L.; Croft, Peter R.			Justifications for using complementary and alternative medicine reported by persons with musculoskeletal conditions: A narrative literature synthesis	PLOS ONE			English	Article							LOW-BACK-PAIN; HEALTH-CARE; RHEUMATOID-ARTHRITIS; PATIENTS PERCEPTIONS; GENERAL-POPULATION; CHINESE IMMIGRANTS; TELEPHONE SURVEY; NATIONAL-SURVEY; THERAPIES; SATISFACTION	Background Complementary and alternative medicine (CAM) is very popular with patients frequently combining it with orthodox health care. The high prevalence of CAM use and satisfaction with CAM reported by patients directly challenges an orthodox system that can only approve such use if it results from the application of biomedical concepts and science. Studies highlighting this as a cultural, sociological and historical phenomenon emphasise the value of choice for consumers of health care. Musculoskeletal conditions typify common problems for which the effectiveness of orthodox care is often unclear. We postulated that the reasons people give for using or not using CAM for musculoskeletal conditions, would therefore indicate the full range of expectations that people have of health care. Furthermore, these reasons would indicate how much people feel orthodox health care is or is not meeting their expectations. Therefore, this study aims to investigate people's reasons for choosing or avoiding CAM for non-traumatic musculoskeletal conditions. Methods A systematic search and narrative synthesis was conducted of published qualitative and quantitative studies related to CAM and non-traumatic musculoskeletal conditions. Results We identified 169 relevant papers detailing 152 separate studies, from which 1486 justifications were extracted concerning CAM use. Content analysis resulted in 11 distinct categories across four themes: practical aspects of care, clinical effectiveness, non-clinical outcomes of care, and a person's philosophy of illness and care. People provided similar rationales for both using and avoiding CAM, emphasising that, whilst CAM is perceived by many patients with musculoskeletal conditions to fill gaps in care (such as practitioner time or quality of the therapeutic relationship), orthodox care also seeks to deliver these aspects of care. However, people who used CAM also highlighted its alignment with their general philosophy and ideas about illness and health care, and often emphasised CAM's capacity to give them control over their condition and its treatment. Conclusion Currently, CAM appears to have a significant role for patients with common painful long-term conditions in providing choices to enable individual needs to be met.	[Corp, Nadia; Jordan, Joanne L.; Croft, Peter R.] Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England	Keele University	Corp, N (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England.	n.corp@keele.ac.uk	Corp, Nadia/N-3498-2019; Corp, Nadia/G-8618-2012; Jordan, Joanne/E-8186-2014	Corp, Nadia/0000-0002-6758-9513; Jordan, Joanne/0000-0002-7191-2977	Arthritis Research UK Strategic Award	Arthritis Research UK Strategic Award	The literature searches and synthesis were supported by an Arthritis Research UK Strategic Award (http://www.arthritisresearchuk.org/) awarded to PRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot N. C., 1997, FORSCH KOMPLEMENTMED, V4, P164, DOI [10.1159/000210318, DOI 10.1159/000210318]; Afari N, 1999, INTEGR MED, V2, P97; Alami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019634; Arcury TA, 1999, AM J HEALTH PROMOT, V14, P7, DOI 10.4278/0890-1171-14.1.7; Artus M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-26; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Augello JDB, 2002, THESIS; Barcan R, 2011, COMPLEMENTARY ALTERN; Barnes PM, 2008, 12 CDC NAT HLTH STAT; Barrett B, 2003, J ALTERN COMPLEM MED, V9, P937, DOI 10.1089/107555303771952271; Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Bishop FL, 2008, AM J PUBLIC HEALTH, V98, P1700, DOI 10.2105/AJPH.2007.110072; Bishop FL, 2007, J HEALTH PSYCHOL, V12, P851, DOI 10.1177/1359105307082447; Bishop FL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-129; Bivins R., 2007, ALTERNATIVE MED HIST; BLACK C, 2009, ASSESSING COMPLEMENT; Bovey M, 2005, J ALTERN COMPLEM MED, V11, P293, DOI 10.1089/acm.2005.11.293; Braunack-Mayer A, 2009, BRIT J GEN PRACT, V59, P478, DOI 10.3399/bjgp09X453495; Brown M, 2010, DISABIL REHABIL, V32, P1645, DOI 10.3109/09638281003649896; Bucker B, 2008, GESUNDHEITSWESEN, V70, P559, DOI 10.1055/s-2008-1081505; Calnan M, 2006, FAM PRACT, V23, P91, DOI 10.1093/fampra/cmi077; Candib L. M, 2004, FAMILIES SYSTEMS HLT, V22, P139; Caspi O, 2004, MED DECIS MAKING, V24, P64, DOI 10.1177/0272989X03261567; Cassidy CM, 1998, J ALTERN COMPLEM MED, V4, P17, DOI 10.1089/acm.1998.4.1-17; Chambers S, 2008, LUPUS, V17, P761, DOI 10.1177/0961203308089404; Chan HK., 2002, HONG KONG NURSING J, V38, P7; Chaudhry SI, 2013, JAMA INTERN MED, V173, P1534, DOI 10.1001/jamainternmed.2013.8732; Choi Y., 2002, REPRESENTATION COPIN; DARZI A, 2007, OUR NHS OUR FUTURE; DeBar LL, 2003, J OROFAC PAIN, V17, P224; Dessio W, 2004, ETHNIC DIS, V14, P189; Dewar AL, 2009, CHRONIC DIS CAN, V29, P162; Dimmock S, 1996, CLIN RHEUMATOL, V15, P478, DOI 10.1007/BF02229645; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; Elder NC, 1997, ARCH FAM MED, V6, P181, DOI 10.1001/archfami.6.2.181; Erickson BE, 2007, J ALTERN COMPLEM MED, V13, P375, DOI 10.1089/acm.2006.6213; Figaro MK, 2004, HEALTH PSYCHOL, V23, P324, DOI 10.1037/0278-6133.23.3.324; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gale N, 2014, SOCIOL COMPASS, V8, P805, DOI 10.1111/soc4.12182; Gerrits MMJG, 2014, PAIN, V155, P53, DOI 10.1016/j.pain.2013.09.005; Goldstein MS, 1998, ALTERN THER HEALTH M, V4, P60; GRAY D, 1985, SOC SCI MED, V21, P507, DOI 10.1016/0277-9536(85)90034-6; Hasan Shahzad S., 2010, Journal of Pharmacy Practice and Research, V40, P294; Haslam D, 2004, INNER CONSULTATION D; Herman Carla J, 2004, Prev Chronic Dis, V1, pA12; Ho KY, 2009, PAIN PHYSICIAN, V12, P685; Howell S L, 1994, Nurse Pract Forum, V5, P98; Ikuyama S, 2009, MOD RHEUMATOL, V19, P253, DOI 10.1007/s10165-009-0156-2; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kim C, 1998, ARCH INTERN MED, V158, P2245, DOI 10.1001/archinte.158.20.2245; Kleinman A., 1980, PATIENTS HEALERS CON; la Cour P, 2008, JCR-J CLIN RHEUMATOL, V14, P332, DOI 10.1097/RHU.0b013e31817a7e1f; Lam TP, 2001, J EPIDEMIOL COMMUN H, V55, P762, DOI 10.1136/jech.55.10.762; Lewis D, 2001, J ALTERN COMPLEM MED, V7, P681, DOI 10.1089/10755530152755234; Liberati A, 2009, PLOS MED, V9; Lim ASH, 1999, PSYCHOL HEALTH, V14, P965; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; Ma GX, 1999, J COMMUN HEALTH, V24, P421, DOI 10.1023/A:1018742505785; Marsh J, 2009, CLIN ORTHOP RELAT R, V467, P2705, DOI 10.1007/s11999-009-0764-3; Mitzdorf U, 1999, J ALTERN COMPLEM MED, V5, P463, DOI 10.1089/acm.1999.5.463; Natural Therapy Pages UK, ALT MED FIND COMPL T; Nayak S, 2001, J Spinal Cord Med, V24, P54; Palinkas LA, 2000, J FAM PRACTICE, V49, P1121; Paskins Z, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-195; Paterson C, 2004, J ALTERN COMPLEM MED, V10, P791; Paterson C, 1999, BRIT J GEN PRACT, V49, P626; Peleg R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-36; Peters D, 2001, ONLINE J RURAL NURS, V2; Popay J., 2006, GUIDANCE CONDUCT NAR; PORTER R, 1985, THEOR SOC, V14, P175, DOI 10.1007/BF00157532; Qidwai Waris, 2003, J Ayub Med Coll Abbottabad, V15, P33; Randall C, 1999, Complement Ther Med, V7, P126, DOI 10.1016/S0965-2299(99)80119-8; Rao JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P619, DOI 10.1002/art.11377; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; Rao JK, 1998, ARTHRIT CARE RES, V11, P253, DOI 10.1002/art.1790110406; Rose G, 2006, MUSCULOSKELET CARE, V4, P101, DOI 10.1002/msc.82; Shah SFUH, 2010, J PAK MED ASSOC, V60, P667; Sharples FMC, 2003, COMPLEMENT THER MED, V11, P243, DOI 10.1016/S0965-2299(03)00107-9; Shmueli A, 2006, EVID-BASED COMPL ALT, V3, P273, DOI 10.1093/ecam/nel009; Shumay DM, 2001, J FAM PRACTICE, V50, P1097; Simpson N, 2001, BRIT J GEN PRACT, V51, P914; Skelton AM, 1996, BRIT J GEN PRACT, V46, P153; Smith JM, 2009, COMPLEMENT THER MED, V17, P281, DOI 10.1016/j.ctim.2009.07.001; Soler JK, 2012, FAM PRACT, V29, P272, DOI 10.1093/fampra/cmr101; Strutt R, 2008, MANUAL THER, V13, P456, DOI 10.1016/j.math.2007.05.013; Thomas K, 2004, J PUBLIC HEALTH, V26, P152, DOI 10.1093/pubmed/fdh139; US National Collaboration on Complementary and Alternative Medicine, 2008, COMPL ALT INT HLTH W; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; von Peter S, 2002, CEPHALALGIA, V22, P395, DOI 10.1046/j.1468-2982.2002.00376.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wieland LS, 2011, ALTERN THER HEALTH M, V17, P50; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; Young AE, 2011, PAIN, V152, P204, DOI 10.1016/j.pain.2010.10.033; Zhang JJ, 2002, SOC SCI MED, V55, P1795, DOI 10.1016/S0277-9536(01)00311-2	94	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200879	10.1371/journal.pone.0200879	http://dx.doi.org/10.1371/journal.pone.0200879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024952	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000439120000063
J	Hunt, D; Drake, LA; Drake, JR				Hunt, Danielle; Drake, Lisa A.; Drake, James R.			Murine macrophage TLR2-Fc gamma R synergy via Fc gamma R licensing of IL-6 cytokine mRNA ribosome binding and translation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; FRANCISELLA-TULARENSIS; DENDRITIC CELLS; IN-VIVO; CROSS-TALK; IMMUNE-RESPONSES; ACTIVATION; PROTECTION; VACCINE; VITRO	Macrophages (Mempty sets) are sentinels of the immune system that use pattern recognition receptors such as Toll-like receptors (TLR) to detect invading pathogens and immune receptors such as Fc gamma R to sense the host's immune state. Crosstalk between these two signaling pathways allows the Mempty set to tailor the cell's overall response to prevailing conditions. However, the molecular mechanisms underlying TLR-Fc gamma R crosstalk are only partially understood. Therefore, we employed an immunologically-relevant Mempty set stimulus, an inactivated gram-negative (b) under bar acterium that bears (TLR2) under bar agonists but no TLR4 agonist (iB(TLR2)) opsonized with a monoclonal antibody (mAb-iB(TLR2)), as a tool to study Fc gamma R regulation of TLR2-driven production of IL-6, a key inflammatory cytokine. We chose this particular agonist as an investigational tool because Mempty set production of any detectable IL-6 in response to mAbiBTLR2 requires both TLR2 and Fc gamma R signaling, making it an excellent system for the study of receptor synergy. Using genetic, pharmacological and immunological approaches, we demonstrate that the murine Mempty set IL-6 response to mAb-iB(TLR2) requires activation of both the TLR/NF-kappa B and Fc gamma R/ITAM signaling pathways. mAb-iB(TLR2) engagement of TLR2 drives NF-kappa B activation and up-regulation of IL-6 mRNA but fails to result in IL-6 cytokine production/release. Here, Src family kinase-driven Fc gamma R ITAM signaling is necessary to enable IL-6 mRNA incorporation into polysomes and translation. These results reveal a novel mechanism by which Fc gamma R ITAM signaling synergizes with TLR signaling, by "licensing" cytokine mRNA ribosome binding/translation to drive a strong murine Mempty set cytokine response.	[Hunt, Danielle; Drake, Lisa A.; Drake, James R.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.	drakej@amc.edu			N.I.H. [PO1 AI-056321]	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by N.I.H. grant PO1 AI-056321 to the Department of Immunology and Microbial Disease.	ATVBAHA, 2009, INFECT IMMUN, V77, P4953; BABADJANOVA Z, 1941, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0129981; Bakema JE, 2015, J IMMUNOL, V194, P1856, DOI 10.4049/jimmunol.1303126; BITSAKTSIS C, 1957, PUBMED, DOI DOI 10.1128/IAI.02289-14; Dai S, 2016, PUBMED, V12, DOI 10.1371/journal.ppat; Dai Shipan, 2016, PLoS Pathog, V12, pe1005504, DOI 10.1371/journal.ppat.1005504; den Dunnen J, 2012, BLOOD, V120, P112, DOI 10.1182/blood-2011-12-399931; DUFFY EB, 1931, PUBMED, DOI DOI 10.1189/JLB.2A1215-555RR; Fong DC, 1996, IMMUNOL LETT, V54, P83, DOI 10.1016/S0165-2478(96)02654-5; Franchini AM, 2013, J BIOL CHEM, V288, P25098, DOI 10.1074/jbc.M113.474106; FRANZ B, 2015, PUBMED, P61064, DOI DOI 10.1155/2015/840842; Franz BJ, 2015, PUBMED, V2015, DOI 10.1155/2015/840842; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; GUNN JS, 1923, PUBMED, DOI DOI 10.1196/ANNALS.1409.006; HAJJAR AM, 1924, PUBMED, DOI DOI 10.1128/IAI.00934-06; HANSEN IS, 2006, PUBMED, DOI DOI 10.1038/S41467-018-03318-5; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; HIRSCH I, 2017, PUBMED, V394, P39271, DOI DOI 10.3389/FIMMU.2017.00394; IGLESIAS BV, 2012, PUBMED, V66, P47654, DOI DOI 10.1038/ICB.2012.66; Johnston S, 2012, NEURAL REGEN RES, V7, P1064, DOI 10.3969/j.issn.1673-5374.2012.14.004; KURTZ SL, 1988, PUBMED, DOI DOI 10.1128/IAI.01249-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEGERING DJ, 2006, MICROB PATHOG, V9, P26; LOPEZPELAEZ M, 1926, PUBMED, DOI DOI 10.1091/MBC.E12-02-0135; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Ng HP, 2015, ARTERIOSCL THROM VAS, V35, P1101, DOI 10.1161/ATVBAHA.115.305290; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Pham GH, 2014, VACCINE, V32, P5212, DOI 10.1016/j.vaccine.2014.07.050; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; PMID, 1978, PUBMED; PMID, 1998, PUBMED; PMID, 2010, PUBMED; PMID, 2006, PUBMED, V7, P7; PMID, 1985, PUBMED; Rabadi SM, 2016, J BIOL CHEM, V291, P5009, DOI 10.1074/jbc.M115.681478; RAWOOL DB, 1939, PUBMED; REN L, 1974, J BIOL CHEM, V115, P3, DOI DOI 10.1074/JBC.M115; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; SUNAGAR R, 1974, PUBMED, DOI DOI 10.2147/VDT.S85545; Sunagar R, 2016, VACCINE, V34, P3396, DOI 10.1016/j.vaccine.2016.04.054; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; van Egmond M, 2015, IMMUNOL REV, V268, P311, DOI 10.1111/imr.12333; VOGELPOEL LT, 1921, PUBMED, DOI DOI 10.1038/NC0MMS6444; Vogelpoel LT, 2015, PUBMED, V6, P79; VOGELPOEL LT, 2015, PUBMED, V79, P59693, DOI DOI 10.3389/FIMMU.2015.00079; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335	50	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200764	10.1371/journal.pone.0200764	http://dx.doi.org/10.1371/journal.pone.0200764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024985	Green Submitted, gold, Green Published			2022-12-26	WOS:000439120000048
J	Roosenhoff, R; van der Vries, E; van der Linden, A; van Amerongen, G; Stittelaar, KJ; Smits, SL; Schutten, M; Fouchier, RAM				Roosenhoff, Rueshandra; van der Vries, Erhard; van der Linden, Anne; van Amerongen, Geert; Stittelaar, Koert J.; Smits, Saskia L.; Schutten, Martin; Fouchier, Ron A. M.			Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; IMMUNIZATION PRACTICES; OSELTAMIVIR TREATMENT; ADVISORY-COMMITTEE; SEASONAL INFLUENZA; VIRAL-INFECTIONS; RECOMMENDATIONS; TRANSMISSION; INFORMATION	Influenza viruses can cause severe life threatening infections in high-risk patients, including young children, the elderly and patients with compromised immunity due to underlying medical conditions or immunosuppressive treatment. The impaired immunity of these patients causes prolonged virus infection and combined with antiviral treatment facilitates the emergence of viruses with resistance mutations. The diverse nature of their immune status makes them a challenging group to study the impact of influenza virus infection and the efficacy of antiviral therapy. Immunocompromised ferrets may represent a suitable animal model to assess influenza virus infection and antiviral treatment strategies in immunocompromised hosts. Here, ferrets were given a daily oral solution of mycophenolate mofetil, tacrolimus and prednisolone sodium phosphate to suppress their immune system. Groups of immunocompromised and immunocompetent ferrets were inoculated with an A/H3N2 influenza virus and were subsequently treated with Oseltamivir or left untreated. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was performed on the throat and nose specimens to study virus replication during the course of infection. All immunocompromised ferrets had prolonged presence of viral RNA and a higher total amount of virus shedding compared to the immunocompetent ferrets. Although Oseltamivir reduced the total amount of virus shedding from the nose and throat of treated ferrets, it also resulted in the emergence of the neuraminidase R292K resistance substitution in all these animals, as determined by mutation specific RT-PCR and next-generation sequencing. No additional mutations that could be associated with the emergence of the R292K resistance mutation were detected. The immunocompromised ferret model can be used to study A/H3N2 virus shedding and is a promising model to study new antiviral strategies and the emergence of antiviral resistance in immunocompromised hosts.	[Roosenhoff, Rueshandra; van der Linden, Anne; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Zuid Holland, Netherlands; [van der Vries, Erhard] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands; [van Amerongen, Geert; Stittelaar, Koert J.; Smits, Saskia L.] Viroclin Biosci BV, Rotterdam, Zuid Holland, Netherlands; [Schutten, Martin] Clin Virol & Diagnost, Alkmaar, Noord Holland, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Zuid Holland, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869	NIAID/NIH [HHSN272201400008C]; European Commission FP7 program ADITEC [280873]; H2020 program COMPARE [643476]; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration [304875]; Volkswagen Foundation	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Commission FP7 program ADITEC; H2020 program COMPARE; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration; Volkswagen Foundation(Volkswagen)	This research was supported by NIAID/NIH contract HHSN272201400008C, European Commission FP7 program ADITEC (280873), H2020 program COMPARE (643476) and European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration (grant 304875). Erhard van der Vries was supported by the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Belser JA, 2015, VIROLOGY, V484, P305, DOI 10.1016/j.virol.2015.06.020; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Cheung DH, 2015, J INFECT DIS, V212, P391, DOI 10.1093/infdis/jiv058; Choi SM, 2011, BLOOD, V117, P5050, DOI 10.1182/blood-2010-11-319186; Coffin SE, 2011, PEDIATR INFECT DIS J, V30, P962, DOI 10.1097/INF.0b013e318232ede9; Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087; Englund J, 2011, BIOL BLOOD MARROW TR, V17, pS2, DOI 10.1016/j.bbmt.2010.11.008; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; FLEURY H, 2009, EURO SURVEILL, V14; Fraaij PL, 2015, ANTIVIR THER, V20, P633, DOI 10.3851/IMP2957; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1; Heinonen S, 2010, CLIN INFECT DIS, V51, P887, DOI 10.1086/656408; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Ison MG, 2008, J HEART LUNG TRANSPL, V27, P282, DOI 10.1016/j.healun.2007.11.575; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Kocik J, 2014, ACTA BIOCHIM POL, V61, P509; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Koszalka P, 2017, INFLUENZA OTHER RESP, V11, P240, DOI 10.1111/irv.12446; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lee N, 2007, ANTIVIR THER, V12, P501; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Meijer WJ, 2015, CASE REP INFECT DIS, V2015, DOI 10.1155/2015/504975; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Moore IN, 2014, J VIROL, V88, P13879, DOI 10.1128/JVI.02341-14; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Organization WH, 2017, WHO 650 000 PEOPL RE, V46, P45; Organization WH, 2017, WHO INFL UPD D 298, V56, P57; Speers DJ, 2010, MED J AUSTRALIA, V192, P166, DOI 10.5694/j.1326-5377.2010.tb03459.x; Stittelaar KJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060168; Suzuki Y, 2015, META GENE, V4, P64, DOI 10.1016/j.mgene.2015.03.003; Takahashi Kazumi, 2003, Antiviral Chemistry & Chemotherapy, V14, P235; van der Vries E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003343; van der Vries E, 2013, J MOL DIAGN, V15, P347, DOI 10.1016/j.jmoldx.2012.11.007; Waghmare A, 2016, BLOOD, V127, P2682, DOI [10.1182/blood-2016-01634873, 10.1182/blood-2016-01-634873]; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Yoo JW, 2015, J MED VIROL, V87, P1649, DOI 10.1002/jmv.24232	50	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200849	10.1371/journal.pone.0200849	http://dx.doi.org/10.1371/journal.pone.0200849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024940	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000061
J	Feng, TQ; Chen, QR; Yi, M; Xiao, ZD				Feng, Tianquan; Chen, Qingrong; Yi, Ming; Xiao, Zhongdang			Improvement of signal-to-noise ratio in parallel neuron arrays with spatially nearest neighbor correlated noise	PLOS ONE			English	Article							STOCHASTIC RESONANCE; MODEL; TRANSMISSION; ENHANCEMENT; ADAPTATION; CRAYFISH; SYSTEMS; CALCIUM	We theoretically investigate the signal-to-noise ratio (SNR) of a parallel array of leaky integrate-and-fire (LIF) neurons that receives a weak periodic signal and uses spatially nearest neighbor correlated noise. By using linear response theory, we derive the analytic expression of the SNR. The results show that the amplitude of internal noise can be increased up to an optimal value, which corresponds to a maximum SNR. Given the existence of spatially nearest neighbor correlated noise in the neural ensemble, the SNR gain of the collective ensemble response can exceed unity, especially for a negative correlation. This nonlinear collective phenomenon of SNR gain amplification may be related to the array stochastic resonance. In addition, we show that the SNR can be improved by varying the number of neurons, frequency, and amplitude of the weak periodic signal. We expect that this investigation will be useful for both controlling the collective response of neurons and enhancing weak signal transmission.	[Feng, Tianquan] Nanjing Normal Univ, Coll Teacher Educ, Nanjing, Jiangsu, Peoples R China; [Feng, Tianquan; Xiao, Zhongdang] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Chen, Qingrong] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China; [Yi, Ming] Huazhong Agr Univ, Coll Sci, Wuhan, Hubei, Peoples R China	Nanjing Normal University; Southeast University - China; Nanjing Normal University; Huazhong Agricultural University	Feng, TQ (corresponding author), Nanjing Normal Univ, Coll Teacher Educ, Nanjing, Jiangsu, Peoples R China.; Feng, TQ (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	tqfeng2@126.com		Feng, Tianquan/0000-0003-4751-4204	National Natural Science Foundation of China [31100752, 11675060, 91330113]; Scientific Research Foundation for Distinguished Scholars of NJNU [1243211602A044]; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program [2015RC021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Distinguished Scholars of NJNU; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program	The research is supported in part by National Natural Science Foundation of China under Grant Nos. 31100752, 11675060, and 91330113, and by Scientific Research Foundation for Distinguished Scholars of NJNU under Grant No. 1243211602A044, by Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program No. 2015RC021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Bruce IC, 1998, INFORM SCIENCES, V111, P303, DOI 10.1016/S0020-0255(98)10010-5; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Casado JM, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011109; Chapeau-Blondeau F, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.060101; ChapeauBlondeau F, 1996, PHYS REV E, V53, P1273, DOI 10.1103/PhysRevE.53.1273; De Pitta M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.030903; Duan FB, 2009, PHYSICA A, V388, P1345, DOI 10.1016/j.physa.2008.12.041; Durrant S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011923; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Feng TQ, 2016, J BIOL SYST, V24, P367, DOI 10.1142/S0218339016500194; Feng TQ, 2015, J BIOL SYST, V23, P289, DOI 10.1142/S0218339015500151; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Gora PF, 2003, ARRAY ENHANCED STOCH; Hashemi M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021917; Jaramillo F, 1998, NAT NEUROSCI, V1, P384, DOI 10.1038/1597; Johnson DH, 1996, J COMPUT NEUROSCI, V3, P275, DOI 10.1007/BF00161089; Kang Q, 2016, IEEE T CYBERNETICS, V46, P2083, DOI 10.1109/TCYB.2015.2464106; Kang YM, 2014, ADV COGNITIVE NEUROD, P209; Lei JZ, 2009, J THEOR BIOL, V256, P485, DOI 10.1016/j.jtbi.2008.10.028; Lindner B, 2001, PHYS REV LETT, V86, P2934, DOI 10.1103/PhysRevLett.86.2934; Liu F, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031907; Liu Q, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041907; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; MANTEGNA RN, 1994, PHYS REV E, V49, pR1792, DOI 10.1103/PhysRevE.49.R1792; McDonnell MD, 2008, STOCHASTIC RESONANCE: FROM SUPRATHRESHOLD STOCHASTIC RESONANCE TO STOCHASTIC SIGNAL QUANTIZATION, P1, DOI 10.1017/CBO9780511535239; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; Moreno-Bote R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028101; Moreno-Bote R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028102; MOSS F, 1995, NATURE, V376, P211, DOI 10.1038/376211a0; Patel A, 2008, IEEE T NEURAL NETWOR, V19, P1993, DOI 10.1109/TNN.2008.2005610; Shea-Brown E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108102; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Torres JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121156; Tuckwell H. C, 1988, INTRO THEORETICAL NE, V1; Wang JW, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-50; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Yang T, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/12/P12015; Zhao Q, 2009, PHYSICA A, V388, P4105, DOI 10.1016/j.physa.2009.06.033	46	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200890	10.1371/journal.pone.0200890	http://dx.doi.org/10.1371/journal.pone.0200890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021023	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400086
J	Mancini, E; Quax, R; De Luca, A; Fidler, S; Stohr, W; Sloot, PMA				Mancini, Emiliano; Quax, Rick; De Luca, Andrea; Fidler, Sarah; Stohr, Wolfgang; Sloot, Peter M. A.			A study on the dynamics of temporary HIV treatment to assess the controversial outcomes of clinical trials: An in-silico approach	PLOS ONE			English	Article							VIRAL SET-POINT; ANTIRETROVIRAL THERAPY; OBSERVATIONAL COHORT; TYPE-1 INFECTION; MODEL; INFORMATION; STRATEGIES; HAART	It is still unclear under which conditions temporary combined antiretroviral therapy (cART) results in a prolonged remission after interruption. Clinical trials have contradicting reposts about the effect of cART during primary HIV infection on the disease progression. Here we propose that the apparent contradiction is due the presence of a window of opportunity for cART treatment observed in the in silico studies. We study non-linear correlations in the HIV dynamics over time using information theory. This approach requires a large dataset of CD4+ T lymphocytes and viral load concentrations over time. Since it is unfeasible to collect the required amount of data in clinical trials we use C-ImmSim, a clinically validated in silico model of the HIV infection, to simulate the HIV infection and temporary cART in 500 virtual patients for a period of 6 years post infection in time steps of 8 hours. We validate the results of our model with two published clinical trials of temporary cART in acute infection and analyse the impact of cART on the immune response. Our quantitative analysis predicts a "window of opportunity" of about ten months after the acute phase during which a temporary cART has significantly longer-lasting beneficial effects on the immune system as compared to treatment during the chronic phase. This window may help to explain the controversial outcomes of clinical trials that differ by the starting time and duration of the short-term course cART and provides a critical insight to develop appropriate protocols for future clinical trials.	[Mancini, Emiliano; Quax, Rick; Sloot, Peter M. A.] Univ Amsterdam, Inst Adv Study, GC, Amsterdam, Netherlands; [De Luca, Andrea] UOC Malattie Infett Univ, Azienda Osped Univ, Siena, Italy; [Fidler, Sarah; Stohr, Wolfgang] UCL, Med Sch, London, England; [Sloot, Peter M. A.] Nanyang Technol Univ, Singapore, Singapore; [Sloot, Peter M. A.] ITMO Univ, St Petersburg, Russia	University of Amsterdam; University of Siena; University Hospital of Siena; University of London; University College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; ITMO University	Mancini, E (corresponding author), Univ Amsterdam, Inst Adv Study, GC, Amsterdam, Netherlands.	e.mancini@uva.nl	De Luca, Andrea/G-8810-2011; Mancini, Emiliano/ABC-1704-2020; Sloot, Peter/B-3078-2014	De Luca, Andrea/0000-0002-9561-9193; Stohr, Wolfgang/0000-0002-6533-2888; Sloot, Peter/0000-0002-3848-5395; Mancini, Emiliano/0000-0002-5613-234X; Quax, Rick/0000-0002-0299-0074	European Commission [FP7-ICT-269978, FP7-ICT-318121, FP7-ICT-317534]; Russian Scientific Foundation [14-21-00137]	European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Scientific Foundation(Russian Science Foundation (RSF))	EM acknowledge the financial support of the European Commission in the context of the VPH-Share project (FP7-ICT-269978). RQ and PMAS acknowledge the financial support of the Future and Emerging Technologies (FET) program within Seventh Framework Programme (FP7) for Research of the European Commission, under the FET-Proactive grant agreement TOPDRIM, number FP7-ICT-318121, as well as the FET-Proactive grant agreement Sophocles, number FP7-ICT-317534. PMAS acknowledges the support of the Russian Scientific Foundation, Project number 14-21-00137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Castiglione F, 2005, INT J MOD PHYS C, V16, P1869, DOI 10.1142/S0129183105008394; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Cellerai C, 2008, CURR OPIN HIV AIDS, V3, P67, DOI 10.1097/COH.0b013e3282f31d4b; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cover T. M., 1991, ELEMENTS INFORM THEO; dos Santos RMZ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168102; Fidler S, 2007, AIDS, V21, P1283, DOI 10.1097/QAD.0b013e3280b07b5b; Fidler S, 2017, JAIDS-J ACQ IMM DEF, V74, P126, DOI 10.1097/qai.0000000000001220; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hadjiandreou M, 2007, MATH BIOSCI ENG, V4, P489, DOI 10.3934/mbe.2007.4.489; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hernandez-Vargas EA, 2013, J THEOR BIOL, V320, P33, DOI 10.1016/j.jtbi.2012.11.028; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Judea P., 2009, CAUSALITY MODELS REA; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Koegl C, 2009, EUR J MED RES, V14, P277; Kretzschmar ME, 2013, P NATL ACAD SCI USA, V110, P15538, DOI 10.1073/pnas.1301801110; Kwon HD, 2007, APPL MATH COMPUT, V188, P1193, DOI 10.1016/j.amc.2006.10.071; Lizier JT, 2010, EUR PHYS J B, V73, P605, DOI 10.1140/epjb/e2010-00034-5; Lundgren J, 2015, HIV MED, V16, P1, DOI 10.1111/hiv.12227; Mancini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036108; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Nowak MA., 2000, VIRUS DYNAMICS MATH; Paci P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-56; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Pantazis N, 2008, AIDS, V22, P2441, DOI 10.1097/QAD.0b013e328319ea4e; Pantazis N, 2016, AIDS, V30, P879, DOI 10.1097/QAD.0000000000000991; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Quax R, 2013, EUR PHYS J-SPEC TOP, V222, P1389, DOI 10.1140/epjst/e2013-01933-9; Quax R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0568; Quax R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01898; Raffi F, 2017, J ANTIMICROB CHEMOTH, V72, P240, DOI 10.1093/jac/dkw369; Seng R, 2008, JAIDS-J ACQ IMM DEF, V49, P251, DOI 10.1097/QAI.0b013e318189a739; Sloot P, 2002, LECT NOTES COMPUT SC, V2493, P282; Steingrover R, 2010, AIDS RES HUM RETROV, V26, P379, DOI 10.1089/aid.2009.0041; Streeck H, 2006, J INFECT DIS, V194, P734, DOI 10.1086/503811; Wu Y, 2012, J MATH BIOL, V64, P495, DOI 10.1007/s00285-011-0422-8	43	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200892	10.1371/journal.pone.0200892	http://dx.doi.org/10.1371/journal.pone.0200892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021018	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400087
J	Yu, SH; Zhao, P; Prabhakar, PK; Sun, TT; Beedle, A; Boons, GJ; Moremen, KW; Wells, L; Steet, R				Yu, Seok-Ho; Zhao, Peng; Prabhakar, Pradeep K.; Sun, Tiantian; Beedle, Aaron; Boons, Geert-Jan; Moremen, Kelley W.; Wells, Lance; Steet, Richard			Defective mucin-type glycosylation on -dystroglycan in COG-deficient cells increases its susceptibility to bacterial proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; dystroglycan; neuraminidase; click chemistry; protease; conserved oligomeric Golgi complex; mucin-type glycan	LOW-DENSITY-LIPOPROTEIN; LASSA VIRUS ENTRY; OF-THE-LITERATURE; CONGENITAL DISORDERS; VIBRIO-CHOLERAE; PROTEIN GLYCOSYLATION; COMPLEX; EXPRESSION; DROSOPHILA; FEATURES	Deficiency in subunits of the conserved oligomeric Golgi (COG) complex results in pleiotropic defects in glycosylation and causes congenital disorders in humans. Insight regarding the functional consequences of this defective glycosylation and the identity of specific glycoproteins affected is lacking. A chemical glycobiology strategy was adopted to identify the surface glycoproteins most sensitive to altered glycosylation in COG-deficient Chinese hamster ovary (CHO) cells. Following metabolic labeling, an unexpected increase in GalNAz incorporation into several glycoproteins, including -dystroglycan (-DG), was noted in cog1-deficient ldlB cells. Western blotting analysis showed a significantly lower molecular weight for -DG in ldlB cells compared with WT CHO cells. The underglycosylated -DG molecules on ldlB cells are highly vulnerable to bacterial proteases that co-purify with V. cholerae neuraminidase, leading to rapid removal of the protein from the cell surface. The purified bacterial mucinase StcE can cleave both WT and ldlB -DG but did not cause rapid degradation of the fragments, implicating other V. cholerae proteases in the final proteolysis of the fragments. Extending terminal glycosylation on the existing mucin-type glycans of ldlB -DG stabilized the resulting fragments, indicating that fragment stability, but not the initial fragmentation of the protein, is influenced by the glycosylation status of the cell. This discovery highlights a functional importance for mucin-type O-glycans found on -DG and reinforces a growing role for these glycans as regulators of extracellular proteolysis and protein stability.	[Yu, Seok-Ho; Zhao, Peng; Prabhakar, Pradeep K.; Sun, Tiantian; Beedle, Aaron; Boons, Geert-Jan; Moremen, Kelley W.; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu	Prabhakar, Pradeep/AAM-8080-2021; Boons, Geert-Jan P H/J-3211-2016; Moremen, Kelley/AAD-4661-2019; Beedle, Aaron/AAI-7014-2020; Beedle, Aaron/K-1902-2015	Boons, Geert-Jan P H/0000-0003-3111-5954; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293; Prabhakar, Pradeep/0000-0003-2450-5890; Beedle, Aaron/0000-0002-1019-3235; Yu, Seok-Ho/0000-0002-8372-1094	National Institutes of Health [P01GM107012, R01GM111939]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, R01GM111939, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01GM107012 (to R. S., K. W. M., L. W., and G.-J. B.) and R01GM111939 (to L. W. and A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Barone R, 2014, SEMIN NEUROL, V34, P357, DOI 10.1055/s-0034-1387197; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; BURNET FM, 1947, AUST J EXP BIOL MED, V25, P219, DOI 10.1038/icb.1947.32; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Fortunato MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097567; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Frappaolo A, 2017, J CELL SCI, V130, P3637, DOI 10.1242/jcs.209049; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Friscourt F, 2012, J AM CHEM SOC, V134, P5381, DOI 10.1021/ja3002666; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Heng S, 2015, FASEB J, V29, P4011, DOI 10.1096/fj.14-269456; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kim YM, 2018, J HUM GENET, V63, P383, DOI 10.1038/s10038-017-0386-7; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KOZARSKY KF, 1986, J CELL BIOL, V102, P1567, DOI 10.1083/jcb.102.5.1567; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; Krasnewich D, 2007, AM J MED GENET C, V145C, P302, DOI 10.1002/ajmg.c.30143; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lubbehusen J, 2010, HUM MOL GENET, V19, P3623, DOI 10.1093/hmg/ddq278; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P657, DOI 10.1007/s10545-017-0066-y; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P195, DOI 10.1007/s10545-016-0012-4; Mbua NE, 2011, CHEMBIOCHEM, V12, P1911, DOI 10.1002/cbic.201100117; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Paesold-Burda P, 2009, HUM MOL GENET, V18, P4350, DOI 10.1093/hmg/ddp389; Palmigiano A, 2017, J MASS SPECTROM, V52, P372, DOI 10.1002/jms.3936; Rymen D, 2015, MOL GENET METAB, V116, P163, DOI 10.1016/j.ymgme.2015.07.003; Rymen D, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-94; SCHNEIDER DR, 1982, J INFECT DIS, V145, P474, DOI 10.1093/infdis/145.4.474; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; STEWARTTULL DES, 1986, J MED MICROBIOL, V22, P325, DOI 10.1099/00222615-22-4-325; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Xia BY, 2013, ANAL BIOCHEM, V442, P178, DOI 10.1016/j.ab.2013.07.037; Yu SH, 2016, J BIOL CHEM, V291, P3982, DOI 10.1074/jbc.M115.700369; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	45	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14534	14544		10.1074/jbc.RA118.003014	http://dx.doi.org/10.1074/jbc.RA118.003014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049793	Green Published, hybrid			2022-12-26	WOS:000444671500030
J	Chakravarti, A; Selvadurai, K; Shahoei, R; Lee, H; Fatma, S; Tajkhorshid, E; Huang, RH				Chakravarti, Arpita; Selvadurai, Kiruthika; Shahoei, Rezvan; Lee, Hugo; Fatma, Shirin; Tajkhorshid, Emad; Huang, Raven H.			Reconstitution and substrate specificity for isopentenyl pyrophosphate of the antiviral radical SAM enzyme viperin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme mechanism; radical; antiviral agent; isoprenoid; adenylation; isopentenyl pyrophosphate; radical addition; radical SAM enzyme; viperin; interferon-stimulated protein; antiviral cellular factor; antiviral protein; hydrogen abstraction	WEST NILE VIRUS; PROTEIN VIPERIN; FUNCTIONAL-CHARACTERIZATION; ENCEPHALITIS-VIRUS; IDENTIFICATION; REPLICATION; INHIBIT; EXPRESSION; INFECTION; BINDING	Viperin is a radical SAM enzyme that has been shown to possess antiviral activity against a broad spectrum of viruses; however, its molecular mechanism is unknown. We report here that recombinant fungal and archaeal viperin enzymes catalyze the addition of the 5-deoxyadenosyl radical (5-dA(center dot)) to the double bond of isopentenyl pyrophosphate (IPP), producing a new compound we named adenylated isopentyl pyrophosphate (AIPP). The reaction is specific for IPP, as other pyrophosphate compounds involved in the mevalonate biosynthetic pathway did not react with 5-dA(center dot). Enzymatic reactions employing IPP derivatives as substrates revealed that any chemical change in IPP diminishes its ability to be an effective substrate of fungal viperin. Mutational studies disclosed that the hydroxyl group on the side chain of Tyr-245 in fungal viperin is the likely source of hydrogen in the last step of the radical addition, providing mechanistic insight into the radical reaction catalyzed by fungal viperin. Structure-based molecular dynamics (MD) simulations of viperin interacting with IPP revealed a good fit of the isopentenyl motif of IPP to the active site cavity of viperin, unraveling the molecular basis of substrate specificity of viperin for IPP. Collectively, our findings indicate that IPP is an effective substrate of fungal and archaeal viperin enzymes and provide critical insights into the reaction mechanism.	[Chakravarti, Arpita; Selvadurai, Kiruthika; Lee, Hugo; Fatma, Shirin; Tajkhorshid, Emad; Huang, Raven H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Shahoei, Rezvan] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Shahoei, Rezvan; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Tajkhorshid, Emad; Huang, Raven H.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Huang, RH (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Huang, RH (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.	huang@illinois.edu	Tajkhorshid, Emad/AAN-8323-2021; fatma, shirin/AIE-7476-2022; Shahoei, Rezvan/AAS-2088-2021	fatma, shirin/0000-0002-4504-4272; Tajkhorshid, Emad/0000-0001-8434-1010	National Institutes of Health [GM107533, P41 GM104601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107533, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM107533 (to R. H. H.) and P41 GM104601 (to E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Ebrahimi KH, 2017, FEBS LETT, V591, P2394, DOI 10.1002/1873-3468.12769; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; Hinson ER, 2010, J IMMUNOL, V184, P5723, DOI 10.4049/jimmunol.0903752; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Hover BM, 2015, P NATL ACAD SCI USA, V112, P6347, DOI 10.1073/pnas.1500697112; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim BH, 2016, NAT IMMUNOL, V17, P481, DOI 10.1038/ni.3440; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Lei MM, 2015, DEV COMP IMMUNOL, V53, P293, DOI 10.1016/j.dci.2015.07.008; Lim ES, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-55; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Mikulecky P, 2018, FEBS LETT, V592, P199, DOI 10.1002/1873-3468.12941; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Nelp MT, 2017, BIOCHEMISTRY-US, V56, P3874, DOI 10.1021/acs.biochem.7b00608; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabbani MAG, 2016, J VIROL, V90, P11145, DOI 10.1128/JVI.01551-16; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Upadhyay AS, 2017, J BIOL CHEM, V292, P13879, DOI 10.1074/jbc.M117.780122; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985	57	9	10	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14122	14133		10.1074/jbc.RA118.003998	http://dx.doi.org/10.1074/jbc.RA118.003998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030381	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000444070700033
J	Baldock, KL; Paquet, C; Howard, NJ; Coffee, NT; Taylor, AW; Daniel, M				Baldock, Katherine L.; Paquet, Catherine; Howard, Natasha J.; Coffee, Neil T.; Taylor, Anne W.; Daniel, Mark			Gender-specific associations between perceived and objective neighbourhood crime and metabolic syndrome	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MEDIATION ANALYSIS; BUILT ENVIRONMENT; SAFETY; WALKING; FEAR; PERCEPTIONS; HEALTH; RISK; POPULATION	Much research has considered the relationship between neighbourhood crime and physical activity, but few studies have assessed clinical outcomes consequent to behaviour, such as cardiometabolic risk. Fewer still have simultaneously assessed perceived and objective measures of crime. Perceptions of crime and actual victimisation vary according to gender; thus, this study sought to assess: 1) correspondence between perceived and objective neighbourhood crime; and 2) gender-specific associations between perceived and reported crime and metabolic syndrome, representing cardiometabolic risk. The indirect effect of neighbourhood crime on metabolic syndrome via walking was additionally evaluated. An Australian population-based biomedical cohort study (2004-2007) collected biomedical, socio-demographic, and neighbourhood perceptions data from n = 1,172 urban-dwelling, adults. Area-level reported crime rates were standardised and linked to individual data based on participants' residential location. Correspondence between actual and perceived crime measures was assessed using Pearson correlation coefficients. Cross-sectional associations between crime and metabolic syndrome were analysed using generalised estimating equations regression models accounting for socio-demographic factors and area-level income. Correspondence between perceived and objective crime was small to medium among men and women (r = 0.17 to 0.33). Among men, metabolic syndrome was related to rates of violent (OR = 1.21, 95% CI 1.08-1.35) and total crime (OR = 1.17, 95% CI 1.04-1.32), after accounting for perceived crime. Among women, metabolic syndrome was related to perceived crime (OR = 1.35, 95% CI 1.14-1.60) after accounting for total reported crime. Among women, there were indirect effects of perceived crime and property crime on metabolic syndrome through walking. Results indicate that crime, an adverse social exposure, is linked to clinical health status. Crime rates, and perceptions of crime and safety, differentially impact upon cardiometabolic health according to gender. Social policy and public health strategies targeting crime reduction, as well as strategies to increase perceptions of safety, have potential to contribute to improved cardiometabolic outcomes.	[Baldock, Katherine L.; Paquet, Catherine] Univ South Australia, Sansom Inst Hlth Res, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Howard, Natasha J.] Univ South Australia, Sansom Inst Hlth Res, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia; [Coffee, Neil T.; Daniel, Mark] Univ Canberra, Fac Hlth, Hlth Res Inst, Ctr Res & Act Publ Hlth, Canberra, ACT, Australia; [Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Daniel, Mark] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Daniel, Mark] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of South Australia; University of South Australia; University of Canberra; University of Adelaide; St Vincent's Hospital Melbourne; University of Melbourne; South Australian Health & Medical Research Institute (SAHMRI)	Baldock, KL (corresponding author), Univ South Australia, Sansom Inst Hlth Res, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA, Australia.	katherine.baldock@unisa.edu.au	Paquet, Catherine/C-3894-2009; Baldock, Katherine/S-8151-2019; Howard, Natasha/A-1214-2011; Taylor, Anne/F-5708-2010; Coffee, Neil/F-4357-2013	Paquet, Catherine/0000-0002-6877-7903; Howard, Natasha/0000-0002-8099-3107; Baldock, Katherine L/0000-0003-3527-1057; Taylor, Anne/0000-0002-4422-7974; Daniel, Mark/0000-0001-9112-134X; Coffee, Neil/0000-0002-5075-0737	National Health and Medical Research Council [631917, 570150]; Research SA Research Chair (Social Epidemiology); National Health and Medical Research Council Post-doctoral Training Research Fellowship [570139]; National Health and Medical Research Council Program [0631947]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Research SA Research Chair (Social Epidemiology); National Health and Medical Research Council Post-doctoral Training Research Fellowship; National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia)	The Spatial Epidemiology and Evaluation Research Group, Centre for Population Health Research at the University of South Australia in collaboration with the South Australian Department of Health conducted this research supported in part under National Health and Medical Research Council Projects (no. 631917 and no. 570150) investigating the relationships between place and metabolic syndrome (PAMS). Additional support was from a Research SA Research Chair (Social Epidemiology) awarded to MD. NJH was supported by National Health and Medical Research Council grants no. 631917 and no. 570150. CP was funded by a National Health and Medical Research Council Post-doctoral Training Research Fellowship (#570139) and salary support from a National Health and Medical Research Council Program Grant (#0631947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2007, BAS COMM PROF DATAPA; Australian Bureau of Statistics, 2003, NAT HLTH SURV US GUI; Australian Bureau of Statistics, 2008, AD SOC ATL 2006 CENS; Australian Bureau of Statistics, 2006, STAT GEOGR; Baldock K, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/589409; Ball K, 2007, J EPIDEMIOL COMMUN H, V61, P108, DOI 10.1136/jech.2006.048520; Ball K, 2010, SOC SCI MED, V71, P807, DOI 10.1016/j.socscimed.2010.04.041; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Boehmer TK, 2007, INT J OBESITY, V31, P968, DOI 10.1038/sj.ijo.0803531; Boehmer T.K., 2006, J PHYS ACT HEALTH, V3, P22, DOI [DOI 10.1123/JPAH.3.1.22, 10.1123/jpah.3.1.22.]; Boehmer TK, 2006, AM J HEALTH PROMOT, V20, P411, DOI 10.4278/0890-1171-20.6.411; Brown BB, 2014, PREV MED, V66, P140, DOI 10.1016/j.ypmed.2014.06.021; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Burdette AM, 2008, SOC SCI MED, V67, P38, DOI 10.1016/j.socscimed.2008.03.029; Burdette HL, 2006, OBESITY, V14, P518, DOI 10.1038/oby.2006.67; Cameron AJ, 2009, DIABETIC MED, V26, P306, DOI 10.1111/j.1464-5491.2009.02681.x; Castle C, 2010, JANCO CLASSIFICATION; Chaix B, 2008, J EPIDEMIOL COMMUN H, V62, P62, DOI 10.1136/jech.2006.056960; Christian H, 2011, PREV MED, V53, P57, DOI 10.1016/j.ypmed.2011.05.004; Daniel M, 2008, HEALTH PLACE, V14, P117, DOI 10.1016/j.healthplace.2007.05.003; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Evenson KR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-146; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fish JS, 2010, AM J PUBLIC HEALTH, V100, P2296, DOI 10.2105/AJPH.2009.183293; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Foster S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0343-4; Foster S, 2010, HEALTH PLACE, V16, P1156, DOI 10.1016/j.healthplace.2010.07.007; Gebel K, 2009, ANN BEHAV MED, V37, P228, DOI 10.1007/s12160-009-9098-3; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; HARTNAGEL TF, 1979, SOC FORCES, V58, P176, DOI 10.2307/2577792; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hjorth MF, 2014, INT J OBESITY, V38, P959, DOI 10.1038/ijo.2013.229; Kerr Z, 2015, PREV MED, V73, P88, DOI 10.1016/j.ypmed.2015.01.017; Kirtland KA, 2003, AM J PREV MED, V24, P323, DOI 10.1016/S0749-3797(03)00021-7; LAGRANGE RL, 1989, CRIMINOLOGY, V27, P697, DOI 10.1111/j.1745-9125.1989.tb01051.x; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Leslie E, 2005, HEALTH PLACE, V11, P227, DOI 10.1016/j.healthplace.2004.05.005; Lorenc T, 2012, HEALTH PLACE, V18, P757, DOI 10.1016/j.healthplace.2012.04.001; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mason P, 2013, SOC SCI MED, V91, P15, DOI 10.1016/j.socscimed.2013.04.011; May DC., 2010, CRIMINAL JUSTICE REV, V35, P159, DOI [10.1177/0734016809349166, DOI 10.1177/0734016809349166]; McDonald NC, 2008, AM J HEALTH PROMOT, V22, P433, DOI 10.4278/ajhp.22.6.433; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McGinn AP, 2008, J PHYS ACT HEALTH, V5, P117, DOI 10.1123/jpah.5.1.117; Medway D, 2016, J ENVIRON PSYCHOL, V45, P135, DOI 10.1016/j.jenvp.2015.12.002; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Nielsen L, 2008, SCAND J PUBLIC HEALT, V36, P369, DOI 10.1177/1403494807088456; Office of Crime Statistics and Research, 2006, TOT 2006 OFF PERS PR; Office of Crime Statistics and Research, 2007, CRIM JUST S AUSTR 20; Oh AY, 2010, J PHYS ACT HEALTH, V7, P432, DOI 10.1123/jpah.7.4.432; Openshaw S., 1984, MODIFIABLE AREAL UNI; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Peterson NA, 2004, HEALTH EDUC RES, V19, P533, DOI 10.1093/her/cyg057; Piro FN, 2006, J EPIDEMIOL COMMUN H, V60, P626, DOI 10.1136/jech.2005.042697; Preacher K. J., 2008, MONTE CARLO METHOD A; Reiss A., 1993, UNDERSTANDING PREVEN; Rennie KL, 2003, INT J EPIDEMIOL, V32, P600, DOI 10.1093/ije/dyg179; Richmond RC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001618; Robinette JW, 2016, SSM-POPUL HLTH, V2, P525, DOI 10.1016/j.ssmph.2016.06.004; Ross CE, 2000, SOC SCI MED, V51, P265, DOI 10.1016/S0277-9536(99)00451-7; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Schafer JA, 2006, J CRIM JUST, V34, P285, DOI 10.1016/j.jcrimjus.2006.03.003; Shareck M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-930; SKOGAN WG, 1974, SOC SCI QUART, V55, P25; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4	77	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201336	10.1371/journal.pone.0201336	http://dx.doi.org/10.1371/journal.pone.0201336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048521	Green Published, gold, Green Accepted			2022-12-26	WOS:000439952400078
J	Averianov, A; Martin, T; Lopatin, A; Skutschas, P; Schellhorn, R; Kolosov, P; Vitenko, D				Averianov, Alexander; Martin, Thomas; Lopatin, Alexey; Skutschas, Pavel; Schellhorn, Rico; Kolosov, Petr; Vitenko, Dmitry			A high-latitude fauna of mid-Mesozoic mammals from Yakutia, Russia	PLOS ONE			English	Article							OSSIFIED MECKELS CARTILAGE; CRETACEOUS MAMMALS; VERTEBRATE FAUNA; NORTHWEST CHINA; JUNGGAR-BASIN; SIBERIA; DINOSAURS; ORIGIN; ALASKA; EAR	The Early Cretaceous (?Berriasian-Barremian) Teete vertebrate locality in Western Yakutia, East Siberia, Russia, has produced mammal remains that are attributed to three taxa: Eleutherodontidae indet. cf. Sineleutherus sp. (Haramiyida; an upper molariform tooth), Khorotherium yakutensis gen. et sp. nov. (Tegotheriidae, Docodonta; maxillary fragment with three molariform teeth and dentary fragment with one molariform tooth), and Sangarotherium aquilonium gen. et sp. nov. (Eutriconodonta incertae sedis; dentary fragment with one erupted molariform tooth and one tooth in crypt). This is the second occurrence of Mesozoic mammals in high latitudes (paleolatitude estimate N 63-70 degrees) of the Northern Hemisphere. In spite of the presumed Early Cretaceous age based on freshwater mollusks, the Teete mammal assemblage has a distinctive Jurassic appearance, being most similar to the Middle-Late Jurassic mammal assemblages known from Siberia, Russia and Xinjiang, China. The smooth transition from Jurassic to Cretaceous biota in Northern Asia is best explained by stable environmental conditions.	[Averianov, Alexander] Russian Acad Sci, Inst Zool, St Petersburg, Russia; [Averianov, Alexander] St Petersburg State Univ, Inst Earth Sci, St Petersburg, Russia; [Averianov, Alexander] Kazan Fed Univ, Inst Geol & Petr Technol, Kazan, Russia; [Martin, Thomas; Schellhorn, Rico] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Lopatin, Alexey] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia; [Skutschas, Pavel; Vitenko, Dmitry] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Kolosov, Petr] Russian Acad Sci, Siberian Branch, Inst Diamond & Precious Met Geol, Yakutsk, Russia	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Saint Petersburg State University; Kazan Federal University; University of Bonn; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences; Saint Petersburg State University; Diamond & Precious Metal Geology Institute Siberian Branch of Russian Academy of Sciences; Russian Academy of Sciences	Averianov, A (corresponding author), Russian Acad Sci, Inst Zool, St Petersburg, Russia.; Averianov, A (corresponding author), St Petersburg State Univ, Inst Earth Sci, St Petersburg, Russia.; Averianov, A (corresponding author), Kazan Fed Univ, Inst Geol & Petr Technol, Kazan, Russia.	dzharakuduk@mail.ru	Lopatin, Alexey/P-7465-2015; Skutschas, Pavel/AAK-1811-2021; Skutschas, Pavel/D-5143-2013; Averianov, Alexander/M-8490-2013	Skutschas, Pavel/0000-0001-8093-2905; Skutschas, Pavel/0000-0001-8093-2905; Schellhorn, Rico/0000-0003-4890-3025; Averianov, Alexander/0000-0001-5948-0799	Russian Foundation for Basic Research [17-54-12041-NNIO]; Deutsche Forschungsgemeinschaft [MA 1643/22-1]; Zoological Institute, Russian Academy of Sciences [AAAA-A17-117022810195-3]; Program of the Russian Academy of Sciences Presidium "Evolution of the organic world"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zoological Institute, Russian Academy of Sciences(Russian Academy of Sciences); Program of the Russian Academy of Sciences Presidium "Evolution of the organic world"	This work was supported by Russian Foundation for Basic Research, http://www.rfbr.ru/rffi/ru/, 17-54-12041-NNIO (Dr. Alexander Averianov); Deutsche Forschungsgemeinschaft, http://www.dfg.de/, MA 1643/22-1 (Prof. Thomas Martin); Zoological Institute, Russian Academy of Sciences, AAAA-A17-117022810195-3 (Dr. Alexander Averianov); and Program of the Russian Academy of Sciences Presidium "Evolution of the organic world". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P121; Averianov Alexander, 2016, Global Geology - English Edition, V19, P187; Averianov A, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1293070; Averianov A, 2015, GEOBIOS-LYON, V48, P131, DOI 10.1016/j.geobios.2015.02.004; Averianov A, 2015, CRETACEOUS RES, V54, P145, DOI 10.1016/j.cretres.2014.12.007; Averianov AO, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1363767; Averianov AO, 2005, ACTA PALAEONTOL POL, V50, P789; BROUWERS EM, 1987, SCIENCE, V237, P1608, DOI 10.1126/science.237.4822.1608; Butler PM, 1997, J VERTEBR PALEONTOL, V17, P435, DOI 10.1080/02724634.1997.10010988; Charlesworth E, REPORT BRIT ASS ADVA, P80; Chow M., 1984, Journal of Vertebrate Paleontology, V3, P226; Chumakov N. M., 1959, TEKTONIKA SSSR, V4, P345; CLEMENS WA, 1993, GEOLOGY, V21, P503, DOI 10.1130/0091-7613(1993)021<0503:PIOATV>2.3.CO;2; Crompton AW, 1993, MAMMAL PHYLOGENY, V1, P30, DOI DOI 10.1007/978-1-4613-9249-1; Eberle JJ, 2012, GEOL SOC AM BULL, V124, P3, DOI 10.1130/B30571.1; Eberle JJ, 2010, EARTH PLANET SC LETT, V296, P481, DOI 10.1016/j.epsl.2010.06.005; Eberle JJ, 2017, J VERTEBRATE PALEONT; Fanti F, 2013, CRETACEOUS RES, V41, P256, DOI 10.1016/j.cretres.2012.12.010; Fiorillo AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091287; Fiorillo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065802; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Gangloff RA, 2005, J PALEONTOL, V79, P997, DOI 10.1666/0022-3360(2005)079[0997:TFPDFT]2.0.CO;2; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P7; Grinenko VS, 2017, NAUKA I OBRAZOVANIE, P33; Hammer W.H., 1997, ENCY DINOSAURS, P562; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kolosov PN, 2009, PALEONTOL J+, V43, P201, DOI 10.1134/S0031030109020129; KRETZOI MIKLOS, 1946, ANN MUS NATION HUNGARLCI, V39, P108; Kurzanov SM, 2003, PALEONTOLOG J, V37, P53; Kurzanov SM, 2000, MAT REG C GEOL SIB F, VII, P356; Linnaeus C., 1758, SYSTEMA NATURAE PER, V1; Lopatin A V, 2017, Dokl Biol Sci, V477, P210, DOI [10.7868/S0869565217310243, 10.1134/S0012496617060011]; Lopatin A V, 2008, Dokl Biol Sci, V419, P107, DOI 10.1134/S0012496608020117; Lopatin AV, 2009, PALEONTOL J+, V43, P453, DOI 10.1134/S0031030109040157; Lopatin A, 2015, J MAMM EVOL, V22, P17, DOI 10.1007/s10914-014-9267-4; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo Zhe-Xi, 2004, Bulletin of Carnegie Museum of Natural History, V36, P159, DOI 10.2992/0145-9058(2004)36[159:EODRIM]2.0.CO;2; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo Zhe-Xi, 2007, Bulletin of Carnegie Museum of Natural History, V39, P27, DOI 10.2992/0145-9058(2007)39[27:AOMSAP]2.0.CO;2; Maisch MW, 2005, NATURWISSENSCHAFTEN, V92, P40, DOI 10.1007/s00114-004-0584-y; Mannion PD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9438; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Marsh O. C., 1887, American Journal of Science (3), Vxxxiii, P327; Martin T, 2004, J VERTEBR PALEONTOL, V24, P195, DOI 10.1671/15; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Martinson GG., 1956, GUID MESOZOIC CENOZO; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Maschenko E.N., 2002, RUSSIAN J THERIOLOGY, V1, P75, DOI DOI 10.15298/rusjtheriol.01.2.01; Matsumoto R, 2015, HIST BIOL, V27, P583, DOI 10.1080/08912963.2014.898296; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Nauka, 1975, TECT YAK; Nicholson DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8848; Osborn H. F., 1888, J ACAD NAT SCI PHILA, V9, P186; PARRINGTON FR, 1971, PHILOS T R SOC B, V261, P231, DOI 10.1098/rstb.1971.0055; Parrington FR., 1978, BIOL SCI, V282, P177; Pfretzschner HU, 2005, ACTA PALAEONTOL POL, V50, P799; Rich TH, 2002, SCIENCE, V295, P979, DOI 10.1126/science.1068920; Rozhdestvensky A.K., 1973, PALEONTOLOGICHESKII, V2, P90; Sigogneau-Russell D, 2003, ACTA PALAEONTOL POL, V48, P357; Skutschas PP, 2017, CRETACEOUS RES, V77, P79, DOI 10.1016/j.cretres.2017.05.004; Skutschas PP, 2015, FOSSIL VERTEBRATES R, P7; Sullivan C, 2014, J VERTEBR PALEONTOL, V34, P243, DOI 10.1080/02724634.2013.787316; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P347; TATARINOV LP, 1994, PALEONTOL ZH, P97; Tennant JP, 2017, BIOL REV, V92, P776, DOI 10.1111/brv.12255; Tuchkov I. I., 1973, PALEOGEOGRAPHY HIST; Vakhrameev V. A., 1957, P INT STRAT C SIB LE, P19; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Zhang Fakui, 1998, Vertebrata Palasiatica, V36, P197; Zhou ZH, 2004, CHINESE SCI BULL, V49, P754, DOI 10.1360/04wd0120; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	76	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199983	10.1371/journal.pone.019998	http://dx.doi.org/10.1371/journal.pone.019998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044817				2022-12-26	WOS:000439942500027
J	Shimamoto, K; Miura, F; Shimatani, Y; Nishioka, K; Inoue, I				Shimamoto, Keiko; Miura, Fumiharu; Shimatani, Yuji; Nishioka, Kenji; Inoue, Ichiro			Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation	PLOS ONE			English	Article							SINUS RHYTHM; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; VENOUS ANATOMY; FOLLOW-UP; AMIODARONE; SIZE; METAANALYSIS; RECURRENCE; CONVERSION	Purpose Catheter ablation of atrial fibrillation (AF) is an effective therapy for selected groups of patients. We evaluated whether quantification of left atrium (LA) or pulmonary vein (PV) by using multi-detector computed tomography (MDCT) may predict the success rate of PV isolation procedure. Methods We included 118 patients younger than 65 years with symptomatic AF (73 paroxysmal, PAF; 45 non-paroxysmal, non-PAF). All patients underwent 256-slice MDCT prior to circumferential PV isolation to evaluate anatomy, volume and dimensions of LA and PV. Results After a mean follow-up of 14 months, complete success was achieved in 50 patients (68.5%) of PAF and in 26 patients (57.8%) of non-PAF. In the PAF group, total PV volume was found to be an independent predictor of AF recurrence, whereas LA volume was not. Logistic regression analysis showed that the probability of AF recurrence was higher in patients with total PV volume greater than 12.0 cm(3)/BSA (m(2)) (AUC 0.682, 95%CI 0.541-0.822). In the non-PAF group, no independent risk factor of LA or PV size was observed for the postoperative recurrence. Conclusions The PV volume quantification may predict the success of AF ablation in patients.	[Shimamoto, Keiko; Miura, Fumiharu; Shimatani, Yuji; Nishioka, Kenji; Inoue, Ichiro] Hiroshima City Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan; [Shimamoto, Keiko] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Res Inst, Suita, Osaka, Japan; [Miura, Fumiharu] Hiroshima Prefectural Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan; [Shimatani, Yuji] Nishinomiya Watanabe Cardiovasc Ctr, Dept Cardiol, Nishinomiya, Hyogo, Japan; [Inoue, Ichiro] Hiroshima City Funairi Citizens Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan	Hiroshima City Hospital; National Cerebral & Cardiovascular Center - Japan	Shimamoto, K (corresponding author), Hiroshima City Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan.; Shimamoto, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Res Inst, Suita, Osaka, Japan.	shima@kyosai.or.jp		Shimamoto, Keiko/0000-0001-6296-150X				Abecasis J, 2009, EUROPACE, V11, P1289, DOI 10.1093/europace/eup198; Al-Khatib SM, 2014, ANN INTERN MED, V160, P760, DOI 10.7326/M13-1467; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Atwood JE, 2007, AM HEART J, V153, P566, DOI 10.1016/j.ahj.2006.12.020; Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Cozma D, 2007, PACE, V30, pS147; CRIJNS HJGM, 1988, EUR HEART J, V9, P634, DOI 10.1093/oxfordjournals.eurheartj.a062553; den Uijl DW, 2011, AM J CARDIOL, V107, P243, DOI 10.1016/j.amjcard.2010.08.069; Doyle JF, 2009, MAYO CLIN PROC, V84, P234, DOI 10.1016/S0025-6196(11)61140-3; Duytschaever A, 2005, CARDIOVASC RES, V67, P69, DOI 10.1016/j.cardiores.2005.02.019; Ehrlich JR, 2003, J PHYSIOL-LONDON, V551, P801, DOI 10.1113/jphysiol.2003.046417; Falk RH, 2006, J AM COLL CARDIOL, V48, P731, DOI 10.1016/j.jacc.2006.05.022; Floria M, 2009, J INTERV CARD ELECTR, V25, P167, DOI 10.1007/s10840-008-9349-4; FUNG YC, 1997, BIOMECHANICS CIRCULA, P404, DOI DOI 10.1161/01.CIR.0000047065.49852.8F; Gaspo R, 1997, CIRC RES, V81, P1045; Gebhard C, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/179632; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hamaguchi S, 2016, BIOL PHARM BULL, V39, P1216, DOI 10.1248/bpb.b15-01013; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Hocini M, 2002, CIRCULATION, V105, P2442, DOI 10.1161/01.CIR.0000016062.80020.11; Hof I, 2009, J CARDIOVASC ELECTR, V20, P1005, DOI 10.1111/j.1540-8167.2009.01504.x; Jongbloed MRM, 2005, J AM COLL CARDIOL, V45, P343, DOI 10.1016/j.jacc.2004.10.040; Kalifa J, 2003, CIRCULATION, V108, P668, DOI 10.1161/01.CIR.0000086979.39843.7B; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato R, 2003, CIRCULATION, V107, P2004, DOI 10.1161/01.CIR.0000061951.81767.4E; Knecht S, 2008, EUROPACE, V10, P931, DOI 10.1093/europace/eun145; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; McLellan AJA, 2014, HEART RHYTHM, V11, P549, DOI 10.1016/j.hrthm.2013.12.025; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; RAWLES JM, 1990, BRIT HEART J, V63, P225; Reddy VY, 2012, HEART RHYTHM, V9, P1789, DOI 10.1016/j.hrthm.2012.07.016; Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x; Tsao HM, 2001, J CARDIOVASC ELECTR, V12, P809, DOI 10.1046/j.1540-8167.2001.00809.x; Tsao HM, 2005, J CARDIOVASC ELECTR, V16, P7, DOI 10.1046/j.1540-8167.2005.04407.x; van der Velden HMW, 2002, CARDIOVASC RES, V54, P270, DOI 10.1016/S0008-6363(01)00557-0; Viskin S, 1999, EUR HEART J, V20, P1429, DOI 10.1053/euhj.1999.1632; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093817; Wittkampf FHM, 2003, CIRCULATION, V107, P21, DOI 10.1161/01.CIR.0000047065.49852.8F; Wozniak-Skowerska I, 2011, INT J CARDIOL, V146, P181, DOI 10.1016/j.ijcard.2009.06.047; Yamase M, 2012, HEART, V98, P1067, DOI 10.1136/heartjnl-2012-302017; Zhuang JH, 2012, EUROPACE, V14, P638, DOI 10.1093/europace/eur364	48	10	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201199	10.1371/journal.pone.0201199	http://dx.doi.org/10.1371/journal.pone.0201199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044877	Green Submitted, gold, Green Published			2022-12-26	WOS:000439942500090
J	Knight, R; Krusi, A; Carson, A; Fast, D; Shannon, K; Shoveller, J				Knight, Rod; Krusi, Andrea; Carson, Anna; Fast, Danya; Shannon, Kate; Shoveller, Jean			Criminalization of HIV non-disclosure: Narratives from young men living in Vancouver, Canada	PLOS ONE			English	Article							PUBLIC-HEALTH; PROSECUTIONS; STIGMA; SEX; TRANSMISSION	Background Previous research has identified the impacts of legal frameworks that criminalize HIV non-disclosure among people living with HIV (e.g., elevated stigma and violence). However, far less is known about the perspectives or experiences of peopleparticularly, menwho are HIV-seronegative or who are unaware of their status. The objective of this paper is to describe the health and social risks that young men perceive to be associated with an HIV diagnosis in the context of Canadas current legal framework pertaining to HIV non-disclosure. Methods We analyzed data from 100 in-depth interviews (20132016) conducted with 85 young men ages 1830 in Vancouver on the topic of the criminalization of HIV non-disclosure. Results Our analysis revealed two dominant narratives in relation to HIV criminalization: (a) interrogation and (b) justification. An interrogation narrative problematized the moral permissibility of criminalizing HIV non-disclosure. In this narrative, Canadas HIV non-disclosure legal framework was characterized as creating unjust barriers to HIV testing uptake, as well as impeding access to and reducing retention in care for those living with HIV. Conversely, a justification narrative featured a surprising number of references to HIV as a "death sentence", despite effective treatments being universally available in Canada. However, most of those who presented the justification narrative asserted that the criminalization of HIV non-disclosure was morally justified in light of the perceived negative stigma-related impacts of HIV (e.g., discrimination; being ostracized from sex or romantic partners, friends, family). The justification narrative often reflected a belief that the legal framework provides both punishment and deterrence, which were perceived to supersede any barriers to care for both HIV-positive and -negative individuals. Conclusion Public education regarding contemporary medical advances in HIV may help contest lay understandings of HIV as a "death sentence", which is particularly relevant to destabilizing justification narratives. However, significant strengthening of HIV stigma-reduction efforts will be needed to move society away from narratives that attempt to justify Canadas current HIV non-disclosure legal framework.	[Knight, Rod; Fast, Danya] British Columbia Ctr Subst Use, Vancouver, BC, Canada; [Knight, Rod; Fast, Danya; Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Krusi, Andrea; Carson, Anna; Shoveller, Jean] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Krusi, Andrea; Shannon, Kate] Gender & Sexual Hlth Initiat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Knight, R (corresponding author), British Columbia Ctr Subst Use, Vancouver, BC, Canada.; Knight, R (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	rod.knight@bccsu.ubc.ca		Knight, Rod/0000-0002-1464-1584; Fast, Danya/0000-0001-5994-3669	Canadian Institutes of Health Research (CIHR) [PJT-148818, HHP-123778, EPP-122906]; US National Institutes of Health [1R01DA043408]; Michael Smith Foundation for Health Research (MSFHR); CIHR; MSFHR; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA038886] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Canadian Institutes of Health Research (CIHR) (PJT-148818, HHP-123778 and EPP-122906) (JS) and the US National Institutes of Health (1R01DA043408). Knight and Fast are supported by Scholar Awards from the Michael Smith Foundation for Health Research (MSFHR). Krusi holds Post-Doctoral Fellowships from CIHR and MSFHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2008, AIDS EDUC PREV, V20, P420, DOI 10.1521/aeap.2008.20.5.420; Adam BD, 2016, CAN J LAW SOC, V31, P1, DOI 10.1017/cls.2016.3; Adam BD, 2014, SEX RES SOC POLICY, V11, P39, DOI 10.1007/s13178-013-0131-8; Adam Barry D, 2011, J Int AIDS Soc, V14 Suppl 2, pS2, DOI 10.1186/1758-2652-14-S2-S2; Ammirati RJ, 2015, AIDS CARE, V27, P926, DOI 10.1080/09540121.2015.1018863; [Anonymous], QUALITATIVE RES YOUN; [Anonymous], 2016, SUMM MEAS CAN PROGR; [Anonymous], 2016, HIV HUMAN RIGHTS ORG; [Anonymous], 2010, CAN HIV AIDS LEG NET; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; British Columbia Centre for Disease Control, 2015, HIV BRIT COL ANN SUR; Callander D, 2013, J HIV-AIDS SOC SERV, V12, P205, DOI 10.1080/15381501.2013.790869; Canadian HIV/ AIDS Legal Network, 2017, RETH JUST 7 S HIV LA; Clandinin J., 2000, NARRATIVE INQUIRY EX; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cortazzi M, 2001, INT J LANG COMM DIS, V36, P252, DOI 10.3109/13682820109177893; Dej E, 2012, CAN J LAW SOC, V27, P55, DOI 10.3138/cjls.27.1.055; Department of Justice, 2017, CRIM JUST SYST RESP; Dodds C, 2008, AIDS CARE, V20, P509, DOI 10.1080/09540120701867131; Gilbert M, 2015, HLTH LITERACY SEXUAL; Good B, 1994, MED RATIONALITY EXPE; Government of British Columbia, POP EST BRIT COLUMBI; Grant I, 2011, PROSECUTION NONDISCL; Harsono D, 2017, AIDS BEHAV, V21, P27, DOI 10.1007/s10461-016-1540-5; Hastings C., 2017, HIV CRIMINALIZATION; Joint United Nations Programme on HIV/ AIDS, 2013, END BROAD CRIM HIV N; Kippax S, 2016, AIDS, V30, P2898, DOI 10.1097/QAD.0000000000001260; Knight R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146513; Lieblich A., 1998, NARRATIVE RES READIN, DOI 10.4135/9781412985253; Loutfy M, 2014, CAN J INFECT DIS MED, V25, P135, DOI 10.1155/2014/498459; Maluwa M., 2002, HEALTH HUM RIGHTS, V6, P1, DOI [https://doi.org/10.2307/4065311, DOI 10.2307/4065311]; Mattingly C., 1998, HEALING DRAMAS CLIN; Mishler E.G., 1991, RES INTERVIEWING; MISHLER E. G., 1986, RES INTERVIEWING CON; Mykhalovskiy E., 2010, HIV NONDISCLOSURE CR; Mykhalovskiy E, 2016, COLD DELIBERATELY DU; Mykhalovskiy E, 2014, PUBL HLTH IMPL CRIM; Mykhalovskiy E, 2012, CAN J LAW SOC, V27, P31, DOI 10.3138/cjls.27.1.031; Mykhalovskiy E, 2011, SOC SCI MED, V73, P668, DOI 10.1016/j.socscimed.2011.06.051; O'Byrne P, 2013, MED HUMANIT, V39, P85, DOI 10.1136/medhum-2013-010366; O'Byrne P, 2013, J ASSOC NURSE AIDS C, V24, P81, DOI 10.1016/j.jana.2012.01.009; Ochs E., 2001, LIVING NARRATIVE CRE; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Patterson S, 2015, INT J EPIDEMIOL, V44, P58, DOI 10.1093/ije/dyu046; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Stein NL, 1997, CONT ISSUES ED; Wood E, 2006, HARM REDUCT J, V3, P18, DOI DOI 10.1186/1477-7517-3-18	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201110	10.1371/journal.pone.0201110	http://dx.doi.org/10.1371/journal.pone.0201110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040831	Green Submitted, Green Published, gold			2022-12-26	WOS:000439749200027
J	Ruzin, A; Pastula, ST; Levin-Sparenberg, E; Jiang, XH; Fryzek, J; Tovchigrechko, A; Lu, B; Qi, YP; Liu, H; Jin, H; Yu, L; Hackett, J; Villafana, T; Esser, MT				Ruzin, Alexey; Pastula, Susan T.; Levin-Sparenberg, Elizabeth; Jiang, Xiaohui; Fryzek, Jon; Tovchigrechko, Andrey; Lu, Bin; Qi, Yanping; Liu, Hui; Jin, Hong; Yu, Li; Hackett, Judith; Villafana, Tonya; Esser, Mark T.			Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL-ANTIBODY; YOUNG-CHILDREN; INFECTION; INFANTS; PALIVIZUMAB; RISK; PREVENTION; INFLUENZA; ILLNESS	Background Respiratory syncytial virus (RSV) is an established cause of serious lower respiratory disease in infants, elderly and high-risk populations. The OUTSMART surveillance program aims to characterize patient populations and currently circulating RSV strains, and monitor temporal and geographic evolution of RSV F and G proteins in the U.S. Methods The OUTSMART 2016-17 study collected RSV-positive samples from 25 RSVAlert (R) laboratories from 4 U.S. regions and Puerto Rico during November 2016 through March 2017. Frequencies of A and B subtypes and genotypes were determined for several demographic and geographic variables. To gauge the representativeness of the OUTSMART patients, results were compared to discharge data from the NEDS and NIS databases. Results A total of 1,041 RSV-positive samples with associated demographic data were obtained and the RSV F gene and second variable region of the G gene were sequenced. The majority of samples (76.0%) came from children under 2 years old: <1 year (48.4%), 1-2 years (27.6%). The OUTSMART patient sample was similar to NEDS and NIS for age, gender, and geographic location. Both OUTSMART and national RSV cases peaked in January. Of OUTSMART samples, 45.3% were subtype A, 53.7% were subtype B and 1.0% were mixed A and B. The percentage of RSV B cases increased with increasing age. Hospitalization (length of hospital stay, LOS, >24 hrs) occurred in 29.0% of patients of which 52.0% had RSV B. Outpatients (LOS <24 hrs) were 64.4% of total of which 73.3% were diagnosed in the ER and discharged, while only 6% were diagnosed in other outpatient settings. Conclusions The OUTSMART 2016-17 study was representative of the U.S. RSV experience. Geographic and temporal information from the RSV surveillance program will be used to establish a molecular baseline of RSV F and G sequence variability and to help inform development of novel agents for RSV prophylaxis and treatment.	[Ruzin, Alexey; Tovchigrechko, Andrey; Yu, Li; Hackett, Judith; Villafana, Tonya; Esser, Mark T.] AstraZeneca MedImmune, Gaithersburg, MD 20878 USA; [Pastula, Susan T.; Levin-Sparenberg, Elizabeth; Jiang, Xiaohui; Fryzek, Jon] Epidstat Inst, Ann Arbor, MI USA; [Lu, Bin; Qi, Yanping; Liu, Hui; Jin, Hong] AstraZeneca MedImmune, Mountain View, CA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Ruzin, A (corresponding author), AstraZeneca MedImmune, Gaithersburg, MD 20878 USA.	ruzina@medimmune.com		Levin-Sparenberg, Elizabeth/0000-0002-2231-3361	AstraZeneca/MedImmune	AstraZeneca/MedImmune(AstraZeneca)	This work was supported by AstraZeneca/MedImmune. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2017, PEDIATR INFECT DIS J, V36, P699, DOI [10.1097/INF.0000000000001533, 10.1097/inf.0000000000001533]; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Binder W, 2017, AM J EMERG MED, V35, P1162, DOI 10.1016/j.ajem.2017.06.022; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Boron ML, 2008, PEDIATR INFECT DIS J, V27, P1095, DOI 10.1097/INF.0b013e3181812c8e; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Broberg EK, 2018, EUROSURVEILLANCE, V23, P9, DOI 10.2807/1560-7917.ES.2018.23.5.17-00284; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Gimferrer L, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.013; Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012; Griffin MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01714-16, 10.1128/aac.01714-16]; Hall Caroline Breese, 2012, Infectious Disorders - Drug Targets, V12, P92; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hcup, 2015, INTR HCUP NAT INP SA; HCUP, 2017, INTR HCUP NAT EM DEP; Higgins D, 2016, VACCINE, V34, P2870, DOI 10.1016/j.vaccine.2016.03.109; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Obando-Pacheco P, 2018, J INFECT DIS, V217, P1356, DOI 10.1093/infdis/jiy056; Pangesti KNA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1968; Paramore LC, 2004, PHARMACOECONOMICS, V22, P275, DOI 10.2165/00019053-200422050-00001; Radin JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114871; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Rose EB, 2018, MMWR-MORBID MORTAL W, V67, P71, DOI 10.15585/mmwr.mm6702a4; Schanzer DL, 2018, INFLUENZA OTHER RESP, V12, P113, DOI 10.1111/irv.12497; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Simoes EAF, 1996, J PEDIATR-US, V129, P214, DOI 10.1016/S0022-3476(96)70245-7; Storch GA, 1998, PEDIATRICS, V102, P648, DOI 10.1542/peds.102.3.648; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Villafana T, 2017, EXPERT REV VACCINES, V16, P737, DOI 10.1080/14760584.2017.1333425; Walsh EE, 2017, CLIN CHEST MED, V38, P29, DOI 10.1016/j.ccm.2016.11.010; Wright ES, 2016, R J, V8, P352; Yu XF, 2015, J CLIN VIROL, V69, P1, DOI 10.1016/j.jcv.2015.05.015; Zhu Q, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1928; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200319	10.1371/journal.pone.0200319	http://dx.doi.org/10.1371/journal.pone.0200319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040837	Green Published, gold, Green Submitted			2022-12-26	WOS:000439749200004
J	Mustonen, T; Nuutinen, M; Vainio, L; Hakkinen, J				Mustonen, Terhi; Nuutinen, Mikko; Vainio, Lari; Hakkinen, Jukka			Upper nasal hemifield location and nonspatial auditory tones accelerate visual detection during dichoptic viewing	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; BINOCULAR-RIVALRY; HEMISPHERIC ASYMMETRIES; CONTRAST SENSITIVITY; LATERAL GENICULATE; SOUND SYMBOLISM; FIELD; RESOLUTION; ATTENTION; TASK	Visual performance is asymmetric across the visual field, but locational biases that occur during dichoptic viewing are not well understood. In this study, we characterized horizontal, vertical and naso-temporal biases in visual target detection during dichoptic stimulation and explored whether the detection was facilitated by non-spatial auditory tones associated with the target's location. The detection time for single monocular targets that were suppressed from view with a 10 Hz dynamic noise mask presented to the other eye was measured at the 4 degrees intercardinal location of each eye with the breaking Continuous Flash Suppression (b-CFS) technique. Each target was either combined with a sound (i.e., high or low pitch tone) that was congruent or incongruent with its vertical location (i.e., upper or lower visual field) or presented without a sound. The results indicated faster detection of targets in the upper rather than lower visual field and faster detection of targets in the nasal than temporal hemifield of each eye. Sounds generally accelerated target detection, but the tone pitch-elevation congruency did not further enhance performance. These findings suggest that visual detection during dichoptic viewing differs from standard viewing conditions with respect to location-related perceptual biases and crossmodal modulation of visual perception. These differences should be carefully considered in experimental designs employing dichoptic stimulation techniques and in display applications that utilize dichoptic viewing.	[Mustonen, Terhi; Nuutinen, Mikko; Vainio, Lari; Hakkinen, Jukka] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland	University of Helsinki	Mustonen, T (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland.	terhi.mustonen@helsinki.fi	Häkkinen, Jukka/A-4122-2019	Häkkinen, Jukka/0000-0003-0215-2238; Nuutinen, Mikko/0000-0002-7429-3710; Mustonen, Terhi/0000-0002-8565-8164; Vainio, Lari/0000-0001-7754-9745				Alsius A, 2013, PSYCHOL SCI, V24, P423, DOI 10.1177/0956797612457378; [Anonymous], 1987, 2261987 ISO; Berger A, 2000, J COGNITIVE NEUROSCI, V12, P421, DOI 10.1162/089892900562246; BERTELSON P, 1969, ACTA PSYCHOL, V30, P145, DOI 10.1016/0001-6918(69)90047-X; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bourne VJ, 2006, LATERALITY, V11, P373, DOI 10.1080/13576500600633982; Carrasco M, 2001, SPATIAL VISION, V15, P61, DOI 10.1163/15685680152692015; Chen XC, 2003, VISION RES, V43, P2207, DOI 10.1016/S0042-6989(03)00359-6; Chen YC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00212; Chiou R, 2012, PERCEPTION, V41, P339, DOI 10.1068/p7161; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; Conrad V, 2010, J VISION, V10, DOI 10.1167/10.10.27; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Drain M, 1996, J EXP PSYCHOL GEN, V125, P139, DOI 10.1037/0096-3445.125.2.139; Duecker F, 2015, NEUROPSYCHOLOGIA, V74, P21, DOI 10.1016/j.neuropsychologia.2014.11.023; Durad AC, 1910, J AMER MED ASSOC, V55, P369, DOI 10.1001/jama.1910.04330050007004; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; FAHLE M, 1988, VISION RES, V28, P293, DOI 10.1016/0042-6989(88)90157-5; Feng J, 2014, I-PERCEPTION, V5, P97, DOI 10.1068/i0625rep; Gayet S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00460; Handa T, 2004, OPTOMETRY VISION SCI, V81, P377, DOI 10.1097/01.opx.0000135085.54136.65; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hung SM, 2017, PSYCHOL SCI, V28, P263, DOI 10.1177/0956797616677313; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Kanai R, 2006, CURR BIOL, V16, P2332, DOI 10.1016/j.cub.2006.10.001; Kauffmann L, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00037; KAUSHALL P, 1975, AM J OPTOM PHYS OPT, V52, P509; Kleiner M, 2007, PERCEPTION, V36, P14; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Laramee R. S., 2002, ACM Transactions on Computer-Human Interaction, V9, P238, DOI 10.1145/568513.568516; Levine MW, 2005, VISION RES, V45, P2820, DOI 10.1016/j.visres.2005.04.001; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Lunghi C, 2014, J NEUROSCI, V34, P784, DOI 10.1523/JNEUROSCI.2732-13.2014; Moors P, 2015, I-PERCEPTION, V6, P48, DOI 10.1068/i0678; Mossbridge JA, 2011, COGNITION, V121, P133, DOI 10.1016/j.cognition.2011.06.003; Mustonen T, 2013, J EXP PSYCHOL-APPL, V19, P333, DOI 10.1037/a0034635; Niebauer CL, 1998, PSYCHON B REV, V5, P147, DOI 10.3758/BF03209471; Niemeier M, 2008, BRAIN COGNITION, V67, P115, DOI 10.1016/j.bandc.2007.12.002; Nuutinen M, 2018, BEHAV RES METHODS, V50, P1933, DOI 10.3758/s13428-017-0961-z; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Patterson R, 2007, HUM FACTORS, V49, P1083, DOI 10.1518/001872007X249947; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Silva MF, 2008, VISION RES, V48, P127, DOI 10.1016/j.visres.2007.10.018; Silva MF, 2010, J VISION, V10, DOI 10.1167/10.6.26; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stein T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00387; STERZER P, 2014, FRONT PSYCHOL, V5, DOI DOI 10.3389/FPSYG.2014.00453; Sylvester R, 2007, J NEUROPHYSIOL, V97, P1495, DOI 10.1152/jn.00835.2006; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; VIRSU V, 1979, EXP BRAIN RES, V37, P475; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang E, 2010, INVEST OPHTH VIS SCI, V51, P588, DOI 10.1167/iovs.08-3076; Yang YH, 2014, EXP BRAIN RES, V232, P1109, DOI 10.1007/s00221-014-3820-5; Yang YH, 2011, CONSCIOUS COGN, V20, P223, DOI 10.1016/j.concog.2010.07.005; Yovel G, 2001, J EXP PSYCHOL HUMAN, V27, P1369, DOI 10.1037/0096-1523.27.6.1369; Zadbood A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00135	68	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199962	10.1371/journal.pone.0199962	http://dx.doi.org/10.1371/journal.pone.0199962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036400	Green Published, Green Submitted, gold			2022-12-26	WOS:000439429200008
J	Flanagan, PR; Fletcher, J; Boyle, H; Sulea, R; Moran, GP; Sullivan, DJ				Flanagan, Peter R.; Fletcher, Jessica; Boyle, Hannah; Sulea, Razvan; Moran, Gary P.; Sullivan, Derek J.			Expansion of the TLO gene family enhances the virulence of Candida species	PLOS ONE			English	Article							ALBICANS; DUBLINIENSIS; EXPRESSION; PATHOGEN; YEASTS	The TLO genes are a family of subtelomeric ORFs in the fungal pathogens Candida albicans and C. dubliniensis encoding a subunit of the Mediator complex homologous to Med2. The more virulent pathogen C. albicans has 15 copies of the gene whereas the less pathogenic species C. dubliniensis has only two. To investigate if expansion of the TLO repertoire in C. dubliniensis has an effect on phenotype and virulence we expressed three representative C. albicans TLO genes (TLO beta 2, TLO gamma 11 and TLO alpha 12) in a wild type C. dubliniensis background, under the control of either their native or the ACT1 promoter. Expression of TLO beta 2 resulted in a hyperfilamentous phenotype, while overexpression of TLO gamma 11 and TLO gamma 12 resulted in enhanced resistance to oxidative stress. Expression of all three TLO genes from the ACT1 promoter resulted in increased virulence in the Galleria infection model. In order to further investigate if individual TLO genes exhibit differences in function we expressed six representative C. albicans TLO genes in a C. dubliniensis Delta tlo 1/Delta tlo2 double mutant. Differences were observed in the ability of the expressed CaTLOs to complement the various phenotypes of the mutant. All TLO genes with the exception of TLO gamma 7 could restore filamentation, however only TLO alpha 9, gamma 11 and alpha 12could restore chlamydospore formation. Differences in the ability of CaTLO genes to restore growth in the presence of H2O2, calcofluor white, Congo red and at 42 degrees C were observed. Only TLO alpha 3 restored wildtype levels of virulence in the Galleria infection model. These data show that expansion of the TLO gene family in C. dubliniensis results in gain of function and that there is functional diversity amongst members of the gene family. We propose that this expansion of the TLO family contributes to the success of C. albicans as a commensal and opportunistic pathogen.	[Flanagan, Peter R.; Fletcher, Jessica; Boyle, Hannah; Sulea, Razvan; Moran, Gary P.; Sullivan, Derek J.] Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin, Ireland; [Flanagan, Peter R.; Fletcher, Jessica; Boyle, Hannah; Sulea, Razvan; Moran, Gary P.] Univ Dublin, Trinity Coll Dublin, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Moran, GP; Sullivan, DJ (corresponding author), Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin, Ireland.; Moran, GP (corresponding author), Univ Dublin, Trinity Coll Dublin, Dublin, Ireland.	Gary.Moran@dental.tcd.ie; Derek.Sullivan@dental.tcd.ie	Sullivan, Derek/A-8269-2008; Flanagan, Peter R/ABB-3713-2021; Moran, Gary/F-3116-2012	Flanagan, Peter R/0000-0002-4690-0560; Moran, Gary/0000-0003-0469-1788; Fletcher, Jessica/0000-0002-8737-1538	Dublin Dental University Hospital; Science Foundation Ireland [11/RFP.1/GEN/3042]	Dublin Dental University Hospital; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The project was supported by the Dublin Dental University Hospital and Science Foundation Ireland (11/RFP.1/GEN/3042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MZ, 2015, GENETICS, V200, P907, DOI 10.1534/genetics.115.177451; Anderson MZ, 2012, EUKARYOT CELL, V11, P1268, DOI 10.1128/EC.00230-12; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Dunn MJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007326; Flanagan PR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00477-17; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Haran J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004658; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hirakawa MP, 2015, GENOME RES, V25, P413, DOI 10.1101/gr.174623.114; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Lee KL, 2009, SABOURAUDIA J MED VE, V13, P148; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu ZL, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01342-17; Liu ZL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006373; Lu Y, 2014, TRENDS MICROBIOL, V22, P707, DOI 10.1016/j.tim.2014.09.001; Moran GP, 2007, MOL MICROBIOL, V66, P915, DOI 10.1111/j.1365-2958.2007.05965.x; Moran GP, 2012, INT J MICROBIOL, V2012, DOI [10.1155/2012/, DOI 10.1155/2012/]; Nishikawa JL, 2016, NATURE, V530, P485, DOI 10.1038/nature16963; Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Staib P, 2001, J BACTERIOL, V183, P2859, DOI 10.1128/JB.183.9.2859-2865.2001; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Uwamahoro N, 2012, PLOS GENET, V8, P54, DOI 10.1371/journal.pgen.1002613; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; Yang Yun-Liang, 2003, Journal of Microbiology Immunology and Infection, V36, P223; Zhang AD, 2012, EUKARYOT CELL, V11, P874, DOI 10.1128/EC.00095-12	29	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200852	10.1371/journal.pone.0200852	http://dx.doi.org/10.1371/journal.pone.0200852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028853	Green Published, gold, Green Submitted			2022-12-26	WOS:000439396900019
J	Kerrick, WGL; Xu, YY; Percival, JM				Kerrick, W. Glenn L.; Xu, Yuanyuan; Percival, Justin M.			nNOS splice variants differentially regulate myofilament function but are dispensable for intracellular calcium and force transients in cardiac papillary muscles	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CA2+ ACTIVATION; S-NITROSYLATION; RATE-CONSTANT; CONTRACTION; FIBERS; HEART; LEAK; DISSOCIATION; BETA	Cardiac muscle expresses three neuronal nitric oxide synthase (nNOS) splice variants: nNOS alpha, nNOS mu and nNOS beta. The functions of these nNOS splice variants in cardiac muscle, particularly myofilament-associated nNOS beta are unclear. To decipher cardiac nNOS splice variant function we investigated myofilament function and intracellular calcium and force transients in demembranated and intact papillary muscles from two lines of nNOS knockout mice. The first line (KN1) lacks nNOS alpha and nNOS mu. The second line (KN2) lacks active nNOS alpha, nNOS mu and nNOS beta. Demembranated KN1 papillary muscles exhibited reduced myofilament ATPase activity (-35%) and specific force (-10%) relative to controls. Demembranated KN2 muscles exhibited a smaller decrease in myofilament ATPase activity (-21 %), but a greater reduction in specific force (-26%) relative to controls. Myofilament calcium sensitivity in demembranated KN1 and KN2 papillary muscles was similar to controls. Thus, papillary muscle-expressed nNOS splice variants are necessary for control levels of myofilament ATPase activity and force generation, but dispensable for myofilament calcium sensitivity. The greater reduction in myofilament ATPase relative to specific force in KN1, but not KN2 muscle, reduced the energy cost of muscle contraction, suggesting that nNOS beta increased the energetic efficiency of contraction in the absence of nNOS mu and nNOS alpha. Analyses of intact KN1 and KN2 papillary muscles showed that both intracellular calcium transients and their evoked force transients were similar to controls at stimulation frequencies between 1 and 3 Hz. Therefore, nNOS was dispensable for baseline excitation-contraction coupling. In summary, these data suggest that nNOS splice variants differentially regulate myofilament function, but not baseline calcium handling in papillary muscles. More importantly, they suggest that nNOS beta is a novel modulator of myofilament function, and ultimately the energetic efficiency of cardiac papillary muscle contraction.	[Kerrick, W. Glenn L.; Xu, Yuanyuan] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Xu, Yuanyuan; Percival, Justin M.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami; University of Miami	Percival, JM (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	j.percival@med.miami.edu		Percival, Justin/0000-0002-7482-4841				Allen K, 2000, J APPL PHYSIOL, V88, P180, DOI 10.1152/jappl.2000.88.1.180; Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; Carnicer R, 2017, CARDIOVASC RES, V113, P321, DOI 10.1093/cvr/cvx002; Carnicer R, 2013, ANTIOXID REDOX SIGN, V18, P1078, DOI 10.1089/ars.2012.4824; Dulce RA, 2015, CIRC RES, V116, P46, DOI 10.1161/CIRCRESAHA.116.305172; Dulce RA, 2013, J BIOL CHEM, V288, P6522, DOI 10.1074/jbc.M112.412130; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; Evangelista AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011209; Figueiredo-Freitas C, 2015, ANTIOXID REDOX SIGN, V23, P1017, DOI 10.1089/ars.2015.6275; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; GUTH K, 1986, PFLUG ARCH EUR J PHY, V407, P552, DOI 10.1007/BF00657515; Gyurko R, 2002, ENDOCRINOLOGY, V143, P2767, DOI 10.1210/en.143.7.2767; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Jang JH, 2015, NITRIC OXIDE-BIOL CH, V50, P20, DOI 10.1016/j.niox.2015.07.005; KERRICK WGL, 1991, J MUSCLE RES CELL M, V12, P53, DOI 10.1007/BF01781174; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Percival Justin M, 2011, Biophys Rev, V3, P209, DOI 10.1007/s12551-011-0060-9; Percival JM, 2010, J CLIN INVEST, V120, P816, DOI 10.1172/JCI40736; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; Robinson JM, 2002, J MOL BIOL, V322, P1065, DOI 10.1016/S0022-2836(02)00855-0; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Szczesna-Cordary D, 2007, FASEB J, V21, P3974, DOI 10.1096/fj.07-8630com; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Zhang YH, 2014, J PHYSIOL-LONDON, V592, P3189, DOI 10.1113/jphysiol.2013.270306; Ziolo MT, 2014, ANTIOXID REDOX SIGN, V21, P2044, DOI 10.1089/ars.2014.5873	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200834	10.1371/journal.pone.0200834	http://dx.doi.org/10.1371/journal.pone.0200834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028847	gold, Green Submitted, Green Published			2022-12-26	WOS:000439396900018
J	DeClercq, V; Langille, MGI; Van Limbergen, J				DeClercq, Vanessa; Langille, Morgan G., I; Van Limbergen, Johan			Differences in adiposity and diet quality among individuals with inflammatory bowel disease in Eastern Canada	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CROHNS-DISEASE; BODY-COMPOSITION; LIFE-STYLE; MASS INDEX; RISK; NUTRITION; IMPACT; PREVALENCE; EXERCISE	The objective of the current study was to characterize the relationship between diet quality and body composition in participants living with IBD, specifically Crohn's disease (CD) or ulcerative colitis (UC), in Atlantic Canada. Participants from the Atlantic Partnership for Tomorrow's Health (PATH) study are residents of one of the four Atlantic Canada provinces. Participants who completed the dietary questionnaire and had body composition measured were included in the study (n = 12,462 without IBD, n = 111 CD, n = 119 UC). A greater number of participants with IBD reported having multiple chronic conditions compared to those without IBD. Those with UC had statistically higher body weight and body mass index (BMI) compared to those without IBD. Overall, significant positive correlations were observed between adiposity and servings of refined grains, and meats and alternatives such as eggs and fish, whereas negative correlations were observed with servings of vegetables, fruit, whole grains, and alternatives such as tofu, and nuts/seeds. Participants with IBD (both CD and UC) consumed more refined grains than those without IBD. Using logistic regression analysis, participants consuming more servings of vegetables and whole grains were less likely to have CD where as those consuming more serving of fruit and bean/legumes were less likely to have UC. In the Atlantic PATH cohort, which includes a region of the world with a high incidence of IBD, distinct differences in adiposity and diet quality were observed in individuals with specific types of IBD compared to those without. There is a need for collaborative efforts to address weight management and diet quality issues in those living with IBD in the Atlantic Canadian region.	[DeClercq, Vanessa] Dalhousie Univ, Populat Canc Res Program, Halifax, NS, Canada; [Langille, Morgan G., I] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Van Limbergen, Johan] Dalhousie Univ, IWK Hlth Ctr, Div Pediat Gastroenterol & Nutr, Dept Pediat, Halifax, NS, Canada; [Van Limbergen, Johan] Dalhousie Univ, Dept Med, Div Digest Care & Endoscopy, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	DeClercq, V (corresponding author), Dalhousie Univ, Populat Canc Res Program, Halifax, NS, Canada.	vanessa.de.clercq@dal.ca	Van Limbergen, Johan/L-1855-2019	Van Limbergen, Johan/0000-0001-5822-4371; Langille, Morgan/0000-0002-6604-3009; DeClercq, Vanessa/0000-0003-4724-7089	Canadian Partnership Against Cancer; Health Canada; Nova Scotia Health Research Foundation (NSHRF); IWK Health Centre; Canadian Institutes of Health Research (CIHR)-CAG-CCC New Investigator Award [201412XGP 340307-205026]; Canadian Foundation of Innovation [35235]; CIHR-SPOR-Chronic Diseases grant (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE - SPOR chronic disease network)	Canadian Partnership Against Cancer; Health Canada; Nova Scotia Health Research Foundation (NSHRF); IWK Health Centre; Canadian Institutes of Health Research (CIHR)-CAG-CCC New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); CIHR-SPOR-Chronic Diseases grant (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE - SPOR chronic disease network)	This work was supported by the following institutions: Canadian Partnership Against Cancer (VD), https://www.partnershipagainstcancer.ca/; Health Canada (VD), https://www.canada.ca/en/health-canada.html; Nova Scotia Health Research Foundation (NSHRF) establishment award (2015-2017) (JVL), https://www.nshrf.ca/; Donation from the MacLeod family (JVL); IWK Health Centre Research Associateship grant (JVL), http://www.iwk.nshealth.ca/corporate-home; Canadian Institutes of Health Research (CIHR)-CAG-CCC New Investigator Award (2015-2020: 201412XGP 340307-205026) (JVL), http://www.cihr-irsc.gc.ca/e/37788.html; Canadian Foundation of Innovation John R. Evans Leadership fund (#35235) (JVL), https://innovation.ca/; and CIHR-SPOR-Chronic Diseases grant (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE - SPOR chronic disease network) (JVL), http://www.cihr-irsc.gc.ca/e/45854.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090962; Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; Uranga JA, 2016, PHARMACOL REP, V68, P816, DOI 10.1016/j.pharep.2016.05.002; Bahler C, 2017, EUR J GASTROEN HEPAT, V29, P916, DOI 10.1097/MEG.0000000000000891; Bao Y, 2013, NEW ENGL J MED, V369, P2001, DOI 10.1056/NEJMoa1307352; Barnes EL, 2017, CLIN GASTROENTEROL H, V15, P1390, DOI 10.1016/j.cgh.2016.12.036; Benchimol EI, 2017, AM J GASTROENTEROL, V112, P1120, DOI 10.1038/ajg.2017.97; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bilski J, 2013, J PHYSIOL PHARMACOL, V64, P143; Boneh RS, 2017, J CROHNS COLITIS, V11, P1205, DOI 10.1093/ecco-jcc/jjx071; Brotherton CS, 2016, CLIN GASTROENTEROL H, V14, P1130, DOI 10.1016/j.cgh.2015.12.029; Bryant RV, 2015, ALIMENT PHARM THER, V41, P895, DOI 10.1111/apt.13156; Bryant RV, 2013, ALIMENT PHARM THER, V38, P213, DOI 10.1111/apt.12372; Cammarota G, 2015, PHARMACOL THERAPEUT, V149, P191, DOI 10.1016/j.pharmthera.2014.12.006; Chan D, 2014, FRONTLINE GASTROENTE, V5, P44, DOI 10.1136/flgastro-2013-100339; Cosnes J, 2010, DIGEST DIS, V28, P411, DOI 10.1159/000320395; D'Souza S, 2008, INFLAMM BOWEL DIS, V14, P367, DOI 10.1002/ibd.20333; DeClercq V, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101155; Ertek S, 2012, ARCH MED SCI, V8, P794, DOI 10.5114/aoms.2012.31614; Halling ML, 2017, WORLD J GASTROENTERO, V23, P6137, DOI 10.3748/wjg.v23.i33.6137; Harper JW, 2013, INFLAMM BOWEL DIS, V19, P2118, DOI 10.1097/MIB.0b013e31829cf401; Health Canada, 2007, EATING WELL CANADAS; International Physical Activity Questionnaire, 2005, INT PHYS ACT QUEST; International Physical Activity Questionnaires, 2002, INT PHYS ACT QUEST; Lee N, 2009, J BONE MINER METAB, V27, P456, DOI 10.1007/s00774-009-0059-5; Lewis JD, 2017, GASTROENTEROLOGY, V152, P398, DOI 10.1053/j.gastro.2016.10.019; Lim Gregory B, 2018, Nat Rev Cardiol, V15, P4, DOI 10.1038/nrcardio.2017.196; M'Koma AE, 2013, CLIN MED INSIGHTS-GA, V6, P33, DOI 10.4137/CGast.S12731; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moran-Ramos S, 2017, ARCH MED RES; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Niewiadomski O, 2016, INTERN MED J, V46, P669, DOI 10.1111/imj.13094; Owczarek D, 2016, WORLD J GASTROENTERO, V22, P895, DOI 10.3748/wjg.v22.i3.895; Park SY, 2017, GASTROENTEROLOGY, V153, P386, DOI 10.1053/j.gastro.2017.04.004; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Rapozo DCM, 2017, WORLD J GASTROENTERO, V23, P2124, DOI 10.3748/wjg.v23.i12.2124; Rocchi A, 2012, CAN J GASTROENTEROL, V26, P811, DOI 10.1155/2012/984575; Saint-Jacques N, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0094-2; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Sigall-Boneh R, 2017, J CROHNS COLITIS, V11, P1407, DOI 10.1093/ecco-jcc/jjx109; Sigall-Boneh R, 2014, INFLAMM BOWEL DIS, V20, P1353, DOI 10.1097/MIB.0000000000000110; Sotos-Prieto M, 2017, NEW ENGL J MED, V377, P143, DOI [10.1056/NEJMoa1613502, 10.1056/nejmoa1613502]; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Sweeney E, 2017, INT J EPIDEMIOL, V46, P1762, DOI 10.1093/ije/dyx124; Sylvester FA, 2009, CLIN GASTROENTEROL H, V7, P452, DOI 10.1016/j.cgh.2008.12.017; Tew GA, 2016, INFLAMM BOWEL DIS, V22, P2933, DOI 10.1097/MIB.0000000000000962; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Turnbaugh PJ, 2017, CELL HOST MICROBE, V21, P278, DOI 10.1016/j.chom.2017.02.021; Wilund KR, 2007, CLIN SCI, V112, P543, DOI 10.1042/CS20060368; YU ZM, 2018, BMJ OPEN, V8, DOI DOI 10.1136/BMJ0PEN-2017-018060	52	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200580	10.1371/journal.pone.0200580	http://dx.doi.org/10.1371/journal.pone.0200580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024912	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000030
J	Huang, HW; Yan, LM; Yang, YL; He, X; Sun, XM; Wang, YM; Zhang, GB; Zhou, JX				Huang, Hua-Wei; Yan, Li-Mei; Yang, Yan-Lin; He, Xuan; Sun, Xiu-Mei; Wang, Yu-Mei; Zhang, Guo-Bin; Zhou, Jian-Xin			Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study	PLOS ONE			English	Article							TENSION PNEUMOCEPHALUS; NEUROSURGICAL PATIENTS; SUPRATENTORIAL CRANIOTOMY; INFRATENTORIAL CRANIOTOMY; EMERGENCE AGITATION; GENERAL-ANESTHESIA; DELAYED EXTUBATION; INTRACRANIAL AIR; SUPINE POSITION; DELIRIUM	Postoperative agitation frequently occurs after general anesthesia and may be associated with serious consequences. However, studies in neurosurgical patients have been in- adequate. We aimed to investigate the incidence and risk factors for early postoperative agitation in patients after craniotomy, specifically focusing on the association between post- operative pneumocephalus and agitation. Adult intensive care unit admitted patients after elective craniotomy under general anesthesia were consecutively enrolled. Patients were assessed using the Sedation-Agitation Scale during the first 24 hours after operation. The patients were divided into two groups based on their maximal Sedation-Agitation Scale: the agitation (Sedation-Agitation Scale >= 5) and non-agitation groups (Sedation-Agitation Scale <= 4). Preoperative baseline data, intraoperative and intensive care unit admission data were recorded and analyzed. Each patient's computed tomography scan obtained within six hours after operation was retrospectively reviewed. Modified Rankin Scale and hospital length of stay after the surgery were also collected. Of the 400 enrolled patients, agitation occurred in 13.0% (95% confidential interval: 9.7-16.3%). Body mass index, total intrave- nous anesthesia, intraoperative fluid intake, intraoperative bleeding and transfusion, consciousness after operation, endotracheal intubation kept at intensive care unit admission and mechanical ventilation, hyperglycemia without a history of diabetes, self-reported pain and postoperative bi-frontal pneumocephalus were used to build a multivariable model. Bi-frontal pneumocephalus and delayed extubation after the operation were identified as inde- pendent risk factors for postoperative agitation. After adjustment for confounding, postoperative agitation was independently associated with worse neurologic outcome (odd ratio: 5.4, 95% confidential interval: 1.1-28.9, P = 0.048). Our results showed that early postoperative agitation was prevalent among post-craniotomy patients and was associated with adverse outcomes. Improvements in clinical strategies relevant to bi-frontal pneumocephalus should be considered.	[Huang, Hua-Wei; Yan, Li-Mei; Yang, Yan-Lin; He, Xuan; Sun, Xiu-Mei; Wang, Yu-Mei; Zhou, Jian-Xin] Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Yan, Li-Mei] Inner Mongolia Peoples Hosp, Dept Crit Care Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Guo-Bin] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhou, JX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China.	zhoujx.cn@icloud.com		Zhou, Jianxin/0000-0003-1320-0979	Beijing Municipal Administration of Hospital [DFL20150502]	Beijing Municipal Administration of Hospital	This study was supported by grants from the Beijing Municipal Administration of Hospital (DFL20150502). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastola P, 2015, INDIAN J ANAESTH, V59, P287, DOI 10.4103/0019-5049.156868; Bruder N, 1999, ANESTH ANALG, V89, P674, DOI 10.1097/00000539-199909000-00027; Bruder N, 1999, J NEUROSURG ANESTH, V11, P282, DOI 10.1097/00008506-199910000-00009; Bruder Nicolas J, 2002, Curr Opin Anaesthesiol, V15, P477, DOI 10.1097/00001503-200210000-00001; Bui JQH, 2011, J NEUROSURG, V115, P1236, DOI 10.3171/2011.8.JNS11105; Cai YH, 2013, J INT MED RES, V41, P208, DOI 10.1177/0300060513475964; Card E, 2015, BRIT J ANAESTH, V115, P411, DOI 10.1093/bja/aeu442; Cata JP, 2011, J NEUROSURG ANESTH, V23, P25, DOI 10.1097/ANA.0b013e3181eee548; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114239; Chevrolet JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5787; Citerio G, 2012, EUR J ANAESTH, V29, P371, DOI 10.1097/EJA.0b013e32835422db; Dabdoub Carlos B, 2015, Surg Neurol Int, V6, P155, DOI 10.4103/2152-7806.166195; Fabregas N, 2007, BEST PRACT RES-CLIN, V21, P431, DOI 10.1016/j.bpa.2007.06.006; Gruenbaum SE, 2017, ANESTH ANALG, V125, P556, DOI 10.1213/ANE.0000000000001946; Hernandez BA, 2017, BRIT J ANAESTH, V119, P288, DOI 10.1093/bja/aex197; Ihab Zidan, 2012, Asian J Neurosurg, V7, P66, DOI 10.4103/1793-5482.98647; ISHIWATA Y, 1988, J NEUROSURG, V68, P58, DOI 10.3171/jns.1988.68.1.0058; Kanaya N, 2002, CAN J ANAESTH, V49, P638, DOI 10.1007/BF03017400; Kim HJ, 2015, CLIN EXP OTORHINOLAR, V8, P46, DOI 10.3342/ceo.2015.8.1.46; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Munk L, 2016, ACTA ANAESTH SCAND, V60, P1059, DOI 10.1111/aas.12717; Oh YS, 2008, J KOREAN NEUROSURG S, V43, P143, DOI 10.3340/jkns.2008.43.3.143; OSBORN AG, 1978, J NEUROSURG, V48, P355, DOI 10.3171/jns.1978.48.3.0355; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Prabhakar H, 2003, J NEUROSURG ANESTH, V15, P278, DOI 10.1097/00008506-200307000-00019; Radtke FM, 2010, MINERVA ANESTESIOL, V76, P394; REASONER DK, 1994, ANESTHESIOLOGY, V80, P1008, DOI 10.1097/00000542-199405000-00009; Reponen E, 2016, WORLD NEUROSURG, V91, P567, DOI 10.1016/j.wneu.2016.03.102; Rhondali O, 2011, J NEUROSURG ANESTH, V23, P118, DOI 10.1097/ANA.0b013e318206d5f8; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Satapathy GC, 2000, BRIT J ANAESTH, V84, P115, DOI 10.1093/oxfordjournals.bja.a013368; Sinclair AG, 2010, RADIOGRAPHICS, V30, P461, DOI 10.1148/rg.302095115; TODD MM, 1993, ANESTHESIOLOGY, V78, P1005, DOI 10.1097/00000542-199306000-00002; TOUNG TJK, 1986, ANESTH ANALG, V65, P65; Wannemuehler TJ, 2016, OTOL NEUROTOL, V37, pE322, DOI 10.1097/MAO.0000000000001141; Wu YX, 2017, J NEUROSURG ANESTH, V29, P281, DOI 10.1097/ANA.0000000000000311; Yu DH, 2010, CAN J ANESTH, V57, P843, DOI 10.1007/s12630-010-9338-9; Zhao LH, 2017, J NEUROSURG ANESTH, V29, P132, DOI 10.1097/ANA.0000000000000260; Ziai WC, 2003, CRIT CARE MED, V31, P2782, DOI 10.1097/01.CCM.0000098860.52812.24; Zimmerman JE, 1998, NEUROSURGERY, V42, P91, DOI 10.1097/00006123-199801000-00019	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201064	10.1371/journal.pone.0201064	http://dx.doi.org/10.1371/journal.pone.0201064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024979	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000086
J	Schmid, S; Bogner, FX				Schmid, Sarah; Bogner, Franz X.			Is there more than the sewage plant? University freshmen's conceptions of the urban water cycle	PLOS ONE			English	Article							MISCONCEPTIONS; STUDENTS; KNOWLEDGE; GENETICS	The concepts of 340 university freshmen concerning urban water cycles include various misconceptions (or intuitive conceptions) which severely contrast with correct scientific ones. Almost no student knew the correct urban water cycle in total, including cycle steps in the appropriate sequence: consumer (given), sewage-plant, nature and waterworks. Concepts mainly omit nature and waterworks, only the sewage plant is included in almost all concepts. This reflects an exaggeration of the importance of the cycle-step sewage plant relative to the other steps, when the topic is taught in school. Students acquired knowledge from two main sources: School and media. Most students are aware of the origin of drinking water, although several concepts reflect a pipe-to-pipe system, where wastewater is cleared in sewage plants and brought back to consumers, skipping the roles of nature and waterworks. Everyday matters with an important impact on our life-standards, like the urban water cycle, need specific attention during school time. Currently, only primary school syllabi include the issue of urban water cycles in Germany. More effort is needed to explain wastewater and drinking water issues in order to correct misconceptions.	[Schmid, Sarah; Bogner, Franz X.] Univ Bayreuth, Dept Biol Educ, ZMNU Ctr Math & Sci Educ, Bayreuth, Bavaria, Germany	University of Bayreuth	Schmid, S (corresponding author), Univ Bayreuth, Dept Biol Educ, ZMNU Ctr Math & Sci Educ, Bayreuth, Bavaria, Germany.	Sarah.schmid@uni-bayreuth.de			BMBF (Federal Ministry of Education and Research) [WAVE2015-820-3290-055]; German Research Foundation (DFG); University of Bayreuth; TrinkWave: Planungsoptionen und Technologien der Wasserwiederverwendung zur Stutzung der Trinkwasserversorgung in urbanen Wasserkreislaufen	BMBF (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth; TrinkWave: Planungsoptionen und Technologien der Wasserwiederverwendung zur Stutzung der Trinkwasserversorgung in urbanen Wasserkreislaufen	This study was funded by the BMBF (Federal Ministry of Education and Research): WAVE2015-820-3290-055; TrinkWave: Planungsoptionen und Technologien der Wasserwiederverwendung zur Stutzung der Trinkwasserversorgung in urbanen Wasserkreislaufen. All statements made by the authors need not necessarily reflect the opinion of the BMBF. Furthermore the study was funded by the German Research Foundation (DFG), and the University of Bayreuth in the funding program Open Access Publishing.	Andresen L., UNDERSTANDING ADULT, P225; Assaraf OB, 2012, CULT STUD SCI EDUCAT, V7, P451, DOI 10.1007/s11422-012-9391-5; Bahar M., 2003, EDUC SCI-THEOR PRACT, V3, P55; Bartel H., 2014, WASSERWIRTSCHATT DEU; Ben-zvi-assaraf O, 2001, NARST ERIC; BMJV, 2001, VER QUAL WASS MENSCH; Bortz J., 2010, FORSCHUNGSMETHODEN E; Brody M.J., 1993, ANN M AM ED RES ASS; Dekker S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00429; diSessa A., 1988, CONSTRUCTISIM COMPUT; Duit R, 2003, INT J SCI EDUC, V25, P671, DOI 10.1080/09500690305016; Fremerey C., 2014, Journal of Water Resource and Protection, V6, P1112, DOI 10.4236/jwarp.2014.612104; Fremerey C, 2015, STUD EDUC EVAL, V44, P9, DOI 10.1016/j.stueduc.2014.11.002; Futschek G., 2013, 10 WORLD C COMP ED J; Gilbert JK, 1982, SCI EDUC, V66, P623, DOI DOI 10.1002/SCE.3730660412; Gropengiesser H., THESIS, P105; Gunckel KL, 2012, J RES SCI TEACH, V49, P843, DOI 10.1002/tea.21024; Hammer D, 1996, AM J PHYS, V64, P1316, DOI 10.1119/1.18376; HEWSON MG, 1983, J RES SCI TEACH, V20, P731, DOI 10.1002/tea.3660200804; Hewson P. W., 1981, European Journal of Science Education, V3, P383, DOI 10.1080/0140528810304004; LAWSON AE, 1988, J RES SCI TEACH, V25, P733, DOI 10.1002/tea.3660250904; Lieflander A.K, 2016, PSYECOLOGY, V7, P25, DOI 10.1080/21711976.2015.1114216; Mayring P., 2015, QUALITATIVE INHALTSA, Vtwelfth; Ministerium fr Kultus,, 2014, JUG SPORT BAD WURTT; Ministerium fur Kultus, 2016, JUG SPORT BAD WURTT; Mohapatra A.K., 2009, INDIAN J SCI TECHNOL, V2, P72; Osterlind K, 2005, INT J SCI EDUC, V27, P891, DOI 10.1080/09500690500038264; Pajares F, 2002, THEOR PRACT, V41, P116, DOI 10.1207/s15430421tip4102_8; Posner G.J., 1982, SCI ED, V66, P211, DOI [10.1002/sce.3730660207, https://doi.org/10.1002/sce.3730660207]; Schmid S, 2015, EDUC RES INT, V2015, DOI 10.1155/2015/826734; Senatsverwaltung fur Bildung, 2006, JUG SPORT BERL RAHM; Senatsverwaltung fur Bildung Jugend und Familie (Berlin) Ministeriums fur Bildung, 2017, JUG SPORT LAND BRAND; Shaw KRM, 2008, GENETICS, V178, P1157, DOI 10.1534/genetics.107.084194; Smith J.P., 1993, J LEARN SCI, V3, P115, DOI [https://doi.org/10.1207/s15327809jls0302_1, DOI 10.1207/S15327809JLS0302_1, 10.1207/s15327809jls0302_1]; Staatsinstitut fur Schulqualitat und Bildungsforschung (ISB), 2004, LEHRPL GYMN BAYERN; Staatsinstitut fur Schulqualitat und Bildungsforschung (ISB), 2017, LEHRPL PLUS GRUNDSCH; Tekkaya C., 2003, RES SCI TECHNOLOGICA, V21, P5, DOI DOI 10.1080/02635140308340; Umweltbundesamt, 2015, BER BUND GES UMW BBG; van Merrienboer JJG, 2005, EDUC PSYCHOL REV, V17, P147, DOI 10.1007/s10648-005-3951-0; Wandersee J. H., 1994, HDB RES SCI TEACHING, P177	40	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200928	10.1371/journal.pone.0200928	http://dx.doi.org/10.1371/journal.pone.0200928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024937	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000069
J	Schweitzer, GG; Collier, SL; Chen, ZJ; McCommis, KS; Pittman, SK; Yoshino, J; Matkovich, SJ; Hsu, FF; Chrast, R; Eaton, JM; Harris, TE; Weihl, CC; Finck, BN				Schweitzer, George G.; Collier, Sara L.; Chen, Zhouji; McCommis, Kyle S.; Pittman, Sara K.; Yoshino, Jun; Matkovich, Scot J.; Hsu, Fong-Fu; Chrast, Roman; Eaton, James M.; Harris, Thurl E.; Weihl, Conrad C.; Finck, Brian N.			Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice	FASEB JOURNAL			English	Article						LPIN1; rhabdomyolysis; diacylglycerol; triacylglycerol; autophagy	PYRUVATE CARRIER 2; LPIN1; RHABDOMYOLYSIS; CLEARANCE; MUTATIONS; AUTOPHAGY; CONTRIBUTES; DEFICIENCY; RESISTANCE; LYSOSOMES	Lipin 1 regulates glycerolipid homeostasis by acting as a phosphatidic acid phosphohydrolase (PAP) enzyme in the triglyceride-synthesis pathway and by regulating transcription factor activity. Mutations in human lipin 1 are a common cause of recurrent rhabdomyolysis in children. Mice with constitutive whole-body lipin 1 deficiency have been used to examine mechanisms connecting lipin 1 deficiency to myocyte injury. However, that mouse model is confounded by lipodystrophy not phenocopied in people. Herein, 2 muscle-specific mouse models were studied: 1) Lpin1 exon 3 and 4 deletion, resulting in a hypomorphic protein without PAP activity, but which preserved transcriptional coregulatory function; and 2) Lpin1 exon 7 deletion, resulting in total protein loss. In both models, skeletal muscles exhibited a chronic myopathy with ongoing muscle fiber necrosis and regeneration and accumulation of phosphatidic acid and, paradoxically, diacylglycerol. Additionally, lipin 1-deficient mice had abundant, but abnormal, mitochondria likely because of impaired autophagy. Finally, these mice exhibited increased plasma creatine kinase following exhaustive exercise when unfed. These data suggest that mice lacking lipin 1-mediated PAP activity in skeletal muscle may serve as a model for determining the mechanisms by which lipin 1 deficiency leads to myocyte injury and for testing potential therapeutic approaches.Schweitzer, G. G., Collier, S. L., Chen, Z., McCommis, K. S., Pittman, S. K., Yoshino, J., Matkovich, S. J., Hsu, F.-F., Chrast, R., Eaton, J. M., Harris, T. E., Weihl, C. C., Finck, B. N. Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice.	[Schweitzer, George G.; Collier, Sara L.; Chen, Zhouji; McCommis, Kyle S.; Yoshino, Jun; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Pittman, Sara K.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Chrast, Roman] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Chrast, Roman] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Eaton, James M.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Karolinska Institutet; University of Virginia	Finck, BN (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	bfinck@wustl.edu	Matkovich, Scot J/B-9077-2009; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Yoshino, Jun/0000-0001-9833-4356; Finck, Brian/0000-0001-5411-3674; McCommis, Kyle/0000-0003-2381-1589; Hsu, Fong-Fu/0000-0001-5368-0183; Chrast, Roman/0000-0003-4189-3514	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK078187]; NIH National Heart, Lung, and Blood Institute [R01 HL119225, T32 HL007275, T32 HL007081]; Washington University Institute of Clinical and Translational Sciences NIH from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000448, KL2 TR000450]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [T32-DK007120, R01 DK101946]; Washington University Institute of Clinical and Translational Sciences NIH Grant [UL1 TR000448, KL2 TR000450]; NIH National Institute on Aging [R01 AG031867]; Washington University Nutrition Obesity Research Center [P30 DK56341]; Diabetes Research Center (DRC) [P30 DK020579]; Metabolomics Facility at Washington University [P30 DK056341]; Washington University NIH National Institute of General Medical Sciences Biomedical Mass Spectrometry Resource [P41 GM103422]; Washington University Genome Technology Access Center in the Department of Genetics [P30 CA91842]; Department of Pathology DRC Electron Microscopy Facility [P60 DK020579]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR002346, KL2TR000450, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119225, T32HL007081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068797, K24AR073317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104995, P30DK056341, R01DK101946, P30DK020579, T32DK007120, R01DK078187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422, T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031867] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington University Institute of Clinical and Translational Sciences NIH from the National Center for Advancing Translational Sciences (NCATS); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Washington University Institute of Clinical and Translational Sciences NIH Grant; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Washington University Nutrition Obesity Research Center; Diabetes Research Center (DRC); Metabolomics Facility at Washington University; Washington University NIH National Institute of General Medical Sciences Biomedical Mass Spectrometry Resource; Washington University Genome Technology Access Center in the Department of Genetics; Department of Pathology DRC Electron Microscopy Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Alan Pestronk and Dr. Abhinav Diwan for technical assistance in interpreting histology, and Dennis J. Dietzen for determining plasma creatine kinase (all from Washington University). This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK078187 and NIH National Heart, Lung, and Blood Institute Grant R01 HL119225 (to B.N.F.). G.G.S. was supported by NIH National Heart, Lung, and Blood Institute Grants T32 HL007275, T32 HL007081, and the Washington University Institute of Clinical and Translational Sciences NIH Grant UL1 TR000448, Subaward KL2 TR000450, from the National Center for Advancing Translational Sciences (NCATS). K.S.M. was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant T32-DK007120. J.Y. was supported by Washington University Institute of Clinical and Translational Sciences NIH Grant UL1 TR000448, Subaward KL2 TR000450. T.E.H. and J.M.E. were supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK101946. C.C.W. and S.K.P were supported by NIH National Institute on Aging Grant R01 AG031867. This work was also supported by the cores of the Washington University Nutrition Obesity Research Center (Grant P30 DK56341), Diabetes Research Center (DRC) (Grant P30 DK020579), the Metabolomics Facility at Washington University (Grant P30 DK056341), and the Washington University NIH National Institute of General Medical Sciences Biomedical Mass Spectrometry Resource (Grant P41 GM103422) to F.-F.H.; the Washington University Genome Technology Access Center in the Department of Genetics (Grant P30 CA91842); and the Department of Pathology DRC Electron Microscopy Facility (Grant P60 DK020579). The authors declare no conflicts of interest.	Alshudukhi AA, 2018, FASEB J, V32, P6796, DOI 10.1096/fj.201800374; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Bergounioux J, 2012, J PEDIATR-US, V160, P1052, DOI 10.1016/j.jpeds.2012.02.033; Chen ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051320; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; De Palma C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00188; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Frazier EP, 2011, MATRIX BIOL, V30, P154, DOI 10.1016/j.matbio.2010.12.004; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hu JS, 2007, J MEMBRANE BIOL, V215, P27, DOI 10.1007/s00232-007-9002-7; Jaradat SA, 2016, META GENE, V7, P90, DOI 10.1016/j.mgene.2015.12.003; Jiang WH, 2015, J BIOL CHEM, V290, P23646, DOI 10.1074/jbc.M115.686519; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; Legendre A, 2018, MOL GENET METAB, V123, P375, DOI 10.1016/j.ymgme.2017.12.429; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; MARTIN A, 1987, BIOCHEM J, V245, P347, DOI 10.1042/bj2450347; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Meijer IA, 2015, MOLEC GENET METAB RE, V5, P85, DOI 10.1016/j.ymgmr.2015.10.010; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Michot C, 2012, J INHERIT METAB DIS, V35, P1119, DOI 10.1007/s10545-012-9461-6; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pichler K, 2015, MUSCLE NERVE, V52, P437, DOI 10.1002/mus.24749; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Reue K, 2000, J LIPID RES, V41, P1067; Ryan TE, 2014, J PHYSIOL-LONDON, V592, P3231, DOI 10.1113/jphysiol.2014.274456; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Schweitzer GG, 2015, JIMD REP, V23, P113, DOI 10.1007/8904_2015_440; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Soufi N, 2014, J BIOL CHEM, V289, P30177, DOI 10.1074/jbc.M114.595850; Timmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014503; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Yi YP, 2006, GEN PHYSIOL BIOPHYS, V25, P149; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhao K, 2012, J LIPID RES, V53, P2102, DOI 10.1194/jlr.M027557	49	13	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					652	667		10.1096/fj.201800361R	http://dx.doi.org/10.1096/fj.201800361R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30028636	Green Published			2022-12-26	WOS:000457401500051
J	Park, CK; Sanchez, JL; Barahona, C; Basantes, LE; Sanchez, J; Hernandez, C; Horton, NC				Park, Chad K.; Sanchez, Jonathan L.; Barahona, Claudia; Basantes, L. Emilia; Sanchez, Juan; Hernandez, Christian; Horton, N. C.			The run-on oligomer filament enzyme mechanism of SgrAI: Part 2. Kinetic modeling of the full DNA cleavage pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; allosteric regulation; DNA endonuclease; structure-function; alternation of enzyme specificity; control of enzyme activation; fiber forming enzyme; filament forming enzyme; Run-on oligomer mechanism	METABOLIC ENZYMES; SACCHAROMYCES-CEREVISIAE; RESTRICTION ENZYMES; REORGANIZATION; ENDONUCLEASE; EXPLORER; SEQUESTRATION; SPECTROMETRY; CYTOOPHIDIUM; SPECIFICITY	Filament or run-on oligomer formation by enzymes is now recognized as a widespread phenomenon with potentially unique enzyme regulatory properties and biological roles. SgrAI is an allosteric type II restriction endonuclease that forms run-on oligomeric filaments with activated DNA cleavage activity and altered DNA sequence specificity. In this two-part work, we measure individual steps in the run-on oligomer filament mechanism to address specific questions of cooperativity, trapping, filament growth mechanisms, and sequestration of activity using fluorophore-labeled DNA, kinetic FRET measurements, and reaction modeling with global data fitting. The final models and rate constants show that the assembly step involving association of SgrAI-DNA complexes into the run-on oligomer filament is relatively slow (3-4 orders of magnitude slower than diffusion limited) and rate-limiting at low to moderate concentrations of SgrAI-DNA. The disassembly step involving dissociation of complexes of SgrAI-DNA from each other in the run-on oligomer filament is the next slowest step but is fast enough to limit the residence time of any one copy of SgrAI or DNA within the dynamic filament. Further, the rate constant for DNA cleavage is found to be 4 orders of magnitude faster in the run-on oligomer filament than in isolated SgrAI-DNA complexes and faster than dissociation of SgrAI-DNA complexes from the run-on oligomer filament, making the reaction efficient in that each association into the filament likely leads to DNA cleavage before filament dissociation.	[Park, Chad K.; Sanchez, Jonathan L.; Barahona, Claudia; Basantes, L. Emilia; Sanchez, Juan; Hernandez, Christian; Horton, N. C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Horton, NC (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	nhorton@email.arizona.edu	Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284; Sanchez, Jonathan/0000-0003-0097-465X	National Science Foundation [MCB-1410355]; Office of the Director of the National Institutes of Health [S10OD013237]; NIGMS, National Institutes of Health [T32GM008659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD013237] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation Grant MCB-1410355, by the Office of the Director of the National Institutes of Health under Grant S10OD013237, and by the NIGMS, National Institutes of Health under Grant T32GM008659 (to J. L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Aughey GN, 2014, BIOL OPEN, V3, P1045, DOI 10.1242/bio.201410165; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Barry RM, 2011, CURR OPIN MICROBIOL, V14, P704, DOI 10.1016/j.mib.2011.09.015; Bitinaite J, 2002, MOL GENET GENOMICS, V267, P664, DOI 10.1007/s00438-002-0701-6; Dryden DTF, 2013, STRUCTURE, V21, P1720, DOI 10.1016/j.str.2013.09.009; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Hingorani-Varma K, 2003, J BIOL CHEM, V278, P40392, DOI 10.1074/jbc.M304603200; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Park CK, 2018, J BIOL CHEM, V293, P14585, DOI 10.1074/jbc.RA118.003680; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Prouteau M, 2017, NATURE, V550, P265, DOI 10.1038/nature24021; Sam MD, 1999, J AM CHEM SOC, V121, P1444, DOI 10.1021/ja983787q; Schmitt DL, 2016, ACS CHEM BIOL, V11, P1917, DOI 10.1021/acschembio.6b00039; Shah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124783; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Suresh HG, 2015, MOL BIOL CELL, V26, P1601, DOI 10.1091/mbc.E14-11-1559; Vajjhala PR, 2017, MOL IMMUNOL, V86, P23, DOI 10.1016/j.molimm.2017.02.012; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Zaganjor E, 2017, J CELL BIOL, V216, P2239, DOI 10.1083/jcb.201706005	39	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14599	14615		10.1074/jbc.RA118.003682	http://dx.doi.org/10.1074/jbc.RA118.003682			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30054273	Green Published, hybrid			2022-12-26	WOS:000446155000003
J	Cuypers, L; Perez, AB; Chueca, N; Aldamiz-Echevarria, T; Alados, JC; Martinez-Sapina, AM; Merino, D; Pineda, JA; Tellez, F; Espinosa, N; Salmeron, J; Rivero-Juarez, A; Vivancos, MJ; Hontanon, V; Vandamme, AM; Garcia, F				Cuypers, Lize; Belen Perez, Ana; Chueca, Natalia; Aldamiz-Echevarria, Teresa; Carlos Alados, Juan; Maria Martinez-Sapina, Ana; Merino, Dolores; Antonio Pineda, Juan; Tellez, Francisco; Espinosa, Nuria; Salmeron, Javier; Rivero-Juarez, Antonio; Jesus Vivancos, Maria; Hontanon, Victor; Vandamme, Anne-Mieke; Garcia, Federico			Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; VIRUS-INFECTION; INJECT DRUGS; RISK-FACTORS; HCV INFECTION; HIV; PEOPLE; TRANSMISSION; RESISTANCE; GENOTYPE	Despite high response rates associated to hepatitis C virus (HCV) treatment, no protective immunity is acquired, allowing for reinfection and continued infectiousness. Distinguishing between relapse and reinfection is crucial for patient counselling and to choose the most appropriate retreatment. Here, refined phylogenetic analysis using multiple genes served to assess genotype and reinfection for 53 patients for whom the virus was sampled before start of therapy and at time of sustained virological response evaluation at week 12. At baseline, genotypes were determined as HCV1a (41.5%), HCV1b (24.5%), HCV4 (18.9%) and HCV3a (15.1%), while six cases revealed to be discordantly assigned by phylogeny and commercial assays. Overall, 60.4% was co-infected with HIV. The large majority was classified as people who inject drugs (78.6%), often co-infected with HIV. Transmission was sexual in seven cases, of which five in HIV-positive men-who-have-sex-with-men. Overall, relapse was defined for 44 patients, while no conclusion was drawn for four patients. Five patients were reinfected with a different HCV strain, of which three with a different genotype, showing that phylogeny is needed not only to determine the genotype, but also to distinguish between relapse and intra-subtype reinfection. Of note, phylogenies are more reliable when longer fragments of the viral genome are being sequenced.	[Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Cuypers, Lize] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Belen Perez, Ana; Chueca, Natalia; Garcia, Federico] Univ Hosp San Cecilio Granada, Dept Clin Microbiol, Inst Invest Ibs, Granada, Spain; [Aldamiz-Echevarria, Teresa] Hosp Gregorio Maranon, Infect Dis Unit, Madrid, Spain; [Carlos Alados, Juan] Univ Hosp Jerez, Clin Microbiol, Cadiz, Spain; [Maria Martinez-Sapina, Ana] Hosp Miguel Servet, Clin Microbiol, Zaragoza, Spain; [Merino, Dolores] Hosp Infanta Elena, Clin Microbiol, Huelva, Spain; [Antonio Pineda, Juan] Univ Hosp Valme, Infect Dis Unit, Seville, Spain; [Tellez, Francisco] Hosp La Linea, AGS Campo Gibraltar, UGC Enfermedades Infecciosas & Microbiol, Cadiz, Spain; [Espinosa, Nuria] Hosp Virgen del Rocio, Clin Microbiol, Seville, Spain; [Salmeron, Javier] Univ Hosp San Cecilio Granada, Inst Invest Ibs, CIBERehd, Hepatol Unit, Granada, Spain; [Rivero-Juarez, Antonio] Univ Cordoba, Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Jesus Vivancos, Maria] Hosp Ramon & Cajal, Clin Microbiol, Madrid, Spain; [Hontanon, Victor] Univ Hosp La Paz, Clin Microbiol, Madrid, Spain; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Hyg & Trop Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal	KU Leuven; University of Oxford; Instituto de Investigacion Biosanitaria IBS Granada; General University Gregorio Maranon Hospital; Miguel Servet University Hospital; Hospital Valme; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Cuypers, L (corresponding author), Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.; Cuypers, L (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.	lize.cuypers@kuleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Pineda, Juan A./AAO-9312-2021; Garcia, Federico/AAA-3175-2020; Chueca, Natalia/T-9734-2019; Rivero-Juarez, Antonio/E-4528-2019; Cuypers, Lize/D-9460-2018	Vandamme, Anne-Mieke/0000-0002-6594-2766; Pineda, Juan A./0000-0002-3751-0296; Garcia, Federico/0000-0001-7611-781X; Chueca, Natalia/0000-0002-3420-3290; Perez, Ana Belen/0000-0001-9655-817X; Rivero-Juarez, Antonio/0000-0002-5813-6889; ALADOS ARBOLEDAS, JUAN CARLOS/0000-0001-5361-3968; Espinosa, Nuria/0000-0003-2249-2352; Hontanon Antonana, Victor/0000-0003-3070-2647; Cuypers, Lize/0000-0002-9433-8752; Tellez, Francisco/0000-0002-9997-6761	FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen) [G.0B23.17N]; Fondo de Investigacion Sanitaria [PI15/00713]; Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER [RD16/0025/0040]; Fundacion Progreso y salud, Junta de Andalucia [PI-0411-2014]; GEHEP-SEIMC [GEHEP-004]	FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER; Fundacion Progreso y salud, Junta de Andalucia(Junta de Andalucia); GEHEP-SEIMC	Part of this research was sponsored by FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen) grant G.0B23.17N. This work was supported in part by grants from Fondo de Investigacion Sanitaria (www.isciii.es) (PI15/00713), Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER (www.red.es/redes/inicio) (RD16/0025/0040), Fundacion Progreso y salud, Junta de Andalucia (http://www.juntadeandalucia.es/fundacionprogresoysalud/es) (PI-0411-2014), and GEHEP-SEIMC (GEHEP-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD/IDSA/IAS-USA, 2017, REC TEST MAN TREAT H; Abdel-Hakeem MS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00274; Abdelrahman T, 2015, HEPATOLOGY, V61, P88, DOI 10.1002/hep.27192; Aguilera A, 2017, J VIRAL HEPATITIS, V24, P725, DOI 10.1111/jvh.12700; Al-Qahtani AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44947; Apers L, 2015, JAIDS-J ACQ IMM DEF, V68, P585, DOI 10.1097/QAI.0000000000000528; Arrais TC, 2008, J MED VIROL, V80, P80, DOI 10.1002/jmv.21050; Bollepalli S, 2008, DIGEST DIS SCI, V53, P517, DOI 10.1007/s10620-007-9856-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chueca N, 2016, PLOS ONE, V11; Cunningham EB, 2015, NAT REV GASTRO HEPAT, V12, P218, DOI 10.1038/nrgastro.2015.36; Cuypers L, 2016, REV MED VIROL, V26, P408, DOI 10.1002/rmv.1895; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; European Association for the Study of the Liver, 2018, J HEPATOL; Fernandez-Caballero JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175564; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Grebely J, 2017, NAT REV GASTRO HEPAT, V14, P641, DOI 10.1038/nrgastro.2017.106; Hagan H, 2015, AIDS, V29, P2335, DOI 10.1097/QAD.0000000000000834; Hoornenborg E, 2017, AIDS, V31, P1603, DOI 10.1097/QAD.0000000000001522; Islam N, 2017, LANCET GASTROENTEROL, V2, P200, DOI 10.1016/S2468-1253(16)30182-0; Jacka B, 2016, J HEPATOL, V64, P1247, DOI 10.1016/j.jhep.2016.02.031; Jacka B, 2014, HEPATOLOGY, V60, P1571, DOI 10.1002/hep.27310; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Lea T, 2013, SEX HEALTH, V10, P448, DOI 10.1071/SH13042; Lemey P, 2005, AIDS, V19, P1551, DOI 10.1097/01.aids.0000182519.92030.ce; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Martin DP, 2017, METHODS MOL BIOL, V1525, P433, DOI 10.1007/978-1-4939-6622-6_17; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; Olmstead AD, 2015, INFECT GENET EVOL, V33, P101, DOI 10.1016/j.meegid.2015.04.017; Paraschiv S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185866; Perez AB, 2017, J HEPATOL, V66, pS313, DOI 10.1016/S0168-8278(17)30947-9; Poordad FF, 2009, ANTIVIR THER, V14, P303; Pradat P, 2017, J INFECTION, V75, P234, DOI 10.1016/j.jinf.2017.05.008; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quer J, 2015, J CLIN MICROBIOL, V53, P219, DOI 10.1128/JCM.02093-14; Robaeys G, 2016, J HEPATOL, V65, P1094, DOI 10.1016/j.jhep.2016.07.042; Sarrazin C, 2017, CLIN INFECT DIS, V64, P44, DOI 10.1093/cid/ciw676; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Silberstein FC, 2016, HEPATOLOGY, V63, P1058, DOI 10.1002/hep.27895; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Sorbo MC, 2018, DRUG RESIST UPDATE, V37, P17, DOI 10.1016/j.drup.2018.01.004; Stamatakis Alexandros, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi0614s51; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Urbanus AT, 2014, AIDS, V28, P781, DOI 10.1097/QAD.0000000000000126; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van der Meer AJ, 2016, J HEPATOL, V65, pS95, DOI 10.1016/j.jhep.2016.07.039	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201268	10.1371/journal.pone.0201268	http://dx.doi.org/10.1371/journal.pone.0201268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044871	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500099
J	Hammerman, M; Dietrich-Zagonel, F; Blomgran, P; Eliasson, P; Aspenberg, P				Hammerman, Malin; Dietrich-Zagonel, Franciele; Blomgran, Parmis; Eliasson, Pernilla; Aspenberg, Per			Different mechanisms activated by mild versus strong loading in rat Achilles tendon healing	PLOS ONE			English	Article							GENE-EXPRESSION; RUPTURE; REPAIR; INJURY	Background Mechanical loading stimulates Achilles tendon healing. However, various degrees of loading appear to have different effects on the mechanical properties of the healing tendon, and strong loading might create microdamage in the tissue. This suggests that different mechanisms might be activated depending on the magnitude of loading. The aim of this study was to investigate these mechanisms further. Methods Female rats had their right Achilles tendon cut transversely and divided into three groups: 1) unloading (calf muscle paralysis by Botox injections, combined with joint fixation by a steel-orthosis), 2) mild loading (Botox only), 3) strong loading (free cage activity). Gene expression was analyzed by PCR, 5 days post-injury, and mechanical testing 8 days post-injury. The occurrence of microdamage was analyzed 3, 5, or 14 days post-injury, by measuring leakage of injected fluorescence-labelled albumin in the healing tendon tissue. Results Peak force, peak stress, and elastic modulus of the healing tendons gradually improved with increased loading as well as the expression of extracellular matrix genes. In contrast, only strong loading increased transverse area and affected inflammation genes. Strong loading led to higher fluorescence (as a sign of microdamage) compared to mild loading at 3 and 5 days post-injury, but not at 14 days. Discussion Our results show that strong loading improves both the quality and quantity of the healing tendon, while mild loading only improves the quality. Strong loading also induces microdamage and alters the inflammatory response. This suggests that mild loading exert its effect via mechanotransduction mechanisms, while strong loading exert its effect both via mechanotransduction and the creation of microdamage. Conclusion In conclusion, mild loading is enough to increase the quality of the healing tendon without inducing microdamage and alter the inflammation in the tissue. This supports the general conception that early mobilization of a ruptured tendon in patients is advantageous.	[Hammerman, Malin; Dietrich-Zagonel, Franciele; Blomgran, Parmis; Eliasson, Pernilla; Aspenberg, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Orthoped, Linkoping, Sweden	Linkoping University	Eliasson, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Orthoped, Linkoping, Sweden.	pernilla.eliasson@gmail.com	Dietrich, Franciele/W-2316-2019; Eliasson, Pernilla/AAY-2126-2020	Dietrich, Franciele/0000-0003-4871-8268; Eliasson, Pernilla/0000-0001-6718-034X; Blomgran, Parmis/0000-0002-2654-1361	Swedish Research Council; Swedish Research Council for Sports Science; Ostergotland County (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Sports Science; Ostergotland County (ALF)	Grants were received from the Swedish Research Council, the Swedish Research Council for Sports Science, and Ostergotland County (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2012, J APPL PHYSIOL, V113, P1398, DOI 10.1152/japplphysiol.00491.2012; Andersson T, 2009, J APPL PHYSIOL, V107, P417, DOI 10.1152/japplphysiol.00414.2009; Blomgran P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29824; Carvalho FA, 2016, BRIT J SPORT MED, V50, P829, DOI 10.1136/bjsports-2016-096093; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Eliasson P, 2013, J APPL PHYSIOL, V114, P1519, DOI 10.1152/japplphysiol.01500.2012; Eliasson P, 2012, J APPL PHYSIOL, V112, P279, DOI 10.1152/japplphysiol.00858.2011; Eliasson P, 2012, J ORTHOP RES, V30, P274, DOI 10.1002/jor.21511; Freedman BR, 2016, J ORTHOP RES, V34, P2172, DOI 10.1002/jor.23253; Galloway MT, 2013, J BONE JOINT SURG AM, V95A, P1620, DOI 10.2106/JBJS.L.01004; Hachinski V, 2010, INT J STROKE, V5, P238, DOI 10.1111/j.1747-4949.2010.00442.x; Hammerman M, 2017, J APPL PHYSIOL, V123, P800, DOI 10.1152/japplphysiol.00323.2017; Hammerman M, 2014, J APPL PHYSIOL, V116, P54, DOI 10.1152/japplphysiol.00741.2013; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Kunes P, 2012, MEDIATORS INFLAMM, V2012, P10, DOI DOI 10.1155/2012/920517; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Palmes D, 2002, J ORTHOPAED RES, V20, P939, DOI 10.1016/S0736-0266(02)00032-3; Schepull T, 2013, AM J SPORT MED, V41, P2550, DOI 10.1177/0363546513501785; Schulze-Tanzil G, 2011, SCAND J MED SCI SPOR, V21, P337, DOI 10.1111/j.1600-0838.2010.01265.x; Singh D, 2017, BRIT J SPORT MED, V51, P1158, DOI 10.1136/bjsports-2016-h4722rep; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Yang D, 2017, IMMUNOL REV, V280, P41, DOI 10.1111/imr.12577	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201211	10.1371/journal.pone.0201211	http://dx.doi.org/10.1371/journal.pone.0201211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044869	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500092
J	Hellwig, S; Nix, DA; Gligorich, KM; O'Shea, JM; Thomas, A; Fuertes, CL; Bhetariya, PJ; Marth, GT; Bronner, MP; Underhill, HR				Hellwig, Sabine; Nix, David A.; Gligorich, Keith M.; O'Shea, John M.; Thomas, Alun; Fuertes, Carrie L.; Bhetariya, Preetida J.; Marth, Gabor T.; Bronner, Mary P.; Underhill, Hunter R.			Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing	PLOS ONE			English	Article							FETAL DNA; MOLECULAR DIAGNOSTICS; MATERNAL PLASMA; CANCER PATIENTS; DIGITAL PCR; MUTATIONS; SEPARATION; EVOLUTION; ORIGIN	Circulating tumor-derived cell-free DNA (ctDNA) enables non-invasive diagnosis, monitoring, and treatment susceptibility testing in human cancers. However, accurate detection of variant alleles, particularly during untargeted searches, remains a principal obstacle to widespread application of cell-free DNA in clinical oncology. In this study, isolation of short cell-free DNA fragments is shown to enrich for tumor variants and improve correction of PCR- and sequencing-associated errors. Subfractions of the mononucleosome of circulating cell-free DNA (ccfDNA) were isolated from patients with melanoma, pancreatic ductal adenocarcinoma, and colorectal adenocarcinoma using a high-throughput-capable automated gel-extraction platform. Using a 128-gene (128 kb) custom next-generation sequencing panel, variant alleles were on average 2-fold enriched in the short fraction (median insert size: similar to 142 bp) compared to the original ccfDNA sample, while 0.7-fold reduced in the fraction corresponding to the principal peak of the mononucleosome (median insert size: similar to 167 bp). Size-selected short fractions compared to the original ccfDNA yielded significantly larger family sizes (i.e., PCR duplicates) during in silico consensus sequence interpretation via unique molecular identifiers. Increments in family size were associated with a progressive reduction of PCR and sequencing errors. Although consensus read depth also decreased at larger family sizes, the variant allele frequency in the short ccfDNA fraction remained consistent, while variant detection in the original ccfDNA was commonly lost at family sizes necessary to minimize errors. These collective findings support the automated extraction of short ccfDNA fragments to enrich for ctDNA while concomitantly reducing false positives through in silico error correction.	[Hellwig, Sabine] ARUP Labs, Salt Lake City, UT USA; [Nix, David A.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Gligorich, Keith M.; Fuertes, Carrie L.; Bronner, Mary P.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [O'Shea, John M.] Univ Utah, Huntsman Canc Inst, Biorepository & Mol Pathol, Salt Lake City, UT USA; [Thomas, Alun] Univ Utah, Div Genet Epidemiol, Dept Family & Prevent Med, Salt Lake City, UT USA; [Thomas, Alun] Univ Utah, Div Publ Hlth, Dept Family & Prevent Med, Salt Lake City, UT USA; [Bhetariya, Preetida J.; Marth, Gabor T.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Underhill, Hunter R.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA; [Underhill, Hunter R.] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Underhill, HR (corresponding author), Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA.; Underhill, HR (corresponding author), Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA.	Hunter.Underhill@hsc.utah.edu	Bhetariya, Preetida/K-4132-2018	Bhetariya, Preetida/0000-0002-1988-3830; Underhill, Hunter/0000-0002-7389-1487; Hellwig, Sabine/0000-0002-9809-947X	Cancer Center Support Grant by the National Cancer Institute of the National Institutes of Health [P30CA042014]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [5UL1TR001067-05]; Biorepository and Molecular Pathology Shared Resource; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER	Cancer Center Support Grant by the National Cancer Institute of the National Institutes of Health; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Biorepository and Molecular Pathology Shared Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was conducted with support from the Biorepository and Molecular Pathology Shared Resource and the Cancer Biostatistics Shared Resource supported by the Cancer Center Support Grant awarded to the Huntsman Cancer Institute by the National Cancer Institute of the National Institutes of Health (P30CA042014). This investigation was supported in part with funding from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 5UL1TR001067-05 (formerly 8UL1TR000105 and UL1RR025764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chan KCA, 2004, CLIN CHEM, V50, P757, DOI 10.1373/clinchem.2003.029934; Donaldson J, 2018, ANNU REV MED, V69, P223, DOI 10.1146/annurev-med-041316-085721; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Garrigou S, 2016, CLIN CHEM, V62, P1129, DOI 10.1373/clinchem.2015.253609; Hahn T, 2009, CLIN CHEM, V55, P2144, DOI 10.1373/clinchem.2009.127480; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Jorgez CJ, 2009, FETAL DIAGN THER, V25, P314, DOI 10.1159/000235877; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kou RQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146638; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lui YNYN, 2002, CLIN CHEM, V48, P421; Manley Leigh J, 2016, J Biomol Tech, V27, P125; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Milbury Coren A, 2014, Biomol Detect Quantif, V1, P8; Murtaza M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9760; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Paweletz CP, 2016, CLIN CANCER RES, V22, P915, DOI 10.1158/1078-0432.CCR-15-1627-T; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; Uyaguari-Diaz MI, 2015, JOVE-J VIS EXP, DOI 10.3791/52685; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111	33	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0197333	10.1371/journal.pone.0197333	http://dx.doi.org/10.1371/journal.pone.0197333			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044795	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500004
J	Mariotto, AB; Zou, ZH; Johnson, CJ; Scoppa, S; Weir, HK; Huang, B				Mariotto, Angela B.; Zou, Zhaohui; Johnson, Christopher J.; Scoppa, Steve; Weir, Hannah K.; Huang, Bin			Geographical, racial and socio-economic variation in life expectancy in the US and their impact on cancer relative survival	PLOS ONE			English	Article							UNITED-STATES; POPULATION; TABLES; SMOKING; LUNG	Purpose Despite gains in life expectancy between 1992 to 2012, large disparities in life expectancy continue to exist in the United States between subgroups of the population. This study aimed to develop detailed life tables (LT), accounting for mortality differences by race, geography, and socio-economic status (SES), to more accurately measure relative cancer survival and life expectancy patterns in the United States. Methods We estimated an extensive set of County SES-LT by fitting Poisson regression models to deaths and population counts for U.S. counties by age, year, gender, race, ethnicity and county-level SES index. We reported life expectancy patterns and evaluated the impact of the County SES-LT on relative survival using data from the Surveillance Epidemiology and End Results (SEER) Program cancer registries. Results Between 1992 and 2012, the largest increase in life expectancy was among black men (6.8 years), however there were still large geographical differences. Life expectancy was highest for Asian or Pacific Islanders (API), and lowest for American Indians and Alaskan Natives (AIAN). In 2010, life expectancies by state ranged from 73 to 82 years for white males, 78 to 86 years for white females, 66 to 75 for black males, and 75 to 81 for black females. Comparisons of relative survival using National LT and the new County SES-LT showed that relative survival using County SES-LT improved relative survival estimates for some demographic groups, particularly in low and high SES areas, among Hispanics and AIAN, and among older male cancer patients. Relative survival using County SES-LT was 7.3% and 6.7% survival points closer to cause-specific survival compared to the National LT relative survival for AIAN and Hispanic cancer patients diagnosed between ages 75 and 84 years, respectively. Importantly, the County SES-LT relative survival estimates were higher in lower SES areas and lower in higher SES areas, reducing differences in relative survival comparisons. Conclusion The use of these new socio-economic life tables (County SES-LT) can provide more accurate estimates of relative survival, improve comparisons of relative survival among registries, better illustrate disparities and cancer control efforts, and should be used as default for cancer relative survival using U.S. data.	[Mariotto, Angela B.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Zou, Zhaohui; Scoppa, Steve] Informat Management Serv Inc, Calverton, MD USA; [Johnson, Christopher J.] Canc Data Registry Idaho, Boise, ID USA; [Weir, Hannah K.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA; [Huang, Bin] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Centers for Disease Control & Prevention - USA; University of Kentucky	Mariotto, AB (corresponding author), NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA.	mariotta@mail.nih.gov						Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 2018, SEER CANC STAT REV; Arias E, 2014, AM J PUBLIC HEALTH, V104, pS312, DOI 10.2105/AJPH.2013.301635; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; Arias Elizabeth, 2008, Natl Vital Stat Rep, V57, P1; Azzani M, 2015, SUPPORT CARE CANCER, V23, P889, DOI 10.1007/s00520-014-2474-y; Baili P, 2008, TUMORI J, V94, P658; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cho H HN, 2011, 201101 NCI; Ederer F, 1959, INSTRUCTIONS IBM 650; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Elandt-Johnson RC, 1990, SURVIVAL MODELS DATA; Ellis L, 2014, BRIT J CANCER, V111, P195, DOI 10.1038/bjc.2014.217; Fuchs VR, 2016, JAMA-J AM MED ASSOC, V316, P1869, DOI 10.1001/jama.2016.14398; Hinchliffe SR, 2012, CANCER EPIDEMIOL, V36, P148, DOI 10.1016/j.canep.2011.09.007; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; Johnson CJ, 2017, CANC N AM 2010 2014, VFour; Mariotto, 2011, J NATL CANCER I, V103, DOI 10.1093/jnci/djr059; Mariotto Angela B, 2014, J Natl Cancer Inst Monogr, V2014, P145, DOI 10.1093/jncimonographs/lgu024; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Skyrud KD, 2014, INT J CANCER, V135, P196, DOI 10.1002/ijc.28645; Stroup Antoinette M., 2014, Journal of the National Cancer Institute Monographs, P218, DOI 10.1093/jncimonographs/lgu017; VERDECCHIA A, 1989, STAT MED, V8, P201, DOI 10.1002/sim.4780080207; Wei Rong, 2012, Natl Vital Stat Rep, V60, P1; Xu J., 2017, NATL VITAL STAT REPO, V66, P4; Yu MD, 2014, CANCER CAUSE CONTROL, V25, P81, DOI 10.1007/s10552-013-0310-1	29	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201034	10.1371/journal.pone.0201034	http://dx.doi.org/10.1371/journal.pone.0201034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044829	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500074
J	Oakley, MS; Chorazeczewski, JK; Aleshnick, M; Anantharaman, V; Majam, V; Chawla, B; Myers, TG; Su, Q; Okoth, WA; Takeda, K; Akue, A; KuKuruga, M; Aravind, L; Kumar, S				Oakley, Miranda S.; Chorazeczewski, Joanna K.; Aleshnick, Maya; Anantharaman, Vivek; Majam, Victoria; Chawla, Bhavna; Myers, Timothy G.; Su, Qin; Okoth, Winter A.; Takeda, Kazuyo; Akue, Adovi; KuKuruga, Mark; Aravind, L.; Kumar, Sanjai			TCR beta-expressing macrophages induced by a pathogenic murine malaria correlate with parasite burden and enhanced phagocytic activity	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; RED PULP MACROPHAGES; ALPHA-BETA; FALCIPARUM-MALARIA; T-CELLS; RECEPTOR; ANEMIA; ATHEROSCLEROSIS; CHILDREN; MICE	Macrophages express a wide array of invariant receptors that facilitate host defense and mediate pathogenesis during pathogen invasion. We report on a novel population of CD11b(high)CD14(+)F4/80(+) macrophages that express TCR beta. This population expands dramatically during a Plasmodium berghei ANKA infection and sequesters in the brain during experimental cerebral malaria. Importantly, measurement of TCR beta transcript and protein levels in macrophages in wildtype versus nude and Rag1 knockout mice establishes that the observed expression is not a consequence of passive receptor expression due to phagocytosis or trogocytosis of peripheral T cells or nonspecific antibody staining to an Fc receptor or cross reactive epitope. We also demonstrate that TCR beta on brain sequestered macrophages undergoes productive gene rearrangements and shows preferential V beta usage. Remarkably, there is a significant correlation in the proportion of macrophages that express TCR beta and peripheral parasitemia. In addition, presence of TCR beta on the macrophage also correlates with a significant increase (1.9 fold) in the phagocytosis of parasitized erythrocytes. By transcriptional profiling, we identify a novel set of genes and pathways that associate with TCR beta expression by the macrophage. Expansion of TCR beta-expressing macrophages points towards a convergence of the innate and adaptive immune responses where both arms of the immune system cooperate to modulate the host response to malaria and possibly other infections.	[Oakley, Miranda S.; Chorazeczewski, Joanna K.; Okoth, Winter A.; Takeda, Kazuyo; Akue, Adovi; KuKuruga, Mark] US FDA, Div Bacterial Parasit & Allergen Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Aleshnick, Maya; Majam, Victoria; Chawla, Bhavna; Kumar, Sanjai] US FDA, Div Emerging & Transfus Transmitted Dis, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Anantharaman, Vivek; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Myers, Timothy G.; Su, Qin] NIAID, Genom Technol Sect, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Oakley, MS (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	miranda.oakley@fda.hhs.gov	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009; Myers, Timothy Gene/0000-0002-7059-5906; Aleshnick, Maya/0000-0001-5471-4242	Food and Drug Administration; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER	Food and Drug Administration(United States Department of Health & Human Services); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by intramural funding from the Food and Drug Administration.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Adu B, 2014, J INFECT DIS, V209, P285, DOI 10.1093/infdis/jit422; Beham AW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002375; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Boubou MI, 1999, INT IMMUNOL, V11, P1553, DOI 10.1093/intimm/11.9.1553; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541; CURFS JHAJ, 1993, PARASITOLOGY, V107, P125, DOI 10.1017/S0031182000067226; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Fauser S, 2000, J NEUROIMMUNOL, V111, P234, DOI 10.1016/S0165-5728(00)00368-4; Fuchs T, 2017, IMMUNOBIOLOGY, V222, P39, DOI 10.1016/j.imbio.2015.09.022; Fuchs T, 2015, BIOCHEM BIOPH RES CO, V456, P59, DOI 10.1016/j.bbrc.2014.11.034; Fuchs T, 2012, LANCET, V379, P1364, DOI 10.1016/S0140-6736(11)61939-9; Galvan MD, 2012, J LEUKOCYTE BIOL, V92, P489, DOI 10.1189/jlb.0212099; Giha HA, 2011, INFECT GENET EVOL, V11, P1674, DOI 10.1016/j.meegid.2011.06.015; Hochman SE, 2015, MBIO, V6, DOI 10.1128/mBio.01390-15; Kai OK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-24; Kim WJ, 2007, IMMUNOL LETT, V111, P57, DOI 10.1016/j.imlet.2007.05.004; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kopper TJ, 2018, J NEUROSCI RES, V96, P969, DOI 10.1002/jnr.24114; Kremen M, 2008, P NATL ACAD SCI USA, V105, P17109, DOI 10.1073/pnas.0808650105; Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; Legrand F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005926; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Montaudouin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010238; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Oakley MS, 2008, INFECT IMMUN, V76, P4518, DOI 10.1128/IAI.00525-08; Oakley MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166814; Oakley MS, 2014, EUR J IMMUNOL, V44, P2680, DOI 10.1002/eji.201344437; Oakley MS, 2013, J IMMUNOL, V191, P4699, DOI 10.4049/jimmunol.1300396; Oakley MS, 2011, INFECT IMMUN, V79, P1244, DOI 10.1128/IAI.00964-10; Oakley MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006793; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; Quigley Maire F, 2011, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1033s94; Stoute JA, 2011, CELL MICROBIOL, V13, P1441, DOI 10.1111/j.1462-5822.2011.01648.x; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185	49	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201043	10.1371/journal.pone.0201043	http://dx.doi.org/10.1371/journal.pone.0201043			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044851	Green Submitted, gold, Green Published			2022-12-26	WOS:000439942500075
J	Tagawa, M; Kurashima, C; Takagi, S; Maekawa, N; Konnai, S; Shimbo, G; Matsumoto, K; Inokuma, H; Kawamoto, K; Miyahara, K				Tagawa, Michihito; Kurashima, Chihiro; Takagi, Satoshi; Maekawa, Naoya; Konnai, Satoru; Shimbo, Genya; Matsumoto, Kotaro; Inokuma, Hisashi; Kawamoto, Keiko; Miyahara, Kazuro			Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma	PLOS ONE			English	Article							DEATH LIGAND 1; IMMUNE CHECKPOINT BLOCKADE; NON-HODGKIN-LYMPHOMA; VISCERAL LEISHMANIASIS; PD-1 EXPRESSION; CANCER-THERAPY; T-LYMPHOCYTES; PROGNOSIS; MALIGNANCIES; LEUKEMIA	B cell high grade lymphoma is the most common hematopoietic malignancy in dogs. Although the immune checkpoint molecules, programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), and immune checkpoint inhibitors have been evaluated for the treatment of various human lymphoid malignancies, the expression of those molecules and their relationship with prognosis remain unknown in canine lymphoma. The objective of this study was to evaluate the expression of costimulatory molecules on peripheral blood lymphocytes and tumor infiltrating lymphocytes, in addition to associated ligand expression in the lymph nodes of patients with B cell multicentric high grade lymphoma. Eighteen patients diagnosed with B cell high grade lymphoma and nine healthy control dogs were enrolled. Flow cytometric analysis revealed that the expression of PD-1 on CD4+ peripheral and tumor infiltrating lymphocytes and CTLA-4 on CD4+ peripheral lymphocytes was significantly higher in the lymphoma group than in the control group. The expression level of CD80 mRNA was significantly lower in the lymphoma group than in the control group. In contrast, there were no significant differences in PD-L1, PD-L2, and CD86 expression between the groups. Dogs with CTLA-4 levels below the cutoff values, which were determined based on receiver operating characteristic curves, on peripheral CD4+, CD8+, and tumor infiltrating CD4+ lymphocytes had significantly longer survival than dogs with values above the cutoff. Although it is uncertain whether the expression of immune checkpoint molecules affect the biological behavior of canine lymphoma, one possible explanation is that PD-1 and CTLA-4 might be associated with the suppression of antitumor immunity in dogs with B cell high grade lymphoma, particularly through CD4+ T cells.	[Tagawa, Michihito; Kurashima, Chihiro; Shimbo, Genya; Miyahara, Kazuro] Obihiro Univ Agr & Vet Med, Vet Med Ctr, Obihiro, Hokkaido, Japan; [Takagi, Satoshi] Hokkaido Univ, Vet Teaching Hosp, Fac Vet Med, Dept Vet Clin Sci, Sapporo, Hokkaido, Japan; [Maekawa, Naoya; Konnai, Satoru] Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Matsumoto, Kotaro; Inokuma, Hisashi] Obihiro Univ Agr & Vet Med, Dept Clin Vet Sci, Obihiro, Hokkaido, Japan; [Kawamoto, Keiko] Obihiro Univ Agr & Vet Med, Res Ctr Global Agromed, Obihiro, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University; Hokkaido University; Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine	Tagawa, M (corresponding author), Obihiro Univ Agr & Vet Med, Vet Med Ctr, Obihiro, Hokkaido, Japan.	mtagawa@obihiro.ac.jp		TAKAGI, Satoshi/0000-0001-6653-5890; Satoru, Konnai/0000-0002-3230-7109				Aresu L, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00077; Bai J F, 2016, Zhonghua Xue Ye Xue Za Zhi, V37, P916, DOI 10.3760/cma.j.issn.0253-2727.2016.10.021; Bryan LJ, 2015, BLOOD REV, V29, P25, DOI 10.1016/j.blre.2014.09.004; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chiku VM, 2016, IMMUNOBIOLOGY, V221, P879, DOI 10.1016/j.imbio.2016.03.007; Dakappagari N, 2012, CYTOM PART B-CLIN CY, V82B, P112, DOI 10.1002/cyto.b.20631; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Filley A, 2018, J NEURO-ONCOL, V137, P469, DOI 10.1007/s11060-018-2753-4; Folk A, 2010, VET IMMUNOL IMMUNOP, V134, P33, DOI 10.1016/j.vetimm.2009.10.006; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hartley G, 2018, VET COMP ONCOL, V16, P352, DOI 10.1111/vco.12386; Hu LY, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0262-z; Hu PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42913; Hude I, 2017, HAEMATOLOGICA, V102, P30, DOI 10.3324/haematol.2016.150656; Kamphorst AO, 2013, IMMUNOTHERAPY-UK, V5, P975, DOI 10.2217/imt.13.91; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kiyasu J, 2015, BLOOD, V126, P2193, DOI 10.1182/blood-2015-02-629600; Kumar SR, 2017, VET COMP ONCOL, V15, P1527, DOI 10.1111/vco.12297; Lenz JA, 2016, J SMALL ANIM PRACT, V57, P429, DOI 10.1111/jsap.12500; Luczynski W, 2006, NEOPLASMA, V53, P301; Maekawa N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09444-2; Maekawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157176; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nakayama S, 2017, BLOOD ADV, V1, P486, DOI 10.1182/bloodadvances.2016000885; Owen L.N., 1980, TNM CLASSIFICATION T, pp46; Panjwani PK, 2018, HUM PATHOL, V71, P91, DOI 10.1016/j.humpath.2017.10.029; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Shosu K, 2016, IN VIVO, V30, P195; Siedlecki CT, 2006, CAN VET J, V47, P52; Tagawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150030; Thanarajasingam G, 2016, FEBS J, V283, P2233, DOI 10.1111/febs.13668; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vail DM., 2013, WITHROW MACEWENS SMA, P608; Waki K, 2014, CANCER SCI, V105, P1229, DOI 10.1111/cas.12502; Wulfing C, 2014, NAT IMMUNOL, V15, P408, DOI 10.1038/ni.2870; Xu-Monette ZY, 2018, BLOOD, V131, P68, DOI 10.1182/blood-2017-07-740993; Yang ZZ, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.1; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang W, 2016, CANCER MED-US, V5, P3077, DOI 10.1002/cam4.874	43	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201222	10.1371/journal.pone.0201222	http://dx.doi.org/10.1371/journal.pone.0201222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040869	gold, Green Published, Green Submitted			2022-12-26	WOS:000439749200032
J	Hong, WS; Haimovich, AD; Taylor, RA				Hong, Woo Suk; Haimovich, Adrian Daniel; Taylor, R. Andrew			Predicting hospital admission at emergency department triage using machine learning	PLOS ONE			English	Article							HEALTH INFORMATION EXCHANGE; MEDICAL-RECORDS; BIG DATA; INDEX; VALIDITY; TEXT	Objective To predict hospital admission at the time of ED triage using patient history in addition to information collected at triage. Methods This retrospective study included all adult ED visits between March 2014 and July 2017 from one academic and two community emergency rooms that resulted in either admission or discharge. A total of 972 variables were extracted per patient visit. Samples were randomly partitioned into training (80%), validation (10%), and test (10%) sets. We trained a series of nine binary classifiers using logistic regression (LR), gradient boosting (XGBoost), and deep neural networks (DNN) on three dataset types: one using only triage information, one using only patient history, and one using the full set of variables. Next, we tested the potential benefit of additional training samples by training models on increasing fractions of our data. Lastly, variables of importance were identified using information gain as a metric to create a low-dimensional model. Results A total of 560,486 patient visits were included in the study, with an overall admission risk of 29.7%. Models trained on triage information yielded a test AUC of 0.87 for LR (95% Cl 0.860.87), 0.87 for XGBoost (95% Cl 0.87-0.88) and 0.87 for DNN (95% Cl 0.87-0.88). Models trained on patient history yielded an AUC of 0.86 for LR (95% Cl 0.86-0.87), 0.87 for XGBoost (95% Cl 0.87-0.87) and 0.87 for DNN (95% Cl 0.87-0.88). Models trained on the full set of variables yielded an AUC of 0.91 for LR (95% Cl 0.91-0.91), 0.92 for XGBoost (95% Cl 0.92-0.93) and 0.92 for DNN (95% Cl 0.92-0.92). All algorithms reached maximum performance at 50% of the training set or less. A low-dimensional XGBoost model built on ESI level, outpatient medication counts, demographics, and hospital usage statistics yielded an AUC of 0.91 (95% Cl 0.91-0.91). Conclusion Machine learning can robustly predict hospital admission using triage information and patient history. The addition of historical information improves predictive performance significantly compared to using triage information alone, highlighting the need to incorporate these variables into prediction models.	[Hong, Woo Suk; Haimovich, Adrian Daniel] Yale Sch Med, New Haven, CT USA; [Taylor, R. Andrew] Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA	Yale University; Yale University	Taylor, RA (corresponding author), Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA.	richard.taylor@yale.edu	PAN, ZEQIANG/X-6341-2018	/0000-0002-9082-6644	James G. Hirsch Endowed Medical Student Research Fellowship at Yale University School of Medicine; National Institutes of Health [1F30CA196191, T32GM007205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	James G. Hirsch Endowed Medical Student Research Fellowship at Yale University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WH is supported by the James G. Hirsch Endowed Medical Student Research Fellowship at Yale University School of Medicine. AH is supported by National Institutes of Health grants 1F30CA196191 and T32GM007205. RT received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E, 2004, ST CLASS DAT ANAL, P639; Adams JG, 2016, JAMA-J AM MED ASSOC, V315, P659, DOI 10.1001/jama.2015.19484; [Anonymous], 2016, P P 22 ACM SIGKDD IN, P785; Arnold TB, 2017, J OPEN SOURCE SOFTWA, DOI [10.21105/joss.00231, DOI 10.21105/JOSS.00231, 10.21105/joss.00296, DOI 10.21105/JOSS.00296]; Banerjee A, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-22; Bara-Corren Y, 2017, EMERG MED J, V34, P308, DOI 10.1136/emermed-2014-203819; Barak-Corren Y, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2785; Baumann MR, 2007, ANN EMERG MED, V49, P234, DOI 10.1016/j.annemergmed.2006.04.011; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Cameron A, 2018, EMERG MED J, V35, P247, DOI 10.1136/emermed-2017-207246; Cameron A, 2017, EMERG MED J, V34, P2, DOI 10.1136/emermed-2014-204455; de Fortuny EJ, 2013, BIG DATA-US, V1, pBD215, DOI 10.1089/big.2013.0037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desautels T, 2016, JMIR MED INF, V4, P67, DOI 10.2196/medinform.5909; Dinh MM, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0111-4; Ebker-White AA, 2018, EMERG MED AUSTRALAS, V30, P511, DOI 10.1111/1742-6723.12940; Ford E, 2016, J AM MED INFORM ASSN, V23, P1007, DOI 10.1093/jamia/ocv180; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Jiang HJ, 2009, HCUP STAT BRIEF 72; Kangovi S, 2013, HEALTH AFFAIR, V32, P1196, DOI 10.1377/hlthaff.2012.0825; Kuhn M., 2013, APPL PREDICTIVE MODE, P27; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Leegon Jeffrey, 2006, AMIA Annu Symp Proc, P1004; Leegon Jeffrey, 2005, AMIA Annu Symp Proc, P1022; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Lucini FR, 2017, INT J MED INFORM, V100, P1, DOI 10.1016/j.ijmedinf.2017.01.001; Lucke JA, 2018, EMERG MED J, V35, P18, DOI 10.1136/emermed-2016-205846; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Peck JS, 2012, ACAD EMERG MED, V19, pE1045, DOI 10.1111/j.1553-2712.2012.01435.x; Poulin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085733; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Savage D., 2017, CAN J EMERG MED, V19, pS116, DOI [10.1017/cem.2017.314, DOI 10.1017/CEM.2017.314]; Schenkel SM, 2018, ANN EMERG MED, V71, P578, DOI 10.1016/j.annemergmed.2018.02.010; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; Shapiro JS, 2006, ANN EMERG MED, V48, P426, DOI 10.1016/j.annemergmed.2006.03.032; Shapiro JS, 2013, HEALTH AFFAIR, V32, P2193, DOI 10.1377/hlthaff.2013.0167; Stekhoven DJ, 2015, ASTROPHYS SOURCE COD; Sun Y, 2011, ACAD EMERG MED, V18, P844, DOI 10.1111/j.1553-2712.2011.01125.x; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Taylor RA, 2016, ACAD EMERG MED, V23, P269, DOI 10.1111/acem.12876; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	52	97	98	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201016	10.1371/journal.pone.0201016	http://dx.doi.org/10.1371/journal.pone.0201016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028888	Green Submitted, Green Published, gold			2022-12-26	WOS:000439396900031
J	Gupta, S; Silveira, DA; Mombach, JCM				Gupta, Shantanu; Silveira, Daner A.; Mombach, Jose Carlos M.			Modeling the role of microRNA-449a in the regulation of the G2/M cell cycle checkpoint in prostate LNCaP cells under ionizing radiation	PLOS ONE			English	Article							DNA-DAMAGE; CANCER; P53; E2F1; ATM; MIR-449A; MYC	Recent studies showed that induced microRNA-449a (miR-449a) enhances a G2/M cell cycle checkpoint arrest in prostate cancer (LNCaP) and lung adenocarcinoma cell lines. In the case of LNCaP cells, upregulated miR-449a directly downregulates c-Myc that is required to induce the cell cycle regulators Cdc25A and Cdc2/CyclinB whose inactivation blocks G2 to M phase transition. However, the molecular mechanisms involved are yet unclear, although in other prostate cancer cells the interactions among p53, miR-449a and Sirt-1 can affect the induction of the G2/M arrest. In order to clarify these molecular mechanisms, in this work we propose a boolean model of the G2/M checkpoint arrest regulation contemplating the influence of miR-449a. The model shows that the cell fate determination between two cellular phenotypes: G2/M-Arrest for DNA repair and G2/M-induced apoptosis is stochastic and influenced by miR-449a state of activation. The results were compared with experimental data available presenting agreement. We also found that several feedback loops are involved in this cell fate regulation and we indicate, through in silico gain or loss of function perturbations of genes, which of these feedback loops are more efficient to favor a specific phenotype.	[Gupta, Shantanu; Silveira, Daner A.; Mombach, Jose Carlos M.] Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM)	Mombach, JCM (corresponding author), Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil.	jcmombach@ufsm.br	Mombach, Jose C. M./L-1484-2013	Mombach, Jose C. M./0000-0002-6602-3905; Gupta, Shantanu/0000-0001-7110-6564; Acunha Silveira, Daner/0000-0003-0621-8345	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [145708/2017-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CAPES; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 145708/2017-9 to DS and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior to SG. S. Gupta and D. A. Silveira acknowledge partial support from CAPES and CNPq, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude W, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00094; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Chappell WH, 2012, CELL CYCLE, V11, P4579, DOI 10.4161/cc.22852; Chen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20067; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chen W, 2017, INT J ONCOL, V51, P435, DOI 10.3892/ijo.2017.4038; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Kauffman S. A., 1992, SPIN GLASSES BIOL, V6, P61, DOI [10.1142/9789814415743_0003, DOI 10.1142/9789814415743_]; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kim JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065242; Kitadate A, 2016, ONCOGENE, V35, P3692, DOI 10.1038/onc.2015.435; Kumar P, 2016, ONCOTARGET, V7, P22791, DOI 10.18632/oncotarget.8061; Li Q, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0435-5; Lin WC, 2001, GENE DEV, V15, P1833; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062383; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064759; Mao AH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27346; Mendes N. D., 2014, ARXIV14113539; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scott SL, 2003, CANCER RES, V63, P7190; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200768	10.1371/journal.pone.0200768	http://dx.doi.org/10.1371/journal.pone.0200768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024932	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000050
J	Prieto, A; Mayas, J; Ballesteros, S				Prieto, Antonio; Mayas, Julia; Ballesteros, Soledad			Alpha and beta band correlates of haptic perceptual grouping: Results from an orientation detection task	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; EVENT-RELATED POTENTIALS; TACTILE DISCRIMINATION; CONFIGURAL PROPERTIES; GESTALT PSYCHOLOGY; NEURAL MECHANISMS; CORTICAL ACTIVITY; WORKING-MEMORY; VISUAL-CORTEX; MOTOR IMAGERY	Behavioral and neurophysiological findings in vision suggest that perceptual grouping is not a unitary process and that different grouping principles have different processing requirements and neural correlates. The present study aims to examine whether the same occurs in the haptic modality using two grouping principles widely studied in vision, spatial proximity and texture similarity. We analyzed behavioral responses (accuracy and response times) and conducted an independent component analysis of brain oscillations in alpha and beta bands for haptic stimuli grouped by spatial proximity and texture similarity, using a speeded orientation detection task performed on a novel haptic device (MonHap). Behavioral results showed faster response times for patterns grouped by spatial proximity relative to texture similarity. Independent component clustering analysis revealed the activation of a bilateral network of sensorimotor and parietal areas while performing the task. We conclude that, as occurs in visual perception, grouping the elements of the haptic scene by means of their spatial proximity is faster than forming the same objects by means of texture similarity. In addition, haptic grouping seems to involve the activation of a network of widely distributed bilateral sensorimotor and parietal areas as reflected by the consistent event-related desynchronization found in alpha and beta bands.	[Prieto, Antonio; Mayas, Julia; Ballesteros, Soledad] Univ Nacl Educ Distancia, Fac Psicol, Studies Aging & Neurodegenerat Dis Res Grp, Dept Psicol Basica 2, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED)	Prieto, A (corresponding author), Univ Nacl Educ Distancia, Fac Psicol, Studies Aging & Neurodegenerat Dis Res Grp, Dept Psicol Basica 2, Madrid, Spain.	antonioprieto@psi.uned.es	Mayas, Julia/L-3679-2014; Prieto, Antonio/A-6370-2012; Ballesteros, Soledad/ABG-8762-2020; Prieto, Antonio/AAI-7946-2021	Mayas, Julia/0000-0001-5003-4995; Prieto, Antonio/0000-0002-3394-5962; Ballesteros, Soledad/0000-0002-8391-9615; Prieto, Antonio/0000-0002-3394-5962	Ministerio de educacion Cultura y Deporte [FPU13/05914]; Ministerio de Economoia y competitividad [PSI2013-41409R]; Universidad Nacional de Educacion a Distancia [2014-028-UNED-PROY]	Ministerio de educacion Cultura y Deporte(Spanish Government); Ministerio de Economoia y competitividad; Universidad Nacional de Educacion a Distancia	A Doctoral Fellowship from Ministerio de educacion Cultura y Deporte (https://www.mecd.gob.es/portada-mecd/)granted to AP (FPU13/05914) supported this work. It was also partially supported by grants from the Ministerio de Economoia y competitividad (http://www.mineco.gob.es/) (PSI2013-41409R) awarded to SB and from the Universidad Nacional de Educacion a Distancia (www.uned.es) (2014-028-UNED-PROY) awarded to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095541; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Baraldi P, 1999, NEUROSCI LETT, V269, P95, DOI 10.1016/S0304-3940(99)00433-4; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Blum J, 2007, EXP BRAIN RES, V182, P59, DOI 10.1007/s00221-007-0963-7; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; Chang D., 2007, P 8 AUSTR C US INT A, V64, P79; Chang D, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P15; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Davis NJ, 2012, J NEUROSCI, V32, P403, DOI 10.1523/JNEUROSCI.5106-11.2012; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; FAGOT J, 1992, BEHAV RES METH INSTR, V24, P54, DOI 10.3758/BF03203470; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Flevaris AV, 2016, NEUROPSYCHOLOGIA, V83, P192, DOI 10.1016/j.neuropsychologia.2015.10.024; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gallace A, 2011, PSYCHOL BULL, V137, P538, DOI 10.1037/a0022335; Gardony AL, 2017, BRAIN COGNITION, V118, P1, DOI 10.1016/j.bandc.2017.07.003; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Grunwald M., 2008, HUMAN HAPTIC PERCEPT; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Han SH, 2004, NEUROSCI LETT, V367, P40, DOI 10.1016/j.neulet.2004.05.098; Han SH, 2002, NEUROSCI LETT, V319, P29, DOI 10.1016/S0304-3940(01)02502-2; Han SH, 2001, PSYCHOPHYSIOLOGY, V38, P926, DOI 10.1111/1469-8986.3860926; Hegner YL, 2007, NEUROIMAGE, V37, P1362, DOI 10.1016/j.neuroimage.2007.07.003; Hummel F, 2003, CLIN NEUROPHYSIOL, V114, P605, DOI 10.1016/S1388-2457(02)00417-0; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Kaas AL, 2013, HUM BRAIN MAPP, V34, P1148, DOI 10.1002/hbm.21500; Karhu J, 1999, J NEUROPHYSIOL, V81, P2017, DOI 10.1152/jn.1999.81.5.2017; Kimchi R, 2004, PSYCHON B REV, V11, P687, DOI 10.3758/BF03196621; Kimchi R, 1998, PSYCHON B REV, V5, P135, DOI 10.3758/BF03209469; KIMCHI R, 1994, PERCEPTION, V23, P489, DOI 10.1068/p230489; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klostermann F, 2007, EUR J NEUROSCI, V25, P1604, DOI 10.1111/j.1460-9568.2007.05417.x; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lin CL, 2012, NEUROIMAGE, V60, P2258, DOI 10.1016/j.neuroimage.2012.02.008; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; Mao LH, 2004, CHINESE SCI BULL, V49, P819, DOI 10.1360/04wc0004; Martinovic J, 2012, FRONT HUM NEUROSCI, V6, P1, DOI 10.3389/fnhum.2012.00049; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Melnik A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04757-8; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Neisser U., 1967, THINKINGJUDGEMENT DE, P61, DOI [10.1037/0096-1523.8.2.194, DOI 10.1037/0096-1523.8.2.194]; Nikolaev AR, 2008, EXP BRAIN RES, V186, P107, DOI 10.1007/s00221-007-1214-7; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Overvliet KE, 2016, VISION RES, V126, P52, DOI 10.1016/j.visres.2015.04.016; Overvliet KE, 2016, PERCEPTION, V45, P71, DOI 10.1177/0301006615594958; Overvliet KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065412; Overvliet KE, 2012, J EXP PSYCHOL HUMAN, V38, P817, DOI 10.1037/a0029222; PFURTSCHELLER G, 1990, Brain Topography, V3, P85, DOI 10.1007/BF01128865; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; POMERANTZ JR, 1989, J EXP PSYCHOL HUMAN, V15, P635, DOI 10.1037/0096-1523.15.4.635; Razpurker-Apfeld I, 2007, PERCEPT PSYCHOPHYS, V69, P732, DOI 10.3758/BF03193775; Revesz G, 1953, PSYCHOL FORSCH, V24, P215, DOI 10.1007/BF00424461; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Sadato N, 1997, J NEUROSCI, V17, P9667; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sebastian M, 2012, NEUROIMAGE, V60, P7, DOI 10.1016/j.neuroimage.2011.11.060; Sebastian M, 2011, NEUROPSYCHOLOGIA, V49, P3967, DOI 10.1016/j.neuropsychologia.2011.10.013; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Snow JC, 2014, J COGNITIVE NEUROSCI, V26, P1154, DOI 10.1162/jocn_a_00548; Stephan KM, 1999, BRAIN, V122, P351, DOI 10.1093/brain/122.2.351; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Talairach J., 1988, COPLANAR STEREOTAXIS; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tibbetts P.E., 2009, Q REV BIOL, DOI [DOI 10.1086/603482, 10.1086/603482]; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; van Wijk BCM, 2012, EUR J NEUROSCI, V36, P2088, DOI 10.1111/j.1460-9568.2012.08122.x; Verlaers K, 2015, ATTEN PERCEPT PSYCHO, V77, P353, DOI 10.3758/s13414-014-0770-8; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Volberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054085; Vukelic M, 2014, NEUROIMAGE, V87, P147, DOI 10.1016/j.neuroimage.2013.10.003; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zaretskaya N, 2015, NEUROIMAGE, V112, P61, DOI 10.1016/j.neuroimage.2015.02.049; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107	100	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201194	10.1371/journal.pone.0201194	http://dx.doi.org/10.1371/journal.pone.0201194			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024961	gold, Green Submitted, Green Published			2022-12-26	WOS:000439120000097
J	Gao, BM; Peng, C; Chen, Q; Zhang, JQ; Shi, Q				Gao, Bingmiao; Peng, Chao; Chen, Qin; Zhang, Junqing; Shi, Qiong			Mitochondrial genome sequencing of a vermivorous cone snail Conus quercinus supports the correlative analysis between phylogenetic relationships and dietary types of Conus species	PLOS ONE			English	Article							NEOGASTROPODA CONIDAE; HIGH-THROUGHPUT; VENOMICS REVEALS; DIVERSITY; EVOLUTION; REPLICATION; CONOTOXINS; GASTROPODA; ALIGNMENT; PEPTIDES	Complete mitochondrial genome (mitogenome) sequence of a worm-hunting cone snail, Conus quercinus, was reported in this study. Its mitogenome, the longest one (16,460 bp) among reported Conus specie, is composed of 13 protein-coding genes (PCGs), 22 transfer RNA (tRNA) genes, two ribosomal RNA (rRNA) genes and one D-loop region. The mitochondrial gene arrangement is highly-conserved and identical to other reported. However, the D-loop region of C. quercinus is the longest (943 bp) with the higher A+T content (71.3%) and a long AT tandem repeat stretch (68 bp). Subsequent phylogenetic analysis demonstrated that three different dietary types (vermivorous, molluscivorous and piscivorous) of cone snails are clustered separately, suggesting that the phylogenetics of cone snails is related to their dietary types. In conclusion, our current work improves our understanding of the mitogenomic structure and evolutionary status of the vermivorous C. quercinus, which support the putative hypothesis that the Conus ancestor was vermivorous.	[Gao, Bingmiao; Zhang, Junqing] Hainan Med Univ, Hainan Prov Key Lab Res & Dev Trop Med Plants, Haikou, Hainan, Peoples R China; [Peng, Chao; Shi, Qiong] BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom, Guangdong Prov Key Lab Mol Breeding Marine Econ A, BGI,BGI Marine, Shenzhen, Peoples R China; [Chen, Qin] Hainan Radio & TV Univ, Sch Agr & Forestry Sci & Technol, Haikou, Hainan, Peoples R China	Hainan Medical University; Beijing Genomics Institute (BGI)	Zhang, JQ (corresponding author), Hainan Med Univ, Hainan Prov Key Lab Res & Dev Trop Med Plants, Haikou, Hainan, Peoples R China.; Shi, Q (corresponding author), BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom, Guangdong Prov Key Lab Mol Breeding Marine Econ A, BGI,BGI Marine, Shenzhen, Peoples R China.	jqzhang2011@163.com; shiqiong@genomics.cn	Gao, Bingmiao/ABE-9834-2020	Gao, Bingmiao/0000-0003-1042-1768	Natural Science Foundation of Hainan Province [317170]; Shenzhen Dapeng Special Project for Industrial Development [PT20170302]; National Natural Science Foundation of China [81560611]	Natural Science Foundation of Hainan Province; Shenzhen Dapeng Special Project for Industrial Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of Hainan Province (No. 317170), Shenzhen Dapeng Special Project for Industrial Development (No. PT20170302), and National Natural Science Foundation of China (No. 81560611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, NUCLEIC ACIDS RES, V39, pD210, DOI 10.1093/nar/gkq1007; Aman JW, 2015, P NATL ACAD SCI USA, V112, P5087, DOI 10.1073/pnas.1424435112; Bandyopadhyay PK, 2008, MOL PHYLOGENET EVOL, V46, P215, DOI 10.1016/j.ympev.2007.08.002; Barghi N, 2016, MITOCHONDRIAL DNA A, V27, P4451, DOI 10.3109/19401736.2015.1089566; Barghi N, 2015, MAR BIOTECHNOL, V17, P81, DOI 10.1007/s10126-014-9595-7; Bouchet P, 2011, J MOLLUS STUD, V77, P273, DOI 10.1093/mollus/eyr017; Brauer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051528; Chen PW, 2016, MITOCHONDRIAL DNA B, V1, P493, DOI 10.1080/23802359.2016.1192502; Chen PW, 2016, MITOCHONDRIAL DNA B, V1, P520, DOI 10.1080/23802359.2016.1197060; Chen PW, 2016, MITOCHONDRIAL DNA A, V27, P2738, DOI 10.3109/19401736.2015.1046172; Cheng JK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-95; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Himaya SWA, 2015, J PROTEOME RES, V14, P4372, DOI 10.1021/acs.jproteome.5b00630; Jin AH, 2013, MOL CELL PROTEOMICS, V12, P3824, DOI 10.1074/mcp.M113.030353; Kumar PS, 2015, ASIAN PAC J TROP MED, V8, P337, DOI 10.1016/S1995-7645(14)60342-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavergne V, 2015, P NATL ACAD SCI USA, V112, pE3782, DOI 10.1073/pnas.1501334112; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Modica MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102160; Olivera BM, 2015, BRAIN BEHAV EVOLUT, V86, P58, DOI 10.1159/000438449; Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011; Peng C, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0122-9; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Phuong MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2755-6; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prashanth JR, 2016, MOL ECOL, V25, P598, DOI 10.1111/mec.13504; Prashanth JR, 2014, FUTURE MED CHEM, V6, P1659, DOI [10.4155/FMC.14.99, 10.4155/fmc.14.99]; Puillandre N, 2014, MOL PHYLOGENET EVOL, V78, P290, DOI 10.1016/j.ympev.2014.05.023; Remigio EA, 2008, MOL ECOL, V17, P1156, DOI 10.1111/j.1365-294X.2007.03627.x; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Safavi-Hemami H, 2016, P NATL ACAD SCI USA, V113, P3227, DOI 10.1073/pnas.1525790113; Sahyoun AH, 2014, MITOCHONDRION, V17, P56, DOI 10.1016/j.mito.2014.05.009; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Uribe JE, 2017, MOL PHYLOGENET EVOL, V107, P142, DOI 10.1016/j.ympev.2016.10.008; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xing Y, 2005, BIOINFORMATICS, V21, P3701, DOI 10.1093/bioinformatics/bti613	45	12	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0193053	10.1371/journal.pone.0193053	http://dx.doi.org/10.1371/journal.pone.0193053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059499	gold, Green Submitted, Green Published			2022-12-26	WOS:000440251600001
J	Luo, XD; Bhakta, T; Jakobsen, M; Naevdal, G				Luo, Xiaodong; Bhakta, Tuhin; Jakobsen, Morten; Naevdal, Geir			Efficient big data assimilation through sparse representation: A 3D benchmark case study in petroleum engineering	PLOS ONE			English	Article							PSEUDOPERIODIC TIME-SERIES; ENSEMBLE KALMAN FILTER; SEISMIC DATA; SATURATION CHANGES; COMPLEX NETWORK; FRAMEWORK; SMOOTHER; PRESSURE	Data assimilation is an important discipline in geosciences that aims to combine the information contents from both prior geophysical models and observational data (observations) to obtain improved model estimates. Ensemble-based methods are among the state-of-the-art assimilation algorithms in the data assimilation community. When applying ensemble-based methods to assimilate big geophysical data, substantial computational resources are needed in order to compute and/or store certain quantities (e.g., the Kalman-gain-type matrix), given both big model and data sizes. In addition, uncertainty quantification of observational data, e.g., in terms of estimating the observation error covariance matrix, also becomes computationally challenging, if not infeasible. To tackle the aforementioned challenges in the presence of big data, in a previous study, the authors proposed a wavelet-based sparse representation procedure for 2D seismic data assimilation problems (also known as history matching problems in petroleum engineering). In the current study, we extend the sparse representation procedure to 3D problems, as this is an important step towards real field case studies. To demonstrate the efficiency of the extended sparse representation procedure, we apply an ensemble-based seismic history matching framework with the extended sparse representation procedure to a 3D benchmark case, the Brugge field. In this benchmark case study, the total number of seismic data is in the order of O(10(6)). We show that the wavelet-based sparse representation procedure is extremely efficient in reducing the size of seismic data, while preserving the salient features of seismic data. Moreover, even with a substantial data-size reduction through sparse representation, the ensemble-based seismic history matching framework can still achieve good estimation accuracy.	[Luo, Xiaodong; Bhakta, Tuhin; Jakobsen, Morten; Naevdal, Geir] IRIS, Bergen, Norway; [Jakobsen, Morten] Univ Bergen, Bergen, Norway	University of Bergen	Luo, XD (corresponding author), IRIS, Bergen, Norway.	xiaodong.luo@iris.no	Naevdal, Geir/A-1551-2009; Luo, Xiaodong/G-5953-2011	Naevdal, Geir/0000-0003-2497-198X; Luo, Xiaodong/0000-0002-0734-862X	CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Eni [243680]; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Petrobras [243680]; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Total [243680]; Research Council of Norway (PETROMAKS); 4D seismic project (Research Council of Norway) - Research Council of Norway [230303]; ConocoPhillips Skandinavia AS; Aker BP ASA; Eni Norge AS; Maersk Oil Norway AS; Lundin Norway AS; Halliburton AS; DEA Norge AS; Neptune Energy Norge AS; Schlumberger Norge AS; Wintershall Norge AS of The National IOR Centre of Norway	CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Eni; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Petrobras; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Total; Research Council of Norway (PETROMAKS)(Research Council of Norway); 4D seismic project (Research Council of Norway) - Research Council of Norway(Research Council of Norway); ConocoPhillips Skandinavia AS; Aker BP ASA; Eni Norge AS; Maersk Oil Norway AS; Lundin Norway AS; Halliburton AS; DEA Norge AS; Neptune Energy Norge AS; Schlumberger Norge AS(Schlumberger); Wintershall Norge AS of The National IOR Centre of Norway	XL acknowledges partial financial supports from the CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway project number 243680), which is funded by industry partners, Eni (www.eni.com), Petrobras (www.petrobras.com), and Total (wvvw.total.com), as well as the Research Council of Norway (PETROMAKS) (ww.forskningsradet.no). All authors acknowledge financial supports from the 4D seismic project (Research Council of Norway project number 230303), which is supported by the Research Council of Norway and the industry partners-ConocoPhillips Skandinavia AS(www.conocophillips.no), Aker BP ASA, Eni Norge AS (www.eninorge.com), Maersk Oil Norway AS (www.maerskoil.com), Orsted AS (https://orsted.com/en/), EquiNor Petroleum AS (www.equinor.com), Lundin Norway AS (lundinnorway.no), Halliburton AS (wm.halliburton.no), DEA Norge AS (www.dea-norge.com), Neptune Energy Norge AS (www.neptuneenergy.com), Schlumberger Norge AS (www.slb.com), Wintershall Norge AS (www.wintershall.no)-of The National IOR Centre of Norway,. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Takemasa Miyoshi and two anonymous reviewers for their valuable comments on the work, and Schlumberger for providing us academic software licenses to ECLIPSE. XL acknowledges partial financial supports from the CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway project number 243680), which is funded by industry partners, Eni (www.eni.com), Petrobras (www.petrobras.com), and Total (www.total.com), as well as the Research Council of Norway (PETROMAKS) (www.forskningsradet.no). All authors acknowledge financial supports from the 4D seismic project (Research Council of Norway project number 230303), which is supported by the Research Council of Norway and the industry partners-ConocoPhillips Skandinavia AS (www.conocophillips.no), Aker BP ASA, Eni Norge AS (www.ernnorge.com), Maersk Oil Norway AS (www.maerskoil.com), Orsted AS (https://orsted.com/en/), EquiNor Petroleum AS (www.equinor.com), Lundin Norway AS (lundin-norway.no), Halliburton AS (www.halliburton.no), DEA Norge AS (www.dea-norge.corn), Neptune Energy Norge AS (www.neptuneenergy.com), Schlumberger Norge AS (www.slb.com), Wintershall Norge AS (www.wintershall.no)-of The National IOR Centre of Norway,. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanonsen S, 2003, SPE RES SIM S SOC PE; Aanonsen SI, 2009, SPE J, V14, P393, DOI 10.2118/117274-PA; [Anonymous], 72 EAGE C EXH; [Anonymous], 2013, SPE RES SIM S SOC PE; [Anonymous], 2013, SPE RES SIM S SOC PE; Avseth P., 2010, QUANTITATIVE SEISMIC; Awotunde AA, 2014, COMPUTAT GEOSCI, V18, P677, DOI 10.1007/s10596-014-9414-2; Bhakta T, 2014, GEOPHYSICS, V79, pM35, DOI 10.1190/GEO2013-0434.1; Buland A, 2003, GEOPHYSICS, V68, P185, DOI 10.1190/1.1543206; Chen Y, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011144; Chen Y, 2010, COMPUTAT GEOSCI, V14, P579, DOI 10.1007/s10596-009-9174-6; Dadashpour M, 2008, J GEOPHYS ENG, V5, P54, DOI 10.1088/1742-2132/5/1/006; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Elsheikh AH, 2013, ADV WATER RESOUR, V56, P14, DOI 10.1016/j.advwatres.2013.02.002; Emerick A, 2011, COMPUTAT GEOSCI, V15, P251, DOI 10.1007/s10596-010-9198-y; Emerick AA, 2016, J PETROL SCI ENG, V139, P219, DOI 10.1016/j.petrol.2016.01.029; Emerick AA, 2012, COMPUTAT GEOSCI, V16, P639, DOI 10.1007/s10596-012-9275-5; Engl H. W., 2000, REGULARIZATION INVER; Evensen G, 2000, MON WEATHER REV, V128, P1852, DOI 10.1175/1520-0493(2000)128<1852:AEKSFN>2.0.CO;2; EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572; Evensen G., 2009, DATA ASSIMILATION EN; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gassmann F., 1951, VIERTEL NAT GES ZURI, V96, P1; Gentilhomme T, 2015, COMPUTAT GEOSCI, V19, P999, DOI 10.1007/s10596-015-9517-4; George AK, 2008, I S BIOMED IMAGING, P1489, DOI 10.1109/ISBI.2008.4541290; Gorszczyk A, 2015, GEOPHYS PROSPECT, V63, P903, DOI 10.1111/1365-2478.12234; Houtekamer PL, 2016, MON WEATHER REV, V144, P4489, DOI 10.1175/MWR-D-15-0440.1; Jack I., 2001, 1 BREAK, V19, P24; Jafarpour B, 2010, MATH GEOSCI, V42, P1, DOI 10.1007/s11004-009-9247-z; Jansen M., 2012, NOISE REDUCTION WAVE, V161; Jazwinski A.H., 2007, STOCHASTIC PROCESSES, P93; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Katterbauer K, 2017, GEOPHYS PROSPECT, V65, P337, DOI 10.1111/1365-2478.12371; Katterbauer K, 2015, SPE J, V20, P923, DOI 10.2118/173896-PA; Katterbauer K, 2015, J PETROL SCI ENG, V128, P160, DOI 10.1016/j.petrol.2015.02.016; Khaninezhad MM, 2014, COMPUTAT GEOSCI, V18, P3, DOI 10.1007/s10596-013-9378-7; Landro M, 2001, GEOPHYSICS, V66, P836, DOI 10.1190/1.1444973; Leeuwenburgh O, 2014, COMPUTAT GEOSCI, V18, P535, DOI 10.1007/s10596-014-9434-y; Luo X, 2016, SPE J; Luo XD, 2017, COMPUTAT GEOSCI, V21, P205, DOI 10.1007/s10596-016-9605-0; Luo XD, 2015, SPE J, V20, P962, DOI 10.2118/176023-PA; Mallat S., 2008, WAVELET TOUR SIGNAL; Mavko G., 2009, ROCK PHYS HDB TOOLS, DOI 10.1192/bjp.182.2.123; MINDLIN RD, 1949, J APPL MECH-T ASME, V16, P259; Miyoshi T, 2016, P IEEE, V104, P2155, DOI 10.1109/JPROC.2016.2602560; Miyoshi T, 2016, B AM METEOROL SOC, V97, P1347, DOI 10.1175/BAMS-D-15-00144.1; Naevdal G, 2002, SPE DOE IMPROVED OIL, P13; NUR A, 1991, SHEAR WAVES IN MARINE SEDIMENTS, P131; Nur A., 1998, LEAD EDGE, V17, P357, DOI [DOI 10.1190/1.1437977, 10.1190/1.1437977]; Pan M, 2008, REMOTE SENS ENVIRON, V112, P1282, DOI 10.1016/j.rse.2007.02.039; Peters E, 2010, SPE RESERV EVAL ENG, V13, P391, DOI 10.2118/119094-PA; Rehman MHU, 2016, INT J INFORM MANAGE, V36, P917, DOI 10.1016/j.ijinfomgt.2016.05.013; Reichle RH, 2002, MON WEATHER REV, V130, P103, DOI 10.1175/1520-0493(2002)130<0103:HDAWTE>2.0.CO;2; Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104; Sahni I, 2005, SPE RESERV EVAL ENG, V8, P53, DOI 10.2118/87820-PA; Sana F, 2016, IEEE J-STARS, V9, P2242, DOI 10.1109/JSTARS.2016.2563163; Shi L, 2016, SCI REPORTS, V6; Skjervheim JA, 2007, SPE J, V12, P282, DOI 10.2118/95789-PA; SPANIAS AS, 1991, IEEE T GEOSCI REMOTE, V29, P407, DOI 10.1109/36.79431; Stai E, 2016, IEEE NETWORK, V30, P11, DOI 10.1109/MNET.2016.7389825; Starck JL, 2009, ASTRON ASTROPHYS, V504, P641, DOI 10.1051/0004-6361/200811388; Sweldens W, 1998, SIAM J MATH ANAL, V29, P511, DOI 10.1137/S0036141095289051; Talagrand O, 1997, J METEOROL SOC JPN, V75, P191, DOI 10.2151/jmsj1965.75.1B_191; Trani M, 2013, SPE J, V18, P159, DOI 10.2118/163043-PA; vanLeeuwen PJ, 1996, MON WEATHER REV, V124, P2898, DOI 10.1175/1520-0493(1996)124<2898:DAAIMI>2.0.CO;2; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008	71	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0198586	10.1371/journal.pone.0198586	http://dx.doi.org/10.1371/journal.pone.0198586			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052628	Green Submitted, Green Published, gold			2022-12-26	WOS:000440006600003
J	Bhasuran, B; Natarajan, J				Bhasuran, Balu; Natarajan, Jeyakumar			Automatic extraction of gene-disease associations from literature using joint ensemble learning	PLOS ONE			English	Article							TEXT-MINING SYSTEM; DRUGS; DATABASE; ENTITY	A wealth of knowledge concerning relations between genes and its associated diseases is present in biomedical literature. Mining these biological associations from literature can provide immense support to research ranging from drug-targetable pathways to biomarker discovery. However, time and cost of manual curation heavily slows it down. In this current scenario one of the crucial technologies is biomedical text mining, and relation extraction shows the promising result to explore the research of genes associated with diseases. By developing automatic extraction of gene-disease associations from the literature using joint ensemble learning we addressed this problem from a text mining perspective. In the proposed work, we employ a supervised machine learning approach in which a rich feature set covering conceptual, syntax and semantic properties jointly learned with word embedding are trained using ensemble support vector machine for extracting gene-disease relations from four gold standard corpora. Upon evaluating the machine learning approach shows promised results of 85.34%, 83.93%, 87.39% and 85.57% of F-measure on EUADR, GAD, CoMAGC and PolySearch corpora respectively. We strongly believe that the presented novel approach combining rich syntax and semantic feature set with domain-specific word embedding through ensemble support vector machines evaluated on four gold standard corpora can act as a new baseline for future works in gene-disease relation extraction from literature.	[Bhasuran, Balu; Natarajan, Jeyakumar] DRDO BU Ctr Life Sci, Bharathiar Univ Campus, Coimbatore, Tamil Nadu, India; [Natarajan, Jeyakumar] Bharathiar Univ, Dept Bioinformat, Data Min & Text Min Lab, Coimbatore, Tamil Nadu, India	Bharathiar University; Defence Research & Development Organisation (DRDO); DRDO BU Center Life Sciences; Bharathiar University	Natarajan, J (corresponding author), DRDO BU Ctr Life Sci, Bharathiar Univ Campus, Coimbatore, Tamil Nadu, India.; Natarajan, J (corresponding author), Bharathiar Univ, Dept Bioinformat, Data Min & Text Min Lab, Coimbatore, Tamil Nadu, India.	n.jeyakumar@yahoo.co.in	BHASURAN, BALU/AAB-1583-2021; Natarajan, Jeyakumar/C-9319-2013	BHASURAN, BALU/0000-0002-9890-4627; Natarajan, Jeyakumar/0000-0003-3981-619X	DRDO BU Centre for Life Sciences, Bharathiar University, Coimbatore, Tamilnadu, India	DRDO BU Centre for Life Sciences, Bharathiar University, Coimbatore, Tamilnadu, India	This work received funding from DRDO BU Centre for Life Sciences, Bharathiar University, Coimbatore, Tamilnadu, India. BB acknowledges the fellowship received from the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bhasuran B, 2016, J BIOMED INFORM, V64, P1, DOI 10.1016/j.jbi.2016.09.009; Bravo A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253128; Bravo A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0472-9; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cano C, 2009, J BIOMED INFORM, V42, P967, DOI 10.1016/j.jbi.2009.02.001; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Chun Hong-Woo, 2006, Pac Symp Biocomput, P4; Claesen M, 2014, J MACH LEARN RES, V15, P141; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dai QG, 2016, CURR PROTEOMICS, V13, P143, DOI 10.2174/157016461302160514005420; Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Hou W-J, 2016, ELECT J COMPUT SCI I, V4, P1; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Karimi S, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2719920; Kemper B, 2010, BIOINFORMATICS, V26, pI374, DOI 10.1093/bioinformatics/btq221; Kilicoglu H., 2017, BRIEFINGS BIOINFORMA; Krallinger M, 2005, DRUG DISCOV TODAY, V10, P439, DOI 10.1016/S1359-6446(05)03376-3; Leaman Robert, 2008, Pac Symp Biocomput, P652; Lee HJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-323; Lee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164680; Levy O, 2014, ADV NEUR IN, V27; Liu RL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-286; Liu YF, 2015, NUCLEIC ACIDS RES, V43, pW535, DOI 10.1093/nar/gkv383; McCormick C., 2015, STATEW AGR L USE BAS, V1, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov T., 2013, ARXIV 160705368, P746, DOI DOI 10.3109/10826089109058901; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Murugesan G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187379; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Neufer PD, CELL METABOLISM; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Pons E, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw046; Singh-Blom UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058977; Song M, 2015, J BIOMED INFORM, V57, P320, DOI 10.1016/j.jbi.2015.08.008; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Van Landeghem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055814; van Mulligen EM, 2012, J BIOMED INFORM, V45, P879, DOI 10.1016/j.jbi.2012.04.004; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Ware M., 2015, STM REPORT OVERVIEW; Williams C. K. I., 2003, J AM STAT ASSOC, V98, P489, DOI DOI 10.1198/JASA.2003.S269; Xu D, 2016, BIOINFORMATICS, V32, P3619, DOI 10.1093/bioinformatics/btw503; Yu M, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P545, DOI 10.3115/v1/p14-2089; Zahid S, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/209814; Zhang DW, 2015, EXPERT SYST APPL, V42, P1857, DOI 10.1016/j.eswa.2014.09.011; Zheng S, 2016, JOINT EUR C MACH LEA, P443, DOI DOI 10.1007/978-3-319-46128-1; Zhou HY, 2016, BIOINFORMATICS, V32, P2831, DOI 10.1093/bioinformatics/btw358	55	25	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200699	10.1371/journal.pone.0200699	http://dx.doi.org/10.1371/journal.pone.0200699			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048465	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400012
J	Rao, GK; Wong, A; Collinge, M; Sarhan, J; Yarovinsky, TO; Ramgolam, VS; Gaestel, M; Pardi, R; Bender, JR				Rao, Gautham K.; Wong, Albert; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Gaestel, Matthias; Pardi, Ruggero; Bender, Jeffrey R.			T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and K	PLOS ONE			English	Article							PROTEIN-KINASE; POSTTRANSCRIPTIONAL REGULATION; ACTIVATED PROTEIN-KINASE-2; BINDING PROTEIN; NUCLEAR EXPORT; IN-VIVO; HUR; STABILITY; TARGET; BIOSYNTHESIS	Activation of the beta(2) integrin lymphocyte function-associated antigen-1 (LFA-1) in T cells induces stabilization of proinflammatory AU-rich element (ARE)-bearing mRNAs, by triggering the nuclear-to-cytoplasmic translocation of the mRNA-binding and-stabilizing protein HuR. However, the mechanism by which LFA-1 engagement controls HuR localization is not known. Here, we identify and characterize four key regulators of LFA-1-induced changes in HuR activity: the p38 pathway kinase MK2 and the constitutive nuclear proteins hnRNPs C, H1 and K. LFA-1 engagement results in rapid, sequential activation of p38 and MK2. Post-LFA-1 activation, MK2 inducibly associates with both hnRNPC and HuR, resulting in the dissociation of HuR from hnRNPs C, H1 and K. Freed from the three hnRNPs, HuR translocates from the nucleus to the cytoplasm, and mediates the stabilization of labile cytokine transcripts. Our results suggest that the modulation of T cell cytokine mRNA half-life is an intricate process that is negatively regulated by hnRNPs C, H1 and K and requires MK2 as a critical activator.	[Rao, Gautham K.; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Rao, Gautham K.; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rao, Gautham K.; Wong, Albert; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Bender, Jeffrey R.] Raymond & Beverly Sackler Fdn Cardiovasc Lab, New Haven, CT 06511 USA; [Wong, Albert] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Gaestel, Matthias] Med Sch Hannover, Inst Biochem, Hannover, Germany; [Pardi, Ruggero] Univ Vita Salute San Raffaele, Fac Med & Surg, Milan, Italy	Yale University; Yale University; Yale University; Hannover Medical School; Vita-Salute San Raffaele University	Bender, JR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Cardiovasc Res Ctr, New Haven, CT 06510 USA.; Bender, JR (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	jeffrey.bender@yale.edu	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652	National Institutes of Health [R01HL043331, T32 GM007223]; American Heart Association [13PRE17110006]; Raymond and Beverly Sackler Foundation [M117394]; Fondazione Cariplo; State of Connecticut Department of Public Health [AWDS01772]; Cariplo Foundation; American Heart Association Predoctoral Fellowship Award [AHA 13PRE14790042]; State of Connecticut Biomedical Research Award [DPH AWDS01772]; NIH [T32 GM007223, R01 HL043331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126412, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Raymond and Beverly Sackler Foundation; Fondazione Cariplo(Fondazione Cariplo); State of Connecticut Department of Public Health; Cariplo Foundation(Fondazione Cariplo); American Heart Association Predoctoral Fellowship Award(American Heart Association); State of Connecticut Biomedical Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: 1. National Institutes of Health: R01HL043331 (JB), https://www.nhlbi.nih.gov/; 2. American Heart Association: 13PRE17110006 (AW), http://professional.heart.org/professional/ResearchPrograms/UCM_316889_Research.jsp; 3. Raymond and Beverly Sackler Foundation M117394 (JB); 4. National Institutes of Health T32 GM007223 (AW), https://researchtraining.nih.gov/programs/training-grants/t32; 5. Fondazione Cariplo (IT), (RP); and 6. State of Connecticut Department of Public Health AWDS01772 (JB).; We are grateful to Jonathan Bogan, Fred Gorelick and Carla Rothlin for helpful advice and feedback, and Dana Brenckle for assistance in the manuscript preparation. The work was supported by a grant from the Cariplo Foundation (R.P., J.R.B.), American Heart Association Predoctoral Fellowship Award AHA 13PRE14790042 (A.W.), State of Connecticut Biomedical Research Award DPH AWDS01772 (J.R.B.), NIH T32 GM007223 (A.W.) and R01 HL043331 (J.R.B.).	Akindahunsi AA, 2005, COMPUT BIOL CHEM, V29, P13, DOI 10.1016/j.compbiolchem.2004.11.002; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Esnault S, 2003, J IMMUNOL, V171, P6780, DOI 10.4049/jimmunol.171.12.6780; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Kim CY, 2008, EXP MOL MED, V40, P669, DOI 10.3858/emm.2008.40.6.669; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Ramgolam VS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014450; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Velusamy T, 2008, BIOCHEMISTRY-US, V47, P6508, DOI 10.1021/bi702338y; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Wang SW, 1999, INFLAMM RES, V48, P533, DOI 10.1007/s000110050499; Wang XY, 1998, LEUKEMIA, V12, P520, DOI 10.1038/sj.leu.2400975	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201103	10.1371/journal.pone.0201103	http://dx.doi.org/10.1371/journal.pone.0201103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048492	Green Submitted, gold, Green Published			2022-12-26	WOS:000439952400049
J	Yan, Y; Yin, XC; Yang, C; Li, SJ; Zhang, BW				Yan, Yan; Yin, Xu-Cheng; Yang, Chun; Li, Sujian; Zhang, Bo-Wen			Biomedical literature classification with a CNNs-based hybrid learning network	PLOS ONE			English	Article							TEXT DETECTION; RECOGNITION; VIDEO; ALGORITHM	Deep learning techniques, e.g., Convolutional Neural Networks (CNNs), have been explosively applied to the research in the fields of information retrieval and natural language processing. However, few research efforts have addressed semantic indexing with deep learning. The use of semantic indexing in the biomedical literature has been limited for several reasons. For instance, MEDLINE citations contain a large number of semantic labels from automatically annotated MeSH terms, and for a great deal of the literature, only the information of the title and the abstract is readily available. In this paper, we propose a Boltzmann Convolutional neural network framework (B-CNN) for biomedicine semantic indexing. In our hybrid learning framework, the CNN can adaptively deal with features of documents that have sequence relationships, and can capture context information accordingly; the Deep Boltzmann Machine (DBM) merges global (the entity in each document) and local information through its training with undirected connections. Additionally, we have designed a hierarchical coarse to fine style indexing structure for learning and classifying documents, and a novel feature extension approach with word sequence embedding and Wikipedia categorization. Comparative experiments were conducted for semantic indexing of biomedical abstract documents; these experiments verified the encouraged performance of our B-CNN model.	[Yan, Yan] China Univ Min & Technol, Sch Mech Elect & Informat Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China; [Yin, Xu-Cheng; Yang, Chun; Zhang, Bo-Wen] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China; [Li, Sujian] Peking Univ, Key Lab Computat Linguist, Minist Educ, Beijing 100871, Peoples R China	China University of Mining & Technology; University of Science & Technology Beijing; Peking University	Yan, Y (corresponding author), China Univ Min & Technol, Sch Mech Elect & Informat Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China.; Yin, XC (corresponding author), Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China.	yanyanustb@126.com; xuchengyin@ustb.edu.cn		Yan, Yan/0000-0002-0187-7010	National Natural Science Foundation of China [61175020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (61175020) by Xu-Cheng Yin. There was no additional external funding received for this study.	Ananiadou S, 2004, J BIOMED INFORM, V37, P393, DOI 10.1016/j.jbi.2004.08.011; Aronson AR, 2007, P WORKSH BIONLP 2007, P105; Bai B, 2009, LECT NOTES COMPUT SC, V5478, P761; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Collobert R., 2008, P 25 ICML, V25, P160, DOI DOI 10.1145/1390156.1390177; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Drakopoulos G, 2016, INT C INF INT SYST A; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Feng MW, 2015, 2015 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P813, DOI 10.1109/ASRU.2015.7404872; Fieschi M, 2004, MEDINFO, V107, P287; Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010; Ge ZY, 2015, IEEE IMAGE PROC, P4112, DOI 10.1109/ICIP.2015.7351579; Glorot X., 2011, P 14 INT C ART INT S, P315; Hingmire S, 2013, SIGIR'13: THE PROCEEDINGS OF THE 36TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH & DEVELOPMENT IN INFORMATION RETRIEVAL, P877; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Hu XH, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P389; Huang SC, 2013, IEEE T NEUR NET LEAR, V24, P1920, DOI 10.1109/TNNLS.2013.2270314; Huang SC, 2011, IEEE T CIRC SYST VID, V21, P1, DOI 10.1109/TCSVT.2010.2087812; Inoue N, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P851, DOI 10.1145/2733373.2806347; Jessen WJ, 2015, NATURE PRECEDINGS; Jimeno-Yepes A, 2013, AMIA 2013; Jung C, 2012, IEEE T IMAGE PROCESS, V21, P1272, DOI 10.1109/TIP.2011.2164420; Karami A, 2014, ACL 2014 WORKSH BION, P128; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lai SW, 2015, AAAI CONF ARTIF INTE, P2267; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee H., 2009, P 26 ANN INT C MACH, P609, DOI [DOI 10.1145/1553374.1553453, 10.1145/1553374.1553453]; Li YJ, 2016, COMPUT ELECTR ENG, V54, P68, DOI 10.1016/j.compeleceng.2016.08.008; Liu JZ, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P115, DOI 10.1145/3077136.3080834; McAuliffe J.D., 2008, ADV NEURAL INFORM PR, P121; McCallum, 2002, MALLET MACHINE LEARN; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov T., 2013, ARXIV 160705368, P746, DOI DOI 10.3109/10826089109058901; Mikolov T, 2012, IEEE W SP LANG TECH, P234, DOI 10.1109/SLT.2012.6424228; Mimno DM, 2012, CORR, V2012; Mirowski P., 2010, P 24 ANN C NEURAL IN, P1; Mishra AK, 2012, IEEE T PATTERN ANAL, V34, P639, DOI 10.1109/TPAMI.2011.171; Montavon Gregoire, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P621, DOI 10.1007/978-3-642-35289-8_33; Mori K, 2014, P IEICE GEN C; Nie L, 2014, MED INF RETR WORKSH, P24; Nie LQ, 2015, IEEE T KNOWL DATA EN, V27, P2107, DOI 10.1109/TKDE.2015.2399298; Nie LQ, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1245, DOI 10.1145/2600428.2611176; Nie YP, 2017, FRONT INFORM TECH EL, V18, P535, DOI 10.1631/FITEE.1601232; Podlesnaya A., 2016, P SAI INT SYST C, P359; Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5; Reed Scott, 2014, ARXIV14126596; Reynolds C, 2017, ERS INT C, pPA406; Salakhutdinov R., 2010, P 13 INT C ARTIFICIA, P693; Santos Cicero Dos, 2014, P COLING 2014 25 INT, P69; Settles B., 2004, P INT JOINT WORKSH N, DOI DOI 10.3115/1567594.1567618; Severyn A, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P373, DOI 10.1145/2766462.2767738; Shen YL, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P373, DOI 10.1145/2567948.2577348; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Steyvers M, 2007, HDB LATENT SEMANTIC; Thabtah FA, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P217, DOI 10.1109/ICDM.2004.10117; Trieschnigg D, 2009, BIOINFORMATICS, V25, P1412, DOI 10.1093/bioinformatics/btp249; Tu YH, 2014, INT CONF SIGN PROCES, P532, DOI 10.1109/ICOSP.2014.7015061; Turian J, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P384; Wang YQ, 2015, INT CONF ACOUST SPEE, P4984, DOI 10.1109/ICASSP.2015.7178919; Wu H., 2014, P WORKSH SEM MATCH I, P46; Xiao T, 2014, APPL 2 LEVEL ATTENTI, V40, P842; Yepes AJ, 2014, P 12 ANN WORKSH AUST, V123; Yin XC, 2016, IEEE T IMAGE PROCESS, V25, P2752, DOI 10.1109/TIP.2016.2554321; Yin XC, 2015, IEEE T PATTERN ANAL, V37, P1930, DOI 10.1109/TPAMI.2014.2388210; Yin XC, 2014, IEEE T PATTERN ANAL, V36, P970, DOI 10.1109/TPAMI.2013.182; Zeng D., 2014, COLING; Zhang SP, 2014, INFORM SCIENCES, V281, P635, DOI 10.1016/j.ins.2013.12.052; Zhang Tong, 2014, ARXIV PREPRINT ARXIV; Zhou J, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2048-y; Zhou P, 2012, INT CONF SIGN PROCES, P557, DOI 10.1109/ICoSP.2012.6491549	81	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0197933	10.1371/journal.pone.0197933	http://dx.doi.org/10.1371/journal.pone.0197933			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048461	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400001
J	Lee, KC; Hsu, WH; Chou, PH; Yiin, JJ; Muo, CH; Lin, YP				Lee, Kwo-Chen; Hsu, Wen-Hsuan; Chou, Po-Han; Yiin, Jia-Jean; Muo, Chih-Hsin; Lin, Yun-Ping			Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; END-STAGE DEMENTIA; ALZHEIMERS-DISEASE; RISK-FACTORS; MORTALITY; PREDICTORS; SCALE; CARE; PREVALENCE; PEOPLE	Background Dementia is characterized by prolonged progressive disability. Therefore, predicting mortality is difficult. An accurate prediction tool may be useful to ensure that end-of-life patients with dementia receive timely palliative care. Purpose This study aims to establish a survival prediction model for elderly patients with dementia in Taiwan. Methods Data from the 2001 to 2010 National Health Insurance Research Database in Taiwan were used to identify 37,289 patients with dementia aged >= 65 years for inclusion in this retrospective longitudinal study. Moreover, this study examined the mortality indicators for dementia among demographic characteristics, chronic physical comorbidities, and medical procedures. A Cox proportional hazards model with time-dependent covariates was used to estimate mortality risk, and risk score functions were formulated using a point system to establish a survival prediction model. The prediction model was then tested using the area under the receiver operating characteristic curve. Results Thirteen mortality risk factors were identified: age, sex, stroke, chronic renal failure, liver cirrhosis, cancer, pressure injury, and retrospectively retrieved factors occurring in the 6 months before death, including nasogastric tube placement, supplemental oxygen supply, >= 2 hospitalization, receiving >= 1 emergency services, >= 2 occurrences of cardiopulmonary resuscitation, and receiving >= 2 endotracheal intubations. The area under the receiver operating characteristic curves for this prediction model for mortality at 6 and 12 months were 0.726 and 0.733, respectively. Conclusions The survival prediction model demonstrated moderate accuracy for predicting mortality at 6 and 12 months before death in elderly patients with dementia. This tool may be valuable for helping health care providers and family caregivers to make end-of-life care decisions.	[Lee, Kwo-Chen; Lin, Yun-Ping] China Med Univ, Sch Nursing, Taichung, Taiwan; [Lee, Kwo-Chen; Hsu, Wen-Hsuan; Lin, Yun-Ping] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Lee, Kwo-Chen] China Med Univ Hosp, Brain Dis Res Ctr, Taichung, Taiwan; [Chou, Po-Han] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Chou, Po-Han] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chou, Po-Han] Natl Chiao Tung Univ, Dept Photon, Hsinchu, Taiwan; [Chou, Po-Han] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yiin, Jia-Jean] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taichung, Taiwan; [Yiin, Jia-Jean] Natl Def Med Ctr, Inst Med Sci, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lin, YP (corresponding author), China Med Univ, Sch Nursing, Taichung, Taiwan.; Lin, YP (corresponding author), China Med Univ Hosp, Dept Nursing, Taichung, Taiwan.	yunping@mail.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	The reason why we have the access to the data used in this study is that the authors (K-CL, W-HH, C-HM, Y-PL) are the employees of the China Medical University Hospital, and that fees for using the dataset were paid by the hospital. However, the fees were supported by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital; the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital; the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Aminoff BZ, 2004, ARCH GERONTOL GERIAT, V38, P123, DOI 10.1016/j.archger.2003.08.007; Brown MA, 2013, PALLIATIVE MED, V27, P389, DOI 10.1177/0269216312465649; Cereda E, 2013, ARCH GERONTOL GERIAT, V56, P437, DOI 10.1016/j.archger.2012.12.001; Chen TF, 2007, NEUROEPIDEMIOLOGY, V28, P142, DOI 10.1159/000102142; Chou PH, 2012, PSYCHOSOMATICS, V53, P463, DOI 10.1016/j.psym.2012.03.007; Connors MH, 2016, J ALZHEIMERS DIS, V52, P967, DOI 10.3233/JAD-150946; Department of Health, 2016, STAT CAUS DEATH 6, V6, P3; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heun R, 2013, EUR PSYCHIAT, V28, P40, DOI 10.1016/j.eurpsy.2011.06.001; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jaul E, 2016, EXP AGING RES, V42, P382, DOI 10.1080/0361073X.2016.1191863; Lunawat A, 2016, INT J SURG, V3, P1414; Marsh GW, 2000, APPL NURS RES, V13, P187, DOI 10.1053/apnr.2000.7654; Mitchell SL, 2004, JAMA-J AM MED ASSOC, V291, P2734, DOI 10.1001/jama.291.22.2734; Mitchell SL, 2010, J PAIN SYMPTOM MANAG, V40, P639, DOI 10.1016/j.jpainsymman.2010.02.014; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Nicholas LH, 2014, HEALTH AFFAIR, V33, P667, DOI 10.1377/hlthaff.2013.1258; Prabhakaran S, 2012, SCAND J SURG, V101, P147, DOI 10.1177/145749691210100302; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Sampson EL, 2013, INT J GERIATR PSYCH, V28, P1015, DOI 10.1002/gps.3919; SCHAAFSMA J, 1994, QUAL LIFE RES, V3, P413, DOI 10.1007/BF00435393; Schonwetter Ronald S, 2003, Am J Hosp Palliat Care, V20, P105, DOI 10.1177/104990910302000208; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Tsai PH, 2007, J GERIATR PSYCH NEUR, V20, P172, DOI 10.1177/0891988707301864; van de Vorst IE, 2016, J AM GERIATR SOC, V64, P37, DOI 10.1111/jgs.13835; van der Steen JT, 2006, J CLIN EPIDEMIOL, V59, P970, DOI 10.1016/j.jclinepi.2005.12.005; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; World Health Organization, 2017, 10 FACTS ON DEM	37	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0178997	10.1371/journal.pone.0178997	http://dx.doi.org/10.1371/journal.pone.0178997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044781	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500001
J	Roman, C; Ernst, B; Thiel, M; Manriquez, P; Chamorro, J				Roman, Catalina; Ernst, Billy; Thiel, Martin; Manriquez, Pablo; Chamorro, Julio			Spatio-temporal migratory dynamics of Jasus frontalis (Milne Edwards, 1837) in Alexander Selkirk Island, Juan Fernandez archipelago, Chile	PLOS ONE			English	Article							SOUTHERN ROCK LOBSTER; CRAB CHIONOECETES-OPILIO; SPINY LOBSTER; MOVEMENT PATTERNS; DECAPOD CRUSTACEANS; ECOLOGICAL RESERVE; HOMARUS-AMERICANUS; SCYLLARIDES-LATUS; PANULIRUS-ARGUS; FISHERY	Knowledge about the spatial patterns and movements of crustaceans has gained importance since the creation of marine protected areas and the development of spatial management for benthic ecosystems. The Juan Fernandez spiny lobster (Jasus frontalis) is an endemic marine species and most valuable resource that exhibits migratory dynamics in a highly spatially regulated fishery. To study movement patterns around Alexander Selkirk Island, a mark-recapture program was implemented in 2008, when approximately 7000 non-commercial (undersized) lobsters were tagged and followed for nearly 14 months. Using quantitative georeferenced data, this study revealed spatial structuring of Juan Fernandez spiny lobster and tested hypotheses about alongshore and inshore-offshore movements. Eight clusters were identified around Alexander Selkirk Island, with moderate time-varying connectivity between them. Seasonal inshore-offshore movements were detected all around the island, but more conspicuously to the north. Average travelling distance was 1.2 km (1.7 sd). Our results confirmed that towards the end of austral spring males and females embark in a seasonal offshore migration to deeper waters, returning to shallower waters only during winter. These findings quantitatively consolidate the conceptual migratory model that local fishermen had already inferred for this resource from about a century of sustainable fishing.	[Roman, Catalina; Manriquez, Pablo] Univ Concepcion, Programa Magister Ciencias Menc Pesquerias, Concepcion, Chile; [Roman, Catalina] Inst Fomento Pesquero, Valparaiso, Chile; [Ernst, Billy; Manriquez, Pablo; Chamorro, Julio] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile; [Ernst, Billy] Nucleo Milenio INVASAL, Concepcion, Chile; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Coquimbo, Chile; [Thiel, Martin] Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Thiel, Martin] CEAZA, Coquimbo, Chile	Universidad de Concepcion; Instituto de Fomento Pesquero (Valparaiso); Universidad de Concepcion; Universidad Catolica del Norte	Ernst, B (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile.; Ernst, B (corresponding author), Nucleo Milenio INVASAL, Concepcion, Chile.	biernst@oceanografia.udec.cl			Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica); FIP (Fondo de Investigacion Pesquera) project "DINAMICA POBLACIONAL Y PESQUERA DE LA LANGOSTA EN LA ISLA ALEJANDRO SELKIRK [FIP 2008-24]; Nucleo Milenio INVASAL; Chile's government program, Iniciativa Cientifica Milenio from Ministerio de Economia, Fomento y Turismo; Fondo de Investigacion Pesquera [FIP 2008-24]	Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FIP (Fondo de Investigacion Pesquera) project "DINAMICA POBLACIONAL Y PESQUERA DE LA LANGOSTA EN LA ISLA ALEJANDRO SELKIRK; Nucleo Milenio INVASAL; Chile's government program, Iniciativa Cientifica Milenio from Ministerio de Economia, Fomento y Turismo; Fondo de Investigacion Pesquera	Catalina Roman received funding from Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica, http://www.conicyt.cl/becasconicyt/) scholarship. Billy Ernst received funding from FIP (Fondo de Investigacion Pesquera) during the development of the project "DINAMICA POBLACIONAL Y PESQUERA DE LA LANGOSTA EN LA ISLA ALEJANDRO SELKIRK, FIP 2008-24 and Nucleo Milenio INVASAL, funded by Chile's government program, Iniciativa Cientifica Milenio from Ministerio de Economia, Fomento y Turismo. The Fondo de Investigacion Pesquera (grant FIP 2008-24) also provided funding. The funding agencies did not have a role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abesamis RA, 2006, FISH B-NOAA, V104, P360; Ahumada M, 2014, LAT AM J AQUAT RES, V42, P213, DOI 10.3856/vol42-issue1-fulltext-18; Arana E. P., 1987, ISLAS OCEANICAS CHIL, P319; Arana P, 1985, INVEST MAR, P188; Arana P, 1976, REV COMITE PERMANENT, V4, P117; Arana P, 1983, ANALISIS PESQUERIAS, P77; Arana P., 1985, INVEST MAR, P157; Arana P, 1992, CIENC TEC MAR, V15, P49; Arana P, 1985, 382 U CAT VALP, P96; Arana P., 1985, INVESTIGACIONES MARI, P125; Arana Patricio M., 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P83; Atkinson L., 2001, THESIS; Atkinson LJ, 2003, AFR J MAR SCI, V25, P387, DOI 10.2989/18142320309504026; Barrett N, 2009, MAR FRESHWATER RES, V60, P417, DOI 10.1071/MF07154; Bauer R.T., 2018, NATURAL HIST CRUSTAC, V5, P203; Bertelsen RD, 2013, FISH RES, V144, P91, DOI 10.1016/j.fishres.2012.12.008; BOOTH JD, 1984, NEW ZEAL J MAR FRESH, V18, P275, DOI 10.1080/00288330.1984.9516049; Booth JD, 1997, B MAR SCI, V61, P111; Brownie C., 1985, STAT INFERENCE BAND, V156; Castilla J. C., 1987, ISLAS OCEANICAS CHIL, P15; Childress Michael J., 2006, P78, DOI 10.1002/9780470995969.ch3; COOPER RA, 1975, T AM FISH SOC, V104, P669, DOI 10.1577/1548-8659(1975)104<669:SAOTAL>2.0.CO;2; COOPER RA, 1971, SCIENCE, V171, P288, DOI 10.1126/science.171.3968.288; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Ernst B, 2005, CAN J FISH AQUAT SCI, V62, P250, DOI 10.1139/F04-201; Ernst B, 2013, 201315 FIP U CONC; Ernst B, 2010, 200824 U CONC DEP OC, P1; Ernst B, 2013, PROYECTO 472836LP12; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Ernst B, 2010, B MAR SCI, V86, P315; Factor JR, 1995, BIOL LOBSTER HOMARUS; Fernandes PG, 1999, GEOENVII, V10, P201; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fraley C, 2007, J STAT SOFTW, V18; Freeman DJ, 2009, MAR ECOL PROG SER, V388, P159, DOI 10.3354/meps08122; Freire J, 1998, HYDROBIOLOGIA, V372, P123, DOI 10.1023/A:1017066920151; Frusher SD, 2001, CAN J FISH AQUAT SCI, V58, P2490, DOI 10.1139/cjfas-58-12-2490; Gardner C, 2003, B MAR SCI, V73, P653; Goldstein JS, 2015, MAR ECOL PROG SER, V524, P197, DOI 10.3354/meps11192; Hartnoll R.G., 1982, P111; Herrnkind W.F., 1980, P349; Herrnkind W.F., 1975, Science Bull nat Hist Mus Los Ang Cty, VNo. 20, P31; KANCIRUK P, 1978, B MAR SCI, V28, P601; Kelly S, 2003, NEW ZEAL J MAR FRESH, V37, P149, DOI 10.1080/00288330.2003.9517153; Kelly S, 2001, MAR FRESHWATER RES, V52, P323, DOI 10.1071/MF00028; Law MH, 2003, ADV NEURAL INFORM PR, P625; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Linnane A, 2005, NEW ZEAL J MAR FRESH, V39, P335, DOI 10.1080/00288330.2005.9517314; Linnane A, 2015, MAR FRESHWATER RES, V66, P623, DOI 10.1071/MF13334; MacDiarmid A.B., 1992, P 2 INT TEMP REEF S, P47; MACDIARMID AB, 1991, MAR ECOL PROG SER, V70, P129, DOI 10.3354/meps070129; MACDIARMID AB, 1989, MAR BIOL, V103, P303, DOI 10.1007/BF00397263; Manriquez P, 2016, THESIS; MARTINS HR, 1985, J CRUSTACEAN BIOL, V5, P294, DOI 10.2307/1547877; MCKOY JL, 1983, NEW ZEAL J MAR FRESH, V17, P357, DOI 10.1080/00288330.1983.9516011; MCKOY JL, 1982, NEW ZEAL J MAR FRESH, V16, P141, DOI 10.1080/00288330.1982.9515957; Mendo T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166343; MONTGOMERY SS, 1995, CRUSTACEANA, V68, P257, DOI 10.1163/156854095X01411; MOORE R, 1984, AUST J MAR FRESH RES, V35, P197; MORALES E, 1985, INVEST MAR, P15; Nichol DG, 2015, FISH B-NOAA, V113, P313, DOI 10.7755/FB.113.3.7; Orensanz J. M., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P441; PARIN NV, 1991, B MAR SCI, V49, P671; Pavez P, 1982, INFORME FINAL SUBSEC, V16, P1; Pequeno R. German, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P27; Pewsey A, 2013, CIRCULAR STAT R; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; R Development Core Team, 2014, R LANG ENV STAT COMP; Rao JS., 2001, TOPICS CIRCULAR STAT; RODDICK DL, 1992, CAN J FISH AQUAT SCI, V49, P1486, DOI 10.1139/f92-164; Rueda M, 2001, ICES J MAR SCI, V58, P1219, DOI 10.1006/jmsc.2001.1122; Sanchez-Carnero N, 2008, P 1 INT C INF TECHN; Skottsberg C, 1918, GEOGR REV, V5, P362, DOI 10.2307/207467; SPANIER E, 1988, MAR ECOL PROG SER, V42, P247, DOI 10.3354/meps042247; Stelzenmuller V, 2007, BIOL CONSERV, V136, P571, DOI 10.1016/j.biocon.2007.01.002; Street RJ, 1973, N Z MIN AGR FISH TEC, P116; Swain DP, 2003, CAN J FISH AQUAT SCI, V60, P897, DOI 10.1139/F03-076; Talavera L., 2000, Intelligent Data Analysis, V4, P19; Tomalin B, 1993, THESIS; Waddington K, 2005, NEW ZEAL J MAR FRESH, V39, P365, DOI 10.1080/00288330.2005.9517317; Wieland K, 2001, SARSIA, V86, P503, DOI 10.1080/00364827.2001.10420489; Wilcox C, 2003, N AM J FISH MANAGE, V23, P241, DOI 10.1577/1548-8675(2003)023<0241:DCFAAM>2.0.CO;2; Ziegler PE, 2003, FISH RES, V61, P107, DOI 10.1016/S0165-7836(02)00240-0	84	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200146	10.1371/journal.pone.0200146	http://dx.doi.org/10.1371/journal.pone.0200146			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044805	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500030
J	Taller, D; Balint, J; Gyula, P; Nagy, T; Barta, E; Baksa, I; Szittya, G; Taller, J; Havelda, Z				Taller, Denes; Balint, Jeannette; Gyula, Peter; Nagy, Tibor; Barta, Endre; Baksa, Ivett; Szittya, Gyorgy; Taller, Janos; Havelda, Zoltan			Expansion of Capsicum annum fruit is linked to dynamic tissue-specific differential expression of miRNA and siRNA profiles	PLOS ONE			English	Article							DEEP SEQUENCING DISCOVERY; SMALL RNAS; CONSERVED MICRORNAS; PROVIDES INSIGHTS; BIOGENESIS; SECONDARY; SUITE; IDENTIFICATION; FUNCTIONALITY; DIVERSITY	Small regulatory RNAs, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs) have emerged as important transcriptional and post-transcriptional regulators controlling a wide variety of physiological processes including fruit development. Data are, however, limited for their potential roles in developmental processes determining economically important traits of crops. The current study aimed to discover and characterize differentially expressed miRNAs and siRNAs in sweet pepper (Capsicum annuum) during fruit expansion. High-throughput sequencing was employed to determine the small regulatory RNA expression profiles in various fruit tissues, such as placenta, seed, and flesh at 28 and 40 days after anthesis. Comparative differential expression analyses of conserved, already described and our newly predicted pepper-specific miRNAs revealed that fruit expansion is accompanied by an increasing level of miRNA-mediated regulation of gene expression. Accordingly, ARGONAUTE1 protein, the primary executor of miRNA-mediated regulation, continuously accumulated to an extremely high level in the flesh. We also identified numerous pepper-specific, heterochromatin-associated 24-nt siRNAs (hetsiRNAs) which were extremely abundant in the seeds, as well as 21-nt and 24-nt phased siRNAs (phasiRNAs) that were expressed mainly in the placenta and the seeds. This work provides comprehensive tissue-specific miRNA and siRNA expression landscape for a developing pepper fruit. We identified several novel, abundantly expressing tissue- and pepper-specific small regulatory RNA species. Our data show that fruit expansion is associated with extensive changes in sRNA abundance, raising the possibility that manipulation of sRNA pathways may be employed to improve the quality and quantity of the pepper fruit.	[Taller, Denes; Balint, Jeannette; Gyula, Peter; Nagy, Tibor; Barta, Endre; Baksa, Ivett; Szittya, Gyorgy; Havelda, Zoltan] Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Godollo, Hungary; [Taller, Janos] Univ Pannonia, Georgikon Fac, Dept Plant Sci & Biotechnol, Keszthely, Hungary	University of Pannonia	Havelda, Z (corresponding author), Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Godollo, Hungary.	havelda.zoltan@abc.naik.hu	Barta, Endre/B-1166-2008; Szittya, Gyorgy/A-2905-2012; Taller, Janos/ABB-9586-2021; Gyula, Péter/N-4445-2014; Szittya, Gyorgy/M-9199-2019	Barta, Endre/0000-0002-6753-0714; Szittya, Gyorgy/0000-0003-2040-2851; Gyula, Péter/0000-0002-3574-2827; Szittya, Gyorgy/0000-0003-2040-2851; Nagy, Tibor/0000-0002-4451-0796; Havelda, Zoltan/0000-0002-6349-7646	National Research, Development and Innovation Office [NKFI-K109438, NKFI-K116602, NKFI-K119701]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by grants from the National Research, Development and Innovation Office (http://nkfih.gov.hu; NKFI-K109438 and NKFI-K116602 were granted to ZH, NKFI-K119701 was granted to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S, FASTQC QUALITY CONTR; Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Baksa I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2209-6; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Bond DM, 2014, TRENDS CELL BIOL, V24, P100, DOI 10.1016/j.tcb.2013.08.001; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dotto MC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004826; Fei QL, 2015, PLANT J, V83, P451, DOI 10.1111/tpj.12900; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Gao C, 2015, PLANT BIOTECHNOL J, V13, P370, DOI 10.1111/pbi.12297; Garcia D, 2008, SEMIN CELL DEV BIOL, V19, P586, DOI 10.1016/j.semcdb.2008.07.013; Ge AJ, 2013, PHYSIOL PLANTARUM, V148, P387, DOI 10.1111/j.1399-3054.2012.01713.x; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hwang DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064238; Kamthan A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00208; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar R, 2014, APPL BIOCHEM BIOTECH, V174, P93, DOI 10.1007/s12010-014-0914-2; Li BB, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1366397; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Li H, 2013, PLANTA, V238, P695, DOI 10.1007/s00425-013-1917-x; Liu ZB, 2017, GENE, V608, P66, DOI 10.1016/j.gene.2017.01.020; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez de Alba AE, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Qin ZR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00586; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Zhai JX, 2015, P NATL ACAD SCI USA, V112, P3146, DOI 10.1073/pnas.1418918112; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhang CQ, 2014, BIOINFORMATICS, V30, P1045, DOI 10.1093/bioinformatics/btt746; Zhang H, 2015, CURR OPIN PLANT BIOL, V27, P84, DOI 10.1016/j.pbi.2015.06.011; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	58	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200207	10.1371/journal.pone.0200207	http://dx.doi.org/10.1371/journal.pone.0200207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044813	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500033
J	Zoll, J; Verweij, PE; Melchers, WJG				Zoll, Jan; Verweij, Paul E.; Melchers, Willem J. G.			Discovery and characterization of novel Aspergillus fumigatus mycoviruses	PLOS ONE			English	Article							AZOLE RESISTANCE; DNA MYCOVIRUS; HYPOVIRULENCE; TRANSMISSION; DSRNAS	In the last few years, increasing numbers of viruses infecting fungi have been identified. In this study, we used an in silico approach for the analysis of deep RNA sequencing data in order to discover and characterize putative genomic ssRNA or dsRNA mycovirus sequences in Aspergillus fumigatus. RNA sequencing reads of A. fumigatus strains were mapped against the A. fumigatus Af293 reference genome. Unmapped reads were collected for de novo assembly. Contigs were analyzed by Blastx comparison with a mycovirus protein database. Assembled viral genomes were used as template for remapping of RNA sequencing reads. In total, deep RNA sequencing results from 11 A. fumigatus strains were analyzed for the presence of mycoviral genomic RNAs. In 9 out of 11 strains, putative mycoviral RNA genomes were identified. Three strains were infected with two different mycovirus species. Two strains were infected with Aspergillus fumigatus polymycovirus type-1 (AfuPmV-1). Four strains contained fully recovered genomic RNA of unknown narna-like viruses designated as Aspergillus fumigatus narnavirus-1 and Aspergillus fumigatus narnavirus-2 (AfuNV-1 and AfuNV-2). Both viruses showed 38% amino acid sequence identity to Beihai narna-like virus-21. Three strains contained partially recovered genomic RNA of an unknown narna-like virus. Two strains contained fully recovered genomic RNAs of an unknown partitivirus designated as Aspergillus fumigatus partitivirus-2 (AfuPV-2) which showed 50% amino acid sequence identity to Alternaria alternata partitivirus-1. Finally, one strain contained fully recovered genomic RNA of an unknown mitovirus designated as Aspergillus fumigatus mitovirus-1 (AfuMV-1) which showed 34% amino acid sequence identity to Sclerotina sclerotiorum mitovirus. In silico analysis of deep RNA sequencing results showed that a majority of the A. fumigatus strains used here were infected with mycoviruses. Four novel A. fumigatus RNA mycoviruses could be identified: two different Aspergillus fumigatus narna-like viruses, one Aspergillus fumigatus partitivirus, and one Aspergillus fumigatus mitovirus.	[Zoll, Jan] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; Ctr Expertise Mycol Radboudumc CWZ, Nijmegen, Netherlands	Radboud University Nijmegen	Zoll, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands.	jan.zoll@radboudumc.nl	Melchers, Willem/C-8819-2015; Verweij, P.E./H-8108-2014; Zoll, G.J./L-4776-2015	Melchers, Willem/0000-0002-5446-2230; Verweij, P.E./0000-0002-8600-9860; Zoll, G.J./0000-0003-2155-7935				Ballard E, 2018, FUNGAL GENET BIOL, V113, P1, DOI 10.1016/j.fgb.2018.02.003; Bartholomaus A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165965; Bhatti MF, 2012, MYCOPATHOLOGIA, V174, P323, DOI 10.1007/s11046-012-9556-5; Bhatti MF, 2011, ARCH VIROL, V156, P1677, DOI 10.1007/s00705-011-1045-5; Brusini J, 2013, J VIROL METHODS, V187, P435, DOI 10.1016/j.jviromet.2012.11.025; Ghabrial SA, 2015, VIROLOGY, V479, P356, DOI 10.1016/j.virol.2015.02.034; Kanhayuwa L, 2015, P NATL ACAD SCI USA, V112, P9100, DOI 10.1073/pnas.1419225112; Kotta-Loizou I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01699; Kotta-Loizou I, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006183; Liu WX, 2008, VIRUS GENES, V37, P322, DOI 10.1007/s11262-008-0265-6; Marzano SYL, 2016, J VIROL, V90, P6846, DOI 10.1128/JVI.00357-16; Mu F, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02540; Niu YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23807-3; Okada R, 2015, J GEN PLANT PATHOL, V81, P103, DOI 10.1007/s10327-014-0575-6; Osaki H, 2016, VIRUS GENES, V52, P835, DOI 10.1007/s11262-016-1379-x; Refos JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077381; Rowley PA, 2017, YEAST, V34, P279, DOI 10.1002/yea.3234; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; van de Sande WWJ, 2010, EUR J CLIN MICROBIOL, V29, P755, DOI 10.1007/s10096-010-0946-7; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; Verweij Paul E, 2016, Lancet Infect Dis, V16, pe251, DOI 10.1016/S1473-3099(16)30138-4; Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885; Wang LP, 2014, J VIROL, V88, P7517, DOI 10.1128/JVI.00538-14; Xavier AD, 2018, VIRUS RES, V244, P21, DOI 10.1016/j.virusres.2017.10.007; Xie JT, 2014, ANNU REV PHYTOPATHOL, V52, P45, DOI 10.1146/annurev-phyto-102313-050222; Yu X, 2013, P NATL ACAD SCI USA, V110, P1452, DOI 10.1073/pnas.1213755110; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107	27	25	26	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200511	10.1371/journal.pone.0200511	http://dx.doi.org/10.1371/journal.pone.0200511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044844	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500059
J	Vos, AM; Jurak, E; de Gijsel, P; Ohm, RA; Henrissat, B; Lugones, LG; Kabel, MA; Wosten, HAB				Vos, Aurin M.; Jurak, Edita; de Gijsel, Peter; Ohm, Robin A.; Henrissat, Bernard; Lugones, Luis G.; Kabel, Mirjam A.; Wosten, Han A. B.			Production of alpha-1,3-L-arabinofuranosidase active on substituted xylan does not improve compost degradation by Agaricus bisporus	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASES; MUSHROOM-COMPOST; SCYTALIDIUM-THERMOPHILUM; BIFIDOBACTERIUM-ADOLESCENTIS; WHEAT; POLYSACCHARIDES; HEMICELLULOSES; ARABINOXYLAN; PURIFICATION; SPECIFICITY	Agaricus bisporus consumes carbohydrates contained in wheat straw based compost used for commercial mushroom production. Double substituted arabinoxylan is part of the similar to 40% of the compost polysaccharides that are not degraded by A. bisporus during its growth and development. Genes encoding alpha-1,3-L- arabinofuranosidase (AXHd3) enzymes that act on xylosyl residues doubly substituted with arabinosyl residues are absent in this mushroom forming fungus. Here, the AXHd3 encoding hgh43 gene of Humicola insolens was expressed in A. bisporus with the aim to improve its substrate utilization and mushroom yield. Transformants secreted active AXHd3 in compost as shown by the degradation of double substituted arabinoxylan oligomers in an in vitro assay. However, carbohydrate composition and degree of arabinosyl substitution of arabinoxylans were not affected in compost possibly due to inaccessibility of the doubly substituted xylosyl residues.	[Vos, Aurin M.; Ohm, Robin A.; Lugones, Luis G.; Wosten, Han A. B.] Univ Utrecht, Dept Biol, Microbiol, Utrecht, Netherlands; [Jurak, Edita; de Gijsel, Peter; Kabel, Mirjam A.] Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Vos, Aurin M.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Jurak, Edita] Aalto Univ, Dept Bioprod & Biosyst, Espoo, Finland	Utrecht University; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Delft University of Technology; Aalto University	Vos, AM (corresponding author), Univ Utrecht, Dept Biol, Microbiol, Utrecht, Netherlands.; Vos, AM (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	A.M.Vos@tudelft.nl	Wösten, Han AB/K-2769-2016; Henrissat, Bernard/J-2475-2012; Ohm, Robin A/I-6689-2016; Jurak, Edita/AAM-2163-2020; Kabel, Mirjam/M-1051-2016	Wösten, Han AB/0000-0002-0399-3648; Henrissat, Bernard/0000-0002-3434-8588; Ohm, Robin A./0000-0003-2548-0074; Kabel, Mirjam/0000-0002-2787-7852; Jurak, Edita/0000-0003-4253-4556	Technology Foundation STW [11108]; technology programme of the Ministry of Economic Affairs	Technology Foundation STW(Technologiestichting STW); technology programme of the Ministry of Economic Affairs	This research was supported and approved by the Technology Foundation STW (11108; http://www.stw.nl/nl/content/how-mushrooms-feed-sugars), applied science division of NWO and the technology programme of the Ministry of Economic Affairs (The Netherlands) CNC Grondstoffen B.V. provided compost used in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baars JJP, 2013, BLOK C INPUT OUTPUT; Borsenberger V, 2014, BBA-GEN SUBJECTS, V1840, P3106, DOI 10.1016/j.bbagen.2014.07.001; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; Ferre H, 2000, EUR J BIOCHEM, V267, P6633, DOI 10.1046/j.1432-1327.2000.01758.x; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Gerrits JPG, 1988, CULTIVATION MUSHROOM, P29; Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A; Grabber JH, 2009, J SCI FOOD AGR, V89, P122, DOI 10.1002/jsfa.3418; Jurak E., 2015, THESIS WAGENINGEN U; Jurak E, 2015, PLOS ONE, V10, P1; Jurak E, 2015, CARBOHYD POLYM, V132, P359, DOI 10.1016/j.carbpol.2015.06.065; Jurak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134169; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kabel MA, 2017, APPL MICROBIOL BIOT, V101, P4363, DOI 10.1007/s00253-017-8294-5; KORMELINK FJM, 1993, J BIOTECHNOL, V27, P249, DOI 10.1016/0168-1656(93)90089-6; Koutaniemi S, 2016, J BIOTECHNOL, V229, P22, DOI 10.1016/j.jbiotec.2016.04.050; Kristensen JB, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-5; Lagaert S, 2010, BIOCHEM BIOPH RES CO, V402, P644, DOI 10.1016/j.bbrc.2010.10.075; LAWTHER JM, 1995, J AGR FOOD CHEM, V43, P667, DOI 10.1021/jf00051a021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez PM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0519-9; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Patyshakuliyeva A, 2015, ENVIRON MICROBIOL, V17, P3098, DOI 10.1111/1462-2920.12967; Pelkmans JF, 2016, APPL MICROBIOL BIOT, V100, P7151, DOI 10.1007/s00253-016-7574-9; PULS J, 1987, ENZYME MICROB TECH, V9, P83, DOI 10.1016/0141-0229(87)90147-5; ROSS RC, 1983, SCI HORTIC-AMSTERDAM, V20, P61, DOI 10.1016/0304-4238(83)90112-7; Sabotic J, 2016, APPL MICROBIOL BIOT, V100, P91, DOI 10.1007/s00253-015-7075-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; STRAATSMA G, 1993, MYCOL RES, V97, P321, DOI 10.1016/S0953-7562(09)81129-5; STRAATSMA G, 1989, J GEN MICROBIOL, V135, P751; STRAATSMA G, 1994, APPL ENVIRON MICROB, V60, P3049, DOI 10.1128/AEM.60.9.3049-3054.1994; Sun RC, 2002, IND CROP PROD, V15, P179, DOI 10.1016/S0926-6690(01)00112-1; Sun RC, 1996, CARBOHYD POLYM, V29, P325, DOI 10.1016/S0144-8617(96)00018-5; Sun RC, 1998, J AGR FOOD CHEM, V46, P2804, DOI 10.1021/jf971078a; SUN RC, 1995, IND CROP PROD, V4, P127, DOI 10.1016/0926-6690(95)00025-8; Sun XF, 2005, J AGR FOOD CHEM, V53, P860, DOI 10.1021/jf040456q; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V51, P606, DOI 10.1007/s002530051439; Vos AM, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0424-z	46	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201090	10.1371/journal.pone.0201090	http://dx.doi.org/10.1371/journal.pone.0201090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040824	Green Published, Green Submitted, gold			2022-12-26	WOS:000439749200024
J	Annibali, O; Piccioni, L; Tomarchio, V; Circhetta, E; Sarlo, C; Franceschini, L; Cantonetti, M; Rizzo, E; Angeletti, S; Tirindelli, MC; Scagnolari, C; Statzu, M; Avvisati, G; Riva, E				Annibali, Ombretta; Piccioni, Livia; Tomarchio, Valeria; Circhetta, Erika; Sarlo, Chiara; Franceschini, Luca; Cantonetti, Maria; Rizzo, Emanuela; Angeletti, Silvia; Tirindelli, Maria Cristina; Scagnolari, Carolina; Statzu, Maura; Avvisati, Giuseppe; Riva, Elisabetta			Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENETIC-VARIATION; INTERLEUKIN 28B; HCV CLEARANCE; IL28B; EXPRESSION; THERAPY; INFECTION; DISEASE	Cytomegalovirus (CMV) infection represents one of the main cause mortality after Stem Cell Transplantation. Recently, a protective effect of the T allele of rs12979860 IL28B Single Nucleotide Polymorphisms (SNPs) against CMV infection in the allogenic stem cell transplantation was suggested. We investigate whether the rs12979860 IL28B SNP and the relative rs368234815 (IFN lambda 4) genotype may affect the incidence of active CMV infection in Autologous stem cell transplantation (Auto-SCT) setting. The study included 99 patients who underwent to Auto-SCT. 1L28 and IFN Delta 4 SNPs were correlated with CMV reactivation along with other clinical and treatment parameters. CMV reactivation by CMV DNAemia was evaluated once a week until day 100 from Auto-SCT. CMV reactivation was documented in 50% (TT-Delta G/Delta G), 35% (CC-TT/TT) and 29.2% (CT-TT/Delta G) of the patients respectively. No differences in CMV copies number were recorded at reactivation between different IL28/IFN lambda 4 genotypes. The analysis of patients older than 60 years showed a significantly higher incidence of active CMV infection in the TT-Delta G/Delta G (83%) population with respect to CC-TT/TT (21%) and CT-TT/Delta G (40%) patients. Our data suggest a negative role of TT-Delta G/Delta G genotype in the CMV reactivation in Auto-SCT. The exposure to rituximab and the pre-infusion presence of anti CMV IgG also significantly influenced CMV reactivation.	[Annibali, Ombretta; Tomarchio, Valeria; Circhetta, Erika; Sarlo, Chiara; Avvisati, Giuseppe] Campus Biomed Univ, Unit Hematol, Stem Cell Transplantat, Rome, Italy; [Piccioni, Livia; Riva, Elisabetta] Campus Biomed Univ, Lab Virol, Rome, Italy; [Franceschini, Luca; Cantonetti, Maria; Rizzo, Emanuela] Tor Vergata Univ, Hematol & Stem Cell Transplant Unit, Rome, Italy; [Angeletti, Silvia] Campus Biomed Univ, Lab Pathol & Microbiol, Rome, Italy; [Tirindelli, Maria Cristina] Campus Biomed Univ, Transfus Med & Cellular Therapy, Rome, Italy; [Scagnolari, Carolina; Statzu, Maura] Sapienza Univ, Dept Mol Med, Lab Virol, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Sapienza University Rome	Riva, E (corresponding author), Campus Biomed Univ, Lab Virol, Rome, Italy.	e.riva@unicampus.it	riva, elisabetta/H-7729-2016; Piccioni, Livia/AAA-5032-2020; Cantonetti, Maria/AAB-9806-2019; SCAGNOLARI, CAROLINA/G-3837-2011	riva, elisabetta/0000-0002-6870-8780; CANTONETTI, Maria/0000-0003-4586-0920; SCAGNOLARI, CAROLINA/0000-0003-1044-1478				Assone T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003199; Bibert S, 2014, AIDS, V28, P1885, DOI 10.1097/QAD.0000000000000379; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bravo D, 2014, J MED VIROL, V86, P838, DOI 10.1002/jmv.23865; Chinnaswamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075495; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Egli A, 2014, J INFECT DIS, V210, P717, DOI 10.1093/infdis/jiu144; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Griffiths SJ, 2015, J INNATE IMMUN, V7, P231, DOI 10.1159/000369902; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Honda M, 2014, HEPATOLOGY, V59, P828, DOI 10.1002/hep.26788; Kamihira S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-40; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Loeffler J, 2006, J CLIN MICROBIOL, V44, P1847, DOI 10.1128/JCM.44.5.1847-1850.2006; Manuel O, 2015, J INFECT DIS, V211, P906, DOI 10.1093/infdis/jiu557; Marchesi Francesco, 2015, World J Transplant, V5, P129, DOI 10.5500/wjt.v5.i3.129; Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x; Murakawa M, 2015, J GASTROEN HEPATOL, V30, P1075, DOI 10.1111/jgh.12902; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rallon NI, 2012, J ANTIMICROB CHEMOTH, V67, P1246, DOI 10.1093/jac/dkr598; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Riva E, 2012, J VIRAL HEPATITIS, V19, P650, DOI 10.1111/j.1365-2893.2012.01606.x; Scagnolari C, 2012, VIRUS RES, V165, P236, DOI 10.1016/j.virusres.2012.02.018; Selvaggi C, 2014, J INFECTION, V68, P467, DOI 10.1016/j.jinf.2013.12.010; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	33	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200221	10.1371/journal.pone.0200221	http://dx.doi.org/10.1371/journal.pone.0200221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036376	Green Submitted, Green Published, gold			2022-12-26	WOS:000439429200010
J	Schutte-Nutgen, K; Edeling, M; Mendl, G; Krahn, MP; Edemir, B; Weide, T; Kremerskothen, J; Michgehl, U; Pavenstadt, H				Schuette-Nuetgen, Katharina; Edeling, Maria; Mendl, Gudrun; Krahn, Michael P.; Edemir, Bayram; Weide, Thomas; Kremerskothen, Joachim; Michgehl, Ulf; Pavenstaedt, Hermann			Getting a Notch closer to renal dysfunction: activated Notch suppresses expression of the adaptor protein Disabled-2 in tubular epithelial cells	FASEB JOURNAL			English	Article						NICD1; Dab2; endocytosis; kidney function	MESENCHYMAL TRANSITION EMT; FUNCTIONAL-ANALYSIS; SIGNALING PATHWAY; KIDNEY FIBROSIS; GENE; ENDOCYTOSIS; DAB2; ROLES; MICE	Reactivation of Notch signaling in kidneys of animal models and patients with chronic kidney disease (CKD) has been shown to contribute to epithelial injury and fibrosis development. Here, we investigated the mechanisms of Notch-induced injury in renal epithelial cells. We performed genome-wide transcriptome analysis to identify Notch target genes using an in vitro system of cultured tubular epithelial cells expressing the intracellular domain of Notch1. One of the top downregulated genes was Disabled-2 (Dab2). With the use of Drosophila nephrocytes as a model system, we found that Dab (the Drosophila homolog of Dab2) knockdown resulted in a significant filtration defect, indicating that loss of Dab2 plays a functional role in kidney disease development. We showed that Dab2 expression in cultured tubular epithelial cells is involved in endocytic regulation and that it also protects cells from TGF--induced epithelial-to-mesenchymal transition. In vivo correlation studies indicated its additional role in renal ischemia-induced injury. Together, these data suggest that Dab2 plays a versatile role in the kidney and may impact on acute and CKDs.Schutte-Nutgen, K., Edeling, M., Mendl, G., Krahn, M. P., Edemir, B., Weide, T., Kremerskothen, J., Michgehl, U., Pavenstadt, H. Getting a Notch closer to renal dysfunction: activated Notch suppresses expression of the adaptor protein Disabled-2 in tubular epithelial cells.	[Schuette-Nuetgen, Katharina; Edeling, Maria; Mendl, Gudrun; Krahn, Michael P.; Edemir, Bayram; Weide, Thomas; Kremerskothen, Joachim; Michgehl, Ulf; Pavenstaedt, Hermann] Univ Hosp Muenster, Internal Med D, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany; [Edemir, Bayram] Univ Hosp Halle Saale, Internal Med 4, Dept Hematol & Oncol, Halle, Saale, Germany	University of Munster; Martin Luther University Halle Wittenberg	Pavenstadt, H (corresponding author), Univ Hosp Muenster, Internal Med D, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany.	hermann.pavenstaedt@ukmuenster.de	Edemir, Bayram/AAF-6845-2020; Krahn, Michael/AAD-4476-2022	Krahn, Michael/0000-0001-7718-9890	Innovative Medizinische Forschung and Jackstadt Stiftung; German Research Foundation (DFG) [SFB699]	Innovative Medizinische Forschung and Jackstadt Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Ralf Adams (Max-Planck-Institute Muenster, Germany) for providing the human Dab2 construct. The authors also thank Katalin Susztak (University of Pennsylvania, Philadelphia, PA, USA) for providing the full-length Notch cDNA. The authors are also immensely grateful to Dominik Kentrup and Stefan Reuter for performing the animal studies. The authors thank Rita Schroter for excellent technical support. This work was supported by the Innovative Medizinische Forschung and Jackstadt Stiftung (to M.E. and H.P.), and the German Research Foundation (DFG) SFB699 (University of Regensburg, Regensburg, Germany) (A13; to M.P.K.). Parts of this article have been published in the Ph.D. thesis of M.E. The authors declare no conflicts of interest.	Adamson SE, 2016, J CLIN INVEST, V126, P1311, DOI 10.1172/JCI79590; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bonegio R, 2012, EXP CELL RES, V318, P986, DOI 10.1016/j.yexcr.2012.02.036; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Finkielstein CV, 2016, BIOESSAYS, V38, pS45, DOI 10.1002/bies.201670907; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Gerlach GF, 2013, WIRES DEV BIOL, V2, P559, DOI 10.1002/wdev.92; Hesketh EE, 2014, JOVE-J VIS EXP, DOI 10.3791/51816; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hochapfel F., 2018, J CELL BIOCH; Hochapfel F, 2017, CELL MOL LIFE SCI, V74, P4573, DOI 10.1007/s00018-017-2593-y; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kawasaki F, 2011, P NATL ACAD SCI USA, V108, pE222, DOI 10.1073/pnas.1102231108; Kentrup D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026419; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Koral K, 2014, AM J PHYSIOL-RENAL, V307, pF1380, DOI 10.1152/ajprenal.00454.2014; Koral K, 2012, AM J PHYSIOL-RENAL, V302, pF1013, DOI 10.1152/ajprenal.00289.2011; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kur E, 2011, DEV DYNAM, V240, P1567, DOI 10.1002/dvdy.22624; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin JC, 2010, BRIT J CANCER, V103, P1716, DOI 10.1038/sj.bjc.6605975; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Schnaper HW, 2003, FRONT BIOSCI-LANDMRK, V8, pE68, DOI 10.2741/925; Schnockel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Schwahn DJ, 1998, ONCOGENE, V17, P1173, DOI 10.1038/sj.onc.1202038; Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Sorensen-Zender I, 2014, AM J PHYSIOL-RENAL, V306, pF907, DOI 10.1152/ajprenal.00030.2014; Song JK, 2010, DEVELOPMENT, V137, P3719, DOI 10.1242/dev.050948; Sweetwyne MT, 2014, KIDNEY INT SUPPL, V4, P91, DOI 10.1038/kisup.2014.17; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Weide T, 2017, J AM SOC NEPHROL, V28, P2093, DOI 10.1681/ASN.2016040474; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Xiao ZC, 2014, INT J BIOCHEM CELL B, V55, P65, DOI 10.1016/j.biocel.2014.08.009; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P209, DOI 10.1681/ASN.2012080795; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P191, DOI 10.1681/ASN.2012080769; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	56	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					821	832		10.1096/fj.201800392RR	http://dx.doi.org/10.1096/fj.201800392RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052485				2022-12-26	WOS:000457401500064
J	Grinkevich, P; Sinha, D; Iermak, I; Guzanova, A; Weiserova, M; Ludwig, J; Mesters, JR; Ettrich, RH				Grinkevich, Pavel; Sinha, Dhiraj; Iermak, Iuliia; Guzanova, Alena; Weiserova, Marie; Ludwig, Jost; Mesters, Jeroen R.; Ettrich, Ruediger H.			Crystal structure of a novel domain of the motor subunit of the Type I restriction enzyme EcoR124 involved in complex assembly and DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; X-ray crystallography; DNA endonuclease; DNA binding protein; Escherichia coli (E; coli); C-terminal domain; EcoR124; GFP fusion; HsdR; restriction-modification	VIBRIO-VULNIFICUS YJ016; ESCHERICHIA-COLI; MODIFICATION SYSTEM; HSDR SUBUNIT; SEQUENCE; PROTEIN; GENES; CRYSTALLIZATION; TRANSLOCATION; PURIFICATION	Although EcoR124 is one of the better-studied Type I restriction-modification enzymes, it still presents many challenges to detailed analyses because of its structural and functional complexity and missing structural information. In all available structures of its motor subunit HsdR, responsible for DNA translocation and cleavage, a large part of the HsdR C terminus remains unresolved. The crystal structure of the C terminus of HsdR, obtained with a crystallization chaperone in the form of pHluorin fusion and refined to 2.45 , revealed that this part of the protein forms an independent domain with its own hydrophobic core and displays a unique -helical fold. The full-length HsdR model, based on the WT structure and the C-terminal domain determined here, disclosed a proposed DNA-binding groove lined by positively charged residues. In vivo and in vitro assays with a C-terminal deletion mutant of HsdR supported the idea that this domain is involved in complex assembly and DNA binding. Conserved residues identified through sequence analysis of the C-terminal domain may play a key role in protein-protein and protein-DNA interactions. We conclude that the motor subunit of EcoR124 comprises five structural and functional domains, with the fifth, the C-terminal domain, revealing a unique fold characterized by four conserved motifs in the IC subfamily of Type I restriction-modification systems. In summary, the structural and biochemical results reported here support a model in which the C-terminal domain of the motor subunit HsdR of the endonuclease EcoR124 is involved in complex assembly and DNA binding.	[Grinkevich, Pavel; Sinha, Dhiraj; Iermak, Iuliia; Ludwig, Jost; Ettrich, Ruediger H.] Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic; [Grinkevich, Pavel] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 1760, Ceske Budejovice 37005, Czech Republic; [Iermak, Iuliia] Max Planck Inst Biochem, Dept Struct Cell Biol Mol Mech DNA Repair, Klopferspitz 18, D-82152 Martinsried, Germany; [Guzanova, Alena; Weiserova, Marie] Acad Sci Czech Republ, Inst Microbiol, Videnska 1083, Prague 14220 4, Czech Republic; [Mesters, Jeroen R.] Univ Lubeck, Inst Biochem, Ratzeburger Allee 160, Lubeck, Germany; [Ettrich, Ruediger H.] Larkin Univ, Coll Biomed Sci, Miami, FL 33169 USA	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Max Planck Society; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Lubeck	Ettrich, RH (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic.; Ettrich, RH (corresponding author), Larkin Univ, Coll Biomed Sci, Miami, FL 33169 USA.	ettrich@nh.cas.cz	Grinkevich, Pavel/AAV-3387-2020; Ludwig, Jost/K-3446-2017; Ettrich, Rudi H/C-1463-2011	Grinkevich, Pavel/0000-0003-1523-7708; Ettrich, Rudi H/0000-0001-8624-7706; Mesters, Jeroen/0000-0001-8532-6699	Czech Science Foundation [P207/12/2323]; Institute of Microbiology, Czech Academy of Sciences; College of Biomedical Sciences, Larkin University; Czech Research Infrastructure for Systems Biology C4SYS [LM2015055]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Microbiology, Czech Academy of Sciences; College of Biomedical Sciences, Larkin University; Czech Research Infrastructure for Systems Biology C4SYS	This work was supported by the Czech Science Foundation (P207/12/2323) and by a Memorandum of Agreement between the Institute of Microbiology, Czech Academy of Sciences, and the College of Biomedical Sciences, Larkin University. Access to instruments and other facilities was supported by the Czech Research Infrastructure for Systems Biology C4SYS (LM2015055). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BERTANI G, 1953, J BACTERIOL, V65, P113, DOI 10.1128/JB.65.2.113-121.1953; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Csefalvay E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128700; Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erwin AL, 2008, J BACTERIOL, V190, P1473, DOI 10.1128/JB.01207-07; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Gao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017346; Grinkevich P, 2016, ACTA CRYSTALLOGR F, V72, P672, DOI 10.1107/S2053230X16011626; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; HORIUCHI K, 1972, P NATL ACAD SCI USA, V69, P3220, DOI 10.1073/pnas.69.11.3220; HUBACEK J, 1970, J MOL BIOL, V50, P111, DOI 10.1016/0022-2836(70)90108-7; JACOB F, 1955, ANN I PASTEUR PARIS, V88, P724; Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kennaway CK, 2012, GENE DEV, V26, P92, DOI 10.1101/gad.179085.111; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; Kobe B, 2015, ACTA CRYSTALLOGR F, V71, P861, DOI 10.1107/S2053230X15011061; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lapkouski M, 2009, NAT STRUCT MOL BIOL, V16, P94, DOI 10.1038/nsmb.1523; Liu YP, 2017, P NATL ACAD SCI USA, V114, P11151, DOI 10.1073/pnas.1711754114; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1982, PREPARATION ANAL PRO, P19; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obarska-Kosinska A, 2008, J MOL BIOL, V376, P438, DOI 10.1016/j.jmb.2007.11.024; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Pages H, 2019, BIOSTRINGS EFFICIENT; Park SY, 2012, ACTA CRYSTALLOGR D, V68, P1570, DOI 10.1107/S0907444912038826; PATEL J, 1992, GENE, V112, P21, DOI 10.1016/0378-1119(92)90298-4; Piekarowicz A, 2001, MOL MICROBIOL, V41, P1199, DOI 10.1046/j.1365-2958.2001.02587.x; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; R Development Core Team, 2017, R LANG ENV STAT COMP; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha D, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3722-8; Sisakova E, 2008, J MOL BIOL, V384, P1273, DOI 10.1016/j.jmb.2008.10.017; SOMMER R, 1979, MOL GEN GENET, V168, P331, DOI 10.1007/BF00271504; SURI B, 1984, EMBO J, V3, P575, DOI 10.1002/j.1460-2075.1984.tb01850.x; TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179; Uyen NT, 2009, NUCLEIC ACIDS RES, V37, P6960, DOI 10.1093/nar/gkp603; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Thor JJ, 2005, J BIOL CHEM, V280, P33652, DOI 10.1074/jbc.M505473200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Youell J, 2008, MICROBIOL MOL BIOL R, V72, P365, DOI 10.1128/MMBR.00043-07	61	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15043	15054		10.1074/jbc.RA118.003978	http://dx.doi.org/10.1074/jbc.RA118.003978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30054276	Green Published, hybrid			2022-12-26	WOS:000445998400009
J	Jensch, A; Frey, Y; Bitschar, K; Weber, P; Schmid, S; Hausser, A; Olayioye, MA; Radde, NE				Jensch, Antje; Frey, Yannick; Bitschar, Katharina; Weber, Patrick; Schmid, Simone; Hausser, Angelika; Olayioye, Monilola A.; Radde, Nicole E.			The tumor suppressor protein DLC1 maintains protein kinase D activity and Golgi secretory function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase D (PKD); Rho (Rho GTPase); deleted in liver cancer 1 (DLC1); secretion; kinetics; model selection; profile likelihood; trans-Golgi network; kinetic modeling	D-MEDIATED PHOSPHORYLATION; C-MU; SIGNALING PATHWAY; RHOA ACTIVITY; NETWORK; ACTIVATION; TRANSPORT; DYNAMICS; CANCER; PKD	Many newly synthesized cellular proteins pass through the Golgi complex from where secretory transport carriers sort them to the plasma membrane and the extracellular environment. The formation of these secretory carriers at the trans-Golgi network is promoted by the protein kinase D (PKD) family of serine/threonine kinases. Here, using mathematical modeling and experimental validation of the PKD activation and substrate phosphorylation kinetics, we reveal that the expression level of the PKD substrate deleted in liver cancer 1 (DLC1), a Rho GTPase-activating protein that is inhibited by PKD-mediated phosphorylation, determines PKD activity at the Golgi membranes. RNAi-mediated depletion of DLC1 reduced PKD activity in a Rho-Rho-associated protein kinase (ROCK)-dependent manner, impaired the exocytosis of the cargo protein horseradish peroxidase, and was associated with the accumulation of the small GTPase RAB6 on Golgi membranes, indicating a protein-trafficking defect. In summary, our findings reveal that DLC1 maintains basal activation of PKD at the Golgi and Golgi secretory activity, in part by down-regulating Rho-ROCK signaling. We propose that PKD senses cytoskeletal changes downstream of DLC1 to coordinate Rho signaling with Golgi secretory function.	[Jensch, Antje; Weber, Patrick; Radde, Nicole E.] Univ Stuttgart, Inst Syst Theory & Automat Control, D-70569 Stuttgart, Germany; [Frey, Yannick; Bitschar, Katharina; Schmid, Simone; Hausser, Angelika; Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Hausser, Angelika; Olayioye, Monilola A.; Radde, Nicole E.] SRCSB, D-70569 Stuttgart, Germany; [Bitschar, Katharina] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany	University of Stuttgart; University of Stuttgart; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Radde, NE (corresponding author), Univ Stuttgart, Inst Syst Theory & Automat Control, D-70569 Stuttgart, Germany.; Olayioye, MA (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany.; Olayioye, MA; Radde, NE (corresponding author), SRCSB, D-70569 Stuttgart, Germany.	monilola.olayioye@izi.uni-stuttgart.de; nicole.radde@ist.uni-stuttgart.de	Hausser, Angelika/AAC-4531-2021	Radde, Nicole/0000-0002-5145-0058; Olayioye, Monilola/0000-0003-1093-263X	Heisenberg program of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [OL239/8]; DFG within the Cluster of Excellence in Simulation Technology at the University of Stuttgart [EXC 310/2]	Heisenberg program of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); DFG within the Cluster of Excellence in Simulation Technology at the University of Stuttgart(German Research Foundation (DFG))	This work was supported in part by Grant ID OL239/8 from the Heisenberg program of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) (to M. A. O.). This work was also supported by the DFG within the Cluster of Excellence in Simulation Technology (Grant EXC 310/2) at the University of Stuttgart (to A. J., N. R., and M. A. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Braun AC, 2015, CELL SIGNAL, V27, P1643, DOI 10.1016/j.cellsig.2015.04.003; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Durand N, 2016, SCI REP-UK, V6, DOI 10.1038/srep35963; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fuchs YF, 2009, TRAFFIC, V10, P858, DOI 10.1111/j.1600-0854.2009.00918.x; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Holeiter G, 2008, CANCER RES, V68, P8743, DOI 10.1158/0008-5472.CAN-08-0984; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Malhotra V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005280; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Popescu NC, 2014, MOL DIAGN THER, V18, P293, DOI 10.1007/s40291-014-0086-3; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; Quassollo G, 2015, CURR BIOL, V25, P971, DOI 10.1016/j.cub.2015.01.075; Roy A, 2017, BBA-REV CANCER, V1868, P283, DOI 10.1016/j.bbcan.2017.05.008; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Weber P, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0147-1; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200	40	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14407	14416		10.1074/jbc.RA118.003787	http://dx.doi.org/10.1074/jbc.RA118.003787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30045871	Green Published, hybrid			2022-12-26	WOS:000444671500020
J	Meincke, J; Hewitt, M; Reischl, M; Rupp, R; Schmidt-Samoa, C; Liebetanz, D				Meincke, Jonna; Hewitt, Manuel; Reischl, Markus; Rupp, Ruediger; Schmidt-Samoa, Carsten; Liebetanz, David			Cortical representation of auricular muscles in humans: A robot-controlled TMS mapping and fMRI study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; BRAIN-STIMULATION; RAPID REORGANIZATION; FACIAL-MUSCLES; HAND; COIL; ORGANIZATION; EXCITATION; INTENSITY	Background Most humans have the ability to activate the auricular muscles. Although (intentional) control suggests an involvement of higher cortical centers underlying posterior auricular muscle (PAM) activation, the cortical representation of the auricular muscles is still unknown. Methods With the purpose of identifying a possible cortical representation area we performed automated robotic and image-guided transcranial magnetic stimulation (TMS) mapping (n = 8) and functional magnetic resonance imaging (fMRI) (n = 13). For topographical comparison, a similar experimental protocol was applied for the first dorsal interosseus muscle (FDI) of the hand. Results The calculated centers of gravity (COGs) of both muscles were located on the precentral gyrus with the PAM COGs located more laterally compared to the FDI. The distance between the mean PAM and mean FDI COG was 26.3 mm. The TMS mapping results were confirmed by fMRI, which showed a dominance of cortical activation within the precentral gyrus during the corresponding motor tasks. The correspondence of TMS and fMRI results was high. Conclusion The involvement of the primary motor cortex in PAM activation might point to an evolved function of the auricular muscles in humans and/or the ability of intentional (and selective) muscle activation.	[Meincke, Jonna; Hewitt, Manuel; Liebetanz, David] Georg August Univ Gottingen, Univ Med Ctr, Clin Clin Neurophysiol, Gottingen, Germany; [Reischl, Markus] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany; [Rupp, Ruediger] Heidelberg Univ Hosp, Spinal Cord Injury Ctr, Heidelberg, Germany; [Schmidt-Samoa, Carsten] Georg August Univ Gottingen, Univ Med Ctr, Dept Cognit Neurol, Gottingen, Germany	University of Gottingen; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; University of Gottingen	Liebetanz, D (corresponding author), Georg August Univ Gottingen, Univ Med Ctr, Clin Clin Neurophysiol, Gottingen, Germany.	dliebet@gwdg.de	Reischl, Markus/H-6970-2013	Reischl, Markus/0000-0002-7780-6374; Meincke, Jonna/0000-0003-0714-1116	German Ministry of Education and Reearch [FKZ 01EZ1122A]; German Federal Ministry of Education and Research [FKZ 01EZ1122A]	German Ministry of Education and Reearch; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by the German Ministry of Education and Reearch (FKZ 01EZ1122A). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Federal Ministry of Education and Research (FKZ 01EZ1122A). We thank N. Focke and F. Awiszus for technical advice and C. Crozier for improving the English.	AMASSIAN VE, 1992, ELECTROEN CLIN NEURO, V85, P291, DOI 10.1016/0168-5597(92)90105-K; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Bashir S, 2013, J CLIN NEUROPHYSIOL, V30, P390, DOI 10.1097/WNP.0b013e31829dda6b; BERZIN F, 1993, ANN ANAT, V175, P195, DOI 10.1016/S0940-9602(11)80182-2; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Bischoff C, 1993, Electromyogr Clin Neurophysiol, V33, P265; Cattaneo L, 2014, NEUROSCI BIOBEHAV R, V38, P135, DOI 10.1016/j.neubiorev.2013.11.002; Cattaneo L, 2010, J CLIN NEUROPHYSIOL, V27, P126, DOI 10.1097/WNP.0b013e3181d65031; CODY DTR, 1969, LARYNGOSCOPE, V79, P400, DOI 10.1288/00005537-196903000-00007; Cruccu G, 1997, MUSCLE NERVE, V20, P418, DOI 10.1002/(SICI)1097-4598(199704)20:4<418::AID-MUS3>3.0.CO;2-D; Darwin C, 1859, ORIGIN SPECIES MEANS; Di Lazzaro V, 2001, EXP BRAIN RES, V138, P268; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Grabski K, 2012, HUM BRAIN MAPP, V33, P2306, DOI 10.1002/hbm.21363; HACKLEY SA, 1993, PSYCHOPHYSIOLOGY, V30, P415, DOI 10.1111/j.1469-8986.1993.tb02065.x; Henle J, 1858, HDB SYSTEMATISCHEN A, V1, P137; Herwig U, 2002, CLIN NEUROPHYSIOL, V113, P462, DOI 10.1016/S1388-2457(02)00026-3; JENNY AB, 1987, NEUROLOGY, V37, P930, DOI 10.1212/WNL.37.6.930; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kantelhardt SR, 2010, ACTA NEUROCHIR, V152, P333, DOI 10.1007/s00701-009-0565-1; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Kiang NY-S, 1963, POSTAURICULAR ELECT; Kiziltan ME, 2010, J ELECTROMYOGR KINES, V20, P508, DOI 10.1016/j.jelekin.2009.07.009; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krings T, 1998, ELECTROMYOGR MOTOR C, V109, P85, DOI 10.1016/S0924-980X(97)00078-7; Lang N, 2011, CEREB CORTEX, V21, P2299, DOI 10.1093/cercor/bhr003; Liepert J, 1999, NEUROSCI LETT, V272, P33, DOI 10.1016/S0304-3940(99)00574-1; Lotze M, 2003, CLIN NEUROPHYSIOL, V114, P306, DOI 10.1016/S1388-2457(02)00380-2; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; MACCABEE PJ, 1993, J PHYSIOL-LONDON, V460, P201, DOI 10.1113/jphysiol.1993.sp019467; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Meincke J, 2016, NEUROIMAGE, V124, P509, DOI 10.1016/j.neuroimage.2015.09.013; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; Morecraft RJ, 2004, NEUROLOGIST, V10, P235, DOI 10.1097/01.nrl.0000138734.45742.8d; Niyazov DM, 2005, CLIN NEUROPHYSIOL, V116, P1601, DOI 10.1016/j.clinph.2005.02.028; O'Beirne GA, 1999, HEARING RES, V138, P115, DOI 10.1016/S0378-5955(99)00159-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Paradiso GO, 2005, J PHYSIOL-LONDON, V567, P323, DOI 10.1113/jphysiol.2005.088542; Richter L, 2013, BRAIN STIMUL, V6, P315, DOI 10.1016/j.brs.2012.06.002; Richter L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060358, 10.1371/journal.pone.0081647]; Rijntjes M, 1997, ANN NEUROL, V41, P621, DOI 10.1002/ana.410410511; Rodel RMW, 2003, ANN OTO RHINOL LARYN, V112, P71; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Saisanen L, 2015, NEUROSURGERY, V77, P394, DOI 10.1227/NEU.0000000000000798; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; Schmalfuss L, 2016, RESTOR NEUROL NEUROS, V34, P79, DOI 10.3233/RNN-150579; Schmidt S, 2015, HUM BRAIN MAPP, V36, P40, DOI 10.1002/hbm.22611; Schwalbe G, 1897, HDB ANATOMIE MENSCHE, V5, P40; Serra G, 1986, Electromyogr Clin Neurophysiol, V26, P661; Terao Y, 1998, EXP BRAIN RES, V121, P145, DOI 10.1007/s002210050446; van de Ruit M, 2016, BRAIN TOPOGR, V29, P56, DOI 10.1007/s10548-015-0447-1; WASSERMANN EM, 1994, EXP BRAIN RES, V100, P121; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Weiss C, 2013, NEUROIMAGE, V66, P531, DOI 10.1016/j.neuroimage.2012.10.046	59	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201277	10.1371/journal.pone.0201277	http://dx.doi.org/10.1371/journal.pone.0201277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052653	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600035
J	Russell, MS; Muralidharan, A; Larocque, L; Cao, JX; Deschambault, Y; Varga, J; Raman, SNT; Li, XG				Russell, Marsha S.; Muralidharan, Abenaya; Larocque, Louise; Cao, Jingxin; Deschambault, Yvon; Varga, Jessie; Raman, Sathya N. Thulasi; Li, Xuguang			Identification and characterisation of the CD40-ligand of Sigmodon hispidus	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IMMUNOSUPPRESSED ANIMAL-MODEL; TUMOR-NECROSIS-FACTOR; COTTON RAT; CD40 LIGAND; DENDRITIC CELLS; PROTECTIVE IMMUNITY; INFLUENZA-VIRUS; B-CELLS; INFECTION	Cotton rats are an important animal model to study infectious diseases. They have demonstrated higher susceptibility to a wider variety of human pathogens than other rodents and are also the animal model of choice for pre-clinical evaluations of some vaccine candidates. However, the genome of cotton rats remains to be fully sequenced, with much fewer genes cloned and characterised compared to other rodent species. Here we report the cloning and characterization of CD40 ligand, whose human and murine counterparts are known to be expressed on a range of cell types including activated T cells and B cells, dendritic cells, granulocytes, macrophages and platelets and exerts a broad array of immune responses. The cDNA for cotton rat CD4OL we isolated is comprised of 1104 nucleotides with an open reading frame (ORF) of 783bp coding for a 260 amino acid protein. The recombinant cotton rat CD4OL protein was recognized by an antibody against mouse CD4OL. Moreover, it demonstrated functional activities on immature bone marrow dendritic cells by upregulating surface maturation markers (CD40, CD54, CD80, and CD86), and increasing IL-6 gene and protein expression. The availability of CD4OL gene identity could greatly facilitate mechanistic research on pathogen-induced-immunopathogenesis and vaccine-elicited immune responses.	[Russell, Marsha S.; Muralidharan, Abenaya; Larocque, Louise; Raman, Sathya N. Thulasi; Li, Xuguang] Hlth Canada, HPFB, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON, Canada; [Russell, Marsha S.; Muralidharan, Abenaya; Larocque, Louise; Raman, Sathya N. Thulasi; Li, Xuguang] WHO Collaborating Ctr Standardizat & Evaluat Biol, Ottawa, ON, Canada; [Muralidharan, Abenaya; Li, Xuguang] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Cao, Jingxin; Deschambault, Yvon; Varga, Jessie] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Health Canada; University of Ottawa; Public Health Agency of Canada	Li, XG (corresponding author), Hlth Canada, HPFB, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON, Canada.; Li, XG (corresponding author), WHO Collaborating Ctr Standardizat & Evaluat Biol, Ottawa, ON, Canada.; Li, XG (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	sean.li@canada.ca		Muralidharan, Abenaya/0000-0003-4065-3922; Li, Xuguang (Sean)/0000-0003-1155-9128	Health Canada	Health Canada	Dr Xuguang Li was supported by a grant from Health Canada. The funders had no role in design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Armstrong C, 1939, PUBLIC HEALTH REP, V54, P1719, DOI 10.2307/4583031; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boukhvalova M, 2015, J VIROL, V89, P9825, DOI 10.1128/JVI.01387-15; Boukhvalova MS, 2013, CURR TOP MICROBIOL, V372, P347, DOI 10.1007/978-3-642-38919-1_17; Chan KH, 2007, CLIN VACCINE IMMUNOL, V14, P1433, DOI 10.1128/CVI.00056-07; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Eichelberger MC, 2007, VIRAL IMMUNOL, V20, P243, DOI 10.1089/vim.2007.0017; Faith RE, 1997, LAB ANIM SCI, V47, P337; Fiumara P, 2001, BRIT J HAEMATOL, V113, P265, DOI 10.1046/j.1365-2141.2001.02593.x; GRAMMER AC, 1995, J IMMUNOL, V154, P4996; Gravel C, 2015, VACCINE, V33, P1129, DOI 10.1016/j.vaccine.2015.01.034; Green MG, 2013, LAB ANIMAL, V42, P170, DOI 10.1038/laban.188; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grossmann ME, 1997, HUM GENE THER, V8, P1935, DOI 10.1089/hum.1997.8.16-1935; Gurunathan S, 1998, J IMMUNOL, V161, P4563; Hashem AM, 2014, J IMMUNOL, V193, P722, DOI 10.4049/jimmunol.1300093; Hauser H, 2004, GENE THER, V11, P924, DOI 10.1038/sj.gt.3302160; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Langley RJ, 1998, P NATL ACAD SCI USA, V95, P14355, DOI 10.1073/pnas.95.24.14355; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Mann J, 2002, J BIOL CHEM, V277, P17125, DOI 10.1074/jbc.M109250200; Masten BJ, 1997, AM J RESP CELL MOL, V16, P335, DOI 10.1165/ajrcmb.16.3.9070619; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Niewiesk S, 2002, LAB ANIM-UK, V36, P357, DOI 10.1258/002367702320389026; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Noelle RJ, 1997, ANN NY ACAD SCI, V815, P384, DOI 10.1111/j.1749-6632.1997.tb52089.x; Ottolini MG, 1999, BONE MARROW TRANSPL, V24, P41, DOI 10.1038/sj.bmt.1701813; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Ottolini MG, 2002, BONE MARROW TRANSPL, V29, P117, DOI 10.1038/sj.bmt.1703326; PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; PORTER DD, 1991, J VIROL, V65, P103, DOI 10.1128/JVI.65.1.103-111.1991; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Reynolds CR, J MOL BIOL; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Saez-Llorens X, 1998, PEDIATR INFECT DIS J, V17, P787, DOI 10.1097/00006454-199809000-00007; Singh-Jasuja H, 2013, IMMUNOBIOLOGY, V218, P28, DOI 10.1016/j.imbio.2012.01.021; Song Y, 2015, CURR DRUG TARGETS, V16, P393, DOI 10.2174/1389450116666150223115628; TSAI JC, 1992, ARCH OPHTHALMOL-CHIC, V110, P1167, DOI 10.1001/archopht.1992.01080200147043; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; van Mierlo GJD, 2002, P NATL ACAD SCI USA, V99, P5561, DOI 10.1073/pnas.082107699; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Williams JV, 2005, J VIROL, V79, P10944, DOI 10.1128/JVI.79.17.10944-10951.2005; Wyde PR, 2000, VACCINE, V19, P42, DOI 10.1016/S0264-410X(00)00151-1	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0199067	10.1371/journal.pone.0199067	http://dx.doi.org/10.1371/journal.pone.0199067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052641	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600005
J	Al-Ajmi, K; Lophatananon, A; Ollier, W; Muir, KR				Al-Ajmi, Kawthar; Lophatananon, Artitaya; Ollier, William; Muir, Kenneth R.			Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors	PLOS ONE			English	Article							SEX-HORMONES; FAMILY-HISTORY; WOMEN; EPIDEMIOLOGY; PREMENOPAUSAL; METAANALYSIS; REANALYSIS; PROPORTION; MENOPAUSE; MENARCHE	Background Anthropometric and reproductive factors have been reported as being established risk factors for breast cancer (BC). This study explores the contribution of anthropometric and reproductive factors in UK females developing BC in a large longitudinal cohort. Methods Data from the UK Biobank prospective study of 273,467 UK females were analyzed. Relative risks (RRs) and 95% confidence intervals (CIs) for each factor were adjusted for age, family history of BC and deprivation score. The analyses were stratified by the menopausal status. Results Over the 9 years of follow up the total number of BC cases were 14,231 with 3,378 (23.7%) incident cases with an incidence rate of 2.09 per 1000 person-years. In pre-menopausal, increase in age, height, having low BMI, low waist to hip ratio, first degree family history of BC, early menarche age, nulliparous, late age at first live birth, high reproductive interval index, and long contraceptive use duration were all significantly associated with an increased BC risk. In post-menopausal, getting older, being taller, having high BMI, first degree BC family history, nulliparous, late age at first live birth, and high reproductive interval index were all significantly associated with an increased risk of BC. The population attributable fraction (PAF) suggested that an early first live birth, lower reproductive interval index and increased number of children can contribute to BC risk reduction up to 50%. Conclusions This study utilizes the UK Biobank study to confirm associations between anthropometric and reproductive factors and the risk of breast cancer development. Result of attributable fraction of risk contributed by each risk factor suggested that lifetime risk of BC can be reduced by controlling weight, reassessing individual approaches to the timing of childbirth and options for contraception and considering early screening for women with family history in the first degree relative.	[Al-Ajmi, Kawthar; Lophatananon, Artitaya; Ollier, William; Muir, Kenneth R.] Univ Manchester, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Manchester	Muir, KR (corresponding author), Univ Manchester, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Fac Biol Med & Hlth, Manchester, Lancs, England.	kenneth.muir@manchester.ac.uk			ICEP - CRUK [C18281/A19169]; Ministry of Higher Education in Oman; MRC [G0100594, G0600237, G0901461, MC_PC_12028] Funding Source: UKRI	ICEP - CRUK; Ministry of Higher Education in Oman; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Kenneth R. Muir and Artitaya Lophatananon received funding through the ICEP supported by CRUK [grant number C18281/A19169]). We also would like to thank Ministry of Higher Education in Oman for their financial support to the first author (Kawthar Al-Ajmi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Zj, 2014, BIRTH WEIGHT CHILDHO, DOI [10.1186/bcr3596, DOI 10.1186/BCR3596]; [Anonymous], 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675; Bates P, 1995, MAMMARY CANC TRANSGE; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Cancer IAfRo, 2008, MON EV CARC RISKS HU, P91; Cancer Research UK, 2014, CANC STAT BREAST CAN; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Cleary MP, 2009, ENDOCRINOLOGY, V150, P2537, DOI 10.1210/en.2009-0070; Dartois L, 2016, INT J CANCER, V138, P2415, DOI 10.1002/ijc.29987; Ebrahim S, 2013, INT J EPIDEMIOL, V42, P1022, DOI 10.1093/ije/dyt105; Folkerd E, 2013, BREAST, V22, pS38, DOI 10.1016/j.breast.2013.07.007; Friedenreich CM, 2001, EUR J CANCER PREV, V10, P15, DOI 10.1097/00008469-200102000-00003; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hewitt J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009161; Horn J, 2013, REPRODUCTIVE FACTORS, DOI [10.1007/s10549-013-2531-0, DOI 10.1007/S10549-013-2531-0]; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; Kelsey JL, 1993, REPROD FACTORS BREAS; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Lahmann PH, 2004, BODY SIZE BREAST CAN, V111, P771; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morris DH, 2010, BRIT J CANCER, V103, P1760, DOI 10.1038/sj.bjc.6605978; Newson R., 2012, STATA MODULE COMPUTE; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Papa V, 1993, INSULIN GROWTH FACTO; Petrisek A, 2000, CANCER PRACT, V8, P135, DOI 10.1046/j.1523-5394.2000.83007.x; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sprague BL, 2008, AM J EPIDEMIOL, V168, P404, DOI 10.1093/aje/kwn143; Thorbjarnardottir T, 2014, ACTA ONCOL, V53, P752, DOI 10.3109/0284186X.2013.878471; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; Winters S, 2017, PROG MOL BIOL TRANSL, V151, P1, DOI 10.1016/bs.pmbts.2017.07.002; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wright CE, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-014-0023-9; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Zhang B, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv219	48	20	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201097	10.1371/journal.pone.0201097	http://dx.doi.org/10.1371/journal.pone.0201097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048498	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400048
J	Ebine, N; Aoki, T; Itoh, M; Fukuoka, Y				Ebine, Naoyuki; Aoki, Tomoko; Itoh, Masahiro; Fukuoka, Yoshiyuki			Differential kinetics of the cardiac, ventilatory, and gas exchange variables during walking under moderate hypoxia	PLOS ONE			English	Article							HEART-RATE; CARDIORESPIRATORY DYNAMICS; NORMOBARIC HYPOXIA; EXERCISE HYPERPNEA; SINUSOIDAL WORK; O-2 UPTAKE; HUMANS	We investigated the effects of moderate hypoxia (FiO(2) = 15%) on different kinetics between pulmonary ventilation ((V)( )over dot(E)) and heart rate (HR) during treadmill walking. Breath-by-breath (V)( )over dot(E), oxygen uptake ((V)( )over dotO(2)), carbon dioxide output ((V)( )over dotCO(2)), and HR were measured in 13 healthy young adults. The treadmill speed was sinusoidally changed from 3 to 6 km.h(-1) with four oscillation periods of 1, 2, 5, and 10 min. The amplitude (Amp), phase shift (PS) and mean values of these kinetics were obtained by harmonic analysis. The mean values of all of these responses during walking at a sinusoidally changing speed became greater under hypoxia compared to normoxia (FiO(2) = 21%), indicating that moderate hypoxia could achieve an increased energy expenditure (increased (V)( )over dotO(2) and (V)( )over dotCO(2)) V and hyperventilation. The Amp values of the (V)( )over dot(E), (V)( )over dotVO(2), and (V)( )over dotCO(2) kinetics were not significantly different between normoxia and hypoxia at most periods, although a significantly smaller Amp of the HR was observed at faster oscillation periods (1 or 2 min).The PS of the HR was significantly greater under hypoxia than normoxia at the 2, 5, and 10 min periods, whereas the PS of the (V)( )over dot(E), (V)( )over dotO(2), and (V)( )over dotCO(2) responses was not significantly different between normoxia and hypoxia at any period. These findings suggest that the lesser changes in Amp and PS in ventilatory and gas exchange kinetics during walking at a sinusoidally changing speed were remarkably different from a deceleration in HR kinetics under moderate hypoxia.	[Ebine, Naoyuki; Fukuoka, Yoshiyuki] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan; [Aoki, Tomoko; Fukuoka, Yoshiyuki] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto, Japan; [Itoh, Masahiro] Kumamoto Univ, Dept Physiol, Grad Sch Life Sci, Chyo Ku, Kumamoto, Japan	Doshisha University; Kumamoto University	Fukuoka, Y (corresponding author), Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan.; Fukuoka, Y (corresponding author), Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto, Japan.	nebine@mail.doshisha.ac.jp		Fukuoka, Yoshiyuki/0000-0001-6409-2694	Japan Society for the Promotion of Science [23680068, 22370091]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported in part by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23680068 to NE, 22370091 to YF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON EA, 1992, J APPL PHYSIOL, V72, P1810, DOI 10.1152/jappl.1992.72.5.1810; Babb TG, 1997, J APPL PHYSIOL, V82, P746, DOI 10.1152/jappl.1997.82.3.746; BAKKER HK, 1980, J APPL PHYSIOL, V48, P289, DOI 10.1152/jappl.1980.48.2.289; BENNETT FM, 1988, J APPL PHYSIOL, V65, P2011, DOI 10.1152/jappl.1988.65.5.2011; CASABURI R, 1977, J APPL PHYSIOL, V42, P300, DOI 10.1152/jappl.1977.42.2.300; Engelen M, 1996, J APPL PHYSIOL, V81, P2500, DOI 10.1152/jappl.1996.81.6.2500; FORSTER HV, 1993, J APPL PHYSIOL, V75, P1385, DOI 10.1152/jappl.1993.75.3.1385; Fukuoka Y, 2002, CLIN SCI, V102, P31, DOI 10.1042/CS20010059; FUKUOKA Y, 1995, ACTA PHYSIOL SCAND, V153, P117, DOI 10.1111/j.1748-1716.1995.tb09842.x; Fukuoka Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168517; Gatterer H, 2015, OBESITY FACTS, V8, P200, DOI 10.1159/000431157; GRIFFITHS TL, 1986, J PHYSIOL-LONDON, V380, P387, DOI 10.1113/jphysiol.1986.sp016292; HAOUZI P, 1992, EUR J APPL PHYSIOL, V64, P410, DOI 10.1007/BF00625059; Haouzi P, 2004, J PHYSIOL-LONDON, V559, P315, DOI 10.1113/jphysiol.2003.057729; Haufe S, 2008, MED SCI SPORT EXER, V40, P1939, DOI 10.1249/MSS.0b013e31817f1988; Horiuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05068-8; Horiuchi M, 2016, BIOL OPEN, V5, P1408, DOI 10.1242/bio.019810; Hotta N, 2008, J SPORT MED PHYS FIT, V48, P129; HUGHSON RL, 1995, RESP PHYSIOL, V101, P87, DOI 10.1016/0034-5687(95)00009-3; Kong ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158589; LINNARSSON D, 1974, ACTA PHYSIOL SCAND, P1; MITCHELL GS, 1990, J APPL PHYSIOL, V69, P718, DOI 10.1152/jappl.1990.69.2.718; MIYAMOTO Y, 1983, JPN J PHYSIOL, V33, P971, DOI 10.2170/jjphysiol.33.971; MURPHY PC, 1989, CARDIOVASC RES, V23, P825, DOI 10.1093/cvr/23.10.825; ROWELL LB, 1986, AM J PHYSIOL, V251, P1038; Tipton MJ, 2017, J PHYSIOL-LONDON, V595, P5729, DOI 10.1113/JP274596; WARD SA, 1987, J APPL PHYSIOL, V63, P2001, DOI 10.1152/jappl.1987.63.5.2001; WASSERMAN K, 1975, J APPL PHYSIOL, V39, P354, DOI 10.1152/jappl.1975.39.3.354; Wiesner S, 2010, OBESITY, V18, P116, DOI 10.1038/oby.2009.193; XING HC, 1991, J APPL PHYSIOL, V71, P2394, DOI 10.1152/jappl.1991.71.6.2394; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1136, DOI 10.1152/jappl.1991.71.3.1136	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200186	10.1371/journal.pone.0200186	http://dx.doi.org/10.1371/journal.pone.0200186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044809	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500031
J	Evans, H; Balasegaram, S; Douthwaite, S; Hunter, L; Kulasegaram, R; Wong, T; Querol-Rubiera, A; Nebbia, G				Evans, Hannah; Balasegaram, Sooria; Douthwaite, Sam; Hunter, Laura; Kulasegaram, Ranjababu; Wong, Terry; Querol-Rubiera, Antonio; Nebbia, Gaia			An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department	PLOS ONE			English	Article							C VIRUS-INFECTION; LIVER-DISEASE; ENGLAND; PREVALENCE; ETHNICITY	Therapies that halt progression of chronic hepatitis B virus (HBV) and achieve a cure for chronic hepatitis C virus (HCV) have encouraged development of innovative strategies to diagnose and link patients to care. We describe the prevalence and risk factors for HBV and HCV infections and use of an opt-out hepatitis testing and integrated linkage to care pathway in a London Emergency Department (ED). ED patients aged >= 16 years having routine blood tests from 15 February-28 March 2016 were tested for hepatitis, unless opted out. Hepatitis B surface antigen (HBsAg) and hepatitis C antibody tests (HCV-Ab, including a confirmatory hepatitis C antigen test (HCV-Ag)) were pre-selected on electronic blood test requests. Linkage to care (attending one clinic appointment) was offered to HBsAg and HCV-Ag patients (new or known-disengaged with care diagnoses). Weighted prevalence estimates and risk factors for seropositivity adjusted by demographics and survey weights were calculated using logistic regression. Hepatitis testing uptake was 56% (3,290/5,865). Overall, 26 HBsAg (10 new diagnoses) and 63 HCV-Ab patients were identified of which 32 were HCV-Ag positive (10 new diagnoses). Weighted seroprevalence of HBsAg was 0.50% (95% CI 0.3-0.8%); HCV-Ab 2.0% (95% CI 1.5-2.7%) and HCV-Ag 1.2% (95% CI 0.8-1.7%). Risk factors for infection were being male (HBsAg: aOR 4.1, 95% CI 1.5-11.3), of non-White British ethnicity (HBsAg: aOR>11) or being homeless (HCV-Ag: aOR 18.9, 95% CI 6.9-51.4). We achieved a high linkage to care uptake for HBsAg (93%) and HCV-Ag (78%) among patients who were contacted and required linkage. A pre-selected hepatitis testing ordering system facilitated a high testing uptake. New and disengaged with care diagnoses and a high HCV prevalence were identified demonstrating the potential to identify and link patients to care in this setting. Strategies connecting clinical care with community outreach services are key for improving patient linkage to care.	[Evans, Hannah; Balasegaram, Sooria] Publ Hlth England, United Kingdom Field Epidemiol Training Programme, London, England; [Evans, Hannah; Balasegaram, Sooria] Publ Hlth England, Field Epidemiol Serv, Natl Infect Serv, London, England; [Douthwaite, Sam; Querol-Rubiera, Antonio; Nebbia, Gaia] Guys & St Thomas NHS Trust, Dept Infect, London, England; [Hunter, Laura] Guys & St Thomas NHS Trust, Emergency Dept, London, England; [Kulasegaram, Ranjababu] Guys & St Thomas NHS Trust, Dept HIV GU Med, London, England; [Wong, Terry] Guys & St Thomas NHS Trust, Gastroenterol & Hepatol Dept, London, England	Public Health England; Public Health England; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Evans, H (corresponding author), Publ Hlth England, United Kingdom Field Epidemiol Training Programme, London, England.; Evans, H (corresponding author), Publ Hlth England, Field Epidemiol Serv, Natl Infect Serv, London, England.	hannah.evans@phe.gov.uk		WONG, TERENCE/0000-0002-5236-9139	educational grant via the Gilead UK; Ireland Fellowship Programme	educational grant via the Gilead UK; Ireland Fellowship Programme	This project has been supported with an educational grant via the Gilead UK and Ireland Fellowship Programme (http://www.ukifellowshipprogramme.com/) to the recipients LH, SD and GN at Guy's & St Thomas' NHS Foundation Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 2015, LIVER INT, V35, P78, DOI 10.1111/liv.12710; Cresswell FV, 2015, CLIN INFECT DIS, V60, P263, DOI 10.1093/cid/ciu782; Department of Health, 2002, REP CHIEF MED OFF; Department of Health, 2009, REF GUID CONS EX TRE; Department of Health, 2017, IMM INF DIS; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Galbraith JW, 2015, HEPATOLOGY, V61, P776, DOI 10.1002/hep.27410; Galbraith JW, 2014, CLIN INFECT DIS, V59, P755, DOI 10.1093/cid/ciu427; Harris M, 2016, J VIRAL HEPATITIS, V23, P479, DOI 10.1111/jvh.12513; Harris RJ, 2016, J VIRAL HEPATITIS, V23, P631, DOI 10.1111/jvh.12529; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Harris RJ, 2012, EUR J PUBLIC HEALTH, V22, P187, DOI 10.1093/eurpub/ckr083; Hempling MC, 2016, INT J STD AIDS, V27, P1267, DOI 10.1177/0956462415613727; Hepatitis C in the UK, 2015, HEP C UK 2015 REP; Homeless Link, 2014, UNHEALTHY STATE HOME; Homeless Link, 2017, HOM SUPP ENGL; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; National Institute for Health and Care Excellence, 2015, HEP B CHRON DIAGN MA; National Institute for Health and Care Excellence, 2012, HEP B C TEST PEOPL R; NHS England, 2015, CLIN COMM POL STAT T; NHS England and Data Services for Commissioners, 2016, COMM ASS METH FLOW C; O'Connell S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150546; Orkin C, 2016, HIV MED, V17, P222, DOI 10.1111/hiv.12364; Patruni B, 2013, TECHNICAL REPORT; Public Health England, 2016, DAT TABL UNL AN MON; Public Health England, 2017, HEP C ENGL 2017 HEAD; Public Health England, 2015, HEP C LOND 2015 REP; Public Health England, 2013, HEP B EP LOND 2012 D; Public Health England, 2016, ANN REP SENT SURV ST; Public Health England, 2017, ANT INF SCREEN LOND; Public Health England, 2015, TURN EV PRACT IMPR A; Russmann S, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-5; Smith T., 2015, ENGLISH INDICES DEPR; Tillmann HL, 2014, WORLD J GASTROENTERO, V20, P6701, DOI 10.3748/wjg.v20.i22.6701; Uddin G, 2010, J VIRAL HEPATITIS, V17, P327, DOI 10.1111/j.1365-2893.2009.01240.x; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041206; World Health Organization, 2016, GLOB HLTH SECT STRAT	37	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0198520	10.1371/journal.pone.0198520	http://dx.doi.org/10.1371/journal.pone.0198520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044779	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500007
J	Shen, KL; Wasserman, M; Liu, DD; Yang, YH; Yang, JF; Guzauskas, GF; Wang, BCM; Hilton, B; Farkouh, R				Shen, Kunling; Wasserman, Matthew; Liu, Dongdong; Yang, Yong-Hong; Yang, Junfeng; Guzauskas, Greg F.; Wang, Bruce C. M.; Hilton, Betsy; Farkouh, Raymond			Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE BURDEN; UNITED-STATES; HEALTH; IMPACT; USA; POPULATION; PREVENTION	Background The burden of pneumococcal disease in China is high, and a 13-valent pneumococcal conjugate vaccine (PCV13) recently received regulatory approval and is available to Chinese infants. PCV13 protects against the most prevalent serotypes causing invasive pneumococcal disease (IPD) in China, but will not provide full societal benefits until made broadly available through a national immunization program (NIP). Objective To estimate clinical and economic benefits of introducing PCV13 into a NIP in China using local cost estimates and accounting for variability in vaccine uptake and indirect (herd protection) effects. Methods We developed a population model to estimate the effect of PCV13 introduction in China. Modeled health states included meningitis, bacteremia, pneumonia (PNE), acute otitis media, death and sequelae, and no disease. Direct healthcare costs and disease incidence data for IPD and PNE were derived from the China Health Insurance and Research Association database; all other parameters were derived from published literature. We estimated total disease cases and associated costs, quality-adjusted life years (QALYs), and deaths for three scenarios from a Chinese Payer Perspective: (1) direct effects only, (2) direct+indirect effects for IPD only, and (3) direct+indirect effects for IPD and inpatient PNE. Results Scenario (1) resulted in 370.3 thousand QALYs gained and 12.8 thousand deaths avoided versus no vaccination. In scenarios (2) and (3), the PCV13 NIP gained 383.2 thousand and 3,580 thousand QALYs, and avoided 13.1 thousand and 147.5 thousand deaths versus no vaccination, respectively. In all three scenarios, the vaccination cost was offset by cost reductions from prevented disease yielding net costs of (sic)29,362.32 million, (sic)29,334.29 million, and (sic)13,524.72 million, respectively. All resulting incremental cost-effectiveness ratios fell below a 2x China GDP cost-effectiveness threshold across a range of potential vaccine prices. Discussion Initiation of a PCV13 NIP in China incurs large upfront costs but is good value for money, and is likely to prevent substantial cases of disease among children and non-vaccinated individuals.	[Shen, Kunling] Capital Med Univ, Beijing Childrens Hosp, Dept Resp Dis, Natl Ctr Childrens Hlth, Beijing, Peoples R China; [Wasserman, Matthew] Pfizer Inc, New York, NY 10017 USA; [Liu, Dongdong; Yang, Junfeng] Pfizer Inc, Beijing, Peoples R China; [Yang, Yong-Hong] Capital Med Univ, Natl Clin Res Ctr Resp Dis,Beijing Pediat Res Ins, Beijing Key Lab Pediat Resp Infect Dis,Lab Microb, Key Lab Major Dis Children,Minist Educ,Beijing Ch, Beijing, Peoples R China; [Yang, Yong-Hong] Capital Med Univ, Natl Clin Res Ctr Resp Dis,Beijing Pediat Res Ins, Beijing Key Lab Pediat Resp Infect Dis,Lab Microb, Natl Key Discipline Pediat,Minist Educ,Beijing Ch, Beijing, Peoples R China; [Guzauskas, Greg F.; Wang, Bruce C. M.] Elysia Grp LLC, New York, NY USA; [Hilton, Betsy; Farkouh, Raymond] Pfizer Inc, Collegeville, PA USA	Capital Medical University; Pfizer; Pfizer; Capital Medical University; Capital Medical University; Pfizer	Wasserman, M (corresponding author), Pfizer Inc, New York, NY 10017 USA.	Matt.Wasserman@pfizer.com		Wasserman, Matthew/0000-0003-3300-2742	Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was sponsored by Pfizer Inc. MW, DL, JY, BH, and RF are employees of Pfizer Inc. The specific roles of these authors are articulated in the 'author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Cao L, 2012, CHI J VACCINE IMMUNI, V5, P419; (CDC) CfDC, GLOB PNEUM DIS VACC; Chan J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021512; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; China Ministry of Health, 1994, NOT ENH REP COV ROUT; Dinleyici EC, 2008, EXPERT REV VACCINES, V7, P1367, DOI 10.1586/14760584.7.9.1367; Earnshaw SR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-101; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Guan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011721; Hausdorff WP, 2002, PEDIATR INFECT DIS J, V21, P1008, DOI 10.1097/00006454-200211000-00007; Ho YC, 2015, HUM VACC IMMUNOTHER, V11, P1081, DOI 10.1080/21645515.2015.1023969; Hu Shanlian, 2014, Value Health Reg Issues, V3, P197, DOI 10.1016/j.vhri.2014.04.007; Klok RM, 2013, CLIN THER, V35, P119, DOI 10.1016/j.clinthera.2012.12.006; Li Y, 2017, HUM VACC IMMUNOTHER, V13, P1681, DOI 10.1080/21645515.2017.1304335; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Maurer KA, 2016, VACCINE, V34, P6343, DOI 10.1016/j.vaccine.2016.10.051; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Mo XT, 2016, PEDIATR INFECT DIS J, V35, pE353, DOI 10.1097/INF.0000000000001288; Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Morrow A, 2007, CAN J INFECT DIS MED, V18, P121, DOI 10.1155/2007/713576; Mucino-Ortega E, 2011, VALUE HEALTH, V14, pS65, DOI 10.1016/j.jval.2011.05.025; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Rose M, 2009, EXPERT REV VACCINES, V8, P1351, DOI [10.1586/erv.09.78, 10.1586/ERV.09.78]; Saokaew S, 2016, PHARMACOECONOMICS, V34, P1211, DOI 10.1007/s40273-016-0439-3; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Strutton DR, 2012, J INFECTION, V64, P54, DOI 10.1016/j.jinf.2011.10.015; The State Council, 2011, PLAN DEV CHIN CHILDR; The State Council, 1992, PLAN DEV CHIN CHILDR; Wagner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097800; Wang B, 2014, VALUE HEALTH, V17, pA275, DOI 10.1016/j.jval.2014.03.1600; Wasserman M., 2016, OPEN FORUM INFECT DI; World Health Organization, 2008, EST HIB PNEUM DEATHS; Wu DBC, 2015, VACCINE, V33, P1633, DOI 10.1016/j.vaccine.2015.01.081; Xia L, 2015, J GERIATR CARDIOL, V12, P502, DOI 10.11909/j.issn.1671-5411.2015.05.021; Yao KH, 2008, VACCINE, V26, P4425, DOI 10.1016/j.vaccine.2008.06.052; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; Zheng JS., 2012, CHIN J VACCINES IMMU, V18, P233, DOI 10.13683/j.wph.2017.06.014; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619	45	13	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201245	10.1371/journal.pone.0201245	http://dx.doi.org/10.1371/journal.pone.0201245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044865	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500094
J	Prakash, K; Gianella, S; Dube, K; Taylor, J; Lee, G; Smith, DM				Prakash, Katya; Gianella, Sara; Dube, Karine; Taylor, Jeff; Lee, GaYoung; Smith, Davey M.			Willingness to participate in HIV research at the end of life (EOL)	PLOS ONE			English	Article							I CANCER TRIALS; CURE RESEARCH; ETHICAL CONSIDERATIONS; CLINICAL-RESEARCH; PHASE-1 ONCOLOGY; PALLIATIVE CARE; ALTRUISM; VACCINE; CHALLENGES; PREVENTION	Introduction Animal models have been vital for scientific discovery but have limitations, especially in infectious disease research. It is essential to develop a means to study these diseases in human models. We hypothesized that altruistic people would willingly participate in research near the end-of-life (EOL), for the benefit of science and to provide one last gift to society. Methodology Two surveys were administered to 377 self-reported HIV-negative and 96 HIV-positive individuals. Hypothetical questions assessed their willingness to participate in altruistic research in the last 6 months of life, which might result in a shortened lifespan or physical discomforts. The self-reported HIV-negative group was also asked about willingness to be exposed to infectious pathogens for the sake of research. Results Almost all responders expressed willingness to participate in research at the EOL, regardless of HIV-status. The majority of participants were willing to endure physical discomfort for the sake of research. 'Blood draws' was identified as the most tolerable physical discomfort (>70% in both groups). In both groups, >60% were willing to shorten their lifespans for the sake of research. A third of the self-reported HIV-negative group expressed willingness to be exposed to at least one infectious agent to participate in EOL research. Conclusions Our exploratory study demonstrates that people would welcome the opportunity to participate in altruistic research near the EOL. Such research could greatly impact the way infectious disease research is conducted. This study is limited however by its hypothetical nature. Further research is necessary to confirm this interest in those with terminal illness before any further clinical research effort at the EOL can be performed.	[Prakash, Katya; Gianella, Sara; Smith, Davey M.] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA; [Dube, Karine] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Taylor, Jeff] AntiViral Res Ctr AVRC San Diego, CAB, San Diego, CA USA; [Lee, GaYoung] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol Immunol, Baltimore, MD USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Gianella, S (corresponding author), Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA.	gianella@ucsd.edu	Prakash, Katya/ABB-2140-2021; Smith, David/GQQ-8257-2022	Gianella, Sara/0000-0002-9927-0849; Prakash, Katya/0000-0002-8653-4657; Smith, Davey/0000-0003-3603-1733	National Institutes of Health; University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, California HIV Reserch Program [P30-AI027763]; department of Veterans Affairs; James B. Pendleton Charitable Trust; National Institutes of Health [AI100665, MH100974, MH097520, DA034978, AI007384, AI027763, AI106039, AI43638, AI074621, AI036214, MH101012, UL1TR000100, CARE U19 AI096113, AI068636-09]; California HIV Reserch Program Ideal award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI007036, U19AI096113, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, California HIV Reserch Program(University of California System); department of Veterans Affairs(US Department of Veterans Affairs); James B. Pendleton Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV Reserch Program Ideal award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported primarily by a grant from the National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30-AI027763 (CNIHR), California HIV Reserch Program Ideal award to Sara Gianella, by the department of Veterans Affairs, the James B. Pendleton Charitable Trust and additional grants from the National Institutes of Health: AI100665, MH100974, MH097520, DA034978, AI007384, AI027763, AI106039, AI43638, AI074621, AI036214, MH101012, UL1TR000100, CARE U19 AI096113 and AI068636-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2003, J PAIN SYMPTOM MANAG, V25, pS25, DOI 10.1016/S0885-3924(03)00057-5; Agrawal M, 2003, JAMA-J AM MED ASSOC, V290, P1075, DOI 10.1001/jama.290.8.1075; Allmark P, 2016, TRANSL LUNG CANCER R, V5, P219, DOI 10.21037/tlcr.2016.03.04; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Beauchamp T, 1989, PRINCIPLES BIOMEDICA; Bolt EE, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1879-3; Casarett D, 2001, J Palliat Med, V4, P441, DOI 10.1089/109662101753381566; Cassel JB, 2016, J PAIN SYMPTOM MANAG, V52, P437, DOI 10.1016/j.jpainsymman.2016.02.014; County of San Diego Health and Human Services Agency (HHSA), MONTHL STD REP, V1; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Dezzutti CS, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20301; Doukas DJ, 2014, CAMB Q HEALTHC ETHIC, V23, P397, DOI 10.1017/S0963180114000073; Dube K, 2017, J VIRUS ERAD, V3, P40; Dube K, 2014, TRENDS MICROBIOL, V22, P547, DOI 10.1016/j.tim.2014.08.003; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Enzinger AC, 2014, J PAIN SYMPTOM MANAG, V47, P1078, DOI 10.1016/j.jpainsymman.2013.07.004; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; Faden R., 1986, HIST THEORY INFORM C; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; FREIREICH EJ, 1979, ANNU REV PHARMACOL, V19, P547, DOI 10.1146/annurev.pa.19.040179.002555; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gianella S, 2017, AIDS, V31, P1, DOI 10.1097/QAD.0000000000001300; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; Gysels MH, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-123; Hajar Rachel, 2011, Heart Views, V12, P42, DOI 10.4103/1995-705X.81548; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Henderson, 2014, AIDS RES HUM RETROV, V31, P1; Henry B, 2012, ACCOUNT RES, V19, P1, DOI 10.1080/08989621.2011.622173; Holm S., 2001, PRINCIPLES BIOMEDICA, P454, DOI 10.1136/jme.28.5.332-a[332-a-332]; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Jansen Lynn A, 2006, IRB, V28, P13; Jansen LA, 2011, J MED ETHICS, V37, P563, DOI 10.1136/jme.2010.038943; Joffe S, 2006, J CLIN ONCOL, V24, P2987, DOI 10.1200/JCO.2005.04.9296; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; Mackin ML, 2009, RES GERONTOL NURS, V2, P162, DOI 10.3928/19404921-20090421-05; Miller FG, 2008, CLIN TRIALS, V5, P617, DOI 10.1177/1740774508097576; Pentz RD, 2012, CANCER-AM CANCER SOC, V118, P4571, DOI 10.1002/cncr.27397; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; PRATT CB, 1991, MED PEDIATR ONCOL, V19, P304, DOI 10.1002/mpo.2950190417; Quinn GP, 2013, MED HEALTH CARE PHIL, V16, P857, DOI 10.1007/s11019-013-9480-6; Rinck GC, 1997, J CLIN ONCOL, V15, P1697, DOI 10.1200/JCO.1997.15.4.1697; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Sanghavi DM, NYTIMES; Shilts R., 1987, BAND PLAYED POLITICS; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stiel S, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0020-4; Sugarman J, 2013, ANN INTERN MED, V159, P490, DOI 10.7326/00030003-4819-159-7-201310010-00694; Weber JS, 2015, J CLIN ONCOL, V33, P278, DOI 10.1200/JCO.2014.58.2635	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199670	10.1371/journal.pone.0199670	http://dx.doi.org/10.1371/journal.pone.0199670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036365	Green Submitted, gold, Green Published			2022-12-26	WOS:000439429200006
J	Hearn, AJ; Cushman, SA; Ross, J; Goossens, B; Hunter, LTB; Macdonald, DW				Hearn, Andrew J.; Cushman, Samuel A.; Ross, Joanna; Goossens, Benoit; Hunter, Luke T. B.; Macdonald, David W.			Spatio-temporal ecology of sympatric felids on Borneo. Evidence for resource partitioning?	PLOS ONE			English	Article							CAT PRIONAILURUS-BENGALENSIS; ACTIVITY PATTERNS; HABITAT SELECTION; CAMERA TRAP; FOREST; LANDSCAPE; PREDATION; OVERLAP; SABAH	Niche differentiation, the partitioning of resources along one or more axes of a species' niche hyper-volume, is widely recognised as an important mechanism for sympatric species to reduce interspecific competition and predation risk, and thus facilitate co-existence. Resource partitioning may be facilitated by behavioural differentiation along three main niche dimensions: habitat, food and time. In this study, we investigate the extent to which these mechanisms can explain the coexistence of an assemblage of five sympatric felids in Borneo. Using multi-scale logistic regression, we show that Bornean felids exhibit differences in both their broad and fine-scale habitat use. We calculate temporal activity patterns and overlap between these species, and present evidence for temporal separation within this felid guild. Lastly, we conducted an all-subsets logistic regression to predict the occurrence of each felid species as a function of the co-occurrence of a large number of other species and showed that Bornean felids co-occurred with a range of other species, some of which could be candidate prey. Our study reveals apparent resource partitioning within the Bornean felid assemblage, operating along all three niche dimension axes. These results provide new insights into the ecology of these species and the broader community in which they live and also provide important information for conservation planning for this guild of predators.	[Hearn, Andrew J.; Ross, Joanna; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, Oxford, England; [Cushman, Samuel A.] US Forest Serv, Rocky Mt Res Stn, Flagstaff, AZ USA; [Goossens, Benoit] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg,Museum Ave, Cardiff, S Glam, Wales; [Goossens, Benoit] Cardiff Univ, Sustainable Pl Res Inst, Cardiff, S Glam, Wales; [Hunter, Luke T. B.] Panthera, New York, NY USA	University of Oxford; United States Department of Agriculture (USDA); United States Forest Service; Cardiff University; Cardiff University	Hearn, AJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, Oxford, England.	Andrew.hearn@zoo.ox.ac.uk	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544	Darwin Initiative; Recanati-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Dr. Holly Reed Conservation Fund award; Point Defiance Zoo and Aquarium; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera; Wild About Cats	Darwin Initiative; Recanati-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Dr. Holly Reed Conservation Fund award; Point Defiance Zoo and Aquarium; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera; Wild About Cats	This research was primarily funded by the Darwin Initiative (www.gov.uk/government/groups/the-darwin-initiative); Recanati-Kaplan Foundation [DWM]; Robertson Foundation (http://www.robertsonfoundation.org/) [DWM]; Sime Darby Foundation (www.yayasansimedarby.com/). The authors received additional funding from Clouded Leopard project (http://www.cloudedleopard.org/) [AJH and JR]; Dr. Holly Reed Conservation Fund award, Point Defiance Zoo and Aquarium (www.pdza.org)[AJH]; Felidae Conservation Fund (www.felidaefund.org) [AJH and JR]; Houston Zoo (www.houstonzoo.org) [AJH]; HG Wills International Trust for Nature Conservation [AJH, JR], Panthera (www.panthera.org) [AJH]; Wild About Cats [AJH and JR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Bezuijen MR, 2000, ORYX, V34, P222, DOI 10.1017/S0030605300031227; Borries C, 2014, RAFFLES B ZOOL, V62, P561; Burnham K P, 2003, MODEL SELECT MULTIMO; Carbone C, 1999, NATURE, V402, P442, DOI 10.1038/46607; Cheyne SM, 2011, ORYX, V45, P119, DOI 10.1017/S003060531000133X; Chua MAH, 2016, MAMMAL RES, V61, P99, DOI 10.1007/s13364-015-0259-4; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Davis DD, 1962, B SINGAPORE NATL MUS, V31, P3; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Fernando N, 2013, THAI J VET MED, V43, P445; Gordon Chris H., 2007, Cat News, V47, P12; Grand J, 2004, CONSERV BIOL, V18, P1063, DOI 10.1111/j.1523-1739.2004.00555.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Hearn AJ, 2019, ORYX, V53, P643, DOI 10.1017/S0030605317001065; Hearn AJ, 2018, BIOL CONSERV, V222, P232, DOI 10.1016/j.biocon.2018.04.016; Hearn AJ, 2016, RAFFLES B ZOOL, P165; Hearn AJ, 2016, RAFFLES B ZOOL, P149; Hearn AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151046; Hearn AJ, 2013, RAFFLES B ZOOL, V61, P871; Jackson P., 1996, BIOL CONSERVATION; Jaksic F.M., 2007, ECOLOGIA COMUNIDADES, V2; Jarvis A, 2008, HOLE FILLED SEAMLESS; Karanth KU, 2000, J ZOOL, V250, P255; Kelly MJ, 2008, ANIM CONSERV, V11, P182, DOI 10.1111/j.1469-1795.2008.00179.x; Kitchener AC, 2004, MAMM BIOL, V69, P349, DOI 10.1078/1616-5047-00154; Krishnamurthy R, 2016, LANDSCAPE ECOL, V31, P1355, DOI 10.1007/s10980-016-0363-0; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; Macdonald David W., 2010, P125; Sanchez MCM, 2014, INT J GEOGR INF SCI, V28, P1531, DOI 10.1080/13658816.2013.776684; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Meredith M., 2016, OVERLAP ESTIMATES CO; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; MILLS MGL, 1992, J ANIM ECOL, V61, P693, DOI 10.2307/5624; Mohamed A, 2009, CAT NEWS, V51, P12; Mohamed A, 2016, RAFFLES B ZOOL, P180; Mohamed A, 2013, J MAMMAL, V94, P82, DOI 10.1644/11-MAMM-A-394.1; Najera F, 2017, J VET MED SCI, V79, P1892, DOI 10.1292/jvms.17-0259; Palomares F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155626; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Rajaratnam R., 2000, THESIS; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ross J, 2013, J ZOOL, V290, P96, DOI 10.1111/jzo.12018; Rustam, 2016, RAFFLES B ZOOL, P157; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Selous E. M., 1935, Sarawak Museum Journal, V4, P263; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Sunquist ME, 2002, WILD CATS WORLD; Sunquist Mel, 1994, Oryx, V28, P67; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Wasserman T., 2012, USDA FOREST SERVICE; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Wilting A, 2016, RAFFLES B ZOOL, P173; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Zeller KA, 2016, LANDSCAPE ECOL, V31, P1319, DOI 10.1007/s10980-015-0301-6	60	38	41	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200828	10.1371/journal.pone.0200828	http://dx.doi.org/10.1371/journal.pone.0200828			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028844	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000439396900016
J	Barua, M; Van Driel, F; Jansen, W				Barua, Mrittika; Van Driel, Francien; Jansen, Willy			Tuberculosis and the sexual and reproductive lives of women in Bangladesh	PLOS ONE			English	Article							RURAL MAHARASHTRA; GENDER; MARRIAGE; STIGMA; TB; PREVALENCE; VIOLENCE; INDIA	When they do not meet norms related to sexuality and reproduction, Bangladeshi women often face abandonment and are thus deprived of an active sexual life, a marital relationship, and motherhood. Little is known about how a stigmatised disease such as tuberculosis (TB) may constrain the reproductive health and sexual lives of women. This article, derived from a larger study on the impact of TB on women's sexual and reproductive health and rights in Narsingdi district and Dhaka, Bangladesh, aims to fill this gap. Based on interviews with nine married women who have or had TB, four husbands, and two mothers-in-law, this article highlights that the ways in which TB impedes on the sexual and reproductive lives of women depends on the stigma within their family and community, their relationships with their husbands, motherhood, their living arrangements, their economic contribution to the family and/or their disclosure of their TB diagnosis. Women with children and supportive husbands retain a stronger position among their in-laws and are less likely to be isolated or rejected. The patients' narratives revealed that the instructions of health workers influenced their decisions about intercourse or abstinence. Future studies should examine the instructions patients receive from health workers regarding their living and sleeping arrangements, sexual intercourse, and pregnancy, as well as policy documents on TB treatment and prevention.	[Barua, Mrittika] Radboud Univ Nijmegen, Radboud Gender & Divers Studies, Nijmegen, Netherlands; [Barua, Mrittika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Van Driel, Francien] Radboud Univ Nijmegen, Anthropol & Dev Studies, Nijmegen, Netherlands; [Jansen, Willy] Radboud Univ Nijmegen, Gender Studies, Nijmegen, Netherlands	Radboud University Nijmegen; Bangladesh Rural Advancement Committee BRAC; BRAC University; Radboud University Nijmegen; Radboud University Nijmegen	Barua, M (corresponding author), Radboud Univ Nijmegen, Radboud Gender & Divers Studies, Nijmegen, Netherlands.; Barua, M (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	mrittikabarua11@gmail.com	Barua, Mrittika/ABU-1532-2022	Barua, Mrittika/0000-0002-6309-234X	NUFFIC (Netherlands Universities Foundation for International Cooperation)	NUFFIC (Netherlands Universities Foundation for International Cooperation)	The research is supported financially by NUFFIC (Netherlands Universities Foundation for International Cooperation) through a PhD scholarship (MB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan G, 2004, GENDER DIFFERENCE TR; Amin S, 1998, POP STUD-J DEMOG, V52, P201, DOI 10.1080/0032472031000150376; Anwary A, 2015, WOMEN STUD INT FORUM, V50, P37, DOI 10.1016/j.wsif.2015.02.011; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Banks N, 2013, ENVIRON URBAN, V25, P95, DOI 10.1177/0956247813477357; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Bhattarai BR, 2016, J NEPAL BUS STUD, V9, P102; Choi NG, 2011, AGING MENT HEALTH, V15, P307, DOI 10.1080/13607863.2010.513042; Chowdhury M.R., 2015, SAARC J TUBERCULOSIS, V11, P21; Chowdhury MRK, 2015, JPN J INFECT DIS, V68, P461, DOI 10.7883/yoken.JJID.2014.522; Das AC, 2017, S E ASIA J PUBLIC HL, V6, P61, DOI [10.3329/seajph.v6i2.31837, DOI 10.3329/SEAJPH.V6I2.31837]; Davids T, 2009, THIRD WORLD Q, V30, P905, DOI 10.1080/01436590902959107; Dodor EA, 2008, INT J TUBERC LUNG D, V12, P1048; Dodor EA, 2009, PSYCHOL HEALTH MED, V14, P170, DOI 10.1080/13548500802199753; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Fahmida R, 2013, WOMEN STUD INT FORUM, V38, P117, DOI 10.1016/j.wsif.2013.03.002; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Garcia Jonathan, 2006, Horiz. antropol., V12, P13, DOI 10.1590/S0104-71832006000200002; Ghosh K, 2011, J POSTGRAD MED, V57, P307, DOI 10.4103/0022-3859.90082; Hardee K, 1999, INT FAM PLAN PERSPEC, V25, pS2, DOI 10.2307/2991865; Hashemi SM, 1996, WORLD DEV, V24, P635, DOI 10.1016/0305-750X(95)00159-A; Hoosen S, 2004, S AFR J PSYCHOL, V34, P487, DOI 10.1177/008124630403400309; Hossain MG, 2016, J BIOSOC SCI, V48, P530, DOI 10.1017/S0021932015000279; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; International Center for Research on Women United Nations Population Fund Ausralian Agency for International Development Asian Forum of Parliamentarian on Population and Development, 2012, CHILD MARRIAGES IN S; Jaggarajamma K, 2008, Indian J Tuberc, V55, P179; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Kabeer N, 1997, DEV CHANGE, V28, P261, DOI 10.1111/1467-7660.00043; KABEER N, 1988, NEW LEFT REV, P95; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Karim F, 2008, INT J TUBERC LUNG D, V12, P1336; Karim F, 2011, PUBLIC HEALTH, V125, P84, DOI 10.1016/j.puhe.2010.10.005; Karim Fazlul, 2007, Anthropol Med, V14, P139, DOI 10.1080/13648470701381440; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Khan M. E., 2000, J FAM WELFARE, V46, P12; Khanum Hamida, 2012, Bangladesh Journal of Zoology, V40, P213; Kiecolt-Glaser JK, 2017, ANNU REV CLIN PSYCHO, V13, P421, DOI 10.1146/annurev-clinpsy-032816-045111; Kumar G, 2014, SAARC J TUBERC LUNG, V10, P15; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Mainuddin Akm, 2015, J Family Reprod Health, V9, P65; Mason PH, 2016, J BIOSOC SCI, V48, P206, DOI 10.1017/S0021932015000115; Meuwly N, 2012, J FAM PSYCHOL, V26, P937, DOI 10.1037/a0030356; Moen T., 2006, INT J QUAL METHODS, V5, P56, DOI [DOI 10.1177/160940690600500405, 10.1177/160940690600500405]; Nahar P, 2000, REPROD HLTH MATTERS, V8; Nahar Papreen, 2011, Anthropol Med, V18, P327, DOI 10.1080/13648470.2011.615911; Padmanabhan N S, 2016, INT J COMMUNITY MED, P2817, DOI [10.18203/2394-6040.ijcmph20163367, DOI 10.18203/2394-6040.IJCMPH20163367]; Rahman M, 2014, ASIA-PAC J PUBLIC HE, V26, P160, DOI 10.1177/1010539511423301; Rashid SF, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S3; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; *UN, 1995, INT C POP DEV CAIR 5; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P837; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization (WHO), 2002, DEF SEX HLTH REP TEC; Zaman K, 2012, EPIDEMIOL INFECT, V140, P1018, DOI 10.1017/S0950268811001609	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201134	10.1371/journal.pone.0201134	http://dx.doi.org/10.1371/journal.pone.0201134			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024977	Green Published, Green Submitted, gold			2022-12-26	WOS:000439120000092
J	Guercio, BJ; Zhang, S; Niedzwiecki, D; Li, YP; Babic, A; Morales-Oyarvide, V; Saltz, LB; Mayer, RJ; Mowat, RB; Whittom, R; Hantel, A; Benson, A; Atienza, D; Messino, M; Kindler, H; Venook, A; Ogino, S; Zoltick, ES; Stampfer, M; Ng, K; Wu, KN; Willett, WC; Giovannucci, EL; Meyerhardt, JA; Fuchs, CS				Guercio, Brendan J.; Zhang, Sui; Niedzwiecki, Donna; Li, Yanping; Babic, Ana; Morales-Oyarvide, Vicente; Saltz, Leonard B.; Mayer, Robert J.; Mowat, Rex B.; Whittom, Renaud; Hantel, Alexander; Benson, Al; Atienza, Daniel; Messino, Michael; Kindler, Hedy; Venook, Alan; Ogino, Shuji; Zoltick, Emilie S.; Stampfer, Meir; Ng, Kimmie; Wu, Kana; Willett, Walter C.; Giovannucci, Edward L.; Meyerhardt, Jeffrey A.; Fuchs, Charles S.			Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)	PLOS ONE			English	Article							COLORECTAL-CANCER; PHYSICAL-ACTIVITY; WEIGHT-GAIN; CARDIOVASCULAR-DISEASE; DIETARY QUESTIONNAIRE; ADJUVANT TREATMENT; DIABETES-MELLITUS; KRAS MUTATION; ENERGY-INTAKE; SOFT DRINKS	Purpose Observational studies have demonstrated increased colon cancer recurrence and mortality in states of excess energy balance, as denoted by factors including sedentary lifestyle, diabetes, increased dietary glycemic load, and increased intake of sugar-sweetened beverages. Nonetheless, the relation between artificially sweetened beverages, a popular alternative for sugar-sweetened beverages, and colon cancer recurrence and survival is unknown. Methods We analyzed data from 1,018 patients with stage III colon cancer who prospectively reported dietary intake during and after chemotherapy while enrolled in a National Cancer Institute-sponsored trial of adjuvant chemotherapy. Using Cox proportional hazards regressions, we assessed associations of artificially sweetened beverage intake with cancer recurrence and mortality. Results Patients consuming one or more 12-ounce servings of artificially sweetened beverages per day experienced an adjusted hazard ratio for cancer recurrence or mortality of 0.54 (95% confidence interval, 0.36 to 0.80) when compared to those who largely abstained (P-trend = .004). Similarly, increasing artificially sweetened beverage intake was also associated with a significant improvement in both recurrence-free survival (P-trend = .005) and overall survival (P-trend = .02). Substitution models demonstrated that replacing a 12-ounce serving of a sugar-sweetened beverage with an isovolumetric serving of an artificially sweetened beverage per day was associated with a 23% lower risk of cancer recurrence and mortality (relative risk, 0.77; 95% confidence interval, 0.63 to 0.95; P= .02). Conclusion Higher artificially sweetened beverage consumption may be associated with significantly reduced cancer recurrence and death in patients with stage III colon cancer. This association may be mediated by substitution for sugar-sweetened alternatives. Further studies are needed to confirm these findings.	[Guercio, Brendan J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Zhang, Sui; Babic, Ana; Morales-Oyarvide, Vicente; Mayer, Robert J.; Ogino, Shuji; Ng, Kimmie; Meyerhardt, Jeffrey A.] Dana Farber Partners CancerCare, Boston, MA USA; [Niedzwiecki, Donna] Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA; [Li, Yanping; Stampfer, Meir; Wu, Kana; Willett, Walter C.; Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Mowat, Rex B.] Toledo Community Hosp, Oncol Program, Toledo, OH USA; [Whittom, Renaud] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Hantel, Alexander] Edward Elmhurst Healthcare, Naperville, IL USA; [Benson, Al] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Atienza, Daniel] Virginia Oncol Associates, Norfolk, VA USA; [Messino, Michael] Mission Hosp Inc, Southeast Clin Oncol Res SCOR Consortium, Asheville, NC USA; [Kindler, Hedy] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA; [Venook, Alan] Univ Calif San Francisco, Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Ogino, Shuji; Stampfer, Meir; Willett, Walter C.; Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Div Mol Pathol Epidemiol MPE, 75 Francis St, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Zoltick, Emilie S.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Zoltick, Emilie S.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Stampfer, Meir; Giovannucci, Edward L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA USA; [Fuchs, Charles S.] Yale Canc Ctr, Yale Sch Med, New Haven, CT 06510 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Duke University; Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center; Universite de Montreal; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University	Fuchs, CS (corresponding author), Yale Canc Ctr, Yale Sch Med, New Haven, CT 06510 USA.	charles.fuchs@yale.edu	li, yan/GTI-4638-2022	Zhang, Sui/0000-0001-8279-6353; Guercio, Brendan/0000-0001-6296-2473; Ogino, Shuji/0000-0002-3909-2323; Niedzwiecki, Donna/0000-0002-3566-0450	National Cancer Institute of the National Institutes of Health [U10CA180821, U10CA180882, U10CA180820, U10A80888]; National Cancer Institute [U10CA060138, U10CA180791, U10CA180836, U10CA180867, UG1CA189858, K07 CA148894, R01 CA118553, R01 CA149222, R01 CA169141, P50 CA127003, R35 CA197735]; American Institute for Cancer Research; National Institutes of Health National Heart, Lung, and Blood Institute [T32HL125232]; National Cancer Institute P30 Cancer Center Support Grant (CCSG) [P30 CA008748]; NATIONAL CANCER INSTITUTE [U10CA180882, P50CA127003, R01CA205406, U10CA180836, UG1CA233180, U10CA180888, U10CA180791, K07CA148894, UG1CA189858, P30CA008748, R01CA118553, U10CA180821, R01CA149222, UG1CA189974, R01CA169141, U10CA180820, U10CA180867, R35CA197735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL125232] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research; National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute P30 Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health (https://www.cancer.gov) under Award Numbers U10CA180821 and U10CA180882 (to the Alliance for Clinical Trials in Oncology), U10CA180820 (to ECOG-ACRIN), and U10A80888 (to SWOG). Additional support from the National Cancer Institute was provided under U10CA060138 (to University of California San Francisco and AV), U10CA180791 (to Memorial Sloan-Kettering Cancer Center), U10CA180836 (to the University of Chicago Comprehensive Cancer Center and HK), U10CA180867 (to Dana-Farber/Partners Cancer Care), and UG1CA189858 (to Southeast Clinical Oncology Research Consortium, Inc., [SCOR]). Support for the trial was also provided by Pharmacia & Upjohn Company, now Pfizer Oncology (https://www.pfizer.com/science/oncology-cancer). CF, KN, and JM are supported in part by grants from the National Cancer Institute (K07 CA148894, R01 CA118553, R01 CA149222, R01 CA169141, and P50 CA127003). DN is supported in part by grant R01 CA149222 from the National Cancer Institute. SO is supported by R35 CA197735 from the National Cancer Institute. KW is supported by a grant from the American Institute for Cancer Research (http://www.aicr.org). EZ is supported by the National Institutes of Health National Heart, Lung, and Blood Institute grant T32HL125232 (https://www.nhlbi.nih.gov). Support was also provided by the National Cancer Institute P30 Cancer Center Support Grant (CCSG) (P30 CA008748) to Memorial Sloan-Kettering. The National Institutes for Health participated in the design of the study as well as review and approval of the manuscript. Non-federal funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Bleich SN, 2014, AM J PUBLIC HEALTH, V104, pE72, DOI 10.2105/AJPH.2013.301556; Campos V, 2015, OBESITY, V23, P2335, DOI 10.1002/oby.21310; Carroll AE, 2015, NY TIMES; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chia CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167241; COX DR, 1972, J R STAT SOC B, V34, P187; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Dignam JJ, 2006, J NATL CANCER I, V98, P1647, DOI 10.1093/jnci/djj442; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Elfhag K, 2007, PHYSIOL BEHAV, V91, P191, DOI 10.1016/j.physbeh.2007.02.005; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Fuchs MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099816; Gardner C, 2012, CIRCULATION, V126, P509, DOI 10.1161/CIR.0b013e31825c42ee; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Guercio BJ, 2015, J CLIN ONCOL, V33, P3598, DOI 10.1200/JCO.2015.61.5062; Gul SS, 2017, APPL PHYSIOL NUTR ME, V42, P77, DOI 10.1139/apnm-2016-0346; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Je Y, 2013, INT J CANCER, V133, P1905, DOI 10.1002/ijc.28208; Lim U, 2006, CANCER EPIDEM BIOMAR, V15, P1654, DOI 10.1158/1055-9965.EPI-06-0203; Ludwig DS, 2009, JAMA-J AM MED ASSOC, V302, P2477, DOI 10.1001/jama.2009.1822; Ma JT, 2016, J NUTR, V146, P2544, DOI 10.3945/jn.116.234047; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; McCullough ML, 2014, J NUTR, V144, P2041, DOI 10.3945/jn.114.197475; Meyerhardt JA, 2005, J CLIN ONCOL, V23, P8453, DOI 10.1200/JCO.2005.02.5460; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2012, JNCI-J NATL CANCER I, V104, P1702, DOI 10.1093/jnci/djs399; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P1789, DOI 10.1093/jnci/djt298; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Pereira MA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0375-z; Pereira MA, 2013, NUTR REV, V71, P433, DOI 10.1111/nure.12038; Peters JC, 2016, OBESITY, V24, P297, DOI 10.1002/oby.21327; Peters JC, 2014, OBESITY, V22, P1415, DOI 10.1002/oby.20737; Rabin RC, 2016, NY TIMES; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schernhammer ES, 2012, AM J CLIN NUTR, V96, P1419, DOI 10.3945/ajcn.111.030833; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Soffritti M., 2005, EUR J ONCOL, V10, P107; Soffritti M, 2007, ENVIRON HEALTH PERSP, V115, P1293, DOI 10.1289/ehp.10271; Sorensen LB, 2014, AM J CLIN NUTR, V100, P36, DOI 10.3945/ajcn.113.081554; Suez Jotham, 2014, Nature, V514, P181, DOI 10.1038/nature13793; U. S. Department of Agriculture, 1989, AGR HDB, V8; Van Loon K, 2013, CLIN COLORECTAL CANC, V12, P95, DOI 10.1016/j.clcc.2012.11.002; Vanselow MS, 2009, AM J CLIN NUTR, V90, P1489, DOI 10.3945/ajcn.2009.27573; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417; Warren RS, 2013, CLIN CANCER RES, V19, P5777, DOI 10.1158/1078-0432.CCR-13-0351; Weihrauch MR, 2004, ANN ONCOL, V15, P1460, DOI 10.1093/annonc/mdh256; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945; Zubrod C.G., 1960, J CHRON DIS, V11, P7	65	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199244	10.1371/journal.pone.0199244	http://dx.doi.org/10.1371/journal.pone.0199244			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024889	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000006
J	Park, N; Kang, E; Park, M; Lee, H; Kang, HG; Yoon, HJ; Kang, U				Park, Namyong; Kang, Eunjeong; Park, Minsu; Lee, Hajeong; Kang, Hee-Gyung; Yoon, Hyung-Jin; Kang, U.			Predicting acute kidney injury in cancer patients using heterogeneous and irregular data	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; BIOMARKERS; THERAPY; MODELS	How can we predict the occurrence of acute kidney injury (AKI) in cancer patients based on machine learning with serum creatinine data? Given irregular and heterogeneous clinical data, how can we make the most of it for accurate AKI prediction? AKI is a common and significant complication in cancer patients, and correlates with substantial morbidity and mortality. Since no effective treatment for AKI still exists, it is important to take timely preventive measures. While several approaches have been proposed for predicting AKI, their scope and applicability are limited as they either assume regular data measured over a short hospital stay, or do not fully utilize heterogeneous data. In this paper, we provide an AKI prediction model with a greater applicability, which relaxes the constraints of existing approaches, and fully utilizes irregular and heterogeneous data for learning the model. In a cohort of 21,022 cancer patients who were registered into Korea Central Cancer Registry (KCCR) in Seoul National University Hospital between January 1, 2004 and December 31, 2013, our method achieves 0.7892 precision, 0.7506 recall, and 0.7576 F-measure in predicting whether a patient will develop AKI during the next 14 days.	[Park, Namyong; Kang, U.] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Eunjeong] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Minsu; Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea; [Kang, Hee-Gyung] Seoul Natl Univ, Childrens Hosp, Pediat, Seoul, South Korea; [Park, Namyong] Carnegie Mellon Univ, Comp Sci Dept, Pittsburgh, PA 15213 USA; [Park, Minsu] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Carnegie Mellon University; Yonsei University; Yonsei University Health System	Kang, U (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	ukang@snu.ac.kr	Kang, Eunjeong/ABA-3646-2021	Kang, Eunjeong/0000-0002-2191-2784; Park, Namyong/0000-0002-3344-2361	Interdisciplinary Research Initiatives Program from College of Engineering, Seoul National University [80020160087]; College of Medicine, Seoul National University [80020160087]	Interdisciplinary Research Initiatives Program from College of Engineering, Seoul National University; College of Medicine, Seoul National University	This work was supported by the Interdisciplinary Research Initiatives Program from College of Engineering and College of Medicine, Seoul National University (grant no. 80020160087). The Institute of Engineering Research at Seoul National University provided research facilities for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Benoit DD, 2005, NEPHROL DIAL TRANSPL, V20, P552, DOI 10.1093/ndt/gfh637; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chang CH, 2016, INT J MED SCI, V13, P19, DOI 10.7150/ijms.13253; Christiansen CF, 2011, EUR J INTERN MED, V22, P399, DOI 10.1016/j.ejim.2011.05.005; Cruz HFD, 2016, P 7 INT S SEM MIN BI, P29; Darmon M, 2006, CRIT CARE, V10, DOI 10.1186/cc4907; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kate RJ, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0277-4; Lam AQ, 2012, CLIN J AM SOC NEPHRO, V7, P1692, DOI 10.2215/CJN.03140312; Lameire NH, 2005, ANN MED, V37, P13, DOI 10.1080/07853890510007205; Lameire NH, 2011, KIDNEY INT, V79, P1047, DOI 10.1038/ki.2011.21; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165280; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rosner MH, 2017, NEW ENGL J MED, V376, P1770, DOI 10.1056/NEJMra1613984; Rudy J., 2017, PY EARTH; Sanchez-Pinto LN, 2016, PEDIATR CRIT CARE ME, V17, P508, DOI 10.1097/PCC.0000000000000750; Sanchez-Pinto LN, 2015, AMIA 2015 AM MED INF; Schneider DF, 2012, J BURN CARE RES, V33, P242, DOI 10.1097/BCR.0b013e318239cc24; Selby NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048580; Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869; Tirunagari S., 2016, COMP INT SSCI 2016 I, P1	31	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199839	10.1371/journal.pone.0199839	http://dx.doi.org/10.1371/journal.pone.0199839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024918	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000011
J	Chen, KC; Wu, CH; Tang, CH; Huang, KC				Chen, Kuan-Chen; Wu, Chu-Hua; Tang, Chao-Hsiun; Huang, Kuo-Cherh			Healthcare resource utilization and costs among patients with rheumatoid arthritis on biologic therapies in Taiwan: A 1-year mirror-image study using a national claims database	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS	Objectives This nationwide population-based study aimed at evaluating healthcare resource utilization and direct medical costs among rheumatoid arthritis (RA) patients receiving biologic therapies in Taiwan. Design and setting A retrospective cohort of 2,425 RA patients who had received first-line tumor necrosis factor (TNF)-alpha antagonist treatment for at least 6 months (the baseline period) between 2007 and 2011 was identified from the National Health Insurance Research Database in Taiwan. Outcome measures Healthcare resource utilization and direct medical costs of those patients were analyzed and compared 1 year before the index date and during the 1-year follow-up. Results Analytical results demonstrated that 87.7% of RA patients received the same TNF-alpha antagonist during the 1-year follow-up, 2.4% of the patients switched to another TNF-alpha antagonist after the baseline period, 7.1% of the study cohort received a second-line biologic agent, while the remaining patients discontinued use of any TNF-alpha antagonist. Compared to 1 year before the index date, there were significant reductions in emergency room visits and hospitalization days for RA patients treated with the same TNF-alpha antagonist during the 1-year follow-up. However, there was an increase of outpatient visits among those patients. For those RA patients who switched to another TNF-alpha antagonist or received a second-line biologic agent, they consumed more healthcare resources. Furthermore, the corresponding medication costs went up markedly during the 1-year follow-up, but nearly all total direct medical costs (biologics excluded) were significantly reduced across the study cohort. Lastly, male patients incurred slightly higher medical costs than their counterparts, albeit in a statistically insignificant fashion. Conclusions This investigation revealed that RA patients treated with biologics utilized fewer emergency room visits and shorter hospitalization days, but incurred higher costs. In summary, this study provides meaningful information on healthcare resource utilization and medical costs of RA patients for healthcare providers and policymakers.	[Chen, Kuan-Chen; Wu, Chu-Hua; Tang, Chao-Hsiun; Huang, Kuo-Cherh] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan; [Chen, Kuan-Chen] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	Taipei Medical University; National Taipei University of Nursing & Health Science (NTUNHS)	Tang, CH; Huang, KC (corresponding author), Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan.	chtang@tmu.edu.tw; kchuang@tmu.edu.tw						Accortt NA, 2017, ADV THER, V34, P2093, DOI 10.1007/s12325-017-0596-6; Baser O, 2015, CLIN THER, V37, P1454, DOI 10.1016/j.clinthera.2015.04.012; Birnbaum H, 2010, CURR MED RES OPIN, V26, P77, DOI 10.1185/03007990903422307; Carmona L, 2007, ACTA REUMATOL PORT, V32, P113; Chastek B, 2017, ADV THER, V34, P2422, DOI 10.1007/s12325-017-0617-5; De Vera MA, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0460-5; Filipovic I, 2011, RHEUMATOLOGY, V50, P1083, DOI 10.1093/rheumatology/keq399; Juillard-Condat B, 2007, THERAPIE, V62, P137, DOI 10.2515/therapie:2007029; Kalkan A, 2014, RHEUMATOLOGY, V53, P153, DOI 10.1093/rheumatology/ket290; Kawatkar AA, 2012, ARTHRIT CARE RES, V64, P1649, DOI 10.1002/acr.21755; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Kwon JM, 2012, RHEUMATOL INT, V32, P2893, DOI 10.1007/s00296-011-2117-2; Meissner Brian, 2014, J Med Econ, V17, P259, DOI 10.3111/13696998.2014.893241; Rosenblatt L, 2013, VALUE HEALTH, V16, pA222, DOI 10.1016/j.jval.2013.03.1127; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Strand V, 2007, AM J MANAG CARE, V13, pS237; Turchetti G, 2013, REUMATISMO, V65, P271, DOI 10.4081/reumatismo.2013.687; Wang H, 2012, VALUE HEALTH, V15, pA35, DOI 10.1016/j.jval.2012.03.198; World Health Organization, CHRON DIS HLTH PROM	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200758	10.1371/journal.pone.0200758	http://dx.doi.org/10.1371/journal.pone.0200758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020997	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400073
J	Nemoto, Y; Saito, R; Oomachi, H				Nemoto, Yui; Saito, Rie; Oomachi, Hitoshi			Seasonal variation of Cesium-137 concentration in Asian black bear (Ursus thibetanus) and wild boar (Sus scrofa) in Fukushima Prefecture, Japan	PLOS ONE			English	Article							HARD MAST PRODUCTION; FOOD-HABITS; HOME-RANGE; CS-137; RADIOCESIUM; MEAT; RADIOACTIVITY; ACCUMULATION; MOOSE; DIET	To elucidate and reduce the risk of radionuclide contamination in wildlife caused by the Tokyo Electric Power Company Fukushima Dai-ichi Nuclear Power Station accident, it is important to understand radionuclide variations in the wild animal population. Here, we used environmental monitoring data and muscle samples collected from Asian black bear (Ursus thibetanus) and wild boar (Sus scrofa) from May 2011 to March 2016 to examine seasonal variation in radiocesium (Cs-137) concentrations in muscle tissues (hereafter, muscle Cs-137) of these important game species in Fukushima Prefecture. We measured muscle Cs-137 of bears and wild boars killed by hunters or in animal control culls. First, using a linear mixed model (LMM), we tested for a positive relationship between muscle Cs-137 and Cs-137 in the soil at the site of capture (hereafter, soil 137 Cs) estimated from a soil Cs-137 deposition map produced by the Japan Atomic Energy Agency. In the LMM, muscle Cs-137 was positively related to estimated soil 137 Cs, which corroborates the results of previous studies. The LMM regression coefficients differed between the two species, with wild boar muscle Cs-137 being higher than that of bears sampled at the same locations. We then employed a generalized additive mixed model (GAMM) to estimate seasonal variation in the muscle Cs-137 of the target species. GAMM showed that muscle Cs-137 varied seasonally and that this seasonal variation also differed between the two species. In bears, muscle Cs-137 decreased from spring to early autumn, before increasing in winter. Wild boar muscle Cs-137 remained low during spring and summer and was high during autumn and early spring. These patterns are likely influenced by differences in diet, habitat use, and physiology between these two species.	[Nemoto, Yui; Saito, Rie; Oomachi, Hitoshi] Fukushima Prefectural Ctr Environm Creat, Res Dept, Miharu Town, Fukushima, Japan		Nemoto, Y (corresponding author), Fukushima Prefectural Ctr Environm Creat, Res Dept, Miharu Town, Fukushima, Japan.	nemoto_yui_01@pref.fukushima.lg.jp			Fukushima Prefecture	Fukushima Prefecture	This work was supported by the budget of Fukushima Prefecture.	Arai T, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-479; Arimoto I, 2011, MAMM STUDY, V36, P199, DOI 10.3106/041.036.0403; Avila R, 1999, J ENVIRON RADIOACTIV, V46, P99, DOI 10.1016/S0265-931X(98)00108-8; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brown JE, 2008, J ENVIRON RADIOACTIV, V99, P1371, DOI 10.1016/j.jenvrad.2008.01.008; Brown JE, 2016, J ENVIRON RADIOACTIV, V153, P141, DOI 10.1016/j.jenvrad.2015.12.011; Calmon P, 2009, J ENVIRON RADIOACTIV, V100, P757, DOI 10.1016/j.jenvrad.2008.11.005; Fielitz U, 2009, J ENVIRON RADIOACTIV, V100, P241, DOI 10.1016/j.jenvrad.2008.12.005; GENOV P, 1981, ACTA THERIOL, V26, P185, DOI 10.4098/AT.arch.81-16; Geras'kin SA, 2008, ENVIRON INT, V34, P880, DOI 10.1016/j.envint.2007.12.012; Geras'kin SA, 2007, J ENVIRON RADIOACTIV, V94, P151, DOI 10.1016/j.jenvrad.2007.01.003; Gulakov AV, 2014, J ENVIRON RADIOACTIV, V127, P171, DOI 10.1016/j.jenvrad.2013.06.008; HALIKAS GC, 1972, COMP BIOCHEM PHYSIOL, V41, P433, DOI 10.1016/0300-9629(72)90074-6; Hashimoto S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02564; Hashimoto S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00416; Hashimoto Yukihiko, 1997, Honyurui Kagaku, V37, P1; Hellgren EC, 1998, URSUS-SERIES, V10, P467; Hinton TG, 2015, J ENVIRON RADIOACTIV, V145, P58, DOI 10.1016/j.jenvrad.2015.03.027; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Hissa R, 1998, ANN ZOOL FENN, V35, P215; Hohmann U, 2005, EUR J WILDLIFE RES, V51, P263, DOI 10.1007/s10344-005-0108-x; IAEA, 2015, FUK DAIICH ACC SAF A; JAEA, 2016, RES DEP RAD CES 5 AI; Kapala J, 2015, J ENVIRON RADIOACTIV, V141, P76, DOI 10.1016/j.jenvrad.2014.11.013; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Koba Yuki, 2009, Honyurui Kagaku, V49, P207; Kodera Y., 2001, WILDL CONS JPN, V6, P109; Kodera Y., 2015, WILD MAMMALS JAPAN, P312; Kodera Yuuji, 2013, Honyurui Kagaku, V53, P279; Koike S, 2012, MAMM STUDY, V37, P21, DOI 10.3106/041.037.0103; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; Merz S, 2015, ENVIRON SCI TECHNOL, V49, P2875, DOI 10.1021/es5057648; Mizoguchi Noriyasu, 1996, Honyurui Kagaku, V36, P33; NELIN P, 1995, J ENVIRON RADIOACTIV, V26, P189, DOI 10.1016/0265-931X(94)00019-S; NELSON RA, 1980, FED PROC, V39, P2955; Nemoto Yui, 2016, Honyurui Kagaku, V56, P105; Oi Toru, 2012, Honyurui Kagaku, V52, P1; Palo RT, 1996, J APPL ECOL, V33, P1077, DOI 10.2307/2404687; Palo RT, 2003, WILDLIFE BIOL, V9, P207, DOI 10.2981/wlb.2003.052; Pumpanen J, 2016, J ENVIRON RADIOACTIV, V161, P73, DOI 10.1016/j.jenvrad.2016.04.024; QGIS Development Team, 2016, OP SOURC GEOSP FDN; R Core Team, 2021, R LANGUAGE ENV STAT; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Semizhon T, 2009, J ENVIRON RADIOACTIV, V100, P988, DOI 10.1016/j.jenvrad.2009.06.023; Sprem N, 2016, SCI TOTAL ENVIRON, V542, P826, DOI 10.1016/j.scitotenv.2015.11.004; Strebl F, 2007, J ENVIRON RADIOACTIV, V98, P137, DOI 10.1016/j.jenvrad.2006.02.009; Tagami K, 2016, ENVIRON SCI TECHNOL, V50, P9424, DOI 10.1021/acs.est.6b03011; The Mammal Society of Japan, 2016, GUID US AN RES; Ulanovsky A, 2008, J ENVIRON RADIOACTIV, V99, P1440, DOI 10.1016/j.jenvrad.2008.01.010; Vilic M, 2005, J ENVIRON RADIOACTIV, V81, P55, DOI 10.1016/j.jenvrad.2004.12.001; Wood SN, 2017, GEN ADDITIVE MODELS, V2; Yamazaki K., 2015, WILD MAMMALS JAPAN, P243	52	16	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200797	10.1371/journal.pone.0200797	http://dx.doi.org/10.1371/journal.pone.0200797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020989	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400077
J	Pande, T; Huddart, S; Xavier, W; Kulavalli, S; Chen, T; Pai, M; Saravu, K				Pande, Tripti; Huddart, Sophie; Xavier, Wilbin; Kulavalli, Srivathsa; Chen, Tanya; Pai, Madhukar; Saravu, Kavitha			Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis	PLOS ONE			English	Article							RISK-FACTORS; EXTRAPULMONARY TUBERCULOSIS; CURRENT STATE; COHORT; CHINA	Background India has a high prevalence of tuberculosis (TB) as well as diabetes mellitus (DM). DM is a chronic disease caused by deficiency of insulin production by the pancreas. The risk of TB amongst DM patients is three times higher than those without. The estimated national prevalence of DM is 7.3%. Despite the growing burden of DM, there are limited studies describing the prevalence of TB-DM in India. Objective Our study estimated the prevalence of DM amongst adult hospitalized TB patients at Kasturba Hospital, Manipal and determined factors associated with the likelihood of DM-TB coprevalence. Methods We conducted a retrospective cohort study at Kasturba Hospital, Manipal Academy of Higher Education. All hospitalized adult patients diagnosed with pulmonary TB (PTB) and extrapulmonary TB (EPTB) between June 1st 2015 and June 30th 2016 were eligible for inclusion. Pediatric and pregnant TB patients were excluded from our study. Data were extracted from medical charts. Descriptive and multivariate analyses were performed in R. Multivariate analysis adjusted for age, gender, type of TB, history of TB, and nutrition (body mass index (BMI)) status. Results A total of 728 patients met the eligibility criteria, 517 (71%) were male, 210 (29%) female, 406 (56%) had PTB and 322 (44%) had EPTB. Amongst those with a nutritional status, 36 (30%) patients were underweight (BMI <18.4 kg/m(2)), 73 (40%) had a normal BMI (18.5kg/m(2)-24.9 kg/m(2)), 15 (8%) were overweight (BMI 25.0 kg/m(2)-29.9 kg/m(2)) and 9 (5%) were obese (BMI >30.0 kg/m(2)). A total of 720 (98.9%) of TB patients had at least one blood sugar test result. The overall prevalence of DM (n = 184) amongst TB patients was 25.3% (95% CI 22.2%, 28.6%). When stratified, it was 35.0% (30.4%, 39.9%) and 13.0% (9.7%, 17.3%) amongst PTB and EPTB patients respectively. TB patients aged 41-60 years had 3.51 times higher odds (aOR 3.51 (2.08, 6.07)) of having DM than patients 40 years or younger. Patients aged 60 years or older had 2.49 times higher odds (aOR 2.49 (1.28, 4.85)) of having DM than younger patients (<40 years). Females had lower odds (aOR 0.80 (0.46, 1.37)) of developing DM than male TB patients and patients with a history of TB had lower odds (aOR 0.73 (0.39, 1.32)) than newly diagnosed TB patients. Additionally, EPTB patients had significantly lower odds (aOR 0.26 (0.15, 0.43)) compared to PTB patients. Underweight patients also had significantly lower odds (aOR 0.25 (0.14, 0.42)) of having DM than normal weight patients. Conclusion Our study found a higher prevalence of TB-DM than the national average. TB-DM co-prevalence was significantly associated with age, type of TB and undernutrition. As India's DM prevalence is expected to rise, TB-DM will become an increasingly important part of the TB epidemic requiring specialized study and care.	[Pande, Tripti; Huddart, Sophie; Pai, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada; [Xavier, Wilbin; Kulavalli, Srivathsa; Saravu, Kavitha] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India; [Chen, Tanya] McGill Univ, Fac Med, Montreal, PQ, Canada; [Huddart, Sophie; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pai, Madhukar; Saravu, Kavitha] Manipal Acad Higher Educ, Manipal McGill Ctr Infect Dis, Prasanna Sch Publ Hlth, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; McGill University; McGill University; Manipal Academy of Higher Education (MAHE)	Saravu, K (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India.; Saravu, K (corresponding author), Manipal Acad Higher Educ, Manipal McGill Ctr Infect Dis, Prasanna Sch Publ Hlth, Manipal, Karnataka, India.	kavithasaravu@gmail.com	Saravu, Kavitha/H-4634-2019; Huddart, Sophie/AAF-8844-2020; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Saravu, Kavitha/0000-0001-6399-1129; Huddart, Sophie/0000-0001-6425-3371; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	TMA Pai Endowment Chair in Transalational Epidemology and Implementation Research from Manipal Academy of Higher Education; Dr TMA Pai Endowment Chair in Translational epidemiology and implementation research from Manipal Academy of Higher Education (MAHE)	TMA Pai Endowment Chair in Transalational Epidemology and Implementation Research from Manipal Academy of Higher Education; Dr TMA Pai Endowment Chair in Translational epidemiology and implementation research from Manipal Academy of Higher Education (MAHE)	The study was supported by TMA Pai Endowment Chair in Transalational Epidemology and Implementation Research from Manipal Academy of Higher Education, awarded to Dr Madhukar Pai.; The authors would like to acknowledge the members of the Medical Records Department for their help and support in providing the necessary data collection documents. This study was supported by Dr TMA Pai Endowment Chair in Translational epidemiology and implementation research awarded to Dr Madhukar Pai from Manipal Academy of Higher Education (MAHE).	Agarwal Anil Kumar, 2017, Indian J Endocrinol Metab, V21, P570, DOI 10.4103/ijem.IJEM_89_17; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Anjana RM, 2017, LANCET DIABETEENDO; [Anonymous], 2017, GLOB INF ED HIV AIDS; Atlas D: International Diabetes Federation, 2015, IDF DIABETES ATLAS; Central TB Division, 2015, REV NAT TB CONTR PRO; Geldsetzer P, 2018, JAMA INTERNAL MED; Government of India, 2017, GUID DOC NUTR CAR SU; Huddart S, 2018, TUBERCULOSIS PERSIST; Isa SE, 2016, CLIN INFECT DIS, V63, P830, DOI 10.1093/cid/ciw381; Jabbar A, 2006, CLIN CHARACTERISTICS; Jain M. K., 2006, Indian Journal of Community Medicine, V31, P137; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jubulis J, 2014, INT J TUBERC LUNG D, V18, P198, DOI 10.5588/ijtld.13.0314; Kasturba Hospital Manipal, 2017, MED REC DEP; Kaveeshwar SA, 2014, AUSTRALAS MED J, V7, P45, DOI [10.4066/AMJ.2013.1979, 10.4066/AMJ.2014.1979]; Kottarath MD, 2017, INT J RES MED SCI, V3, P2810; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Kumpatla S, 2013, PUBLIC HEALTH ACTION, V3, pS23, DOI 10.5588/pha.13.0035; Lawson L, 2017, INT J INFECT DIS, V61, P121, DOI 10.1016/j.ijid.2017.06.014; Lee PH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002072; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Li L, 2012, TROP MED INT HEALTH, V17, P1294, DOI 10.1111/j.1365-3156.2012.03068.x; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Magee MJ, 2016, EPIDEMIOL INFECT, V144, P2209, DOI 10.1017/S0950268816000364; Mi FL, 2013, TROP MED INT HEALTH, V18, P1379, DOI 10.1111/tmi.12198; Ministry of Health & Family Welfare, 2017, REV NAT TUB CONTR PR; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; National Institute on Alcohol Abuse and Alcoholism, 2017, ALC FACTS STAT; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Patel AK, 2012, NATL J MED RES, V2, P309; Pizzol Damiano, 2018, BMC Res Notes, V11, P99, DOI 10.1186/s13104-018-3209-9; Pizzol D, 2016, TROP MED INT HEALTH, V21, P694, DOI 10.1111/tmi.12704; Raghuraman S, 2014, N AM J MED SCI, V6, P30, DOI 10.4103/1947-2714.125863; Ramachandran A, 2005, J Assoc Physicians India, V53, P34; Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604; Sharma SK, 2017, INDIAN J MED RES, V145, P448, DOI 10.4103/ijmr.IJMR_1950_16; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tahir Z, 2016, AFR HEALTH SCI, V16, P671, DOI 10.4314/ahs.v16i3.5; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Workneh MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175925; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR	49	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200838	10.1371/journal.pone.0200838	http://dx.doi.org/10.1371/journal.pone.0200838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021016	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400081
J	Cai, C; Sang, CJ; Du, J; Jia, HB; Tu, JY; Wan, Q; Bao, BH; Xie, SL; Huang, Y; Li, A; Li, JY; Yang, K; Wang, S; Lu, QW				Cai, Chen; Sang, Caijun; Du, Juan; Jia, Haibo; Tu, Jiayi; Wan, Qing; Bao, Binghao; Xie, Shanglun; Huang, Ying; Li, Ao; Li, Jiayu; Yang, Kun; Wang, Song; Lu, Qunwei			Knockout of tnni1b in zebrafish causes defects in atrioventricular valve development via the inhibition of the myocardial wnt signaling pathway	FASEB JOURNAL			English	Article						CRISPR; Cas9; cardiac troponin I; heart valve; lef1; tcf3	CARDIAC TROPONIN-I; EPITHELIAL-MESENCHYMAL TRANSITION; DEVELOPING HEART; MOUSE MODEL; EXPRESSION; CUSHION; CARDIOMYOPATHY; SKELETAL; ISOFORM; RISK	The proper development of atrioventricular (AV) valves is critical for heart morphogenesis and for the formation of the cardiac conduction system. Defects in AV valve development are the most common type of congenital heart defect. Cardiac troponin I (ctnni), a structural and regulatory protein involved in cardiac muscle contraction, is a subunit of the troponin complex, but the functions and molecular mechanisms of ctnni during early heart development remain unclear. We created a knockout zebrafish model in which troponin I type 1b (tnni1b) (Tnni-HC, heart and craniofacial) was deleted using the clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat-associated protein system. In the homozygous mutant, the embryos showed severe pericardial edema, malformation of the heart tube, reduction of heart rate without contraction and with almost no blood flow, heart cavity congestion, and lack of an endocardial ring or valve leaflet, resulting in 88.8 +/- 6.0% lethality at 7 d postfertilization. Deletion of tnni1b caused the abnormal expression of several markers involved in AV valve development, including bmp4, cspg2, has2, notch1b, spp1, and Alcam. Myocardial re-expression of tnni1b in mutants partially rescued the pericardial edema phenotype and AV canal (AVC) developmental defects. We further showed that tnni1b knockout in zebrafish and ctnni knockdown in rat h9c2 myocardial cells inhibited cardiac wnt signaling and that myocardial reactivation of wnt signaling partially rescued the abnormal expression of AVC markers caused by the tnni1b deletion. Taken together, our data suggest that tnni1b plays a vital role in zebrafish AV valve development by regulating the myocardial wnt signaling pathway.Cai, C., Sang, C., Du, J., Jia, H., Tu, J., Wan, Q., Bao, B., Xie, S., Huang, Y., Li, A., Li, J., Yang, K., Wang, S., Lu, Q. Knockout of tnni1b in zebrafish causes defects in atrioventricular valve development via the inhibition of myocardial wnt signaling pathway.	[Cai, Chen; Sang, Caijun; Jia, Haibo; Tu, Jiayi; Wan, Qing; Bao, Binghao; Xie, Shanglun; Huang, Ying; Li, Ao; Li, Jiayu; Lu, Qunwei] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Du, Juan] Huazhong Univ Sci & Technol, Sch Hosp, Wuhan, Hubei, Peoples R China; [Yang, Kun; Wang, Song] Wuhan Sports Univ, Exercise Immunol Ctr, Wuhan 430079, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan Sports University	Lu, QW (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.; Wang, S (corresponding author), Wuhan Sports Univ, Exercise Immunol Ctr, Wuhan 430079, Hubei, Peoples R China.	wangsong@whsu.edu.cn; luqw@hust.edu.cn		shanglun, xie/0000-0002-8947-1399	Ministry of Science and Technology of China [2013CB945300]; National Natural Science Foundation of China [81770102]; Natural Science Foundation of Hubei Province [2016CKB707]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The authors thank Prof. Jianfeng Zhou (Tongji Hospital, Wuhan, China) for providing the plasmids of the CRISPR/Cas9 system, Prof. Yun Deng (Hunan Normal University Changsha City, China) for the kind gift of pTol2-myl7-IRES-EGFP plasmid, and the laboratories of Prof. Qing Wang and Prof. Mugen Liu (Huazhong University of Science and Technology) for help with feeding zebrafish and for the cell culture. This study was supported by the Ministry of Science and Technology of China (2013CB945300), the National Natural Science Foundation of China (81770102), and the Natural Science Foundation of Hubei Province (2016CKB707). The authors declare no conflicts of interest.	Ahmad F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002642; Ahuja S, 2016, DEV BIOL, V412, P71, DOI 10.1016/j.ydbio.2016.02.003; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; AUSONI S, 1991, DEVELOPMENT, V112, P1041; Bai Y, 2013, J MOL CELL CARDIOL, V57, P82, DOI 10.1016/j.yjmcc.2013.01.008; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Burns CG, 2006, BIOTECHNIQUES, V40, P274, DOI 10.2141/000112135; Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127; Chen Tingfang, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P230; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; England J, 2017, J MOL CELL CARDIOL, V106, P1, DOI 10.1016/j.yjmcc.2017.03.006; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fu CY, 2009, GENE EXPR PATTERNS, V9, P348, DOI 10.1016/j.gep.2009.02.001; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Gillers BS, 2015, CIRC RES, V116, P398, DOI 10.1161/CIRCRESAHA.116.304731; Goddard LM, 2017, DEV CELL, V43, P274, DOI 10.1016/j.devcel.2017.09.023; Gomez-Stallons MV, 2016, ARTERIOSCL THROM VAS, V36, P1398, DOI 10.1161/ATVBAHA.116.307526; Houk AR, 2016, METHOD CELL BIOL, V134, P335, DOI 10.1016/bs.mcb.2016.03.002; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang XP, 1999, CIRC RES, V84, P1; Huang XP, 2000, J MOL CELL CARDIOL, V32, P2221, DOI 10.1006/jmcc.2000.1249; Hulin A, 2017, CARDIOVASC RES, V113, P40, DOI 10.1093/cvr/cvw229; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Katrukha IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1447, DOI 10.1134/S0006297913130063; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim JD, 2014, MOL CELLS, V37, P406, DOI 10.14348/molcells.2014.0072; Lagendijk AK, 2013, TRENDS CARDIOVAS MED, V23, P135, DOI 10.1016/j.tcm.2012.10.002; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Liu Lian, 2017, Shengli Xuebao, V69, P267, DOI 10.13294/j.aps.2017.0026; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; Lu QW, 2013, J GERIATR CARDIOL, V10, P91, DOI [10.3724/SP.J.1263.2012.07131, 10.3969/j.issn.1671-5411.2013.01.014]; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; MARTIN AF, 1991, J MOL CELL CARDIOL, V23, P583, DOI 10.1016/0022-2828(91)90050-V; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Oliveira SM, 2012, CIRC RES, V110, P1192, DOI 10.1161/CIRCRESAHA.111.259952; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pang KL, 2017, J MOL CELL CARDIOL, V108, P114, DOI 10.1016/j.yjmcc.2017.05.012; PARMACEK MS, 1991, CIRCULATION, V84, P991, DOI 10.1161/01.CIR.84.3.991; Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454; Peal DS, 2009, DEV DYNAM, V238, P3103, DOI 10.1002/dvdy.22154; Qiu SL, 2015, J PATHOL, V237, P330, DOI 10.1002/path.4579; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Saxon JG, 2017, DEV BIOL, V430, P113, DOI 10.1016/j.ydbio.2017.08.008; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Sogah VM, 2010, DEV DYNAM, V239, P3115, DOI 10.1002/dvdy.22445; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Solaro RJ, 1996, J MOL CELL CARDIOL, V28, P217; Solis RS, 2011, PROTEIN SCI, V20, P894, DOI 10.1002/pro.623; Tang M, 2017, J CANCER RES CLIN, V143, P793, DOI 10.1007/s00432-016-2333-y; Tauc HM, 2012, GENESIS, V50, P466, DOI 10.1002/dvg.22021; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tiwari RP, 2012, MOL DIAGN THER, V16, P371, DOI 10.1007/s40291-012-0011-6; Verhoeven MC, 2011, BIRTH DEFECTS RES A, V91, P435, DOI 10.1002/bdra.20804; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060244; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Zhang HY, 1997, DEV GENES EVOL, V207, P340, DOI 10.1007/s004270050121	82	8	8	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					696	710		10.1096/fj.201800481RR	http://dx.doi.org/10.1096/fj.201800481RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30044923				2022-12-26	WOS:000457401500054
J	Leitao, L; Alves, CJ; Alencastre, IS; Sousa, DM; Neto, E; Conceicao, F; Leitao, C; Aguiar, P; Almeida-Porada, G; Lamghari, M				Leitao, Luis; Alves, Cecilia J.; Alencastre, Ines S.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Leitao, Catarina; Aguiar, Paulo; Almeida-Porada, Graca; Lamghari, Meriem			Bone marrow cell response after injury and during early stage of regeneration is independent of the tissue-of-injury in 2 injury models	FASEB JOURNAL			English	Article						bone injury; muscle injury; mesenchymal stromal cells; endothelial cells	MESENCHYMAL STEM-CELLS; HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; WOUND REPAIR; B-CELLS; G-CSF; DIFFERENTIATION; MOBILIZATION	Selectively recruiting bone marrow (BM)-derived stem and progenitor cells to injury sites is a promising therapeutic approach. The coordinated action of soluble factors is thought to trigger the mobilization of stem cells from the BM and recruit them to lesions to contribute to tissue regeneration. Nevertheless, the temporal response profile of the major cellular players and soluble factors involved in priming the BM and recruiting BM-derived cells to promote regeneration is unknown. We show that injury alters the BM cellular composition, introducing population-specific fluctuations during tissue regeneration. We demonstrate that injury causes an immediate, transient response of mesenchymal stromal cells and endothelial cells followed by a nonoverlapping increase in hematopoietic stem and progenitor cells. Moreover, BM reaction is identical whether the injury is inflicted on skin and muscle or also involves a bone defect, but these 2 injury paradigms trigger distinct systemic cytokine responses. Together, our results indicate that the BM response to injury in the early stages of regeneration is independent of the tissue-of-injury based on the 2 models used, but the injured tissue dictates the systemic cytokine response.LeitAo, L., Alves, C. J., Alencastre, I. S., Sousa, D. M., Neto, E., ConceicAo, F., LeitAo, C., Aguiar, P., Almeida-Porada, G., Lamghari, M. Bone marrow cell response after injury and during early stage of regeneration is independent of the tissue-of-injury in 2 injury models.	[Leitao, Luis; Alves, Cecilia J.; Alencastre, Ines S.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Leitao, Catarina; Aguiar, Paulo; Lamghari, Meriem] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal; [Leitao, Luis; Alves, Cecilia J.; Alencastre, Ines S.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Aguiar, Paulo; Lamghari, Meriem] Univ Porto, Inst Engn Biomed INEB, Porto, Portugal; [Leitao, Luis; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, ICBAS, Porto, Portugal; [Leitao, Catarina] Univ Porto, IBMC, Porto, Portugal; [Neto, Estrela] FMUP, Porto, Portugal; [Almeida-Porada, Graca] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Wake Forest University	Lamghari, M (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal.	lamghari@ineb.up.pt	Sousa, Daniela/C-1485-2014; Aguiar, Paulo/AAD-2462-2020; Conceição, Francisco/HCI-8740-2022; Neto, Estrela C/M-2561-2013; Lamghari, Meriem/K-2159-2013	Sousa, Daniela/0000-0001-8498-0664; Aguiar, Paulo/0000-0003-4164-5713; Neto, Estrela C/0000-0003-2334-2292; Lamghari, Meriem/0000-0002-2500-4548; Alves, Cecilia Juliana/0000-0002-0719-574X; Alencastre, Ines/0000-0002-5591-5596; Conceicao, Francisco/0000-0003-4587-2470; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation, Portugal 2020; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274];  [PTDC/BIMMED/4041/2014];  [SFRH/BD/109686/2015];  [SFRH/BD/128771/2017];  [SFRH/BPD/75285/2010];  [SFRH/BPD/115341/2016]	Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation, Portugal 2020; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; ; ; ; ; 	The authors thank Ana Geros (Instituto de Investigacao e Inovacao em Saude) for helping with MatLab software. This study was financed by Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation, Portugal 2020, and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the Institute for Research and Innovation in Health Sciences Project (POCI-01-0145-FEDER-007274), as well as the framework of the financed Project PTDC/BIMMED/4041/2014. L.L. and F.C. are recipients of Ph.D. fellowships (SFRH/BD/109686/2015 and SFRH/BD/128771/2017, respectively). I.S.A. and D.M.S. are recipients of post-doctoral fellowships (SFRH/BPD/75285/2010 and SFRH/BPD/115341/2016, respectively). The authors declare no conflicts of interest.	Alves CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165465; Ammirante M, 2013, GENE DEV, V27, P1435, DOI 10.1101/gad.220202.113; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bonig Halvard, 2012, Methods Mol Biol, V904, P1, DOI 10.1007/978-1-61779-943-3_1; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen WK, 2018, J CELL PHYSIOL, V233, P1095, DOI 10.1002/jcp.25967; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Chung L, 2017, ADV DRUG DELIVER REV, V114, P184, DOI 10.1016/j.addr.2017.07.006; Colmone A, 2008, TRANSL RES, V151, P1, DOI 10.1016/j.trsl.2007.09.003; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; De Silva K, 2001, WOUND REPAIR REGEN, V9, P495, DOI 10.1046/j.1524-475x.2001.00495.x; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Ding YC, 2010, TRANSPLANTATION, V89, P270, DOI 10.1097/TP.0b013e3181c6ffbe; Drukala J, 2012, STEM CELL REV REP, V8, P184, DOI 10.1007/s12015-011-9272-4; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fisher JN, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9352598; Gehling UM, 2010, WORLD J GASTROENTERO, V16, P217, DOI 10.3748/wjg.v16.i2.217; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Hasselblatt M, 2007, ACTA NEUROPATHOL, V113, P45, DOI 10.1007/s00401-006-0152-y; He NN, 2014, BONE MARROW RES, DOI 10.1155/2014/128436; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim Hee Jung, 2017, Dev Reprod, V21, P1, DOI 10.12717/DR.2017.21.1.001; Kim N, 2015, INT J STEM CELLS, V8, P54, DOI 10.15283/ijsc.2015.8.1.54; Kirby GTS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/285869; Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kovtun A, 2016, EUR CELLS MATER, V32, P152, DOI 10.22203/eCM.v032a10; Kumar S, 2012, BONE, V50, P1012, DOI 10.1016/j.bone.2012.01.027; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lapid K., 2008, STEMBOOK; Lee SW, 2009, J ORTHOP RES, V27, P295, DOI 10.1002/jor.20736; Li B, 2010, STEM CELL RES, V4, P17, DOI 10.1016/j.scr.2009.08.001; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nitzsche F, 2017, STEM CELLS, V35, P1446, DOI 10.1002/stem.2614; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Perlin JR, 2017, J MOL MED, V95, P809, DOI 10.1007/s00109-017-1559-8; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponte AL, 2012, STEM CELLS DEV, V21, P3162, DOI 10.1089/scd.2012.0048; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; REBAR AH, 1993, TOXICOL PATHOL, V21, P118, DOI 10.1177/019262339302100202; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Rennert RC, 2012, REGEN MED, V7, P833, DOI [10.2217/RME.12.82, 10.2217/rme.12.82]; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shah S, 2009, J TRAUMA, V67, P315, DOI 10.1097/TA.0b013e3181a5c9c7; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Silva AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091406; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Wirsdorfer F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155870; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yang C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0804-1; Yu HK, 2013, CLIN CANCER RES, V19, P5340, DOI 10.1158/1078-0432.CCR-12-3685; Yu VWC, 2016, CURR OPIN HEMATOL, V23, P331, DOI 10.1097/MOH.0000000000000265	72	4	4	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					857	872		10.1096/fj.201800610RR	http://dx.doi.org/10.1096/fj.201800610RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30044924				2022-12-26	WOS:000457401500067
J	Gao, Z; Liao, Y; Chen, C; Liao, CY; He, DX; Chen, JM; Ma, JX; Liu, ZG; Wu, YL				Gao, Zhan; Liao, Yi; Chen, Chao; Liao, Chunyan; He, Danxue; Chen, Jingmeng; Ma, Jianxing; Liu, Zuguo; Wu, Yalin			Conversion of all-trans-retinal into all-trans-retinal dimer reflects an alternative metabolic/antidotal pathway of all-trans-retinal in the retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinal metabolism; photoreceptor; retina; retinoid; phagocytosis; all-trans-retinal; all-trans-retinal dimer; metabolic; antidotal pathway; primary porcine RPE cells; retina	PIGMENT EPITHELIAL-CELLS; POTENTIAL THERAPEUTIC AGENTS; PHOTORECEPTOR OUTER SEGMENTS; RECESSIVE STARGARDT-DISEASE; VISUAL CYCLE; TRANSPORTER ABCA4; LIPOFUSCIN; RPE; A2E; IDENTIFICATION	Free all-trans-retinal (atRAL) and retinal pigment epithelium (RPE) lipofuscin are both considered to play etiological roles in Stargardt disease and age-related macular degeneration. A2E and all-trans-retinal dimer (atRAL-dimer) are two well characterized bisretinoid constituents of RPE lipofuscin. In this study, we found that, after treatment of primary porcine RPE (pRPE) cells with atRAL, atRAL-dimer readily formed and accumulated in a concentration- and time-dependent manner, but A2E was barely detected. Cell-based assays revealed that atRAL, the precursor of atRAL-dimer, significantly altered the morphology of primary pRPE cells and decreased cell viability at a concentration of 80 m regardless of light exposure. By contrast, atRAL-dimer was not cytotoxic and phototoxic to primary pRPE cells. Compared with atRAL and A2E, atRAL-dimer was more vulnerable to light, followed by the generation of its photocleaved products. Moreover, we observed the presence of atRAL-dimer in reaction mixtures of atRAL with porcine rod outer segments (ROS), RPE/choroid, or neural retina. Taken together, we here proposed an alternative metabolic/antidotal pathway of atRAL in the retina: atRAL that evades participation of the visual (retinoid) cycle undergoes a condensation reaction to yield atRAL-dimer in both ROS and RPE. Translocation of atRAL, all-trans N-retinylidene-phosphatidylethanolamine (NR-PE), atRAL-dimer, and photocleavage products of atRAL-dimer from ROS into RPE is accomplished by phagocytosing shed ROS on a daily basis. Without causing damage to RPE cells, light breaks up total atRAL-dimer within RPE cells to release low-molecular-weight photocleavage fragments. The latter, together with ROS-atRAL-dimer photocleavage products, may easily move across membranes and thereby be metabolically eliminated.	[Gao, Zhan; Liao, Yi; Chen, Chao; Liao, Chunyan; He, Danxue; Liu, Zuguo; Wu, Yalin] Xiamen Univ, Coll Med, Eye Inst, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiangan South Rd, Xiamen 361102, Peoples R China; [Chen, Jingmeng] Xiamen Univ, Coll Med, Clin Skills Training Ctr, Xiamen 361102, Peoples R China; [Ma, Jianxing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	Xiamen University; Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wu, YL (corresponding author), Xiamen Univ, Coll Med, Eye Inst, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiangan South Rd, Xiamen 361102, Peoples R China.	yalinw@xmu.edu.cn		Chao, Chen/0000-0002-3191-0838	China National Natural Science Foundation [81570857, 81700864]; Sanming Project of Medicine in Shenzhen [SZSM201612022]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Fujian Province [2017J01148, 2016J01412]; research grant for young and mid-aged teachers of Fujian Province [JAT160011]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Sanming Project of Medicine in Shenzhen; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); research grant for young and mid-aged teachers of Fujian Province	This work was supported in part by grants from the China National Natural Science Foundation (81570857 to Y. W. and 81700864 to Y. L.), the Sanming Project of Medicine in Shenzhen (SZSM201612022 to Z. L. and Y. W.), the Fundamental Research Funds for the Central Universities (to Y. W. and Y. L.), and the Natural Science Foundation of Fujian Province (2017J01148 to Y. W. and 2016J01412 to Y. L.) and in part by a research grant for young and mid-aged teachers of Fujian Province (JAT160011 to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Chen CH, 2002, BIOPHYS J, V83, P1403, DOI 10.1016/S0006-3495(02)73911-8; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fishkin N, 2004, CHEM REC, V4, P120, DOI 10.1002/tcr.20000; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Li J, 2016, TOXICOLOGY, V371, P41, DOI 10.1016/j.tox.2016.10.005; Li J, 2013, J BIOL CHEM, V288, P35671, DOI 10.1074/jbc.M113.511386; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Liu X, 2016, INVEST OPHTH VIS SCI, V57, P1017, DOI 10.1167/iovs.15-18429; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sullivan JM, 2009, EXP EYE RES, V89, P602, DOI 10.1016/j.exer.2009.03.005; Sun H, 2001, J BIOENERG BIOMEMBR, V33, P523, DOI 10.1023/A:1012883306823; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; vonRuckmann A, 1997, INVEST OPHTH VIS SCI, V38, P478; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Zhao JL, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20734	30	5	5	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14507	14519		10.1074/jbc.RA118.002447	http://dx.doi.org/10.1074/jbc.RA118.002447			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049796	Green Published, hybrid			2022-12-26	WOS:000444671500028
J	Summer, D; Kroess, A; Woerndle, R; Rangger, C; Klingler, M; Haas, H; Kremser, L; Lindner, HH; von Guggenberg, E; Decristoforo, C				Summer, Dominik; Kroess, Andrea; Woerndle, Rudolf; Rangger, Christine; Klingler, Maximilian; Haas, Hubertus; Kremser, Leopold; Lindner, Herbert H.; von Guggenberg, Elisabeth; Decristoforo, Clemens			Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression	PLOS ONE			English	Article							RGD PEPTIDES; STRATEGIES; ANALOGS; CHOLECYSTOKININ	Positron emission tomography (PET) with radiolabelled peptide-based tracers has attracted great interest in oncology over the past decades. The success of imaging is closely related to sufficient uptake of the radiotracer in malignant tissue and for this sufficient biological half-life, particularly in the bloodstream, is mandatory. Fast enzymatic degradation during circulation leading to insufficient imaging abilities of peptide-based radioligands remains a major issue. The design of multimeric constructs, bearing multiple targeting moieties, has been widely applied to improve target interaction. This concept may also be applied to prolong the biological half-life of peptide-based radiopharmaceuticals as enzymatic degradation can result in formation of metabolites still capable to interact with the target binding site. In this study we aimed to identify such metabolites and therefore we utilized the siderophore-based bifunctional chelator fusarinine C (FSC) for the design of novel mono-and multimeric constructs, bearing minigastrin (MG) analogues as targeting moieties to address cholecystokinin-2 receptors (CCK2R) which are overexpressed in a variety of cancerous diseases and are well known for fast enzymatic degradation, particularly for truncated des-(Glu) 5-MG members, such as MG11. FSC-based imaging probes were radiolabelled with gallium-68 and characterized in vitro (logD, protein binding, affinity and cell-uptake studies, stability and metabolite studies, as well as generation of corresponding metabolites by artificial enzymatic degradation) and in vivo (biodistribution in A431-CCK2R/A431-mock tumour xenografted BALB/c nude mice and stability in blood of living BALB/c mice and analysis of corresponding organ homogenates and urine to identify degradation products). In summary, multimerization was accompanied by partial improvement towards targeting abilities. Identified metabolites formed by artificial enzymatic cleavage of trimeric FSC-MG conjugates in vitro contained intact binding sequences for the receptor. Furthermore, the 68 Ga-labelled trimers exhibiting increasing uptake of radioligand in tumour tissue over time and improved in vivo stability in blood samples of living animals of the trimers compared to corresponding mono-and dimers, strongly supporting our hypothesis.	[Summer, Dominik; Kroess, Andrea; Woerndle, Rudolf; Rangger, Christine; Klingler, Maximilian; von Guggenberg, Elisabeth; Decristoforo, Clemens] Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria; [Haas, Hubertus] Med Univ Innsbruck, Bioctr, Div Mol Biol, Innsbruck, Austria; [Kremser, Leopold; Lindner, Herbert H.] Med Univ Innsbruck, Bioctr, Div Clin Biochem, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Decristoforo, C (corresponding author), Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria.	Clemens.Decristoforo@i-med.ac.at	Decristoforo, Clemens/AAR-4868-2020; von Guggenberg, Elisabeth/L-8088-2019	Decristoforo, Clemens/0000-0003-0566-4036; von Guggenberg, Elisabeth/0000-0003-4944-4705	Austrian Science Fund (FWF) [P 25899-B23]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) grant P 25899-B23 to CD.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Aloj L, 2004, J NUCL MED, V45, P485; Carlucci G, 2012, CURR PHARM DESIGN, V18, P2501, DOI 10.2174/13816128112092501; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Kaloudi A, 2016, CANCER BIOTHER RADIO, V31, P20, DOI 10.1089/cbr.2015.1935; Klingler M, 2018, THERANOSTICS, V8, P2896, DOI 10.7150/thno.24378; Laverman P, 2011, EUR J NUCL MED MOL I, V38, P1410, DOI 10.1007/s00259-011-1806-0; Li ZB, 2008, EUR J NUCL MED MOL I, V35, P1100, DOI 10.1007/s00259-007-0692-y; Li ZB, 2007, J NUCL MED, V48, P1162, DOI 10.2967/jnumed.107.039859; Lindner S, 2014, BIOCONJUGATE CHEM, V25, P489, DOI 10.1021/bc4004662; Liu S, 2007, BIOCONJUGATE CHEM, V18, P438, DOI 10.1021/bc0603081; Mather SJ, 2007, J NUCL MED, V48, P615, DOI 10.2967/jnumed.106.037085; Ocak M, 2011, EUR J NUCL MED MOL I, V38, P1426, DOI 10.1007/s00259-011-1818-9; Ocak M, 2011, NUCL MED BIOL, V38, P171, DOI 10.1016/j.nucmedbio.2010.07.009; Sosabowski JK, 2009, J NUCL MED, V50, P2082, DOI 10.2967/jnumed.109.064808; Summer D, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/3171794; Summer D, 2017, BIOCONJUGATE CHEM, V28, P1722, DOI 10.1021/acs.bioconjchem.7b00182; von Guggenberg E, 2009, J MED CHEM, V52, P4786, DOI 10.1021/jm900400w; Wangler C, 2010, CHEMBIOCHEM, V11, P2168, DOI 10.1002/cbic.201000386; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Zhai CY, 2016, MOL IMAGING BIOL, V18, P758, DOI 10.1007/s11307-016-0931-3	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0201224	10.1371/journal.pone.0201224	http://dx.doi.org/10.1371/journal.pone.0201224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059514	gold, Green Published, Green Submitted			2022-12-26	WOS:000440251600028
J	Castellote, JM; Kofler, M				Castellote, Juan M.; Kofler, Markus			StartReact effects in first dorsal interosseous muscle are absent in a pinch task, but present when combined with elbow flexion	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; MOVEMENT-RELATED ACTIVATION; STARTLING ACOUSTIC STIMULI; CHOICE-REACTION TIME; AUDITORY STARTLE; FUNCTIONAL-ORGANIZATION; ELECTRICAL-STIMULATION; DESCENDING PATHWAYS; MOTOR PREPARATION; STROKE SURVIVORS	Objective To provide a neurophysiological tool for assessing sensorimotor pathways, which may differ for those involving distal muscles in simple tasks from those involving distal muscles in a kinetic chain task, or proximal muscles in both. Methods We compared latencies and magnitudes of motor responses in a reaction time paradigm in a proximal (biceps brachii, BB) and a distal (first dorsal interosseous, FDI) muscle following electrical stimuli used as imperative signal (IS) delivered to the index finger. These stimuli were applied during different motor tasks: simple tasks involving either one muscle, e.g. flexing the elbow for BB (FLEX), or pinching a pen for FDI (PINCH); combined tasks engaging both muscles by pinching and flexing simultaneously (PINCH-FLEX). Stimuli were of varying intensity and occasionally elicited a startle response, and a StartReact effect. Results In BB, response latencies decreased gradually and response amplitudes increased progressively with increasing IS intensities for non-startling trials, while for trials containing startle responses, latencies were uniformly shortened and response amplitudes similarly augmented across all IS intensities in both FLEX and PINCH-FLEX. In FDI, response latencies decreased gradually and response amplitudes increased progressively with increasing IS intensities in both PINCH and PINCH-FLEX for non-startling trials, but, unlike in BB for the simple task, in PINCH for trials containing startle responses as well. In PINCH-FLEX, FDI latencies were uniformly shortened and amplitudes similarly increased across all stimulus intensities whenever startle signs were present. Conclusions Our results suggest the presence of different sensorimotor pathways supporting a dissociation between simple tasks that involve distal upper limb muscles (FDI in PINCH) from simple tasks involving proximal muscles (BB in FLEX), and combined tasks that engage both muscles (FDI and BB in PINCH-FLEX), all in accordance with differential importance in the control of movements by cortical and subcortical structures. Significance Simple assessment tools may provide useful information regarding the differential involvement of sensorimotor pathways in the control of both simple and combined tasks that engage proximal and distal muscles.	[Castellote, Juan M.] Carlos III Inst Hlth, Natl Sch Occupat Med, Madrid, Spain; [Castellote, Juan M.] Univ Complutense Madrid, Radiol, Rehabil & Physiotherapy, Madrid, Spain; [Kofler, Markus] Hochzirl Hosp, Dept Neurol, Zirl, Austria	Instituto de Salud Carlos III; Escuela Nacional de Medicina del Trabajo (ENMT); Complutense University of Madrid	Castellote, JM (corresponding author), Carlos III Inst Hlth, Natl Sch Occupat Med, Madrid, Spain.; Castellote, JM (corresponding author), Univ Complutense Madrid, Radiol, Rehabil & Physiotherapy, Madrid, Spain.	jmcastel@isciii.es	Kofler, Markus/P-5585-2019; Castellote, Juan M./ABG-4178-2020	Kofler, Markus/0000-0002-2962-0903; Castellote, Juan/0000-0002-7242-8730	Instituto de Salud Carlos III [ESPY-112/18]; Government of Spain [PRX12/00349]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of Spain(Spanish Government)	All the funding received during this study are grants ESPY-112/18 from Instituto de Salud Carlos III and PRX12/00349 from Government of Spain to J. M. Castellote. There was no additional external funding received for this study.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Alvarez-Blanco S, 2009, EXP BRAIN RES, V195, P285, DOI 10.1007/s00221-009-1784-7; Baker S. N., 2017, J NEUROSCI, V37, P3368, DOI DOI 10.1523/JNEUROSCI.3368-16; BALDISSERA F, 1993, EXP BRAIN RES, V96, P513; Bernstein N A., 1967, COORDINATION REGULAT; Blouin JS, 2006, J PHYSIOL-LONDON, V573, P857, DOI 10.1113/jphysiol.2006.108274; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; BRUHN P, 1977, CORTEX, V13, P373, DOI 10.1016/S0010-9452(77)80018-X; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; Carlsen AN, 2003, EXP BRAIN RES, V152, P510, DOI 10.1007/s00221-003-1575-5; Carlsen AN, 2007, EXP BRAIN RES, V176, P199, DOI 10.1007/s00221-006-0610-8; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2010, BRAIN RES, V1322, P38, DOI 10.1016/j.brainres.2010.01.076; Carlsen AN, 2009, J NEUROPHYSIOL, V101, P306, DOI 10.1152/jn.00878.2007; Castellote JM, 2015, CLIN NEUROPHYSIOL, V126, P1879, DOI 10.1016/j.clinph.2015.01.028; Castellote JM, 2004, EXP BRAIN RES, V158, P35, DOI 10.1007/s00221-004-1866-5; Castellote JM, 2007, EXP BRAIN RES, V177, P129, DOI 10.1007/s00221-006-0659-4; Castellote JM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8471546; Castellote JM, 2012, J NEUROPHYSIOL, V108, P2501, DOI 10.1152/jn.01111.2011; Cattell J.M., 1886, BRAIN, V8, P512, DOI [DOI 10.1093/BRAIN/8.4.512, 10.1093/brain/8.4.512]; Chae J, 1998, AM J PHYS MED REHAB, V77, P516, DOI 10.1097/00002060-199811000-00013; Chae J, 2000, ASSIST TECHNOL, V12, P33, DOI 10.1080/10400435.2000.10132008; COLEBATCH JG, 1990, BRAIN, V113, P1843, DOI 10.1093/brain/113.6.1843; Davis M, 2008, REV NEUROSCIENCE, V19, P171; de Noordhout AM, 1999, BRAIN, V122, P1327, DOI 10.1093/brain/122.7.1327; Dean JC, 2013, EXERC SPORT SCI REV, V41, P36, DOI 10.1097/JES.0b013e3182724bb0; Dean LR, 2017, J NEUROPHYSIOL, V117, P1713, DOI 10.1152/jn.01009.2015; Delval A, 2012, NEUROSCIENCE, V219, P166, DOI 10.1016/j.neuroscience.2012.05.032; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Ferber-Viart C, 1999, ACTA OTO-LARYNGOL, V119, P6; Grosse P, 2003, J NEUROPHYSIOL, V90, P1654, DOI 10.1152/jn.00125.2003; Haaland KY, 2012, ARCH PHYS MED REHAB, V93, P1957, DOI 10.1016/j.apmr.2012.05.011; HATAYAMA T, 1993, PERCEPT MOTOR SKILL, V76, P1139, DOI 10.2466/pms.1993.76.3c.1139; Honeycutt CF, 2015, CLIN NEUROPHYSIOL, V126, P160, DOI 10.1016/j.clinph.2014.05.025; Honeycutt CF, 2013, J NEUROPHYSIOL, V110, P1476, DOI 10.1152/jn.00866.2012; Ibitoye MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149024; Ilamkar KR, 2014, J CLIN DIAGN RES, V8, P124, DOI 10.7860/JCDR/2014/7221.4026; JASKOWSKI P, 1994, PERCEPT MOTOR SKILL, V79, P995; Jones TA, 2015, PHYSIOLOGY, V30, P358, DOI 10.1152/physiol.00014.2015; Kesar TM, 2010, PHYS THER, V90, P55, DOI 10.2522/ptj.20090140; Kofler M, 2003, CLIN NEUROPHYSIOL, V114, P973, DOI 10.1016/S1388-2457(03)00060-9; Kofler M, 2001, BRAIN RES, V921, P206, DOI 10.1016/S0006-8993(01)03120-1; Kofler M, 2001, CLIN NEUROPHYSIOL, V112, P1053, DOI 10.1016/S1388-2457(01)00540-5; KOHFELD DL, 1971, J EXP PSYCHOL, V88, P251, DOI 10.1037/h0030891; Kuypers H. G. J. M, 1981, HDB PHYSL 1 1, VII; Lakhani B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036407; Landis C, 1939, STARTLE PATTERN; Lang CE, 2007, NEUROREHAB NEURAL RE, V21, P279, DOI 10.1177/1545968306296964; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; LEMON RN, 1995, J NEUROSCI, V15, P6145; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; MacDonald SWS, 2008, PSYCHOL AGING, V23, P595, DOI 10.1037/0882-7974.23.3.595; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Marinovic W, 2016, NEUROSCI LETT, V618, P134, DOI 10.1016/j.neulet.2016.03.009; Marinovic W, 2015, PSYCHOPHYSIOLOGY, V52, P1698, DOI 10.1111/psyp.12540; Marinovic W, 2015, J NEUROPHYSIOL, V113, P3455, DOI 10.1152/jn.00154.2015; Marinovic W, 2014, J PHYSIOL-LONDON, V592, P153, DOI 10.1113/jphysiol.2013.254581; Marinovic W, 2013, J NEUROPHYSIOL, V109, P996, DOI 10.1152/jn.01119.2011; Maslovat D, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12300; Maslovat D, 2014, J EXP PSYCHOL HUMAN, V40, P2005, DOI 10.1037/a0037522; Maslovat D, 2011, BEHAV NEUROSCI, V125, P226, DOI 10.1037/a0022567; MATSUMOTO J, 1992, ANN NEUROL, V32, P41, DOI 10.1002/ana.410320108; Nieuwenhuijzen PHJA, 2000, J NEUROPHYSIOL, V84, P65, DOI 10.1152/jn.2000.84.1.65; Nonnekes J, 2014, J NEUROL, V261, P943, DOI 10.1007/s00415-014-7304-0; Nonnekes J, 2014, J NEUROSCI, V34, P275, DOI 10.1523/JNEUROSCI.2948-13.2014; Pertovaara A, 1996, EXP BRAIN RES, V107, P497; Pieron H, 1913, ANN PSYCHOL, V20, P17; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; POSNER MI, 1966, SCIENCE, V152, P1712, DOI 10.1126/science.152.3730.1712; Queralt A, 2008, J PHYSIOL-LONDON, V586, P4453, DOI 10.1113/jphysiol.2008.156042; Queralt A, 2008, EXP BRAIN RES, V185, P603, DOI 10.1007/s00221-007-1185-8; Queralt A, 2010, GAIT POSTURE, V31, P185, DOI 10.1016/j.gaitpost.2009.10.003; Ramchurn A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00557; Reynolds RF, 2007, J PHYSIOL-LONDON, V583, P1107, DOI 10.1113/jphysiol.2007.136192; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Sanegre MT, 2004, EXP BRAIN RES, V155, P527, DOI 10.1007/s00221-004-1849-6; Sathian K, 2011, NEUROREHAB NEURAL RE, V25, p21S, DOI 10.1177/1545968311410941; Serrien B, 2017, HUM MOVEMENT SCI, V55, P156, DOI 10.1016/j.humov.2017.08.009; Sheffler LR, 2015, PHYS MED REH CLIN N, V26, P611, DOI 10.1016/j.pmr.2015.06.006; Siegmund GP, 2001, J PHYSIOL-LONDON, V535, P289, DOI 10.1111/j.1469-7793.2001.00289.x; Stevenson AJT, 2014, NEUROSCIENCE, V269, P21, DOI 10.1016/j.neuroscience.2014.03.041; Stuss D., 1994, NEUROPSYCHOLOGY, V8, P316, DOI [DOI 10.1037/0894-4105.8.3.316, DOI 10.1037//0894-4105.8.3.316]; Thevathasan W, 2011, BRAIN, V134, P2085, DOI 10.1093/brain/awr131; Tresilian JR, 2006, NEUROSCIENCE, V142, P579, DOI 10.1016/j.neuroscience.2006.06.029; Valldeoriola F, 1998, NEUROLOGY, V51, P1315, DOI 10.1212/WNL.51.5.1315; Valls-Sole J, 2005, EXP BRAIN RES, V165, P541, DOI 10.1007/s00221-005-2332-8; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole Josep, 2004, Suppl Clin Neurophysiol, V57, P554; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; Valls-Sole J, 2012, J PAIN, V13, P620, DOI 10.1016/j.jpain.2011.11.003; Valls-Sole J, 2012, CLIN NEUROPHYSIOL, V123, P13, DOI 10.1016/j.clinph.2011.04.029; VallsSole J, 1997, BRAIN RES, V751, P155, DOI 10.1016/S0006-8993(97)00027-9; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Varoqui D, 2011, MOTOR CONTROL, V15, P187, DOI 10.1123/mcj.15.2.187; Winges SA, 2008, J NEUROPHYSIOL, V99, P1119, DOI 10.1152/jn.01059.2007; Yeomans JS, 2002, NEUROSCI BIOBEHAV R, V26, P1, DOI 10.1016/S0149-7634(01)00057-4; Zaaimi B, 2018, J NEUROPHYSIOL, V119, P235, DOI 10.1152/jn.00672.2017; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	101	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201301	10.1371/journal.pone.0201301	http://dx.doi.org/10.1371/journal.pone.0201301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048503	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400071
J	Mirzakhalili, E; Epureanu, BI; Gourgou, E				Mirzakhalili, Ehsan; Epureanu, Bogdan I.; Gourgou, Eleni			A mathematical and computational model of the calcium dynamics in Caenorhabditis elegans ASH sensory neuron	PLOS ONE			English	Article							C-ELEGANS; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NERVOUS-SYSTEM; TRP CHANNELS; CA2+ ATPASE; RECEPTOR; RETICULUM; EXPRESSION; GENE	We propose a mathematical and computational model that captures the stimulus-generated Ca2+ transients in the C. elegans ASH sensory neuron. The rationale is to develop a tool that will enable a cross-talk between modeling and experiments, using modeling results to guide targeted experimental efforts. The model is built based on biophysical events and molecular cascades known to unfold as part of neurons' Ca2+ homeostasis mechanism, as well as on Ca2+ signaling events. The state of ion channels is described by their probability of being activated or inactivated, and the remaining molecular states are based on biochemically defined kinetic equations or known biochemical motifs. We estimate the parameters of the model using experimental data of hyperosmotic stimulus-evoked Ca2+ transients detected with a FRET sensor in young and aged worms, unstressed and exposed to oxidative stress. We use a hybrid optimization method composed of a multi-objective genetic algorithm and nonlinear least-squares to estimate the model parameters. We first obtain the model parameters for young unstressed worms. Next, we use these values of the parameters as a starting point to identify the model parameters for stressed and aged worms. We show that the model, in combination with experimental data, corroborates literature results. In addition, we demonstrate that our model can be used to predict ASH response to complex combinations of stimulation pulses. The proposed model includes for the first time the ASH Ca2+ dynamics observed during both "on" and "off" responses. This mathematical and computational effort is the first to propose a dynamic model of the Ca2+ transients' mechanism in C. elegans neurons, based on biochemical pathways of the cell's Ca2+ homeostasis machinery. We believe that the proposed model can be used to further elucidate the Ca2+ dynamics of a key C. elegans neuron, to guide future experiments on C. elegans neurobiology, and to pave the way for the development of more mathematical models for neuronal Ca2+ dynamics.	[Mirzakhalili, Ehsan; Epureanu, Bogdan I.; Gourgou, Eleni] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Gourgou, Eleni] Univ Michigan, Sch Med, Dept Internal Med, Div Geriatr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gourgou, E (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Gourgou, E (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Geriatr, Ann Arbor, MI 48109 USA.	egourgou@umich.edu	Gourgou, Eleni/AAC-9120-2019; Mirzakhalili, Ehsan/ABD-1511-2021	Gourgou, Eleni/0000-0003-1561-5545; Mirzakhalili, Ehsan/0000-0002-1926-0035	National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation [1161874]	National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation(National Science Foundation (NSF))	The authors acknowledge the National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation for the support of this work (Grant 1161874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Alemany R, 2007, BBA-BIOMEMBRANES, V1768, P964, DOI 10.1016/j.bbamem.2006.09.024; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bansaghi S, 2014, J BIOL CHEM; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bargmann Cornelia I, 2006, WormBook, P1; Baylis HA, 1999, J MOL BIOL, V294, P467, DOI 10.1006/jmbi.1999.3229; Baylis HA, 2012, BBA-GEN SUBJECTS, V1820, P1253, DOI 10.1016/j.bbagen.2011.11.009; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bogeski I, 2014, ANTIOXID REDOX SIGN, V21, P859, DOI 10.1089/ars.2014.6019; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; Cho JH, 2000, GENE, V261, P211, DOI 10.1016/S0378-1119(00)00536-9; Chokshi TV, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3615821; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Chung SH, 2013, IN VIVO NEURONAL CAL; Croisier H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069598; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Gao J, 1998, PFLUG ARCH EUR J PHY, V435, P479, DOI 10.1007/s004240050542; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Goodman MB, 2012, METHOD CELL BIOL, V107, P409, DOI 10.1016/B978-0-12-394620-1.00014-X; Gourgou E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38147; Gower NJD, 2001, J MOL BIOL, V306, P145, DOI 10.1006/jmbi.2000.4388; Guo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6655; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616; Kato HK, 2012, J PHYSIOL-LONDON, V590, P3019, DOI 10.1113/jphysiol.2012.232942; Kato S, 2014, NEURON, V81, P616, DOI 10.1016/j.neuron.2013.11.020; KAY AR, 1987, J PHYSIOL-LONDON, V392, P603, DOI 10.1113/jphysiol.1987.sp016799; Keener J., 2009, MATH PHYSL, V1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kilts JD, 2002, J BIOL CHEM, V277, P31257, DOI 10.1074/jbc.M203640200; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kraev A, 1999, J BIOL CHEM, V274, P4254, DOI 10.1074/jbc.274.7.4254; Krzyzanowski MC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003619; Kuramochi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168415; Larsch J, 2015, CELL REP, V12, P1748, DOI 10.1016/j.celrep.2015.08.032; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Laurent P, 2015, ELIFE, V4, DOI 10.7554/eLife.04241; Lee JC, 2014, J MOL HISTOL, V45, P497, DOI 10.1007/s10735-014-9578-z; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; Li G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13234; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Lindsay TH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1304; Lockery SR, 2009, NAT NEUROSCI, V12, P365, DOI 10.1038/nn0409-365; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; Lombardi MS, 2002, MOL PHARMACOL, V62, P379, DOI 10.1124/mol.62.2.379; Lushington GH, 2005, J MOL GRAPH MODEL, V24, P175, DOI 10.1016/j.jmgm.2005.07.003; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Michaelis ML, 1996, LIFE SCI, V59, P405, DOI 10.1016/0024-3205(96)00319-0; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Murchison D, 1999, CELL CALCIUM, V25, P439, DOI 10.1054/ceca.1999.0048; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; Nikoletopoulou Vassiliki, 2012, Frontiers in Genetics, V3, P200, DOI 10.3389/fgene.2012.00200; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nishida M, 2013, BIOCHEM BIOPH RES CO, V434, P210, DOI 10.1016/j.bbrc.2013.03.040; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; Ogawa N, 2016, J BIOL CHEM, V291, P4197, DOI 10.1074/jbc.M115.700278; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Praitis V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003506; Rakowski F, 2013, FRONTIERS COMPUTATIO, V7, P11911, DOI [10.1523/JNEUROSCI.0594-09.2009, DOI 10.1523/JNEUROSCI.0594-09.2009]; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Roayaie K, 1998, NEURON; Sassa T, 2013, NEUROSCI LETT, V555, P248, DOI 10.1016/j.neulet.2013.06.001; Sharma V, 2017, J BIOL CHEM; Sharma V, 2013, GENETICS, V195, P611, DOI 10.1534/genetics.113.153106; Shipley FB, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00028; Tang YH, 1996, BIOPHYS J, V70, P246, DOI 10.1016/S0006-3495(96)79567-X; Tanimoto Y, 2017, ELIFE, V6, DOI 10.7554/eLife.21629; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Thiele TR, 2009, J NEUROSCI, V29, P11904, DOI 10.1523/JNEUROSCI.0594-09.2009; Todorovic SM, 2014, ANTIOXID REDOX SIGN, V21, P880, DOI 10.1089/ars.2013.5610; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Wang W, 2015, BIOCHEM BIOPH RES CO, V461, P463, DOI 10.1016/j.bbrc.2015.04.017; Williams PDE, 2018, J NEUROSCIENCE; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Xiao R, 2011, ADV EXP MED BIOL, V704, P323, DOI 10.1007/978-94-007-0265-3_18; Ye JX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062714; Zahratka JA, 2015, J NEUROPHYSIOL, V113, P1041, DOI 10.1152/jn.00665.2014; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhao J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00058; Zou W, 2017, POLYM RESPONSES C EL, V7, P42295, DOI [10.1038/srep42295, DOI 10.1038/SREP42295]; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	111	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201302	10.1371/journal.pone.0201302	http://dx.doi.org/10.1371/journal.pone.0201302			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048509	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400072
J	Popov, VV; Nechaev, DI; Supin, AY; Sysueva, EV				Popov, Vladimir V.; Nechaev, Dmitry I.; Supin, Alexander Ya.; Sysueva, Evgeniya V.			Adaptation processes in the auditory system of a beluga whale Delphinapterus leucas	PLOS ONE			English	Article							SHORT-TERM ADAPTATION; NERVE FIBERS; RESPONSES; MASKING; POTENTIALS; RECOVERY; STIMULI; RANGE; MODEL	The effects of prolonged sound stimuli (tone pip trains) on evoked potentials (the rate following response, RFR) were investigated in a beluga whale. The stimuli (rhythmic tone pips) were of 64 kHz frequency at levels from 80 to 140 dB re 1 mu Pa. During stimulation, every 1000 ms stimulus level either was kept constant (the steady-state stimulation) or changed up/down by 20 or 40 dB. With such stimulus presentation manner, RFR amplitude varied as follows. (i) After a stimulus level increase, the response amplitude increased quickly and then decayed slowly. The more the level increased, the higher the response amplitude increased. (ii) After a stimulus level decrease, the response amplitude was suppressed and then recovered slowly. The more the level decreased, the stronger was the response suppression. (iii) At the end of the 1000 ms window, the response amplitude approached, but did not reach, the amplitude characteristic of the steady-state stimulation. As a result, both after a sound level increase and decrease, the responses were almost stabilized during an analysis time as short as 1 s. This stabilization is attributed to an adaptation process. RFR decay after initial increase could be approximated by an exponent with a time constant of 59.4 +/- 1.8 (standard error) ms; RFR recovery after initial decrease could be approximated by an exponent with a time constant of 139.2 +/- 9.9 ms.	[Popov, Vladimir V.; Nechaev, Dmitry I.; Supin, Alexander Ya.; Sysueva, Evgeniya V.] Russian Acad Sci, Inst Ecol & Evolut, Lab Sensory Syst Vertebrates, Moscow, Russia	Russian Academy of Sciences	Popov, VV (corresponding author), Russian Acad Sci, Inst Ecol & Evolut, Lab Sensory Syst Vertebrates, Moscow, Russia.	popov.vl.vl@gmail.com	Popov, Vladimir V/J-6534-2018	Popov, Vladimir/0000-0002-7542-9093	Russian Foundation for Basic Research [15-04-01068]; Russian Science Foundation [17-74-20107]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The Russian Foundation for Basic Research (grant 15-04-01068 http://www.rfbr.ru/rffi/eng) awarded to V.V.P. had a role in the study design and methodology. The Russian Science Foundation (project No.17-74-20107 http://rscf.ru/en) awarded to E.V.S. had a role in providing the research resource base, data collection and analysis and animal care.	Au W. W., 1993, SONAR DOLPHINS; Au W.W.L., 2008, PRINCIPLES MARINE BI; CHIMENTO TC, 1991, J ACOUST SOC AM, V90, P263, DOI 10.1121/1.401296; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; EGGERMONT JJ, 1973, AUDIOLOGY, V12, P221; EGGERMONT JJ, 1985, HEARING RES, V18, P57, DOI 10.1016/0378-5955(85)90110-8; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; HEWITT MJ, 1991, J ACOUST SOC AM, V90, P904, DOI 10.1121/1.401957; HUANG CM, 1981, ELECTROEN CLIN NEURO, V52, P394, DOI 10.1016/0013-4694(81)90021-3; Kiang NYS, 1965, DISCHARGE PATTERNS S; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; MEDDIS R, 1988, J ACOUST SOC AM, V83, P1056, DOI 10.1121/1.396050; Popov VV, 2016, J ACOUST SOC AM, V139, P1101, DOI 10.1121/1.4943554; Popov VV, 1998, J COMP PHYSIOL A, V183, P9; SMITH RL, 1979, J ACOUST SOC AM, V65, P166, DOI 10.1121/1.382260; SMITH RL, 1977, J NEUROPHYSIOL, V40, P1098, DOI 10.1152/jn.1977.40.5.1098; SMITH RL, 1980, BRAIN RES, V184, P499, DOI 10.1016/0006-8993(80)90817-3; SMITH RL, 1975, BIOL CYBERN, V17, P169, DOI 10.1007/BF00364166; SMITH RL, 1982, BIOL CYBERN, V44, P107, DOI 10.1007/BF00317970; Supin A.Y., 2001, SENSORY PHYSL AQUATI, DOI 10.1007/978-1-4615-1647-7; Wen B, 2012, J NEUROPHYSIOL, V108, P69, DOI 10.1152/jn.00055.2012; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; Wiemeister NF, 1988, HEARING RES, V34, P367; YOUNG E, 1973, J ACOUST SOC AM, V54, P1535, DOI 10.1121/1.1914451	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201121	10.1371/journal.pone.0201121	http://dx.doi.org/10.1371/journal.pone.0201121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048516	Green Submitted, gold, Green Published			2022-12-26	WOS:000439952400051
J	Berry, S; Weinmann, O; Fritz, AK; Rust, R; Wolfer, D; Schwab, ME; Gerber, U; Ster, J				Berry, Stewart; Weinmann, Oliver; Fritz, Ann-Kristina; Rust, Ruslan; Wolfer, David; Schwab, Martin E.; Gerber, Urs; Ster, Jeanne			Loss of Nogo-A, encoded by the schizophrenia risk gene Rtn4, reduces mGlu3 expression and causes hyperexcitability in hippocampal CA3 circuits	PLOS ONE			English	Article							MORRIS WATER MAZE; SYNAPTIC PLASTICITY; THETA OSCILLATIONS; NEURAL REPRESENTATIONS; NETWORK OSCILLATIONS; PATTERN COMPLETION; DELETION SYNDROME; BIPOLAR DISORDER; PLACE AVOIDANCE; SLICE CULTURES	Recent investigations of Nogo-A, a well characterized protein inhibitor of neurite outgrowth in the brain, have revealed additional functions including a role in neuropsychiatric disorders such as schizophrenia. Here we examined Nogo-A functions in mouse CA3 hippocampal circuitry. Patch clamp recordings showed that the absence of Nogo-A results in a hyperactive network. In addition, mGlu3 metabotropic glutamate receptors, which exhibit mutations in certain forms of schizophrenia, were downregulated specifically in the CA3 area. Furthermore, Nogo-A(-/-) mice showed disordered theta oscillations with decreased incidence and frequency, similar to those observed in mGlu3(-/-) mice. As disruptions in theta rhythmicity are associated with impaired spatial navigation, we tested mice using modified Morris water maze tasks. Mice lacking Nogo-A exhibited altered search strategies, displaying greater dependence on global as opposed to local reference frames. This link between Nogo-A and mGlu3 receptors may provide new insights into mechanisms underlying schizophrenia.	[Berry, Stewart; Weinmann, Oliver; Rust, Ruslan; Schwab, Martin E.; Gerber, Urs; Ster, Jeanne] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Fritz, Ann-Kristina; Wolfer, David] Univ Zurich, Inst Anat, Zurich, Switzerland; [Rust, Ruslan; Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Ster, Jeanne] CNRS, UMR 5203, Montpellier, France; [Ster, Jeanne] INSERM, U1191, Inst Genom Fonct, Montpellier, France; [Ster, Jeanne] Univ Montpellier I, Montpellier, France; [Ster, Jeanne] Univ Montpellier 2, UMR 5203, Montpellier, France	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Ster, J (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.; Ster, J (corresponding author), CNRS, UMR 5203, Montpellier, France.; Ster, J (corresponding author), INSERM, U1191, Inst Genom Fonct, Montpellier, France.; Ster, J (corresponding author), Univ Montpellier I, Montpellier, France.; Ster, J (corresponding author), Univ Montpellier 2, UMR 5203, Montpellier, France.	Jeanne.Ster@igf.cnrs.fr	Wolfer, David P/B-3293-2016; Rust, Ruslan/ABA-2514-2020	Wolfer, David P/0000-0002-5957-1401; Rust, Ruslan/0000-0003-3376-3453; Ster, Jeanne/0000-0002-7277-9135	Swiss National Science Foundation [31003A_143373 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation grant 31003A_143373 / 1 to U.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; Brunner J, 2013, J NEUROSCI, V33, P7285, DOI 10.1523/JNEUROSCI.4537-12.2013; Butler JL, 2015, CURR OPIN NEUROBIOL, V31, P40, DOI 10.1016/j.conb.2014.07.025; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Entlerova M, 2013, PHYSIOL BEHAV, V120, P11, DOI 10.1016/j.physbeh.2013.06.024; Fischer Y, 2004, J PHYSIOL-LONDON, V554, P156, DOI 10.1113/jphysiol.2003.055558; Fischer Y, 1999, J PHYSIOL-LONDON, V519, P405, DOI 10.1111/j.1469-7793.1999.0405m.x; Fischer Y, 2002, J PHYSIOL-LONDON, V539, P857, DOI 10.1113/jphysiol.2001.013050; Fujioka R, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-31; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Huber AB, 2002, J NEUROSCI, V22, P3553; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Knierim JJ, 2011, PHYSIOL REV, V91, P1245, DOI 10.1152/physrev.00021.2010; Koukkou M, 2000, J PSYCHIATR RES, V34, P57, DOI 10.1016/S0022-3956(99)00040-0; Lee H, 2015, NEURON, V87, P1093, DOI 10.1016/j.neuron.2015.07.012; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Mayhew TM, 2002, J MICROSC-OXFORD, V205, P153, DOI 10.1046/j.0022-2720.2001.00977.x; Mazhari S, 2010, PSYCHIAT RES, V179, P253, DOI 10.1016/j.psychres.2009.09.002; Mossner R, 2008, EUR NEUROPSYCHOPHARM, V18, P768, DOI 10.1016/j.euroneuro.2008.05.007; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Neunuebel JP, 2013, J NEUROSCI, V33, P9246, DOI 10.1523/JNEUROSCI.0946-13.2013; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; Petrasek T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00090; Petrasek T, 2014, NEUROBIOL LEARN MEM, V107, P42, DOI 10.1016/j.nlm.2013.10.015; Petrinovic MM, 2013, P NATL ACAD SCI USA, V110, P1083, DOI 10.1073/pnas.1214255110; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Sauer JF, 2015, ELIFE, V4, DOI 10.7554/eLife.04979; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Stephany CE, 2014, J NEUROSCI, V34, P11631, DOI 10.1523/JNEUROSCI.0545-14.2014; Ster J, 2011, P NATL ACAD SCI USA, V108, P9993, DOI 10.1073/pnas.1100548108; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suh J, 2013, NEURON, V80, P484, DOI 10.1016/j.neuron.2013.09.014; Tan EC, 2005, MOL BRAIN RES, V139, P212, DOI 10.1016/j.molbrainres.2005.05.010; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Wang XX, 2002, J NEUROSCI, V22, P5505; Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x; Willi R, 2013, NEUROBIOL DIS, V54, P150, DOI 10.1016/j.nbd.2013.01.011; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Zagrebelsky M, 2017, NEUROBIOL LEARN MEM, V138, P154, DOI 10.1016/j.nlm.2016.06.022; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zemmar A, 2018, CEREB CORTEX, V28, P2109, DOI 10.1093/cercor/bhx116; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014	53	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200896	10.1371/journal.pone.0200896	http://dx.doi.org/10.1371/journal.pone.0200896			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040841	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000439749200015
J	Birceanu, O; Wilkie, MP				Birceanu, Oana; Wilkie, Michael Patrick			Post-exposure effects of the piscicide 3-trifluoromethyl-4-nitrophenol (TFM) on the stress response and liver metabolic capacity in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							LAMPREY PETROMYZON-MARINUS; SEA LAMPREY; ENVIRONMENTAL LEVELS; GLUCOSE-HOMEOSTASIS; GLYCOGEN-METABOLISM; ROUTINE TREATMENT; FOOD-DEPRIVATION; LAMPRICIDE TFM; ACUTE TOXICITY; LAKE STURGEON	The piscicide 3-trifluoromethyl-4-nitrophenol (TFM) has been used to control invasive sea lamprey (Petromyzon marinus) populations in the Great Lakes for almost 60 years. Applied to rivers and streams containing larval lampreys, TFM seldom harms non-target fishes, but the effects of sub-lethal treatments on fish physiology are not well understood. We examined the effects of 9 h exposure to TFM on the stress axis and liver metabolic capacity of rainbow trout (Oncorhynchus mykiss) using in vivo and in vitro approaches. The fish that had been acutely exposed to TFM in vivo had increased plasma cortisol levels at 12 h post-treatment, but TFM exposure did not interfere with in vitro cortisol production in head kidney preparations. Subjecting trout to an acute handling stressor 12 h post-TFM exposure resulted in a relative attenuation of the plasma cortisol and glucose response compared to pre-stress levels. We conclude that routine TFM treatments can lead to elevations of plasma cortisol following exposure, plus a relative dampening of the stress response in rainbow trout, with high cortisol levels lasting at least 12 h post-treatment. Since the ability of the fish to produce cortisol and the liver metabolic capacity were not compromised following TFM exposure, it is likely that their ability to cope with other stressors is not altered in the long-term.	[Birceanu, Oana; Wilkie, Michael Patrick] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada	Wilfrid Laurier University	Birceanu, O (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada.	obirceanu@gmail.com	Birceanu, Oana/J-9137-2019	Birceanu, Oana/0000-0002-3345-8769	Wilfrid Laurier University; Great Lakes Fishery Commission Grant	Wilfrid Laurier University; Great Lakes Fishery Commission Grant	This work was supported by a Category A Internal grant (2015 competition) from Wilfrid Laurier University, awarded to OB and MPW, and by a Great Lakes Fishery Commission Grant Awarded to MPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Aluru N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010741; Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; BANHEGYI G, 1988, BIOCHIM BIOPHYS ACTA, V967, P429, DOI 10.1016/0304-4165(88)90106-7; Begg K, 2004, J FISH BIOL, V64, P133, DOI 10.1111/j.1095-8649.2004.00290.x; Best C, 2014, AQUAT TOXICOL, V155, P190, DOI 10.1016/j.aquatox.2014.06.014; Bills TD, 2003, J GREAT LAKES RES, V29, P510, DOI 10.1016/S0380-1330(03)70512-7; Birceanu O., 2014, COMP BIOCH PHYSL C, V160, P873; Birceanu O, 2015, AQUAT TOXICOL, V168, P11, DOI 10.1016/j.aquatox.2015.09.002; Birceanu O, 2015, AQUAT TOXICOL, V161, P51, DOI 10.1016/j.aquatox.2015.01.028; Birceanu O, 2011, COMP BIOCHEM PHYS C, V153, P342, DOI 10.1016/j.cbpc.2010.12.005; Birceanu O, 2009, AQUAT TOXICOL, V94, P265, DOI 10.1016/j.aquatox.2009.07.012; Bleau H, 1996, AQUAT TOXICOL, V34, P221, DOI 10.1016/0166-445X(95)00040-B; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boogaard MA, 2003, J GREAT LAKES RES, V29, P529, DOI 10.1016/S0380-1330(03)70514-0; Boogaard MA, 2015, ENVIRON TOXICOL CHEM, V34, P1634, DOI 10.1002/etc.2959; Bussy U, 2017, ANAL BIOANAL CHEM, V28, P1; CAMPBELL PM, 1994, AQUACULTURE, V120, P151, DOI 10.1016/0044-8486(94)90230-5; CLARKE DJ, 1991, AQUAT TOXICOL, V20, P35, DOI 10.1016/0166-445X(91)90040-G; Clifford AM, 2012, T AM FISH SOC, V141, P1697, DOI 10.1080/00028487.2012.713887; Dawson VK, 2002, J AGR FOOD CHEM, V50, P6780, DOI 10.1021/jf020443h; DiBattista JD, 2005, J EXP BIOL, V208, P2707, DOI 10.1242/jeb.01690; Faught E., 2016, R SOC, V3, P1; Fierro-Castro C, 2015, COMP BIOCHEM PHYS A, V190, P39, DOI 10.1016/j.cbpa.2015.09.002; Geslin M, 2004, GEN COMP ENDOCR, V135, P70, DOI 10.1016/S0016-6480(03)00283-1; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; GLFC, 2011, STRAT VIS GREAT LAK; Henry M, 2015, COMP BIOCHEM PHYS C, V169, P35, DOI 10.1016/j.cbpc.2014.12.003; Ings JS, 2012, AQUAT TOXICOL, V108, P53, DOI 10.1016/j.aquatox.2011.09.009; Ings JS, 2011, ENVIRON SCI TECHNOL, V45, P2368, DOI 10.1021/es103122g; KANE AS, 1994, T AM FISH SOC, V123, P217, DOI 10.1577/1548-8659(1994)123<0217:UGKFTN>2.3.CO;2; Laursen DC, 2013, PHYSIOL BEHAV, V122, P147, DOI 10.1016/j.physbeh.2013.08.026; LECH JJ, 1972, COMPARATIVE, V3, P160, DOI 10.1016/0010-4035(72)90021-3; LECH JJ, 1974, BIOCHEM PHARMACOL, V23, P2403, DOI 10.1016/0006-2952(74)90231-7; Madaro A, 2015, J EXP BIOL, V218, P2538, DOI 10.1242/jeb.120535; Madison BN, 2015, CAN J FISH AQUAT SCI, V72, P673, DOI 10.1139/cjfas-2014-0409; McConville MB, 2016, ENVIRON SCI TECHNOL, V50, P9998, DOI 10.1021/acs.est.6b02607; McDonald DG, 2007, J GREAT LAKES RES, V33, P20, DOI 10.3394/0380-1330(2007)33[20:RTGTUO]2.0.CO;2; Middaugh CR, 2014, J GREAT LAKES RES, V40, P1010, DOI 10.1016/j.jglr.2014.09.010; Miller LL, 2011, TOXICOL APPL PHARM, V253, P137, DOI 10.1016/j.taap.2011.03.021; Miller LL, 2009, J APPL TOXICOL, V29, P681, DOI 10.1002/jat.1458; Milligan CL, 2003, J EXP BIOL, V206, P3167, DOI 10.1242/jeb.00538; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; O'Connor LM, 2017, J GREAT LAKES RES, V43, P189, DOI 10.1016/j.jglr.2016.10.011; Panserat S, 2000, AM J PHYSIOL-REG I, V278, pR1164, DOI 10.1152/ajpregu.2000.278.5.R1164; POTTINGER TG, 1992, FISH PHYSIOL BIOCHEM, V10, P55, DOI 10.1007/BF00004654; Rawlings NC, 1998, J TOXICOL ENV HEAL A, V54, P21, DOI 10.1080/009841098159006; Sakamoto K, 2016, ENVIRON SCI TECHNOL, V50, P3462, DOI 10.1021/acs.est.6b01051; Sandhu N, 2014, AQUAT TOXICOL, V146, P20, DOI 10.1016/j.aquatox.2013.10.010; Sandhu N, 2011, AQUAT TOXICOL, V103, P92, DOI 10.1016/j.aquatox.2011.02.011; Shanghavi DS, 1999, J EXP BIOL, V202, P2161; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soengas JL, 1998, PHYSIOL ZOOL, V71, P285, DOI 10.1086/515925; Vijayan MM, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P182, DOI 10.1079/9781845935535.0182; Vijayan MM, 1996, J EXP BIOL, V199, P2467; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; VIJAYAN MM, 1994, CAN J ZOOL, V72, P379, DOI 10.1139/z94-054; VIJAYAN MM, 1992, CAN J FISH AQUAT SCI, V49, P2260, DOI 10.1139/f92-247; Vue C, 2002, J AGR FOOD CHEM, V50, P6786, DOI 10.1021/jf0204708; Wilkie MP, 2007, CAN J FISH AQUAT SCI, V64, P1174, DOI 10.1139/F07-082; Yeh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079406; Zolderdo AJ, 2016, J EXP BIOL, V219, P1237, DOI 10.1242/jeb.135798	61	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200782	10.1371/journal.pone.0200782	http://dx.doi.org/10.1371/journal.pone.0200782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036372	Green Published, gold, Green Submitted			2022-12-26	WOS:000439429200017
J	Northcutt, AJ; Fischer, EK; Puhl, JG; Mesce, KA; Schulz, DJ				Northcutt, Adam J.; Fischer, Eva K.; Puhl, Joshua G.; Mesce, Karen A.; Schulz, David J.			An annotated CNS transcriptome of the medicinal leech, Hirudo verbana: De novo sequencing to characterize genes associated with nervous system activity	PLOS ONE			English	Article							IDENTIFIED LEECH NEURONS; HIRUDO-MEDICINALIS; INWARD CURRENTS; LEAK CHANNELS; MOTOR PATTERN; P-NEURONS; EXPRESSION; ACETYLCHOLINE; SEROTONIN; MODULATION	The medicinal leech is one of the most venerated model systems for the study of fundamental nervous system principles, ranging from single-cell excitability to complex sensorimotor integration. Yet, molecular analyses have yet to be extensively applied to complement the rich history of electrophysiological study that this animal has received. Here, we generated the first de novo transcriptome assembly from the entire central nervous system of Hirudo verbana, with the goal of providing a molecular resource, as well as to lay the foundation for a comprehensive discovery of genes fundamentally important for neural function. Our assembly generated 107,704 contigs from over 900 million raw reads. Of these 107,704 contigs, 39,047 (36%) were annotated using NCBI's validated RefSeq sequence database. From this annotated central nervous system transcriptome, we began the process of curating genes related to nervous system function by identifying and characterizing 126 unique ion channel, receptor, transporter, and enzyme contigs. Additionally, we generated sequence counts to estimate the relative abundance of each identified ion channel and receptor contig in the transcriptome through Kallisto mapping. This transcriptome will serve as a valuable community resource for studies investigating the molecular underpinnings of neural function in leech and provide a reference for comparative analyses.	[Northcutt, Adam J.; Schulz, David J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Fischer, Eva K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Puhl, Joshua G.; Mesce, Karen A.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Puhl, Joshua G.; Mesce, Karen A.] Univ Minnesota, Grad Program Neurosci, St Paul, MN 55108 USA	University of Missouri System; University of Missouri Columbia; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schulz, DJ (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	schulzd@missouri.edu		Northcutt, Adam/0000-0001-5815-1854; Schulz, David/0000-0003-4532-5362; Fischer, Eva K/0000-0002-2916-0900	National Science Foundation (DBS-IOS) [1454904]	National Science Foundation (DBS-IOS)	This work was funded by a grant from the National Science Foundation (DBS-IOS #1454904) awarded to Karen Mesce and David Schulz.	Aisemberg GO, 2001, DEV GENES EVOL, V211, P589, DOI 10.1007/s00427-001-0183-2; Angstadt JD, 1999, J COMP PHYSIOL A, V184, P49, DOI 10.1007/s003590050305; Ashburner M, 2001, GENOME RES, V11, P1425; Baker MW, 2006, J NEUROSCI METH, V156, P145, DOI 10.1016/j.jneumeth.2006.02.026; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BIGIANI A, 1990, J EXP BIOL, V151, P423; Bisson G, 2011, J NEUROPHYSIOL, V106, P78, DOI 10.1152/jn.01043.2010; Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x; Blackshaw SE, 2003, J NEUROBIOL, V55, P355, DOI 10.1002/neu.10214; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; BRODFUEHRER PD, 1995, J NEUROBIOL, V27, P403, DOI 10.1002/neu.480270312; Burland T G, 2000, Methods Mol Biol, V132, P71; Choi SL, 2010, J NEUROGENET, V24, P75, DOI 10.3109/01677061003770614; CLINE HT, 1983, J COMP NEUROL, V215, P351, DOI 10.1002/cne.902150309; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crisp KM, 2004, J EXP BIOL, V207, P4535, DOI 10.1242/jeb.01315; Crisp KM, 2003, J COMP PHYSIOL A, V189, P461, DOI 10.1007/s00359-003-0424-0; Crisp KM, 2002, J COMP NEUROL, V442, P115, DOI 10.1002/cne.10077; Dierkes PW, 2004, BRAIN RES, V1013, P159, DOI 10.1016/j.brainres.2004.03.038; Dykes IM, 2006, DEV GENES EVOL, V216, P185, DOI 10.1007/s00427-005-0048-1; GASCOIGNE L, 1991, COMP BIOCHEM PHYS C, V99, P369, DOI 10.1016/0742-8413(91)90258-U; GERASIMO.VD, 1967, NATURE, V214, P1351, DOI 10.1038/2141351b0; Gerry SP, 2011, BIOL LETTERS, V7, P885, DOI 10.1098/rsbl.2011.0303; GOLDERMANN M, 1994, J COMP PHYSIOL A, V174, P231; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grey KB, 2009, INVERTEBR NEUROSCI, V9, P11, DOI 10.1007/s10158-008-0085-3; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harley CM, 2015, J NEUROPHYSIOL, V113, P3610, DOI 10.1152/jn.00135.2015; Harley CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086120; Harley CM, 2013, J EXP BIOL, V216, P1890, DOI 10.1242/jeb.075911; Hibsh D, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.15; Hibsh D, 2014, BIOINFORMATICS, V30, P310, DOI 10.1093/bioinformatics/btt570; HOCHSTRATE P, 1995, GLIA, V15, P43, DOI 10.1002/glia.440150106; Kandarian B, 2012, DEV GENES EVOL, V222, P29, DOI 10.1007/s00427-011-0387-z; Klees G, 2005, J MEMBRANE BIOL, V208, P27, DOI 10.1007/s00232-005-0816-x; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; KRISTAN WB, 1976, J EXP BIOL, V65, P643; KRISTAN WB, 1979, BRAIN RES, V167, P215, DOI 10.1016/0006-8993(79)90282-8; LENT CM, 1988, SCI AM, V258, P98, DOI 10.1038/scientificamerican0688-98; Lohr C, 1997, J EXP BIOL, V200, P2565; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; MacManes M. D., 2016, BIORXIV, DOI [10.1101/035642, DOI 10.1101/035642]; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; McClellan AD, 2008, J NEUROSCI, V28, P650, DOI 10.1523/JNEUROSCI.3840-07.2008; McGrath LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2373-3; Mesce KA, 2002, BRAIN BEHAV EVOLUT, V60, P339, DOI 10.1159/000067793; Mesce KA, 2001, J NEUROPHYSIOL, V85, P2039, DOI 10.1152/jn.2001.85.5.2039; Mesce KA, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.175687; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Mullins OJ, 2012, J NEUROPHYSIOL, V107, P2730, DOI 10.1152/jn.00107.2012; Nikitina A, 2016, MITOCHONDRIAL DNA B, V1, P254, DOI 10.1080/23802359.2016.1157774; Northcutt AJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3215-z; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pastor J, 1996, J NEUROPHYSIOL, V75, P2268, DOI 10.1152/jn.1996.75.6.2268; Petrauskien L, 2009, INVERTEBR BIOL, V128, P324, DOI 10.1111/j.1744-7410.2009.00180.x; Pipkin JE, 2016, J COMP NEUROL, V524, P3677, DOI 10.1002/cne.24120; Puhl JG, 2008, J NEUROSCI, V28, P4192, DOI 10.1523/JNEUROSCI.0136-08.2008; Ransdell JL, 2013, J NEUROPHYSIOL, V110, P42, DOI 10.1152/jn.00009.2013; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; SARGENT PB, 1977, J NEUROPHYSIOL, V40, P453, DOI 10.1152/jn.1977.40.2.453; SCHLUE WR, 1976, J NEUROPHYSIOL, V39, P1176, DOI 10.1152/jn.1976.39.6.1176; SCHMIDT J, 1992, J EXP BIOL, V171, P329; Sergeeva S S, 1998, Ross Fiziol Zh Im I M Sechenova, V84, P735; Siddall ME, 2007, P R SOC B, V274, P1481, DOI 10.1098/rspb.2007.0248; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; SIMONI A, 1990, BRAIN RES, V522, P118, DOI 10.1016/0006-8993(90)91585-5; STEWART RR, 1989, J EXP BIOL, V141, P1; Summers T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06114-1; Summers T, 2014, J EXP BIOL, V217, P4167, DOI 10.1242/jeb.110049; Thorogood MSE, 1999, J COMP NEUROL, V405, P334, DOI 10.1002/(SICI)1096-9861(19990315)405:3<334::AID-CNE4>3.0.CO;2-I; Tribut F, INVERTEBR NEUROSCI, V4, P25, DOI [10.1007/s101589900003, DOI 10.1007/S101589900003]; Trontelj P, 2004, PARASITOL RES, V94, P118, DOI 10.1007/s00436-004-1181-x; Trueta C, 2003, J PHYSIOL-LONDON, V547, P405, DOI 10.1113/jphysiol.2002.030684; Vergote D, 2004, J BIOL CHEM, V279, P43828, DOI 10.1074/jbc.M403073200; Wagenaar DA, 2015, J EXP BIOL, V218, P3353, DOI 10.1242/jeb.113860; WALLACE BG, 1982, J NEUROSCI, V2, P1108; Wang Y, 2015, NEUROSCIENCE, V298, P397, DOI 10.1016/j.neuroscience.2015.04.040; Wang YQ, 2016, J NEUROPHYSIOL, V116, P619, DOI 10.1152/jn.00235.2016; Yazdani N, 2013, DEV NEUROBIOL, V73, P571, DOI 10.1002/dneu.22082	81	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201206	10.1371/journal.pone.0201206	http://dx.doi.org/10.1371/journal.pone.0201206			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028871	Green Submitted, Green Published, gold			2022-12-26	WOS:000439396900045
J	Yang, PS; Pak, HN; Park, DH; Yoo, J; Kim, TH; Uhm, JS; Kim, YD; Nam, HS; Joung, B; Lee, MH; Heo, JH				Yang, Pil-Sung; Pak, Hui-Nam; Park, Dong-Hyuk; Yoo, Joonsang; Kim, Tae-Hoon; Uhm, Jae-Sun; Kim, Young Dae; Nam, Hyo Suk; Joung, Boyoung; Lee, Moon-Hyoung; Heo, Ji Hoe			Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke	PLOS ONE			English	Article							THROMBOEMBOLISM; PREVENTION; FREQUENCY; CHADS(2)	Introduction Cardioembolic (CE) risks is usually considered as the main mechanism of ischemic stroke in non-valvular atrial fibrillation (NVAF) patients. However, a substantial number of ischemic strokes in NVAF patients are related to non-CE mechanisms. The aim of this study was to investigate the non-CE risk factors in ischemic stroke patients had NVAF. Methods We included 401 patients (65.6% male, 68.6 +/- 9.6 years old) who had been hospitalized due to ischemic stroke and had a known or newly diagnosed NVAF. The CE (intracardiac thrombus, dense spontaneous echo contrast, or low left atrial appendage flow velocity) and non-CE (complex aortic plaque, significant carotid stenosis, or intracranial arterial stenosis) risk factors were investigated at the time of the index stroke. Results The number of CE and non-CE risk factors increased with increasing CHA(2)DS(2)-VASc scores (p for trends < 0.001). The presence of CE risk factors was independently associated with persistent atrial fibrillation (p < 0.001), body mass index (p = 0.003), heart failure (p = 0.003), and left atrial volume index (p < 0.001). In contrast, the presence of non-CE risk factors was independently associated with age (p < 0.001), hypertension (p = 0.049), diabetes (p = 0.030), and coronary artery calcium score (CACS; p < 0.001). CACS had the added value in predicting non-CE risk factors of ischemic stroke regardless of the CHA(2)DS(2)-VASc risk category (p < 0.001). Conclusion Non-CE risk factors in ischemic stroke patients with NVAF are associated with high CHA(2)DS(2)-VASc score and CACS. Atherosclerotic non-CE risk factors should be considered as potential mechanisms of stroke even in patients with AF-associated ischemic stroke.	[Yang, Pil-Sung; Pak, Hui-Nam; Park, Dong-Hyuk; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung] Yonsei Univ Hlth Syst, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Yoo, Joonsang; Kim, Young Dae; Nam, Hyo Suk; Heo, Ji Hoe] Yonsei Univ Hlth Syst, Dept Neurol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Dept Internal Med, Div Cardiol, Seoul, South Korea.; Heo, JH (corresponding author), Yonsei Univ Hlth Syst, Dept Neurol, Seoul, South Korea.	hnpak@yuhs.ac; jhheo@yuhs.ac	; Pak, Hui-Nam/C-4266-2015	Yoo, Joonsang/0000-0003-1169-6798; Lee, Moon-Hyoung/0000-0002-7268-0741; Kim, Young Dae/0000-0001-5750-2616; Uhm, Jae-Sun/0000-0002-1611-8172; Joung, Boyoung/0000-0001-9036-7225; Pak, Hui-Nam/0000-0002-3256-3620; Kim, Tae-Hoon/0000-0003-4200-3456; Yang, Pil-sung/0000-0002-6552-1742; Heo, Ji Hoe/0000-0001-9898-3321; NAM, HYO SUK/0000-0002-4415-3995	Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea [A085136]	Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (https://www.htdream.kr/) [A085136 to HNP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bernhardt P, 2005, J AM COLL CARDIOL, V45, P1807, DOI 10.1016/j.jacc.2004.11.071; Borissoff JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055784; CHA M, 2012, EUR J NEUROL, V19, pDS2; Chang YJ, 2002, CEREBROVASC DIS, V13, P16, DOI 10.1159/000047740; Evans A, 2001, STROKE, V32, P2828, DOI 10.1161/hs1201.099520; Ganesan AN, 2016, EUR HEART J, V37, P1591, DOI 10.1093/eurheartj/ehw007; GOESSENS BM, 1991, STROKE, DOI DOI 10.1161/STR0KEAHA.106.477091; Goldman ME, 1999, J AM SOC ECHOCARDIOG, V12, P1080, DOI 10.1016/S0894-7317(99)70105-7; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Hermann DM, 2013, STROKE, V44, P1008, DOI 10.1161/STROKEAHA.111.678078; Holmstedt CA, 2013, LANCET NEUROL, V12, P1106, DOI 10.1016/S1474-4422(13)70195-9; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim YD, 2011, STROKE, V42, P930, DOI 10.1161/STROKEAHA.110.602987; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lee IO, 2012, J PHARMACOL EXP THER, V343, P253, DOI 10.1124/jpet.112.194837; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Liu FD, 2016, ANN MED, V48, P367, DOI 10.1080/07853890.2016.1179390; Malik R, 2016, NEUROLOGY, V86, P1217, DOI 10.1212/WNL.0000000000002528; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mitchell LB, 2014, HEART, V100, P1524, DOI 10.1136/heartjnl-2013-305303; Nakamura A, 2016, CEREBROVASC DIS, V42, P196, DOI 10.1159/000445723; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; RAGOSTA M, 1994, CIRCULATION, V89, P1262, DOI 10.1161/01.CIR.89.3.1262; REDDY VY, 1961, CIRCULATION, V112, P720, DOI DOI 10.1161/CIRCULATI0NAHA.112; Tremblay-Gravel M, 2015, J CARDIOVASC ELECTR, V26, P509, DOI 10.1111/jce.12652; Yarmohammadi H, 2013, AM J CARDIOL, V112, P678, DOI 10.1016/j.amjcard.2013.04.047; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; THROMB HAEMOST, P268	32	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201062	10.1371/journal.pone.0201062	http://dx.doi.org/10.1371/journal.pone.0201062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028885	Green Published, gold, Green Submitted			2022-12-26	WOS:000439396900038
J	Ballot, A; Scherer, PI; Wood, SA				Ballot, Andreas; Scherer, Pia, I; Wood, Susanna A.			Variability in the anatoxin gene clusters of Cuspidothrix issatschenkoi from Germany, New Zealand, China and Japan	PLOS ONE			English	Article							ANABAENA-FLOS-AQUAE; IN-SILICO PCR; 1ST REPORT; APHANIZOMENON-ISSATSCHENKOI; CYANOBACTERIAL TOXINS; HOMOANATOXIN-A; BIOSYNTHESIS; STRAIN; IDENTIFICATION; MICROCYSTIN	Anatoxin-a and homoanatoxin-a are neurotoxic cyanotoxins produced by benthic and planktonic cyanobacteria worldwide. These toxins are produced by the cyanobacterial genera Dolichospermum, Cuspidothrix, Phormidium, Oscillatoria, Tychonema and Cylindrospermum. In the present study the ana gene clusters (anaA-anaG; c. 21.1 kilobases) of two anatoxin producing Cuspidothrix issatschenkoi strains from Germany: (NIVA-CYA 711) and New Zealand (CAWBG02) were sequenced and compared with the ana gene clusters of two C. issatschenkoi strains from Japan (RM-6 and LBRI48) and one from China (CHABD3). All five ana gene clusters are characterized by the same gene order for anaA-anaG. Similarities were highest (99.56-99.57%) between German (NIVA-CYA 711), New Zealand (CAWBG02) and Chinese (CHABD3) strains. Similarities were lower (91.40-91.67%) when compared to the Japanese strains (RM-6 and LBRI48). Collectively, 2,037 variable sites (328 single nucleotide polymorphisms and 9 insertions/deletions, comprising 1,709 nucleotides) were found in the ana gene clusters of the German, New Zealand and Japanese strains compared to the Chinese strain (CHABD3). The ana gene clusters of the German (NIVA-CYA 711), New Zealand (CAWBG02) and Japanese (RM-6 and LBRI48) strains were characterized by 83, 84, 255 and 231 SNP's compared to the Chinese strain (CHABD3), respectively. The anaE and anaF genes showed the highest variability in all five strains and are recommended as the best genetic markers for further phylogenetic studies of the ana gene cluster from C. issatschenkoi.	[Ballot, Andreas] Norwegian Inst Water Res, Oslo, Norway; [Scherer, Pia, I] Tech Univ Munich, Limnol Res Stn Iffeldorf, Munich, Germany; [Wood, Susanna A.] Cawthron Inst, Private Bag 2, Nelson, New Zealand	Norwegian Institute for Water Research (NIVA); Technical University of Munich; Cawthron Institute	Ballot, A (corresponding author), Norwegian Inst Water Res, Oslo, Norway.	andreas.ballot@niva.no	Ballot, Andreas/G-7752-2019	Ballot, Andreas/0000-0002-4088-0677	New Zealand Ministry of Business, Innovation and Employment [UOWX1503, CAWX1317]; European Cooperation in Science and Technology COST Action [ES1105 CYANOCOST]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); European Cooperation in Science and Technology COST Action(European Cooperation in Science and Technology (COST))	SAW thanks the New Zealand Ministry of Business, Innovation and Employment for funding through the 'Enhancing the health and resilience of New Zealand lakes' (UOWX1503) and the 'Safe New Zealand Seafood' (CAWX1317) programmes.; We want to thank the European Cooperation in Science and Technology COST Action ES1105 CYANOCOST for networking and knowledge transfer support.	Ballot A, 2010, TOXICON, V56, P964, DOI 10.1016/j.toxicon.2010.06.021; Ballot A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167552; Brown NM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2738-7; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Bruno M., 2016, HDB CYANOBACTERIAL M, P138; Bumke-Vogt C, 1999, ENVIRON TOXICOL, V14, P117, DOI 10.1002/(SICI)1522-7278(199902)14:1<117::AID-TOX15>3.0.CO;2-V; Christiansen G, 2006, APPL ENVIRON MICROB, V72, P117, DOI 10.1128/AEM.72.1.117-123.2006; Cires S, 2016, HARMFUL ALGAE, V54, P21, DOI 10.1016/j.hal.2015.09.007; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; DEVLIN JP, 1977, CAN J CHEM, V55, P1367, DOI 10.1139/v77-189; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Duchene S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000094; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; GALLON JR, 1994, PHYTOCHEMISTRY, V35, P1195, DOI 10.1016/S0031-9422(00)94821-0; Gugger M, 2005, TOXICON, V45, P919, DOI 10.1016/j.toxicon.2005.02.031; Gugger M, 2018, CYLINDROSPER MUM STA; Hepperle D., 2008, SEQUENTIX DIGITAL DN; Hodoki Y, CUSPIDOTHRIX ISSATSC; Jiang YG, 2015, HARMFUL ALGAE, V46, P43, DOI 10.1016/j.hal.2015.05.005; Kaebernick M, 2001, ENVIRON MICROBIOL, V3, P669, DOI 10.1046/j.1462-2920.2001.00241.x; Kalendar R, 2014, METHODS MOL BIOL, V1116, P271, DOI 10.1007/978-1-62703-764-8_18; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; KomuYrek J., 2013, SUSSWASSERFLORA MITT, V19/3, P1; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Mann S, 2011, BIOCHEMISTRY-US, V50, P7184, DOI 10.1021/bi200892a; Mejean A, 2014, TOXICON, V91, P15, DOI 10.1016/j.toxicon.2014.07.016; Mejean A, 2010, J BACTERIOL, V192, P5264, DOI 10.1128/JB.00704-10; Quiblier C, 2013, WATER RES, V47, P5464, DOI 10.1016/j.watres.2013.06.042; Rantala-Ylinen A, 2011, APPL ENVIRON MICROB, V77, P7271, DOI 10.1128/AEM.06022-11; Shah SAA, 2017, MAR DRUGS, V15, DOI 10.3390/md15110354; Shams S, 2015, WATER RES, V69, P68, DOI 10.1016/j.watres.2014.11.006; SKULBERG OM, 1992, ENVIRON TOXICOL CHEM, V11, P321, DOI [10.1897/1552-8618(1992)11[321:IOANOS]2.0.CO;2, 10.1002/etc.5620110306]; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Watanabe MF, 2003, PHYCOLOGIA, V42, P364, DOI 10.2216/i0031-8884-42-4-364.1; Wood SA, 2007, TOXICON, V50, P292, DOI 10.1016/j.toxicon.2007.03.025; Wood SA, 2007, J PHYCOL, V43, P356, DOI 10.1111/j.1529-8817.2007.00318.x	36	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200774	10.1371/journal.pone.0200774	http://dx.doi.org/10.1371/journal.pone.0200774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024929	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000439120000051
J	Luben, R; Hayat, S; Mulligan, A; Lentjes, M; Wareham, N; Pharoah, P; Khaw, KT				Luben, Robert; Hayat, Shabina; Mulligan, Angela; Lentjes, Marleen; Wareham, Nicholas; Pharoah, Paul; Khaw, Kay-Tee			Alcohol consumption and future hospital usage: The EPIC-Norfolk prospective population study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; DIFFERENT DIMENSIONS; REDUCED MORTALITY; SOCIAL-CLASS; RISK; MEN; METAANALYSIS; ASSOCIATION; DRINKERS	Background Heavy drinkers of alcohol are reported to use hospitals more than non-drinkers, but it is unclear whether light-to-moderate drinkers use hospitals more than non-drinkers. Objective We examined the relationship between alcohol consumption in 10,883 men and 12,857 women aged 40-79 years in the general population and subsequent admissions to hospital and time spent in hospital. Methods Participants from the EPIC-Norfolk prospective population-based study were followed for ten years (1999-2009) using record linkage. Results Compared to current non-drinkers, men who reported any alcohol drinking had a lower risk of spending more than twenty days in hospital multivariable adjusted OR 0.80 (95%CI 0.68-0.94) after adjusting for age, smoking status, education, social class, body mass index and prevalent diseases. Women who were current drinkers were less likely to have any hospital admissions multivariable adjusted OR 0.84 (95%CI 0.74-0.95), seven or more admissions OR 0.77 (95% CI 0.66-0.88) or more than twenty hospital days OR 0.70 (95%CI 0.62-0.80). However, compared to lifelong abstainers, men who were former drinkers had higher risk of any hospital admissions multivariable adjusted OR 2.22 (95%CI 1.51-3.28) and women former drinkers had higher risk of seven or more admissions OR 1.30 (95%CI 1.01-1.67). Conclusion Current alcohol consumption was associated with lower risk of future hospital usage compared with non-drinkers in this middle aged and older population. In men, this association may in part be due to whether former drinkers are included in the non-drinker reference group but in women, the association was consistent irrespective of the choice of reference group. In addition, there were few participants in this cohort with very high current alcohol intake. The measurement of past drinking, the separation of non-drinkers into former drinkers and lifelong abstainers and the choice of reference group are all influential in interpreting the risk of alcohol consumption on future hospitalisation.	[Luben, Robert; Hayat, Shabina; Mulligan, Angela; Lentjes, Marleen; Pharoah, Paul; Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Wareham, Nicholas] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England	University of Cambridge; University of Cambridge	Luben, R (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	robert.luben@phpc.cam.ac.uk	Luben, Robert N/H-5519-2015; Pharoah, Paul/V-6658-2019; Khaw, Kay-Tee/AAZ-3209-2021	Luben, Robert N/0000-0002-5088-6343; Pharoah, Paul/0000-0001-8494-732X; Lentjes, Marleen/0000-0003-4713-907X	Medical Research Council UK [G9502233, G0401527]; Cancer Research UK [C864/A8257, C864/A2883]; MRC [MR/N003284/1, MC_UU_12015/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The design and conduct of the EPIC-Norfolk study and collection and management of the data was supported by programme grants from the Medical Research Council UK (G9502233, G0401527) and Cancer Research UK (C864/A8257, C864/A2883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are independent from funders and sponsors and had access to all the data.	[Anonymous], 2011, GSS METH SER; Bell S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j909; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; BLAND R, 1979, SOCIOLOGY, V13, P283, DOI 10.1177/003803857901300209; Boniface S, 2013, EUR J PUBLIC HEALTH, V23, P1076, DOI 10.1093/eurpub/ckt016; Burton R., 2016, PUBLIC HLTH BURDEN A; Chief Medical Officers, 2016, ALC GUID REV REP GUI; Dawson DA, 2000, ALCOHOL CLIN EXP RES, V24, P72, DOI 10.1097/00000374-200001000-00012; Day N, 1999, BRIT J CANCER, V80, P95; Degerud E, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002476; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Hayat SA, 2014, INT J EPIDEMIOL, V43, P1063, DOI 10.1093/ije/dyt086; Holst C, 2017, DIABETOLOGIA, V60, P1941, DOI 10.1007/s00125-017-4359-3; House of Commons Science and Technology Committee, 2011, 11 REP SESS 2010 12; Jones L, 2013, UPDATING ENGLAND SPE; Kalinowski A, 2016, ADDICTION, V111, P1293, DOI 10.1111/add.13341; Katikireddi SV, 2017, LANCET PUBLIC HEALTH, V2, pE267, DOI 10.1016/S2468-2667(17)30078-6; Knott C, 2015, DIABETES CARE, V38, P1804, DOI 10.2337/dc15-0710; Luben R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009461; McFadden E, 2009, EUR J EPIDEMIOL, V24, P231, DOI 10.1007/s10654-009-9332-0; Naimi TS, 2017, ADDICTION, V112, P207, DOI 10.1111/add.13451; Public Health England, 2014, LOC ALC PROF ENGL LA; Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Robinson M, 2013, ALCOHOL ALCOHOLISM, V48, P231, DOI 10.1093/alcalc/ags098; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; SHAPER AG, 1988, LANCET, V2, P1267; Smyth A, 2015, LANCET, V386, P1945, DOI 10.1016/S0140-6736(15)00235-4; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Wannamethee SG, 1997, INT J EPIDEMIOL, V26, P523, DOI 10.1093/ije/26.3.523; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200747	10.1371/journal.pone.0200747	http://dx.doi.org/10.1371/journal.pone.0200747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020973	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400070
J	Farrow, SC; Kamileen, MO; Meades, J; Ameyaw, B; Xiao, YL; O'Connor, SE				Farrow, Scott C.; Kamileen, Mohamed O.; Meades, Jessica; Ameyaw, Belinda; Xiao, Youli; O'Connor, Sarah E.			Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural product biosynthesis; cytochrome P450; natural product biosynthesis; secondary metabolism; plant biochemistry; ibogaine; monoterpene indole alkaloid; Tabernanthe iboga; O-methyltransferase; Illumina sequencing; transcriptomics	INDOLE ALKALOIDS; EFFICIENT	Monoterpenoid indole alkaloids are a large (approximate to 3000 members) and structurally diverse class of metabolites restricted to a limited number of plant families in the order Gentianales. Tabernanthe iboga or iboga (Apocynaceae) is native to western equatorial Africa and has been used in traditional medicine for centuries. Howard Lotsof is credited with bringing iboga to the attention of Western medicine through his accidental discovery that iboga can alleviate opioid withdrawal symptoms. Since this observation, iboga has been investigated for its use in the general management of addiction. We were interested in elucidating ibogaine biosynthesis to understand the unique reaction steps en route to ibogaine. Furthermore, because ibogaine is currently sourced from plant material, these studies may help improve the ibogaine supply chain through synthetic biology approaches. Here, we used next-generation sequencing to generate the first iboga transcriptome and leveraged homology-guided gene discovery to identify the penultimate hydroxylase and final O-methyltransferase steps in ibogaine biosynthesis, herein named ibogamine 10-hydroxylase (I10H) and noribogaine-10-O-methyltransferase (N10OMT). Heterologous expression in Saccharomyces cerevisiae (I10H) or Escherichia coli (N10OMT) and incubation with putative precursors, along with HPLC-MS analysis, confirmed the predicted activities of both enzymes. Moreover, high expression levels of their transcripts were detected in ibogaine-accumulating plant tissues. These discoveries coupled with our publicly available iboga transcriptome will contribute to additional gene discovery efforts and could lead to the stabilization of the global ibogaine supply chain and to the development of ibogaine as a treatment for addiction.	[Farrow, Scott C.; Kamileen, Mohamed O.; Meades, Jessica; Ameyaw, Belinda; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Xiao, Youli] Chinese Acad Sci, Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200000, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	O'Connor, SE (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	sarah.oconnor@jic.ac.uk	O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	O'Connor, Sarah/0000-0003-0356-6213; Farrow, Scott/0000-0001-7106-8924; Kamileen, Mohamed Omar/0000-0002-1346-1055; Ameyaw, Belinda/0000-0001-6391-713X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004561/1]; European Molecular Biology Organization (EMBO) Long-term Fellowship [ALTF 846-2016]; CAS-BBSRC alliance	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO) Long-term Fellowship(European Molecular Biology Organization (EMBO)); CAS-BBSRC alliance	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/J004561/1 (to S. E. O. and Y. X.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Molecular Biology Organization (EMBO) Long-term Fellowship ALTF 846-2016.; Supported by the CAS-BBSRC alliance.	Alper K R, 2001, Alkaloids Chem Biol, V56, P1, DOI 10.1016/S0099-9598(01)56005-8; Alper KR, 2008, J ETHNOPHARMACOL, V115, P9, DOI 10.1016/j.jep.2007.08.034; Bisset N. G., 1989, WAGENINGEN AGR U PAP, V89, P1; Caputi L, 2018, SCIENCE, V360, P1235, DOI 10.1126/science.aat4100; Carnicella S, 2010, ADDICT BIOL, V15, P424, DOI 10.1111/j.1369-1600.2010.00251.x; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Delaude C., 1984, B SOC ROY SC LIEGE, V53, P206; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; GUNASEKERA SP, 1980, PHYTOCHEMISTRY, V19, P1213, DOI 10.1016/0031-9422(80)83086-X; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KHUONGHUU F, 1976, TETRAHEDRON, V32, P2539, DOI 10.1016/0040-4020(76)88023-4; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; MULAMBA T, 1981, J NAT PROD, V44, P184, DOI 10.1021/np50014a007; Nomura T, 2010, PLANT SIGNAL BEHAV, V5, P875, DOI [10.4161/psb.5.7.11901, 10.1074/jbc.M109.086157]; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; OKUYAMA E, 1992, CHEM PHARM BULL, V40, P2075, DOI 10.1248/cpb.40.2075; POPE HG, 1969, ECON BOT, V23, P174, DOI 10.1007/BF02860623; RASTOGI K, 1980, PHYTOCHEMISTRY, V19, P1209, DOI 10.1016/0031-9422(80)83085-8; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Szabo LF, 2008, MOLECULES, V13, P1875, DOI 10.3390/molecules13081875; Tang BQ, 2014, J NAT PROD, V77, P1839, DOI 10.1021/np500240b; YAMASAKI M, 1964, TETRAHEDRON LETT, P1499; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	25	20	20	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13821	13833		10.1074/jbc.RA118.004060	http://dx.doi.org/10.1074/jbc.RA118.004060			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030374	Green Published, hybrid			2022-12-26	WOS:000444070700008
J	Migliorini, RP; Peters, FB; Favarini, MO; Kasper, CB				Migliorini, Raissa Prior; Peters, Felipe Bortolotto; Favarini, Marina Ochoa; Kasper, Carlos Benhur			Trophic ecology of sympatric small cats in the Brazilian Pampa	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; GEOFFROYS CAT; FOOD-HABITS; SOUTHEASTERN BRAZIL; LEOPARDUS-GEOFFROYI; CARNIVORA FELIDAE; PUMA-YAGOUAROUNDI; FEEDING ECOLOGY; SOUTHERN BRAZIL; ARGENTINA	Information about resource partitioning among small cat species that live in sympatry in South America is fairly incomplete. Knowledge about feeding habits is essential for understanding the role of these predators in the environment, the impact on prey populations, and potential competition among themselves and with other carnivores. This study aimed to describe and compare the diet of four sympatric small cats in the grasslands of southern Brazil. We analysed the stomach contents of 37 Geoffroy's cats (Leopardus geoffroi), 27 margays (Leopardus wiedii), 14 pampas cats (Leopardus colocola), and 20 jaguarundis (Herpailurus yagouaroundi) obtained as road kill in the Brazilian Pampa in southern Brazil. Small mammals were the most representative class consumed by all cats, followed by Ayes, Reptilia, and Amphibia. Some items, such as rodents Ca via aperea, Akodon sp., Oligoryzomys sp. and Passeriformes were consumed by all cat species. Niche overlap varied widely, from 10% (margay x jaguarundi) to 92% (jaguarundi x pampas cat). Niche breadth indicated that jaguarundi were the most specialized of the cats (B-sta = 0.24) in this region, with a diet closely associated to C. aperea. Margay consumed more items associated with arboreal behaviour than other cat species, but consumed more terrestrial items than arboreal ones. The pampas cat consumed mostly terrestrial species associated with open fields. Geoffroy's cat consumed mammals found in a diversity of habitats, indicating high ecological flexibility. Species with more similarity in diet such as jaguarundi and pampas cat probably present temporal segregation in activity. In conclusion, despite their habitat and diet similarities, these four species explore distinct microhabitats by foraging different prey groups, what favor them to live in sympatry.	[Migliorini, Raissa Prior; Kasper, Carlos Benhur] Univ Fed Pampa, LABIMAVE Lab Biol Mamiferos & Aves, Sao Gabriel, SP, Brazil; [Peters, Felipe Bortolotto; Favarini, Marina Ochoa] Area Vida Consultoria Ambiental, Canoas, RS, Brazil	Universidade Federal do Pampa	Migliorini, RP (corresponding author), Univ Fed Pampa, LABIMAVE Lab Biol Mamiferos & Aves, Sao Gabriel, SP, Brazil.	raissa.biopampa@gmail.com		Kasper, Carlos Benhur/0000-0002-7089-6119; Migliorini, Raissa/0000-0002-4999-4275				Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Bencke GA, 2010, IHERINGIA SER ZOOL, V100, P519, DOI 10.1590/S0073-47212010000400022; Bianchi RD, 2011, ZOOLOGIA-CURITIBA, V28, P127, DOI 10.1590/S1984-46702011000100018; Bisceglia SBC, 2011, J ARID ENVIRON, V75, P1024, DOI 10.1016/j.jaridenv.2011.03.016; Bisceglia SBC, 2008, J ARID ENVIRON, V72, P1120, DOI 10.1016/j.jaridenv.2007.11.003; Bonvicino CR., 2008, GUIA ROEDORES BRASIL, V2008, p120p; Canepuccia AD, 2007, MAMM BIOL, V72, P163, DOI 10.1016/j.mambio.2006.07.003; Christoff AU, 2013, MAMIFEROS RIO GRANDE, P343; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Costa Henrique Caldeira, 2015, Herpetologia Brasileira, V4, P75; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; DAY MG, 1966, J ZOOL, V148, P201, DOI 10.1111/j.1469-7998.1966.tb02948.x; de Oliveira Tadeu G., 2010, P559; de Oliveira Tadeu G., 1998, Mammalian Species, V579, P1; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Eisenberg J.M., 1989, CARNIVORE BEHAV ECOL, P1, DOI [10.1007/978-1-4757-4716-4_1, DOI 10.1007/978-1-4757-4716-4_1]; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Facure KG, 1996, MAMMALIA, V60, P499; Fajardo Ursula, 2014, Rev. peru biol., V21, P061, DOI 10.15381/rpb.v21i1.8248; Gardner A.L., 2007, MAMMALS S AM; Gonzalez E.M., 2012, MAMIFEROS URUGUAY GU; GREENE HW, 1983, OIKOS, V40, P151, DOI 10.2307/3544212; Guichon ML, 1998, MAMMALIA, V62, P23, DOI 10.1515/mamm.1998.62.1.23; Hammar O, 2001, PALAEONTOL ELECTRON; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kasper CB, 2016, BRAZ J BIOL, V76, P228, DOI 10.1590/1519-6984.19414; Kasper CB, 2016, MAMMALIA, V80, P143, DOI 10.1515/mammalia-2014-0126; KILTIE RA, 1984, OECOLOGIA, V61, P411, DOI 10.1007/BF00379644; Kitchener A.C., 2017, REVISED TAXONOMY FEL; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; KLEIMAN DG, 1973, ANIM BEHAV, V21, P637, DOI 10.1016/S0003-3472(73)80088-0; Kruuk H., 1986, P353; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; LEVINS RICHARD, 1968; Macdonald David W., 2010, P3; Magezi GS, 2013, THESIS; Manfredi C, 2004, J MAMMAL, V85, P1111, DOI 10.1644/BWG-133.1; Manfredi C, 2011, MAMM BIOL, V76, P313, DOI 10.1016/j.mambio.2011.01.009; Mazim F. D., 2016, SERIE EDITORIAL FAUN, P311; Mittermeier R.A., 2009, HDB MAMMALS WORLD CA, V1; Napolitano C, 2008, MOL ECOL, V17, P678, DOI 10.1111/j.1365-294X.2007.03606.x; Nilsen EB, 2012, TECH ECOL CONSERVAT, P256; Oliveira TG., 2005, GUIA CAMPO FELINOS B; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; PATTA PILLAR V. DE, 2009, CAMPOS SULINOS CONSE; Patton J.L., 2015, MAMMALS S AM, V2; Pereira JA, 2012, J ARID ENVIRON, V76, P36, DOI 10.1016/j.jaridenv.2011.08.006; Pereira JA, 2010, J ARID ENVIRON, V74, P1106, DOI 10.1016/j.jaridenv.2010.03.017; Pinkas L, 1971, FISH B, V152, P1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Reis N.R., 2011, MAMIFEROS BRASIL, V2nd ed., P347; Rinaldi Alcides Ricieri, 2015, Biotemas, V28, P155; Rocha-Mendes F, 2010, BIOTA NEOTROP, V10, P21, DOI 10.1590/S1676-06032010000400001; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Segalla MV, 2014, S AM J HERPETOL, V5, P34; Sigrist T, 2014, GUIA CAMPO AVES BRAS; Silva-Pereira JE, 2011, MAMM BIOL, V76, P308, DOI 10.1016/j.mambio.2010.09.001; Sousa KS, 2008, MAMM BIOL, V73, P303, DOI 10.1016/j.mambio.2007.04.001; Tofoli CF, 2009, BRAZ J BIOL, V69, P871, DOI 10.1590/S1519-69842009000400015; Tortato MA, 2013, BIODIVERSIDADE BRASI, P76; Trigo T.C., 2013, MAMIFEROS RIO GRANDE, P343; Wang E, 2002, STUD NEOTROP FAUNA E, V37, P207, DOI 10.1076/snfe.37.3.207.8564; WORLD WILDLIFE FUND (WWF), 2017, TERR EC WORLD	65	7	11	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201257	10.1371/journal.pone.0201257	http://dx.doi.org/10.1371/journal.pone.0201257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052676	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600034
J	Chen, YS; Fan, YH; Tien, CF; Yueh, A; Chang, RY				Chen, Yi-Shiuan; Fan, Yi-Hsin; Tien, Chih-Feng; Yueh, Andrew; Chang, Ruey-Yi			The conserved stem-loop II structure at the 3' untranslated region of Japanese encephalitis virus genome is required for the formation of subgenomic flaviviral RNA	PLOS ONE			English	Article							ELEMENTS; INTERFERENCE; SEQUENCES; NUCLEASE; DUPLICATIONS; PSEUDOKNOT; CELLS	Flaviviruses accumulate abundant subgenomic RNA (sfRNA) in infected cells. It has been reported that sfRNA results from stalling of host 5'-to-3' exoribonuclease XRN1 at the highly structured RNA of the 3' untranslated region (UTR). Although XRN1 digestion of a 3'-terminal 800-nt RNA could stall at a position to generate the sfRNA in vitro, we found that knocking out XRN1 had no effect on the accumulation of sfRNA in Japanese encephalitis virus (JEV) infected cells. Mutagenesis studies revealed that the stemloop II (SLII) at the 3' UTR is required for the accumulation of sfRNA. According to the results of an in vitro RNA-dependent RNA polymerase (RdRp) assay, the (-)10431-10566 RNA fragment, containing the putative promoter on the antigenome for the sfRNA transcription, binds to RdRp protein and exhibits a strong promoter activity. Taken together, our results indicate that the JEV sfRNA could be transcribed initially and then be trimmed by XRN1 or other unidentified exoribonucleases.	[Chen, Yi-Shiuan; Fan, Yi-Hsin; Tien, Chih-Feng; Chang, Ruey-Yi] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan; [Yueh, Andrew] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan	National Dong Hwa University; National Health Research Institutes - Taiwan	Chang, RY (corresponding author), Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan.	rchang@gms.ndhu.edu.tw		Chang, Ruey-Yi/0000-0003-2528-2211	Ministry of Science and Technology, Taiwan, Republic of China [MOST 103-2320-B-259-002-MY3]	Ministry of Science and Technology, Taiwan, Republic of China	This work was supported by grant MOST 103-2320-B-259-002-MY3 from the Ministry of Science and Technology, Taiwan, Republic of China (https://www.most.gov.tw/) to R-YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026; Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737; Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16; Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015; Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599; Kim YG, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-59; Li WM, 2006, J VIROL, V80, P3395, DOI 10.1128/JVI.80.7.3395-3405.2006; Li XF, 2010, J GEN VIROL, V91, P1218, DOI 10.1099/vir.0.013854-0; Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004; Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030; Liu RK, 2016, J VIROL, V90, P7864, DOI 10.1128/JVI.00869-16; Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016; Maeda A, 2008, VIROLOGY, V371, P130, DOI 10.1016/j.virol.2007.09.018; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009; Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535; Pu SY, 2014, J GEN VIROL, V95, P1493, DOI 10.1099/vir.0.064915-0; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Yun SI, 2009, J VIROL, V83, P7909, DOI 10.1128/JVI.02541-08	45	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201250	10.1371/journal.pone.0201250	http://dx.doi.org/10.1371/journal.pone.0201250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048535	gold, Green Published, Green Submitted			2022-12-26	WOS:000439952400066
J	Hooijberg, EH; Miller, M; Cray, C; Buss, P; Steenkamp, G; Goddard, A				Hooijberg, Emma H.; Miller, Michele; Cray, Carolyn; Buss, Peter; Steenkamp, Gerhard; Goddard, Amelia			Serum protein electrophoresis in healthy and injured southern white rhinoceros (Ceratotherium simum simum)	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; ACUTE-PHASE PROTEINS; REFERENCE INTERVALS; BIOCHEMICAL VALUES; DICEROS-BICORNIS; PLASMA-PROTEINS; HORSES; BLOOD; FRACTIONS; CHEMISTRY	Investigation of globulin fractions by serum protein electrophoresis (SPE) is the first step towards evaluation of the proteome in the southern white rhinoceros (Ceratotherium simum simum). Furthermore, identification of changes in globulins in animals with poaching and other injuries can guide discovery of potentially useful biomarkers of inflammation. The aim of this study was to develop reference intervals for agarose gel SPE in healthy white rhinoceros and to compare these serum protein electrophoresis results to those from animals with tissue trauma. Reference intervals for total serum protein and agarose gel electrophoretic albumin and globulin fractions were generated using serum samples from 49 healthy free-ranging adult white rhinoceros. A standardised gating system together with identification of specific proteins by mass spectrometry aided in fraction identification. Six globulin fractions were identified: alpha 1a, alpha 1b, alpha 2, beta 1, beta 2 and gamma. Reference intervals were generated for total serum protein (76-111 g/L), albumin (10-27 g/L) and globulin fractions (alpha 1a: 1.6-3.2 g/L; alpha 1b: 1.7-3.6 g/L; alpha 2: 16.1-26.6 g/L; beta 1: 6.6-18.2 g/L; beta 2: 11.8-30.4 g/L; gamma: 10.4-23.1 g/L; albumin: globulin ratio: 0.12-0.39). Results were compared to those from 30 animals with various degrees and chronicities of tissue trauma. Wounded animals had lower concentrations of total serum protein, albumin, total globulin, alpha and beta 1 globulins, lower percentages of alpha 2 and beta 1 globulins, and higher percentages of beta 2 and gamma globulins. These protein changes are similar to those seen in human patients with wounds rather than classic acute phase or chronic inflammatory responses.	[Hooijberg, Emma H.; Steenkamp, Gerhard; Goddard, Amelia] Univ Pretoria, Dept Compan Anim Clin Studies, Fac Vet Sci, Pretoria, South Africa; [Miller, Michele] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sci & Technol,Div Mol Biol & Human Genet, Natl Res Fdn Ctr Excellence Biomed TB Res,Med Res, Stellenbosch, South Africa; [Cray, Carolyn] Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Miami, FL 33136 USA; [Buss, Peter] South African Natl Pk, Vet Wildlife Serv, Kruger Natl Pk, Skukuza, South Africa	University of Pretoria; National Research Foundation - South Africa; Stellenbosch University; University of Miami	Hooijberg, EH (corresponding author), Univ Pretoria, Dept Compan Anim Clin Studies, Fac Vet Sci, Pretoria, South Africa.	emma.hooijberg@up.ac.za	Hooijberg, Emma/AAR-9821-2020; Steenkamp, Gerhard/AAP-3362-2021; Miller, Michele/ABA-1332-2020	Hooijberg, Emma/0000-0002-4367-799X; Goddard, Amelia/0000-0002-8415-4802; Steenkamp, Gerhard/0000-0001-8428-7309; Miller, Michele/0000-0002-5883-6076	Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, South Africa; Health and Welfare Sector Education and Training Authority, South Africa	Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, South Africa; Health and Welfare Sector Education and Training Authority, South Africa	Funding for this project was provided by: The Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, South Africa; Postgraduate research bursary from the Health and Welfare Sector Education and Training Authority, South Africa.	Alberghina D, 2013, CAN J VET RES, V77, P293; Alberghina D, 2011, J VET DIAGN INVEST, V23, P111, DOI 10.1177/104063871102300119; Andriansyah, 2013, J ZOO WILDLIFE MED, V44, P280, DOI 10.1638/2012-0046R2.1; Atherton MJ, 2013, VET J, V196, P320, DOI 10.1016/j.tvjl.2012.12.010; Atherton MJ, 2013, VET J, V196, P315, DOI 10.1016/j.tvjl.2012.12.011; Baker R J, 1986, Vet Clin Pathol, V15, P20, DOI 10.1111/j.1939-165X.1986.tb00653.x; BAKER RJ, 1988, CAN J VET RES, V52, P308; Barrera R, 2010, ARCH MED VET, V42, P173, DOI 10.4067/S0301-732X2010000300008; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Chromy BA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-281; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Crisman MV, 2008, VET CLIN N AM-EQUINE, V24, P285, DOI 10.1016/j.cveq.2008.03.004; Department of Environmental Affairs RoSA, 2016, MIN EDN MOL HIGHL PR; Eckersall PD, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P117; French J. M., 1995, Equine Veterinary Education, V7, P33, DOI 10.1111/j.2042-3292.1995.tb01179.x; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; FURUKAWA T, 1986, JPN J VET SCI, V48, P643; Geffre A, 2009, VET CLIN PATH, V38, P477, DOI 10.1111/j.1939-165X.2009.00155.x; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Gerou-Ferriani M, 2011, VET CLIN PATH, V40, P159, DOI 10.1111/j.1939-165X.2011.00310.x; Gimenez M, 2010, VET CLIN PATH, V39, P227, DOI 10.1111/j.1939-165X.2009.00204.x; Giordano A, 2010, VET CLIN PATH, V39, P464, DOI 10.1111/j.1939-165X.2010.00255.x; Govender D, 2011, J S AFR VET ASSOC, V82, P36; HATTINGH J, 1980, COMP BIOCHEM PHYS A, V67, P203, DOI 10.1016/0300-9629(80)90432-6; HATTINGH J, 1983, COMP BIOCHEM PHYS A, V75, P441, DOI 10.1016/0300-9629(83)90107-X; Hooijberg E, 2015, P 25 ANN ECVIM CA C; Hooijberg EH, 2017, VET CLIN PATH, V46, P287, DOI 10.1111/vcp.12490; Interlab S. r. l, 2016, EL PROC SER PROT BET; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Keffen RH, 1994, P S RHIN GAM RANCH A; Knapp SE, 1997, J WILDLIFE DIS, V33, P492, DOI 10.7589/0090-3558-33.3.492; KOCK MD, 1990, J ZOO WILDLIFE MED, V21, P283; KRISTENSEN F, 1977, AM J VET RES, V38, P1089; KRISTENSEN F, 1977, AM J VET RES, V38, P399; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; Lehnhardt M, 2005, BURNS, V31, P159, DOI 10.1016/j.burns.2004.08.015; Marco I, 1999, RES VET SCI, V66, P81, DOI 10.1053/rvsc.1998.0248; Mathebula N, 2012, J ZOO WILDLIFE MED, V43, P530, DOI 10.1638/2011-0259R.1; MATTHEWS AG, 1982, EQUINE VET J, V14, P322, DOI 10.1111/j.2042-3306.1982.tb02443.x; Miller M, 2015, J WILDLIFE DIS, V51, P916, DOI 10.7589/2015-03-081; Miller M, 2012, J ZOO WILDLIFE MED, V43, pS55, DOI 10.1638/2011-0147.1; Modise A., 2017, MINISTER MOLEWA HIGH; MUSOKE AJ, 1982, IMMUNOLOGY, V45, P663; Nagyova V, 2016, SMALL RUMINANT RES, V144, P145, DOI 10.1016/j.smallrumres.2016.09.016; OSBALDISTON GW, 1972, BRIT VET J, V128, P386, DOI 10.1016/S0007-1935(17)36832-X; Otiende MY, 2015, BMC VET RES, V11, DOI 10.1186/s12917-014-0316-2; Piccione G, 2014, J APPL ANIM RES, V42, P123, DOI 10.1080/09712119.2013.795900; PIENAAR D J, 1991, Koedoe, V34, P97; Pompeo M, 2007, OSTOMY WOUND MANAG, V53, P30; Quain AM, 2015, WOUNDS, V27, P327; Riond B, 2009, VET CLIN PATH, V38, P73, DOI 10.1111/j.1939-165X.2008.00100.x; Rosenthal KL, 2005, AM J VET RES, V66, P375, DOI 10.2460/ajvr.2005.66.375; Sample SH, 2015, VET CLIN PATH, V44, P194, DOI 10.1111/vcp.12248; Seal U.S., 1976, Journal Zool Anim Med, V7, P11; Stockham S.L., 2008, FUNDAMENTALS VET CLI, V2nd ed., P369, DOI [10.1186/s13071-021-04626-4, DOI 10.1186/S13071-021-04626-4]; Taylor SS, 2010, J FELINE MED SURG, V12, P643, DOI 10.1016/j.jfms.2010.03.018; Teare JA., 2013, SPECIES360 PHYSIOLOG; THOMAS LA, 1992, AM J VET RES, V53, P2241; VAHALA J, 1994, ACTA VET BRNO, V63, P99, DOI 10.2754/avb199463020099; Vance CK, 2004, J ZOO WILDLIFE MED, V35, P435, DOI 10.1638/04-014; VANHEERDEN J, 1985, J S AFR VET ASSOC, V56, P187	62	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200347	10.1371/journal.pone.0200347	http://dx.doi.org/10.1371/journal.pone.0200347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044807	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500045
J	Shackleton, CM				Shackleton, Charlie M.			Urban street names: An opportunity to examine biocultural relationships?	PLOS ONE			English	Article							BIODIVERSITY; DIVERSITY; POLITICS; PLACE; SENSE	With increasing urbanisation there is concern regarding loss of experience and knowledge of biodiversity amongst urban populations. Yet biodiversity representations are retained in many art and functional forms, including names of places, buildings, institutions and streets. These manifestations offer a window to examine the relationship between humans and their experienced or imagined environment using a biocultural lens. I quantified the current prevalence of urban streets named after animals or plant species, the diversity of species represented, whether they are native or non-native, whether representative of the biome in which the town was situated and the change in prevalence through time. The street names of 48 towns in a one degree wide south-north belt across seven of South African's biomes were captured and analysed. Of the 4,359 street names, 11.1% were named after plants (218 species) and 5.3% after animals (131 species), although some towns had none and others more than 40%. Approximately half of the plants were native to South Africa, whereas over 80% of the animals were. There was no correspondence between the species composition reflected in street names and the biome in which towns were located. The proportion of streets named after plants or animals has generally increased over the last two hundred years. These results provide insights into the bioculturally defined plants and animals that are valued by past and present urban communities, showing that they are generally from a wider array than can be found or experienced in the local setting.	[Shackleton, Charlie M.] Rhodes Univ, Dept Environm Sci, Grahamstown, South Africa	Rhodes University	Shackleton, CM (corresponding author), Rhodes Univ, Dept Environm Sci, Grahamstown, South Africa.	c.shackleton@ru.ac.za	Shackleton, Charlie/GLV-1260-2022; Shackleton, Charlie M/F-4177-2014	Shackleton, Charlie/0000-0002-8489-6136; 	national Research Foundation of South Africa	national Research Foundation of South Africa(National Research Foundation - South Africa)	This work was funded by the national Research Foundation of South Africa (http://www.nrf.ac.za/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman DH, 2003, AREA, V35, P163, DOI 10.1111/1475-4762.00250; Augustins G., 2004, HIST ANTHR, V15, P289; Azaryahu M, 1997, POLIT GEOGR, V16, P479, DOI 10.1016/S0962-6298(96)00053-4; Azaryahu M, 1996, ENVIRON PLANN D, V14, P311, DOI 10.1068/d140311; Baker S, 2015, LOCAL ENVIRON, V20, P321, DOI 10.1080/13549839.2013.842964; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Bobo KS, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-2; Bonie M, 2015, ENVIRON SCI POLICY, V54, P487, DOI 10.1016/j.envsci.2015.05.009; Botzat A, 2016, GLOBAL ENVIRON CHANG, V39, P220, DOI 10.1016/j.gloenvcha.2016.04.008; Cocks M, 2006, HUM ECOL, V34, P185, DOI 10.1007/s10745-006-9013-5; Czembrowski P, 2016, URBAN FOR URBAN GREE, V20, P89, DOI 10.1016/j.ufug.2016.07.010; DEAT, 2012, SOUTH AFR ENV OUTL; Elands BHM, 2015, BIODIVERS CONSERV, V24, P3347, DOI 10.1007/s10531-015-0985-6; Fagundez J, 2016, APPL GEOGR, V74, P23, DOI 10.1016/j.apgeog.2016.06.012; Garibaldi A, 2004, ECOL SOC, V9; Gavin MC, 2015, TRENDS ECOL EVOL, V30, P140, DOI 10.1016/j.tree.2014.12.005; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; Guyot S, 2007, S AFR GEOGR J, V89, P55, DOI 10.1080/03736245.2007.9713873; Horwitz P, 2001, ECOSYST HEALTH, V7, P253, DOI 10.1046/j.1526-0992.2001.01044.x; Kerley GIH, 2003, S AFR J WILDL RES, V33, P13; McCracken DP, 2012, CRIT ARTS, V26, P447, DOI 10.1080/02560046.2012.723800; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Posey DA, 2009, CULTURAL SPIRITUAL V, P1; Pretty J., 2009, CONSERV SOC, V7, P100, DOI DOI 10.4103/0972-4923.58642; Rangnekar D, 2004, 8 UNCTADICTSD; Rohrschneider R, 2015, CIVIC CULTURE TRANSF, P193; Shoval N, 2013, T I BRIT GEOGR, V38, P612, DOI 10.1111/tran.12003; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Stedman RC, 2003, SOC NATUR RESOUR, V16, P671, DOI 10.1080/08941920309189; Teuber R, 2010, J INT FOOD AGRIBUS M, V22, P277, DOI 10.1080/08974431003641612; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x	33	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200891	10.1371/journal.pone.0200891	http://dx.doi.org/10.1371/journal.pone.0200891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044855	Green Submitted, gold, Green Published			2022-12-26	WOS:000439942500068
J	Lunn, TJ; Gerwin, M; Buettel, JC; Brook, BW				Lunn, Tamika J.; Gerwin, Melissa; Buettel, Jessie C.; Brook, Barry W.			Impact of intense disturbance on the structure and composition of wet-eucalypt forests: A case study from the Tasmanian 2016 wildfires	PLOS ONE			English	Article							MOUNTAIN ASH FOREST; PACIFIC-NORTHWEST; FIRE; REGENERATION; ABUNDANCE; ESTABLISHMENT; CONSERVATION; COMMUNITIES; BAKER,R.T.; RESPONSES	Fire is a key process in eucalypt communities, exerting a strong influence on the composition, structure and functioning of forests. Much of the research on the fire response of temperate, wet-sclerophyll trees in Australia comes from Victoria, where the dominant eucalypt is Eucalyptus regnans. In contrast, central and northern Tasmanian forests, dominated by Eucalyptus delegatensis, are relatively understudied. There is a need to determine whether Tasmanian wet-sclerophyll forests, though the same forest type in name, are functionally different in floristics and response to fire. Here we document the forest community response to a natural wildfire event in Tasmania-using opportunistic before/after control/impact (BACI) data from pre-existing monitoring plots. Uniting pre- and post-fire floristic data, we quantified mortality and regeneration of eucalypt, acacia and other dominant tree species, and tree ferns, Dicksonia antarctica, in response to wildfire. We also evaluated the density of eucalypt and acacia seedling establishment between burnt and unburnt forests, and quantified faunal responses to fire. Despite moderate-to-high intensity burning in patches across the plot, mortality of eucalypts, acacias and tree ferns due to fire were low. By contrast, fire-sensitive rainforest species showed low survival, though were able to persist in unburnt refugia. Eucalypt and acacia seedling regeneration was high in the burnt plot, suggesting that E. delegatensis forests regenerate without stand-replacing fire events. This contrasts to Victorian E. regnans forests, whose persistence is dependent on high-severity stand-replacing events. We also found some group-specific avifaunal and invertebrate responses to the fire event, which are broadly reflective of responses documented in other Victorian-based studies. Our results have implications for Tasmanian wet-forest silvicultural practices, which are based on the principle of stand-replacement after fire. The broader relevance of this work to forest ecology is in demonstrating the serendipitous opportunities that can arise with baseline monitoring plots.	[Lunn, Tamika J.; Gerwin, Melissa; Buettel, Jessie C.; Brook, Barry W.] Univ Tasmania, Sch Nat Sci, ARC Ctr Excellence Australian Biodivers & Heritag, Sandy Bay, Tas, Australia	University of Tasmania	Lunn, TJ (corresponding author), Univ Tasmania, Sch Nat Sci, ARC Ctr Excellence Australian Biodivers & Heritag, Sandy Bay, Tas, Australia.	tamika.lunn@utas.edu.au	Lunn, Tamika J/AAL-2093-2020; CABAH, ARC/T-6419-2019	Lunn, Tamika J/0000-0003-4439-2045; Buettel, Jessie/0000-0001-6737-7468	Australian Research Council [FL160100101]	Australian Research Council(Australian Research Council)	All authors were supported by an Australian Laureate Fellowship, awarded to BWB by the Australian Research Council (FL160100101, http://www.arc.gov.au/australian-laureate-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P301, DOI 10.1016/0378-1127(94)90115-5; BATTAGLIA M, 1993, AUST J BOT, V41, P119, DOI 10.1071/BT9930119; Benyon RG, 2013, FOREST ECOL MANAG, V294, P197, DOI 10.1016/j.foreco.2012.04.003; Bowman D, 1984, J BIOGEOGR, P427; Bowman DMJS, 2014, GLOBAL CHANGE BIOL, V20, P1008, DOI 10.1111/gcb.12433; Bowman DM, 2017, NATURE ECOLOGY EVOLU, V1, P1; BOWMAN DMJS, 1986, AUST J BOT, V34, P63, DOI 10.1071/BT9860063; Buddle CM, 2000, ECOGRAPHY, V23, P424, DOI 10.1034/j.1600-0587.2000.230405.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cremer K., 1977, DISTANCE SEED DISPER; CREMER K. W., 1965, AUSTRALIAN J BOT, V13, P303; Fuchs SA, 2003, CAN J FOREST RES, V33, P1408, DOI [10.1139/x03-070, 10.1139/X03-070]; Hickey J. E., 1999, Australian Forestry, V62, P66; HILL RS, 1984, AUST J BOT, V32, P481, DOI 10.1071/BT9840481; HOWARD TM, 1973, AUST J BOT, V21, P79, DOI 10.1071/BT9730079; Jones DT, 2005, METH ECOL, P221, DOI 10.1002/9780470750513.ch10; KIRKPATRICK JB, 1982, SEARCH, V13, P136; Lane PNJ, 2010, ENVIRON MODELL SOFTW, V25, P467, DOI 10.1016/j.envsoft.2009.11.001; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Linden DW, 2013, FOREST ECOL MANAG, V310, P1045, DOI 10.1016/j.foreco.2013.08.059; Loyn Richard H., 1997, Pacific Conservation Biology, V3, P221; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; Marris E, 2016, NATURE, V530, P137, DOI 10.1038/nature.2016.19308; McCarthy MA, 1998, FOREST ECOL MANAG, V104, P43, DOI 10.1016/S0378-1127(97)00231-4; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; OKSANEN J, 1983, VEGETATIO, V52, P181, DOI 10.1007/BF00044995; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Ough K, 2004, FOREST ECOL MANAG, V199, P153, DOI 10.1016/j.foreco.2004.05.030; Ough K., 1996, Australian Forestry, V59, P178; Pausas JG, 2015, FUNCT ECOL, V29, P315, DOI 10.1111/1365-2435.12372; Pearson SF, 2001, ECOL APPL, V11, P840, DOI 10.1890/1051-0761(2001)011[0840:BBRTRB]2.0.CO;2; Perry GLW, 2008, J VEG SCI, V19, P705, DOI 10.3170/2008-8-18441; Prior LD, 2016, AUST J BOT, V64, P193, DOI 10.1071/BT15259; RIDPATH MG, 1966, IBIS, V108, P348; Skvarla M. J., 2014, Journal of the Entomological Society of Ontario, V145, P15; Smith AL, 2014, ECOSYSTEMS, V17, P258, DOI 10.1007/s10021-013-9721-9; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Verner J., 1985, Current Ornithology, V2, P247; Vivian LM, 2008, AUSTRAL ECOL, V33, P55, DOI 10.1111/j.1442-9993.2007.01790.x; Ward DF, 2001, J INSECT CONSERV, V5, P47, DOI 10.1023/A:1011317423622; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wood SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137811; York A, 1999, J INSECT CONSERV, V3, P191, DOI 10.1023/A:1009643627781; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	47	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200905	10.1371/journal.pone.0200905	http://dx.doi.org/10.1371/journal.pone.0200905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028860	Green Published, gold, Green Accepted			2022-12-26	WOS:000439396900025
J	Okura, T; Nakamura, R; Fujioka, Y; Kawamoto-Kitao, S; Ito, Y; Matsumoto, K; Shoji, K; Sumi, K; Matsuzawa, K; Izawa, S; Ueta, E; Kato, M; Imamura, T; Taniguchi, S; Yamamoto, K				Okura, Tsuyoshi; Nakamura, Risa; Fujioka, Yohei; Kawamoto-Kitao, Sonoko; Ito, Yuichi; Matsumoto, Kazuhisa; Shoji, Kyoko; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Ueta, Etsuko; Kato, Masahiko; Imamura, Takeshi; Taniguchi, Shin-ichi; Yamamoto, Kazuhiro			Body mass index >= 23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; GLUCOSE-METABOLISM; SENSITIVITY; MUSCLE; LIVER; DIET; BMI	Background Screening for undiagnosed type 2 diabetes mellitus is recommended for Asian Americans with a body mass index >= 23. However, the optimal body mass index cut-off score for predicting the risk of diabetes mellitus in Japanese people is not well known. The aim of this study was to determine the best body mass index cut-off score for predicting insulin resistance and diabetes mellitus in the Japanese population. Methods This study had two parts, a clinical investigation and a retrospective observational investigation. In the clinical part of the study, 58 participants (26 with type 2 diabetes mellitus and 32 non-diabetics) underwent a hyperinsulinemic-euglycemic clamp from which their glucose disposal rate was measured. For the retrospective part of the study, medical check-up data from 88,305 people in the Tottori Prefecture were analyzed for clinical evidence of diabetes mellitus. The optimal BMI cut-off scores for prediction of insulin resistance and diabetes mellitus were determined. Results In the clamp study, the optimal body mass index cut-off score to predict insulin resistance in non-diabetic patients was 22.7. All participants with type 2 diabetes mellitus were insulin resistant, and the optimal body mass index cut-off score for prediction of severe insulin resistance was 26.2. When the data from the type 2 diabetic and the non-diabetic participants were combined, the optimal body mass index cut-off score for prediction of insulin resistance was 23.5. Analysis of 88,305 medical check-up records yielded an optimal body mass index cut-off score for prediction of diabetes mellitus of 23.6. Conclusions These results suggest that having a body mass index >= 23 is a risk factor for insulin resistance and diabetes mellitus in the Japanese population.	[Okura, Tsuyoshi; Nakamura, Risa; Fujioka, Yohei; Kawamoto-Kitao, Sonoko; Ito, Yuichi; Matsumoto, Kazuhisa; Shoji, Kyoko; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan; [Ueta, Etsuko] Tottori Univ, Fac Med, Sch Hlth Sci, Yonago, Tottori, Japan; [Imamura, Takeshi] Tottori Univ, Fac Med, Div Mol Pharmacol, Yonago, Tottori, Japan; [Taniguchi, Shin-ichi] Tottori Univ, Fac Med, Dept Reg Med, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Okura, T (corresponding author), Tottori Univ, Fac Med, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan.	ohkura@tottori-u.ac.jp		Okura, Tsuyoshi/0000-0003-3713-6617	JSPS KAKENHI [16K08935]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS KAKENHI Grant-in-Aid for Scientific Research (C) grant number 16K08935.	AKAZAWA Y, 1994, DIABETES RES CLIN PR, V24, pS23, DOI 10.1016/0168-8227(94)90223-2; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Kakehi S, 2016, AM J PHYSIOL-ENDOC M, V310, pE32, DOI 10.1152/ajpendo.00220.2015; Kang ES, 2005, METABOLISM, V54, P206, DOI 10.1016/j.metabol.2004.08.014; Kawaguchi M, 2014, J CLIN ENDOCR METAB, V99, P3343, DOI 10.1210/jc.2014-1896; Kawamori R, 1998, DIABETES RES CLIN PR, V41, P35, DOI 10.1016/S0168-8227(98)00056-4; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ohkura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-21; Okura T, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5139750; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Sakurai Y, 2011, J DIABETES INVEST, V2, P310, DOI 10.1111/j.2040-1124.2010.00091.x; Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Takeno K, 2016, J CLIN ENDOCR METAB, V101, P3676, DOI 10.1210/jc.2016-1650; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; The Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology, 2002, ETH GUID EP RES; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Yamauchi K, 2014, ACTA DIABETOL, V51, P441, DOI 10.1007/s00592-013-0535-1; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201052	10.1371/journal.pone.0201052	http://dx.doi.org/10.1371/journal.pone.0201052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028879	Green Published, Green Submitted, gold			2022-12-26	WOS:000439396900036
J	Duman-Scheel, M; Eggleson, KK; Achee, NL; Grieco, JP; Hapairai, LK				Duman-Scheel, Molly; Eggleson, Kathleen K.; Achee, Nicole L.; Grieco, John P.; Hapairai, Limb K.			Mosquito control practices and perceptions: An analysis of economic stakeholders during the Zika epidemic in Belize, Central America	PLOS ONE			English	Article							AEDES-AEGYPTI; WEST	The tourist-based economy of Belize, a tropical hub for eco-tourism, is at high risk to be disproportionately impacted by established and emerging mosquito-borne diseases such as Zika. An online survey was used to probe economic stakeholders working in the Belize tourism industry about their mosquito control practices and perceptions. Responses demonstrated that the respondents have good working knowledge of mosquitoes and mosquito-borne illnesses. Most businesses surveyed engage in some means of mosquito control, either through larval source reduction or use of insecticides on the premises. Larvicide use was significantly correlated with a general willingness to use insecticides, as well as belief that treatment of water will reduce mosquito densities and disease transmission. A majority of the respondents agreed that they would be interested in buying a new larvicide to be used on the business premises if it were shown to be safe and effective. The safety of mosquito control products for humans, animals, plants, and the environment in general, followed by product effectiveness, are the most critical determinants of mosquito control purchasing decisions. A majority of respondents agreed that control of mosquitoes and mosquito-borne illnesses is central to the success of their tourist-based industry. Respondents expressed significant concern that the Zika epidemic was over-sensationalized by the media, and that this negatively impacted their livelihoods. The respondents, many of whom are associated with eco/sustainable businesses, also voiced concerns that chemical pesticides could have a negative impact on human health and the environment and expressed a desire for balance between effective mosquito control and preservation of the rich biodiversity of Belize. This study provided a framework for further engagement activities in Belize and other Caribbean nations, uncovered both concerns and support for emerging mosquito control technologies, and revealed opportunities for further debate and educational outreach efforts.	[Duman-Scheel, Molly; Hapairai, Limb K.] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA; [Duman-Scheel, Molly; Eggleson, Kathleen K.; Achee, Nicole L.; Grieco, John P.; Hapairai, Limb K.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Duman-Scheel, Molly; Achee, Nicole L.; Grieco, John P.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Eggleson, Kathleen K.] Indiana Univ Sch Med, Dept Med, South Bend, IN USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Duman-Scheel, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	mscheel@nd.edu		Hapairai, Limb/0000-0002-2943-1061; Grieco, John/0000-0002-2080-8598; Achee, Nicole/0000-0001-6939-2055	United States Agency for International Development [AID-OAA-F-16-00097]	United States Agency for International Development(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development (https://www.usaid.gov/) award #AID-OAA-F-16-00097 to MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, MEXICO J; [Anonymous], 2016, AED AEG GELBF; Blamey RK, 2001, PRINCIPLES ECOTOURIS; Blersch David M., 2013, Environment Development and Sustainability, V15, P67, DOI 10.1007/s10668-012-9374-4; Brown DM, 2014, VECTOR-BORNE ZOONOT, V14, P291, DOI 10.1089/vbz.2013.1364; CDC, 2018, TRAV HLTH; CDC, 2018, NAT CTR EM ZOON INF; CDC, 2018, DENGUE; CDC, 2018, ZIK PREGN; CDC, 2018, ZIK VIR; Chadee DD, 2007, ACTA TROP, V104, P1, DOI 10.1016/j.actatropica.2007.06.006; Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1792; Cruise complete, 2018, BEL CRUIS; Despain D., 2015, AM ATTITUDES GMO FOO; Destinations Belize, 2018, VAC PLANN PLAC PEN B; Dusfour I, 2010, J PEST SCI, V83, P41, DOI 10.1007/s10340-009-0268-7; Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035; Finke MS, 2004, J AGROBIOTECHNOLOGY, V6, P7; Funk C, PUBLIC OPINION FOOD; Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y; Hapairai LK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13566-y; Honey M., 2008, ECOTOURISM SUSTAINAB; Kumar A., 2013, MALARIAWORLD J, V4, P1, DOI DOI 10.1038/NC0MMS3618; Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009; Magnusson MK, 2002, APPETITE, V39, P9, DOI 10.1006/appe.2002.0486; Moerbeek H., 2005, International Journal of Consumer Studies, V29, P308, DOI 10.1111/j.1470-6431.2005.00441.x; Mysore K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2112-5; Naturally Belize, 2018, BEL ECOT; Oliva CF, 2014, ACTA TROP, V132, pS130, DOI 10.1016/j.actatropica.2013.11.019; Online-Utility.org, 2018, TEXT AN; PAHO, 2017, DENG FEV AM; PAHO, 2017, ZIK EPID REP; Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961; Subramaniam TSS, 2012, BIOTECHNOL J, V7, P1323, DOI 10.1002/biot.201200282; Van Ekert E, 2014, J INSECT PHYSIOL, V70, P143, DOI 10.1016/j.jinsphys.2014.08.001; von Schomberg R., 2011, TECH NIKFOLGEN ABSCH; Wagman J., 2014, SPATIAL REPELLENCY F; WHO, 2018, ZIK VIR; WHO, 2018, VECT SURV CONTR; Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; World Health Organization, 2009, DENGUE GUIDELINES DI	42	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201075	10.1371/journal.pone.0201075	http://dx.doi.org/10.1371/journal.pone.0201075			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024951	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000089
J	Qian, KV; Wang, SM; Fu, MN; Zhou, JF; Singh, JP; Li, MD; Yang, YF; Zhang, KS; Wu, J; Nie, YZ; Ruan, HB; Yang, XY				Qian, Kevin; Wang, Simeng; Fu, Minnie; Zhou, Jinfeng; Singh, Jay Prakash; Li, Min-Dian; Yang, Yunfan; Zhang, Kaisi; Wu, Jing; Nie, Yongzhan; Ruan, Hai-Bin; Yang, Xiaoyong			Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-linked N-acetylglucosamine (O-GlcNAc); O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); E1A binding protein p300 (P300); CCAAT-enhancer-binding protein (C; EBP); extracellular-signal-regulated kinase (ERK); pancreatic cancer; O-GlcNAcase (OGA)	BETA-N-ACETYLGLUCOSAMINE; ACTIVATED PROTEIN-KINASE; GLUCOSE DEPRIVATION; LINKING METABOLISM; UP-REGULATION; C/EBP-BETA; GLCNACYLATION; TRANSFERASE; PHOSPHORYLATION; GLYCOSYLATION	Many intracellular proteins are reversibly modified by O-linked GlcNAc (O-GlcNAc), a post-translational modification that dynamically regulates fundamental cellular processes in response to diverse environmental cues. Accumulating evidence indicates that both excess and deficiency of protein O-GlcNAcylation can have deleterious effects on the cell, suggesting that maintenance of O-GlcNAc homeostasis is essential for proper cellular function. However, the mechanisms through which O-GlcNAc homeostasis is maintained in the physiologic state and altered in the disease state have not yet been investigated. Here, we demonstrate the existence of a homeostatic mechanism involving mutual regulation of the O-GlcNAc-cycling enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) at the transcriptional level. Specifically, we found that OGA promotes Ogt transcription through cooperation with the histone acetyltransferase p300 and transcription factor CCAAT/enhancer-binding protein (C/EBP). To examine the role of mutual regulation of OGT and OGA in the disease state, we analyzed gene expression data from human cancer data sets, which revealed that OGT and OGA expression levels are highly correlated in numerous human cancers, particularly in pancreatic adenocarcinoma. Using a Kras(G12D)-driven primary mouse pancreatic ductal adenocarcinoma (PDAC) cell line, we found that inhibition of extracellular signal-regulated kinase (ERK) signaling decreases OGA glycosidase activity and reduces OGT mRNA and protein levels, suggesting that ERK signaling may alter O-GlcNAc homeostasis in PDAC by modulating OGA-mediated Ogt transcription. Our study elucidates a transcriptional mechanism that regulates cellular O-GlcNAc homeostasis, which may lay a foundation for exploring O-GlcNAc signaling as a therapeutic target for human disease.	[Qian, Kevin; Wang, Simeng; Fu, Minnie; Singh, Jay Prakash; Li, Min-Dian; Yang, Yunfan; Zhang, Kaisi; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06510 USA; [Qian, Kevin; Wang, Simeng; Fu, Minnie; Singh, Jay Prakash; Li, Min-Dian; Yang, Yunfan; Zhang, Kaisi; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06510 USA; [Qian, Kevin; Li, Min-Dian; Zhang, Kaisi; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Wang, Simeng; Zhou, Jinfeng; Nie, Yongzhan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Wu, Jing] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Ruan, Hai-Bin] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	Yale University; Yale University; Yale University; Air Force Military Medical University; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Yang, XY (corresponding author), Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06510 USA.	xiaoyong.yang@yale.edu	Wang, Simeng/W-8686-2018; Li, Min-Dian/F-1721-2015; Ruan, Hai-Bin/AAN-7777-2021; Yang, Yunfan/AAN-9231-2020	Li, Min-Dian/0000-0002-3650-1507; Ruan, Hai-Bin/0000-0002-3858-1272; Yang, Yunfan/0000-0002-5266-7208	National Institutes of Health [R01 DK089098, R01DK102648, P01DK057751]; American Cancer Society [RSG-14-244-01-TBE]; State of Connecticut [DPH2014-0139]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK102648, R01DK089098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); State of Connecticut; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 DK089098, R01DK102648, and P01DK057751; American Cancer Society Grant RSG-14-244-01-TBE; and State of Connecticut Grant DPH2014-0139 (to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Champattanachai V, 2013, PROTEOMICS, V13, P2088, DOI 10.1002/pmic.201200126; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Ferrari A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00182-7; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Groves JA, 2017, J BIOL CHEM, V292, P6493, DOI 10.1074/jbc.M116.760785; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Josefowicz SZ, 2016, MOL CELL, V64, P347, DOI 10.1016/j.molcel.2016.09.026; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Muthusamy S, 2015, J BIOL CHEM, V290, P31013, DOI 10.1074/jbc.M115.677534; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Park SK, 2017, CELL REP, V20, P1088, DOI 10.1016/j.celrep.2017.07.017; Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Wang T, 2017, NAT CELL BIOL, V19, P833, DOI 10.1038/ncb3562; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang YR, 2014, ADV BIOCHEM HEALTH D, V10, P3, DOI 10.1007/978-1-4939-0464-8_1; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zhang ER, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag0486; Zhang XL, 2015, MOL CELL BIOCHEM, V410, P101, DOI 10.1007/s11010-015-2542-8; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	58	43	43	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13989	14000		10.1074/jbc.RA118.004709	http://dx.doi.org/10.1074/jbc.RA118.004709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30037904	Green Published, hybrid			2022-12-26	WOS:000444070700023
J	Liu, ZJL; Zhou, YJ; Ding, RL; Xie, F; Fu, SZ; Wu, JB; Yang, LL; Wen, QL				Liu, Zong-Jun-Lin; Zhou, Yu-Juan; Ding, Rui-Lin; Xie, Fang; Fu, Shao-Zhi; Wu, Jing-Bo; Yang, Ling-Lin; Wen, Qing-Lian			In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR-2; CANCER; ANGIOGENESIS; PATHWAYS; VEGF	The effect of apatinib on the formation of vasculogenic mimicry (VM) was studied in a malignant melanoma cell line. MUM-2B cells cultured in three-dimensional Matrigel were treated with varying concentrations (0, 0.01, 0.05, 0.1, 0.5 mu mol/L) of apatinib to test its effect on VM in vitro, followed by MTT proliferation and transwell invasion assays to determine the effect of apatinib on cell proliferation and invasion of MUM-2B cells. In vivo, we used a melanoma cancer model to test the effect of short-term apatinib (100, 200, 300 mg/kg) treatment on VM. Western blotting, immunohistochemistry staining, and CD31-PAS dual staining were performed to assess the expression of VEGFR-2, ERK-1/2, P13K, and MMP-2, and formation of VM. The results showed apatinib-treated groups formed a lesser number of VM in 3D matrigel, while the cell viability in MTT proliferation assay and the number of migration cells in transwell invasion assay were significantly lower in apatinib-treated groups. In addition, short-term apatinib treatment inhibited angiogenesis, VM formation, and tumor growth in models of melanoma cancer. Mice in apatinib-treated groups showed a markedly reduced expression of VEGFR-2, ERK-1/2, P13K, and MMP-2. In summary, apatinib could inhibit the expression of VEGFR-2, and downregulate the ERK1/2/PI3K/MMP-2 signaling cascade, which may be one of the underlying mechanisms by which apatinib inhibits angiogenesis and the development of VM in models of melanoma cancer, and restrains the formation of VM by MUM-2B cells. Apatinib shows inhibitory effects on cell proliferation and invasion of MUM-2B cells, which is a close relationship with the VM.	[Liu, Zong-Jun-Lin; Zhou, Yu-Juan; Xie, Fang; Fu, Shao-Zhi; Wu, Jing-Bo; Yang, Ling-Lin; Wen, Qing-Lian] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Sichuan, Peoples R China; [Ding, Rui-Lin] Southwest Med Univ, Affiliated Hosp, Inst Drug Clin Trial, GCP Ctr, Luzhou, Sichuan, Peoples R China	Southwest Medical University; Southwest Medical University	Wen, QL (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Sichuan, Peoples R China.	wql73115@hotmail.com	Fu, ShaoZhi/ABI-5082-2020; Fu, ShaoZhi/L-4019-2017; Wu, Jing/GZK-5063-2022	Fu, ShaoZhi/0000-0002-8666-4304; Fu, ShaoZhi/0000-0002-8666-4304; 	Jiangsu Hengrui Medicine Co., Ltd (Lianyungang, Jiangsu, China)	Jiangsu Hengrui Medicine Co., Ltd (Lianyungang, Jiangsu, China)	We are applying the grant support from Jiangsu Hengrui Medicine Co., Ltd (Lianyungang, Jiangsu, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi SA, 2010, ARCH IRAN MED, V13, P498, DOI 010136/AIM.009; Clemente M, 2010, VET PATHOL, V47, P265, DOI 10.1177/0300985809353167; Darrington E, 2012, ASIAN J ANDROL, V14, P745, DOI 10.1038/aja.2011.197; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Frenkel S, 2008, EYE, V22, P948, DOI 10.1038/sj.eye.6702783; Geng RX, 2015, EXPERT OPIN PHARMACO, V16, P117, DOI 10.1517/14656566.2015.981526; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Liu ZC, 2011, PATHOL RES PRACT, V207, P645, DOI 10.1016/j.prp.2011.07.012; Longo R, 2007, CANCER CHEMOTH PHARM, V60, P151, DOI 10.1007/s00280-006-0403-6; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Qu B, 2010, MED HYPOTHESES, V74, P360, DOI 10.1016/j.mehy.2009.08.020; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Stratmann A, 2001, INT J CANCER, V91, P273, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q; Sun W, 2013, ONCOL REP, V27, P1990; Tian S, 2011, CANCER SCI, V102, P1374, DOI 10.1111/j.1349-7006.2011.01939.x; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Wu L, 2017, IRAN J BASIC MED SCI, V20, P990, DOI 10.22038/IJBMS.2017.9263; Xie F, 2017, DRUG DELIV, V24, P1410, DOI 10.1080/10717544.2017.1378938; Xu XF, 2010, ACTA OPHTHALMOL, V88, pE160, DOI 10.1111/j.1755-3768.2010.01942.x; Xu Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-16; Yang XJ, 1996, J NEUROSCI, V16, P6089; Yao XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057188	26	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200845	10.1371/journal.pone.0200845	http://dx.doi.org/10.1371/journal.pone.0200845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052652	Green Published, gold, Green Submitted			2022-12-26	WOS:000440006600017
J	Fernandez-Cabrera, MR; Higuera-Matas, A; Fernaud-Espinosa, I; DeFelipe, J; Ambrosio, E; Miguens, M				Fernandez-Cabrera, Monica R.; Higuera-Matas, Alejandro; Fernaud-Espinosa, Isabel; DeFelipe, Javier; Ambrosio, Emilio; Miguens, Miguel			Selective effects Delta(9)-tetrahydrocannabinol on medium spiny neurons in the striatum	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; LONG-TERM POTENTIATION; DENDRITIC SPINES; CANNABINOID RECEPTOR; NUCLEUS-ACCUMBENS; HIPPOCAMPAL MORPHOLOGY; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; DISTAL DENDRITES	Derivatives from the Cannabis plant are the most commonly abused illegal substances in the world. The main psychoactive component found in the plant, Delta-9-tetrahydrocannabinol (THC), exerts its effects through the endocannabinoid system. Manipulations of this system affect some types of learning that seem to be dependent on dorsal striatum synaptic plasticity. Dendritic spines exhibit important synaptic functional attributes and a potential for plasticity, which is thought to mediate long-lasting changes in behaviour. To study the possible structural plasticity changes that prolonged THC administration might exert in the dorsal striatum, adult, male C57BL6/J mice were intraperitoneally injected with THC (10mg/kg) or vehicle for 15 days followed by a 7-day drug-free period. Using single cell intracellular injections of Lucifer Yellow, confocal microscopy, and 3D reconstruction of labelled neurons, we studied dendritic spine density and spine size in medium spiny neurons (MSNs) of the anterior dorsolateral striatum (aDLS) and posterior dorsomedial striatum (pDMS). We found that the THC treatment increased dendritic spine density in the distal part of the dendrites of MSNs in the pDMS, but no changes were found in the rest of the parameters analysed in either region studied. We also observed that dendritic spines of MSNs of pDMS presented lower volume and surface area values than MSNs of the aDLS. These results seem to indicate that THC could induce structural plasticity alterations in the circuits involving pDMS MSNs.	[Fernandez-Cabrera, Monica R.; Higuera-Matas, Alejandro; Ambrosio, Emilio] UNED, Fac Psicol, Dept Psicobiol, Madrid, Spain; [Fernaud-Espinosa, Isabel; DeFelipe, Javier; Miguens, Miguel] UPM, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain; [DeFelipe, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Miguens, Miguel] UNED, Fac Psicol, Dept Psicol Basica 1, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Universidad Nacional de Educacion a Distancia (UNED)	Miguens, M (corresponding author), UPM, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain.; Miguens, M (corresponding author), UNED, Fac Psicol, Dept Psicol Basica 1, Madrid, Spain.	mmiguens@psi.uned.es	Fernaud-Espinosa, Isabel/H-1875-2015; Higuera-Matas, Alejandro/E-6565-2013; Miguens, Miguel/L-4911-2014; DEFELIPE, JAVIER/D-1195-2014	Fernaud-Espinosa, Isabel/0000-0003-2391-0704; Higuera-Matas, Alejandro/0000-0003-3438-9387; Miguens, Miguel/0000-0002-7320-822X; DEFELIPE, JAVIER/0000-0001-5484-0660	Spanish Ministry of Health, Social Services and Equality [PND-2016I073]; Carlos III Health Institute [RTA-RD16/020/0022]; Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED) [CB06/05/0066]; Spanish Ministry of Economy and Competitiveness [SAF 2015-66603-P, PSI2016-80082-P, PSI80541-P]; Directorate General of Research of the Autonomous Community of Madrid [S-2011/BMD-2308]; European Union [JUST/2013/DPIP/AG/4823-EU MADNESS]	Spanish Ministry of Health, Social Services and Equality(Spanish Government); Carlos III Health Institute(Instituto de Salud Carlos III); Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED); Spanish Ministry of Economy and Competitiveness(Spanish Government); Directorate General of Research of the Autonomous Community of Madrid; European Union(European Commission)	Funding for this study was provided by the Spanish Ministry of Health, Social Services and Equality (http://www.pnsd.msssi.gob.es;grant PND-2016I073 to E.A.); the Carlos III Health Institute (http://www.isciii.es; grant RTA-RD16/020/0022 to E.A; the Centre for Networked Biomedical Research into Neurodegenerative Diseases (https://www.ciberned.es; CIBERNED, CB06/05/0066 to J.DF.); the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/idi; grant SAF 2015-66603-P to J.DF, grant PSI2016-80082-P to MM, and grant PSI80541-P to E.A); the Directorate General of Research of the Autonomous Community of Madrid (https://www.madrimasd.org/madrid-ciencia-tecnologia/convocatorias; grant S-2011/BMD-2308, Activities Programme I+D+I CANNAB-CM to EA); and European Union (https://ec.europa.eu/info/funding-tenders_en; grant JUST/2013/DPIP/AG/4823-EU MADNESS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2017, EUR DRUG REP; Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Ballesteros-Yanez I, 2007, NEUROSCIENCE, V146, P1536, DOI 10.1016/j.neuroscience.2007.03.017; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2013, CURR OPIN NEUROBIOL, V23, P564, DOI 10.1016/j.conb.2013.01.025; Benavides-Piccione R, 2013, CEREB CORTEX, V23, P1798, DOI 10.1093/cercor/bhs154; Bosch C, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00100; Bosch C, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.2015.00060, 10.3389/fnana.7015.00060]; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Candelaria-Cook FT, 2014, BRAIN RES, V1542, P104, DOI 10.1016/j.brainres.2013.10.039; Carvalho AF, 2016, BRAIN STRUCT FUNCT, V221, P407, DOI 10.1007/s00429-014-0914-6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dumitriu D, 2012, J NEUROSCI, V32, P6957, DOI 10.1523/JNEUROSCI.5718-11.2012; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Ehlinger DG, 2017, NEUROSCIENCE, V356, P242, DOI 10.1016/j.neuroscience.2017.05.036; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; Gipson CD, 2017, GENES BRAIN BEHAV, V16, P101, DOI 10.1111/gbb.12324; Goodman J, 2015, NEUROBIOL LEARN MEM, V125, P1, DOI 10.1016/j.nlm.2015.06.008; Grutzendler J, 2002, NATURE, P420, DOI [10.1038/101038/nature01276, DOI 10.1038/101038/NATURE01276]; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hart G, 2018, J NEUROSCI, V38, P1311, DOI 10.1523/JNEUROSCI.2850-17.2017; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; Kolb B, 2006, SYNAPSE, V60, P429, DOI 10.1002/syn.20313; Kolb B, 2018, SYNAPSE, V72, DOI 10.1002/syn.22020; Konur S, 2003, J NEUROBIOL, V56, P95, DOI 10.1002/neu.10229; KREUZ DS, 1973, SCIENCE, V179, P391, DOI 10.1126/science.179.4071.391; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Li YL, 2003, NEUROPSYCHOPHARMACOL, V28, P1082, DOI 10.1038/sj.npp.1300115; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Miguens M, 2015, CEREB CORTEX, V25, P56, DOI 10.1093/cercor/bht200; Morena M, 2014, NEUROBIOL LEARN MEM, V112, P30, DOI 10.1016/j.nlm.2013.12.010; Murray JE, 2012, NEUROPSYCHOPHARMACOL, V37, P2456, DOI 10.1038/npp.2012.104; Narushima M, 2006, NEUROSCI RES, V54, P159, DOI 10.1016/j.neures.2005.12.004; Nazzaro C, 2012, NAT NEUROSCI, V15, P284, DOI 10.1038/nn.3022; Niyuhire F, 2007, J PHARMACOL EXP THER, V322, P1067, DOI 10.1124/jpet.107.119594; Oikonomou KD, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00292; Parsons LH, 2015, NAT REV NEUROSCI, V16, P579, DOI 10.1038/nrn4004; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rubino T, 2005, J NEUROCHEM, V93, P984, DOI 10.1111/j.1471-4159.2005.03101.x; Rubino T, 2009, HIPPOCAMPUS, V19, P763, DOI 10.1002/hipo.20554; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Saravia R, 2017, BIOL PSYCHIAT, V81, P625, DOI 10.1016/j.biopsych.2016.07.007; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Selvas A, 2017, ADDICT BIOL, V22, P78, DOI 10.1111/adb.12294; Shan Q, 2014, J NEUROSCI, V34, P9196, DOI 10.1523/JNEUROSCI.0313-14.2014; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; Spiga S, 2011, CURR NEUROPHARMACOL, V9, P200, DOI 10.2174/157015911795017083; Spiga S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00110; Spiga S, 2010, ADDICT BIOL, V15, P266, DOI 10.1111/j.1369-1600.2010.00218.x; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wise LE, 2012, ACS CHEM NEUROSCI, V3, P369, DOI 10.1021/cn200130s; Xu NL, 2006, J NEUROSCI, V26, P3002, DOI 10.1523/JNEUROSCI.5220-05.2006; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010	87	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200950	10.1371/journal.pone.0200950	http://dx.doi.org/10.1371/journal.pone.0200950			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048477	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400036
J	Park, C; Kim, J; Kim, J; Park, S				Park, Chihyun; Kim, JungRim; Kim, Jeongwoo; Park, Sanghyun			Machine learning-based identification of genetic interactions from heterogeneous gene expression profiles	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NETWORK; ASSOCIATION; DATABASE	The identification of disease-related genes and disease mechanisms is an important research goal; many studies have approached this problem by analysing genetic networks based on gene expression profiles and interaction datasets. To construct a gene network, correlations or associations among pairs of genes must be obtained. However, when gene expression data are heterogeneous with high levels of noise for samples assigned to the same condition, it is difficult to accurately determine whether a gene pair represents a significant gene-gene interaction (GGI). In order to solve this problem, we proposed a random forest-based method to classify significant GGIs from gene expression data. To train the model, we defined novel feature sets and utilised various high-confidence interactome datasets to deduce the correct answer set from known disease-specific genes. Using Alzheimer's disease data, the proposed method showed remarkable accuracy, and the GGIs established in the analysis can be used to build a meaningful genetic network that can explain the mechanisms underlying Alzheimer's disease.	[Park, Chihyun; Kim, JungRim; Kim, Jeongwoo; Park, Sanghyun] Yonsei Univ, Dept Comp Sci, Seoul, South Korea	Yonsei University	Park, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul, South Korea.	sanghyun@yonsei.ac.kr		Park, Chihyun/0000-0003-4995-2312	Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT [NRF 2015M3C4A7065522]	Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT	This research was supported by Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (NRF 2015M3C4A7065522).	Ahn J, 2011, BIOINFORMATICS, V27, P1846, DOI 10.1093/bioinformatics/btr283; [Anonymous], 1998, NEURAL NETWORKS COMP; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Deshpande R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068664; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Gaiteri C, 2016, NAT REV NEUROL, V12, P413, DOI 10.1038/nrneurol.2016.84; Gov E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05298-w; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han ZP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179677; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Hu YS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0252-z; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; John G. H., 1995, MORGAN KAUFMANN, P338; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Koo CL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/432375; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Liang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040498; Madhukar NS, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00172; Narayanan M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145304; Park C, 2017, EXPERT SYST APPL, V85, P249, DOI 10.1016/j.eswa.2017.05.042; Park C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086309; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Siangphoe U, 2017, BRIEF BIOINFORM, V18, P602, DOI 10.1093/bib/bbw050; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Upstill-Goddard R, 2013, BRIEF BIOINFORM, V14, P251, DOI 10.1093/bib/bbs024; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yang YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5232; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201056	10.1371/journal.pone.0201056	http://dx.doi.org/10.1371/journal.pone.0201056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048494	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400045
J	Pun, KD; Rishal, P; Infanti, JJ; Bjorngaard, JH; Koju, R; Schei, B; Darj, E				Pun, Kunta Devi; Rishal, Poonam; Infanti, Jennifer Jean; Bjorngaard, Johan Hakon; Koju, Rajendra; Schei, Berit; Darj, Elisabeth		ADVANCE Study Grp	Exposure to domestic violence influences pregnant women's preparedness for childbirth in Nepal: A cross-sectional study	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; BIRTH-PREPAREDNESS; COMPLICATION READINESS; MIDWIVES; DISTRICT	Objective This study aimed to evaluate if domestic violence affected women's ability to prepare for childbirth. Birth preparedness and complication readiness (BP/CR) includes saving money, arranging transportation, identifying a skilled birth attendant, a health facility, and a blood donor before childbirth. During data collection, Nepal experienced two earthquakes and therefore it was possible to examine associations between domestic violence, women's BP/CR and effects of the earthquakes. Methods Women who were between 12 and 28 weeks of gestation participated in a descriptive crosssectional study at a hospital antenatal clinic in Nepal, where they completed a structured questionnaire on sociodemographic characteristics, obstetric history, experiences of domestic violence, and BP/CR. The 5-item Abuse Assessment Screen was used to assess prevalence of domestic violence, and a questionnaire on safe motherhood obtained from Jhpiego was used to assess BP/CR status. The participants self-completed the questionnaire on a tablet computer. Those who reported at least three out of five BP/CR activities were considered prepared for childbirth. Results A total of 1011 women participated in the study: 433 pre-earthquakes and 578 post-earthquakes. With respect to BP/CR, 78% had identified a health facility for childbirth and 65% had saved money prior to childbirth. Less than 50% had identified a birth attendant to assist with the delivery, transportation to a health facility, or arranged for a potential blood donor. Prior to the earthquakes, 38% were unprepared; by contrast, almost 62% were not prepared after the earthquakes. A significant association was found between exposure to violence and not being prepared for childbirth (AOR = 2.3, 95% CI: 1.4-3.9). The women with increased odds of not being prepared for childbirth were illiterate (AOR = 9.9, 95% CI: 5.7-17), young (AOR = 3.4, 95% CI: 1.6-7.2), from the most oppressed social classes (AOR = 3.0, 95% CI: 1.2-7.6), were married to illiterate husbands (AOR = 2.5, 95% CI: 1.2-5.2), had attended fewer than four antenatal visits (AOR = 2.0, 95% CI: 1.4-2.6), had low incomes (AOR = 1.7, 95% CI: 1.1-2.9) or lived in rural settings (AOR = 1.5, 95% confidence interval CI: 1.2-2.1). Conclusion The paper identifies vulnerable women who require extra care from the health system, and draws attention to the need for interventions to reduce the harmful effects of domestic violence on women's preparations for childbirth.	[Pun, Kunta Devi; Koju, Rajendra] Kathmandu Univ, Sch Med Sci, Dhulikhel, Kavre, Nepal; [Pun, Kunta Devi; Rishal, Poonam; Infanti, Jennifer Jean; Bjorngaard, Johan Hakon; Schei, Berit; Darj, Elisabeth] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway; [Pun, Kunta Devi; Rishal, Poonam; Darj, Elisabeth] Cent Norway Reg Hlth Author, Stjordal, Norway; [Bjorngaard, Johan Hakon] St Olavs Univ Hosp, Res Ctr Broset, Trondheim, Norway; [Schei, Berit; Darj, Elisabeth] St Olavs Univ Hosp, Dept Obstet & Gynecol, Trondheim, Norway; [Darj, Elisabeth] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Kathmandu University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Uppsala University	Pun, KD (corresponding author), Kathmandu Univ, Sch Med Sci, Dhulikhel, Kavre, Nepal.; Pun, KD (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway.; Pun, KD (corresponding author), Cent Norway Reg Hlth Author, Stjordal, Norway.	kunta.devi.pun@ntnu.no			Research Council of Norway [220893]; Samarbeidsorganet [16/29034]; Research Council of Norway; Liaison Committee; Samarbeidsorganet HMN-NTNU	Research Council of Norway(Research Council of Norway); Samarbeidsorganet; Research Council of Norway(Research Council of Norway); Liaison Committee; Samarbeidsorganet HMN-NTNU	This study was funded by the Research Council of Norway, grant number 220893, http://www.forskningsradet.no/en/The_Research_ Council/1138785832539, to BS. Research Council of Norway has funded the project under its Global Health and Vaccination Research (GLOBVAC) Program: 'Evaluating interventions in antenatal care to identify and assist victims of gender based violence in Nepal and Sri Lanka'. This study is also funded by the Samarbeidsorganet, grant number 16/29034, https://helse-midt.no/samarbeidsorganet, to ED. Along with Research Council of Norway, this project was funded by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology; Samarbeidsorganet HMN-NTNU.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Ahmad J, 2016, J INTERPERS VIOLENCE, V31, P3111, DOI 10.1177/0886260515584341; August F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125978; Basile H., 2007, EDITED CTR DIS CONTR; Bhatnagar T, 2013, AIDS BEHAV, V17, P2260, DOI 10.1007/s10461-013-0414-3; Bhatta DN, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-14; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Central Bureau of Statistics, 2016, DISTR PROF KAVR 2074; Chan KL, 2011, VIOLENCE VICTIMS, V26, P364, DOI 10.1891/0886-6708.26.3.364; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; Del Barco R., 2004, TOOLS INDICATORS MAT, P330; Garcia-Moreno C, 2005, WHO MULTI COUNTRY ST; Gebre M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137570; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Idowu A, 2015, INT J MCH AIDS, V4, P47, DOI DOI 10.21106/ijma.55; Jahanfar S., 2014, INTERVENTIONS PREVEN, pCD009414; Jayatilleke AC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1674-9; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Markos D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-282; Mazumdar R, 2014, INDIA AL AMEEN J MED, V7, P52; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health New ERA Nepal Health Sector Support Program (NHSSP) Inner City fund (ICF), 2017, NEP HLTH FAC SURV 20; Mukhopadhyay Dipta Kanti, 2016, J Family Med Prim Care, V5, P404; Mukhopadhyay Dipta Kanti, 2013, Indian J Public Health, V57, P147, DOI 10.4103/0019-557X.119827; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Nursing department of Dhulikhel Hospital, 2015, REP OBST GYN WARD; O'Reilly R, 2010, TRAUMA VIOLENCE ABUS, V11, P190, DOI 10.1177/1524838010378298; Omari PK, 2016, KENYA AM J MED SCI, V6, P123; Palladino CL, 2011, OBSTET GYNECOL, V118, P1056, DOI 10.1097/AOG.0b013e31823294da; Pandey J.P., 2013, MATERNAL CHILD HLTH; Parkinson D., 2017, J INTERPERS VIOLENCE; Pun KD, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31964; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rajib Saha APS., 2014, INT J PUBLIC HLTH RE, V4, P510; Rathod SD, 2011, J INTERPERS VIOLENCE, V26, P2437, DOI 10.1177/0886260510385125; Sakurai K, 2017, DISASTER MED PUBLIC, V11, P216, DOI 10.1017/dmp.2016.109; Stenson K, 2005, MIDWIFERY, V21, P311, DOI 10.1016/j.midw.2005.01.002; Stenson K, 2001, MIDWIFERY, V17, P2, DOI 10.1054/midw.2000.0241; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations, 2016, SUSTAINABLE SEVELOPM; Urassa DP, 2012, TANZAN J HLTH RES, V14, P42; Whitney R, 2017, J STRUCT ENG, V143, DOI 10.1061/(ASCE)ST.1943-541X.0001717; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2013, LONDON SCH HYGIENE T	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200234	10.1371/journal.pone.0200234	http://dx.doi.org/10.1371/journal.pone.0200234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048459	Green Published, gold, Green Submitted			2022-12-26	WOS:000439952400005
J	Bratek, E; Ziembowicz, A; Bronisz, A; Salinska, E				Bratek, Ewelina; Ziembowicz, Apolonia; Bronisz, Agnieszka; Salinska, Elzbieta			The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia	PLOS ONE			English	Article							N-ACETYLASPARTYLGLUTAMATE; CELL-DEATH; IMMATURE RAT; AGONIST; NEUROPROTECTION; NEURONS; DAMAGE; MODEL; GLUTATHIONE; LY379268	Birth asphyxia resulting in brain hypoxia-ischemia (H-I) can cause neonatal death or lead to persistent brain damage. Recent investigations have shown that group II metabotropic glutamate receptor (mGluR2/3) activation can provide neuroprotection against H-I but the mechanism of this effect is not clear. The aim of this study was to investigate whether mGluR2/3 agonists applied a short time after H-I reduce brain damage in an experimental model of birth asphyxia, and whether a decrease in oxidative stress plays a role in neuroprotection. Neonatal H-I in 7-day-old rats was used as an experimental model of birth asphyxia. Rats were injected intra peritoneally with mGluR2 (LY 379268) or mGluR3 (NAAG) agonists 1 h or 6 h after H-I (5 mg/kg). The weight deficit of the ischemic brain hemisphere, radical oxygen species (ROS) content levels, antioxidant enzymes activity and the concentrations of reduced glutathione (GSH) were measured. Both agonists reduced weight loss in the ischemic hemisphere and mitigated neuronal degeneration in the CA1 hippocampal region and cerebral cortex. Both agonists reduced the elevated levels of ROS in the ipsilateral hemisphere observed after H-I and prevented an increase in antioxidant enzymes activity in the injured hemisphere restoring them to control levels. A decrease in GSH level was also restored after agonists application. The results show that the activation of mGluR2 and mGluR3 a short time after H-I triggers neuroprotective mechanisms that act through the inhibition of oxidative stress and ROS production. The prevention of ROS production by the inhibition of glutamate release and decrease in its extracellular concentration is likely the main mechanism involved in the observed neuroprotection.	[Bratek, Ewelina; Ziembowicz, Apolonia; Salinska, Elzbieta] Polish Acad Sci, Dept Neurochem, Mossakowski Med Res Ctr, Warsaw, Poland; [Bronisz, Agnieszka] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA USA	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Salinska, E (corresponding author), Polish Acad Sci, Dept Neurochem, Mossakowski Med Res Ctr, Warsaw, Poland.	esalinska@imdik.pan.pl	Bronisz, Agnieszka/G-5980-2019; Bronisz, Agnieszka/M-3485-2019	Bronisz, Agnieszka/0000-0002-5841-1051; Bronisz, Agnieszka/0000-0002-5841-1051; Salinska, Elzbieta/0000-0003-4212-221X	Polish Ministry of Scientific Research and Higher Education; Polish National Science Centre [2016/23/N/NZ7/01942]	Polish Ministry of Scientific Research and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Centre	This work was supported by founds from the Polish Ministry of Scientific Research and Higher Education for the MMRC-KNOW 2013-2017 project and by Polish National Science Centre grant no. 2016/23/N/NZ7/01942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Bakthavachalam P, 2017, J NEUROL SCI, V375, P417, DOI 10.1016/j.jns.2017.02.043; Barkhuizen M, 2017, NEUROSCI BIOBEHAV R, V75, P166, DOI 10.1016/j.neubiorev.2017.01.042; Berent-Spillson A, 2007, J NEUROCHEM, V101, P342, DOI 10.1111/j.1471-4159.2006.04373.x; Bond A, 1998, NEUROREPORT, V9, P1191, DOI 10.1097/00001756-199804200-00042; Bond A, 2000, J PHARMACOL EXP THER, V294, P800; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno V, 1998, J NEUROSCI, V18, P9594; Bruno V, 2017, NEUROPHARMACOLOGY, V115, P180, DOI 10.1016/j.neuropharm.2016.04.044; Buonocore G, 2001, BIOL NEONATE, V79, P180; Cai ZW, 2002, EUR J PHARMACOL, V437, P139, DOI 10.1016/S0014-2999(02)01289-X; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Caraci F, 2012, NEUROCHEM INT, V61, P559, DOI 10.1016/j.neuint.2012.01.017; Charriaut-Marlangue C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010061; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; Demarest TG, 2016, J NEUROCHEM, V137, P714, DOI 10.1111/jnc.13590; Doi K, 2012, J MATERN-FETAL NEO M, V25, P706, DOI 10.3109/14767058.2011.587061; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Folbergrova J, 2012, EXP NEUROL, V233, P421, DOI 10.1016/j.expneurol.2011.11.009; Gonda X, 2012, CURR PHARM DESIGN, V18, P1558, DOI 10.2174/138161212799958521; Hachem LD, 2016, STEM CELLS DEV, V25, P1223, DOI 10.1089/scd.2015.0389; Hascup ER, 2010, J NEUROCHEM, V115, P1608, DOI 10.1111/j.1471-4159.2010.07066.x; Imre G, 2007, CNS DRUG REV, V13, P444; Johnson EC, 2011, J NEUROCHEM, V119, P896, DOI 10.1111/j.1471-4159.2011.07480.x; Lin SH, 2001, J CEREBR BLOOD F MET, V21, P262, DOI 10.1097/00004647-200103000-00010; Lu XCM, 2000, EUR J PHARMACOL, V408, P233, DOI 10.1016/S0014-2999(00)00762-7; Lyon L, 2008, SYNAPSE, V62, P842, DOI 10.1002/syn.20553; Maiese K, 2008, OXID MED CELL LONGEV, V1, P1; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Motolese M, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0158-2; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Netto CA, 2017, J NEUROSCI RES, V95, P409, DOI 10.1002/jnr.23828; Nicoletti F, 2015, CURR OPIN PHARMACOL, V20, P89, DOI 10.1016/j.coph.2014.12.002; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rice ME, 1998, NEUROSCIENCE, V82, P1213; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Spillson AB, 2003, EXP NEUROL, V184, pS97, DOI 10.1016/j.expneurol.2003.08.001; Thomas AG, 2001, EUR J PHARMACOL, V430, P33, DOI 10.1016/S0014-2999(01)01239-0; Van Hemelrijck A, 2005, J NEUROCHEM, V95, P1287, DOI 10.1111/j.1471-4159.2005.03450.x; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; Weis SN, 2012, MITOCHONDRION, V12, P271, DOI 10.1016/j.mito.2011.10.002; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Zhang X, 2015, HIPPOCAMPUS, V25, P286, DOI 10.1002/hipo.22372; Zhou F, 2006, J NEUROSCI RES, V84, P268, DOI 10.1002/jnr.20897	52	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200933	10.1371/journal.pone.0200933	http://dx.doi.org/10.1371/journal.pone.0200933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044838	gold, Green Submitted, Green Published			2022-12-26	WOS:000439942500071
J	Crandell, KE; Smith, AF; Crino, OL; Tobalske, BW				Crandell, Kristen E.; Smith, Austin F.; Crino, Ondi L.; Tobalske, Bret W.			Coping with compliance during take-off and landing in the diamond dove (Geopelia cuneata)	PLOS ONE			English	Article							JUMPING PERFORMANCE; ANOLIS-CAROLINENSIS; PERCH COMPLIANCE; KINEMATICS; LOCOMOTION; SUBSTRATE; MECHANICS; BEHAVIOR; LIZARDS; FLIGHT	The natural world is filled with substrates of varying properties that challenge locomotor abilities. Birds appear to transition smoothly from aerial to terrestrial environments during take-offs and landings using substrates that are incredibly variable. It may be challenging to control movement on and off compliant (flexible) substrates such as twigs, yet birds routinely accomplish such tasks. Previous research suggests that birds do not use their legs to harness elastic recoil from perches. Given avian mastery of take-off and landing, we hypothesized that birds instead modulate wing, body and tail movements to effectively use compliant perches. We measured take-off and landing performance of diamond doves (Geopelia cuneata (N= 5) in the laboratory and perch selection in this species in the field (N = 25). Contrary to our hypothesis, doves do not control take-off and landing on compliant perches as effectively as they do on stiff perches. They do not recover elastic energy from the perch, and take-off velocities are thus negatively impacted. Landing velocities remain unchanged, which suggests they may not anticipate the need to compensate for compliance. Legs and wings function as independent units: legs produce lower initial velocities when taking off from a compliant substrate, which negatively impacts later flight velocities. During landing, significant stability problems arise with compliance that are ameliorated by the wings and tail. Collectively, we suggest that the diamond dove maintains a generalized take-off and landing behavior regardless of perch compliance, leading us to conclude that perch compliance represents a challenge for flying birds. Free-living diamond doves avoid the negative impacts of compliance by preferentially selecting perches of larger diameter, which tend to be stiffer.	[Crandell, Kristen E.; Smith, Austin F.; Tobalske, Bret W.] Univ Montana, Div Biol Sci, Field Res Stn Ft Missoula, Missoula, MT 59812 USA; [Crandell, Kristen E.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Crino, Ondi L.] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic, Australia	University of Montana System; University of Montana; Bangor University; Deakin University	Crandell, KE (corresponding author), Univ Montana, Div Biol Sci, Field Res Stn Ft Missoula, Missoula, MT 59812 USA.; Crandell, KE (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	kristen.crandell@gmail.com	Crandell, Kristen/Y-4610-2019	Crandell, Kristen/0000-0002-2150-3198	National Science Foundation [CMMI 1234737]; Dial-Drollinger Charitable Foundation; Montana Space Grant Consortium	National Science Foundation(National Science Foundation (NSF)); Dial-Drollinger Charitable Foundation; Montana Space Grant Consortium	This research was funded by the National Science Foundation (Grant #CMMI 1234737 to BWT), the Dial-Drollinger Charitable Foundation, and the Montana Space Grant Consortium (to KEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R M, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P315; ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Astley HC, 2015, J EXP BIOL, V218, P3360, DOI 10.1242/jeb.121715; Bonser RHC, 1999, FUNCT ECOL, V13, P102, DOI 10.1046/j.1365-2435.1999.00290.x; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Earls KD, 2000, J EXP BIOL, V203, P725; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gilman CA, 2013, FUNCT ECOL, V27, P374, DOI 10.1111/1365-2435.12063; Gilman CA, 2012, J EXP BIOL, V215, P220, DOI 10.1242/jeb.061838; Green PR, 1998, J EXP BIOL, V201, P3309; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Irschick DJ, 2005, BIOL J LINN SOC, V85, P223, DOI 10.1111/j.1095-8312.2005.00487.x; Jackson BE, 2011, J EXP BIOL, V214, P2354, DOI 10.1242/jeb.052829; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; LeBlanc S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153477; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Patel M, 2014, NEUROSCI LETT, V579, P97, DOI 10.1016/j.neulet.2014.07.010; Provini P, 2014, J EXP BIOL; Provini P, 2012, J EXP BIOL, V215, P4115, DOI 10.1242/jeb.074484; Ribak G, 2012, FUNCT ECOL, V26, P493, DOI 10.1111/j.1365-2435.2011.01943.x; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; Sellers WI, 2013, PLOS ONE, V8; Team RDC, 2008, R LANG ENV SATISTICA; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; Tobalske BW, 2004, J EXP BIOL, V207, P1345, DOI 10.1242/jeb.00889; Vogel S., 2003, COMP BIOMECHANICS LI	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199662	10.1371/journal.pone.0199662	http://dx.doi.org/10.1371/journal.pone.0199662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044804	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500015
J	Feng, SY; Gao, J; Li, Y				Feng, ShunYi; Gao, Jie; Li, Yong			A retrospective analysis of leucocyte count as a strong predictor of survival for patients with acute paraquat poisoning	PLOS ONE			English	Article							PLASMA	The aim of this study is the identification of a reliable predictor of prognosis to optimize the treatment of acute paraquat (PQ) poisoning patients. We performed a retrospective analysis on 96 patients with acute PQ poisoning to evaluate leucocyte count as a predictor of 90-day survival. These patients were admitted to the emergency department from May 2012 to February 2017. Kaplan-Meier method was used to compare the 90-day survival. Cox proportional hazard models were utilized to estimate the hazard ratios (HR) and 95% confidence intervals (CI). Receiver operating characteristic (ROC) analysis was conducted to analyze the discriminatory potential of leucocyte with respect to 90-day survival. Result showed that leucocyte was significantly higher among nonsurvivors than that among survivors (p<0.001). Leukocyte was also an independent predictor of survival according to the multi-variate Cox analysis (HR 1.103; 95%CI: 1.062-1.146; p<0.001). The area under the curve (AUC) for leucocyte (AUC 0.911; 95%CI: 0.855-0.966; p<0.001) showed a discriminatory potential similar to that of the plasma PQ concentration (AUC 0.961; 95%CI: 0.926-0.997; p<0.001) in predicting 90-day survival. The leucocyte count is a strong predictor of survival in patients with acute PQ poisoning.	[Feng, ShunYi; Gao, Jie; Li, Yong] Cangzhou Cent Hosp, Emergency Dept, Cangzhou City, Peoples R China		Li, Y (corresponding author), Cangzhou Cent Hosp, Emergency Dept, Cangzhou City, Peoples R China.	ly13333367871@hotmail.com						BISMUTH C, 1982, NOUV PRESSE MED, V11, P3239; Bismuth C, 1986, Dev Toxicol Environ Sci, V12, P347; Eddleston M, 2003, QJM-INT J MED, V96, P809, DOI 10.1093/qjmed/hcg137; Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42; Fengjun Jiao, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P906; Gawarammana IB, 2010, CLIN TOXICOL, V48, P347, DOI 10.3109/15563651003641794; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; HART TB, 1984, LANCET, V2, P1222; Hong SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111674; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; KAOJARERN S, 1991, VET HUM TOXICOL, V33, P115; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17299; Lin CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085354; Liu S, 2016, MED SCI MONITOR, V22, P1342, DOI 10.12659/MSM.897930; Liu Z., 2016, INT J DISTRIB SENS N, V12, P1; Mitra S, 2006, BBA-MOL BASIS DIS, V1762, P732, DOI 10.1016/j.bbadis.2006.06.011; PROUDFOOT AT, 1979, LANCET, V2, P330; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; Tan J T, 2013, Med J Malaysia, V68, P384; Wu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094697; Zhang H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130035; Zhou DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36235	26	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201200	10.1371/journal.pone.0201200	http://dx.doi.org/10.1371/journal.pone.0201200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044873	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500091
J	Gong, L; Qiu, XH; Huang, J; Xu, W; Bai, JQ; Zhang, J; Su, H; Xu, CM; Huang, ZH				Gong, Lu; Qiu, Xiao Hui; Huang, Juan; Xu, Wen; Bai, Jun Qi; Zhang, Jing; Su, He; Xu, Chu Mei; Huang, Zhi Hai			Constructing a DNA barcode reference library for southern herbs in China: A resource for authentication of southern Chinese medicine	PLOS ONE			English	Article							ITS2	Southern Chinese Medicine (SCM) is an important sect of Traditional Chinese Medicine (TCM) with its own special cultural style. Species identification is essential for TCM quality control because authentic herbs are possibly substituted with adulterants that would threaten the health of the public or even cause death. Here, we provided the first local reference DNA barcode library based on the second internal transcribed spacer (ITS2) for the molecular identification of SCM. A total of 1512 specimens of southern herbs representing 359 species were collected under the instructions and identification of taxonomic experts. Genomic DNA was extracted, and the PCR reaction proceeded according to standard procedures. After Sanger sequencing, sequence assembling and annotation, a reliable ITS2 barcode library with 1276 sequences from 309 species of Southern herbs was constructed. The PCR efficiency of the whole samples was 84.39%. Characteristics of the ITS2 barcode were analyzed, including sequence lengths and GC contents in different taxa. Neighbor-joining trees based on Kimura 2-Parameter (K2P) genetic distances showed a 67.56% successful rate of species identification with ITS2 barcode. In addition, 96.57% of species could be successfully identified at the genus level by the BLAST method. Eleven plant species were discovered to be cryptic. In addition, we found that there is an incorrect sequence existing in the public database, making a reliable local DNA barcode reference more meaningful. ITS2 barcodes exhibit advantages in TCM identification. This DNA barcode reference library could be used in Southern Chinese Medicine quality control, thus contributing to protecting public health.	[Gong, Lu; Qiu, Xiao Hui; Huang, Juan; Xu, Wen; Bai, Jun Qi; Zhang, Jing; Su, He; Xu, Chu Mei; Huang, Zhi Hai] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Gong, Lu; Qiu, Xiao Hui; Huang, Juan; Xu, Wen; Bai, Jun Qi; Zhang, Jing; Su, He; Xu, Chu Mei; Huang, Zhi Hai] China Acad Chinese Med Sci, Guangdong Branch, Guangzhou, Guangdong, Peoples R China; [Qiu, Xiao Hui] Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; China Academy of Chinese Medical Sciences; Guangzhou University of Chinese Medicine	Huang, ZH (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China.; Huang, ZH (corresponding author), China Acad Chinese Med Sci, Guangdong Branch, Guangzhou, Guangdong, Peoples R China.	zhhuang7308@163.com	Xu, Wen/H-6226-2011	Gong, Lu/0000-0002-1245-0506; , Wen/0000-0002-3913-3607; Huang, Zhihai/0000-0003-3075-4690	Guangdong Provincial Hospital of Chinese Medicine Special Fund [2015KT1817]; China Academy of Chinese Medical Sciences Special Fund for Health Service Development of Chinese Medicine [ZZ0908067]	Guangdong Provincial Hospital of Chinese Medicine Special Fund; China Academy of Chinese Medical Sciences Special Fund for Health Service Development of Chinese Medicine	This work was supported by Guangdong Provincial Hospital of Chinese Medicine Special Fund (2015KT1817, http://www.gdhtcm.com/) and the China Academy of Chinese Medical Sciences Special Fund for Health Service Development of Chinese Medicine (ZZ0908067), ZH Huang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Cyranoski David, 2017, Nature, V551, P552, DOI 10.1038/nature.2017.23038; Gu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067818; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Heubl G., 2013, EVIDENCE RATIONAL BA, P27, DOI DOI 10.1007/978-3-7091-0442-2_2; Hou G, 2017, MOL ECOL RESOUR; Huang ZH, 2017, DNA BARCODES CHINESE; Huang ZH, ECOLOGICAL SUITABILI; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Marichamy K., 2014, SCI PARK, V1, P23218045, DOI [DOI 10.9780/23218045/1202013/49, 10.9780/23218045/1202013/49]; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Nithaniyal S, 2017, GENOME, V60, P139, DOI 10.1139/gen-2015-0225; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Spouge John L, 2012, Methods Mol Biol, V858, P365, DOI 10.1007/978-1-61779-591-6_17; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Uetz P, 2017, NATURE, V545, P412, DOI 10.1038/545412c; Wang FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160611; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Xiang H, 2016, PUBLIC HEALTH, V136, P185, DOI 10.1016/j.puhe.2016.02.031; Xu SZ, 2017, MOL ECOL RESOUR, V94; Yu N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04674-w; Zhang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125995	33	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201240	10.1371/journal.pone.0201240	http://dx.doi.org/10.1371/journal.pone.0201240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044868	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500093
J	Pericak, AA; Thomas, CJ; Kroodsma, DA; Wasson, MF; Ross, MRV; Clinton, NE; Campagna, DJ; Franklin, Y; Bernhardt, ES; Amos, JF				Pericak, Andrew A.; Thomas, Christian J.; Kroodsma, David A.; Wasson, Matthew F.; Ross, Matthew R. V.; Clinton, Nicholas E.; Campagna, David J.; Franklin, Yolandita; Bernhardt, Emily S.; Amos, John F.			Mapping the yearly extent of surface coal mining in Central Appalachia using Landsat and Google Earth Engine	PLOS ONE			English	Article							MOUNTAINTOP REMOVAL; TIME-SERIES; FOREST; DOWNSTREAM; IMPACTS; MINES; DISTURBANCE; COVER	Surface mining for coal has taken place in the Central Appalachian region of the United States for well over a century, with a notable increase since the 1970s. Researchers have quantified the ecosystem and health impacts stemming from mining, relying in part on a geospatial dataset defining surface mining's extent at a decadal interval. This dataset, however, does not deliver the temporal resolution necessary to support research that could establish causal links between mining activity and environmental or public health and safety outcomes, nor has it been updated since 2005. Here we use Google Earth Engine and Landsat imagery to map the yearly extent of surface coal mining in Central Appalachia from 1985 through 2015, making our processing models and output data publicly available. We find that 2,900 km(2) of land has been newly mined over this 31-year period. Adding this more-recent mining to surface mines constructed prior to 1985, we calculate a cumulative mining footprint of 5,900 km(2). Over the study period, correlating active mine area with historical surface mine coal production shows that each metric ton of coal is associated with 12 m(2) of actively mined land. Our automated, open-source model can be regularly updated as new surface mining occurs in the region and can be refined to capture mining reclamation activity into the future. We freely and openly offer the data for use in a range of environmental, health, and economic studies; moreover, we demonstrate the capability of using tools like Earth Engine to analyze years of remotely sensed imagery over spatially large areas to quantify land use change.	[Pericak, Andrew A.; Ross, Matthew R. V.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC USA; [Thomas, Christian J.; Kroodsma, David A.; Franklin, Yolandita; Amos, John F.] SkyTruth, Shepherdstown, WV 25443 USA; [Wasson, Matthew F.] Appalachian Voices, Boone, NC USA; [Clinton, Nicholas E.] Google Inc, Google Earth Engine Team, Mountain View, CA USA; [Campagna, David J.] West Virginia Univ, Dept Geol & Geog, Morgantown, WV USA	Duke University; Google Incorporated; West Virginia University	Thomas, CJ (corresponding author), SkyTruth, Shepherdstown, WV 25443 USA.	christian@skytruth.org	Ross, Matthew R.V./AAH-5785-2020; Bernhardt, Emily/B-4541-2010; /D-9940-2011	Ross, Matthew R.V./0000-0001-9105-4255; Thomas, Christian/0000-0001-9574-224X; /0000-0003-3031-621X	Foundation for the Carolinas; National Science Foundation Graduate Research Fellowship Program; National Science Foundation Earth Sciences Hydrological Sciences [1417405]; Cornell Douglas Foundation; Wallace Genetic Foundation; SkyTruth; Appalachian Voices; Google, Inc.	Foundation for the Carolinas; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation Earth Sciences Hydrological Sciences; Cornell Douglas Foundation; Wallace Genetic Foundation; SkyTruth; Appalachian Voices; Google, Inc.(Google Incorporated)	We gratefully acknowledge financial support from the Foundation for the Carolinas (https://www.fftc.org/) to the Nicholas School of the Environment (AAP, MRVR, ESB); the National Science Foundation Graduate Research Fellowship Program (https://www.nsfgrfp.org/) and National Science Foundation Earth Sciences Hydrological Sciences (https://www.nsf.gov/div/index.jsp?div=EAR; grant 1417405) (AAP, MRVR, ESB); the Cornell Douglas Foundation (http://www. cornelldouglas.org/) (CJT, DAK, YF, JFA); and the Wallace Genetic Foundation (http://www. wallacegenetic.org/) (CJT, DAK, YF, JFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Various authors are employed by non-profit or commercial institutions; the specific roles of these authors are articulated in the 'author contributions' section. The funder SkyTruth provided support in the form of salaries for authors CJT, DAK, YF, JFA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Appalachian Voices provided support in the form of salaries for author MFW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Google, Inc., provided support in the form of salaries for author NEC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Apache Software Foundation, 2004, AP LIC VERS 2 0; Arnold MC, 2015, ENVIRON TOXICOL CHEM, V34, P1039, DOI 10.1002/etc.2885; Bier RL, 2015, ISME J, V9, P1378, DOI 10.1038/ismej.2014.222; Carter M, 1989, 89362 US GEOL SURV, P63; Daniels WL, 2016, ENVIRON POLLUT, V216, P371, DOI 10.1016/j.envpol.2016.05.044; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Fox JF, 2010, ENVIRON SCI TECHNOL, V44, P2144, DOI 10.1021/es903301j; Franklin JA, 2012, NEW FOREST, V43, P905, DOI 10.1007/s11056-012-9342-8; Fritz KM, 2010, J N AM BENTHOL SOC, V29, P673, DOI 10.1899/09-060.1; Hartman H.L., 2002, INTRO MINING ENG; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Knuckles TL, 2013, MICROCIRCULATION, V20, P158, DOI 10.1111/micc.12014; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Lutz BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073203; Maxwell A. E., 2013, Natural Science, V5, P229; Milici RC, 2000, INT J COAL GEOL, V44, P251, DOI 10.1016/S0166-5162(00)00013-6; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Odenheimer J, 2015, GEOCHEM-EXPLOR ENV A, V15, P131, DOI 10.1144/geochem2014-276; Oliphant AJ, 2017, BIOL INVASIONS, V19, P179, DOI 10.1007/s10530-016-1271-6; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Pond GJ, 2014, ENVIRON MANAGE, V54, P919, DOI 10.1007/s00267-014-0319-6; Price SJ, 2016, J APPL ECOL, V53, P459, DOI 10.1111/1365-2664.12585; Ross MRV, 2016, ENVIRON SCI TECHNOL, V50, P2064, DOI 10.1021/acs.est.5b04532; Sen S, 2012, PHOTOGRAMM ENG REM S, V78, P223, DOI 10.14358/PERS.78.3.223; SkyTruth, 2009, MOUNT REM MIN 1; Townsend PA, 2009, REMOTE SENS ENVIRON, V113, P62, DOI 10.1016/j.rse.2008.08.012; U. S. Energy Information Administration, 2016, ANN COAL REP 2015; United States Department of Labor Mine Safety and Health Administration, ACC ILLN INJ EMPL SE; Voss KA, 2017, LIMNOL OCEANOGR, V62, P1754, DOI 10.1002/lno.10531; Wickham JD, 2007, LANDSCAPE ECOL, V22, P179, DOI 10.1007/s10980-006-9040-z; Wickham J, 2013, BIOSCIENCE, V63, P335, DOI 10.1525/bio.2013.63.5.7; Zipper CE, 2011, ENVIRON MANAGE, V47, P751, DOI 10.1007/s00267-011-9670-z; [No title captured]	35	57	57	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0197758	10.1371/journal.pone.0197758	http://dx.doi.org/10.1371/journal.pone.0197758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044790	Green Published, gold			2022-12-26	WOS:000439942500005
J	Uchino, K; Tateishi, R; Nakagomi, R; Fujiwara, N; Minami, T; Sato, M; Enooku, K; Nakagawa, H; Asaoka, Y; Kondo, Y; Shibahara, J; Shiina, S; Koike, K				Uchino, Koji; Tateishi, Ryosuke; Nakagomi, Ryo; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Enooku, Kenichiro; Nakagawa, Hayato; Asaoka, Yoshinari; Kondo, Yuji; Shibahara, Junji; Shiina, Shuichiro; Koike, Kazuhiko			Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; IRON-OVERLOAD; CONTROLLED-TRIAL; RISK; MORTALITY; PHLEBOTOMY; MANAGEMENT; THERAPY; BIOPSY	Background & aims Hepatic iron accumulation can accelerate liver injury in patients with various chronic liver diseases and lead to hepatocarcinogenesis. We elucidated the impact of serum levels of ferritin on the prognosis of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA) in a large cohort. Methods We retrospectively analyzed 578 treatment-naive HCC patients who underwent RFA. We divided our cohort into four groups by the quartile points of serum ferritin level: G1 (<= 55 ng/mL, n = 148), G2 (56-130 ng/mL, n = 142), G3 (131-243 ng/mL, n = 144) and G4 (>= 244 ng/ mL, n = 144). We analyzed the recurrence and survival of patients using the Kaplan-Meier method. We also evaluated pathological iron deposition among patients with a solitary tumor smaller than 2 cm. Results The cumulative rates of overall recurrence and survival at 5 years were 81.6% and 66.3%, respectively. The serum levels of ferritin were correlated with pathological iron deposition. There were no significant differences in recurrence and survival rates according to serum levels of ferritin and pathological hepatic iron deposition. Conclusions Serum levels of ferritin do not affect the prognosis of HCC patients undergoing RFA.	[Uchino, Koji; Tateishi, Ryosuke; Nakagomi, Ryo; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Enooku, Kenichiro; Nakagawa, Hayato; Asaoka, Yoshinari; Kondo, Yuji; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shibahara, Junji] Kyorin Univ, Dept Pathol, Schoole Med, Tokyo, Japan; [Shiina, Shuichiro] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; Kyorin University; Juntendo University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Fujiwara, Naoto/Y-5938-2019; Tateishi, Ryosuke/G-7758-2014; Asaoka, Yoshinari/ABC-5412-2021; Nakagawa, Hayato/I-2837-2012	Fujiwara, Naoto/0000-0002-4109-3421; Tateishi, Ryosuke/0000-0003-3021-2517; Asaoka, Yoshinari/0000-0002-2805-8226; Nakagawa, Hayato/0000-0002-6973-5094	AMED [JP17fk0210304, JP18fk0210040]; Miyakawa Memorial Research Foundation	AMED(Japan Agency for Medical Research and Development (AMED)); Miyakawa Memorial Research Foundation	This work was supported in part by AMED under Grant Number JP17fk0210304, JP18fk0210040, and Miyakawa Memorial Research Foundation.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chapoutot C, 2000, GUT, V46, P711, DOI 10.1136/gut.46.5.711; Deugnier Y, 2011, SEMIN LIVER DIS, V31, P260, DOI 10.1055/s-0031-1286057; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Facciorusso A, 2014, J GASTROEN HEPATOL, V29, P1905, DOI 10.1111/jgh.12618; FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Fujita N, 2009, CANCER EPIDEM BIOMAR, V18, P424, DOI 10.1158/1055-9965.EPI-08-0725; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Hagstrom H, 2016, LIVER INT, V36, P1688, DOI 10.1111/liv.13144; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Lambrecht RW, 2011, GASTROENTEROLOGY, V140, P1490, DOI 10.1053/j.gastro.2011.01.053; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Maiwall R, 2014, J HEPATOL, V61, P43, DOI 10.1016/j.jhep.2014.03.027; Manousou P, 2011, LIVER INT, V31, P730, DOI 10.1111/j.1478-3231.2011.02488.x; Metwally MA, 2004, AM J GASTROENTEROL, V99, P286, DOI 10.1111/j.1572-0241.2004.04049.x; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Scheuer PJ, 2000, LIVER BIOPSY INTERPR; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Sohda T, 1999, BIOCHEM GENET, V37, P63, DOI 10.1023/A:1018718101579; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Tanaka H, 2008, BRIT J CANCER, V98, P580, DOI 10.1038/sj.bjc.6604204; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; Uchino K, 2016, HEPATOL RES, V46, P259, DOI 10.1111/hepr.12517; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.23537; Weismuller TJ, 2011, HEPATOLOGY, V54, P2114, DOI 10.1002/hep.24635; Yano M, 2004, J GASTROENTEROL, V39, P570, DOI 10.1007/s00535-003-1344-z; Yano M, 2002, AM J GASTROENTEROL, V97, P133, DOI 10.1111/j.1572-0241.2002.05436.x; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646	45	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200943	10.1371/journal.pone.0200943	http://dx.doi.org/10.1371/journal.pone.0200943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044835	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500072
J	Kreitschitz, A; Gorb, SN				Kreitschitz, Agnieszka; Gorb, Stanislav N.			The micro- and nanoscale spatial architecture of the seed mucilage-Comparative study of selected plant species	PLOS ONE			English	Article							PRIMARY-CELL WALLS; PECTIC ARABINAN; NEGEV DESERT; ARTEMISIA L.; CELLULOSE; GERMINATION; MICROFIBRILS; ASTERACEAE; MODELS; TAXA	The seed coat mucilage envelope is formed just after hydration and surrounds the seed as a gel-like, transparent capsule. The mucilage envelope represents a special type of modified cell wall with all of the typical polysaccharides i.e. cellulose, pectins and hemicelluloses. The chemical composition of the mucilage is well-recognized but its structural organization remains unclear. In the presented study, we visualized the spatial architecture of the seed mucilage envelope of selected taxa which produce cellulose mucilage. Using critical point drying (CPD) and scanning electron microscopy (SEM) imaging, we demonstrated the structural details of the mucilage from the micro- down to the nanoscale. The mucilage, after CPD, had a visibly spatial structure which differed between the studied taxa; for example, a tangled organization in Arabidopsis thaliana and a more ordered arrangement in Ocimum basilicum were revealed. In general, the mucilaginous fibrillary components formed network made of long, unbranched, thicker cellulose fibrils together with shorter, thinner and, often branched other polysaccharides. Cellulose fibrils built a kind of scaffold for the rest of the components which were spread between them and/or covered their surface. The cellulose fibrils were attached to the seed surface, and therefore prevent the loss of the mucilage envelope during mechanical impacts. The loose architecture and special chemical composition of the mucilaginous cell wall is important for water binding and storage, which are crucial for the proper functioning of the seed mucilage envelope.	[Kreitschitz, Agnieszka; Gorb, Stanislav N.] Univ Kiel, Dept Funct Morphol & Biomech, Kiel, Germany; [Kreitschitz, Agnieszka] Univ Wroclaw, Inst Expt Biol, Dept Plant Dev Biol, Wroclaw, Poland	University of Kiel; University of Wroclaw	Kreitschitz, A (corresponding author), Univ Kiel, Dept Funct Morphol & Biomech, Kiel, Germany.; Kreitschitz, A (corresponding author), Univ Wroclaw, Inst Expt Biol, Dept Plant Dev Biol, Wroclaw, Poland.	agnieszka.kreitschitz@uwr.edu.pl		Kreitschitz, Agnieszka/0000-0002-3045-843X	Short Term Scientific Mission; COST Action [TD0906]; European Union's Horizon 2020 research and innovation programme under the Maria Sklodowska-Curie grant [702293]	Short Term Scientific Mission; COST Action(European Cooperation in Science and Technology (COST)); European Union's Horizon 2020 research and innovation programme under the Maria Sklodowska-Curie grant	This work was supported by Short Term Scientific Mission, COST Action TD0906; European Union's Horizon 2020 research and innovation programme under the Maria Sklodowska-Curie grant agreement No 702293.	Arsovski AA, 2009, PLANT PHYSIOL, V150, P1219, DOI 10.1104/pp.109.138388; Bhatt A, 2016, J ARID ENVIRON, V128, P73, DOI 10.1016/j.jaridenv.2016.01.008; Braune W., 1975, PRAKTIKUM ANATOMII R; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Capitani MI, 2013, J SCI FOOD AGR, V93, P3856, DOI 10.1002/jsfa.6327; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Ciolacu D, 2011, CELL CHEM TECHNOL, V45, P13; Salgado-Cruz MD, 2013, IND CROP PROD, V51, P453, DOI 10.1016/j.indcrop.2013.09.036; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Donaldson LA, 2001, IAWA J, V22, P213, DOI 10.1163/22941932-90000280; FILUTOWICZ A, 1951, MIKROTECHNIKA ROSLIN; GRUBERT M, 1974, Acta Biologica Venezuelica, V8, P315; Gutterman Y, 1996, ISRAEL J PLANT SCI, V44, P125, DOI 10.1080/07929978.1996.10676641; Gutterman Y, 1997, J ARID ENVIRON, V35, P695, DOI 10.1006/jare.1996.0192; HAUGHN GW, 2012, FRONT PLANT SCI, V3, DOI DOI 10.3389/FPLS.2012.00001; Huang Z, 1999, S AFR J BOT, V65, P187, DOI 10.1016/S0254-6299(15)30972-8; Huang ZY, 1999, ISR J PLANT SCI, V47, P27, DOI 10.1080/07929978.1999.10676748; Ioelovich M, 2008, BIORESOURCES, V3, P1403; Jaddu S, 2018, J PHARM PHYTO, V7, P1320; Jarvis MC, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0045; Kreitschitz A, 2007, FLORA, V202, P570, DOI 10.1016/j.flora.2006.12.003; Kreitschitz A, 2017, FLORA, V229, P9, DOI 10.1016/j.flora.2017.02.010; Kreitschitz A, 2015, ACTA BIOMATER, V17, P152, DOI 10.1016/j.actbio.2015.01.042; Kreitschitz A, 2012, SEED SCI RES, V22, P177, DOI 10.1017/S0960258512000098; Liesche J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-226; Macquet A, 2007, PLANT CELL PHYSIOL, V48, P984, DOI 10.1093/pcp/pcm068; Makouate HF, 2012, BOTHALIA, V42, P7, DOI 10.4102/abc.v42i1.4; Marga F, 2005, PLANT J, V43, P181, DOI 10.1111/j.1365-313X.2005.02447.x; McCann MC, 1990, J EXP BOT, V45, P1683; Mendu V, 2011, PLANT PHYSIOL, V157, P441, DOI 10.1104/pp.111.179069; Nakashima J, 1997, PLANT CELL PHYSIOL, V38, P818, DOI 10.1093/oxfordjournals.pcp.a029240; Naran R, 2008, PLANT PHYSIOL, V148, P132, DOI 10.1104/pp.108.123513; North HM, 2014, ANN BOT-LONDON, V114, P1251, DOI 10.1093/aob/mcu011; Prajapati VD, 2013, CARBOHYD POLYM, V92, P1685, DOI 10.1016/j.carbpol.2012.11.021; Ryding O, 2002, SYST GEOGR PLANTS, V71, P503; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; SATIATJEUNEMAITRE B, 1992, PROTOPLASMA, V167, P33, DOI 10.1007/BF01353578; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sullivan S, 2011, PLANT PHYSIOL, V156, P1725, DOI 10.1104/pp.111.179077; Sun Y, 2012, AUST J BOT, V60, P439, DOI 10.1071/BT11314; Terashima N, 2009, J WOOD SCI, V55, P409, DOI 10.1007/s10086-009-1049-x; Tsai AYL, 2017, PLANT PHYSIOL, V173, P1059, DOI 10.1104/pp.16.01600; Voiniciuc C, 2015, PLANT PHYSIOL, V169, P403, DOI 10.1104/pp.15.00851; Voiniciuc C, 2015, INT J MOL SCI, V16, P3452, DOI 10.3390/ijms16023452; Voiniciuc C, 2013, PLANT CELL, V25, P944, DOI 10.1105/tpc.112.107888; Western TL, 2012, SEED SCI RES, V22, P1, DOI 10.1017/S0960258511000249; Windsor JB, 2000, PLANT J, V22, P483, DOI 10.1046/j.1365-313x.2000.00756.x; Yang XJ, 2012, PERSPECT PLANT ECOL, V14, P434, DOI 10.1016/j.ppees.2012.09.002; Zykwinska A, 2007, J EXP BOT, V58, P1795, DOI 10.1093/jxb/erm037	51	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200522	10.1371/journal.pone.0200522	http://dx.doi.org/10.1371/journal.pone.0200522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040844	gold, Green Published, Green Submitted			2022-12-26	WOS:000439749200006
J	Torres, KL; Marino, JM; Rocha, DAP; de Mello, MB; Farah, HHD; Reis, RD; Alves, VDR; Gomes, E; Martins, TR; Soares, AC; de Oliveire, CM; Levi, JE				Torres, Katia Luz; Marino, Josiane Montanho; Pires Rocha, Danielle Albuquerque; de Mello, Monica Bandeira; de Melo Farah, Heydy Halanna; Reis, Renato dos Santos; Rodrigues Alves, Valquiria do Carmo; Gomes, Edson; Martins, Toni Ricardo; Soares, Ana Carolina; de Oliveire, Cristina Mendes; Levi, Jose Eduardo			Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas	PLOS ONE			English	Article							CANCER SCREENING-PROGRAM; HUMAN-PAPILLOMAVIRUS; LATIN-AMERICA; RURAL CHINA; METAANALYSIS; IMPLEMENTATION; COLLECTION; TRIALS; TESTS; WOMEN	Objective To evaluate both the performance and acceptability of a method coupling self-sampling with detection of cervical malignancy via elevated HPV 16 and 18 E6 oncoproteins (OncoE6((TM)) Cervical Test) in remote areas in Brazil. Methods Women living in rural villages in proximity to Coari city, Amazonas, Brazil were invited to participate in a cervical cancer screening study. 412 subjects were enrolled; there were no refusals. In addition to E6 protein detection, DNA was extracted from the brushes and evaluated for HPV genotypes by PCR (PGMY09/11), followed by typing by the Papillocheck (TM) if positive. Subjects who were found to be positive for OncoE6 or HPV-DNA were referred for colposcopy. Results For 110 subjects (27%) this was the first cervical cancer exam. Overall the HPV-DNA prevalence was 19.1% (n = 79); 1.4% (n = 6) were positive by the OncoE6 Test. Fifty-six women attended the invitation for colposcopy where nine had an abnormal cervix and were subsequently biopsied. Histopathological analysis revealed 2 CIN3, 2 carcinomas and 5 CIN1. OncoE6 called two out of the three HPV 16 or 18 associated CIN3+ lesions. Conclusions The findings suggest that self-administered sample collection in combination with OncoE6 Test is feasible in this population. This could enable expanded screening coverage while ensuring a high specificity which is imperative given the remote geographic location, since women bearing abnormal test results would necessitate travel and logistical burden to access colposcopy and treatment.	[Torres, Katia Luz; Pires Rocha, Danielle Albuquerque] Univ Fed Amazonas UFAM, Programa Posgrad Ciencias Saude, Manaus, Amazonas, Brazil; [Torres, Katia Luz; de Melo Farah, Heydy Halanna; Rodrigues Alves, Valquiria do Carmo] Univ Fed Amazonas UFAM, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Torres, Katia Luz; de Mello, Monica Bandeira; Rodrigues Alves, Valquiria do Carmo] Fundacao Ctr Oncol Estado Amazonas FCECON, Manaus, Amazonas, Brazil; [Marino, Josiane Montanho; Pires Rocha, Danielle Albuquerque; Reis, Renato dos Santos] Univ Fed Amazonas UFAM, Coari, Amazonas, Brazil; [Gomes, Edson] Lab Sebastiao Marinho, Manaus, Amazonas, Brazil; [Martins, Toni Ricardo; Soares, Ana Carolina; de Oliveire, Cristina Mendes; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil	Universidade Federal de Amazonas; Universidade Federal de Amazonas; Universidade Federal de Amazonas; Universidade de Sao Paulo	Levi, JE (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.	dudilevi@usp.br	Rocha, Danielle/HGB-8799-2022; Torres, K. L./AGN-0021-2022; Gomes, Edson/AAB-5618-2020	Torres, K. L./0000-0003-0922-5866; 	FAPEAM Grant [062.00650/2015]	FAPEAM Grant	This study was sponsored by FAPEAM Grant# 062.00650/2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa RFA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138945; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arrossi S, 2015, INT J CANCER, V137, P1709, DOI 10.1002/ijc.29530; Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Bychkovsky BL, 2016, CANCER-AM CANCER SOC, V122, P502, DOI 10.1002/cncr.29813; Carozzi FM, 2016, J CLIN VIROL, V76, pS22, DOI 10.1016/j.jcv.2015.10.025; Derchain S, 2016, REV BRAS GINECOL OBS, V38, P161, DOI 10.1055/s-0036-1582399; Diaz RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139677; Enerly E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151978; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Jeronimo J, 2016, J CLIN VIROL, V76, pS69, DOI 10.1016/j.jcv.2015.11.035; Lazcano-Ponce E, 2014, INT J CANCER, V135, P109, DOI 10.1002/ijc.28639; Mariano VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164892; Ministerio da Saude (BR). Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2017, COORD PREV VIG EST 2; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rossi PG, 2015, BRIT J CANCER, V112, P667, DOI 10.1038/bjc.2015.11; SIM-Sistema de Informac E sobre Mortalidade, DATASUS MIN SAUD; Subramaniam A, 2011, J LOW GENIT TRACT DI, V15, P110, DOI 10.1097/LGT.0b013e3181f515a2; Valdez M, 2016, INT J CANCER, V138, P1453, DOI 10.1002/ijc.29877; Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006; Zhao FH, 2013, CANCER PREV RES, V6, P938, DOI 10.1158/1940-6207.CAPR-13-0091	22	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							eO201262	10.1371/journal.pone.0201262	http://dx.doi.org/10.1371/journal.pone.0201262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036381	Green Submitted, Green Published, gold			2022-12-26	WOS:000439429200033
J	Worthy, SE; Haynes, L; Chambers, M; Bethune, D; Kan, E; Chung, K; Ota, R; Taylor, CJ; Glater, EE				Worthy, Soleil E.; Haynes, Lillian; Chambers, Melissa; Bethune, Danika; Kan, Emily; Chung, Kevin; Ota, Ryan; Taylor, Charles J.; Glater, Elizabeth E.			Identification of attractive odorants released by preferred bacterial food found in the natural habitats of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PREFERENCE; BEHAVIOR	Food choice is critical for survival because organisms must choose food that is edible and nutritious and avoid pathogenic food. Many organisms, including the nematode C. elegans, use olfaction to detect and distinguish among food sources. C. elegans exhibits innate preferences for the odors of different bacterial species. However, little is known about the preferences of C. elegans for bacterial strains isolated from their natural environment as well as the attractive volatile compounds released by preferred natural bacteria isolates. We tested food odor preferences of C. elegans for non-pathogenic bacteria found in their natural habitats. We found that C. elegans showed a preference for the odor of six of the eight tested bacterial isolates over its standard food source, E. coli HB101. Using solid-phase microextraction and gas chromatography coupled with mass spectrometry, we found that four of six attractive bacterial isolates (Alcaligenes sp. JUb4, Providenica sp. JUb5, Providencia sp. JUb39, and Flavobacteria sp. JUb43) released isoamyl alcohol, a well-studied C. elegans attractant, while both non-attractive isolates (Raoultella sp. JUb38 and Acinetobacter sp. JUb68) released very low or non-detectable amounts of isoamyl alcohol. In conclusion, we find that isoamyl alcohol is likely an ethologically relevant odor that is released by some attractive bacterial isolates in the natural environment of C. elegans.	[Worthy, Soleil E.; Taylor, Charles J.] Pomona Coll, Dept Chem, Claremont, CA 91711 USA; [Haynes, Lillian] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Chambers, Melissa; Bethune, Danika; Kan, Emily; Chung, Kevin; Ota, Ryan; Glater, Elizabeth E.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA	Claremont Colleges; Pomona College; Claremont Colleges; Harvey Mudd College; Claremont Colleges; Pomona College	Glater, EE (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	elizabeth.glater@pomona.edu	Taylor, Chuck/Q-6879-2019	Glater, Elizabeth/0000-0003-0205-8209	Pomona College; Harvey Mudd College; Pomona College Summer Undergraduate Research Program; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program; Support of Mentors and their Students in the Neurosciences Grant (SOMAS2012)	Pomona College; Harvey Mudd College; Pomona College Summer Undergraduate Research Program; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program; Support of Mentors and their Students in the Neurosciences Grant (SOMAS2012)	Funding came from Pomona College (EG, CT), Harvey Mudd College (EG), Pomona College Summer Undergraduate Research Program (DB, RO, KC), a grant to Pomona College and Harvey Mudd College from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program (SW, LH), and Support of Mentors and their Students in the Neurosciences Grant (SOMAS2012) (MC, EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Choi JI, 2016, ISME J, V10, P558, DOI 10.1038/ismej.2015.134; Collin S, 2012, J AGR FOOD CHEM, V60, P380, DOI 10.1021/jf203832c; Glater EE, 2014, G3-GENES GENOM GENET, V4, P265, DOI 10.1534/g3.113.008649; Gomila M A, 2015, FRONT MICROBIOL; Harris G, 2014, J NEUROSCI, V34, P9389, DOI 10.1523/JNEUROSCI.0012-14.2014; Hsueh YP, 2017, ELIFE, V6, DOI [10.7554/eLife.20023, 10.7554/elife.20023]; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Pereira S, 2012, J NEUROSCI, V32, P9035, DOI 10.1523/JNEUROSCI.4221-11.2012; Samuel BS, 2016, P NATL ACAD SCI USA, V113, pE3941, DOI 10.1073/pnas.1607183113; Schulenburg H, 2017, GENETICS, V206, P55, DOI 10.1534/genetics.116.195511; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Vos P, 2009, THE FIRMICUTES, V3; Worthy SE, 2018, CHEM SENSES, V43, P169, DOI 10.1093/chemse/bjy001; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134401; Zhang CM, 2016, J BIOL CHEM, V291, P23618, DOI 10.1074/jbc.M116.741132; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	25	23	23	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201158	10.1371/journal.pone.0201158	http://dx.doi.org/10.1371/journal.pone.0201158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036396	Green Published, gold, Green Submitted			2022-12-26	WOS:000439429200031
J	Choi, W; Jeon, ES; Chun, KY; Kim, YR; Park, KB; Kim, KB; Han, CS				Choi, Wook; Jeon, Eun-Seok; Chun, Kyoung-Yong; Kim, Young-Rok; Park, Kyeong-Beom; Kim, Ki-Bum; Han, Chang-Soo			A low-noise silicon nitride nanopore device on a polymer substrate	PLOS ONE			English	Article							SOLID-STATE NANOPORES; DNA TRANSLOCATION; SINGLE; MEMBRANE; IDENTIFICATION; MOLECULES; TRANSPORT; DISCRIMINATION; HOMOPOLYMERS; PASSIVATION	We report a novel low-noise nanopore device employing a polymer substrate. The Si substrate of a fabricated Si-substrate-based silicon nitride (Si3N4) membrane was replaced with a polymer substrate. As such, laser machining was used to make a micro-size hole through the polyimide (PI) substrate, and a thin Si3N4 membrane was then transferred onto the PI substrate. Finally, a nanopore was formed in the membrane using a transmission electron microscope for detection of biomolecules. Compared to the Si-substrate-based device, the dielectric noise was greatly reduced and the root-mean-square noise level was decreased from 146.7 to 5.4 pA. Using this device, the translocation of double-strand deoxyribonucleic acid (DNA) was detected with a high signal/noise (S/N) ratio. This type of device is anticipated to be available for future versatile sequencing technologies.	[Choi, Wook; Jeon, Eun-Seok; Chun, Kyoung-Yong; Han, Chang-Soo] Korea Univ, Coll Engn, Sch Mech Engn, Seoul, South Korea; [Kim, Young-Rok; Han, Chang-Soo] Kyung Hee Univ, Coll Life Sci, Inst Life Sci & Resources, Yongin, South Korea; [Kim, Young-Rok; Han, Chang-Soo] Kyung Hee Univ, Coll Life Sci, Dept Food Sci & Biotechnol, Yongin, South Korea; [Park, Kyeong-Beom; Kim, Ki-Bum] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea	Korea University; Kyung Hee University; Kyung Hee University; Seoul National University (SNU)	Han, CS (corresponding author), Korea Univ, Coll Engn, Sch Mech Engn, Seoul, South Korea.; Han, CS (corresponding author), Kyung Hee Univ, Coll Life Sci, Inst Life Sci & Resources, Yongin, South Korea.; Han, CS (corresponding author), Kyung Hee Univ, Coll Life Sci, Dept Food Sci & Biotechnol, Yongin, South Korea.	cshan@korea.ac.kr	Choi, Wook/M-9705-2013	Choi, Wook/0000-0002-3431-5137	Basic Science Research Program through the National Research Foundation of Korea - the Ministry of Science, ICT and Future Planning in Korea [NRF-2018R1A2A1A05023556]; ERC Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning in Korea [NRF-2016R1A5A1010148]	Basic Science Research Program through the National Research Foundation of Korea - the Ministry of Science, ICT and Future Planning in Korea; ERC Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning in Korea	This work was supported by Basic Science Research Program (Grant no. NRF-2018R1A2A1A05023556) and ERC Program (Grant no. NRF-2016R1A5A1010148) through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning in Korea.	Aberle AG, 1997, PROG PHOTOVOLTAICS, V5, P29, DOI 10.1002/(SICI)1099-159X(199701/02)5:1<29::AID-PIP149>3.0.CO;2-M; Apel PY, 2001, NUCL INSTRUM METH B, V184, P337, DOI 10.1016/S0168-583X(01)00722-4; Bafna JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157399; Boersma AJ, 2012, ANGEW CHEM INT EDIT, V51, P9606, DOI 10.1002/anie.201205687; Borukhov I, 1997, PHYS REV LETT, V79, P435, DOI 10.1103/PhysRevLett.79.435; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Dimitrov V, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065502; Feng JD, 2015, NAT NANOTECHNOL, V10, P1070, DOI [10.1038/nnano.2015.219, 10.1038/NNANO.2015.219]; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Ghosh M., 1996, POLYIMIDES FUNDAMENT, V1st; Goto Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31324; Healy K, 2007, NANOMEDICINE-UK, V2, P875, DOI 10.2217/17435889.2.6.875; Jeon TJ, 2008, LAB CHIP, V8, P1742, DOI 10.1039/b807932c; Kaps S, 2017, ACS OMEGA, V2, P2985, DOI 10.1021/acsomega.7b00041; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kim MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/20/205302; Kowalczyk SW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315101; Larkin J, 2013, ACS NANO, V7, P10121, DOI 10.1021/nn404326f; Lee MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07448; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Li W, 2013, ACS NANO, V7, P4129, DOI 10.1021/nn4004567; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Lim MC, 2015, J NANOSCI NANOTECHNO, V15, P5971, DOI 10.1166/jnn.2015.10500; Liu L, 2013, DEF TECHNOL, V9, P121, DOI 10.1016/j.dt.2013.10.004; Ma SD, 2016, POLYM ADVAN TECHNOL, V27, P414, DOI 10.1002/pat.3686; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Mara A, 2004, NANO LETT, V4, P497, DOI 10.1021/nl035141o; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Miles BN, 2013, CHEM SOC REV, V42, P15, DOI 10.1039/c2cs35286a; Mitsui T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036102; Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92; Park KB, 2016, NANOSCALE, V8, P5755, DOI 10.1039/c5nr09085g; Purnell RF, 2008, NANO LETT, V8, P3029, DOI 10.1021/nl802312f; Ramirez P, 2015, NANO ENERGY, V16, P375, DOI 10.1016/j.nanoen.2015.07.013; Reiner JE, 2012, CHEM REV, V112, P6431, DOI 10.1021/cr300381m; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Stava E, 2010, IEEE T NANOBIOSCI, V9, P307, DOI 10.1109/TNB.2010.2076830; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Steinbock LJ, 2013, ACS NANO, V7, P11255, DOI 10.1021/nn405029j; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; Tabard-Cossa V, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/30/305505; TSURU T, 1991, J CHEM ENG JPN, V24, P511, DOI 10.1252/jcej.24.511; van den Hout M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115304; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388; Wanunu M, 2007, NANO LETT, V7, P1580, DOI 10.1021/nl070462b; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wu MY, 2009, NANO LETT, V9, P479, DOI 10.1021/nl803613s; Xie P, 2012, NAT NANOTECHNOL, V7, P119, DOI [10.1038/nnano.2011.217, 10.1038/NNANO.2011.217]; Zhou Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03287	59	8	10	10	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200831	10.1371/journal.pone.0200831	http://dx.doi.org/10.1371/journal.pone.0200831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028848	gold, Green Submitted, Green Published			2022-12-26	WOS:000439396900017
J	Shi, LX; Yang, YH; Xie, Q; Miao, H; Bo, KL; Song, ZC; Wang, Y; Xie, BY; Zhang, SP; Gu, XF				Shi, Lixue; Yang, Yuhong; Xie, Qing; Miao, Han; Bo, Kailiang; Song, Zichao; Wang, Ye; Xie, Bingyan; Zhang, Shengping; Gu, Xingfang			Inheritance and QTL mapping of cucumber mosaic virus resistance in cucumber (Cucumis Sativus L.)	PLOS ONE			English	Article							VIRAL RESISTANCE; GENE; TOBACCO; GENOME	The commercial yield of cucurbit crops infected with Cucumber mosaic virus (CMV) severely decreases. Chemical treatments against CMV are not effective; therefore, genetic resistance is considered the primary line of defense. Here, we studied resistance to CMV in cucumber inbred line '02245' using a recombinant inbred line (RIL) population generated from a cross between '65G' and '02245' as susceptible and resistant parents, respectively. Genetic analysis revealed that CMV resistance in cucumber is quantitatively inherited. Analysis of the RIL population revealed that a quantitative trait locus (QTL) was found on chromosome 6; named cmv6.1, this QTL was delimited by SSR9-56 and SSR11-177 and explained 31.7% of the phenotypic variation in 2016 and 28.2% in 2017. The marker SSR11-1, which is close to the locus, was tested on 78 different cucumber accessions and found to have an accuracy of 94% in resistant and moderately resistant lines but only 67% in susceptible lines. The mapped QTL was delimited within a region of 1,624.0 kb, and nine genes related to disease resistance were identified. Cloning and alignment of the genomic sequences of these nine genes between '65G' and '02245' revealed that Csa6M133680 had four single-base substitutions within the coding sequences (CDSs) and two single-base substitutions in its 3'-untranslated region, and the other eight genes showed 100% nucleotide sequence identity in their exons. Expression pattern analyses of Csa6M133680 in '65G' and '02245' revealed that the expression levels of Csa6M133680 significantly differed between '65G' and '02245' at 80 h after inoculation with CMV and that the expression in '02245' was 4.4 times greater than that in '65G'. The above results provide insights into the fine mapping and marker-assisted selection in cucumber breeding for CMV resistance.	[Shi, Lixue; Yang, Yuhong; Xie, Qing; Miao, Han; Bo, Kailiang; Song, Zichao; Wang, Ye; Xie, Bingyan; Zhang, Shengping; Gu, Xingfang] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Zhang, SP; Gu, XF (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China.	zhangshengping@caas.cn; guxingfang@caas.cn	Bo, Kailiang/HGE-7253-2022		Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVF-CAAS); earmarked fund for Modern Agro-industry Technology Research System [CARS-25]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China	Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVF-CAAS); earmarked fund for Modern Agro-industry Technology Research System; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China	This study was supported by the Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVF-CAAS); the earmarked fund for Modern Agro-industry Technology Research System (CARS-25); and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China.; The authors would like to thank Dr. Graham Collins, formerly of the University of Adelaide, South Australia, for proofreading. This study was supported by the Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVF-CAAS); the Earmarked Fund for Modern Agro-industry Technology Research System (CARS25); and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China.	Abbink TEM, 1998, MOL PLANT MICROBE IN, V11, P1242, DOI 10.1094/MPMI.1998.11.12.1242; Amano M, 2013, THEOR APPL GENET, V126, P2983, DOI 10.1007/s00122-013-2187-5; Chen Z, 2017, J INTEGR AGR, V16, P115, DOI [10.1016/S2095-3119(16)61416-8, 10.1016/s2095-3119(16)61416-8]; Edwardson J R, 1992, CRC HDB VIRUSES INFE, P505; Guiu-Aragones C, 2014, MOL BREEDING, V34, P351, DOI 10.1007/s11032-014-0038-y; Guo GJ, 2017, THEOR APPL GENET, V130, P41, DOI 10.1007/s00122-016-2790-3; Huang H H., 2007, THESIS; KOOISTRA E, 1969, Euphytica, V18, P326, DOI 10.1007/BF00397779; Lin CY, 2012, TRANSGENIC RES, V21, P231, DOI 10.1007/s11248-011-9523-9; Lu HW, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0263-z; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Ministry of Agriculture of the People's Republic of China, 2010, RUL EV CUC RES CU 7; Pan J.Q., 2009, J SHANGHAI VEGETABLE, V4, P86; Price WC, 1934, PHYTOPATHOLOGY, V24, P743; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; RISSER G, 1977, ANN AMELIOR PLANT, V27, P509; Seo YS, 2006, P NATL ACAD SCI USA, V103, P11856, DOI 10.1073/pnas.0604815103; Song ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167845; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; TIAN GL, 2015, MOL BREEDING, V35; Tian GL, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0524-5; Wang H., 2006, HEILONGJIANG AGR SCI, V5, P124; Wang J H., 2010, THESIS; Wang M, 1997, J CHANGJIANG VEGETAB, P1; WASUWAT SL, 1961, PHYTOPATHOLOGY, V51, P423; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Yao MH, 2013, EUPHYTICA, V193, P135, DOI 10.1007/s10681-013-0953-8; Zhang HaiYing, 2005, Journal of Agricultural Biotechnology, V13, P709; Zhang SP, 2010, J AM SOC HORTIC SCI, V135, P53, DOI 10.21273/JASHS.135.1.53; Zhou H. J, 2005, THESIS; Zhou J, 2012, THESIS; Zvereva AS, 2012, VIRUSES-BASEL, V4, P2578, DOI 10.3390/v4112578	32	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200571	10.1371/journal.pone.0200571	http://dx.doi.org/10.1371/journal.pone.0200571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30021020	gold, Green Submitted, Green Published			2022-12-26	WOS:000439022400056
J	Fu, WY; Liu, Y; Sun, C; Yin, H				Fu, Wenyan; Liu, Yang; Sun, Christina; Yin, Hang			Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy	FASEB JOURNAL			English	Article						mitochondria; autophagy; aging; insulin sensitivity; diabetes	BROWN ADIPOCYTES; TUMOR-SUPPRESSOR; COLD-EXPOSURE; AUTOPHAGY; FAT; CELL; ACTIVATION; STRESS; MOUSE; MICE	Aging of white adipose tissue (WAT) is associated with reduced insulin sensitivity, which contributes to whole-body glucose intolerance. WAT aging in mice impairs cold-induced beige adipocyte recruitment (beiging), which has been attributed to the senescence of adipose progenitor cells. Tumor suppressor p53 has also been implicated in WAT aging. However, whether p53-related cellular aging in mature white adipocytes is causative of age-impaired WAT beiging remains unknown. It is also unclear whether transient p53 inhibition can rescue WAT beiging. Herein, we report that p53 increased in adipose tissues of 28-wk-old (aged) mice with impaired beiging capability. Cold exposure decreased p53 in beiging WAT of young mice but not in aged mice. In aged mice, inducible p53 ablation in differentiated adipocytes restored cold-induced WAT beiging and augmented whole-body energy expenditure and insulin sensitivity. Transient pharmacological inhibition of p53 led to the same beneficial effects. Mechanistically, cold exposure repressed autophagy in beiging WAT of young mice yet increased autophagy in aged WAT. p53-ablation reduced microtubule-associated protein light chain 3-mediated mitochondria clearance (mitophagy) and hence facilitated the increase of mitochondria during beiging. These findings suggest that p53-induced mitophagy in aged white adipocytes impedes WAT beiging and may be therapeutically targeted to improve insulin sensitivity in aged WAT.Fu, W., Liu, Y., Sun, C., Yin, H. Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy.	[Fu, Wenyan; Liu, Yang; Yin, Hang] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Fu, Wenyan; Liu, Yang; Yin, Hang] Univ Georgia, Ctr Mol Med, Athens, GA 30602 USA; [Sun, Christina] Augusta Univ, Dept Biol Sci, Augusta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Yin, H (corresponding author), Univ Georgia, 325 Riverbend Rd,Ctr Mol Med 2228, Athens, GA 30602 USA.	hyin@uga.edu	Yin, Hang/J-3613-2019; Liu, Yang/GSN-4444-2022	Yin, Hang/0000-0002-9621-0138; Liu, Yang/0000-0001-8364-1476	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR070178]; American Heart Association [17GRNT33700260]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070178] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Jarrod Call (The University of Georgia) for constructive discussion of the project. Research reported in this publication was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 1R01AR070178, and American Heart Association Grant-in-Aid 17GRNT33700260 (to H.Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or American Heart Association. The authors declare no conflicts of interest.	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023; Berry DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10184; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chen CY, 2012, J BIOL CHEM, V287, P44498, DOI 10.1074/jbc.M112.399790; Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Goldman SJ, 2011, ANTIOXID REDOX SIGN, V14, P1971, DOI 10.1089/ars.2010.3777; Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268; Hallenborg P, 2016, AM J PHYSIOL-ENDOC M, V310, pE116, DOI 10.1152/ajpendo.00119.2015; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HEATON JM, 1972, J ANAT, V112, P35; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Itahana Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030776; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kung CP, 2016, J ENDOCRINOL, V231, pR61, DOI 10.1530/JOE-16-0324; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lu XD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8526; Lusk G, 1928, ELEMENTS SCI NUTR; Ma Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12709; Martinez-Lopez N, 2013, EMBO REP, V14, P795, DOI 10.1038/embor.2013.111; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Narita M, 2009, AUTOPHAGY, V5, P1046, DOI 10.4161/auto.5.7.9444; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Soro-Arnaiz I, 2016, CELL REP, V16, P2991, DOI 10.1016/j.celrep.2016.08.041; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tran CM, 2016, DIABETES, V65, P927, DOI 10.2337/db15-0502; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang EY, 2013, HYPERTENSION, V62, P70, DOI 10.1161/HYPERTENSIONAHA.113.01028; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	59	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					844	856		10.1096/fj.201800577R	http://dx.doi.org/10.1096/fj.201800577R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052487	Green Published			2022-12-26	WOS:000457401500066
J	Rowarth, NM; MacRae, TH				Rowarth, Nathan M.; MacRae, Thomas H.			Post-diapause synthesis of ArHsp40-2, a type 2 J-domain protein from Artemia franciscana, is developmentally regulated and induced by stress	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DROSOPHILA-MELANOGASTER; SARCOPHAGA-CRASSIPALPIS; DETYROSINATED TUBULIN; MOLECULAR CHAPERONES; ENCYSTED EMBRYOS; BRINE SHRIMP; CHILL COMA; FLESH FLY; IN-VIVO	Post-diapause cysts of Artemia franciscana undergo a well-defined developmental process whereby internal differentiation leads to rupture of the cyst shell, release of membrane-enclosed nauplii and hatching to yield swimming larvae. The post-diapause development of A. franciscana has been examined at biochemical and molecular levels, yet little is known about molecular chaperone function during this process. In addressing this we recently described ArHsp40, a type 1 J-domain protein in post-diapause A. franciscana cysts and larvae. The current report describes ArHsp40-2, a second J-domain protein from A. franciscana. ArHsp40-2 is a type 2 J-domain protein, lacking a zinc binding domain but containing other domains characteristic of these proteins. Notably, ArHsp40-2 possesses a double barrel beta-domain structure in its substrate binding region, as does ArHsp40. qPCR revealed a relatively low amount of ArHsp40-2 mRNA in 0 h cysts which increased significantly until the E1 stage, most likely as a result of enhanced transcription, after which it declined. An antibody specific to ArHsp40-2 was produced and used to show that like its mRNA, ArHsp40-2 accumulated until the E1 stage and then decreased to amounts lower than those in 0 h cysts. The synthesis of ArHsp40-2 was induced by heat shock indicating that ArHsp40-2 is involved in stress resistance in cysts and nauplii. Accumulation in cysts during early post-diapause development followed by its sharp decline suggests a role in protein disaggregation/refolding, a function of Hsp40s from other organisms, where ArHsp40-2 assists in the rescue of proteins sequestered during diapause by p26, an abundant small heat shock protein (sHsp) in A. franciscana cysts.	[Rowarth, Nathan M.; MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	MacRae, TH (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tmacrae@dal.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-04882]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Natural Sciences and Engineering Research Council of Canada; RGPIN-2016-04882; to THM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen T, 2003, INVERTEBR REPROD DEV, V44, P33, DOI 10.1080/07924259.2003.9652551; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; Clegg JS, 2011, J INSECT PHYSIOL, V57, P660, DOI 10.1016/j.jinsphys.2010.11.023; Clegg JS, 1996, PHYSIOL ZOOL, V69, P49, DOI 10.1086/physzool.69.1.30164200; Clegg JS, 1997, J EXP BIOL, V200, P467; Clegg JS, 2000, J EXP MAR BIOL ECOL, V252, P85, DOI 10.1016/S0022-0981(00)00239-2; Clegg JS, 2000, CELL TISSUE RES, V301, P433, DOI 10.1007/s004410000249; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Hand S., 2013, CRYOBIOLOGY CRYOTECH, V59, P41; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Hengherr S, 2011, COMP BIOCHEM PHYS A, V160, P137, DOI 10.1016/j.cbpa.2011.05.032; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Hwang JS, 2005, ARCH INSECT BIOCHEM, V59, P197, DOI 10.1002/arch.20057; Iryani MTM, 2017, J EXP MAR BIOL ECOL, V487, P106, DOI 10.1016/j.jembe.2016.12.004; Jackson SA, 1996, DEV GROWTH DIFFER, V38, P153; Jiang GJ, 2016, CELL STRESS CHAPERON, V21, P1077, DOI 10.1007/s12192-016-0732-2; King AM, 2013, FEBS J, V280, P4761, DOI 10.1111/febs.12442; King AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043723; Kirstein J, 2017, AGING CELL, V16, P1414, DOI 10.1111/acel.12686; LANGDON CM, 1991, DEV BIOL, V148, P147, DOI 10.1016/0012-1606(91)90325-W; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Ma WM, 2013, BIOCHEM J, V449, P285, DOI 10.1042/BJ20121259; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MacRae TH, 2016, CELL STRESS CHAPERON, V21, P9, DOI 10.1007/s12192-015-0635-7; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Marklund EG, 2018, CELL STRESS CHAPERON, V23, P723, DOI 10.1007/s12192-018-0884-3; Michaud MR, 2011, J INSECT PHYSIOL, V57, P203, DOI 10.1016/j.jinsphys.2010.11.007; Mogk A, 2018, MOL CELL, V69, P214, DOI 10.1016/j.molcel.2018.01.004; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Norouzitallab P, 2015, FISH SHELLFISH IMMUN, V42, P395, DOI 10.1016/j.fsi.2014.11.017; Pavlides SC, 2011, J INSECT PHYSIOL, V57, P635, DOI 10.1016/j.jinsphys.2011.03.022; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; Xiang H, 1995, BIOCHEM CELL BIOL, V73, P673, DOI 10.1139/o95-075; Zhang GJ, 2011, J INSECT PHYSIOL, V57, P1115, DOI 10.1016/j.jinsphys.2011.02.016; Zhou Q, 2008, MAR BIOTECHNOL, V10, P438, DOI 10.1007/s10126-007-9079-0	52	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201477	10.1371/journal.pone.0201477	http://dx.doi.org/10.1371/journal.pone.0201477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048537	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400092
J	Watt, ED; Judson, RS				Watt, Eric D.; Judson, Richard S.			Uncertainty quantification in ToxCast high throughput screening	PLOS ONE			English	Article							IN-VIVO HAZARD; ENVIRONMENTAL CHEMICALS; WILD BOOTSTRAP; PHASE-I; TOXICITY; EXPOSURE; BIOACTIVITY; DOSIMETRY; IMPACT; PRIORITIZATION	High throughput screening (HTS) projects like the U.S. Environmental Protection Agency's ToxCast program are required to address the large and rapidly increasing number of chemicals for which we have little to no toxicity measurements. Concentration-response parameters such as potency and efficacy are extracted from HTS data using nonlinear regression, and models and analyses built from these parameters are used to predict in vivo and in vitro toxicity of thousands of chemicals. How these predictions are impacted by uncertainties that stem from parameter estimation and propagated through the models and analyses has not been well explored. While data size and complexity makes uncertainty quantification computationally expensive for HTS datasets, continued advancements in computational resources have allowed these computational challenges to be met. This study uses non-parametric bootstrap resampling to calculate uncertainties in concentration-response parameters from a variety of HTS assays. Using the ToxCast estrogen receptor model for bioactivity as a case study, we highlight how these uncertainties can be propagated through models to quantify the uncertainty in model outputs. Uncertainty quantification in model outputs is used to identify potential false positives and false negatives and to determine the distribution of model values around semi-arbitrary activity cutoffs, increasing confidence in model predictions. At the individual chemical-assay level, curves with high variability are flagged for manual inspection or retesting, focusing subject-matter-expert time on results that need further input. This work improves the confidence of predictions made using HTS data, increasing the ability to use this data in risk assessment.	[Watt, Eric D.; Judson, Richard S.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Watt, Eric D.] Oak Ridge Inst Sci Educ, Oak Ridge, TN USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Judson, RS (corresponding author), US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.	Judson.richard@epa.gov		Judson, Richard/0000-0002-2348-9633; Watt, Eric/0000-0002-1211-0229	U.S. EPA	U.S. EPA(United States Environmental Protection Agency)	This work was funded by the U.S. EPA to EDW. This project was supported in part by an appointment to the Research Participation Program at the National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and EPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Attene-Ramos MS, 2015, ENVIRON HEALTH PERSP, V123, P49, DOI 10.1289/ehp.1408642; Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015; Auerbach S, 2016, ENVIRON HEALTH PERSP, V124, P1141, DOI 10.1289/ehp.1510456; Barrier M, 2011, REPROD TOXICOL, V31, P383, DOI 10.1016/j.reprotox.2011.01.007; Beam Andrew, 2014, J Pharmacogenomics Pharmacoproteomics, V5, P1000121; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Davidson R, 2008, J ECONOMETRICS, V146, P162, DOI 10.1016/j.jeconom.2008.08.003; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dowle M, 2015, R SAPORTA SL CONTRIB; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Filer D. L., 2016, BIOINFORMATICS, V33; Filer DL, 2016, TCPL TOXCAST DATA AN; Friedman KP, 2016, TOXICOL SCI, V151, P160, DOI 10.1093/toxsci/kfw034; Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525; Hsieh JH, 2015, J BIOMOL SCREEN, V20, P887, DOI 10.1177/1087057115581317; Huang RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05664; Huang RL, 2011, ENVIRON HEALTH PERSP, V119, P1142, DOI 10.1289/ehp.1002952; Janesick AS, 2016, ENVIRON HEALTH PERSP, V124, P1214, DOI 10.1289/ehp.1510352; Jiang H, 2012, BIOMETRIKA, V99, P973, DOI 10.1093/biomet/ass051; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kavlock RJ, 2009, RISK ANAL, V29, P485, DOI 10.1111/j.1539-6924.2008.01168.x; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kleinstreuer NC, 2013, TOXICOL SCI, V131, P40, DOI 10.1093/toxsci/kfs285; Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412; Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Lim CW, 2013, TECHNOMETRICS, V55, P150, DOI 10.1080/00401706.2012.749166; Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h; LIU RY, 1988, ANN STAT, V16, P1696, DOI 10.1214/aos/1176351062; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; MAMMEN E, 1993, ANN STAT, V21, P255, DOI 10.1214/aos/1176349025; Mansouri K, 2016, ENVIRON HEALTH PERSP, V124, P1023, DOI 10.1289/ehp.1510267; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; McDonough PM, 2011, ASSAY DRUG DEV TECHN, V9, P262, DOI 10.1089/adt.2010.0302; Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949; National Research Council (NRC), 2007, J TOXICOL ENV HEAL B, DOI [DOI 10.1080/10937404.2010.483176, 10.1080/10937404.2010.483176]; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; R Core Team, 2013, R LANG ENV STAT COMP; Rager JE, 2016, ENVIRON INT, V88, P269, DOI 10.1016/j.envint.2015.12.008; Reif DM, 2013, BIOINFORMATICS, V29, P402, DOI 10.1093/bioinformatics/bts686; Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180; Richard AM, 2016, CHEM RES TOXICOL, V29, P1225, DOI 10.1021/acs.chemrestox.6b00135; Rotroff DM, 2013, CHEM RES TOXICOL, V26, P1097, DOI 10.1021/tx400117y; Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220; Shah I, 2016, ENVIRON HEALTH PERSP, V124, P910, DOI 10.1289/ehp.1409029; Shah I, 2016, REGUL TOXICOL PHARM, V79, P12, DOI 10.1016/j.yrtph.2016.05.008; Shah I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014584; Shockley KR, 2015, DRUG DISCOV TODAY, V20, P296, DOI 10.1016/j.drudis.2014.10.005; Shockley KR, 2012, ENVIRON HEALTH PERSP, V120, P1107, DOI 10.1289/ehp.1104688; Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007; Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI 10.1021/tx400021f; Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Stossi F, 2014, CHEM BIOL, V21, P743, DOI 10.1016/j.chembiol.2014.03.013; Tal TL, 2014, REPROD TOXICOL, V48, P51, DOI 10.1016/j.reprotox.2014.05.014; Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178; Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; U.S. EPA, 2014, EPAHQOPP20140614; US EPA O US EPA, 2015, TSCA CHEM SUBST INV; Wambaugh JF, 2013, ENVIRON SCI TECHNOL, V47, P8479, DOI 10.1021/es400482g; Watt ED, 2016, TOXBOOT BOOTSTRAP ME; Wetmore BA, 2014, TOXICOL SCI, V142, P210, DOI 10.1093/toxsci/kfu169; Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012; Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	73	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0196963	10.1371/journal.pone.0196963	http://dx.doi.org/10.1371/journal.pone.0196963			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044784	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500003
J	Bialkowska, K; Marciniak, W; Muszynska, M; Baszuk, P; Gupta, S; Jaworska-Bieniek, K; Sukiennicki, G; Durda, K; Gromowski, T; Prajzendanc, K; Cybulski, C; Huzarski, T; Gronwald, J; Debniak, T; Scott, RJ; Lubinski, J; Jakubowska, A				Bialkowska, Katarzyna; Marciniak, Wojciech; Muszynska, Magdalena; Baszuk, Piotr; Gupta, Satish; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Durda, Katarzyna; Gromowski, Tomasz; Prajzendanc, Karolina; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Debniak, Tadeusz; Scott, Rodney J.; Lubinski, Jan; Jakubowska, Anna			Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population	PLOS ONE			English	Article							METALLOPROTEINASE-1 PROMOTER POLYMORPHISM; COLORECTAL-CANCER; BREAST-CANCER; SINGLE-NUCLEOTIDE; INCREASED RISK; SUPPLEMENT USE; SERUM ZINC; SUSCEPTIBILITY; METALLOTHIONEIN; CARCINOMA	Introduction Prostate cancer is one of the most commonly diagnosed malignancies among men in Western populations. Evidence reported in the literature suggests that zinc may be related to prostate cancer. In this study we evaluated the association of serum zinc levels and polymorphisms in genes encoding zinc-dependent proteins with prostate cancer in Poland. Methods The study group consisted of 197 men affected with prostate cancer and 197 healthy men. Serum zinc levels were measured and 5 single nucleotide polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13, MT2A genes were genotyped. Results The mean serum zinc level was higher in prostate cancer patients than in healthy controls (898.9 +/- 12.01 mu g/I vs. 856.6 +/- 13.05 mu g/I, p<0.01). When compared in quartiles a significant association of higher zinc concentration with the incidence of prostate cancer was observed. The highest OR (OR = 4.41, 95%CI 2.07-9.37, p<0.01) was observed in 3rd quartile (>853.0-973.9 mu/I). Among five analyzed genetic variants, rs11568818 in MMP-7 appeared to be correlated with 2-fold increased prostate cancer risk (OR = 2.39, 95% CI = 1.19-4.82, p = 0.015). Conclusion Our results suggest a significant correlation of higher serum zinc levels with the diagnosis of prostate cancer. The polymorphism rs11568818 in MMP-7 gene was also associated with an increased prostate cancer risk in Poland.	[Bialkowska, Katarzyna; Baszuk, Piotr; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Durda, Katarzyna; Gromowski, Tomasz; Prajzendanc, Karolina; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Debniak, Tadeusz; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Marciniak, Wojciech; Muszynska, Magdalena; Lubinski, Jan] Read Gene SA, Grzepnica, Poland; [Gupta, Satish] Strand Life Sci, Bangalore, Karnataka, India; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW, Australia; [Scott, Rodney J.] NSW Hlth Pathol, Div Mol Med, Newcastle, NSW, Australia; [Jakubowska, Anna] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, Szczecin, Poland	Pomeranian Medical University; University of Newcastle; Pomeranian Medical University	Bialkowska, K (corresponding author), Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland.	katarzyna.kaczm@gmail.com	Huzarski, Tomasz/AAQ-2161-2021; Jakubowska, Anna/O-8050-2014; Scott, Rodney/B-2827-2013	Huzarski, Tomasz/0000-0003-3857-4854; Jakubowska, Anna/0000-0002-5650-0501; Marciniak, Wojciech/0000-0001-7270-0063; Bialkowska, Katarzyna/0000-0001-8489-6665; Lubinski, Jan/0000-0003-2931-3003; Scott, Rodney/0000-0001-7724-3404	National Science Centre [DEC-2012/07/N/NZ4/02433]; Read-Gene S.A.	National Science Centre(National Science Centre, Poland); Read-Gene S.A.	The project was financially supported by National Science Centre, grant no. DEC-2012/07/N/NZ4/02433. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Read-Gene S.A. provided support in the form of salaries for authors WM, MM, JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adabi Z, 2015, ARCH MED RES, V46, P546, DOI 10.1016/j.arcmed.2015.08.004; Asamoto M, 2001, CANCER RES, V61, P4693; Aydin A, 2006, CLIN BIOCHEM, V39, P176, DOI 10.1016/j.clinbiochem.2005.11.018; Biondi ML, 2000, CLIN CHEM, V46, P2023; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Christudoss P, 2011, INDIAN J UROL, V27, P14, DOI 10.4103/0970-1591.78405; Cybulski C, 2006, J MED GENET, V43, P863, DOI 10.1136/jmg.2006.044974; Cybulski C, 2004, CANCER RES, V64, P1215, DOI 10.1158/0008-5472.CAN-03-2502; Cybulski C, 2013, BRIT J CANCER, V108, P461, DOI 10.1038/bjc.2012.486; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Darago A, 2011, CLIN CHEM LAB MED, V49, P1699, DOI 10.1515/CCLM.2011.651; Delgado-Enciso I, 2008, GYNECOL OBSTET INVES, V65, P68, DOI 10.1159/000108282; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Epstein MM, 2011, AM J CLIN NUTR, V93, P586, DOI 10.3945/ajcn.110.004804; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Feng P, 2002, PROSTATE, V52, P311, DOI 10.1002/pros.10128; Forma E, 2012, CANCER GENET-NY, V205, P432, DOI 10.1016/j.cancergen.2012.05.005; Gallus S, 2007, EUR UROL, V52, P1052, DOI 10.1016/j.eururo.2007.01.094; Ghilardi G, 2003, CLIN CHEM, V49, P1940, DOI 10.1373/clinchem.2003.018911; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Goel T, 2006, SCAND J UROL NEPHROL, V40, P108, DOI 10.1080/00365590500368922; Gonzalez A, 2009, NUTR CANCER, V61, P206, DOI 10.1080/01635580802419749; Grindel BJ, 2014, MATRIX BIOL, V36, P64, DOI 10.1016/j.matbio.2014.04.005; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Hale V, 2014, PROSTATE CANCER, V2014, DOI 10.1155/2014/294575; Hebbring SJ, 2006, CANCER EPIDEM BIOMAR, V15, P935, DOI 10.1158/1055-9965.EPI-05-0910; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Hoffmann TJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14248; Holubova M, 2014, METALLOMICS, V6, P1240, DOI 10.1039/c4mt00065j; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Jormsjo S, 2001, ARTERIOSCL THROM VAS, V21, P1834, DOI 10.1161/hq1101.098229; Kaba M, 2014, ASIAN PAC J CANCER P, V15, P2625, DOI 10.7314/APJCP.2014.15.6.2625; Kayaalti Z, 2010, TOXICOL APPL PHARM, V245, P252, DOI 10.1016/j.taap.2010.03.007; Kesh K, 2015, J BIOL CHEM, V290, P14391, DOI 10.1074/jbc.M114.630129; Kita K, 2006, HUM GENET, V120, P553, DOI 10.1007/s00439-006-0238-6; Kluzniak W, 2013, PROSTATE, V73, P542, DOI 10.1002/pros.22594; Kratochvilova M, 2017, PROSTATE, V77, P604, DOI 10.1002/pros.23304; Kristal AR, 1999, CANCER EPIDEM BIOMAR, V8, P887; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Leitzmann MF, 2003, J NATL CANCER I, V95, P1004, DOI 10.1093/jnci/95.13.1004; Li XM, 2005, ASIAN J ANDROL, V7, P323, DOI 10.1111/j.1745-7262.2005.00044.x; Liang JY, 1999, PROSTATE, V40, P200; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; National Cancer Registry, MAL NEOPL PROST GLAN; Ouyang XS, 2001, CARCINOGENESIS, V22, P965, DOI 10.1093/carcin/22.6.965; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; Park SY, 2013, PROSTATE, V73, P261, DOI 10.1002/pros.22565; Peng QS, 2015, ONCOTARGETS THER, V8, P2519, DOI 10.2147/OTT.S83004; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Saeed HM, 2013, ASIAN PAC J CANCER P, V14, P6025, DOI 10.7314/APJCP.2013.14.10.6025; Saeed HM, 2013, ACTA BIOCHIM POL, V60, P405; Seppala EH, 2003, BRIT J CANCER, V89, P1966, DOI 10.1038/sj.bjc.6601425; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Nguyen SV, 2013, ANTICANCER RES, V33, P3247; Srivastava P, 2012, ARCH MED RES, V43, P117, DOI 10.1016/j.arcmed.2012.02.006; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Vira H, 2017, LUPUS, V26, P937, DOI 10.1177/0961203316682855; Wu J, 2013, CLIN BIOCHEM, V46, P1649, DOI 10.1016/j.clinbiochem.2013.07.015; Yamasaki M, 2007, ONCOL REP, V18, P1145; Yu CY, 2002, CANCER RES, V62, P6430; Zaichick V. Ye., 1997, International Urology and Nephrology, V29, P565, DOI 10.1007/BF02552202; Zhang JH, 2005, CARCINOGENESIS, V26, P1748, DOI 10.1093/carcin/bgi144; Zhou YF, 2005, CARCINOGENESIS, V26, P1117, DOI 10.1093/carcin/bgi057; Zhou YF, 2004, CARCINOGENESIS, V25, P399, DOI 10.1093/carcin/bgh020	67	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201065	10.1371/journal.pone.0201065	http://dx.doi.org/10.1371/journal.pone.0201065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036379	Green Submitted, Green Published, gold			2022-12-26	WOS:000439429200024
J	Nunez-Vivanco, G; Fierro, A; Moya, P; Iturriaga-Vasquez, P; Reyes-Parada, M				Nunez-Vivanco, Gabriel; Fierro, Angelica; Moya, Pablo; Iturriaga-Vasquez, Patricio; Reyes-Parada, Miguel			3D similarities between the binding sites of monoaminergic target proteins	PLOS ONE			English	Article							X-RAY STRUCTURES; OXIDASE-B; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; AMPHETAMINE DERIVATIVES; CRYSTAL-STRUCTURES; BACTERIAL HOMOLOG; LIGAND-BINDING; IN-VIVO	The study of binding site similarities can be relevant to understand the interaction of different drugs at several molecular targets. The increasing availability of protein crystal structures and the development of novel algorithms designed to evaluate three-dimensional similarities, represent a great opportunity to explore the existence of electronic and shape features shared by clinically relevant proteins, which could assist drug design and discovery. Proteins involved in the recognition of monoaminergic neurotransmitters, such as monoamine transporters or monoamine oxidases (MAO) have been related to several psychiatric and neurological disorders such as depression or Parkinson's disease. In this work, we evaluated the possible existence of similarities among the binding sites of the serotonin transporter (SERT), the dopamine transporter (DAT), MAO-A and MAO-B. This study was carried out using molecular simulation methodologies linked to the statistical algorithm PocketMatch, which was modified in order to obtain similarities profiles. Our results show that DAT and SERT exhibit a high degree of 3-D similarities all along the pathway that is presumably involved in the substrate transport process. Distinct differences, on the other hand, were found both at the extracellular and the intracellular ends of the transporters, which might be involved in the selective initial recognition of the corresponding substrate. Similarities were also found between the active (catalytic) site of MAO-A and the extracellular vestibule of SERT (the S2 binding site). These results suggest some degree of structural convergence for these proteins, which have different functions, tissue distribution and genetic origin, but which share the same endogenous ligand (serotonin). Beyond the functional implications, these findings are valuable for the design of both selective and non-selective ligands.	[Nunez-Vivanco, Gabriel] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Nunez-Vivanco, Gabriel] Univ Talca, Escuela Ingn Civil Bioinformat, Talca, Chile; [Fierro, Angelica] Pontificia Univ Catolica Chile, Santiago, Chile; [Moya, Pablo] Univ Valparaiso, Inst Fisiol, Valparaiso, Chile; [Moya, Pablo] Univ Valparaiso, CINV, Valparaiso, Chile; [Iturriaga-Vasquez, Patricio] Univ la Frontera, Fac Ingn & Ciencias, Temuco, Chile; [Reyes-Parada, Miguel] Univ Santiago Chile, Fac Med Sci, Sch Med, Santiago, Chile; [Reyes-Parada, Miguel] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Talca; Universidad de Talca; Pontificia Universidad Catolica de Chile; Universidad de Valparaiso; Universidad de Valparaiso; Universidad de La Frontera; Universidad de Santiago de Chile; Universidad Autonoma de Chile	Nunez-Vivanco, G (corresponding author), Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile.; Nunez-Vivanco, G (corresponding author), Univ Talca, Escuela Ingn Civil Bioinformat, Talca, Chile.; Reyes-Parada, M (corresponding author), Univ Santiago Chile, Fac Med Sci, Sch Med, Santiago, Chile.; Reyes-Parada, M (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	ganunez@utalca.cl; miguel.reyes@usach.cl	Fierro, Angelica/AAJ-2533-2020	Fierro, Angelica/0000-0002-6507-4188; Nunez Vivanco, Gabriel/0000-0002-2858-1789; Moya, Pablo/0000-0001-6409-1544	Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [1170662, 1141272, 1150615, 1161375]; ICM MINECOM (Iniciativa Cientifica Milenio, Ministerio de Economia) [NC130011, P09-022-F]	Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM MINECOM (Iniciativa Cientifica Milenio, Ministerio de Economia)	This project was partially supported by Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico) grants 1170662 (MRP), 1141272 (PM), 1150615 (PIV), 1161375 (AF) and the ICM MINECOM (Iniciativa Cientifica Milenio, Ministerio de Economia) grants NC130011 and P09-022-F, www.conicyt.cl/fondecyt, http://www.iniciativamilenio.cl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen J, 2016, ACS CHEM NEUROSCI, V7, P1406, DOI 10.1021/acschemneuro.6b00164; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Binda C, 2004, J MED CHEM, V47, P1767, DOI 10.1021/jm031087c; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Binda C, 2011, INT REV NEUROBIOL, V100, P1, DOI 10.1016/B978-0-12-386467-3.00001-7; Bonivento D, 2010, J BIOL CHEM, V285, P36849, DOI 10.1074/jbc.M110.169482; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; De Colibus L, 2005, THREE DIMENSIONAL ST; De Deurwaerdere P, 2017, PROG NEUROBIOL, V151, P1, DOI 10.1016/j.pneurobio.2017.02.001; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; Fierro A, 2013, AN INTEGRATED VIEW O, P405; Fierro A, 2007, BIOORGAN MED CHEM, V15, P5198, DOI 10.1016/j.bmc.2007.05.021; Gani OA, 2015, BBA-PROTEINS PROTEOM, V1854, P1605, DOI 10.1016/j.bbapap.2015.05.004; Gobbi M, 2002, J NEUROCHEM, V82, P1435, DOI 10.1046/j.1471-4159.2002.01073.x; Grouleff J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00235; Haddad Y, 2016, ACS CHEM NEUROSCI, V7, P1607, DOI 10.1021/acschemneuro.6b00242; Hidalgo S, 2017, ACS CHEM NEUROSCI, V8, P2168, DOI 10.1021/acschemneuro.7b00089; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jalencas X, 2013, MOL INFORM, V32, P976, DOI 10.1002/minf.201300082; Kazmier K, 2017, CURR OPIN STRUC BIOL, V45, P100, DOI 10.1016/j.sbi.2016.12.006; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Larsen MB, 2011, J NEUROSCI, V31, P6605, DOI 10.1523/JNEUROSCI.0576-11.2011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loland CJ, 2015, BBA-GEN SUBJECTS, V1850, P500, DOI 10.1016/j.bbagen.2014.04.011; Ma JC, 2004, J MOL BIOL, V338, P103, DOI 10.1016/j.jmb.2004.02.032; Maurer W. D., 1975, Computing Surveys, V7, P5, DOI 10.1145/356643.356645; McDonald GR, 2010, PHARMACOL RES, V62, P475, DOI 10.1016/j.phrs.2010.09.001; Moller-Acuna P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134444; Najmanovich RJ, 2017, CURR OPIN STRUC BIOL, V45, P85, DOI 10.1016/j.sbi.2016.11.024; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Purves D, 2001, NEUROSCIENCE, V2nd edition; Reyes-Parada M., 2005, CURR ENZYM INHIB, V1, P85, DOI DOI 10.2174/1573408052952711; Roche DB, 2015, INT J MOL SCI, V16, P29829, DOI 10.3390/ijms161226202; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Rudnick G, 2011, BIOCHEMISTRY-US, V50, P7462, DOI 10.1021/bi200926b; Scorza MC, 1997, BIOCHEM PHARMACOL, V54, P1361, DOI 10.1016/S0006-2952(97)00405-X; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Sotomayor-Zarate R, 2012, BASIC CLIN PHARMACOL, V111, P371, DOI 10.1111/j.1742-7843.2012.00926.x; Stahl S.M., 2021, ESSENTIAL PSYCHOPHAR; Topiol S, 2016, BIOORG MED CHEM LETT, V26, P5058, DOI 10.1016/j.bmcl.2016.08.087; Vulpetti A, 2012, FUTURE MED CHEM, V4, P1971, DOI [10.4155/fmc.12.147, 10.4155/FMC.12.147]; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Zhong HL, 2012, PSYCHOPHARMACOLOGY, V219, P1, DOI 10.1007/s00213-011-2463-5; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	61	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200637	10.1371/journal.pone.0200637	http://dx.doi.org/10.1371/journal.pone.0200637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028869	Green Published, gold, Green Submitted			2022-12-26	WOS:000439396900011
J	Chen, CJ; Liao, WL; Chang, CT; Liao, HY; Tsai, FJ				Chen, Chao-Jung; Liao, Wen-Ling; Chang, Chiz-Tzung; Liao, Hsin-Yi; Tsai, Fuu-Jen			Urine proteome analysis by C-18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy	PLOS ONE			English	Article							CLARA CELL PROTEIN; RENAL-FUNCTION; AMINO-ACID; MARKERS; BETA-2-MICROGLOBULIN; IDENTIFICATION; PURIFICATION	Diabetic nephropathy (DN) is one of the most common complications in diabetic patients. New noninvasive markers are still needed for the early detection of DN before identifiable alternations in kidney function or urine albumin excretion occurs. A C-18 plate and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were used to compare the urinary protein profiles of 238 subjects from the following 4 groups: patients with type 2 diabetic (T2D) with microalbuminuria, patients with DM without micro- or macroalbuminuria, patients with micro- or macroalbuminuria due to nondiabetic disease, and healthy controls. beta 2-microglobulin (B2M) and Clara-cell protein (CC16) were found to be highly released in the urine of patients with proteinuria due to nondiabetic or diabetic diseases. In differentiating nephropathy from healthy subject, the B2M and CC16 markers have a combined sensitivity and specificity of 77.3% and 91.8%, respectively. In distinguishing T2D with microalbuminuria from T2D patients, the combined markers have sensitivity and specificity of 66% and 73%, respectively. The predictive ability of B2M and CC16 for early renal functional decline (ERFD) was validated in 125 T2D patients with a follow-up times. The odds ratio (OR) of combined B2M and CC16 markers for developing ERFD was 7.59 (95% CI: 1.97-29.24). The detection of B2M and CC16 with the C-18 plate-MALDI-TOF MS approach could be an attractive and practical assay for rapid diagnosis of nephropathy in nondiabetic/diabetic patients and as a predictor of ERFD among T2D patients who had not manifested significant kidney disease at baseline.	[Chen, Chao-Jung; Liao, Hsin-Yi] China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan; [Chen, Chao-Jung; Liao, Wen-Ling] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Liao, Wen-Ling] China Med Univ Hosp, Ctr Personalized Med, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ, Coll Med, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, CJ (corresponding author), China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan.; Chen, CJ (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Tsai, FJ (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan.	cjchen@mail.cmu.edu.tw; do704@mail.cmuh.org.tw	Chen, Chao-Jung/E-5481-2011	Chen, Chao-Jung/0000-0003-3834-9243	China Medical University Hospital [DMR-106-126]; Ministry of Science and Technology [MOST 105-2113-M-039-006]; Academia Sinica's Diabetes Biosignature Project [BM 10601010027]	China Medical University Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica's Diabetes Biosignature Project	This work was supported by grants from the China Medical University Hospital (DMR-106-126), the Ministry of Science and Technology (MOST 105-2113-M-039-006), and Academia Sinica's Diabetes Biosignature Project (BM 10601010027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the China Medical University Hospital (DMR-106-126), the Ministry of Science and Technology (MOST 105-2113-M-039-006), and Academia Sinica's Diabetes Biosignature Project (BM 10601010027).	BERNARD A, 1993, CLIN CHIM ACTA, V223, P189, DOI 10.1016/0009-8981(93)90077-H; BERNARD A, 1991, CLIN CHIM ACTA, V201, P231, DOI 10.1016/0009-8981(91)90374-L; BERNARD A, 1995, TOXICOL LETT, V77, P145, DOI 10.1016/0378-4274(95)03284-3; Chang CT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164846; Chang CT, 2015, CLIN CHIM ACTA, V440, P115, DOI 10.1016/j.cca.2014.11.019; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dihazi H, 2007, CLIN CHEM, V53, P1636, DOI 10.1373/clinchem.2007.088260; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hong CY, 1998, J DIABETES COMPLICAT, V12, P43, DOI 10.1016/S1056-8727(97)00045-7; Indovina P, 2013, MASS SPECTROM REV, V32, P129, DOI 10.1002/mas.21355; JACKSON PJ, 1988, J CHROMATOGR, V452, P359, DOI 10.1016/S0021-9673(01)81460-6; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liao HY, 2016, ANALYST, V141, P2183, DOI 10.1039/c6an00113k; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Martin-Granado A, 2009, PEDIATR NEPHROL, V24, P747, DOI 10.1007/s00467-008-1078-5; Moresco RN, 2013, CLIN CHIM ACTA, V421, P17, DOI 10.1016/j.cca.2013.02.019; Otu HH, 2007, DIABETES CARE, V30, P638, DOI 10.2337/dc06-1656; Papale M, 2010, DIABETES CARE, V33, P2409, DOI 10.2337/dc10-0345; PISCATOR M, 1991, KIDNEY INT, V40, pS15; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; SCHARDIJN GHC, 1987, KIDNEY INT, V32, P635, DOI 10.1038/ki.1987.255; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sharifiaghdas F, 2011, UROL J, V8, P277; SINGH G, 1988, BIOCHIM BIOPHYS ACTA, V950, P329, DOI 10.1016/0167-4781(88)90129-7; Tan HT, 2012, MASS SPECTROM REV, V31, P583, DOI 10.1002/mas.20356; Wu J, 2011, DIABETES RES CLIN PR, V91, P213, DOI 10.1016/j.diabres.2010.11.036; Yoshikawa R, 2007, DIABETES RES CLIN PR, V76, P358, DOI 10.1016/j.diabres.2006.09.004; Zhang Y, 2009, TRANSPLANTATION, V87, P1807, DOI 10.1097/TP.0b013e3181a66595	28	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200945	10.1371/journal.pone.0200945	http://dx.doi.org/10.1371/journal.pone.0200945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024955	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000072
J	Griebel, J; Utz, M; Hermisson, J; Wolinska, J				Griebel, Johanna; Utz, Margarete; Hermisson, Joachim; Wolinska, Justyna			The establishment of hybrids of the Daphnia longispina complex explained by a mathematical model incorporating different overwintering life history strategies	PLOS ONE			English	Article							SPECIES COMPLEX; TRANSGRESSIVE SEGREGATION; REPRODUCTIVE ISOLATION; SEXUAL REPRODUCTION; GENE FLOW; HYBRIDIZATION; DYNAMICS; COMMUNITIES; POPULATIONS; ADAPTATION	Interspecific hybridization (i.e. mating between species) occurs frequently in animals. Among cyclical parthenogens, hybrids can proliferate and establish through parthenogenetic reproduction, even if their sexual reproduction is impaired. In water fleas of the Daphnia longispina species complex, interspecific hybrids hatch from sexually produced dormant eggs. However, fewer hybrid genotypes contribute to the dormant egg bank and their hatching rate from dormant eggs is reduced, compared to eggs resulting from intraspecific crosses. Therefore, Daphnia hybrids would benefit from adaptations that increase their survival over winter as parthenogenetic lineages, avoiding the need to re-establish populations after winter from sexually produced dormant eggs. Here, we constructed a mathematical model to examine the conditions that could explain the frequently observed establishment of hybrids in the D. longispina species complex. Specifically, we compared the outcome of hybrid and parental taxa competition given a reduced contribution of hybrids to hatchlings from the sexually produced dormant egg bank, but their increased ability to survive winter as parthenogenetic lineages. In addition, different growth rates of parental species and differences in average annual temperatures were evaluated for their influence on hybrid production and establishment. Our model shows that increased overwinter performance as parthenogenetic females can compensate for reduced success in sexual reproduction, across all tested scenarios for varying relative growth rates of parental species. This pattern holds true for lower annual temperatures, but at higher temperatures hybrids were less successful. Consequently, hybrids might become less abundant as temperatures rise due to climate change, resulting in reduced diversity and faster differentiation of the parental species.	[Griebel, Johanna; Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Griebel, Johanna] Ludwig Maximilian Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Utz, Margarete] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Hermisson, Joachim] Univ Vienna, Dept Math, Vienna, Austria; [Wolinska, Justyna] Free Univ Berlin, Dept Biol Chem Pharm, Inst Biol, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Munich; University of Groningen; University of Vienna; Free University of Berlin	Griebel, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany.; Griebel, J (corresponding author), Ludwig Maximilian Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	j_griebel@gmx.de	Wolinska, Justyna/N-6455-2014		German Science Foundation [WO 1587/4-1, 1587/6-1]; Leibniz Association	German Science Foundation(German Research Foundation (DFG)); Leibniz Association	This research was funded by the German Science Foundation grant to JW (WO 1587/4-1 and 1587/6-1). We thank the Leibniz Association's Open Access Publishing Funds for co-financing this publication. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; [Anonymous], MATHEMATICA; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Declerck S, 2003, J PLANKTON RES, V25, P93, DOI 10.1093/plankt/25.1.93; Domis LND, 2007, OECOLOGIA, V150, P682, DOI 10.1007/s00442-006-0549-2; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Gorski PR, 1996, LIMNOL OCEANOGR, V41, P1815, DOI 10.4319/lo.1996.41.8.1815; Griebel J, 2016, J EVOLUTION BIOL, V29, P810, DOI 10.1111/jeb.12828; Griebel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140275; Janko K, 2018, MOL ECOL, V27, P248, DOI 10.1111/mec.14377; Johannesson K, 1995, EVOLUTION, V49, P1180, DOI 10.1111/j.1558-5646.1995.tb04445.x; Kagawa K, 2018, ECOL LETT, V21, P264, DOI 10.1111/ele.12891; Keller B, 2004, LIMNOL OCEANOGR, V49, P1393, DOI 10.4319/lo.2004.49.4_part_2.1393; Keller B, 2008, PHILOS T R SOC B, V363, P2943, DOI 10.1098/rstb.2008.0044; Keller B, 2007, LIMNOL OCEANOGR, V52, P984, DOI 10.4319/lo.2007.52.3.0984; Lampert W, 2010, LIMNOL OCEANOGR, V55, P1893, DOI 10.4319/lo.2010.55.5.1893; Louette G, 2007, OIKOS, V116, P419, DOI 10.1111/j.2006.0030-1299.15381.x; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Petrusek A, 2008, PHILOS T R SOC B, V363, P2931, DOI 10.1098/rstb.2008.0026; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1329; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Schalau K, 2008, OECOLOGIA, V157, P531, DOI 10.1007/s00442-008-1081-3; Scheffer M, 2001, LIMNOL OCEANOGR, V46, P1780, DOI 10.4319/lo.2001.46.7.1780; Scheffer M, 1997, OIKOS, V80, P519, DOI 10.2307/3546625; Seda J, 2007, J PLANKTON RES, V29, P619, DOI 10.1093/plankt/fbm044; Seidendorf B, 2007, LIMNOL OCEANOGR, V52, P385, DOI 10.4319/lo.2007.52.1.0385; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SPAAK P, 1995, OECOLOGIA, V104, P501, DOI 10.1007/BF00341348; STROSS RG, 1968, BIOL BULL, V134, P176, DOI 10.2307/1539976; WEIDER LJ, 1991, OECOLOGIA, V87, P506, DOI 10.1007/BF00320413; WOLF HG, 1987, HYDROBIOLOGIA, V145, P213, DOI 10.1007/BF02530282; Wolinska J, 2006, P ROY SOC B-BIOL SCI, V273, P1977, DOI 10.1098/rspb.2006.3523; Wolinska J, 2007, FRESHWATER BIOL, V52, P1198, DOI 10.1111/j.1365-2427.2007.01757.x; Yin MB, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-80; Yin MB, 2010, MOL ECOL, V19, P4168, DOI 10.1111/j.1365-294X.2010.04807.x	41	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200802	10.1371/journal.pone.0200802	http://dx.doi.org/10.1371/journal.pone.0200802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024954	Green Published, gold			2022-12-26	WOS:000439120000054
J	Mehri, R; Mavriplis, C; Fenech, M				Mehri, Rym; Mavriplis, Catherine; Fenech, Marianne			Red blood cell aggregates and their effect on non-Newtonian blood viscosity at low hematocrit in a two-fluid low shear rate microfluidic system	PLOS ONE			English	Article							ERYTHROCYTE AGGREGATION; RHEOLOGY; FLOW; MICROCIRCULATION; RESISTANCE; MODEL	Red blood cells (RBCs) are the most abundant cells in human blood. Remarkably RBCs deform and bridge together to form aggregates under very low shear rates. The theory and mechanics behind aggregation are, however, not yet completely understood. The main objective of this work is to quantify and characterize RBC aggregates in order to enhance the current understanding of the non-Newtonian behaviour of blood in microcirculation. Suspensions of human blood were flowed and observed in vitro in poly-di-methyl-siloxane (PDMS) microchannels to characterize RBC aggregates. These microchannels were fabricated using standard photolithography methods. Experiments were performed using a micro particle image velocimetry (mu PIV) system for shear rate measurements, coupled with a high-speed camera for flow visualization. RBC aggregate sizes were quantified in controlled and measurable shear rate environments for 5, 10 and 15% hematocrit. Aggregate sizes were determined using image processing techniques, while apparent viscosity was measured using optical viscometry. For the samples suspended at 5% H, aggregate size was not strongly correlated with shear rate. For the 10% H suspensions, in contrast, lowering the shear rate below 10 s(-1) resulted in a significant increase of RBC aggregate sizes. The viscosity was found to increase with decreasing shear rate and increasing hematocrit, exemplifying the established non-Newtonian shear-thinning behaviour of blood. Increase in aggregation size did not translate into a linear increase of the blood viscosity. Temperature was shown to affect blood viscosity as expected, however, no correlation for aggregate size with temperature was observed. Non-Newtonian parameters associated with power law and Carreau models were determined by fitting the experimental data and can be used towards the simple modeling of blood's non-Newtonian behaviour in microcirculation. This work establishes a relationship between RBC aggregate sizes and corresponding shear rates and one between RBC aggregate sizes and apparent blood viscosity at body and room temperatures, in a microfluidic environment for low hematocrit. Effects of hematocrit, shear rate, viscosity and temperature on RBC aggregate sizes have been quantified.	[Mehri, Rym; Mavriplis, Catherine; Fenech, Marianne] Univ Ottawa, Dept Mech Engn, Ottawa, ON, Canada	University of Ottawa	Mehri, R (corresponding author), Univ Ottawa, Dept Mech Engn, Ottawa, ON, Canada.	rmehri@uottawa.ca			National Science and Engineering Research Council of Canada (Alexander Graham Bell Canada Graduate Scholarship) [CGSD2-459381-2014]; National Science and Engineering Research Council of Canada [RGPIN-371562-2009, RGPIN-20150-6188]; Canada Foundation for Innovation [31112]	National Science and Engineering Research Council of Canada (Alexander Graham Bell Canada Graduate Scholarship); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was funded by the National Science and Engineering Research Council of Canada through Dr. R. Mehri (Alexander Graham Bell Canada Graduate Scholarship CGSD2-459381-2014) and through Dr. C. Mavriplis (#RGPIN-371562-2009) and Dr. M. Fenech (#RGPIN-20150-6188). This work was also supported by the Canada Foundation for Innovation through Dr. M. Fenech (#31112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt O., 2011, RED BLOOD CELL AGGRE; Bessonov N, 2016, MATH MODEL NAT PHENO, V11, P1, DOI 10.1051/mmnp/201611101; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V280, pH222, DOI 10.1152/ajpheart.2001.280.1.H222; BUREAU M, 1980, BIORHEOLOGY, V17, P191; Cabel M, 1997, AM J PHYSIOL-HEART C, V272, pH1020; CARREAU PJ, 1972, T SOC RHEOL, V16, P99, DOI 10.1122/1.549276; Casson N., 1959, RHEOLOGY DISPERSED S; Caton F., 2015, WORKSH AGR RYTH EC S; CHEN SQ, 1994, CLIN HEMORHEOL, V14, P497; Cheung YK, 2009, LAB CHIP TECHNOLOGY, P115; Chevalier J, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2940219; CHIEN S, 1966, J APPL PHYSIOL, V21, P81, DOI 10.1152/jappl.1966.21.1.81; CHO YI, 1991, BIORHEOLOGY, V28, P241; COKELET GR, 1991, CIRC RES, V68, P1, DOI 10.1161/01.RES.68.1.1; COKELET GR, 1963, T SOC RHEOL, V7, P303, DOI 10.1122/1.548959; Dusting J, 2009, J BIOMECH, V42, P1438, DOI 10.1016/j.jbiomech.2009.04.004; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; Galambos P., 1998, MICROELECTROMECH SYS, V66, P187; GROSS JF, 1974, AM J PHYSIOL, V226, P1117, DOI 10.1152/ajplegacy.1974.226.5.1117; Guillot P, 2006, LANGMUIR, V22, P6438, DOI 10.1021/la060131z; Herschel WH, 1926, KOLLOID Z, V39, P291, DOI 10.1007/BF01432034; Jamalabadi MYA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192138; Kaliviotis E, 2008, CLIN HEMORHEOL MICRO, V39, P235, DOI 10.3233/CH-2008-1087; Kaliviotis E, 2011, MED ENG PHYS, V33, P824, DOI 10.1016/j.medengphy.2010.09.004; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kim S, 2005, AM J PHYSIOL-HEART C, V288, pH584, DOI 10.1152/ajpheart.00690.2004; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1947, DOI 10.1152/ajpheart.00764.2006; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; Mehri R, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaa0ad; Mehri R, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027351; Mehri R., 2016, THESIS; Mehri R, 2015, JOVE-J VIS EXP, DOI 10.3791/52719; Mehri R, 2014, J MED BIOL ENG, V34, P469, DOI 10.5405/jmbe.1695; MERRILL EW, 1966, CIRC RES, V18, P437, DOI 10.1161/01.RES.18.4.437; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; NEUMANN FJ, 1987, PFLUG ARCH EUR J PHY, V408, P524, DOI 10.1007/BF00585080; Owens RG, 2006, J NON-NEWTON FLUID, V140, P57, DOI 10.1016/j.jnnfm.2006.01.015; PERKKIO J, 1983, B MATH BIOL, V45, P41, DOI 10.1007/BF02459386; Pitts KL, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/10/105302; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Reiner M., 1955, RHEAOLOGIE ORIQUE; Sherwood JM, 2014, BIOMECH MODEL MECHAN, V13, P259, DOI 10.1007/s10237-012-0449-9; Shibeshi SS, 2005, APPL RHEOL, V15, P398, DOI 10.1515/arh-2005-0020; SKALAK R, 1981, J BIOMECH ENG-T ASME, V103, P102, DOI 10.1115/1.3138253; Solomon DE, 2014, MICROFLUID NANOFLUID, V16, P677, DOI 10.1007/s10404-013-1261-2; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Vijayaratnam PRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128178; Walburn FJ, 1975, WINT ANN M; Yasuda K., 1979, INVESTIGATION ANALOG; Zhang JB, 2000, J BIOMECH, V33, P355, DOI 10.1016/S0021-9290(99)00101-3	53	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199911	10.1371/journal.pone.0199911	http://dx.doi.org/10.1371/journal.pone.0199911			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024907	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000013
J	Orlando, S; Triulzi, I; Ciccacci, F; Palla, I; Palombi, L; Marazzi, MC; Giuliano, M; Floridia, M; Mancinelli, S; Mutemba, E; Turchetti, G				Orlando, S.; Triulzi, I; Ciccacci, F.; Palla, I; Palombi, L.; Marazzi, M. C.; Giuliano, M.; Floridia, M.; Mancinelli, S.; Mutemba, E.; Turchetti, G.			Delayed diagnosis and treatment of tuberculosis in HIV plus patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF	PLOS ONE			English	Article							CLOSE FAMILY CONTACTS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; INCOME COUNTRIES; SOUTH-INDIA; ATTACK RATE; SEGREGATION; OUTCOMES; AFRICA; BURDEN	Background Tuberculosis (TB) represents the ninth leading cause of death worldwide. In 2016 are estimated 1.3 million TB deaths among HIV negative people and an additional 374,000 deaths among HIV positive people. In 2016 are estimated 1.4 million new cases of TB in people living with HIV (PLHIV), 74% of whom were living in Africa. In light of these data, the reduction of mortality caused by TB in PLHIV is strongly required specially in low-income countries as Mozambique. According to international guidelines, the initial TB screening in HIV+ patients should be done with the four symptoms screening (4SS: fever, current cough, night sweats and weight loss). The diagnostic test more used in resource-limited countries is smear microscopy (SMEAR). World Health Organization (WHO) recommended Lateral Flow urine LipoArabinoMannan assay (LF-LAM) in immunocompromised patients; in 2010 WHO endorsed the use of Xpert Mycobacterium Tuberculosis/Rifampicin (MTB/RIF) test for rapid TB diagnosis but the assay is not used as screening test in all HIV+ patients irrespectively of symptoms due to cost and logistical barriers. The paper aims to evaluate the cost-effectiveness of three screening protocols: standard (4SS and SMEAR in positive patients to 4SS); MTB/RIF; LF-LAM / MTB/RI Methods We developed a model to assess the cost-effectiveness of the MTB/RIF protocol versus the common standard and LF-LAM / MTB/RIF protocol. The model considered a sample of 1,000 HIV+ antiretroviral treatment naive patients in Mozambique. We evaluated disability- adjusted life year (DALY) averted for each protocol, cost per DALY, and incremental cost-effectiveness ratio (ICER), over 1-year, assuming a national healthcare system perspective. The model considered the delayed diagnosis as the time elapsed between a false negative test and the diagnosis and treatment of TB. Additional health system organization delay is defined as the time interval between positive test and treatment initiation caused by a delay in the delivery of results due organization of services. We conducted a sensitivity analysis on more relevant variables. Results The MTB/RIF protocol was cost-effective as compared to the standard protocol with an ICER of $56.54 per DALY saved. In a cohort of 1,000 patients MTB/RIF and LF-LAM / MTB/RIF protocol generated 1,281 and 1,254 DALY's saved respectively, with a difference of 174 and 147 DALY respect to the standard protocol. The total cost of MTB/RIF protocol was lower ($92,263) than the standard ($147,226) and the LF-LAM / MTB/RIF ($113,196). Therefore, the cost per DALY saved including new infections due to delayed diagnosis with the standard protocol was $79.06, about 5 fold higher than MTB/RIF and LF-LAM / MTB/RIF protocols. The cost of additional TB infections due to delays in diagnosis plus health system delay seemed the more relevant costs. The low sensibility and sensitivity of the standard protocol led to a high number of false negatives, thus delayed TB diagnoses and treatment lead to the development of newly transmitted TB infections. Conclusions Our study shows that the MTB/RIF adoption could lead to an increasing of TB case-finding and a reduction in costs compared with standard and LF-LAM / MTB/RIF protocols.	[Orlando, S.; Ciccacci, F.; Palombi, L.; Mancinelli, S.] Univ Tor Vergata, Dept Biomed, Rome, Italy; [Triulzi, I; Palla, I; Turchetti, G.] Scuola Super Sant Anna, Inst Management, Pisa, Italy; [Marazzi, M. C.] LUMSA Univ, Dept Human Sci, Rome, Italy; [Giuliano, M.; Floridia, M.] Ist Super Sanita, Natl Ctr Global Hlth, Rome, Italy; [Mutemba, E.] Community St Egidio, DREAM Programme, Maputo, Mozambique	University of Rome Tor Vergata; Scuola Superiore Sant'Anna; Universita LUMSA; Istituto Superiore di Sanita (ISS)	Orlando, S (corresponding author), Univ Tor Vergata, Dept Biomed, Rome, Italy.; Triulzi, I (corresponding author), Scuola Super Sant Anna, Inst Management, Pisa, Italy.	stefano.orlando@uniroma2.it; i.triulzi@santannapisa.it	Ciccacci, Fausto/AAF-8625-2020; Orlando, Stefano/AAU-2937-2021; Floridia, Marco/Q-6571-2017; Giuliano, Marina/V-8991-2017; Turchetti, Giuseppe/K-5393-2018	Ciccacci, Fausto/0000-0003-0262-707X; Orlando, Stefano/0000-0001-9706-4075; Floridia, Marco/0000-0003-3971-0141; Giuliano, Marina/0000-0003-2789-7797; Palla, Ilaria/0000-0002-4126-5721; Turchetti, Giuseppe/0000-0002-1877-5459				Ahmad D, 2000, CAN MED ASSOC J, V163, P157; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; [Anonymous], WORLD BANK NAT ACC D; [Anonymous], COST EFF STRAT PLANN; [Anonymous], 2011, GUID INT TUB CAS FIN; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Claassens MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172881; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Davies PDO, 1995, RESP MED, P833; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Floridia M, 2017, CLIN INFECT DIS, V65, P1878, DOI 10.1093/cid/cix641; Garcia-Basteiro AL, 2018, PULMONOLOGY, V24, P73, DOI 10.1016/j.rppnen.2017.12.002; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/ajrccm.165.7.2107040; Internal Clinical Guidelines Team (UK), 2016, TUB PREV DIAGN MAN S; KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517; Mancinelli S, 2017, HIV MED, V18, P573, DOI 10.1111/hiv.12492; Marazzi MC, 2005, DREAM AN INTEGRATED; Medecins Sans Frontieres STP, 2017, OUT STEP 2017 TB POL; Menberu Martha Alemayehu, 2016, Int J Microbiol, V2016, P9058109, DOI 10.1155/2016/9058109; Mills EJ, 2011, AIDS, V25, P851, DOI 10.1097/QAD.0b013e32834564e9; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; NOBLE RC, 1981, AM J INFECT CONTROL, V9, P6, DOI 10.1016/S0196-6553(81)80003-X; RAMAKRISHNAN C, 1961, B WORLD HEALTH ORGAN, V24, P129; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Shah M, 2013, AIDS, V27, P2883, DOI 10.1097/QAD.0000000000000008; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Stop TB Partnership, 2014, ACT REP 2012 2013; Sun D, 2013, INT J TUBERC LUNG D, V17, P552, DOI 10.5588/ijtld.12.0627; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; UNAIDS, FACT SHEET WOLD AIDS; Vassall A, 2017, LANCET GLOB HEALTH, V5, pE710, DOI [10.1016/S2214-109X(17)30205-X, 10.1016/s2214-109x(17)30205-x]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Vree M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-210; WHO, 2017, GLOB TUB REP 2017; *WORLD BANK, 1993, WORLD DEV REP; World Health O, 2015, USE LATERAL FLOW URI; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2013, SYST SCREEN ACT TUB	43	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200523	10.1371/journal.pone.0200523	http://dx.doi.org/10.1371/journal.pone.0200523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024890	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000025
J	Sendi, H; Mead, I; Wan, MM; Mehrab-Mohseni, M; Koch, K; Atala, A; Bonkovsky, HL; Bishop, CE				Sendi, Hossein; Mead, Ivy; Wan, Meimei; Mehrab-Mohseni, Marjan; Koch, Kenneth; Atala, Anthony; Bonkovsky, Herbert L.; Bishop, Colin E.			miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; LIPID-METABOLISM; DISEASE; OVEREXPRESSION; SENSITIVITY; HOMEOSTASIS; SYSTEMS	To investigate the role of miR-122 in the development and regression of non-alcoholic fatty liver disease (NAFLD) in vitro, we used multicellular 3D human liver organoids developed in our laboratory. These organoids consist of primary human hepatocytes, Kupffer cells, quiescent stellate cells and liver sinusoidal endothelial cells. They remain viable and functional for 4 weeks expressing typical markers of liver function such as synthesis of albumin, urea, and alpha-1 p450 drug metabolism. Before mixing, hepatic cells were transduced with lentivirus to inhibit miR122 expression (ABM, CA). Immediately after the organoids were fully formed (day 4) or after 1 or 2 weeks of additional incubation (days 11 or 18), the organoids were analyzed using fluorescent live/dead staining and ATP production; total RNA was extracted for qPCR gene expression profiling. Our results show that miR-122 inhibition in liver organoids leads to inflammation, necrosis, steatosis and fibrosis. This was associated with increase in inflammatory cytokines (IL6, TNF), chemokines (CCL2, CCL3) and increase in a subset of Matrix Metaloproteinases (MMP8, MMP9). An altered expression of key genes in lipid metabolism (i.e LPL, LDLR) and insulin signaling (i.e GLUT4, IRS1) was also identified. Conclusion: Our results highlight the role of miR-122 inhibition in liver inflammation, steatofibrosis and dysregulation of insulin signaling. Patients with NAFLD are known to have altered levels of miR-122, therefore we suggest that miR-122 mimics could play a useful role in reversing liver steatofibrosis and insulin resistance seen in patients with NAFLD.	[Sendi, Hossein; Mehrab-Mohseni, Marjan; Koch, Kenneth; Bonkovsky, Herbert L.] Wake Forest Baptist Med Ctr, Sect Gastroenterol, Lab Liver Dis & Metab Disorders, Winston Salem, NC 27157 USA; [Sendi, Hossein; Mead, Ivy; Wan, Meimei; Atala, Anthony; Bishop, Colin E.] Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA; [Sendi, Hossein] UNC Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA; [Mehrab-Mohseni, Marjan] UNC Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Sendi, H (corresponding author), Wake Forest Baptist Med Ctr, Sect Gastroenterol, Lab Liver Dis & Metab Disorders, Winston Salem, NC 27157 USA.; Sendi, H (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.; Sendi, H (corresponding author), UNC Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA.	hsendi@email.unc.edu	Sendi, Hossein/W-1049-2019; Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230; Sendi, Hossein/0000-0002-1054-6571	Defense Threat Reduction Agency (DTRA) under Space and Naval Warfare Systems Center Pacific (SSC PACIFIC) [N66001-13-C-2027]; NIH [R01DK110167-01A1, R15 HL 117199, U54 DK 083909 9]; Defense Threat Reduction Agency [N66001-13-C-2027]	Defense Threat Reduction Agency (DTRA) under Space and Naval Warfare Systems Center Pacific (SSC PACIFIC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	We greatly thank Defense Threat Reduction Agency Contracts N66001-13-C-2027 (AA & CEB) and NIH R01DK110167-01A1 (CEB) R15 HL 117199 (HLB), U54 DK 083909 9 (HLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbal E, 2016, WIEN KLIN WOCHENSCHR, V128, P48, DOI 10.1007/s00508-014-0680-8; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Caligiuri A, 2016, INT J MOL SCI, V17, P9, DOI [10.1111/j.1572-0241.2007.01774.x, DOI 10.1111/J.1572-0241.2007.01774.X]; Clarke JD, 2014, J APPL TOXICOL, V34, P726, DOI 10.1002/jat.2960; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Csak T, 2015, LIVER INT, V35, P532, DOI 10.1111/liv.12633; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Iimuro Y, 2008, PHARM RES-DORDR, V25, P249, DOI 10.1007/s11095-007-9311-7; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kirovski G, 2011, EXP MOL PATHOL, V91, P780, DOI 10.1016/j.yexmp.2011.08.001; Lauschke VM, 2016, CHEM RES TOXICOL, V29, P1936, DOI 10.1021/acs.chemrestox.6b00150; Lefebvre E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158156; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Liu G, 2016, J LIPID RES, V57, P1155, DOI 10.1194/jlr.M065011; Nantasanti S, 2016, STEM CELL TRANSL MED, V5, P325, DOI 10.5966/sctm.2015-0152; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sendi H, 2012, HEPAT MON, V12, P312, DOI 10.5812/hepatmon.6128; Shibata S, 2007, LIFE SCI, V80, P546, DOI 10.1016/j.lfs.2006.10.003; Skardal A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08879-x; Sun MX, 2015, CLIN RES HEPATOL GAS, V39, pS60, DOI 10.1016/j.clinre.2015.06.015; Thakral S, 2015, CURR GENE THER, V15, P142, DOI 10.2174/1566523214666141224095610; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wu GY, 2017, CELL PHYSIOL BIOCHEM, V44, P1651, DOI 10.1159/000485765; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zeng CX, 2015, ONCOTARGET, V6, P12224, DOI 10.18632/oncotarget.3652	37	32	33	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200847	10.1371/journal.pone.0200847	http://dx.doi.org/10.1371/journal.pone.0200847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024933	gold, Green Submitted, Green Published			2022-12-26	WOS:000439120000059
J	Soares, AMS; Oliveira, JTA; Rocha, CQ; Ferreira, ATS; Perales, J; Zanatta, AC; Vilegas, W; Silvan, CR; Costa, LM				Soares, Alexandra M. S.; Oliveira, Jose T. A.; Rocha, Claudia Q.; Ferreira, Andre T. S.; Perales, Jonas; Zanatta, Ana Caroline; Vilegas, Wagner; Silvan, Carolina R.; Costa-Junior, Livio M.			Myracrodruon urundeuva seed exudates proteome and anthelmintic activity against Haemonchus contortus	PLOS ONE			English	Article							PLANT CYSTEINE PROTEINASES; IN-VITRO; GASTROINTESTINAL NEMATODES; CAENORHABDITIS-ELEGANS; DEFENSE; RESISTANCE; PROTEASES; SHEEP; VIVO; CHITINASES	Seed exudates are plant-derived natural bioactive compounds consisting of a complex mixture of organic and inorganic molecules. Plant seed exudates have been poorly studied against parasite nematodes. This study was undertaken to identify proteins in the Myracrodruon urundeuva seed exudates and to assess the anthelmintic activity against Haemonchus contortus, an important parasite of small ruminants. M. urundeuva seed exudates (SEX) was obtained after immersion of seeds in sodium acetate buffer. SEX was fractionated with ammonium sulfate at 0-90% concentration to generate the ressuspended pellet (SEXF1) and the supernatant (SEXF2). SEX, SEXF1, and SEXF2 were exhaustively dialyzed against distilled water (cut-off: 12 kDa) and the protein contents determined. Mass spectrometry analyses of SEX, SEXF1, and SEXF2 were done to identify proteins and secondary metabolites. The seed exudates contained protease, protease inhibitor, peptidase, chitinase, and lipases as well as the low molecular weight secondary compounds ellagic acid and quercetin rhamnoside. SEX inhibited H. contortus larval development (LDA) (IC50 = 0.29 mg mL(-1)), but did not affect larval exsheathment (LEIA). On the other hand, although SEXF1 and SEXF2 inhibited H. contortus LEIA (IC50 = 1.04 and 0.93 mg mL(-1), respectively), they showed even greater inhibition efficiency of H. contortus larval development (IC50 = 0.29 and 0.42 mg mL(-1), respectively). To the best of our knowledge, this study is the first to show the anthelmintic activity of plant exudates against a gastrointestinal nematode. Moreover, it suggests the potential of exuded proteins as candidates to negatively interfere with H. contortus life cycle.	[Soares, Alexandra M. S.] Univ Fed Maranhao, Exact Sci Ctr & Technol, Lab Plant Biochem, Chem Engn Program, Sao Luis, Maranhao, Brazil; [Oliveira, Jose T. A.] Univ Fed Ceara, Lab Plant Def Prot, Campus Pici, Fortaleza, Ceara, Brazil; [Rocha, Claudia Q.] Univ Fed Maranhao, Ctr Exact Sci & Technol, Dept Chem, Lab Adv Studies Phytomed, Sao Luis, Maranhao, Brazil; [Ferreira, Andre T. S.; Perales, Jonas] Fundacao Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, RJ, Brazil; [Zanatta, Ana Caroline; Vilegas, Wagner] Inst Biosci, Bioprospecting, Lab Nat Prod, Coastal Campus Sao Vicente, Sao Vicente, SP, Brazil; [Silvan, Carolina R.; Costa-Junior, Livio M.] Univ Fed Maranhao, Ctr Biol & Hlth Sci, Dept Pathol, Lab Parasite Control, Sao Luis, Maranhao, Brazil	Universidade Federal do Maranhao; Universidade Federal do Ceara; Universidade Federal do Maranhao; Fundacao Oswaldo Cruz; Universidade Federal do Maranhao	Soares, AMS (corresponding author), Univ Fed Maranhao, Exact Sci Ctr & Technol, Lab Plant Biochem, Chem Engn Program, Sao Luis, Maranhao, Brazil.; Costa, LM (corresponding author), Univ Fed Maranhao, Ctr Biol & Hlth Sci, Dept Pathol, Lab Parasite Control, Sao Luis, Maranhao, Brazil.	alexandra.ufma@gmail.com; livio.martins@ufma.br	Zanatta, Ana C./ABA-7695-2020; da Rocha, Claudia Quintino/U-8013-2019; Vilegas, Wagner/S-3209-2019; Rocha, Cláudia Quintino da/C-2320-2013; Costa-Junior, Livio M/H-7530-2012	Zanatta, Ana C./0000-0003-0199-4521; da Rocha, Claudia Quintino/0000-0002-3578-1869; Rocha, Cláudia Quintino da/0000-0002-3578-1869; Costa-Junior, Livio M/0000-0002-1475-049X; Rocha e Silva, Carolina/0000-0001-8667-1064	CNPq (The Brazilian National Council for Scientific and Technological Development) [447877/2014-3]; FAPEMA (Maranhao State Research Foundation) [PRONEM-01773/14]; CNPq; CNPq (The Brazilian National Council for Scientific and Technological Development); FAPEMA (Maranhao State Research Foundation)	CNPq (The Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMA (Maranhao State Research Foundation); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (The Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMA (Maranhao State Research Foundation)	The authors acknowledge the CNPq (The Brazilian National Council for Scientific and Technological Development) 447877/2014-3, and FAPEMA (Maranhao State Research Foundation) PRONEM-01773/14, for financial support. We also thank CNPq for awarding a fellowship to L.M. Costa-Junior and J. Perales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the CNPq (The Brazilian National Council for Scientific and Technological Development) and FAPEMA (Maranhao State Research Foundation) for financial support. We also thank CNPq for awarding a fellowship to L.M. Costa-Junior and J. Perales.	Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Anusuya Sathiyanarayanan, 2014, Archives of Phytopathology and Plant Protection, V47, P1611, DOI 10.1080/03235408.2013.853457; Araujo SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189803; Barros M, 2010, BRAZ J CHEM ENG, V27, P15, DOI 10.1590/S0104-66322010000100002; Bauri RK, 2015, INDIAN J NAT PROD RE, V6, P268; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga FR, 2014, RES VET SCI, V97, P527, DOI 10.1016/j.rvsc.2014.09.005; Carvalho CES, 2017, EXP PARASITOL, V175, P59, DOI 10.1016/j.exppara.2017.02.012; COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U; Day B, 2011, ANNU REV PHYTOPATHOL, V49, P483, DOI 10.1146/annurev-phyto-072910-095426; Demeler J, 2010, VET PARASITOL, V174, P58, DOI 10.1016/j.vetpar.2010.08.020; Duarte N.F., 2006, Planta daninha, V24, P329, DOI 10.1590/S0100-83582006000200016; Eltelib HA, 2011, J PLANT PHYSIOL, V168, P619, DOI 10.1016/j.jplph.2010.09.003; Faccin H, 2016, J CHROMATOGR A, V1427, P111, DOI 10.1016/j.chroma.2015.12.017; Feofilova EP, 2010, MICROBIOLOGY+, V79, P711, DOI 10.1134/S0026261710060019; Gadahi JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159796; Goncalves PC., 1998, MANUAL DIAGNOSTICO H; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Harder A, 2016, ADV PARASIT, V93, P69, DOI 10.1016/bs.apar.2016.02.010; Heim C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1032-x; HUBERT J, 1992, VET REC, V130, P442, DOI 10.1136/vr.130.20.442; Jackson F, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P25, DOI 10.1007/978-90-481-3297-3_3; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Kohli A, 2012, PHYSIOL PLANTARUM, V145, P165, DOI 10.1111/j.1399-3054.2012.01573.x; Levecke B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-255; Lica ICL, 2018, FOOD RES INT, V105, P1039, DOI 10.1016/j.foodres.2017.11.051; Mali R. G., 2008, Natural Product Radiance, V7, P466; MANSFIELD LS, 1992, COMP BIOCHEM PHYS B, V103, P681, DOI 10.1016/0305-0491(92)90390-D; Martinez M, 2012, PHYSIOL PLANTARUM, V145, P85, DOI 10.1111/j.1399-3054.2012.01569.x; Mondal H, 2015, PAK VET J, V35, P58; Monteiro JM, 2006, J ETHNOPHARMACOL, V105, P173, DOI 10.1016/j.jep.2005.10.016; Monteiro JM, 2012, ACTA BOT BRAS, V26, P125, DOI 10.1590/S0102-33062012000100014; Ndjonka D, 2014, J HELMINTHOL, V88, P481, DOI 10.1017/S0022149X1300045X; Pahoja V. M., 2002, Pakistan Journal of Applied Sciences, V2, P474; Pesquet E, 2012, PHYSIOL PLANTARUM, V145, P1, DOI 10.1111/j.1399-3054.2012.01614.x; de Araujo IDR, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1918-6; Rios-de Alvarez L, 2012, VET PARASITOL, V187, P267, DOI 10.1016/j.vetpar.2012.01.005; ROBERTS FHS, 1950, AUST J AGR RES, V1, P99, DOI 10.1071/AR9500099; Rocha RO, 2015, J AGR FOOD CHEM, V63, P5335, DOI 10.1021/acs.jafc.5b01109; Rose Hannah, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P209, DOI 10.1016/j.ijppaw.2014.01.001; Scarafoni A, 2013, FEBS J, V280, P1443, DOI 10.1111/febs.12140; Schiltz S, 2015, J APPL MICROBIOL, V119, P1467, DOI 10.1111/jam.12946; Souza TM, 2015, ACTA TROP, V152, P49, DOI 10.1016/j.actatropica.2015.08.010; Stepek G, 2007, PARASITOLOGY, V134, P103, DOI 10.1017/S0031182006001302; Stepek G, 2006, PARASITOLOGY, V132, P681, DOI 10.1017/S003118200500973X; Tariq KA, 2008, J HELMINTHOL, V82, P227, DOI 10.1017/S0022149X08972515; Vermeire JJ, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030039; Veronico P, 2001, MOL GENET GENOMICS, V266, P28, DOI 10.1007/s004380100513	50	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200848	10.1371/journal.pone.0200848	http://dx.doi.org/10.1371/journal.pone.0200848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024949	Green Submitted, Green Published, gold			2022-12-26	WOS:000439120000060
J	Sommer, CA; Capilla, A; Molina-Estevez, FJ; Gianotti-Sommer, A; Skvir, N; Caballero, I; Chowdhury, S; Mostoslavsky, G				Sommer, Cesar A.; Capilla, Amalia; Molina-Estevez, Francisco J.; Gianotti-Sommer, Andreia; Skvir, Nicholas; Caballero, Ignacio; Chowdhury, Sanjib; Mostoslavsky, Gustavo			Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COLORECTAL-CANCER; LACTATE-DEHYDROGENASE; HUMAN COLON; IN-VITRO; MUTATIONS; ADENOCARCINOMAS; DIFFERENTIATION; GENERATION; ORGANOIDS	Mutations in the gene Adenomatous Polyposis Coli or APC appear in most sporadic cases of colorectal cancer and it is the most frequent mutation causing hereditary Familial Adenomatous Polyposis. The detailed molecular mechanism by which APC mutations predispose to the development of colorectal cancer is not completely understood. This is in part due to the lack of accessibility to appropriate models that recapitulate the early events associated with APC mediated intestinal transformation. We have established a novel platform utilizing human induced Pluripotent Stem cells or iPSC from normal or FAP-specific APC mutant individuals and evaluated the effect of the mutation in the cells before and after differentiation into intestinal organoids. In order to minimize genetic background effects, we also established an isogenic platform using TALEN-mediated gene editing. Comparison of normal and APC mutant iPSC revealed a significant defect in cell identity and polarity due to the presence of APC in heterozygosity as well as chromosomal aberrations including abnormal anaphases and centrosome numbers. Importantly, upon specification into intestinal progeny, APC heterozygosity was responsible for a major change in the transcriptional identity of the cells with dysregulation of key signaling pathways, including metabolic reprogramming, abnormal lipid metabolism and intestinal-specific cadherin expression. In conclusion, we have developed a novel iPSC/intestinal model of APC mutagenesis and provide strong evidence that APC in heterozygosity imparts a clear phenotypic and molecular defect, affecting basic cellular functions and integrity, providing novel insights in the earlier events of APC-mediated tumorigenesis.	[Sommer, Cesar A.; Capilla, Amalia; Molina-Estevez, Francisco J.; Gianotti-Sommer, Andreia; Chowdhury, Sanjib; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Sect Gastroenterol, Boston, MA 02118 USA; [Sommer, Cesar A.; Capilla, Amalia; Molina-Estevez, Francisco J.; Gianotti-Sommer, Andreia; Skvir, Nicholas; Caballero, Ignacio; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA	Boston University; Boston University	Mostoslavsky, G (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Gastroenterol, Boston, MA 02118 USA.; Mostoslavsky, G (corresponding author), Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA.	gmostosl@bu.edu	Capilla, Amalia/AAW-5955-2021	Capilla, Amalia/0000-0002-9546-9818; Skvir, Nicholas/0000-0002-3067-4458; Molina-Estevez, F. Javier/0000-0001-9565-2199; Mostoslavsky, Gustavo/0000-0002-0784-2169	NIH [1R01CA175727-01, 1UL1TR001430]; CTSI [TL1TR001410];  [R24HL123828];  [U01TR001810]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001410, U01TR001810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were funded in part by NIH 1R01CA175727-01 to GM. A.C. is a Postdoctoral Research Fellow under a T32 CTSI Award TL1TR001410. We are grateful to Brian R. Tilton of the BUSM Flow Cytometry Core for technical assistance, supported by NIH Grant 1UL1TR001430, and Drs. Greg Miller and Marianne James of the CReM, supported by grants R24HL123828 and U01TR001810.	Amos-Landgraf JM, 2012, P NATL ACAD SCI USA, V109, P2060, DOI 10.1073/pnas.1120753109; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Blaker H, 2003, AM J CLIN PATHOL, V120, P418, DOI 10.1309/4E4WG3AYGJNCD11P; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Crespo M, 2017, NAT MED, V23, P878, DOI 10.1038/nm.4355; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Mondesir J, 2016, J BLOOD MED, V7, P171, DOI 10.2147/JBM.S70716; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nelson SA, 2012, DIS MODEL MECH, V5, P940, DOI 10.1242/dmm.008607; Panarelli NC, 2012, AM J CLIN PATHOL, V138, P211, DOI 10.1309/AJCPKSHXI3XEHW1J; Park S, 2017, STEM CELL REP, V8, P1076, DOI 10.1016/j.stemcr.2016.12.017; Patel BB, 2011, ONCOTARGET, V2, P197, DOI 10.18632/oncotarget.241; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Wang J, 2015, ONCOTARGET, V6, P19456, DOI 10.18632/oncotarget.3318; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Yeung AT, 2008, CANCER RES, V68, P7579, DOI 10.1158/0008-5472.CAN-08-0856	43	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200657	10.1371/journal.pone.0200657	http://dx.doi.org/10.1371/journal.pone.0200657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024920	Green Submitted, gold, Green Published			2022-12-26	WOS:000439120000038
J	Tatsuki, H; Yokobori, T; Katayama, C; Kato, R; Takahashi, R; Osone, K; Takada, T; Yajima, R; Motegi, Y; Ogawa, H; Fujii, T; Shirabe, K; Kuwano, H; Asao, T				Tatsuki, Hironori; Yokobori, Takehiko; Katayama, Chika; Kato, Ryuji; Takahashi, Ryo; Osone, Katsuya; Takada, Takahiro; Yajima, Reina; Motegi, Yoko; Ogawa, Hiroomi; Fujii, Takaaki; Shirabe, Ken; Kuwano, Hiroyuki; Asao, Takayuki			A novel one-step lens cleaning device using air and water flow for endoscopic surgery	PLOS ONE			English	Article							MAINTAIN	In a surgical operation requiring endoscopy, it is essential to obtain a clear endoscopic view. However, it is often disturbed by the contamination on the lens during the surgery. No device can clean the lens surface simply and completely. Many surgeons are hampered by the impaired view and the distraction by the repeated cleaning of the lens. Therefore, we developed a novel endoscope cleaning device to address this problem. The device was made of 3D-printed rubber-like plastic. It contains a syringe filled with saline and an aspiration system. It would be used intraoperatively to wash the lens surface in a few seconds with rapid flow of water and air. The cleaning ability of the device was evaluated using mayonnaise with adenosine triphosphate (ATP) as a model contaminant. The gauze-wiping maneuver was selected as control. After each maneuver, the clarity of the endoscopic view was evaluated, and residual contaminants were assessed quantitatively with ATP assay. The cleaning device obtained a crisp and clear view and eliminated the contaminant on the lens every time after a single cleaning maneuver. The gauze-wiping maneuver required for the lens to be wiped at least three times to obtain a clear view, and even then, some contaminants remained. Repeated contamination and cleaning using gauze led to accumulation of contaminants on the lens, which resulted in difficulty in cleaning the lens as the operation proceeded. The cleaning device did not show such accumulation. Our novel cleaning device with air and water flow has been shown to wash out the lens contaminants completely and immediately in a simple manner. It is expected to improve the safety and cost-effectiveness of endoscopic surgery.	[Tatsuki, Hironori; Yokobori, Takehiko; Katayama, Chika; Kato, Ryuji; Takahashi, Ryo; Osone, Katsuya; Takada, Takahiro; Yajima, Reina; Motegi, Yoko; Ogawa, Hiroomi; Fujii, Takaaki; Shirabe, Ken; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma, Japan; [Asao, Takayuki] Gunma Univ Initiat Adv Res, Big Data Ctr Integrat Anal, Maebashi, Gunma, Japan	Gunma University	Tatsuki, H; Yokobori, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma, Japan.	m14702038@gunma-u.ac.jp; bori45@gunma-u.ac.jp						Brown JA, 2008, J ENDOUROL, V22, P2413, DOI 10.1089/end.2008.0212; Cassera MA, 2011, SURG INNOV, V18, P150, DOI 10.1177/1553350611399297; Lawrentschuk N, 2010, J ENDOUROL, V24, P905, DOI 10.1089/end.2009.0594; Macia I, 2010, INTERACT CARDIOV TH, V11, P522, DOI 10.1510/icvts.2010.241760; Runia AJ, 2009, SURG ENDOSC, V23, P2849, DOI 10.1007/s00464-009-0648-3; Sutton E, 2010, SURG ENDOSC, V24, P1240, DOI 10.1007/s00464-009-0753-3; Van Deurzen DFP, 2005, SURG ENDOSC, V19, P299, DOI 10.1007/s00464-004-8231-4; Yong N, 2016, SURG LAPARO ENDO PER, V26, P286, DOI 10.1097/SLE.0000000000000289	8	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200749	10.1371/journal.pone.0200749	http://dx.doi.org/10.1371/journal.pone.0200749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020986	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400071
J	Dijk, W; Ruppert, PMM; Oost, LJ; Kersten, S				Dijk, Wieneke; Ruppert, Philip M. M.; Oost, Lynette J.; Kersten, Sander			Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein metabolism; adipocyte; furin; lipase; human; ANGPTL4; lipoprotein lipase; angiopoietin-like 4; PCSK; triglycerides	TRIGLYCERIDE-METABOLISM; PROPROTEIN CONVERTASES; ENDOTHELIAL LIPASE; ADIPOSE-TISSUE; HEPATIC LIPASE; IN-VIVO; ANGPTL3; PROTEIN; FURIN; GPIHBP1	Lipoprotein lipase (LPL) catalyzes the breakdown of circulating triglycerides in muscle and fat. LPL is inhibited by several proteins, including angiopoietin-like 4 (ANGPTL4), and may be cleaved by members of the proprotein convertase subtilisin/kexin (PCSK) family. Here, we aimed to investigate the cleavage of LPL in adipocytes by PCSKs and study the potential involvement of ANGPTL4. A substantial portion of LPL in mouse and human adipose tissue was cleaved into N- and C-terminal fragments. Treatment of different adipocytes with the PCSK inhibitor decanoyl-RVKR-chloromethyl ketone markedly decreased LPL cleavage, indicating that LPL is cleaved by PCSKs. Silencing of Pcsk3/furin significantly decreased LPL cleavage in cell culture medium and lysates of 3T3-L1 adipocytes. Remarkably, PCSK-mediated cleavage of LPL in adipocytes was diminished by Angptl4 silencing and was decreased in adipocytes and adipose tissue of Angptl4(-/-) mice. Differences in LPL cleavage between Angptl4(-/-) and WT mice were abrogated by treatment with decanoyl-RVKR-chloromethyl ketone. Induction of ANGPTL4 in adipose tissue during fasting enhanced PCSK-mediated LPL cleavage, concurrent with decreased LPL activity, in WT but not Angptl4(-/-) mice. In adipocytes, after removal of cell surface LPL by heparin, levels of N-terminal LPL were still markedly higher in WT compared with Angptl4(-/-) adipocytes, suggesting that stimulation of PCSK-mediated LPL cleavage by ANGPTL4 occurs intracellularly. Finally, treating adipocytes with insulin increased full-length LPL and decreased N-terminal LPL in an ANGPTL4-dependent manner. In conclusion, ANGPTL4 promotes PCSK-mediated intracellular cleavage of LPL in adipocytes, likely contributing to regulation of LPL in adipose tissue. Our data provide further support for an intracellular action of ANGPTL4 in adipocytes.	[Dijk, Wieneke; Ruppert, Philip M. M.; Oost, Lynette J.; Kersten, Sander] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Dijk, Wieneke] INSERM, U1087, Inst Thorax, F-44000 Nantes, France	Wageningen University & Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Kersten, S (corresponding author), Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	sander.kersten@wur.nl	Dijk, Wieneke/T-1856-2018; Oost, Lynette/AAY-1410-2021; Kersten, Sander/A-1116-2011; Ruppert, Philip/AAO-5002-2021	Dijk, Wieneke/0000-0003-1676-7751; Kersten, Sander/0000-0003-4488-7734; Ruppert, Philip/0000-0002-4028-8200	Fondation Leducq [12CVD04]	Fondation Leducq(Leducq Foundation)	This study was supported by Fondation Leducq Grant 12CVD04. The authors declare that they have no conflicts of interest with the contents of this article.	Alex S, 2013, MOL CELL BIOL, V33, P1303, DOI 10.1128/MCB.00858-12; Allan CM, 2016, J LIPID RES, V57, P1889, DOI 10.1194/jlr.M070813; BENSADOUN A, 1991, ANNU REV NUTR, V11, P217, DOI 10.1146/annurev.nu.11.070191.001245; BENZEEV O, 1994, J LIPID RES, V35, P1511; Catoire M, 2014, P NATL ACAD SCI USA, V111, pE1043, DOI 10.1073/pnas.1400889111; CHAJEKSHAUL T, 1985, BIOCHIM BIOPHYS ACTA, V837, P123, DOI 10.1016/0005-2760(85)90235-8; Chi X, 2017, MOL METAB, V6, P1137, DOI 10.1016/j.molmet.2017.06.014; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; CISAR LA, 1989, J BIOL CHEM, V264, P1767; Cushing EM, 2017, MOL METAB, V6, P809, DOI 10.1016/j.molmet.2017.06.007; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dijk W, 2018, J CLIN LIPIDOL, V12, P773, DOI 10.1016/j.jacl.2018.02.006; Dijk W, 2016, J LIPID RES, V57, P1949, DOI 10.1194/jlr.M067363ERR; Dijk W, 2016, CURR OPIN LIPIDOL, V27, P249, DOI 10.1097/MOL.0000000000000290; Dijk W, 2015, ELIFE, V4, DOI 10.7554/eLife.08428; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P4570; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gin P, 2012, HUM MOL GENET, V21, P2961, DOI 10.1093/hmg/dds127; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; Haller JF, 2017, J LIPID RES, V58, P1166, DOI 10.1194/jlr.M075689; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; KERN PA, 1990, J LIPID RES, V31, P17; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Liu J, 2010, J BIOL CHEM, V285, P27561, DOI 10.1074/jbc.M110.144279; Lookene A, 2000, BIOCHEM BIOPH RES CO, V271, P15, DOI 10.1006/bbrc.2000.2530; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; Makoveichuk E, 2013, BIOCHEM BIOPH RES CO, V441, P941, DOI 10.1016/j.bbrc.2013.11.013; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Musunuru K, 2016, CIRC RES, V118, P579, DOI 10.1161/CIRCRESAHA.115.306398; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.20958; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.12095; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Turpeinen H, 2013, CURR GENOMICS, V14, P453, DOI 10.2174/1389202911314050010; Wang Y, 2015, P NATL ACAD SCI USA, V112, P11630, DOI 10.1073/pnas.1515374112; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Xu YX, 2018, ATHEROSCLEROSIS, V268, P196, DOI 10.1016/j.atherosclerosis.2017.08.031	52	39	41	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14134	14145		10.1074/jbc.RA118.002426	http://dx.doi.org/10.1074/jbc.RA118.002426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30021841	hybrid, Green Published			2022-12-26	WOS:000444070700034
J	Macpherson, A; Liu, XF; Dedi, N; Kennedy, J; Carrington, B; Durrant, O; Heywood, S; van den Elsen, J; Lawson, ADG				Macpherson, Alex; Liu, Xiaofeng; Dedi, Neesha; Kennedy, Jeffery; Carrington, Bruce; Durrant, Oliver; Heywood, Sam; van den Elsen, Jean; Lawson, Alastair D. G.			The rational design of affinity-attenuated OmCI for the purification of complement C5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement system; mutagenesis; biophysics; protein purification; complement; complement component C5; immune evasion; OmCI	STRUCTURAL BASIS; 5TH COMPONENT; DOUBLE-BLIND; ECULIZUMAB; INHIBITOR; EFFICACY; RECEPTOR; CONVERTASE; SAFETY; PATHWAY	Complement component C5 is the target of the mAb eculizumab and is the focus of a sustained drug discovery effort to prevent complement-induced inflammation in a range of autoimmune diseases. The immune evasion protein OmCI binds to and potently inactivates C5; this tight-binding interaction can be exploited to affinity-purify C5 protein from serum, offering a vastly simplified protocol compared with existing methods. However, breaking the high-affinity interaction requires conditions that risk denaturing or activating C5. We performed structure-guided in silico mutagenesis to identify prospective OmCI residues that contribute significantly to the binding affinity. We tested our predictions in vitro, using site-directed mutagenesis, and characterized mutants using a range of biophysical techniques, as well as functional assays. Our biophysical analyses suggest that the C5-OmCI interaction is complex with potential for multiple binding modes. We present single mutations that lower the affinity of OmCI for C5 and combinations of mutations that significantly decrease or entirely abrogate formation of the complex. The affinity-attenuated forms of OmCI are suitable for affinity purification and allow elution under mild conditions that are nondenaturing or activating to C5. We present the rational design, biophysical characterization, and experimental validation of affinity-reduced forms of OmCI as tool reagents to enable the affinity purification of C5.	[Macpherson, Alex; Liu, Xiaofeng; Dedi, Neesha; Kennedy, Jeffery; Carrington, Bruce; Durrant, Oliver; Heywood, Sam; Lawson, Alastair D. G.] UCB Celltech, 216 Bath Rd, Slough SL1 3WE, Berks, England; [Macpherson, Alex; van den Elsen, Jean] Univ Bath, Dept Biol & Biochem, Bath BA2 7AX, Avon, England	Celltech Group Ltd; University of Bath	Macpherson, A (corresponding author), UCB Celltech, 216 Bath Rd, Slough SL1 3WE, Berks, England.	Alex.Macpherson@ucb.com		van den Elsen, Jean/0000-0002-0367-1956; Durrant, Oliver/0000-0003-3183-7025; Macpherson, Alex/0000-0002-4508-5322	UCB	UCB(UCB Pharma SA)	This work has been funded by UCB. Except for J.v.d.E., all authors are UCB employees and may hold shares and/or share options in UCB.	Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; DESSAUER A, 1983, IMMUNOBIOLOGY, V164, P370, DOI 10.1016/S0171-2985(83)80033-3; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Hill Anita, 2005, Clin Adv Hematol Oncol, V3, P849; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Howard JF, 2017, LANCET NEUROL, V16, P976, DOI 10.1016/S1474-4422(17)30369-1; Howard JF, 2013, MUSCLE NERVE, V48, P76, DOI 10.1002/mus.23839; Johnson CK, 2015, CURR OPIN ORGAN TRAN, V20, P643, DOI 10.1097/MOT.0000000000000249; Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196; Kaabak M, 2018, PEDIATR TRANSPLANT, V22, DOI 10.1111/petr.13129; Kuhn N, 2016, BIOCONJUGATE CHEM, V27, P2359, DOI 10.1021/acs.bioconjchem.6b00369; KUNKEL SL, 1980, J IMMUNOL METHODS, V35, P337, DOI 10.1016/0022-1759(80)90259-8; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Lockington D, 2010, CAN J OPHTHALMOL, V45, P649, DOI 10.3129/i10-060; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084; Nunn M. A., 2016, MODIFIED OMCI COMPLE; Onell A, 2005, J MOL RECOGNIT, V18, P307, DOI 10.1002/jmr.745; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; Rathbone J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003573; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, INT IMMUNOPHARMACOL, V1, P415, DOI 10.1016/S1567-5769(00)00039-4; Ricklin D, 2016, SEMIN IMMUNOL, V28, P208, DOI 10.1016/j.smim.2016.06.001; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; Roversi P, 2013, J BIOL CHEM, V288, P18789, DOI 10.1074/jbc.M112.420331; Roy U, 2007, BIOCHEM MOL BIOL EDU, V35, P238, DOI 10.1002/bmb.65; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; Serna M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10587; SJOHOLM AG, 1975, SCAND J IMMUNOL, V4, P25, DOI 10.1111/j.1365-3083.1975.tb02596.x; Sottrup-Jensen L, 2014, METHODS MOL BIOL, V1100, P93, DOI 10.1007/978-1-62703-724-2_7; Volk AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31365; WETSEL RA, 1980, J IMMUNOL METHODS, V35, P319, DOI 10.1016/0022-1759(80)90258-6; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Yehoshua Z, 2014, OPHTHALMOLOGY, V121, P693, DOI 10.1016/j.ophtha.2013.09.044	42	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14112	14121		10.1074/jbc.RA118.004043	http://dx.doi.org/10.1074/jbc.RA118.004043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030376	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000444070700032
J	Brown, DM; Jones, S; Daniel, ZCTR; Brearley, MC; Lewis, JE; Ebling, FJP; Parr, T; Brameld, JM				Brown, David M.; Jones, Sarah; Daniel, Zoe C. T. R.; Brearley, Madelaine C.; Lewis, Jo E.; Ebling, Francis J. P.; Parr, Tim; Brameld, John M.			Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; I DOSE-ESCALATION; SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; OLDER PERSONS; ER STRESS; PHENYLBUTYRATE; ACID; ATROPHY; SARCOPENIA	Previously, we highlighted induction of an integrated stress response (ISR) gene program in skeletal muscle of pigs treated with a beta-adrenergic agonist. Hence we tested the hypothesis that the ER-stress inhibitor, sodium 4-phenylbutyrate (PBA), would inhibit Clenbuterol-mediated muscle growth and reduce expression of genes that are known indicators of an ISR in mice. Clenbuterol (1 mg/kg/day) administered to C57BL6/J mice for 21 days increased body weight (p<0.001), muscle weights (p<0.01), and muscle fibre diameters (p<0.05). Co-administration of PBA (100mg/kg/day) did not alter the Clenbuterol-mediated phenotype, nor did PBA alone have any effects compared to that of the vehicle treated mice. Clenbuterol increased skeletal muscle mRNA expression of phosphoserine amino transferase 1 (PSAT1, p<0.001) and cyclophillin A (p<0.01) at day 3, but not day 7. Clenbuterol decreased mRNA expression of activating transcription factor (ATF) 4 and ATF5 at day 3 (p<0.05) and day 7 (p<0.01), X-box binding protein 1 (XBP1) variant 2 mRNA at day 3 only (p<0.01) and DNA damage inducible transcript 3 (DDIT3/CHOP) mRNA at day 7 only (p<0.05). Co-administration of PBA had no effect on Clenbuterol-induced changes in skeletal muscle gene expression. In contrast, treatment of C2C12 myotubes with 5mM PBA (8hr) attenuated the thapsigargin-induced ISR gene program. Prolonged (24-48hr) treatment with PBA caused atrophy (p<0.01), reduced neoprotein synthesis (p<0.0001) and decreased expression of myogenin and fast myosin heavy chain genes (p<0.01), indicating an inhibition of myogenic differentiation. In summary, Clenbuterol did not induce an ISR gene program in mouse muscle. On the contrary, it reduced expression of a number of ISR genes, but it increased expression of PSAT1 mRNA. Co-administration of PBA had no effect on Clenbuterol-mediated muscle growth or gene expression in mice, whereas PBA did inhibit thapsigargin-induced ISR gene expression in cultured C2C12 cells and appeared to inhibit myogenic differentiation, independent of altering ISR gene expression.	[Brown, David M.; Jones, Sarah; Daniel, Zoe C. T. R.; Brearley, Madelaine C.; Parr, Tim; Brameld, John M.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Lewis, Jo E.; Ebling, Francis J. P.] Univ Nottingham, Med Sch, Sch Life Sci, Nottingham, England	University of Nottingham; University of Nottingham	Brameld, JM (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	John.Brameld@Nottingham.ac.uk	Brameld, John/AAB-1745-2021; Ebling, Francis/Q-6193-2019	Brameld, John/0000-0003-4942-080X; Ebling, Francis/0000-0002-7316-9582; Lewis, Jo Edward/0000-0002-5722-6778; Parr, Tim/0000-0003-2490-9457; Sholto, Madelaine/0000-0001-7306-9242	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/MM001385/1]; Zoetis; BBSRC [BB/M001385/1, BB/M017524/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) (grant number BB/MM001385/1) and by Zoetis (formerly Pfizer Animal Health). The funders had no input into the study design, data collection and analysis or preparation of manuscript. The MF20 monoclonal antibody was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28693; Brown D. M., 2016, J CACHEXIA SARCOPE 1, V7, P626, DOI [10.1002/jcsm.12164, DOI 10.1002/JCSM.12164]; Brown DM, 2015, AGEING RES REV, V24, P263, DOI 10.1016/j.arr.2015.08.007; Brown DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114365; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; BRUSILOW SW, 1991, PEDIATR RES, V29, P147, DOI 10.1203/00006450-199102000-00009; BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503; Camacho LH, 2007, INVEST NEW DRUG, V25, P131, DOI 10.1007/s10637-006-9017-4; Cao AL, 2016, LAB INVEST, V96, P610, DOI 10.1038/labinvest.2016.44; Collins A, 1995, BLOOD, V85; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gilbert J, 2001, CLIN CANCER RES, V7, P2292; Hamilton DL, 2014, AM J PHYSIOL-ENDOC M, V307, pE365, DOI 10.1152/ajpendo.00674.2013; Hu HL, 2014, CELL PHYSIOL BIOCHEM, V33, P1899, DOI 10.1159/000362967; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jellbauer S, 2016, INFECT IMMUN, V84, P2639, DOI 10.1128/IAI.00132-16; Kim HJ, 2011, MED SCI SPORT EXER, V43, P18, DOI 10.1249/MSS.0b013e3181e4c5d1; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34036; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P130, DOI 10.1016/j.nmd.2003.11.006; NEWMARK HL, 1995, J CELL BIOCHEM, P247; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Park Y, 2017, CELL REP, V19, P1083, DOI 10.1016/j.celrep.2017.04.042; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Rubenstein R, 1998, AM J RESP CRIT CARE, V157; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Spurlock DM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-320; Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; WILEY JC, 2010, PLOONE PUBLIC LIB, V5, DOI DOI 10.1371/JOURNAL.PONE.0009135; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zeng MC, 2017, TOXICOL LETT, V271, P26, DOI 10.1016/j.toxlet.2017.02.023; Zhang L, 2016, DIS MODEL MECH, V9, P799, DOI 10.1242/dmm.023242	46	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201481	10.1371/journal.pone.0201481	http://dx.doi.org/10.1371/journal.pone.0201481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052661	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000440006600047
J	Ye, CF; Ma, T; Wu, D; Ceritoglu, C; Miller, MI; Mori, S				Ye, Chenfei; Ma, Ting; Wu, Dan; Ceritoglu, Can; Miller, Michael I.; Mori, Susumu			Atlas pre-selection strategies to enhance the efficiency and accuracy of multi-atlas brain segmentation tools	PLOS ONE			English	Article							SELECTION; ONTOLOGY; MRI	Multi-atlas brain segmentation of human brain MR images allows quantification research in structural neuroimaging. To achieve high accuracy and computational efficiency of segmentation relies on a custom subset of atlases for each target subject. However, the criterion for atlas pre-selection remains an open question. In this study, two atlas pre-selection approaches based on location-based feature matching were proposed and compared to random and mutual information-based methods using a database of 47 atlases. A varying number of atlases ranked top with hierarchical structural granularity were compared using Dice overlap. The results indicated that the proposed 4L approach consistently led to the highest level of accuracy at a given number of employed atlases in both adult and geriatric populations. In addition, the proposed two methods (4L and LV) can reduce 20 times computational time compared with the stereotypical mutual information-based method. Our pre-selection strategy would provide better segmentation performance in terms of both accuracy and efficiency. The proposed atlas pre-selection will be further implemented into our online automatic brain image segmentation system (www.mricloud.org).	[Ye, Chenfei; Ma, Ting] Harbin Inst Technol, Shenzhen Grad Sch, Dept Elect & Informat, Shenzhen, Guangdong, Peoples R China; [Ma, Ting] Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China; [Ma, Ting; Wu, Dan; Ceritoglu, Can; Mori, Susumu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Sch Med, Ctr Imaging Sci, Baltimore, MD USA; [Mori, Susumu] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA	Harbin Institute of Technology; University Town of Shenzhen; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute	Ma, T (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Elect & Informat, Shenzhen, Guangdong, Peoples R China.; Ma, T (corresponding author), Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China.; Ma, T (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA.	tmahit@outlook.com	Ye, Chenfei/K-9207-2016; Ma, Ting/N-3320-2014	Ye, Chenfei/0000-0001-5265-3546; Ma, Ting/0000-0001-8819-6228	Basic Research Foundation Key Project Track of Shenzhen Science and Technology Program [JCYJ20160509162237418, JCYJ20170413110656460]; Basic Research Foundation of Shenzhen Science and Technology Program [JCYJ20150403161923510]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	Basic Research Foundation Key Project Track of Shenzhen Science and Technology Program; Basic Research Foundation of Shenzhen Science and Technology Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The author T. M. received three fundings: The Basic Research Foundation Key Project Track of Shenzhen Science and Technology Program (JCYJ20160509162237418, JCYJ20170413110656460), and the Basic Research Foundation of Shenzhen Science and Technology Program (JCYJ20150403161923510).	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Ceritoglu C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00151; Chau W, 2005, NEUROIMAGE, V25, P408, DOI 10.1016/j.neuroimage.2004.12.007; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Djamanakova A, 2014, NEUROIMAGE, V101, P168, DOI 10.1016/j.neuroimage.2014.06.046; Mai J, 2007, ATLAS OF HUMAN BRAIN, P02, DOI DOI 10.1016/J.NEUROIMAGE.2014.06.046; Nam H, 2009, COMMUN NUMER METH EN, V25, P583, DOI 10.1002/cnm.1176; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Puelles L, 2013, TRENDS NEUROSCI, V36, P570, DOI 10.1016/j.tins.2013.06.004; Sanroma G, 2014, IEEE T MED IMAGING, V33, P1939, DOI 10.1109/TMI.2014.2327516; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tang XY, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00061; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065591; TANG XY, 2013, PLOS ONE, V8; Wu D, 2016, NEUROIMAGE, V125, P120, DOI 10.1016/j.neuroimage.2015.10.042; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050	17	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200294	10.1371/journal.pone.0200294	http://dx.doi.org/10.1371/journal.pone.0200294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052643	Green Published, Green Submitted, gold			2022-12-26	WOS:000440006600007
J	Held, M; Santeramo, I; Wilm, B; Murray, P; Levy, R				Held, Marie; Santeramo, Ilaria; Wilm, Bettina; Murray, Patricia; Levy, Raphael			Ex vivo live cell tracking in kidney organoids using light sheet fluorescence microscopy	PLOS ONE			English	Article							PLANE ILLUMINATION MICROSCOPY; SINGLE-PARTICLE TRACKING; STEM-CELLS; SELF-ORGANIZATION; PROGENITOR CELLS; TISSUES; MOUSE; SUSPENSIONS; EXPRESSION; GENERATION	Screening cells for their differentiation potential requires a combination of tissue culture models and imaging methods that allow for long-term tracking of the location and function of cells. Embryonic kidney re-aggregation in vitro assays have been established which allow for the monitoring of organotypic cell behaviour in re-aggregated and chimeric renal organoids. However, evaluation of cell integration is hampered by the high photonic load of standard fluorescence microscopy which poses challenges for imaging three-dimensional systems in real-time over a time course. Therefore, we employed light sheet microscopy, a technique that vastly reduces photobleaching and phototoxic effects. We have also developed a new method for culturing the re-aggregates which involves immersed culture, generating organoids which more closely reflect development in vivo. To facilitate imaging from various angles, we embedded the organoids in a freely rotatable hydrogel cylinder. Endpoint fixing and staining were performed to provide additional biomolecular information. We succeeded in imaging labelled cells within re-aggregated kidney organoids over 15 hours and tracking their fate while simultaneously monitoring the development of organotypic morphological structures. Our results show that Wt1-expressing embryonic kidney cells obtained from transgenic mice could integrate into re-aggregated chimeric kidney organoids and contribute to developing nephrons. Furthermore, the nascent proximal tubules that formed in the re-aggregated tissues using the new culture method displayed secretory function, as evidenced by their ability to secrete an organic anion mimic into the tubular lumen.	[Held, Marie; Levy, Raphael] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England; [Santeramo, Ilaria; Wilm, Bettina; Murray, Patricia] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Levy, R (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.; Wilm, B; Murray, P (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England.	bwilm@liverpool.ac.uk; embryo@liverpool.ac.uk; rapha@liverpool.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Murray, Patricia/0000-0003-1316-148X; Held, Marie/0000-0003-0118-5898	UK Regenerative Medicine Platform [MR/K026739/1]; BBSRC [BB/L014947/1]; Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; MRC [MR/K015931/1, MR/M009114/1, MR/K026739/1] Funding Source: UKRI	UK Regenerative Medicine Platform; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Regenerative Medicine Platform (MR/K026739/1, http://www.ukrmp.org.uk/). We acknowledge the Liverpool Centre for Cell Imaging (CCI) for provision of imaging equipment, in particular the Zeiss Lightsheet Z.1 funded by BBSRC (https://www.bbsrc.ac.uk/) Alert13 grant number BB/L014947/1 and technical assistance. I.S. was funded by the Nephrotools FP7 Marie Curie training grant (http://www.nephrotools.com/), and Alder Hey Children's Kidney fund (http://www. alderheychildrenskidneyfund.org/). We would also like to thank Thomas Wilm for help with the genotyping of the mice, and Marco Marcello and David Mason for help with technical assistance and image analysis support.; This work was supported by the UK Regenerative Medicine Platform (MR/K026739/1). We acknowledge the Liverpool Centre for Cell Imaging (CCI) for provision of imaging equipment, in particular the Zeiss Lightsheet Z. 1 funded by BBSRC Alert13 grant number BB/L014947/1 and technical assistance. I.S. was funded by the Nephrotools FP7 Marie Curie training grant, and Alder Hey Children's Kidney fund. We would also like to thank Thomas Wilm for help with the genotyping of the mice, and Marco Marcello and David Mason for help with technical assistance and image analysis support.	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Davies JA, 2014, PEDIATR NEPHROL, V29, P519, DOI 10.1007/s00467-013-2579-4; Davies Jamie A, 2012, Methods Mol Biol, V886, P135, DOI 10.1007/978-1-61779-851-1_12; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; GROBSTEIN C, 1956, EXP CELL RES, V10, P424, DOI 10.1016/0014-4827(56)90016-7; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Henry KS, 2001, ENVIRON TOXICOL CHEM, V20, P2611, DOI 10.1002/etc.5620201129; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Icha J, 2016, USING LIGHT SHEET FL, DOI [10.3791/53966, DOI 10.3791/53966]; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Junttila S, 2015, J AM SOC NEPHROL, V26, P1126, DOI 10.1681/ASN.2013060584; Kaufmann A, 2012, DEVELOPMENT, V139, P3242, DOI 10.1242/dev.082586; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Lawrence ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep09092; Lefevre JG, 2017, DEVELOPMENT, V144, P1087, DOI 10.1242/dev.140228; Lindstrom NO, 2015, ELIFE, V4, DOI 10.7554/eLife.04000; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Lorenzo C, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-22; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Pampaloni F, 2015, CELL TISSUE RES, V360, P129, DOI 10.1007/s00441-015-2144-5; Pampaloni F, 2015, METHODS MOL BIOL, V1251, P43, DOI 10.1007/978-1-4939-2080-8_3; Pampaloni F, 2014, INTEGR BIOL-UK, V6, P988, DOI 10.1039/c4ib00121d; Parreira KS, 2009, PFLUG ARCH EUR J PHY, V458, P745, DOI 10.1007/s00424-009-0667-x; Poguzhelskaya E, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-19; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Rak-Raszewska A, 2016, EUR J PHARMACOL, V790, P3, DOI 10.1016/j.ejphar.2016.07.011; Rak-Raszewska A, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/959807; Rak-Raszewska A, 2012, ORGANOGENESIS, V8, P125, DOI 10.4161/org.22597; Ranghini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062953; Riccio P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002382; Saarela U, 2017, DEVELOPMENT, V144, P1113, DOI 10.1242/dev.142950; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Sebinger DDR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010550; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Strnad P, 2016, NAT METHODS, V13, P139, DOI [10.1038/NMETH.3690, 10.1038/nmeth.3690]; Swoger J, 2014, COLD SPRING HARBOR P, V2014; Swoger Jim, 2014, Cold Spring Harb Protoc, V2014, P114, DOI 10.1101/pdb.prot080184; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Torres M, 1995, DEVELOPMENT, V121, P4057; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Wilm B, 2016, METHODS MOL BIOL, V1467, P23, DOI 10.1007/978-1-4939-4023-3_3; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yamashita N, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.101206	57	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0199918	10.1371/journal.pone.0199918	http://dx.doi.org/10.1371/journal.pone.0199918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048451	gold, Green Submitted, Green Published			2022-12-26	WOS:000439952400004
J	Koklic, T; Urbancic, I; Zdovc, I; Golob, M; Umek, P; Arsov, Z; Drazic, G; Pintaric, S; Dobeic, M; Strancar, J				Koklic, Tilen; Urbancic, Iztok; Zdovc, Irena; Golob, Majda; Umek, Polona; Arsov, Zoran; Drazic, Goran; Pintaric, Stefan; Dobeic, Martin; Strancar, Janez			Surface deposited one-dimensional copper-doped TiO2 nanomaterials for prevention of health care acquired infections	PLOS ONE			English	Article							OXYGEN-CENTERED RADICALS; LISTERIA-MONOCYTOGENES; TITANATE NANOTUBES; HYDROGEN-PEROXIDE; TITANIUM-DIOXIDE; FLUORESCENCE MICROSPECTROSCOPY; HETEROGENEOUS PHOTOCATALYSIS; PHOSPHORYLATED NITRONE; ANTIMICROBIAL ACTIVITY; MICROBIAL-CELLS	Bacterial infections acquired in healthcare facilities including hospitals, the so called healthcare acquired or nosocomial infections, are still of great concern worldwide and represent a significant economical burden. One of the major causes of morbidity is infection with Methicillin Resistant Staphylococcus aureus (MRSA), which has been reported to survive on surfaces for several months. Bactericidal activity of copper-TiO2 thin films, which release copper ions and are deposited on glass surfaces and heated to high temperatures, is well known even when illuminated with very weak UVA light of about 10 mu W/cm(2). Lately, there is an increased intrerest for one-dimensional TiO2 nanomaterials, due to their unique properties, low cost, and high thermal and photochemical stability. Here we show that copper doped TiO2 nanotubes produce about five times more center dot OH radicals as compared to undoped TiO2 nanotubes and that effective surface disinfection, determined by a modified ISO 22196:2011 test, can be achieved even at low intensity UVA light of 30 mu W/cm(2). The nanotubes can be deposited on a preformed surface at room temperature, resulting in a stable deposition resistant to multiple washings. Up to 10(3) microorganisms per cm(2) can be inactivated in 24 hours, including resistant strains such as Methicillin-resistant Staphylococcus aureus (MRSA) and Extended-spectrum beta-lactamase Escherichia coli (E. coli ESBL). This disinfection method could provide a valuable alternative to the current surface disinfection methods.	[Koklic, Tilen; Urbancic, Iztok; Umek, Polona; Arsov, Zoran; Strancar, Janez] Jozef Stefan Inst, Dept Condensed Matter Phys, Ljubljana, Slovenia; [Koklic, Tilen; Zdovc, Irena; Umek, Polona; Arsov, Zoran; Strancar, Janez] NAMASTE Ctr Excellence, Ljubljana, Slovenia; [Urbancic, Iztok] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Human Immunol Unit, Oxford, England; [Zdovc, Irena; Golob, Majda] Univ Ljubljana, Inst Microbiol & Parasitol, Fac Vet, Ljubljana, Slovenia; [Drazic, Goran] Natl Inst Chem, Dept Chem Mat, Ljubljana, Slovenia; [Pintaric, Stefan; Dobeic, Martin] Univ Ljubljana, Fac Vet, Inst Environm & Anim Hyg Anim Behav, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Oxford; University of Ljubljana; National Institute of Chemistry - Slovenia; University of Ljubljana	Strancar, J (corresponding author), Jozef Stefan Inst, Dept Condensed Matter Phys, Ljubljana, Slovenia.; Strancar, J (corresponding author), NAMASTE Ctr Excellence, Ljubljana, Slovenia.	janez.strancar@ijs.si	Drazic, Goran/A-2017-2008; Urbančič, Iztok/AAU-3027-2020	Drazic, Goran/0000-0001-7809-8050; Urbančič, Iztok/0000-0003-3603-6585; Arsov, Zoran/0000-0001-7894-3648; Strancar, Janez/0000-0001-8032-132X	Slovenian Research Agency ARRS, Javna Agencija za Raziskovalno Dejavnost RS [P1-0060]; NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future, ADVANCED BIO MATERIALS	Slovenian Research Agency ARRS, Javna Agencija za Raziskovalno Dejavnost RS; NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future, ADVANCED BIO MATERIALS	This study was supported by Slovenian Research Agency ARRS, Javna Agencija za Raziskovalno Dejavnost RS, research core funding no. (P1-0060), prof. Janez Strancar; and NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future, ADVANCED BIO MATERIALS, prof. Janez Strancar.	Abreu AC, 2013, J ANTIMICROB CHEMOTH, V68, P2718, DOI 10.1093/jac/dkt281; Adams EG, 1977, FREE RADICALS BIOL, p52 ; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Baureder M, 2012, FEMS MICROBIOL LETT, V331, P160, DOI 10.1111/j.1574-6968.2012.02567.x; Bhalla A, 2004, INFECT CONT HOSP EP, V25, P164, DOI 10.1086/502369; Buchalska M, 2015, ACS CATAL, V5, P7424, DOI 10.1021/acscatal.5b01562; Cadnum JL, 2015, AM J INFECT CONTROL, V43, P1357, DOI 10.1016/j.ajic.2015.07.016; Ciesla P, 2004, J MOL CATAL A-CHEM, V224, P17, DOI 10.1016/j.molcata.2004.08.043; De Jong WH, 2013, BIOMATERIALS, V34, P8333, DOI 10.1016/j.biomaterials.2013.06.048; Silva AADE, 2012, BRAZ J MICROBIOL, V43, P1620, DOI [10.1590/S1517-83822012000400047, 10.1590/S1517-838220120004000047]; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Ditta IB, 2008, APPL MICROBIOL BIOT, V79, P127, DOI 10.1007/s00253-008-1411-8; Dunlop PSM, 2010, J PHOTOCH PHOTOBIO A, V216, P303, DOI 10.1016/j.jphotochem.2010.07.004; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Emeline AV, 2005, J PHYS CHEM B, V109, P18515, DOI 10.1021/jp0523367; Foster HA, 2010, J PHOTOCH PHOTOBIO A, V216, P283, DOI 10.1016/j.jphotochem.2010.09.017; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; FREJAVILLE C, 1994, J CHEM SOC CHEM COMM, P1793, DOI 10.1039/c39940001793; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Garrido V, 2010, FOOD CONTROL, V21, P896, DOI 10.1016/j.foodcont.2009.12.007; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Herrmann JM, 2010, J PHOTOCH PHOTOBIO A, V216, P85, DOI 10.1016/j.jphotochem.2010.05.015; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Huang C, 2007, APPL PHYS A-MATER, V87, P781, DOI 10.1007/s00339-007-3902-3; HUDSON JA, 1994, J FOOD PROTECT, V57, P204, DOI 10.4315/0362-028X-57.3.204; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Kakuma Y, 2015, PHYS CHEM CHEM PHYS, V17, P18691, DOI 10.1039/c5cp02004b; Khare P, 2018, ACS SUSTAIN CHEM ENG, V6, P579, DOI 10.1021/acssuschemeng.7b02929; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kupferschmidt K, 2016, SCIENCE, V352, P758, DOI 10.1126/science.352.6287.758; Litter MI, 1999, APPL CATAL B-ENVIRON, V23, P89, DOI 10.1016/S0926-3373(99)00069-7; Lock N, 2013, DALTON T, V42, P9555, DOI 10.1039/c3dt00122a; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; Molling JW, 2014, NANOTECHNOL SCI APPL, V7, P97, DOI 10.2147/NSA.S70782; Muers M., 2007, NAT NEWS, DOI [10.1038/news070903-14, DOI 10.1038/NEWS070903-14]; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Nian JN, 2006, J PHYS CHEM B, V110, P25817, DOI 10.1021/jp064209w; Noimark S, 2013, ADV DRUG DELIVER REV, V65, P570, DOI 10.1016/j.addr.2012.07.003; Perron GG, 2015, EVOL APPL, V8, P211, DOI 10.1111/eva.12254; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Qiu XQ, 2012, ACS NANO, V6, P1609, DOI 10.1021/nn2045888; Rodrigues D, 2013, APPL SURF SCI, V270, P1, DOI 10.1016/j.apsusc.2012.11.119; ROSENOW EM, 1987, J FOOD PROTECT, V50, P452, DOI 10.4315/0362-028X-50.6.452; Rossvoll E, 2014, INT J FOOD MICROBIOL, V185, P82, DOI 10.1016/j.ijfoodmicro.2014.05.020; Sato T, 2006, BIOCHEM ENG J, V30, P199, DOI 10.1016/j.bej.2006.04.002; Selmani A, 2015, J PHYS CHEM C, V119, P19729, DOI 10.1021/acs.jpcc.5b02027; Sluban M, 2017, J CATAL, V346, P161, DOI 10.1016/j.jcat.2016.12.015; Sunada K, 2003, ENVIRON SCI TECHNOL, V37, P4785, DOI 10.1021/es034106g; Umek P, 2008, J PHYS CHEM C, V112, P15311, DOI 10.1021/jp805005k; Umek P, 2007, J NANOSCI NANOTECHNO, V7, P3502, DOI 10.1166/jnn.2007.838; Urbancic I, 2013, OPT EXPRESS, V21, P25291, DOI 10.1364/OE.21.025291; Urbancic I, 2013, BIOPHYS J, V105, P919, DOI 10.1016/j.bpj.2013.07.005; Volker C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075026; Vogel R, 2004, SPECTROCHIM ACTA A, V60, P245, DOI 10.1016/S1386-1425(03)00218-X; WATANABE T, 1977, J PHYS CHEM-US, V81, P1845, DOI 10.1021/j100534a012; Wright GD, 2007, CELL, V130, P781, DOI 10.1016/j.cell.2007.08.023; Wu B, 2010, SCI TOTAL ENVIRON, V408, P1755, DOI 10.1016/j.scitotenv.2009.11.004; Wu TX, 1998, J PHYS CHEM B, V102, P5845, DOI 10.1021/jp980922c; Xin BF, 2008, APPL SURF SCI, V254, P2569, DOI 10.1016/j.apsusc.2007.09.002; Yang MY, 2014, CHEM SOC REV, V43, P6511, DOI 10.1039/c4cs00117f; Yi J, 2012, J PHYS CHEM C, V116, P10090, DOI 10.1021/jp301405e; You M, 2010, CRYST GROWTH DES, V10, P983, DOI 10.1021/cg9012944; Zhang J, 2014, J PHYS CHEM C, V118, P10824, DOI 10.1021/jp501214m; Zhang J, 2013, J PHYS CHEM C, V117, P1383, DOI 10.1021/jp3105166	66	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201490	10.1371/journal.pone.0201490	http://dx.doi.org/10.1371/journal.pone.0201490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048536	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400094
J	Sanchez-Lanzas, R; Castano, JG				Sanchez-Lanzas, Raul; Castano, Jose G.			Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DANON DISEASE; HUMAN DJ-1; STABILITY; DEGRADATION; EXPRESSION; AUTOPHAGY; L166P	Mutations in PARK7/DJ-1 gene are associated with familial autosomal recessive Parkinson disease. Recently, lysosomes and chaperone mediated autophagy (CMA) has been reported to participate in the degradation of DJ-1/PARK7 protein. Lamp-2A isoform is considered as the lysosomal receptor for the uptake of proteins being degraded by the CMA pathway. We have used several cell lines with disrupted LAMP2 gene expression and their respective control cells to test the possible role of lysosomal degradation and in particular CMA in DJ-1/PARK7 degradation. Interruption of LAMP-2 expression did not result in an increase of the steady-state protein levels of DJ-1/PARK7, as it would have been expected. Furthermore, no change in DJ-1/PARK7 protein levels were observed upon inhibition of lysosomal function with NH4Cl or NH4Cl plus leupeptin, or after activation of CMA by serum starvation for 24h. Accordingly, we have not found any evidence that DJ-1/PARK7 protein levels are regulated via lysosomal degradation or the CMA pathway.	[Sanchez-Lanzas, Raul; Castano, Jose G.] UAM, Fac Med, Inst Invest Biomed Alberto Sols, Dept Bioquim,CSIC, Madrid, Spain; [Sanchez-Lanzas, Raul; Castano, Jose G.] UAM, Fac Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBERNED	Castano, JG (corresponding author), UAM, Fac Med, Inst Invest Biomed Alberto Sols, Dept Bioquim,CSIC, Madrid, Spain.; Castano, JG (corresponding author), UAM, Fac Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	joseg.castano@uam.es		G. Castano, Jose/0000-0002-6579-8442	MINECO [SAF-2012-34556]; CIBERNED	MINECO(Spanish Government); CIBERNED(Instituto de Salud Carlos III)	This work was supported by grants from MINECO SAF-2012-34556 and CIBERNED to JGC.	Alvarez-Castelao B, 2012, BBA-MOL CELL RES, V1823, P524, DOI 10.1016/j.bbamcr.2011.11.010; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Endo Y, 2015, ACTA NEUROPATHOL, V129, P391, DOI 10.1007/s00401-015-1385-4; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Rothaug M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0182-y; Sanchez-Lanzas R, 2016, BBA-MOL BASIS DIS, V1862, P1423, DOI 10.1016/j.bbadis.2016.04.014; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang B, 2016, APPL COMPOSITE MAT, P1, DOI [10.1080/15548627.2015.1100356, DOI 10.1080/15548627.2015.1100356]; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wisniewski JR, 2016, J PROTEOME RES, V15, P2321, DOI 10.1021/acs.jproteome.6b00403	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201152	10.1371/journal.pone.0201152	http://dx.doi.org/10.1371/journal.pone.0201152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048497	Green Submitted, Green Published, gold			2022-12-26	WOS:000439952400053
J	Sandinge, AS; Janefeldt, A; Pehrsson, S; Nylander, S				Sandinge, Ann-Sofie; Janefeldt, Annika; Pehrsson, Susanne; Nylander, Sven			Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452	PLOS ONE			English	Article							P2Y(12) RECEPTOR ANTAGONIST; ACUTE CORONARY SYNDROMES; CLOPIDOGREL; INHIBITION; ANTIDOTE; AZD6140	Ticagrelor, a P2Y(12) antagonist, is approved for prevention of thromboembolic events. MEDI2452 is a potential reversal agent for ticagrelor and ticagrelor active metabolite (TAM). The total plasma exposure of ticagrelor and TAM in patients are roughly 0.5 +/- 1 and 0.2 +/- 0.5 mu mol/L, respectively. Both have similar high potency vs. P2Y(12) (Ki 2 nmol/L) but are plasma protein-bound to 99.8% and only the 0.2% free fraction is able to inhibit the P2Y(12) receptor. Thus, for unbound concentration measurements to be a proof of mechanism bio-marker for MEDI2452 a very high sensitivity is required. Using established techniques as equilibrium dialysis and LC-MS/MS, made it possible to evaluate the efficacy of the reversal agent by measuring reduction of unbound concentration of ticagrelor in the presence of MEDI2452. With challenges such as ultra-low concentrations, small sample volumes, recovery issues and adsorption to plastic we managed to develop a highly sensitive assay for determining unbound concentration levels of ticagrelor and TAM in plasma with a quantification limit of 30 pmol/L and 45 pmol/L, respectively. With this method we were able to detect close to a 100-fold MEDI2452 mediated reduction in the unbound concentration of both ticagrelor and TAM. The assay provided proof of mechanism as MEDI2452 concentration-and dose-dependently eliminated unbound concentration of ticagrelor and reversed its antiplatelet activity in preclinical models and will support future development of MEDI2452.	[Sandinge, Ann-Sofie; Janefeldt, Annika; Pehrsson, Susanne; Nylander, Sven] AstraZeneca, Cardiovasc Renal & Metab Innovat Med & Early Dev, Gothenburg, Sweden	AstraZeneca	Sandinge, AS (corresponding author), AstraZeneca, Cardiovasc Renal & Metab Innovat Med & Early Dev, Gothenburg, Sweden.	ann-sofie.sandinge@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	The authors confirm that the funder AstraZeneca, provided support in the form of salaries for authors [AS, AJ, SP, SN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Almquist J, 2016, CPT-PHARMACOMET SYST, V5, P313, DOI 10.1002/psp4.12089; Becker RC, 2011, EUR HEART J, V32, P2933, DOI 10.1093/eurheartj/ehr422; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Buchanan A, 2015, BLOOD, V125, P3484, DOI 10.1182/blood-2015-01-622928; Dolgin E, 2015, NAT BIOTECHNOL, V33, P117, DOI 10.1038/nbt0215-117; Nilsson LB, 2013, BIOANALYSIS, V5, P3033, DOI [10.4155/BIO.13.274, 10.4155/bio.13.274]; Pehrsson S, 2017, J THROMB HAEMOST, V15, P1213, DOI 10.1111/jth.13680; Ramirez FD, 2017, CIRC RES, V120, P1916, DOI 10.1161/CIRCRESAHA.117.310628; Sillen H, 2011, J CHROMATOGR B, V879, P2315, DOI 10.1016/j.jchromb.2011.06.023; Sillen H, 2010, J CHROMATOGR B, V878, P2299, DOI 10.1016/j.jchromb.2010.06.018; Springthorpe B, 2007, BIOORG MED CHEM LETT, V17, P6013, DOI 10.1016/j.bmcl.2007.07.057; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Storey RF, 2011, HEART, V97, P1262, DOI 10.1136/hrt.2009.184242; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	15	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201202	10.1371/journal.pone.0201202	http://dx.doi.org/10.1371/journal.pone.0201202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048515	Green Published, Green Submitted, gold			2022-12-26	WOS:000439952400060
J	Ahmad, A; Zulaily, N; Shahril, MR; Abdullah, EFHS; Ahmed, A				Ahmad, Aryati; Zulaily, Nurzaime; Shahril, Mohd Razif; Abdullah, Engku Fadzli Hasan Syed; Ahmed, Amran			Association between socioeconomic status and obesity among 12-year-old Malaysian adolescents	PLOS ONE			English	Article							CHILDHOOD OBESITY; CHILDREN; PREVALENCE; OVERWEIGHT; ADULTHOOD; INCOME	The epidemic of obesity in developed countries is commonly associated with poor dietary habit and sedentary lifestyle. However, other determinants, including education background and family income, may contribute towards the problem especially in developing countries. This study aimed to determine the influence of socioeconomic status (SES) on obesity among 12-year-old school adolescents in Terengganu, Malaysia. Body weight and height were measured and BMI was categorised based on WHO z-score cut-off points. Information was obtained from self-reported questionnaire on parents' education background, family income and occupation. A total of 3,798 school adolescents aged 12 years (44% boys and 56% girls) were recruited. There was no significant difference in BMI status between boys and girls, or between rural and urban participants. There were significant differences between BMI categories and gender, household income and SES level within rural areas. In the urban areas, significant differences were found between BMI categories and gender, parents' occupational and educational level, household income and size, and SES level. A logistic regression model found several SES factors to be predictors of obesity in this population, namely, gender, household size, father's occupation level, household income level and SES level. Each component of SES has been significantly associated with the BMI category of school adolescents, particularly in the urban areas. This suggests the requirement of multifaceted approaches, including the role of family, society and authorities, in the effort to curtail adolescent obesity.	[Ahmad, Aryati; Zulaily, Nurzaime; Shahril, Mohd Razif] Univ Sultan Zainal Abidin, Fac Hlth Sci, Gong Badak Campus, Kuala Nerus, Terengganu, Malaysia; [Abdullah, Engku Fadzli Hasan Syed] Univ Sultan Zainal Abidin, Fac Informat & Comp, Besut Campus, Besut, Terengganu, Malaysia; [Ahmed, Amran] Univ Malaysia Perlis, Inst Engn Math, Pauh Putra Campus, Arau, Perlis, Malaysia	Universiti Sultan Zainal Abidin; Universiti Sultan Zainal Abidin; Universiti Malaysia Perlis	Ahmad, A (corresponding author), Univ Sultan Zainal Abidin, Fac Hlth Sci, Gong Badak Campus, Kuala Nerus, Terengganu, Malaysia.	aryatiahmad@unisza.edu.my	Shahril, Mohd Razif/K-7320-2015	Shahril, Mohd Razif/0000-0002-8680-3087; Zulaily, Nurzaime/0000-0002-3439-3442	Malaysian Ministry of Higher Education [FRGS/2/2013/SKK/UNISZA/01/1]	Malaysian Ministry of Higher Education	This study has been funded by the Malaysian Ministry of Higher Education under Grant Number FRGS/2/2013/SKK/UNISZA/01/1 (https://www.mohe.gov.my/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their great gratitude to the Malaysian Ministry of Higher Education for funding this study (FRGS/2/2013/SKK/UNISZA/01/1), and the Malaysian Ministry of Education with Terengganu State Education Department for permission to conduct this survey. We would also like to express our enormous appreciation to the PE teachers, parents and students for their willingness to participate. Special thanks to members of the Health of Adolescents in Terengganu (HAT) study and also the enumerators for their valuable contribution to this study.	Abudayya A, 2007, NUTR RES, V27, P762, DOI 10.1016/j.nutres.2007.09.017; Anderson PM, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0001; Aris T, 2015, NATL HLTH MORBIDITY, VII; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Boey CCM, 2003, J PAEDIATR CHILD H, V39, P352, DOI 10.1046/j.1440-1754.2003.00173.x; Brown JE, 2010, SOC SCI MED, V70, P1816, DOI 10.1016/j.socscimed.2010.01.040; Fadzli SA., 2016, INT J SOFTW ENG ITS, V10, P89; Gallagher AM, 2002, PUBLIC HEALTH, V116, P332, DOI 10.1038/sj.ph.1900871; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Herforth A, 2015, FOOD SECUR, V7, P505, DOI 10.1007/s12571-015-0455-8; Hofferth SL, 2005, J POLICY ANAL MANAG, V24, P703, DOI 10.1002/pam.20134; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, V2; Khor GL, 2009, SINGAP MED J, V50, P303; Lamerz A, 2005, INT J OBESITY, V29, P373, DOI 10.1038/sj.ijo.0802914; Lee G, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-28; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Majid HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155447; Ministry of Human Resources Malaysia, 2010, MAL STAND CLASS OCC, V3rd ed.; Mok TP, 2011, ECON ANAL POLICY, V41, P203, DOI 10.1016/S0313-5926(11)50020-7; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ozguven Isil, 2010, J Clin Res Pediatr Endocrinol, V2, P111, DOI 10.4274/jcrpe.v2i3.111; Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092; Racette SB, 2001, PHYS THER, V83, P1810; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Samani-Radia D, 2011, INT J OBESITY, V35, P128, DOI 10.1038/ijo.2010.116; Shariff Z M, 2000, Malays J Nutr, V6, P17; Shariff ZM, 2015, NUTR RES PRACT, V9, P278, DOI 10.4162/nrp.2015.9.3.278; Unit Perancang Ekonomi, 2010, RANC MAL KES 2011 20; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903; WHO, 2009, WHO TECH REP SER, V958, P1; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; Zaini M Z Anuar, 2005, Asia Pac J Public Health, V17, P71, DOI 10.1177/101053950501700203; Zalilah M. S., 2006, SMJ Singapore Medical Journal, V47, P491	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200577	10.1371/journal.pone.0200577	http://dx.doi.org/10.1371/journal.pone.0200577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044842	Green Published, gold, Green Submitted			2022-12-26	WOS:000439942500061
J	Almigbal, TH; Schattner, P				Almigbal, Turky H.; Schattner, Peter			The willingness of Saudi men with type 2 diabetes to discuss erectile dysfunction with their physicians and the factors that influence this	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; HEALTH; ATTITUDES; CARE; CONSULTATION; BARRIERS; SEEKING; ISSUES	Objectives The study's objectives were to find out the proportion of Saudi men with type 2 diabetes who have been asked by their physicians about erectile dysfunction (ED) in the last year, to determine the willingness of Saudi men with type 2 diabetes to discuss ED, and to explore the factors that may be related to their willingness to discuss ED with their physicians. Methods This study employed a cross-sectional survey design using a quantitative self-administered questionnaire among 309 Saudi men with type 2 diabetes. The study was conducted in hospital-based primary care clinics at King Khalid University Hospital, Riyadh, Saudi Arabia during the period from July to September 2015. Results The mean age of the patients was 60.2 years with the mean duration of diabetes approximately 12.5 years. Few of the patients (9.7%) had been asked by their physicians about ED within the last year of attending the clinics although most patients (84.8%) were willing to discuss this issue. The presence of ED among the respondents was 89%. Two participants' characteristics were associated with a willingness to discuss ED with the physicians. These characteristics were age above 60 (OR = 0.25, 95% CI: 0.11-0.55), and having severe ED (OR = 0.26, 95% CI: 0.08-0.85). The respondents' main barriers to discussing ED with their physicians were embarrassing the doctor, ED is a personal issue, too old or too sick to address ED issues now, no effective treatment available, and the doctor is too young to discuss ED with. Conclusions Most patients who have type 2 diabetes are not asked about ED within the last year of attendance even though most are willing to discuss it with their physicians. Being older and suffering more severe ED will result in being less willing to discuss ED with their doctor. Further research is needed to explore the barriers which prevent physicians from discussing ED with their patients who have diabetes.	[Almigbal, Turky H.] King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia; [Almigbal, Turky H.; Schattner, Peter] Monash Univ, Sch Primary Hlth Care, Dept Gen Practice, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia	King Saud University; Monash University	Almigbal, TH (corresponding author), King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia.; Almigbal, TH (corresponding author), Monash Univ, Sch Primary Hlth Care, Dept Gen Practice, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.	almogbal@yahoo.com			College of Medicine Research Centre, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	College of Medicine Research Centre, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This project was supported by the College of Medicine Research Centre, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.	Al-Nozha MM, 2004, SAUDI MED J, V25, P1603; AlMogbel TA, 2014, INT J HEALTH SCI-IJH, V8, P347; Alwakeel LS, 2008, ANN SAUDI MED, V28, P260; American Diabetes Association, 2017, Diabetes Care, V40, pS88; Byrne M, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-40; Camacho ME, 2005, INT J IMPOT RES, V17, pS52, DOI 10.1038/sj.ijir.3901429; Campos C, 2012, POSTGRAD MED, V124, P90, DOI 10.3810/pgm.2012.11.2615; Corona G, 2013, J ENDOCRINOL INVEST, V36, P864, DOI 10.3275/8969; Corona G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157915; Corona G, 2014, J SEX MED, V11, P2065, DOI 10.1111/jsm.12601; Corona G, 2012, EXPERT OPIN EMERG DR, V17, P239, DOI 10.1517/14728214.2012.683411; Faraj RI, 2013, INT J MED SCI PUBLIC, V1, P09; Federation ID, 2013, IDF DIABETES ATLAS; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Flaget-Greener M, 2015, SEX RELATSH THER, V30, P10, DOI 10.1080/14681994.2014.948297; Frost M, 2012, AGE AGEING, V41, P177, DOI 10.1093/ageing/afr153; Garcia-Cruz E, 2017, ACTAS UROL ESP; Gazzaruso C, 2004, CIRCULATION, V110, P22, DOI 10.1161/01.CIR.0000133278.81226.C9; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Grant PS, 2009, ACTA DIABETOL, V46, P285, DOI 10.1007/s00592-008-0084-1; Guzu AH, 2012, J CLIN OUTCOMES MANA, V19, P551; Harding JR, 2017, EDUC GERONTOL, V43, P462, DOI 10.1080/03601277.2017.1326226; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Hermans MP, 2009, DIABETES METAB, V35, P484, DOI 10.1016/j.diabet.2009.06.003; IBM Corp, 2012, REL 2013 IBM SPSS ST; Jiann BP, 2009, J SEX MED, V6, P2008, DOI 10.1111/j.1743-6109.2009.01264.x; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403; Lo WH, 2014, ASIAN J ANDROL, V16, P755, DOI 10.4103/1008-682X.127823; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; McCabe MP, 2016, J SEX MED, V13, P153, DOI 10.1016/j.jsxm.2015.12.015; Mellor RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078802; Morsy H, 2016, HUMAN ANDROL, V6, P65; National Institute for Health and Care Excellence, 2015, TYP 2 DIAB AD MAN; Nicolai MPJ, 2013, CLIN RES CARDIOL, V102, P329, DOI 10.1007/s00392-013-0549-2; Penson DF, 2003, DIABETES CARE, V26, P1093, DOI 10.2337/diacare.26.4.1093; Perttula E, 1999, POSTGRAD MED J, V75, P83, DOI 10.1136/pgmj.75.880.83; Rahman S, 2007, DIABETES OBES METAB, V9, P767, DOI 10.1111/j.1463-1326.2006.00655.x; Rosen RC, 2009, J SEX MED, V6, P1414, DOI 10.1111/j.1743-6109.2008.01209.x; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rutte A, 2016, J SEX MARITAL THER, V42, P324, DOI 10.1080/0092623X.2015.1033578; Seid A, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0167-5; Shamloul R, 2004, INT J IMPOT RES, V16, P452, DOI 10.1038/sj.ijir.3901248; Smith ML, 2016, MATURITAS, V92, P168, DOI 10.1016/j.maturitas.2016.07.022; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Tsigarovski G, 2017, J SEX MED, V14, pE192, DOI 10.1016/j.jsxm.2017.03.230; Varkonyi T, 2009, DIABETES OLD AGE, P149; Walsh TJ, 2014, INT J IMPOT RES, V26, P112, DOI 10.1038/ijir.2013.46; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043673	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201105	10.1371/journal.pone.02011O5	http://dx.doi.org/10.1371/journal.pone.02011O5			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044848				2022-12-26	WOS:000439942500081
J	Beheshti, A; Ray, S; Fogle, H; Berrios, D; Costes, SV				Beheshti, Afshin; Ray, Shayoni; Fogle, Homer; Berrios, Daniel; Costes, Sylvian V.			A microRNA signature and TGF-beta 1 response were identified as the key master regulators for spaceflight response	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELL; SIMULATED MICROGRAVITY; CANCER PROGRESSION; SPACE RADIATION; IMMUNE-SYSTEM; TGF-BETA; AGE; CARCINOGENESIS; IRRADIATION	Translating fundamental biological discoveries from NASA Space Biology program into health risk from space flights has been an ongoing challenge. We propose to use NASA GeneLab database to gain new knowledge on potential systemic responses to space. Unbiased systems biology analysis of transcriptomic data from seven different rodent datasets reveals for the first time the existence of potential "master regulators" coordinating a systemic response to microgravity and/or space radiation with TGF-beta 1 being the most common regulator. We hypothesized the space environment leads to the release of biomolecules circulating inside the blood stream. Through datamining we identified 13 candidate microRNAs (miRNA) which are common in all studies and directly interact with TGF-beta 1 that can be potential circulating factors impacting space biology. This study exemplifies the utility of the GeneLab data repository to aid in the process of performing novel hypothesis-based research.	[Beheshti, Afshin; Fogle, Homer] NASA, Ames Res Ctr, WYLE, Moffett Field, CA 94035 USA; [Ray, Shayoni; Berrios, Daniel] NASA, Ames Res Ctr, USRA, Moffett Field, CA 94035 USA; [Costes, Sylvian V.] NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Beheshti, A (corresponding author), NASA, Ames Res Ctr, WYLE, Moffett Field, CA 94035 USA.; Costes, SV (corresponding author), NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA.	afshin.beheshti@nasa.gov; sylvain.v.costes@nasa.gov	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014; Costes, Sylvain/D-2522-2013	Beheshti, Afshin/0000-0003-4643-531X; Costes, Sylvain/0000-0002-8542-2389	GeneLab Project at NASA Ames Research Center, through NASA's Space Biology Program in the Division of Space Life and Physical Sciences Research and Applications (SLPSRA)	GeneLab Project at NASA Ames Research Center, through NASA's Space Biology Program in the Division of Space Life and Physical Sciences Research and Applications (SLPSRA)	Research funding was provided by the GeneLab Project at NASA Ames Research Center, through NASA's Space Biology Program in the Division of Space Life and Physical Sciences Research and Applications (SLPSRA). Any use of trade names is for descriptive purposes only and does not imply endorsement by the US Government.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Barcellos-Hoff MH, 2015, LIFE SCI SPACE RES, V6, P92, DOI 10.1016/j.lssr.2015.07.006; Barcellos-Hoff MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005474; Beheshti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22613-1; Beheshti A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170521; Beheshti A, 2015, ONCOTARGET, V6, P35419, DOI 10.18632/oncotarget.6214; Beheshti A, 2015, CANCER RES, V75, P1134, DOI 10.1158/0008-5472.CAN-14-1053; Blaber EA, 2015, STEM CELLS DEV, V24, P2605, DOI 10.1089/scd.2015.0218; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Chen YJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.80; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Elston Rebecca, 2012, J Signal Transduct, V2012, P294097, DOI 10.1155/2012/294097; Gambara G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169314; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; Jasinski-Bergner S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju257; Jessup JM, 2000, IN VITRO CELL DEV-AN, V36, P367; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kim MR, 2015, MOL CANCER RES, V13, P319, DOI 10.1158/1541-7786.MCR-14-0098-T; Komatsu S, 2014, BRIT J CANCER, V111, P1614, DOI 10.1038/bjc.2014.451; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; McCarville JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068961; McGirt LY, 2014, J INVEST DERMATOL, V134, P1101, DOI 10.1038/jid.2013.461; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Moreno-Villanueva M, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0019-7; Moyer EL, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.2; Navarro F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132767; Nguyen DH, 2011, CANCER CELL, V19, P640, DOI 10.1016/j.ccr.2011.03.011; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Ravi D, 2016, CANCER RES, V76, P3319, DOI 10.1158/0008-5472.CAN-15-2477; Ray S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003319; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang J, 2014, STEM CELLS, V32, P649, DOI 10.1002/stem.1533; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wage J, 2015, J RADIAT RES, V56, P792, DOI 10.1093/jrr/rrv043; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0; WESTERLIND KC, 1995, J BONE MINER RES, V10, P843; Worthington JJ, 2012, IMMUNOBIOLOGY, V217, P1259, DOI 10.1016/j.imbio.2012.06.009	56	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199621	10.1371/journal.pone.0199621	http://dx.doi.org/10.1371/journal.pone.0199621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044882	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500014
J	Francois, M; Clais, B; Blanchon, T; Souty, C; Hanslik, T; Rossignol, L				Francois, Mathilde; Clais, Barbara; Blanchon, Thierry; Souty, Cecile; Hanslik, Thomas; Rossignol, Louise			Factors associated with the duration of symptoms in adult women with suspected cystitis in primary care	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ACUTE UNCOMPLICATED CYSTITIS; RANDOMIZED CONTROLLED-TRIALS; CROSS-SECTIONAL SURVEY; ANTIMICROBIAL RESISTANCE; CLINICAL-ASPECTS; GENERAL-PRACTICE; EMPIRIC THERAPY; PLACEBO; EPIDEMIOLOGY	Objective The aim of this study was to identify factors associated to the duration of symptoms of cystitis. Patients and methods We conducted a nested survival study using Druti study data. Druti was a cross-sectional survey conducted in adult women visiting a general practitioner in France, for a suspected urinary tract infection between January 2012 and February 2013. For this study, urine cultures were systematically performed for all women. The evolution of symptoms were monitored daily for two weeks. This nested study considered only women with suspected cystitis from Druti; women with pyelonephritis were excluded. To identify independent predictors for duration of symptoms, a Cox proportional hazards regression model was performed. Results In Druti, 449 patients had a suspected cystitis. Among them, 440 had a follow up at two weeks. Out of the 440 patients, 424 had a prescription of antibiotic treatment (96.4%). The urine culture was positive for 326 patients (74.1%). The median duration of symptoms after consultation was two days (interquartile 1-3). The absence of urinary frequency (median two days versus three days, p = 0.008), age over 55 years (median two days versus three days, p<0.001) and patient's bet about the presence of a urinary tract infection (median two days, p = 0.021) were associated to a longer duration of symptoms. Positive culture (p = 0.99) and presence of a multi-drug resistant organism (p = 0.38) did not influence the duration of symptoms. Conclusion In a real-life study, factors influencing the duration of symptoms are clinical factors. The delay before re-evaluation in case of persistent symptoms after treatment could be adapted according to the initial clinical examination.	[Francois, Mathilde; Hanslik, Thomas] Univ Versailles St Quentin En Yvelines, Versailles, France; [Francois, Mathilde] Univ Paris Saclay, Hop Paul Brousse, Ctr Rech Epidemiol & Sante Populat, INSERM,UMR1018, Villejuif, France; [Clais, Barbara] Univ Paris 05, Dept Med Gen, Paris, France; [Blanchon, Thierry; Souty, Cecile; Rossignol, Louise] Sorbonne Univ, IPLESP, INSERM, UMRS 1136, Paris, France; [Hanslik, Thomas] Hop Univ Ambroise Pare, AP HP, Boulogne, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Francois, M (corresponding author), Univ Versailles St Quentin En Yvelines, Versailles, France.; Francois, M (corresponding author), Univ Paris Saclay, Hop Paul Brousse, Ctr Rech Epidemiol & Sante Populat, INSERM,UMR1018, Villejuif, France.	dr.francois.m@gmail.com	BLANCHON, Thierry/AAK-6254-2020	FRANCOIS, Mathilde/0000-0001-8117-7016	Health General Direction of France (DGS); Corporate Foundation GPM; French Urology Association	Health General Direction of France (DGS); Corporate Foundation GPM; French Urology Association	This work was supported by the Health General Direction of France (DGS); the Corporate Foundation GPM; and the French Urology Association during the study period. The funders had no role in the study design, data collection, analyses, decision to publish or preparation of the manuscript.	Abrahamian FM, 2011, INFECTION, V39, P507, DOI 10.1007/s15010-011-0163-z; Afssaps, 2008, DIAGN ANT INF UR BAC; Baerheim A, 1999, SCAND J PRIM HEALTH, V17, P170, DOI 10.1080/028134399750002593; Baerheim Anders, 2003, MedGenMed, V5, P1; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Boelle P-Y, 1999, SANG THROMB VAISS, V11, P45; Bollestad M, 2015, SCAND J PRIM HEALTH, V33, P57, DOI 10.3109/02813432.2015.1041827; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Colgan R, 2011, AM FAM PHYSICIAN, V84, P771; Falagas ME, 2010, J ANTIMICROB CHEMOTH, V65, P1862, DOI 10.1093/jac/dkq237; Falagas ME, 2009, J INFECTION, V58, P91, DOI 10.1016/j.jinf.2008.12.009; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Francois M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1620-2; Grabe M, 2015, EUROPEAN ASS UROLOGY; Greendale GA, 1999, LANCET, V353, P571, DOI 10.1016/S0140-6736(98)05352-5; Guay DRP, 2008, DRUGS, V68, P1169, DOI 10.2165/00003495-200868090-00002; HARDING GKM, 1994, INT J ANTIMICROB AG, V4, P83, DOI 10.1016/0924-8579(94)90038-8; Heytens S, 2011, J WOMENS HEALTH, V20, P1117, DOI 10.1089/jwh.2010.2302; Holm A, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0629-5; Hooton TM, 2012, JAMA-J AM MED ASSOC, V307, P583, DOI 10.1001/jama.2012.80; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Keating Karen N, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P457, DOI 10.1586/14737167.5.4.457; Kinouani S, 2017, MED MALADIES INFECT, V47, P401, DOI 10.1016/j.medmal.2017.05.003; Knottnerus BJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-71; Lane DR, 2011, EMERG MED CLIN N AM, V29, P539, DOI 10.1016/j.emc.2011.04.001; Leydon GM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c279; Leydon GM, 2009, BRIT J GEN PRACT, V59, P490, DOI 10.3399/bjgp09X453459; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Little P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5633; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McNulty CAM, 2006, J ANTIMICROB CHEMOTH, V58, P1000, DOI 10.1093/jac/dkl368; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Medina-Bombardo D, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-111; Moulin B, 2012, NEPHROLOGIE; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Neuzillet Y, 2012, MED MALADIES INFECT, V42, P66, DOI 10.1016/j.medmal.2011.07.005; Nicolle LE, 2003, INT J ANTIMICROB AG, V22, P1, DOI 10.1016/S0924-8579(03)00101-8; Raz R, 2002, CLIN INFECT DIS, V34, P1165, DOI 10.1086/339812; Rossignol L, 2017, INFECTION, V45, P33, DOI 10.1007/s15010-016-0910-2; Rossignol L, 2015, J INFECTION, V71, P302, DOI 10.1016/j.jinf.2015.05.012; Samson E, 2008, IDENTIFICATION MARQU; Savonitto S, 2016, AM J MED, V129, P1205, DOI 10.1016/j.amjmed.2016.05.031; Societe de Pathologie Infectieuse de Langue Francaise, 2014, DIAGN ANT INF URIN B; Societe Francaise de Microbiologie, 2010, REM REF MICR MED 201; STAMM WE, 1991, REV INFECT DIS, V13, P77; Team RC, 2012, R LANG ENV STAT COMP; Timsit JF, 2005, REV MAL RESPIR, V22, P1058, DOI 10.1016/S0761-8425(05)85739-0	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201057	10.1371/journal.pone.0201057	http://dx.doi.org/10.1371/journal.pone.0201057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044831	gold, Green Published, Green Submitted			2022-12-26	WOS:000439942500076
J	Mazar, J; Li, YJ; Rosado, A; Phelan, P; Kedarinath, K; Parks, GD; Alexander, KA; Westmoreland, TJ				Mazar, Joseph; Li, Yujia; Rosado, Amy; Phelan, Peter; Kedarinath, Kritika; Parks, Griffith D.; Alexander, Kenneth A.; Westmoreland, Tamarah J.			Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24	PLOS ONE			English	Article							RISK GROUP; INFECTION; SYSTEM; CANCER; ACTIVATION; HEPATITIS; CARCINOMA	Neuroblastoma is the second most common childhood tumor. Survival is poor even with intensive therapy. In a search for therapies to neuroblastoma, we assessed the oncolytic potential of Zika virus. Zika virus is an emerging mosquito-borne pathogen unique among flaviviruses because of its association with congenital defects. Recent studies have shown that neuronal progenitor cells are likely the human target of Zika virus. Neuroblastoma has been shown to be responsive to infection. In this study, we show that neuroblastoma cells are widely permissive to Zika infection, revealing extensive cytopathic effects (CPE) and producing high titers of virus. However, a single cell line appeared poorly responsive to infection, producing undetectable levels of non-structural protein 1 (NS1), limited CPE, and low virus titers. A comparison of these poorly permissive cells to highly permissive neuroblastoma cells revealed a dramatic loss in the expression of the cell surface glycoprotein CD24 in poorly permissive cells. Complementation of CD24 expression in these cells led to the production of detectable levels of NS1 expression after infection with Zika, as well as dramatic increases in viral titers and CPE. Complementary studies using the Zika virus index strain and a north African isolate confirmed these phenotypes. These results suggest a possible role for CD24 in host cell specificity by Zika virus and offer a potential therapeutic target for its treatment. In addition, Zika viral therapy can serve as an adjunctive treatment for neuroblastoma by targeting tumor cells that can lead to recurrent disease and treatment failure.	[Mazar, Joseph; Rosado, Amy; Phelan, Peter; Alexander, Kenneth A.; Westmoreland, Tamarah J.] Nemours Childrens Hosp, Dept Biomed Res, Orlando, FL 32827 USA; [Li, Yujia; Kedarinath, Kritika; Parks, Griffith D.; Alexander, Kenneth A.; Westmoreland, Tamarah J.] Univ Cent Florida, Coll Med, Burnett Sch Biol Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Mazar, J; Westmoreland, TJ (corresponding author), Nemours Childrens Hosp, Dept Biomed Res, Orlando, FL 32827 USA.; Westmoreland, TJ (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biol Sci, Orlando, FL 32816 USA.	jm0151@nemours.org; tamarah.westmoreland@nemours.org	Mazar, Joseph/AAQ-8199-2020	Mazar, Joseph/0000-0002-3713-4251	Nemours Foundation; Nemours Children's Hospital; Florida High Tech Corridor	Nemours Foundation; Nemours Children's Hospital; Florida High Tech Corridor	The Nemours Foundation and Nemours Children's Hospital along with the regional economic development initiative of the Florida High Tech Corridor supported all funding for these studies. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ONCOTARGET, V8, P6589; [Anonymous], 2017, ONCOTARGET, V8, P6589; Aref S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100294; Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT TEST T; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; GEORGIADES JERZY, 1959, BIUL INST MED MORSKIEJ W GDANSKU, V10, P49; Gilliam DT, 2017, NEUROBIOL DIS, V99, P133, DOI 10.1016/j.nbd.2016.12.011; Hadac EM, 2004, VIROLOGY, V329, P217, DOI 10.1016/j.virol.2004.08.036; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; HOSTER HA, 1949, CANCER RES, V9, P473; HOUGH MR, 1994, GENOMICS, V22, P154, DOI 10.1006/geno.1994.1356; Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026; Institute NC, 2017, NEUR TREATM PDQ PAT; Kaid C, 2018, CANC RES; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lacroix J, 2010, INT J CANCER, V127, P1230, DOI 10.1002/ijc.25168; Latchman DS, 2005, CURR OPIN MOL THER, V7, P415; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li DL, 2009, HEPATOLOGY, V50, P735, DOI 10.1002/hep.23047; Li Y, 2013, J CANCER RES CLIN, V139, P933, DOI 10.1007/s00432-013-1406-4; Lim SC, 2005, BIOMED PHARMACOTHER, V59, pS351, DOI 10.1016/S0753-3322(05)80076-9; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mazar J, 2017, ONCOTARGET, V8, P6589, DOI 10.18632/oncotarget.14244; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Papaioannou Georgia, 2005, Cancer Imaging, V5, P116, DOI 10.1102/1470-7330.2005.0104; Poncet C, 1996, ACTA NEUROPATHOL, V91, P400, DOI 10.1007/s004010050442; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8; Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; SMITH RR, 1956, CANCER, V9, P1211, DOI 10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7; SOUTHAM CM, 1952, CANCER, V5, P1025, DOI 10.1002/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; TAYLOR AW, 1953, BRIT MED J, V1, P589, DOI 10.1136/bmj.1.4810.589; Toyoda H, 2011, INT J ONCOL, V38, P81, DOI 10.3892/ijo_00000826; Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784; Zhang SC, 2012, CANCER LETT, V325, P227, DOI 10.1016/j.canlet.2012.07.008; Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093	53	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200358	10.1371/journal.pone.0200358	http://dx.doi.org/10.1371/journal.pone.0200358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044847	Green Published, Green Submitted, gold			2022-12-26	WOS:000439942500047
J	Unterberger, C; Brunner, L; Nabernegg, S; Steininger, KW; Steiner, AK; Stabentheiner, E; Monschein, S; Truhetz, H				Unterberger, Christian; Brunner, Lukas; Nabernegg, Stefan; Steininger, Karl W.; Steiner, Andrea K.; Stabentheiner, Edith; Monschein, Stephan; Truhetz, Heimo			Spring frost risk for regional apple production under a warmer climate	PLOS ONE			English	Article							HEMISPHERE ATMOSPHERIC BLOCKING; FRUIT-TREES; PHENOLOGICAL MODELS; DAMAGE; PROTECTION; TEMPERATURE; FUTURE	Spring frosts, as experienced in Europe in April 2016 and 2017, pose a considerable risk to agricultural production, with the potential to cause significant damages to agricultural yields. Meteorological blocking events (stable high-pressure systems) have been shown to be one of the factors that trigger cold spells in spring. While current knowledge does not allow for drawing conclusions as to any change in future frequency and duration of blocking episodes due to climate change, the combination of their stable occurrence with the biological system under a warming trend can lead to economic damage increases. To evaluate future frost risk for apple producers in south-eastern Styria, we combine a phenological sequential model with highly resolved climate projections for Austria. Our model projects a mean advance of blooming of -1.6 +/- 0.9 days per decade, shifting the bloom onset towards early April by the end of the 21st century. Our findings indicate that overall frost risk for apple cultures will remain in a warmer climate and potentially even increase due to a stronger connection between blocking and cold spells in early spring that can be identified from observational data. To prospectively deal with frost risk, measures are needed that either stabilize crop yields or ensure farmers' income by other means. We identify appropriate adaptation measures and relate their costs to the potential frost risk increase. Even if applied successfully, the costs of these measures in combination with future residual damages represent additional climate change related costs.	[Unterberger, Christian; Brunner, Lukas; Nabernegg, Stefan; Steininger, Karl W.; Steiner, Andrea K.; Truhetz, Heimo] Karl Franzens Univ Graz, Wegener Ctr Climate & Global Change, Graz, Austria; [Unterberger, Christian; Brunner, Lukas; Nabernegg, Stefan] Karl Franzens Univ Graz, FWF DK Climate Change, Graz, Austria; [Unterberger, Christian] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Brunner, Lukas] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Nabernegg, Stefan; Steininger, Karl W.] Karl Franzens Univ Graz, Dept Econ, Graz, Austria; [Steiner, Andrea K.] Karl Franzens Univ Graz, Inst Geophys Astrophys & Meteorol, Inst Phys, Graz, Austria; [Stabentheiner, Edith; Monschein, Stephan] Karl Franzens Univ Graz, Inst Biol, Graz, Austria	University of Graz; University of Graz; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Graz; University of Graz; University of Graz	Unterberger, C (corresponding author), Karl Franzens Univ Graz, Wegener Ctr Climate & Global Change, Graz, Austria.; Unterberger, C (corresponding author), Karl Franzens Univ Graz, FWF DK Climate Change, Graz, Austria.; Unterberger, C (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland.	christian.unterberger@uni-graz.at	Nabernegg, Stefan/AAP-9248-2020; Steininger, Karl/O-6971-2016; Steiner, Andrea K/F-7980-2017; Brunner, Lukas/AAP-7583-2020	Nabernegg, Stefan/0000-0003-3785-2103; Steininger, Karl/0000-0003-3850-9315; Steiner, Andrea K/0000-0003-1201-3303; Brunner, Lukas/0000-0001-5760-4524; Unterberger, Christian/0000-0001-8367-231X	Austrian Science Fund (FWF) [W 1256-G15]; Marietta Blau Grant by the Austrian Exchange Service (OeAD); Austrian Federal Ministry of Science, Research and Economy (BMWFW)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Marietta Blau Grant by the Austrian Exchange Service (OeAD); Austrian Federal Ministry of Science, Research and Economy (BMWFW)	Christian Unterberger, Lukas Brunner and Stefan Nabernegg are students in the Doctoral Programme Climate Change at the University of Graz. This programme is funded by the Austrian Science Fund (FWF) under research grant W 1256-G15 (Doctoral Programme Climate Change - Uncertainties, Thresholds and Coping Strategies). Additionally, Lukas Brunner was financially supported by a Marietta Blau Grant by the Austrian Exchange Service (OeAD), financed by funds from the Austrian Federal Ministry of Science, Research and Economy (BMWFW).	Aerts JCJH, 2011, GLOBAL ENVIRON CHANG, V21, P1045, DOI 10.1016/j.gloenvcha.2011.04.005; AGRI4CAST, 2017, JRC MARS B CROP MON, P25; #AGRI4CAST, 2016, JRC MARS B, P24; Anconelli S, 2002, PHYS CHEM EARTH, V27, P1103, DOI 10.1016/S1474-7065(02)00146-8; [Anonymous], 2017, OSTERREICHISCHE HAGE; [Anonymous], 2017, OBST PARTNER STEIERM; [Anonymous], 2017, PEP725 PAN EUR PHEN; [Anonymous], 2016, OSTERREICHISCHE HAGE; Austrian Ministry for Sustainability and Tourism, 2017, GRUN BER 2017 BER SI; Bieli M, 2015, Q J ROY METEOR SOC, V141, P98, DOI 10.1002/qj.2339; Brunner L, 2017, J CLIMATE, V30, P585, DOI 10.1175/JCLI-D-16-0518.1; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Cattiaux J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044613; Charrier G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00259; Chimani B, 2015, PROJEKTENDBERICHT; Chmielewski FM, 2011, METEOROL Z, V20, P487, DOI 10.1127/0941-2948/2011/0258; Chuine I, 2016, GLOBAL CHANGE BIOL, V22, P3444, DOI 10.1111/gcb.13383; Clements CB, 2003, J APPL METEOROL, V42, P752, DOI 10.1175/1520-0450(2003)042<0752:CSAEIA>2.0.CO;2; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Croci-Maspoli M, 2007, J CLIMATE, V20, P633, DOI 10.1175/JCLI4029.1; D'Andrea F, 1998, CLIM DYNAM, V14, P385, DOI 10.1007/s003820050230; Dantec CF, 2015, J ECOL, V103, P1044, DOI 10.1111/1365-2745.12403; Davini P, 2016, J CLIMATE, V29, P8823, DOI 10.1175/JCLI-D-16-0242.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; European Commission, 2018, APPL DASHB AGR MARK; Francis J, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0170; Francis JA, 2017, B AM METEOROL SOC, V98, P2551, DOI 10.1175/BAMS-D-17-0006.1; Frei C, 2014, INT J CLIMATOL, V34, P1585, DOI 10.1002/joc.3786; Fu YSH, 2015, NATURE, V526, P104, DOI 10.1038/nature15402; Giorgi F, 2008, WMO B, V53; Grossi P, 2005, HUEBNER INT SER RISK, V25, P1, DOI 10.1007/b100669; HAMER PJC, 1986, AGR FOREST METEOROL, V37, P159, DOI 10.1016/0168-1923(86)90006-7; Haslinger K, 2016, METEOROL Z, V25, P137, DOI 10.1127/metz/2015/0604; Hiebl J, 2016, THEOR APPL CLIMATOL, V124, P161, DOI 10.1007/s00704-015-1411-4; Hoffmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075033; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Kaukoranta T, 2010, AGR FOOD SCI, V19, P144, DOI 10.2137/145960610791542352; Kretschmer M, 2018, B AM METEOROL SOC, V99, P49, DOI 10.1175/BAMS-D-16-0259.1; Kroner N, 2017, CLIM DYNAM, V48, P3425, DOI 10.1007/s00382-016-3276-3; Kunz A, 2016, ACTA HORTIC, V1130, P49, DOI 10.17660/ActaHortic.2016.1130.7; Legave JM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01054; Lenz A, 2016, FUNCT ECOL, V30, P1480, DOI 10.1111/1365-2435.12623; Lenz A, 2013, NEW PHYTOL, V200, P1166, DOI 10.1111/nph.12452; Luttenberger W, 2017, AKTUELLE HINWEISE FR; Matsueda M, 2017, GEOPHYS RES LETT, V44, P5158, DOI 10.1002/2017GL073336; Mosedale JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141218; Perrot A., 1967, FROSTSCHUTZBEREGNUNG; Rex D. F., 1950, TELLUS, V2, P196, DOI [DOI 10.1111/J.2153-3490.1950.TB00331.X, 10.3402/tellusa.v2i3.8546, DOI 10.3402/TELLUSA.V2I3.8546, 10.1111/j.2153-3490.1950.tb00331.x]; Ribeiro AC, 2006, AGR FOREST METEOROL, V141, P71, DOI 10.1016/j.agrformet.2006.08.019; Rodrigo J, 2000, SCI HORTIC-AMSTERDAM, V85, P155, DOI 10.1016/S0304-4238(99)00150-8; Sgubin G, 2018, AGR FOREST METEOROL, V250, P226, DOI 10.1016/j.agrformet.2017.12.253; Sillmann J, 2011, J CLIMATE, V24, P5899, DOI 10.1175/2011JCLI4075.1; Statistik Austria, 2017, LAND FORSTW AGR FLAC; Statistik Austria, 2012, INT ANL NACH ART 201; Statistik Austria, 2017, ZUS PROD WIRTSCH LAN; Steinbauer L, 2016, KW17 FROST SCHNEE ST, P20; Switanek MB, 2017, HYDROL EARTH SYST SC, V21, P2649, DOI 10.5194/hess-21-2649-2017; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vaysse P, 1994, PROTECTION VERGERS C; VERGEINER I, 1987, METEOROL ATMOS PHYS, V36, P264, DOI 10.1007/BF01045154; Vitasse Y, 2018, AGR FOREST METEOROL, V248, P60, DOI 10.1016/j.agrformet.2017.09.005; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Ward PJ, 2011, NAT HAZARD EARTH SYS, V11, P3181, DOI 10.5194/nhess-11-3181-2011; Whan K, 2016, J CLIMATE, V29, P4361, DOI 10.1175/JCLI-D-15-0493.1; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	68	36	37	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200201	10.1371/journal.pone.0200201	http://dx.doi.org/10.1371/journal.pone.0200201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044808	Green Submitted, Green Published, gold			2022-12-26	WOS:000439942500032
J	Xie, L; Liu, AG; Peng, LY; Wang, SJ; Zhang, YP; Wang, XS				Xie, Li; Liu, Ai-Guo; Peng, Li-Yan; Wang, Su-Jie; Zhang, Yin-Ping; Wang, Xian-Song			Expression of E-prostanoid receptors in nasal polyp tissues of smoking and nonsmoking patients with chronic rhinosinusitis	PLOS ONE			English	Article							PROSTAGLANDIN E-2; CIGARETTE-SMOKE; GENE-TRANSCRIPTION; INFLAMMATION; CHINESE; CELLS; PATHOGENESIS; CLASSIFICATION; ACTIVATION; FEATURES	Background Different inflammatory reactions have been observed in the polyp tissues of nonsmokers and smokers with chronic rhinosinusitis (CRS). E-prostanoid (EP) receptors play a role in the inflammatory processes. Cigarette smoke (CS) exposure regulates EP-receptor expression levels promoting inflammatory mediator release from various inflammatory cells. In this study, we characterize the EP-receptor expression profiles in the polyps of nonsmoking and smoking CRS patients to explore the possible role of CS in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP). Methods Polyp biopsies were obtained from 28 non-smoking and 21 smoking CRSwNP patients. Histopathological characteristics were observed under a light microscope. The prostaglandin E2 (PGE2), TNF-alpha, and IL-8 contents in polyp tissues were detected using enzyme-linked immunosorbent assay. Immunostaining was used to locate EP receptors in polyps. Messenger RNA and protein expression of EP receptors were examined using quantitative real-time polymerase chain reaction and Western blot, respectively. Results More severe inflammatory reactions occurred in polyp tissues of smoking CRSwNP patients. The PGE2, TNF-alpha, and IL-8 in tissue homogenate levels were significantly higher in smoking CRSwNP patients than those in nonsmoking CRSwNP patients. Moreover, the distribution of each EP receptor subtype was similar in both groups. Compared with the EP-receptor expression in nonsmokers, messenger RNA and protein of EP2 and EP4 receptor were significantly down-expressed in smoking patients, but EP1 and EP3 receptors did not show significant differences. Conclusion CS exposure downregulates the expression levels of EP2 and EP4 receptors and stimulates the production of PGE(2) and the proinflammatory cytokine IL-8 and TNF-alpha in polyp tissues of CRS patients. The down-expressed EP2 and EP4 receptors might be associated with severe inflammatory reactions in smoking CRSwNP patients.	[Xie, Li; Liu, Ai-Guo; Peng, Li-Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China; [Wang, Su-Jie] Zhengzhou Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China; [Zhang, Yin-Ping; Wang, Xian-Song] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University; Huazhong University of Science & Technology	Wang, XS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan, Hubei, Peoples R China.	xiansongw@hust.edu.cn	peng, li/GQH-5153-2022		National Natural Science Foundation of China [81271072, 81270062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China grant number: 81271072 to AGL and grant number: 81270062 to XSW.	Ahn JC, 2016, JAMA OTOLARYNGOL, V142, P162, DOI 10.1001/jamaoto.2015.3142; Aso H, 2013, AM J RESP CELL MOL, V48, P322, DOI 10.1165/rcmb.2012-0158OC; Boulet LP, 2006, CHEST, V129, P661, DOI 10.1378/chest.129.3.661; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Dhong HJ, 2005, ACTA OTO-LARYNGOL, V125, P169, DOI 10.1080/00016480410015767; Erbek Selim S, 2008, Kulak Burun Bogaz Ihtis Derg, V18, P216; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gao T, 2016, INT FORUM ALLERGY RH, V6, P66, DOI 10.1002/alr.21631; Hadar T, 2009, INHAL TOXICOL, V21, P1119, DOI 10.3109/08958370902767070; Houser SM, 2008, LARYNGOSCOPE, V118, P1521, DOI 10.1097/MLG.0b013e31817d01b8; Hu Y, 2012, LARYNGOSCOPE, V122, P498, DOI 10.1002/lary.22507; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Hurbankova M, 2012, CENT EUR J PUBL HEAL, V20, P54, DOI 10.21101/cejph.a3689; Huvenne W, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-100; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kilty SJ, 2011, RHINOLOGY, V49, P533, DOI 10.4193/Rhino10.298; Konya V, 2013, J ALLERGY CLIN IMMUN, V131, P532, DOI 10.1016/j.jaci.2012.05.008; Krzeski A, 2011, RHINOLOGY, V49, P577, DOI [10.4193/Rhin10.038, 10.4193/Rhino.10.038]; Kule ZG, 2014, J CRANIOFAC SURG, V25, P946, DOI 10.1097/SCS.0000000000000731; Lee KI, 2014, AM J RHINOL ALLERGY, V28, P208, DOI 10.2500/ajra.2014.28.4055; Lin SK, 2007, AM J RHINOL, V21, P251, DOI 10.2500/ajr.2007.21.2958; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; LUND VJ, 1995, ANN OTO RHINOL LARYN, V104, P17, DOI 10.1177/000348949510410s02; Luschnig-Schratl P, 2011, CELL MOL LIFE SCI, V68, P3573, DOI 10.1007/s00018-011-0642-5; Machado-Carvalho L, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0100-7; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Morimoto K, 2014, J IMMUNOL, V192, P1130, DOI 10.4049/jimmunol.1300290; Mortuaire G, 2015, HISTOL HISTOPATHOL, V30, P1447, DOI [10.4670/HH-11-632, 10.14670/HH-11-632]; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Rahman I, 2002, MOL CELL BIOCHEM, V234, P239, DOI 10.1023/A:1015905010086; Sastry BVR, 1999, PHARMACOLOGY, V58, P70, DOI 10.1159/000028270; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Stefanelli P, 2012, PROSTAG OTH LIPID M, V99, P24, DOI 10.1016/j.prostaglandins.2012.04.002; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Uhliarova B, 2014, INHAL TOXICOL, V26, P419, DOI 10.3109/08958378.2014.910284; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang XS, 2006, ALLERGY, V61, P503, DOI 10.1111/j.1398-9995.2006.01043.x; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Xie L, 2015, AM J RHINOL ALLERGY, V29, P322, DOI 10.2500/ajra.2015.29.4205; Yang CM, 2009, AM J PHYSIOL-LUNG C, V297, pL892, DOI 10.1152/ajplung.00151.2009; Zaslona Z, 2014, J ALLERGY CLIN IMMUN, V133, P379, DOI 10.1016/j.jaci.2013.07.037; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200989	10.1371/journal.pone.0200989	http://dx.doi.org/10.1371/journal.pone.0200989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040868	Green Submitted, gold, Green Published			2022-12-26	WOS:000439749200020
J	Moghimi, S; Torkashvand, A; Mohammadi, M; Yaseri, M; Saunders, LJ; Lin, SC; Weinreb, RN				Moghimi, Sasan; Torkashvand, Ali; Mohammadi, Massood; Yaseri, Mehdi; Saunders, Luke J.; Lin, Shan C.; Weinreb, Robert N.			Classification of primary angle closure spectrum with hierarchical cluster analysis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LASER PERIPHERAL IRIDOPLASTY; ANTERIOR SEGMENT; QUANTITATIVE-EVALUATION; PLATEAU IRIS; IRIDOTOMY; SUBTYPES; PARAMETERS; SUSPECTS; GLAUCOMA	Purpose To classify subjects with primary angle closure into clusters based on features from anterior segment optical coherence tomography (ASOCT) imaging and to explore how these clusters correspond to disease subtypes, including primary angle closure suspect (PACS), primary angle closure glaucoma(PACG), acute primary angle closure (APAC) and fellow eyes of APAC and reveal the factors that become more predominant in each subtype of angle closure. Method A cross-sectional study of 248 eyes of 198 subjects(88 PACS eyes, 53 PACG eyes, 54 APAC eyes and 53 fellow eyes of APAC) that underwent complete examination including gonioscopy, A-scan biometry, and ASOCT. An agglomerative hierarchical clustering method was used to classify eyes based on ASOCT parameters. Results Statistical clustering analysis produced three clusters among which the anterior segment parameters were significantly different. Cluster 1(43 eyes) had the smallest anterior chamber depth(ACD) and area, as well as the greatest lens vault (p<0.001 for all). Cluster 2(113 eyes) had the thickest iris at 2000 microns(p = 0.048), and largest iris area(p<0.001), and the deepest ACD (p<0.001). Cluster 3(92 eyes) was characterized by elements of both clusters 1 and 2 and a higher iris curvature(p<0.001). There was a statistically significant difference in the distribution of clusters among subtypes of angle closure eyes(p<0.001). Although the patterns of clusters were similar in PACS and PACG eyes, with the majority of the eyes classified into cluster 2(55%, and 62%, respectively), the highest proportion of APAC and fellow eyes were assigned to clusters 1(44%) and 3 (51%), respectively. Conclusion Hierarchical cluster analysis identified three clusters with different features. Predominant anatomical components are different among subtypes of primary angle closure.	[Moghimi, Sasan; Saunders, Luke J.; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Moghimi, Sasan; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Inst, La Jolla, CA 92093 USA; [Moghimi, Sasan; Torkashvand, Ali; Mohammadi, Massood] Univ Tehran Med Sci, Tehran Univ Res Ctr, Tehran, Iran; [Yaseri, Mehdi] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Lin, Shan C.] Univ Calif San Francisco, San Francisco Med Sch, Koret Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of California System; University of California San Francisco	Weinreb, RN (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.; Weinreb, RN (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Inst, La Jolla, CA 92093 USA.	rweinreb@ucsd.ed	mohammadi, massood/ABG-2563-2020; Yaseri, Mehdi/I-1645-2018	mohammadi, massood/0000-0002-3017-6643; Weinreb, Robert/0000-0001-9553-3202; Torkashvand, Ali/0000-0001-5779-3935; Yaseri, Mehdi/0000-0002-4066-873X				Baek S, 2013, INVEST OPHTH VIS SCI, V54, P848, DOI 10.1167/iovs.12-10391; Eslami Y, 2013, CLIN EXP OPHTHALMOL, V41, P368, DOI 10.1111/j.1442-9071.2012.02871.x; Foster PJ, 2002, SEMIN OPHTHALMOL; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Guzman CP, 2013, INVEST OPHTH VIS SCI, V54, P5281, DOI 10.1167/iovs.13-12285; He M, 2006, EYE, V20, P3, DOI 10.1038/sj.eye.6701797; He MG, 2007, OPHTHALMOLOGY, V114, P494, DOI 10.1016/j.ophtha.2006.06.053; HOW AC, 2012, OPHTHALMOLOGY, V119, DOI DOI 10.1016/J.0PHTHA.2012.01.019; Kumar RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1269, DOI 10.1001/archophthalmol.2009.241; Lam DSC, 2008, OPHTHALMOLOGY, V115, P1134, DOI 10.1016/j.ophtha.2007.10.033; Lam DSC, 2002, OPHTHALMOLOGY, V109, P1591, DOI 10.1016/S0161-6420(02)01158-2; Lee S, 2014, INVEST OPHTH VIS SCI, V55; Liu L, 2011, CLIN EXP OPHTHALMOL, V39, P614, DOI 10.1111/j.1442-9071.2011.02521.x; Lowe R F, 1962, Br J Ophthalmol, V46, P641, DOI 10.1136/bjo.46.11.641; Moghimi S, 2014, EYE, V28, P337, DOI 10.1038/eye.2013.296; Moghimi S, 2016, EYE SCI, V26, P121; Moghimi S, 2016, J CURR OPHTHALMOL, V28, P170, DOI 10.1016/j.joco.2016.06.005; Moghimi S, 2016, AM J OPHTHALMOL, V166, P133, DOI 10.1016/j.ajo.2016.03.032; Moghimi S, 2014, CLIN EXP OPHTHALMOL, V42, P615, DOI 10.1111/ceo.12285; Moghimi S, 2013, AM J OPHTHALMOL, V155, P664, DOI 10.1016/j.ajo.2012.10.014; Nolan W, 2008, CURR OPIN OPHTHALMOL, V19, P115, DOI 10.1097/ICU.0b013e3282f40bba; Nonaka A, 2007, AM J OPHTHALMOL, V143, P695, DOI 10.1016/j.ajo.2006.11.018; Nongpiur M, 2016, EYE; Nongpiur ME, 2013, OPHTHALMOLOGY, V120, P2525, DOI 10.1016/j.ophtha.2013.05.028; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Ritch R, 2004, OPHTHALMOLOGY, V111, P104, DOI 10.1016/j.ophtha.2003.05.001; Shabana N, 2012, CLIN EXP OPHTHALMOL, V40, P792, DOI 10.1111/j.1442-9071.2012.02805.x; Sng CCA, 2014, OPHTHALMOLOGY, V121, P119, DOI 10.1016/j.ophtha.2013.08.004; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017; Zhang T., 1996, ACM SIGMOD RECORD	30	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199157	10.1371/journal.pone.0199157	http://dx.doi.org/10.1371/journal.pone.0199157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036362	gold, Green Published			2022-12-26	WOS:000439429200003
J	Gao, QF; Shi, YJ; Mo, D; Nie, JC; Yang, M; Rozelle, S; Sylvia, S				Gao, Qiufeng; Shi, Yaojiang; Mo, Di; Nie, Jingchun; Yang, Meredith; Rozelle, Scott; Sylvia, Sean			Medical waste management in three areas of rural China	PLOS ONE			English	Article							HEALTH-CARE WASTE; TREATMENT TECHNOLOGIES; PROVINCE; MODEL	Objective The purpose of this paper is to describe current practices of medical waste management, including its generation, investments, collection, storage, segregation, and disposal, and to explore the level of support from upper tiers of the government and health care system for medical waste management in rural China. Methods The authors draw on a dataset comprised of 209 randomly selected rural township health centers (THCs) in 21 counties in three provinces of China: Anhui, Shaanxi and Sichuan. Surveys were administered to health center administrators in sample THCs in June 2015. Results The results show that the generation rate of medical waste was about 0.18 kg/bed, 0.15 kg/ patient, or 0.13 kg/person per day on average. Such per capita levels are significant given China's large rural population. Although investments of medical waste facilities and personnel in THCs have improved, results show that compliance with national regulations is low. For example, less than half of hazardous medical waste was packed in sealed containers or containers labeled with bio-hazard markings. None of the THCs segregated correctly according to the categories required by formal Chinese regulations. Many THCs reported improper disposal methods of medical waste. Our results also indicate low levels of staff training and low rates of centralized disposal in rural THCs. Conclusions Medical waste is a serious environmental issue that is rising on the agenda of policymakers. While a large share of THCs has invested in medical waste facilities and personnel, it appears that actual compliance remains low. Using evidence of low rates of training and centralized disposal, we surmise that a lack of support from upper tiers of management is one contributing factor. Given these findings, we recommend that China's policymakers should enhance support from upper tiers and improve monitoring as well as incentives in order to improve medical waste management.	[Gao, Qiufeng; Shi, Yaojiang; Nie, Jingchun] Shaanxi Normal Univ, Ctr Expt Econ Educ, Xian, Shaanxi, Peoples R China; [Mo, Di; Yang, Meredith; Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Sylvia, Sean] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA	Shaanxi Normal University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sylvia, S (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	sean_sylvia@unc.edu	Jingchun, Nie/F-4974-2016	Jingchun, Nie/0000-0002-7006-5796	111 Project [B16031]; Fundamental Research Funds for the Central Universities [2016CBZ011]	111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the 111 Project (Grant number B16031) and the Fundamental Research Funds for the Central Universities (Grant number 2016CBZ011).	Abd El-Salam MM, 2010, J ENVIRON MANAGE, V91, P618, DOI 10.1016/j.jenvman.2009.08.012; Caniato M, 2015, J ENVIRON MANAGE, V153, P93, DOI 10.1016/j.jenvman.2015.01.039; Chartier Y., 2014, SAFE MANAGEMENT WAST; Chen Y, 2013, WASTE MANAGE RES, V31, P1237, DOI 10.1177/0734242X13507314; Chen Y, 2009, WASTE MANAGE, V29, P1996, DOI 10.1016/j.wasman.2008.11.031; China Department of State, 2003, HAZ WAST MED WAST TR; China Ministry of Health, 2003, MED WAST CAT; China Ministry of Health, 2011, MEAS ADM TOWNSH HLTH; Da Silva CE, 2005, WASTE MANAGE, V25, P600, DOI 10.1016/j.wasman.2004.03.002; Fryxell GE, 2003, ENVIRON PLANN C, V21, P445, DOI 10.1068/c0013w; Gai RY, 2010, WASTE MANAGE, V30, P246, DOI 10.1016/j.wasman.2008.08.023; Gai RY, 2009, WASTE MANAGE RES, V27, P336, DOI 10.1177/0734242X09104384; Geng Y, 2013, J MATER CYCLES WASTE, V15, P310, DOI 10.1007/s10163-013-0118-9; Han J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2003; Hipgrave D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001337; Liu HC, 2015, RENEW SUST ENERG REV, V41, P932, DOI 10.1016/j.rser.2014.08.061; Liu HC, 2014, ENVIRON EARTH SCI, V72, P4179, DOI 10.1007/s12665-014-3314-6; Lu C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060562; Malekahmadi F, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/s40201-014-0116-4; Mao ZM, 2011, WASTE MISMANAGEMENT; Miyazaki M, 2005, WASTE MANAGE, V25, P616, DOI 10.1016/j.wasman.2005.01.003; Muhlich M, 2003, J HOSP INFECT, V55, P260, DOI 10.1016/j.jhin.2003.08.017; National Bureau of Statistics of China, 2016, CHIN STAT YB 2015; National Bureau of Statistics of China, 2017, CHIN STAT YB 2016; National Health and Family Planning Commission, 2016, CHIN HLTH FAM PLANN; Nie Li, 2016, Journal of Environmental Protection, V7, P93, DOI 10.4236/jep.2016.71009; Nie Li, 2014, Journal of Environmental Protection, V5, P803; Patil AD, 2001, J ENVIRON MANAGE, V63, P211, DOI 10.1006/jema.2001.0453; Qian J, 2015, J ASIAN PUBLIC POLIC, V8, P19, DOI 10.1080/17516234.2014.1003454; Sabour MR, 2007, WASTE MANAGE, V27, P584, DOI 10.1016/j.wasman.2006.05.010; Shen CL, 2014, ANN ECON FINANC, V15, P135; Shi H, 2017, WASTE MANAGE, V59, P508, DOI 10.1016/j.wasman.2016.11.016; Shinee E, 2008, WASTE MANAGE, V28, P435, DOI 10.1016/j.wasman.2006.12.022; Stall NM, 2013, CAN J SURG, V56, P97, DOI 10.1503/cjs.015711; WHO, 2015, WATER SANITATION HYG; World Bank World Health Organization Ministry of Finance National Health and Family Planning Commission Ministry of Human Resources and Social Security, 2016, 107176 WORLD BANK WH, P202; World Health Organization (WHO), 2018, HLTH CAR WAST; Yan M, 2011, J MATER CYCLES WASTE, V13, P213, DOI 10.1007/s10163-011-0020-2; Yi HM, 2015, HEALTH AFFAIR, V34, P1391, DOI 10.1377/hlthaff.2014.1114; Zhang HJ, 2013, WASTE MANAGE RES, V31, P655, DOI 10.1177/0734242X13482161; Zhang Y, 2009, WASTE MANAGE, V29, P1376, DOI 10.1016/j.wasman.2008.10.023	41	7	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200889	10.1371/journal.pone.0200889	http://dx.doi.org/10.1371/journal.pone.0200889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028841	Green Published, Green Submitted, gold			2022-12-26	WOS:000439396900022
J	Zacher, LS; Kruse, GH; Hardy, SM				Zacher, Leah Sloan; Kruse, Gordon H.; Hardy, Sarah Mincks			Autumn distribution of Bristol Bay red king crab using fishery logbooks	PLOS ONE			English	Article							LOCAL SPATIAL AUTOCORRELATION; BERING-SEA; PARALITHODES-CAMTSCHATICUS; GRAIN-SIZE; ABUNDANCE; BEHAVIOR; INVERTEBRATES	Spatial distributions of fished species must be well characterized to avoid local depletions, identify critical habitat, and predict and mitigate interactions with other fisheries. The Bristol Bay red king crab (Paralithodes camtschaticus) fishery is one of the largest crab fisheries in Alaska. Summer crab distributions have been well documented by decades of bottom trawl surveys. However, crab movement and distribution are poorly understood outside the summer survey period, which creates several management challenges. One important component of fishery management is the existence of no-trawl zones, which are intended to protect crab from bottom trawl fisheries. However, it is difficult to evaluate the placement of no-trawl zones, because most crab bycatch occurs in trawl fisheries during winter when crab distributions are unknown. Daily fishing logs, kept by skippers in the red king crab fleet since 2005, contain detailed information on the spatial distribution of catch and effort of legal sized male crab during the autumn crab fishery. However, data contained in these hand-written logbooks have not been readily accessible. We digitized daily fishing logs from 2005 to 2016 and used spatial information on catch and effort to infer geographic distributions of legal sized male king crab during the crab fishing season. Changes in distribution were tracked across this 12-yr period and comparisons were made between warm and cold temperature regimes. In warm years (2005, 2014-2016), crab aggregated in the center of Bristol Bay, Alaska, while in cold years (2007-2013) they were closer to the Alaska Peninsula. The majority of crab were caught in no-trawl areas (63.4% on average), but variations occurred among years and with temperature regime (40.0-86.8% in no-trawl zones). As temperatures continue to shift in the Bering Sea, it will be important to continue monitoring crab distributions outside the summer survey period.	[Zacher, Leah Sloan; Hardy, Sarah Mincks] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Kruse, Gordon H.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau Ctr, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Zacher, LS (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	lmsloan@alaska.edu		Mincks, Sarah/0000-0002-3328-712X	Bering Sea Fisheries Research Foundation; National Science Foundation (NSF) Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) Integrative Graduate Education and Research Traineeship (IGERT) [DGE-0801720]; Rasmuson Fisheries Research Center Graduate Fellowship	Bering Sea Fisheries Research Foundation; National Science Foundation (NSF) Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); Rasmuson Fisheries Research Center Graduate Fellowship	Financial support for digitizing Daily Fishing Logs was provided by the Bering Sea Fisheries Research Foundation (http://www.bsfrf.org/) [to LSZ]. Support for graduate student, LSZ, was provided by the National Science Foundation (NSF) Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) Integrative Graduate Education and Research Traineeship (IGERT) (#DGE-0801720) (http://www.sfos.uaf.edu/mesas/about.php) and the Rasmuson Fisheries Research Center Graduate Fellowship (http://www.uaf.edu/cfos/research/major-research-programs/rasmuson-fisheries-resear/rfrc-fellowships/). Funding organizations did not play any role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Abbott JK, 2012, ECOL APPL, V22, P762, DOI 10.1890/11-1319.1; Ackley D, 1999, LOW WAKE FI, V16, P511; ADF& G, 2014, COMM KING TANN CRAB; ADF& G staff, 2000, 4K0055 ADF G STAFF; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2003, GEODA TM 09 USERS GU; Aydin K, 2016, STOCK ASSESSMENT FIS; Blackford MG, 1979, PIONEERING MODERN SM, V6; Boots B, 2002, ECOSCIENCE, V9, P168, DOI 10.1080/11956860.2002.11682703; Bright DB, 1967, THESIS; Bush K, 2017, STOCK ASSESSMENT FIS; Chilton E. A., 2010, BIOL MANAGEMENT EXPL, P249; Christiansen JS, 2015, DIVERS DISTRIB, V21, P1004, DOI 10.1111/ddi.12321; Cressie N., 1991, SPATIAL STAT DIGITAL, P87; DALY BJ, 2016, NOAA T MEMO AFSC, V327, P1, DOI DOI 10.7289/V5/TM-AFSC-327; Dew CB, 2008, N AM J FISH MANAGE, V28, P1618, DOI 10.1577/M07-038.1; Duffy-Anderson JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178955; ESRI, 2018, ARCGIS DESKTOP RELEA; Evans D., 2012, EVALUATION ADVERSE I, P37; Falk-Petersen J, 2011, ICES J MAR SCI, V68, P479, DOI 10.1093/icesjms/fsq192; Fina M, 2005, MAR POLICY, V29, P311, DOI 10.1016/j.marpol.2004.05.005; Fissel B., 2016, STOCK ASSESSMENT FIS; Fitch H, 2011, 1222 AL DEP FISH GAM; Garber-Yonts B.E., 2016, EC STATUS REPORT SUM; Hsu C., 1987, THESIS; Kruse GH, 2010, ICES J MAR SCI, V67, P1866, DOI 10.1093/icesjms/fsq136; Loher T, 2005, FISH OCEANOGR, V14, P292, DOI 10.1111/j.1365-2419.2005.00337.x; Loher T., 2001, THESIS; McConnaughey RA, 2000, CAN J FISH AQUAT SCI, V57, P2410, DOI 10.1139/cjfas-57-12-2410; McGonigle C, 2014, ESTUAR COAST SHELF S, V147, P123, DOI 10.1016/j.ecss.2014.05.025; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Nippes WE, 1991, 4K914 AL DEP FISH GA; NPFMC, 2013, BRIST BAY RED KING C; O'Sullivan D, 2014, GEOGRAPHIC INFORM AN; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ord JK, 2001, J REGIONAL SCI, V41, P411, DOI 10.1111/0022-4146.00224; Shirley T.C., 1990, P INT S KING TANNER, P51; Simpson R. R., 1968, Int N Pacif Fish Commn, V24, P111; Smith, 1999, NMFSAFSC104 NOAA US; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stevens BG, 2014, KING CRABS OF THE WORLD: BIOLOGY AND FISHERIES MANAGEMENT, P1; STONE RP, 1993, CAN J FISH AQUAT SCI, V50, P750, DOI 10.1139/f93-086; Sundet JH, 2000, CRUSTACEAN ISS, V12, P193; Takeshita K., 1990, P INT S KING TANN CR, P427; WIESER W, 1959, LIMNOL OCEANOGR, V4, P181, DOI 10.4319/lo.1959.4.2.0181; Yeung C, 2006, MAR ECOL PROG SER, V318, P47, DOI 10.3354/meps318047; Zheng J, 2006, PROG OCEANOGR, V68, P184, DOI 10.1016/j.pocean.2006.02.002; [No title captured]	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201190	10.1371/journal.pone.0201190	http://dx.doi.org/10.1371/journal.pone.0201190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028882	Green Submitted, Green Published, gold			2022-12-26	WOS:000439396900044
J	Hassan, BK; Cunha, DB; da Veiga, GV; Pereira, RA; Sichieri, R				Hassan, Brune Kulik; Cunha, Diana Barbosa; da Veiga, Gloria Valeria; Pereira, Rosangela Alves; Sichieri, Rosely			Changes in breakfast frequency and composition during adolescence: The Adolescent Nutritional Assessment Longitudinal Study, a cohort from Brazil	PLOS ONE			English	Article							ANTHROPOMETRIC MEASUREMENTS; SKIPPING BREAKFAST; FOOD-CONSUMPTION; NUTRIENT INTAKE; FAMILY MEAL; WEIGHT-GAIN; CHILDREN; PATTERNS; ASSOCIATION; BEHAVIORS	Objectives To estimate changes over time of breakfast frequency and foods/food groups consumed at breakfast. Methods Cohort of 809 students aged 10-16 years old from Rio de Janeiro, Brazil, enrolled in 2010, and followed for three years. Breakfast skippers were those not eating breakfast. Those with breakfast frequency of 4 or less times per week were considered irregular breakfast eaters. Changes over time of breakfast frequency and breakfast foods/food groups were analyzed by generalized estimating equations. Results At baseline, overweight/obese girls had higher prevalence of irregular breakfast than those non-overweight/obese (40% vs. 26%; p = 0.005); among boys, there was no significant difference in the prevalence of irregular breakfast according to weight status. After three years, among girls there was an increase in the risk of irregular breakfast consumption (RR = 1.29; 95% CI: 1.08; 1.54) and breakfast skipping (RR = 1.63; 95% CI: 1.12; 2.38). Also, overweight/obese boys (RR = 1.40, 95% CI: 1.03, 1.89) and non-overweight/obese girls (RR = 1.54, 95% CI: 1.17, 2.04) had higher risk of irregular breakfast in three years, compared to baseline. After three years, boys changed the consumption of foods/food groups at breakfast and presented higher risk of decreased intake of fruits (RR = 1.60, 95% CI: 1.20, 2.13), sandwiches and snacks (RR = 1.58, 95% CI: 1.12, 2.22), chips (RR = 1.43, 95% CI: 1.01, 2.13), and ham (RR = 1.52, 95% CI: 1.12, 2.07), and lower risk of cheese intake (RR = 0.73, 95% CI: 0.53, 1.00). Girls had higher risk of decreased intake of fruits (RR = 2.08, 95% CI: 1.47, 2.95), milk (RR = 1.49, 95% CI: 1.07, 2.08), chocolate powder (RR = 1.54, 95% CI: 1.11, 2.14) and ham (RR = 1.65, 95% CI: 1.16, 2.36). Conclusions Changes in breakfast patterns are different according to sex. Also, different changes in breakfast frequency according to BMI category were found. Consumption patterns of some foods/food groups have a tendency to become changed from initial to middle adolescence.	[Hassan, Brune Kulik; Cunha, Diana Barbosa; Sichieri, Rosely] State Univ Rio de Janeiro UERJ, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [da Veiga, Gloria Valeria; Pereira, Rosangela Alves] Fed Univ Rio de Janeiro UFRJ, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro	Hassan, BK (corresponding author), State Univ Rio de Janeiro UERJ, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.	bkulik@gmail.com	Pereira, Rosangela Alves/D-8830-2013	Pereira, Rosangela Alves/0000-0002-9886-9796; Hassan, Bruna/0000-0001-5484-4880	National Council for Scientific and Technological Development [47667/2011-9]; Research Support Foundation of the State of Rio de Janeiro [E-26/110.847/2009, E-26/110.626/2011, E-26/110.774/2013, E-26/200.173/2015]; Coordination for the Improvement of Higher Education Personnel [23038.007702/2011-5]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of the State of Rio de Janeiro; Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the National Council for Scientific and Technological Development (grant 47667/2011-9), the Research Support Foundation of the State of Rio de Janeiro (grants E-26/110.847/2009, E-26/110.626/2011, E-26/110.774/2013 and E-26/200.173/2015) and Coordination for the Improvement of Higher Education Personnel (grant 23038.007702/2011-5).	Affenito SG, 2005, J AM DIET ASSOC, V105, P938, DOI 10.1016/j.jada.2005.03.003; Affinita A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-44; Ahadi Z, 2015, PUBLIC HEALTH, V129, P740, DOI 10.1016/j.puhe.2015.03.019; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Albertson AM, 2007, OBESITY, V15, P2282, DOI 10.1038/oby.2007.271; Araujo MC, 2010, J AM DIET ASSOC, V110, P1170, DOI 10.1016/j.jada.2010.05.008; Berkey CS, 2003, INT J OBESITY, V27, P1258, DOI 10.1038/sj.ijo.0802402; Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410; Burgess-Champoux TL, 2009, J NUTR EDUC BEHAV, V41, P79, DOI 10.1016/j.jneb.2008.03.113; Campos Lício de Albuquerque, 2007, Rev. Bras. Saude Mater. Infant., V7, P183, DOI 10.1590/S1519-38292007000200009; Correa AS, 2016, NUTRIRE, V41, P3; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023; Dhurandhar EJ, 2016, CURR OPIN ENDOCRINOL, V23, P384, DOI 10.1097/MED.0000000000000281; Dialektakou KD, 2008, J AM DIET ASSOC, V108, P1517, DOI 10.1016/j.jada.2008.06.435; Doku D, 2013, PUBLIC HEALTH NUTR, V16, P864, DOI 10.1017/S136898001100276X; Fismen AS, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0115-y; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, P515; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V2nd, P1; Fulkerson JA, 2014, J NUTR EDUC BEHAV, V46, P2, DOI 10.1016/j.jneb.2013.07.012; Habicht J P, 1974, Bol Oficina Sanit Panam, V76, P375; Hallstrom L, 2012, PUBLIC HEALTH NUTR, V12, P1; Hawkes C, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006506, 10.1590/S1518-8787.2016050006506]; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Inchley J., 2016, HLTH BEHAV SCH AGED; Instituto Brasileiro de Geografia e Estat oA stica, 2010, PESQ ORC FAM 2008 2; Instituto Brasileiro de Geografia e Estat oA stica, 2012, PESQ NAC SAU ESC; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA - IBGE, 2010, PESQ ORC FAM BRAS 20; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Lawman HG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-604; Lazarou C, 2015, PUBLIC HEALTH NUTR, V18, P1308, DOI 10.1017/S1368980014001967; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lytle LA, 2000, AM J HEALTH PROMOT, V14, P222, DOI 10.4278/0890-1171-14.4.222; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Mattos LL, 2000, REV SAUDE PUBLICA; Merten MJ, 2009, J AM DIET ASSOC, V109, P1384, DOI 10.1016/j.jada.2009.05.008; Nakamura S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2748-z; Neumark-Sztainer D, 2000, J NUTR EDUC, V32, P329, DOI 10.1016/S0022-3182(00)70592-9; Neumark-Sztainer D, 2007, J AM DIET ASSOC, V107, P448, DOI 10.1016/j.jada.2006.12.013; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; Patterson E., 2005, GUIDELINES DATA PROC; Pedersen TP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-445; Pedersen TP, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-9; Pederson D, 1996, ANTHROPOMETRICA, P77; Philippi S. T., 2008, PIRAMIDE ALIMENTOS F, DOI [10.1016/j.jada.2009.05.008, DOI 10.1016/J.JADA.2009.05.008]; Estima CDP, 2009, APPETITE, V52, P735, DOI 10.1016/j.appet.2009.03.017; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Safiri S, 2016, INT J PEDIATR-MASSHA, V4, P1505; Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445; Sjoberg A, 2003, EUR J CLIN NUTR, V57, P1569, DOI 10.1038/sj.ejcn.1601726; Smith KJ, 2010, AM J CLIN NUTR, V92, P1316, DOI 10.3945/ajcn.2010.30101; Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005; Stang JS, 2012, KRAUSES FOOD NUTR TH, P410; Sune FR, 2007, CAD SAUDE PUBLICA, V23, P1361, DOI 10.1590/S0102-311X2007000600011; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; Timlin MT, 2007, NUTR REV, V65, P268, DOI 10.1111/j.1753-4887.2007.tb00304.x; Trancoso SC, 2010, REV NUTR, V23, P859, DOI 10.1590/S1415-52732010000500016; Utter J, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-50; Veiga G. V. da, 2013, Revista de Saude Publica, V47, p212S, DOI 10.1590/S0034-89102013000200007; Vereecken C, 2009, INT J PUBLIC HEALTH, V54, P180, DOI 10.1007/s00038-009-5409-5	60	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200587	10.1371/journal.pone.0200587	http://dx.doi.org/10.1371/journal.pone.0200587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024906	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000032
J	Pulerwitz, J; Mathur, S; Woznica, D				Pulerwitz, Julie; Mathur, Sanyukta; Woznica, Daniel			How empowered are girls/young women in their sexual relationships? Relationship power, HIV risk, and partner violence in Kenya	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; GENDER; HIV/AIDS; PREVALENCE; INFECTION; AFRICA; MEN	Background Gendered power dynamics within couple relationships can constrain women from achieving positive sexual and reproductive health outcomes. But little is known about relationship power among adolescents, and tools to measure it are rarely validated among adolescents. We tested the Sexual Relationship Power Scale (SRPS) among adolescent girls and young women (AGYW) and examined associations with select health outcomes. Methods A 16-item adaptation of the SRPS was administered to AGYW aged 15-24 in Kenya (n = 1,101). Confirmatory factor analysis (CFA) and theta coefficients assessed scale performance for three age bands: 15-17, 18-20, and 21-24 years old. Relationship power levels were examined and multivariate logistic regressions assessed the relationship between power, and partner violence and HIV risk outcomes. Results CFAs confirmed a one factor structure for each subgroup, and thetas for final 15-item scales were robust (>.82). Most respondents reported limited power in their sexual relationships, however older respondents consistently reported lower levels of power. Relationship power was strongly associated with several outcomes, even when controlling for socioeconomic status and schooling. For example, AGYW who reported more relationship power were 12, 6, and 7 times less likely (ages 21-24, 18-20, and 15-17, respectively) to experience sexual violence (p<0.001). Significant relationships were also found in multivariate analyses for physical partner violence (all three age bands), using a condom at last sex (18-20-year-olds), and increased knowledge of partner's HIV status (21-24-year-olds). Conclusions The SRPS is a good measure of relationship power for several age bands within AGYW, and power is experienced differently by older and younger AGYW. Low relationship power was a consistent predictor of partner violence, as well as an important predictor of HIV risk. Interventions seeking to address HIV and violence should also explicitly address relationship power and utilize validated tools (like the SRPS) to evaluate impacts.	[Pulerwitz, Julie; Mathur, Sanyukta] Populat Council, HIV & AIDS Program, Washington, DC 20008 USA; [Woznica, Daniel] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Population Council; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pulerwitz, J (corresponding author), Populat Council, HIV & AIDS Program, Washington, DC 20008 USA.	jpulerwitz@popcouncil.org		Mathur, Sanyukta/0000-0003-1645-6734	Bill & Melinda Gates Foundation [OPP1150068, OPP1136778]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Bill & Melinda Gates Foundation, https://www.gatesfoundation.org/, Grant Numbers OPP1150068 and OPP1136778, SM received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARO H, 1995, AM PSYCHOL, V50, P437, DOI 10.1037/0003-066X.50.6.437; [Anonymous], 2009, WOM HLTH TOD EV TOM; Black J.T, 1992, MULTIVARIATE DATA AN; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Blum Robert W, 2014, Int J Adolesc Med Health, V26, P321, DOI 10.1515/ijamh-2013-0327; Campbell ANC, 2009, J URBAN HEALTH, V86, P951, DOI 10.1007/s11524-009-9405-0; Campbell C, 2010, AIDS CARE, V22, P1569, DOI 10.1080/09540121.2010.525812; Commentary Bruce J., 2015, GLOB PUBLIC HEALTH, V10, P225, DOI [10.1080/17441692.2014.986170, DOI 10.1080/17441692.2014.986170]; Connell R., 1987, GENDER POWER SOC PER; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Haberland N, 2017, INT AIDS SOC C 2017; Haberland NA, 2015, INT PERSPECT SEX R H, V41, P31, DOI 10.1363/4103115; Hatcher AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049821; Higgins JA, 2014, AM J PUBLIC HEALTH, V104, P612, DOI 10.2105/AJPH.2013.301670; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Igras SM, 2014, GLOB PUBLIC HEALTH, V9, P555, DOI 10.1080/17441692.2014.908230; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kenya National Bureau of Statistics MoH National AIDS Control Council KEMRI NCPAD DHS Program ICF International, 2015, KENYA DEMOGRAPHIC HL; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; London School of Hygiene & Tropical Medicine, 2017, STUD PROT IMP EV PEP; Lundgren R, 2019, CULT HEALTH SEX, V21, P387, DOI 10.1080/13691058.2018.1471160; Mah TL, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-33; Martin CL, 2002, PSYCHOL BULL, V128, P903, DOI 10.1037//0033-2909.128.6.903; Mathur S, PLOS ONE; Mavedzenge SN, 2011, JAIDS-J ACQ IMM DEF, V58, P89, DOI 10.1097/QAI.0b013e3182254038; McMahon JM, 2015, ARCH SEX BEHAV, V44, P267, DOI 10.1007/s10508-014-0355-6; National AIDS and STI Control Programme (NASCOP),, 2014, KENY AIDS IND SURV 2; Population Council, 2016, DREAMS PROJ BRIEF; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; UNAIDS, 2016, PREV GAP REP; Wingood GM, 1998, AM J COMMUN PSYCHOL, V26, P29, DOI 10.1023/A:1021830023545; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	38	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199733	10.1371/journal.pone.0199733	http://dx.doi.org/10.1371/journal.pone.0199733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024908	Green Published, gold, Green Submitted			2022-12-26	WOS:000439120000010
J	Rovito, R; Warnatz, HJ; Kielbasa, SM; Mei, H; Amstislayskiy, V; Arens, R; Yaspo, ML; Lehrach, H; Kroes, ACM; Goeman, JJ; Vossen, ACTM				Rovito, Roberta; Warnatz, Hans-Joerg; Kielbasa, Szymon M.; Mei, Hailiang; Amstislayskiy, Vyacheslav; Arens, Ramon; Yaspo, Marie-Laure; Lehrach, Hans; Kroes, Aloys C. M.; Goeman, Jelle J.; Vossen, Ann C. T. M.			Impact of congenital cytomegalovirus infection on transcriptomes from archived dried blood spots in relation to long-term clinical outcome	PLOS ONE			English	Article							T-CELL RESPONSES; MESSENGER-RNA; GENE-EXPRESSION; CMV INFECTION; HEARING-LOSS; BODY-FLUIDS; IDENTIFICATION; NEWBORNS; MARKERS; LOAD	Congenital Cytomegalovirus infection (cCMV) is the leading infection in determining permanent long-term impairments (LTI), and its pathogenesis is largely unknown due to the complex interplay between viral, maternal, placental, and child factors. The cellular activity, considered to be the result of the response to exogenous and endogenous factors, is captured by the determination of gene expression profiles. In this study, we determined whole blood transcriptomes in relation to cCMV, CMV viral load and LTI development at 6 years of age by using RNA isolated from neonatal dried blood spots (DBS) stored at room temperature for 8 years. As DBS were assumed to mainly reflect the neonatal immune system, particular attention was given to the immune pathways using the global test. Additionally, differential expression of individual genes was performed using the voom/limma function packages. We demonstrated feasibility of RNA sequencing from archived neonatal DBS of children with cCMV, and non-infected controls, in relation to LTI and CMV viral load. Despite the lack of statistical power to detect individual genes differences, pathway analysis suggested the involvement of innate immune response with higher CMV viral loads, and of antiinflammatory markers in infected children that did not develop LTI. Finally, the T cell exhaustion observed in infected neonates, in particular with higher viral load, did not correlate with LTI, therefore other mechanisms are likely to be involved in the long-term immune dysfunction. Despite these data demonstrate limitation in determining prognostic markers for LTI by means of transcriptome analysis, this exploratory study represents a first step in unraveling the pathogenesis of cCMV, and the aforementioned pathways certainly merit further evaluation.	[Rovito, Roberta; Kroes, Aloys C. M.; Vossen, Ann C. T. M.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands; [Warnatz, Hans-Joerg; Amstislayskiy, Vyacheslav; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Otto Warburg Lab Gene Regulat & Syst Biol Canc, Berlin, Germany; [Kielbasa, Szymon M.; Goeman, Jelle J.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Mei, Hailiang] Leiden Univ, Med Ctr, Sequencing Anal Support Core, Leiden, Netherlands; [Arens, Ramon] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [Lehrach, Hans] Alacris Theranost GmbH, Berlin, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rovito, R (corresponding author), Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands.	R.Rovito@lumc.nl	Kiełbasa, Szymon M./K-2792-2019; Vossen, Ann/HIR-2262-2022; Goeman, Jelle/AAT-1300-2020; Arens, Ramon/V-4010-2018; Kielbasa, Szymon/G-1636-2018	Goeman, Jelle/0000-0003-4283-0259; Arens, Ramon/0000-0001-5058-4110; Rovito, Roberta/0000-0002-8640-844X; Kielbasa, Szymon/0000-0003-2805-6535; Vossen, Ann/0000-0003-1750-2843; Amstislavskiy, Vyacheslav/0000-0002-1384-7599	European Union [316655]; Alacris Theranostics GmbH; National Institute of Public Health and the Environment (RIVM)	European Union(European Commission); Alacris Theranostics GmbH; National Institute of Public Health and the Environment (RIVM)	This work was supported by European Union Seventh Framework Programme FP7/2012-2016 under grant agreement number 316655 (VACTRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HL is a founder and the chairman of Alacris Theranostics GmbH, Berlin, Germany. Alacris Theranostics GmbH provided support in the form of salary for author HL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; The CROCUS study was initiated and supported by the National Institute of Public Health and the Environment (RIVM), we thank Marjolein Korndewal for the use of the CROCUS study clinical data. We thank Daniela Balzereit, Simon Dokel, Alexander Kovacsovics and Matthias Linser (Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer, Max Planck Institute for Molecular Genetics, Berlin, Germany) for sequencing library preparation and Illumina HiSeq sequencing.	Alvarez M, 2004, ANAL BIOCHEM, V335, P289, DOI 10.1016/j.ab.2004.09.002; Bauer M, 1999, J FORENSIC SCI, V44, P1232; Binda S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-24; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Bybjerg-Grauholm J, 2017, MOL GENET METAB REP, V10, P33, DOI 10.1016/j.ymgmr.2016.12.004; Cannon MJ, 2014, REV MED VIROL, V24, P291, DOI 10.1002/rmv.1790; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; de Vries JJC, 2012, METHODS MOL BIOL, V903, P169, DOI 10.1007/978-1-61779-937-2_10; de Vries JJC, 2009, J CLIN VIROL, V46, pS37, DOI 10.1016/j.jcv.2009.09.001; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005; Fabbri E, 2011, BJOG-INT J OBSTET GY, V118, P448, DOI 10.1111/j.1471-0528.2010.02822.x; Forner G, 2015, J INFECT DIS, V212, P67, DOI 10.1093/infdis/jiu627; Furlan R, 2000, J NEUROIMMUNOL, V111, P86, DOI 10.1016/S0165-5728(00)00377-5; Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x; Gabrielli L, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-63; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Guerra B, 2000, AM J OBSTET GYNECOL, V183, P476, DOI 10.1067/mob.2000.106347; Haak PT, 2009, NEONATOLOGY, V95, P210, DOI 10.1159/000155652; Halwachs-Baumann G, 2002, J CLIN VIROL, V25, pS81; Hassan J, 2007, CLIN EXP IMMUNOL, V147, P465, DOI 10.1111/j.1365-2249.2007.03302.x; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Huygens A, 2015, J INFECT DIS; Iyer A, 2013, ACTA PAEDIATR, V102, pe2, DOI 10.1111/apa.12044; Jelle J., 2006, J R STAT SOC B, V68, P477; Juusola J, 2005, FORENSIC SCI INT, V152, P1, DOI 10.1016/j.forsciint.2005.02.020; Juusola J, 2003, FORENSIC SCI INT, V135, P85, DOI 10.1016/S0379-0738(03)00197-X; Kalpoe JS, 2004, J CLIN MICROBIOL, V42, P1498, DOI 10.1128/JCM.42.4.1498-1504.2004; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Khoo SK, 2011, PATHOL INT, V61, P1, DOI 10.1111/j.1440-1827.2010.02611.x; Korndewal MJ, 2017, DEV MED CHILD NEUROL, V59, P1261, DOI 10.1111/dmcn.13556; Korndewal MJ, 2015, EPIDEMIOL INFECT, P1; Lanari M, 2006, PEDIATRICS, V117, pE76, DOI 10.1542/peds.2005-0629; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Lewis DB, 2011, DEV IMMUNOLOGY ROLE, P80; Lidehall AK, 2013, SCAND J IMMUNOL, V77, P135, DOI 10.1111/sji.12013; Lilleri D, 2007, J INFECT DIS, V195, P1062, DOI 10.1086/512245; Liu ZJ, 2007, J MED VIROL, V79, P1500, DOI 10.1002/jmv.20927; Maeno Y, 2003, ACTA TROP, V87, P295, DOI 10.1016/S0001-706X(03)00096-2; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; McDade TW, 2016, BIODEMOGR SOC BIOL, V62, P182, DOI 10.1080/19485565.2016.1185600; Neto EC, 2004, EMERG INFECT DIS, V10, P1069, DOI 10.3201/eid1006.030830; Ho NT, 2013, PEDIATR RES, V73, P450, DOI 10.1038/pr.2012.200; Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752; Numazaki Kei, 2002, Congenital Anomalies, V42, P181, DOI 10.1111/j.1741-4520.2002.tb00891.x; Park KW, 2005, J NEUROSCI RES, V81, P397, DOI 10.1002/jnr.20483; Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015; PASS RF, 1983, J INFECT DIS, V148, P953, DOI 10.1093/infdis/148.6.953; Redeker A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01953; Redeker A, 2014, EUR J IMMUNOL, V44, P1046, DOI 10.1002/eji.201343946; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross SA, 2009, PEDIATR INFECT DIS J, V28, P588, DOI 10.1097/INF.0b013e3181979a27; Rovito R, 2017, CLIN CHIM ACTA, V473, P191, DOI 10.1016/j.cca.2017.08.029; Rovito R, 2017, J IMMUNOL, V198, P102, DOI 10.4049/jimmunol.1601182; Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801; van Hoof A, 2002, CURR BIOL, V12, pR285, DOI 10.1016/S0960-9822(02)00802-3; Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348; Visser M, 2011, INT J LEGAL MED, V125, P253, DOI 10.1007/s00414-010-0545-2; Wang L, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0281-9; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wunsch M, 2015, VIRUSES-BASEL, V7, P4414, DOI 10.3390/v7082828; Zanghellini F, 1999, J INFECT DIS, V180, P702, DOI 10.1086/314939; Zubakov D, 2008, INT J LEGAL MED, V122, P135, DOI 10.1007/s00414-007-0182-6; Zubakov D, 2009, INT J LEGAL MED, V123, P71, DOI 10.1007/s00414-008-0249-z	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200652	10.1371/journal.pone.0200652	http://dx.doi.org/10.1371/journal.pone.0200652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024899	Green Published, gold			2022-12-26	WOS:000439120000037
J	Stendardo, M; Casillo, V; Schito, M; Ballerin, L; Stomeo, F; Vitali, E; Nardini, M; Maietti, E; Boschetto, P				Stendardo, Mariarita; Casillo, Valeria; Schito, Michela; Ballerin, Licia; Stomeo, Francesco; Vitali, Emanuela; Nardini, Marco; Maietti, Elisa; Boschetto, Piera			Forced expiratory volume in one second: A novel predictor of work disability in subjects with suspected obstructive sleep apnea	PLOS ONE			English	Article							LUNG-FUNCTION; EPWORTH SLEEPINESS; MANAGEMENT; ABILITY; OBESITY; SCALE; MULTIMORBIDITY; ASSOCIATION; ABSENTEEISM; POPULATION	Whether the association of work disability with obstructive sleep apnea (OSA) is mainly due to the disease, i.e. the number and frequency of apneas-hypoapneas, or to coexisting factors independent from the disease, is not well-established. In this study, we aim to evaluate work ability in a group of subjects undergoing OSA workup and to identify the major contributors of impaired work ability. In a cross-sectional study, we enrolled 146 consecutive subjects who have been working for the last five years and referred to the sleep disorders outpatients' clinic of the University-Hospital of Ferrara, Italy, with suspected OSA. After completing an interview in which the Work Ability Index (WAI) and the Epworth Sleepiness Scale (ESS) questionnaires were administered to assess work ability and excessive daytime sleepiness, respectively, subjects underwent overnight polysomnography for OSA diagnosing and spirometry. Of the 146 subjects, 140 (96%) completed the tests and questionnaires and, of these, 66 exhibited work disability (WAI < 37). OSA was diagnosed (apnea-hypopnea index >= 5) in 45 (68%) of the 66 subjects. After controlling for confounders, a lower level of forced expiratory volume at 1 second (FEV1), [odds ratio 0.97 (95% CI 0.95-1.00)], older age [1.09 (95% CI 1.03-1.15)], excessive daytime sleepiness [3.16 (95% CI 1.20-8.34)] and a worse quality of life [0.96 (95% CI 0.94-1.00)], but not OSA [1.04 (95% CI 0.41-2.62)], were associated with work disability. Patients with a higher number of diseases, in which OSA was not included, and a lower quality of life had an increased probability of absenteeism in the previous 12 months. In subjects with suspected OSA, FEV i can be an important predictor of work disability.	[Stendardo, Mariarita; Casillo, Valeria; Schito, Michela; Vitali, Emanuela; Boschetto, Piera] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Ballerin, Licia] Univ Hosp Ferrara, Resp Unit, Ferrara, Italy; [Stomeo, Francesco] Univ Hosp Ferrara, Ear Nose & Throat & Audiol Dept, Ferrara, Italy; [Nardini, Marco] Univ Hosp & Publ Hlth Serv Ferrara, Dept Prevent & Protect, Ferrara, Italy; [Maietti, Elisa] Univ Hosp Ferrara, Ctr Clin & Epidemiol Res, Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna	Boschetto, P (corresponding author), Univ Ferrara, Dept Med Sci, Ferrara, Italy.	bsp@unife.it	Boschetto, Piera/AAM-3247-2020; VARRECCHIA, TIWANA/AAJ-8712-2021	Boschetto, Piera/0000-0003-3889-1681; 				Accattoli M P, 2008, G Ital Med Lav Ergon, V30, P297; Alavinia SM, 2009, OCCUP MED-OXFORD, V59, P32, DOI 10.1093/occmed/kqn148; AlGhanim N, 2008, LUNG, V186, P7, DOI 10.1007/s00408-007-9055-5; Allen AJMH, 2015, CHEST, V147, P1422, DOI 10.1378/chest.14-1949; Aurora RN, 2011, SLEEP, V34, P1707, DOI 10.5665/sleep.1442; BaHammam AS, 2016, SLEEP BREATH, V20, P447, DOI 10.1007/s11325-015-1223-x; Basoglu OK, 2014, CLIN RESPIR J, V8, P167, DOI 10.1111/crj.12054; Boschetto P, 2016, INT J CARDIOL, V203, P798, DOI 10.1016/j.ijcard.2015.11.079; Casimirri E, 2014, INT J OCCUP MED ENV, V27, P343, DOI 10.2478/s13382-014-0256-x; CHARLSON ME, 1987, J CHRON DIS, V40, P31, DOI 10.1016/0021-9681(87)90094-4; Chervin RD, 2000, J SLEEP RES, V9, P399, DOI 10.1046/j.1365-2869.2000.0227a.x; Dean B, 2010, J OCCUP ENVIRON MED, V52, P144, DOI 10.1097/JOM.0b013e3181c99505; El Fassi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-305; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Ervasti J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079855; Frangolias DD, 2003, AM J RESP CRIT CARE, V167, P150, DOI 10.1164/rccm.2202053; Gupta MA, 2016, SLEEP MED REV, V28, P55, DOI 10.1016/j.smrv.2015.07.002; Habibi E, 2012, INT J PREVENTIVE MED, V3, P776; Hendriks SM, 2015, J AFFECT DISORDERS, V178, P121, DOI 10.1016/j.jad.2015.03.004; Huang TY, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02421-2017; Iversen KK, 2010, EUR J HEART FAIL, V12, P685, DOI 10.1093/eurjhf/hfq050; Jetha A, 2016, J OCCUP ENVIRON MED, V58, P485, DOI 10.1097/JOM.0000000000000702; Jonassen TM, 2018, CLIN RESPIR J, V12, P31, DOI 10.1111/crj.12472; Kendzerska T, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01361-2016; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Kunos L, 2017, LUNG, V195, P127, DOI 10.1007/s00408-016-9957-1; Masa JF, 2011, SLEEP BREATH, V15, P549, DOI 10.1007/s11325-010-0399-3; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Omachi TA, 2009, SLEEP, V32, P791, DOI 10.1093/sleep/32.6.791; Reynolds AC, 2017, SLEEP HEALTH, V3, P357, DOI 10.1016/j.sleh.2017.06.003; Robroek SJW, 2013, SCAND J WORK ENV HEA, V39, P233, DOI 10.5271/sjweh.3354; Sforza E, 2011, EUR RESPIR J, V37, P1137, DOI 10.1183/09031936.00043210; Shrestha N, 2016, CURR OBES REP, V5, P344, DOI 10.1007/s13679-016-0227-6; Sundstrup E, 2017, SCAND J WORK ENV HEA, V43, P146, DOI 10.5271/sjweh.3620; Teng AY, 2012, CLIN CHEST MED, V33, P731, DOI 10.1016/j.ccm.2012.09.003; Ubalde-Lopez M, 2016, INT ARCH OCC ENV HEA, V89, P667, DOI 10.1007/s00420-015-1104-4; van den Berg TIJ, 2009, OCCUP ENVIRON MED, V66, P211, DOI 10.1136/oem.2008.039883; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	41	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201045	10.1371/journal.pone.0201045	http://dx.doi.org/10.1371/journal.pone.0201045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024962	gold, Green Published, Green Submitted			2022-12-26	WOS:000439120000083
